PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kozor, R; Grieve, SM; Buchholz, S; Kaye, S; Darke, S; Bhindi, R; Figtree, GA				Kozor, Rebecca; Grieve, Stuart M.; Buchholz, Stefan; Kaye, Sharlene; Darke, Shane; Bhindi, Ravinay; Figtree, Gemma A.			Regular Cocaine Use Is Associated with Increased Systolic Blood Pressure, Aortic Stiffness and Left Ventricular Mass in Young Otherwise Healthy Individuals	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; MYOCARDIAL INJURY; SELF-REPORT; ABUSE; DYSFUNCTION; AUSTRALIA; SYDNEY; OBESE; MEN	Background: The cardiovascular impact of cocaine use in otherwise healthy individuals who consider themselves `social' users is not well established. Methods/Results: Twenty regular cocaine users and 20 control subjects were recruited by word-of-mouth. Cardiovascular magnetic resonance was performed to assess cardiac and vascular structure and function. Cocaine users had higher systolic blood pressure compared to non-users (134 +/- 11 vs 126 +/- 11 mmHg, p = 0.036), a finding independent of age, body surface area, smoking and alcohol consumption. Cocaine use was associated with increased arterial stiffness - reflected by reduced aortic compliance (1.3 +/- 0.2 vs 1.7 +/- 0.5 cm(2) x 10(2).mmHg(-1), p = 0.004), decreased distensibility (3.8 +/- 0.9 vs 5.1 +/- 1.4 mmHg(-1).10(-3), p = 0.001), increased stiffness index (2.6 +/- 0.6 vs 2.1 +/- 0.6, p = 0.005), and higher pulse wave velocity (5.1 +/- 0.6 vs 4.4 +/- 0.6 m.s(-1), p = 0.001). This change in aortic stiffness was independent of vessel wall thickness. Left ventricular mass was 18% higher in cocaine users (124 +/- 25 vs 105 +/- 16 g, p = 0.01), a finding that was independent of body surface area, and left atrial diameter was larger in the user group than controls (3.8 +/- 0.6 vs 3.5 +/- 0.3 cm, p = 0.04). The increased left ventricular mass, systolic blood pressure and vascular stiffness measures were all associated with duration and/or frequency of cocaine use. No late gadolinium enhancement or segmental wall motion abnormalities were seen in any of the subjects. Conclusions: Compared with the non-user control cohort, cocaine users had increased aortic stiffness and systolic blood pressure, associated with greater left ventricular mass. These measures are all well known risk factors for premature cardiovascular events, highlighting the dangers of cocaine use, even in a `social' setting, and have important public health implications.	[Kozor, Rebecca; Grieve, Stuart M.; Bhindi, Ravinay; Figtree, Gemma A.] Univ Sydney, Kolling Inst Med Res, North Shore Heart Res Grp, Sydney, NSW 2006, Australia; [Kozor, Rebecca; Buchholz, Stefan; Bhindi, Ravinay; Figtree, Gemma A.] Royal N Shore Hosp, Dept Cardiol, Sydney, NSW, Australia; [Grieve, Stuart M.] Univ Sydney, Sydney Med Sch, Sydney Translat Imaging Lab, Sydney, NSW 2006, Australia; [Kaye, Sharlene; Darke, Shane] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia	University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; University of Sydney; University of Sydney; University of New South Wales Sydney	Figtree, GA (corresponding author), Univ Sydney, Kolling Inst Med Res, North Shore Heart Res Grp, Sydney, NSW 2006, Australia.	gemma.figtree@sydney.edu.au	Kozor, Rebecca/AAG-6610-2021; Grieve, Stuart/A-5093-2012	Kaye, Sharlene/0000-0002-7657-5105; Grieve, Stuart/0000-0002-2712-157X; Kozor, Rebecca/0000-0002-6437-5018	Heart Research Australia	Heart Research Australia	Kozor received a grant from Heart Research Australia (http://www.heartresearch.com.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquaro GD, 2011, HEART, V97, P2056, DOI 10.1136/hrt.2011.226977; Australian Institute of Health and Welfare, 2010, DRUG STAT SER, V25; BERTOLET BD, 1990, CLIN CARDIOL, V13, P323, DOI 10.1002/clc.4960130505; Bigi MAB, 2008, ECHOCARDIOGR-J CARD, V25, P308, DOI 10.1111/j.1540-8175.2007.00593.x; BOEHRER JD, 1992, J AM COLL CARDIOL, V20, P90, DOI 10.1016/0735-1097(92)90142-A; BRICKNER ME, 1991, CIRCULATION, V84, P1130, DOI 10.1161/01.CIR.84.3.1130; Buchholz S, 2010, EUR HEART J, V31, P1422, DOI 10.1093/eurheartj/ehq036; CHAKKO S, 1992, J AM COLL CARDIOL, V20, P1168, DOI 10.1016/0735-1097(92)90374-V; Chan W, 2012, INTERN MED J, V42, P7, DOI 10.1111/j.1445-5994.2011.02606.x; Cuspidi C, 2009, J HUM HYPERTENS, V23, P728, DOI 10.1038/jhh.2009.16; Daniel JC, 2007, J VASC SURG, V46, P427, DOI 10.1016/j.jvs.2007.05.040; Darke S, 1998, DRUG ALCOHOL DEPEN, V51, P253, DOI 10.1016/S0376-8716(98)00028-3; Figtree GA, 2011, JACC-CARDIOVASC INTE, V4, P137, DOI 10.1016/j.jcin.2010.09.026; Hando J, 1997, ADDICTION, V92, P173, DOI 10.1111/j.1360-0443.1997.tb03650.x; Hollander JE, 2008, ANN EMERG MED, V51, pS18, DOI 10.1016/j.annemergmed.2007.11.008; Ibrahim ESH, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-26; Joly L, 2009, HYPERTENSION, V54, P421, DOI 10.1161/HYPERTENSIONAHA.109.133645; Kaye S, 2004, DRUG ALCOHOL REV, V23, P391, DOI 10.1080/09595230412331324518; Kaye S, 2004, ADDICTION, V99, P1315, DOI 10.1111/j.1360-0443.2004.00875.x; Kerns William Ii, 1997, Journal of Emergency Medicine, V15, P321, DOI 10.1016/S0736-4679(97)00003-6; Kozel NJ, 1985, NATL I DRUG ABUSE NI, V61, P136; KUGELMASS AD, 1993, CIRCULATION, V88, P876, DOI 10.1161/01.CIR.88.3.876; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Ledgerwood DM, 2008, ADDICT BEHAV, V33, P1131, DOI 10.1016/j.addbeh.2008.04.009; Maceira AM, 2006, J CARDIOVASC MAGN R, V8, P417, DOI 10.1080/10976640600572889; Maceira AM, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-65; Mani V, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-10; McCance-Katz EF, 1998, BIOL PSYCHIAT, V44, P250, DOI 10.1016/S0006-3223(97)00426-5; MOLITERNO DJ, 1994, NEW ENGL J MED, V330, P454, DOI 10.1056/NEJM199402173300702; PENG SK, 1989, ARCH PATHOL LAB MED, V113, P842; PEREZREYES M, 1992, LIFE SCI, V51, P553, DOI 10.1016/0024-3205(92)90224-D; Pradhan L, 2008, CARDIOVASC TOXICOL, V8, P161, DOI 10.1007/s12012-008-9025-z; Ren SQ, 2006, AM J CARDIOL, V97, P1085, DOI 10.1016/j.amjcard.2005.10.056; Robaei D, 2010, EUR HEART J, V31, P2446, DOI 10.1093/eurheartj/ehq229; Westenberg JJM, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-2	35	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e89710	10.1371/journal.pone.0089710	http://dx.doi.org/10.1371/journal.pone.0089710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717541	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000007
J	Pearce, W; Holmberg, K; Hellsten, I; Nerlich, B				Pearce, Warren; Holmberg, Kim; Hellsten, Iina; Nerlich, Brigitte			Climate Change on Twitter: Topics, Communities and Conversations about the 2013 IPCC Working Group 1 Report	PLOS ONE			English	Article							POLITICS; CARBON	In September 2013 the Intergovernmental Panel on Climate Change published its Working Group 1 report, the first comprehensive assessment of physical climate science in six years, constituting a critical event in the societal debate about climate change. This paper analyses the nature of this debate in one public forum: Twitter. Using statistical methods, tweets were analyzed to discover the hashtags used when people tweeted about the IPCC report, and how Twitter users formed communities around their conversational connections. In short, the paper presents the topics and tweeters at this particular moment in the climate debate. The most used hashtags related to themes of science, geographical location and social issues connected to climate change. Particularly noteworthy were tweets connected to Australian politics, US politics, geoengineering and fracking. Three communities of Twitter users were identified. Researcher coding of Twitter users showed how these varied according to geographical location and whether users were supportive, unsupportive or neutral in their tweets about the IPCC. Overall, users were most likely to converse with users holding similar views. However, qualitative analysis suggested the emergence of a community of Twitter users, predominantly based in the UK, where greater interaction between contrasting views took place. This analysis also illustrated the presence of a campaign by the non-governmental organization Avaaz, aimed at increasing media coverage of the IPCC report.	[Pearce, Warren; Nerlich, Brigitte] Univ Nottingham, Sch Sociol & Social Policy, Inst Sci & Soc, Nottingham NG7 2RD, England; [Holmberg, Kim; Hellsten, Iina] Vrije Univ Amsterdam, Dept Org Sci, Amsterdam, Netherlands	University of Nottingham; Vrije Universiteit Amsterdam	Pearce, W (corresponding author), Univ Nottingham, Sch Sociol & Social Policy, Inst Sci & Soc, Nottingham NG7 2RD, England.	warren.pearce@nottingham.ac.uk	Holmberg, Kim/A-6840-2010; Pearce, Warren/V-3279-2019	Holmberg, Kim/0000-0002-4185-9298; Pearce, Warren/0000-0001-6884-3854; Nerlich, Brigitte/0000-0001-6617-7827	Economic and Social Research Council [RES-360-25-0068]; Leverhulme Trust in the UK [RP2011-SP-013]; Dutch Scientific Organization in the Netherlands (NWO-ORA) [464-10-077]; ESRC [ES/I014926/1] Funding Source: UKRI; Economic and Social Research Council [ES/I014926/1] Funding Source: researchfish	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Leverhulme Trust in the UK(Leverhulme Trust); Dutch Scientific Organization in the Netherlands (NWO-ORA); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The authors acknowledge the support of the Economic and Social Research Council (RES-360-25-0068) and the Leverhulme Trust (RP2011-SP-013) in the UK, and the Dutch Scientific Organization in the Netherlands (NWO-ORA grant 464-10-077). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott T, 2012, OUR PLAN ABOLISH CAR; Adamic L. A., 2005, 3 INT WORKSH LINK DI, P36, DOI DOI 10.1145/1134271.1134277; [Anonymous], 2013, WHOS MOST POW CLIM S; [Anonymous], 2013, NOW SEND MESS UK MED; [Anonymous], 2013, LEADERS DEBATE CLIMA; [Anonymous], 2013, NOW SEND MESS TOP UK; Australian Government Department of the Environment, 2011, LAUNCH CLIM COMM; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Baxter L. A., 2010, VOICING RELATIONSHIP, DOI [10.4135/9781452230344, DOI 10.4135/9781452230344]; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boyd D, 2010, P ANN HICSS, P1657; Bruns A., 2008, INFORM POLITY, V13, P71, DOI [DOI 10.3233/IP-2008-0141, 10.3233/IP-2008-0141]; Bruns A., 2011, P 6 EUR CONS POL RES, P1; Bruns A, 2012, J TECHNOL HUMAN SERV, V30, P160, DOI 10.1080/15228835.2012.744249; Cha M, 2012, IEEE T SYST MAN CY A, V42, P991, DOI 10.1109/TSMCA.2012.2183359; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Chmiel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022207; Collins L, 2013, MAK SCI PUBLIC; Connor S., 2013, INDEPENDENT; Corner A, 2012, CLIMATIC CHANGE, V114, P463, DOI 10.1007/s10584-012-0424-6; Crowley K, 2013, WIRES CLIM CHANGE, V4, P603, DOI 10.1002/wcc.239; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; Elsasser SW, 2013, AM BEHAV SCI, V57, P754, DOI 10.1177/0002764212469800; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Greenberg S, 2013, INSIDE GOP REPORT FO; Hoffman AJ, 2011, ORGAN ENVIRON, V24, P3, DOI 10.1177/1086026611404336; Honeycutt C., 2009, P 2009 42 HAW INT C, P1, DOI [10.1109/HICSS.2009.89, DOI 10.1109/HICSS.2009.89]; Huang J., 2010, P 21 ACM C HYP HYP, P173, DOI [10.1145/1810617.1810647, DOI 10.1145/1810617.1810647]; Hulme M, 2012, NAT CLIM CHANGE, V2, P223, DOI 10.1038/nclimate1459; Intergovernmental Panel on Climate Change, 2012, PRINC GOV IPCC WORK; Intergovernmental Panel on Climate Change, 2013, KEY DAT AR5 SCHED; Jaspal R, 2012, PUBLIC UNDERST SCI; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; Koteyko N, 2013, GEOGR J, V179, P74, DOI 10.1111/j.1475-4959.2012.00479.x; Koteyko N, 2010, SCI COMMUN, V32, P25, DOI 10.1177/1075547009340421; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lin Y-R, 2013, RISING TIDES RISING; Aiello LM, 2013, IEEE T MULTIMEDIA, V15, P1268, DOI 10.1109/TMM.2013.2265080; Marres Noortje, 2005, MAKING THINGS PUBLIC, P922; McCright AM, 2011, SOCIOL QUART, V52, P155, DOI 10.1111/j.1533-8525.2011.01198.x; Morton O, 2013, HELIOPHAGE; Moser SC, 2014, ADAPTIVE CHALLENGE C; Nerlich B, 2009, GLOBAL ENVIRON CHANG, V19, P345, DOI 10.1016/j.gloenvcha.2009.03.001; Painter J, 2011, POLES APART INT REPO; Revkin A, 2012, DOT EARTH BLOG; Royal Society, 2013, NEXT STEPS CLIM SCI; Sasahara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061823; Shukla P.R., 2022, CLIMATE CHANGE 2013; Small TA, 2011, INFORM COMMUN SOC, V14, P872, DOI 10.1080/1369118X.2011.554572; Stilgoe J, 2013, GUARD POLIT SCI; Swart NC, 2012, NAT CLIM CHANGE, V2, P134, DOI 10.1038/nclimate1421; The Royal Society, 2009, GEOENG CLIM SCI GOV; Thelwall M, 2009, SYNTHESIS LECT INFOR, DOI [10.2200/S00176ED1V01Y200903ICR004, DOI 10.2200/S00176ED1V01Y200903ICR004]; Wilkinson D, 2011, SOC SCI COMPUT REV, V29, P387, DOI 10.1177/0894439310378979; Yardi S., 2010, B SCI TECHNOL SOC, V30, P316, DOI 10.1177/0270467610380011	55	117	118	4	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94785	10.1371/journal.pone.0094785	http://dx.doi.org/10.1371/journal.pone.0094785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24718388	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000334339000145
J	Svendsen, JC; Genz, J; Anderson, WG; Stol, JA; Watkinson, DA; Enders, EC				Svendsen, Jon C.; Genz, Janet; Anderson, W. Gary; Stol, Jennifer A.; Watkinson, Douglas A.; Enders, Eva C.			Evidence of Circadian Rhythm, Oxygen Regulation Capacity, Metabolic Repeatability and Positive Correlations between Forced and Spontaneous Maximal Metabolic Rates in Lake Sturgeon Acipenser fulvescens	PLOS ONE			English	Article							NONMIGRATORY THREESPINE STICKLEBACK; GUPPIES POECILIA-RETICULATA; SWIMMING PERFORMANCE; JUVENILE ATLANTIC; WHITE STURGEON; GREEN STURGEON; INTRASPECIFIC VARIATION; ENVIRONMENTAL HYPOXIA; AEROBIC CAPACITY; CONSUMPTION RATE	Animal metabolic rate is variable and may be affected by endogenous and exogenous factors, but such relationships remain poorly understood in many primitive fishes, including members of the family Acipenseridae (sturgeons). Using juvenile lake sturgeon (Acipenser fulvescens), the objective of this study was to test four hypotheses: 1) A. fulvescens exhibits a circadian rhythm influencing metabolic rate and behaviour; 2) A. fulvescens has the capacity to regulate metabolic rate when exposed to environmental hypoxia; 3) measurements of forced maximum metabolic rate (MMRF) are repeatable in individual fish; and 4) MMRF correlates positively with spontaneous maximum metabolic rate (MMRS). Metabolic rates were measured using intermittent flow respirometry, and a standard chase protocol was employed to elicit MMRF. Trials lasting 24 h were used to measure standard metabolic rate (SMR) and MMRS. Repeatability and correlations between MMRF and MMRS were analyzed using residual body mass corrected values. Results revealed that A. fulvescens exhibit a circadian rhythm in metabolic rate, with metabolism peaking at dawn. SMR was unaffected by hypoxia (30% air saturation (O-2sat)), demonstrating oxygen regulation. In contrast, MMRF was affected by hypoxia and decreased across the range from 100% O-2sat to 70% O-2sat. MMRF was repeatable in individual fish, and MMRF correlated positively with MMRS, but the relationships between MMRF and MMRS were only revealed in fish exposed to hypoxia or 24 h constant light (i.e. environmental stressor). Our study provides evidence that the physiology of A. fulvescens is influenced by a circadian rhythm and suggests that A. fulvescens is an oxygen regulator, like most teleost fish. Finally, metabolic repeatability and positive correlations between MMRF and MMRS support the conjecture that MMRF represents a measure of organism performance that could be a target of natural selection.	[Svendsen, Jon C.; Stol, Jennifer A.; Watkinson, Douglas A.; Enders, Eva C.] Fisheries & Oceans Canada, Winnipeg, MB, Canada; [Svendsen, Jon C.] Univ Porto, Interdisciplinary Ctr Marine & Environm Res, P-4100 Oporto, Portugal; [Genz, Janet] Univ West Georgia, Dept Biol, Carrollton, GA USA; [Anderson, W. Gary] Univ Manitoba, Dept Biol Sci, Winnipeg, MB, Canada	Fisheries & Oceans Canada; Universidade do Porto; University System of Georgia; University of West Georgia; University of Manitoba	Svendsen, JC (corresponding author), Fisheries & Oceans Canada, Winnipeg, MB, Canada.	jos@aqua.dtu.dk	Enders, Eva/G-9804-2019; Quality, Aquaculture Seafood/AAD-7718-2019; Svendsen, Jon Christian/J-2716-2013	Enders, Eva/0000-0003-2103-0359; Svendsen, Jon Christian/0000-0002-0273-0985	Manitoba Hydro; Natural Sciences and Engineering Research Council of Canada in Canada [311909]; Foundation for Science and Technology (FCT) [SFRH/BPD/89473/2012]	Manitoba Hydro; Natural Sciences and Engineering Research Council of Canada in Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	Funding in support of this research was provided to WGA by Manitoba Hydro (http://www.hydro.mb.ca/) and Natural Sciences and Engineering Research Council of Canada Discovery Grant (http://www.nserc-crsng.gc.ca/professors-professeurs/grants-subs/dgigp-psigp_eng.asp) (Number 311909) in Canada. This research was partially supported by a grant (SFRH/BPD/89473/2012) from the Foundation for Science and Technology (FCT; http://www.fct.pt/index.phtml.pt) in Portugal to JCS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PJ, 2007, ENVIRON BIOL FISH, V79, P211, DOI 10.1007/s10641-006-9049-9; Baker DW, 2005, PHYSIOL BIOCHEM ZOOL, V78, P916, DOI 10.1086/432860; Barton BA, 2002, INTEGR COMP BIOL, V42, P517, DOI 10.1093/icb/42.3.517; Beale A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3769; Behrens JW, 2007, MAR BIOL, V150, P1365, DOI 10.1007/s00227-006-0456-4; Biro PA, 2010, TRENDS ECOL EVOL, V25, P653, DOI 10.1016/j.tree.2010.08.003; Boldsen MM, 2013, COMP BIOCHEM PHYS A, V165, P22, DOI 10.1016/j.cbpa.2013.01.027; BOUJARD T, 1992, ENVIRON BIOL FISH, V35, P109, DOI 10.1007/BF00002186; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; BURGGREN WW, 1978, RESP PHYSIOL, V34, P171, DOI 10.1016/0034-5687(78)90026-9; Burton T, 2011, P ROY SOC B-BIOL SCI, V278, P3465, DOI 10.1098/rspb.2011.1778; Cech JJ, 2002, J APPL ICHTHYOL, V18, P320, DOI 10.1046/j.1439-0426.2002.00362.x; Chappell M, 2004, PHYSIOL BIOCHEM ZOOL, V77, P27, DOI 10.1086/378920; Coppack T, 2011, J ORNITHOL, V152, P67, DOI 10.1007/s10336-011-0708-z; Crocker CE, 2002, J APPL ICHTHYOL, V18, P338, DOI 10.1046/j.1439-0426.2002.00411.x; Crocker CE, 1997, ENVIRON BIOL FISH, V50, P383, DOI 10.1023/A:1007362018352; Cutts CJ, 2002, FUNCT ECOL, V16, P73, DOI 10.1046/j.0269-8463.2001.00603.x; Dalziel AC, 2012, J EXP BIOL, V215, P3587, DOI 10.1242/jeb.071951; Dalziel AC, 2012, EVOLUTION, V66, P1226, DOI 10.1111/j.1558-5646.2011.01498.x; Dalziel AC, 2012, J EXP BIOL, V215, P746, DOI 10.1242/jeb.065425; Farrell AP, 2009, FISH PHYSIOL, V27, P487, DOI 10.1016/S1546-5098(08)00011-3; Forsythe PS, 2012, J FISH BIOL, V81, P35, DOI 10.1111/j.1095-8649.2012.03308.x; Forsythe PS, 2012, CAN J FISH AQUAT SCI, V69, P60, DOI 10.1139/F2011-132; Franklin PA, 2013, NZ J MAR FR IN PRESS, DOI [10.1080/00288330.2013.827123, DOI 10.1080/00288330.2013.827123]; Hughes G.M., 1981, P121; Husak JF, 2006, FUNCT ECOL, V20, P1080, DOI 10.1111/j.1365-2435.2006.01195.x; Irschick DJ, 2005, EVOLUTION, V59, P1579; Irschick D, 2007, PHYSIOL BIOCHEM ZOOL, V80, P557, DOI 10.1086/521203; Irschick DJ, 2008, EVOL ECOL RES, V10, P177; Jones EA, 2007, J EXP BIOL, V210, P3422, DOI 10.1242/jeb.005744; Jordan AD, 2007, PHYSIOL BIOCHEM ZOOL, V80, P178, DOI 10.1086/510565; Kearney MR, 2012, AM NAT, V180, P546, DOI 10.1086/667860; Kieffer JD, 2001, J EXP BIOL, V204, P4281; Killen SS, 2013, TRENDS ECOL EVOL, V28, P651, DOI 10.1016/j.tree.2013.05.005; Kim WS, 1997, MAR ECOL PROG SER, V153, P293, DOI 10.3354/meps153293; Langerhans RB, 2009, BIOL LETTERS, V5, P488, DOI 10.1098/rsbl.2009.0179; Lankford SE, 2005, PHYSIOL BIOCHEM ZOOL, V78, P599, DOI 10.1086/430687; Lankford SE, 2003, COMP BIOCHEM PHYS A, V135, P291, DOI 10.1016/S1095-6433(03)00075-8; Losos JB, 2002, J ZOOL, V258, P57, DOI 10.1017/S0952836902001206; Mayfield RB, 2004, T AM FISH SOC, V133, P961, DOI 10.1577/T02-144.1; McBryan TL, 2013, INTEGR COMP BIOL, V53, P648, DOI 10.1093/icb/ict066; McKenzie DJ, 2007, J FISH BIOL, V70, P651, DOI 10.1111/j.1095-8649.2007.01337.x; MCKENZIE DJ, 1995, FISH PHYSIOL BIOCHEM, V14, P341, DOI 10.1007/BF00003373; Niitepold K, 2013, J EXP BIOL, V216, P1388, DOI 10.1242/jeb.080739; NONNOTTE G, 1993, RESP PHYSIOL, V91, P71, DOI 10.1016/0034-5687(93)90090-W; Norin T, 2011, J EXP BIOL, V214, P1668, DOI 10.1242/jeb.054205; Odell JP, 2003, J EXP BIOL, V206, P3707, DOI 10.1242/jeb.00613; Oufiero CE, 2011, ECOLOGY, V92, P170, DOI 10.1890/09-1912.1; Oufiero CE, 2009, FUNCT ECOL, V23, P969, DOI 10.1111/j.1365-2435.2009.01571.x; Pagan DNM, 2012, J HERPETOL, V46, P253, DOI 10.1670/11-105; Perry SF, 2009, FISH PHYSIOL, V27, P193, DOI 10.1016/S1546-5098(08)00005-8; Peyric E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073209; Pollock MS, 2007, ENVIRON REV, V15, P1, DOI 10.1139/a06-006; Priede I.G., 1985, P33; RANDALL DJ, 1992, J EXP BIOL, V170, P113; Reebs SG, 2002, REV FISH BIOL FISHER, V12, P349, DOI 10.1023/A:1025371804611; ROSS LG, 1988, COMP BIOCHEM PHYS A, V89, P637, DOI 10.1016/0300-9629(88)90846-8; RUER PM, 1987, AQUACULTURE, V62, P45, DOI 10.1016/0044-8486(87)90183-9; Schurmann H, 1997, J FISH BIOL, V50, P1166, DOI 10.1006/jfbi.1997.0387; STEFFENSEN JF, 1989, FISH PHYSIOL BIOCHEM, V6, P49, DOI 10.1007/BF02995809; Svendsen JC, 2013, J EXP BIOL, V216, P3564, DOI 10.1242/jeb.083089; Svendsen JC, 2010, J EXP BIOL, V213, P2177, DOI 10.1242/jeb.041368; Svendsen JC, 2012, CAN J ZOOL, V90, P1, DOI [10.1139/z11-095, 10.1139/Z11-095]; ULTSCH GR, 1981, J COMP PHYSIOL, V142, P439, DOI 10.1007/BF00688973; Urbina MA, 2012, COMP BIOCHEM PHYS A, V161, P301, DOI 10.1016/j.cbpa.2011.11.011; Virani NA, 2000, COMP BIOCHEM PHYS A, V126, P397, DOI 10.1016/S1095-6433(00)00219-1; Walker JA, 2005, FUNCT ECOL, V19, P808, DOI 10.1111/j.1365-2435.2005.01033.x; White CR, 2013, J EXP BIOL, V216, P1763, DOI 10.1242/jeb.076562; Wilson AM, 2013, NATURE, V498, P185, DOI 10.1038/nature12295; Wu RSS, 2002, MAR POLLUT BULL, V45, P35, DOI 10.1016/S0025-326X(02)00061-9	70	43	43	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94693	10.1371/journal.pone.0094693	http://dx.doi.org/10.1371/journal.pone.0094693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718688	gold, Green Published, Green Submitted			2022-12-25	WOS:000334339000137
J	Yu, XH; Ge, NJ; Guo, X; Shen, SQ; Liang, J; Huang, XJ; Wan, SG; Xing, JL; Huang, QC; Yang, YF				Yu, Xiaohe; Ge, Naijian; Guo, Xu; Shen, Shuqun; Liang, Jun; Huang, Xiaojun; Wan, Shaogui; Xing, Jingliang; Huang, Qichao; Yang, Yefa			Genetic Variants in the EPCAM Gene Is Associated with the Prognosis of Transarterial Chemoembolization Treated Hepatocellular Carcinoma with Portal Vein Tumor Thrombus	PLOS ONE			English	Article							CELL ADHESION MOLECULE; CANCER; EXPRESSION; CD326	The epithelial cell adhesion molecule (EPCAM) is involved in the tumorigenesis and progression of many malignancies, including hepatocellular carcinoma (HCC). Single nucleotide polymorphisms (SNPs) of EPCAM have been reported to be with the risk and prognosis of several malignancies. However, the association of SNPs in EPCAM gene with the prognosis of HCC patients has never been investigated. In this study, two functional SNPs (rs1126497 and rs1421) in the EPCAM gene were selected and genotyped in a cohort of 448 unresectable Chinese HCC patients treated by TACE. The association of the two SNPs with the overall survival (OS) of patients was assessed by univariate and multivariate Cox proportional hazards model and Kaplan-Meier curve. Our data showed that there was no significant association between either SNP and OS of patients. However, in the stratified analysis, the variant-containing genotypes (WV+VV) of SNP rs1126497 exhibited a significant association with poorer OS in HCC patients who had portal vein tumor thrombus (PVTT) in multivariate analysis of Cox proportional hazard model (hazard ratio, 1.71; 95% confidence interval, 1.16-2.53, P = 0.007), and in Kaplan-Meier curve analysis (P = 0.023), comparing to those carrying wild-type genotype. Our results suggest that SNP rs1126497 in the EPCAM gene may serve as an independent prognosis biomarker for unresectable HCC patient with PVTT, which warranted further validating investigation.	[Yu, Xiaohe; Ge, Naijian; Shen, Shuqun; Liang, Jun; Yang, Yefa] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Radioact Intervent, Shanghai, Peoples R China; [Guo, Xu] Cell Engn Res Ctr, State Key Lab Canc Biol, Xian, Shaanxi, Peoples R China; [Guo, Xu] Dept Cell Biol, Xian, Shaanxi, Peoples R China; [Huang, Xiaojun; Xing, Jingliang; Huang, Qichao] Fourth Mil Med Univ, Expt Teaching Ctr Basic Med, Xian 710032, Shaanxi, Peoples R China; [Wan, Shaogui] Henan Univ, Pharmaceut Coll, Kaifeng, Henan, Peoples R China	Naval Medical University; Henan University	Huang, QC (corresponding author), Fourth Mil Med Univ, Expt Teaching Ctr Basic Med, Xian 710032, Shaanxi, Peoples R China.	huangqichao1@163.com; yangyefa66@163.com	Huang, Qichao/K-5706-2018		National Natural Science Foundation of China [81272522]; New Century Excellent Talents in University [81171966]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by grants 81272522 from the National Natural Science Foundation of China and grants 81171966 from New Century Excellent Talents in University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JS, 2012, INT J ONCOL, V41, P2150, DOI 10.3892/ijo.2012.1631; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chamary JV, 2006, NAT REV GENET, V7, P98, DOI 10.1038/nrg1770; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Fouse SD, 2013, CANCER CELL, V23, P711, DOI 10.1016/j.ccr.2013.05.016; Gutzmer R, 2004, J IMMUNOL, V173, P1023, DOI 10.4049/jimmunol.173.2.1023; Hu M, 2012, MOL BIOL REP, V39, P7303, DOI 10.1007/s11033-012-1560-9; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jia LZ, 2012, ACTA MED OKAYAMA, V66, P131; Jiang L, 2011, BREAST CANCER RES TR, V126, P487, DOI 10.1007/s10549-010-1094-6; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Luo J, 2011, ANN SURG ONCOL, V18, P413, DOI 10.1245/s10434-010-1321-8; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Osta WA, 2004, CANCER RES, V64, P5818, DOI 10.1158/0008-5472.CAN-04-0754; Pak MG, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-53; Patriarca C, 2012, CANCER TREAT REV, V38, P68, DOI 10.1016/j.ctrv.2011.04.002; Shastry BS, 2009, METHODS MOL BIOL, V578, P3, DOI 10.1007/978-1-60327-411-1_1; Shi G, 2013, METHODS; Song DS, 2013, WORLD J GASTROENTERO, V19, P4679, DOI 10.3748/wjg.v19.i29.4679; Sun YF, 2013, HEPATOLOGY, V57, P1458, DOI 10.1002/hep.26151; Trzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152; Winter MJ, 2003, EXP CELL RES, V285, P50, DOI 10.1016/S0014-4827(02)00045-9; Wu L, 2010, CANCER BIOTHER RADIO, V25, P657, DOI 10.1089/cbr.2010.0801; Xue TC, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-60; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang Y, 2014, CANCER SCI, V105, P89, DOI 10.1111/cas.12318	29	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93416	10.1371/journal.pone.0093416	http://dx.doi.org/10.1371/journal.pone.0093416			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718422	gold, Green Published, Green Submitted			2022-12-25	WOS:000334339000031
J	Zhang, H; Su, YJ; Zhou, WW; Wang, SW; Xu, PX; Yu, XL; Liu, RT				Zhang, He; Su, Ya-jing; Zhou, Wei-wei; Wang, Shao-wei; Xu, Peng-xin; Yu, Xiao-lin; Liu, Rui-tian			Activated Scavenger Receptor A Promotes Glial Internalization of A beta	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; AMYLOID-BETA; MICROGLIAL ACTIVATION; NEURONAL VIABILITY; SIGNALING PATHWAYS; TRANSGENIC MICE; PEPTIDE; PHAGOCYTOSIS; CLEARANCE; CELLS	Beta-amyloid (Ab) aggregates have a pivotal role in pathological processing of Alzheimer's disease (AD). The clearance of Ab monomer or aggregates is a causal strategy for AD treatment. Microglia and astrocytes are the main macrophages that exert critical neuroprotective roles in the brain. They may effectively clear the toxic accumulation of Ab at the initial stage of AD, however, their functions are attenuated because of glial overactivation. In this study, we first showed that heptapeptide XD4 activates the class A scavenger receptor (SR-A) on the glia by increasing the binding of Ab to SR-A, thereby promoting glial phagocytosis of Ab oligomer in microglia and astrocytes and triggering intracellular mitogen-activated protein kinase (MAPK) signaling cascades. Moreover, XD4 enhances the internalization of A beta monomers to microglia and astrocytes through macropinocytosis or SR-A-mediated phagocytosis. Furthermore, XD4 significantly inhibits A beta oligomer-induced cytotoxicity to glial cells and decreases the production of proinflammatory cytokines, such as TNF-alpha and IL-1 beta, in vitro and in vivo. Our findings may provide a novel strategy for AD treatment by activating SR-A.	[Zhang, He; Zhou, Wei-wei; Wang, Shao-wei; Xu, Peng-xin; Yu, Xiao-lin; Liu, Rui-tian] Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing, Peoples R China; [Zhang, He] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Su, Ya-jing] Ningxia Univ, Sch Life Sci, Yinchuan, Peoples R China	Chinese Academy of Sciences; Institute of Process Engineering, CAS; Tsinghua University; Ningxia University	Yu, XL (corresponding author), Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing, Peoples R China.	rtliu@home.ipe.ac.cn; yuxiaolin@home.ipe.ac.cn			National Natural Science Foundation of China [30971012, 81171014]; National Science and Technology Major Projects of New Drugs [2012ZX09103301-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Projects of New Drugs	This work was supported by grants from the National Natural Science Foundation of China (30971012 and 81171014) and the National Science and Technology Major Projects of New Drugs (2012ZX09103301-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon R, 2005, J BIOL CHEM, V280, P30406, DOI 10.1074/jbc.M414686200; Allaman I, 2010, J NEUROSCI, V30, P3326, DOI 10.1523/JNEUROSCI.5098-09.2010; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Broersen K, 2010, ALZHEIMERS RES THER, V2, DOI 10.1186/alzrt36; Coller SP, 2001, J LEUKOCYTE BIOL, V70, P142; Cornejo F, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/895651; D'Andrea MR, 2004, NEUROBIOL AGING, V25, P675, DOI 10.1016/j.neurobiolaging.2003.12.026; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; ElKhoury J, 1996, NATURE, V382, P716; Frautschy SA, 1998, AM J PATHOL, V152, P307; Frenkel D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3030; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hsu HY, 2001, J BIOL CHEM, V276, P28719, DOI 10.1074/jbc.M011117200; Husemann J, 2002, GLIA, V40, P195, DOI 10.1002/glia.10148; Jones RS, 2013, J NEUROIMMUNE PHARM, V8, P301, DOI 10.1007/s11481-012-9427-3; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lee CYD, 2010, J NEURAL TRANSM, V117, P949, DOI 10.1007/s00702-010-0433-4; Lue LF, 2001, NEUROBIOL AGING, V22, P945, DOI 10.1016/S0197-4580(01)00311-6; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Mohamed A, 2011, INT J ALZHEIMERS DIS, V2011, DOI DOI 10.4061/2011/127984; Mukhopadhyay S, 2011, BLOOD, V117, P1319, DOI 10.1182/blood-2010-03-276733; Paresce DM, 1996, NEURON, V17, P553, DOI 10.1016/S0896-6273(00)80187-7; Prokop Stefan, 2013, Acta Neuropathol, V126, P461; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Rogers J, 2001, NEUROCHEM INT, V39, P333, DOI 10.1016/S0197-0186(01)00040-7; Stuart LM, 2007, J BIOL CHEM, V282, P27392, DOI 10.1074/jbc.M702887200; Tuppo EE, 2005, INT J BIOCHEM CELL B, V37, P289, DOI 10.1016/j.biocel.2004.07.009; Verdier Y, 2004, J PEPT SCI, V10, P229, DOI 10.1002/psc.573; Wilkinson K, 2012, INT J ALZHEIMERS DIS, V2012, DOI [DOI 10.1155/2012/489456, 10.1155/2012/489456]; Xue D, 2012, NEUROBIOL DIS, V46, P701, DOI 10.1016/j.nbd.2012.03.013; Yang CN, 2011, NEUROBIOL DIS, V42, P221, DOI 10.1016/j.nbd.2011.01.005; Yu XF, 2011, J BIOL CHEM, V286, P18795, DOI 10.1074/jbc.M111.224345	33	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94197	10.1371/journal.pone.0094197	http://dx.doi.org/10.1371/journal.pone.0094197			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718459	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000087
J	Cai, L; Chen, L; Johnson, D; Gao, Y; Mandal, P; Fang, M; Tu, ZY; Huang, YP				Cai, Lu; Chen, Lei; Johnson, David; Gao, Yong; Mandal, Prashant; Fang, Min; Tu, Zhiying; Huang, Yingping			Integrating Water Flow, Locomotor Performance and Respiration of Chinese Sturgeon during Multiple Fatigue-Recovery Cycles	PLOS ONE			English	Article							REPEAT SWIMMING PERFORMANCE; SALMON ONCORHYNCHUS-NERKA; ACIPENSER-SINENSIS; MODEL SELECTION; BEHAVIOR; SPEED; RIVER; TEMPERATURE; METABOLISM; VELOCITY	The objective of this study is to provide information on metabolic changes occurring in Chinese sturgeon (an ecologically important endangered fish) subjected to repeated cycles of fatigue and recovery and the effect on swimming capability. Fatigue-recovery cycles likely occur when fish are moving through the fishways of large dams and the results of this investigation are important for fishway design and conservation of wild Chinese sturgeon populations. A series of four stepped velocity tests were carried out successively in a Steffensen-type swimming respirometer and the effects of repeated fatigue-recovery on swimming capability and metabolism were measured. Significant results include: (1) critical swimming speed decreased from 4.34 bl/s to 2.98 bl/s; (2) active oxygen consumption (i.e. the difference between total oxygen consumption and routine oxygen consumption) decreased from 1175 mgO(2)/kg to 341 mgO(2)/kg and was the primary reason for the decrease in U-crit; (3) excess post-exercise oxygen consumption decreased from 36 mgO(2)/kg to 22 mgO(2)/kg; (4) with repeated step tests, white muscle (anaerobic metabolism) began contributing to propulsion at lower swimming speeds. Therefore, Chinese sturgeon conserve energy by swimming efficiently and have high fatigue recovery capability. These results contribute to our understanding of the physiology of the Chinese sturgeon and support the conservation efforts of wild populations of this important species.	[Cai, Lu; Fang, Min; Tu, Zhiying; Huang, Yingping] Collaborat Innovat Ctr Geo Hazards & Ecoenvironm, Yichang, Hubei Province, Peoples R China; [Chen, Lei; Gao, Yong] China Three Gorges Project Corp, Inst Chinese Sturgeon Res, Yichang, Peoples R China; [Johnson, David; Mandal, Prashant; Fang, Min; Tu, Zhiying; Huang, Yingping] China Three Gorges Univ, Minist Educ, Engn Res Ctr Ecoenvironm Gorges Reservoir Reg 3, Yichang, Peoples R China; [Johnson, David] Ferrum Coll, Sch Nat Sci & Math, Ferrum, VA USA	China Three Gorges Corporation; China Three Gorges University	Huang, YP (corresponding author), Collaborat Innovat Ctr Geo Hazards & Ecoenvironm, Yichang, Hubei Province, Peoples R China.	yingpinghuang@126.com			Major Science and Technology Program for Water Pollution Control and Treatment in the National Twelfth Five-Year Plan of China [2012ZX07104-002-04]; National Nature Science Foundation of China [50979049, 51309140]	Major Science and Technology Program for Water Pollution Control and Treatment in the National Twelfth Five-Year Plan of China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Major Science and Technology Program for Water Pollution Control and Treatment in the National Twelfth Five-Year Plan of China (Grant number: 2012ZX07104-002-04) and the National Nature Science Foundation of China (Grant number: 50979049, 51309140). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; BARTHEM RB, 1991, BIOL CONSERV, V55, P339, DOI 10.1016/0006-3207(91)90037-A; Behrens JW, 2006, J EXP MAR BIOL ECOL, V331, P208, DOI 10.1016/j.jembe.2005.10.012; Billard R, 2001, REV FISH BIOL FISHER, V10, P355; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Cai L, 2014, FISH PHYSIOL BIOCHEM, V40, P491, DOI 10.1007/s10695-013-9860-0; Cai L, 2013, J EXP ZOOL PART A, V319A, P149, DOI 10.1002/jez.1780; Castro-Santos T, 2005, J EXP BIOL, V208, P421, DOI 10.1242/jeb.01380; Castro-Santos T, 2013, CAN J FISH AQUAT SCI, V70, P280, DOI 10.1139/cjfas-2012-0186; Cheong TS, 2006, ENVIRON BIOL FISH, V77, P197, DOI 10.1007/s10641-006-9071-y; Cooke SJ, 2008, FISHERIES, V33, P321, DOI 10.1577/1548-8446-33.7.321; Deslauriers D, 2012, CAN J ZOOL, V90, P345, DOI 10.1139/Z2012-004; Farrell AP, 1998, J EXP BIOL, V201, P2183; Fu SJ, 2013, OECOLOGIA, V173, P343, DOI 10.1007/s00442-013-2626-7; Guo Bai-Fu, 2011, Acta Hydrobiologica Sinica, V35, P940; He X, 2013, J FISH BIOL, V82, P1047, DOI 10.1111/j.1095-8649.2012.12015.x; Herrmann JP, 2000, J FISH BIOL, V57, P746, DOI [10.1006/jfbi.2000.1348, 10.1111/j.1095-8649.2000.tb00272.x]; Hu JY, 2009, P NATL ACAD SCI USA, V106, P9339, DOI 10.1073/pnas.0809434106; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.1093/biomet/76.2.297; Jain KE, 2003, J EXP BIOL, V206, P3569, DOI 10.1242/jeb.00588; Jain KE, 1998, CAN J ZOOL, V76, P1488, DOI 10.1139/cjz-76-8-1488; Jaric I, 2012, SCIENTOMETRICS, V90, P715, DOI 10.1007/s11192-011-0583-7; JONES DR, 1982, CAN J ZOOL, V60, P1131, DOI 10.1139/z82-157; Killen SS, 2012, P ROY SOC B-BIOL SCI, V279, P357, DOI 10.1098/rspb.2011.1006; Langerhans RB, 2008, INTEGR COMP BIOL, V48, P750, DOI 10.1093/icb/icn092; Lee CG, 2003, J EXP BIOL, V206, P3253, DOI 10.1242/jeb.00548; MacNutt MJ, 2004, J FISH BIOL, V65, P342, DOI 10.1111/j.0022-1112.2004.00453.x; Marras S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072815; Ohlberger J, 2006, J COMP PHYSIOL B, V176, P17, DOI 10.1007/s00360-005-0024-0; Pang X, 2013, J COMP PHYSIOL B, V183, P99, DOI 10.1007/s00360-012-0690-7; Peake SJ, 2004, FISH FISHERIES SERIE, V27, P147; Pettersson LB, 2000, P ROY SOC B-BIOL SCI, V267, P759, DOI 10.1098/rspb.2000.1068; Pikitch EK, 2005, FISH FISH, V6, P233, DOI 10.1111/j.1467-2979.2005.00190.x; Pon LB, 2009, J FISH BIOL, V74, P1323, DOI 10.1111/j.1095-8649.2009.02213.x; ROME LC, 1990, J EXP BIOL, V154, P163; Svendsen JC, 2010, J EXP BIOL, V213, P2177, DOI 10.1242/jeb.041368; Rodriguez TT, 2006, ECOL ENG, V27, P37, DOI 10.1016/j.ecoleng.2005.09.015; Tierney KB, 2004, J FISH DIS, V27, P663, DOI 10.1111/j.1365-2761.2004.00590.x; Tu ZY, 2012, J EXP ZOOL PART A, V317A, P294, DOI 10.1002/jez.1723; Tu ZY, 2011, HYDROBIOLOGIA, V675, P119, DOI 10.1007/s10750-011-0809-y; Turvey ST, 2010, CONSERV BIOL, V24, P778, DOI 10.1111/j.1523-1739.2009.01395.x; Van Leeuwen TE, 2011, J ANIM ECOL, V80, P1012, DOI 10.1111/j.1365-2656.2011.01841.x; Wang C, 2013, J APPL ICHTHYOL, V29, P31, DOI 10.1111/jai.12094; Webber JD, 2007, T AM FISH SOC, V136, P402, DOI 10.1577/T06-064.1; Wei Q, 2004, J APPL ICHTHYOL, V20, P321, DOI 10.1111/j.1439-0426.2004.00593.x; [危起伟 Wei Qiwei], 2013, [中国水产科学, Journal of Fishery Sciences of China], V20, P1; Wei QW, 1997, ENVIRON BIOL FISH, V48, P241, DOI 10.1023/A:1007395612241; Xie P, 2003, SCIENCE, V302, P1149; Xie SG, 2007, FISHERIES, V32, P343; Yagci O, 2010, ECOL ENG, V36, P36, DOI 10.1016/j.ecoleng.2009.09.007	51	14	18	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94345	10.1371/journal.pone.0094345	http://dx.doi.org/10.1371/journal.pone.0094345			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714585	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900121
J	Das, B; Satapathy, T; Kar, SK; Hazra, RK				Das, Biswadeep; Satapathy, Truptimayee; Kar, Santanu K.; Hazra, Rupenangshu K.			Genetic Structure and Wolbachia Genotyping in Naturally Occurring Populations of Aedes albopictus across Contiguous Landscapes of Orissa, India	PLOS ONE			English	Article							CYTOPLASMIC INCOMPATIBILITY; CHIKUNGUNYA VIRUS; MOLECULAR INVESTIGATIONS; ALLELE FREQUENCY; TIGER MOSQUITO; EASTERN INDIA; DENGUE VIRUS; OUTBREAKS; PHYLOGENY; EVOLUTION	Background: Aedes albopictus has recently been implicated as a major vector in the emergence of dengue and chikungunya in several parts of India, like Orissa, which is gradually gaining endemicity for arboviral diseases. Ae. albopictus is further known to be naturally infected with Wolbachia (maternally inherited bacterium), which causes cytoplasmic incompatibility (CI) in mosquitoes leading to sperm-egg incompatibility inducing the death of embryo. Knowledge of genetic diversity of Ae. albopictus, along with revealing the type of Wolbachia infection in Ae. albopictus is important to explore the genetic and biological characteristics of Ae. albopictus, prior to exploring the uses of CI-based vector control strategies. In this study, we assessed the population genetic structure and the pattern of Wolbachia infection in Ae. albopictus mosquitoes of Orissa. Methods and Results: Ae. albopictus mosquitoes were collected from 15 districts representing the four physiographical regions of Orissa from 2010-2012, analyzed for genetic variability at seven microsatellite loci and genotyped for Wolbachia strain detection using wsp gene primers. Most microsatellite markers were successfully amplified and were polymorphic, showing moderate genetic structure among all geographic populations (F-ST = 0.088). Genetic diversity was high (F-ST = 0.168) in Coastal Plains populations when compared with other populations, which was also evident from cluster analyses that showed most Coastal Plains populations consisted of a separate genetic cluster. Genotyping analyses revealed that Wolbachia-infected Ae. albopictus field populations of Orissa were mostly superinfected with wAlbA and wAlbB strains. Wolbachia superinfection was more pronounced in the Coastal Plain populations. Conclusion: High genetic structure and Wolbachia superinfection, observed in the Coastal Plain populations of Orissa suggested it to be genetically and biologically more unique than other populations, and hence could influence their vectorial attributes. Such high genetic diversity observed among Coastal Plains populations could be attributed to multiple introductions of Ae. albopictus in this region.	[Das, Biswadeep; Satapathy, Truptimayee; Kar, Santanu K.; Hazra, Rupenangshu K.] Reg Med Res Ctr, Dept Med Entomol, Bhubaneswar, Orissa, India	Indian Council of Medical Research (ICMR); ICMR - Regional Medical Research Centre (RMRC), Bhubaneswar	Hazra, RK (corresponding author), Reg Med Res Ctr, Dept Med Entomol, Bhubaneswar, Orissa, India.	rupenkh@yahoo.co.in	Das, Biswadeep/AAX-5120-2020	Das, Biswadeep/0000-0001-8214-3600				Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Barraud PJ, 1934, FAMILY CULICIDAE TRI, P217; Belkhir K., 2001, GENETIX 4 02 LOGICIE; Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Calvitti M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-254; Chambers EW, 2007, J HERED, V98, P202, DOI 10.1093/jhered/esm015; COEN E, 1982, J MOL BIOL, V158, P17, DOI 10.1016/0022-2836(82)90448-X; Cornuet JM, 1996, GENETICS, V144, P2001; Das B, 2013, J VECTOR DIS, V50, P147; Das B, 2013, INFECT GENET EVOL, V16, P401, DOI 10.1016/j.meegid.2013.03.016; Das B, 2012, INFECT GENET EVOL, V12, P1094, DOI 10.1016/j.meegid.2012.03.012; Das B, 2012, TROP MED INT HEALTH, V17, P235, DOI 10.1111/j.1365-3156.2011.02899.x; Delatte H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002111; Delatte H, 2010, VECTOR-BORNE ZOONOT, V10, P249, DOI 10.1089/vbz.2009.0026; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Dobson SL, 2004, HEREDITY, V93, P135, DOI 10.1038/sj.hdy.6800458; Donnelly MJ, 2001, MOL BIOL EVOL, V18, P1353, DOI 10.1093/oxfordjournals.molbev.a003919; Dwibedi B, 2011, INDIAN J MED RES, V133, P316; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hartl D., 2007, PRINCIPLES POPULATIO; HAWLEY W A, 1988, Journal of the American Mosquito Control Association, V4, P2; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Hoffmann AA, 2005, NATURE, V436, P189, DOI 10.1038/436189a; HOLM S, 1979, SCAND J STAT, V6, P65; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jiggins FM, 2001, P ROY SOC B-BIOL SCI, V268, P1423, DOI 10.1098/rspb.2001.1656; Kalra N. L., 1997, Dengue Bulletin, V21, P84; KIMURA M, 1978, P NATL ACAD SCI USA, V75, P2868, DOI 10.1073/pnas.75.6.2868; Lehmann T, 1999, J HERED, V90, P613, DOI 10.1093/jhered/90.6.613; MANTEL N, 1967, CANCER RES, V27, P209; Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989; Nei M., 1987, MOL EVOLUTIONARY GEN; Niyas KP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-189; Porretta D, 2006, MOL ECOL NOTES, V6, P880, DOI 10.1111/j.1471-8286.2006.01384.x; POZZA GD, 1992, J AM MOSQUITO CONTR, V8, P318; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; SCHNEIDER S., 2000, ARLEQUIN VERSION 2 0; Sinkins SP, 2004, INSECT BIOCHEM MOLEC, V34, P723, DOI 10.1016/j.ibmb.2004.03.025; Smith CEG, 1956, J TROP MED HYG, V59, P3; TABACHNICK WJ, 1995, PARASITOL TODAY, V11, P27, DOI 10.1016/0169-4758(95)80105-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turelli M, 1999, INSECT MOL BIOL, V8, P243, DOI 10.1046/j.1365-2583.1999.820243.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Xi ZY, 2005, INSECT BIOCHEM MOLEC, V35, P903, DOI 10.1016/j.ibmb.2005.03.015; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	50	12	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94094	10.1371/journal.pone.0094094	http://dx.doi.org/10.1371/journal.pone.0094094			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714653	Green Published, gold, Green Submitted			2022-12-25	WOS:000334160900081
J	de Wijk, RA; He, W; Mensink, MGJ; Verhoeven, RHG; de Graaf, C				de Wijk, Rene A.; He, Wei; Mensink, Manon G. J.; Verhoeven, Rob H. G.; de Graaf, Cees			ANS Responses and Facial Expressions Differentiate between the Taste of Commercial Breakfast Drinks	PLOS ONE			English	Article							EMOTIONS	The high failure rate of new market introductions, despite initial successful testing with traditional sensory and consumer tests, necessitates the development of other tests. This study explored the ability of selected physiological and behavioral measures of the autonomic nervous system (ANS) to distinguish between repeated exposures to foods from a single category (breakfast drinks) and with similar liking ratings. In this within-subject study 19 healthy young adults sipped from five breakfast drinks, each presented five times, while ANS responses (heart rate, skin conductance response and skin temperature), facial expressions, liking, and intensities were recorded. The results showed that liking was associated with increased heart rate and skin temperature, and more neutral facial expressions. Intensity was associated with reduced heart rate and skin temperature, more neutral expressions and more negative expressions of sadness, anger and surprise. Strongest associations with liking were found after 1 second of tasting, whereas strongest associations with intensity were found after 2 seconds of tasting. Future studies should verify the contribution of the additional information to the prediction of market success.	[de Wijk, Rene A.; He, Wei; Mensink, Manon G. J.; Verhoeven, Rob H. G.] Wageningen Univ & Res Ctr, Wageningen, Netherlands; [de Wijk, Rene A.; de Graaf, Cees] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	de Wijk, RA (corresponding author), Wageningen Univ & Res Ctr, Wageningen, Netherlands.	rene.dewijk@wur.nl						Aue T, 2007, BIOL PSYCHOL, V74, P347, DOI 10.1016/j.biopsycho.2006.09.001; Danner L, 2013, FOOD QUAL P IN PRESS, DOI [10.1016/j.foodq-ual.2013.01.004, DOI 10.1016/J.FOODQ-UAL.2013.01.004]; de Wijk RA, 2012, FOOD QUAL PREFER, V26, P196, DOI 10.1016/j.foodqual.2012.04.015; Delplanque S, 2009, EMOTION, V9, P316, DOI 10.1037/a0015369; Desmet PMA, 2008, APPETITE, V50, P290, DOI 10.1016/j.appet.2007.08.003; Ekman P, 1992, PHILOS T ROYAL SOC B; Ellsworth PC, 2003, SER AFFECTIVE SCI, P572; Frijda N, 1999, WELL BEING FDN HEDON, P190; GILBERT AN, 1987, CHEM SENSES, V12, P355, DOI 10.1093/chemse/12.2.355; He W, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00110; King SC, 2010, FOOD QUAL PREFER, V21, P168, DOI 10.1016/j.foodqual.2009.02.005; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; Maier A, 2007, INFLUENCE PRATIQUES; Park B, 2005, PERS SOC PSYCHOL REV, V9, P108, DOI 10.1207/s15327957pspr0902_2; ROLLS BJ, 1981, PHYSIOL BEHAV, V27, P137, DOI 10.1016/0031-9384(81)90310-3; Rozin P., 1999, WELL BEING FDN HEDON, P109; Steiner J E, 1973, Symp Oral Sens Percept, P254; Steiner JE, 2001, NEUROSCI BIOBEHAV R, V25, P53, DOI 10.1016/S0149-7634(00)00051-8; van Kuilenburg H, 2005, LECT NOTES ARTIF INT, V3720, P194, DOI 10.1007/11564096_22; Zeinstra GG, 2009, FOOD QUAL PREFER, V20, P620, DOI 10.1016/j.foodqual.2009.07.002	20	64	65	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93823	10.1371/journal.pone.0093823	http://dx.doi.org/10.1371/journal.pone.0093823			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714107	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900052
J	Gnoli, A; Puglisi, A; Sarracino, A; Vulpiani, A				Gnoli, Andrea; Puglisi, Andrea; Sarracino, Alessandro; Vulpiani, Angelo			Nonequilibrium Brownian Motion beyond the Effective Temperature	PLOS ONE			English	Article							FLUCTUATION-DISSIPATION; TRANSITION; LIQUIDS	The condition of thermal equilibrium simplifies the theoretical treatment of fluctuations as found in the celebrated Einstein's relation between mobility and diffusivity for Brownian motion. Several recent theories relax the hypothesis of thermal equilibrium resulting in at least two main scenarios. With well separated timescales, as in aging glassy systems, equilibrium Fluctuation-Dissipation Theorem applies at each scale with its own "effective'' temperature. With mixed timescales, as for example in active or granular fluids or in turbulence, temperature is no more well-defined, the dynamical nature of fluctuations fully emerges and a Generalized Fluctuation-Dissipation Theorem (GFDT) applies. Here, we study experimentally the mixed timescale regime by studying fluctuations and linear response in the Brownian motion of a rotating intruder immersed in a vibro-fluidized granular medium. Increasing the packing fraction, the system is moved from a dilute single-timescale regime toward a denser multiple-timescale stage. Einstein's relation holds in the former and is violated in the latter. The violation cannot be explained in terms of effective temperatures, while the GFDT is able to impute it to the emergence of a strong coupling between the intruder and the surrounding fluid. Direct experimental measurements confirm the development of spatial correlations in the system when the density is increased.	[Gnoli, Andrea; Puglisi, Andrea; Sarracino, Alessandro; Vulpiani, Angelo] CNR, Ist Sistemi Complessi, Rome, Italy; [Gnoli, Andrea; Puglisi, Andrea; Sarracino, Alessandro; Vulpiani, Angelo] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; [Sarracino, Alessandro] Univ Paris 06, CNRS, Lab Phys Theor Mat Condensee, Unite Mixte Rech 7600, Paris, France	Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR); Sapienza University Rome; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Puglisi, A (corresponding author), CNR, Ist Sistemi Complessi, Rome, Italy.	andrea.puglisi@roma1.infn.it	Gnoli, Andrea/AAY-2499-2020; Puglisi, Andrea/C-5566-2008	Gnoli, Andrea/0000-0003-2981-7199; Puglisi, Andrea/0000-0002-7229-9457; Sarracino, Alessandro/0000-0003-3686-0822	Italian MIUR [RBID08Z9JE, 2009PYYZM5]	Italian MIUR(Ministry of Education, Universities and Research (MIUR))	The authors acknowledge the support of the Italian MIUR under the grants: FIRB-IDEAS n. RBID08Z9JE. AP and AV acknowledge the support of the Italian MIUR under the grant PRIN n. 2009PYYZM5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baiesi M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.010602; Berthier L, 2013, NAT PHYS, V9, P310, DOI [10.1038/NPHYS2592, 10.1038/nphys2592]; Berthier L, 2011, REV MOD PHYS, V83, P587, DOI 10.1103/RevModPhys.83.587; Bialke J, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.168301; Crisanti A, 2003, J PHYS A-MATH GEN, V36, pR181, DOI 10.1088/0305-4470/36/21/201; Cugliandolo LF, 2011, J PHYS A-MATH THEOR, V44, DOI 10.1088/1751-8113/44/48/483001; D'Anna G, 2003, NATURE, V424, P909, DOI 10.1038/nature01867; Einstein A, 1905, ANN PHYS-BERLIN, V17, P549, DOI 10.1002/andp.19053220806; Fiege A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.098001; Fily Y, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.235702; Gnoli A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.120601; Hayakawa H, 2005, PHYSICA D, V205, P48, DOI 10.1016/j.physd.2004.12.011; Jaeger HM, 1996, REV MOD PHYS, V68, P1259, DOI 10.1103/RevModPhys.68.1259; Joubaud S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.130601; Keys AS, 2007, NAT PHYS, V3, P260, DOI 10.1038/nphys572; KUBO R, 1966, REP PROG PHYS, V29, P255, DOI 10.1088/0034-4885/29/1/306; Lippiello E, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.036104; Loi D, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.051111; Makse HA, 2002, NATURE, V415, P614, DOI 10.1038/415614a; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; Marconi UMB, 2008, PHYS REP, V461, P111, DOI 10.1016/j.physrep.2008.02.002; Ono IK, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.095703; Orpe AV, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.238001; Puglisi A, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/08/P08016; Sarracino A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/34001; Sarracino A, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/04/P04013; Seifert U, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/12/126001; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Villamaina D, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/07/P07024; Wang P, 2006, NAT PHYS, V2, P526, DOI 10.1038/nphys366	30	26	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93720	10.1371/journal.pone.0093720	http://dx.doi.org/10.1371/journal.pone.0093720			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714671	Green Published, gold, Green Submitted			2022-12-25	WOS:000334160900044
J	Kondo, S; Bottos, A; Allegood, JC; Masson, R; Maurer, FG; Genoud, C; Kaeser, P; Huwiler, A; Murakami, M; Spiegel, S; Hynes, NE				Kondo, Shunya; Bottos, Alessia; Allegood, Jeremy C.; Masson, Regis; Maurer, Francisca G.; Genoud, Christel; Kaeser, Patrick; Huwiler, Andrea; Murakami, Masato; Spiegel, Sarah; Hynes, Nancy E.			Memo Has a Novel Role in S1P Signaling and Crucial for Vascular Development	PLOS ONE			English	Article							SPHINGOSINE KINASE-1 EXPRESSION; PROTEIN-COUPLED RECEPTOR; LYMPHOCYTE EGRESS; ENDOTHELIAL-CELLS; SPHINGOSINE-1-PHOSPHATE; EDG-1; LAMELLIPODIA; 1-PHOSPHATE; INHIBITION; LINKS	Memo is a conserved protein that was identified as an essential mediator of tumor cell motility induced by receptor tyrosine kinase activation. Here we show that Memo null mouse embryonic fibroblasts (MEFs) are impaired in PDGF-induced migration and this is due to a defect in sphingosine-1-phosphate (S1P) signaling. S1P is a bioactive phospholipid produced in response to multiple stimuli, which regulates many cellular processes. S1P is secreted to the extracellular milieu where it exerts its function by binding a family of G-protein coupled receptors (S1PRs), causing their activation in an autocrine or paracrine manner. The process, termed cell-autonomous S1PR signaling, plays a role in survival and migration. Indeed, PDGF uses cell-autonomous S1PR signaling to promote cell migration; we show here that this S1P pathway requires Memo. Using vascular endothelial cells (HUVECs) with Memo knock-down we show that their survival in conditions of serum-starvation is impaired. Furthermore, Memo loss in HUVECs causes a reduction of junctional VE-cadherin and an increase in sprout formation. Each of these phenotypes is rescued by S1P or S1P agonist addition, showing that Memo also plays an important role in cell-autonomous S1PR signaling in endothelial cells. We also produced conventional and endothelial cell-specific conditional Memo knock-out mouse strains and show that Memo is essential for embryonic development. Starting at E13.5 embryos of both strains display bleeding and other vascular problems, some of the phenotypes that have been described in mouse strains lacking S1PRs. The essential role of Memo in embryonic vascular development may be due in part to alterations in S1P signaling. Taken together our results show that Memo has a novel role in the S1P pathway and that Memo is needed to promote cell-autonomous S1PR activation.	[Kondo, Shunya; Bottos, Alessia; Masson, Regis; Maurer, Francisca G.; Genoud, Christel; Kaeser, Patrick; Hynes, Nancy E.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Allegood, Jeremy C.; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA USA; [Kaeser, Patrick; Hynes, Nancy E.] Univ Basel, Basel, Switzerland; [Huwiler, Andrea] Univ Bern, Inst Pharmacol, Bern, Switzerland; [Murakami, Masato] Novartis Inst Biomed Res, Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Virginia Commonwealth University; University of Basel; University of Bern; Novartis	Hynes, NE (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	nancy.hynes@fmi.ch		genoud, christel/0000-0002-0933-9911	Novartis Research Foundation; Swiss National Science Foundation [SNF 310030A-121574, 310030B-138674]; EU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043880] Funding Source: NIH RePORTER	Novartis Research Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EU(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Novartis Research Foundation (http://www.fmi.ch/), the Swiss National Science Foundation (http://www.snf.ch/en/Pages/default.aspx): SNF 310030A-121574 and 310030B-138674, and the EU FP6 Integrated Project-TRANSFOG (http://www.healthcompetence.eu/converis/publicweb/project/3397; jsessionid = 6e322a0cc3a9c0b0b0016ec382f9? show = Person). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Benseddik K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055211; Beuvink I, 2005, CELL, V120, P747, DOI 10.1016/j.cell.2004.12.040; Doll F, 2005, BBA-MOL CELL BIOL L, V1738, P72, DOI 10.1016/j.bbalip.2005.12.001; Fukuhara S, 2012, J CLIN INVEST, V122, P1416, DOI 10.1172/JCI60746; Gaengel K, 2012, DEV CELL, V23, P587, DOI 10.1016/j.devcel.2012.08.005; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Haenzi B, 2013, FASEB J; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1215904, 10.1126/science.1244693]; Hisano Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038941; Hobson JP, 2001, SCIENCE, V291, P1800, DOI 10.1126/science.1057559; Huwiler A, 2006, BBA-MOL CELL BIOL L, V1761, P367, DOI 10.1016/j.bbalip.2006.02.007; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jung B, 2012, DEV CELL, V23, P600, DOI 10.1016/j.devcel.2012.07.015; Kharel Y, 2011, BIOCHEM J, V440, P345, DOI 10.1042/BJ20110817; Kim RH, 2009, BBA-MOL CELL BIOL L, V1791, P692, DOI 10.1016/j.bbalip.2009.02.011; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kono M, 2004, J BIOL CHEM, V279, P29367, DOI 10.1074/jbc.M403937200; Kono M, 2008, BBA-MOL CELL BIOL L, V1781, P435, DOI 10.1016/j.bbalip.2008.07.001; Kunkel GT, 2013, NAT REV DRUG DISCOV, V12, P688, DOI 10.1038/nrd4099; Le Stunff H, 2004, J BIOL CHEM, V279, P34290, DOI 10.1074/jbc.M404907200; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Lucke S, 2010, CELL PHYSIOL BIOCHEM, V26, P87, DOI 10.1159/000315109; Maceyka M, 2008, MOL CELL BIOL, V28, P5687, DOI 10.1128/MCB.00465-08; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Marone R, 2004, NAT CELL BIOL, V6, P515, DOI 10.1038/ncb1134; Meira M, 2009, J CELL SCI, V122, P787, DOI 10.1242/jcs.032094; Mizugishi K, 2005, MOL CELL BIOL, V25, P11113, DOI 10.1128/MCB.25.24.11113-11121.2005; OLIVERA A, 1994, ANAL BIOCHEM, V223, P306, DOI 10.1006/abio.1994.1589; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Qiu C, 2008, J BIOL CHEM, V283, P2734, DOI 10.1074/jbc.M703523200; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Rosenfeldt HM, 2001, FASEB J, V15, P2649, DOI 10.1096/fj.01-0523com; Sanna MG, 2006, NAT CHEM BIOL, V2, P434, DOI 10.1038/nchembio804; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Schlatter ID, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032501; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Sorokin AV, 2013, ONCOGENE, V32, P3130, DOI 10.1038/onc.2012.327; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Waters D, 2006, FASEB J, V20, pA1058; Yamaguchi T, 2010, GENE DEV, V24, P455, DOI 10.1101/gad.552310; Zaoui K, 2008, J CELL BIOL, V183, P401, DOI 10.1083/jcb.200805107; Zaoui K, 2010, P NATL ACAD SCI USA, V107, P18517, DOI 10.1073/pnas.1000975107	46	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94114	10.1371/journal.pone.0094114	http://dx.doi.org/10.1371/journal.pone.0094114			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714781	Green Published, gold			2022-12-25	WOS:000334160900085
J	Spiotto, MT; Weichselbaum, RR				Spiotto, Michael T.; Weichselbaum, Ralph R.			Comparison of 3D Confromal Radiotherapy and Intensity Modulated Radiotherapy with or without Simultaneous Integrated Boost during Concurrent Chemoradiation for Locally Advanced Head and Neck Cancers	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMAS; RADIATION-THERAPY; ACCELERATED RADIOTHERAPY; STANDARD FRACTIONATION; IMRT; CHEMOTHERAPY; SIB	Objective: Radiotherapy techniques have evolved from 3D conformal radiotherapy (3D-CRT) to intensity modulated radiotherapy (IMRT) where boost fields are delivered either sequentially (IMRTseq) or with a simultaneous integrated boost (IMRT+ SIB). Our goal was to compare the outcomes of patients treated with IMRT+ SIB to traditional standards. Methods: We analyzed the efficacy and toxicity of patients treated with concurrent chemoradiation using 3D-CRT, IMRTseq or IMRT+ SIB. Between 1993 and 2012, 379 patients with non-metastatic Stage III-IV head and neck squamous cell cancer were treated with concurrent chemoradiation using 3D-CRT (n = 125), IMRTseq (n = 120) and IMRT+ SIB (n = 134). Results: Patients treated with any technique had similar rates of 2y local control, 2y regional control, 2y progression free survival and 2y overall survival. Patients treated with IMRT+ SIB had lower rates acute toxicity according to Grade 3 or greater mucositis (3D-CRT: 44.0% vs. IMRTseq: 36.7% vs. IMRT+ SIB: 22.4%; P<.0001), dermatitis (3D-CRT: 44.0% vs. IMRTseq: 20.0% vs. IMRT+ SIB: 7.5%; P<.0001) and feeding tube placement during radiotherapy (3D-CRT: 80.0% vs. IMRTseq: 50.8% vs. IMRT+ SIB: 44.0%; P<.0001) as well as late toxicity as measured by feeding tube use (P<.0001) and tracheostomy use (P<.0001). On multivariate analysis, IMRT+ SIB predicted for less mucositis, dermatitis and feeding tube use compared to 3D-CRT and for less dermatitis compared to IMRTseq. Conclusions: Compared to 3D-CRT and IMRTseq, IMRT+ SIB provided similar outcomes and potentially less toxicity indicating it is a feasible technique for chemoradiation in locally advanced head and neck cancer.	[Spiotto, Michael T.; Weichselbaum, Ralph R.] Univ Chicago, Med Ctr, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA; [Spiotto, Michael T.; Weichselbaum, Ralph R.] Univ Chicago, Dept Radiat Oncol, Hosp & Hlth Sci Syst, Chicago, IL 60637 USA	University of Chicago; University of Chicago Medical Center; University of Chicago	Spiotto, MT (corresponding author), Univ Chicago, Med Ctr, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA.	mspiotto@radonc.uchicago.edu	Spiotto, Michael/AAC-8331-2021		Burroughs Wellcome Career Award for Medical Scientists; Fanconi Anemia Research Fund; NATIONAL CANCER INSTITUTE [R25CA132822] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	Burroughs Wellcome Career Award for Medical Scientists(Burroughs Wellcome Fund); Fanconi Anemia Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	M.T.S. was supported by a grant from the Burroughs Wellcome Career Award for Medical Scientists and the Fanconi Anemia Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang K, 2010, INT J RADIAT ONCOL, V77, P1, DOI 10.1016/j.ijrobp.2010.01.019; Brizel DM, 1998, NEW ENGL J MED, V338, P1798, DOI 10.1056/NEJM199806183382503; Chao KSC, 2003, INT J RADIAT ONCOL, V55, P312, DOI 10.1016/S0360-3016(02)03940-8; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cozzi L, 2004, INT J RADIAT ONCOL, V58, P617, DOI 10.1016/j.ijrobp.2003.09.059; Eisbruch A, 2010, INT J RADIAT ONCOL, V76, P1333, DOI 10.1016/j.ijrobp.2009.04.011; Franceschini D, 2013, LARYNGOSCOPE, V123, pE97, DOI 10.1002/lary.24257; Fu KK, 2000, INT J RADIAT ONCOL, V48, P7, DOI 10.1016/S0360-3016(00)00663-5; Karnofsky DA, 1949, CLIN EVALUATION CHEM; Lauve A, 2004, INT J RADIAT ONCOL, V60, P374, DOI 10.1016/j.ijrobp.2004.03.010; Leclerc M, 2013, RADIOTHER ONCOL, V106, P333, DOI 10.1016/j.radonc.2013.03.002; Lee NY, 2007, INT J RADIAT ONCOL, V69, P459, DOI 10.1016/j.ijrobp.2007.03.013; Lee SW, 2006, INT J RADIAT ONCOL, V65, P152, DOI 10.1016/j.ijrobp.2005.10.040; Mohan R, 2000, INT J RADIAT ONCOL, V46, P619, DOI 10.1016/S0360-3016(99)00438-1; Montejo ME, 2011, INT J RADIAT ONCOL, V81, pE845, DOI 10.1016/j.ijrobp.2010.10.021; Nutting CM, 2011, LANCET ONCOL, V12, P127, DOI 10.1016/S1470-2045(10)70290-4; Orlandi E, 2010, CRIT REV ONCOL HEMAT, V73, P111, DOI 10.1016/j.critrevonc.2009.03.003; Overgaard J, 2003, LANCET, V362, P933, DOI 10.1016/S0140-6736(03)14361-9; Palazzi M, 2006, TUMORI J, V92, P503, DOI 10.1177/030089160609200607; Schwartz M, 2007, OTOLARYNG HEAD NECK, V136, P549, DOI 10.1016/j.otohns.2006.10.044; Studer G, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-7; Xia P, 2000, INT J RADIAT ONCOL, V48, P329, DOI 10.1016/S0360-3016(00)00585-X	22	37	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94456	10.1371/journal.pone.0094456	http://dx.doi.org/10.1371/journal.pone.0094456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714187	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900134
J	He, LY; Han, XT; Yu, ZM				He, Liyan; Han, Xiaotian; Yu, Zhiming			A Rare Phaeodactylum tricornutum Cruciform Morphotype: Culture Conditions, Transformation and Unique Fatty Acid Characteristics	PLOS ONE			English	Article							FLUORESCENCE METHOD; CARBON FIXATION; DIATOM; BIODIESEL; REVEALS	A rare Phaeodactylum tricornutum cruciform morphotype was obtained and stabilized with a proportion of more than 31.3% in L1 medium and is reported for the first time. Long-term culture and observation showed that the cruciform morphotype was capable of transforming to the oval form following the degeneration of arms by two processes. After three months of culture, four morphotypes existed in a relatively stable proportion in culture for six months (10.5% for oval, 11.3% for fusiform, 37.2% for triradiate and 41.0% for cruciform). Low temperature was particularly beneficial for cruciform cell formation. As the culture temperature decreased from 25 degrees C to 10 degrees C, the percentage of the cruciform morphotype increased from 39.1% to 55.3% approximately. The abundant cruciform cells endowed this strain with unique fatty acid characteristics. The strain cultured at 15 degrees C showed both maximum content of neutral lipid in a single cell and total yield. The maximum content of fatty acid methyl esters was C16: 1 for Phaeodactylum tricornutum cultured at four temperatures (43.82% to 50.82%), followed by C16: 0 (20.47% to 22.65%). Unique fatty acid composition endowed this strain with excellent quality for biodiesel production.	[He, Liyan; Han, Xiaotian; Yu, Zhiming] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [He, Liyan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yu, ZM (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China.	zyu@qdio.ac.cn		Yu, Zhiming/0000-0003-0377-1129	National Natural Science Foundation of China [2011CB2009001]; State Oceanic Administration Project [GHME2001SW02]; Funds for Creative Research Groups of China [41121064]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Oceanic Administration Project; Funds for Creative Research Groups of China(Science Fund for Creative Research Groups)	This work was financially supported by the National Natural Science Foundation of China (2011CB2009001), the State Oceanic Administration Project (GHME2001SW02) and the Funds for Creative Research Groups of China (41121064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartual A, 2008, BOT MAR, V51, P350, DOI 10.1515/BOT.2008.047; Bartual A, 2011, DIATOM RES, V26, P243, DOI 10.1080/0269249X.2011.619365; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Brennan L, 2012, J MICROBIOL METH, V90, P137, DOI 10.1016/j.mimet.2012.03.020; Chauton MS, 2013, PLANT PHYSIOL, V161, P1034, DOI 10.1104/pp.112.206177; Chen W, 2011, BIORESOURCE TECHNOL, V102, P135, DOI 10.1016/j.biortech.2010.06.076; Cooper MS, 2010, J BIOSCI BIOENG, V109, P198, DOI 10.1016/j.jbiosc.2009.08.004; De Martino A, 2007, J PHYCOL, V43, P992, DOI 10.1111/j.1529-8817.2007.00384.x; De Martino A, 2011, PROTIST, V162, P462, DOI 10.1016/j.protis.2011.02.002; Desbois AP, 2010, J MAR BIOL ASSOC UK, V90, P769, DOI 10.1017/S0025315409991366; Fabris M, 2012, PLANT J, V70, P1004, DOI 10.1111/j.1365-313X.2012.04941.x; Francius G, 2008, ENVIRON MICROBIOL, V10, P1344, DOI 10.1111/j.1462-2920.2007.01551.x; Garcia MCC, 2005, PROCESS BIOCHEM, V40, P297, DOI 10.1016/j.procbio.2004.01.016; Govender T, 2012, BIORESOURCE TECHNOL, V114, P507, DOI 10.1016/j.biortech.2012.03.024; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; Hyka P, 2013, BIOTECHNOL ADV, V31, P2, DOI 10.1016/j.biotechadv.2012.04.007; Jiang HM, 2004, J PHYCOL, V40, P651, DOI 10.1111/j.1529-8817.2004.03112.x; Knothe G, 2006, J AM OIL CHEM SOC, V83, P823, DOI 10.1007/s11746-006-5033-y; Lapuerta M, 2009, ENERG POLICY, V37, P4337, DOI 10.1016/j.enpol.2009.05.049; LEWIN JC, 1958, J GEN MICROBIOL, V18, P418, DOI 10.1099/00221287-18-2-418; Liu CP, 2005, MICRON, V36, P545, DOI 10.1016/j.micron.2005.05.001; Montsant A, 2005, PLANT PHYSIOL, V137, P500, DOI 10.1104/pp.104.052829; Phukan MM, 2011, APPL ENERG, V88, P3307, DOI 10.1016/j.apenergy.2010.11.026; Radakovits R, 2011, METAB ENG, V13, P89, DOI 10.1016/j.ymben.2010.10.003; Scala S, 2002, PLANT PHYSIOL, V129, P993, DOI 10.1104/pp.010713; Stanley MS, 2007, EUR J PHYCOL, V42, P191, DOI 10.1080/09670260701240863; Tesson B, 2009, BOT MAR, V52, P104, DOI 10.1515/BOT.2009.012; Valenzuela J, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-40; VELTKAMP CJ, 1994, HYDROBIOLOGIA, V288, P33, DOI 10.1007/BF00006803; WILSON DP, 1946, J MAR BIOL ASSOC UK, V26, P235, DOI 10.1017/S002531540001211X; Zendejas FJ, 2012, BIOTECHNOL BIOENG, V109, P1146, DOI 10.1002/bit.24395	32	11	12	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93922	10.1371/journal.pone.0093922	http://dx.doi.org/10.1371/journal.pone.0093922			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710200	Green Published, gold, Green Submitted			2022-12-25	WOS:000334159800071
J	Zhou, Y; Liu, L; Huang, WF; Yuan, M; Zhou, F; Li, XH; Lin, YJ				Zhou, Yong; Liu, Li; Huang, Weifeng; Yuan, Meng; Zhou, Fei; Li, Xianghua; Lin, Yongjun			Overexpression of OsSWEET5 in Rice Causes Growth Retardation and Precocious Senescence	PLOS ONE			English	Article							AUXIN-INDUCED GROWTH; MONOSACCHARIDE TRANSPORTER; ARABIDOPSIS-THALIANA; DISEASE RESISTANCE; SUGAR TRANSPORTERS; POLLEN DEVELOPMENT; MOLECULAR-CLONING; GALACTOSE; GENE; PLANTS	As a novel sugar transporter family, SWEETs play important roles in plant growth and development. Here, we characterized a SWEET gene named OsSWEET5 through its overexpression in rice. Heterologous expression assay indicated that OsSWEET5 encoded a galactose transporter in yeast. OsSWEET5-overexpressing plants displayed the phenotypes of growth retardation and precocious senescence at seedling stage. GC-MS analysis showed that the sugar levels were largely altered in the leaves of the OsSWEET5-overexpressing plants. Molecular analysis revealed that these phenotypes might be due to the transcriptional changes of the genes involved in sugar metabolism and transport. In addition, the transgenic plants showed a lower level of auxin with altered transcription of genes involved in auxin signaling and translocation pathways. However, no obvious phenotype was observed between the amiRNA-OsSWEET5 transgenic lines and WT plants, which could be a result of the functional redundancy of the galactose transporters in rice. Taken together, our findings suggest that OsSWEET5 plays a crucial role in regulating the crosstalk between sugar and auxin in rice.	[Zhou, Yong; Huang, Weifeng; Yuan, Meng; Zhou, Fei; Li, Xianghua; Lin, Yongjun] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China; [Zhou, Yong; Huang, Weifeng; Yuan, Meng; Zhou, Fei; Li, Xianghua; Lin, Yongjun] Huazhong Agr Univ, Natl Ctr Plant Gene Res, Wuhan, Peoples R China; [Liu, Li] Univ Calif Davis, Davis, CA 95616 USA	Huazhong Agricultural University; Huazhong Agricultural University; University of California System; University of California Davis	Lin, YJ (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China.	yongjunlin@mail.hzau.edu.cn	Yuan, Meng/E-4949-2013	Yuan, Meng/0000-0003-1381-9202	National High Technology Research and Development Program of China (863 Program); National Natural Science Foundation of China; National Program of Transgenic Variety Development of China	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program of Transgenic Variety Development of China	This research was funded by the National High Technology Research and Development Program of China (863 Program), the National Natural Science Foundation of China and the National Program of Transgenic Variety Development of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANKER L, 1974, ACTA BOT NEERL, V23, P705, DOI 10.1111/j.1438-8677.1974.tb00980.x; Antony G, 2010, PLANT CELL, V22, P3864, DOI 10.1105/tpc.110.078964; Baker RF, 2012, MOL PLANT, V5, P766, DOI 10.1093/mp/sss054; Braun DM, 2012, SCIENCE, V335, P173, DOI 10.1126/science.1216828; Buttner M, 2000, BBA-BIOMEMBRANES, V1465, P263, DOI 10.1016/S0005-2736(00)00143-7; Chardon F, 2013, CURR BIOL, V23, P697, DOI 10.1016/j.cub.2013.03.021; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; CHEUNG SP, 1991, PLANT CELL PHYSIOL, V32, P1015, DOI 10.1093/oxfordjournals.pcp.a078164; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Du H, 2012, J EXP BOT, V63, P6467, DOI 10.1093/jxb/ers300; Du H, 2011, PLANT MOL BIOL, V77, P547, DOI 10.1007/s11103-011-9830-9; Eom JS, 2011, PLANT PHYSIOL, V157, P109, DOI 10.1104/pp.111.176982; Frey PA, 1996, FASEB J, V10, P461, DOI 10.1096/fasebj.10.4.8647345; Fu J, 2011, PLANT PHYSIOL, V155, P589, DOI 10.1104/pp.110.163774; Gamas P, 1996, MOL PLANT MICROBE IN, V9, P233, DOI 10.1094/MPMI-9-0233; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Jiang HW, 2007, PLANT J, V52, P197, DOI 10.1111/j.1365-313X.2007.03221.x; Kant S, 2009, PLANT SIGNAL BEHAV, V4, P1174, DOI 10.4161/psb.4.12.10043; Kant S, 2009, PLANT PHYSIOL, V151, P691, DOI 10.1104/pp.109.143875; KENYON WH, 1985, PLANT PHYSIOL, V77, P183, DOI 10.1104/pp.77.1.183; Klemens PAW, 2013, PLANT PHYSIOL, V163, P1338, DOI 10.1104/pp.113.224972; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KRUL WR, 1977, PHYSIOL PLANTARUM, V41, P249, DOI 10.1111/j.1399-3054.1977.tb04878.x; Lalonde S, 1999, PLANT CELL, V11, P707, DOI 10.1105/tpc.11.4.707; LeClere S, 2010, PLANT PHYSIOL, V153, P306, DOI 10.1104/pp.110.155226; Lee EJ, 2007, PLANT CELL PHYSIOL, V48, P405, DOI 10.1093/pcp/pcm009; LELOIR LF, 1951, ARCH BIOCHEM BIOPHYS, V33, P186, DOI 10.1016/0003-9861(51)90096-3; Leon P, 2003, TRENDS PLANT SCI, V8, P110, DOI 10.1016/S1360-1385(03)00011-6; Li CL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002196; Liu L, 2010, PLANT PHYSIOL, V153, P1239, DOI 10.1104/pp.110.157123; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu LX, 2012, PLANT CELL REP, V31, P1173, DOI 10.1007/s00299-012-1239-7; Mao DH, 2011, THEOR APPL GENET, V122, P373, DOI 10.1007/s00122-010-1453-z; Mishra BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004502; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; O'Donoghue EM, 2009, PLANTA, V229, P709, DOI 10.1007/s00425-008-0862-6; Ohto MA, 2006, PLANT CELL PHYSIOL, V47, P1603, DOI 10.1093/pcp/pcl027; Park SY, 2007, PLANT CELL, V19, P1649, DOI 10.1105/tpc.106.044891; Paul MJ, 2001, J EXP BOT, V52, P1383, DOI 10.1093/jexbot/52.360.1383; Poschet G, 2010, PLANT CELL PHYSIOL, V51, P1571, DOI 10.1093/pcp/pcq100; ROBERTS RM, 1971, PLANT PHYSIOL, V48, P36, DOI 10.1104/pp.48.1.36; Rojas-Escudero E, 2004, J CHROMATOGR A, V1027, P117, DOI 10.1016/j.chroma.2003.10.131; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Ruan YL, 2012, MOL PLANT, V5, P763, DOI 10.1093/mp/sss046; Sagar M, 2013, PLANT PHYSIOL, V161, P1362, DOI 10.1104/pp.113.213843; Sairanen I, 2012, PLANT CELL, V24, P4907, DOI 10.1105/tpc.112.104794; SAUER N, 1990, EMBO J, V9, P3045, DOI 10.1002/j.1460-2075.1990.tb07500.x; Sauer N, 2007, FEBS LETT, V581, P2309, DOI 10.1016/j.febslet.2007.03.048; Schneidereit A, 2005, PLANTA, V221, P48, DOI 10.1007/s00425-004-1420-5; Sherson SM, 2000, PLANT J, V24, P849, DOI 10.1046/j.1365-313x.2000.00935.x; Slewinski TL, 2011, MOL PLANT, V4, P641, DOI 10.1093/mp/ssr051; Slewinski TL, 2010, PLANT SIGNAL BEHAV, V5, P687, DOI 10.4161/psb.5.6.11575; Slewinski TL, 2009, J EXP BOT, V60, P881, DOI 10.1093/jxb/ern335; STADLER R, 1995, PLANT PHYSIOL, V107, P33, DOI 10.1104/pp.107.1.33; Stadler R, 2003, PLANT PHYSIOL, V133, P528, DOI 10.1104/pp.103.024240; Tang N, 2012, PLANT PHYSIOL, V158, P1755, DOI 10.1104/pp.111.190389; Truernit E, 1999, PLANT J, V17, P191, DOI 10.1046/j.1365-313X.1999.00372.x; Wang YQ, 2007, PLANT MOL BIOL, V65, P439, DOI 10.1007/s11103-007-9228-x; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Williams LE, 2000, TRENDS PLANT SCI, V5, P283, DOI 10.1016/S1360-1385(00)01681-2; YAMAMOTO R, 1988, PLANT PHYSIOL, V86, P1223, DOI 10.1104/pp.86.4.1223; YAMAMOTO R, 1981, PHYSIOL PLANTARUM, V53, P543, DOI 10.1111/j.1399-3054.1981.tb02748.x; Ye RJ, 2012, PLANT CELL REP, V31, P1159, DOI 10.1007/s00299-012-1238-8; Yuan M, 2013, MOL PLANT, V6, P665, DOI 10.1093/mp/sst035; Zhang H, 2010, PLANT CELL, V22, P672, DOI 10.1105/tpc.109.073668	67	57	79	5	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94210	10.1371/journal.pone.0094210	http://dx.doi.org/10.1371/journal.pone.0094210			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709840	gold, Green Submitted, Green Published			2022-12-25	WOS:000334159800120
J	Kihira, Y; Miyake, M; Hirata, M; Hoshina, Y; Kato, K; Shirakawa, H; Sakaue, H; Yamano, N; Izawa-Ishizawa, Y; Ishizawa, K; Ikeda, Y; Tsuchiya, K; Tamaki, T; Tomita, S				Kihira, Yoshitaka; Miyake, Mariko; Hirata, Manami; Hoshina, Yoji; Kato, Kana; Shirakawa, Hitoshi; Sakaue, Hiroshi; Yamano, Noriko; Izawa-Ishizawa, Yuki; Ishizawa, Keisuke; Ikeda, Yasumasa; Tsuchiya, Koichiro; Tamaki, Toshiaki; Tomita, Shuhei			Deletion of Hypoxia-Inducible Factor-1 alpha in Adipocytes Enhances Glucagon-Like Peptide-1 Secretion and Reduces Adipose Tissue Inflammation	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; INSULIN-RESISTANCE; MACROPHAGE INFILTRATION; 3T3-L1 ADIPOCYTES; MICE DEFICIENT; TNF-ALPHA; KINASE-A; OBESITY; EXPRESSION; ADIPONECTIN	It is known that obese adipose tissues are hypoxic and express hypoxia-inducible factor (HIF)-1 alpha. Although some studies have shown that the expression of HIF-1 alpha in adipocytes induces glucose intolerance, the mechanisms are still not clear. In this study, we examined its effects on the development of type 2 diabetes by using adipocyte-specific HIF-1 alpha knockout (ahKO) mice. ahKO mice showed improved glucose tolerance compared with wild type (WT) mice. Macrophage infiltration and mRNA levels of monocyte chemotactic protein-1 (MCP-1) and tumor necrosis factor alpha (TNF alpha) were decreased in the epididymal adipose tissues of high fat diet induced obese ahKO mice. The results indicated that the obesity-induced adipose tissue inflammation was suppressed in ahKO mice. In addition, in the ahKO mice, serum insulin levels were increased under the free-feeding but not the fasting condition, indicating that postprandial insulin secretion was enhanced. Serum glucagon-like peptide-1 (GLP-1) levels were also increased in the ahKO mice. Interestingly, adiponectin, whose serum levels were increased in the obese ahKO mice compared with the obese WT mice, stimulated GLP-1 secretion from cultured intestinal L cells. Therefore, insulin secretion may have been enhanced through the adiponectin-GLP-1 pathway in the ahKO mice. Our results suggest that the deletion of HIF-1 alpha in adipocytes improves glucose tolerance by enhancing insulin secretion through the GLP-1 pathway and by reducing macrophage infiltration and inflammation in adipose tissue.	[Kihira, Yoshitaka; Hirata, Manami; Hoshina, Yoji; Yamano, Noriko; Izawa-Ishizawa, Yuki; Ikeda, Yasumasa; Tamaki, Toshiaki] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Pharmacol, Tokushima 770, Japan; [Miyake, Mariko; Ishizawa, Keisuke; Tsuchiya, Koichiro] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Med Pharmacol, Tokushima 770, Japan; [Hirata, Manami; Hoshina, Yoji] Univ Tokushima, Fac Med, Student Lab, Tokushima 770, Japan; [Kato, Kana; Shirakawa, Hitoshi] Tohoku Univ, Grad Sch Agr Sci, Lab Nutr, Sendai, Miyagi 980, Japan; [Sakaue, Hiroshi] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Nutr & Metab, Tokushima 770, Japan; [Tomita, Shuhei] Tottori Univ, Fac Med, Div Mol Pharmacol, Tottori 680, Japan	Tokushima University; Tokushima University; Tokushima University; Tohoku University; Tokushima University; Tottori University	Tomita, S (corresponding author), Tottori Univ, Fac Med, Div Mol Pharmacol, Tottori 680, Japan.	tomita@med.tottori-u.ac.jp	Yamano-Adachi, Noriko/AAH-8605-2019; Sakaue, Hiroshi/ABE-2337-2021; Shirakawa, Hitoshi/D-1406-2009	Yamano-Adachi, Noriko/0000-0002-2167-5379; Sakaue, Hiroshi/0000-0002-2468-2363; Ikeda, Yasumasa/0000-0003-4318-7349; SHIRAKAWA, HITOSHI/0000-0002-4828-5274; Hoshina, Yoji/0000-0003-0228-664X	Kato Memorial Bioscience Foundation; KAKENHI [23790089]; Grants for the Regional Innovation Cluster Program; SENSHIN Medical Research Foundation; The Naito Foundation; Grants-in-Aid for Scientific Research [25860063, 24590381, 23790089] Funding Source: KAKEN	Kato Memorial Bioscience Foundation; KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants for the Regional Innovation Cluster Program; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); The Naito Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by the Kato Memorial Bioscience Foundation, by KAKENHI (23790089), by Grants for the Regional Innovation Cluster Program, by SENSHIN Medical Research Foundation and by The Naito Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouzakri K, 2007, J BIOL CHEM, V282, P7783, DOI 10.1074/jbc.M608602200; Chai WD, 2012, DIABETES, V61, P888, DOI 10.2337/db11-1073; Chen XH, 2010, MOL CELL ENDOCRINOL, V328, P63, DOI 10.1016/j.mce.2010.07.005; Chung LTK, 2009, BIOCHEM BIOPH RES CO, V390, P613, DOI 10.1016/j.bbrc.2009.10.015; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Curat CA, 2004, DIABETES, V53, P1285, DOI 10.2337/diabetes.53.5.1285; DRUCKER DJ, 1994, MOL ENDOCRINOL, V8, P1646, DOI 10.1210/me.8.12.1646; Gao H, 2007, ENDOCRINE, V32, P90, DOI 10.1007/s12020-007-9011-4; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; HAFFNER SM, 1995, DIABETES, V44, P1386, DOI 10.2337/diabetes.44.12.1386; Halberg N, 2008, ENDOCRIN METAB CLIN, V37, P753, DOI 10.1016/j.ecl.2008.07.002; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Jiang CT, 2013, J BIOL CHEM, V288, P3844, DOI 10.1074/jbc.M112.426338; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Langin D, 2006, TRENDS ENDOCRIN MET, V17, P314, DOI 10.1016/j.tem.2006.08.003; Lee YS, 2012, DIABETOLOGIA, V55, P2456, DOI 10.1007/s00125-012-2592-3; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Marchetti P, 2013, ADV EXP MED BIOL, V771, P288; Mojsilovic-Petrovic J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-12; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; Stolarczyk E, 2013, CELL METAB, V17, P520, DOI 10.1016/j.cmet.2013.02.019; Toft-Nielsen MB, 2001, J CLIN ENDOCR METAB, V86, P3717, DOI 10.1210/jc.86.8.3717; Tomita S, 2003, MOL CELL BIOL, V23, P6739, DOI 10.1128/MCB.23.19.6739-6749.2003; Vilsboll T, 2003, J CLIN ENDOCR METAB, V88, P2706, DOI 10.1210/jc.2002-021873; Wang B, 2007, PFLUG ARCH EUR J PHY, V455, P479, DOI 10.1007/s00424-007-0301-8; Wang P, 2008, J CELL PHYSIOL, V216, P3, DOI 10.1002/jcp.21386; Weir GC, 2013, ANN NY ACAD SCI, V1281, P92, DOI 10.1111/nyas.12031; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Yu JN, 2011, EUR J CELL BIOL, V90, P1000, DOI 10.1016/j.ejcb.2011.06.004; Zhang XM, 2010, J BIOL CHEM, V285, P32869, DOI 10.1074/jbc.M110.135509	42	45	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93856	10.1371/journal.pone.0093856	http://dx.doi.org/10.1371/journal.pone.0093856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705496	Green Published, Green Submitted, gold			2022-12-25	WOS:000334107500078
J	Ul-Haq, Z; Mackay, DF; Pell, JP				Ul-Haq, Zia; Mackay, Daniel F.; Pell, Jill P.			Association between Self-Reported General and Mental Health and Adverse Outcomes: A Retrospective Cohort Study of 19 625 Scottish Adults	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; QUALITY-OF-LIFE; RATED HEALTH; PSYCHOLOGICAL DISTRESS; FOLLOW-UP; WHITEHALL-II; MORTALITY; PARTICIPANTS; RISK; METAANALYSIS	Objective: Self-reported general health and mental health are independent predictors of all-cause mortality. This study examines whether they are also independent predictors of incident cancer, coronary heart disease and psychiatric hospitalisation. Methods: We conducted a retrospective, population cohort study by linking the 19 625 Scottish adults who participated in the Scottish Health Surveys 1995-2003, to hospital admissions, cancer registration and death certificate records. We conducted Cox proportional hazard models adjusting for potential confounders including age, sex, socioeconomic status, alcohol, smoking status, body mass index, hypertension and diabetes. Results: Poor general health was reported by 1215 (6.2%) participants and was associated with cancer registrations (adjusted Hazard Ratio [HR] 1.30, 95% Cl 1.10, 1.55), coronary heart disease events (adjusted HR 2.30, 95% Cl 1.86, 2.84) and psychiatric hospitalisations (adjusted HR 2.42, 95% Cl 1.65, 3.56). There was evidence of dose relationships and the associations remained significant after adjustment for mental health. 3172 (16%) participants had poor mental health (GHQ >= 4). After adjustment for general health, the associations between poor mental health and coronary heart disease events (adjusted HR 1.36, 95% Cl 1.13, 1.63) and all-cause death (adjusted HR 1.38, 95% Cl 1.23, 1.55) became non-significant, but mental health remained associated with psychiatric hospitalisations (fully adjusted HR 2.02, 95% Cl 1.48, 2.75). Conclusion: Self-reported general health is a significant predictor of a range of clinical outcomes independent of mental health. The association between mental health and non-psychiatric outcomes is mediated by general health but it is an independent predictor of psychiatric outcome. Individuals with poor general health or mental health warrant close attention.	[Ul-Haq, Zia; Mackay, Daniel F.; Pell, Jill P.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Ul-Haq, Zia] Khyber Med Univ, KPK, Inst Publ Hlth & Social Sci, Peshawar, Pakistan	University of Glasgow; Khyber Medical University	Pell, JP (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland.	jill.pell@glasgow.ac.uk	Ul Haq, Zia/GZM-0053-2022	Pell, Jill/0000-0002-8898-7035; ul haq, zia/0000-0001-5124-2171				Badawi G, 2013, J AFFECT DISORDERS, V145, P100, DOI 10.1016/j.jad.2012.07.018; Bath PA, 2003, GERONTOLOGIST, V43, P387, DOI 10.1093/geront/43.3.387; Benjamins MR, 2004, SOC SCI MED, V59, P1297, DOI 10.1016/j.socscimed.2003.01.001; Benyamini Y, 2000, J GERONTOL B-PSYCHOL, V55, pP107, DOI 10.1093/geronb/55.2.P107; Brotman DJ, 2007, LANCET, V370, P1089, DOI 10.1016/S0140-6736(07)61305-1; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Gao W, 2010, EUR J CANCER, V46, P2036, DOI 10.1016/j.ejca.2010.03.033; General Register Office, 1966, CLASS OCC; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Gray L, 2010, INT J EPIDEMIOL, V39, P345, DOI 10.1093/ije/dyp155; Hamer M, 2009, J PSYCHOSOM RES, V66, P255, DOI 10.1016/j.jpsychores.2008.11.002; Hirve S, 2012, INT J EPIDEMIOL, V41, P1719, DOI 10.1093/ije/dys163; Idler EL, 2000, AM J EPIDEMIOL, V152, P874, DOI 10.1093/aje/152.9.874; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Kivimaki M, 2003, BRIT MED J, V327, P364, DOI 10.1136/bmj.327.7411.364; Kosloski K, 2005, J GERONTOL B-PSYCHOL, V60, pP296, DOI 10.1093/geronb/60.6.P296; Latham K, 2013, J GERONTOL B-PSYCHOL, V68, P107, DOI 10.1093/geronb/gbs104; Lazzarino AI, 2013, PSYCHOSOM MED, V75, P311, DOI 10.1097/PSY.0b013e3182898e6d; Lekander M, 2004, PSYCHOSOM MED, V66, P559, DOI 10.1097/01.psy.0000130491.95823.94; Martikainen P, 1999, SOC SCI MED, V48, P1117, DOI 10.1016/S0277-9536(98)00416-X; Mavaddat N, 2011, J EPIDEMIOL COMMUN H, V65, P800, DOI 10.1136/jech.2009.090845; Montlahuc C, 2011, NEUROLOGY, V77, P1457, DOI 10.1212/WNL.0b013e31823303e1; Guimaraes JMN, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-676; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Nielsen ABS, 2008, SCAND J PUBLIC HEALT, V36, P3, DOI 10.1177/1403494807085242; Oguz S, 2013, MEASURING NATL WELL; Robinson KL, 2004, ANN EPIDEMIOL, V14, P467, DOI 10.1016/j.annepidem.2003.11.007; Russ TC, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4933; Salomon JA, 2004, BMJ-BRIT MED J, V328, P258, DOI 10.1136/bmj.37963.691632.44; Scotland NHS, 2010, HOSP REC DAT MON; Sen A, 2002, BRIT MED J, V324, P860, DOI 10.1136/bmj.324.7342.860; Smith KW, 1999, QUAL LIFE RES, V8, P447, DOI 10.1023/A:1008928518577; St John P, 2013, J GERIATR PSYCH NEUR, V26, P41, DOI 10.1177/0891988713476369; Stansfeld SA, 2002, INT J EPIDEMIOL, V31, P248, DOI 10.1093/ije/31.1.248; Tiainen K, 2013, AGE AGEING, V42, P468, DOI 10.1093/ageing/aft030; Ul-Haq Z, 2013, PSYCHOL MED, V1-10; Ul-Haq Z, 2014, J EPIDEMIOL COMMUN H, V68, P340, DOI 10.1136/jech-2013-203077; Ul-Haq Z, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-143; van der Linde RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065290; World Health Organization, 1996, HLTH INT SURV INT HA	40	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93857	10.1371/journal.pone.0093857	http://dx.doi.org/10.1371/journal.pone.0093857			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6MJ	24705574	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000334107500079
J	Hirata, Y; Funato, Y; Takano, Y; Miki, H				Hirata, Yusuke; Funato, Yosuke; Takano, Yu; Miki, Hiroaki			Mg2+ -dependent Interactions of ATP with the Cystathionine-beta-Synthase (CBS) Domains of a Magnesium Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CONE-ROD DYSTROPHY; CRYSTAL-STRUCTURE; BINDING; MUTATIONS; ANCIENT; AMPK	Ancient conserved domain protein/cyclin M (CNNM) family proteins are evolutionarily conserved Mg2+ transporters. However, their biochemical mechanism of action remains unknown. Here, we show the functional importance of the commonly conserved cystathionine-beta-synthase (CBS) domains and reveal their unique binding ability to ATP. Deletion mutants of CNNM2 and CNNM4, lacking the CBS domains, are unable to promote Mg2+ efflux. Furthermore, the substitution of one amino acid residue in the CBS domains of CNNM2, which is associated with human hereditary hypomagnesemia, abrogates Mg2+ efflux. Binding analyses reveal that the CBS domains of CNNM2 bind directly to ATP and not AMP in a manner dependent on the presence of Mg2+, which is inhibited in a similar pattern by the disease-associated amino acid substitution. The requirement of Mg2+ for these interactions is a unique feature among CBS domains, which can be explained by the presence of highly electronegative surface potentials around the ATP binding site on CNNM2. These results demonstrate that the CBS domains play essential roles in Mg2+ efflux, probably through interactions with ATP. Interactions with ATP, which mostly forms complexes with Mg2+ in cells, may account for the rapid Mg2+ transport by CNNM family proteins.	[Hirata, Yusuke; Funato, Yosuke; Miki, Hiroaki] Osaka Univ, Dept Cellular Regulat, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Takano, Yu] Osaka Univ, Lab Prot Informat, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Miki, H (corresponding author), Osaka Univ, Dept Cellular Regulat, Microbial Dis Res Inst, 3-1 Yamadaoka, Suita, Osaka 5650871, Japan.	hmiki@biken.osaka-u.ac.jp	Hirata, Yusuke/T-9580-2019; Takano, Yu/H-1785-2014	Hirata, Yusuke/0000-0002-1428-2075; Takano, Yu/0000-0002-4165-8672	Japan Society for the Promotion of Science (JSPS); Osaka University; JSPS; Ministry of Education, Culture, Sports, Science, and Technology-Japan; Taniguchi Memorial Fellowship project - Research Foundation for Microbial Diseases of Osaka University	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Osaka University; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Taniguchi Memorial Fellowship project - Research Foundation for Microbial Diseases of Osaka University	This work was supported by Funding Program for Next Generation World-Leading Researchers from Japan Society for the Promotion of Science (JSPS) (to H. M.), Exciting Leading-Edge Research Projects from Osaka University (to H. M.), and Grants-in-aid for Scientific Research from JSPS and Ministry of Education, Culture, Sports, Science, and Technology-Japan (to H. M. and Y.F.).; Supported by the Taniguchi Memorial Fellowship project funded by the Research Foundation for Microbial Diseases of Osaka University.	Alexander RT, 2008, J AM SOC NEPHROL, V19, P1451, DOI 10.1681/ASN.2008010098; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Baykov AA, 2011, ACS CHEM BIOL, V6, P1156, DOI 10.1021/cb200231c; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Blaszczyk J, 2000, STRUCTURE, V8, P1049, DOI 10.1016/S0969-2126(00)00502-5; Cai J, 2002, BIOCHEMISTRY-US, V41, P8058, DOI 10.1021/bi012082p; Carling D, 2011, NAT CHEM BIOL, V7, P512, DOI [10.1038/nchembio.610, 10.1038/NCHEMBIO.610]; de Baaij JHF, 2012, J BIOL CHEM, V287, P13644, DOI 10.1074/jbc.M112.342204; GIBSON MM, 1991, MOL MICROBIOL, V5, P2753, DOI 10.1111/j.1365-2958.1991.tb01984.x; Goytain A, 2005, PHYSIOL GENOMICS, V22, P382, DOI 10.1152/physiolgenomics.00058.2005; Gunther T, 2006, MAGNESIUM RES, V19, P225; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; Hattori M, 2009, EMBO J, V28, P3602, DOI 10.1038/emboj.2009.288; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kinjo Akira R, 2007, Biophysics (Nagoya-shi), V3, P75, DOI 10.2142/biophysics.3.75; Labesse G, 2013, STRUCTURE, V21, P975, DOI 10.1016/j.str.2013.03.011; Lis M., 2011, IMMUNOME RES, V7, P1, DOI DOI 10.4172/1745-7580.1000041; McIntosh DB, 2004, J BIOL CHEM, V279, P32515, DOI 10.1074/jbc.M403242200; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Parry DA, 2009, AM J HUM GENET, V84, P266, DOI 10.1016/j.ajhg.2009.01.009; Polok B, 2009, AM J HUM GENET, V84, P259, DOI 10.1016/j.ajhg.2009.01.006; Quamme GA, 2010, AM J PHYSIOL-CELL PH, V298, pC407, DOI 10.1152/ajpcell.00124.2009; Romani AMP, 2011, ARCH BIOCHEM BIOPHYS, V512, P1, DOI 10.1016/j.abb.2011.05.010; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Stuiver M, 2011, AM J HUM GENET, V88, P333, DOI 10.1016/j.ajhg.2011.02.005; Tameling WIL, 2002, PLANT CELL, V14, P2929, DOI 10.1105/tpc.005793; Wang CY, 2003, GENE, V306, P37, DOI 10.1016/S0378-1119(02)01210-6; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Yamazaki D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003983	33	66	66	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14731	14739		10.1074/jbc.M114.551176	http://dx.doi.org/10.1074/jbc.M114.551176			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24706765	Green Published, hybrid			2022-12-25	WOS:000337248100029
J	Touat-Hamici, Z; Legrain, Y; Bulteau, AL; Chavatte, L				Touat-Hamici, Zahia; Legrain, Yona; Bulteau, Anne-Laure; Chavatte, Laurent			Selective Up-regulation of Human Selenoproteins in Response to Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; MESSENGER-RNA STABILITY; NONSENSE-MEDIATED DECAY; SELENOCYSTEINE INCORPORATION; SELENIUM-DEFICIENCY; BINDING PROTEIN; GENE-EXPRESSION; HUMAN HEALTH; MUTATIONS; MACHINERY	Selenocysteine is inserted into selenoproteins via the translational recoding of a UGA codon, normally used as a stop signal. This process depends on the nature of the selenocysteine insertion sequence element located in the 3' UTR of selenoprotein mRNAs, selenium bioavailability, and, possibly, exogenous stimuli. To further understand the function and regulation of selenoproteins in antioxidant defense and redox homeostasis, we investigated how oxidative stress influences selenoprotein expression as a function of different selenium concentrations. We found that selenium supplementation of the culture media, which resulted in a hierarchical up-regulation of selenoproteins, protected HEK293 cells from reactive oxygen species formation. Furthermore, in response to oxidative stress, we identified a selective up-regulation of several selenoproteins involved in antioxidant defense (Gpx1, Gpx4, TR1, SelS, SelK, and Sps2). Interestingly, the response was more efficient when selenium was limiting. Although a modest change in mRNA levels was noted, we identified a novel translational control mechanism stimulated by oxidative stress that is characterized by up-regulation of UGA-selenocysteine recoding efficiency and relocalization of SBP2, selenocysteine-specific elongation factor, and L30 recoding factors from the cytoplasm to the nucleus.	[Touat-Hamici, Zahia; Legrain, Yona; Chavatte, Laurent] CNRS, Ctr Genet Mol, UPR3404, F-91198 Gif Sur Yvette, France; [Bulteau, Anne-Laure] CNRS UMR 8104, Ctr Rech Inst Cochin, INSERM U567, F-75005 Paris, France; [Bulteau, Anne-Laure; Chavatte, Laurent] CNRS UPPA, Lab Chim Analyt Bioinorgan & Environm, UMR5254, F-64000 Pau, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Pau et des Pays de l'Adour	Chavatte, L (corresponding author), CNRS UPPA, Lab Chim Analyt Bioinorgan & Environm, UMR5254, F-64000 Pau, France.	laurent.chavatte@univ-pau.fr	bulteau, anne-laure/AAN-4004-2020	Chavatte, Laurent/0000-0001-7696-2431	CNRS (ATIP program); Fondation pour la Recherche Medicale; Ligue Contre le Cancer (Comite de l'Essonne); Association pour la Recherche sur le Cancer [4849]; Programme Interdisciplinaire de Recherche du CNRS Longevite et Vieillissement; Agence Nationale de la Recherche [ANR-09-BLAN-0048]; Ministere de l'Enseignement Superieur et de la Recherche	CNRS (ATIP program); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Ligue Contre le Cancer (Comite de l'Essonne); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Programme Interdisciplinaire de Recherche du CNRS Longevite et Vieillissement; Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission)	This work was supported by the CNRS (ATIP program) (to L. C.), by the Fondation pour la Recherche Medicale (to L. C.), by the Ligue Contre le Cancer (Comite de l'Essonne) (to L. C.), by Association pour la Recherche sur le Cancer grant 4849 (to L. C.), by the Programme Interdisciplinaire de Recherche du CNRS Longevite et Vieillissement (to L. C.), and by Agence Nationale de la Recherche grant ANR-09-BLAN-0048 (to L. C.).; Supported by a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche.	Allmang C, 2009, BBA-GEN SUBJECTS, V1790, P1415, DOI 10.1016/j.bbagen.2009.03.003; Arbogast S, 2009, ANN NEUROL, V65, P677, DOI 10.1002/ana.21644; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Arner ESJ, 2002, METHOD ENZYMOL, V347, P226; Azevedo MF, 2010, J CLIN ENDOCR METAB, V95, P4066, DOI 10.1210/jc.2009-2611; Banning A, 2005, MOL CELL BIOL, V25, P4914, DOI 10.1128/MCB.25.12.4914-4923.2005; BERMANO G, 1995, BIOCHEM J, V311, P425, DOI 10.1042/bj3110425; Bermano G, 1996, FEBS LETT, V387, P157, DOI 10.1016/0014-5793(96)00493-0; Berry MJ, 2001, BIOFACTORS, V14, P17, DOI 10.1002/biof.5520140104; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Brigelius-Flohe Regina, 2012, Int J Cell Biol, V2012, P486147, DOI 10.1155/2012/486147; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Budiman ME, 2009, MOL CELL, V35, P479, DOI 10.1016/j.molcel.2009.06.026; Buelna-Chontal M, 2013, CELL SIGNAL, V25, P2548, DOI 10.1016/j.cellsig.2013.08.007; Burk RF, 2008, FREE RADICAL BIO MED, V44, P1617, DOI 10.1016/j.freeradbiomed.2008.01.016; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; Chavatte L, 2005, NAT STRUCT MOL BIOL, V12, P408, DOI 10.1038/nsmb922; Conrad M, 2010, ANTIOXID REDOX SIGN, V12, P851, DOI 10.1089/ars.2009.2912; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; de Jesus LA, 2006, MOL CELL BIOL, V26, P1795, DOI 10.1128/MCB.26.5.1795-1805.2006; Ding F, 1999, RNA, V5, P1561, DOI 10.1017/S1355838299991598; Driscoll DM, 2003, ANNU REV NUTR, V23, P17, DOI 10.1146/annurev.nutr.23.011702.073318; Dumitrescu AM, 2005, NAT GENET, V37, P1247, DOI 10.1038/ng1654; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; Ferreiro A, 2002, AM J HUM GENET, V71, P739, DOI 10.1086/342719; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; Karlenius TC, 2011, BIOTECHNIQUES, V50, P295, DOI 10.2144/000113666; Kasaikina MV, 2012, BBA-MOL CELL RES, V1823, P1633, DOI 10.1016/j.bbamcr.2012.02.018; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Latreche L, 2012, RNA BIOL, V9, P681, DOI 10.4161/rna.20147; Latreche L, 2009, NUCLEIC ACIDS RES, V37, P5868, DOI 10.1093/nar/gkp635; Legrain Y, 2014, J BIOL CHEM, V289, P6299, DOI 10.1074/jbc.M113.526863; LEI XG, 1995, J NUTR, V125, P1438; Low SC, 2000, EMBO J, V19, P6882, DOI 10.1093/emboj/19.24.6882; Miniard AC, 2010, NUCLEIC ACIDS RES, V38, P4807, DOI 10.1093/nar/gkq247; Muller M, 2010, GENES NUTR, V5, P297, DOI 10.1007/s12263-010-0168-8; Papp LV, 2006, MOL CELL BIOL, V26, P4895, DOI 10.1128/MCB.02284-05; Papp LV, 2010, ANTIOXID REDOX SIGN, V12, P797, DOI 10.1089/ars.2009.2913; Papp LV, 2010, ANTIOXID REDOX SIGN, V12, P793, DOI 10.1089/ars.2009.2973; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Sachdev SW, 2001, BIOCHEM J, V357, P851; Schoenmakers E, 2010, J CLIN INVEST, V120, P4220, DOI 10.1172/JCI43653; Shchedrina VA, 2010, ANTIOXID REDOX SIGN, V12, P839, DOI 10.1089/ars.2009.2865; Small-Howard A, 2006, MOL CELL BIOL, V26, P2337, DOI 10.1128/MCB.26.6.2337-2346.2006; Steinbrenner H, 2009, BBA-GEN SUBJECTS, V1790, P1478, DOI 10.1016/j.bbagen.2009.02.014; Stoytcheva ZR, 2009, BBA-GEN SUBJECTS, V1790, P1429, DOI 10.1016/j.bbagen.2009.05.012; Sun XL, 2001, MOL BIOL CELL, V12, P1009, DOI 10.1091/mbc.12.4.1009; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; Suzuki T, 2008, J BIOL CHEM, V283, P2021, DOI 10.1074/jbc.M708352200; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Papp LV, 2007, ANTIOXID REDOX SIGN, V9, P775, DOI 10.1089/ars.2007.1528; Wingler K, 1999, EUR J BIOCHEM, V259, P149, DOI 10.1046/j.1432-1327.1999.00012.x; Xu XM, 2005, J BIOL CHEM, V280, P41568, DOI 10.1074/jbc.M506696200	53	72	74	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14750	14761		10.1074/jbc.M114.551994	http://dx.doi.org/10.1074/jbc.M114.551994			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24706762	Green Published, hybrid			2022-12-25	WOS:000337248100031
J	Chen, Z; Jolley, B; Caldwell, C; Gallie, DR				Chen, Zhong; Jolley, Blair; Caldwell, Christian; Gallie, Daniel R.			Eukaryotic Translation Initiation Factor eIFiso4G Is Required to Regulate Violaxanthin De-epoxidase Expression in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Photosynthesis; Protein Synthesis; RNA; Translation; Translation Initiation Factors; VDE; eIFiso4G	CAP-INDEPENDENT TRANSLATION; POLY(A) BINDING-PROTEIN; POLY(A)-BINDING PROTEIN; PLANTS; LIGHT; RNA; EIF4A; PHOTOINHIBITION; PHOTOSYNTHESIS; FLUORESCENCE	Background: The initiation factor eIFiso4G organizes the assembly of those factors needed to initiate translation of plant mRNAs. Results: Loss of eIFiso4G results in increased violaxanthin de-epoxidase expression and increased xanthophyll cycle activity. Conclusion: eIFiso4G is required to maintain VDE expression at an optimal level. Significance: Of the two isoforms of eIF4G, eIFiso4G is required specifically to support photosynthetic activity. The eukaryotic translation initiation factor (eIF) 4G is a scaffold protein that organizes the assembly of those initiation factors needed to recruit the 40 S ribosomal subunit to an mRNA. Plants, like many eukaryotes, express two eIF4G isoforms. eIFiso4G, one of the isoforms specific to plants, is unique among eukaryotic eIF4G proteins in that it is highly divergent and unusually small in size, raising the possibility of functional specialization. In this study, the role of eIFiso4G in plant growth was investigated using null mutants for the eIF4G isoforms in Arabidopsis. eIFiso4G loss of function mutants exhibited smaller cell, leaf, plant size, and biomass accumulation that correlated with its reduced photosynthetic activity, phenotypes not observed with the eIF4G loss of function mutant. Although no change in photorespiration or dark respiration was observed in the eIFiso4G loss of function mutant, a reduction in chlorophyll levels and an increase in the level of nonphotochemical quenching were observed. An increase in xanthophyll cycle activity and the generation of reactive oxygen species contributed to the qE and qI components of nonphotochemical quenching, respectively. An increase in the transcript and protein levels of violaxanthin de-epoxidase in the eIFiso4G loss of function mutant and an increase in its xanthophyll de-epoxidation state correlated with the higher qE associated with loss of eIFiso4G expression. These observations indicate that eIFiso4G expression is required to regulate violaxanthin de-epoxidase expression and to support photosynthetic activity.	[Chen, Zhong; Jolley, Blair; Caldwell, Christian; Gallie, Daniel R.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Gallie, DR (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.	drgallie@citrus.ucr.edu			National Science Foundation [DBI-0820047]; University of California Agricultural Experiment Station	National Science Foundation(National Science Foundation (NSF)); University of California Agricultural Experiment Station(University of California System)	This work was supported by National Science Foundation Grant DBI-0820047 and grants from the University of California Agricultural Experiment Station (to D.R.G.).	ARO EM, 1993, BIOCHIM BIOPHYS ACTA, V1143, P113, DOI 10.1016/0005-2728(93)90134-2; Asada K., 1987, PHOTOINHIBITION, P227; Bi XP, 2000, BIOCHEMISTRY-US, V39, P5758, DOI 10.1021/bi992322p; Browning KS, 1996, PLANT MOL BIOL, V32, P107, DOI 10.1007/BF00039380; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; Cheng SJ, 2006, J BIOL CHEM, V281, P24351, DOI 10.1074/jbc.M605404200; Cheng SJ, 2013, TRANSLATION, V1, DOI 10.4161/trla.24038; Cheng SJ, 2010, BIOCHEMISTRY-US, V49, P8251, DOI 10.1021/bi1008529; DEMMIGADAMS B, 1992, PLANT CELL ENVIRON, V15, P411, DOI 10.1111/j.1365-3040.1992.tb00991.x; Flexas J, 2002, ANN BOT-LONDON, V89, P183, DOI 10.1093/aob/mcf027; Gallie DR, 2002, NUCLEIC ACIDS RES, V30, P3401, DOI 10.1093/nar/gkf457; Gallie DR, 2002, PLANT MOL BIOL, V50, P949, DOI 10.1023/A:1021220910664; Gallie DR, 2001, J VIROL, V75, P12141, DOI 10.1128/JVI.75.24.12141-12152.2001; Gallie DR, 2001, J BIOL CHEM, V276, P36951, DOI 10.1074/jbc.M103869200; Gay CA, 2002, ANAL BIOCHEM, V304, P42, DOI 10.1006/abio.2001.5566; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; HAGER A, 1969, PLANTA, V89, P224, DOI 10.1007/BF00385028; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; HAVAUX M, 1991, J PHOTOCH PHOTOBIO B, V8, P361, DOI 10.1016/1011-1344(91)80112-U; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Le H, 2000, J BIOL CHEM, V275, P17452, DOI 10.1074/jbc.M001186200; Le H, 1997, J BIOL CHEM, V272, P16247, DOI 10.1074/jbc.272.26.16247; Lellis AD, 2010, PLANT MOL BIOL, V74, P249, DOI 10.1007/s11103-010-9670-z; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Mayberry LK, 2009, PLANT PHYSIOL, V150, P1844, DOI 10.1104/pp.109.138438; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Muller-Moule P, 2004, PLANT PHYSIOL, V134, P1163, DOI 10.1104/pp.103.032375; Nishiyama Y, 2006, BBA-BIOENERGETICS, V1757, P742, DOI 10.1016/j.bbabio.2006.05.013; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Preiss T, 2003, BIOESSAYS, V25, P1201, DOI 10.1002/bies.10362; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; Saul H, 2009, PLANT J, V60, P1031, DOI 10.1111/j.1365-313X.2009.04021.x; TARUN SZ, 1995, GENE DEV, V9, P2997, DOI 10.1101/gad.9.23.2997; Wei CC, 1998, BIOCHEMISTRY-US, V37, P1910, DOI 10.1021/bi9724570; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7	39	16	17	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13926	13936		10.1074/jbc.M114.555151	http://dx.doi.org/10.1074/jbc.M114.555151			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24706761	Green Published, hybrid			2022-12-25	WOS:000335984600024
J	Schworer, SA; Smirnova, II; Kurbatova, I; Bagina, U; Churova, M; Fowler, T; Roy, AL; Degterev, A; Poltorak, A				Schworer, Stephen A.; Smirnova, Irina I.; Kurbatova, Irina; Bagina, Uliana; Churova, Maria; Fowler, Trent; Roy, Ananda L.; Degterev, Alexei; Poltorak, Alexander			Toll-like Receptor-mediated Down-regulation of the Deubiquitinase Cylindromatosis ( CYLD) Protects Macrophages from Necroptosis in Wild-derived Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Deubiquitination; Gene Regulation; Mouse Genetics; Necrosis (Necrotic Death); Toll-like Receptor (TLR); Forward Genetic Mapping; Wild-derived Mice	NF-KAPPA-B; TUMOR-SUPPRESSOR GENE; PROGRAMMED NECROSIS; CELL-DEATH; NEGATIVE REGULATOR; RIP1 KINASE; ENZYME CYLD; ACTIVATION; INFLAMMATION; PHOSPHORYLATION	Background: Necroptosis is a regulated signaling pathway leading to necrotic cell death. Results: Genetic mapping identified that down-regulation of the deubiquitinase CYLD confers resistance to necroptosis in a wild-derived mouse strain. Conclusion: Different strains of inbred mice regulate cell death pathways using distinct mechanisms. Significance: Genetic diversity of wild-derived mice underlies phenotypic diversity, which can identify novel mechanisms of regulation in cell death signaling. Pathogen recognition by the innate immune system initiates the production of proinflammatory cytokines but can also lead to programmed host cell death. Necroptosis, a caspase-independent cell death pathway, can contribute to the host defense against pathogens or cause damage to host tissues. Receptor-interacting protein (RIP1) is a serine/threonine kinase that integrates inflammatory and necroptotic responses. To investigate the mechanisms of RIP1-mediated activation of immune cells, we established a genetic screen on the basis of RIP1-mediated necroptosis in wild-derived MOLF/EiJ mice, which diverged from classical laboratory mice over a million years ago. When compared with C57BL/6, MOLF/EiJ macrophages were resistant to RIP1-mediated necroptosis induced by Toll-like receptors. Using a forward genetic approach in a backcross panel of mice, we identified cylindromatosis (CYLD), a deubiquitinase known to act directly on RIP1 and promote necroptosis in TNF receptor signaling, as the gene conferring the trait. We demonstrate that CYLD is required for Toll-like receptor-induced necroptosis and describe a novel mechanism by which CYLD is down-regulated at the transcriptional level in MOLF/EiJ macrophages to confer protection from necroptosis.	[Schworer, Stephen A.; Roy, Ananda L.; Poltorak, Alexander] Tufts Univ, Sch Med, Sackler Sch Biomed Sci, Grad Program Immunol, Boston, MA 02111 USA; [Schworer, Stephen A.] Tufts Univ, Sch Med, Sackler Sch Biomed Sci, Med Scientist Training Program, Boston, MA 02111 USA; [Smirnova, Irina I.] Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, Sackler Sch Biomed Sci, Boston, MA 02111 USA; [Fowler, Trent; Roy, Ananda L.; Degterev, Alexei] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Sackler Sch Biomed Sci, Boston, MA 02111 USA; [Roy, Ananda L.; Poltorak, Alexander] Tufts Univ, Sch Med, Grad Program Genet, Sackler Sch Biomed Sci, Boston, MA 02111 USA; [Kurbatova, Irina; Churova, Maria; Poltorak, Alexander] Russian Acad Sci, Inst Biol, Karelian Res Ctr, Petrozavodsk 185910, Russia; [Bagina, Uliana] Petrozavodsk State Univ, Petrozavodsk 185910, Russia	Tufts University; Tufts University; Tufts University; Tufts University; Tufts University; Russian Academy of Sciences; Karelian Research Centre of the Russian Academy of Sciences; Institute of Biology of Karelian Research Centre RAS; Petrozavodsk State University	Poltorak, A (corresponding author), Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, Boston, MA 02111 USA.	alexander.poltorak@tufts.edu	Churova, Maria/A-5912-2014; Kurbatova, Irina/A-5535-2014	Churova, Maria/0000-0002-8895-0806; Kurbatova, Irina/0000-0001-7620-7065; Schworer, Stephen/0000-0001-7741-8972	National Institutes of Health [AI056234, AI090419]; Government of the Russian Federation (Article 220) [GK 11.G34.31.0052, RFFI 13-04-40267-H13]; Eshe Fund; Keck Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056234, R56AI056234, R21AI090419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Government of the Russian Federation (Article 220); Eshe Fund; Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI056234 and AI090419 (to A. P.). This work was also supported by Government of the Russian Federation (Article 220) Grants GK 11.G34.31.0052, and RFFI 13-04-40267-H13 (to A. P.), by the Eshe Fund, and by the Keck Foundation.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Conner JR, 2008, J EXP MED, V205, P305, DOI 10.1084/jem.20071499; Conner JR, 2010, P NATL ACAD SCI USA, V107, P11477, DOI 10.1073/pnas.1006894107; Conner JR, 2009, J EXP MED, V206, P1615, DOI 10.1084/jem.20090490; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Duprez L, 2009, MICROBES INFECT, V11, P1050, DOI 10.1016/j.micinf.2009.08.013; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Flannery SM, 2011, J BIOL CHEM, V286, P23688, DOI 10.1074/jbc.M111.248351; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gilchrist DA, 2012, GENE DEV, V26, P933, DOI 10.1101/gad.187781.112; Gosse SG, 2005, CELL SIGNAL, V17, P1352, DOI 10.1016/j.cellsig.2005.02.002; Guenet JL, 2003, TRENDS GENET, V19, P24, DOI 10.1016/S0168-9525(02)00007-0; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; He SD, 2011, P NATL ACAD SCI USA, V108, P20054, DOI 10.1073/pnas.1116302108; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hovelmeyer N, 2007, J EXP MED, V204, P2615, DOI 10.1084/jem.20070318; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iwai K, 2012, TRENDS CELL BIOL, V22, P355, DOI 10.1016/j.tcb.2012.04.001; Jin W, 2008, J CLIN INVEST, V118, P1858, DOI 10.1172/JCI34257; Jono H, 2004, J BIOL CHEM, V279, P36171, DOI 10.1074/jbc.M406638200; Kaiser WJ, 2013, J BIOL CHEM, V288, P31268, DOI 10.1074/jbc.M113.462341; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Kuphal S, 2011, ONCOGENE, V30, P4523, DOI 10.1038/onc.2011.163; Kwak H, 2013, SCIENCE, V339, P950, DOI 10.1126/science.1229386; Liang G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019613; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Liu P, 2012, LEUKEMIA, V26, P1293, DOI 10.1038/leu.2011.357; Lu JF, 2008, CANCER RES, V68, P9384, DOI 10.1158/0008-5472.CAN-08-2655; Lukens JR, 2013, NATURE, V498, P224, DOI 10.1038/nature12174; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Massoumi R, 2010, TRENDS BIOCHEM SCI, V35, P392, DOI 10.1016/j.tibs.2010.02.007; Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044; McComb S, 2012, CELL DEATH DIFFER, V19, P1791, DOI 10.1038/cdd.2012.59; Moquin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076841; Moseman AP, 2013, J IMMUNOL, V191, P5615, DOI 10.4049/jimmunol.1301438; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Rajput A, 2011, IMMUNITY, V34, P340, DOI 10.1016/j.immuni.2010.12.018; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Strober W, 2011, MUCOSAL IMMUNOL, V4, P484, DOI 10.1038/mi.2011.29; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Urbanik T, 2011, INT J ONCOL, V38, P121, DOI 10.3892/ijo_00000831; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wang L, 2005, MOL CELL BIOL, V25, P7953, DOI 10.1128/MCB.25.18.7953-7965.2005; Wertz IE, 2010, CELL DEATH DIFFER, V17, P14, DOI 10.1038/cdd.2009.168; Wu JF, 2013, CELL RES, V23, P994, DOI 10.1038/cr.2013.91; Yang HN, 2011, NAT GENET, V43, P648, DOI 10.1038/ng.847; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746; Zhong S, 2007, ONCOGENE, V26, P2621, DOI 10.1038/sj.onc.1210041	60	26	27	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14422	14433		10.1074/jbc.M114.547547	http://dx.doi.org/10.1074/jbc.M114.547547			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24706750	hybrid, Green Published			2022-12-25	WOS:000335984600067
J	Lage, MD; Pittman, AMC; Roncador, A; Cellini, B; Tucker, CL				Lage, Melissa D.; Pittman, Adrianne M. C.; Roncador, Alessandro; Cellini, Barbara; Tucker, Chandra L.			Allele-specific Characterization of Alanine: Glyoxylate Aminotransferase Variants Associated with Primary Hyperoxaluria	PLOS ONE			English	Article							ALANINEGLYOXYLATE AMINOTRANSFERASE; CRYSTAL-STRUCTURE; MAJOR ALLELE; AGXT GENE; IN-VITRO; TYPE-1; MUTATIONS; DIMERIZATION; STABILITY; PHENOTYPE	Primary Hyperoxaluria Type 1 (PH1) is a rare autosomal recessive kidney stone disease caused by deficiency of the peroxisomal enzyme alanine: glyoxylate aminotransferase (AGT), which is involved in glyoxylate detoxification. Over 75 different missense mutations in AGT have been found associated with PH1. While some of the mutations have been found to affect enzyme activity, stability, and/or localization, approximately half of these mutations are completely uncharacterized. In this study, we sought to systematically characterize AGT missense mutations associated with PH1. To facilitate analysis, we used two high-throughput yeast-based assays: one that assesses AGT specific activity, and one that assesses protein stability. Approximately 30% of PH1-associated missense mutations are found in conjunction with a minor allele polymorphic variant, which can interact to elicit complex effects on protein stability and trafficking. To better understand this allele interaction, we functionally characterized each of 34 mutants on both the major (wild-type) and minor allele backgrounds, identifying mutations that synergize with the minor allele. We classify these mutants into four distinct categories depending on activity/stability results in the different alleles. Twelve mutants were found to display reduced activity in combination with the minor allele, compared with the major allele background. When mapped on the AGT dimer structure, these mutants reveal localized regions of the protein that appear particularly sensitive to interactions with the minor allele variant. While the majority of the deleterious effects on activity in the minor allele can be attributed to synergistic interaction affecting protein stability, we identify one mutation, E274D, that appears to specifically affect activity when in combination with the minor allele.	[Lage, Melissa D.; Pittman, Adrianne M. C.; Tucker, Chandra L.] Duke Univ, Dept Biol, Durham, NC 27706 USA; [Roncador, Alessandro; Cellini, Barbara] Univ Verona, Sect Biol Chem, Dept Life Sci & Reprod, I-37100 Verona, Italy; [Tucker, Chandra L.] Univ Colorado, Denver Sch Med, Dept Pharmacol, Aurora, CO USA	Duke University; University of Verona; University of Colorado System; University of Colorado Anschutz Medical Campus	Tucker, CL (corresponding author), Duke Univ, Dept Biol, Durham, NC 27706 USA.	chandra.tucker@ucdenver.edu	Cellini, Barbara/AAC-6401-2019; Tucker, Chandra/F-6842-2011	Cellini, Barbara/0000-0002-5221-9288; Tucker, Chandra/0000-0003-3033-1786	National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01DK81584]; Oxalosis and Hyperoxaluria Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081584] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Oxalosis and Hyperoxaluria Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (grant number R01DK81584) and the Oxalosis and Hyperoxaluria Foundation to C. L. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cellini B, 2007, BIOCHEM J, V408, P39, DOI 10.1042/BJ20070637; Cellini B, 2010, BIOCHIMIE, V92, P1801, DOI 10.1016/j.biochi.2010.08.005; Cellini B, 2010, P NATL ACAD SCI USA, V107, P2896, DOI 10.1073/pnas.0908565107; Coulter-Mackie MB, 2006, MOL GENET METAB, V89, P349, DOI 10.1016/j.ymgme.2006.07.013; Coulter-Mackie MB, 2005, MOL GENET METAB, V86, P172, DOI 10.1016/j.ymgme.2005.05.005; Danpure CJ, 2005, AM J NEPHROL, V25, P303, DOI 10.1159/000086362; DANPURE CJ, 1993, AM J HUM GENET, V53, P417; Fodor K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001309; Frishberg Y, 2005, AM J NEPHROL, V25, P269, DOI 10.1159/000086357; Hopper ED, 2008, J BIOL CHEM, V283, P30493, DOI 10.1074/jbc.M803525200; Leiper JM, 1996, J CELL BIOL, V135, P939, DOI 10.1083/jcb.135.4.939; Lumb MJ, 2003, BIOCHEM J, V374, P79, DOI 10.1042/BJ20030371; Lumb MJ, 1999, J BIOL CHEM, V274, P20587, DOI 10.1074/jbc.274.29.20587; Lumb MJ, 2000, J BIOL CHEM, V275, P36415, DOI 10.1074/jbc.M006693200; Mesa-Torres N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071963; Monico CG, 2007, J AM SOC NEPHROL, V18, P1905, DOI 10.1681/ASN.2006111230; Oppici E, 2013, BBA-MOL BASIS DIS, V1832, P2277, DOI 10.1016/j.bbadis.2013.09.002; Oppici E, 2013, PROTEINS, V81, P1457, DOI 10.1002/prot.24300; Oppici E, 2012, MOL GENET METAB, V105, P132, DOI 10.1016/j.ymgme.2011.09.033; Pey AL, 2011, AMINO ACIDS, V41, P1233, DOI 10.1007/s00726-010-0801-2; Pittman AMC, 2012, GENETICS, V192, P831, DOI 10.1534/genetics.112.143750; PURDUE PE, 1991, P NATL ACAD SCI USA, V88, P10900, DOI 10.1073/pnas.88.23.10900; PURDUE PE, 1990, J CELL BIOL, V111, P2341, DOI 10.1083/jcb.111.6.2341; Robbiano A, 2010, J NEPHROL, V23, P667; Schlosser T, 2004, YEAST, V21, P63, DOI 10.1002/yea.1058; Williams E, 2007, CLIN CHEM, V53, P1216, DOI 10.1373/clinchem.2006.084434; Williams EL, 2009, HUM MUTAT, V30, P910, DOI 10.1002/humu.21021; Zhang XX, 2003, J MOL BIOL, V331, P643, DOI 10.1016/S0022-2836(03)00791-5	28	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94338	10.1371/journal.pone.0094338	http://dx.doi.org/10.1371/journal.pone.0094338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718375	gold, Green Submitted, Green Published			2022-12-25	WOS:000334339000105
J	Mao, YY; Reiprich, S; Wegner, M; Fritzsch, B				Mao, YanYan; Reiprich, Simone; Wegner, Michael; Fritzsch, Bernd			Targeted Deletion of Sox10 by Wnt1-cre Defects Neuronal Migration and Projection in the Mouse Inner Ear	PLOS ONE			English	Article							SPIRAL GANGLION NEURONS; NERVOUS-SYSTEM DEVELOPMENT; CRANIAL NEURAL CREST; HAIR-CELLS; COCHLEOVESTIBULAR GANGLION; COCHLEAR INNERVATION; WAARDENBURG-SYNDROME; SENSORY EPITHELIA; AUDITORY-SYSTEM; EXPRESSION	Sensory nerves of the brainstem are mostly composed of placode-derived neurons, neural crest-derived neurons and neural crest-derived Schwann cells. This mixed origin of cells has made it difficult to dissect interdependence for fiber guidance. Inner ear-derived neurons are known to connect to the brain after delayed loss of Schwann cells in ErbB2 mutants. However, the ErbB2 mutant related alterations in the ear and the brain compound interpretation of the data. We present here a new model to evaluate exclusively the effect of Schwann cell loss on inner ear innervation. Conditional deletion of the neural crest specific transcription factor, Sox10, using the rhombic lip/neural crest specific Wnt1-cre driver spares Sox10 expression in the ear. We confirm that neural crest-derived cells provide a stop signal for migrating spiral ganglion neurons. In the absence of Schwann cells, spiral ganglion neurons migrate into the center of the cochlea and even out of the ear toward the brain. Spiral ganglion neuron afferent processes reach the organ of Corti, but many afferent fibers bypass the organ of Corti to enter the lateral wall of the cochlea. In contrast to this peripheral disorganization, the central projection to cochlear nuclei is normal. Compared to ErbB2 mutants, conditional Sox10 mutants have limited cell death in spiral ganglion neurons, indicating that the absence of Schwann cells alone contributes little to the embryonic survival of neurons. These data suggest that neural crest-derived cells are dispensable for all central and some peripheral targeting of inner ear neurons. However, Schwann cells provide a stop signal for migratory spiral ganglion neurons and facilitate proper targeting of the organ of Corti by spiral ganglion afferents.	[Mao, YanYan; Fritzsch, Bernd] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Mao, YanYan] Shandong Univ, Prov Hosp, Jinan 250100, Peoples R China; [Reiprich, Simone; Wegner, Michael] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany	University of Iowa; Shandong University; University of Erlangen Nuremberg	Fritzsch, B (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.	bernd-fritzsch@uiowa.edu		Fritzsch, Bernd/0000-0002-4882-8398; Wegner, Michael/0000-0002-4586-3294	NIH [R01 DC 005590];  [P30 DC010362]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC010362, R01DC005590] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a NIH grant (R01 DC 005590) to B. F. and in part by P30 DC010362. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appler JM, 2013, J NEUROSCI, V33, P3679, DOI 10.1523/JNEUROSCI.4703-12.2013; Begbie J, 2001, SCIENCE, V294, P595, DOI 10.1126/science.1062028; Bondurand N, 2007, AM J HUM GENET, V81, P1169, DOI 10.1086/522090; Bondurand N, 2013, DEV BIOL, V382, P330, DOI 10.1016/j.ydbio.2013.04.024; Breuskin I, 2010, J NEUROCHEM, V114, P1827, DOI 10.1111/j.1471-4159.2010.06897.x; Breuskin I, 2009, DEV BIOL, V335, P327, DOI 10.1016/j.ydbio.2009.09.007; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Chaoui A, 2011, HUM MUTAT, V32, P1436, DOI 10.1002/humu.21583; Coate TM, 2013, SEMIN CELL DEV BIOL, V24, P460, DOI 10.1016/j.semcdb.2013.04.003; Coate TM, 2012, NEURON, V73, P49, DOI 10.1016/j.neuron.2011.10.029; Coppola E, 2010, P NATL ACAD SCI USA, V107, P2066, DOI 10.1073/pnas.0910213107; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Duncan J, 2011, JOVE-J VIS EXP, DOI 10.3791/2451; Duncan JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062046; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; ERNFORS P, 1995, NEURON, V14, P1153, DOI 10.1016/0896-6273(95)90263-5; Farinas I, 2001, J NEUROSCI, V21, P6170, DOI 10.1523/JNEUROSCI.21-16-06170.2001; Finzsch M, 2008, DEVELOPMENT, V135, P637, DOI 10.1242/dev.010454; Finzsch M, 2010, J CELL BIOL, V189, P701, DOI 10.1083/jcb.200912142; Folgueras AR, 2009, P NATL ACAD SCI USA, V106, P16451, DOI 10.1073/pnas.0908507106; Freter S, 2013, DEVELOPMENT, V140, P3595, DOI 10.1242/dev.091033; Freyer L, 2011, DEVELOPMENT, V138, P5403, DOI 10.1242/dev.069849; Fritzsch B, 2005, BRAIN RES BULL, V66, P249, DOI 10.1016/j.brainresbull.2005.05.016; FRITZSCH B, 1993, DEV BRAIN RES, V74, P122, DOI 10.1016/0165-3806(93)90091-N; Fritzsch B, 1997, J NEUROSCI, V17, P6213; Fritzsch B, 2002, J NEUROBIOL, V53, P143, DOI 10.1002/neu.10098; Fritzsch B, 2013, EVOL DEV, V15, P63, DOI 10.1111/ede.12015; Fritzsch B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009377; Frob F, 2012, GLIA, V60, P806, DOI 10.1002/glia.22310; Graham A, 2004, DEV DYNAM, V229, P5, DOI 10.1002/dvdy.10442; Green SH, 2012, ANAT REC, V295, P1877, DOI 10.1002/ar.22587; Jahan I, 2010, CELL TISSUE RES, V341, P95, DOI 10.1007/s00441-010-0984-6; Kersigo J, 2011, GENESIS, V49, P326, DOI 10.1002/dvg.20714; Lopez DE, 1999, J COMP NEUROL, V415, P160; Lu CC, 2011, J NEUROSCI, V31, P10903, DOI 10.1523/JNEUROSCI.2358-11.2011; Mak ACY, 2009, GENE EXPR PATTERNS, V9, P444, DOI 10.1016/j.gep.2009.04.003; Maklad A, 1999, J VESTIBUL RES-EQUIL, V9, P387; Maklad A, 2010, CELL TISSUE RES, V340, P303, DOI 10.1007/s00441-010-0944-1; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Mollaaghababa R, 2003, ONCOGENE, V22, P3024, DOI 10.1038/sj.onc.1206442; Monsonego-Ornan E, 2012, DEV BIOL, V364, P162, DOI 10.1016/j.ydbio.2012.01.028; Morris JK, 2006, BRAIN RES, V1091, P186, DOI 10.1016/j.brainres.2006.02.090; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; Nichols DH, 2006, DEV DYNAM, V235, P285, DOI 10.1002/dvdy.20611; Nishizaki K, 1998, ORL-J OTO-RHIN-LARYN, V60, P267, DOI 10.1159/000027608; O'Neill P, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2036; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Orita Y, 1999, ACTA OTO-LARYNGOL, P22; Pan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030358; Pan N, 2011, HEARING RES, V275, P66, DOI 10.1016/j.heares.2010.12.002; Pauley S, 2006, DEV DYNAM, V235, P2470, DOI 10.1002/dvdy.20839; Reiprich S, 2008, MOL BIOL CELL, V19, P1575, DOI 10.1091/mbc.E07-08-0782; Reiprich S, 2010, J NEUROCHEM, V112, P744, DOI 10.1111/j.1471-4159.2009.06498.x; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Ruben RJ, 1967, ACTA OTO LARYNGOLOGI, V220, P221; Sandell LL, 2014, DEV BIOL, V385, P200, DOI 10.1016/j.ydbio.2013.11.009; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; SilosSantiago I, 1997, EUR J NEUROSCI, V9, P2045, DOI 10.1111/j.1460-9568.1997.tb01372.x; Simmons D, 2011, SPRINGER HANDB AUDIT, V38, P187, DOI 10.1007/978-1-4419-7070-1_7; Stenqvist A, 2005, EMBO REP, V6, P973, DOI 10.1038/sj.embor.7400512; Steventon B, 2014, DEV BIOL, DOI [10.1016/j.ydbio.2014.1001.1021, DOI 10.1016/J.YDBIO.2014.1001.1021]; Taylor KM, 2005, DEV CELL, V9, P593, DOI 10.1016/j.devcel.2005.09.016; Tessarollo L, 2004, J NEUROSCI, V24, P2575, DOI 10.1523/JNEUROSCI.5514-03.2004; VONBARTHELD CS, 1991, DEVELOPMENT, V113, P455; Wakaoka T, 2013, HEARING RES, V302, P17, DOI 10.1016/j.heares.2013.05.003; Wang SZ, 2013, J NEUROSCI, V33, P12242, DOI 10.1523/JNEUROSCI.5736-12.2013; Yang T, 2011, HEARING RES, V278, P21, DOI 10.1016/j.heares.2011.03.002	68	49	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94580	10.1371/journal.pone.0094580	http://dx.doi.org/10.1371/journal.pone.0094580			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718611	Green Published, gold			2022-12-25	WOS:000334339000133
J	Ozdogan, M				Ozdogan, Mutlu			A Practical and Automated Approach to Large Area Forest Disturbance Mapping with Remote Sensing	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; LANDSAT RECORD; CLASSIFICATION; CARBON; ALGORITHMS; ACCURACY; DYNAMICS; PATTERNS; CLIMATE; IMAGES	In this paper, I describe a set of procedures that automate forest disturbance mapping using a pair of Landsat images. The approach is built on the traditional pair-wise change detection method, but is designed to extract training data without user interaction and uses a robust classification algorithm capable of handling incorrectly labeled training data. The steps in this procedure include: i) creating masks for water, non-forested areas, clouds, and cloud shadows; ii) identifying training pixels whose value is above or below a threshold defined by the number of standard deviations from the mean value of the histograms generated from local windows in the short-wave infrared (SWIR) difference image; iii) filtering the original training data through a number of classification algorithms using an n-fold cross validation to eliminate mislabeled training samples; and finally, iv) mapping forest disturbance using a supervised classification algorithm. When applied to 17 Landsat footprints across the U. S. at five-year intervals between 1985 and 2010, the proposed approach produced forest disturbance maps with 80 to 95% overall accuracy, comparable to those obtained from traditional approaches to forest change detection. The primary sources of mis-classification errors included inaccurate identification of forests (errors of commission), issues related to the land/water mask, and clouds and cloud shadows missed during image screening. The approach requires images from the peak growing season, at least for the deciduous forest sites, and cannot readily distinguish forest harvest from natural disturbances or other types of land cover change. The accuracy of detecting forest disturbance diminishes with the number of years between the images that make up the image pair. Nevertheless, the relatively high accuracies, little or no user input needed for processing, speed of map production, and simplicity of the approach make the new method especially practical for forest cover change analysis over very large regions.	[Ozdogan, Mutlu] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA; [Ozdogan, Mutlu] Univ Wisconsin, Ctr Sustainabil & Global Environm, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ozdogan, M (corresponding author), Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA.	ozdogan@wisc.edu		Ozdogan, Mutlu/0000-0002-1707-3375	NASA Land Cover Land Use Change (LCLUC) program [NNX08AK77G]; USDA Hatch Act Formula Funds	NASA Land Cover Land Use Change (LCLUC) program(National Aeronautics & Space Administration (NASA)); USDA Hatch Act Formula Funds	This work was partially funded by NASA Land Cover Land Use Change (LCLUC) program (NNX08AK77G) and USDA Hatch Act Formula Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson PM, 1997, INT J REMOTE SENS, V18, P699, DOI 10.1080/014311697217224; Baumann M, 2012, REMOTE SENS ENVIRON, V124, P174, DOI 10.1016/j.rse.2012.05.001; Birdsey RA, 2003, POTENTIAL OF U.S. FOREST SOILS TO SEQUESTER CARBON AND MITIGATE THE GREENHOUSE EFFECT, P15; Breiman L., 2017, CLASSIFICATION REGRE; Brodley CE, 1999, J ARTIF INTELL RES, V11, P131, DOI 10.1613/jair.606; Brodley CE, 1996, INT GEOSCI REMOTE SE, P1379, DOI 10.1109/IGARSS.1996.516669; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Cohen WB, 2002, ECOSYSTEMS, V5, P122, DOI 10.1007/s10021-001-0060-X; Cohen WB, 2001, INT J REMOTE SENS, V22, P2279, DOI 10.1080/014311601300229827; Cohen WB, 1998, PHOTOGRAMM ENG REM S, V64, P293; Collins JB, 1996, REMOTE SENS ENVIRON, V56, P66, DOI 10.1016/0034-4257(95)00233-2; Congalton R. G., 1999, ASSESSING ACCURACY R, DOI 10.1201/9780429052729; CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B; Coops NC, 2010, FOREST ECOL MANAG, V259, P2355, DOI 10.1016/j.foreco.2010.03.008; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; CRIST EP, 1985, REMOTE SENS ENVIRON, V17, P301, DOI 10.1016/0034-4257(85)90102-6; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; Fry JA, 2011, PHOTOGRAMM ENG REM S, V77, P859; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Goward S, 2006, PHOTOGRAMM ENG REM S, V72, P1155, DOI 10.14358/PERS.72.10.1155; Goward SN, 1997, PHOTOGRAMM ENG REM S, V63, P887; Healey SP, 2006, REMOTE SENS ENVIRON, V101, P115, DOI 10.1016/j.rse.2005.12.006; Healey SP, 2005, REMOTE SENS ENVIRON, V97, P301, DOI 10.1016/j.rse.2005.05.009; Houghton RA, 2003, GLOBAL CHANGE BIOL, V9, P500, DOI 10.1046/j.1365-2486.2003.00620.x; Hsu C-W, 2001, PRACTICAL GUIDE SUPP; Huang C, 2002, INT J REMOTE SENS, V23, P725, DOI 10.1080/01431160110040323; Huang CQ, 2008, REMOTE SENS ENVIRON, V112, P970, DOI 10.1016/j.rse.2007.07.023; Huang CQ, 2010, REMOTE SENS ENVIRON, V114, P183, DOI 10.1016/j.rse.2009.08.017; Huang CQ, 2009, INT J DIGIT EARTH, V2, P195, DOI 10.1080/17538940902801614; Huang CQ, 2009, REMOTE SENS ENVIRON, V113, P1430, DOI 10.1016/j.rse.2008.06.016; Irons JR, 2006, PHOTOGRAMM ENG REM S, V72, P1102; Kauth RJ, 1976, P REM SENS DAT W LAF, P367; Kavzoglu T, 2009, INT J APPL EARTH OBS, V11, P352, DOI 10.1016/j.jag.2009.06.002; Kennedy RE, 2012, REMOTE SENS ENVIRON, V122, P117, DOI 10.1016/j.rse.2011.09.024; Kennedy RE, 2010, REMOTE SENS ENVIRON, V114, P2897, DOI 10.1016/j.rse.2010.07.008; Knights D, 2011, ISME J, V5, P570, DOI 10.1038/ismej.2010.148; Lallich S, 2002, LECT NOTES ARTIF INT, V2366, P5; Lefsky MA, 2003, REMOTE SENSING OF FOREST ENVIRONMENTS: CONCEPTS AND CASE STUDIES, P13; Lin CF, 2004, PATTERN RECOGN LETT, V25, P1647, DOI 10.1016/j.patrec.2004.06.009; Lin CJ, 2002, IEEE T NEURAL NETWOR, V13, P1045, DOI 10.1109/TNN.2002.1031937; Liu SG, 2004, ENVIRON MANAGE, V33, pS442, DOI 10.1007/s00267-003-9152-z; Lu D, 2004, INT J REMOTE SENS, V25, P2365, DOI 10.1080/0143116031000139863; Lunetta RS, 2004, REMOTE SENS ENVIRON, V89, P444, DOI 10.1016/j.rse.2003.10.022; Mantero P, 2005, IEEE T GEOSCI REMOTE, V43, P559, DOI 10.1109/TGRS.2004.842022; Montgomery D. C., 1992, INTRO LINEAR REGRESS; Mountrakis G, 2011, ISPRS J PHOTOGRAMM, V66, P247, DOI 10.1016/j.isprsjprs.2010.11.001; Potere D, 2007, PHOTOGRAMM ENG REM S, V73, P783, DOI 10.14358/PERS.73.7.783; Sanchez JS, 2003, PATTERN RECOGN LETT, V24, P1015, DOI 10.1016/S0167-8655(02)00225-8; Scholkopf B., 2001, LEARNING KERNELS; SINGH A, 1989, INT J REMOTE SENS, V10, P989, DOI 10.1080/01431168908903939; Song C, 2001, REMOTE SENS ENVIRON, V75, P230, DOI 10.1016/S0034-4257(00)00169-3; Suykens JAK, 2002, NEUROCOMPUTING, V48, P85, DOI 10.1016/S0925-2312(01)00644-0; Thornton PE, 2002, AGR FOREST METEOROL, V113, P185, DOI 10.1016/S0168-1923(02)00108-9; Tsujinishi D, 2003, NEURAL NETWORKS, V16, P785, DOI 10.1016/S0893-6080(03)00110-2; Vapnik V., 1979, ESTIMATION DEPENDENC, V27, P5165; WOODCOCK C, 1992, INT J REMOTE SENS, V13, P3167, DOI 10.1080/01431169208904109; Wulder MA, 2005, CAN J REMOTE SENS, V31, P421, DOI 10.5589/m05-026; Zhu GB, 2002, REMOTE SENS ENVIRON, V80, P233, DOI 10.1016/S0034-4257(01)00305-4; Zhu Z, 2012, REMOTE SENS ENVIRON, V118, P83, DOI 10.1016/j.rse.2011.10.028; Zollner PA, 2008, FOR EC MANAGE, V254, P524	63	10	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e78438	10.1371/journal.pone.0078438	http://dx.doi.org/10.1371/journal.pone.0078438			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717283	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000001
J	Zhou, ZH; Karnaukhova, E; Rajabi, M; Reeder, K; Chen, TN; Dhawan, S; Kozlowski, S				Zhou, Zhao-Hua; Karnaukhova, Elena; Rajabi, Mohsen; Reeder, Kelly; Chen, Trina; Dhawan, Subhash; Kozlowski, Steven			Oversulfated Chondroitin Sulfate Binds to Chemokines and Inhibits Stromal Cell- Derived Factor-1 Mediated Signaling in Activated T Cells	PLOS ONE			English	Article							HEPARIN; RECEPTOR; SDF-1; CXCR4; GLYCOSAMINOGLYCANS; FACTOR-1-ALPHA; TRAFFICKING; RECRUITMENT; EXPRESSION; SELECTIN	Oversulfated chondroitin sulfate (OSCS), a member of the glycosaminoglycan (GAG) family, was a contaminant in heparin that was linked to the 2008 heparin adverse events in the US. Because of its highly negative charge, OSCS can interact with many components of the contact and immune systems. We have previously demonstrated that OSCS inhibited the complement classical pathway by binding C1 inhibitor and potentiating its interaction with C1s. In the present study, by using surface plasmon resonance, we found OSCS interacts with T cell chemokines that can impact adaptive immunity. The binding of OSCS to stromal cell-derived factor-1 (SDF-1) chemokines, SDF-1 alpha and SDF-1 beta, caused a significant change in the secondary structures of these chemokines as detected by far- ultraviolet circular dichroism spectra analysis. Functionally, OSCS binding profoundly inhibited SDF-1-induced calcium mobilization and T cell chemotaxis. Imaging flow cytometry revealed T cell morphological changes mediated by SDF-1 alpha were completely blocked by OSCS. We conclude that the OSCS, a past contaminant in heparin, has broad interactions with the components of the human immune system beyond the contact and complement systems, and that may explain, in part, prior OSCS-related adverse events, while suggesting potentially useful therapeutic applications for related GAGs in the control of inflammation.	[Zhou, Zhao-Hua; Reeder, Kelly; Chen, Trina; Kozlowski, Steven] US FDA, Ctr Drug Evaluat & Res, Div Monoclonal Antibodies, Bethesda, MD 20014 USA; [Karnaukhova, Elena] US FDA, Ctr Biol Evaluat & Res, Div Hematol, Bethesda, MD 20014 USA; [Rajabi, Mohsen] US FDA, Ctr Drug Evaluat & Res, Off Pharmaceut Sci, Div Therapeut Proteins,Off Biotechnol, Bethesda, MD 20014 USA; [Dhawan, Subhash] US FDA, Ctr Biol Evaluat & Res, Div Emerging & Transfus Transmitted Dis, Bethesda, MD 20014 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Kozlowski, S (corresponding author), US FDA, Ctr Drug Evaluat & Res, Div Monoclonal Antibodies, Bethesda, MD 20014 USA.	Steven.Kozlowski@fda.hhs.gov	Zhou, Zhaohua/AGR-4892-2022		Intramural Research Program of the US Food and Drug Administration	Intramural Research Program of the US Food and Drug Administration	This research was supported by the Intramural Research Program of the US Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendas Gerd, 2012, Int J Cell Biol, V2012, P676731, DOI 10.1155/2012/676731; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Carpenter JF, 2009, J PHARM SCI-US, V98, P1201, DOI 10.1002/jps.21530; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; de Paz LL, 2007, ACS CHEM BIOL, V2, P735, DOI 10.1021/cb700159m; Dettin M, 2004, J MED CHEM, V47, P3058, DOI 10.1021/jm031067a; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Gubina E, 2002, BLOOD, V99, P2518, DOI 10.1182/blood.V99.7.2518; Guerrini M, 2008, NAT BIOTECHNOL, V26, P669, DOI 10.1038/nbt1407; Hamel DJ, 2009, METHOD ENZYMOL, V461, P71, DOI 10.1016/S0076-6879(09)05404-4; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Hattori K, 2003, LEUKEMIA LYMPHOMA, V44, P575, DOI 10.1080/1042819021000037985; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; KALTER ES, 1985, J INFECT DIS, V151, P1019, DOI 10.1093/infdis/151.6.1019; Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200; King CS, 2007, CHEST, V131, P507, DOI 10.1378/chest.06-1861; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Laguri C, 2008, CARBOHYD RES, V343, P2018, DOI 10.1016/j.carres.2008.01.047; Laguri C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001110; Li BZ, 2009, BIOCHEM PHARMACOL, V78, P292, DOI 10.1016/j.bcp.2009.04.012; LUKACS NW, 1995, BLOOD, V86, P2767; Mikhailov D, 1999, J BIOL CHEM, V274, P25317, DOI 10.1074/jbc.274.36.25317; Mulloy B, 2006, BIOCHEM SOC T, V34, P409, DOI 10.1042/BST0340409; Murdoch C, 2000, BLOOD, V95, P3032; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Oehmcke S, 2010, J MOL MED, V88, P121, DOI 10.1007/s00109-009-0564-y; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Qian Y, 2010, PROG MOL BIOL TRANSL, V93, P395, DOI [10.1016/s1877-1173(10)93017-2, 10.1016/S1877-1173(10)93017-2]; Rabin RL, 1999, J IMMUNOL, V162, P3840; Rek A, 2009, BBA-PROTEINS PROTEOM, V1794, P577, DOI 10.1016/j.bbapap.2009.01.001; Sadir R, 2001, J BIOL CHEM, V276, P8288, DOI 10.1074/jbc.M008110200; Seeger FH, 2012, CIRC RES, V111, P854, DOI 10.1161/CIRCRESAHA.112.265678; Sierra MD, 2004, BLOOD, V103, P2452; Sweeney EA, 2001, ANN NY ACAD SCI, V938, P48; Tami C, 2008, BIOMATERIALS, V29, P4808, DOI 10.1016/j.biomaterials.2008.08.024; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tomczak A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036151; Volpi N, 2012, ELECTROPHORESIS, V33, P1531, DOI 10.1002/elps.201100479; Wu YT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000520; Yu L, 2006, GENE, V374, P174, DOI 10.1016/j.gene.2006.02.001; Zhang SY, 2012, J BIOL CHEM, V287, P5542, DOI 10.1074/jbc.M111.314716; Zhou ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047296; Zhou ZH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034978; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	49	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94402	10.1371/journal.pone.0094402	http://dx.doi.org/10.1371/journal.pone.0094402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718687	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000118
J	Anand, P; Grigoryan, A; Bhuiyan, MH; Ueberheide, B; Russell, V; Quinonez, J; Moy, P; Chait, BT; Poget, SF; Holford, M				Anand, Prachi; Grigoryan, Alexandre; Bhuiyan, Mohammed H.; Ueberheide, Beatrix; Russell, Victoria; Quinonez, Jose; Moy, Patrick; Chait, Brian T.; Poget, Sebastien F.; Holford, Mande			Sample Limited Characterization of a Novel Disulfide-Rich Venom Peptide Toxin from Terebrid Marine Snail Terebra variegata	PLOS ONE			English	Article							MU-CONOTOXIN PIIIA; 3-DIMENSIONAL STRUCTURE; CHANNEL BLOCKER; CONUS PEPTIDES; SUPERFAMILY; DISCOVERY; ISOMERS; SYSTEM; KIIIA; MODEL	Disulfide-rich peptide toxins found in the secretions of venomous organisms such as snakes, spiders, scorpions, leeches, and marine snails are highly efficient and effective tools for novel therapeutic drug development. Venom peptide toxins have been used extensively to characterize ion channels in the nervous system and platelet aggregation in haemostatic systems. A significant hurdle in characterizing disulfide-rich peptide toxins from venomous animals is obtaining significant quantities needed for sequence and structural analyses. Presented here is a strategy for the structural characterization of venom peptide toxins from sample limited (4 ng) specimens via direct mass spectrometry sequencing, chemical synthesis and NMR structure elucidation. Using this integrated approach, venom peptide Tv1 from Terebra variegata was discovered. Tv1 displays a unique fold not witnessed in prior snail neuropeptides. The novel structural features found for Tv1 suggest that the terebrid pool of peptide toxins may target different neuronal agents with varying specificities compared to previously characterized snail neuropeptides.	[Anand, Prachi; Grigoryan, Alexandre; Russell, Victoria; Quinonez, Jose; Moy, Patrick; Holford, Mande] City Univ New York Hunter Coll & Grad Ctr, Dept Chem & Biochem, New York, NY 10021 USA; [Holford, Mande] Amer Museum Nat Hist, New York, NY 10024 USA; [Bhuiyan, Mohammed H.; Poget, Sebastien F.] CUNY, Coll Staten Isl & Grad Ctr, Dept Chem, New York, NY USA; [Ueberheide, Beatrix] NYU, NYU Langone Med Ctr, New York, NY USA; [Chait, Brian T.] Rockefeller Univ, New York, NY 10021 USA	American Museum of Natural History (AMNH); City University of New York (CUNY) System; New York University; NYU Langone Medical Center; Rockefeller University	Anand, P (corresponding author), City Univ New York Hunter Coll & Grad Ctr, Dept Chem & Biochem, New York, NY 10021 USA.	mholford@hunter.cuny.edu	Anand, Prachi/H-6134-2019	Anand, Prachi/0000-0002-9176-5791; Ueberheide, Beatrix/0000-0003-2512-0204; Holford, Mande/0000-0001-9476-2687	NSF-CHE [1247550]; Camille Dreyfus Teacher Scholar Award from the Camille and Henry Dreyfus Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103314] Funding Source: NIH RePORTER	NSF-CHE(National Science Foundation (NSF)); Camille Dreyfus Teacher Scholar Award from the Camille and Henry Dreyfus Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Mande Holford acknowledges funding from NSF-CHE 1247550 (www.nsf.gov) and The Camille Dreyfus Teacher Scholar Award from the Camille and Henry Dreyfus Foundation (http://www.dreyfus.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DJ, 1999, DRUG DEVELOP RES, V46, P219; Bhatia S, 2012, J PROTEOME RES, V11, P4191, DOI 10.1021/pr300312h; Bhattacharyya M, 2013, MOL BIOSYST, V9, P1340, DOI 10.1039/c3mb25534d; Bouchet P, 2009, DEEP-SEA RES PT II, V56, P1724, DOI 10.1016/j.dsr2.2009.05.033; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bulaj G, 2008, CURR OPIN CHEM BIOL, V12, P441, DOI 10.1016/j.cbpa.2008.07.012; Castelin M, 2012, MOL PHYLOGENET EVOL, V64, P21, DOI 10.1016/j.ympev.2012.03.001; Chalkley RJ, 2006, J AM SOC MASS SPECTR, V17, P1271, DOI 10.1016/j.jasms.2006.05.017; Cheek S, 2006, J MOL BIOL, V359, P215, DOI 10.1016/j.jmb.2006.03.017; Corpuz GP, 2005, BIOCHEMISTRY-US, V44, P8176, DOI 10.1021/bi047541b; CUSHMAN DW, 1991, HYPERTENSION, V17, P589, DOI 10.1161/01.HYP.17.4.589; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Du WH, 2007, FEBS J, V274, P2596, DOI 10.1111/j.1742-4658.2007.05795.x; Dutertre S, 2010, J BIOL CHEM, V285, P13315, DOI 10.1074/jbc.R109.076596; Escoubas P, 2008, J MASS SPECTROM, V43, P279, DOI 10.1002/jms.1389; Favreau P, 2006, TOXICON, V47, P676, DOI 10.1016/j.toxicon.2006.01.020; Favreau P, 2009, CURR OPIN PHARMACOL, V9, P594, DOI 10.1016/j.coph.2009.05.006; Foley SF, 2008, ANAL BIOCHEM, V377, P95, DOI 10.1016/j.ab.2008.02.025; Franco A, 2006, PROG MOLEC, V43, P83, DOI 10.1007/978-3-540-30880-5_4; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Goransson U, 2003, J BIOL CHEM, V278, P48188, DOI 10.1074/jbc.M308771200; Han YH, 2006, FEBS J, V273, P4972, DOI 10.1111/j.1742-4658.2006.05493.x; Holford M, 2009, TOXICON, V53, P90, DOI 10.1016/j.toxicon.2008.10.017; Holford M, 2009, MOL BIOL EVOL, V26, P15, DOI 10.1093/molbev/msn211; Imperial JS, 2003, TOXICON, V42, P391, DOI 10.1016/S0041-0101(03)00169-7; Imperial JS, 2008, J BIOL CHEM, V283, P23026, DOI 10.1074/jbc.M800084200; Imperial JS, 2007, J EXP ZOOL PART B, V308B, P744, DOI 10.1002/jez.b.21195; Jacob RB, 2010, CELL MOL LIFE SCI, V67, P17, DOI 10.1007/s00018-009-0125-0; Jakubowski JA, 2004, ANAL CHEM, V76, P6541, DOI 10.1021/ac0494376; Kaas Q, 2008, BIOINFORMATICS, V24, P445, DOI 10.1093/bioinformatics/btm596; Keizer DW, 2003, J BIOL CHEM, V278, P46805, DOI 10.1074/jbc.M309222200; Kendel Y, 2013, TOXINS, V5, P1043, DOI 10.3390/toxins5051043; Khoo KK, 2012, BIOCHEMISTRY-US, V51, P9826, DOI 10.1021/bi301256s; King GF, 2013, ANNU REV ENTOMOL, V58, P475, DOI 10.1146/annurev-ento-120811-153650; King GF, 2011, EXPERT OPIN BIOL TH, V11, P1469, DOI 10.1517/14712598.2011.621940; Koh CY, 2012, TOXICON, V59, P497, DOI 10.1016/j.toxicon.2011.03.017; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; McDougal OM, 2004, BIOCHEMISTRY-US, V43, P425, DOI 10.1021/bi0353732; McDougal OM, 2008, BIOCHEMISTRY-US, V47, P2826, DOI 10.1021/bi702388b; Miljanich GP, 2004, CURR MED CHEM, V11, P3029, DOI 10.2174/0929867043363884; Nair SS, 2006, ANAL CHEM, V78, P8082, DOI 10.1021/ac0607764; Olivera BM, 2007, MOL INTERV, V7, P251, DOI 10.1124/mi.7.5.7; Olivera BM, 2006, J BIOL CHEM, V281, P31173, DOI 10.1074/jbc.R600020200; Prashanth JR, 2012, TOXICON, V60, P470, DOI 10.1016/j.toxicon.2012.04.340; Quinton L, 2007, J PROTEOME RES, V6, P3216, DOI 10.1021/pr070142t; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Santos AD, 2004, J BIOL CHEM, V279, P17596, DOI 10.1074/jbc.M309654200; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shon KJ, 1998, J NEUROSCI, V18, P4473; Tayo LL, 2010, J PROTEOME RES, V9, P2292, DOI 10.1021/pr901032r; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Tietze AA, 2012, ANGEW CHEM INT EDIT, V51, P4058, DOI 10.1002/anie.201107011; Ueberheide BM, 2009, P NATL ACAD SCI USA, V106, P6910, DOI 10.1073/pnas.0900745106; Vetter I, 2012, CURR TOP MED CHEM, V12, P1546, DOI 10.2174/156802612802652457; Vetter I, 2011, AMINO ACIDS, V40, P15, DOI 10.1007/s00726-010-0516-4; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang Q, 2008, TOXICON, V51, P813, DOI 10.1016/j.toxicon.2007.12.007; West PJ, 2002, BIOCHEMISTRY-US, V41, P15388, DOI 10.1021/bi0265628; Yao SG, 2008, BIOCHEMISTRY-US, V47, P10940, DOI 10.1021/bi801010u; Zhang MM, 2007, J BIOL CHEM, V282, P30699, DOI 10.1074/jbc.M704616200; Zhang MM, 2006, BIOCHEMISTRY-US, V45, P3723, DOI 10.1021/bi052162j	62	22	23	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94122	10.1371/journal.pone.0094122	http://dx.doi.org/10.1371/journal.pone.0094122			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713808	gold, Green Published			2022-12-25	WOS:000334160900088
J	Bowler, M; Anderson, M; Montes, D; Perez, P; Mayor, P				Bowler, Mark; Anderson, Matt; Montes, Daniel; Perez, Pedro; Mayor, Pedro			Refining Reproductive Parameters for Modelling Sustainability and Extinction in Hunted Primate Populations in the Amazon	PLOS ONE			English	Article							FEMALE; IMPACT; FOREST; MANAGEMENT; PATTERNS; MAMMALS; AREA	Primates are frequently hunted in Amazonia. Assessing the sustainability of hunting is essential to conservation planning. The most-used sustainability model, the 'Production Model', and more recent spatial models, rely on basic reproductive parameters for accuracy. These parameters are often crudely estimated. To date, parameters used for the Amazon's most-hunted primate, the woolly monkey (Lagothrix spp.), come from captive populations in the 1960s, when captive births were rare. Furthermore, woolly monkeys have since been split into five species. We provide reproductive parameters calculated by examining the reproductive organs of female Poeppig's woolly monkeys (Lagothrix poeppigii), collected by hunters as part of their normal subsistence activity. Production was 0.48-0.54 young per female per year, and an interbirth interval of 22.3 to 25.2 months, similar to parameters from captive populations. However, breeding was seasonal, which imposes limits on the maximum reproductive rate attainable. We recommend the use of spatial models over the Production Model, since they are less sensitive to error in estimated reproductive rates. Further refinements to reproductive parameters are needed for most primate taxa. Methods like ours verify the suitability of captive reproductive rates for sustainability analysis and population modelling for populations under differing conditions of hunting pressure and seasonality. Without such research, population modelling is based largely on guesswork.	[Bowler, Mark; Anderson, Matt] San Diego Zoo Global Inst Conservat Res, Escondido, CA 92027 USA; [Bowler, Mark] Univ St Andrews, Sch Psychol, St Andrews, Fife, Scotland; [Montes, Daniel; Perez, Pedro; Mayor, Pedro] Yavari Conservac & Uso Sostenible YAVACUS, Iquitos, Loreto, Peru; [Mayor, Pedro] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Bellaterra, Spain	University of St Andrews; Autonomous University of Barcelona	Bowler, M (corresponding author), San Diego Zoo Global Inst Conservat Res, Escondido, CA 92027 USA.	mark@markbowler.com	Bowler, Mark/I-1967-2019; Mayor, Pedro/D-6359-2015; Mayor, Pedro/AAC-2871-2021	Bowler, Mark/0000-0001-5236-3477; Mayor, Pedro/0000-0001-5297-792X; 				Agostinelli C., 2011, R PACKAGE CIRCULAR C; Alvard MS, 1997, CONSERV BIOL, V11, P977, DOI 10.1046/j.1523-1739.1997.96047.x; Ange-van Heugten K, 2008, INT J PRIMATOL, V29, P183, DOI 10.1007/s10764-008-9233-1; Aquino Rolando, 2007, Rev. peru biol., V14, P181; Begon M., 2009, ECOLOGY INDIVIDUALS; Bodmer R., 2004, PEOPLE NATURE WILDLI, P199; Bodmer RE, 1997, CONSERV BIOL, V11, P460, DOI 10.1046/j.1523-1739.1997.96022.x; Bodmer RE, 2004, HUNTING NEOTROPICAL, P201; Bodmer Richard E., 2004, P299; Bodmer Richard E., 2000, Conservation Biology Series (Cambridge), V3, P277; Carnegie SD, 2011, INT J PRIMATOL, V32, P1076, DOI 10.1007/s10764-011-9523-x; Chacon RJ, 2012, ETHICS OF ANTHROPOLOGY AND AMERINDIAN RESEARCH: REPORTING ON ENVIRONMENTAL DEGRADATION AND WARFARE, P1, DOI 10.1007/978-1-4614-1065-2; Cheney DL, 1998, REPROD SUCCESS, P384; COLE LC, 1954, Q REV BIOL, V29, P103, DOI 10.1086/400074; da Silva Maria N.F., 2005, Neotropical Primates, V13, P31, DOI 10.1896/1413-4705.13.2.31; DELANY MJ, 1982, MAMMAL ECOLOGY; Di Fiore A, 2014, 83 ANN M AM ASS PHYS; Di Fiore A., 2011, PRIMATES PERSPECTIVE, P155; DiFiore A, 1997, THESIS U CALIFORNIA; DUNBAR RIM, 1995, ANIM BEHAV, V50, P1071, DOI 10.1016/0003-3472(95)80107-3; Eisenberg JF., 1999, MAMMALS NEOTROPICS C; FA JE, 1995, CONSERV BIOL, V9, P1107, DOI 10.1046/j.1523-1739.1995.951107.x; Fang T., 2008, CERTIFICACION PIELES, P210; Fiore A Di, MOL PHYLOGE IN PRESS; FitzGibbon C, 1998, BEHAVIORAL ECOLOGY AND CONSERVATION BIOLOGY, P449; FITZGIBBON CD, 1995, CONSERV BIOL, V9, P1116, DOI [10.1046/j.1523-1739.1995.9051116.x, 10.1046/j.1523-1739.1995.9051085.x-i1]; Flowerdew J.R., 1987, MAMMALS THEIR REPROD; Fooden J., 1963, Journal of Mammalogy, V44, P213, DOI 10.2307/1377454; FRANZEN M, 2005, THESIS U CALIFORNIA; Franzen M., 2006, ENVIRON CONSERV, V33, P1; Gavin MC, 2007, BIOL CONSERV, V134, P64, DOI 10.1016/j.biocon.2006.07.011; Mayor PG, 2010, EUR J WILDLIFE RES, V56, P681, DOI 10.1007/s10344-010-0379-8; Groves CP, 2005, MAMMAL SPECIES WORLD, P111; Groves CP, 2001, PRIMATE TAXONOMY; *INT COMM VET EMBR, 1994, NOM EMBR VET; Isaac NJB, 2004, P ROY SOC B-BIOL SCI, V271, P1135, DOI 10.1098/rspb.2004.2724; IUCN, 2022, IUCN RED LIST THREAT; JOSHI NV, 1991, THEOR POPUL BIOL, V40, P211, DOI 10.1016/0040-5809(91)90053-I; Levi T, 2009, J APPL ECOL, P46804; Levi T, 2011, ECOL APPL, V21, P1802, DOI 10.1890/10-0375.1; Mack D., 1978, International Zoo Yearbook, V18, P117, DOI 10.1111/j.1748-1090.1978.tb00239.x; Matthews LJ, 2008, AM J PHYS ANTHROPOL, V137, P245, DOI 10.1002/ajpa.20859; Mayor P, 2011, ANIM REPROD SCI, V128, P123, DOI 10.1016/j.anireprosci.2011.09.009; Mayor P, 2012, ANIMAL REPROD SCI; Mayor P, 2012, AM J PRIMATOL, V74, P1006, DOI 10.1002/ajp.22051; Mayor P, 2009, EUR J WILDLIFE RES, V55, P631, DOI 10.1007/s10344-009-0312-1; McCullough D.R., 1987, P535; Mena P, 2000, BIOL RESOURCE MANAGE, P57; Milner-Gulland, 2007, CONSERVATION SUSTAIN; Milner-Gulland EJ, 2001, TRENDS ECOL EVOL, V16, P686, DOI 10.1016/S0169-5347(01)02278-9; Mooney JC, 1999, ZOO BIOL, V18, P421, DOI 10.1002/(SICI)1098-2361(1999)18:5&lt;421::AID-ZOO7&gt;3.0.CO;2-6; Muchaal PK, 1999, CONSERV BIOL, V13, P385, DOI 10.1046/j.1523-1739.1999.013002385.x; Nishimura A., 1990, Science and Engineering Review of Doshisha University, V31, P87; Nishimura A, 2003, INT J PRIMATOL, V24, P707, DOI 10.1023/A:1024681703616; Novaro AJ, 2000, CONSERV BIOL, V14, P713, DOI 10.1046/j.1523-1739.2000.98452.x; Nowak R, 1999, WALKERS MAMMALS WORL, P538; Ohl-Schacherer J, 2007, CONSERV BIOL, V21, P1174, DOI 10.1111/j.1523-1739.2007.00759.x; Parathian HE, 2010, AM J PRIMATOL, V72, P855, DOI 10.1002/ajp.20816; PERES C A, 1991, Oryx, V25, P89; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; PERES CA, 1990, BIOL CONSERV, V54, P47, DOI 10.1016/0006-3207(90)90041-M; Peres CA, 2001, CONSERV BIOL, V15, P1490, DOI 10.1046/j.1523-1739.2001.01089.x; PUERTAS P, 1993, BIODIVERS CONSERV, V2, P586, DOI 10.1007/BF00051959; Puertas P, 1999, THESIS U FLORIDA; Puertas Pablo E., 2004, P123; R Core Team, 2012, R LANG ENV STAT COMP; Robinson J.G., 1991, P415; Robinson J.G., 1987, P69; Robinson JG, 2000, BIOL RESOURCE MANAGE, P13; ROBINSON JG, 1986, OECOLOGIA, V68, P516, DOI 10.1007/BF00378765; Robinson JG, 1999, J WILDLIFE MANAGE, V63, P1, DOI 10.2307/3802482; Robinson John G., 1994, Oryx, V28, P249, DOI 10.1017/S0030605300028647; Rylands Anthony B., 2000, Neotropical Primates, V8, P61; Sadler TW, 1985, LANGMANS MED EMBRIOL, P424; Schmitt CA, WOOLLY MONKEY BEHAV; Shanee S, 2011, INT J PRIMATOL, V32, P691, DOI 10.1007/s10764-011-9495-x; Shepard Glenn H., 2002, Cambridge Studies in Biological and Evolutionary Anthropology, V29, P101; Siren A, 2004, CONSERV BIOL, V18, P1315, DOI 10.1111/j.1523-1739.2004.00024.x; Slade NA, 1998, CONSERV BIOL, V12, P148, DOI 10.1046/j.1523-1739.1998.96273.x; Suarez E, 2009, ANIM CONSERV, V12, P364, DOI 10.1111/j.1469-1795.2009.00262.x; Urbani B., 2005, J ANTHROPOL SCI, V83, P89; Vickers W.T., 1991, P53; Williams L., 1967, International Zoo Yearbook, V7, P86, DOI 10.1111/j.1748-1090.1967.tb00329.x; WOLF RH, 1975, LAB ANIM SCI, V25, P814	84	15	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93625	10.1371/journal.pone.0093625	http://dx.doi.org/10.1371/journal.pone.0093625			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714614	Green Published, gold			2022-12-25	WOS:000334160900041
J	Cai, J; Feng, J; Xie, SL; Wang, FP; Xu, QF				Cai, Jin; Feng, Jia; Xie, Shulian; Wang, Feipeng; Xu, Qiufeng			Laminaria japonica Extract, an Inhibitor of Clavibater michiganense Subsp Sepedonicum	PLOS ONE			English	Article							BACTERIAL RING ROT; ANTIMICROBIAL ACTIVITY; CHEMICAL-COMPOSITION; VOLATILE COMPONENTS; ESSENTIAL OIL; ANTIFUNGAL ACTIVITY; PYRUVATE-KINASE; CELL-MEMBRANE; CAUSAL AGENT; IN-VITRO	Bacterial ring rot of potato is one of the most serious potato plant and tuber diseases. Laminaria japonica extract was investigated for its antimicrobial activity against Clavibater michiganense subsp. sepedonicum (Spieckermann & Kotthoff) Davis et al., the causative agent of bacterial ring rot of potato. The results showed that the optimum extraction conditions of antimicrobial substances from L. japonica were an extraction temperature of 80 degrees C, an extraction time of 12 h, and a solid to liquid ratio of 1: 25. Active compounds of L. japonica were isolated by solvent partition, thin layer chromatography (TLC) and column chromatography. All nineteen fractionations had antimicrobial activities against C. michiganense subsp. sepedonicum, while Fractionation three (Fr. 3) had the highest (P<0.05) antimicrobial activity. Chemical composition analysis identified a total of 26 components in Fr. 3. The main constituents of Fr. 3 were alkanes (80.97%), esters (5.24%), acids (4.87%) and alcohols (2.21%). Antimicrobial activity of Fr. 3 against C. michiganense subsp. sepedonicum could be attributed to its ability to damage the cell wall and cell membrane, induce the production of reactive oxygen species (ROS), increase cytosolic Ca2+ concentration, inhibit the glycolytic pathway (EMP) and tricarboxylic acid (TCA) cycle, inhibit protein and nucleic acid synthesis, and disrupt the normal cycle of DNA replication. These findings indicate that L. japonica extracts have potential for inhibiting C. michiganense subsp. sepedonicum.	[Cai, Jin; Feng, Jia; Xie, Shulian; Wang, Feipeng; Xu, Qiufeng] Shanxi Univ, Sch Life Sci, Taiyuan, Peoples R China	Shanxi University	Xie, SL (corresponding author), Shanxi Univ, Sch Life Sci, Taiyuan, Peoples R China.	xiesl@sxu.edu.cn						Abdel-Monaim MF, 2011, CROP PROT, V30, P185, DOI 10.1016/j.cropro.2010.09.016; Ahuja I, 2012, TRENDS PLANT SCI, V17, P73, DOI 10.1016/j.tplants.2011.11.002; Alteri CJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000448; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Antony J., 2006, Sensor Review, V26, P227, DOI 10.1108/02602280610675519; Asano T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003581; Avila JG, 1999, J ETHNOPHARMACOL, V66, P75, DOI 10.1016/S0378-8741(98)00203-7; Bagheri-Gavkosh S, 2009, MYCOPATHOLOGIA, V168, P249, DOI 10.1007/s11046-009-9220-x; BAKKEN LR, 1987, MICROBIAL ECOL, V13, P103, DOI 10.1007/BF02011247; Barros L, 2007, EUR FOOD RES TECHNOL, V225, P151, DOI 10.1007/s00217-006-0394-x; Bernardo-Gil MG, 2009, J SUPERCRIT FLUID, V49, P32, DOI 10.1016/j.supflu.2008.12.004; Boussaada O, 2009, J ESSENT OIL RES, V21, P179, DOI 10.1080/10412905.2009.9700142; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brady N. C., 1984, NATURE PROPERTIES SO, P528; Cardoso RA, 2010, GENET MOL RES, V9, P231, DOI 10.4238/vol9-1gmr688; Castro MS, 2005, PROTEIN PEPTIDE LETT, V12, P13; Chen CZS, 2002, BIOMATERIALS, V23, P3359, DOI 10.1016/S0142-9612(02)00036-4; Chen JC, 2007, CURR BIOL, V17, pR203, DOI 10.1016/j.cub.2007.01.031; Chen Y, 1994, FOOD FERMENT IND, V3, P26; Chen YJ, 2012, J SCI FOOD AGR, V92, P1937, DOI 10.1002/jsfa.5565; CHENG KJ, 1970, J BACTERIOL, V104, P748, DOI 10.1128/JB.104.2.748-753.1970; Cheng XL, 2013, RSC ADV, V3, P2296, DOI 10.1039/c2ra23131j; Choi YS, 2012, MEAT SCI, V91, P1, DOI 10.1016/j.meatsci.2011.11.011; Devi KP, 2010, J ETHNOPHARMACOL, V130, P107, DOI 10.1016/j.jep.2010.04.025; Dhankhar Sandeep, 2012, Recent Pat Antiinfect Drug Discov, V7, P242; Diez C, 2008, J CHROMATOGR A, V1180, P10, DOI 10.1016/j.chroma.2007.12.036; Efthimiadou EK, 2008, BIOORG MED CHEM LETT, V18, P4033, DOI 10.1016/j.bmcl.2008.05.115; Efthimiadou EK, 2010, J INORG BIOCHEM, V104, P455, DOI 10.1016/j.jinorgbio.2009.12.019; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; FRIEDLANDER ML, 1984, J CLIN PATHOL, V37, P961, DOI 10.1136/jcp.37.9.961; [耿飞 GENG Fei], 2011, [食品科学, Food Science], V32, P88; Go H, 2010, TOXICOL IN VITRO, V24, P1546, DOI 10.1016/j.tiv.2010.06.018; Gulec C, 2007, ASIAN J CHEM, V19, P4069; Haines LR, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000373; HALLIWELL B, 1984, BIOCHEM J, V219, P1, DOI 10.1042/bj2190001; HALLIWELL B, 1994, NUTR REV, V52, P253; Han GY, 2002, J INORG BIOCHEM, V91, P230, DOI 10.1016/S0162-0134(02)00369-0; HARA S, 1995, J BIOL CHEM, V270, P29923, DOI 10.1074/jbc.270.50.29923; Holley RA, 2005, FOOD MICROBIOL, V22, P273, DOI 10.1016/j.fm.2004.08.006; Huang CB, 2010, ARCH ORAL BIOL, V55, P555, DOI 10.1016/j.archoralbio.2010.05.009; Ibrahim HR, 1996, J AGR FOOD CHEM, V44, P3799, DOI 10.1021/jf960133x; Imura Y, 2007, BBA-BIOMEMBRANES, V1768, P2578, DOI 10.1016/j.bbamem.2007.06.013; Ippolito A, 2000, CROP PROT, V19, P715, DOI 10.1016/S0261-2194(00)00095-8; Jia XY, 2010, CHROMATOGRAPHIA, V71, P839, DOI 10.1365/s10337-010-1547-4; Karabay-Yavasoglu NU, 2007, PHYTOTHER RES, V21, P153, DOI 10.1002/ptr.2045; Khan MSA, 2011, PHYTOMEDICINE, V19, P48, DOI 10.1016/j.phymed.2011.07.005; Kilickap E, 2010, INT J ADV MANUF TECH, V49, P911, DOI 10.1007/s00170-009-2469-x; Knight SC, 1997, ANNU REV PHYTOPATHOL, V35, P349, DOI 10.1146/annurev.phyto.35.1.349; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kumar A, 2009, AFR J PHARM PHARMACO, V3, P560; Kumar RS, 2008, J INORG BIOCHEM, V102, P234, DOI 10.1016/j.jinorgbio.2007.08.005; LEPECQ JB, 1967, J MOL BIOL, V27, P87, DOI 10.1016/0022-2836(67)90353-1; Li LR, 2013, APPL MICROBIOL BIOT, V97, P1711, DOI 10.1007/s00253-012-4352-1; Li N, 2005, FOOD CHEM TOXICOL, V43, P421, DOI 10.1016/j.fct.2004.12.001; Li QQ, 2010, EUR J PHARMACOL, V626, P146, DOI 10.1016/j.ejphar.2009.09.044; Lieberthal W, 1998, AM J PHYSIOL-RENAL, V274, pF315, DOI 10.1152/ajprenal.1998.274.2.F315; Liu RM, 2002, FOOD FERM IND, V29, P61; Liu X, 2009, EUR FOOD RES TECHNOL, V229, P247, DOI 10.1007/s00217-009-1057-5; Lu X, 2012, APPL MICROBIOL BIOT, V95, P939, DOI 10.1007/s00253-011-3793-2; Lupea AX, 2003, REV CHIM-BUCHAREST, V54, P923; Mattevi A, 1996, FEBS LETT, V389, P15, DOI 10.1016/0014-5793(96)00462-0; Michielin EMZ, 2009, BIORESOURCE TECHNOL, V100, P6615, DOI 10.1016/j.biortech.2009.07.061; Mori IC, 2004, PLANT PHYSIOL, V135, P702, DOI 10.1104/pp.104.042069; MUIRHEAD KA, 1985, BIO-TECHNOL, V3, P337, DOI 10.1038/nbt0485-337; Munger J, 2006, PLOS PATHOG, V2, P1165, DOI 10.1371/journal.ppat.0020132; Muthukumar A, 2010, CROP PROT, V29, P1483, DOI 10.1016/j.cropro.2010.08.009; Navarro C, 2011, NATURE, V478, P119, DOI 10.1038/nature10431; Nishida M, 2006, J CHROMATOGR B, V842, P106, DOI 10.1016/j.jchromb.2006.07.039; Ozdemir G, 2006, PHARM BIOL, V44, P183, DOI 10.1080/13880200600685949; Palic R, 2002, FLAVOUR FRAG J, V17, P323, DOI 10.1002/ffj.1084; Passos XS, 2003, PHARM BIOL, V41, P319, DOI 10.1076/phbi.41.5.319.15936; Peng ZF, 2012, CARBOHYD POLYM, V89, P1022, DOI 10.1016/j.carbpol.2012.03.043; POLITOFF AL, 1969, J GEN PHYSIOL, V53, P498, DOI 10.1085/jgp.53.4.498; Qiu YE, 2004, XINJIANG AGR SCI, P88; Rafiqi M, 2012, CURR OPIN PLANT BIOL, V15, P477, DOI 10.1016/j.pbi.2012.05.003; Rigden DJ, 1999, J MOL BIOL, V291, P615, DOI 10.1006/jmbi.1999.2918; Rizwan K, 2012, INT J MOL SCI, V13, P6440, DOI 10.3390/ijms13056440; Schepers E, 2009, J IMMUNOL METHODS, V348, P74, DOI 10.1016/j.jim.2009.07.002; SECOR GA, 1987, AM POTATO J, V64, P699; Shen HM, 1996, FREE RADICAL BIO MED, V21, P139, DOI 10.1016/0891-5849(96)00019-6; SIKKEMA J, 1995, MICROBIOL REV, V59, P201, DOI 10.1128/MMBR.59.2.201-222.1995; Sinek K, 2012, ASIAN J CHEM, V24, P1931; Smania A. Jr., 1999, International Journal of Medicinal Mushrooms, V1, P325; Song Feng-ping, 2009, Chinese Journal of Pesticide Science, V11, P213; Sukatar A, 2006, ANN MICROBIOL, V56, P275, DOI 10.1007/BF03175018; Sun L, 2003, J CHROMATOGR A, V1014, P165, DOI 10.1016/S0021-9673(03)00574-0; Talibi I, 2012, CROP PROT, V35, P41, DOI 10.1016/j.cropro.2011.12.016; Tarushi A, 2009, J INORG BIOCHEM, V103, P898, DOI 10.1016/j.jinorgbio.2009.03.007; Tseng CK, 2001, J APPL PHYCOL, V13, P375, DOI 10.1023/A:1017972812576; Ultee A, 2002, APPL ENVIRON MICROB, V68, P1561, DOI 10.1128/AEM.68.4.1561-1568.2002; Valiei M, 2011, J MED PLANTS RES, V5, P6972, DOI 10.5897/JMPR11.963; van Beckhoven JRCM, 2002, J APPL MICROBIOL, V93, P840, DOI 10.1046/j.1365-2672.2002.01765.x; van der Wolf JM, 2005, J PHYTOPATHOL, V153, P358, DOI 10.1111/j.1439-0434.2005.00985.x; Wang C, 2013, LIFE SCI, V92, P1004, DOI 10.1016/j.lfs.2013.03.016; Wang GuanLin, 2005, Scientia Agricultura Sinica, V38, P2321; Wang HK, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029452, 10.1371/journal.pone.0041330, 10.1371/journal.pone.0038619]; Wang J, 2013, INT J FOOD MICROBIOL, V161, P151, DOI 10.1016/j.ijfoodmicro.2012.11.025; Wang QA, 2010, ARCH MICROBIOL, V192, P893, DOI 10.1007/s00203-010-0617-1; Wu PG, 2010, BIOMATERIALS, V31, P7526, DOI 10.1016/j.biomaterials.2010.06.032; Xiong JH, 2007, FOOD MACH, V23, P78; Yang DM, 2010, J CHIN I FOOD SCI TE, V10, P47; Yang WW, 2013, ENVIRON TOXICOL PHAR, V35, P320, DOI 10.1016/j.etap.2013.01.006; Yao XL, 2012, FOOD CHEM, V132, P1883, DOI 10.1016/j.foodchem.2011.12.021; Yayli N, 2006, TURK J CHEM, V30, P71; Yun Bao-Yi, 2012, Yao Xue Xue Bao, V47, P1587; ZENG CK, 1984, HYDROBIOLOGIA, V116, P152; [郑怡 Zheng Yi], 2004, [海洋科学, Marine Sciences], V28, P42; Zhou W, 2010, CHROMATOGRAPHIA, V72, P719, DOI 10.1365/s10337-010-1747-y; Zito P, 2011, NAT PROD RES, V25, P1339, DOI 10.1080/14786419.2010.535157; 陈云, 2010, [山西农业科学, Journal of Shanxi Agricultural Sciences], V38, P140	111	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94329	10.1371/journal.pone.0094329	http://dx.doi.org/10.1371/journal.pone.0094329			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714388	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900117
J	Tseng, LC; Zhang, CJ; Cheng, CM; Xu, HY; Hsu, CH; Jiang, YJ				Tseng, Li-Chuan; Zhang, Chengjin; Cheng, Chun-Mei; Xu, Haoying; Hsu, Chia-Hao; Jiang, Yun-Jin			New Classes of Mind Bomb-Interacting Proteins Identified from Yeast Two-Hybrid Screens	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; ANKYRIN REPEAT DOMAIN; ASPARAGINYL HYDROXYLATION; LIQUID FACETS; IN-VIVO; NOTCH; HYPOXIA; DEGRADATION; HIF-1-ALPHA; MIB2	Notch signaling pathway defines an evolutionarily conserved mechanism in cell-fate determination in a broad spectrum of developmental processes through local cell interactions. mind bomb (mib) encodes an E3 ubiquitin ligase that is involved in Notch activation through Delta ubiquitylation and internalization. To further dissect the function of Mib, two yeast two-hybrid screens for zebrafish Mib/Mib2-binding proteins with different strategies have been performed. 81 putative interesting proteins were discovered and classified into six groups: ubiquitin proteasome pathway, cytoskeleton, trafficking, replication/transcription/translation factors, cell signaling and others. Confirmed by coimmunoprecipitation (Co-IP), Mib interacted with four tested proteins: ubiquitin specific protease 1 (Usp1), ubiquitin specific protease 9 (Usp9), tumornecrosis-factor-receptor-associated factor (TRAF)-binding domain (Trabid)/zinc finger, RAN-binding domain containing 1 (Zranb1) and hypoxia-inducible factor 1, alpha subunit inhibitor (Hif1an)/factor inhibiting HIF 1 (Fih-1). Usp1, Usp9, Trabid and Fih-1 also bound to zebrafish Mib2, a Mib homolog with similar structural domains and functions. Both Mib and Mib2 can ubiquitylate Trabid and Fih-1, indicating a potential regulating role of Mib and Mib2 on Trabid and Fih-1 and, furthermore, the possible involvement of Notch signaling in hypoxia-regulated differentiation, tumorigenesis and NF-kappa B pathway. Finally, functions of confirmed Mib/Mib2-interacting proteins are collated, summarized and hypothesized, which depicts a regulating network beyond Notch signaling.	[Tseng, Li-Chuan; Cheng, Chun-Mei; Hsu, Chia-Hao; Jiang, Yun-Jin] Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan Town, Miaoli County, Taiwan; [Zhang, Chengjin; Xu, Haoying; Jiang, Yun-Jin] Natl Univ Singapore, Inst Mol & Cell Biol, Lab Dev Signalling & Patterning, Singapore 117548, Singapore; [Hsu, Chia-Hao] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Jiang, Yun-Jin] Natl Chung Hsing Univ, Ctr Biotechnol, Taichung 40227, Taiwan; [Jiang, Yun-Jin] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan	National Health Research Institutes - Taiwan; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National Tsing Hua University; National Chung Hsing University; National Taiwan University	Jiang, YJ (corresponding author), Natl Hlth Res Inst, Inst Mol & Genom Med, Zhunan Town, Miaoli County, Taiwan.	yjjiang@nhri.org.tw	Jiang, Yun-Jin/E-3995-2010	Jiang, Yun-Jin/0000-0003-0499-7306; HSU, CHIA-HAO/0000-0001-6920-0316	Agency of Science, Technology and Research (A*STAR), Singapore; National Health Research Institutes, Taiwan [MG-102-PP-13, MG-102-PP-14]; National Science Council, Taiwan [NSC 102-2321-B-400-018, 100-2911-I-400-002, 100-2311-B-400-001-MY3]	Agency of Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR)); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Agency of Science, Technology and Research (A*STAR, http://www.a-star.edu.sg), Singapore, the National Health Research Institutes (http://www.nhri.org.tw), Taiwan (MG-102-PP-13 and MG-102-PP-14) and grants from the National Science Council (http://web1.nsc.gov.tw), Taiwan (NSC 102-2321-B-400-018, 100-2911-I-400-002 and 100-2311-B-400-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artayanis-Tsakonas S, 2010, CURR TOP DEV BIOL, V92, P1, DOI 10.1016/S0070-2153(10)92001-2; Berndt JD, 2011, J CELL BIOL, V194, P737, DOI 10.1083/jcb.201107021; Brooks CL, 2007, ONCOGENE, V26, P7262, DOI 10.1038/sj.onc.1210531; Carrasco-Rando M, 2008, DEVELOPMENT, V135, P849, DOI 10.1242/dev.015529; Chen X, 2002, GENE DEV, V16, P289, DOI 10.1101/gad.961502; Choe EA, 2007, J NEUROSCI, V27, P9503, DOI 10.1523/JNEUROSCI.1408-07.2007; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Cockman ME, 2009, MOL CELL PROTEOMICS, V8, P535, DOI 10.1074/mcp.M800340-MCP200; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Cunningham LA, 2012, BEHAV BRAIN RES, V227, P410, DOI 10.1016/j.bbr.2011.08.002; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Evans PC, 2001, BIOCHEM J, V357, P617, DOI 10.1042/0264-6021:3570617; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Fukuba H, 2008, NEUROSCI LETT, V433, P209, DOI 10.1016/j.neulet.2007.12.069; Fukuba H, 2007, BIOCHEM BIOPH RES CO, V353, P324, DOI 10.1016/j.bbrc.2006.12.051; Gao W, 2012, ARTHRITIS RHEUM-US, V64, P2104, DOI 10.1002/art.34397; Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hansson EM, 2004, SEMIN CANCER BIOL, V14, P320, DOI 10.1016/j.semcancer.2004.04.011; Hardy AP, 2009, J MOL BIOL, V392, P994, DOI 10.1016/j.jmb.2009.07.070; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hing HK, 1999, EUR J CELL BIOL, V78, P690, DOI 10.1016/S0171-9335(99)80037-5; Horn S, 2012, P NATL ACAD SCI USA, V109, P7356, DOI 10.1073/pnas.1203605109; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jeong HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036359; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Jin YJ, 2002, J BIOL CHEM, V277, P46980, DOI 10.1074/jbc.M208585200; Jurd R, 2008, J BIOL CHEM, V283, P301, DOI 10.1074/jbc.M705580200; Kang K, 2013, J BIOL CHEM, V288, P2580, DOI 10.1074/jbc.M112.398263; Kazanjian A, 2010, GASTROENTEROLOGY, V139, P918, DOI 10.1053/j.gastro.2010.05.081; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Koo BK, 2005, J BIOL CHEM, V280, P22335, DOI 10.1074/jbc.M501631200; Kopan R, 2002, J CELL SCI, V115, P1095; Kwon DY, 2013, MOL BIOL CELL, V24, P1863, DOI 10.1091/mbc.E13-01-0042; Lai EC, 2005, DEVELOPMENT, V132, P2319, DOI 10.1242/dev.01825; Le Borgne R, 2005, PLOS BIOL, V3, P688, DOI 10.1371/journal.pbio.0030096; Lecourtois M, 1998, CURR BIOL, V8, P771, DOI 10.1016/S0960-9822(98)70300-8; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Louvi A, 2012, SEMIN CELL DEV BIOL, V23, P473, DOI 10.1016/j.semcdb.2012.02.005; Ma M, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030018; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Maldonado-Baez L, 2006, TRENDS CELL BIOL, V16, P505, DOI 10.1016/j.tcb.2006.08.001; Maxwell PH, 2005, SEMIN CELL DEV BIOL, V16, P523, DOI 10.1016/j.semcdb.2005.03.001; McNeill LA, 2002, BIOCHEM J, V367, P571, DOI 10.1042/BJ20021162; Moretti J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000545; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Mukherjee T, 2011, SCIENCE, V332, P1210, DOI 10.1126/science.1199643; Musse AA, 2012, SEMIN CELL DEV BIOL, V23, P429, DOI 10.1016/j.semcdb.2012.01.011; Nguyen HT, 2007, J CELL BIOL, V179, P219, DOI 10.1083/jcb.200708135; O'Neill L.A., 2000, SCI STKE, V2000, pRE1, DOI DOI 10.1126/STKE.2000.44.RE1; Oldham CE, 2002, CURR BIOL, V12, P1112, DOI 10.1016/S0960-9822(02)00900-4; Ossipova O, 2009, DEV CELL, V17, P222, DOI 10.1016/j.devcel.2009.06.010; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Porazzi P, 2012, ENDOCRINOLOGY, V153, P5645, DOI 10.1210/en.2011-1888; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Sainson RCA, 2006, TRENDS MOL MED, V12, P141, DOI 10.1016/j.molmed.2006.02.001; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Stempin CC, 2011, J BIOL CHEM, V286, P37147, DOI 10.1074/jbc.M111.263384; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Takeuchi T, 2005, AM J PATHOL, V166, P1817, DOI 10.1016/S0002-9440(10)62491-1; Tse WKF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-637; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Woelk T, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-11; Xie Y, 2013, J BIOL CHEM, V288, P2976, DOI 10.1074/jbc.M112.430066; Yamamoto M, 2010, DEVELOPMENT, V137, P2527, DOI 10.1242/dev.051011; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yoo KW, 2006, FEBS LETT, V580, P4409, DOI 10.1016/j.febslet.2006.07.009; Zhang CJ, 2007, J MOL BIOL, V366, P1115, DOI 10.1016/j.jmb.2006.11.096; Zhang CJ, 2007, DEV BIOL, V305, P14, DOI 10.1016/j.ydbio.2007.01.034; Zhang JZ, 2012, G3-GENES GENOM GENET, V2, P1563, DOI 10.1534/g3.112.003780; Zhang LG, 2009, AM J PHYSIOL-CELL PH, V297, pC1275, DOI 10.1152/ajpcell.00214.2009; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105	75	25	26	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93394	10.1371/journal.pone.0093394	http://dx.doi.org/10.1371/journal.pone.0093394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714733	Green Published, gold, Green Submitted			2022-12-25	WOS:000334160900026
J	Wang, JY; Wang, CY; Huang, YS; Chen, PF; Huang, KY; Chou, P; Lian, WC; Lee, CC				Wang, Jen-Yu; Wang, Cheng-Yi; Huang, Yung-Sung; Chen, Pin-Fan; Huang, Kuang-Yung; Chou, Pesus; Lian, Wei-Cheng; Lee, Ching-Chih			Increased Risk of Ischemic Stroke after Hyperosmolar Hyperglycemic State: A Population-Based Follow-Up Study	PLOS ONE			English	Article							DIABETIC-PATIENTS; OXIDATIVE STRESS; GLUCOSE; PREVALENCE; KETOACIDOSIS; MORTALITY; DIAGNOSIS; HEALTH; MEN	Background: Although much attention has been focused on the association between chronic hyperglycemia and cerebrovascular diseases in type 2 diabetes mellitus (DM) patients, there is no data regarding the risk of ischemic stroke after a hyperosmolar hyperglycemic state (HHS) attack. The objective of this study was to investigate the risk of ischemic stroke in type 2 DM patients after an HHS attack. Methods: From 2004 to 2008, this retrospective observational study was conducted on a large cohort of Taiwanese using Taiwan's National Health Insurance Research Database (NHIRD). We identified 19,031 type 2 DM patients who were discharged with a diagnosis of HHS and 521,229 type 2 DM patients without an HHS diagnosis. Using the propensity score generated from logistic regression models, conditional on baseline covariates, we matched 19,031 type 2 DM patients with an HHS diagnosis with the same number from the comparison cohort. The one-year cumulative rate for ischemic stroke was estimated using the Kaplan-Meier method. After adjusting covariates, Cox proportional hazard regression was used to compute the adjusted one-year rate of ischemic stroke. Results: Of the patients sampled, 1,810 (9.5%) of the type 2 DM patients with HHS and 996 (5.2%) of the comparison cohort developed ischemic stroke during the one-year follow-up period. After adjusting for covariates, the adjusted HR for developing ischemic stroke during the one-year follow-up period was 1.8 (95% C. I., 1.67 to 1.95, P<0.001) for type 2 DM patients with HHS compared with those without HHS. Conclusion: Although DM is a well-recognized risk factor for atherosclerosis, type 2 DM patients that have suffered a HHS attacks are at an increased risk of developing ischemic stroke compared with those without HHS.	[Wang, Jen-Yu; Wang, Cheng-Yi] Fu Jen Cathol Univ, Cardinal Tien Hosp, Sch Med, Dept Internal Med, New Taipei City, Taiwan; [Huang, Yung-Sung] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Neurol, Chiayi, Taiwan; [Chen, Pin-Fan; Lian, Wei-Cheng] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Chiayi, Taiwan; [Huang, Kuang-Yung; Lian, Wei-Cheng; Lee, Ching-Chih] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Huang, Kuang-Yung] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Chou, Pesus; Lee, Ching-Chih] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Chou, Pesus; Lee, Ching-Chih] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Educ, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Clin Epidemiol & Biostat, Chiayi, Taiwan	Cardinal Tien Hospital; Fu Jen Catholic University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital	Lian, WC (corresponding author), Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Div Endocrinol & Metab, Chiayi, Taiwan.	hematcd2@hotmail.com; hematcd@hotmail.com						Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Bruno A, 1999, NEUROLOGY, V52, P280, DOI 10.1212/WNL.52.2.280; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Ceriello A, 2008, DIABETES, V57, P1349, DOI 10.2337/db08-0063; Chen CY, 2007, PEDIATRICS, V119, pE435, DOI 10.1542/peds.2006-1477; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chiasson JL, 2003, CAN MED ASSOC J, V168, P859; Chu C H, 2001, Chang Gung Med J, V24, P345; DECOURTENMYERS G, 1988, STROKE, V19, P623, DOI 10.1161/01.STR.19.5.623; Engstrom G, 2001, STROKE, V32, P1098, DOI 10.1161/01.STR.32.5.1098; Fadini GP, 2011, DIABETES RES CLIN PR, V94, P172, DOI 10.1016/j.diabres.2011.06.018; FOSTER DW, 1983, NEW ENGL J MED, V309, P159; Kang JH, 2009, STROKE, V40, P3443, DOI 10.1161/STROKEAHA.109.562017; Kitabchi AE, 2006, ENDOCRIN METAB CLIN, V35, P725, DOI 10.1016/j.ecl.2006.09.006; Liao CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031527; Lin HC, 2007, J URBAN HEALTH, V84, P604, DOI 10.1007/s11524-007-9195-1; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; LORBER D, 1995, MED CLIN N AM, V79, P39, DOI 10.1016/S0025-7125(16)30083-9; McFadden E, 2009, STROKE, V40, P1070, DOI 10.1161/STROKEAHA.108.533414; Moulin T, 1997, EUR NEUROL, V38, P10, DOI 10.1159/000112896; NEDERGAARD M, 1987, BRAIN RES, V408, P79, DOI 10.1016/0006-8993(87)90360-X; Pasticci MB, 2013, NEW MICROBIOL, V36, P193; Quagliaro L, 2003, DIABETES, V52, P2795, DOI 10.2337/diabetes.52.11.2795; Resnick HE, 2001, J CLIN EPIDEMIOL, V54, P869, DOI 10.1016/S0895-4356(01)00359-6; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Tseng CH, 2004, DIABETES CARE, V27, P1605, DOI 10.2337/diacare.27.7.1605	27	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94155	10.1371/journal.pone.0094155	http://dx.doi.org/10.1371/journal.pone.0094155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714221	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900095
J	Wolter, T; Steinbrecher, T; Trauner, D; Elstner, M				Wolter, Tino; Steinbrecher, Thomas; Trauner, Dirk; Elstner, Marcus			Ligand Photo-Isomerization Triggers Conformational Changes in iGluR2 Ligand Binding Domain	PLOS ONE			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; DYNAMICS; ACTIVATION; SIMULATION; AGONIST	Neurological glutamate receptors bind a variety of artificial ligands, both agonistic and antagonistic, in addition to glutamate. Studying their small molecule binding properties increases our understanding of the central nervous system and a variety of associated pathologies. The large, oligomeric multidomain membrane protein contains a large and flexible ligand binding domains which undergoes large conformational changes upon binding different ligands. A recent application of glutamate receptors is their activation or inhibition via photo-switchable ligands, making them key systems in the emerging field of optochemical genetics. In this work, we present a theoretical study on the binding mode and complex stability of a novel photo-switchable ligand, ATA-3, which reversibly binds to glutamate receptors ligand binding domains (LBDs). We propose two possible binding modes for this ligand based on flexible ligand docking calculations and show one of them to be analogues to the binding mode of a similar ligand, 2-BnTetAMPA. In long MD simulations, it was observed that transitions between both binding poses involve breaking and reforming the T686-E402 protein hydrogen bond. Simulating the ligand photo-isomerization process shows that the two possible configurations of the ligand azo-group have markedly different complex stabilities and equilibrium binding modes. A strong but slow protein response is observed after ligand configuration changes. This provides a microscopic foundation for the observed difference in ligand activity upon light-switching.	[Wolter, Tino; Steinbrecher, Thomas; Elstner, Marcus] Karlsruhe Inst Technol, Inst Phys Chem, Dept Theoret Chem Biol, D-76021 Karlsruhe, Germany; [Trauner, Dirk] Univ Munich, Dept Chem, Munich, Germany; [Trauner, Dirk] Ctr Integrated Prot Sci, Munich, Germany	Helmholtz Association; Karlsruhe Institute of Technology; University of Munich; University of Munich	Elstner, M (corresponding author), Karlsruhe Inst Technol, Inst Phys Chem, Dept Theoret Chem Biol, D-76021 Karlsruhe, Germany.	marcus.elstner@kit.edu	Elstner, Marcus/H-3463-2013		Deutsche Forschungsgemeinschaft [FOR 1279]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (FOR 1279, "Protein-based Photo293 switches") (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arinaminpathy Y, 2006, MOL PHARMACOL, V69, P5, DOI 10.1124/mol.105.016691; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Arvola M, 1996, J BIOL CHEM, V271, P15527, DOI 10.1074/jbc.271.26.15527; Asztely F, 1996, MOL NEUROBIOL, V12, P1, DOI 10.1007/BF02740744; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Dingledine R, 1999, PHARMACOL REV, V51, P7; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Knegtel RMA, 1997, J MOL BIOL, V266, P424, DOI 10.1006/jmbi.1996.0776; Lau A, 2007, STRUCTURE; Lau AY, 2011, NAT STRUCT MOL BIOL, V18, P283, DOI 10.1038/nsmb.2010; Lodge D, 2009, NEUROPHARMACOLOGY, V56, P6, DOI 10.1016/j.neuropharm.2008.08.006; Nguyen PH, 2006, CHEM PHYS, V323, P36, DOI 10.1016/j.chemphys.2005.08.047; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Stawski P, 2012, ANGEW CHEM INT EDIT, V51, P5748, DOI 10.1002/anie.201109265; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vogensen SB, 2007, J MED CHEM, V50, P2408, DOI 10.1021/jm061439q; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wolter T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058774	24	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e92716	10.1371/journal.pone.0092716	http://dx.doi.org/10.1371/journal.pone.0092716			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713651	gold, Green Published, Green Submitted			2022-12-25	WOS:000334160900008
J	Maumus, F; Quesneville, H				Maumus, Florian; Quesneville, Hadi			Deep Investigation of Arabidopsis thaliana Junk DNA Reveals a Continuum between Repetitive Elements and Genomic Dark Matter	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; IDENTIFICATION; METHYLATION; ANNOTATION; SEQUENCES; FAMILIES	Eukaryotic genomes contain highly variable amounts of DNA with no apparent function. This so- called junk DNA is composed of two components: repeated and repeat- derived sequences ( together referred to as the repeatome), and nonannotated sequences also known as genomic dark matter. Because of their high duplication rates as compared to other genomic features, transposable elements are predominant contributors to the repeatome and the products of their decay is thought to be a major source of genomic dark matter. Determining the origin and composition of junk DNA is thus important to help understanding genome evolution as well as host biology. In this study, we have used a combination of tools enabling to show that the repeatome from the small and reducing A. thaliana genome is significantly larger than previously thought. Furthermore, we present the concepts and results from a series of innovative approaches suggesting that a significant amount of the A. thaliana dark matter is of repetitive origin. As a tentative standard for the community, we propose a deep compendium annotation of the A. thaliana repeatome that may help addressing farther genome evolution as well as transcriptional and epigenetic regulation in this model plant.	[Maumus, Florian; Quesneville, Hadi] INRA, Res Unit Genom Info, URGI, UR1 164, F-78026 Versailles, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); INRAE; UDICE-French Research Universities; Universite Paris Saclay	Maumus, F (corresponding author), INRA, Res Unit Genom Info, URGI, UR1 164, F-78026 Versailles, France.	florian.maumus@versailles.inra.fr; hadi.quesneville@versailles.inra.fr	Quesneville, Hadi/AAG-1048-2020; Maumus, Florian/O-5426-2016	Quesneville, Hadi/0000-0003-3001-4908; Maumus, Florian/0000-0001-7325-0527	French national research agency [ANR-08-KBBE-012, ANR-2011-BSV6-00801]	French national research agency(French National Research Agency (ANR))	FM was supported by two grants from the French national research agency (ANR-08-KBBE-012, ANR-2011-BSV6-00801) attributed to Hadi Quesneville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrieu O, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-94; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Bergman CM, 2007, BRIEF BIOINFORM, V8, P382, DOI 10.1093/bib/bbm048; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BRITTEN RJ, 1968, SCIENCE, V161, P529, DOI 10.1126/science.161.3841.529; Brosius J, 1999, GENETICA, V107, P209, DOI 10.1023/A:1004018519722; Buisine N, 2008, GENOMICS, V91, P467, DOI 10.1016/j.ygeno.2008.01.005; Clauss MJ, 2006, TRENDS PLANT SCI, V11, P449, DOI 10.1016/j.tplants.2006.07.005; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cowley M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003234; Dassanayake M, 2011, NAT GENET, V43, P913, DOI 10.1038/ng.889; Dawkins R, 1976, SELFISH GENE; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Devos KM, 2002, GENOME RES, V12, P1075, DOI 10.1101/gr.132102; DOOLITTLE WF, 1980, NATURE, V284, P601, DOI 10.1038/284601a0; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Fedoroff NV, 2012, SCIENCE, V338, P758, DOI 10.1126/science.338.6108.758; Flutre T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016526; Franzke A, 2011, TRENDS PLANT SCI, V16, P108, DOI 10.1016/j.tplants.2010.11.005; Gu WJ, 2008, ANAL BIOCHEM, V380, P77, DOI 10.1016/j.ab.2008.05.015; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 1996, COMPUT CHEM, V20, P119, DOI 10.1016/S0097-8485(96)80013-1; KARLIN S, 1995, TRENDS GENET, V11, P283; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LANGLEY CH, 1988, GENET RES, V52, P223, DOI 10.1017/S0016672300027695; Lerat E, 2010, HEREDITY, V104, P520, DOI 10.1038/hdy.2009.165; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lysak MA, 2009, MOL BIOL EVOL, V26, P85, DOI 10.1093/molbev/msn223; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; OHNO S, 1972, BROOKHAVEN SYM BIOL, P366; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Oyama RK, 2008, PLANT SYST EVOL, V273, P257, DOI 10.1007/s00606-008-0017-z; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Quesneville H, 2005, PLOS COMPUT BIOL, V1, P166, DOI 10.1371/journal.pcbi.0010022; Quesneville H, 2003, J MOL EVOL, V57, pS50, DOI 10.1007/s00239-003-0007-2; Rebollo R, 2012, ANNU REV GENET, V46, P21, DOI 10.1146/annurev-genet-110711-155621; Schneeberger K, 2011, P NATL ACAD SCI USA, V108, P10249, DOI 10.1073/pnas.1107739108; Slotte T, 2013, NAT GENET, V45, P831, DOI 10.1038/ng.2669; Smit A, 1996, REPEATMASKER OPEN 30; Smit AFA, 2008, REPEATMODELER OP 1 0; THOMAS CA, 1971, ANNU REV GENET, V5, P237, DOI 10.1146/annurev.ge.05.120171.001321; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wu HJ, 2012, P NATL ACAD SCI USA, V109, P12219, DOI 10.1073/pnas.1209954109; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zytnicki M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025988	48	39	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94101	10.1371/journal.pone.0094101	http://dx.doi.org/10.1371/journal.pone.0094101			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709859	Green Published, gold, Green Submitted			2022-12-25	WOS:000334159800101
J	Feng, F; Jiang, YB; Yuan, M; Shen, J; Yin, HB; Geng, DY; Xu, JR; Hua, YQ; Shi, JY; Shi, YX; Zhang, ZY				Feng, Feng; Jiang, Yebin; Yuan, Min; Shen, Jie; Yin, Huabin; Geng, Daoying; Xu, Jianrong; Hua, Yanqing; Shi, Jingyun; Shi, Yuxin; Zhang, Zhiyong			Association of Radiologic Findings with Mortality in Patients with Avian Influenza H7N9 Pneumonia	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; VIRUS; INFECTION	Background: The novel H7N9 virus causes severe illness, including pneumonia and acute respiratory distress syndrome, with high rates of mortality. We investigated the association of initial radiologic characteristics obtained at admission with clinical outcomes in patients with avian influenza H7N9 pneumonia. Methods: Demographics, comorbidities, clinical findings, radiologic appearance and scores of the affected lung parenchyma were compared between survivor group (n = 15) and mortality group (n = 7). Two radiologic scores were calculated, one using chest radiography and one using CT. Follow-up CT scans at discharge were analyzed in 12 patients of the survival group. Results: All the patients in mortality group developed acute respiratory distress syndrome and required mechanical ventilation, while in the survival group 33% (5/15) developed acute respiratory distress syndrome (P < 0.05) and 27% (4/15) required mechanical ventilation (P < 0.05). The mean radiographic and CT scores of the mortality group were 50% higher compared to the survival group ( P < 0.05). ROC analysis revealed an area under curve of 0.738 for the radiographic score with an optimal cutoff value of a score of 19 for prediction of mortality, with a sensitivity of 71% and a specificity of 67%, and an area under curve of 0.833 for the CT score with an optimal cutoff value of a CT score of 21 for prediction of mortality, with a sensitivity of 86% and a specificity of 73%. The mean CT score of the affected lung parenchyma at discharge was 30% lower than the initial CT examination ( P < 0.05). Conclusion: High initial radiologic score is associated with mortality in patients with avian influenza H7N9 pneumonia.	[Feng, Feng; Jiang, Yebin; Yuan, Min; Shen, Jie; Shi, Yuxin; Zhang, Zhiyong] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Radiol, Shanghai 200433, Peoples R China; [Yin, Huabin] Fudan Univ, Peoples Hosp Shanghai 5, Dept Radiol, Shanghai 200433, Peoples R China; [Geng, Daoying] Fudan Univ, Huashan Hosp, Dept Radiol, Shanghai 200433, Peoples R China; [Xu, Jianrong] Shanghai Jiao Tong Univ, Renji Hosp, Dept Radiol, Shanghai, Peoples R China; [Hua, Yanqing] Fudan Univ, Huadong Hosp, Dept Radiol, Shanghai 200433, Peoples R China; [Shi, Jingyun] Tongji Univ, Shanghai Pulm Hosp, Dept Radiol, Shanghai 200092, Peoples R China; [Jiang, Yebin] Univ Michigan, Ctr Canc, Ann Arbor, MI 48109 USA; [Feng, Feng] Nantong Univ, Nantong Tumor Hosp, Dept Radiol, Nantong, Peoples R China	Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University; Fudan University; Tongji University; University of Michigan System; University of Michigan; Nantong University	Shi, YX (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Radiol, Shanghai 200433, Peoples R China.	shiyx828288@163.com; zhangzy@shaphc.org	Cao, Xin/AAX-8367-2021; Shi, Jing/HHS-6413-2022					Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Bay A, 2007, EUR J RADIOL, V61, P245, DOI 10.1016/j.ejrad.2006.10.006; Chang YC, 2005, RADIOLOGY, V236, P1067, DOI 10.1148/radiol.2363040958; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Franquet T, 2011, RADIOLOGY, V260, P18, DOI 10.1148/radiol.11092149; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Grieser C, 2012, EUR J RADIOL, V81, P389, DOI 10.1016/j.ejrad.2010.12.085; Grinblat L, 2003, RADIOLOGY, V228, P802, DOI 10.1148/radiol.2283030671; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Kim EA, 2002, RADIOGRAPHICS, V22, pS137, DOI 10.1148/radiographics.22.suppl_1.g02oc15s137; Ko SF, 2004, RADIOLOGY, V233, P173, DOI 10.1148/radiol.2323031547; Li P, 2011, EUR J RADIOL, V80, pE146, DOI 10.1016/j.ejrad.2010.05.029; Lu SH, 2013, BIOSCI TRENDS, V7, P109, DOI 10.5582/bst.2013.v7.2.109; Marchiori E, 2011, AM J ROENTGENOL, V196, pW723, DOI 10.2214/AJR.10.5109; Marchiori E, 2011, EUR J RADIOL, V77, P80, DOI 10.1016/j.ejrad.2009.06.017; Marchiori E, 2010, EUR J RADIOL, V74, P93, DOI 10.1016/j.ejrad.2009.11.005; Parry J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2222; Qureshi NR, 2006, J THORAC IMAG, V21, P259, DOI 10.1097/01.rti.0000213573.94032.53; So LKY, 2003, LANCET, V361, P1615, DOI 10.1016/S0140-6736(03)13265-5; Uyeki TM, 2013, NEW ENGL J MED, V368, P1862, DOI 10.1056/NEJMp1304661; Wang QL, 2013, RADIOLOGY, V268, P882, DOI 10.1148/radiol.13130988; World Health Organization, 2013, NUMB CONF HUM CAS AV	23	28	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93885	10.1371/journal.pone.0093885	http://dx.doi.org/10.1371/journal.pone.0093885			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705783	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500084
J	Le Texier, L; Durand, J; Lavault, A; Hulin, P; Collin, O; Le Bras, Y; Cuturi, MC; Chiffoleau, E				Le Texier, Laetitia; Durand, Justine; Lavault, Amelie; Hulin, Philippe; Collin, Olivier; Le Bras, Yvan; Cuturi, Maria-Cristina; Chiffoleau, Elise			LIMLE, a New Molecule Over-Expressed following Activation, Is Involved in the Stimulatory Properties of Dendritic Cells	PLOS ONE			English	Article							PANCREATIC SPASMOLYTIC POLYPEPTIDE; REGULATORY T-CELLS; ALLOGRAFT TOLERANCE; PROTEIN-STRUCTURE; SUBCELLULAR-LOCALIZATION; ENDOTHELIAL-CELLS; SYNAPSE FORMATION; NUCLEAR EXPORT; ACTIN; INDUCTION	Dendritic cells are sentinels of the immune system distributed throughout the body, that following danger signals will migrate to secondary lymphoid organs to induce effector T cell responses. We have identified, in a rodent model of graft rejection, a new molecule expressed by dendritic cells that we have named LIMLE (RGD1310371). To characterize this new molecule, we analyzed its regulation of expression and its function. We observed that LIMLE mRNAs were rapidly and strongly up regulated in dendritic cells following inflammatory stimulation. We demonstrated that LIMLE inhibition does not alter dendritic cell maturation or cytokine production following Toll-like-receptor stimulation. However, it reduces their ability to stimulate effector T cells in a mixed leukocyte reaction or T cell receptor transgenic system. Interestingly, we observed that LIMLE protein localized with actin at some areas under the plasma membrane. Moreover, LIMLE is highly expressed in testis, trachea, lung and ciliated cells and it has been shown that cilia formation bears similarities to formation of the immunological synapse which is required for the T cell activation by dendritic cells. Taken together, these data suggest a role for LIMLE in specialized structures of the cytoskeleton that are important for dynamic cellular events such as immune synapse formation. In the future, LIMLE may represent a new target to reduce the capacity of dendritic cells to stimulate T cells and to regulate an immune response.	[Le Texier, Laetitia; Durand, Justine; Lavault, Amelie; Cuturi, Maria-Cristina; Chiffoleau, Elise] INSERM, U1064, Nantes, France; [Le Texier, Laetitia; Durand, Justine; Lavault, Amelie; Cuturi, Maria-Cristina; Chiffoleau, Elise] CHU Nantes, ITUN, Inst Transplantat & Rech Transplantat, F-44035 Nantes 01, France; [Le Texier, Laetitia; Durand, Justine; Lavault, Amelie; Cuturi, Maria-Cristina; Chiffoleau, Elise] Univ Nantes, Fac Med, Nantes, France; [Hulin, Philippe] SFR Sante, Plateforme MicroPICell, Nantes, France; [Collin, Olivier; Le Bras, Yvan] IRISA INRIA, Plateforme GenOuest, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Nantes Universite; UDICE-French Research Universities; Universite Paris Saclay	Chiffoleau, E (corresponding author), INSERM, U1064, Nantes, France.	elise.chiffoleau@univ-nantes.fr	Le Bras, Yvan/B-4017-2010; Chiffoleau, Elise/N-2982-2018	Le Bras, Yvan/0000-0002-8504-068X; Chiffoleau, Elise/0000-0001-6167-682X; Collin, Olivier/0000-0002-8959-8402	Ministere de l'Enseignement Superieur et de la Recherche; Fondation Progreffe; Fondation Centaure	Ministere de l'Enseignement Superieur et de la Recherche; Fondation Progreffe; Fondation Centaure	This work was supported by a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche and by Fondation Progreffe and Fondation Centaure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Alwan MM, 2003, J IMMUNOL, V171, P4479, DOI 10.4049/jimmunol.171.9.4479; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BAKER ME, 1988, BIOCHEM J, V253, P307, DOI 10.1042/bj2530307; Bannert N, 2003, J BIOL CHEM, V278, P42190, DOI 10.1074/jbc.M306669200; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bouma G, 2011, BLOOD, V118, P2492, DOI 10.1182/blood-2011-03-340265; Celli S, 2011, NAT MED, V17, P744, DOI 10.1038/nm.2376; CHARREAU B, 1994, TRANSPLANTATION, V58, P1222, DOI 10.1097/00007890-199412150-00015; Cheng SL, 2007, J BIOMED SCI, V14, P87, DOI 10.1007/s11373-006-9130-6; Chiffoleau E, 2002, J IMMUNOL, V168, P5058, DOI 10.4049/jimmunol.168.10.5058; Chiffoleau E, 2002, AM J TRANSPLANT, V2, P745, DOI 10.1034/j.1600-6143.2002.20808.x; Condamine T, 2010, J LEUKOCYTE BIOL, V88, P507, DOI 10.1189/jlb.1109738; David A, 1997, CYTOKINE, V9, P818, DOI 10.1006/cyto.1997.0234; Eisenhaber F, 2003, NUCLEIC ACIDS RES, V31, P3631, DOI 10.1093/nar/gkg537; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Gingras AR, 2010, J BIOL CHEM, V285, P29577, DOI 10.1074/jbc.M109.095455; Griffiths GM, 2010, J CELL BIOL, V189, P397, DOI 10.1083/jcb.201002027; Grummt I, 2006, CURR OPIN GENET DEV, V16, P191, DOI 10.1016/j.gde.2006.02.001; HELMKE RJ, 1987, IN VITRO CELL DEV B, V23, P567; Heslan JM, 2006, TRANSPLANTATION, V82, P1185, DOI 10.1097/01.tp.0000236573.01428.f3; Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182; Hu P, 2004, GENE DEV, V18, P3010, DOI 10.1101/gad.1250804; Kelley LA, 2009, PROTEIN ENG DES SEL, V22, P561, DOI 10.1093/protein/gzp035; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klatt AR, 2007, BIOLOGICALS, V35, P321, DOI 10.1016/j.biologicals.2006.12.003; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lammermann T, 2009, BLOOD, V113, P5703, DOI 10.1182/blood-2008-11-191882; Le Texier L, 2011, AM J TRANSPLANT, V11, P429, DOI 10.1111/j.1600-6143.2010.03336.x; Lee HJ, 2012, INFLAMM RES, V61, P817, DOI 10.1007/s00011-012-0474-2; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louvet C, 2004, TRANSPLANTATION, V78, P1259, DOI 10.1097/01.TP.0000140482.20336.77; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; Martinez-Borra J, 2012, ADV EXP MED BIOL, V738, P277, DOI 10.1007/978-1-4614-1680-7_16; McClintock TS, 2008, PHYSIOL GENOMICS, V32, P198, DOI 10.1152/physiolgenomics.00128.2007; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nobile C, 2008, BLOOD, V111, P3579, DOI 10.1182/blood-2007-08-107755; ONO K, 1969, J THORAC CARDIOV SUR, V57, P225, DOI 10.1016/S0022-5223(19)42744-X; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Peche H, 2005, AM J TRANSPLANT, V5, P255, DOI 10.1111/j.1600-6143.2004.00683.x; Peche H, 2003, TRANSPLANTATION, V76, P1503, DOI 10.1097/01.TP.0000092494.75313.38; Ponting CP, 2000, J MOL BIOL, V302, P1041, DOI 10.1006/jmbi.2000.4087; Qi TY, 2011, J BIOL CHEM, V286, P15171, DOI 10.1074/jbc.M110.184374; Reichardt P, 2007, BLOOD, V110, P1519, DOI 10.1182/blood-2006-10-053793; Roncarolo MG, 2001, J EXP MED, V193, pF5, DOI 10.1084/jem.193.2.F5; Roy A, 2011, JOVE-J VIS EXP, DOI 10.3791/3259; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Spisek R, 2001, CANCER IMMUNOL IMMUN, V50, P417, DOI 10.1007/s002620100215; Tatarano S, 2012, INT J ONCOL, V40, P951, DOI 10.3892/ijo.2011.1294; Thebault P, 2007, AM J TRANSPLANT, V7, P2472, DOI 10.1111/j.1600-6143.2007.01960.x; Thebault P, 2009, J IMMUNOL, V183, P3099, DOI 10.4049/jimmunol.0803767; THIM L, 1988, BIOCHEM J, V253, P309; THIM L, 1989, FEBS LETT, V250, P85, DOI 10.1016/0014-5793(89)80690-8; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Tubb B, 2002, EXP CELL RES, V275, P92, DOI 10.1006/excr.2002.5486; van Helden SFG, 2006, J IMMUNOL, V177, P1567, DOI 10.4049/jimmunol.177.3.1567; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Wada A, 1998, EMBO J, V17, P1635, DOI 10.1093/emboj/17.6.1635; Watts C, 2007, CURR OPIN IMMUNOL, V19, P73, DOI 10.1016/j.coi.2006.11.014; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Yamashiro S, 2012, CRIT REV IMMUNOL, V32, P11, DOI 10.1615/CritRevImmunol.v32.i1.20; Yeats C, 2006, NUCLEIC ACIDS RES, V34, pD281, DOI 10.1093/nar/gkj057; Yokoyama WM, 2003, NAT REV IMMUNOL, V3, P304, DOI 10.1038/nri1055; Zanin-Zhorov A, 2011, TRENDS IMMUNOL, V32, P358, DOI 10.1016/j.it.2011.04.007; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	67	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93894	10.1371/journal.pone.0093894	http://dx.doi.org/10.1371/journal.pone.0093894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705920	Green Submitted, Green Published, gold			2022-12-25	WOS:000334107500088
J	Pan, Y; Tao, QS; Wang, HP; Xiong, SD; Zhang, R; Chen, TP; Tao, LL; Zhai, ZM				Pan, Ying; Tao, Qianshan; Wang, Huiping; Xiong, Shudao; Zhang, Rui; Chen, Tianping; Tao, Lili; Zhai, Zhimin			Dendritic Cells Decreased the Concomitant Expanded Tregs and Tregs Related IL-35 in Cytokine-Induced Killer Cells and Increased Their Cytotoxicity against Leukemia Cells	PLOS ONE			English	Article							REGULATORY T-CELLS; ADOPTIVE IMMUNOTHERAPY; CIK CELLS; SUPPRESSION; EXPANSION; CANCER	Regulatory T cells (Tregs) are potent immunosuppressive cells and essential for inducing immune tolerance. Recent studies have reported that Tregs and Tregs related cytokines can inhibit the antitumor activity of cytokine-induced killer (CIK) cells, but dendritic cells co-cultured CIK (DC-CIK) cells can be used for induction of a specific immune response by blocking of Tregs and TGF-beta, IL-10. As a novel identified cytokine, IL-35 is specially produced by Tregs and plays an essential role in immune regulation. However, it remains unknown whether IL-35 roles in tumor immunotherapy mediated by CIK and DC-CIK cells. In this study, we cultured CIK and DC-CIK cells from the same healthy adult samples, and investigated their phenotype, proliferation, cytotoxic activity against leukemia cell lines K562 and NB4 by FCM and CCK-8, measured IL-35, TGF-beta and IL-10 protein by ELISA, detected Foxp3, IL-35 and IL-35 receptor mRNA by Real-time PCR, respectively. We found Tregs and IL-35 concomitantly expanded by a time-dependent way during the generation of CIK cells, but DC significantly down-regulated the expression of them and simultaneously up-regulated the proliferation ability as well as cytotoxic activity of CIK cells against leukemia cell lines. Therefore, our data suggested that DC decreased concomitant expanded Tregs and Tregs related IL-35 in CIK cells and might contribute to improve their cytotoxicity against leukemia cells in vitro.	[Zhai, Zhimin] Anhui Med Univ, Hosp 2, Dept Hematol, Hefei, Anhui, Peoples R China; Hematol Res Ctr, Hefei, Anhui, Peoples R China	Anhui Medical University	Zhai, ZM (corresponding author), Anhui Med Univ, Hosp 2, Dept Hematol, Hefei, Anhui, Peoples R China.	zzm889@126.com	wang, hui/GRS-4730-2022		National Natural Science Foundation of China [81272259]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (item No. 81272259). The funders had no role in study design, data collection and analysis.	Antony PA, 2005, J IMMUNOTHER, V28, P120, DOI 10.1097/01.cji.0000155049.26787.45; Bardel E, 2008, J IMMUNOL, V181, P6898, DOI 10.4049/jimmunol.181.10.6898; Chaturvedi V, 2011, J IMMUNOL, V186, P6661, DOI 10.4049/jimmunol.1100315; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Hontscha C, 2011, J CANCER RES CLIN, V137, P305, DOI 10.1007/s00432-010-0887-7; Jiang JT, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-83; Li H, 2007, J CLIN IMMUNOL, V27, P317, DOI 10.1007/s10875-007-9076-0; Li Hui, 2005, Zhonghua Yi Xue Za Zhi, V85, P3134; Lin GH, 2012, J IMMUNOTHER, V35, P337, DOI 10.1097/CJI.0b013e318255ada3; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Marten A, 2001, J IMMUNOTHER, V24, P502, DOI 10.1097/00002371-200111000-00007; Mesiano G, 2012, EXPERT OPIN BIOL TH, V12, P673, DOI 10.1517/14712598.2012.675323; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; Olioso P, 2009, HEMATOL ONCOL, V27, P130, DOI 10.1002/hon.886; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Schmidt J, 2004, CANCER IMMUNOL IMMUN, V53, P1018, DOI 10.1007/s00262-004-0554-4; SCHMIDTWOLF IGH, 1993, EXP HEMATOL, V21, P1673; SCHMIDTWOLF IGH, 1991, J EXP MED, V174, P139, DOI 10.1084/jem.174.1.139; Schmitt EG, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00152; Shevach EM, 2012, TRENDS IMMUNOL, V33, P626, DOI 10.1016/j.it.2012.07.007; Thanendrarajan S, 2012, EXPERT OPIN BIOL TH, V12, P565, DOI 10.1517/14712598.2012.668879; Wang ZH, 2013, J IMMUNOL, V190, P2415, DOI 10.4049/jimmunol.1202535; Whiteside TL, 2012, EXPERT OPIN BIOL TH, V12, P1383, DOI 10.1517/14712598.2012.707184; Whiteside TL, 2012, SEMIN CANCER BIOL, V22, P327, DOI 10.1016/j.semcancer.2012.03.004; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018	28	23	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93591	10.1371/journal.pone.0093591	http://dx.doi.org/10.1371/journal.pone.0093591			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705499	Green Submitted, Green Published, gold			2022-12-25	WOS:000334107500045
J	Paik, J; Haenisch, M; Muller, CH; Goldstein, AS; Arnold, S; Isoherranen, N; Brabb, T; Treuting, PM; Amory, JK				Paik, Jisun; Haenisch, Michael; Muller, Charles H.; Goldstein, Alex S.; Arnold, Samuel; Isoherranen, Nina; Brabb, Thea; Treuting, Piper M.; Amory, John K.			Inhibition of Retinoic Acid Biosynthesis by the Bisdichloroacetyldiamine WIN 18,446 Markedly Suppresses Spermatogenesis and Alters Retinoid Metabolism in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-A; HUMAN CYTOCHROME-P450; BINDING-PROTEIN; DEHYDROGENASE; EXPRESSION; TESTIS; RAT; DEFICIENT; ANIMALS; ALCOHOL	Knowledge of the regulation of testicular retinoic acid synthesis is crucial for understanding its role in spermatogenesis. Bisdichloroacetyldiamines strongly inhibit spermatogenesis. We reported previously that one of these compounds, WIN 18,446, potently inhibited spermatogenesis in rabbits by inhibiting retinoic acid synthesis. To understand how WIN 18,446 inhibits retinoic acid synthesis, we characterized its effects on human retinal dehydrogenase ALDH1A2 in vitro as well as its effects on retinoid metabolism in vivo using mice. WIN 18,446 strongly and irreversibly inhibited ALDH1A2 in vitro. In vivo, WIN 18,446 treatment completely abolished spermatogenesis after 4 weeks of treatment and modestly reduced adiposity in mice fed a chow diet. Effects of WIN 18,446 on retinoid concentrations were tissue-dependent. Although lung and liver retinyl ester concentrations were lower in WIN 18,446-treated animals, adipose retinyl ester levels were increased following the treatment. Interestingly, animals treated with WIN 18,446 had significantly higher circulating retinol concentrations compared with control mice. The effect on spermatogenesis by WIN18,446 was not prevented by simultaneous treatment with retinoic acid, whereas effects on other tissues were partially or completely reversed. Cessation of WIN 18,446 treatment for 4 weeks reversed most retinoid-related phenotypes except for inhibition of spermatogenesis. Our data suggest that WIN 18,446 may be a useful model of systemic acquired retinoic acid deficiency. Given the effects observed in our study, inhibition of retinoic acid biosynthesis may have relevance for the treatment of obesity and in the development of novel male contraceptives.	[Paik, Jisun; Haenisch, Michael; Brabb, Thea; Treuting, Piper M.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Muller, Charles H.] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Arnold, Samuel; Isoherranen, Nina] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA; [Amory, John K.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Goldstein, Alex S.] Focused Sci, Newcastle, WA 98059 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Paik, J (corresponding author), Univ Washington, Dept Comparat Med, 1959 NE Pacific St HSB T140Q, Seattle, WA 98195 USA.	jpaik@uw.edu	Treuting, Piper M./AAB-2721-2019	Treuting, Piper M./0000-0002-1812-1519; Amory, John/0000-0002-7419-435X	National Institutes of Health from the Eunice Kennedy Shriver NICHD [U01 HD060488, U54 HD42454]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD060488, U54HD042454] Funding Source: NIH RePORTER	National Institutes of Health from the Eunice Kennedy Shriver NICHD; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants U01 HD060488 and U54 HD42454 from the Eunice Kennedy Shriver NICHD (to J. K. A.).	AMANN RP, 1986, ENVIRON HEALTH PERSP, V70, P149; Amory JK, 2011, J ANDROL, V32, P111, DOI 10.2164/jandrol.110.010751; Arnold SLM, 2012, J LIPID RES, V53, P587, DOI 10.1194/jlr.D019745; Asaoka Y, 2013, EXP TOXICOL PATHOL, V65, P817, DOI 10.1016/j.etp.2012.11.008; Blaner William S., 1994, P229; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Clugston RD, 2013, BBA-MOL CELL BIOL L, V1831, P1276, DOI 10.1016/j.bbalip.2013.04.006; DROBECK HANS P., 1962, EXPTL AND MOLECULAR PATHOL, V1, P251, DOI 10.1016/0014-4800(62)90023-0; Fierce Y, 2008, ARCH BIOCHEM BIOPHYS, V472, P126, DOI 10.1016/j.abb.2008.02.010; FOLCH J, 1957, J BIOL CHEM, V226, P497; GERLACH TH, 1991, FASEB J, V5, P86, DOI 10.1096/fasebj.5.1.1991596; Griswold MD, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096610; Hartmann S, 2001, J CHROMATOGR B, V751, P265, DOI 10.1016/S0378-4347(00)00481-3; HELLER CG, 1961, TOXICOL APPL PHARM, V3, P1, DOI 10.1016/0041-008X(61)90002-3; HOWELL JMG, 1963, J REPROD FERTIL, V5, P159, DOI 10.1530/jrf.0.0050159; HUANG HFS, 1979, BIOL REPROD, V21, P891, DOI 10.1095/biolreprod21.4.891; Kane MA, 2005, BIOCHEM J, V388, P363, DOI 10.1042/BJ20041867; KEILSON B, 1979, J NUTR, V109, P787, DOI 10.1093/jn/109.5.787; Kiefer FW, 2012, NAT MED, V18, P918, DOI 10.1038/nm.2757; KURLANDSKY SB, 1995, J BIOL CHEM, V270, P17850, DOI 10.1074/jbc.270.30.17850; Lamb AL, 1999, BIOCHEMISTRY-US, V38, P6003, DOI 10.1021/bi9900471; Munson L, 2004, THERIOGENOLOGY, V62, P81, DOI 10.1016/j.theriogenology.2003.07.026; Packer A. I., 1999, RETINOIDS BIOCH MOL, P347; Paik J, 2000, BIOCHEMISTRY-US, V39, P8073, DOI 10.1021/bi992152g; Paik J, 2005, EXP CELL RES, V303, P183, DOI 10.1016/j.yexcr.2004.09.019; Paik J, 2010, COMPARATIVE MED, V60, P189; Petersen PM, 1999, SCAND J WORK ENV HEA, V25, P31; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Quadro L, 2002, J BIOL CHEM, V277, P30191, DOI 10.1074/jbc.M205046200; Reichert B, 2011, MOL ENDOCRINOL, V25, P799, DOI 10.1210/me.2010-0465; Soprano Dianne Robert, 1994, P257; Taimi M, 2004, J BIOL CHEM, V279, P77, DOI 10.1074/jbc.M308337200; Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499; Vernet N, 2006, ENDOCRINOLOGY, V147, P96, DOI 10.1210/en.2005-0953; VOGEL S, 1999, RETINOIDS BIOCH MOL, P31; Wang XS, 1996, J BIOL CHEM, V271, P16288, DOI 10.1074/jbc.271.27.16288; White JA, 2000, P NATL ACAD SCI USA, V97, P6403, DOI 10.1073/pnas.120161397; Wolbach SB, 1925, J EXP MED, V42, P753, DOI 10.1084/jem.42.6.753; Wu JW, 2008, ASIAN J ANDROL, V10, P569, DOI 10.1111/j.1745-7262.2008.00408.x	39	49	52	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					15104	15117		10.1074/jbc.M113.540211	http://dx.doi.org/10.1074/jbc.M113.540211			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24711451	Green Published, hybrid			2022-12-25	WOS:000337248100061
J	Plaza, JGR; Morales-Nava, R; Diener, C; Schreiber, G; Gonzalez, ZD; Ortiz, MTL; Blake, IO; Pantoja, O; Volkmer, R; Klipp, E; Herrmann, A; Del Rio, G				Rodriguez Plaza, Jonathan G.; Morales-Nava, Rosmarbel; Diener, Christian; Schreiber, Gabriele; Gonzalez, Zyanya D.; Lara Ortiz, Maria Teresa; Ortega Blake, Ivan; Pantoja, Omar; Volkmer, Rudolf; Klipp, Edda; Herrmann, Andreas; Del Rio, Gabriel			Cell Penetrating Peptides and Cationic Antibacterial Peptides TWO SIDES OF THE SAME COIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-FACTOR RECEPTOR; PROTEIN-COUPLED RECEPTOR; FACTOR PHEROMONE RECEPTOR; SACCHAROMYCES-CEREVISIAE; AMPHOTERICIN-B; ANTIMICROBIAL PEPTIDES; ASPERGILLUS-NIDULANS; CARGO DELIVERY; MEMBRANE; BINDING	Cell penetrating peptides (CPP) and cationic antibacterial peptides (CAP) have similar physicochemical properties and yet it is not understood how such similar peptides display different activities. To address this question, we used Iztli peptide 1 (IP-1) because it has both CPP and CAP activities. Combining experimental and computational modeling of the internalization of IP-1, we show it is not internalized by receptor-mediated endocytosis, yet it permeates into many different cell types, including fungi and human cells. We also show that IP-1 makes pores in the presence of high electrical potential at the membrane, such as those found in bacteria and mitochondria. These results provide the basis to understand the functional redundancy of CPPs and CAPs.	[Rodriguez Plaza, Jonathan G.; Diener, Christian; Gonzalez, Zyanya D.; Lara Ortiz, Maria Teresa; Del Rio, Gabriel] Univ Nacl Autonoma Mexico, Biochem & Struct Biol Dept, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Morales-Nava, Rosmarbel; Ortega Blake, Ivan] Univ Nacl Autonoma Mexico, Inst Ciencias Fis, Mat Sci & Biophys Dept, Cuernavaca 62210, Morelos, Mexico; [Schreiber, Gabriele; Pantoja, Omar] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca 62210, Morelos, Mexico; [Volkmer, Rudolf] Charite, Inst Med Immunol, D-10117 Berlin, Germany; [Volkmer, Rudolf] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Klipp, Edda; Herrmann, Andreas] Humboldt Univ, D-10115 Berlin, Germany	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Humboldt University of Berlin	Del Rio, G (corresponding author), Univ Nacl Autonoma Mexico, Biochem & Struct Biol Dept, Inst Fisiol Celular, Circuito Exterior S-N Ciudad Univ, Mexico City 04510, DF, Mexico.	gdelrio@ifc.unam.mx	Diener, Christian/X-9574-2019	Diener, Christian/0000-0002-7476-0868; Pantoja, Omar/0000-0002-6538-9059; Volkmer, Rudolf/0000-0003-4710-1143	Alexander von Humboldt Foundation; Consejo Nacional de Ciencia y Tecnologia [82308, 128575]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica [IN205911, IG100513]; German Research Council [CRC740]	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); German Research Council(German Research Foundation (DFG))	This work was supported in part by the Alexander von Humboldt Foundation, Consejo Nacional de Ciencia y Tecnologia (82308 and 128575), Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica Grants IN205911 and IG100513 (to G. D. R. and I. O. B.), and German Research Council Grant CRC740 (to E. K. and A. H.).	Arap W, 2002, P NATL ACAD SCI USA, V99, P1527, DOI 10.1073/pnas.241655998; Bajaj A, 2004, BIOCHEMISTRY-US, V43, P13564, DOI 10.1021/bi0494018; Birchler JA, 2012, P NATL ACAD SCI USA, V109, P14746, DOI 10.1073/pnas.1207726109; BLUMER KJ, 1988, J BIOL CHEM, V263, P10836; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chen QJ, 1996, MOL CELL BIOL, V16, P247; Cohen BE, 2010, J MEMBRANE BIOL, V238, P1, DOI 10.1007/s00232-010-9313-y; CORONADO R, 1983, BIOPHYS J, V43, P231, DOI 10.1016/S0006-3495(83)84343-4; David NE, 1997, J BIOL CHEM, V272, P15553, DOI 10.1074/jbc.272.24.15553; del Rio G, 2001, FEBS LETT, V494, P213, DOI 10.1016/S0014-5793(01)02348-1; Deshayes S, 2005, CELL MOL LIFE SCI, V62, P1839, DOI 10.1007/s00018-005-5109-0; Domergue R, 2005, SCIENCE, V308, P866, DOI 10.1126/science.1108640; Dosil M, 2000, MOL CELL BIOL, V20, P5321, DOI 10.1128/MCB.20.14.5321-5329.2000; Dube P, 1998, MOL CELL BIOL, V18, P7205, DOI 10.1128/MCB.18.12.7205; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Ellerby HM, 2008, J MED CHEM, V51, P5887, DOI 10.1021/jm800495u; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Gonzalez-Damian J, 2010, J MEMBRANE BIOL, V237, P41, DOI 10.1007/s00232-010-9301-2; Harriss LM, 2011, J AM CHEM SOC, V133, P14507, DOI 10.1021/ja204275t; Henriques ST, 2006, BIOCHEM J, V399, P1, DOI 10.1042/BJ20061100; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Huang WM, 2002, BIOPHYS J, V83, P3245, DOI 10.1016/S0006-3495(02)75326-5; JENNESS DD, 1983, CELL, V35, P521, DOI 10.1016/0092-8674(83)90186-1; JENNESS DD, 1986, CELL, V46, P345, DOI 10.1016/0092-8674(86)90655-0; Jones AT, 2012, J CONTROL RELEASE, V161, P582, DOI 10.1016/j.jconrel.2012.04.003; Kafri R, 2009, CELL, V136, P389, DOI 10.1016/j.cell.2009.01.027; Kagan BL, 2012, MOL PHARMACEUT, V9, P708, DOI 10.1021/mp200419b; Kawasaki L, 2002, MOL MICROBIOL, V45, P1153, DOI 10.1046/j.1365-2958.2002.03087.x; Kilk K, 2009, TOXICOLOGY, V265, P87, DOI 10.1016/j.tox.2009.09.016; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Lee BK, 2001, J BIOL CHEM, V276, P37950; Li LR, 2012, INT J ANTIMICROB AG, V40, P337, DOI 10.1016/j.ijantimicag.2012.05.026; Mak DOD, 1995, BIOPHYS J, V69, P2323, DOI 10.1016/S0006-3495(95)80102-5; MATSUZAKI K, 1995, BIOCHEMISTRY-US, V34, P6521, DOI 10.1021/bi00019a033; McBride SM, 2011, MICROBIOL-SGM, V157, P1457, DOI 10.1099/mic.0.045997-0; Morgera F, 2009, BIOCHEM J, V417, P727, DOI 10.1042/BJ20081726; Nan YH, 2011, J PEPT SCI, V17, P812, DOI 10.1002/psc.1408; Oltvai ZN, 2002, SCIENCE, V298, P763, DOI 10.1126/science.1078563; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Paternostre M., 1996, MANUAL MEMBRANE LIPI, P202, DOI [10.1016/j.ejps.2009.02.021, 10.1007/978-3-642-79837-5, DOI 10.1016/J.EJPS.2009.02.021]; Pooga Margus, 2005, V298, P77; RATHS SK, 1988, J BIOL CHEM, V263, P17333; Recamier KS, 2010, J MEMBRANE BIOL, V237, P31, DOI 10.1007/s00232-010-9304-z; Plaza JGR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040125; Soid-Raggi G, 2006, MOL MICROBIOL, V59, P854, DOI 10.1111/j.1365-2958.2005.04996.x; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; SUAREZISLA BA, 1983, BIOCHEMISTRY-US, V22, P2319, DOI 10.1021/bi00279a003; Thomson K. B., 2012, YEAST PHEROMONE MODE; Toshima JY, 2006, P NATL ACAD SCI USA, V103, P5793, DOI 10.1073/pnas.0601042103; Venegas B, 2003, BIOPHYS J, V85, P2323, DOI 10.1016/S0006-3495(03)74656-6; Vives E, 2005, J CONTROL RELEASE, V109, P77, DOI 10.1016/j.jconrel.2005.09.032; WEINER JL, 1993, J BIOL CHEM, V268, P8070; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	53	36	36	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14448	14457		10.1074/jbc.M113.515023	http://dx.doi.org/10.1074/jbc.M113.515023			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24706763	Green Published, hybrid			2022-12-25	WOS:000337248100002
J	Hino, K; Saito, A; Kido, M; Kanemoto, S; Asada, R; Takai, T; Cui, M; Cui, X; Imaizumi, K				Hino, Kenta; Saito, Atsushi; Kido, Miori; Kanemoto, Soshi; Asada, Rie; Takai, Tomoko; Cui, Min; Cui, Xiang; Imaizumi, Kazunori			Master Regulator for Chondrogenesis, Sox9, Regulates Transcriptional Activation of the Endoplasmic Reticulum Stress Transducer BBF2H7/CREB3L2 in Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cartilage; Cell Biology; Chondrogenesis; Protein Secretion; Transcription Factors; BBF2H7; ER Stress Transducer; Sox9	UNFOLDED PROTEIN RESPONSE; CREB/ATF-FAMILY; INDIAN HEDGEHOG; OASIS FAMILY; CARTILAGE FORMATION; BONE-FORMATION; RETINOIC ACID; COLLAGEN GENE; II COLLAGEN; MOUSE MODEL	Background: BBF2H7 promotes cartilage matrix protein secretion through activation of Sec23a expression during chondrogenesis. Results: Sox9 induces BBF2H7 expression, followed by accelerating secretion of cartilage matrix proteins in chondrocytes. Conclusion: Sox9 simultaneously induces Bbf2h7 and Col2, followed by promoting secretion of Col2 through activation of BBF2H7-Sec23a signaling. Significance: This might be the first to define mechanisms for cartilage matrix protein secretion regulated by Sox9. The endoplasmic reticulum (ER) stress transducer, box B-binding factor 2 human homolog on chromosome 7 (BBF2H7), is a basic leucine zipper (bZIP) transmembrane transcription factor. This molecule is activated in response to ER stress during chondrogenesis. The activated BBF2H7 accelerates cartilage matrix protein secretion through the up-regulation of Sec23a, which is responsible for protein transport from the ER to the Golgi apparatus and is a target of BBF2H7. In the present study, we elucidated the mechanisms of the transcriptional activation of Bbf2h7 in chondrocytes. The transcription of Bbf2h7 is regulated by Sex determining region Y-related high-mobility group box 9 (Sox9), a critical factor for chondrocyte differentiation that facilitates the expression of one of the major cartilage matrix proteins Type II collagen (Col2), through binding to the Sox DNA-binding motif in the Bbf2h7 promoter. BBF2H7 is activated as a transcription factor in response to physiological ER stress caused by abundant synthesis of cartilage matrix proteins, and consequently regulates the secretion of cartilage matrix proteins. Taken together, our findings demonstrate novel regulatory mechanisms of Sox9 for controlling the secretion of cartilage matrix proteins through the activation of BBF2H7-Sec23a signaling during chondrogenesis.	[Hino, Kenta; Saito, Atsushi; Kido, Miori; Kanemoto, Soshi; Asada, Rie; Takai, Tomoko; Cui, Min; Cui, Xiang; Imaizumi, Kazunori] Hiroshima Univ, Dept Biochem, Inst Biomed & Hlth Sci, Minami Ku, Hiroshima 7348553, Japan	Hiroshima University	Saito, A (corresponding author), Hiroshima Univ, Dept Biochem, Inst Biomed & Hlth Sci, Minami Ku, I-2-3 Kasumi, Hiroshima 7348553, Japan.	asaito@hiroshima-u.ac.jp; imaizumi@hiroshima-u.ac.jp		Kitamura, Rie/0000-0001-8347-6909	Japan Society for the Promotion of Science KAKENHI [25251014, 25650069, 24689058, 24659678]; Takeda Science Foundation; SEI Group CSR Foundation; INAMORI FOUNDATION; Uehara Memorial Foundation; Princess Takamatsu Cancer Research Fund; Cell Science Research Foundation; Grants-in-Aid for Scientific Research [25650069] Funding Source: KAKEN	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); SEI Group CSR Foundation; INAMORI FOUNDATION; Uehara Memorial Foundation(Uehara Memorial Foundation); Princess Takamatsu Cancer Research Fund; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Japan Society for the Promotion of Science KAKENHI (25251014, 25650069, 24689058, and 24659678), Takeda Science Foundation, SEI Group CSR Foundation, INAMORI FOUNDATION, and The Uehara Memorial Foundation, and by a Research Grant of the Princess Takamatsu Cancer Research Fund and The Cell Science Research Foundation.	Adham IM, 2005, MOL CELL BIOL, V25, P7657, DOI 10.1128/MCB.25.17.7657-7664.2005; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Amano K, 2009, MOL BIOL CELL, V20, P4541, DOI 10.1091/mbc.E09-03-0227; Asada R, 2011, J BIOCHEM, V149, P507, DOI 10.1093/jb/mvr041; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bridgewater LC, 1998, J BIOL CHEM, V273, P14998, DOI 10.1074/jbc.273.24.14998; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cao GT, 2002, J HUM GENET, V47, P373, DOI 10.1007/s100380200053; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; HOSKING BM, 1995, NUCLEIC ACIDS RES, V23, P2626, DOI 10.1093/nar/23.14.2626; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Kondo S, 2012, CELL DEATH DIFFER, V19, P1939, DOI 10.1038/cdd.2012.77; Kondo S, 2007, MOL CELL BIOL, V27, P1716, DOI 10.1128/MCB.01552-06; Kondo S, 2011, IUBMB LIFE, V63, P233, DOI 10.1002/iub.433; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Lu R, 1997, MOL CELL BIOL, V17, P5117, DOI 10.1128/MCB.17.9.5117; Lui WO, 2008, CANCER RES, V68, P7156, DOI 10.1158/0008-5472.CAN-08-1085; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Ng LJ, 1997, DEV BIOL, V183, P108, DOI 10.1006/dbio.1996.8487; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Saito A, 2014, MOL CELL, V53, P127, DOI 10.1016/j.molcel.2013.11.008; Saito A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1971; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Smits P, 2001, DEV CELL, V1, P277, DOI 10.1016/S1534-5807(01)00003-X; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Stolt CC, 2002, GENE DEV, V16, P165, DOI 10.1101/gad.215802; Storlazzi CT, 2003, HUM MOL GENET, V12, P2349, DOI 10.1093/hmg/ddg237; Tchenio T, 2000, NUCLEIC ACIDS RES, V28, P411, DOI 10.1093/nar/28.2.411; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; VANDEWETERING M, 1993, EMBO J, V12, P3847, DOI 10.1002/j.1460-2075.1993.tb06063.x; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Xie WF, 1999, J BONE MINER RES, V14, P757, DOI 10.1359/jbmr.1999.14.5.757; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F	47	55	57	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13810	13820		10.1074/jbc.M113.543322	http://dx.doi.org/10.1074/jbc.M113.543322			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24711445	Green Published, hybrid			2022-12-25	WOS:000335984600015
J	Black, BJ; Gu, L; Mohanty, SK				Black, Bryan J.; Gu, Ling; Mohanty, Samarendra K.			Highly Effective Photonic Cue for Repulsive Axonal Guidance	PLOS ONE			English	Article							NEURONAL GROWTH CONES; RETINAL GANGLION-CELLS; ADULT GOLDFISH RETINA; MOLECULAR-MECHANISMS; ION CHANNELS; EXPLANT CULTURE; ACTIN; TEMPERATURE; CA2+	In vivo nerve repair requires not only the ability to regenerate damaged axons, but most importantly, the ability to guide developing or regenerating axons along paths that will result in functional connections. Furthermore, basic studies in neuroscience and neuro-electronic interface design require the ability to construct in vitro neural circuitry. Both these applications require the development of a noninvasive, highly effective tool for axonal growth-cone guidance. To date, a myriad of technologies have been introduced based on chemical, electrical, mechanical, and hybrid approaches (such as electro-chemical, optofluidic flow and photo-chemical methods). These methods are either lacking in desired spatial and temporal selectivity or require the introduction of invasive external factors. Within the last fifteen years however, several attractive guidance cues have been developed using purely light based cues to achieve axonal guidance. Here, we report a novel, purely optical repulsive guidance technique that uses low power, near infrared light, and demonstrates the guidance of primary goldfish retinal ganglion cell axons through turns of up to 120 degrees and over distances of similar to 90 mu m.	[Black, Bryan J.; Gu, Ling; Mohanty, Samarendra K.] Univ Texas Arlington, Dept Phys, Biophys & Physiol Grp, Arlington, TX 76019 USA	University of Texas System; University of Texas Arlington	Mohanty, SK (corresponding author), Univ Texas Arlington, Dept Phys, Biophys & Physiol Grp, POB 19059, Arlington, TX 76019 USA.	smohanty@uta.edu						ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; BERNHARDT R, 1989, J COMP NEUROL, V284, P119, DOI 10.1002/cne.902840109; Blau A, 2001, J NEUROSCI METH, V112, P65, DOI 10.1016/S0165-0270(01)00458-7; Borisy GG, 2000, CURR OPIN CELL BIOL, V12, P104, DOI 10.1016/S0955-0674(99)00063-0; Chedotal A., 2010, COLD SPRING HARBOR P, V2; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Ehrlicher A, 2002, P NATL ACAD SCI USA, V99, P16024, DOI 10.1073/pnas.252631899; Ehrlicher A, 2007, METHOD CELL BIOL, V83, P495, DOI 10.1016/S0091-679X(07)83021-4; Erskine L, 2007, DEV BIOL, V308, P1, DOI 10.1016/j.ydbio.2007.05.013; Fawcett J, 2002, SPINAL CORD, V40, P615, DOI 10.1038/sj.sc.3101328; Fischer D, 2004, J NEUROSCI, V24, P8726, DOI 10.1523/JNEUROSCI.2774-04.2004; Fohlmeister JF, 2010, J NEUROPHYSIOL, V103, P1357, DOI 10.1152/jn.00123.2009; Fromherz P, 2006, ANN NY ACAD SCI, V1093, P143, DOI 10.1196/annals.1382.011; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Gomez TM, 2000, J NEUROBIOL, V44, P174, DOI 10.1002/1097-4695(200008)44:2<174::AID-NEU7>3.3.CO;2-I; Harada Y, 1996, OPT COMMUN, V124, P529, DOI 10.1016/0030-4018(95)00753-9; HARRELSON AL, 1992, J EXP ZOOL, V261, P310, DOI 10.1002/jez.1402610310; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hoffman-Kim D, 2010, ANNU REV BIOMED ENG, V12, P203, DOI 10.1146/annurev-bioeng-070909-105351; Huang XH, 2006, PHOTOCHEM PHOTOBIOL, V82, P412, DOI 10.1562/2005-12-14-RA-754; Inatani M, 2005, NATURWISSENSCHAFTEN, V92, P549, DOI 10.1007/s00114-005-0042-5; Jesse F, 2013, BIOMED OPT EXPRESS, V4, P614, DOI 10.1364/BOE.4.000614; LANDRETH GE, 1979, BRAIN RES, V161, P39, DOI 10.1016/0006-8993(79)90194-X; LANDRETH GE, 1976, BRAIN RES, V118, P299, DOI 10.1016/0006-8993(76)90714-9; LIU Y, 1995, BIOPHYS J, V68, P2137, DOI 10.1016/S0006-3495(95)80396-6; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092; Mai J, 2009, J NEUROSCI, V29, P7450, DOI 10.1523/JNEUROSCI.1121-09.2009; Mathew M, 2010, J NEUROSCI METH, V186, P196, DOI 10.1016/j.jneumeth.2009.11.018; Ming GL, 2002, NATURE, V417, P411, DOI 10.1038/nature745; Mohanty SK, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2983663; Mohanty SK, 2005, OPT LETT, V30, P2596, DOI 10.1364/OL.30.002596; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; Niranjan PS, 2003, J CHEM PHYS, V119, P4070, DOI 10.1063/1.1592499; PATEL N, 1982, J NEUROSCI, V2, P483; Pittman AJ, 2008, DEVELOPMENT, V135, P2865, DOI 10.1242/dev.025049; SACHS F, 1991, MOL CELL BIOCHEM, V104, P57; Sachs F, 2010, PHYSIOLOGY, V25, P50, DOI 10.1152/physiol.00042.2009; Sappington RM, 2009, INVEST OPHTH VIS SCI, V50, P717, DOI 10.1167/iovs.08-2321; Stuhrmann B, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1863812; Talavera K, 2008, TRENDS NEUROSCI, V31, P287, DOI 10.1016/j.tins.2008.03.002; Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wu T, 2012, J R SOC INTERFACE, V9, P535, DOI 10.1098/rsif.2011.0351; Wu T, 2012, NAT PHOTONICS, V6, P62, DOI [10.1038/nphoton.2011.287, 10.1038/NPHOTON.2011.287]; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zeck G, 2001, P NATL ACAD SCI USA, V98, P10457, DOI 10.1073/pnas.181348698	47	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e86292	10.1371/journal.pone.0086292	http://dx.doi.org/10.1371/journal.pone.0086292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717339	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000002
J	Douard, V; Patel, C; Lee, J; Tharabenjasin, P; Williams, E; Fritton, JC; Sabbagh, Y; Ferraris, RP				Douard, Veronique; Patel, Chirag; Lee, Jacklyn; Tharabenjasin, Phuntila; Williams, Edek; Fritton, J. Christopher; Sabbagh, Yves; Ferraris, Ronaldo P.			Chronic High Fructose Intake Reduces Serum 1,25 (OH)(2)D-3 Levels in Calcium-Sufficient Rodents	PLOS ONE			English	Article							VITAMIN-D; RAT; TRANSPORTERS; RECEPTOR; DEFICIENCY; METABOLISM; ABSORPTION; EXPRESSION; RESISTANCE; FGF-23	Excessive fructose consumption inhibits adaptive increases in intestinal Ca2+ transport in lactating and weanling rats with increased Ca2+ requirements by preventing the increase in serum levels of 1,25(OH)(2)D-3. Here we tested the hypothesis that chronic fructose intake decreases 1,25(OH)(2)D-3 levels independent of increases in Ca2+ requirements. Adult mice fed for five wk a high glucose-low Ca2+ diet displayed expected compensatory increases in intestinal and renal Ca2+ transporter expression and activity, in renal CYP27B1 (coding for 1 alpha-hydroxylase) expression as well as in serum 1,25(OH)(2)D-3 levels, compared with mice fed isocaloric glucose- or fructose-normal Ca2+ diets. Replacing glucose with fructose prevented these increases in Ca2+ transporter, CYP27B1, and 1,25(OH)(2)D-3 levels induced by a low Ca2+ diet. In adult mice fed for three mo a normal Ca2+ diet, renal expression of CYP27B1 and of CYP24A1 (24-hydroxylase) decreased and increased, respectively, when the carbohydrate source was fructose instead of glucose or starch. Intestinal and renal Ca2+ transporter activity and expression did not vary with dietary carbohydrate. To determine the time course of fructose effects, a high fructose or glucose diet with normal Ca2+ levels was fed to adult rats for three mo. Serum levels of 1,25(OH)(2)D-3 decreased and of FGF23 increased significantly over time. Renal expression of CYP27B1 and serum levels of 1,25(OH)(2)D-3 still decreased in fructose-compared to those in glucose-fed rats after three mo. Serum parathyroid hormone, Ca2+ and phosphate levels were normal and independent of dietary sugar as well as time of feeding. Thus, chronically high fructose intakes can decrease serum levels of 1,25(OH)(2)D-3 in adult rodents experiencing no Ca2+ stress and fed sufficient levels of dietary Ca2+. This finding is highly significant because fructose constitutes a substantial portion of the average diet of Americans already deficient in vitamin D.	[Douard, Veronique; Patel, Chirag; Lee, Jacklyn; Tharabenjasin, Phuntila; Ferraris, Ronaldo P.] Rutgers Biomed & Hlth Sci, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ USA; [Williams, Edek; Fritton, J. Christopher] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA; [Fritton, J. Christopher] RBHS, New Jersey Med Sch, Dept Orthopaed, Newark, NJ USA; [Sabbagh, Yves] Sanofi Co, Sanofi Genzyme R&D Ctr, Tissue Protect & Repair, Genzyme, Framingham, MA USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Sanofi-Aventis; Genzyme Corporation	Douard, V (corresponding author), INRA, UMR1913, MICALIS, Jouy En Josas, France.	veronique.douard@jouy.inra.fr	Sabbagh, Yves/I-9792-2019; Douard, veronique/AAU-6271-2020	Sabbagh, Yves/0000-0001-5339-6705; Fritton, James/0000-0002-6475-7622	National Science Foundation [IOS-1121049]; Foundation of UMDNJ; Benjamin Delessert Foundation	National Science Foundation(National Science Foundation (NSF)); Foundation of UMDNJ; Benjamin Delessert Foundation	This work was supported by the National Science Foundation (IOS-1121049 to RPF). The work also received support from the Foundation of UMDNJ (RPF), and the Benjamin Delessert Foundation (to V. Douard). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benn BS, 2008, ENDOCRINOLOGY, V149, P3196, DOI 10.1210/en.2007-1655; Bischoff-Ferrari HA, 2011, ANN NUTR METAB, V59, P17, DOI 10.1159/000332069; Bogden JD, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-34; Bray GA, 2013, ADV NUTR, V4, P220, DOI 10.3945/an.112.002816; Brini M, 2009, PFLUG ARCH EUR J PHY, V457, P657, DOI 10.1007/s00424-008-0505-6; Brown AJ, 2005, ARCH BIOCHEM BIOPHYS, V437, P51, DOI 10.1016/j.abb.2005.02.007; Christakos S, 2012, RHEUM DIS CLIN N AM, V38, P1, DOI 10.1016/j.rdc.2012.03.003; Dekker MJ, 2010, AM J PHYSIOL-ENDOC M, V299, pE685, DOI 10.1152/ajpendo.00283.2010; Douard V, 2008, J PHYSIOL-LONDON, V586, P3657, DOI 10.1113/jphysiol.2008.155226; Douard V, 2008, ENDOCRINOLOGY, V149, P409, DOI 10.1210/en.2007-0906; Douard V, 2013, AM J PHYSIOL-ENDOC M, V304, pE1303, DOI 10.1152/ajpendo.00582.2012; Douard V, 2013, J PHYSIOL-LONDON, V591, P401, DOI 10.1113/jphysiol.2011.215731; Douard V, 2012, GASTROENTEROLOGY, V142, pS557; Douard V, 2012, FASEB J, V26, P707, DOI 10.1096/fj.11-190264; Douard V, 2010, J AM SOC NEPHROL, V21, P261, DOI 10.1681/ASN.2009080795; Forrest KYZ, 2011, NUTR RES, V31, P48, DOI 10.1016/j.nutres.2010.12.001; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hoenderop JGJ, 2002, FASEB J, V16, P1398, DOI 10.1096/fj.02-0225com; Johnson RJ, 2009, ENDOCR REV, V30, P96, DOI 10.1210/er.2008-0033; Luong KVQ, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-89; Kirchner S, 2008, AM J CLIN NUTR, V87, P1028, DOI 10.1093/ajcn/87.4.1028; Krauss RM, 2006, AM J CLIN NUTR, V83, P1025, DOI 10.1093/ajcn/83.5.1025; Lieben L, 2010, BONE, V47, P301, DOI 10.1016/j.bone.2010.04.595; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; Marriott BP, 2009, J NUTR, V139, pS1228, DOI 10.3945/jn.108.098277; Nakayama T, 2010, AM J PHYSIOL-RENAL, V298, pF712, DOI 10.1152/ajprenal.00433.2009; Rodriguez-Ortiz ME, 2012, J AM SOC NEPHROL, V23, P1190, DOI 10.1681/ASN.2011101006; Sakaki T, 2005, FRONT BIOSCI, V10, P119; SCHEDL HP, 1985, J CLIN INVEST, V76, P1871, DOI 10.1172/JCI112181; Shimada T, 2004, BIOCHEM BIOPH RES CO, V314, P409, DOI 10.1016/j.bbrc.2003.12.102; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Wood RJ, 1998, ENDOCRINOLOGY, V139, P3843, DOI 10.1210/en.139.9.3843; Yu XJ, 2005, BONE, V36, P971, DOI 10.1016/j.bone.2005.03.002	35	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93611	10.1371/journal.pone.0093611	http://dx.doi.org/10.1371/journal.pone.0093611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718641	Green Published, Green Submitted, gold			2022-12-25	WOS:000334339000039
J	Durruthy-Durruthy, J; Briggs, SF; Awe, J; Ramathal, CY; Karumbayaram, S; Lee, PC; Heidmann, JD; Clark, A; Karakikes, I; Loh, KM; Wu, JC; Hoffman, AR; Byrne, J; Pera, RAR; Sebastiano, V				Durruthy-Durruthy, Jens; Briggs, Sharon F.; Awe, Jason; Ramathal, Cyril Y.; Karumbayaram, Saravanan; Lee, Patrick C.; Heidmann, Julia D.; Clark, Amander; Karakikes, Ioannis; Loh, Kyle M.; Wu, Joseph C.; Hoffman, Andrew R.; Byrne, James; Pera, Renee A. Reijo; Sebastiano, Vittorio			Rapid and Efficient Conversion of Integration-Free Human Induced Pluripotent Stem Cells to GMP-Grade Culture Conditions	PLOS ONE			English	Article							SOMATIC-CELLS; GENERATION; VECTOR	Data suggest that clinical applications of human induced pluripotent stem cells (hiPSCs) will be realized. Nonetheless, clinical applications will require hiPSCs that are free of exogenous DNA and that can be manufactured through Good Manufacturing Practice (GMP). Optimally, derivation of hiPSCs should be rapid and efficient in order to minimize manipulations, reduce potential for accumulation of mutations and minimize financial costs. Previous studies reported the use of modified synthetic mRNAs to reprogram fibroblasts to a pluripotent state. Here, we provide an optimized, fully chemically defined and feeder-free protocol for the derivation of hiPSCs using synthetic mRNAs. The protocol results in derivation of fully reprogrammed hiPSC lines from adult dermal fibroblasts in less than two weeks. The hiPSC lines were successfully tested for their identity, purity, stability and safety at a GMP facility and cryopreserved. To our knowledge, as a proof of principle, these are the first integration-free iPSCs lines that were reproducibly generated through synthetic mRNA reprogramming that could be putatively used for clinical purposes.	[Durruthy-Durruthy, Jens; Briggs, Sharon F.; Ramathal, Cyril Y.; Pera, Renee A. Reijo; Sebastiano, Vittorio] Stanford Univ, Dept Obstet & Gynecol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Durruthy-Durruthy, Jens; Briggs, Sharon F.; Ramathal, Cyril Y.; Pera, Renee A. Reijo; Sebastiano, Vittorio] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Awe, Jason; Karumbayaram, Saravanan; Lee, Patrick C.; Clark, Amander; Byrne, James] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA; [Awe, Jason; Lee, Patrick C.; Byrne, James] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Karumbayaram, Saravanan] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA USA; [Heidmann, Julia D.; Hoffman, Andrew R.] Stanford Univ, Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Clark, Amander] Univ Calif Los Angeles, Inst Mol Biol, Dept Mol Cellular & Dev Biol, Los Angeles, CA 90024 USA; [Karakikes, Ioannis; Wu, Joseph C.] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Karakikes, Ioannis; Wu, Joseph C.] Stanford Univ, Dept Med, Dept Cardiol, Stanford, CA 94305 USA; [Loh, Kyle M.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of California System; University of California Los Angeles; Stanford University; Stanford University; Stanford University	Sebastiano, V (corresponding author), Stanford Univ, Dept Obstet & Gynecol, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	vsebast@stanford.edu	; Wu, Joseph/H-1067-2013	Loh, Kyle/0000-0002-8042-0149; Wu, Joseph/0000-0002-6068-8041; Karakikes, Ioannis/0000-0002-4348-600X; Byrne, James/0000-0002-2232-292X; Hoffman, Andrew/0000-0002-0145-1917; Reijo Pera, Renee/0000-0002-6487-1329	National Institutes of Health grant through the National Heart Lung and Blood Institute [U01 HL100397, U01 HL099776, R01 HL113006]; National Institute of Child Health and Human Development (NICHD) [U54 HD068158]; California Institute for Regenerative Medicine [TR3-05569]; NIH Research Project Grant [R01-GM09031]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD068158, U54HD068158] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113006, U01HL099776, U01HL100397] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044] Funding Source: NIH RePORTER	National Institutes of Health grant through the National Heart Lung and Blood Institute; National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NIH Research Project Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This study was supported by a National Institutes of Health grant through the National Heart Lung and Blood Institute (U01 HL100397, U01 HL099776, and R01 HL113006), the National Institute of Child Health and Human Development (NICHD U54 HD068158 as part of the Specialized Cooperative Centers Program in Reproduction and Infertility Research), the California Institute for Regenerative Medicine (TR3-05569), and the NIH Research Project Grant (R01-GM09031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awe JP, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt246; Byrne JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007118; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Cho HJ, 2010, BLOOD, V116, P386, DOI 10.1182/blood-2010-02-269589; Dowey SN, 2012, NAT PROTOC, V7, P2013, DOI 10.1038/nprot.2012.121; Goh PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081622; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Ji JF, 2012, STEM CELLS, V30, P435, DOI 10.1002/stem.1011; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Karakikes I., 2013, STEM CELLS TRANSL ME, DOI 10.5966/sctm.2013-0110; Karumbayaram S, 2012, STEM CELL TRANSL MED, V1, P36, DOI 10.5966/sctm.2011-0001; Loh KM, 2014, CELL STEM C IN PRESS, V14; Merling RK, 2013, BLOOD, V121, pE98, DOI 10.1182/blood-2012-03-420273; Okita K, 2011, PHILOS T R SOC B, V366, P2198, DOI 10.1098/rstb.2011.0016; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Warren L, 2012, SCI REP-UK, V2, DOI 10.1038/srep00657; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001	20	31	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94231	10.1371/journal.pone.0094231	http://dx.doi.org/10.1371/journal.pone.0094231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718618	Green Published, Green Submitted, gold			2022-12-25	WOS:000334339000093
J	Elfwing, S; Doya, K				Elfwing, Stefan; Doya, Kenji			Emergence of Polymorphic Mating Strategies in Robot Colonies	PLOS ONE			English	Article							REPRODUCTIVE STRATEGIES; GENETIC-POLYMORPHISM; TACTICS; EVOLUTION; INSTABILITY; DIMORPHISM; SWORDTAIL; SELECTION; SUCCESS	Polymorphism has fascinated evolutionary biologists since the time of Darwin. Biologists have observed discrete alternative mating strategies in many different species. In this study, we demonstrate that polymorphic mating strategies can emerge in a colony of hermaphrodite robots. We used a survival and reproduction task where the robots maintained their energy levels by capturing energy sources and physically exchanged genotypes for the reproduction of offspring. The reproductive success was dependent on the individuals' energy levels, which created a natural trade-off between the time invested in maintaining a high energy level and the time invested in attracting mating partners. We performed experiments in environments with different density of energy sources and observed a variety in the mating behavior when a robot could see both an energy source and a potential mating partner. The individuals could be classified into two phenotypes: 1) forager, who always chooses to capture energy sources, and 2) tracker, who keeps track of potential mating partners if its energy level is above a threshold. In four out of the seven highest fitness populations in different environments, we found subpopulations with distinct differences in genotype and in behavioral phenotype. We analyzed the fitnesses of the foragers and the trackers by sampling them from each subpopulation and mixing with different ratios in a population. The fitness curves for the two subpopulations crossed at about 25% of foragers in the population, showing the evolutionary stability of the polymorphism. In one of those polymorphic populations, the trackers were further split into two subpopulations: (strong trackers) and (weak trackers). Our analyses show that the population consisting of three phenotypes also constituted several stable polymorphic evolutionarily stable states. To our knowledge, our study is the first to demonstrate the emergence of polymorphic evolutionarily stable strategies within a robot evolution framework.	[Elfwing, Stefan; Doya, Kenji] Grad Univ, Okinawa Inst Sci & Technol, Neural Computat Unit, Okinawa, Japan	Okinawa Institute of Science & Technology Graduate University	Elfwing, S (corresponding author), Grad Univ, Okinawa Inst Sci & Technol, Neural Computat Unit, Okinawa, Japan.	elfwing@oist.jp; doya@oist.jp	Elfwing, Stefan/G-2940-2015; Doya, Kenji/B-5841-2015	Elfwing, Stefan/0000-0001-6689-1000; Doya, Kenji/0000-0002-2446-6820				ANDERSON WW, 1969, P NATL ACAD SCI USA, V64, P190, DOI 10.1073/pnas.64.1.190; BISAZZA A, 1993, MAR BEHAV PHYSIOL, V23, P257, DOI 10.1080/10236249309378869; Brockmann HJ, 2008, ALTERNATIVE REPRODUCTIVE TACTICS: AN INTEGRATIVE APPROACH, P25, DOI 10.1017/CBO9780511542602.003; Brockmann HJ, 2001, ADV STUD BEHAV, V30, P1, DOI 10.1016/S0065-3454(01)80004-8; BROCKMANN HJ, 1992, ANIM BEHAV, V44, P653, DOI 10.1016/S0003-3472(05)80293-3; Da Rold F, 2011, ADAPT BEHAV, V19, P317, DOI 10.1177/1059712311417737; Darwin C., 1874, DESCENT MAN SELECTIO; Darwin C., 1859, ORIGIN SPECIES MEANS; Darwin C, 1987, CORRESPONDENCE C DAR; Doya K, 2005, ADAPT BEHAV, V13, P149, DOI 10.1177/105971230501300206; Elfwing S, 2011, ADAPT BEHAV, V19, P101, DOI 10.1177/1059712310397633; Elfwing S, 2009, LECT NOTES COMPUT SC, V5864, P638, DOI 10.1007/978-3-642-10684-2_71; Ficici S. G., 2000, P 2000 GEN EV COMP C, P927; Floreano D, 2007, CURR BIOL, V17, P514, DOI 10.1016/j.cub.2007.01.058; Floreano D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000292; Fogel DB, 1997, BIOSYSTEMS, V44, P135, DOI 10.1016/S0303-2647(97)00050-6; FOGEL DB, 1995, COM ADAP SY, P565; Fogel GB, 1998, ECOL MODEL, V109, P283, DOI 10.1016/S0304-3800(98)00068-4; Ford EB, 1975, ECOLOGICAL GENETICS; GADGIL M, 1972, AM NAT, V106, P574, DOI 10.1086/282797; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; LANK DB, 1995, NATURE, V378, P59, DOI 10.1038/378059a0; Leonard JL, 2006, INTEGR COMP BIOL, V46, P349, DOI 10.1093/icb/icj041; Mappes T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001687; Maynard Smith, 1998, EVOL GENET; Maynard Smith J., 1982, pi; Mitri S, 2009, PNAS, V106; Mitri S, 2011, P ROY SOC B-BIOL SCI, V278, P378, DOI 10.1098/rspb.2010.1407; Ng AY, 1999, MACHINE LEARNING, PROCEEDINGS, P278; RADWAN J, 1995, HEREDITY, V74, P669, DOI 10.1038/hdy.1995.91; Roulin A, 2003, J AVIAN BIOL, V34, P393, DOI 10.1111/j.0908-8857.2003.03139.x; RUBENSTEIN DI, 1980, LIMITS ACTION ALLOCA, P65; Rummery G. A, 1994, SARSA MODIFIED CONNE; RYAN MJ, 1992, AM NAT, V139, P21, DOI 10.1086/285311; SANDELL M, 1992, AM NAT, V139, P177, DOI 10.1086/285319; SHUSTER SM, 1991, NATURE, V350, P608, DOI 10.1038/350608a0; Sinervo A, 2001, J HERED, V92, P198, DOI 10.1093/jhered/92.2.198; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Sutton RS, 1996, ADV NEUR IN, V8, P1038; Svensson EI, 2009, EVOL ECOL, V23, P93, DOI 10.1007/s10682-007-9208-2; Tarapore D, 2010, BEHAV ECOL SOCIOBIOL, V64, P675, DOI 10.1007/s00265-009-0885-4; THOMPSON CW, 1993, BEHAV ECOL SOCIOBIOL, V33, P137, DOI 10.1007/BF00216593; Utami SS, 2002, BEHAV ECOL, V13, P643, DOI 10.1093/beheco/13.5.643; Waibel M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000615; Wischmann S, 2012, PNAS; ZIMMERER EJ, 1989, EVOLUTION, V43, P1298, DOI 10.1111/j.1558-5646.1989.tb02576.x	48	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93622	10.1371/journal.pone.0093622	http://dx.doi.org/10.1371/journal.pone.0093622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717898	gold, Green Published, Green Submitted			2022-12-25	WOS:000334339000040
J	Loitfelder, M; Fazekas, F; Koschutnig, K; Fuchs, S; Petrovic, K; Ropele, S; Pichler, A; Jehna, M; Langkammer, C; Schmidt, R; Neuper, C; Enzinger, C				Loitfelder, Marisa; Fazekas, Franz; Koschutnig, Karl; Fuchs, Siegrid; Petrovic, Katja; Ropele, Stefan; Pichler, Alexander; Jehna, Margit; Langkammer, Christian; Schmidt, Reinhold; Neuper, Christa; Enzinger, Christian		Bio TechMed Initiative	Brain Activity Changes in Cognitive Networks in Relapsing-Remitting Multiple Sclerosis - Insights from a Longitudinal fMRI Study	PLOS ONE			English	Article							EARLY-STAGE; IMPAIRMENT; MS; REORGANIZATION; DYSFUNCTION; BATTERY; TESTS; MRI	Background: Extrapolations from previous cross-sectional fMRI studies suggest cerebral functional changes with progression of Multiple Sclerosis (MS), but longitudinal studies are scarce. We assessed brain activation changes over time in MS patients using a cognitive fMRI paradigm and examined correlations with clinical and cognitive status and brain morphology. Methods: 13 MS patients and 15 healthy controls (HC) underwent MRI including fMRI (go/no-go task), neurological and neuropsychological exams at baseline (BL) and follow-up (FU; minimum 12, median 20 months). We assessed estimates of and changes in fMRI activation, total brain and subcortical grey matter volumes, cortical thickness, and T2-lesion load. Bland-Altman (BA) plots served to assess fMRI signal variability. Results: Cognitive and disability levels remained largely stable in the patients. With the fMRI task, both at BL and FU, patients compared to HC showed increased activation in the insular cortex, precuneus, cerebellum, posterior cingulate cortex, and occipital cortex. At BL, patients vs. HC also had lower caudate nucleus, thalamus and putamen volumes. Over time, patients (but not HC) demonstrated fMRI activity increments in the left inferior parietal lobule. These correlated with worse single-digit-modality test (SDMT) performance. BA-plots attested to reproducibility of the fMRI task. In the patients, the right caudate nucleus decreased in volume which again correlated with worsening SDMT performance. Conclusions: Given preserved cognitive performance, the increased activation at BL in the patients may be viewed as largely adaptive. In contrast, the negative correlation with SDMT performance suggests increasing parietal activation over time to be maladaptive. Several areas with purported relevance for cognition showed decreased volumes at BL and right caudate nucleus volume decline correlated with decreasing SDMT performance. This highlights the dynamics of functional changes and the strategic importance of specific brain areas for cognitive processes in MS.	[Loitfelder, Marisa; Fazekas, Franz; Fuchs, Siegrid; Petrovic, Katja; Ropele, Stefan; Pichler, Alexander; Langkammer, Christian; Schmidt, Reinhold; Enzinger, Christian] Med Univ Graz, Dept Neurol, Graz, Austria; [Jehna, Margit; Enzinger, Christian] Med Univ Graz, Dept Radiol, Div Neuroradiol, Graz, Austria; [Koschutnig, Karl; Neuper, Christa] Karl Franzens Univ Graz, Inst Psychol, Graz, Austria	Medical University of Graz; Medical University of Graz; University of Graz	Enzinger, C (corresponding author), Med Univ Graz, Dept Neurol, Graz, Austria.	chris.enzinger@medunigraz.at	Jehna, Margit/M-9873-2017; Koschutnig, Karl/W-3106-2019; Schmidt, Reinhold/E-1137-2014; Langkammer, Christian/AAC-9044-2020	Koschutnig, Karl/0000-0001-6234-0498; Langkammer, Christian/0000-0002-7097-9707; Jehna, Margit/0000-0003-3376-7753				Amann M, 2011, HUM BRAIN MAPP, V32, P1704, DOI 10.1002/hbm.21142; Amato MP, 2010, MULT SCLER, V16, P1474, DOI 10.1177/1352458510380089; [Anonymous], 1981, MANUAL WISCONSIN CAR; Audoin B, 2008, MULT SCLER J, V14, P786, DOI 10.1177/1352458508089360; Audoin B, 2003, HUM BRAIN MAPP, V20, P51, DOI 10.1002/hbm.10128; Audoin B, 2006, J NEUROL SCI, V245, P87, DOI 10.1016/j.jns.2005.08.026; Batista S, 2012, J NEUROL, V259, P139, DOI 10.1007/s00415-011-6147-1; Bonavita S, 2011, MULT SCLER J, V17, P411, DOI 10.1177/1352458510394609; Boringa JB, 2001, MULT SCLER, V7, P263, DOI 10.1177/135245850100700409; Cardinal KS, 2008, MULT SCLER, V14, P465, DOI 10.1177/1352458507084263; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Han X, 2006, NEUROIMAGE, V32, P180, DOI 10.1016/j.neuroimage.2006.02.051; Huijbregts SCJ, 2004, NEUROLOGY, V63, P335, DOI 10.1212/01.WNL.0000129828.03714.90; Huijbregts SCJ, 2006, J NEUROL SCI, V245, P187, DOI 10.1016/j.jns.2005.07.018; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lansley J, 2013, NEUROSCI BIOBEHAV R, V37, P819, DOI 10.1016/j.neubiorev.2013.03.006; Loitfelder M, 2011, NEUROLOGY, V76, P526, DOI 10.1212/WNL.0b013e31820b75cf; Mainero C, 2006, J NEUROL SCI, V245, P93, DOI 10.1016/j.jns.2005.08.024; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Piras MR, 2003, J NEUROL NEUROSUR PS, V74, P878, DOI 10.1136/jnnp.74.7.878; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Rocca MA, 2005, LANCET NEUROL, V4, P618, DOI 10.1016/S1474-4422(05)70171-X; Rocca MA, 2012, NEUROLOGY, V79, P1449, DOI 10.1212/WNL.0b013e31826d5f10; Smith AM, 2009, J NEUROL SCI, V281, P58, DOI 10.1016/j.jns.2009.02.366; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; Sonder JM, 2013, MULT SCLER; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Strober L, 2009, MULT SCLER J, V15, P1077, DOI 10.1177/1352458509106615	30	35	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93715	10.1371/journal.pone.0093715	http://dx.doi.org/10.1371/journal.pone.0093715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718105	gold, Green Published, Green Submitted			2022-12-25	WOS:000334339000044
J	Luthi, F; Deriaz, O; Vuistiner, P; Burrus, C; Hilfiker, R				Luthi, Francois; Deriaz, Olivier; Vuistiner, Philippe; Burrus, Cyrille; Hilfiker, Roger			Predicting Non Return to Work after Orthopaedic Trauma: The Wallis Occupational Rehabilitation RisK (WORRK) Model	PLOS ONE			English	Article							LOW-BACK-PAIN; QUALITY-OF-LIFE; HEALTH-SERVICE NEEDS; VOCATIONAL-REHABILITATION; SELF-REPORT; EXTERNAL VALIDATION; FUNCTIONAL RECOVERY; CASE COMPLEXITY; GENE SELECTION; RANDOM FOREST	Background: Workers with persistent disabilities after orthopaedic trauma may need occupational rehabilitation. Despite various risk profiles for non-return-to-work (non-RTW), there is no available predictive model. Moreover, injured workers may have various origins (immigrant workers), which may either affect their return to work or their eligibility for research purposes. The aim of this study was to develop and validate a predictive model that estimates the likelihood of non-RTW after occupational rehabilitation using predictors which do not rely on the worker's background. Methods: Prospective cohort study (3177 participants, native (51%) and immigrant workers (49%)) with two samples: a) Development sample with patients from 2004 to 2007 with Full and Reduced Models, b) External validation of the Reduced Model with patients from 2008 to March 2010. We collected patients' data and biopsychosocial complexity with an observer rated interview (INTERMED). Non-RTW was assessed two years after discharge from the rehabilitation. Discrimination was assessed by the area under the receiver operating curve (AUC) and calibration was evaluated with a calibration plot. The model was reduced with random forests. Results: At 2 years, the non-RTW status was known for 2462 patients (77.5% of the total sample). The prevalence of nonRTW was 50%. The full model (36 items) and the reduced model (19 items) had acceptable discrimination performance (AUC 0.75, 95% CI 0.72 to 0.78 and 0.74, 95% CI 0.71 to 0.76, respectively) and good calibration. For the validation model, the discrimination performance was acceptable (AUC 0.73; 95% CI 0.70 to 0.77) and calibration was also adequate. Conclusions: Non-RTW may be predicted with a simple model constructed with variables independent of the patient's education and language fluency. This model is useful for all kinds of trauma in order to adjust for case mix and it is applicable to vulnerable populations like immigrant workers.	[Luthi, Francois; Burrus, Cyrille] Clin Romande Readaptat Suvacare, Dept Musculoskeletal Rehabil, Sion, Switzerland; [Luthi, Francois; Deriaz, Olivier; Vuistiner, Philippe; Burrus, Cyrille; Hilfiker, Roger] Clin Romande Readaptat Suvacare, Inst Rech Readaptat, Sion, Switzerland; [Luthi, Francois] Univ Lausanne Hosp, Dept Appareil Locomoteur, Hop Orthoped, Lausanne, Switzerland; [Vuistiner, Philippe] Univ Lausanne Hosp, Inst Social & Prevent Med, Lausanne, Switzerland; [Hilfiker, Roger] Univ Appl Sci & Arts Western Switzerland Valais, Sch Hlth Sci, Sion, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Luthi, F (corresponding author), Clin Romande Readaptat Suvacare, Dept Musculoskeletal Rehabil, Sion, Switzerland.	francois.luthi@crr-suva.ch	Vuistiner, Philippe/AAD-5010-2020; Hilfiker, Roger/E-2846-2010	Hilfiker, Roger/0000-0001-8662-6116; Vuistiner, Philippe/0000-0002-2661-4970				Ballabeni P, 2011, J OCCUP REHABIL, V21, P43, DOI 10.1007/s10926-010-9255-3; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Black JA, 2011, J TRAUMA, V71, P1003, DOI 10.1097/TA.0b013e3182238833; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burrus C, 2009, ARCH PHYS MED REHAB, V90, P1499, DOI 10.1016/j.apmr.2009.03.014; Chamberlain MA, 2009, J REHABIL MED, V41, P856, DOI 10.2340/16501977-0457; Chou R, 2010, JAMA-J AM MED ASSOC, V303, P1295, DOI 10.1001/jama.2010.344; Clay FJ, 2012, J OCCUP REHABIL, V22, P363, DOI 10.1007/s10926-012-9354-4; Clay FJ, 2010, INJURY, V41, P787, DOI 10.1016/j.injury.2010.04.005; Clay FJ, 2010, J REHABIL MED, V42, P162, DOI 10.2340/16501977-0495; Clay FJ, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-6; Collins GS, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e4181; Committee on Injury Scaling, 1998, ABBR INJ SCAL AIS 98; Coutu MF, 2007, J OCCUP REHABIL, V17, P522, DOI 10.1007/s10926-007-9089-9; De Cosmo S, 2013, DIABETES CARE, V36, P2830, DOI 10.2337/dc12-1906; de Jonge P, 2004, GEN HOSP PSYCHIAT, V26, P147, DOI 10.1016/j.genhosppsych.2003.09.001; De Jonge P, 2003, PSYCHOSOM MED, V65, P997, DOI 10.1097/01.PSY.0000097332.77685.C8; de Jonge P, 2002, J PSYCHOSOM RES, V52, P25, DOI 10.1016/S0022-3999(01)00309-9; de Jonge P, 2003, PSYCHOSOM MED, V65, P534, DOI 10.1097/01.PSY.0000077504.01963.1B; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Diaz-Uriarte R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-328; Fadyl J, 2008, J OCCUP REHABIL, V18, P362, DOI 10.1007/s10926-008-9153-0; Fadyl JK, 2010, DISABIL REHABIL, V32, P1173, DOI 10.3109/09638281003653302; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Gabbe BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025862; Gobelet C, 2007, DISABIL REHABIL, V29, P1405, DOI 10.1080/09638280701315060; Gurm HS, 2013, J AM COLL CARDIOL, V61, P2242, DOI 10.1016/j.jacc.2013.03.026; Hazard RG, 1996, SPINE, V21, P945, DOI 10.1097/00007632-199604150-00008; Hepp U, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003635; Hilfiker R, 2007, EUR SPINE J, V16, P1755, DOI 10.1007/s00586-007-0433-8; Hoefsmit N, 2012, J OCCUP REHABIL, V22, P462, DOI 10.1007/s10926-012-9359-z; Hosmer DW, 2013, WILEY SER PROBAB ST, P89; Huyse FJ, 1999, GEN HOSP PSYCHIAT, V21, P39, DOI 10.1016/S0163-8343(98)00057-7; Iakova M, 2012, J OCCUP REHABIL, V22, P532, DOI 10.1007/s10926-012-9369-x; Jensen OK, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-140; Kadakia RJ, 2012, J ORTHOP TRAUMA; Kendrick D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-584; King J, 2012, J AM GERIATR SOC, V60, P569, DOI 10.1111/j.1532-5415.2011.03844.x; Laisne F, 2012, DISABIL REHABIL, V34, P1912, DOI 10.3109/09638288.2012.729362; Luthi F, 2011, DISABIL REHABIL, V33, P2544, DOI 10.3109/09638288.2011.579223; Lydell M, 2005, J REHABIL MED, V37, P281, DOI 10.1080/16501970510030255; Lyons RA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001140; MACKENZIE EJ, 1988, JAMA-J AM MED ASSOC, V260, P3290, DOI 10.1001/jama.260.22.3290; MACKENZIE EJ, 1987, AM J PUBLIC HEALTH, V77, P329, DOI 10.2105/AJPH.77.3.329; MACKENZIE EJ, 1988, J TRAUMA, V28, P281, DOI 10.1097/00005373-198803000-00003; MacKenzie EJ, 2007, J TRAUMA, V63, pS54, DOI 10.1097/TA.0b013e31815acb09; MacKenzie EJ, 2006, J TRAUMA, V61, P688, DOI 10.1097/01.ta.0000195985.56153.68; Mannion AF, 2007, NAT CLIN PRACT RHEUM, V3, P610, DOI 10.1038/ncprheum0646; Matsuzaki H, 2009, J HAND SURG-AM, V34A, P880, DOI 10.1016/j.jhsa.2009.02.009; Matzer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041775; McCauley Linda A, 2005, AAOHN J, V53, P313; Moons KGM, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b606; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Ottosson C, 2005, J TRAUMA, V58, P553, DOI 10.1097/01.TA.0000152634.66513.AF; Ponsford J, 2008, J TRAUMA, V64, P1001, DOI 10.1097/TA.0b013e31809fec16; Pransky GS, 2006, SPINE, V31, P690, DOI 10.1097/01.brs.0000202761.20896.02; R Core Team, 2021, R LANG ENV STAT COMP; Perez ER, 2012, ETHNIC HEALTH, V17, P563, DOI 10.1080/13557858.2012.730606; Scerri M, 2006, JOINT BONE SPINE, V73, P736, DOI 10.1016/j.jbspin.2005.12.012; Schellingerhout JM, 2010, SPINE, V35, pE827, DOI 10.1097/BRS.0b013e3181d85ad5; Segui-Gomez M, 2003, EPIDEMIOL REV, V25, P3, DOI 10.1093/epirev/mxg007; Shi QY, 2014, J HAND THER, V27, P55, DOI 10.1016/j.jht.2013.10.001; Siroky DS, 2009, STAT SURV, V3, P147, DOI 10.1214/07-SS033; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sloots M, 2010, EUR J PHYS REHAB MED, V46, P505; Steyerberg EW, 1999, J CLIN EPIDEMIOL, V52, P935, DOI 10.1016/S0895-4356(99)00103-1; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Stiefel FC, 1999, GEN HOSP PSYCHIAT, V21, P49, DOI 10.1016/S0163-8343(98)00061-9; Stiefel FC, 1999, SPINE, V24, P378, DOI 10.1097/00007632-199902150-00017; Stiefel FC, 2006, MED CLIN N AM, V90, P713, DOI 10.1016/j.mcna.2006.05.006; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Toien K, 2012, INJURY, V43, P1606, DOI 10.1016/j.injury.2011.03.038; Urso-Baiarda F, 2008, Int J Surg, V6, P45, DOI 10.1016/j.ijsu.2007.09.001; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vlasveld MC, 2012, J OCCUP REHABIL, V22, P118, DOI 10.1007/s10926-011-9326-0; Von Korff M, 2000, SPINE, V25, P3140, DOI 10.1097/00007632-200012150-00009; Wasiak R, 2007, J OCCUP REHABIL, V17, P766, DOI 10.1007/s10926-007-9101-4; Wolfe F, 2009, ARTHRIT RHEUM-ARTHR, V61, P667, DOI 10.1002/art.24428; Yohannes AM, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-105; Young AE, 2013, SPINE, V38, P2279, DOI 10.1097/BRS.0000000000000016	81	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94268	10.1371/journal.pone.0094268	http://dx.doi.org/10.1371/journal.pone.0094268			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24718689	Green Published, Green Submitted, gold			2022-12-25	WOS:000334339000099
J	Tognon, E; Wollscheid, N; Cortese, K; Tacchetti, C; Vaccari, T				Tognon, Emiliana; Wollscheid, Nadine; Cortese, Katia; Tacchetti, Carlo; Vaccari, Thomas			ESCRT-0 Is Not Required for Ectopic Notch Activation and Tumor Suppression in Drosophila	PLOS ONE			English	Article							MOSAIC ANALYSIS; COMPLEX; ENDOSOMES; MACHINERY; VPS25; PROTEINS; VACUOLAR; SCREEN; SYSTEM; CELLS	Multivesicular endosome (MVE) sorting depends on proteins of the Endosomal Sorting Complex Required for Transport (ESCRT) family. These are organized in four complexes (ESCRT-0, -I, -II, -III) that act in a sequential fashion to deliver ubiquitylated cargoes into the internal luminal vesicles (ILVs) of the MVE. Drosophila genes encoding ESCRT-I, -II, -III components function in sorting signaling receptors, including Notch and the JAK/STAT signaling receptor Domeless. Loss of ESCRT-I, -II, -III in Drosophila epithelia causes altered signaling and cell polarity, suggesting that ESCRTs genes are tumor suppressors. However, the nature of the tumor suppressive function of ESCRTs, and whether tumor suppression is linked to receptor sorting is unclear. Unexpectedly, a null mutant in Hrs, encoding one of the components of the ESCRT-0 complex, which acts upstream of ESCRT-I, -II, -III in MVE sorting is dispensable for tumor suppression. Here, we report that two Drosophila epithelia lacking activity of Stam, the other known components of the ESCRT-0 complex, or of both Hrs and Stam, accumulate the signaling receptors Notch and Dome in endosomes. However, mutant tissue surprisingly maintains normal apico-basal polarity and proliferation control and does not display ectopic Notch signaling activation, unlike cells that lack ESCRT-I, -II, -III activity. Overall, our in vivo data confirm previous evidence indicating that the ESCRT-0 complex plays no crucial role in regulation of tumor suppression, and suggest re-evaluation of the relationship of signaling modulation in endosomes and tumorigenesis.	[Tognon, Emiliana; Wollscheid, Nadine; Vaccari, Thomas] Ist FIRC Oncol Mol, IFOM, Milan, Italy; [Cortese, Katia; Tacchetti, Carlo] Univ Genoa, Dipartimento Med Sperimentale, DIMES, Genoa, Italy; [Tacchetti, Carlo] Ist Sci San Raffaele, Expt Imaging Ctr, I-20132 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; University of Genoa; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Vaccari, T (corresponding author), Ist FIRC Oncol Mol, IFOM, IFOM IEO Campus, Milan, Italy.	thomas.vaccari@ifom.eu	Vaccari, Thomas/B-1945-2015; Cortese, Katia/AAC-2990-2021	Vaccari, Thomas/0000-0002-6231-7105; TACCHETTI, CARLO/0000-0003-4602-000X; Cortese, Katia/0000-0001-9218-8933	AIRC (Associazione Italiana Ricerca sul Cancro) [6118]; Telethon Italia [GGP13225]; Compagnia San Paolo (Torino) [2011.1172]; AIRC IG [12035]	AIRC (Associazione Italiana Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); Telethon Italia(Fondazione Telethon); Compagnia San Paolo (Torino)(Compagnia di San Paolo); AIRC IG(Fondazione AIRC per la ricerca sul cancro)	This work was supported by AIRC (Associazione Italiana Ricerca sul Cancro- http://www.airc.it) startup grant# 6118 (TV), by Telethon Italia (http://www.telethon.it) grant# GGP13225 (TV), by Compagnia San Paolo (Torino- http://www.compagnia.torino.it) grant# 2011.1172 (CT), and by AIRC IG grant# 12035 (CT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Bilodeau PS, 2002, NATURE CELL BIOL, V8; Blanc C, 2009, TRAFFIC, V10, P161, DOI 10.1111/j.1600-0854.2008.00855.x; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Chanut-Delalande H, 2007, GENETICS, V176, P2177, DOI 10.1534/genetics.107.073890; Chanut-Delalande H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010245; Deng WM, 2001, DEVELOPMENT, V128, P4737; Dukes JD, 2011, MOL BIOL CELL, V22, P3192, DOI 10.1091/mbc.E11-04-0343; Goentoro LA, 2006, GENESIS, V44, P66, DOI 10.1002/gene.20184; Gullapalli A, 2006, MOL BIOL CELL, V17, P1228, DOI 10.1091/mbc.E05-09-0899; Herz HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004165; Herz HM, 2006, DEVELOPMENT, V133, P1871, DOI 10.1242/dev.02356; Hori K, 2011, J CELL BIOL, V195, P1005, DOI 10.1083/jcb.201104146; Jekely G, 2003, EMBO REP, V4, P1163, DOI 10.1038/sj.embor.7400019; Katoh Y, 2004, J BIOL CHEM, V279, P24435, DOI 10.1074/jbc.M400059200; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Kobia F, 2014, MOL ONCOL, V8, P207, DOI 10.1016/j.molonc.2013.11.002; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Leung K, 2008, TRAFFIC COPENHAGEN D; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Lopez-Schier H, 2001, GENE DEV, V15, P1393, DOI 10.1101/gad.200901; Mellman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016949; Menut L, 2007, GENETICS, V177, P1667, DOI 10.1534/genetics.107.078360; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Newsome TP, 2000, DEVELOPMENT, V127, P851; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Robinson BS, 2011, CELL CYCLE, V10, P4110, DOI 10.4161/cc.10.23.18243; Roegiers F, 2009, GENETICS, V182, P407, DOI 10.1534/genetics.109.101808; Rusten TE, 2012, NAT CELL BIOL, V14, P38, DOI 10.1038/ncb2381; Sachse M, 2002, MOL BIOL CELL, V13, P1313, DOI 10.1091/mbc.01-10-0525; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Schneider M, 2013, J CELL SCI, V126, P645, DOI 10.1242/jcs.116590; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; Stuffers S, 2008, EXPT CELL RES; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Vaccari T, 2010, DEVELOPMENT, V137, P1825, DOI 10.1242/dev.045484; Vaccari T, 2009, J CELL SCI, V122, P2413, DOI 10.1242/jcs.046391; Woodfield SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056021; Yousefian J, 2013, J CELL SCI, V126, P1583, DOI 10.1242/jcs.114934	46	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93987	10.1371/journal.pone.0093987	http://dx.doi.org/10.1371/journal.pone.0093987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718108	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000062
J	Liao, JC; Ho, CH; Liang, FW; Wang, JJ; Lin, KC; Chio, CC; Kuo, JR				Liao, Jen-Chieh; Ho, Chung-Han; Liang, Fu-Wen; Wang, Jhi-Joung; Lin, Kao-Chang; Chio, Chung-Ching; Kuo, Jinn-Rung			One-Year Mortality Associations in Hemodialysis Patients after Traumatic Brain Injury-An Eight-Year Population-Based Study	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; STAGE RENAL-DISEASE; LONG-TERM SURVIVAL; REPLACEMENT THERAPY; PROLONGED STAY; RESOURCE USE; IMPACT; DIALYSIS; OUTCOMES; RISK	Purpose: This study aimed to investigate the one-year mortality associations in hemodialysis patients who underwent neurosurgical intervention after traumatic brain injury (TBI) using a nationwide database in Taiwan. Materials and Methods: An age-and gender-matched longitudinal cohort study of 4416 subjects, 1104 TBI patients with end-stage renal disease (ESRD) and 3312 TBI patients without ESRD, was conducted using the National Health Insurance Research Database in Taiwan between January 2000 and December 2007. The demographic characteristics, length of stay (LOS), length of ICU stay, length of ventilation (LOV), and tracheostomy were collected and analyzed. The co-morbidities of hypertension (HTN), diabetes mellitus (DM), myocardial infarction (MI), stroke, and heart failure (HF) were also evaluated. Results: TBI patients with ESRD presented a shorter LOS, a longer length of ICU stay and LOV, and a higher percentage of comorbidities compared with those without ESRD. TBI patients with ESRD displayed a stable trend of one-year mortality rate, 75.82% to 76.79%, from 2000-2007. For TBI patients with ESRD, the median survival time was 0.86 months, and preexisting stroke was a significant risk factor of mortality (HR: 1.29, 95% C.I.: 1.08-1.55). Pre-existing DM (HR: 1.35, 95% C.I.: 1.12-1.63) and MI (HR: 1.61, 95% C.I.: 1.07-2.42) effect on the mortality in ESRD patients who underwent TBI surgical intervention in the younger (age < 65) and older (age >= 65) population, respectively. In addition, the length of ICU stay and tracheostomy may provide important information to predict the mortality risk. Conclusions: This is the first report indicating an increased risk of one-year mortality among TBI patients with a pre-existing ERSD insult. Comorbidities were more common in TBI patients with ESRD. Physicians should pay more attention to TBI patients with ESRD based on the status of age, comorbidities, length of ICU stay, and tracheostomy to improve their survival.	[Liao, Jen-Chieh; Chio, Chung-Ching; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan; [Ho, Chung-Han; Wang, Jhi-Joung; Lin, Kao-Chang; Kuo, Jinn-Rung] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Liang, Fu-Wen] Natl Cheng Kung Univ, Coll Med, Inst Publ Hlth, Tainan 70101, Taiwan; [Lin, Kao-Chang; Kuo, Jinn-Rung] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Ho, Chung-Han] Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan	Chi Mei Hospital; Chi Mei Hospital; National Cheng Kung University; Southern Taiwan University of Science & Technology; Chia Nan University of Pharmacy & Science	Kuo, JR (corresponding author), Chi Mei Med Ctr, Dept Neurosurg, Tainan, Taiwan.	kuojinnrung@gmail.com		Ho, Chung-Han/0000-0001-5925-8477; Liang, Fu-Wen/0000-0002-3396-037X				Arabi Y, 2002, INT J QUAL HEALTH C, V14, P403, DOI 10.1093/intqhc/14.5.403; Bagshaw SM, 2006, AM J KIDNEY DIS, V48, P402, DOI 10.1053/j.ajkd.2006.06.002; Bell M, 2008, CRIT CARE MED, V36, P2773, DOI 10.1097/CCM.0b013e318187815a; Chae JW, 2011, NEPHRON CLIN PRACT, V117, pC379, DOI 10.1159/000321525; Chan M, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/715807; Chapman RJ, 2009, CRIT CARE, V13, DOI 10.1186/cc7867; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Chien CC, 2012, AM J HYPERTENS, V25, P900, DOI 10.1038/ajh.2012.60; Chiu WT, 1997, NEUROL RES, V19, P261, DOI 10.1080/01616412.1997.11740811; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Davenport A, 2001, AM J KIDNEY DIS, V37, P457, DOI 10.1053/ajkd.2001.22068; Dhanani J, 2013, J THORAC CARDIOV SUR, V146, P90, DOI 10.1016/j.jtcvs.2012.06.037; Freeman BD, 2005, CRIT CARE MED, V33, P2513, DOI 10.1097/01.CCM.0000186369.91799.44; Gale SC, 2007, AM SURGEON, V73, P454; Gogbashian A, 2004, EUR J CARDIO-THORAC, V25, P695, DOI 10.1016/j.ejcts.2004.02.022; Hamilton MA, 2011, ANESTH ANALG, V112, P1392, DOI 10.1213/ANE.0b013e3181eeaae5; Heyland DK, 1998, CHEST, V114, P192, DOI 10.1378/chest.114.1.192; Higgins TL, 2003, CRIT CARE MED, V31, P45, DOI 10.1097/00003246-200301000-00007; Hoffmann F, 2011, NEPHROL DIAL TRANSPL, V26, P1634, DOI 10.1093/ndt/gfq609; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; HWANG SJ, 2000, ACTA NEPHROL, V14, P139; Insurance BoNH, 2002, NAT HLTH INS ANN STA; Iseki K, 2000, NEPHROL DIAL TRANSPL, V15, P1808, DOI 10.1093/ndt/15.11.1808; Iseki K, 1996, KIDNEY INT, V50, P1672, DOI 10.1038/ki.1996.484; Kawamura M, 1998, AM J KIDNEY DIS, V31, P991, DOI 10.1053/ajkd.1998.v31.pm9631844; Kuo HW, 2007, AM J KIDNEY DIS, V49, P46, DOI 10.1053/j.ajkd.2006.10.007; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Laupland KB, 2006, CHEST, V129, P954, DOI 10.1378/chest.129.4.954; Liu CY., 2006, J HLTH MANAGEMENT, V4, P1, DOI DOI 10.29805/JHM.200606.0001; Lok CE, 2004, NEPHROL DIAL TRANSPL, V19, P3098, DOI 10.1093/ndt/gfh540; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Miller RS, 2000, J TRAUMA, V48, P229, DOI 10.1097/00005373-200002000-00006; Murakami M, 2004, NEUROL MED-CHIR, V44, P225, DOI 10.2176/nmc.44.225; PLUMMER AL, 1989, CHEST, V96, P178, DOI 10.1378/chest.96.1.178; Prevention CfDCa, 2010, GET STATS TRAUM BRAI; Rhodes A, 2011, INTENS CARE MED, V37, P1466, DOI 10.1007/s00134-011-2299-9; Rothen HU, 2007, INTENS CARE MED, V33, P1329, DOI 10.1007/s00134-007-0690-3; Rumbak MJ, 2004, CRIT CARE MED, V32, P1689, DOI 10.1097/01.CCM.0000134835.05161.B6; Schirmer-Mikalsen K, 2013, ACTA ANAESTH SCAND, V57, P46, DOI 10.1111/j.1399-6576.2012.02785.x; Sood MM, 2011, NEPHROL DIAL TRANSPL, V26, P2965, DOI 10.1093/ndt/gfq835; Strijack B, 2009, J AM SOC NEPHROL, V20, P2441, DOI 10.1681/ASN.2009040366; *SYST USRD, 2005, USRDS 2005 ANN DAT R; System URD, 1998, USRDS 1998 ANN DAT R; System USRD, 2019, ANN DAT REP; Taylor MD, 2002, J TRAUMA, V53, P407, DOI 10.1097/00005373-200209000-00001; Thompson HJ, 2010, ANN SURG, V252, P370, DOI 10.1097/SLA.0b013e3181df03d6; TOMITA J, 1995, AM J KIDNEY DIS, V25, P405, DOI 10.1016/0272-6386(95)90101-9; Wang HK, 2012, INJURY, V43, P1432, DOI 10.1016/j.injury.2011.03.059; Weissman C, 2000, INTENS CARE MED, V26, P1319, DOI 10.1007/s001340000612; Weissman C, 1997, CRIT CARE MED, V25, P1594, DOI 10.1097/00003246-199709000-00031; Yang WC, 2008, NEPHROL DIAL TRANSPL, V23, P3977, DOI 10.1093/ndt/gfn406	52	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93956	10.1371/journal.pone.0093956	http://dx.doi.org/10.1371/journal.pone.0093956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7FA	24714730	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900066
J	Hare, JM; Ferrell, JC; Witkowski, TA; Grice, AN				Hare, Janelle M.; Ferrell, Joshua C.; Witkowski, Travis A.; Grice, Alison N.			Prophage Induction and Differential RecA and UmuDAb Transcriptome Regulation in the DNA Damage Responses of Acinetobacter baumannii and Acinetobacter baylyi	PLOS ONE			English	Article							COLI LEXA PROTEIN; ESCHERICHIA-COLI; INDUCED MUTAGENESIS; GENOME SEQUENCE; GENE-EXPRESSION; CELL-DIVISION; VERSATILE; SYSTEM; SIPHOVIRIDAE; PATHOGENESIS	The SOS response to DNA damage that induces up to 10% of the prokaryotic genome requires RecA action to relieve LexA transcriptional repression. In Acinetobacter species, which lack LexA, the error-prone polymerase accessory UmuDAb is instead required for ddrR induction after DNA damage, suggesting it might be a LexA analog. RNA-Seq experiments defined the DNA damage transcriptome (mitomycin C-induced) of wild type, recA and umuDAb mutant strains of both A. baylyi ADP1 and A. baumannii ATCC 17978. Of the typical SOS response genes, few were differentially regulated in these species; many were repressed or absent. A striking 38.4% of all ADP1 genes, and 11.4% of all 17978 genes, were repressed under these conditions. In A. baylyi ADP1, 66 genes (2.0% of the genome), including a CRISPR/Cas system, were DNA damage-induced, and belonged to four regulons defined by differential use of recA and umuDAb. In A. baumannii ATCC 17978, however, induction of 99% of the 152 mitomycin C-induced genes depended on recA, and only 28 of these genes required umuDAb for their induction. 90% of the induced A. baumannii genes were clustered in three prophage regions, and bacteriophage particles were observed after mitomycin C treatment. These prophages encoded esvI, esvK1, and esvK2, ethanol-stimulated virulence genes previously identified in a Caenorhabditis elegans model, as well as error-prone polymerase alleles. The induction of all 17978 error-prone polymerase alleles, whether prophage-encoded or not, was recA dependent, but only these DNA polymerase V-related genes were de-repressed in the umuDAb mutant in the absence of DNA damage. These results suggest that both species possess a robust and complex DNA damage response involving both recA-dependent and recA-independent regulons, and further demonstrates that although umuDAb has a specialized role in repressing error-prone polymerases, additional regulators likely participate in these species' transcriptional response to DNA damage.	[Hare, Janelle M.; Ferrell, Joshua C.; Witkowski, Travis A.; Grice, Alison N.] Morehead State Univ, Dept Biol & Chem, Morehead, KY 40351 USA	Morehead State University	Hare, JM (corresponding author), Morehead State Univ, Dept Biol & Chem, Morehead, KY 40351 USA.	jm.hare@morehead-st.edu	Hare, Janelle/AAG-1144-2019	Hare, Janelle/0000-0001-5482-8143; Ferrell, Joshua/0000-0003-4570-8240	KBRIN NIH grant [P20GM103436]; NIH [R15GM085722-02]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM085722, P20GM103436] Funding Source: NIH RePORTER	KBRIN NIH grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a KBRIN NIH grant (P20GM103436) and NIH grant R15GM085722-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella M, 2007, J BACTERIOL, V189, P8855, DOI 10.1128/JB.01213-07; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Allocati N, 2009, FEBS J, V276, P58, DOI 10.1111/j.1742-4658.2008.06743.x; Aranda J, 2013, J BACTERIOL, V195, P5577, DOI 10.1128/JB.00853-13; Aranda J, 2011, J BACTERIOL, V193, P3740, DOI 10.1128/JB.00389-11; Aranda J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-279; Aravind L, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-20; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barbe V, 2004, NUCLEIC ACIDS RES, V32, P5766, DOI 10.1093/nar/gkh910; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; BRENT R, 1981, P NATL ACAD SCI-BIOL, V78, P4204, DOI 10.1073/pnas.78.7.4204; Brussow H, 2001, MOL MICROBIOL, V39, P213, DOI 10.1046/j.1365-2958.2001.02228.x; Cirz RT, 2006, J BACTERIOL, V188, P7101, DOI 10.1128/JB.00807-06; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; Deghorain M, 2012, VIRUSES-BASEL, V4, P3316, DOI 10.3390/v4123316; Di Nocera PP, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-224; ERASO JM, 1994, J BACTERIOL, V176, P32, DOI 10.1128/JB.176.1.32-43.1994; Erill I, 2003, BIOINFORMATICS, V19, P2225, DOI 10.1093/bioinformatics/btg303; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Gohl O, 2006, APPL ENVIRON MICROB, V72, P1394, DOI 10.1128/AEM.72.2.1394-1401.2006; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hare JM, 2006, APPL ENVIRON MICROB, V72, P4036, DOI 10.1128/AEM.02774-05; Hare JM, 2012, FEMS MICROBIOL LETT, V334, P57, DOI 10.1111/j.1574-6968.2012.02618.x; Hare JM, 2012, MICROBIOL-SGM, V158, P601, DOI 10.1099/mic.0.054668-0; Hauck Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044597; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; HORII T, 1981, CELL, V27, P515, DOI 10.1016/0092-8674(81)90393-7; HUISMAN O, 1981, NATURE, V290, P797, DOI 10.1038/290797a0; Jara M, 2003, J BACTERIOL, V185, P2493, DOI 10.1128/JB.185.8.2493-2502.2003; Jeon J, 2012, J VIROL, V86, P12437, DOI 10.1128/JVI.02132-12; Khil PP, 2002, MOL MICROBIOL, V44, P89, DOI 10.1046/j.1365-2958.2002.02878.x; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; Klaiman D, 2014, NUCLEIC ACIDS RES, V42, P328, DOI 10.1093/nar/gkt851; LITTLE JW, 1980, P NATL ACAD SCI-BIOL, V77, P3225, DOI 10.1073/pnas.77.6.3225; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longkumer T, 2014, MICROBIOL-SGM, V160, P102, DOI 10.1099/mic.0.070664-0; Mortensen BL, 2012, CELL MICROBIOL, V14, P1336, DOI 10.1111/j.1462-5822.2012.01817.x; Norton MD, 2013, J BACTERIOL, V195, P1335, DOI 10.1128/JB.02176-12; Petrovski S, 2012, J VIROL, V86, P358, DOI 10.1128/JVI.05460-11; Rauch PJG, 1996, MICROBIOL-UK, V142, P1025, DOI 10.1099/00221287-142-4-1025; ROBERTS JW, 1975, P NATL ACAD SCI USA, V72, P147, DOI 10.1073/pnas.72.1.147; Rutala WA, 2010, INFECT CONT HOSP EP, V31, P1025, DOI 10.1086/656244; SCHOEMAKER JM, 1984, J BACTERIOL, V158, P551, DOI 10.1128/JB.158.2.551-561.1984; Smith MG, 2007, GENE DEV, V21, P601, DOI 10.1101/gad.1510307; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; WALKER GC, 1996, SOS RESPONSE ESCHERI; Young DM, 2005, ANNU REV MICROBIOL, V59, P519, DOI 10.1146/annurev.micro.59.051905.105823; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	49	36	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93861	10.1371/journal.pone.0093861	http://dx.doi.org/10.1371/journal.pone.0093861			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709747	Green Submitted, gold, Green Published			2022-12-25	WOS:000334159800059
J	Henning, CHCA; Zarnekow, N; Hedtrich, J; Stark, S; Turk, K; Laudes, M				Henning, Christian H. C. A.; Zarnekow, Nana; Hedtrich, Johannes; Stark, Sascha; Tuerk, Kathrin; Laudes, Matthias			Identification of Direct and Indirect Social Network Effects in the Pathophysiology of Insulin Resistance in Obese Human Subjects	PLOS ONE			English	Article							EARLY-ONSET OBESITY; PROPENSITY SCORE; OVERWEIGHT; ASSOCIATION; CHILDREN; MUTATION; BMI	Objective: The aim of the present study was to examine to what extent different social network mechanisms are involved in the pathogenesis of obesity and insulin-resistance. Design: We used nonparametric and parametric regression models to analyse whether individual BMI and HOMA-IR are determined by social network characteristics. Subjects and Methods: A total of 677 probands (EGO) and 3033 social network partners (ALTER) were included in the study. Data gathered from the probands include anthropometric measures, HOMA-IR index, health attitudes, behavioural and socio- economic variables and social network data. Results: We found significant treatment effects for ALTERs frequent dieting (p < 0.001) and ALTERs health oriented nutritional attitudes (p, 0.001) on EGO's BMI, establishing a significant indirect network effect also on EGO's insulin resistance. Most importantly, we also found significant direct social network effects on EGO's insulin resistance, evidenced by an effect of ALTERs frequent dieting (p = 0.033) and ALTERs sport activities (p = 0.041) to decrease EGO's HOMA-IR index independently of EGO's BMI. Conclusions: Social network phenomena appear not only to be relevant for the spread of obesity, but also for the spread of insulin resistance as the basis for type 2 diabetes. Attitudes and behaviour of peer groups influence EGO's health status not only via social mechanisms, but also via socio- biological mechanisms, i.e. higher brain areas might be influenced not only by biological signals from the own organism, but also by behaviour and knowledge from different human individuals. Our approach allows the identification of peer group influence controlling for potential homophily even when using cross-sectional observational data.	[Henning, Christian H. C. A.; Zarnekow, Nana; Hedtrich, Johannes; Stark, Sascha] Univ Kiel, Inst Agr Econ, Kiel, Germany; [Tuerk, Kathrin; Laudes, Matthias] Univ Kiel, Dept Internal Med 1, Kiel, Germany	University of Kiel; University of Kiel	Henning, CHCA (corresponding author), Univ Kiel, Inst Agr Econ, Kiel, Germany.	chenning@ae.uni-kiel.de	Laudes, Matthias/C-8885-2011	Ziesmer, Johannes/0000-0001-5950-4199	federal ministry of education and research (BMBF) [0315540A, DRKS00005285]	federal ministry of education and research (BMBF)(Federal Ministry of Education & Research (BMBF))	The study is funded by the federal ministry of education and research (BMBF), Number: 0315540A, DRKS00005285. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr DB, 2009, OBESITY, V17, P723, DOI 10.1038/oby.2008.615; Bandura A., 1986, SOCIAL FDN THOUGHT A; Battiston S, 2004, COMPLEX DYNAMICS EC, P355; Berkman L. F., 2000, SOCIAL EPIDEMIOLOGY, V1, P137, DOI DOI 10.4135/9781412952576.N192]; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Cohen-Cole E, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2533; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; de la Haye K, 2010, SOC NETWORKS, V32, P161, DOI 10.1016/j.socnet.2009.09.001; Duncan GE, 2003, DIABETES CARE, V26, P557, DOI 10.2337/diacare.26.3.557; Fletcher A, 2011, J EPIDEMIOL COMMUN H, V65, P548, DOI 10.1136/jech.2010.113936; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Frankort A, 2012, INT J OBESITY, V36, P627, DOI 10.1038/ijo.2011.213; George S, 2004, SCIENCE, V304, P1325, DOI 10.1126/science.1096706; Golley RK, 2013, INT J OBESITY, V37, P546, DOI 10.1038/ijo.2012.212; Gu Xing S., 1993, J COMPUTATIONAL GRAP, V2, P405, DOI [DOI 10.1080/10618600.1993.10474623, DOI 10.7326/0003-4819-152-6-201003160-00008]; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Hung CCC, 2004, DIABETES, V53, P2461, DOI 10.2337/diabetes.53.9.2461; Johns D, 2010, EVERYTHING IS CONTAG; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; MANSKI CF, 1993, REV ECON STUD, V60, P531, DOI 10.2307/2298123; Marks DL, 2004, AM J MED GENET A, V126A, P267, DOI 10.1002/ajmg.a.20600; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Moore S, 2009, J PUBLIC HEALTH-UK, V31, P175, DOI 10.1093/pubmed/fdn104; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Shalizi CR, 2011, SOCIOL METHOD RES, V40, P211, DOI 10.1177/0049124111404820; Shoham DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039795; Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601; Snijders T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd; Snijders TAB, 2010, SOC NETWORKS, V32, P44, DOI 10.1016/j.socnet.2009.02.004; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Turconi G, 2006, EUR J NUTR, V45, P136, DOI 10.1007/s00394-005-0571-x; Valente TW, 2008, SOCIAL NETWORKS HLTH; Van der Gaag M, 2005, SOC NETWORKS, V27, P21; Wasserman S., 1994, SOCIAL NETWORK ANAL; Waters E, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001871.pub3; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404	41	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93860	10.1371/journal.pone.0093860	http://dx.doi.org/10.1371/journal.pone.0093860			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7EP	24710599	Green Published, gold, Green Submitted			2022-12-25	WOS:000334159800058
J	Iyer, S; Reyes, J; Killingback, T				Iyer, Swami; Reyes, Joshua; Killingback, Timothy			An Application of Evolutionary Game Theory to Social Dilemmas: The Traveler ' s Dilemma and the Minimum Effort Coordination Game	PLOS ONE			English	Article							COOPERATION; DYNAMICS; TRAGEDY; POPULATIONS; BEHAVIOR; RESOLVE; ORIGIN; SIZE	The Traveler's Dilemma game and the Minimum Effort Coordination game are two social dilemmas that have attracted considerable attention due to the fact that the predictions of classical game theory are at odds with the results found when the games are studied experimentally. Moreover, a direct application of deterministic evolutionary game theory, as embodied in the replicator dynamics, to these games does not explain the observed behavior. In this work, we formulate natural variants of these two games as smoothed continuous-strategy games. We study the evolutionary dynamics of these continuous-strategy games, both analytically and through agent-based simulations, and show that the behavior predicted theoretically is in accord with that observed experimentally. Thus, these variants of the Traveler's Dilemma and the Minimum Effort Coordination games provide a simple resolution of the paradoxical behavior associated with the original games.	[Iyer, Swami] Univ Massachusetts, Dept Comp Sci, Boston, MA 02125 USA; [Reyes, Joshua] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA; [Killingback, Timothy] Univ Massachusetts, Dept Math, Boston, MA 02125 USA	University of Massachusetts System; University of Massachusetts Boston; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Boston	Killingback, T (corresponding author), Univ Massachusetts, Dept Math, Harbor Campus, Boston, MA 02125 USA.	timothy.killingback@umb.edu						Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Anderson SP, 2001, GAME ECON BEHAV, V34, P177, DOI 10.1006/game.2000.0800; AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BASU K, 1994, AM ECON REV, V84, P391; Basu K, 2007, SCI AM, V296, P90, DOI 10.1038/scientificamerican0607-90; Basu K, 2011, SOC CHOICE WELFARE, V37, P575, DOI 10.1007/s00355-011-0577-7; Becker T., 2005, EXPERTS PLAYING TRAV; BRYANT J, 1983, Q J ECON, V98, P525, DOI 10.2307/1886025; Camerer CF, 2004, Q J ECON, V119, P861, DOI 10.1162/0033553041502225; Capra CM, 1999, AM ECON REV, V89, P678, DOI 10.1257/aer.89.3.678; Capraro V, 2013, LECT NOTES COMPUT SC, V8146, P146, DOI 10.1007/978-3-642-41392-6_13; Capraro V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072427; Costa-Gomes M, 2001, ECONOMETRICA, V69, P1193, DOI 10.1111/1468-0262.00239; Doebeli M, 2004, SCIENCE, V306, P859, DOI 10.1126/science.1101456; Dufwenberg M, 2000, INT J IND ORGAN, V18, P7, DOI 10.1016/S0167-7187(99)00031-4; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; FLOOD MM, 1958, MANAGE SCI, V5, P5, DOI 10.1287/mnsc.5.1.5; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Goeree JK, 2001, AM ECON REV, V91, P1402, DOI 10.1257/aer.91.5.1402; Goeree JK, 1999, P NATL ACAD SCI USA, V96, P10564, DOI 10.1073/pnas.96.19.10564; Halpern JY, 2012, GAME ECON BEHAV, V74, P184, DOI 10.1016/j.geb.2011.05.012; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hofbauer J., 1998, EVOLUTIONARY GAMES P; Holt CA, 2004, P NATL ACAD SCI USA, V101, P3999, DOI 10.1073/pnas.0308738101; Ifti M, 2004, J THEOR BIOL, V231, P97, DOI 10.1016/j.jtbi.2004.06.003; ISAAC RM, 1988, Q J ECON, V103, P179, DOI 10.2307/1882648; Killingback T, 1996, P ROY SOC B-BIOL SCI, V263, P1135, DOI 10.1098/rspb.1996.0166; Killingback T, 1999, P ROY SOC B-BIOL SCI, V266, P1723, DOI 10.1098/rspb.1999.0838; Killingback T, 2006, P ROY SOC B-BIOL SCI, V273, P1477, DOI 10.1098/rspb.2006.3476; Killingback Timothy, 2010, Biology Theory, V5, P3, DOI 10.1162/BIOT_a_00019; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Li RH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058597; Manapat ML, 2012, J THEOR BIOL, V303, P119, DOI 10.1016/j.jtbi.2012.03.014; Maynard Smith J., 1982, pi; MCKELVEY RD, 1995, GAME ECON BEHAV, V10, P6, DOI 10.1006/game.1995.1023; Metz J, 1996, STOCHAST SPATIAL STR, P183; Nakamaru M, 1997, J THEOR BIOL, V184, P65, DOI 10.1006/jtbi.1996.0243; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Riehl C, 2011, P ROY SOC B-BIOL SCI, V278, P1728, DOI 10.1098/rspb.2010.1752; Riehl C, 2009, WILSON J ORNITHOL, V121, P679, DOI 10.1676/09-017.1; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Skyrms B, 2003, STAG HUNT EVOLUTION; STAHL DO, 1994, J ECON BEHAV ORGAN, V25, P309, DOI 10.1016/0167-2681(94)90103-1; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Tirole J., 1988, THEORY IND ORG; van Baalen M, 1998, J THEOR BIOL, V193, P631, DOI 10.1006/jtbi.1998.0730; VANHUYCK JB, 1990, AM ECON REV, V80, P234; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wright JR, 2010, AAAI CONF ARTIF INTE, P901	55	12	12	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93988	10.1371/journal.pone.0093988	http://dx.doi.org/10.1371/journal.pone.0093988			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7EP	24709851	gold, Green Published, Green Submitted			2022-12-25	WOS:000334159800081
J	Ndumbi, P; Falutz, J; Pai, NP; Tsoukas, CM				Ndumbi, Patricia; Falutz, Julian; Pai, Nitika Pant; Tsoukas, Christos M.			Delay in cART Initiation Results in Persistent Immune Dysregulation and Poor Recovery of T-Cell Phenotype Despite a Decade of Successful HIV Suppression	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; C-REACTIVE PROTEIN; ANTIRETROVIRAL THERAPY; LYMPHOCYTE SUBSETS; INFECTED PATIENTS; CONTROLLED-TRIAL; CYTOMEGALOVIRUS; HOMEOSTASIS; COUNT; AIDS	Background: Successful combination antiretroviral therapy (cART) increases levels of CD4+ T-cells, however this increase may not accurately reflect long-term immune recovery since T-cell dysregulation and loss of T-cell homeostasis often persist. We therefore assessed the impact of a decade of effective cART on immune regulation, T-cell homeostasis, and overall T-cell phenotype. Methods: We conducted a retrospective study of 288 HIV+ cART-naive patients initiating therapy. We identified 86 individuals who received cART for at least a decade, of which 44 consistently maintained undetectable plasma HIV-RNA levels throughout therapy. At baseline, participants were classified into three groups according to pre-treatment CD4+ T-cell counts: Group I (CD4 < 200 cells/mm(3)); Group II (CD4: 200-350 cells/mm(3)); Group III (CD4 > 350 cells/mm(3)). Outcomes of interest were: (1) CD4+ T-cell count restoration (CD4 > 532 cells/mm(3)); (2) normalization of CD4: CD8 T-cell ratio (1.2-3.3); (3) maintenance of CD3+ T-cell homeostasis (CD3: 65%-85% of peripheral lymphocytes); (4) normalization of the complete T Cell phenotype (TCP). Results: Despite a decade of sustained successful cART, complete T-cell phenotype normalization only occurred in 16% of patients, most of whom had initiated therapy at high CD4+ T-cell counts (> 350 cells/mm(3)). The TCP parameter that was the least restored among patients was the CD4: CD8 T-cell ratio. Conclusions: Failure to normalize the complete T-cell phenotype was most apparent in patients who initiated cART with a CD4+ T-cell count < 200 cells/mm(3). The impact of this impaired T-cell phenotype on life-long immune function and potential comorbidities remains to be elucidated.	[Ndumbi, Patricia; Falutz, Julian; Tsoukas, Christos M.] McGill Univ, Ctr Hlth, Immune Deficiency Treatment Ctr, Montreal, PQ, Canada; [Pai, Nitika Pant] McGill Univ, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ, Canada	McGill University; McGill University	Ndumbi, P (corresponding author), McGill Univ, Ctr Hlth, Immune Deficiency Treatment Ctr, Montreal, PQ, Canada.	patricia.ndumbi@mail.mcgill.ca; chris.tsoukas@muhc.mcgill.ca		Pant Pai, Nitika/0000-0002-4672-0500	Canadian Institutes of Health Research (CIHR) [200303HHP-118726-HSR-CFAC-26137]; McGill University Health Center (MUHC)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); McGill University Health Center (MUHC)	This work was supported by research funding from the Canadian Institutes of Health Research (CIHR) grant 200303HHP-118726-HSR-CFAC-26137. Paticia Ndumbi was also supported by the McGill University Health Center (MUHC) graduate fellowship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLEMAN LM, 1993, J ACQ IMMUN DEF SYND, V6, P144; Althoff KN, 2010, AIDS, V24, P2467, DOI 10.1097/QAD.0b013e32833e6d14; Baker JV, 2008, JAIDS-J ACQ IMM DEF, V48, P541, DOI 10.1097/QAI.0b013e31817bebb3; Bower JE, 2003, JNCI-J NATL CANCER I, V95, P1165, DOI 10.1093/jnci/djg0019; Cameron DW, 1998, LANCET, V351, P543, DOI 10.1016/S0140-6736(97)04161-5; Carmichael K F, 2006, Afr J Med Med Sci, V35, P53; Chattopadhyay PK, 2006, AIDS RES HUM RETROV, V22, P501, DOI 10.1089/aid.2006.22.501; EDELMAN AS, 1989, FASEB J, V3, P22, DOI 10.1096/fasebj.3.1.2562947; FAHEY JL, 1984, AM J MED, V76, P95, DOI 10.1016/0002-9343(84)90756-3; FERGUSON FG, 1995, J GERONTOL A-BIOL, V50, pB378, DOI 10.1093/gerona/50A.6.B378; Gange SJ, 1998, P NATL ACAD SCI USA, V95, P10848, DOI 10.1073/pnas.95.18.10848; Goodrum F, 2012, CELL MICROBIOL, V14, P644, DOI 10.1111/j.1462-5822.2012.01774.x; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; Hirsch M, 1999, J INFECT DIS, V180, P659, DOI 10.1086/314948; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Jain V, 2013, J INFECT DIS, V208, P1202, DOI 10.1093/infdis/jit311; Keller M, 2009, AIDS, V23, P731, DOI 10.1097/QAD.0b013e328326f77f; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Khoruts A, 2005, IMMUNOL LETT, V98, P23, DOI 10.1016/j.imlet.2004.10.022; LABALETTE M, 1994, CLIN EXP IMMUNOL, V95, P465; Leung V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077665; Lo J, 2010, AIDS, V24, P243, DOI 10.1097/QAD.0b013e328333ea9e; MALONE JL, 1990, J ACQ IMMUN DEF SYND, V3, P144; Malphettes M, 2009, CLIN INFECT DIS, V49, P1329, DOI 10.1086/606059; Margolick J B, 1997, Semin Immunol, V9, P381, DOI 10.1006/smim.1997.0096; MARGOLICK JB, 1995, NAT MED, V1, P674, DOI 10.1038/nm0795-674; Margolick JB, 1993, JAIDS J ACQUIRED IMM, V6; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Muhlestein JB, 2000, CIRCULATION, V102, P1917, DOI 10.1161/01.CIR.102.16.1917; Naeger DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008886; Ndumbi P, 2013, AIDS; Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208; Shete A, 2010, INDIAN J MED RES, V132, P667; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Stockinger B, 2004, CURR OPIN IMMUNOL, V16, P775, DOI 10.1016/j.coi.2004.09.003; Strindhall J, 2012, AGE DORDR; Torti C, 2012, CLIN MICROBIOL INFEC, V18, P449, DOI 10.1111/j.1469-0691.2011.03650.x; Vila LM, 2006, ARTHRIT RHEUM-ARTHR, V55, P799, DOI 10.1002/art.22224; Wikby A, 1998, MECH AGEING DEV, V102, P187, DOI 10.1016/S0047-6374(97)00151-6; Wikby A, 2008, BIOGERONTOLOGY, V9, P299, DOI 10.1007/s10522-008-9138-6; Zhu JH, 1999, J AM COLL CARDIOL, V34, P1738, DOI 10.1016/S0735-1097(99)00410-6; ZOLLAPAZNER S, 1987, P NATL ACAD SCI USA, V84, P5404, DOI 10.1073/pnas.84.15.5404	42	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94018	10.1371/journal.pone.0094018	http://dx.doi.org/10.1371/journal.pone.0094018			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710051	Green Submitted, gold, Green Published			2022-12-25	WOS:000334159800087
J	Schwarz, ST; Afzal, M; Morgan, PS; Bajaj, N; Gowland, PA; Auer, DP				Schwarz, Stefan T.; Afzal, Mohammed; Morgan, Paul S.; Bajaj, Nin; Gowland, Penny A.; Auer, Dorothee P.			The 'Swallow Tail' Appearance of the Healthy Nigrosome - A New Accurate Test of Parkinson's Disease: A Case-Control and Retrospective Cross-Sectional MRI Study at 3T	PLOS ONE			English	Article							SUBSTANTIA-NIGRA; DIFFERENTIAL-DIAGNOSIS; CLINICAL-DIAGNOSIS; HUMAN BRAIN	There is no well-established in vivo marker of nigral degeneration in Parkinson's disease (PD). An ideal imaging marker would directly mirror the loss of substantia nigra dopaminergic neurones, which is most prominent in sub-regions called nigrosomes. High-resolution, iron-sensitive, magnetic resonance imaging (MRI) at 7T allows direct nigrosome-1 visualisation in healthy people but not in PD. Here, we investigated the feasibility of nigrosome-1 detection using 3T - susceptibility weighted (SWI) MRI and the diagnostic accuracy that can be achieved for diagnosing PD in a clinical population. 114 high-resolution 3T - SWI-scans were reviewed consisting of a prospective case-control study in 19 subjects ( 10 PD, 9 controls) and a retrospective cross-sectional study in 95 consecutive patients undergoing routine clinical SWI-scans (. 50 years, 9 PD, 81 non-PD, 5 non-diagnostic studies excluded). Two raters independently classified subjects into PD and non-PD according to absence or presence of nigrosome-1, followed by consensus reading. Diagnostic accuracy was assessed against clinical diagnosis as gold standard. Absolute inter-and intra-rater agreement was >= 94%(kappa >= 0.82,p < 0.001). In the prospective study 8/9 control and 8/10 PD; and in the retrospective study 77/81 non-PD and all 9 PD subjects were correctly classified. Diagnostic accuracy of the retrospective cohort was: sensitivity 100%, specificity 95%, NPV 1, PPV 0.69 and accuracy 96% which dropped to 91% when including non-diagnostic scans (`intent to diagnose'). The healthy nigrosome-1 can be readily depicted on high-resolution 3T - SWI giving rise to a `swallow tail' appearance of the dorsolateral substantia nigra, and this feature is lost in PD. Visual radiological assessment yielded a high diagnostic accuracy for PD vs. an unselected clinical control population. Assessing the substantia nigra on SWI for the typical `swallow tail' appearance has potential to become a new and easy applicable 3T MRI diagnostic tool for nigral degeneration in PD.	[Schwarz, Stefan T.; Auer, Dorothee P.] Univ Nottingham, Sch Med, Div Clin Neurosci, Nottingham, England; [Afzal, Mohammed] Nottingham Univ Hosp NHS Trust, Dept Med, Nottingham, England; [Morgan, Paul S.] Nottingham Univ Hosp NHS Trust, Nottingham, England; [Bajaj, Nin] Nottingham Univ Hosp NHS Trust, Dept Neurol, Nottingham, England; [Gowland, Penny A.] Sir Peter Mansfield Magnet Resonance Ctr, Sch Phys & Astron, Nottingham, England	University of Nottingham; Nottingham University Hospital NHS Trust; Nottingham University Hospital NHS Trust; Nottingham University Hospital NHS Trust; University of Nottingham	Schwarz, ST (corresponding author), Univ Nottingham, Sch Med, Div Clin Neurosci, Nottingham, England.	stefan.schwarz@nottingham.ac.uk	Gowland, Penny A./I-9016-2012	Gowland, Penny A./0000-0002-4900-4817; Auer, Dorothee P./0000-0002-4745-3635; Morgan, Paul/0000-0002-5870-1446	Special Trustees for Nottingham University Hospital [STR 82/04/N]; Multiple System Atrophy Trust; Medical Research Council [G0901321]; National Institute for Health Research UK (Academic Clinical Lectureship); Medical Research Council [MC_PC_12019] Funding Source: researchfish; National Institute for Health Research [CL-2010-12-004] Funding Source: researchfish; MRC [G0901321, MC_PC_12019] Funding Source: UKRI	Special Trustees for Nottingham University Hospital; Multiple System Atrophy Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research UK (Academic Clinical Lectureship); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The prospective substudy was co-funded by Special Trustees for Nottingham University Hospital (Grant Ref: STR 82/04/N), the Sarah Matheson Trust (now Multiple System Atrophy Trust founded by Sarah Matheson, No reference number given (http://www.msatrust.org.uk), and the Medical Research Council (Grant Ref: G0901321). The author S.T. Schwarz is funded by the National Institute for Health Research UK (Academic Clinical Lectureship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj N, 2013, J NEUROL NEUROSUR PS, V84, P1288, DOI 10.1136/jnnp-2012-304436; Bak Thomas H, 2007, Pract Neurol, V7, P245; Baudrexel S, 2010, NEUROIMAGE, V51, P512, DOI 10.1016/j.neuroimage.2010.03.005; Berg D, 2008, LANCET NEUROL, V7, P1044, DOI 10.1016/S1474-4422(08)70239-4; Blazejewska AI, 2013, NEUROLOGY, V81, P534, DOI 10.1212/WNL.0b013e31829e6fd2; Bossuyt PM, 2003, BRIT MED J, V326, P41, DOI 10.1136/bmj.326.7379.41; Damier P, 1999, BRAIN, V122, P1421, DOI 10.1093/brain/122.8.1421; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Fahn S, 1987, RECENT DEV PARKINSON; FEARNLEY JM, 1991, BRAIN, V114, P2283, DOI 10.1093/brain/114.5.2283; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hauser RA, 2012, J NEUROIMAGING, V22, P225, DOI 10.1111/j.1552-6569.2011.00583.x; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hotter A, 2009, MOVEMENT DISORD, V24, pS711, DOI 10.1002/mds.22648; Hughes AJ, 2002, BRAIN, V125, P861, DOI 10.1093/brain/awf080; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; Kohn MA, 2013, ACAD EMERG MED, V20, P1194, DOI 10.1111/acem.12255; Kwon DH, 2012, ANN NEUROL, V71, P267, DOI 10.1002/ana.22592; Lehericy S, 2012, MOVEMENT DISORD, V27, P822, DOI 10.1002/mds.25015; Lotfipour AK, 2012, J MAGN RESON IMAGING, V35, P48, DOI 10.1002/jmri.22752; Mahlknecht P, 2010, NEURODEGENER DIS, V7, P300, DOI 10.1159/000314495; Massey LA, 2012, MOVEMENT DISORD, V27, P1755, DOI 10.1002/mds.24968; Meara J, 1999, AGE AGEING, V28, P99, DOI 10.1093/ageing/28.2.99; Meijer FJA, 2013, J NEUROL SCI, V332, P21, DOI 10.1016/j.jns.2013.06.032; Schrag A, 2002, J NEUROL NEUROSUR PS, V73, P529, DOI 10.1136/jnnp.73.5.529; Schwarz ST, 2013, NEUROIMAGE-CLIN, V3, P481, DOI 10.1016/j.nicl.2013.10.006; Schwarz ST, 2011, MOVEMENT DISORD, V26, P1633, DOI 10.1002/mds.23722; Wallis LI, 2008, J MAGN RESON IMAGING, V28, P1061, DOI 10.1002/jmri.21563; Wang J, 2013, DRUG DISCOV TODAY, V18, P155, DOI 10.1016/j.drudis.2012.09.001; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Zecca L, 2008, J NEUROCHEM, V106, P1866, DOI 10.1111/j.1471-4159.2008.05541.x; Zhang W, 2009, NEUROSCI BULL, V25, P353, DOI 10.1007/s12264-009-0225-8	35	188	206	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93814	10.1371/journal.pone.0093814	http://dx.doi.org/10.1371/journal.pone.0093814			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710392	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800054
J	Fitch-Rogalsky, C; Steber, W; Mahler, M; Lupton, T; Martin, L; Barr, SG; Mosher, DP; Wick, J; Fritzler, MJ				Fitch-Rogalsky, Christie; Steber, Whitney; Mahler, Michael; Lupton, Terri; Martin, Liam; Barr, Susan G.; Mosher, Dianne P.; Wick, James; Fritzler, Marvin J.			Clinical and Serological Features of Patients Referred through a Rheumatology Triage System because of Positive Antinuclear Antibodies	PLOS ONE			English	Article							PRIMARY-CARE PHYSICIANS; LUPUS-ERYTHEMATOSUS; CLASSIFICATION CRITERIA; DIAGNOSTIC ALGORITHM; HEALTHY-INDIVIDUALS; AUTOIMMUNE-DISEASES; AMERICAN-COLLEGE; PREDICTIVE-VALUE; ANTI-DFS70 ANTIBODIES; IMMUNOLOGICAL TESTS	Background: The referral of patients with positive anti-nuclear antibody ( ANA) tests has been criticized as an inappropriate use of medical resources. The utility of a positive ANA test in a central triage (CT) system was studied by determining the autoantibody profiles and clinical diagnoses of patients referred to rheumatologists through a CT system because of a positive ANA test. Methods: Patients that met three criteria were included: (1) referred to Rheumatology CT over a three year interval; (2) reason for referral was a ``positive ANA''; (3) were evaluated by a certified rheumatologist. The CT clinical database was used to obtain demographic and clinical information and a serological database was used to retrieve specific ANA and/or extractable nuclear antigen (ENA) test results. Clinical information was extracted from the consulting rheumatologist's report. Results: 15,357 patients were referred through the CT system; 643 (4.1%) of these because of a positive ANA and of these 263 (40.9%) were evaluated by a certified rheumatologist. In 63/263 (24%) of ANA positive patients, the specialist provided a diagnosis of an ANA associated rheumatic disease (AARD) while 69 (26.2%) had no evidence of any disease; 102 (38.8%) had other rheumatologic diagnoses and 29 (11%) had conditions that did not meet AARD classification criteria. Of ANA positive archived sera, 15.1% were anti-DFS70 positive and 91.2% of these did not have an AARD. Conclusions: This is the first study to evaluate the serological and clinical features of patients referred through a CT system because of a positive ANA. The spectrum of autoantibody specificities was wide with anti-Ro52/TRIM21 being the most common autoantibody detected. Approximately 15% of referrals had only antibodies to DFS70, the vast majority of which did not have clinical evidence for an AARD. These findings provide insight into the utility of autoantibody testing in a CT system.	[Fitch-Rogalsky, Christie; Steber, Whitney; Lupton, Terri; Martin, Liam; Barr, Susan G.; Mosher, Dianne P.; Wick, James; Fritzler, Marvin J.] Univ Calgary, Fac Med, Calgary, AB, Canada; [Mahler, Michael] INOVA Diagnost Inc, San Diego, CA USA	University of Calgary; Inova Diagnostics, Inc.	Fritzler, MJ (corresponding author), Univ Calgary, Fac Med, Calgary, AB, Canada.	fritzler@ucalgary.ca		Wick, James/0000-0002-1210-5294; Addison, Christie/0000-0001-8346-3884	Mitogen Advanced Diagnostics Laboratory; University of Calgary, Division of Rheumatology, at the University of Calgary	Mitogen Advanced Diagnostics Laboratory; University of Calgary, Division of Rheumatology, at the University of Calgary	This project was funded and supported by resources from Mitogen Advanced Diagnostics Laboratory and as well as funds allocated to the Arthritis Society Research Chair by the University of Calgary, Division of Rheumatology, at the University of Calgary. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles AM, 2013, AM J MED, V126, P342, DOI 10.1016/j.amjmed.2012.09.014; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Bellando-Randone S, 2012, POL ARCH MED WEWN, V122, P18, DOI 10.20452/pamw.1487; Bonaguri C, 2011, AUTOIMMUN REV, V11, P1, DOI 10.1016/j.autrev.2011.06.006; Bonaguri C, 2009, ANN NY ACAD SCI, V1173, P124, DOI 10.1111/j.1749-6632.2009.04635.x; Bossuyt X, 2008, ANN RHEUM DIS, V67, P1061, DOI 10.1136/ard.2007.084228; CONRAD K, 2007, ETIOPATHOGENESIS PRE, P16; Emery P, 2002, ANN RHEUM DIS, V61, P290, DOI 10.1136/ard.61.4.290; Esdaile JM, 1996, J RHEUMATOL, V23, P1891; Fritzler M.J., 2011, PREDICTION PREVENTIO, P584; Fritzler MJ, 2012, AUTOIMMUN HIGHLIGHTS, V3, P51, DOI 10.1007/s13317-012-0030-7; Fritzler MJ, 2011, ARTHRITIS RHEUM-US, V63, P19, DOI 10.1002/art.30078; Funovits J, 2010, ANN RHEUM DIS, V69, P1589, DOI 10.1136/ard.2010.130310; Gamez-Nava JI, 1998, BRIT J RHEUMATOL, V37, P1215; Gormley GJ, 2003, RHEUMATOLOGY, V42, P763, DOI 10.1093/rheumatology/keg213; Gran JT, 2000, CLIN RHEUMATOL, V19, P450, DOI 10.1007/s100670070004; Heinlen LD, 2007, ARTHRITIS RHEUM, V56, P2344, DOI 10.1002/art.22665; Johnson SR, 2012, ARTHRIT CARE RES, V64, P358, DOI 10.1002/acr.20684; JUBY A, 1991, J RHEUMATOL, V18, P354; Kavanaugh AF, 2002, ARTHRIT RHEUM-ARTHR, V47, P546, DOI 10.1002/art.10558; Lard LR, 2001, AM J MED, V111, P446, DOI 10.1016/S0002-9343(01)00872-5; Lateef A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3919; Lyons PA, 2012, NEW ENGL J MED, V367, P214, DOI 10.1056/NEJMoa1108735; Lyons R, 2005, ANN NY ACAD SCI, V1050, P217, DOI 10.1196/annals.1313.023; Mahler M, 2012, J RHEUMATOL, V39, P2104, DOI 10.3899/jrheum.120598; Mahler M, 2012, AUTOIMMUN REV, V11, P642, DOI 10.1016/j.autrev.2011.11.005; Mahler M, 2010, ANN NY ACAD SCI, V1183, P267, DOI 10.1111/j.1749-6632.2009.05127.x; Man A, 2013, CLIN RHEUMATOL, V32, P601, DOI 10.1007/s10067-012-2141-y; Mariz HA, 2011, ARTHRITIS RHEUM-US, V63, P191, DOI 10.1002/art.30084; Meacock R, 2013, PHARMACOECONOMICS, V31, P49, DOI 10.1007/s40273-012-0007-4; Miyara M, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/703759; Muro Y, 2008, LUPUS, V17, P171, DOI 10.1177/0961203307086311; Narain S, 2004, ARCH INTERN MED, V164, P2435, DOI 10.1001/archinte.164.22.2435; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; Qian JY, 2010, RHEUMATOL INT, V30, P705, DOI 10.1007/s00296-009-1297-5; SHIEL WC, 1989, J RHEUMATOL, V16, P782; Shoenfeld Y, 2007, ANN NY ACAD SCI, V1109, P138, DOI 10.1196/annals.1398.016; Shojania K, 2000, CAN MED ASSOC J, V162, P1157; Solomon DH, 2002, ARTHRIT RHEUM-ARTHR, V47, P434, DOI 10.1002/art.10561; Stinton LM, 2007, LUPUS, V16, P394, DOI 10.1177/0961203307078391; Stinton LM, 2007, AUTOIMMUN REV, V7, P77, DOI 10.1016/j.autrev.2007.08.003; Suarez-Almazor ME, 1998, J RHEUMATOL, V25, P1980; Tampoia M, 2003, CLIN CHIM ACTA, V333, P181, DOI 10.1016/S0009-8981(03)00183-9; Tan EM, 1997, ARTHRITIS RHEUM-US, V40, P1601, DOI 10.1002/art.1780400909; Trouw LA, 2012, AUTOIMMUN REV, V12, P318, DOI 10.1016/j.autrev.2012.05.007; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098; Vlachoyiannopoulos PG, 1998, J RHEUMATOL, V25, P886; VONMUHLEN CA, 1995, SEMIN ARTHRITIS RHEU, V24, P323, DOI 10.1016/S0049-0172(95)80004-2; Watanabe A, 2004, ARTHRITIS RHEUM-US, V50, P892, DOI 10.1002/art.20096; Wiik AS, 2012, AUTOIMMUN HIGHLIGHTS, V3, P35, DOI 10.1007/s13317-012-0029-0; Wiik AS, 2005, SCAND J RHEUMATOL, V34, P260, DOI 10.1080/03009740500202664; Wiik AS, 2004, ARTHRIT RHEUM-ARTHR, V51, P291, DOI 10.1002/art.20229; Wiles NJ, 2001, ARTHRITIS RHEUM-US, V44, P1033, DOI 10.1002/1529-0131(200105)44:5<1033::AID-ANR182>3.3.CO;2-7; Yang P, 2012, CURR OPIN OPHTHALMOL, V23, P528, DOI 10.1097/ICU.0b013e328358b937; Yazdany J, 2013, ARTHRIT CARE RES, V65, P329, DOI 10.1002/acr.21930	55	54	57	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93812	10.1371/journal.pone.0093812	http://dx.doi.org/10.1371/journal.pone.0093812			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705829	Green Submitted, Green Published, gold			2022-12-25	WOS:000334107500068
J	Colinas, M; Shaw, HV; Loubery, S; Kaufmann, M; Moulin, M; Fitzpatrick, TB				Colinas, Maite; Shaw, Holly V.; Loubery, Sylvain; Kaufmann, Markus; Moulin, Michael; Fitzpatrick, Teresa B.			A Pathway for Repair of NAD(P) H in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRIDOXINE 5'-PHOSPHATE OXIDASE; L-2-HYDROXYGLUTARIC ACIDURIA; CRYSTAL-STRUCTURE; ARABIDOPSIS; PROTEIN; IDENTIFICATION; EXPRESSION; NADH; LOCALIZATION; MECHANISM	Unwanted enzyme side reactions and spontaneous decomposition of metabolites can lead to a build-up of compounds that compete with natural enzyme substrates and must be dealt with for efficient metabolism. It has recently been realized that there are enzymes that process such compounds, formulating the concept of metabolite repair. NADH and NADPH are vital cellular redox cofactors but can form non-functional hydrates (named NAD(P) HX) spontaneously or enzymatically that compete with enzymes dependent on NAD(P) H, impairing normal enzyme function. Here we report on the functional characterization of components of a potential NAD(P) H repair pathway in plants comprising a stereospecific dehydratase (NNRD) and an epimerase (NNRE), the latter being fused to a vitamin B-6 salvage enzyme. Through the use of the recombinant proteins, we show that the ATP-dependent NNRD and NNRE act concomitantly to restore NAD(P) HX to NAD(P) H. NNRD behaves as a tetramer and NNRE as a dimer, but the proteins do not physically interact. In vivo fluorescence analysis demonstrates that the proteins are localized to mitochondria and/or plastids, implicating these as the key organelles where this repair is required. Expression analysis indicates that whereas NNRE is present ubiquitously, NNRD is restricted to seeds but appears to be dispensable during the normal Arabidopsis life cycle.	[Colinas, Maite; Shaw, Holly V.; Loubery, Sylvain; Kaufmann, Markus; Moulin, Michael; Fitzpatrick, Teresa B.] Univ Geneva, Dept Bot & Plant Biol, CH-1211 Geneva, Switzerland	University of Geneva	Fitzpatrick, TB (corresponding author), Univ Geneva, Dept Bot & Plant Biol, CH-1211 Geneva, Switzerland.	theresa.fitzpatrick@unige.ch	Frikha, Fakher/AFM-9007-2022	Frikha, Fakher/0000-0003-3261-7884; Colinas, Maite/0000-0001-7053-2983; Loubery, Sylvain/0000-0001-7061-9456	Swiss National Science Foundation [PPOOA_1191186, 31003A-141117/1]; University of Geneva; Ernest Boninchi Foundation; Ernst and Lucie Schmidheiny Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Geneva; Ernest Boninchi Foundation; Ernst and Lucie Schmidheiny Foundation	This work was supported by Swiss National Science Foundation Grants PPOOA_1191186 and 31003A-141117/1 (to T. B. F.) as well as the University of Geneva. This work was also supported by the Ernest Boninchi Foundation and the Ernst and Lucie Schmidheiny Foundation.	ACHESON SA, 1988, BIOCHEMISTRY-US, V27, P7371, DOI 10.1021/bi00419a030; Adler LN, 2011, J BIOL CHEM, V286, P21511, DOI 10.1074/jbc.M111.238774; Biswal BK, 2005, ACTA CRYSTALLOGR D, V61, P1492, DOI 10.1107/S0907444905026673; Bocobza SE, 2008, TRENDS PLANT SCI, V13, P526, DOI 10.1016/j.tplants.2008.07.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canto C, 2013, MOL ASPECTS MED, V34, P1168, DOI 10.1016/j.mam.2013.01.004; CHAYKIN S, 1956, J BIOL CHEM, V220, P811; Cheng G, 2002, STRUCTURE, V10, P225, DOI 10.1016/S0969-2126(02)00708-6; CHURCHICH JE, 1984, EUR J BIOCHEM, V138, P327, DOI 10.1111/j.1432-1033.1984.tb07918.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dekkers BJW, 2012, PLANT CELL PHYSIOL, V53, P28, DOI 10.1093/pcp/pcr113; Di Salvo M, 1998, PROTEIN EXPRES PURIF, V13, P349, DOI 10.1006/prep.1998.0904; di Salvo M. L., 2010, BIOCHIM BIOPHYS ACTA, V1814, P1597; di Salvo ML, 2003, BBA-PROTEINS PROTEOM, V1647, P76, DOI 10.1016/S1570-9639(03)00060-8; di Salvo ML, 2002, J MOL BIOL, V315, P385, DOI 10.1006/jmbi.2001.5254; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Finkemeier I, 2011, PLANT PHYSIOL, V155, P1779, DOI 10.1104/pp.110.171595; Gonzalez E, 2007, PLANT PHYSIOL, V145, P985, DOI 10.1104/pp.107.105189; Grefen C, 2010, PLANT J, V64, P355, DOI 10.1111/j.1365-313X.2010.04322.x; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Jha KN, 2008, ENDOCRINOLOGY, V149, P2108, DOI 10.1210/en.2007-0582; Jin JB, 2001, PLANT CELL, V13, P1511, DOI 10.1105/tpc.13.7.1511; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kleinboelting N, 2012, NUCLEIC ACIDS RES, V40, pD1211, DOI 10.1093/nar/gkr1047; Ling SHM, 2008, MOL CELL BIOL, V28, P5965, DOI 10.1128/MCB.00761-08; Linster CL, 2013, NAT CHEM BIOL, V9, P72, DOI [10.1038/NCHEMBIO.1141, 10.1038/nchembio.1141]; Marbaix AY, 2011, J BIOL CHEM, V286, P41246, DOI 10.1074/jbc.C111.310847; MEINHART JO, 1956, J BIOL CHEM, V220, P821; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Musayev FN, 2003, PROTEIN SCI, V12, P1455, DOI 10.1110/ps.0356203; Niehaus T. D., 2014, PLANT PHYSL IN PRESS; Pollak N, 2007, BIOCHEM J, V402, P205, DOI 10.1042/BJ20061638; Prabhakar P, 1998, ARCH BIOCHEM BIOPHYS, V360, P195, DOI 10.1006/abbi.1998.0939; RAFTER GW, 1954, J BIOL CHEM, V208, P799; Rzem R, 2007, J INHERIT METAB DIS, V30, P681, DOI 10.1007/s10545-007-0487-0; Safo MK, 2000, STRUCTURE, V8, P751, DOI 10.1016/S0969-2126(00)00162-3; Sang YY, 2007, FEBS LETT, V581, P344, DOI 10.1016/j.febslet.2006.12.028; Sang YY, 2011, PLANT PHYSIOL BIOCH, V49, P88, DOI 10.1016/j.plaphy.2010.10.003; Shumilin IA, 2012, STRUCTURE, V20, P1715, DOI 10.1016/j.str.2012.07.016; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Szydlowski N, 2013, PLANT J, V75, P40, DOI 10.1111/tpj.12195; Van Schaftingen E, 2009, J INHERIT METAB DIS, V32, P135, DOI 10.1007/s10545-008-1042-3; Van Schaftingen E, 2013, J INHERIT METAB DIS, V36, P427, DOI 10.1007/s10545-012-9571-1; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672; YOSHIDA A, 1975, ARCH BIOCHEM BIOPHYS, V169, P298, DOI 10.1016/0003-9861(75)90344-6; Zhang RG, 2002, J STRUCT BIOL, V139, P161, DOI 10.1016/S1047-8477(02)00532-4	47	18	18	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14692	14706		10.1074/jbc.M114.556092	http://dx.doi.org/10.1074/jbc.M114.556092			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24706747	Green Published, hybrid			2022-12-25	WOS:000337248100026
J	Henriksen, DP; Brabrand, M; Lassen, AT				Henriksen, Daniel Pilsgaard; Brabrand, Mikkel; Lassen, Annmarie Touborg			Prognosis and Risk Factors for Deterioration in Patients Admitted to a Medical Emergency Department	PLOS ONE			English	Article							IN-HOSPITAL MORTALITY; VITAL SIGNS; ADMISSION; CARE; ASSOCIATION; COHORT; SCORE; WARD	Objective: Patients that initially appear stable on arrival to the hospital often have less intensive monitoring of their vital signs, possibly leading to excess mortality. The aim was to describe risk factors for deterioration in vital signs and the related prognosis among patients with normal vital signs at arrival to a medical emergency department (MED). Design and setting: Single-centre, retrospective cohort study of all patients admitted to the MED from September 2010-August 2011. Subjects: Patients were included when their vital signs (systolic blood pressure, pulse rate, respiratory rate, Glasgow Coma Scale, oxygen saturation and temperature) were within the normal range at arrival. Deterioration was defined as a deviation from the defined normal range 2-24 hours after arrival. Results: 4292 of the 6257 (68.6%) admitted to the MED had a full set of vital signs at first presentation, 1440/4292 (33.6%) had all normal vital signs and were included in study, 44.0% were male, median age 64 years (5th/95th percentile: 21-90 years) and 446/1440 (31.0%) deteriorated within 24 hours. Independent risk factors for deterioration included age 65-84 years odds ratio (OR): 1.79 (95% confidence interval [CI]: 1.27-2.52), 85+ years OR 1.67 (95% CI: 1.10-2.55), Do-not-attempt-to-resuscitate order OR 3.76 (95% CI: 1.37-10.31) and admission from the open general ED OR 1.35 (95% CI: 1.07-1.71). Thirty-day mortality was 7.9% (95% CI: 5.5-10.7%) among deteriorating patients and 1.9% (95% CI: 1.2-3.0%) among the non-deteriorating, hazard ratio 4.11 (95% CI: 2.38-7.10). Conclusions: Among acutely admitted medical patients who arrive with normal vital signs, 31.0% showed signs of deterioration within 24 hours. Risk factors included old age, Do-not-attempt-to-resuscitate order, admission from the open general ED. Thirty-day mortality among patients with deterioration was four times higher than among non-deteriorating patients. Further research is needed to determine whether intensified monitoring of vital signs can help to prevent deterioration or mortality among medical emergency patients.	[Henriksen, Daniel Pilsgaard; Lassen, Annmarie Touborg] Odense Univ Hosp, Dept Emergency Med, DK-5000 Odense, Denmark; [Brabrand, Mikkel] Sydvestjysk Sygehus, Dept Med, Esbjerg, Denmark	University of Southern Denmark; Odense University Hospital	Henriksen, DP (corresponding author), Odense Univ Hosp, Dept Emergency Med, DK-5000 Odense, Denmark.	dphenriksen@health.sdu.dk	Lassen, Annmarie/AAA-5816-2019; Brabrand, Mikkel/F-7276-2011	Brabrand, Mikkel/0000-0002-3340-8251; Henriksen, Daniel Pilsgaard/0000-0003-1303-6195; Lassen, Annmarie/0000-0003-4942-6152	University of Southern Denmark; Research Foundation of Odense University Hospital; philanthropically private fund TrygFonden given; philanthropically private fund	University of Southern Denmark; Research Foundation of Odense University Hospital; philanthropically private fund TrygFonden given; philanthropically private fund	DPH was supported by: University of Southern Denmark, The Research Foundation of Odense University Hospital, as well as an unrestricted grant from the philanthropically private fund TrygFonden given to the University of Southern Denmark. ATL was supported by an unrestricted grant from the philanthropically private fund TrygFonden given to University of Southern Denmark, and is employed as a consultant at the Department of Emergency Medicine, Odense University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong B, 2008, EMERG MED J, V25, P799, DOI 10.1136/emj.2007.052951; Barfod C, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-29; Barfod C, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-28; Bleyer AJ, 2011, RESUSCITATION, V82, P1387, DOI 10.1016/j.resuscitation.2011.06.033; Buist M, 2004, RESUSCITATION, V62, P137, DOI 10.1016/j.resuscitation.2004.03.005; Centre for Clinical Practice at NICE (UK), 2007, NICE CLIN GUIDEL, V50, P1; Farley H, 2010, ACAD EMERG MED, V17, P718, DOI 10.1111/j.1553-2712.2010.00796.x; Fuhrmann L, 2008, RESUSCITATION, V77, P325, DOI 10.1016/j.resuscitation.2008.01.009; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Goldhill DR, 1999, ANAESTHESIA, V54, P853; Guttmann A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2983; Hallas J, 2001, PHARMACOEPIDEM DR S, V10, P619, DOI 10.1002/pds.638; Hands C, 2013, BMJ QUAL SAF, V22, P719, DOI 10.1136/bmjqs-2013-001954; Hogan H, 2012, BMJ QUAL SAF, V21, P737, DOI 10.1136/bmjqs-2011-001159; Jones D, 2013, RESUSCITATION, V84, P1029, DOI 10.1016/j.resuscitation.2013.01.013; Kellett J, 2011, EUR J INTERN MED, V22, P375, DOI 10.1016/j.ejim.2011.03.005; Kennedy M, 2010, ACAD EMERG MED, V17, P1080, DOI 10.1111/j.1553-2712.2010.00872.x; Lighthall GK, 2009, RESUSCITATION, V80, P1264, DOI 10.1016/j.resuscitation.2009.08.012; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Schmidt Morten, 2010, Clin Epidemiol, V2, P195, DOI 10.2147/CLEP.S12171; Scott I, 2009, INT J QUAL HEALTH C, V21, P397, DOI 10.1093/intqhc/mzp045; Simchen E, 2007, CRIT CARE MED, V35, P449, DOI 10.1097/01.CCM.0000253407.89594.15; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wuerz R, 2001, ACAD EMERG MED, V8, P61	27	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94649	10.1371/journal.pone.0094649	http://dx.doi.org/10.1371/journal.pone.0094649			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718637	gold, Green Published, Green Submitted			2022-12-25	WOS:000334339000136
J	Leiguez, E; Giannotti, KC; Moreira, V; Matsubara, MH; Gutierrez, JM; Lomonte, B; Rodriguez, JP; Balsinde, J; Teixeira, C				Leiguez, Elbio; Giannotti, Karina Cristina; Moreira, Vanessa; Matsubara, Marcio Hideki; Maria Gutierrez, Jose; Lomonte, Bruno; Pablo Rodriguez, Juan; Balsinde, Jesus; Teixeira, Catarina			Critical Role of TLR2 and MyD88 for Functional Response of Macrophages to a Group IIA-Secreted Phospholipase A(2) from Snake Venom	PLOS ONE			English	Article							LIPID BODY FORMATION; SATURATED FATTY-ACIDS; TOLL-LIKE RECEPTOR-4; BOTHROPS-ASPER; HUMAN MONOCYTES; MYOTOXIC PHOSPHOLIPASES; SIGNALING PATHWAYS; INSULIN-RESISTANCE; INNATE IMMUNITY; IN-VIVO	The snake venom MT-III is a group IIA secreted phospholipase A(2) (sPLA(2)) enzyme with functional and structural similarities with mammalian pro-inflammatory sPLA(2)s of the same group. Previously, we demonstrated that MT-III directly activates the innate inflammatory response of macrophages, including release of inflammatory mediators and formation of lipid droplets (LDs). However, the mechanisms coordinating these processes remain unclear. In the present study, by using TLR2(-/-) or MyD88(-/-) or C57BL/6 (WT) male mice, we report that TLR2 and MyD88 signaling have a critical role in MT-III-induced inflammatory response in macrophages. MT-III caused a marked release of PGE(2), PGD(2), PGJ(2), IL-1 beta and IL-10 and increased the number of LDs in WT macrophages. In MT-III-stimulated TLR2(-/-) macrophages, formation of LDs and release of eicosanoids and cytokines were abrogated. In MyD88(-/-) macrophages, MT-III-induced release of PGE(2), IL-1 beta and IL-10 was abrogated, but release of PGD(2) and PGJ(2) was maintained. In addition, COX-2 protein expression seen in MT-III-stimulated WT macrophages was abolished in both TLR2(-/-) and MyD88(-/-) cells, while perilipin 2 expression was abolished only in MyD88 2/2 cells. We further demonstrated a reduction of saturated, monounsaturated and polyunsaturated fatty acids and a release of the TLR2 agonists palmitic and oleic acid from MT-III-stimulated WT macrophages compared with WT control cells, thus suggesting these fatty acids as major messengers for MT-III-induced engagement of TLR2/MyD88 signaling. Collectively, our findings identify for the first time a TLR2 and MyD88-dependent mechanism that underlies group IIA sPLA(2)-induced inflammatory response in macrophages.	[Leiguez, Elbio; Giannotti, Karina Cristina; Moreira, Vanessa; Matsubara, Marcio Hideki; Teixeira, Catarina] Inst Butantan, Farmacol Lab, Sao Paulo, Brazil; [Maria Gutierrez, Jose; Lomonte, Bruno] Univ Costa Rica, Fac Microbiol, Inst Clodomiro Picado, San Jose, Costa Rica; [Pablo Rodriguez, Juan] Univ Nacl Nordeste, FACENA, Lab Invest Prot, Corrientes, Argentina; [Pablo Rodriguez, Juan; Balsinde, Jesus] Inst Biol & Genet Mol, Eicosanoid Res Div, Valladolid, Spain	Instituto Butantan; Universidad Costa Rica; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UVA - Instituto de Biologia y Genetica Molecular (IBGM)	Teixeira, C (corresponding author), Inst Butantan, Farmacol Lab, Sao Paulo, Brazil.	cteixeir@usp.br	moreira, vanessa/GQO-7744-2022; Balsinde, Jesús/C-7833-2018; Lomonte, Bruno/B-8862-2019; Teixeira, Catarina/AAT-6243-2020; Gutiérrez, José/GSJ-1846-2022; Leiguez, Elbio/B-3899-2018; Leiguez, Elbio/P-7248-2014; Giannotti, Karina Cristina/L-5215-2013; Giannotti, Karina Cristina/B-3878-2018; Teixeira, Catarina/C-6124-2013; Moreira, Vanessa/D-6190-2012	Balsinde, Jesús/0000-0002-4157-6714; Lomonte, Bruno/0000-0003-2419-6469; Teixeira, Catarina/0000-0001-5887-7663; Leiguez, Elbio/0000-0001-6677-2060; Giannotti, Karina Cristina/0000-0001-5165-8716; Moreira, Vanessa/0000-0001-5579-3069; Rodriguez, Juan Pablo/0000-0002-8713-7178; Gutierrez, Jose Maria/0000-0001-8385-3081	FAPESP, Sao Paulo, Brazil [11/21341-5, 10/06345-1]; INCTTOX, Sao Paulo, Brazil [573790/2008-6]; CNPq PQ, Brazil [306920/2011-5]; Spanish Ministery of Science and Innovation, Spain [BFU2010-18826]	FAPESP, Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); INCTTOX, Sao Paulo, Brazil; CNPq PQ, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Spanish Ministery of Science and Innovation, Spain	This investigation was supported by research grants from FAPESP, Sao Paulo, Brazil (www.fapesp.br), grants 11/21341-5 and 10/06345-1, INCTTOX, Sao Paulo, Brazil (www.incttox.com.br), grant 573790/2008-6, CNPq PQ, Brazil (www.cnpq.br), grant 306920/2011-5, Brazil, Spanish Ministery of Science and Innovation, Spain (http://web.micinn.es/), grant BFU2010-18826. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Astudillo AM, 2011, BBA-MOL CELL BIOL L, V1811, P97, DOI 10.1016/j.bbalip.2010.11.009; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Bryant KJ, 2011, J BIOL CHEM, V286, P2492, DOI 10.1074/jbc.M110.123927; Calvete JJ, 2011, ACTA CHIM SLOV, V58, P629; Carneiro AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076233; Casanova JL, 2011, ANNU REV IMMUNOL, V29, P447, DOI 10.1146/annurev-immunol-030409-101335; Chaves F, 1998, TOXICON, V36, P1861, DOI 10.1016/S0041-0101(98)00107-X; Chavez-Sanchez L, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-117; Choudhury RP, 2005, NAT CLIN PRACT CARD, V2, P309, DOI 10.1038/ncpcardio0195; Cole JE, 2010, EXPERT REV CARDIOVAS, V8, P1619, DOI 10.1586/ERC.10.149; Corsini E, 2002, TOXICOL IN VITRO, V16, P427, DOI 10.1016/S0887-2333(02)00023-1; D'Avila H, 2006, J IMMUNOL, V176, P3087, DOI 10.4049/jimmunol.176.5.3087; DiazOreiro C, 1997, TOXICON, V35, P241, DOI 10.1016/S0041-0101(96)00128-6; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Feingold KR, 2010, ATHEROSCLEROSIS, V209, P81, DOI 10.1016/j.atherosclerosis.2009.08.042; Frasch SC, 2012, PROG LIPID RES, V51, P199, DOI 10.1016/j.plipres.2012.03.001; Ghesquiere SAI, 2005, J LIPID RES, V46, P201, DOI 10.1194/jlr.M400253-JLR200; Granata F, 2005, J IMMUNOL, V174, P464, DOI 10.4049/jimmunol.174.1.464; Guijas C, 2012, J LIPID RES, V53, P2343, DOI 10.1194/jlr.M028423; GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z; Han Xinbing, 2012, ROLE IL 10 ATHEROSCL; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Heid HW, 1998, CELL TISSUE RES, V294, P309, DOI 10.1007/s004410051181; Heusinkveld M, 2011, J IMMUNOL, V187, P1157, DOI 10.4049/jimmunol.1100889; Hirata T, 2012, ADV IMMUNOL, V116, P143, DOI 10.1016/B978-0-12-394300-2.00005-3; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Iwata H, 2012, CURR ATHEROSCLER REP, V14, P484, DOI 10.1007/s11883-012-0267-7; KAISER II, 1990, ARCH BIOCHEM BIOPHYS, V278, P319, DOI 10.1016/0003-9861(90)90266-2; Karabina SA, 2010, BIOCHIMIE, V92, P594, DOI 10.1016/j.biochi.2010.02.002; Kikawada E, 2007, BLOOD, V110, P561, DOI 10.1182/blood-2006-10-052258; Kini R. M., 1997, VENOM PHOSPHOLIPASE, P1; Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671; Larigauderie G, 2004, ARTERIOSCL THROM VAS, V24, P504, DOI 10.1161/01.ATV.0000115638.27381.97; Lee JY, 2004, J BIOL CHEM, V279, P16971, DOI 10.1074/jbc.M312990200; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Leiguez E, 2011, J LEUKOCYTE BIOL, V90, P155, DOI 10.1189/jlb.0510263; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Liu YF, 2008, MED HYPOTHESES, V70, P314, DOI 10.1016/j.mehy.2007.05.030; Loures FV, 2011, INFECT IMMUN, V79, P2470, DOI 10.1128/IAI.00375-10; MacKenzie KF, 2013, J IMMUNOL, V190, P565, DOI 10.4049/jimmunol.1202462; Magalhaes KG, 2010, J INFECT DIS, V202, P1369, DOI 10.1086/656477; McGettrick AF, 2007, BRIT J HAEMATOL, V139, P185, DOI 10.1111/j.1365-2141.2007.06802.x; Moreira V, 2008, TOXICON, V52, P428, DOI 10.1016/j.toxicon.2008.06.012; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nicolaou G, 2010, CURR OPIN LIPIDOL, V21, P427, DOI 10.1097/MOL.0b013e32833cacd5; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Okamura Y, 2001, J BIOL CHEM, V276, P10229, DOI 10.1074/jbc.M100099200; Pacheco P, 2002, J IMMUNOL, V169, P6498, DOI 10.4049/jimmunol.169.11.6498; Persson J, 2007, BIOCHEM BIOPH RES CO, V363, P1020, DOI 10.1016/j.bbrc.2007.09.074; Robenek H, 2005, J LIPID RES, V46, P1331, DOI 10.1194/jlr.M400323-JLR200; Sarov-Blat L, 2007, ARTERIOSCL THROM VAS, V27, P1115, DOI 10.1161/ATVBAHA.106.138990; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shridas P, 2011, J IMMUNOL, V187, P482, DOI 10.4049/jimmunol.1003552; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Song MJ, 2006, BIOCHEM BIOPH RES CO, V346, P739, DOI 10.1016/j.bbrc.2006.05.170; Surh YJ, 2011, BIOCHEM PHARMACOL, V82, P1335, DOI 10.1016/j.bcp.2011.07.100; TAKAYAMA K, 1994, J BIOL CHEM, V269, P2241; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Teixeira C, 2009, TOXICON, V54, P988, DOI 10.1016/j.toxicon.2009.05.026; Triggiani M, 2005, J ALLERGY CLIN IMMUN, V116, P1000, DOI 10.1016/j.jaci.2005.08.011; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Wang J, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-139; Yedgar S, 2006, BBA-MOL CELL BIOL L, V1761, P1373, DOI 10.1016/j.bbalip.2006.08.003; Yu L, 2012, CELL MOL LIFE SCI, V69, P935, DOI 10.1007/s00018-011-0864-6; Zuliani JP, 2005, TOXICON, V46, P523, DOI 10.1016/j.toxicon.2005.06.017; Zuliani JP, 2005, TOXICON, V45, P335, DOI 10.1016/j.toxicon.2004.11.004	74	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93741	10.1371/journal.pone.0093741	http://dx.doi.org/10.1371/journal.pone.0093741			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718259	Green Published, Green Submitted, gold			2022-12-25	WOS:000334339000045
J	Schreier, VN; Petho, L; Orban, E; Marquardt, A; Petre, BA; Mezo, G; Manea, M				Schreier, Verena Natalie; Petho, Lilla; Orban, Erika; Marquardt, Andreas; Petre, Brindusa Alina; Mezo, Gabor; Manea, Marilena			Protein Expression Profile of HT-29 Human Colon Cancer Cells after Treatment with a Cytotoxic Daunorubicin-GnRH-III Derivative Bioconjugate	PLOS ONE			English	Article							DISULFIDE-ISOMERASE EXPRESSION; HORMONE-RELEASING HORMONE; ACID-BINDING PROTEIN; HEAT-SHOCK PROTEINS; DOWN-REGULATION; DRUG; RECEPTORS; HSP70; ADENOCARCINOMA; CHEMOTHERAPY	Targeted delivery of chemotherapeutic agents is a new approach for the treatment of cancer, which provides increased selectivity and decreased systemic toxicity. We have recently developed a promising drug delivery system, in which the anticancer drug daunorubicin (Dau) was attached via oxime bond to a gonadotropin-releasing hormone-III (GnRH-III) derivative used as a targeting moiety (Glp-His-Trp-Lys(Ac)-His-Asp-Trp-Lys(Dau = Aoa)-Pro-Gly-NH2; Glp = pyroglutamic acid, Ac = acetyl; Aoa = aminooxyacetyl). This bioconjugate exerted in vitro cytostatic/cytotoxic effect on human breast, prostate and colon cancer cells, as well as significant in vivo tumor growth inhibitory effect on colon carcinoma bearing mice. In our previous studies, H-Lys(Dau = Aoa)-OH was identified as the smallest metabolite produced in the presence of rat liver lysosomal homogenate, which was able to bind to DNA in vitro. To get a deeper insight into the mechanism of action of the bioconjugate, changes in the protein expression profile of HT-29 human colon cancer cells after treatment with the bioconjugate or free daunorubicin were investigated by mass spectrometry-based proteomics. Our results indicate that several metabolism-related proteins, molecular chaperons and proteins involved in signaling are differently expressed after targeted chemotherapeutic treatment, leading to the conclusion that the bioconjugate exerts its cytotoxic action by interfering with multiple intracellular processes.	[Schreier, Verena Natalie; Petho, Lilla; Manea, Marilena] Univ Konstanz, Dept Chem, Constance, Germany; [Petho, Lilla; Orban, Erika; Mezo, Gabor] MTA ELTE Res Grp Peptide Chem, Budapest, Hungary; [Marquardt, Andreas] Univ Konstanz, Prote Facil, Constance, Germany; [Petre, Brindusa Alina] Alexandru Ioan Cuza Univ, Fac Chem, Iasi, Romania; [Manea, Marilena] Univ Konstanz, Zukunftskolleg, Constance, Germany	University of Konstanz; University of Konstanz; Alexandru Ioan Cuza University; University of Konstanz	Manea, M (corresponding author), Univ Konstanz, Dept Chem, Constance, Germany.	marilena.manea@uni-konstanz.de	Petho, Lilla/I-7502-2018; Petre, Brindusa/S-8307-2016	Petho, Lilla/0000-0002-0298-3341; 	University of Konstanz (Zukunftskolleg) [879/08]; University of Konstanz (Young Scholar Fund) [462/12]; Hungarian National Science Fund [OTKA NK 77485, K 104045]; Romanian National Authority for Scientific Research, CNCS-UEFISCDI [PN-II-RU-TE-2011-3-0038]	University of Konstanz (Zukunftskolleg); University of Konstanz (Young Scholar Fund); Hungarian National Science Fund; Romanian National Authority for Scientific Research, CNCS-UEFISCDI	This work was supported by grants from the University of Konstanz (Zukunftskolleg, Project 879/08 and Young Scholar Fund, Project 462/12), the Hungarian National Science Fund (OTKA NK 77485 and K 104045) and by Romanian National Authority for Scientific Research, CNCS-UEFISCDI (PN-II-RU-TE-2011-3-0038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ataman-Onal Y, 2011, Patent No. [US20110104701 A1, 20110104701A1]; Balaburski GM, 2013, MOL CANCER RES, V11, P219, DOI 10.1158/1541-7786.MCR-12-0547-T; Berns H, 2000, FASEB J, V14, P2549, DOI 10.1096/fj.99-1038com; Cao XR, 2010, DISCRETE EVENT DYN S, V20, P1, DOI 10.1007/s10626-010-0088-1; Didelot C, 2007, CURR MED CHEM, V14, P2839, DOI 10.2174/092986707782360079; Egger S, 2010, BIOCHEM SOC T, V38, P1378, DOI 10.1042/BST0381378; Engel J, 2012, EXPERT OPIN INV DRUG, V21, P891, DOI 10.1517/13543784.2012.685128; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Goloudina AR, 2012, CANCER LETT, V325, P117, DOI 10.1016/j.canlet.2012.06.003; Goplen D, 2006, CANCER RES, V66, P9895, DOI 10.1158/0008-5472.CAN-05-4589; Grivicich I, 2007, INT J COLORECTAL DIS, V22, P1201, DOI 10.1007/s00384-007-0307-x; Junqin L, 2012, J BIOSCI MED, V2, P1; Kovacs M, 2002, J NEUROENDOCRINOL, V14, P647, DOI 10.1046/j.1365-2826.2002.00828.x; Li ZY, 2008, INT J CANCER, V123, P2377, DOI 10.1002/ijc.23808; Limonta P, 2012, ENDOCR REV, V33, P784, DOI 10.1210/er.2012-1014; Lovas S, 1998, J PEPT RES, V52, P384; Majumdar S, 2012, MED RES REV, V32, P637, DOI 10.1002/med.20225; Manea M, 2013, PROTEIN PEPTIDE LETT, V20, P439, DOI 10.2174/092986613805290381; Manea M, 2012, ANTI-CANCER DRUG, V23, P90, DOI 10.1097/CAD.0b013e32834bb6b4; Manea M, 2011, BIOCONJUGATE CHEM, V22, P1320, DOI 10.1021/bc100547p; Mezo G, 2010, EXPERT OPIN DRUG DEL, V7, P79, DOI 10.1517/17425240903418410; Musch MW, 2001, CELL GROWTH DIFFER, V12, P419; Nagai Masahiro, 2012, Biomol Concepts, V3, P307, DOI 10.1515/bmc-2011-0068; Nagy A, 2005, CURR PHARM DESIGN, V11, P1167, DOI 10.2174/1381612053507594; Orban E, 2011, BIOCONJUGATE CHEM, V22, P2154, DOI 10.1021/bc2004236; Orban E, 2011, AMINO ACIDS, V41, P469, DOI 10.1007/s00726-010-0766-1; Rensen WM, 2009, ONCOGENE, V28, P1748, DOI 10.1038/onc.2009.24; Riddick DS, 2005, DRUG METAB DISPOS, V33, P1083, DOI 10.1124/dmd.105.004374; Ropponen K, 1998, CANCER RES, V58, P342; Sarto C, 2000, ELECTROPHORESIS, V21, P1218, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1218::AID-ELPS1218>3.3.CO;2-8; Schlage P, 2011, J CONTROL RELEASE, V156, P170, DOI 10.1016/j.jconrel.2011.08.005; Sinha P, 1999, ELECTROPHORESIS, V20, P2952, DOI 10.1002/(SICI)1522-2683(19991001)20:14<2952::AID-ELPS2952>3.0.CO;2-H; Wang TP, 2010, EXP CELL RES, V316, P2893, DOI 10.1016/j.yexcr.2010.07.017; Westphalen S, 2000, INT J ONCOL, V17, P1063; Zamanian M, 2013, PATHOL ONCOL RES, V19, P149, DOI 10.1007/s12253-012-9600-2; Zhong SY, 2011, ANTICANCER RES, V31, P1659	37	7	7	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94041	10.1371/journal.pone.0094041	http://dx.doi.org/10.1371/journal.pone.0094041			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718594	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000072
J	Ezeh, PC; Lauer, FT; MacKenzie, D; McClain, S; Liu, KJ; Hudson, LG; Gandolfi, AJ; Burchiel, SW				Ezeh, Peace C.; Lauer, Fredine T.; MacKenzie, Debra; McClain, Shea; Liu, Ke Jian; Hudson, Laurie G.; Gandolfi, A. Jay; Burchiel, Scott W.			Arsenite Selectively Inhibits Mouse Bone Marrow Lymphoid Progenitor Cell Development In Vivo and In Vitro and Suppresses Humoral Immunity In Vivo	PLOS ONE			English	Article							GENE-EXPRESSION; POLY(ADP-RIBOSE) POLYMERASE-1; CYTOKINE SECRETION; OXIDATIVE STRESS; EXPOSURE; ACID; PROLIFERATION; TOXICITY	It is known that exposure to As+3 via drinking water causes a disruption of the immune system and significantly compromises the immune response to infection. The purpose of these studies was to assess the effects of As+3 on bone marrow progenitor cell colony formation and the humoral immune response to a T-dependent antigen response (TDAR) in vivo. In a 30 day drinking water study, mice were exposed to 19, 75, or 300 ppb As+3. There was a decrease in bone marrow cell recovery, but not spleen cell recovery at 300 ppb As+3. In the bone marrow, As+3 altered neither the expression of CD34+ and CD38+ cells, markers of early hematopoietic stem cells, nor CD452-/CD105+, markers of mesenchymal stem cells. Spleen cell surface marker CD45 expression on B cells (CD19+), T cells (CD3+), T helper cells (CD4+) and cytotoxic T cells (CD8+), natural killer (NK+), and macrophages (Mac 1+) were not altered by the 30 day in vivo As+3 exposure. Functional assays of CFU-B colony formation showed significant selective suppression (p < 0.05) by 300 ppb As+3 exposure, whereas CFU-GM formation was not altered. The TDAR of the spleen cells was significantly suppressed at 75 and 300 ppb As+3. In vitro studies of the bone marrow revealed a selective suppression of CFU-B by 50 nM As+3 in the absence of apparent cytotoxicity. Monomethylarsonous acid (MMA(+3)) demonstrated a dose-dependent and selective suppression of CFU-B beginning at 5 nM (p < 0.05). MMA(+3) suppressed CFU-GM formation at 500 nM, a concentration that proved to be nonspecifically cytotoxic. As+5 did not suppress CFU-B and/or CFU-GM in vitro at concentrations up to 500 nM. Collectively, these results demonstrate that As+3 and likely its metabolite (MMA(+3)) target lymphoid progenitor cells in mouse bone marrow and mature B and T cell activity in the spleen.	[Ezeh, Peace C.; Lauer, Fredine T.; MacKenzie, Debra; McClain, Shea; Liu, Ke Jian; Hudson, Laurie G.; Burchiel, Scott W.] Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA; [Gandolfi, A. Jay] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA	University of New Mexico; University of Arizona	Burchiel, SW (corresponding author), Univ New Mexico, Coll Pharm, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA.	sburchiel@salud.unm.edu			NIH [1R01ES019968-01A1]; University of Arizona Superfund Program [ES 04940]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019968, P42ES004940, P30ES006694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103400] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Arizona Superfund Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by NIH grant 1R01ES019968-01A1. The MMA+3 was prepared in the Synthetic Core of the Southwest Environmental Health Sciences Center (ES 06694) and supplied by the University of Arizona Superfund Program (ES 04940). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2012, TOXICOL SCI, V129, P305, DOI 10.1093/toxsci/kfs202; Andrew AS, 2006, ENVIRON HEALTH PERSP, V114, P1193, DOI 10.1289/ehp.9008; Aposhian HV, 2000, CHEM RES TOXICOL, V13, P693, DOI 10.1021/tx000114o; Argos M, 2006, CANCER EPIDEM BIOMAR, V15, P1367, DOI 10.1158/1055-9965.EPI-06-0106; Argos M, 2010, LANCET, V376, P252, DOI 10.1016/S0140-6736(10)60481-3; Banerjee N, 2009, J CLIN IMMUNOL, V29, P582, DOI 10.1007/s10875-009-9304-x; Biswas R, 2008, HUM EXP TOXICOL, V27, P381, DOI 10.1177/0960327108094607; Burchiel SW, 2009, TOXICOL APPL PHARM, V241, P253, DOI 10.1016/j.taap.2009.09.019; Carsetti R, 2000, J EXP MED, V191, P5, DOI 10.1084/jem.191.1.5; Cheng HYY, 2004, ONCOGENE, V23, P3603, DOI 10.1038/sj.onc.1207466; Cooper KL, 2013, TOXICOL APPL PHARM, V269, P81, DOI 10.1016/j.taap.2013.03.008; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Drobna Z, 2009, CHEM RES TOXICOL, V22, P1713, DOI 10.1021/tx900179r; Engstrom K, 2011, ENVIRON HEALTH PERSP, V119, P182, DOI 10.1289/ehp.1002471; Engstrom KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053732; Flora SJS, 2011, FREE RADICAL BIO MED, V51, P257, DOI 10.1016/j.freeradbiomed.2011.04.008; Fujihara J, 2010, TOXICOL APPL PHARM, V243, P292, DOI 10.1016/j.taap.2009.11.020; Gamble MV, 2007, AM J CLIN NUTR, V86, P1202, DOI 10.1093/ajcn/86.4.1202; Healy SM, 1998, TOXICOL APPL PHARM, V148, P65, DOI 10.1006/taap.1997.8306; Hughes MF, 2011, TOXICOL SCI, V123, P305, DOI 10.1093/toxsci/kfr184; Irons RD, 1985, TOXICOLOGY BLOOD BON; King BS, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.393504; Kozul CD, 2008, CHEM-BIOL INTERACT, V173, P129, DOI 10.1016/j.cbi.2008.02.008; Kozul CD, 2009, ENVIRON HEALTH PERSP, V117, P1441, DOI 10.1289/ehp.0900911; Lauer FT, 2013, J TOXICOL ENV HEAL A, V76, P16, DOI 10.1080/15287394.2012.722521; Lengfelder E, 2012, LEUKEMIA, V26, P433, DOI 10.1038/leu.2011.245; Li Q, 2010, TOXICOL APPL PHARM, V245, P344, DOI 10.1016/j.taap.2010.03.020; Liu ZJ, 2006, ENVIRON HEALTH PERSP, V114, P527, DOI 10.1289/ehp.8600; Macoch M, 2013, TOXICOL APPL PHARM, V266, P204, DOI 10.1016/j.taap.2012.11.008; Mercedes M, 2007, TOXICOL APPL PHARM, V222, P381, DOI 10.1016/j.taap.2006.12.018; Morzadec C, 2012, TOXICOLOGY, V300, P46, DOI 10.1016/j.tox.2012.05.025; Morzadec C, 2012, TOXICOL APPL PHARM, V262, P217, DOI 10.1016/j.taap.2012.05.004; Nielson MG, 2010, 20105199 US GEOL SUR, P69; Qin XJ, 2012, TOXICOL SCI, V127, P120, DOI 10.1093/toxsci/kfs099; Randall TD, 1996, BLOOD, V87, P4057, DOI 10.1182/blood.V87.10.4057.bloodjournal87104057; Rocha-Amador DO, 2011, ENVIRON TOXICOL PHAR, V32, P399, DOI 10.1016/j.etap.2011.08.004; Soto-Pena GA, 2006, FASEB J, V20, P779, DOI 10.1096/fj.05-4860fje; Styblo M, 2000, ARCH TOXICOL, V74, P289, DOI 10.1007/s002040000134; Sun XG, 2013, ELECTRON J QUAL THEO, P1; Thomas DJ, 2001, TOXICOL APPL PHARM, V176, P127, DOI 10.1006/taap.2001.9258; Vernhet L, 2008, ENVIRON TOXICOL, V23, P263, DOI 10.1002/tox.20334	41	25	28	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93920	10.1371/journal.pone.0093920	http://dx.doi.org/10.1371/journal.pone.0093920			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714590	Green Published, gold, Green Submitted			2022-12-25	WOS:000334160900060
J	Giovati, L; Gallo, A; Masoero, F; Cerioli, C; Ciociola, T; Conti, S; Magliani, W; Polonelli, L				Giovati, Laura; Gallo, Antonio; Masoero, Francesco; Cerioli, Carla; Ciociola, Tecla; Conti, Stefania; Magliani, Walter; Polonelli, Luciano			Vaccination of Heifers with Anaflatoxin Improves the Reduction of Aflatoxin B-1 Carry Over in Milk of Lactating Dairy Cows	PLOS ONE			English	Article							INCLUSION; ADJUVANTS; WATER; M1	It was previously reported that injection of anaflatoxin B-1 (AnAFB(1)) conjugated to keyhole limpet hemocyanin (KLH), together with Freund's adjuvant, was effective in inducing in cows a long lasting titer of anti-aflatoxin B1 (AFB(1)) antibodies (Abs), cross-reacting with other aflatoxins, which were able to hinder, proportionally to their titer, the secretion of aflatoxin M-1 (AFM(1)) into the milk of cows continuously fed with AFB(1). According to anti-AFB(1) Ab titer, 50% of the vaccinated cows were recognized as high responder animals. In an attempt to prepare a more effective formulation for vaccination of cows, it was compared the immunogenicity, in Holstein Friesian heifers, of AnAFB(1) covalently conjugated to KLH or to recombinant diphtheria toxin (CRM197) molecules, and injected together with various adjuvants. This study demonstrated that injection of AnAFB(1) conjugated to KLH and mixed with complete (priming) and incomplete Freund's adjuvant (boosters), as in the previous schedule of immunization, was the most effective regimen for inducing Ab responses against AFB(1), although pre-calving administration could increase the effectiveness of vaccination, resulting in 100% high responder animals. After one booster dose at the beginning of the milk production cycle, anti-AFB(1) Ab titers were comparable to those recorded at the end of the immunization schedule, and proved to be effective in reducing significantly AFB(1) carry over, as AFM(1), from feed to milk. Pre-calving vaccination of dairy heifers with conjugated AnAFB(1), adjuvated with complete and incomplete Freund's adjuvant, may represent the most effective tool for preventing the public health hazard constituted by milk and cheese contaminated with aflatoxins.	[Giovati, Laura; Ciociola, Tecla; Conti, Stefania; Magliani, Walter; Polonelli, Luciano] Univ Parma, Dipartimento Sci Biomed Biotecnol & Traslaz, Unita Microbiol & Virol, I-43100 Parma, Italy; [Gallo, Antonio; Masoero, Francesco; Cerioli, Carla] Univ Cattolica Sacro Cuore, Fac Agr, Ist Sci Alimenti Nutr, Piacenza, Italy	University of Parma; Catholic University of the Sacred Heart; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR)	Magliani, W (corresponding author), Univ Parma, Dipartimento Sci Biomed Biotecnol & Traslaz, Unita Microbiol & Virol, I-43100 Parma, Italy.	walter.magliani@unipr.it	Gallo, Antonio/B-1382-2010; Ciociola, Tecla/AFN-5212-2022; Conti, Stefania/N-3558-2015; Giovati, Laura/ABH-7376-2020; Ciociola, Tecla/HCH-2453-2022	Gallo, Antonio/0000-0002-4700-4450; Ciociola, Tecla/0000-0001-6499-2545; Conti, Stefania/0000-0001-9973-8352; GIOVATI, LAURA/0000-0001-7514-1789; MASOERO, Francesco/0000-0002-0373-6051; CERIOLI, Carla/0000-0001-5598-9782	Fondazione Cassa di Risparmio di Parma e Piacenza	Fondazione Cassa di Risparmio di Parma e Piacenza	This work was supported by funds from "Fondazione Cassa di Risparmio di Parma e Piacenza'' http://www.fondazionecrp.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1986, OFFICIAL J EUROPEAN, VL358, P1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHU FS, 1977, APPL ENVIRON MICROB, V33, P1125, DOI 10.1128/AEM.33.5.1125-1128.1977; CHU FS, 1977, J ASSOC OFF ANA CHEM, V60, P791; Eaton D. L, 1994, TOXICOLOGY AFLATOXIN; El Khoury A, 2011, FOOD CONTROL, V22, P1695, DOI 10.1016/j.foodcont.2011.04.001; Food and Agriculture Organization, 2004, FAO Food and Nutrition Paper, P1; Gallo A, 2010, FOOD ADDIT CONTAM A, V27, P54, DOI 10.1080/02652030903207219; Galvano F, 1996, J FOOD PROTECT, V59, P1079, DOI 10.4315/0362-028X-59.10.1079; GIANNINI G, 1984, NUCLEIC ACIDS RES, V12, P4063, DOI 10.1093/nar/12.10.4063; GUPTA RK, 1995, VACCINE, V13, P1263, DOI 10.1016/0264-410X(95)00011-O; Hermanson GT, 2008, BIOCONJUGATE TECHNIQUES, 2ND EDITION, P1, DOI 10.1016/B978-0-12-370501-3.00001-1; Huwig A, 2001, TOXICOL LETT, V122, P179, DOI 10.1016/S0378-4274(01)00360-5; International Agency for Research on Cancer, 2012, IARC MON EV CARC RIS, V100F, P225; Jouany JP, 2007, ANIM FEED SCI TECH, V137, P342, DOI 10.1016/j.anifeedsci.2007.06.009; Kanra G, 2003, PEDIATR INT, V45, P314, DOI 10.1046/j.1442-200X.2003.01706.x; Kanungo L, 2014, FOOD AGR IMMUNOL, V25, P467, DOI 10.1080/09540105.2013.837031; Kolossova A, 2009, 23997 EUR EN; Kutz RE, 2009, J DAIRY SCI, V92, P3959, DOI 10.3168/jds.2009-2031; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; LANGONE JJ, 1975, RES COMMUN CHEM PATH, V10, P163; LEE NJ, 1995, J AGR FOOD CHEM, V43, P1730, DOI 10.1021/jf00054a060; Littell RC, 1998, J ANIM SCI, V76, P1216; Masoero F, 2009, ANIM FEED SCI TECH, V150, P34, DOI 10.1016/j.anifeedsci.2008.07.009; MCLEAN M, 1995, PHARMACOL THERAPEUT, V65, P163, DOI 10.1016/0163-7258(94)00054-7; Moschini M, 2008, ANIM FEED SCI TECH, V147, P292, DOI 10.1016/j.anifeedsci.2008.01.010; NAKAJIMA N, 1995, BIOCONJUGATE CHEM, V6, P123, DOI 10.1021/bc00031a015; PHILLIPS TD, 1988, POULTRY SCI, V67, P243, DOI 10.3382/ps.0670243; Phillips TD, 2002, ADV EXP MED BIOL, V504, P157; Pietri A., 2009, International Journal of Dairy Science, V4, P34, DOI 10.3923/ijds.2009.34.42; Piva G, 1995, NUTR RES, V5, P689; Polonelli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026777; Rahimi E, 2012, B ENVIRON CONTAM TOX, V89, P158, DOI 10.1007/s00128-012-0616-9; Riahi-Zanjani B, 2013, MYCOTOXIN RES, V29, P271, DOI 10.1007/s12550-013-0179-6; STAROS JV, 1986, ANAL BIOCHEM, V156, P220, DOI 10.1016/0003-2697(86)90176-4; VELDMAN A, 1992, ANIM PROD, V55, P163, DOI 10.1017/S0003356100037417; Williams JH, 2004, AM J CLIN NUTR, V80, P1106, DOI 10.1093/ajcn/80.5.1106; Xu QH, 2006, BIOCONJUGATE CHEM, V17, P1508, DOI 10.1021/bc060083u	38	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94440	10.1371/journal.pone.0094440	http://dx.doi.org/10.1371/journal.pone.0094440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714096	gold, Green Published, Green Submitted			2022-12-25	WOS:000334160900132
J	Ho, TH; Caughey, GE; Shakib, S				Ho, Tam H.; Caughey, Gillian E.; Shakib, Sepehr			Guideline Compliance in Chronic Heart Failure Patients with Multiple Comorbid Diseases: Evaluation of an Individualised Multidisciplinary Model of Care	PLOS ONE			English	Article							OUTCOMES; ADHERENCE; QUALITY	Objective: To assess the impact of individualised, reconciled evidence-based recommendations (IRERs) and multidisciplinary care in patients with chronic heart failure (CHF) on clinical guideline compliance for CHF and common comorbid conditions. Design and setting: A retrospective hospital clinical audit conducted between 1(st) July 2006 and February 2011. Participants: A total of 255 patients with a diagnosis of CHF who attended the Multidisciplinary Ambulatory Consulting Services (MACS) clinics, at the Royal Adelaide Hospital, were included. Main outcome measures: Compliance with Australian clinical guideline recommendations for CHF, atrial fibrillation, diabetes mellitus and ischaemic heart disease. Results: Study participants had a median of eight medical conditions (IQR 6-10) and were on an average of 10 (64) unique medications. Compliance with clinical guideline recommendations for pharmacological therapy for CHF, comorbid atrial fibrillation, diabetes or ischaemic heart disease was high, ranging from 86% for lipid lowering therapy to 98% anti-platelet agents. For all conditions, compliance with lifestyle recommendations was lower than pharmacological therapy, ranging from no podiatry reviews for CHF patients with comorbid diabetes to 75% for heart failure education. Concordance with many guideline recommendations was significantly associated if the patient had IRERs determined, a greater number of recommendations, more clinic visits or if patients participated in a heart failure program. Conclusions: Despite the high number of comorbid conditions and resulting complexity of the management, high compliance to clinical guideline recommendations was associated with IRER determination in older patients with CHF. Importantly these recommendations need to be communicated to the patient's general practitioner, regularly monitored and adjusted at clinic visits.	[Ho, Tam H.; Shakib, Sepehr] Royal Adelaide Hosp, Dept Clin Pharmacol, Adelaide, SA 5000, Australia; [Caughey, Gillian E.] Univ S Australia, Sch Pharm & Med Sci, Sansom Inst, Qual Use Med & Pharm Res Ctr, Adelaide, SA 5001, Australia	Royal Adelaide Hospital; University of South Australia	Shakib, S (corresponding author), Royal Adelaide Hosp, Dept Clin Pharmacol, Adelaide, SA 5000, Australia.	ssshakib@gmail.com		Caughey, Gillian/0000-0003-1192-4121				[Anonymous], 2008, THER GUID CARD VERS; [Anonymous], 2009, THER GUID END VERS 4; [Anonymous], 2011, GUID PREV DET MAN CH; Australian Institute of Health and Welfare (AIHW) and the National Heart Foundation of Australia (NHFA), 2004, HEART STROK VASC DIS, P140; Borgstedt Johanna, 2009, Journal of Pharmacy Practice and Research, V39, P186; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Braunstein JB, 2003, J AM COLL CARDIOL, V42, P1226, DOI 10.1016/S0735-1097(03)00947-1; Caughey GE, 2011, DRUGS AGING, V28, P1; Fonarow GC, 2008, CIRC-HEART FAIL, V1, P98, DOI 10.1161/CIRCHEARTFAILURE.108.772228; Granger BB, 2005, LANCET, V366, P2005, DOI 10.1016/S0140-6736(05)67760-4; Hauptman PJ, 2008, J CARD FAIL, V14, P801, DOI 10.1016/j.cardfail.2008.10.005; Krum H, 2003, LANCET, V362, P147, DOI 10.1016/S0140-6736(03)13869-X; Krum H, 2001, MED J AUSTRALIA, V174, P439, DOI 10.5694/j.1326-5377.2001.tb143369.x; Lainscak M, 2007, EUR J HEART FAIL, V9, P292, DOI 10.1016/j.ejheart.2006.07.007; McMurray JJV, 2003, EUR HEART J SUPPL, V5, P3, DOI 10.1016/S1520-765X(03)80002-0; National Heart Foundation of Australia, 2010, MULT CAR PEOPL CHRON; Reuben DB, 2012, NEW ENGL J MED, V366, P777, DOI 10.1056/NEJMp1113631; Sheikh JI, 1986, CLIN GERONTOLOGY GUI, P6165; Vitry AI, 2008, MED J AUSTRALIA, V189, P360, DOI 10.5694/j.1326-5377.2008.tb02079.x; White HD, 2005, LANCET, V366, P1989, DOI 10.1016/S0140-6736(05)67761-6; Wilson MMG, 2005, AM J CLIN NUTR, V82, P1074, DOI 10.1093/ajcn/82.5.1074	21	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93129	10.1371/journal.pone.0093129	http://dx.doi.org/10.1371/journal.pone.0093129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714369	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000334160900015
J	Shao, J; Choe, V; Cheng, HL; Tsai, YC; Weissman, AM; Luo, SW; Rao, H				Shao, Jia; Choe, Vitnary; Cheng, Haili; Tsai, Yien Che; Weissman, Allan M.; Luo, Shiwen; Rao, Hai			Ubiquitin Ligase gp78 Targets Unglycosylated Prion Protein PrP for Ubiquitylation and Degradation	PLOS ONE			English	Article							PROTEASOME SYSTEM; ENDOPLASMIC-RETICULUM; MISFOLDED PRP; DISEASES; DYSFUNCTION; PATHWAY	Prion protein PrP is a central player in several devastating neurodegenerative disorders, including mad cow disease and Creutzfeltd-Jacob disease. Conformational alteration of PrP into an aggregation-prone infectious form PrPSc can trigger pathogenic events. How levels of PrP are regulated is poorly understood. Human PrP is known to be degraded by the proteasome, but the specific proteolytic pathway responsible for PrP destruction remains elusive. Here, we demonstrate that the ubiquitin ligase gp78, known for its role in protein quality control, is critical for unglycosylated PrP ubiquitylation and degradation. Furthermore, C-terminal sequences of PrP protein are crucial for its ubiquitylation and degradation. Our study reveals the first ubiquitin ligase specifically involved in prion protein PrP degradation and PrP sequences crucial for its turnover. Our data may lead to a new avenue to control PrP level and pathogenesis.	[Shao, Jia; Luo, Shiwen] Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China; [Choe, Vitnary; Cheng, Haili; Rao, Hai] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Tsai, Yien Che; Weissman, Allan M.] NCI, Lab Prot Dynam & Signaling, Frederick, MD 21701 USA	Nanchang University; University of Texas System; University of Texas Health San Antonio; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Luo, SW (corresponding author), Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China.	shiwenluo@ncu.edu.cn; raoh@uthscsa.edu	Cheng, Haili/AGG-8193-2022	Cheng, Haili/0000-0002-1860-3585; Tsai, Yien Che/0000-0001-9624-1092; RAO, HAI/0000-0002-4235-2210	NIH [GM 078085]; Welch Foundation [AQ-1747]; Department of Defense [W911NF-11-10466]; NSFC [81060095]; 973 Program of China [2010CB535001]; 555 Program of Jiangxi; Center for Cancer Research, National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE [ZIABC009392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078085] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Department of Defense(United States Department of Defense); NSFC(National Natural Science Foundation of China (NSFC)); 973 Program of China(National Basic Research Program of China); 555 Program of Jiangxi; Center for Cancer Research, National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HR and SL are supported by the NIH (GM 078085), the Welch Foundation (AQ-1747), and the Department of Defense (W911NF-11-10466), NSFC (81060095), 973 Program of China (2010CB535001) and 555 Program of Jiangxi. AMW is supported by the Center for Cancer Research, National Cancer Institute, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2006, NAT REV MICROBIOL, V4, P765, DOI 10.1038/nrmicro1492; Aguzzi A, 2012, NAT NEUROSCI, V15, P936, DOI 10.1038/nn.3120; Andre R, 2012, PRION, V6, P32, DOI 10.4161/pri.6.1.18272; Apodaca J, 2006, BIOCHEM BIOPH RES CO, V347, P319, DOI 10.1016/j.bbrc.2006.06.078; Ashok A, 2008, MOL BIOL CELL, V19, P3463, DOI 10.1091/mbc.E08-01-0087; Ciechanover A, 2013, BIOORGAN MED CHEM, V21, P3400, DOI 10.1016/j.bmc.2013.01.056; Dantuma NP, 2010, CARDIOVASC RES, V85, P263, DOI 10.1093/cvr/cvp255; Dennissen FJA, 2012, PROG NEUROBIOL, V96, P190, DOI 10.1016/j.pneurobio.2012.01.003; Deriziotis P, 2011, EMBO J, V30, P3065, DOI 10.1038/emboj.2011.224; Dron M, 2009, J GEN VIROL, V90, P2050, DOI 10.1099/vir.0.010082-0; Ermonval M, 2003, BIOCHIMIE, V85, P33, DOI 10.1016/S0300-9084(03)00040-3; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Lloyd S, 2011, TOP CURR CHEM, V305, P1, DOI 10.1007/128_2011_157; Ma JY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002589; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Needham PG, 2013, BBA-MOL CELL RES, V1833, P2447, DOI 10.1016/j.bbamcr.2013.03.018; Nunziante M, 2011, J BIOL CHEM, V286, P33942, DOI 10.1074/jbc.M111.272617; Roucou X, 2003, J BIOL CHEM, V278, P40877, DOI 10.1074/jbc.M306177200; Stolz A, 2010, BBA-MOL CELL RES, V1803, P694, DOI 10.1016/j.bbamcr.2010.02.005; Tsai YC, 2012, MOL BIOL CELL, V23, P4484, DOI 10.1091/mbc.E12-08-0631; Yedidia Y, 2001, EMBO J, V20, P5383, DOI 10.1093/emboj/20.19.5383	26	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e92290	10.1371/journal.pone.0092290	http://dx.doi.org/10.1371/journal.pone.0092290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714645	gold, Green Published, Green Submitted			2022-12-25	WOS:000334160900004
J	Zingg, W; Cartier, V; Inan, C; Touveneau, S; Theriault, M; Gayet-Ageron, A; Clergue, F; Pittet, D; Walder, B				Zingg, Walter; Cartier, Vanessa; Inan, Cigdem; Touveneau, Sylvie; Theriault, Michel; Gayet-Ageron, Angele; Clergue, Francois; Pittet, Didier; Walder, Bernhard			Hospital-Wide Multidisciplinary, Multimodal Intervention Programme to Reduce Central Venous Catheter-Associated Bloodstream Infection	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; CARE-ASSOCIATED INFECTION; HEALTH-CARE; ATTRIBUTABLE COST; HAND HYGIENE; PREVENTION; SIMULATION; IMPACT; COMPLICATIONS; INSERTION	Central line-associated bloodstream infection (CLABSI) is the major complication of central venous catheters (CVC). The aim of the study was to test the effectiveness of a hospital-wide strategy on CLABSI reduction. Between 2008 and 2011, all CVCs were observed individually and hospital-wide at a large university-affiliated, tertiary care hospital. CVC insertion training started from the 3rd quarter and a total of 146 physicians employed or newly entering the hospital were trained in simulator workshops. CVC care started from quarter 7 and a total of 1274 nurses were trained by their supervisors using a web-based, modular, e-learning programme. The study included 3952 patients with 6353 CVCs accumulating 61,366 catheter-days. Hospital-wide, 106 patients had 114 CLABSIs with a cumulative incidence of 1.79 infections per 100 catheters. We observed a significant quarterly reduction of the incidence density (incidence rate ratios [95% confidence interval]: 0.92 [0.88-0.96]; P < 0.001) after adjusting for multiple confounders. The incidence densities (n/1000 catheter-days) in the first and last study year were 2.3/1000 and 0.7/1000 hospital-wide, 1.7/1000 and 0.4/1000 in the intensive care units, and 2.7/1000 and 0.9/1000 in non-intensive care settings, respectively. Median time-to-infection was 15 days (Interquartile range, 8-22). Our findings suggest that clinically relevant reduction of hospital-wide CLABSI was reached with a comprehensive, multidisciplinary and multimodal quality improvement programme including aspects of behavioural change and key principles of good implementation practice. This is one of the first multimodal, multidisciplinary, hospital-wide training strategies successfully reducing CLABSI.	[Zingg, Walter; Touveneau, Sylvie; Gayet-Ageron, Angele; Pittet, Didier] Univ Hosp Geneva, Infect Control Programme, Geneva, Switzerland; [Cartier, Vanessa; Inan, Cigdem; Clergue, Francois; Walder, Bernhard] Univ Hosp Geneva, Div Anaesthesiol, Geneva, Switzerland; [Touveneau, Sylvie; Theriault, Michel] Univ Hosp Geneva, Dept Nursing, Geneva, Switzerland; [Touveneau, Sylvie; Theriault, Michel] Univ Hosp Geneva, WHO, Collaborating Ctr Patient Safety, Geneva, Switzerland; [Pittet, Didier] Fac Med, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; World Health Organization; University of Geneva	Zingg, W (corresponding author), Univ Hosp Geneva, Infect Control Programme, Geneva, Switzerland.	walter.zingg@hcuge.ch		Gayet-Ageron, Angele/0000-0002-6164-9693	University of Geneva Hospitals	University of Geneva Hospitals	The project was a quality improvement program financed by the University of Geneva Hospitals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apisarnthanarak A, 2010, AM J INFECT CONTROL, V38, P449, DOI 10.1016/j.ajic.2009.08.017; Barsuk JH, 2010, ACAD MED, V85, pS9, DOI 10.1097/ACM.0b013e3181ed436c; Barsuk JH, 2009, CRIT CARE MED, V37, P2697, DOI 10.1097/CCM.0b013e3181a57bc1; Barsuk JH, 2009, ARCH INTERN MED, V169, P1420, DOI 10.1001/archinternmed.2009.215; Berenholtz SM, 2004, CRIT CARE MED, V32, P2014, DOI 10.1097/01.CCM.0000142399.70913.2F; Bouadma L, 2010, CLIN INFECT DIS, V51, P1115, DOI 10.1086/656737; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Damschroder LJ, 2009, QUAL SAF HEALTH CARE, V18, P434, DOI 10.1136/qshc.2009.034199; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; DePalo VA, 2010, QUAL SAF HEALTH CARE, V19, P555, DOI 10.1136/qshc.2009.038265; Dudeck MA, 2011, AM J INFECT CONTROL, V39, P798, DOI 10.1016/j.ajic.2011.10.001; Edwards R, 2012, LANCET INFECT DIS, V12, P318, DOI 10.1016/S1473-3099(11)70283-3; Eggimann P, 2000, LANCET, V355, P1864, DOI 10.1016/S0140-6736(00)02291-1; Evans LV, 2010, QUAL SAF HEALTH CARE, V19, pI42, DOI 10.1136/qshc.2010.042168; Evans LV, 2010, ACAD MED, V85, P1462, DOI 10.1097/ACM.0b013e3181eac9a3; Freixas N, 2013, CLIN MICROBIOL INFEC, V19, P838, DOI 10.1111/1469-0691.12049; Gastmeier P, 2006, J HOSP INFECT, V64, P16, DOI 10.1016/j.jhin.2006.04.017; Goetz AM, 1998, INFECT CONT HOSP EP, V19, P842; Guerin K, 2010, AM J INFECT CONTROL, V38, P430, DOI 10.1016/j.ajic.2010.03.007; Higuera F, 2007, INFECT CONT HOSP EP, V28, P31, DOI 10.1086/510812; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Kaye J, 2000, AM J INFECT CONTROL, V28, P197, DOI 10.1016/S0196-6553(00)90028-2; Khouli H, 2011, CHEST, V139, P80, DOI 10.1378/chest.10-0979; Koll BS, 2008, JT COMM J QUAL PATIE, V34, P713, DOI 10.1016/S1553-7250(08)34094-X; Lankford MG, 2003, EMERG INFECT DIS, V9, P217; Levine SA, 2007, J AM GERIATR SOC, V55, P1281, DOI 10.1111/j.1532-5415.2007.01205.x; Lin DM, 2013, JT COMM J QUAL PATIE, V39, P51, DOI 10.1016/S1553-7250(13)39008-4; Lloyd B, 2009, HEALTH PROMOT J AUST, V20, P151, DOI 10.1071/HE09151; Marra AR, 2010, AM J INFECT CONTROL, V38, P434, DOI 10.1016/j.ajic.2009.11.012; Marschall J, 2008, INFECT CONT HOSP EP, V29, pS22, DOI 10.1086/591059; Merrer J, 2001, JAMA-J AM MED ASSOC, V286, P700, DOI 10.1001/jama.286.6.700; Miller RS, 2010, J TRAUMA, V68, P23, DOI 10.1097/TA.0b013e3181c82678; Miyachi H, 2007, AM J INFECT CONTROL, V35, P115, DOI 10.1016/j.ajic.2006.09.003; Parienti JJ, 2008, JAMA-J AM MED ASSOC, V299, P2413, DOI 10.1001/jama.299.20.2413; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost Peter J, 2004, Jt Comm J Qual Saf, V30, P59; Pronovost PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c309; RICHET H, 1990, J CLIN MICROBIOL, V28, P2520, DOI 10.1128/JCM.28.11.2520-2525.1990; Rosenthal VD, 2012, AM J INFECT CONTROL, V40, P396, DOI 10.1016/j.ajic.2011.05.020; Rubinson L, 2005, INFECT CONT HOSP EP, V26, P525, DOI 10.1086/502579; Saint S, 2010, INFECT CONT HOSP EP, V31, P901, DOI 10.1086/655459; Tedja R, 2014, INFECT CONT HOSP EP, V35, P164, DOI 10.1086/674856; Timsit JF, 2009, JAMA-J AM MED ASSOC, V301, P1231, DOI 10.1001/jama.2009.376; Vonberg RP, 2006, INFECT CONT HOSP EP, V27, P357, DOI 10.1086/503339; Warren DK, 2006, CRIT CARE MED, V34, P2084, DOI 10.1097/01.CCM.0000227648.15804.2D; Zingg W, 2009, J HOSP INFECT, V73, P41, DOI 10.1016/j.jhin.2009.05.015; Zingg W, 2011, CURR OPIN INFECT DIS, V24, P377, DOI 10.1097/QCO.0b013e32834811ed; Zingg W, 2008, BEST PRACT RES-CLIN, V22, P407, DOI 10.1016/j.bpa.2008.05.007; Zingg W, 2009, CRIT CARE MED, V37, P2167, DOI 10.1097/CCM.0b013e3181a02d8f	49	43	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93898	10.1371/journal.pone.0093898	http://dx.doi.org/10.1371/journal.pone.0093898			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714418	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900057
J	Choi, YS; Yoon, S; Kim, KL; Yoo, J; Song, P; Kim, M; Shin, YE; Yang, WJ; Noh, JE; Cho, HS; Kim, S; Chung, J; Ryu, SH				Choi, Yoon Sup; Yoon, Soomin; Kim, Kyung-Lock; Yoo, Jiho; Song, Parkyong; Kim, Minsoo; Shin, Young-Eun; Yang, Won Jun; Noh, Jung-eun; Cho, Hyun-soo; Kim, Sanguk; Chung, Junho; Ryu, Sung Ho			Computational Design of Binding Proteins to EGFR Domain II	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; DATA-BANK; EVOLUTIONARY CONSERVATION; TRANSMEMBRANE PROTEINS; INTERACTION NETWORKS; FACTOR RECEPTOR; CANCER-THERAPY; PHASE-I; COMPLEX; ANTICALINS	We developed a process to produce novel interactions between two previously unrelated proteins. This process selects protein scaffolds and designs protein interfaces that bind to a surface patch of interest on a target protein. Scaffolds with shapes complementary to the target surface patch were screened using an exhaustive computational search of the human proteome and optimized by directed evolution using phage display. This method was applied to successfully design scaffolds that bind to epidermal growth factor receptor (EGFR) domain II, the interface of EGFR dimerization, with high reactivity toward the target surface patch of EGFR domain II. One potential application of these tailor-made protein interactions is the development of therapeutic agents against specific protein targets.	[Choi, Yoon Sup; Yoon, Soomin; Kim, Minsoo; Yang, Won Jun; Chung, Junho] Seoul Natl Univ, Sch Med, Canc Res Inst, Seoul, South Korea; [Choi, Yoon Sup; Kim, Sanguk; Ryu, Sung Ho] Pohang Univ Sci & Technol POSTECH, Sch Interdisciplinary Biosci & Bioengn I Bio, Pohang, South Korea; [Yoon, Soomin; Yang, Won Jun; Chung, Junho] Seoul Natl Univ, Sch Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Choi, Yoon Sup; Kim, Kyung-Lock; Song, Parkyong; Shin, Young-Eun; Noh, Jung-eun; Ryu, Sung Ho] Pohang Univ Sci & Technol POSTECH, Div Integrat Biosci & Biotechnol, Pohang, South Korea; [Yoo, Jiho; Cho, Hyun-soo] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Syst Biol, Seoul 120749, South Korea; [Kim, Minsoo] Scripps Korea Antibody Inst, Chunchon, South Korea; [Kim, Sanguk] Pohang Univ Sci & Technol POSTECH, Div IT Convergence Engn, Pohang, South Korea; [Choi, Yoon Sup] KT Inst Convergence Technol, Seoul, South Korea	Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Seoul National University (SNU); Pohang University of Science & Technology (POSTECH); Yonsei University; Pohang University of Science & Technology (POSTECH)	Kim, S (corresponding author), Pohang Univ Sci & Technol POSTECH, Sch Interdisciplinary Biosci & Bioengn I Bio, Pohang, South Korea.	sukim@postech.ac.kr; junhochung@me.com; sungho@postech.ac.kr		Kim, Kyung Lock/0000-0001-6514-4935; Kim, Sanguk/0000-0002-3449-3814; Yoo, Jiho/0000-0002-0864-2142; Ryu, Sung Ho/0000-0003-0913-3048	Cancer Research Institute; Seoul National University [cri-12-1]; National Research Foundation of Korea (NRF); Korean government (MEST) [2013R1A2A1A03010110]; Korean government [2010-0028684]	Cancer Research Institute; Seoul National University; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korean government(Korean Government)	This study was supported by a research grant from the Cancer Research Institute, Seoul National University (cri-12-1), a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2013R1A2A1A03010110). This work was also supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (No. 2010-0028684). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baig I, 2004, BIOCHEMISTRY-US, V43, P5562, DOI 10.1021/bi035879k; Bairoch A, 2004, BRIEF BIOINFORM, V5, P39, DOI 10.1093/bib/5.1.39; Berg J, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-51; Bianco R, 2007, INT J BIOCHEM CELL B, V39, P1416, DOI 10.1016/j.biocel.2007.05.008; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Chai JJ, 2003, J BIOL CHEM, V278, P20327, DOI 10.1074/jbc.C300134200; Choi YS, 2010, NUCLEIC ACIDS RES, V38, pW450, DOI 10.1093/nar/gkq328; Choi YS, 2009, PROTEINS, V77, P14, DOI 10.1002/prot.22410; Cohen GH, 2005, ACTA CRYSTALLOGR D, V61, P628, DOI 10.1107/S0907444905007870; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Garrett TPJ, 2009, P NATL ACAD SCI USA, V106, P5082, DOI 10.1073/pnas.0811559106; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; Getmanova EV, 2006, CHEM BIOL, V13, P549, DOI 10.1016/j.chembiol.2005.12.009; Goel R, 2011, MOL BIOTECHNOL, V48, P87, DOI 10.1007/s12033-010-9336-8; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Ladner Robert C, 2007, Biotechnol Genet Eng Rev, V24, P1; Levy ED, 2008, CURR OPIN STRUC BIOL, V18, P349, DOI 10.1016/j.sbi.2008.03.003; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Lo Conte L, 2000, NUCLEIC ACIDS RES, V28, P257, DOI 10.1093/nar/28.1.257; Lockhart AC, 2005, SEMIN ONCOL, V32, P432, DOI 10.1053/j.seminoncol.2005.06.015; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Pokala N, 2005, J MOL BIOL, V347, P203, DOI 10.1016/j.jmb.2004.12.019; Schlehuber S, 2005, DRUG DISCOV TODAY, V10, P23, DOI 10.1016/S1359-6446(04)03294-5; Schlehuber S, 2005, EXPERT OPIN BIOL TH, V5, P1453, DOI 10.1517/14712598.5.11.1453; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Schneidman-Duhovny D, 2003, PROTEINS, V52, P107, DOI 10.1002/prot.10397; Scott AM, 2007, P NATL ACAD SCI USA, V104, P4071, DOI 10.1073/pnas.0611693104; SHERIFF S, 1987, P NATL ACAD SCI USA, V84, P8075, DOI 10.1073/pnas.84.22.8075; Sivasubramanian A, 2006, STRUCTURE, V14, P401, DOI 10.1016/j.str.2005.11.022; Skerra A, 2007, CURR OPIN BIOTECH, V18, P295, DOI 10.1016/j.copbio.2007.04.010; Skerra A, 2007, CURR OPIN MOL THER, V9, P336; Stumpp MT, 2008, DRUG DISCOV TODAY, V13, P695, DOI 10.1016/j.drudis.2008.04.013; Stumpp MT, 2007, CURR OPIN DRUG DISC, V10, P153; Sussman JL, 1998, ACTA CRYSTALLOGR D, V54, P1078, DOI 10.1107/S0907444998009378; Tolcher AW, 2011, CLIN CANCER RES, V17, P363, DOI 10.1158/1078-0432.CCR-10-1411; Tusnady GE, 2005, NUCLEIC ACIDS RES, V33, pD275, DOI 10.1093/nar/gki002; Tusnady GE, 2004, BIOINFORMATICS, V20, P2964, DOI 10.1093/bioinformatics/bth340; van Noort V, 2004, EMBO REP, V5, P280, DOI 10.1038/sj.embor.7400090; Wagner A, 2003, P ROY SOC B-BIOL SCI, V270, P457, DOI 10.1098/rspb.2002.2269; Woodburn JR, 1999, PHARMACOL THERAPEUT, V82, P241, DOI 10.1016/S0163-7258(98)00045-X; Xu LH, 2002, CHEM BIOL, V9, P933, DOI 10.1016/S1074-5521(02)00187-4; Yamada T, 2009, NAT REV MOL CELL BIO, V10, P791, DOI 10.1038/nrm2787	47	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e92513	10.1371/journal.pone.0092513	http://dx.doi.org/10.1371/journal.pone.0092513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710267	gold, Green Submitted, Green Published			2022-12-25	WOS:000334159800013
J	Cook, LC; Hillhouse, AE; Myles, MH; Lubahn, DB; Bryda, EC; Davis, JW; Franklin, CL				Cook, Lydia C.; Hillhouse, Andrew E.; Myles, Matthew H.; Lubahn, Dennis B.; Bryda, Elizabeth C.; Davis, J. Wade; Franklin, Craig L.			The Role of Estrogen Signaling in a Mouse Model of Inflammatory Bowel Disease: A Helicobacter Hepaticus Model	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GENE-EXPRESSION; RECEPTOR-BETA; MICROSCOPIC COLITIS; INFECTION; MICE; IMMUNITY; GENDER; RISK; DIFFERENTIATION	The pathogenesis of inflammatory bowel diseases (IBD), Crohn's disease and ulcerative colitis, is due in part to interactions between the immune system, genetics, the environment, and endogenous microbiota. Gonadal sex hormones (GSH), such as estrogen, are thought to be involved in the development of IBD as variations in disease severity occur during pregnancy, menopause, or oral contraceptives use. In certain strains of mice, infection with Helicobacter hepaticus triggers IBD-like mucosal inflammation that is more severe in female mice than in males, suggesting a role for GSH in this model. To determine the role of estrogen signaling in microbiota-induced intestinal inflammation, estrogen receptor (ER) a and b knock-out (KO) mice, ER agonists, and adoptive transfers were utilized. We demonstrate that, when signaling is limited to ERb on a non-CD4(+) cell subset, disease is less severe and this correlates with decreased expression of pro-inflammatory mediators.	[Cook, Lydia C.; Hillhouse, Andrew E.; Myles, Matthew H.; Bryda, Elizabeth C.; Franklin, Craig L.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA; [Hillhouse, Andrew E.] Univ Missouri, Dept Mol Microbiol & Immunol, Columbia, MO USA; [Myles, Matthew H.] IDEXX Labs, Columbia, MO USA; [Lubahn, Dennis B.] Univ Missouri, Dept Biochem, Columbia, MO USA; [Davis, J. Wade] Univ Missouri, Dept Hlth Management & Informat, Columbia, MO USA; [Davis, J. Wade] Univ Missouri, Dept Stat, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Franklin, CL (corresponding author), Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65211 USA.	franklinc@missouri.edu		Myles, Matthew/0000-0002-8685-516X	National Institutes of Health [K26 RR018811]; JE Wagner Endowment (University of Missouri); NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR018811] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JE Wagner Endowment (University of Missouri); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by funding from the National Institutes of Health (grant K26 RR018811) and the JE Wagner Endowment (University of Missouri). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beagley KW, 2003, FEMS IMMUNOL MED MIC, V38, P13, DOI 10.1016/S0928-8244(03)00202-5; Bebo BF, 2001, J IMMUNOL, V166, P2080, DOI 10.4049/jimmunol.166.3.2080; Bousvaros A, 2006, INFLAMM BOWEL DIS, V12, P885, DOI 10.1097/01.mib.0000228358.25364.8b; Brant SR, 2008, INFLAMM BOWEL DIS, V14, pS2, DOI 10.1002/ibd.20540; Cahill RJ, 1997, INFECT IMMUN, V65, P3126, DOI 10.1128/IAI.65.8.3126-3131.1997; Campbell-Thompson M, 2001, CANCER RES, V61, P632; Chadwick CC, 2005, P NATL ACAD SCI USA, V102, P2543, DOI 10.1073/pnas.0405841102; Cornish JA, 2008, AM J GASTROENTEROL, V103, P2394, DOI 10.1111/j.1572-0241.2008.02064.x; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Ferguson CB, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.39566.681458.BE; Gleicher N, 2007, J AUTOIMMUN, V28, P1, DOI 10.1016/j.jaut.2006.12.004; GODET PG, 1995, GUT, V37, P668, DOI 10.1136/gut.37.5.668; Gunel O, 2003, INFLAMMATION, V27, P351; Harnish DC, 2004, AM J PHYSIOL-GASTR L, V286, pG118, DOI 10.1152/ajpgi.00024.2003; Harris HA, 2003, ENDOCRINOLOGY, V144, P4241, DOI 10.1210/en.2003-0550; Jansson L, 1998, INFLAMM RES, V47, P290, DOI 10.1007/s000110050332; Kane SV, 2008, AM J GASTROENTEROL, V103, P1193, DOI 10.1111/j.1572-0241.2007.01700.x; Kao KT, 2009, WORLD J GASTROENTERO, V15, P3122, DOI 10.3748/wjg.15.3122; Khalili H, 2012, GUT; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Liu HY, 2002, J NEUROSCI RES, V70, P238, DOI 10.1002/jnr.10409; Livingston RS, 2004, COMPARATIVE MED, V54, P301; Looijer-van Langen M, 2011, AM J PHYSIOL-GASTR L, V300, pG621, DOI 10.1152/ajpgi.00274.2010; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; Maggio-Price L, 2006, CANCER RES, V66, P828, DOI 10.1158/0008-5472.CAN-05-2448; Maggio-Price L, 2005, AM J PATHOL, V166, P1793, DOI 10.1016/S0002-9440(10)62489-3; Maggio-Price L, 2002, AM J PATHOL, V160, P739, DOI 10.1016/S0002-9440(10)64894-8; Mao A, 2005, J IMMUNOL, V175, P5146, DOI 10.4049/jimmunol.175.8.5146; McCarthy M, 2000, LANCET, V356, P1088, DOI 10.1016/S0140-6736(05)74535-9; Mewshaw RE, 2005, J MED CHEM, V48, P3953, DOI 10.1021/jm058173s; Mohammadi M, 1996, INFECT IMMUN, V64, P238, DOI 10.1128/IAI.64.1.238-245.1996; Myles MH, 2007, INFLAMM BOWEL DIS, V13, P822, DOI 10.1002/ibd.20138; Myles MH, 2003, INFECT IMMUN, V71, P3885, DOI 10.1128/IAI.71.7.3885-3893.2003; Nalbandian G, 2005, IMMUNOL RES, V31, P91, DOI 10.1385/IR:31:2:091; Phiel KL, 2005, IMMUNOL LETT, V97, P107, DOI 10.1016/j.imlet.2004.10.007; Riis L, 2006, AM J GASTROENTEROL, V101, P1539, DOI 10.1111/j.1572-0241.2006.00602.x; Riley LK, 1996, J CLIN MICROBIOL, V34, P942, DOI 10.1128/JCM.34.4.942-946.1996; Saleiro D, 2012, INT J CANCER, V131, P2553, DOI 10.1002/ijc.27578; Siracusa MC, 2008, J IMMUNOL, V180, P1423, DOI 10.4049/jimmunol.180.3.1423; Subramanian S, 2005, CLIN IMMUNOL, V115, P162, DOI 10.1016/j.clim.2005.01.006; Subramanian S, 2003, J IMMUNOL, V170, P1548, DOI 10.4049/jimmunol.170.3.1548; Verdu EF, 2002, AM J PHYSIOL-GASTR L, V283, pG27, DOI 10.1152/ajpgi.00460.2001; Cives MV, 2009, AM J GASTROENTEROL, V104, P534, DOI 10.1038/ajg.2008.70; Wada-Hiraike O, 2006, BIOCHEM SOC T, V34, P1114, DOI 10.1042/BST0341114; Wada-Hiraike O, 2006, P NATL ACAD SCI USA, V103, P2959, DOI 10.1073/pnas.0511271103; Whary MT, 1998, INFECT IMMUN, V66, P3142, DOI 10.1128/IAI.66.7.3142-3148.1998; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Williams JJ, 2008, CLIN GASTROENTEROL H, V6, P35, DOI 10.1016/j.cgh.2007.10.031; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	50	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94209	10.1371/journal.pone.0094209	http://dx.doi.org/10.1371/journal.pone.0094209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709804	Green Submitted, Green Published, gold			2022-12-25	WOS:000334159800119
J	Kim, YS; Park, JH; Choi, SJ; Bae, JY; Ahn, DK; McKemy, DD; Bae, YC				Kim, Yun Sook; Park, Jun Hong; Choi, Su Jung; Bae, Jin Young; Ahn, Dong Kuk; McKemy, David D.; Bae, Yong Chul			Central Connectivity of Transient Receptor Potential Melastatin 8-Expressing Axons in the Brain Stem and Spinal Dorsal Horn	PLOS ONE			English	Article							TRIGEMINAL SUBNUCLEUS CAUDALIS; PRIMARY AFFERENT TERMINALS; SUBSTANCE-P; SENSORY NEURONS; PRESYNAPTIC INHIBITION; COLD SENSITIVITY; NUCLEAR-COMPLEX; LOW-TEMPERATURE; ORALIS NEURONS; HUMAN SKIN	Transient receptor potential melastatin 8 (TRPM8) ion channels mediate the detection of noxious and innocuous cold and are expressed by primary sensory neurons, but little is known about the processing of the TRPM8-mediated cold information within the trigeminal sensory nuclei (TSN) and the spinal dorsal horn (DH). To address this issue, we characterized TRPM8-positive (+) neurons in the trigeminal ganglion and investigated the distribution of TRPM8+ axons and terminals, and their synaptic organization in the TSN and in the DH using light and electron microscopic immunohistochemistry in transgenic mice expressing a genetically encoded axonal tracer in TRPM8+ neurons. TRPM8 was expressed in a fraction of small myelinated primary afferent fibers (23.7%) and unmyelinated fibers (76.3%), suggesting that TRPM8-mediated cold is conveyed via C and A delta afferents. TRPM8+ axons were observed in all TSN, but at different densities in the dorsal and ventral areas of the rostral TSN, which dominantly receive sensory afferents from intra- and perioral structures and from the face, respectively. While synaptic boutons arising from A delta and non-peptidergic C afferents usually receive many axoaxonic contacts and form complex synaptic arrangements, TRPM8+ boutons arising from afferents of the same classes of fibers showed a unique synaptic connectivity; simple synapses with one or two dendrites and sparse axoaxonic contacts. These findings suggest that TRPM8-mediated cold is conveyed via a specific subset of C and A delta afferent neurons and is processed in a unique manner and differently in the TSN and DH.	[Kim, Yun Sook; Park, Jun Hong; Choi, Su Jung; Bae, Jin Young; Ahn, Dong Kuk; Bae, Yong Chul] Kyungpook Natl Univ, Sch Dent, Dept Anat & Neurobiol, Taegu, South Korea; [McKemy, David D.] Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA	Kyungpook National University; University of Southern California	Bae, YC (corresponding author), Kyungpook Natl Univ, Sch Dent, Dept Anat & Neurobiol, Taegu, South Korea.	ycbae@knu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) [2012-0009328]; Ministry of Education, Science and Technology	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF, 2012-0009328) funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen GV, 1996, BRAIN RES, V715, P125, DOI 10.1016/0006-8993(95)01580-9; ALVAREZ FJ, 1993, J COMP NEUROL, V329, P472, DOI 10.1002/cne.903290405; ALVAREZ FJ, 1992, J NEUROSCI, V12, P2901, DOI 10.1523/JNEUROSCI.12-08-02901.1992; Bae YC, 2005, BRAIN RES, V1060, P118, DOI 10.1016/j.brainres.2005.08.042; Bae YC, 2004, J COMP NEUROL, V478, P62, DOI 10.1002/cne.20272; Bae YC, 2000, J COMP NEUROL, V418, P299; BAE YC, 1994, J COMP NEUROL, V348, P121, DOI 10.1002/cne.903480107; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Campero M, 2001, J PHYSIOL-LONDON, V535, P855, DOI 10.1111/j.1469-7793.2001.t01-1-00855.x; Campero M, 1996, J PHYSIOL-LONDON, V497, P565, DOI 10.1113/jphysiol.1996.sp021789; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Craig AD, 2001, J NEUROPHYSIOL, V86, P856, DOI 10.1152/jn.2001.86.2.856; DALLEL R, 1990, BRAIN RES, V521, P95, DOI 10.1016/0006-8993(90)91529-P; DALLEL R, 1988, BRAIN RES, V448, P7, DOI 10.1016/0006-8993(88)91096-7; DARIANSMITH I, 1973, J NEUROPHYSIOL, V36, P325, DOI 10.1152/jn.1973.36.2.325; Dellarole A, 2008, J COMP NEUROL, V511, P318, DOI 10.1002/cne.21845; Dessem D, 2007, J NEUROPHYSIOL, V98, P214, DOI 10.1152/jn.00990.2006; Dhaka A, 2008, J NEUROSCI, V28, P566, DOI 10.1523/JNEUROSCI.3976-07.2008; DUBNER R, 1975, J NEUROPHYSIOL, V38, P1373, DOI 10.1152/jn.1975.38.6.1373; GRAHAM B, 1994, J NEUROPHYSIOL, V71, P538, DOI 10.1152/jn.1994.71.2.538; He YF, 2000, BRAIN RES, V860, P203, DOI 10.1016/S0006-8993(00)02042-4; Ishida Y, 2009, J COMP NEUROL, V514, P131, DOI 10.1002/cne.22000; Kim YS, 2008, J COMP NEUROL, V506, P627, DOI 10.1002/cne.21544; Kim YS, 2010, J COMP NEUROL, V518, P687, DOI 10.1002/cne.22238; Knowlton WM, 2011, CURR PHARM BIOTECHNO, V12, P68; Knowlton WM, 2010, PAIN, V150, P340, DOI 10.1016/j.pain.2010.05.021; KNYIHARCSILLIK E, 1982, J COMP NEUROL, V210, P376, DOI 10.1002/cne.902100405; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Li JL, 1997, J COMP NEUROL, V378, P508, DOI 10.1002/(SICI)1096-9861(19970224)378:4<508::AID-CNE6>3.0.CO;2-6; Ma QP, 2001, EUR J NEUROSCI, V13, P2099, DOI 10.1046/j.0953-816x.2001.01586.x; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Moldrich RX, 2010, J COMP NEUROL, V518, P3645, DOI 10.1002/cne.22445; Oakden EL, 1998, NEUROSCIENCE, V84, P1197, DOI 10.1016/S0306-4522(97)00550-2; OLSSON KA, 1991, EXP BRAIN RES, V84, P115; OLSZEWSKI J, 1950, J COMP NEUROL, V92, P401, DOI 10.1002/cne.900920305; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; RIBEIRODASILVA A, 1989, J COMP NEUROL, V281, P497, DOI 10.1002/cne.902810402; SEGEV I, 1990, J NEUROPHYSIOL, V63, P987, DOI 10.1152/jn.1990.63.5.987; Sessle BJ, 2000, CRIT REV ORAL BIOL M, V11, P57, DOI 10.1177/10454411000110010401; SHIGENAGA Y, 1983, BRAIN RES, V277, P201, DOI 10.1016/0006-8993(83)90928-9; Simone DA, 1997, J NEUROPHYSIOL, V77, P2049, DOI 10.1152/jn.1997.77.4.2049; Starkey ML, 2009, J COMP NEUROL, V513, P51, DOI 10.1002/cne.21944; Sugimoto T, 1998, BRAIN RES, V783, P158, DOI 10.1016/S0006-8993(97)01176-1; Sugimoto T, 1997, J COMP NEUROL, V378, P425, DOI 10.1002/(SICI)1096-9861(19970217)378:3<425::AID-CNE9>3.0.CO;2-5; Sutherland FI, 2002, J COMP NEUROL, V452, P154, DOI 10.1002/cne.10374; Takashima Y, 2007, J NEUROSCI, V27, P14147, DOI 10.1523/JNEUROSCI.4578-07.2007; Xing H, 2006, J NEUROPHYSIOL, V95, P1221, DOI 10.1152/jn.01035.2005; Yabuta NH, 1996, J COMP NEUROL, V374, P436, DOI 10.1002/(SICI)1096-9861(19961021)374:3<436::AID-CNE8>3.0.CO;2-2; Yeo EJ, 2010, J COMP NEUROL, V518, P4134, DOI 10.1002/cne.22369; Yoshida A, 2001, J NEUROSCI, V21, P6298, DOI 10.1523/JNEUROSCI.21-16-06298.2001; Yoshida A, 1998, J COMP NEUROL, V401, P308; Zanotto KL, 2007, J NEUROPHYSIOL, V97, P966, DOI 10.1152/jn.00996.2006	53	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94080	10.1371/journal.pone.0094080	http://dx.doi.org/10.1371/journal.pone.0094080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710558	Green Submitted, gold, Green Published			2022-12-25	WOS:000334159800097
J	Makki, K; Taront, S; Molendi-Coste, O; Bouchaert, E; Neve, B; Eury, E; Lobbens, S; Labalette, M; Duez, H; Staels, B; Dombrowicz, D; Froguel, P; Wolowczuk, I				Makki, Kassem; Taront, Solenne; Molendi-Coste, Olivier; Bouchaert, Emmanuel; Neve, Bernadette; Eury, Elodie; Lobbens, Stephane; Labalette, Myriam; Duez, Helene; Staels, Bart; Dombrowicz, David; Froguel, Philippe; Wolowczuk, Isabelle			Beneficial Metabolic Effects of Rapamycin Are Associated with Enhanced Regulatory Cells in Diet-Induced Obese Mice	PLOS ONE			English	Article							LINKED INSULIN-RESISTANCE; NECROSIS-FACTOR-ALPHA; MATURE-ONSET OBESITY; NF-KAPPA-B; ADIPOSE-TISSUE; GLUCOSE-INTOLERANCE; SUPPRESSOR-CELLS; MAMMALIAN TARGET; MTOR INHIBITION; SKELETAL-MUSCLE	The "mechanistic target of rapamycin'' (mTOR) is a central controller of growth, proliferation and/or motility of various cell-types ranging from adipocytes to immune cells, thereby linking metabolism and immunity. mTOR signaling is overactivated in obesity, promoting inflammation and insulin resistance. Therefore, great interest exists in the development of mTOR inhibitors as therapeutic drugs for obesity or diabetes. However, despite a plethora of studies characterizing the metabolic consequences of mTOR inhibition in rodent models, its impact on immune changes associated with the obese condition has never been questioned so far. To address this, we used a mouse model of high-fat diet (HFD)-fed mice with and without pharmacologic mTOR inhibition by rapamycin. Rapamycin was weekly administrated to HFD-fed C57BL/6 mice for 22 weeks. Metabolic effects were determined by glucose and insulin tolerance tests and by indirect calorimetry measures of energy expenditure. Inflammatory response and immune cell populations were characterized in blood, adipose tissue and liver. In parallel, the activities of both mTOR complexes (e. g. mTORC1 and mTORC2) were determined in adipose tissue, muscle and liver. We show that rapamycin-treated mice are leaner, have enhanced energy expenditure and are protected against insulin resistance. These beneficial metabolic effects of rapamycin were associated to significant changes of the inflammatory profiles of both adipose tissue and liver. Importantly, immune cells with regulatory functions such as regulatory T-cells (Tregs) and myeloid-derived suppressor cells (MDSCs) were increased in adipose tissue. These rapamycin-triggered metabolic and immune effects resulted from mTORC1 inhibition whilst mTORC2 activity was intact. Taken together, our results reinforce the notion that controlling immune regulatory cells in metabolic tissues is crucial to maintain a proper metabolic status and, more generally, comfort the need to search for novel pharmacological inhibitors of the mTOR signaling pathway to prevent and/or treat metabolic diseases.	[Makki, Kassem; Taront, Solenne; Neve, Bernadette; Eury, Elodie; Lobbens, Stephane; Froguel, Philippe; Wolowczuk, Isabelle] Lille Pasteur Inst, CNRS, UMR 8199, Lille, France; [Makki, Kassem; Taront, Solenne; Molendi-Coste, Olivier; Bouchaert, Emmanuel; Neve, Bernadette; Eury, Elodie; Lobbens, Stephane; Labalette, Myriam; Duez, Helene; Staels, Bart; Dombrowicz, David; Froguel, Philippe; Wolowczuk, Isabelle] Univ Lille 2, Lille, France; [Makki, Kassem; Taront, Solenne; Molendi-Coste, Olivier; Bouchaert, Emmanuel; Neve, Bernadette; Eury, Elodie; Lobbens, Stephane; Duez, Helene; Staels, Bart; Dombrowicz, David; Froguel, Philippe; Wolowczuk, Isabelle] EGID, Lille, France; [Molendi-Coste, Olivier; Bouchaert, Emmanuel; Duez, Helene; Staels, Bart; Dombrowicz, David] Lille Pasteur Inst, INSERM, UMR1011, Lille, France; [Labalette, Myriam] Univ Lille 2, CHRU Lille, Inst Immunol, Lille, France; [Labalette, Myriam] Univ Lille 2, EA 2686, Lille, France; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Genom Common Dis, London, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Imperial College London	Froguel, P (corresponding author), Lille Pasteur Inst, CNRS, UMR 8199, Lille, France.	P.froguel@imperial.ac.uk; isabelle.wolowczuk@good.ibl.fr	Staels, Bart/N-9497-2016; Neve, Bernadette/J-6008-2014; FROGUEL, Philippe/O-6799-2017; LABALETTE, Myriam/M-4203-2018; Duez, Helene/M-7609-2017; BOUCHAERT, Emmanuel/AFU-7112-2022; Duez, Helene/AAC-3217-2019; Dombrowicz, David/F-7044-2013; DEZITTER, Solenne/N-5219-2018	Staels, Bart/0000-0002-3784-1503; Neve, Bernadette/0000-0003-1516-1379; FROGUEL, Philippe/0000-0003-2972-0784; LABALETTE, Myriam/0000-0002-1524-9891; BOUCHAERT, Emmanuel/0000-0003-2558-9862; Duez, Helene/0000-0002-4130-7987; Dombrowicz, David/0000-0002-0485-8923; Molendi-Coste, Olivier/0000-0002-0498-9456; wolowczuk, isabelle/0000-0001-6692-6904; DEZITTER, Solenne/0000-0001-5850-7291	Centre National de la Recherche Scientifique (CNRS); Ministere de l'Enseignement Superieur et de la Recherche	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Enseignement Superieur et de la Recherche	The work was supported by the Centre National de la Recherche Scientifique (CNRS). K. M. was supported by a doctoral grant from the Ministere de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, AM J HEALTH-SYST PH, V56, P2177; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Blagosklonny MV, 2011, CELL CYCLE, V10, P4217, DOI 10.4161/cc.10.24.18595; Bruun JM, 2003, AM J PHYSIOL-ENDOC M, V285, pE527, DOI 10.1152/ajpendo.00110.2003; Chang GR, 2009, BASIC CLIN PHARMACOL, V105, P188, DOI 10.1111/j.1742-7843.2009.00427.x; Chang GR, 2009, J PHARMACOL SCI, V109, P496, DOI 10.1254/jphs.08215FP; Chen X, 2013, OBES REV, V14, P568, DOI 10.1111/obr.12033; Chida D, 2006, DIABETES, V55, P971, DOI 10.2337/diabetes.55.04.06.db05-1250; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Elia M, 1992, World Rev Nutr Diet, V70, P68; Eller K, 2011, DIABETES, V60, P2954, DOI 10.2337/db11-0358; Fang YM, 2013, CELL METAB, V17, P456, DOI 10.1016/j.cmet.2013.02.008; Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922; Gabrysova L, 2011, EUR J IMMUNOL, V41, P1242, DOI 10.1002/eji.201041073; Garcia MC, 2006, DIABETES, V55, P1205, DOI 10.2337/db05-1304; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Khamzina L, 2005, ENDOCRINOLOGY, V146, P1473, DOI 10.1210/en.2004-0921; Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07; Lamming DW, 2013, AGING CELL, V12, P712, DOI 10.1111/acel.12097; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528; Lees JR, 2011, CURR OPIN IMMUNOL, V23, P692, DOI 10.1016/j.coi.2011.07.004; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Macia L, 2006, J IMMUNOL, V177, P5997, DOI 10.4049/jimmunol.177.9.5997; Mathis D, 2013, CELL METAB, V17, P851, DOI 10.1016/j.cmet.2013.05.008; Matsuki T, 2003, J EXP MED, V198, P877, DOI 10.1084/jem.20030299; Minhajuddin M, 2005, J IMMUNOL, V174, P5823, DOI 10.4049/jimmunol.174.9.5823; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Procaccini C, 2012, J IMMUNOL, V189, P2941, DOI 10.4049/jimmunol.1200935; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Simons PJ, 2007, J ENDOCRINOL, V192, P289, DOI 10.1677/JOE-06-0047; Sun S, 2012, ANN REV NUTR; Tang T, 2010, J BIOL CHEM, V285, P4637, DOI 10.1074/jbc.M109.068007; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Verwaerde C, 2006, SCAND J IMMUNOL, V64, P457, DOI 10.1111/j.1365-3083.2006.01791.x; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Xia S, 2011, J BIOL CHEM, V286, P23591, DOI 10.1074/jbc.M111.237123; Xu HY, 2002, ENDOCRINOLOGY, V143, P1502, DOI 10.1210/en.143.4.1502; Yang H, 2009, BLOOD, V114, P3803, DOI 10.1182/blood-2009-03-213595; Yang SB, 2012, J MOL MED, V90, P575, DOI 10.1007/s00109-011-0834-3; Ye Lan, 2012, Frontiers in Genetics, V3, P177, DOI 10.3389/fgene.2012.00177; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297	60	48	49	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e92684	10.1371/journal.pone.0092684	http://dx.doi.org/10.1371/journal.pone.0092684			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710396	Green Submitted, Green Published, gold			2022-12-25	WOS:000334159800016
J	Park, SJ; Umemoto, T; Saito-Adachi, M; Shiratsuchi, Y; Yamato, M; Nakai, K				Park, Sung-Joon; Umemoto, Terumasa; Saito-Adachi, Mihoko; Shiratsuchi, Yoshiko; Yamato, Masayuki; Nakai, Kenta			Computational Promoter Modeling Identifies the Modes of Transcriptional Regulation in Hematopoietic Stem Cells	PLOS ONE			English	Article							FACTOR-BINDING SITES; GENE-EXPRESSION; SELF-RENEWAL; DNA-SEQUENCES; PROGENITOR CELLS; HUMAN GENOME; BLOOD STEM; QUIESCENCE; DIFFERENTIATION; LANDSCAPE	Extrinsic and intrinsic regulators are responsible for the tight control of hematopoietic stem cells (HSCs), which differentiate into all blood cell lineages. To understand the fundamental basis of HSC biology, we focused on differentially expressed genes (DEGs) in long-term and short-term HSCs, which are closely related in terms of cell development but substantially differ in their stem cell capacity. To analyze the transcriptional regulation of the DEGs identified in the novel transcriptome profiles obtained by our RNA-seq analysis, we developed a computational method to model the linear relationship between gene expression and the features of putative regulatory elements. The transcriptional regulation modes characterized here suggest the importance of transcription factors (TFs) that are expressed at steady state or at low levels. Remarkably, we found that 24 differentially expressed TFs targeting 21 putative TF-binding sites contributed significantly to transcriptional regulation. These TFs tended to be modulated by other nondifferentially expressed TFs, suggesting that HSCs can achieve flexible and rapid responses via the control of nondifferentially expressed TFs through a highly complex regulatory network. Our novel transcriptome profiles and new method are powerful tools for studying the mechanistic basis of cell fate decisions.	[Park, Sung-Joon; Saito-Adachi, Mihoko; Nakai, Kenta] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan; [Umemoto, Terumasa; Shiratsuchi, Yoshiko; Yamato, Masayuki] Tokyo Womens Med Univ, Inst Adv Biomed Engn & Sci, Tokyo, Japan	University of Tokyo; Tokyo Women's Medical University	Nakai, K (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan.	knakai@ims.u-tokyo.ac.jp	Nakai, Kenta/B-7293-2009	Nakai, Kenta/0000-0002-8721-8883; Park, Sung-Joon/0000-0002-1774-9590; Saito-Adachi, Mihoko/0000-0001-9213-0184	Research on Applying Health Technology, Health and Labour Sciences by the Ministry of Health, Labour and Welfare, Japan	Research on Applying Health Technology, Health and Labour Sciences by the Ministry of Health, Labour and Welfare, Japan	This work was supported by Research on Applying Health Technology, Health and Labour Sciences by the Ministry of Health, Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; Bissels U, 2012, HAEMATOL-HEMATOL J, V97, P160, DOI 10.3324/haematol.2011.051730; Bonzanni N, 2013, BIOINFORMATICS, V29, P80, DOI 10.1093/bioinformatics/btt243; Boyle P, 2010, PLANT SIGNAL BEHAV, V5, P629, DOI 10.4161/psb.5.6.11570; Brown KK, 1999, DIABETES, V48, P1415, DOI 10.2337/diabetes.48.7.1415; Bussemaker HJ, 2007, ANNU REV BIOPH BIOM, V36, P329, DOI 10.1146/annurev.biophys.36.040306.132725; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chotinantakul K, 2012, BONE MARROW RES, DOI 10.1155/2012/270425; Chute JP, 2010, MOL ENDOCRINOL, V24, P1, DOI 10.1210/me.2009-0332; Diffner E, 2013, BLOOD, V121, P2289, DOI 10.1182/blood-2012-07-446120; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Ficara F, 2008, CELL STEM CELL, V2, P484, DOI 10.1016/j.stem.2008.03.004; Forsberg EC, 2006, STEM CELL REV, V2, P23, DOI 10.1007/s12015-006-0005-z; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Gazit R, 2013, STEM CELL REP, V1, P266, DOI 10.1016/j.stemcr.2013.07.004; Ghiaur G, 2013, P NATL ACAD SCI US; Hannah R, 2011, EXP HEMATOL, V39, P531, DOI 10.1016/j.exphem.2011.02.009; Henke BR, 1998, J MED CHEM, V41, P5020, DOI 10.1021/jm9804127; Hoang T, 2004, ONCOGENE, V23, P7188, DOI 10.1038/sj.onc.1207937; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irie T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr173; Karlsson G, 2013, CELL REP, V4, P642, DOI 10.1016/j.celrep.2013.07.020; KAWANA M, 1995, MOL CELL BIOL, V15, P4225; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lauritzen S.L, 1996, GRAPHICAL MODELS; Liebermann DA, 1998, INT J ONCOL, V12, P685; Liu PC, 2011, PHYSIOL GENOMICS, V43, P1117, DOI 10.1152/physiolgenomics.00099.2011; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Miranda-Saavedra D, 2009, NUCLEIC ACIDS RES, V37, pD873, DOI 10.1093/nar/gkn854; Mirshekar-Syahkal B, 2013, HAEMATOLOGICA, V98, P163, DOI 10.3324/haematol.2012.070789; Moignard V, 2013, NAT CELL BIOL, V15, P363, DOI 10.1038/ncb2709; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Okada S, 1999, BLOOD, V93, P816, DOI 10.1182/blood.V93.3.816.403k21_816_825; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Park SJ, 2013, GENE DEV, V27, P2736, DOI 10.1101/gad.227926.113; Park SJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S50; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; Peng C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038614; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shen LJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059070, 10.1371/journal.pone.0077077, 10.1371/journal.pone.0077515]; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Umemoto T, 2012, BLOOD, V119, P83, DOI 10.1182/blood-2011-02-335430; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Weishaupt H, 2010, BLOOD, V115, P247, DOI 10.1182/blood-2009-07-235176; Whichard ZL, 2010, BLOOD, V115, P2339, DOI 10.1182/blood-2009-08-215798; Whitfield TW, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r50; Will B, 2013, NAT IMMUNOL, V14, P437, DOI 10.1038/ni.2572; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wozniak RJ, 2008, MOL CELL BIOL, V28, P6681, DOI 10.1128/MCB.01061-08; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Yu SY, 2012, CELL STEM CELL, V11, P207, DOI 10.1016/j.stem.2012.05.021; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705; Zhong JF, 2005, P NATL ACAD SCI USA, V102, P2448, DOI 10.1073/pnas.0409459102; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	64	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93853	10.1371/journal.pone.0093853	http://dx.doi.org/10.1371/journal.pone.0093853			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710559	Green Submitted, gold, Green Published			2022-12-25	WOS:000334159800057
J	Liou, JW; Chang, FT; Chung, Y; Chen, WY; Fischer, WB; Hsu, HJ				Liou, Je-Wen; Chang, Fang-Tzu; Chung, Yi; Chen, Wen-Yi; Fischer, Wolfgang B.; Hsu, Hao-Jen			In Silico Analysis Reveals Sequential Interactions and Protein Conformational Changes during the Binding of Chemokine CXCL-8 to Its Receptor CXCR1	PLOS ONE			English	Article							N-TERMINAL DOMAIN; MOLECULAR-DYNAMICS; INTERLEUKIN-8; ACTIVATION; AFFINITY; IDENTIFICATION; RECOGNITION; MUTAGENESIS; NMR	Chemokine CXCL-8 plays a central role in human immune response by binding to and activate its cognate receptor CXCR1, a member of the G-protein coupled receptor (GPCR) family. The full-length structure of CXCR1 is modeled by combining the structures of previous NMR experiments with those from homology modeling. Molecular docking is performed to search favorable binding sites of monomeric and dimeric CXCL-8 with CXCR1 and a mutated form of it. The receptor-ligand complex is embedded into a lipid bilayer and used in multi ns molecular dynamics (MD) simulations. A multi-steps binding mode is proposed: (i) the N-loop of CXCL-8 initially binds to the N-terminal domain of receptor CXCR1 driven predominantly by electrostatic interactions; (ii) hydrophobic interactions allow the N-terminal Glu-Leu-Arg (ELR) motif of CXCL-8 to move closer to the extracellular loops of CXCR1; (iii) electrostatic interactions finally dominate the interaction between the N-terminal ELR motif of CXCL-8 and the EC-loops of CXCR1. Mutation of CXCR1 abrogates this mode of binding. The detailed binding process may help to facilitate the discovery of agonists and antagonists for rational drug design.	[Liou, Je-Wen; Chen, Wen-Yi] Tzu Chi Univ, Sch Med, Dept Biochem, Hualien, Taiwan; [Chang, Fang-Tzu; Chung, Yi; Hsu, Hao-Jen] Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan; [Liou, Je-Wen] Natl Dong Hwa Univ, Nanotechnol Res Ctr, Hualien, Taiwan; [Fischer, Wolfgang B.] Natl Yang Ming Univ, Sch Biomed Sci & Engn, Inst Biophoton, Taipei 112, Taiwan; [Fischer, Wolfgang B.] Natl Yang Ming Univ, BMIRC, Taipei 112, Taiwan	Tzu Chi University; Tzu Chi University; National Dong Hwa University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Hsu, HJ (corresponding author), Tzu Chi Univ, Dept Life Sci, Hualien, Taiwan.	hjhsu32@mail.tcu.edu.tw	Liou, Je-Wen/ABB-2157-2020; Hsu, Hao-Jen/ABE-3718-2020	Liou, Je-Wen/0000-0002-6181-7263; Hsu, Hao-Jen/0000-0001-6096-7481; Fischer, Wolfgang/0000-0001-7753-1828	Tzu Chi University [TCIRP101005]; National Science Council Taiwan [NSC100-2218-E-320-001-MY3]	Tzu Chi University; National Science Council Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by Tzu Chi University (TCIRP101005), and the National Science Council Taiwan (NSC100-2218-E-320-001-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDWIN ET, 1991, P NATL ACAD SCI USA, V88, P502, DOI 10.1073/pnas.88.2.502; Barter EF, 2012, BIOCHEMISTRY-US, V51, P1322, DOI 10.1021/bi201615y; Chen R, 2003, PROTEINS, V51, P397, DOI 10.1002/prot.10334; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P1689, DOI 10.1021/bi00459a004; David R, 2008, J AM CHEM SOC, V130, P15311, DOI 10.1021/ja802453x; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Gozansky EK, 2005, J MOL BIOL, V345, P651, DOI 10.1016/j.jmb.2004.11.003; HEBERT CA, 1991, J BIOL CHEM, V266, P18989; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; Hsu HJ, 2012, J MOL MODEL, V18, P501, DOI 10.1007/s00894-011-1092-6; Huynh N, 2008, BIOPOLYMERS, V89, P52, DOI 10.1002/bip.20851; Joseph PRB, 2010, J BIOL CHEM, V285, P29262, DOI 10.1074/jbc.M110.146555; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kuschert GSV, 1998, BIOCHEMISTRY-US, V37, P11193, DOI 10.1021/bi972867o; Lebard DN, 2012, PLOS COMPUTATIONAL B, V8, P1; LEONG SR, 1994, J BIOL CHEM, V269, P19343; Li L, 2003, PROTEINS, V53, P693, DOI 10.1002/prot.10460; Love M, 2012, BIOCHEMISTRY-US, V51, P733, DOI 10.1021/bi201601k; Lowman HB, 1996, J BIOL CHEM, V271, P14344, DOI 10.1074/jbc.271.24.14344; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Nasser MW, 2009, J IMMUNOL, V183, P3425, DOI 10.4049/jimmunol.0900305; Nicholls DJ, 2008, MOL PHARMACOL, V74, P1193, DOI 10.1124/mol.107.044610; Park SH, 2012, NATURE, V491, P779, DOI 10.1038/nature11580; Park SH, 2011, J MOL BIOL, V414, P194, DOI 10.1016/j.jmb.2011.08.025; Prado GN, 2007, BIOCHEMISTRY-US, V46, P8961, DOI 10.1021/bi7004043; Rajagopalan L, 2004, J BIOL CHEM, V279, P30000, DOI 10.1074/jbc.M313883200; Rajagopalan L, 2006, BIOSCIENCE REP, V26, P325, DOI 10.1007/s10540-006-9025-9; Rajarathnam K, 1999, BIOCHEMISTRY-US, V38, P7653, DOI 10.1021/bi990033v; Rajarathnam K, 2006, BIOCHEMISTRY-US, V45, P7882, DOI 10.1021/bi0605944; Ravindran A, 2009, BIOCHEMISTRY-US, V48, P8795, DOI 10.1021/bi901194p; Sharma B, 2010, EXPERT OPIN THER TAR, V14, P435, DOI 10.1517/14728221003652471; Skelton NJ, 1999, STRUCTURE, V7, P157, DOI 10.1016/S0969-2126(99)80022-7; Sramala I, 2003, BIOPHYS J, V84, P3276, DOI 10.1016/S0006-3495(03)70052-6; Suetomi K, 1999, J BIOL CHEM, V274, P11768, DOI 10.1074/jbc.274.17.11768; Szpakowska M, 2012, BIOCHEM PHARMACOL, V84, P1366, DOI 10.1016/j.bcp.2012.08.008; WEBB LMC, 1993, P NATL ACAD SCI USA, V90, P7158, DOI 10.1073/pnas.90.15.7158; WU DQ, 1993, SCIENCE, V261, P101, DOI 10.1126/science.8316840; Yuan SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047114; Zhou J, 2004, J PHYS CHEM B, V108, P17418, DOI 10.1021/jp038048x	41	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94178	10.1371/journal.pone.0094178	http://dx.doi.org/10.1371/journal.pone.0094178			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705928	Green Published, Green Submitted, gold			2022-12-25	WOS:000334107500130
J	Bao, B; Azmi, AS; Aboukameel, A; Ahmad, A; Bolling-Fischer, A; Sethi, S; Ali, S; Li, YW; Kong, DJ; Banerjee, S; Back, J; Sarkar, FH				Bao, Bin; Azmi, Asfar S.; Aboukameel, Amro; Ahmad, Aamir; Bolling-Fischer, Aliccia; Sethi, Seema; Ali, Shadan; Li, Yiwei; Kong, Dejuan; Banerjee, Sanjeev; Back, Jessica; Sarkar, Fazlul H.			Pancreatic Cancer Stem-like Cells Display Aggressive Behavior Mediated via Activation of FoxQ1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLATE BINDING-PROTEIN; TUMOR-GROWTH; COLORECTAL-CANCER; RECEPTOR-ALPHA; ANALOG CDF; EXPRESSION; METASTASIS; SURVIVAL; TUMORIGENICITY; CURCUMIN	Subpopulations of cancer stem cells (CSCs) or cancer stem-like cells (CSLCs) have been identified from most tumors, including pancreatic cancer (PC), and the existence of these cells is clinically relevant. Emerging evidence suggests that CSLCs participate in cell growth/proliferation, migration/invasion, metastasis, and chemo-radiotherapy resistance, ultimately contributing to poor clinical outcome. However, the pathogenesis and biological significance of CSLCs in PC has not been well characterized. In the present study, we found that isolated triple-marker-positive (CD44(+)/CD133(+)/EpCAM(+)) cells of human PC MiaPaCa-2 and L3.6pl cells behave as CSLCs. These CSLCs exhibit aggressive behavior, such as increased cell growth, migration, clonogenicity, and self-renewal capacity. The mRNA expression profiling analysis showed that CSLCs (CD44(+)/CD133(+)/EpCAM(+)) exhibit differential expression of more than 1,600 mRNAs, including FoxQ1, compared with the triple-marker-negative (CD44(-)/CD133(-)/EpCAM(-)) cells. The knockdown of FoxQ1 by its siRNA in CSLCs resulted in the inhibition of aggressive behavior, consistent with the inhibition of EpCAM and Snail expression. Mouse xenograft tumor studies showed that CSLCs have a 100-fold higher potential for tumor formation and rapid tumor growth, consistent with overexpression of CSC-associated markers/mediators, including FoxQ1, compared with its parental MiaPaCa-2 cells. The inhibition of FoxQ1 attenuated tumor formation and growth, and expression of CSC markers in the xenograft tumor derived from CSLCs of MiaPaCa-2 cells. These data clearly suggest the role of differentially expressed genes in the regulation of CSLC characteristics, further suggesting that targeting some of these genes could be important for the development of novel therapies for achieving better treatment outcome of PC.	[Bao, Bin; Azmi, Asfar S.; Ahmad, Aamir; Sethi, Seema; Li, Yiwei; Kong, Dejuan; Banerjee, Sanjeev; Sarkar, Fazlul H.] Wayne State Univ, Dept Pathol, Sch Med, Detroit, MI 48201 USA; [Aboukameel, Amro; Bolling-Fischer, Aliccia; Sarkar, Fazlul H.] Wayne State Univ, Genom Core Facil, Sch Med, Detroit, MI 48201 USA; [Ali, Shadan] Wayne State Univ, Dept Oncol, Sch Med, Detroit, MI 48201 USA; [Back, Jessica] Wayne State Univ, Flow Cytometry Core Facil, Karmanos Canc Inst, Detroit, MI 48201 USA	Wayne State University; Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Sarkar, FH (corresponding author), Wayne State Univ, Dept Pathol, Sch Med, Karmanos Canc Inst,Hudson Webber Canc Res Ctr 740, 4100 John R St, Detroit, MI 48201 USA.	fsarkar@med.wayne.edu	Ahmad, Aamir/E-8747-2010	Ahmad, Aamir/0000-0003-1784-5723; AZMI, ASFAR/0000-0003-1178-9505				Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598; Allard JE, 2007, GYNECOL ONCOL, V107, P52, DOI 10.1016/j.ygyno.2007.05.018; Altaner C, 2008, NEOPLASMA, V55, P369; Bao B, 2012, CANCER RES, V72, P335, DOI 10.1158/0008-5472.CAN-11-2182; Bao B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017850; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Clarhaut J, 2013, LEUKEMIA RES, V37, P948, DOI 10.1016/j.leukres.2013.04.026; D'Angelica M, 2011, MODERN PATHOL, V24, P1221, DOI 10.1038/modpathol.2011.82; Ebel W., 2007, CANC IMMUN, V7, P6; Feng J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039937; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hermann PC, 2010, SEMIN CANCER BIOL, V20, P77, DOI 10.1016/j.semcancer.2010.03.004; Hermann PC, 2009, EXPERT OPIN BIOL TH, V9, P1271, DOI 10.1517/14712590903246362; Kallioniemi A, 2012, CANCER GENET-NY, V205, P267, DOI 10.1016/j.cancergen.2012.05.009; Kaneda H, 2010, CANCER RES, V70, P2053, DOI 10.1158/0008-5472.CAN-09-2161; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Katoh Y, 2006, INT J MOL MED, V18, P1019; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li YW, 2013, CANCER LETT, V338, P94, DOI 10.1016/j.canlet.2012.03.018; Liang SH, 2013, TUMOR BIOL, V34, P2605, DOI 10.1007/s13277-013-0808-x; Ma W, 2013, CELL CYCLE, V12, P88, DOI 10.4161/cc.23028; Sarkar FH, 2009, MINERVA CHIR, V64, P489; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sun HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055693; Toffoli G, 1998, INT J CANCER, V79, P121, DOI 10.1002/(SICI)1097-0215(19980417)79:2<121::AID-IJC4>3.0.CO;2-V; van Vlerken LE, 2013, STEM CELL TRANSL MED, V2, P43, DOI 10.5966/sctm.2012-0036; Lopez MAV, 2011, STEM CELLS DEV, V20, P1011, DOI 10.1089/scd.2010.0355; Villageois P, 2012, AM J STEM CELLS, V1, P42; Wood LD, 2012, ONCOTARGET, V3, P668; Xia LM, 2014, HEPATOLOGY, V59, P958, DOI 10.1002/hep.26735; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Zhang HJ, 2011, CANCER RES, V71, P1292, DOI 10.1158/0008-5472.CAN-10-2825; Zhu ZH, 2013, INT J ONCOL, V42, P1271, DOI 10.3892/ijo.2013.1807	34	43	52	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14520	14533		10.1074/jbc.M113.532887	http://dx.doi.org/10.1074/jbc.M113.532887			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24719318	Green Published, hybrid			2022-12-25	WOS:000337248100011
J	He, HZ; Singh, I; Wek, SA; Dey, S; Baird, TD; Wek, RC; Georgiadis, MM				He, Hongzhen; Singh, Isha; Wek, Sheree A.; Dey, Souvik; Baird, Thomas D.; Wek, Ronald C.; Georgiadis, Millie M.			Crystal Structures of GCN2 Protein Kinase C-terminal Domains Suggest Regulatory Differences in Yeast and Mammals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSLATION INITIATION; TRANSFER-RNA; PHOSPHORYLATION; ACTIVATION; BINDING; MICE; DIMERIZATION; EXPRESSION; MECHANISM	In response to amino acid starvation, GCN2 phosphorylation of eIF2 leads to repression of general translation and initiation of gene reprogramming that facilitates adaptation to nutrient stress. GCN2 is a multidomain protein with key regulatory domains that directly monitor uncharged tRNAs which accumulate during nutrient limitation, leading to activation of this eIF2 kinase and translational control. A critical feature of regulation of this stress response kinase is its C-terminal domain (CTD). Here, we present high resolution crystal structures of murine and yeast CTDs, which guide a functional analysis of the mammalian GCN2. Despite low sequence identity, both yeast and mammalian CTDs share a core subunit structure and an unusual interdigitated dimeric form, albeit with significant differences. Disruption of the dimeric form of murine CTD led to loss of translational control by GCN2, suggesting that dimerization is critical for function as is true for yeast GCN2. However, although both CTDs bind single-and double-stranded RNA, murine GCN2 does not appear to stably associate with the ribosome, whereas yeast GCN2 does. This finding suggests that there are key regulatory differences between yeast and mammalian CTDs, which is consistent with structural differences.	[He, Hongzhen; Singh, Isha; Wek, Sheree A.; Dey, Souvik; Baird, Thomas D.; Wek, Ronald C.; Georgiadis, Millie M.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Georgiadis, Millie M.] Indiana Univ Purdue Univ, Dept Chem & Chem Biol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis	Wek, RC (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	rwek@iu.edu; mgeorgia@iu.edu	Singh, Isha/GWV-6216-2022; Singh, Isha/AHA-8448-2022	Baird, Thomas/0000-0002-0280-9984	National Institutes of Health [GM049164]; Showalter Research Trust;  [T32DK064466]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK064466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM049164, R01GM049164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Showalter Research Trust; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM049164 (to R. C. W. and M. M. G.) and Predoctoral Fellowship T32DK064466 (T. D. B.). This work was also supported by the Showalter Research Trust (R. C. W.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; del Pino J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047272; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eyries M, 2014, NAT GENET, V46, P65, DOI 10.1038/ng.2844; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200; Jiang HY, 2005, BIOCHEM J, V385, P371, DOI 10.1042/BJ20041164; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Narasimhan J, 2004, J BIOL CHEM, V279, P22820, DOI 10.1074/jbc.M402228200; Qiu HF, 1998, MOL CELL BIOL, V18, P2697, DOI 10.1128/MCB.18.5.2697; RAMIREZ M, 1991, MOL CELL BIOL, V11, P3027, DOI 10.1128/MCB.11.6.3027; Ravindran R, 2014, SCIENCE, V343, P313, DOI 10.1126/science.1246829; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Sood R, 2000, GENETICS, V154, P787; Teske BF, 2011, METHOD ENZYMOL, V490, P333, DOI 10.1016/B978-0-12-385114-7.00019-2; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Won S, 2012, J VIROL, V86, P1802, DOI 10.1128/JVI.05660-11; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhu SH, 1998, J BIOL CHEM, V273, P1808, DOI 10.1074/jbc.273.3.1808	35	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					15023	15034		10.1074/jbc.M114.560789	http://dx.doi.org/10.1074/jbc.M114.560789			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24719324	hybrid, Green Published			2022-12-25	WOS:000337248100054
J	Yuan, ZH; Syed, MA; Panchal, D; Joo, M; Colonna, M; Brantly, M; Sadikot, RT				Yuan, Zhihong; Syed, Mansoor Ali; Panchal, Dipti; Joo, Myungsoo; Colonna, Marco; Brantly, Mark; Sadikot, Ruxana T.			Triggering Receptor Expressed on Myeloid Cells 1 (TREM-1)-mediated Bcl-2 Induction Prolongs Macrophage Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-ASSOCIATED MACROPHAGES; KAPPA-B ACTIVATION; GROWTH-RESPONSE 2; TREM-1 EXPRESSION; MITOCHONDRIAL FUSION; TRANSCRIPTION FACTOR; NECROSIS-FACTOR; EGR FAMILY; APOPTOSIS; INFLAMMATION	Triggering receptor expressed on myeloid cells 1 (TREM-1) is a superimmunoglobulin receptor expressed on myeloid cells that plays an important role in the amplification of inflammation. Recent studies suggest a role for TREM-1 in tumor-associated macrophages with relationship to tumor growth and progression. Whether the effects of TREM-1 on inflammation and tumor growth are mediated by an alteration in cell survival signaling is not known. In these studies, we show that TREM-1 knock-out macrophages exhibit an increase in apoptosis of cells in response to lipopolysaccharide (LPS) suggesting a role for TREM-1 in macrophage survival. Specific ligation of TREM-1 with monoclonal TREM-1 (mTREM-1) or overexpression of TREM-1 with adeno-TREM-1 induced B-cell lymphoma-2 (Bcl-2) with depletion of the key executioner caspase-3 prevents the cleavage of poly(ADP-ribose) polymerase. TREM-1 knockout cells showed lack of induction of Bcl2 with an increase in caspase-3 activation in response to lipopolysaccharide. In addition overexpression of TREM-1 with adeno-TREM-1 led to an increase in mitofusins (MFN1 and MFN2) and knockdown of TREM-1 decreased the expression of mitofusins suggesting that TREM-1 contributes to the maintenance of mitochondrial integrity favoring cell survival. Investigations into potential mechanisms by which TREM-1 alters cell survival showed that TREM-1-induced Bcl-2 in an Egr2-dependent manner. Furthermore, our data shows that expression of Egr2 in response to specific ligation of TREM-1 is ERK mediated. These data for the first time provide novel mechanistic insights into the role of TREM-1 as an anti-apoptotic protein that prolongs macrophage survival.	[Yuan, Zhihong; Sadikot, Ruxana T.] Vet Affairs Med Ctr, Gainesville, FL 32610 USA; [Yuan, Zhihong; Brantly, Mark; Sadikot, Ruxana T.] Univ Florida, Div Pulm Crit Care & Sleep Med, Gainesville, FL 32610 USA; [Syed, Mansoor Ali; Panchal, Dipti] Univ Illinois, Sect Pulm Crit Care & Sleep Med, Chicago, IL 60612 USA; [Joo, Myungsoo] Pusan Univ, Dept Immunol, Yangsan 626870, South Korea; [Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); State University System of Florida; University of Florida; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pusan National University; Pusan National University Hospital; Washington University (WUSTL)	Sadikot, RT (corresponding author), Univ Florida, Sect Pulm Crit Care & Sleep Med, 1601 SW Archer Rd, Gainesville, FL 32608 USA.	rtsadikot@ufl.edu	syed, mansoor ali/I-6957-2018; Brantly, Mark/AAH-2922-2020; syed, Mansoor ali/G-8986-2013	syed, Mansoor ali/0000-0003-2697-7832; Yuan, Zhihong/0000-0002-2300-0463; Colonna, Marco/0000-0001-5222-4987	Department of Veterans Affairs; Veterans Affairs [I01BX001786] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a grant from the Department of Veterans Affairs.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Bassiri H, 2009, IMMUNOL CELL BIOL, V87, P361, DOI 10.1038/icb.2009.20; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Brooks C, 2007, P NATL ACAD SCI USA, V104, P11649, DOI 10.1073/pnas.0703976104; Busca A, 2009, CURR GENOMICS, V10, P306, DOI 10.2174/138920209788920967; Byers DE, 2011, CHEST, V140, P768, DOI 10.1378/chest.10-2132; Byrne AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069246; Cerveny KL, 2007, TRENDS CELL BIOL, V17, P563, DOI 10.1016/j.tcb.2007.08.006; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Cleland MM, 2011, CELL DEATH DIFFER, V18, P235, DOI 10.1038/cdd.2010.89; Cohen HB, 2013, J LEUKOCYTE BIOL, V94, P913, DOI 10.1189/jlb.0413236; Colonna M, 2003, J INFECT DIS, V187, pS397, DOI 10.1086/374754; Cookson BT, 2001, TRENDS MICROBIOL, V9, P113, DOI 10.1016/S0966-842X(00)01936-3; Devos T, 2008, TRANSPLANTATION, V85, P1489, DOI 10.1097/TP.0b013e31816f24af; Dower K, 2008, J IMMUNOL, V180, P3520, DOI 10.4049/jimmunol.180.5.3520; Droin NM, 2003, MOL CELL BIOL, V23, P7638, DOI 10.1128/MCB.23.21.7638-7647.2003; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fiandalo M. V., 2012, Experimental Oncology, V34, P165; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Fullerton JN, 2013, J PATHOL, V231, P8, DOI 10.1002/path.4232; Galdiero MR, 2013, J CELL PHYSIOL, V228, P1404, DOI 10.1002/jcp.24260; Galdiero MR, 2013, IMMUNOBIOLOGY, V218, P1402, DOI 10.1016/j.imbio.2013.06.003; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Harris JE, 2004, J IMMUNOL, V173, P7331, DOI 10.4049/jimmunol.173.12.7331; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Hensley P, 2013, BIOL CHEM, V394, P831, DOI 10.1515/hsz-2013-0128; Hirano S, 2002, IMMUNOLOGY, V107, P86, DOI 10.1046/j.1365-2567.2002.01487.x; Ho CC, 2008, AM J RESP CRIT CARE, V177, P763, DOI 10.1164/rccm.200704-641OC; Hu WH, 2009, DNA CELL BIOL, V28, P13, DOI 10.1089/dna.2008.0782; JOSEPH LJ, 1988, P NATL ACAD SCI USA, V85, P7164, DOI 10.1073/pnas.85.19.7164; Kao SC, 2009, SCIENCE, V323, P651, DOI 10.1126/science.1166562; Keeton AB, 2003, ENDOCRINOLOGY, V144, P5402, DOI 10.1210/en.2003-0592; Klesney-Tait J, 2013, J CLIN INVEST, V123, P138, DOI 10.1172/JCI64181; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Kumbrink J, 2010, J CELL BIOCHEM, V111, P207, DOI 10.1002/jcb.22690; LaRock CN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003793; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lauritsen JPH, 2008, J IMMUNOL, V181, P7778, DOI 10.4049/jimmunol.181.11.7778; Lawson VJ, 2010, EUR J IMMUNOL, V40, P232, DOI 10.1002/eji.200939567; Lazarevic V, 2009, NAT IMMUNOL, V10, P306, DOI 10.1038/ni.1696; Liao R, 2012, CANCER SCI, V103, P984, DOI 10.1111/j.1349-7006.2012.02273.x; Lichtnekert J, 2013, CURR OPIN PHARMACOL, V13, P555, DOI 10.1016/j.coph.2013.05.013; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Mager GM, 2008, J BIOL CHEM, V283, P18187, DOI 10.1074/jbc.M803330200; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Myouzen K, 2010, HUM MOL GENET, V19, P2313, DOI 10.1093/hmg/ddq092; Nathan C, 2001, NAT MED, V7, P530, DOI 10.1038/87846; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Ornatowska M, 2007, AM J PHYSIOL-LUNG C, V293, pL1377, DOI 10.1152/ajplung.00140.2007; Peter ME, 2011, NATURE, V471, P310, DOI 10.1038/471310a; Rodrigues MF, 2013, IMMUNOLOGY, V139, P503, DOI 10.1111/imm.12097; Rolland SG, 2010, CURR OPIN CELL BIOL, V22, P852, DOI 10.1016/j.ceb.2010.07.014; Rolland SG, 2009, J CELL BIOL, V186, P525, DOI 10.1083/jcb.200905070; Sadikot RT, 2004, J IMMUNOL, V172, P1801, DOI 10.4049/jimmunol.172.3.1801; Sadikot RT, 2001, AM J RESP CRIT CARE, V164, P873, DOI 10.1164/ajrccm.164.5.2008059; Syed MA, 2010, EXP CELL RES, V316, P3140, DOI 10.1016/j.yexcr.2010.08.009; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tessarz AAS, 2008, IMMUNOL LETT, V116, P111, DOI 10.1016/j.imlet.2007.11.021; Venken K, 2002, NEUROGENETICS, V4, P37, DOI 10.1007/s10048-001-0124-2; Waxman AB, 2009, AM J RESP CELL MOL, V41, P385, DOI 10.1165/rcmb.2008-0302OC; Wu J, 2012, CANCER RES, V72, P3977, DOI 10.1158/0008-5472.CAN-12-0938; Wyllie AH, 2010, MOL NEUROBIOL, V42, P4, DOI 10.1007/s12035-010-8125-5; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yuan ZH, 2012, INT J BIOCHEM CELL B, V44, P2032, DOI 10.1016/j.biocel.2012.08.001; Zeng H, 2007, EUR J IMMUNOL, V37, P2300, DOI 10.1002/eji.200737270; Zhang Y, 2007, FEBS LETT, V581, P2168, DOI 10.1016/j.febslet.2007.01.095; Zheng H, 2010, EUR J IMMUNOL, V40, P162, DOI 10.1002/eji.200839156; Zhou JG, 2013, INT IMMUNOPHARMACOL, V17, P155, DOI 10.1016/j.intimp.2013.06.009	70	49	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					15118	15129		10.1074/jbc.M113.536490	http://dx.doi.org/10.1074/jbc.M113.536490			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24711453	Green Published, hybrid			2022-12-25	WOS:000337248100062
J	Choi, MY; Kohler, R; Meer, RKV; Neupert, S; Predel, R				Choi, Man-Yeon; Koehler, Rene; Meer, Robert K. Vander; Neupert, Susanne; Predel, Reinhard			Identification and Expression of Capa Gene in the Fire Ant, Solenopsis invicta	PLOS ONE			English	Article							MANDUCA-SEXTA ALLATOTROPIN; AMERICAN COCKROACH; DROSOPHILA-MELANOGASTER; PERISYMPATHETIC ORGANS; FUNCTIONAL EXPRESSION; MOLECULAR-CLONING; PROTEIN HORMONES; TOBACCO HAWKMOTH; NERVOUS-SYSTEM; CLEAVAGE SITES	Recent genome analyses suggested the absence of a number of neuropeptide genes in ants. One of the apparently missing genes was the capa gene. Capa gene expression in insects is typically associated with the neuroendocrine system of abdominal ganglia; mature CAPA peptides are known to regulate diuresis and visceral muscle contraction. The apparent absence of the capa gene raised questions about possible compensation of these functions. In this study, we re-examined this controversial issue and searched for a potentially unrecognized capa gene in the fire ant, Solenopsis invicta. We employed a combination of data mining and a traditional PCR-based strategy using degenerate primers designed from conserved amino acid sequences of insect capa genes. Our findings demonstrate that ants possess and express a capa gene. As shown by MALDI-TOF mass spectrometry, processed products of the S. invicta capa gene include three CAPA periviscerokinins and low amounts of a pyrokinin which does not have the C-terminal WFGPRLa motif typical of CAPA pyrokinins in other insects. The capa gene was found with two alternative transcripts in the CNS. Within the ventral nerve cord, two capa neurons were immunostained in abdominal neuromeres 2-5, respectively, and projected into ventrally located abdominal perisympathetic organs (PSOs), which are the major hormone release sites of abdominal ganglia. The ventral location of these PSOs is a characteristic feature and was also found in another ant, Atta sexdens.	[Choi, Man-Yeon; Meer, Robert K. Vander] USDA ARS, Ctr Med Agr & Vet Entomol, Gainesville, FL USA; [Koehler, Rene; Neupert, Susanne; Predel, Reinhard] Univ Cologne, Bioctr, Inst Zool, D-50931 Cologne, Germany	United States Department of Agriculture (USDA); University of Cologne	Choi, MY (corresponding author), USDA ARS, Hort Crops Res Unit, Corvallis, OR USA.	mychoi@ars.usda.gov; rpredel@uni-koeln.de	Predel, Reinhard/O-5243-2015	Choi, Man-yeon/0000-0003-0769-380X	Deutsche Forschungsgemeinschaft [Predel 595/6-1, Predel 595/6-2, 766/9-1]; Luxemburg Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Luxemburg Foundation	The authors acknowledge the financial assistance of the Deutsche Forschungsgemeinschaft (Predel 595/6-1, 2; 766/9-1) and Luxemburg Foundation ( to RK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks W.A., 1981, AATSS21 USDA SEA; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; Cazzamali G, 2005, BIOCHEM BIOPH RES CO, V335, P14, DOI 10.1016/j.bbrc.2005.07.038; Choi MY, 2011, J INSECT PHYSIOL, V57, P161, DOI 10.1016/j.jinsphys.2010.10.008; Choi MY, 2009, CELL TISSUE RES, V335, P431, DOI 10.1007/s00441-008-0721-6; Davies SA, 2013, GEN COMP ENDOCR, V188, P60, DOI 10.1016/j.ygcen.2013.03.012; Davis NT, 1996, MICROSC RES TECHNIQ, V35, P201, DOI 10.1002/(SICI)1097-0029(19961015)35:3&lt;201::AID-JEMT3&gt;3.0.CO;2-Q; East P, 1996, REGUL PEPTIDES, V67, P1, DOI 10.1016/S0167-0115(96)00109-7; Eckert M, 1999, CELL TISSUE RES, V295, P159, DOI 10.1007/s004410051222; Gabilondo H, 2011, MECH DEVELOP, V128, P208, DOI 10.1016/j.mod.2011.01.002; Hauser F, 2010, J PROTEOME RES, V9, P5296, DOI 10.1021/pr100570j; Horodyski FM, 2001, PEPTIDES, V22, P263, DOI 10.1016/S0196-9781(00)00378-8; Hummon AB, 2006, SCIENCE, V314, P647, DOI 10.1126/science.1124128; Iversen A, 2002, BIOCHEM BIOPH RES CO, V299, P924, DOI 10.1016/S0006-291X(02)02798-5; Iversen A, 2002, BIOCHEM BIOPH RES CO, V299, P628, DOI 10.1016/S0006-291X(02)02709-2; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kean L, 2002, AM J PHYSIOL-REG I, V282, pR1297, DOI 10.1152/ajpregu.00584.2001; Kim YJ, 2008, PEPTIDES, V29, P268, DOI 10.1016/j.peptides.2007.12.001; Lee Jae Min, 2012, Front Endocrinol (Lausanne), V3, P6, DOI 10.3389/fendo.2012.00006; Lee KY, 2002, PEPTIDES, V23, P1933, DOI 10.1016/S0196-9781(02)00181-X; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; Loi PK, 2004, J EXP BIOL, V207, P3681, DOI 10.1242/jeb.01186; Ma PWK, 2000, J INSECT PHYSIOL, V46, P221, DOI 10.1016/S0022-1910(99)00174-2; Melcher C, 2006, PLOS BIOL, V4, P316, DOI 10.1371/journal.pbio.0040068; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Neupert S, 2014, EUPA OPEN PROTEOMICS; Neupert S, 2010, PEPTIDES, V31, P408, DOI 10.1016/j.peptides.2009.09.021; Neupert S, 2009, J NEUROCHEM, V111, P757, DOI 10.1111/j.1471-4159.2009.06361.x; Niven JE, 2008, ANNU REV ENTOMOL, V53, P253, DOI 10.1146/annurev.ento.52.110405.091322; Nygaard S, 2011, GENOME RES, V21, P1339, DOI 10.1101/gr.121392.111; Predel R, 2003, PEPTIDES, V24, P1457, DOI 10.1016/j.peptides.2003.07.020; Predel R, 2006, CELL MOL LIFE SCI, V63, P2477, DOI 10.1007/s00018-006-6187-3; Predel R, 1999, INSECT BIOCHEM MOLEC, V29, P139, DOI 10.1016/S0965-1748(98)00117-9; PREDEL R, 1995, PEPTIDES, V16, P61, DOI 10.1016/0196-9781(94)00144-U; Predel R, 1998, PEPTIDES, V19, P801, DOI 10.1016/S0196-9781(98)00019-9; Predel R, 2013, PEPTIDES, V41, P2, DOI 10.1016/j.peptides.2012.12.009; Predel R, 2010, J PROTEOME RES, V9, P2006, DOI 10.1021/pr901187p; Predel R, 2007, J COMP NEUROL, V500, P498, DOI 10.1002/cne.21183; Raabe M., 1983, Advances in Insect Physiology, V17, P205, DOI 10.1016/S0065-2806(08)60219-2; Rosenkilde C, 2003, BIOCHEM BIOPH RES CO, V309, P485, DOI 10.1016/j.bbrc.2003.08.022; Santos JG, 2006, CELL TISSUE RES, V326, P187, DOI 10.1007/s00441-006-0211-7; Southey BR, 2008, BIOINFORMATICS, V24, P815, DOI 10.1093/bioinformatics/btn044; Suska A, 2011, DEV BIOL, V353, P72, DOI 10.1016/j.ydbio.2011.02.015; Taylor PA, 1996, EUR J BIOCHEM, V239, P588, DOI 10.1111/j.1432-1033.1996.0588u.x; Veenstra JA, 2000, ARCH INSECT BIOCHEM, V43, P49, DOI 10.1002/(SICI)1520-6327(200002)43:2&lt;49::AID-ARCH1&gt;3.0.CO;2-M; Wegener C, 2006, J NEUROCHEM, V96, P1362, DOI 10.1111/j.1471-4159.2005.03634.x; Wegener C, 2010, METHODS MOL BIOL, V615, P117, DOI 10.1007/978-1-60761-535-4_9; WILLE ALVARO, 1961, REV BIOL TROP, V9, P117; Wurm Y, 2011, P NATL ACAD SCI USA, V108, P5679, DOI 10.1073/pnas.1009690108	49	10	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94274	10.1371/journal.pone.0094274	http://dx.doi.org/10.1371/journal.pone.0094274			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718032	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000100
J	Jank, JM; Maier, EM; Reiss, DD; Haslbeck, M; Kemter, KF; Truger, MS; Sommerhoff, CP; Ferdinandusse, S; Wanders, RJ; Gersting, SW; Muntau, AC				Jank, Johanna M.; Maier, Esther M.; Reiss, Dunja D.; Haslbeck, Martin; Kemter, Kristina F.; Truger, Marietta S.; Sommerhoff, Christian P.; Ferdinandusse, Sacha; Wanders, Ronald J.; Gersting, Soren W.; Muntau, Ania C.			The Domain-Specific and Temperature-Dependent Protein Misfolding Phenotype of Variant Medium-Chain acyl-CoA Dehydrogenase	PLOS ONE			English	Article							MILD MCAD DEFICIENCY; ACID BETA-OXIDATION; NEW-YORK-STATE; COENZYME-A; PREVALENT MUTATION; GENETIC-DEFECTS; PHENYLKETONURIA; IDENTIFICATION; STABILITY; ORGANIZATION	The implementation of expanded newborn screening programs reduced mortality and morbidity in medium-chain acyl-CoA dehydrogenase deficiency (MCADD) caused by mutations in the ACADM gene. However, the disease is still potentially fatal. Missense induced MCADD is a protein misfolding disease with a molecular loss-of-function phenotype. Here we established a comprehensive experimental setup to analyze the structural consequences of eight ACADM missense mutations (p. Ala52Val, p. Tyr67His, p. Tyr158His, p. Arg206Cys, p. Asp266Gly, p. Lys329Glu, p. Arg334Lys, p. Arg413Ser) identified after newborn screening and linked the corresponding protein misfolding phenotype to the site of side-chain replacement with respect to the domain. With fever being the crucial risk factor for metabolic decompensation of patients with MCADD, special emphasis was put on the analysis of structural and functional derangements related to thermal stress. Based on protein conformation, thermal stability and kinetic stability, the molecular phenotype in MCADD depends on the structural region that is affected by missense-induced conformational changes with the central beta-domain being particularly prone to structural derangement and destabilization. Since systematic classification of conformational derangements induced by ACADM mutations may be a helpful tool in assessing the clinical risk of patients, we scored the misfolding phenotype of the variants in comparison to p. Lys329Glu (K304E), the classical severe mutation, and p. Tyr67His (Y42H), discussed to be mild. Experiments assessing the impact of thermal stress revealed that mutations in the ACADM gene lower the temperature threshold at which MCAD loss-of-function occurs. Consequently, increased temperature as it occurs during intercurrent infections, significantly increases the risk of further conformational derangement and loss of function of the MCAD enzyme explaining the life-threatening clinical courses observed during fever episodes. Early and aggressive antipyretic treatment thus may be life-saving in patients suffering from MCADD.	[Jank, Johanna M.; Maier, Esther M.; Reiss, Dunja D.; Kemter, Kristina F.; Truger, Marietta S.; Gersting, Soren W.; Muntau, Ania C.] Univ Munich, Dr von Hauner Childrens Hosp, Dept Mol Pediat, Munich, Germany; [Haslbeck, Martin] Tech Univ Munich, Dept Chem, Garching, Germany; [Sommerhoff, Christian P.] Univ Munich, Inst Lab Med, Munich, Germany; [Ferdinandusse, Sacha; Wanders, Ronald J.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Lab Med,Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands; [Ferdinandusse, Sacha; Wanders, Ronald J.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Dept Pediat,Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands	University of Munich; Technical University of Munich; University of Munich; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Muntau, AC (corresponding author), Univ Munich, Dr von Hauner Childrens Hosp, Dept Mol Pediat, Munich, Germany.	Ania.Muntau@med.lmu.de	Haslbeck, Martin/A-4413-2013; Gersting, Soeren/D-4612-2011	Ferdinandusse, Sacha/0000-0002-7738-5709; Gersting, Soeren/0000-0001-7482-4748	Deutsche Forschungsgemeinschaft [MA 2227/3-1]; Bavarian Genome Research Network; SHS International Gesellschaft fur klinische Ernahrung GmbH	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bavarian Genome Research Network; SHS International Gesellschaft fur klinische Ernahrung GmbH	This work was supported by the Deutsche Forschungsgemeinschaft, grant MA 2227/3-1, the Bavarian Genome Research Network, and the SHS International Gesellschaft fur klinische Ernahrung GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen BS, 2001, AM J HUM GENET, V68, P1408, DOI 10.1086/320602; Antonarakis SE, 1998, HUM MUTAT, V11, P1; Arnold GL, 2010, MOL GENET METAB, V99, P263, DOI 10.1016/j.ymgme.2009.10.188; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; BROSS P, 1993, BIOCHIM BIOPHYS ACTA, V1182, P264, DOI 10.1016/0925-4439(93)90068-C; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; CARTIER N, 1994, ARCH PEDIATRIE, V1, P243; Chou YW, 2012, ARCH BIOCHEM BIOPHYS, V520, P74, DOI 10.1016/j.abb.2012.02.015; Dessein AF, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-26; Gersting SW, 2008, AM J HUM GENET, V83, P5, DOI 10.1016/j.ajhg.2008.05.013; Ghisla S, 2004, EUR J BIOCHEM, V271, P494, DOI 10.1046/j.1432-1033.2003.03946.x; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; Gregersen N, 2004, EUR J BIOCHEM, V271, P470, DOI 10.1046/j.1432-1033.2003.03949.x; Gregersen N, 2000, EUR J PEDIATR, V159, pS213, DOI 10.1007/PL00014406; GREGERSEN N, 1991, CLIN CHIM ACTA, V203, P23, DOI 10.1016/0009-8981(91)90153-4; Gregersen N, 2008, J INHERIT METAB DIS, V31, P643, DOI 10.1007/s10545-008-0990-y; Grosse SD, 2006, GENET MED, V8, P205, DOI 10.1097/01.gim.0000204472.25153.8d; IAFOLLA AK, 1994, J PEDIATR-US, V124, P409, DOI 10.1016/S0022-3476(94)70363-9; JAKOB U, 1995, J BIOL CHEM, V270, P14412, DOI 10.1074/jbc.270.24.14412; Kim JJP, 2004, EUR J BIOCHEM, V271, P483, DOI 10.1046/j.1432-1033.2003.03948.x; LEHMAN TC, 1990, ANAL BIOCHEM, V186, P280, DOI 10.1016/0003-2697(90)90080-S; Levy HL, 2010, GENET MED, V12, pS213, DOI 10.1097/GIM.0b013e3181fe5d77; Li H, 2010, BRAIN DEV-JPN, V32, P362, DOI 10.1016/j.braindev.2009.06.001; Maier EM, 2005, HUM MUTAT, V25, P443, DOI 10.1002/humu.20163; Maier EM, 2009, HUM MOL GENET, V18, P1612, DOI 10.1093/hmg/ddp079; MATSUBARA Y, 1989, J BIOL CHEM, V264, P16321; Muntau AC, 2002, NEW ENGL J MED, V347, P2122, DOI 10.1056/NEJMoa021654; Nasser I, 2004, BBA-MOL BASIS DIS, V1690, P22, DOI 10.1016/j.bbadis.2004.04.008; Nichols MJ, 2008, AM J MED GENET A, V146A, P610, DOI 10.1002/ajmg.a.32192; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; O'Reilly L, 2004, EUR J BIOCHEM, V271, P4053, DOI 10.1111/j.1432-1033.2004.04343.x; Pey AL, 2008, J CLIN INVEST, V118, P2858, DOI 10.1172/JCI34355; Smith EH, 2010, MOL GENET METAB, V100, P241, DOI 10.1016/j.ymgme.2010.04.001; Sturm M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045110; ter Veld F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006449; Thorolfsson M, 2002, BIOCHEMISTRY-US, V41, P7573, DOI 10.1021/bi0160720; Touw CML, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-43; Touw CML, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-30; Trefz FK, 2009, J PEDIATR-US, V154, P700, DOI 10.1016/j.jpeds.2008.11.040; Waddell L, 2006, MOL GENET METAB, V87, P32, DOI 10.1016/j.ymgme.2005.09.020; Wanders RJA, 2010, J INHERIT METAB DIS, V33, P479, DOI 10.1007/s10545-010-9104-8; WILCKEN B, 1994, ARCH DIS CHILD, V70, P410, DOI 10.1136/adc.70.5.410; Wilcken B, 2013, SCIENCE, V342, P197, DOI 10.1126/science.1243944; YOKOTA I, 1991, AM J HUM GENET, V49, P1280; YOKOTA I, 1990, J CLIN INVEST, V86, P1000, DOI 10.1172/JCI114761; Yusupov R, 2010, MOL GENET METAB, P1; Zolkipli Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017534; Zschocke J, 2001, HUM GENET, V108, P404, DOI 10.1007/s004390100501	48	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93852	10.1371/journal.pone.0093852	http://dx.doi.org/10.1371/journal.pone.0093852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718418	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000049
J	Jay, CV; Grebmeier, JM; Fischbach, AS; McDonald, TL; Cooper, LW; Hornsby, F				Jay, Chadwick V.; Grebmeier, Jacqueline M.; Fischbach, Anthony S.; McDonald, Trent L.; Cooper, Lee W.; Hornsby, Fawn			Pacific Walrus (Odobenus rosmarus divergens) Resource Selection in the Northern Bering Sea	PLOS ONE			English	Article							HIERARCHICAL PATCH DYNAMICS; LAWRENCE-ISLAND POLYNYA; CHUKCHI SEAS; PROTECTED AREAS; CALORIC CONTENT; ICE; SEDIMENTATION; AVAILABILITY; CLIMATE; SCALES	The Pacific walrus is a large benthivore with an annual range extending across the continental shelves of the Bering and Chukchi Seas. We used a discrete choice model to estimate site selection by adult radio-tagged walruses relative to the availability of the caloric biomass of benthic infauna and sea ice concentration in a prominent walrus wintering area in the northern Bering Sea (St. Lawrence Island polynya) in 2006, 2008, and 2009. At least 60% of the total caloric biomass of dominant macroinfauna in the study area was composed of members of the bivalve families Nuculidae, Tellinidae, and Nuculanidae. Model estimates indicated walrus site selection was related most strongly to tellinid bivalve caloric biomass distribution and that walruses selected lower ice concentrations from the mostly high ice concentrations that were available to them (quartiles: 76%, 93%, and 99%). Areas with high average predicted walrus site selection generally coincided with areas of high organic carbon input identified in other studies. Projected decreases in sea ice in the St. Lawrence Island polynya and the potential for a concomitant decline of bivalves in the region could result in a northward shift in the wintering grounds of walruses in the northern Bering Sea.	[Jay, Chadwick V.; Fischbach, Anthony S.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99504 USA; [Grebmeier, Jacqueline M.; Cooper, Lee W.] Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA; [McDonald, Trent L.; Hornsby, Fawn] Western EcoSyst Technol Inc, Laramie, WY USA	United States Department of the Interior; United States Geological Survey; University System of Maryland; University of Maryland Center for Environmental Science	Jay, CV (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99504 USA.	cjay@usgs.gov	Cooper, Lee W./E-5251-2012; Grebmeier, Jacqueline/L-9805-2013	Cooper, Lee W./0000-0001-7734-8388; Grebmeier, Jacqueline/0000-0001-7624-3568	U.S. National Science Foundation [ARC-082290]; North Pacific Research Board (BSIERP) [B67]; U.S. Fish & Wildlife Service; U.S. Geological Survey; North Pacific Research Board (NPRB) [632]; U.S. National Science Foundation; U.S. Geological Survey, Ecosystems Mission Area, Wildlife Program, and North Pacific Research Board (NPRB) [B67]; BEST-BSIERP Bering Sea Project [136]	U.S. National Science Foundation(National Science Foundation (NSF)); North Pacific Research Board (BSIERP); U.S. Fish & Wildlife Service(US Fish & Wildlife Service); U.S. Geological Survey(United States Geological Survey); North Pacific Research Board (NPRB); U.S. National Science Foundation(National Science Foundation (NSF)); U.S. Geological Survey, Ecosystems Mission Area, Wildlife Program, and North Pacific Research Board (NPRB); BEST-BSIERP Bering Sea Project	Financial support was provided to PIs Grebmeier and Cooper through the U.S. National Science Foundation (ARC-082290) and the North Pacific Research Board (BSIERP Project B67). Walrus tagging data in 2006 was obtained from a separate project with financial support from U.S. Fish & Wildlife Service, U.S. Geological Survey, and North Pacific Research Board (NPRB # 632). Tagging data in 2008 and 2009 was obtained specifically for this project with ship and aerial support from the U.S. National Science Foundation and financial support from the U.S. Geological Survey, Ecosystems Mission Area, Wildlife Program, and North Pacific Research Board (NPRB # B67). This work was assigned the following project numbers: BEST-BSIERP Bering Sea Project publication number 136 and NPRB publication number 480. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bluhm BA, 2008, ECOL APPL, V18, pS77, DOI 10.1890/06-0562.1; Boyce MS, 2006, DIVERS DISTRIB, V12, P269, DOI 10.1111/j.1366-9516.2006.00243.x; BRAWN VM, 1968, J FISH RES BOARD CAN, V25, P1803, DOI 10.1139/f68-166; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burns J.J., 1981, E BERING SEA SHELF O, V2, P781; Carriere MA, 2010, CAN J ZOOL, V88, P846, DOI 10.1139/Z10-048; CAVALIERI DJ, 1991, J GEOPHYS RES-OCEANS, V96, P21989, DOI 10.1029/91JC02335; Collecte Localisation Satellites, 2011, ARG US MAN; Cooper LW, 2013, DEEP-SEA RES PT II, V94, P31, DOI 10.1016/j.dsr2.2013.03.009; Cooper LW, 2012, DEEP-SEA RES PT II, V65-70, P141, DOI 10.1016/j.dsr2.2012.02.002; Cooper LW, 2002, MAR ECOL PROG SER, V226, P13, DOI 10.3354/meps226013; Costa DP, 2003, ECOL MONOGR, V73, P27, DOI 10.1890/0012-9615(2003)073[0027:EOABDS]2.0.CO;2; Danielson S, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003268; Dedrick KR, 2001, CAN J REMOTE SENS, V27, P457, DOI 10.1080/07038992.2001.10854887; Douglas DC, 2012, METHODS ECOL EVOL, V3, P999, DOI 10.1111/j.2041-210X.2012.00245.x; Douglas DC, 2010, 20101176 US GEOL SUR, P1; Fauchald P, 2006, OECOLOGIA, V149, P383, DOI 10.1007/s00442-006-0463-7; FAY F H, 1985, Mammalian Species, P1, DOI 10.2307/3503810; Fay F.H., 1982, 74 US FISH WILDF SER; Fay FH, 1977, PB273505 UD DEP COMM; FEDER HM, 1994, MAR ECOL PROG SER, V111, P171, DOI 10.3354/meps111171; Grebmeier JM, 2006, PROG OCEANOGR, V71, P331, DOI 10.1016/j.pocean.2006.10.001; Grebmeier JM, 2012, ANNU REV MAR SCI, V4, P63, DOI 10.1146/annurev-marine-120710-100926; GREBMEIER JM, 1989, MAR ECOL PROG SER, V51, P253, DOI 10.3354/meps051253; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; GREBMEIER JM, 1988, MAR ECOL PROG SER, V48, P57, DOI 10.3354/meps048057; GREBMEIER JM, 1995, J GEOPHYS RES-OCEANS, V100, P4439, DOI 10.1029/94JC02198; Hondolero D, 2012, POLAR BIOL, V35, P637, DOI 10.1007/s00300-011-1107-x; Jay CV, 2012, MAR ECOL PROG SER, V468, P1, DOI 10.3354/meps10057; Jay CV, 2011, POLAR BIOL, V34, P1065, DOI 10.1007/s00300-011-0967-4; Jay CV, 2010, MAR ECOL PROG SER, V407, P293, DOI 10.3354/meps08575; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; Kovacs Kit M., 2011, Marine Biodiversity, V41, P181, DOI 10.1007/s12526-010-0061-0; Laidre KL, 2008, ECOL APPL, V18, pS97, DOI 10.1890/06-0546.1; Lindqvist C, 2009, ZOOL SCR, V38, P113, DOI 10.1111/j.1463-6409.2008.00364.x; Lovvorn JR, 2014, ECOL APPL, V24, P396, DOI 10.1890/13-0411.1; Lovvorn JR, 2013, MAR ECOL PROG SER, V489, P245, DOI 10.3354/meps10439; Lovvorn JR, 2009, ECOL APPL, V19, P1596, DOI 10.1890/08-1193.1; Manly B.F.J., 2002, RESOURCE SELECTION A; McDonald TL, 2006, J WILDLIFE MANAGE, V70, P375, DOI 10.2193/0022-541X(2006)70[375:DMIWSE]2.0.CO;2; OLIVER JS, 1983, FISH B-NOAA, V81, P501; Partington K, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001623; SHEATHER SJ, 1991, J ROY STAT SOC B MET, V53, P683; Sheffield G, 2009, MAR MAMMAL SCI, V25, P761, DOI 10.1111/j.1748-7692.2009.00316.x; Spreen G, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2005JC003384; STIRLING I, 1980, ARCTIC, V33, P303; STOKER S., 1978, THESIS U ALASKA FAIR; Stoker S, 1981, E BERING SEA SHELF O, P1069; STRINGER WJ, 1991, ARCTIC, V44, P164; Tynan CT, 1997, ARCTIC, V50, P308, DOI 10.14430/arctic1113; Wang MY, 2012, DEEP-SEA RES PT II, V65-70, P46, DOI 10.1016/j.dsr2.2012.02.022; Wilt LM, 2012, THESIS U MARYLAND CO; Wu JG, 1995, Q REV BIOL, V70, P439, DOI 10.1086/419172	54	29	29	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93035	10.1371/journal.pone.0093035	http://dx.doi.org/10.1371/journal.pone.0093035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717979	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000024
J	Lu, S; Wang, RX; Cai, CL; Liang, JB; Xu, LC; Miao, SY; Wang, LF; Song, W				Lu, Shan; Wang, Renxian; Cai, Congli; Liang, Junbo; Xu, Longchang; Miao, Shiying; Wang, Linfang; Song, Wei			Small Kinetochore Associated Protein (SKAP) Promotes UV-Induced Cell Apoptosis through Negatively Regulating Pre-mRNA Processing Factor 19 (Prp19)	PLOS ONE			English	Article							COMPLEX; DEATH; INTERACTS; U5	Apoptosis is a regulated cellular suicide program that is critical for the development and maintenance of healthy tissues. Previous studies have shown that small kinetochore associated protein (SKAP) cooperates with kinetochore and mitotic spindle proteins to regulate mitosis. However, the role of SKAP in apoptosis has not been investigated. We have identified a new interaction involving SKAP, and we propose a mechanism through which SKAP regulates cell apoptosis. Our experiments demonstrate that both overexpression and knockdown of SKAP sensitize cells to UV-induced apoptosis. Further study has revealed that SKAP interacts with Pre-mRNA processing Factor 19 (Prp19). We find that UV-induced apoptosis can be inhibited by ectopic expression of Prp19, whereas silencing Prp19 has the opposite effect. Additionally, SKAP negatively regulates the protein levels of Prp19, whereas Prp19 does not alter SKAP expression. Finally, rescue experiments demonstrate that the pro-apoptotic role of SKAP is executed through Prp19. Taken together, these findings suggest that SKAP promotes UV-induced cell apoptosis by negatively regulating the anti-apoptotic protein Prp19.	[Lu, Shan; Wang, Renxian; Cai, Congli; Liang, Junbo; Xu, Longchang; Miao, Shiying; Wang, Linfang; Song, Wei] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Biochem & Mol Biol,State Key Lab Med Mol Bio, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Song, W (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Biochem & Mol Biol,State Key Lab Med Mol Bio, Beijing 100730, Peoples R China.	songwei@ibms.pumc.edu.cn	王, 任先/HHS-8169-2022; Xu, Lon Chang/HGU-1004-2022; Liang, Junbo/AFN-3446-2022		State Key Laboratory Special fund from the Ministry of Science [2060204]; National Important Research Plan of China [2012BAI31B08, 2012CB944902, 2011CB944302]; National Natural Sciences Foundation of China [81101855]; Specialized Research Fund for the Doctoral Program of Higher Education [20111106120018]	State Key Laboratory Special fund from the Ministry of Science; National Important Research Plan of China; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the State Key Laboratory Special fund from the Ministry of Science (2060204), grants from the National Important Research Plan of China (2012BAI31B08, 2012CB944902, and 2011CB944302), a grant from the National Natural Sciences Foundation of China (81101855), and grants from the Specialized Research Fund for the Doctoral Program of Higher Education (20111106120018, 20111106120018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Bachelor MA, 2004, J BIOL CHEM, V279, P42658, DOI 10.1074/jbc.M406626200; Chan SP, 2005, J BIOL CHEM, V280, P31190, DOI 10.1074/jbc.M505060200; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Chanarat S, 2011, GENE DEV, V25, P1147, DOI 10.1101/gad.623411; Cheng XW, 2012, FEBS LETT, V586, P1497, DOI 10.1016/j.febslet.2012.04.005; David CJ, 2011, GENE DEV, V25, P972, DOI 10.1101/gad.2038011; Duan S, 2003, J BIOL CHEM, V278, P1346, DOI 10.1074/jbc.M209269200; Dunsch AK, 2011, J CELL BIOL, V192, P959, DOI 10.1083/jcb.201008023; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fang L, 2009, CELL CYCLE, V8, P2819, DOI 10.4161/cc.8.17.9514; HENRIQUES JAP, 1980, GENETICS, V95, P273; Hofmann JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074851; Huang YJ, 2012, J BIOL CHEM, V287, P1500, DOI 10.1074/jbc.M111.277194; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Lu XY, 2007, BIOCHEM BIOPH RES CO, V354, P968, DOI 10.1016/j.bbrc.2007.01.097; Mahajan KN, 2003, P NATL ACAD SCI USA, V100, P10746, DOI 10.1073/pnas.1631060100; Makarova OV, 2004, EMBO J, V23, P2381, DOI 10.1038/sj.emboj.7600241; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Qiao Y, 2004, CELL RES, V14, P197, DOI 10.1038/sj.cr.7290220; Rai Nirendra K, 2005, Int J Low Extrem Wounds, V4, P138, DOI 10.1177/1534734605280018; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Sato M, 2010, EXP CELL RES, V316, P2871, DOI 10.1016/j.yexcr.2010.06.018; Schmidt JC, 2010, J CELL BIOL, V191, P269, DOI 10.1083/jcb.201006129; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Wang XD, 2001, GENE DEV, V15, P2922; Wang XW, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.406652; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030	30	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e92712	10.1371/journal.pone.0092712	http://dx.doi.org/10.1371/journal.pone.0092712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718257	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000017
J	Moore, KA; Stanton, ML				Moore, Kara A.; Stanton, Maureen L.			Propagule Limitation, Disparate Habitat Quality, and Variation in Phenotypic Selection at a Local Species Range Boundary	PLOS ONE			English	Article							INTERSPECIFIC COMPETITION; FITNESS VARIATION; ANNUAL PLANTS; EVOLUTION; LIMITS; ADAPTATION; POPULATIONS; DISPERSAL; CLIMATE; NICHE	Adaptation to novel conditions beyond current range boundaries requires the presence of suitable sites within dispersal range, but may be impeded when emigrants encounter poor habitat and sharply different selection pressures. We investigated fine-scale spatial heterogeneity in ecological dynamics and selection at a local population boundary of the annual plant Gilia tricolor. In two years, we planted G. tricolor seeds in core habitat, margin habitat at the edge of the local range, and exterior habitat in order to measure spatial and temporal variation in habitat quality, opportunity for selection, and selection on phenotypic traits. We found a striking decline in average habitat quality with distance from the population core, yet some migrant seeds were successful in suitable, unoccupied microsites at and beyond the range boundary. Total and direct selection on four out of five measured phenotypic traits varied across habitat zones, as well as between years. Moreover, the margin habitat often exerted unique selection pressures that were not intermediate between core and exterior habitats. This study reveals that a combination of ecological and evolutionary forces, including propagule limitation, variation in habitat quality and spatial heterogeneity in phenotypic selection may reduce opportunities for adaptive range expansion, even across a very local population boundary.	[Moore, Kara A.; Stanton, Maureen L.] Univ Calif Davis, Ctr Populat Biol, Dept Ecol & Evolut, Davis, CA 95616 USA	University of California System; University of California Davis	Moore, KA (corresponding author), Univ Calif Davis, Ctr Populat Biol, Dept Ecol & Evolut, Davis, CA 95616 USA.	kmoore@ucdavis.edu			NSF [DEB-0919230]	NSF(National Science Foundation (NSF))	This project was funded by NSF grant DEB-0919230, http://www.nsf.gov/div/index.jsp?div=DEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHIYALY SAK, 1993, HEREDITY, V70, P22, DOI 10.1038/hdy.1993.4; Angert AL, 2005, EVOLUTION, V59, P1671, DOI 10.1111/j.0014-3820.2005.tb01817.x; Angert AL, 2008, EVOLUTION, V62, P2660, DOI 10.1111/j.1558-5646.2008.00471.x; [Anonymous], 1991, EVOLUTIONARY GENETIC; ANTONOVICS J, 1976, ANN MO BOT GARD, V63, P224, DOI 10.2307/2395303; Baack EJ, 2006, ECOLOGY, V87, P2736, DOI 10.1890/0012-9658(2006)87[2736:EFLTDO]2.0.CO;2; Baythavong BS, 2011, AM NAT, V178, P75, DOI 10.1086/660281; Bertness MD, 1997, ECOLOGY, V78, P1976, DOI 10.1890/0012-9658(1997)078[1976:TROPII]2.0.CO;2; Blows MW, 2005, ECOLOGY, V86, P1371, DOI 10.1890/04-1209; BRADSHAW AD, 1991, ANN BOT-LONDON, V67, P5, DOI 10.1093/oxfordjournals.aob.a088209; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Broitman BR, 2008, ECOLOGY, V89, pS81, DOI 10.1890/08-0635.1; Case TJ, 2005, OIKOS, V108, P28, DOI 10.1111/j.0030-1299.2005.13148.x; Case TJ, 2000, AM NAT, V155, P583, DOI 10.1086/303351; Castilla JC, 2004, P NATL ACAD SCI USA, V101, P8517, DOI 10.1073/pnas.0401921101; CONNELL JH, 1961, ECOLOGY, V42, P710, DOI 10.2307/1933500; CROW JF, 1958, AM ANTHROPOL, V60, P1; Dlugosch KM, 2008, ECOL LETT, V11, P701, DOI 10.1111/j.1461-0248.2008.01181.x; Donohue K, 2005, EVOLUTION, V59, P758, DOI 10.1111/j.0014-3820.2005.tb01751.x; Donohue K, 2005, EVOLUTION, V59, P771, DOI 10.1111/j.0014-3820.2005.tb01752.x; Eckhart VM, 2011, AM NAT, V178, pS26, DOI 10.1086/661782; Emery NC, 2011, EVOLUTION, V65, P1011, DOI 10.1111/j.1558-5646.2010.01183.x; Filin I, 2008, AM NAT, V172, P233, DOI 10.1086/589459; Gaylord B, 2000, AM NAT, V155, P769, DOI 10.1086/303357; Geber MA, 2005, EVOLUTION, V59, P521; Gomulkiewicz R, 1999, THEOR POPUL BIOL, V55, P283, DOI 10.1006/tpbi.1998.1405; HOLT RD, 1992, EVOL ECOL, V6, P433, DOI 10.1007/BF02270702; KAWECKI TJ, 1995, EVOL ECOL, V9, P38, DOI 10.1007/BF01237695; Kingsolver JG, 2012, EVOL ECOL, V26, P1101, DOI 10.1007/s10682-012-9563-5; Kramer HAC, 2011, PLANT ECOL, V212, P1887, DOI 10.1007/s11258-011-9961-8; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.1111/j.1558-5646.1983.tb00236.x, 10.2307/2408842]; Leger EA, 2007, J EVOLUTION BIOL, V20, P1090, DOI 10.1111/j.1420-9101.2006.01292.x; LINHART YB, 1988, EVOLUTION, V42, P1047, DOI 10.1111/j.1558-5646.1988.tb02523.x; MACNAIR MR, 1993, NEW PHYTOL, V124, P541, DOI 10.1111/j.1469-8137.1993.tb03846.x; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; Moeller DA, 2012, ECOLOGY, V93, P1036, DOI 10.1890/11-1462.1; Moore KA, 2011, SERPENTINE MODEL EVO; Moore KA, 2009, ECOLOGY, V90, P378, DOI 10.1890/07-1753.1; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PRIMACK RB, 1992, CONSERV BIOL, V6, P513, DOI 10.1046/j.1523-1739.1992.06040513.x; RAUSHER MD, 1992, EVOLUTION, V46, P616, DOI 10.2307/2409632; Rice KJ, 2003, FRONT ECOL ENVIRON, V1, P469, DOI 10.1890/1540-9295(2003)001[0469:MMRITF]2.0.CO;2; Scheiner SM, 2002, EVOLUTION, V56, P2156, DOI 10.1111/j.0014-3820.2002.tb00140.x; SCHERFF EJ, 1994, OIKOS, V69, P405, DOI 10.2307/3545853; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Stratton DA, 1998, EVOLUTION, V52, P678, DOI 10.2307/2411263; TERBORGH J, 1971, Ecology (Washington D C), V52, P23, DOI 10.2307/1934735; Turnbull LA, 2000, OIKOS, V88, P225, DOI 10.1034/j.1600-0706.2000.880201.x; WOODWARD FI, 1987, VEGETATIO, V69, P189, DOI 10.1007/BF00038700; Wright JW, 2006, EVOL ECOL RES, V8, P1; Zuur Alain F., 2009, P1	51	4	4	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e89404	10.1371/journal.pone.0089404	http://dx.doi.org/10.1371/journal.pone.0089404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717472	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000005
J	Shimamoto, R; Amano, N; Ichisaka, T; Watanabe, A; Yamanaka, S; Okita, K				Shimamoto, Ren; Amano, Naoki; Ichisaka, Tomoko; Watanabe, Akira; Yamanaka, Shinya; Okita, Keisuke			Generation and Characterization of Induced Pluripotent Stem Cells from Aid-Deficient Mice	PLOS ONE			English	Article						`	CYTIDINE DEAMINASE AID; MOUSE SOMATIC-CELLS; DNA METHYLATION; ANTIBODY DIVERSIFICATION; HUMAN FIBROBLASTS; B-CELLS; GENOME; DEMETHYLATION; HYPERMUTATION; EXPRESSION	It has been shown that DNA demethylation plays a pivotal role in the generation of induced pluripotent stem (iPS) cells. However, the underlying mechanism of this action is still unclear. Previous reports indicated that activation-induced cytidine deaminase (Aid, also known as Aicda) is involved in DNA demethylation in several developmental processes, as well as cell fusion-mediated reprogramming. Based on these reports, we hypothesized that Aid may be involved in the DNA demethylation that occurs during the generation of iPS cells. In this study, we examined the function of Aid in iPS cell generation using Aid knockout (Aid(-/-)) mice expressing a GFP reporter under the control of a pluripotent stem cell marker, Nanog. By introducing Oct3/4, Sox2, Klf4 and c-Myc, Nanog-GFP-positive iPS cells could be generated from the fibroblasts and primary B cells of Aid(-/-) mice. Their induction efficiency was similar to that of wild-type (Aid(+/+)) iPS cells. The Aid(-/-) iPS cells showed normal proliferation and gave rise to chimeras, indicating their capacity for self-renewal and pluripotency. A comprehensive DNA methylation analysis showed only a few differences between Aid(+/+) and Aid(-/-) iPS cells. These data suggest that Aid does not have crucial functions in DNA demethylation during iPS cell generation.	[Shimamoto, Ren; Amano, Naoki; Ichisaka, Tomoko; Watanabe, Akira; Yamanaka, Shinya; Okita, Keisuke] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA	Kyoto University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Okita, K (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto, Japan.	okita@cira.kyoto-u.ac.jp		Okita, Keisuke/0000-0001-5806-1090	Leading Project of Ministry of Education, Culture, Sports, Science (MEXT); Japan Society for the Promotion of Science (JSPS)	Leading Project of Ministry of Education, Culture, Sports, Science (MEXT); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by a grant from the Leading Project of Ministry of Education, Culture, Sports, Science (MEXT), a grant from the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) of Japan Society for the Promotion of Science (JSPS) (to SY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Bhutani N, 2013, FASEB J, V27, P1107, DOI 10.1096/fj.12-222125; Bhutani N, 2011, CELL, V146, P866, DOI 10.1016/j.cell.2011.08.042; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Eminli S, DIFFERENTIATION STAG, DOI [10.1038/ng.428, DOI 10.1038/NG.428]; Fritz EL, 2013, NAT IMMUNOL, V14, P749, DOI 10.1038/ni.2616; GASSMANN M, 1995, P NATL ACAD SCI USA, V92, P1292, DOI 10.1073/pnas.92.5.1292; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Habib O, 2014, STEM CELLS DEV, V23, P209, DOI 10.1089/scd.2013.0337; Hogart A, 2012, GENOME RES, V22, P1407, DOI 10.1101/gr.132878.111; Hogenbirk MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069815; Hollenbach PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009001; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Jeong KS, 2005, BIOCHEM BIOPH RES CO, V335, P1211, DOI 10.1016/j.bbrc.2005.08.015; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Kumar R, 2013, NATURE, V500, P89, DOI 10.1038/nature12299; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Luo M, 2013, STEM CELLS, V31, P1278, DOI 10.1002/stem.1374; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mandal PK, 2008, CELL, V135, DOI 10.1016/j.cell.2008.09.028; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Meiner VL, 1996, P NATL ACAD SCI USA, V93, P14041, DOI 10.1073/pnas.93.24.14041; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nair SS, 2011, EPIGENETICS-US, V6, P34, DOI 10.4161/epi.6.1.13313; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; Nakanishi T, 2002, GENOMICS, V80, P564, DOI 10.1006/geno.2002.7008; Oka K, 1997, J BIOL CHEM, V272, P1456, DOI 10.1074/jbc.272.39.24387; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Pawlak M, 2011, GENE DEV, V25, P1035, DOI 10.1101/gad.2039011; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rada C, 2002, P NATL ACAD SCI USA, V99, P7003, DOI 10.1073/pnas.092160999; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Serre D, 2010, NUCLEIC ACIDS RES, V38, P391, DOI 10.1093/nar/gkp992; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Young MA, 2012, CELL STEM CELL, V10, P570, DOI 10.1016/j.stem.2012.03.002; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	59	17	17	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94735	10.1371/journal.pone.0094735	http://dx.doi.org/10.1371/journal.pone.0094735			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718089	Green Submitted, gold, Green Published			2022-12-25	WOS:000334339000140
J	Smith, HK; Matthews, KG; Oldham, JM; Jeanplong, F; Falconer, SJ; Bass, JJ; Senna-Salerno, M; Bracegirdle, JW; McMahon, CD				Smith, Heather K.; Matthews, Kenneth G.; Oldham, Jenny M.; Jeanplong, Ferenc; Falconer, Shelley J.; Bass, James J.; Senna-Salerno, Monica; Bracegirdle, Jeremy W.; McMahon, Christopher D.			Translational Signalling, Atrogenic and Myogenic Gene Expression during Unloading and Reloading of Skeletal Muscle in Myostatin-Deficient Mice	PLOS ONE			English	Article							HEAVY-CHAIN ISOFORMS; MYOFIBRILLAR PROTEIN-SYNTHESIS; HYDROXY-BETA-METHYLBUTYRATE; GROWTH-FACTOR-I; SATELLITE CELLS; ELECTROPHORETIC SEPARATION; GEL ELECTROPHORESIS; MESSENGER-RNAS; SOLEUS MUSCLE; MYOD	Skeletal muscles of myostatin null (Mstn(2/2)) mice are more susceptible to atrophy during hind limb suspension (HS) than are muscles of wild-type mice. Here we sought to elucidate the mechanism for this susceptibility and to determine if Mstn(2/2) mice can regain muscle mass after HS. Male Mstn(2/2) and wild-type mice were subjected to 0, 2 or 7 days of HS or 7 days of HS followed by 1, 3 or 7 days of reloading (n = 6 per group). Mstn(2/2) mice lost more mass from muscles expressing the fast type IIb myofibres during HS and muscle mass was recovered in both genotypes after reloading for 7 days. Concentrations of MAFbx and MuRF1 mRNA, crucial ligases regulating the ubiquitin-proteasome system, but not MUSA1, a BMP-regulated ubiquitin ligase, were increased more in muscles of Mstn(2/2) mice, compared with wild-type mice, during HS and concentrations decreased in both genotypes during reloading. Similarly, concentrations of LC3b, Gabarapl1 and Atg4b, key effectors of the autophagy-lysosomal system, were increased further in muscles of Mstn(2/2) mice, compared with wild-type mice, during HS and decreased in both genotypes during reloading. There was a greater abundance of 4E-BP1 and more bound to eIF4E in muscles of Mstn(2/2) compared with wild-type mice (P, 0.001). The ratio of phosphorylated to total eIF2a increased during HS and decreased during reloading, while the opposite pattern was observed for rpS6. Concentrations of myogenic regulatory factors (MyoD, Myf5 and myogenin) mRNA were increased during HS in muscles of Mstn(2/2) mice compared with controls (P, 0.001). We attribute the susceptibility of skeletal muscles of Mstn(2/2) mice to atrophy during HS to an up-and downregulation, respectively, of the mechanisms regulating atrophy of myofibres and translation of mRNA. These processes are reversed during reloading to aid a faster rate of recovery of muscle mass in Mstn(2/2) mice.	[Smith, Heather K.] Univ Auckland, Dept Sport & Exercise Sci, Auckland 1, New Zealand; [Matthews, Kenneth G.; Oldham, Jenny M.; Jeanplong, Ferenc; Falconer, Shelley J.; Senna-Salerno, Monica; Bracegirdle, Jeremy W.; McMahon, Christopher D.] AgResearch, Ruakura Agr Ctr, Hamilton, New Zealand; [Bass, James J.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand	University of Auckland; AgResearch - New Zealand; University of Auckland	McMahon, CD (corresponding author), AgResearch, Ruakura Agr Ctr, Hamilton, New Zealand.	chris.mcmahon@agresearch.co.nz	Jeanplong, Ferenc/M-4920-2013	Falconer, Shelley/0000-0003-2860-3842; Bracegirdle, Jeremy/0000-0002-9471-4527	Marsden Fund, a division of the Royal Society of New Zealand	Marsden Fund, a division of the Royal Society of New Zealand	This research was supported by a grant from the Marsden Fund, a division of the Royal Society of New Zealand. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alway SE, 2001, EXP PHYSIOL, V86, P509, DOI 10.1113/eph8602235; Alway SE, 2013, EXP GERONTOL, V48, P973, DOI 10.1016/j.exger.2013.06.005; Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; Amthor H, 2009, P NATL ACAD SCI USA, V106, P7479, DOI 10.1073/pnas.0811129106; Attaix D, 2010, CURR OPIN CLIN NUTR, V13, P223, DOI 10.1097/MCO.0b013e328338b9a6; Baldwin Kenneth M, 2013, Front Physiol, V4, P284, DOI 10.3389/fphys.2013.00284; Bamman MM, 1999, ELECTROPHORESIS, V20, P466, DOI 10.1002/(SICI)1522-2683(19990301)20:3<466::AID-ELPS466>3.0.CO;2-7; BAR A, 1988, FEBS LETT, V235, P153, DOI 10.1016/0014-5793(88)81253-5; Blaauw B, 2009, FASEB J, V23, P3896, DOI 10.1096/fj.09-131870; Blough ER, 1996, ANAL BIOCHEM, V233, P31, DOI 10.1006/abio.1996.0003; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bonaldo P, 2013, DIS MODEL MECH, V6, P25, DOI 10.1242/dmm.010389; Bruusgaard JC, 1985, J APPL PHYSIOL, V113, P290, DOI [10.1152/japplphysiol.00436, DOI 10.1152/JAPPLPHYSIOL.00436]; Carlson CJ, 1999, AM J PHYSIOL-REG I, V277, pR601, DOI 10.1152/ajpregu.1999.277.2.R601; Chakravarthy MV, 2000, J APPL PHYSIOL, V89, P1365, DOI 10.1152/jappl.2000.89.4.1365; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Dumont N, 2008, AM J PHYSIOL-REG I, V295, pR1831, DOI 10.1152/ajpregu.90318.2008; Ekmark M, 2007, J PHYSIOL-LONDON, V584, P637, DOI 10.1113/jphysiol.2007.141457; Eley HL, 2007, BIOCHEM J, V407, P113, DOI 10.1042/BJ20070651; Eley HL, 2007, AM J PHYSIOL-ENDOC M, V293, pE923, DOI 10.1152/ajpendo.00314.2007; Fitts RH, 2000, J APPL PHYSIOL, V89, P823, DOI 10.1152/jappl.2000.89.2.823; Frenette J, 2002, AM J PHYSIOL-REG I, V282, pR351, DOI 10.1152/ajpregu.00189.2001; FRITZ JD, 1989, ANAL BIOCHEM, V180, P205, DOI 10.1016/0003-2697(89)90116-4; GenStat, 2003, GENSTAT; Giger JM, 2000, AM J PHYSIOL-CELL PH, V278, pC1153, DOI 10.1152/ajpcell.2000.278.6.C1153; Giger JM, 2009, J APPL PHYSIOL, V107, P1204, DOI 10.1152/japplphysiol.00344.2009; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; Girgenrath S, 2004, MUSCLE NERVE; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Haddad F, 2006, J APPL PHYSIOL, V100, P433, DOI 10.1152/japplphysiol.01203.2005; Haidet AM, 2008, P NATL ACAD SCI USA, V105, P4318, DOI 10.1073/pnas.0709144105; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hornberger TA, 2001, AM J PHYSIOL-CELL PH, V281, pC179, DOI 10.1152/ajpcell.2001.281.1.C179; Hughes SM, 1997, MECH DEVELOP, V61, P151, DOI 10.1016/S0925-4773(96)00631-4; HUGHES SM, 1993, DEVELOPMENT, V118, P1137; Jackson JR, 2012, AM J PHYSIOL-CELL PH, V303, pC854, DOI 10.1152/ajpcell.00207.2012; Kimball SR, 1999, INT J BIOCHEM CELL B, V31, P25, DOI 10.1016/S1357-2725(98)00128-9; Kitzmann M, 2001, CELL MOL LIFE SCI, V58, P571, DOI 10.1007/PL00000882; Klimek MEB, 2010, BIOCHEM BIOPH RES CO, V391, P1548, DOI 10.1016/j.bbrc.2009.12.123; Krawiec BJ, 2005, AM J PHYSIOL-ENDOC M, V289, pE969, DOI 10.1152/ajpendo.00126.2005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lalani R, 2000, J ENDOCRINOL, V167, P417, DOI 10.1677/joe.0.1670417; Lee JY, 2011, BIOCHEM BIOPH RES CO, V415, P632, DOI 10.1016/j.bbrc.2011.10.124; Lee SJ, 2012, P NATL ACAD SCI USA, V109, pE2353, DOI 10.1073/pnas.1206410109; Lundby C, 2005, EUR J APPL PHYSIOL, V95, P351, DOI 10.1007/s00421-005-0022-7; Machida S, 2004, MED SCI SPORT EXER, V36, P52, DOI 10.1249/01.MSS.0000106175.24978.84; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; McFarlane C, 2006, J CELL PHYSIOL, V209, P501, DOI 10.1002/jcp.20757; McMahon CD, 2003, AM J PHYSIOL-ENDOC M, V285, pE82, DOI 10.1152/ajpendo.00275.2002; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Megeney LA, 1995, BIOCHEM CELL BIOL, V73, P723, DOI 10.1139/o95-080; Mendias CL, 2008, P NATL ACAD SCI USA, V105, P388, DOI 10.1073/pnas.0707069105; Mendias CL, 2006, J APPL PHYSIOL, V101, P898, DOI 10.1152/japplphysiol.00126.2006; Mizunoya W, 2008, ANAL BIOCHEM, V377, P111, DOI 10.1016/j.ab.2008.02.021; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; Mozdziak PE, 1999, AVIAT SPACE ENVIR MD, V70, P511; Murakami T, 2008, ANAT SCI INT, V83, P68, DOI 10.1111/j.1447-073x.2007.00205.x; Okamoto T, 2011, J PHYSIOL SCI, V61, P537, DOI 10.1007/s12576-011-0175-6; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; OLSON EN, 1992, DEV BIOL, V154, P261, DOI 10.1016/0012-1606(92)90066-P; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Reardon KA, 2001, MUSCLE NERVE, V24, P893, DOI 10.1002/mus.1086.abs; Reiser PJ, 1998, AM J PHYSIOL-HEART C, V274, pH1048, DOI 10.1152/ajpheart.1998.274.3.H1048; RILEY DA, 1992, J APPL PHYSIOL, V73, pS33, DOI 10.1152/jappl.1992.73.2.S33; Rodino-Klapac LR, 2009, MUSCLE NERVE, V39, P283, DOI 10.1002/mus.21244; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Sartori R, 2013, NAT GENET, V45, P1309, DOI 10.1038/ng.2772; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Schmalbruch H, 2000, MUSCLE NERVE, V23, P617, DOI 10.1002/(SICI)1097-4598(200004)23:4<617::AID-MUS22>3.0.CO;2-Y; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seiliez I, 2013, GEN COMP ENDOCR, V186, P9, DOI 10.1016/j.ygcen.2013.02.008; Shavlakadze T, 2009, BIOGERONTOLOGY; TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337, DOI 10.1152/jappl.1993.75.5.2337; Taylor WE, 2001, AM J PHYSIOL-ENDOC M, V280, pE221, DOI 10.1152/ajpendo.2001.280.2.E221; THOMASON DB, 1987, J APPL PHYSIOL, V63, P130, DOI 10.1152/jappl.1987.63.1.130; THOMASON DB, 1989, AM J PHYSIOL, V257, pR300, DOI 10.1152/ajpregu.1989.257.2.R300; THOMASON DB, 1990, J APPL PHYSIOL, V68, P1, DOI 10.1152/jappl.1990.68.1.1; Tisdale MJ, 2009, PHYSIOL REV, V89, P381, DOI 10.1152/physrev.00016.2008; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Wehling M, 2000, FASEB J, V14, P103, DOI 10.1096/fasebj.14.1.103; Welle S, 2006, AM J PHYSIOL-ENDOC M, V290, pE409, DOI 10.1152/ajpendo.00433.2005; Welle S, 2009, AM J PHYSIOL-ENDOC M, V296, pE567, DOI 10.1152/ajpendo.90862.2008; Wheeler MT, 1999, AM J PHYSIOL-CELL PH, V276, pC1069, DOI 10.1152/ajpcell.1999.276.5.C1069; White RB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-21; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	91	18	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94356	10.1371/journal.pone.0094356	http://dx.doi.org/10.1371/journal.pone.0094356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718581	Green Published, Green Submitted, gold			2022-12-25	WOS:000334339000109
J	Theys, C; Wouters, J; Ghesquiere, P				Theys, Catherine; Wouters, Jan; Ghesquiere, Pol			Diffusion Tensor Imaging and Resting-State Functional MRI-Scanning in 5-and 6-Year-Old Children: Training Protocol and Motion Assessment	PLOS ONE			English	Article							ATTENTION DEFICIT/HYPERACTIVITY DISORDER; HEAD MOTION; PREPARING CHILDREN; CONNECTIVITY; FMRI; SEDATION; IMPACT	Advanced Magnetic Resonance Imaging (MRI) techniques such as Diffusion Tensor Imaging (DTI) and resting-state functional MRI (rfMRI) are widely used to study structural and functional neural connectivity. However, as these techniques are highly sensitive to motion artifacts and require a considerable amount of time for image acquisition, successful acquisition of these images can be challenging to complete with certain populations. This is especially true for young children. This paper describes a new approach termed the 'submarine protocol', designed to prepare 5- and 6-year-old children for advanced MRI scanning. The submarine protocol aims to ensure that successful scans can be acquired in a time-and resource-efficient manner, without the need for sedation. This manuscript outlines the protocol and details its outcomes, as measured through the number of children who completed the scanning procedure and analysis of the degree of motion present in the acquired images. Seventy-six children aged between 5.8 and 6.9 years were trained using the submarine protocol and subsequently underwent DTI and rfMRI scanning. After completing the submarine protocol, 75 of the 76 children (99%) completed their DTI-scan and 72 children (95%) completed the full 35-minute scan session. Results of diffusion data, acquired in 75 children, showed that the motion in 60 of the scans (80%) did not exceed the threshold for excessive motion. In the rfMRI scans, this was the case for 62 of the 71 scans (87%). When placed in the context of previous studies, the motion data of the 5- and 6-year-old children reported here were as good as, or better than those previously reported for groups of older children (i.e., 8-year-olds). Overall, this study shows that the submarine protocol can be used successfully to acquire DTI and rfMRI scans in 5 and 6-year-old children, without the need for sedation or lengthy training procedures.	[Theys, Catherine; Wouters, Jan] Katholieke Univ Leuven, ExpORL, Louvain, Belgium; [Theys, Catherine] Univ Canterbury, New Zealand Inst Language Brain & Behav, Christchurch 1, New Zealand; [Ghesquiere, Pol] Katholieke Univ Leuven, Parenting & Special Educ Res Unit, Leuven, Belgium	KU Leuven; KU Leuven	Theys, C (corresponding author), Katholieke Univ Leuven, ExpORL, Louvain, Belgium.	Catherine.Theys@canterbury.ac.nz	Ghesquière, Pol/B-9226-2009; Wouters, Jan/D-1800-2015	Ghesquière, Pol/0000-0001-9056-7550; Wouters, Jan/0000-0002-0093-698X	Research Fund KU Leuven [OT/12/044, PDMK/12/140]; Research Foundation - Flanders (FWO Vlaanderen) [G.0920.12, V456712N]	Research Fund KU Leuven(KU Leuven); Research Foundation - Flanders (FWO Vlaanderen)(FWO)	This study has been funded by grants OT/12/044 and PDMK/12/140 of the Research Fund KU Leuven (http://www.kuleuven.be/research/funding/) and grants G.0920.12 and V456712N of the Research Foundation - Flanders (FWO Vlaanderen - http://www.fwo.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byars AW, 2002, J CHILD NEUROL, V17, P885, DOI 10.1177/08830738020170122201; de Bie HMA, 2012, HUM BRAIN MAPP, V33, P1189, DOI 10.1002/hbm.21280; de Bie HMA, 2010, EUR J PEDIATR, V169, P1079, DOI 10.1007/s00431-010-1181-z; DiFrancesco MW, 2013, J MAGN RESON IMAGING, V38, P1184, DOI 10.1002/jmri.24082; Hallowell LM, 2008, PEDIATR RADIOL, V38, P271, DOI 10.1007/s00247-007-0704-x; Hopkins KL, 1999, NEUROIMAG CLIN N AM, V9, P1; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Klaver P, 2008, NEUROIMAGE, V39, P1815, DOI 10.1016/j.neuroimage.2007.11.009; Lawson GR, 2000, ARCH DIS CHILD, V82, P150, DOI 10.1136/adc.82.2.150; Leemans A, 2009, INT SOC MAGN RES MED, P3537; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Ling J, 2012, HUM BRAIN MAPP, V33, P50, DOI 10.1002/hbm.21192; Mills Kathryn L, 2012, Front Psychiatry, V3, P2, DOI 10.3389/fpsyt.2012.00002; Peeva MG, 2013, NEUROIMAGE-CLIN, V3, P234, DOI 10.1016/j.nicl.2013.08.011; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raschle N, 2012, ANN NY ACAD SCI, V1252, P43, DOI 10.1111/j.1749-6632.2012.06457.x; Raschle NM, 2011, NEUROIMAGE, V57, P742, DOI 10.1016/j.neuroimage.2010.09.055; Satterthwaite TD, 2013, NEUROIMAGE, V83, P45, DOI 10.1016/j.neuroimage.2013.06.045; Satterthwaite TD, 2012, NEUROIMAGE, V60, P623, DOI 10.1016/j.neuroimage.2011.12.063; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Uddin LQ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00458; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; van Ewijk H, 2012, NEUROSCI BIOBEHAV R, V36, P1093, DOI 10.1016/j.neubiorev.2012.01.003; Vandermosten M, 2012, NEUROSCI BIOBEHAV R, V36, P1532, DOI 10.1016/j.neubiorev.2012.04.002; Wilke M, 2012, NEUROIMAGE, V59, P2062, DOI 10.1016/j.neuroimage.2011.10.043; Yerys BE, 2009, HUM BRAIN MAPP, V30, P3426, DOI 10.1002/hbm.20767; Yuan WH, 2009, HUM BRAIN MAPP, V30, P1481, DOI 10.1002/hbm.20616; Zhou ZY, 2011, MAGN RESON IMAGING, V29, P230, DOI 10.1016/j.mri.2010.06.022	28	48	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94019	10.1371/journal.pone.0094019	http://dx.doi.org/10.1371/journal.pone.0094019			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718364	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000066
J	Chowdhury, MYE; Li, R; Kim, JH; Park, ME; Kim, TH; Pathinayake, P; Weeratunga, P; Song, MK; Son, HY; Hong, SP; Sung, MH; Lee, JS; Kim, CJ				Chowdhury, Mohammed Y. E.; Li, Rui; Kim, Jae-Hoon; Park, Min-Eun; Kim, Tae-Hwan; Pathinayake, Prabuddha; Weeratunga, Prasanna; Song, Man Ki; Son, Hwa-Young; Hong, Seung-Pyo; Sung, Moon-Hee; Lee, Jong-Soo; Kim, Chul-Joong			Mucosal Vaccination with Recombinant Lactobacillus casei-Displayed CTA1-Conjugated Consensus Matrix Protein-2 (sM2) Induces Broad Protection against Divergent Influenza Subtypes in BALB/c Mice	PLOS ONE			English	Article							VIRUS-LIKE PARTICLE; MONOCLONAL-ANTIBODY; FUSION PROTEIN; DNA VACCINES; LACTIC-ACID; M2 PROTEIN; T-CELLS; ADJUVANT; IMMUNITY; SURFACE	To develop a safe and effective mucosal vaccine against pathogenic influenza viruses, we constructed recombinant Lactobacillus casei strains that express conserved matrix protein 2 with (pgsA-CTA1-sM2/L. casei) or without (pgsA-sM2/L. casei) cholera toxin subunit A1 (CTA1) on the surface. The surface localization of the fusion protein was verified by cellular fractionation analyses, flow cytometry and immunofluorescence microscopy. Oral and nasal inoculations of recombinant L. casei into mice resulted in high levels of serum immunoglobulin G (IgG) and mucosal IgA. However, the conjugation of cholera toxin subunit A1 induced more potent mucosal, humoral and cell-mediated immune responses. In a challenge test with 10 MLD50 of A/EM/Korea/W149/06(H5N1), A/Puerto Rico/8/34(H1N1), A/Aquatic bird /Korea/W81/2005(H5N2), A/ Aquatic bird/Korea/W44/2005(H7N3), and A/Chicken/Korea/116/2004(H9N2) viruses, the recombinant pgsA-CTA1-sM2/L. casei provided better protection against lethal challenges than pgsA-sM2/L. casei, pgsA/L. casei and PBS in mice. These results indicate that mucosal immunization with recombinant L. casei expressing CTA1-conjugated sM2 protein on its surface is an effective means of eliciting protective immune responses against diverse influenza subtypes.	[Chowdhury, Mohammed Y. E.; Li, Rui; Kim, Jae-Hoon; Park, Min-Eun; Kim, Tae-Hwan; Pathinayake, Prabuddha; Weeratunga, Prasanna; Son, Hwa-Young; Lee, Jong-Soo; Kim, Chul-Joong] Chungnam Natl Univ, Coll Vet Med, Plus Program BK21, Taejon, South Korea; [Song, Man Ki] Int Vaccine Inst, Div Sci Lab, Seoul, South Korea; [Hong, Seung-Pyo; Sung, Moon-Hee] BioLeaders Corp, Taejon, South Korea; [Chowdhury, Mohammed Y. E.] Chittagong Vet & Anim Sci Univ, Fac Vet Med, Chittagong, Bangladesh	Chungnam National University; International Vaccine Institute	Lee, JS (corresponding author), Chungnam Natl Univ, Coll Vet Med, Plus Program BK21, Taejon, South Korea.	jongsool@cnu.ac.kr; cjkim@cnu.ac.kr	Weeratunga, Prasanna/GWZ-5169-2022	Weeratunga, Prasanna/0000-0001-6366-7628; Lee, Jong-Soo/0000-0001-5119-0711; Weeratunga, Prasanna/0000-0002-4258-6025; Pathinayake, Prabuddha/0000-0002-4947-5918; Son, Hwa-Young/0000-0003-4388-0952; Kim, Chul-Joong/0000-0001-8827-6332; Chowdhury, Mohammed/0000-0003-0935-705X	Korea Research Council of Fundamental Science and Technology; KRIBB Initiative program [KGM0821113]; Animal, Plant and Fisheries Quarantine and Inspection Agency (QIA) [Z-1541779, 2013-1181]	Korea Research Council of Fundamental Science and Technology; KRIBB Initiative program; Animal, Plant and Fisheries Quarantine and Inspection Agency (QIA)	This study was supported by the National Agenda Project grant from the Korea Research Council of Fundamental Science and Technology and the KRIBB Initiative program (Grant no. KGM0821113) and the Internal Research Fund of Animal, Plant and Fisheries Quarantine and Inspection Agency (QIA)(Grant no. Z-1541779, 2013-1181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren L, 1998, IMMUNOL CELL BIOL, V76, P280, DOI 10.1046/j.1440-1711.1998.00750.x; [Anonymous], FIELDS VIROLOGY; Bermudez-Humaran LG, 2013, CURR OPIN MICROBIOL, V16, P278, DOI 10.1016/j.mib.2013.06.002; Bermudez-Humaran LG, 2009, HUM VACCINES, V5, P264, DOI 10.4161/hv.5.4.7553; Beyer WEP, 2002, VACCINE, V20, P1340, DOI 10.1016/S0264-410X(01)00471-6; Bodewes R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005538; Candela T, 2006, MOL MICROBIOL, V60, P1091, DOI 10.1111/j.1365-2958.2006.05179.x; Couch RB, 2008, VACCINE, V26, pD5, DOI 10.1016/j.vaccine.2008.05.076; De Filette M, 2006, VACCINE, V24, P544, DOI 10.1016/j.vaccine.2005.08.061; DICKINSON BL, 1995, INFECT IMMUN, V63, P1617, DOI 10.1128/IAI.63.5.1617-1623.1995; Dieye Y, 2001, J BACTERIOL, V183, P4157, DOI 10.1128/JB.183.14.4157-4166.2001; El Bakkouri K, 2011, J IMMUNOL, V186, P1022, DOI 10.4049/jimmunol.0902147; Eliasson DG, 2008, VACCINE, V26, P1243, DOI 10.1016/j.vaccine.2007.12.027; Eriksson AM, 2004, J IMMUNOL, V173, P3310, DOI 10.4049/jimmunol.173.5.3310; Fiers W, 2004, VIRUS RES, V103, P173, DOI 10.1016/j.virusres.2004.02.030; Fiore AE, 2009, CURR TOP MICROBIOL, V333, P43, DOI 10.1007/978-3-540-92165-3_3; Frace AM, 1999, VACCINE, V17, P2237, DOI 10.1016/S0264-410X(99)00005-5; Fu TM, 2009, VIROLOGY, V385, P218, DOI 10.1016/j.virol.2008.11.035; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Ionescu RM, 2006, J PHARM SCI-US, V95, P70, DOI 10.1002/jps.20493; ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Jimenez GS, 2007, HUM VACCINES, V3, P157, DOI 10.4161/hv.3.5.4175; Kang SM, 2011, VIRUS RES, V162, P31, DOI 10.1016/j.virusres.2011.09.037; Kim MC, 2013, ANTIVIR RES, V99, P328, DOI 10.1016/j.antiviral.2013.06.010; Lalor PA, 2008, J INFECT DIS, V197, P1643, DOI 10.1086/588431; Lee JS, 2006, J VIROL, V80, P4079, DOI 10.1128/JVI.80.8.4079-4087.2006; Lee JS, 2000, NAT BIOTECHNOL, V18, P645, DOI 10.1038/76494; Lei H, 2010, VIROLOGY, V407, P319, DOI 10.1016/j.virol.2010.08.007; Liu DQ, 2012, APPL MICROBIOL BIOT, V93, P2437, DOI 10.1007/s00253-011-3734-0; Mannam P, 2004, INFECT IMMUN, V72, P3444, DOI 10.1128/IAI.72.6.3444-3450.2004; Mohamadzadeh M, 2005, P NATL ACAD SCI USA, V102, P2880, DOI 10.1073/pnas.0500098102; Moon HJ, 2012, VET MICROBIOL, V160, P277, DOI 10.1016/j.vetmic.2012.05.035; Mozdzanowska K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-118; Narita J, 2006, APPL ENVIRON MICROB, V72, P269, DOI 10.1128/AEM.72.1.269-275.2006; Oran AE, 2003, J IMMUNOL, V171, P1999, DOI 10.4049/jimmunol.171.4.1999; Poo H, 2006, INT J CANCER, V119, P1702, DOI 10.1002/ijc.22035; Price GE, 2009, VACCINE, V27, P6512, DOI 10.1016/j.vaccine.2009.08.053; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Quan FS, 2013, VIRAL IMMUNOL, V26, P385, DOI 10.1089/vim.2013.0013; Shata MT, 2001, J VIROL, V75, P9665, DOI 10.1128/JVI.75.20.9665-9670.2001; Shaw DM, 2000, IMMUNOLOGY, V100, P510, DOI 10.1046/j.1365-2567.2000.00069.x; Shim BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027953; Song JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014538; Song MK, 2010, World Intellectual Property Organization patent, Patent No. [WO2010046783, 2010046783]; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Sui ZW, 2010, ARCH VIROL, V155, P535, DOI 10.1007/s00705-010-0621-4; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; Wang RF, 2008, ANTIVIR RES, V80, P168, DOI 10.1016/j.antiviral.2008.06.002; Wang Z, 2011, CLIN VACCINE IMMUNOL, V19, P174; Wu F, 2007, VACCINE, V25, P8868, DOI 10.1016/j.vaccine.2007.09.056; Wu F, 2009, VACCINE, V27, P4320, DOI 10.1016/j.vaccine.2009.04.075; Xin KQ, 2003, BLOOD, V102, P223, DOI 10.1182/blood-2003-01-0110; Zhao GY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-9; Zou P, 2005, INT IMMUNOPHARMACOL, V5, P631, DOI 10.1016/j.intimp.2004.12.005	56	31	31	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94051	10.1371/journal.pone.0094051	http://dx.doi.org/10.1371/journal.pone.0094051			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714362	Green Submitted, gold, Green Published			2022-12-25	WOS:000334160900075
J	Dziasko, MA; Armer, HE; Levis, HJ; Shortt, AJ; Tuft, S; Daniels, JT				Dziasko, Marc A.; Armer, Hannah E.; Levis, Hannah J.; Shortt, Alex J.; Tuft, Stephen; Daniels, Julie T.			Localisation of Epithelial Cells Capable of Holoclone Formation In Vitro and Direct Interaction with Stromal Cells in the Native Human Limbal Crypt	PLOS ONE			English	Article							STEM-CELLS; STEM/PROGENITOR CELLS; CORNEAL EPITHELIUM; PROGENITOR CELLS; N-CADHERIN; NICHE; TRANSDIFFERENTIATION; IDENTIFICATION; KERATINOCYTE; MELANOCYTES	Limbal epithelial stem cells (LESCs) are essential to maintain the transparent ocular surface required for vision. Despite great advances in our understanding of ocular stem cell biology over the last decade, the exact location of the LESC niche remains unclear. In the present study we have used in vitro clonal analysis to confirm that limbal crypts provide a niche for the resident LESCs. We have used high-resolution imaging of the basal epithelial layer at the limbus to identify cells with a morphology consistent with stem cells that were only present within the basal layer of the limbal crypts. These cells are proximal to limbal stromal cells suggesting direct cell-to-cell interaction. Serial block-face scanning electron microscopy (SBFSEM) confirmed that the putative LESCs are indeed in direct contact with cells in the underlying stroma, a contact that is facilitated by focal basement membrane interruptions. Limbal mesenchymal cells previously identified in the human limbus collocate in the crypt-rich limbal stromal area in the vicinity of LESCs and may be involved in the cell-to-cell contact revealed by SBFSEM. We also observed a high population of melanocytes within the basal layer of the limbal crypts. From these observations we present a three dimensional reconstruction of the LESC niche in which the stem cell is closely associated and maintained by both dendritic pigmented limbal melanocytes and elongated limbal stromal cells.	[Dziasko, Marc A.; Levis, Hannah J.; Shortt, Alex J.; Daniels, Julie T.] UCL, Inst Ophthalmol, Dept Ocular Biol & Therapeut, London, England; [Armer, Hannah E.] UCL, Inst Ophthalmol, Imaging unit, London, England; [Shortt, Alex J.; Tuft, Stephen] Moorfields Eye Hosp NHS Fdn Trust, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust	Dziasko, MA (corresponding author), UCL, Inst Ophthalmol, Dept Ocular Biol & Therapeut, London, England.	marc.dziasko.11@ucl.ac.uk	Levis, Hannah/AAH-6556-2019; Shortt, Alex/C-7782-2014	Levis, Hannah/0000-0002-3923-1178; Daniels, Julie/0000-0003-2099-9360; Shortt, Alex/0000-0001-6576-3875	National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; Special Trustees of Moorfields Eye Hospital; National Institute for Health Research [CL-2009-18-007] Funding Source: researchfish	National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust; UCL Institute of Ophthalmology; Special Trustees of Moorfields Eye Hospital; National Institute for Health Research(National Institute for Health Research (NIHR))	The research was funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology and a Stem Cell Initiative Award from the Special Trustees of Moorfields Eye Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Branch MJ, 2012, INVEST OPHTH VIS SCI, V53, P5109, DOI 10.1167/iovs.11-8673; Chen SY, 2011, TISSUE ENG PART C-ME, V17, P537, DOI [10.1089/ten.TEC.2010.0609, 10.1089/ten.tec.2010.0609]; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; Dravida S, 2005, DEV BRAIN RES, V160, P239, DOI 10.1016/j.devbrainres.2005.09.008; Dua HS, 2005, BRIT J OPHTHALMOL, V89, P529, DOI 10.1136/bjo.2004.049742; EBATO B, 1988, INVEST OPHTH VIS SCI, V29, P1533; Espana EM, 2003, INVEST OPHTH VIS SCI, V44, P5130, DOI 10.1167/iovs.03-0584; GIPSON IK, 1989, EYE, V3, P132, DOI 10.1038/eye.1989.21; Goldberg M F, 1982, Trans Am Ophthalmol Soc, V80, P155; GRAVES BASIL, 1934, BRIT JOUR OPHTHALMOL, V18, P305, DOI 10.1136/bjo.18.6.305; Hayashi R, 2007, STEM CELLS, V25, P289, DOI 10.1634/stemcells.2006-0167; Higa K, 2005, EXP EYE RES, V81, P218, DOI 10.1016/j.exer.2005.01.023; Higa K, 2013, STEM CELL RES, V10, P147, DOI 10.1016/j.scr.2012.11.001; Higa K, 2009, INVEST OPHTH VIS SCI, V50, P4640, DOI 10.1167/iovs.09-3503; Kawasaki S, 2006, EXP EYE RES, V82, P293, DOI 10.1016/j.exer.2005.07.001; Mariappan I, 2010, NAT PROTOC, V5, P1470, DOI 10.1038/nprot.2010.115; Notara M, 2010, STEM CELL RES, V5, P188, DOI 10.1016/j.scr.2010.07.002; Pearton DJ, 2005, P NATL ACAD SCI USA, V102, P3714, DOI 10.1073/pnas.0500344102; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Pinnamaneni N, 2012, STEM CELLS, V30, P1059, DOI 10.1002/stem.1100; Polisetty N, 2008, MOL VIS, V14, P431; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Romano AC, 2003, INVEST OPHTH VIS SCI, V44, P5125, DOI 10.1167/iovs.03-0628; Schlotzer-Schrehardt U, 2005, EXP EYE RES, V81, P247, DOI 10.1016/j.exer.2005.02.016; Shortt AJ, 2007, STEM CELLS, V25, P1402, DOI 10.1634/stemcells.2006-0580; Song XQ, 2002, P NATL ACAD SCI USA, V99, P14813, DOI 10.1073/pnas.232389399; Xie HT, 2011, STEM CELLS, V29, P1874, DOI 10.1002/stem.743; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	35	68	68	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94283	10.1371/journal.pone.0094283	http://dx.doi.org/10.1371/journal.pone.0094283			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714106	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900112
J	Lima, AJS; Hoogeveen-Westerveld, M; Nakashima, A; Maat-Kievit, A; van den Ouweland, A; Halley, D; Kikkawa, U; Nellist, M				Lima, Arthur Jorge Santiago; Hoogeveen-Westerveld, Marianne; Nakashima, Akio; Maat-Kievit, Anneke; van den Ouweland, Ans; Halley, Dicky; Kikkawa, Ushio; Nellist, Mark			Identification of Regions Critical for the Integrity of the TSC1-TSC2-TBC1D7 Complex	PLOS ONE			English	Article							TSC1; HAMARTIN; TUBERIN; PROTEIN; TBC1D7; DOMAIN; INDIVIDUALS; SUBUNIT; GROWTH	The TSC1-TSC2-TBC1D7 complex is an important negative regulator of the mechanistic target of rapamycin complex 1 that controls cell growth in response to environmental cues. Inactivating TSC1 and TSC2 mutations cause tuberous sclerosis complex (TSC), an autosomal dominant disorder characterised by the occurrence of benign tumours in various organs and tissues, notably the brain, skin and kidneys. TBC1D7 mutations have not been reported in TSC patients but homozygous inactivation of TBC1D7 causes megaencephaly and intellectual disability. Here, using an exon-specific deletion strategy, we demonstrate that some regions of TSC1 are not necessary for the core function of the TSC1-TSC2 complex. Furthermore, we show that the TBC1D7 binding site is encoded by TSC1 exon 22 and identify amino acid residues involved in the TSC1-TBC1D7 interaction.	[Lima, Arthur Jorge Santiago; Hoogeveen-Westerveld, Marianne; Maat-Kievit, Anneke; van den Ouweland, Ans; Halley, Dicky; Nellist, Mark] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands; [Nakashima, Akio; Kikkawa, Ushio] Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 657, Japan	Erasmus University Rotterdam; Erasmus MC; Kobe University	Nellist, M (corresponding author), Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands.	m.nellist@erasmusmc.nl	Kievit, Anneke/O-8830-2014		Department of Clinical Genetics, Erasmus MC	Department of Clinical Genetics, Erasmus MC	The study was supported by the Department of Clinical Genetics, Erasmus MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttila V, 2013, NAT GENET, V45, P912, DOI 10.1038/ng.2676; Benvenuto G, 2000, ONCOGENE, V19, P6306, DOI 10.1038/sj.onc.1204009; Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119; Capo-Chichi JM, 2013, J MED GENET, V50, P740, DOI 10.1136/jmedgenet-2013-101680; Dibble CC, 2012, MOL CELL, V47, P535, DOI 10.1016/j.molcel.2012.06.009; Frasa MAM, 2012, NAT REV MOL CELL BIO, V13, P67, DOI 10.1038/nrm3267; Hoogeveen-Westerveld M, 2012, HUM MUTAT, V33, P476, DOI 10.1002/humu.22007; Hoogeveen-Westerveld M, 2011, HUM MUTAT, V32, P424, DOI 10.1002/humu.21451; Hoogeveen-Westerveld M, 2010, BBA-MOL BASIS DIS, V1802, P774, DOI 10.1016/j.bbadis.2010.06.004; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Martinez T, 2013, HUM GENET, V132, P481, DOI 10.1007/s00439-013-1288-1; Mozaffari M, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-88; Nakashima A, 2007, BIOCHEM BIOPH RES CO, V361, P218, DOI 10.1016/j.bbrc.2007.07.011; Nellist M, 2005, EUR J HUM GENET, V13, P59, DOI 10.1038/sj.ejhg.5201276; Nellist M, 1999, J BIOL CHEM, V274, P35647, DOI 10.1074/jbc.274.50.35647; NELLIST M, 1993, CELL, V75, P1305; Northrup H, 2013, PEDIATR NEUROL, V49, P243, DOI 10.1016/j.pediatrneurol.2013.08.001; Rosner M, 2008, MUTAT RES-REV MUTAT, V658, P234, DOI 10.1016/j.mrrev.2008.01.001; Sato N, 2010, GENE CHROMOSOME CANC, V49, P353, DOI 10.1002/gcc.20747; Structural genetics consortium, 2011, CRYST STRUCT HUM TBC; Sun W, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3135; van Slegtenhorst M, 1998, HUM MOL GENET, V7, P1053, DOI 10.1093/hmg/7.6.1053; vanSlegtenhorst M, 1997, SCIENCE, V277, P805, DOI 10.1126/science.277.5327.805; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Zhang JW, 2013, NAT CELL BIOL, V15, P1186, DOI 10.1038/ncb2822	28	23	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93940	10.1371/journal.pone.0093940	http://dx.doi.org/10.1371/journal.pone.0093940			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714658	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900063
J	Parmar, HB; Barry, C; Duncan, R				Parmar, Hirendrasinh B.; Barry, Chris; Duncan, Roy			Polybasic Trafficking Signal Mediates Golgi Export, ER Retention or ER Export and Retrieval Based on Membrane-Proximity	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; TRANSMEMBRANE PROTEINS; BABOON REOVIRUS; FUSION; MOTIFS; TRANSPORT; RECOGNITION; REQUIRES	Trafficking of integral membrane proteins between the ER and Golgi complex, and protein sorting and trafficking between the TGN and endosomal/lysosomal compartments or plasma membranes, are dependent on cis-acting, linear amino acid sorting signals. Numerous sorting signals of this type have been identified in the cytoplasmic domains of membrane proteins, several of which rely on basic residues. A novel Golgi export signal that relies on a membrane-proximal polybasic motif (PBM) was recently identified in the reptilian reovirus p14 protein, a representative of an unusual group of bitopic fusion-associated small transmembrane (FAST) proteins encoded by fusogenic orthoreoviruses and responsible for cell-cell fusion and syncytium formation. Using immunofluorescence microscopy, cell surface immunofluorescence, and endoglycosidase H assays, we now show the p14 PBM can mediate several distinct trafficking functions depending on its proximity to the transmembrane domain (TMD). When present within 4-residues of the TMD it serves as a Golgi export signal, but when located at the C-terminus of the 68-residue p14 cytoplasmic endodomain it functions as an ER retention signal. The PBM has no effect on protein trafficking when located at an internal position in the cytoplasmic domain. When present in both membrane-proximal and -distal locations, the PBMs promote export to, and efficient retrieval from, the Golgi complex. Interestingly, the conflicting trafficking signals provided by two PBMs induces extensive ER tubulation and segregation of ER components. These studies highlight how a single trafficking signal in a simple transmembrane protein can have remarkably diverse, position-dependent effects on protein trafficking and ER morphogenesis.	[Parmar, Hirendrasinh B.; Barry, Chris; Duncan, Roy] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Duncan, Roy] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Duncan, Roy] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Duncan, R (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.	roy.duncan@dal.ca	Barry, Christopher/G-5843-2015	Barry, Christopher/0000-0002-5413-5918; Duncan, Roy/0000-0002-5162-5081	Natural Sciences and Engineering Research Council of Canada (NSERC); Nova Scotia Health Research Foundation (NSHRF); Cancer Research Training Program (CRTP) with funding from the Dalhousie Cancer Research Program (DCRP)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Nova Scotia Health Research Foundation (NSHRF); Cancer Research Training Program (CRTP) with funding from the Dalhousie Cancer Research Program (DCRP)	This work was funded by a grant to R.D. from the Natural Sciences and Engineering Research Council of Canada (NSERC). C.B. was supported by scholarships from the Nova Scotia Health Research Foundation (NSHRF) and the Cancer Research Training Program (CRTP) with funding from the Dalhousie Cancer Research Program (DCRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Andersson H, 1999, J BIOL CHEM, V274, P15080, DOI 10.1074/jbc.274.21.15080; ANTIN PB, 1991, DEV BIOL, V143, P111, DOI 10.1016/0012-1606(91)90058-B; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Boutilier J, 2011, CURR TOP MEMBR, V68, P107, DOI 10.1016/B978-0-12-385891-7.00005-2; Brown CW, 2009, J VIROL, V83, P552, DOI 10.1128/JVI.01921-08; Chen SL, 2013, CURR OPIN CELL BIOL, V25, P428, DOI 10.1016/j.ceb.2013.02.006; Cobbold C, 2003, TRENDS CELL BIOL, V13, P639, DOI 10.1016/j.tcb.2003.10.008; Corcoran JA, 2004, J VIROL, V78, P4342, DOI 10.1128/JVI.78.8.4342-4351.2004; Dawe S, 2005, J VIROL, V79, P6216, DOI 10.1128/JVI.79.10.6216-6226.2005; Dawe S, 2002, J VIROL, V76, P2131, DOI 10.1128/JVI.76.5.2131-2140.2002; De Matteis MA, 2008, NAT REV MOL CELL BIO, V9, P273, DOI 10.1038/nrm2378; Dong CM, 2012, TRAFFIC, V13, P857, DOI 10.1111/j.1600-0854.2012.01351.x; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Guo H, 2013, VIRUS RES, V171, P129, DOI 10.1016/j.virusres.2012.11.011; Gut A, 1998, EMBO J, V17, P1919, DOI 10.1093/emboj/17.7.1919; Hardt B, 2003, GLYCOBIOLOGY, V13, P159, DOI 10.1093/glycob/cwg013; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Jackson LP, 2012, DEV CELL, V23, P1255, DOI 10.1016/j.devcel.2012.10.017; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Lu L, 2013, MOL BIOL CELL, V24, P1020, DOI 10.1091/mbc.E12-08-0575; Ma WF, 2013, EMBO J, V32, P926, DOI 10.1038/emboj.2013.41; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Parmar HB, 2014, MOL BIOL CE IN PRESS; Racine T, 2009, J VIROL, V83, P5951, DOI 10.1128/JVI.00171-09; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Salsman J, 2005, J VIROL, V79, P8090, DOI 10.1128/JVI.79.13.8090-8100.2005; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Shikano S, 2003, P NATL ACAD SCI USA, V100, P5783, DOI 10.1073/pnas.1031748100; Shmulevitz M, 2000, EMBO J, V19, P902, DOI 10.1093/emboj/19.5.902; Thalmann CM, 2010, VIROLOGY, V402, P26, DOI 10.1016/j.virol.2009.11.048; Top D, 2005, EMBO J, V24, P2980, DOI 10.1038/sj.emboj.7600767; Venditti R, 2014, TRENDS CELL BIOL, V24, P9, DOI 10.1016/j.tcb.2013.08.005; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198; Zhang XP, 2011, J BIOL CHEM, V286, P20525, DOI 10.1074/jbc.M111.222034; Zurek N, 2011, TRAFFIC, V12, P28, DOI 10.1111/j.1600-0854.2010.01134.x	44	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94194	10.1371/journal.pone.0094194	http://dx.doi.org/10.1371/journal.pone.0094194			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714640	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900103
J	Sandes, JM; Fontes, A; Regis-Da-Silva, CG; De Castro, MCAB; Lima-Junior, CG; Silva, FPL; Vasconcellos, MLAA; Figueiredo, RCBQ				Sandes, Jana M.; Fontes, Adriana; Regis-Da-Silva, Carlos G.; De Castro, Maria C. A. Brelaz; Lima-Junior, Claudio G.; Silva, Fabio P. L.; Vasconcellos, Mario L. A. A.; Figueiredo, Regina C. B. Q.			Trypanosoma cruzi Cell Death Induced by the Morita-Baylis-Hillman Adduct 3-Hydroxy-2-Methylene-3-(4-Nitrophenylpropanenitrile)	PLOS ONE			English	Article							APOPTOSIS; AUTOPHAGY; MITOCHONDRIAL; INHIBITORS; PATHWAYS; MARKERS; DRUGS	Chagas disease, caused by the protozoan Trypanosoma cruzi, remains a serious health concern due to the lack of effective vaccines or satisfactory treatment. In the search for new compounds against this neglected disease, we have previously demonstrated that the compound 3-Hydroxy-2-methylene-3-(4-nitrophenylpropanenitrile) (MBHA3), derived from the Morita-Baylis-Hillman reaction, effectively caused a loss of viability in both the epimastigote and trypomastigote forms. However, the mechanisms of parasite death elicited by MBHA3 remain unknown. The aim of this study was to better understand the morphophysiological changes and the mechanism of cell death induced by MBHA3 treatment on T. cruzi. To perform this analysis, we used confocal microscopy and flow cytometry to monitor the fluorescent probes such as annexin-V/ propidium iodide (AV/PI), calcein-AM/ethidium homodimer (CA/EH), acridine orange (AO) and rhodamine 123 (Rho 123). Lower concentrations of MBHA3 led to alterations in the mitochondrial membrane potential and AO labeling, but did not decrease the viability of the epimastiogote forms, as determined by the CA/EH and AV/PI assays. Conversely, treatment with higher concentrations of MBHA3 led to extensive plasma membrane damage, loss of mitochondrion membrane potential, DNA fragmentation and acidification of the cytoplasm. Our findings suggest that at higher concentrations, MBHA3 induces T. cruzi epimastigote death by necrosis in a mitochondrion-dependent manner.	[Sandes, Jana M.; Figueiredo, Regina C. B. Q.] Centro Pesquisas Aggeu Magalhaes, Dept Microbiol, Recife, PE, Brazil; [Fontes, Adriana] Univ Fed Pernambuco, Dept Biofis & Radiobiol, Recife, PE, Brazil; [Regis-Da-Silva, Carlos G.] Ctr Pesquisas Goncalo Moniz, Lab Biol Parasitaria, Salvador, BA, Brazil; [De Castro, Maria C. A. Brelaz] Ctr Pesquisas Aggeu Magalhaes, Dept Immunol, Recife, PE, Brazil; [Lima-Junior, Claudio G.; Silva, Fabio P. L.; Vasconcellos, Mario L. A. A.] Univ Fed Paraiba, Dept Quim, LASOM PB, BR-58059900 Joao Pessoa, Paraiba, Brazil	Universidade Federal de Pernambuco; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal da Paraiba	Figueiredo, RCBQ (corresponding author), Centro Pesquisas Aggeu Magalhaes, Dept Microbiol, Recife, PE, Brazil.	bressan@cpqam.fiocruz.br	Lima, Claudio Gabriel/AAC-7580-2019; Vasconcellos, Mario/AAI-2777-2021; FIGUEIREDO, REGINA/T-7230-2019; FIGUEIREDO, REGINA CBQ/N-2800-2013; de Castro, Maria Carolina Accioly Brelaz/AAV-5606-2020; Fontes, Adriana/T-5789-2019; FIGUEIREDO, REGINA CELIA BRESSAN QUEIROZ/GWU-9395-2022	de Castro, Maria Carolina Accioly Brelaz/0000-0003-2205-0618; Fontes, Adriana/0000-0003-4675-2163; FIGUEIREDO, REGINA/0000-0001-5806-0944; Lima-Junior, Claudio/0000-0001-6570-8999	CNPq; FIOCRUZ/CPQAM; PDTIS/FIOCRUZ; FACEPE	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FIOCRUZ/CPQAM; PDTIS/FIOCRUZ; FACEPE(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE))	This work was supported by CNPq, FIOCRUZ/CPQAM, PDTIS/FIOCRUZ and FACEPE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez VE, 2008, J BIOL CHEM, V283, P3454, DOI 10.1074/jbc.M708474200; Arnoult D, 2002, CELL DEATH DIFFER, V9, P65, DOI 10.1038/sj.cdd.4400951; Basavaiah D, 2012, CHEM SOC REV, V41, P68, DOI 10.1039/c1cs15174f; Bruchhaus I, 2007, TRENDS PARASITOL, V23, P376, DOI 10.1016/j.pt.2007.06.004; Cormier O, 2012, AUTOPHAGY, V8, P252, DOI 10.4161/auto.8.2.18618; Das M, 2001, J CELL SCI, V114, P2461; de Souza ROMA, 2007, EUR J MED CHEM, V42, P99, DOI 10.1016/j.ejmech.2006.07.013; Demoro B, 2012, DALTON T, V41, P6468, DOI 10.1039/c2dt12179d; Tonin LTD, 2009, EUR J MED CHEM, V44, P1745, DOI 10.1016/j.ejmech.2008.03.044; Erdelyi P, 2011, J CELL SCI, V124, P1510, DOI 10.1242/jcs.080192; Galluzzi L, 2007, CELL DEATH DIFFER, V14, P1237, DOI 10.1038/sj.cdd.4402148; Gatti R, 1998, J HISTOCHEM CYTOCHEM, V46, P895, DOI 10.1177/002215549804600804; Guimaraes CA, 2004, EUR J BIOCHEM, V271, P1638, DOI 10.1111/j.1432-1033.2004.04084.x; Jimenez-Ruiz A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-104; JONES KH, 1985, J HISTOCHEM CYTOCHEM, V33, P77, DOI 10.1177/33.1.2578146; Kessler RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055497; Khademvatan S, 2011, BRAZ J INFECT DIS, V15, P442, DOI [10.1590/S1413-86702011000500005, 10.1016/S1413-8670(11)70225-2]; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Lee WK, 2006, AM J PHYSIOL-CELL PH, V291, pC195, DOI 10.1152/ajpcell.00641.2005; Lima CG, 2012, BIOORGAN MED CHEM, V20, P3954, DOI 10.1016/j.bmc.2012.04.061; Luder CGK, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-116; Marinho FD, 2011, MEM I OSWALDO CRUZ, V106, P507, DOI 10.1590/S0074-02762011000400021; Menna-Barreto RFS, 2009, MICRON, V40, P157, DOI 10.1016/j.micron.2008.08.003; Montalvetti A, 2003, J BIOL CHEM, V278, P17075, DOI 10.1074/jbc.M210467200; Neto RLM, 2011, EXP PARASITOL, V127, P215, DOI 10.1016/j.exppara.2010.07.020; Nishikawa T, 2010, ANN SURG ONCOL, V17, P592, DOI 10.1245/s10434-009-0696-x; Pritchett TL, 2012, CELL DEATH DIFFER, V19, P1069, DOI 10.1038/cdd.2011.200; Proto WR, 2013, NAT REV MICROBIOL, V11, P58, DOI 10.1038/nrmicro2929; Ricci MS, 2006, ONCOLOGIST, V11, P342, DOI 10.1634/theoncologist.11-4-342; Salomon CJ, 2012, J PHARM SCI-US, V101, P888, DOI 10.1002/jps.23010; Sandes JM, 2010, BIOORG CHEM, V38, P190, DOI 10.1016/j.bioorg.2010.06.003; Shang XJ, 2009, J ANDROL, V30, P122, DOI 10.2164/jandrol.108.005629; Smirlis D, 2011, VIRULENCE, V2, P253, DOI 10.4161/viru.2.3.16278; Soeiro Maria de Nazare C, 2011, Open Med Chem J, V5, P21, DOI 10.2174/1874104501105010021; Szajnman SH, 2003, BIOORG MED CHEM LETT, V13, P3231, DOI 10.1016/S0960-894X(03)00663-2; Tait JF, 2008, J NUCL MED, V49, P1573, DOI 10.2967/jnumed.108.052803; Uchiyama Y, 2008, HISTOCHEM CELL BIOL, V129, P407, DOI 10.1007/s00418-008-0406-y; Wong RSY, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-87; Worthen C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000678; Wu YC, 2012, METHOD CELL BIOL, V107, P297, DOI 10.1016/B978-0-12-394620-1.00010-2	40	30	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93936	10.1371/journal.pone.0093936	http://dx.doi.org/10.1371/journal.pone.0093936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714638	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900062
J	Wen, S; Zhang, HM; Li, YS; Wang, N; Zhang, WW; Yang, K; Wu, NN; Chen, X; Deng, F; Liao, Z; Zhang, JH; Zhang, Q; Yan, ZJ; Liu, W; Zhang, ZL; Ye, JX; Deng, YL; Zhou, GL; Luu, HH; Haydon, RC; Shi, LL; He, TC; Wei, GH				Wen, Sheng; Zhang, Hongmei; Li, Yasha; Wang, Ning; Zhang, Wenwen; Yang, Ke; Wu, Ningning; Chen, Xian; Deng, Fang; Liao, Zhan; Zhang, Junhui; Zhang, Qian; Yan, Zhengjian; Liu, Wei; Zhang, Zhonglin; Ye, Jixing; Deng, Youlin; Zhou, Guolin; Luu, Hue H.; Haydon, Rex C.; Shi, Lewis L.; He, Tong-Chuan; Wei, Guanghui			Characterization of Constitutive Promoters for piggyBac Transposon-Mediated Stable Transgene Expression in Mesenchymal Stem Cells (MSCs)	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; OSTEOGENIC DIFFERENTIATION; SELECTION	Multipotent mesenchymal stem cells (MSCs) can undergo self-renewal and give rise to multi-lineages under given differentiation cues. It is frequently desirable to achieve a stable and high level of transgene expression in MSCs in order to elucidate possible molecular mechanisms through which MSC self-renewal and lineage commitment are regulated. Retroviral or lentiviral vector-mediated gene expression in MSCs usually decreases over time. Here, we choose to use the piggyBac transposon system and conduct a systematic comparison of six commonly-used constitutive promoters for their abilities to drive RFP or firefly luciferase expression in somatic HEK-293 cells and MSC iMEF cells. The analyzed promoters include three viral promoters (CMV, CMV-IVS, and SV40), one housekeeping gene promoter (UbC), and two composite promoters of viral and housekeeping gene promoters (hEFH and CAG-hEFH). CMV-derived promoters are shown to drive the highest transgene expression in HEK-293 cells, which is however significantly reduced in MSCs. Conversely, the composite promoter hEFH exhibits the highest transgene expression in MSCs whereas its promoter activity is modest in HEK-293 cells. The reduced transgene expression driven by CMV promoters in MSCs may be at least in part caused by DNA methylation, or to a lesser extent histone deacetlyation. However, the hEFH promoter is not significantly affected by these epigenetic modifications. Taken together, our results demonstrate that the hEFH composite promoter may be an ideal promoter to drive long-term and high level transgene expression using the piggyBac transposon vector in progenitor cells such as MSCs.	[Wen, Sheng; Li, Yasha; Yang, Ke; Wu, Ningning; Zhang, Qian; Liu, Wei; He, Tong-Chuan; Wei, Guanghui] Chongqing Med Univ, Chongqing Stem Cell Therapy & Engn Ctr, Key Lab Pediat, Minist Educ,Stem Cell Biol & Therapy Lab,Children, Chongqing, Peoples R China; [Wen, Sheng; Li, Yasha; Yang, Ke; Wu, Ningning; Zhang, Qian; Liu, Wei; He, Tong-Chuan; Wei, Guanghui] Chongqing Med Univ, Childrens Hosp, Dept Urol, Chongqing, Peoples R China; [Zhang, Hongmei] Chongqing Med Univ, Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing, Peoples R China; [Zhang, Hongmei] Chongqing Med Univ, Affiliated Hosp Stomatol, Chongqing, Peoples R China; [Zhang, Hongmei; Wang, Ning; Zhang, Wenwen; Yang, Ke; Wu, Ningning; Chen, Xian; Deng, Fang; Liao, Zhan; Zhang, Junhui; Zhang, Qian; Yan, Zhengjian; Liu, Wei; Zhang, Zhonglin; Ye, Jixing; Deng, Youlin; Zhou, Guolin; Luu, Hue H.; Haydon, Rex C.; Shi, Lewis L.] Univ Chicago, Med Ctr, Dept Orthopaed Surg & Rehabil Med, Mol Oncol Lab, Chicago, IL 60637 USA; [Zhang, Wenwen; Wu, Ningning; Chen, Xian; Zhang, Junhui; Yan, Zhengjian; Deng, Youlin; He, Tong-Chuan] Chongqing Med Univ, Key Lab Diagnost Med, Minist Educ, Chongqing, Peoples R China; [Zhang, Wenwen; Wu, Ningning; Chen, Xian; Zhang, Junhui; Yan, Zhengjian; Deng, Youlin; He, Tong-Chuan] Chongqing Med Univ, Sch Clin Diagnost Med, Chongqing, Peoples R China; [Wang, Ning; Wu, Ningning; Chen, Xian; Zhang, Junhui; Yan, Zhengjian; Deng, Youlin; He, Tong-Chuan] Chongqing Med Univ, Affiliated Hosp, Chongqing, Peoples R China; [Wang, Ning; Deng, Fang] Third Mil Med Univ, Affiliated Southwest Hosp, Dept Cell Biol, Chongqing, Peoples R China; [Wang, Ning; Deng, Fang] Third Mil Med Univ, Affiliated Southwest Hosp, Dept Oncol, Chongqing, Peoples R China; [Liao, Zhan] Cent S Univ, Affiliated Xiang Ya Hosp, Dept Orthopaed Surg, Changsha, Hunan, Peoples R China; [Zhang, Zhonglin] Wuhan Univ, Affiliated Zhongnan Hosp, Dept Surg, Wuhan 430072, Peoples R China; [Ye, Jixing] Chongqing Univ, Sch Bioengn, Chongqing 630044, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; University of Chicago; University of Chicago Medical Center; Chongqing Medical University; Chongqing Medical University; Army Medical University; Central South University; Wuhan University; Chongqing University	He, TC (corresponding author), Chongqing Med Univ, Chongqing Stem Cell Therapy & Engn Ctr, Key Lab Pediat, Minist Educ,Stem Cell Biol & Therapy Lab,Children, Chongqing, Peoples R China.	tche@uchicago.edu; guanghuiwei2012@gmail.com		Deng, Fang/0000-0002-7927-5394	National Institutes of Health; 973 Program of the Ministry of Science and Technology (MOST) of China [2011CB707906]; National Natural Science Foundation of China [81370701]; Program for Innovation Team Building at Higher Education Institutions in Chongqing, China; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 973 Program of the Ministry of Science and Technology (MOST) of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Innovation Team Building at Higher Education Institutions in Chongqing, China; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The reported work was supported in part by research grants from the National Institutes of Health (RCH, TCH and HHL), the 973 Program of the Ministry of Science and Technology (MOST) of China (#2011CB707906 to TCH), National Natural Science Foundation of China (# 81370701 to GW), and the 2013 Program for Innovation Team Building at Higher Education Institutions in Chongqing, China (to GW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; Bi Y, 2009, J CELL BIOCHEM, V108, P295, DOI 10.1002/jcb.22254; Choi KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072184; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Di Matteo Mario, 2012, Methods Mol Biol, V859, P241, DOI 10.1007/978-1-61779-603-6_14; Ellis J, 2005, CURR GENE THER, V5, P367, DOI 10.2174/1566523054546233; Fisher CL, 2011, CURR OPIN GENET DEV, V21, P140, DOI 10.1016/j.gde.2011.01.015; Gao YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082436; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Hotta A, 2008, J CELL BIOCHEM, V105, P940, DOI 10.1002/jcb.21912; Huang EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032428; Kim A, 2011, MOL CELL BIOCHEM, V354, P301, DOI 10.1007/s11010-011-0832-3; KIM DW, 1990, GENE, V91, P217, DOI 10.1016/0378-1119(90)90091-5; Kim JH, 2013, THER ADV MUSCULOSKEL, V5, P13, DOI 10.1177/1759720X12466608; Kong YH, 2013, CELL PHYSIOL BIOCHEM, V32, P1187, DOI 10.1159/000354518; Krishnan M, 2005, FASEB J, V19, P106, DOI 10.1096/fj.05-4551fje; Lamplot JD, 2013, AM J STEM CELLS, V2, P1; Li M, 2013, INT J MED SCI, V10, P1035, DOI 10.7150/ijms.6639; Li XH, 2013, P NATL ACAD SCI USA, V110, pE2279, DOI 10.1073/pnas.1305987110; Liew CG, 2007, STEM CELLS, V25, P1521, DOI 10.1634/stemcells.2006-0634; Liu X, 2013, J CELL MOL MED; Luo Q, 2007, GENE, V395, P160, DOI 10.1016/j.gene.2007.02.030; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Mehta AK, 2009, GENE, V428, P20, DOI 10.1016/j.gene.2008.09.033; MIYAZAKI J, 1989, GENE, V79, P269; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Orkin SH, 2011, CELL, V145, P835, DOI 10.1016/j.cell.2011.05.019; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rastegar Farbod, 2010, World J Stem Cells, V2, P67, DOI 10.4252/wjsc.v2.i4.67; Rival-Gervier S, 2013, MOL THER, V21, P1536, DOI 10.1038/mt.2013.131; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Shenaq DS, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/519028; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shui W, 2013, J BIOMED MAT RES A; Stewart R, 2008, REGEN MED, V3, P505, DOI 10.2217/17460751.3.4.505; WAKABAYASHIITO N, 1994, J BIOL CHEM, V269, P29831; Wang R, 2008, STEM CELLS DEV, V17, P279, DOI 10.1089/scd.2007.0084; Wang X, 2013, J BIOMED MAT RES A; Wang Y, 2013, J ORTHOP RES; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Yang K, 2012, J INVEST DERMATOL, V132, P2479, DOI 10.1038/jid.2012.145; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032; Yusa K, 2011, P NATL ACAD SCI USA, V108, P1531, DOI 10.1073/pnas.1008322108; Zhang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073086; Zhang WW, 2013, INT J MED SCI, V10, P1888, DOI 10.7150/ijms.6019; Zhu GH, 2009, DIFFERENTIATION, V78, P195, DOI 10.1016/j.diff.2009.06.001	48	41	41	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94397	10.1371/journal.pone.0094397	http://dx.doi.org/10.1371/journal.pone.0094397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714676	gold, Green Submitted, Green Published			2022-12-25	WOS:000334160900125
J	Widderich, N; Hoppner, A; Pittelkow, M; Heider, J; Smits, SHJ; Bremer, E				Widderich, Nils; Hoeppner, Astrid; Pittelkow, Marco; Heider, Johann; Smits, Sander H. J.; Bremer, Erhard			Biochemical Properties of Ectoine Hydroxylases from Extremophiles and Their Wider Taxonomic Distribution among Microorganisms	PLOS ONE			English	Article							COMPATIBLE SOLUTE ECTOINE; TETRAHYDROPYRIMIDINE DERIVATIVES; TRANSCRIPTIONAL REGULATOR; ACIDIPHILIUM-CRYPTUM; BIOSYNTHESIS GENES; ESCHERICHIA-COLI; GLYCINE BETAINE; SP NOV.; HYDROXYECTOINE; BACTERIUM	Ectoine and hydroxyectoine are well-recognized members of the compatible solutes and are widely employed by microorganisms as osmostress protectants. The EctABC enzymes catalyze the synthesis of ectoine from the precursor L-aspartate-beta-semialdehyde. A subgroup of the ectoine producers can convert ectoine into 5-hydroxyectoine through a region-selective and stereospecific hydroxylation reaction. This compatible solute possesses stress-protective and function-preserving properties different from those of ectoine. Hydroxylation of ectoine is carried out by the EctD protein, a member of the non-heme-containing iron (II) and 2-oxoglutarate-dependent dioxygenase superfamily. We used the signature enzymes for ectoine (EctC) and hydroxyectoine (EctD) synthesis in database searches to assess the taxonomic distribution of potential ectoine and hydroxyectoine producers. Among 6428 microbial genomes inspected, 440 species are predicted to produce ectoine and of these, 272 are predicted to synthesize hydroxyectoine as well. Ectoine and hydroxyectoine genes are found almost exclusively in Bacteria. The genome context of the ect genes was explored to identify proteins that are functionally associated with the synthesis of ectoines; the specialized aspartokinase Ask_Ect and the regulatory protein EctR. This comprehensive in silico analysis was coupled with the biochemical characterization of ectoine hydroxylases from microorganisms that can colonize habitats with extremes in salinity (Halomonas elongata), pH (Alkalilimnicola ehrlichii, Acidiphilium cryptum), or temperature (Sphingopyxis alaskensis, Paenibacillus lautus) or that produce hydroxyectoine very efficiently over ectoine (Pseudomonas stutzeri). These six ectoine hydroxylases all possess similar kinetic parameters for their substrates but exhibit different temperature stabilities and differ in their tolerance to salts. We also report the crystal structure of the Virgibacillus salexigens EctD protein in its apo-form, thereby revealing that the iron-free structure exists already in a pre-set configuration to incorporate the iron catalyst. Collectively, our work defines the taxonomic distribution and salient biochemical properties of the ectoine hydroxylase protein family and contributes to the understanding of its structure.	[Widderich, Nils; Pittelkow, Marco; Heider, Johann; Bremer, Erhard] Univ Marburg, Dept Biol, Microbiol Lab, Marburg, Germany; [Widderich, Nils] Max Planck Inst Terr Microbiol, Emeritus Grp RK Thauer, D-35043 Marburg, Germany; [Hoeppner, Astrid] Univ Dusseldorf, XRay Facil & Crystal Farm, Dusseldorf, Germany; [Smits, Sander H. J.] Univ Dusseldorf, Inst Biochem, Dusseldorf, Germany; [Heider, Johann; Bremer, Erhard] Univ Marburg, Ctr Synthet Microbiol, LOEWE, Marburg, Germany	Philipps University Marburg; Max Planck Society; Heinrich Heine University Dusseldorf	Smits, SHJ (corresponding author), Univ Dusseldorf, Inst Biochem, Univ Str 1, Dusseldorf, Germany.	sander.smits@hhu.de; bremer@biologie.uni-marburg.de	Heider, Johann/Y-2291-2018; Heider, Johann/ABA-7877-2021; Heider, Johann/A-1833-2012	Heider, Johann/0000-0001-8328-9716; Heider, Johann/0000-0001-8328-9716; Hoeppner, Astrid/0000-0002-7076-5936	Deutsche Forschungsgemeinschaft [SFB 987]; LOEWE program of the state of Hessen (via the Centre for Synthetic Microbiology, SYNMIKRO; Marburg); Max-Planck Institute for terrestrial Microbiology (Marburg); Fonds der Chemischen Industrie; initiative "Fit for Excellence" of the Heinrich-Heine University of Dusseldorf; International Max Planck Research School for Environmental, Cellular and Molecular Microbiology (IMPRS-Mic, Marburg)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); LOEWE program of the state of Hessen (via the Centre for Synthetic Microbiology, SYNMIKRO; Marburg); Max-Planck Institute for terrestrial Microbiology (Marburg); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); initiative "Fit for Excellence" of the Heinrich-Heine University of Dusseldorf; International Max Planck Research School for Environmental, Cellular and Molecular Microbiology (IMPRS-Mic, Marburg)	Funding for this study was generously provided by grants from the Deutsche Forschungsgemeinschaft through the SFB 987 and the LOEWE program of the state of Hessen (via the Centre for Synthetic Microbiology, SYNMIKRO; Marburg) (both to J.H. and E. B.), a contribution from the Max-Planck Institute for terrestrial Microbiology (Marburg) through the Emeritus Group of R. K. Thauer (to N.W.), by the Fonds der Chemischen Industrie (to E. B.) and by the initiative "Fit for Excellence" of the Heinrich-Heine University of Dusseldorf (to A. H. and S.H.J.S.). N.W. war partly funded by the International Max Planck Research School for Environmental, Cellular and Molecular Microbiology (IMPRS-Mic, Marburg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aik W, 2012, CURR OPIN STRUC BIOL, V22, P691, DOI 10.1016/j.sbi.2012.10.001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Becker J, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-110; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bestvater Thorsten, 2008, Saline Syst, V4, P12, DOI 10.1186/1746-1448-4-12; Bilgin AA, 2004, FEMS MICROBIOL ECOL, V49, P137, DOI 10.1016/j.femsec.2003.08.018; Borges N, 2002, EXTREMOPHILES, V6, P209, DOI 10.1007/s007920100236; Bremer E, 2000, BACTERIAL STRESS RESPONSES, P79; BROWN AD, 1976, BACTERIOL REV, V40, P803, DOI 10.1128/MMBR.40.4.803-846.1976; Bursy J, 2008, APPL ENVIRON MICROB, V74, P7286, DOI 10.1128/AEM.00768-08; Bursy J, 2007, J BIOL CHEM, V282, P31147, DOI 10.1074/jbc.M704023200; Calderon MI, 2004, MICROBIOL-SGM, V150, P3051, DOI 10.1099/mic.0.27122-0; Cayley S, 2003, BIOCHEMISTRY-US, V42, P12596, DOI 10.1021/bi0347297; CAYLEY S, 1992, J BACTERIOL, V174, P1586, DOI 10.1128/jb.174.5.1586-1595.1992; da Costa M. S., 1998, V61, P117; Doan VT, 2013, APPL MICROBIOL BIOT, V97, P6271, DOI 10.1007/s00253-012-4528-8; Eilert E, 2013, J BIOTECHNOL, V167, P85, DOI 10.1016/j.jbiotec.2013.02.005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GALINSKI EA, 1994, FEMS MICROBIOL REV, V15, P95, DOI 10.1111/j.1574-6976.1994.tb00128.x; GALINSKI EA, 1985, EUR J BIOCHEM, V149, P135, DOI 10.1111/j.1432-1033.1985.tb08903.x; Garcia-Estepa R, 2006, J BACTERIOL, V188, P3774, DOI 10.1128/JB.00136-06; Graf R, 2008, CLIN DERMATOL, V26, P326, DOI 10.1016/j.clindermatol.2008.01.002; Grzyska PK, 2010, P NATL ACAD SCI USA, V107, P3982, DOI 10.1073/pnas.0911565107; Hangasky JA, 2013, METALLOMICS, V5, P287, DOI 10.1039/c3mt20153h; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hoeft SE, 2007, INT J SYST EVOL MICR, V57, P504, DOI 10.1099/ijs.0.64576-0; Hoffmann T, 2013, J BACTERIOL, V195, P510, DOI 10.1128/JB.01505-12; INBAR L, 1988, J BIOL CHEM, V263, P16014; INBAR L, 1993, EUR J BIOCHEM, V214, P897, DOI 10.1111/j.1432-1033.1993.tb17993.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Kuhlmann AU, 2008, APPL ENVIRON MICROB, V74, P4560, DOI 10.1128/AEM.00492-08; Kuhlmann AU, 2011, J BACTERIOL, V193, P4699, DOI 10.1128/JB.05270-11; Kuhlmann AU, 2002, APPL ENVIRON MICROB, V68, P772, DOI 10.1128/AEM.68.2.772-783.2002; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Kurz Matthias, 2008, Saline Syst, V4, P6, DOI 10.1186/1746-1448-4-6; Kurz M, 2010, APPL ENVIRON MICROB, V76, P5452, DOI 10.1128/AEM.00686-10; Kusel K, 1999, APPL ENVIRON MICROB, V65, P3633; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lentzen G, 2006, APPL MICROBIOL BIOT, V72, P623, DOI 10.1007/s00253-006-0553-9; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; LIPPERT K, 1992, APPL MICROBIOL BIOT, V37, P61; Lo CC, 2009, MICROBIOL MOL BIOL R, V73, P594, DOI 10.1128/MMBR.00024-09; Louis P, 1997, MICROBIOL-UK, V143, P1141, DOI 10.1099/00221287-143-4-1141; LOVENBERG W, 1963, J BIOL CHEM, V238, P3899; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mead DA, 2012, STAND GENOMIC SCI, V6, P366, DOI 10.4056/sigs.2605792; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mustakhimov II, 2012, BIOCHEMISTRY-MOSCOW+, V77, P857, DOI 10.1134/S0006297912080068; Mustakhimov II, 2010, J BACTERIOL, V192, P410, DOI 10.1128/JB.00553-09; Nordberg H, 2014, NUCLEIC ACIDS RES, V42, pD26, DOI 10.1093/nar/gkt1069; Ongagna-Yhombi SY, 2013, APPL ENVIRON MICROB, V79, P5038, DOI 10.1128/AEM.01008-13; Ono H, 1999, J BACTERIOL, V181, P91, DOI 10.1128/JB.181.1.91-99.1999; Pastor JM, 2010, BIOTECHNOL ADV, V28, P782, DOI 10.1016/j.biotechadv.2010.06.005; PETERS P, 1990, FEMS MICROBIOL LETT, V71, P157; Pflughoeft KJ, 2003, APPL ENVIRON MICROB, V69, P5919, DOI 10.1128/AEM.69.10.5919-5927.2003; Polz MF, 2013, TRENDS GENET, V29, P170, DOI 10.1016/j.tig.2012.12.006; Prabhu J, 2004, APPL ENVIRON MICROB, V70, P3130, DOI 10.1128/AEM.70.5.3130-3132.2004; Reshetnikov AS, 2011, EXTREMOPHILES, V15, P653, DOI 10.1007/s00792-011-0396-x; Reshetnikov AS, 2006, ARCH MICROBIOL, V184, P286, DOI 10.1007/s00203-005-0042-z; Reuter K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010647; Rodriguez-Moya J, 2013, APPL ENVIRON MICROB, V79, P1018, DOI 10.1128/AEM.02774-12; Roessler M, 2001, ENVIRON MICROBIOL, V3, P743, DOI 10.1046/j.1462-2920.2001.00252.x; Saum Stephan H, 2008, Saline Syst, V4, P4, DOI 10.1186/1746-1448-4-4; Schubert T, 2007, APPL ENVIRON MICROB, V73, P3343, DOI 10.1128/AEM.02482-06; Schwibbert K, 2011, ENVIRON MICROBIOL, V13, P1973, DOI 10.1111/j.1462-2920.2010.02336.x; Seip B, 2011, APPL ENVIRON MICROB, V77, P1368, DOI 10.1128/AEM.02124-10; Shikuma NJ, 2013, ENVIRON MICROBIOL, V15, P1387, DOI 10.1111/j.1462-2920.2012.02805.x; Sims D, 2009, STAND GENOMIC SCI, V1, P12, DOI 10.4056/sigs.761; Spang A, 2010, TRENDS MICROBIOL, V18, P331, DOI 10.1016/j.tim.2010.06.003; Stoveken N, 2011, J BACTERIOL, V193, P4456, DOI 10.1128/JB.00345-11; Straganz GD, 2006, CHEMBIOCHEM, V7, P1536, DOI 10.1002/cbic.200600152; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; Thompson JD, 2000, NUCLEIC ACIDS RES, V28, P2919, DOI 10.1093/nar/28.15.2919; Ting L, 2010, ENVIRON MICROBIOL, V12, P2658, DOI 10.1111/j.1462-2920.2010.02235.x; Vancanneyt M, 2001, INT J SYST EVOL MICR, V51, P73, DOI 10.1099/00207713-51-1-73; Vargas Carmen, 2008, Saline Syst, V4, P14, DOI 10.1186/1746-1448-4-14; VREELAND RH, 1980, INT J SYST BACTERIOL, V30, P485, DOI 10.1099/00207713-30-2-485; Widderich N, 2014, J MOL BIOL, V426, P586, DOI 10.1016/j.jmb.2013.10.028; Witt EMHJ, 2011, APPL MICROBIOL BIOT, V91, P113, DOI 10.1007/s00253-011-3211-9; Wood JM, 2011, ANNU REV MICROBIOL, V65, P215, DOI 10.1146/annurev-micro-090110-102815; Wood JM, 2001, COMP BIOCHEM PHYS A, V130, P437, DOI 10.1016/S1095-6433(01)00442-1; Yan DL, 2011, APPL ENVIRON MICROB, V77, P6763, DOI 10.1128/AEM.05257-11; Yan YL, 2008, P NATL ACAD SCI USA, V105, P7564, DOI 10.1073/pnas.0801093105	84	53	62	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93809	10.1371/journal.pone.0093809	http://dx.doi.org/10.1371/journal.pone.0093809			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714029	Green Published, gold			2022-12-25	WOS:000334160900050
J	Wilson, AM; Chiodo, VA; Boye, SL; Brecha, NC; Hauswirth, WW; Di Polo, A				Wilson, Ariel M.; Chiodo, Vince A.; Boye, Sanford L.; Brecha, Nicholas C.; Hauswirth, William W.; Di Polo, Adriana			Inhibitor of Apoptosis-Stimulating Protein of p53 (iASPP) Is Required for Neuronal Survival after Axonal Injury	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; OPTIC-NERVE; NEUROTROPHIC FACTOR; ASPP FAMILY; DEATH; ACTIVATION; EXPRESSION; PUMA; AXOTOMY; CANCER	The transcription factor p53 mediates the apoptosis of post-mitotic neurons exposed to a wide range of stress stimuli. The apoptotic activity of p53 is tightly regulated by the apoptosis-stimulating proteins of p53 (ASPP) family members: ASPP1, ASPP2 and iASPP. We previously showed that the pro-apoptotic members ASPP1 and ASPP2 contribute to p53-dependent death of retinal ganglion cells (RGCs). However, the role of the p53 inhibitor iASPP in the central nervous system (CNS) remains to be elucidated. To address this, we asked whether iASPP contributes to the survival of RGCs in an in vivo model of acute optic nerve damage. We demonstrate that iASPP is expressed by injured RGCs and that iASPP phosphorylation at serine residues, which increase iASPP affinity towards p53, is significantly reduced following axotomy. We show that short interference RNA (siRNA)-induced iASPP knockdown exacerbates RGC death, whereas adeno-associated virus (AAV)-mediated iASPP expression promotes RGC survival. Importantly, our data also demonstrate that increasing iASPP expression in RGCs downregulates p53 activity and blocks the expression of pro-apoptotic targets PUMA and Fas/CD95. This study demonstrates a novel role for iASPP in the survival of RGCs, and provides further evidence of the importance of the ASPP family in the regulation of neuronal loss after axonal injury.	[Wilson, Ariel M.; Di Polo, Adriana] Univ Montreal, Univ Montreal Hosp Res Ctr CR CHUM, Dept Neurosci, Montreal, PQ, Canada; [Wilson, Ariel M.; Di Polo, Adriana] Univ Montreal, Univ Montreal Hosp Res Ctr CR CHUM, Grpe Rech Syst Nerveux Cent, Montreal, PQ, Canada; [Chiodo, Vince A.; Boye, Sanford L.; Hauswirth, William W.] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; [Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA USA; [Brecha, Nicholas C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA USA	Universite de Montreal; Universite de Montreal; State University System of Florida; University of Florida; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Di Polo, A (corresponding author), Univ Montreal, Univ Montreal Hosp Res Ctr CR CHUM, Dept Neurosci, Montreal, PQ, Canada.	adriana.di.polo@umontreal.ca		hauswirth, william/0000-0002-3244-4947	Canadian Institutes of Health Research [CIHR-VIH-105439]; National Institutes of Health [NIH EY021721]; Macula Vision Research Foundation; Research to Prevent Blindness Inc.; NATIONAL EYE INSTITUTE [R01EY004067, P30EY021721] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000764] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macula Vision Research Foundation; Research to Prevent Blindness Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by a grant from the Canadian Institutes of Health Research to ADP (CIHR-VIH-105439), and in part by the National Institutes of Health (NIH EY021721), the Macula Vision Research Foundation and Research to Prevent Blindness Inc. (WWH). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo-Barriuso M, 2013, INVEST OPHTH VIS SCI, V54, P4249, DOI 10.1167/iovs.12-11451; Ahn J, 2009, J BIOL CHEM, V284, P13812, DOI 10.1074/jbc.M808821200; Ao Y, 2001, ONCOGENE, V20, P2720, DOI 10.1038/sj.onc.1204352; Bergamaschi D, 2004, MOL CELL BIOL, V24, P1341, DOI 10.1128/MCB.24.3.1341-1350.2004; Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Bergamaschi D, 2006, NAT GENET, V38, P1133, DOI 10.1038/ng1879; BERKELAAR M, 1994, J NEUROSCI, V14, P4368, DOI 10.1523/jneurosci.14-07-04368.1994; Cheng L, 2002, J NEUROSCI, V22, P3977, DOI 10.1523/JNEUROSCI.22-10-03977.2002; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Gabriel R, 1998, NEUROSCI LETT, V247, P179, DOI 10.1016/S0304-3940(98)00323-1; Gaub P, 2011, BRAIN, V134, P2134, DOI 10.1093/brain/awr142; Gregory M, 2011, PLOS ONE, V6; Guo Y, 2008, BIOCHEM BIOPH RES CO, V375, P1, DOI 10.1016/j.bbrc.2008.07.055; Hamar P, 2004, P NATL ACAD SCI USA, V101, P14883, DOI 10.1073/pnas.0406421101; Hauswirth WW, 2000, METHOD ENZYMOL, V316, P743; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jiang LL, 2011, CLIN CANCER RES, V17, P6924, DOI 10.1158/1078-0432.CCR-11-0588; Jin SQ, 2003, ONCOGENE, V22, P8536, DOI 10.1038/sj.onc.1206907; Ju KR, 2006, BRAIN RES, V1122, P209, DOI 10.1016/j.brainres.2006.09.022; Kim HS, 2005, BRAIN RES, V1057, P17, DOI 10.1016/j.brainres.2005.07.005; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Knights CD, 2006, J CELL BIOL, V173, P533, DOI 10.1083/jcb.200512059; Krummel KA, 2005, P NATL ACAD SCI USA, V102, P10188, DOI 10.1073/pnas.0503068102; Kwong JMK, 2010, INVEST OPHTH VIS SCI, V51, P1052, DOI 10.1167/iovs.09-4098; Lambert PF, 1998, J BIOL CHEM, V273, P33048, DOI 10.1074/jbc.273.49.33048; Lebrun-Julien F, 2009, MOL CELL NEUROSCI, V40, P410, DOI 10.1016/j.mcn.2008.12.005; Leon S, 2000, J NEUROSCI, V20, P4615, DOI 10.1523/JNEUROSCI.20-12-04615.2000; Levkovitch-Verbin H, 2006, INVEST OPHTH VIS SCI, V47, P2491, DOI 10.1167/iovs.05-0996; Li GL, 2011, MOL CELL BIOCHEM, V350, P193, DOI 10.1007/s11010-010-0698-9; Li SJ, 2012, ONCOL REP, V28, P133, DOI 10.3892/or.2012.1778; Liu H, 2009, LEUKEMIA RES, V33, P1243, DOI 10.1016/j.leukres.2009.02.016; Liu L, 1999, MOL CELL BIOL, V19, P1202; Liu ZJ, 2008, CANCER INVEST, V26, P878, DOI 10.1080/07357900801965042; Liu ZZ, 2012, MED ONCOL, V29, P3381, DOI 10.1007/s12032-012-0306-9; Lopez CD, 2000, MOL CELL BIOL, V20, P8018, DOI 10.1128/MCB.20.21.8018-8025.2000; Lu M, 2013, CANCER CELL, V23, P618, DOI 10.1016/j.ccr.2013.03.013; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Nadal-Nicolas FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049830; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Pernet V, 2006, BRAIN, V129, P1014, DOI 10.1093/brain/awl015; Pernet V, 2005, J NEUROCHEM, V93, P72, DOI 10.1111/j.1471-4159.2005.03002.x; PERRY VH, 1981, NEUROSCIENCE, V6, P931, DOI 10.1016/0306-4522(81)90174-3; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Rodriguez A, 2013, J COMP NEUR IN PRESS; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Schlamp CL, 2013, MOL VIS, V19, P1387; Slee EA, 2004, ONCOGENE, V23, P9007, DOI 10.1038/sj.onc.1208088; Unger T, 1999, ONCOGENE, V18, P3205, DOI 10.1038/sj.onc.1202656; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; Wax MB, 2008, J NEUROSCI, V28, P12085, DOI 10.1523/JNEUROSCI.3200-08.2008; Wilson AM, 2012, GENE THER, V19, P127, DOI 10.1038/gt.2011.142; Wilson AM, 2013, J NEUROSCI, V33, P2205, DOI 10.1523/JNEUROSCI.2635-12.2013; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Yamaguchi H, 2009, J BIOL CHEM, V284, P11171, DOI 10.1074/jbc.M809268200; Yang JP, 1999, J BIOL CHEM, V274, P15662, DOI 10.1074/jbc.274.22.15662; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zhang B, 2011, PROSTATE CANCER P D, V14, P219, DOI 10.1038/pcan.2011.25; Zhang XW, 2005, LEUKEMIA RES, V29, P179, DOI 10.1016/j.leukres.2004.07.001; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105	61	29	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94175	10.1371/journal.pone.0094175	http://dx.doi.org/10.1371/journal.pone.0094175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714389	Green Published, gold, Green Submitted			2022-12-25	WOS:000334160900097
J	Chojnacki, RM; Vas, J; Andersen, IL				Chojnacki, Rachel M.; Vas, Judit; Andersen, Inger Lise			The Effects of Prenatal Stocking Densities on the Fear Responses and Sociality of Goat ( Capra hircus) Kids	PLOS ONE			English	Article							DOMESTIC GOAT; INDIVIDUAL RECOGNITION; EMOTIONAL REACTIVITY; BIRTH-WEIGHT; GROUP-SIZE; STRESS; BEHAVIOR; DISCRIMINATION; ORGANIZATION; GROWTH	relatively little research has been done on how prenatal social stress affects farm animals such as goats. Here, we use the operational description of `stress' as "physical or perceived threats to homeostasis.'' The aim of this study was to investigate the prenatal effects of different herd densities on the fear responses and sociality of goat kids. Pregnant Norwegian dairy goats were exposed to high, medium or low prenatal animal density treatments throughout gestation ( 1.0, 2.0 or 3.0 m 2 per animal, respectively). One kid per litter was subjected to two behavioral tests at 5 weeks of age. The `social test' was applied to assess the fear responses, sociality and social recognition skills when presented with a familiar and unfamiliar kid and the `separation test' assessed the behavioral coping skills when isolated. The results indicate goat kids from the highest prenatal density of 1.0 m 2 were more fearful than the kids from the lower prenatal densities ( i.e. made more escape attempts ( separation test: P < 0.001) and vocalizations ( social test: P, 0.001; separation test: P, 0.001). This effect was more pronounced in females than males in the high density ( vocalizations; social test: P, 0.001; separation test: P < 0.001) and females were generally more social than males. However, goat kids did not differentiate between a familiar and an unfamiliar kid at 5 weeks of age and sociality was not affected by the prenatal density treatment. We conclude that high animal densities during pregnancy in goats produce offspring that have a higher level of fear, particularly in females. Behavioral changes in offspring that occur as an effect of prenatal stress are of high importance as many of the females are recruited to the breeding stock of dairy goats.	[Chojnacki, Rachel M.; Vas, Judit; Andersen, Inger Lise] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway	Norwegian University of Life Sciences	Chojnacki, RM (corresponding author), Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway.	Rachel.Chojnacki@nmbu.no	Vas, Judit/GRJ-7640-2022		EU [FP7-KBBE-2010-4]	EU(European Commission)	This study was conducted in frame of the Animal Welfare Indicators project (AWIN), which was financed by the EU VII Framework programme (FP7-KBBE-2010-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEY JC, 1994, SMALL RUMINANT RES, V13, P103, DOI 10.1016/0921-4488(94)90038-8; Andersen IL, 2008, APPL ANIM BEHAV SCI, V114, P132, DOI 10.1016/j.applanim.2008.01.007; Andersen IL, 2007, APPL ANIM BEHAV SCI, V108, P89, DOI 10.1016/j.applanim.2006.10.015; Andersen IL, 2011, APPL ANIM BEHAV SCI, V134, P136, DOI 10.1016/j.applanim.2011.08.003; ANDERSON DK, 1985, BRAIN RES, V332, P113, DOI 10.1016/0006-8993(85)90394-4; [Anonymous], 1988, P AUST SOC ANIM PROD; Asher MR, 2004, J MAMMAL, V85, P788, DOI 10.1644/BNS-012; Avishai-Eliner S, 2002, TRENDS NEUROSCI, V25, P518, DOI 10.1016/S0166-2236(02)02241-5; Barbazanges A, 1996, J NEUROSCI, V16, P3943; Barroso FG, 2000, APPL ANIM BEHAV SCI, V69, P35, DOI 10.1016/S0168-1591(00)00113-1; Beaulieu AD, 2010, J ANIM SCI, V88, P2767, DOI 10.2527/jas.2009-2222; Boivin X, 1996, APPL ANIM BEHAV SCI, V48, P61, DOI 10.1016/0168-1591(95)01019-X; Braastad BO, 1998, APPL ANIM BEHAV SCI, V57, P157, DOI 10.1016/S0168-1591(97)00114-7; Braastad BO, 1998, APPL ANIM BEHAV SCI, V61, P159, DOI 10.1016/S0168-1591(98)00188-9; Briefer E, 2011, ANIM COGN, V14, P585, DOI 10.1007/s10071-011-0396-3; Briefer EF, 2013, APPL ANIM BEHAV SCI, V146, P45, DOI 10.1016/j.applanim.2013.03.007; Briefer EF, 2012, P ROY SOC B-BIOL SCI, V279, P3749, DOI 10.1098/rspb.2012.0986; Briefer EF, 2012, ANIM BEHAV, V83, P991, DOI 10.1016/j.anbehav.2012.01.020; BROOM DM, 1988, APPL ANIM BEHAV SCI, V20, P5, DOI 10.1016/0168-1591(88)90122-0; Burton C, 2006, BEHAV NEUROSCI, V120, P665, DOI 10.1037/0735-7044.120.3.665; Cabrera RA, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-42; Charil A, 2010, BRAIN RES REV, V65, P56, DOI 10.1016/j.brainresrev.2010.06.002; CHRISTIAN JJ, 1958, ENDOCRINOLOGY, V63, P517, DOI 10.1210/endo-63-5-517; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Clarke AS, 1997, ANN NY ACAD SCI, V807, P490, DOI 10.1111/j.1749-6632.1997.tb51947.x; CLARKE AS, 1993, DEV PSYCHOBIOL, V26, P293, DOI 10.1002/dev.420260506; Coe CL, 2003, BIOL PSYCHIAT, V54, P1025, DOI 10.1016/S0006-3223(03)00698-X; DEPASSILLE AM, 1995, APPL ANIM BEHAV SCI, V45, P201, DOI 10.1016/0168-1591(95)00622-Y; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Estanislau C, 2005, BEHAV BRAIN RES, V163, P70, DOI 10.1016/j.bbr.2005.04.003; Estevez I, 2007, APPL ANIM BEHAV SCI, V103, P185, DOI 10.1016/j.applanim.2006.05.025; Faerevik G, 2006, APPL ANIM BEHAV SCI, V99, P205, DOI 10.1016/j.applanim.2005.10.012; FOURNIER F, 1995, ANIM BEHAV, V49, P1449, DOI 10.1016/0003-3472(95)90066-7; FRIDE E, 1984, DEV PSYCHOBIOL, V17, P651; Fujioka A, 2006, NEUROSCIENCE, V141, P907, DOI 10.1016/j.neuroscience.2006.04.046; GHEUSI G, 1994, BEHAV PROCESS, V33, P59, DOI 10.1016/0376-6357(94)90060-4; Hayashi A, 1998, INT J DEV NEUROSCI, V16, P209, DOI 10.1016/S0736-5748(98)00028-8; Kaiser S, 2005, NEUROSCI BIOBEHAV R, V29, P283, DOI 10.1016/j.neubiorev.2004.09.015; Kapoor A, 2009, BEHAV BRAIN RES, V197, P144, DOI 10.1016/j.bbr.2008.08.018; Kay G, 1998, PHYSIOL BEHAV, V63, P397, DOI 10.1016/S0031-9384(97)00456-3; Keil NM, 2012, ANIM COGN, V15, P913, DOI 10.1007/s10071-012-0518-6; Kendrick KM, 1996, BEHAV PROCESS, V38, P19, DOI 10.1016/0376-6357(96)00006-X; Koba Y, 2009, ANIM SCI J, V80, P98, DOI 10.1111/j.1740-0929.2008.00597.x; Krueger K, 2011, ANIM COGN, V14, P245, DOI 10.1007/s10071-010-0358-1; Lemaire V, 2000, P NATL ACAD SCI USA, V97, P11032, DOI 10.1073/pnas.97.20.11032; Lemasson A, 2009, ANIM COGN, V12, P693, DOI 10.1007/s10071-009-0229-9; LICKLITER RE, 1984, APPL ANIM BEHAV SCI, V12, P245, DOI 10.1016/0168-1591(84)90117-5; LICKLITER RE, 1987, APPL ANIM BEHAV SCI, V19, P137, DOI 10.1016/0168-1591(87)90210-3; Ligout S, 2004, ANIM BEHAV, V68, P785, DOI 10.1016/j.anbehav.2004.01.008; Ligout S, 2004, BEHAVIOUR, V141, P617, DOI 10.1163/1568539041166744; Ligout S, 2003, ANIM BEHAV, V65, P1109, DOI 10.1006/anbe.2003.2139; Ligout S, 2002, APPL ANIM BEHAV SCI, V76, P239, DOI 10.1016/S0168-1591(02)00015-1; Lui CC, 2011, NEUROCHEM INT, V58, P434, DOI 10.1016/j.neuint.2011.01.002; Maletinska J, 2002, BEHAVIOUR, V139, P975, DOI 10.1163/156853902320387927; Marchlewska-Koj A, 2003, PHYSIOL BEHAV, V79, P671, DOI 10.1016/S0031-9384(03)00168-9; Millman ST, 2001, SOCIAL COGNITION FAR; Miranda-de la Lama GC, 2010, SMALL RUMINANT RES, V90, P1, DOI 10.1016/j.smallrumres.2010.01.006; Murmu MS, 2006, EUR J NEUROSCI, V24, P1477, DOI 10.1111/j.1460-9568.2006.05024.x; Nishio H, 2001, INT J DEV NEUROSCI, V19, P37, DOI 10.1016/S0736-5748(00)00070-8; NOWAK R, 1990, DEV PSYCHOBIOL, V23, P285, DOI 10.1002/dev.420230307; OBRIEN PH, 1988, APPL ANIM BEHAV SCI, V21, P209, DOI 10.1016/0168-1591(88)90110-4; Ohkawa T, 1987, Nihon Naibunpi Gakkai Zasshi, V63, P823; Patin V, 2005, DEV BRAIN RES, V160, P265, DOI 10.1016/j.devbrainres.2005.09.010; Patt A, 2012, APPL ANIM BEHAV SCI, V138, P47, DOI 10.1016/j.applanim.2012.02.012; Poindron P, 2007, HORM BEHAV, V52, P99, DOI 10.1016/j.yhbeh.2007.03.023; Porter RH, 2001, BEHAVIOUR, V138, P207, DOI 10.1163/15685390151074384; PORTER RH, 1995, APPL ANIM BEHAV SCI, V45, P239, DOI 10.1016/0168-1591(95)00630-B; R Core Team, 2022, R LANG ENV STAT COMP; RICHARDSON C, 1978, BRIT VET J, V134, P181, DOI 10.1016/S0007-1935(17)33543-1; Roussel S, 2005, HORM BEHAV, V47, P256, DOI 10.1016/j.yhbeh.2004.09.010; Roussel S, 2004, APPL ANIM BEHAV SCI, V85, P259, DOI 10.1016/j.applanim.2003.11.006; Roussel-Huchette S, 2008, APPL ANIM BEHAV SCI, V109, P275, DOI 10.1016/j.applanim.2007.02.005; SACHS BD, 1978, ANIM BEHAV, V26, P678, DOI 10.1016/0003-3472(78)90134-3; Sachser N, 1996, PHYSIOL BEHAV, V60, P589, DOI 10.1016/S0031-9384(96)80036-9; Sachser N, 1998, PSYCHONEUROENDOCRINO, V23, P891, DOI 10.1016/S0306-4530(98)00059-6; SCHNEIDER ML, 1992, DEV PSYCHOBIOL, V25, P427, DOI 10.1002/dev.420250604; SHACKLETON DM, 1984, J ANIM SCI, V58, P500, DOI 10.2527/jas1984.582500x; Shi J, 2007, MAMMALIA MAMM, V69, P185; Siebert K, 2011, APPL ANIM BEHAV SCI, V131, P53, DOI 10.1016/j.applanim.2011.01.003; Silanikove N, 2000, SMALL RUMINANT RES, V35, P181, DOI 10.1016/S0921-4488(99)00096-6; SZURAN T, 1994, BEHAV BRAIN RES, V65, P153, DOI 10.1016/0166-4328(94)90100-7; TAKAHASHI LK, 1992, PHYSIOL BEHAV, V51, P319, DOI 10.1016/0031-9384(92)90147-T; UNO H, 1990, DEV BRAIN RES, V53, P157, DOI 10.1016/0165-3806(90)90002-G; Vas J, 2013, APPL ANIM BEHAV SCI, V147, P117, DOI 10.1016/j.applanim.2013.04.009; VELAZQUEZMOCTEZUMA J, 1993, PHYSIOL BEHAV, V53, P443, DOI 10.1016/0031-9384(93)90137-5; WARD IL, 1972, SCIENCE, V175, P82, DOI 10.1126/science.175.4017.82; Weinstock M, 1997, NEUROSCI BIOBEHAV R, V21, P1, DOI 10.1016/S0149-7634(96)00014-0; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Weinstock M, 2007, NEUROCHEM RES, V32, P1730, DOI 10.1007/s11064-007-9339-4; Wu J, 2007, BRAIN RES, V1141, P205, DOI 10.1016/j.brainres.2007.01.024; Zhu ZL, 2004, J NEUROSCI RES, V78, P837, DOI 10.1002/jnr.20338	91	7	7	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94253	10.1371/journal.pone.0094253	http://dx.doi.org/10.1371/journal.pone.0094253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710177	gold, Green Published, Green Submitted			2022-12-25	WOS:000334159800129
J	de Souza, JES; Fonseca, AF; Valieris, R; Carraro, DM; Wang, JYJ; Kolodner, RD; de Souza, SJ				de Souza, Jorge E. S.; Fonseca, Andre F.; Valieris, Renan; Carraro, Dirce M.; Wang, Jean Y. J.; Kolodner, Richard D.; de Souza, Sandro J.			S-Score: A Scoring System for the Identification and Prioritization of Predicted Cancer Genes	PLOS ONE			English	Article							HUMAN BREAST; MUTATIONS; CARCINOMA; PATHWAY; GENOMES; NOTCH1; LMO7	A new method, which allows for the identification and prioritization of predicted cancer genes for future analysis, is presented. This method generates a gene-specific score called the "S-Score'' by incorporating data from different types of analysis including mutation screening, methylation status, copy-number variation and expression profiling. The method was applied to the data from The Cancer Genome Atlas and allowed the identification of known and potentially new oncogenes and tumor suppressors associated with different clinical features including shortest term of survival in ovarian cancer patients and hormonal subtypes in breast cancer patients. Furthermore, for the first time a genome-wide search for genes that behave as oncogenes and tumor suppressors in different tumor types was performed. We envisage that the S-score can be used as a standard method for the identification and prioritization of cancer genes for follow-up studies.	[de Souza, Jorge E. S.; Fonseca, Andre F.; Valieris, Renan] Inst Bioinformat & Biotechnol, Sao Paulo, Brazil; [de Souza, Jorge E. S.] Univ Sao Paulo, Fac Med, Ctr Cell Therapy, BR-14049 Ribeirao Preto, Brazil; [de Souza, Jorge E. S.] Univ Sao Paulo, Fac Med, Reg Blood Ctr, Dept Clin Med, BR-14049 Ribeirao Preto, Brazil; [Fonseca, Andre F.; de Souza, Sandro J.] Univ Fed Rio Grande do Norte, Inst Brain, Natal, RN, Brazil; [de Souza, Jorge E. S.; Valieris, Renan; Carraro, Dirce M.] Int Res Ctr, CIPE AC Camargo Canc Ctr, Sao Paulo, Brazil; [Wang, Jean Y. J.; Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Moores UCSD Canc Ctr, San Diego, CA 92103 USA; [Wang, Jean Y. J.; Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92103 USA; [Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Moores UCSD Canc Ctr,San Diego Branch, Dept Med & Cellular & Mol Med,Ludwig Inst Canc Re, San Diego, CA 92103 USA; [Kolodner, Richard D.] Univ Calif San Diego, Sch Med, Inst Genom Med, San Diego, CA 92103 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Rio Grande do Norte; A.C.Camargo Cancer Center; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	de Souza, SJ (corresponding author), Univ Fed Rio Grande do Norte, Inst Brain, Natal, RN, Brazil.	sandro@neuro.ufrn.br	carraro, dirce/C-9179-2009; de Souza, Sandro Jose/AAG-6270-2020	carraro, dirce/0000-0001-5667-1418; 	CNPq [483775/2012-6]; National Institutes of Health [GM26017]; NATIONAL CANCER INSTITUTE [R01CA043054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026017, R37GM026017] Funding Source: NIH RePORTER	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by CNPq grant 483775/2012-6 to SJS and by National Institutes of Health grant GM26017 to RDK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Burska UL, 2013, J BIOL CHEM; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Collier LS, 2006, CURR OPIN GENET DEV, V16, P23, DOI 10.1016/j.gde.2005.11.001; Dai JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021120; Eifert C, 2012, NAT REV CANCER, V12, P572, DOI 10.1038/nrc3299; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Gangula NR, 2013, J BIOL CHEM; Gnad F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S3-S7; Hu QD, 2011, MOL CELL BIOL, V31, P3223, DOI 10.1128/MCB.01365-10; Huang L, 2011, CANCER-AM CANCER SOC, V117, P3363, DOI 10.1002/cncr.25870; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; McKenzie EA, 2007, BRIT J PHARMACOL, V151, P1, DOI 10.1038/sj.bjp.0707182; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nakamura H, 2005, CANCER LETT, V220, P95, DOI 10.1016/j.canlet.2004.07.023; Nakamura H, 2011, EXP THER MED, V2, P1053, DOI 10.3892/etm.2011.329; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Patel VN, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003237; Pope WB, 2008, RADIOLOGY, V249, P268, DOI 10.1148/radiol.2491072000; Tanaka-Okamoto M, 2009, CANCER SCI, V100, P608, DOI 10.1111/j.1349-7006.2009.01091.x; Viatour P, 2011, J EXP MED, V208, P1963, DOI 10.1084/jem.20110198; Volgestein B, 2013, SCIENCE, V339, P1546; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zins K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074924	29	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94147	10.1371/journal.pone.0094147	http://dx.doi.org/10.1371/journal.pone.0094147			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710071	gold, Green Published			2022-12-25	WOS:000334159800107
J	Hosseini-Mazinani, M; Mariotti, R; Torkzaban, B; Sheikh-Hassani, M; Ataei, S; Cultrera, NGM; Pandolfi, S; Baldoni, L				Hosseini-Mazinani, Mehdi; Mariotti, Roberto; Torkzaban, Bahareh; Sheikh-Hassani, Massoma; Ataei, Saeedeh; Cultrera, Nicolo G. M.; Pandolfi, Saverio; Baldoni, Luciana			High Genetic Diversity Detected in Olives beyond the Boundaries of the Mediterranean Sea	PLOS ONE			English	Article							OLEA-EUROPAEA L.; CULTIVATED OLIVES; WILD OLIVES; DOMESTICATION; CUSPIDATA; SOFTWARE; DIFFERENTIATION; IDENTIFICATION; PROVINCE; HISTORY	Background: Olive trees (Olea europaea subsp. europaea var. europaea) naturally grow in areas spanning the Mediterranean basin and towards the East, including the Middle East. In the Iranian plateau, the presence of olives has been documented since very ancient times, though the early history of the crop in this area is shrouded in uncertainty. Methods: The varieties presently cultivated in Iran and trees of an unknown cultivation status, surviving under extreme climate and soil conditions, were sampled from different provinces and compared with a set of Mediterranean cultivars. All samples were analyzed using SSR and chloroplast markers to establish the relationships between Iranian olives and Mediterranean varieties, to shed light on the origins of Iranian olives and to verify their contribution to the development of the current global olive variation. Results: Iranian cultivars and ecotypes, when analyzed using SSR markers, clustered separately from Mediterranean cultivars and showed a high number of private alleles, on the contrary, they shared the same single chlorotype with the most widespread varieties cultivated in the Mediterranean. Conclusion: We hypothesized that Iranian and Mediterranean olive trees may have had a common origin from a unique center in the Near East region, possibly including the western Iranian area. The present pattern of variation may have derived from different environmental conditions, distinct levels and selection criteria, and divergent breeding opportunities found by Mediterranean and Iranian olives. These unexpected findings emphasize the importance of studying the Iranian olive germplasm as a promising but endangered source of variation.	[Hosseini-Mazinani, Mehdi; Torkzaban, Bahareh; Sheikh-Hassani, Massoma; Ataei, Saeedeh] Natl Inst Genet Engn & Biotechnol, Tehran, Iran; [Mariotti, Roberto; Cultrera, Nicolo G. M.; Pandolfi, Saverio; Baldoni, Luciana] CNR, Inst Biosci & Bioresources, Perugia, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR)	Baldoni, L (corresponding author), Natl Inst Genet Engn & Biotechnol, Tehran, Iran.	hosseini@nigeb.ac.ir; luciana.baldoni@ibbr.cnr.it	Cultrera, Nicolò G/P-7376-2018; Baldoni, Luciana/A-4411-2016; mariotti, roberto/AAG-7294-2021	Cultrera, Nicolò G/0000-0003-1361-7539; Baldoni, Luciana/0000-0002-3221-333X; mariotti, roberto/0000-0002-9111-5123; BALDONI, LUCIANA/0000-0002-6636-0055				Al-Ameri TK, 2011, ARAB J GEOSCI, V4, P945, DOI 10.1007/s12517-010-0159-5; Baali-Cherif D, 2005, ANN BOT-LONDON, V96, P823, DOI 10.1093/aob/mci232; Baldoni L, 2006, ANN BOT-LONDON, V98, P935, DOI 10.1093/aob/mcl178; Baldoni L, 2009, MOL BREEDING, V24, P213, DOI 10.1007/s11032-009-9285-8; Belaj A, 2012, TREE GENET GENOMES, V8, P365, DOI 10.1007/s11295-011-0447-6; Besnard G, 2007, J BIOGEOGR, V34, P736, DOI 10.1111/j.1365-2699.2006.01653.x; Besnard G, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2833; Besnard G, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-80; Besnard G, 2009, ANN BOT-LONDON, V104, P143, DOI 10.1093/aob/mcp105; Blondel J, 2006, HUM ECOL, V34, P713, DOI 10.1007/s10745-006-9030-4; Breton C, 2006, J BIOGEOGR, V33, P1916, DOI 10.1111/j.1365-2699.2006.01544.x; Breton C, 2009, CR BIOL, V332, P1059, DOI 10.1016/j.crvi.2009.08.001; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Colledge S, 2004, CURR ANTHROPOL, V45, pS35, DOI 10.1086/422086; Cornuet JM, 1996, GENETICS, V144, P2001; Djamali M, 2009, VEG HIST ARCHAEOBOT, V18, P123, DOI 10.1007/s00334-008-0178-2; Floor Willem, 2005, ENCY IRANICA; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Hannachi H, 2009, GENET RESOUR CROP EV, V56, P393, DOI 10.1007/s10722-008-9374-2; Hemmat MA, 2012, ARCH SCI, V65; Hosseini-Mazinani S, 2002, ACTA HORTIC, V634, P145; Jacquemoud-Collet, 2006, DARWIN SOFTWARE VERS; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kaniewski D, 2012, BIOL REV, V87, P885, DOI 10.1111/j.1469-185X.2012.00229.x; Lovell JL, 2010, RADIOCARBON, V52, P364, DOI 10.1017/S0033822200045410; Mariotti R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-211; Mousavi S, 2014, GENET RESOUR CROP EV, V61, P775, DOI 10.1007/s10722-013-0071-4; Noormohammadi Z, 2012, GENET MOL RES, V11, P707, DOI 10.4238/2012.March.19.4; Noormohammadi Z, 2007, HORTSCIENCE, V42, P1545, DOI 10.21273/HORTSCI.42.7.1545; Noormohammadi Zahra, 2009, Acta Biologica Szegediensis, V53, P27; Omrani-Sabbaghi A, 2007, SCI HORTIC-AMSTERDAM, V112, P439, DOI 10.1016/j.scienta.2006.12.051; Park SDE, 2001, MICROSATELLITE TOOLK; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pickersgill B, 2007, ANN BOT-LONDON, V100, P925, DOI 10.1093/aob/mcm193; Pritchard JK, 2009, DOCUMENTATION STRUCT; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sadeghi H, 1992, CULTIVATION PRESERVA; Sanei S. J., 2012, Annual Review & Research in Biology, V2, P27; Sheidai M, 2010, SCIENCEASIA, V36, P187, DOI 10.2306/scienceasia1513-1874.2010.36.187; Sheidai M, 2009, CYTOLOGIA, V74, P369, DOI 10.1508/cytologia.74.369; Terral JF, 2004, J BIOGEOGR, V31, P63, DOI 10.1046/j.0305-0270.2003.01019.x; Trujillo I, 2012, ACTA HORTIC, V949, P47; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; VAVILOV N. I., 1949, Chronica botanica, V13; Zohary D., 2000, Domestication of plants in the Old World: the origin and spread of cultivated plants in West Asia, Europe and the Nile Valley; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001	48	28	28	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93146	10.1371/journal.pone.0093146	http://dx.doi.org/10.1371/journal.pone.0093146			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709858	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800022
J	Kumichel, A; Knust, E				Kumichel, Alexandra; Knust, Elisabeth			Apical Localisation of Crumbs in the Boundary Cells of the Drosophila Hindgut Is Independent of Its Canonical Interaction Partner Stardust	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; ZONULA ADHERENS FORMATION; EPITHELIAL-CELLS; PLASMA-MEMBRANE; PHOTORECEPTOR MORPHOGENESIS; CYTOPLASMIC DOMAIN; POLARITY PROTEINS; COMPLEX; JUNCTIONS; NEUROBLASTS	The transmembrane protein Crumbs/Crb is a key regulator of apico-basal epithelial cell polarity, both in Drosophila and in vertebrates. In most cases studied so far, the apical localisation of Drosophila Crumbs depends on the interaction of its C-terminal amino acids with the scaffolding protein Stardust. Consequently, embryos lacking either Crumbs or Stardust develop a very similar phenotype, characterised by the loss of epithelial tissue integrity and cell polarity in many epithelia. An exception is the hindgut, which is not affected by the loss of either gene. The hindgut is a single layered epithelial tube composed of two cell populations, the boundary cells and the principal cells. Here we show that Crumbs localisation in the principal cells depends on Stardust, similarly to other embryonic epithelia. In contrast, localisation of Crumbs in the boundary cells does not require Stardust and is independent of its PDZ domain- and FERM-domain binding motifs. In line with this, the considerable upregulation of Crumbs in boundary cells is not followed by a corresponding upregulation of its canonical binding partners. Our data are the first to suggest a mechanism controlling apical Crumbs localisation, which is independent of its conserved FERM- and PDZ-domain binding motifs.	[Kumichel, Alexandra; Knust, Elisabeth] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Max Planck Society	Knust, E (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	knust@mpi-cbg.de			Max-Planck Society (MPG)	Max-Planck Society (MPG)(Max Planck Society)	This work was supported by the Max-Planck Society (MPG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apodaca G, 2012, NAT CELL BIOL, V14, P1235, DOI 10.1038/ncb2635; Bachmann A, 2004, J CELL SCI, V117, P1899, DOI 10.1242/jcs.01029; Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Berger S, 2007, GENETICS, V176, P2189, DOI 10.1534/genetics.107.071449; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Blankenship JT, 2007, J CELL SCI, V120, P3099, DOI 10.1242/jcs.004770; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bulgakova NA, 2008, J CELL SCI, V121, P2018, DOI 10.1242/jcs.031088; Bulgakova NA, 2009, J CELL SCI, V122, P2587, DOI 10.1242/jcs.023648; Campbell K, 2009, J CELL SCI, V122, P2604, DOI 10.1242/jcs.047183; Cao XW, 2012, CELL RES, V22, P793, DOI 10.1038/cr.2012.64; Chen J, 2013, EXP CELL RES, V319, P1357, DOI 10.1016/j.yexcr.2013.03.021; Duan YY, 2012, J BIOL CHEM, V287, P40547, DOI 10.1074/jbc.M112.403584; Ellenbroek SIJ, 2012, SEMIN CANCER BIOL, V22, P208, DOI 10.1016/j.semcancer.2012.02.012; Elsum I, 2012, ESSAYS BIOCHEM, V53, P141, DOI [10.1042/bse0530141, 10.1042/BSE0530141]; Fan SL, 2007, J CELL BIOL, V178, P387, DOI 10.1083/jcb.200609096; Fletcher GC, 2012, CURR BIOL, V22, P1116, DOI 10.1016/j.cub.2012.04.020; Fuss B, 2002, CURR BIOL, V12, P171; Golachowska MR, 2010, TRENDS CELL BIOL, V20, P618, DOI 10.1016/j.tcb.2010.08.004; Grawe F, 1996, DEVELOPMENT, V122, P951; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; HAN KY, 1993, EMBO J, V12, P2723, DOI 10.1002/j.1460-2075.1993.tb05934.x; Harris KP, 2008, J CELL BIOL, V183, P1129, DOI 10.1083/jcb.200807020; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Horne-Badovinac S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040008; Huang J, 2009, P NATL ACAD SCI USA, V106, P8284, DOI 10.1073/pnas.0900641106; Iwaki DD, 2002, MECH DEVELOP, V114, P71, DOI 10.1016/S0925-4773(02)00061-8; Janich P, 2007, FEBS LETT, V581, P1783, DOI 10.1016/j.febslet.2007.03.065; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; Kempkens O, 2006, EUR J CELL BIOL, V85, P753, DOI 10.1016/j.ejcb.2006.03.003; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Klose S, 2013, G3-GENES GENOM GENET, V3, P153, DOI 10.1534/g3.112.005074; Krahn MP, 2010, J CELL BIOL, V190, P751, DOI 10.1083/jcb.201006029; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Laprise P, 2006, DEV CELL, V11, P363, DOI 10.1016/j.devcel.2006.06.001; Lemmers C, 2004, MOL BIOL CELL, V15, P1324, DOI 10.1091/mbc.E03-04-0235; Lengyel JA, 2002, DEV BIOL, V243, P1, DOI 10.1006/dbio.2002.0577; Letizia A, 2013, J CELL SCI, V126, P2157, DOI 10.1242/jcs.122382; Ling C, 2010, P NATL ACAD SCI USA, V107, P10532, DOI 10.1073/pnas.1004279107; Makarova O, 2003, GENE, V302, P21, DOI 10.1016/S0378111902010843; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Murakami R, 2001, J MORPHOL, V248, P144, DOI 10.1002/jmor.1025; Muschalik N, 2011, J CELL SCI, V124, P3715, DOI 10.1242/jcs.091223; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Pocha SM, 2011, CURR BIOL, V21, P1111, DOI 10.1016/j.cub.2011.05.007; Revenu C, 2012, MOL BIOL CELL, V23, P324, DOI 10.1091/mbc.E11-09-0765; Richard M, 2006, DEV DYNAM, V235, P895, DOI 10.1002/dvdy.20595; Richard M, 2009, EUR J CELL BIOL, V88, P765, DOI 10.1016/j.ejcb.2009.07.006; Roeth JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007634; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; Roper K, 2000, NAT CELL BIOL, V2, P582, DOI 10.1038/35023524; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797; Soplop NH, 2012, DEV DYNAM, V241, P759, DOI 10.1002/dvdy.23749; Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200; Tanentzapf G, 2000, J CELL BIOL, V151, P891, DOI 10.1083/jcb.151.4.891; TEPASS U, 1994, DEV BIOL, V161, P563, DOI 10.1006/dbio.1994.1054; TEPASS U, 1993, DEV BIOL, V159, P311, DOI 10.1006/dbio.1993.1243; TEPASS U, 1990, ROUX ARCH DEV BIOL, V199, P189, DOI 10.1007/BF01682078; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; Thelin WR, 2007, J CLIN INVEST, V117, P364, DOI 10.1172/JCI30376; Walmsley SJ, 2012, AM J PHYSIOL-RENAL, V302, pF1465, DOI 10.1152/ajprenal.00390.2011; Weisz OA, 2009, J CELL SCI, V122, P4253, DOI 10.1242/jcs.032615; Whiteman EL, 2014, MOL CELL BIOL, V34, P43, DOI 10.1128/MCB.00999-13; WIESCHAUS E, 1984, ROUX ARCH DEV BIOL, V193, P296, DOI 10.1007/BF00848158; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5; WODARZ A, 1993, MECH DEVELOP, V44, P175, DOI 10.1016/0925-4773(93)90066-7; Xiao ZJ, 2011, DEV DYNAM, V240, P2646, DOI 10.1002/dvdy.22778; Zhou B, 2011, DEV BIOL, V360, P87, DOI 10.1016/j.ydbio.2011.09.009; Zou J, 2012, DEV CELL, V22, P1261, DOI 10.1016/j.devcel.2012.03.007	77	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94038	10.1371/journal.pone.0094038	http://dx.doi.org/10.1371/journal.pone.0094038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710316	Green Published, gold			2022-12-25	WOS:000334159800092
J	Ulrich, D; Edwards, SL; Su, K; White, JF; Ramshaw, JAM; Jenkin, G; Deprest, J; Rosamilia, A; Werkmeister, JA; Gargett, CE				Ulrich, Daniela; Edwards, Sharon L.; Su, Kai; White, Jacinta F.; Ramshaw, John A. M.; Jenkin, Graham; Deprest, Jan; Rosamilia, Anna; Werkmeister, Jerome A.; Gargett, Caroline E.			Influence of Reproductive Status on Tissue Composition and Biomechanical Properties of Ovine Vagina	PLOS ONE			English	Article							PELVIC ORGAN PROLAPSE; RAT VAGINA; COLLAGENS; PROTEOGLYCANS; TERMINOLOGY; PREGNANCY; DELIVERY	Objective: To undertake a comprehensive analysis of the biochemical tissue composition and passive biomechanical properties of ovine vagina and relate this to the histo-architecture at different reproductive stages as part of the establishment of a large preclinical animal model for evaluating regenerative medicine approaches for surgical treatment of pelvic organ prolapse. Methods: Vaginal tissue was collected from virgin (n = 3), parous (n = 6) and pregnant sheep (n = 6; mean gestation; 132 d; term = 145 d). Tissue histology was analyzed using H+E and Masson's Trichrome staining. Biochemical analysis of the extracellular matrix proteins used a hydroxyproline assay to quantify total collagen, SDS PAGE to measure collagen III/I+III ratios, dimethylmethylene blue to quantify glycosaminoglycans and amino acid analysis to quantify elastin. Uniaxial tensiometry was used to determine the Young's modulus, maximum stress and strain, and permanent strain following cyclic loading. Results: Vaginal tissue of virgin sheep had the lowest total collagen content and permanent strain. Parous tissue had the highest total collagen and lowest elastin content with concomitant high maximum stress. In contrast, pregnant sheep had the highest elastin and lowest collagen contents, and thickest smooth muscle layer, which was associated with low maximum stress and poor dimensional recovery following repetitive loading. Conclusion: Pregnant ovine vagina was the most extensible, but the weakest tissue, whereas parous and virgin tissues were strong and elastic. Pregnancy had the greatest impact on tissue composition and biomechanical properties, compatible with significant tissue remodeling as demonstrated in other species. Biochemical changes in tissue protein composition coincide with these altered biomechanical properties.	[Ulrich, Daniela; Jenkin, Graham; Gargett, Caroline E.] MIMR, Ritchie Ctr, PHI Inst Med Res, Melbourne, Vic, Australia; [Ulrich, Daniela; Rosamilia, Anna; Gargett, Caroline E.] Monash Univ, Dept Obstet & Gynecol, Melbourne, Vic 3004, Australia; [Edwards, Sharon L.; Su, Kai; White, Jacinta F.; Ramshaw, John A. M.; Werkmeister, Jerome A.] CSIRO, Mat Sci Engn, Melbourne, Vic, Australia; [Deprest, Jan] Univ Hosp Leuven, Dept Obstet & Gynecol, Louvain, Belgium	Prince Henry's Institute of Medical Research; Monash University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); KU Leuven; University Hospital Leuven	Werkmeister, JA (corresponding author), CSIRO, Mat Sci Engn, Melbourne, Vic, Australia.	Jerome.Werkmeister@csiro.au	Gargett, Caroline E/Q-7911-2019; White, Jacinta F/D-6961-2013; Gold, Daniela/ABE-4818-2020; Gargett, Caroline Eve/I-4895-2019	Gargett, Caroline E/0000-0002-3590-2077; White, Jacinta F/0000-0002-4855-0170; Gold, Daniela/0000-0002-7196-454X; Ramshaw, John A.M./0000-0002-2131-3685; Deprest, Jan/0000-0002-4920-945X	Australian National Health and Medical Research Council [1021126, 1042298]; CASS Foundation; South East Melbourne Alliance for Regenerative Therapies (SMART) grant; Victorian Government's Operational Infrastructure Support Program; Monash University; SMART; Australian Stem Cell Centre; Australian Government as part of the National Collaborative Research Infrastructure Strategy	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); CASS Foundation; South East Melbourne Alliance for Regenerative Therapies (SMART) grant; Victorian Government's Operational Infrastructure Support Program; Monash University(Monash University); SMART; Australian Stem Cell Centre; Australian Government as part of the National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science)	The authors acknowledge support from the Australian National Health and Medical Research Council grants (1021126) (to CEG JAW AR) and Senior Research Fellowship 1042298 (to CEG), the CASS Foundation (to CEG), South East Melbourne Alliance for Regenerative Therapies (SMART) grant (to CEG JAW AR SE) and the Victorian Government's Operational Infrastructure Support Program. DU received scholarships from Monash University, SMART and the Australian Stem Cell Centre. JD is a fundamental clinical researcher from the Fonds Wetenschappelijk Onderzoek Vlaanderen (1801207N). This research has been facilitated by access to Australian Proteome Analysis Facility which is funded by an initiative of the Australian Government as part of the National Collaborative Research Infrastructure Strategy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramowitch SD, 2009, EUR J OBSTET GYN R B, V144, pS146, DOI 10.1016/j.ejogrb.2009.02.022; Alperin M, 2010, INT UROGYNECOL J, V21, P1169, DOI 10.1007/s00192-010-1149-6; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; CHAN D, 1984, ANAL BIOCHEM, V139, P322, DOI 10.1016/0003-2697(84)90012-5; CHANDRASEKHAR S, 1987, ANAL BIOCHEM, V161, P103, DOI 10.1016/0003-2697(87)90658-0; Couchman JR, 2012, J HISTOCHEM CYTOCHEM, V60, P885, DOI 10.1369/0022155412464638; Couri Bruna M, 2012, Expert Rev Obstet Gynecol, V7, P249; De Landsheere L, 2013, INT UROGYNECOL J, V24, P2011, DOI 10.1007/s00192-013-2111-1; DELANCEY JOL, 1992, AM J OBSTET GYNECOL, V166, P1717, DOI 10.1016/0002-9378(92)91562-O; Deprest J, 2013, BJOG-INT J OBSTET GY, V120, P141, DOI 10.1111/1471-0528.12088; Diani J, 2009, EUR POLYM J, V45, P601, DOI 10.1016/j.eurpolymj.2008.11.017; Edwards SL, 2013, J MECH BEHAV BIOMED, V23, P53, DOI 10.1016/j.jmbbm.2013.04.002; Ennen S, 2011, THERIOGENOLOGY, V75, P212, DOI 10.1016/j.theriogenology.2010.08.007; Haylen BT, 2010, NEUROUROL URODYNAM, V29, P4, DOI 10.1002/nau.20798; Hulmes DJS, 2002, J STRUCT BIOL, V137, P2, DOI 10.1006/jsbi.2002.4450; Jean-Charles C, 2010, INT UROGYNECOL J, V21, P1535, DOI 10.1007/s00192-010-1208-z; Lowder JL, 2007, OBSTET GYNECOL, V109, P136, DOI 10.1097/01.AOG.0000250472.96672.6c; Lukacz ES, 2006, OBSTET GYNECOL, V107, P1253, DOI 10.1097/01.AOG.0000218096.54169.34; Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311; Ozog Y, 2011, INT UROGYNECOL J, V22, P1099, DOI 10.1007/s00192-011-1440-1; Rahn DD, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.02.022; Ramshaw JAM, 2009, J MATER SCI-MATER M, V20, P3, DOI 10.1007/s10856-008-3415-4; Rubod C, 2012, J UROLOGY, V79; Rubod C, 2008, INT UROGYNECOL J, V19, P811, DOI 10.1007/s00192-007-0533-3; Rubod C, 2007, J UROLOGY, V178, P320, DOI 10.1016/j.juro.2007.03.040; SHEPHERD PR, 1992, VET REC, V130, P564, DOI 10.1136/vr.130.25.564; SYKES B, 1976, BIOCHEM BIOPH RES CO, V72, P1472, DOI 10.1016/S0006-291X(76)80180-5; Ulrich D, 2014, TISSUE ENG PT A, V20, P785, DOI 10.1089/ten.TEA.2013.0170; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0	29	30	31	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93172	10.1371/journal.pone.0093172	http://dx.doi.org/10.1371/journal.pone.0093172			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709913	Green Published, gold, Green Submitted			2022-12-25	WOS:000334159800024
J	Sasaki, H; Takeuchi, I; Okada, M; Sawada, R; Kanie, K; Kiyota, Y; Honda, H; Kato, R				Sasaki, Hiroto; Takeuchi, Ichiro; Okada, Mai; Sawada, Rumi; Kanie, Kei; Kiyota, Yasujiro; Honda, Hiroyuki; Kato, Ryuji			Label-Free Morphology-Based Prediction of Multiple Differentiation Potentials of Human Mesenchymal Stem Cells for Early Evaluation of Intact Cells	PLOS ONE			English	Article							SENESCENCE; GENE; EXPRESSION; SHAPE; APOPTOSIS; CULTURE; TENSION; TARGET; P53	Precise quantification of cellular potential of stem cells, such as human bone marrow-derived mesenchymal stem cells (hBMSCs), is important for achieving stable and effective outcomes in clinical stem cell therapy. Here, we report a method for image-based prediction of the multiple differentiation potentials of hBMSCs. This method has four major advantages: ( 1) the cells used for potential prediction are fully intact, and therefore directly usable for clinical applications; ( 2) predictions of potentials are generated before differentiation cultures are initiated; ( 3) prediction of multiple potentials can be provided simultaneously for each sample; and ( 4) predictions of potentials yield quantitative values that correlate strongly with the experimental data. Our results show that the collapse of hBMSC differentiation potentials, triggered by in vitro expansion, can be quantitatively predicted far in advance by predicting multiple potentials, multi-lineage differentiation potentials ( osteogenic, adipogenic, and chondrogenic) and population doubling potential using morphological features apparent during the first 4 days of expansion culture. In order to understand how such morphological features can be effective for advance predictions, we measured gene-expression profiles of the same early undifferentiated cells. Both senescence-related genes ( p16 and p21) and cytoskeleton-related genes (PTK2, CD146, and CD49) already correlated to the decrease of potentials at this stage. To objectively compare the performance of morphology and gene expression for such early prediction, we tested a range of models using various combinations of features. Such comparison of predictive performances revealed that morphological features performed better overall than gene-expression profiles, balancing the predictive accuracy with the effort required for model construction. This benchmark list of various prediction models not only identifies the best morphological feature conversion method for objective potential prediction, but should also allow clinicians to choose the most practical morphology-based prediction method for their own purposes.	[Sasaki, Hiroto; Kanie, Kei; Honda, Hiroyuki; Kato, Ryuji] Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Nagoya, Aichi 4648601, Japan; [Takeuchi, Ichiro] Nagoya Inst Technol, Grad Sch Engn, Dept Comp Sci Sci & Engn Simulat, Nagoya, Aichi, Japan; [Okada, Mai; Kanie, Kei; Kato, Ryuji] Nagoya Univ, Grad Sch Pharmaceut Sci, Dept Basic Med Sci, Nagoya, Aichi 4648601, Japan; [Sawada, Rumi] Natl Inst Hlth Sci, Div Med Devices, Setagaya Ku, Tokyo 1588501, Japan; [Kiyota, Yasujiro] Nikon Inc, Chiyoda Ku, Tokyo, Japan	Nagoya University; Nagoya Institute of Technology; Nagoya University; National Institute of Health Sciences - Japan; Nikon Corporation	Kato, R (corresponding author), Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Nagoya, Aichi 4648601, Japan.	kato-r@ps.nagoya-u.ac.jp	Kato, Ryuji/I-6952-2014; Kanie, Kei/AAO-1186-2021	Kanie, Kei/0000-0002-0833-6997	New Energy and Industrial Technology Development Organization (NEDO) [09C46036a]; Japan Society for the Promotion of Science (JSPS) [25.8678]; Hori Sciences and Arts Foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hori Sciences and Arts Foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors are grateful for financial support from the New Energy and Industrial Technology Development Organization (NEDO), which provided the Grant for Industrial Technology Research (Financial Support to Young Researchers, 09C46036a); the Japan Society for the Promotion of Science (JSPS) no. 25.8678; the Hori Sciences and Arts Foundation; and the Program for Leading Graduate Schools "Integrative Graduate Education and Research in Green Natural Sciences" from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur A, 2009, J CELL PHYSIOL, V218, P237, DOI 10.1002/jcp.21592; Ben Azouna N, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt97; Bin Noh H, 2010, GENES GENOM, V32, P87, DOI 10.1007/s13258-010-0868-x; Braude P, 2005, BMJ-BRIT MED J, V330, P1159, DOI 10.1136/bmj.330.7501.1159; Caplan AI, 2001, TRENDS MOL MED, V7, P259, DOI 10.1016/S1471-4914(01)02016-0; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Comer KA, 1998, ONCOGENE, V16, P1299, DOI 10.1038/sj.onc.1201645; Docheva D, 2008, J CELL MOL MED, V12, P537, DOI 10.1111/j.1582-4934.2007.00138.x; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Futamura Y, 2012, CHEM BIOL, V19, P1620, DOI 10.1016/j.chembiol.2012.10.014; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Ito T, 2008, CYTOTECHNOLOGY, V56, P1, DOI 10.1007/s10616-007-9092-1; Ito T, 2007, BIOCHEM BIOPH RES CO, V359, P108, DOI 10.1016/j.bbrc.2007.05.067; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jordan P, 1999, ONCOGENE, V18, P6835, DOI 10.1038/sj.onc.1203233; Kim JJ, 2013, METHODS MOL BIOL, V1052, P41, DOI 10.1007/7651_2013_29; Kinkel AD, 2004, CYTOTECHNOLOGY, V46, P49, DOI 10.1007/s10616-004-3903-4; KONSTANTINOV KB, 1994, CYTOTECHNOLOGY, V14, P233, DOI 10.1007/BF00749619; Massague J, 2012, FEBS LETT, V586, P1953, DOI 10.1016/j.febslet.2012.03.023; Matsuoka F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055082; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Misselwitz B, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-30; Motaln H, 2010, CANCER-AM CANCER SOC, V116, P2519, DOI 10.1002/cncr.25056; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; ROSKELLEY CD, 1994, P NATL ACAD SCI USA, V91, P12378, DOI 10.1073/pnas.91.26.12378; Rosland GV, 2009, CANCER RES, V69, P5331, DOI 10.1158/0008-5472.CAN-08-4630; Seiler C, 2012, J TISSUE ENG REGEN M; Settleman J, 2004, MOL CELL, V14, P148, DOI 10.1016/S1097-2765(04)00207-2; Shibata KR, 2007, STEM CELLS, V25, P2371, DOI 10.1634/stemcells.2007-0225; STEEDMAN HF, 1950, Q J MICROSC SCI, V91, P477; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107; Vega SL, 2012, J BIOMOL SCREEN, V17, P1151, DOI 10.1177/1087057112453853; Wang DJ, 2004, J BIOL CHEM, V279, P43725, DOI 10.1074/jbc.M407368200; Wang YW, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/652034; WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zuckerman V, 2009, J PATHOL, V219, P3, DOI 10.1002/path.2584	43	35	36	48	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93952	10.1371/journal.pone.0093952	http://dx.doi.org/10.1371/journal.pone.0093952			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705458	Green Published, Green Submitted, gold			2022-12-25	WOS:000334107500097
J	Wallace, DJ; Angus, DC; Seymour, CW; Yealy, DM; Carr, BG; Kurland, K; Boujoukos, A; Kahn, JM				Wallace, David J.; Angus, Derek C.; Seymour, Christopher W.; Yealy, Donald M.; Carr, Brendan G.; Kurland, Kristen; Boujoukos, Arthur; Kahn, Jeremy M.			Geographic Access to High Capability Severe Acute Respiratory Failure Centers in the United States	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; DISTRESS-SYNDROME; CARE; TRANSPORT; OUTCOMES; QUALITY; IMPACT	Objective: Optimal care of adults with severe acute respiratory failure requires specific resources and expertise. We sought to measure geographic access to these centers in the United States. Design: Cross-sectional analysis of geographic access to high capability severe acute respiratory failure centers in the United States. We defined high capability centers using two criteria: (1) provision of adult extracorporeal membrane oxygenation (ECMO), based on either 2008-2013 Extracorporeal Life Support Organization reporting or provision of ECMO to 2010 Medicare beneficiaries; or (2) high annual hospital mechanical ventilation volume, based 2010 Medicare claims. Setting: Nonfederal acute care hospitals in the United States. Measurements and Main Results: We defined geographic access as the percentage of the state, region and national population with either direct or hospital-transferred access within one or two hours by air or ground transport. Of 4,822 acute care hospitals, 148 hospitals met our ECMO criteria and 447 hospitals met our mechanical ventilation criteria. Geographic access varied substantially across states and regions in the United States, depending on center criteria. Without interhospital transfer, an estimated 58.5% of the national adult population had geographic access to hospitals performing ECMO and 79.0% had geographic access to hospitals performing a high annual volume of mechanical ventilation. With interhospital transfer and under ideal circumstances, an estimated 96.4% of the national adult population had geographic access to hospitals performing ECMO and 98.6% had geographic access to hospitals performing a high annual volume of mechanical ventilation. However, this degree of geographic access required substantial interhospital transfer of patients, including up to two hours by air. Conclusions: Geographic access to high capability severe acute respiratory failure centers varies widely across states and regions in the United States. Adequate referral center access in the case of disasters and pandemics will depend highly on local and regional care coordination across political boundaries.	[Wallace, David J.; Angus, Derek C.; Seymour, Christopher W.; Boujoukos, Arthur; Kahn, Jeremy M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA 15260 USA; [Wallace, David J.; Seymour, Christopher W.; Yealy, Donald M.] Univ Pittsburgh, Sch Med, Dept Emergency Med, Pittsburgh, PA USA; [Carr, Brendan G.] Univ Penn, Perelman Sch Med, Dept Emergency Med, Philadelphia, PA 19104 USA; [Kurland, Kristen] Carnegie Mellon Univ, Sch Publ Policy & Management, Heinz Coll, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; Pennsylvania Medicine; Carnegie Mellon University	Wallace, DJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA 15260 USA.	wallacedj@upmc.edu	Angus, Derek C/E-9671-2012	Kahn, Jeremy/0000-0001-9688-5576	National Institutes of Health [K12-HL109068, K23-GM104022]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL109068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM104022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Grant support was received from the National Institutes of Health: K12-HL109068 (Wallace), K23-GM104022 (Seymour). The NIH had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Adalja AA, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.09.016; [Anonymous], 2013, MMWR-MORBID MORTAL W, V62, P557; [Anonymous], 2010, AM HOSP ASS ANN SURV; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Branas CC, 2005, JAMA-J AM MED ASSOC, V293, P2626, DOI 10.1001/jama.293.21.2626; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Carr BG, 2009, ANN EMERG MED, V54, P261, DOI 10.1016/j.annemergmed.2008.11.016; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; Dowdy DW, 2006, INTENS CARE MED, V32, P1115, DOI 10.1007/s00134-006-0217-3; Finlayson SRG, 1999, MED CARE, V37, P204, DOI 10.1097/00005650-199902000-00010; Gastner MT, 2004, P NATL ACAD SCI USA, V101, P7499, DOI 10.1073/pnas.0400280101; Guerin C, 2013, NEW ENGL J MED, V368, P2159, DOI 10.1056/NEJMoa1214103; HAGEN H, 1989, Tidsskrift for den Norske Laegeforening, V109, P607; Halpern SD, 2011, CURR OPIN CRIT CARE, V17, P648, DOI 10.1097/MCC.0b013e32834c7a53; Henneman PL, 2011, J EMERG MED, V40, P333, DOI 10.1016/j.jemermed.2009.08.058; Herridge MS, 2011, NEW ENGL J MED, V364, P1293, DOI 10.1056/NEJMoa1011802; Horwitz JR, 2013, CIRCULATION, V128, P803, DOI 10.1161/CIRCULATIONAHA.112.000836; Jernigan D, 2013, MMWR-MORBID MORTAL W, V62, P366; Kahn JM, 2006, NEW ENGL J MED, V355, P41, DOI 10.1056/NEJMsa053993; Kahn JM, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-239; Klein MB, 2009, JAMA-J AM MED ASSOC, V302, P1774, DOI 10.1001/jama.2009.1548; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Lerner EB, 1999, ACAD EMERG MED, V6, P1127, DOI 10.1111/j.1553-2712.1999.tb00115.x; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Minnesota Population Center, 2011, NAT HIST GOGR INF SY; Nathens AB, 2004, J TRAUMA, V56, P173, DOI 10.1097/01.TA.0000056159.65396.7C; Noah MA, 2011, JAMA-J AM MED ASSOC, V306, P1659, DOI 10.1001/jama.2011.1471; Office of Assistant Secretary for Preparedness and Response, HSOP HEALTHC COAL TR; Papazian L, 2010, NEW ENGL J MED, V363, P1107, DOI 10.1056/NEJMoa1005372; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Quan H, 2004, MED CARE, V42, P801, DOI 10.1097/01.mlr.0000132391.59713.0d; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rubinson L, 2013, MED CARE, V51, P259, DOI 10.1097/MLR.0b013e31827da8ea; Seymour CW, 2008, CRIT CARE, V12, DOI 10.1186/cc6909; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Uusaro A, 2002, INTENS CARE MED, V28, P1122, DOI 10.1007/s00134-002-1348-9; Valta P, 1999, CRIT CARE MED, V27, P2367, DOI 10.1097/00003246-199911000-00008; Wallace DJ, 2014, ACAD EMERG MED, V21, P9, DOI 10.1111/acem.12289; Wunsch H, 2010, CRIT CARE MED, V38, P1947, DOI 10.1097/CCM.0b013e3181ef4460	40	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94057	10.1371/journal.pone.0094057	http://dx.doi.org/10.1371/journal.pone.0094057			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705417	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500115
J	Yan, HD; Zhang, F; Kolkin, J; Wang, CY; Xia, Z; Fan, CY				Yan, Hede; Zhang, Feng; Kolkin, Jon; Wang, Chunyang; Xia, Zhen; Fan, Cunyi			Mechanisms of Nerve Capping Technique in Prevention of Painful Neuroma Formation	PLOS ONE			English	Article							ALIGNED ELECTROSPUN NANOFIBERS; STUMP TRANSPLANTATION; TRAUMATIC NEUROMA; NEUROPATHIC PAIN; POTENTIAL ROLE; SCHWANN-CELLS; REGENERATION; GROWTH; AUTOTOMY; VEIN	Nerve capping techniques have been introduced as a promising treatment modality for the treatment of painful neuroma with varied outcomes; however, its exact mechanism is still unknown. RhoA is one of the members of the RAS superfamily of GTPases that operate as molecular switches and plays an important role in peripheral nerve regeneration. Our aim was to investigate the structural and morphologic mechanisms by which the nerve capping technique prevents the formation of painful neuromas after neuroectomy. We also hoped to provide a theoretical basis for this treatment approach. An aligned nanofiber conduit was used for the capping procedure and the sciatic nerve of Sprague-Dawley rats was selected as the animal model. Behavioral analysis, extent of neuroma formation, histological assessment, expressions of pain markers of substance P and c-fos, molecular biological changes as well as ultrastructural features were investigated and compared with the findings in a no-capping control group. The formation of traumatic neuromas was significantly inhibited in the capping group with relatively "normal'' structural and morphological features and no occurrence of autotomy and significantly lower expression of pain markers compared to the no-capping group. The gene expression of RhoA was consistently in a higher level in the capping group within 8 weeks after surgery. This study shows that capping technique will alter the regeneration state of transected nerves and reduce painful neuroma formation, indicating a promising approach for the treatment of painful neuroma. The initiation of the "regenerative brake'' induced by structural as well as morphological improvements in the severed nerve is theorized to be most likely a key mechanism for the capping technique in the prevention of painful neuroma formation.	[Yan, Hede; Wang, Chunyang; Xia, Zhen; Fan, Cunyi] Shanghai Jiao Tong Univ, Dept Orthoped, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Yan, Hede] Wenzhou Med Univ, Affiliated Hosp 2, Dept Orthopaed, Div Plast & Hand Surg, Wenzhou, Peoples R China; [Zhang, Feng] Univ Mississippi, Med Ctr, Div Plast Surg, Jackson, MS 39216 USA; [Kolkin, Jon] Duke Raleigh Hosp, Dept Plast & Hand Surg, Raleigh, NC USA	Shanghai Jiao Tong University; Wenzhou Medical University; University of Mississippi; University of Mississippi Medical Center	Fan, CY (corresponding author), Shanghai Jiao Tong Univ, Dept Orthoped, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China.	fancunyi888@gmail.com	fan, cunyi/ABI-7199-2020	fan, cunyi/0000-0002-7854-5233	National Natural Science Foundation of China [81171477]; Key Project of Health Bureau of Shanghai [2012412]; Health Department of Zhejiang province [201338025]; Department of Education of Zhejiang Province [20051185]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Health Bureau of Shanghai; Health Department of Zhejiang province; Department of Education of Zhejiang Province	This study was supported by funding from the National Natural Science Foundation of China (81171477), Key Project of Health Bureau of Shanghai (2012412), Health Department of Zhejiang province (201338025), and the Department of Education of Zhejiang Province (20051185). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atherton DD, 2006, J HAND SURG-BRIT EUR, V31B, P652, DOI 10.1016/j.jhsb.2006.06.009; Beilke MC, 2013, ANAL CHIM ACTA, V761, P201, DOI 10.1016/j.aca.2012.11.028; CAMPBELL J B, 1963, J Trauma, V3, P303; CARLTON SM, 1991, NEUROSCI LETT, V131, P88, DOI 10.1016/0304-3940(91)90343-R; Ceballos D, 1999, EXP NEUROL, V158, P290, DOI 10.1006/exnr.1999.7111; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cheng C, 2008, EXP NEUROL, V212, P358, DOI 10.1016/j.expneurol.2008.04.023; Chew SY, 2008, BIOMATERIALS, V29, P653, DOI 10.1016/j.biomaterials.2007.10.025; CODERRE TJ, 1986, PAIN, V26, P61, DOI 10.1016/0304-3959(86)90174-0; COLLINS WF, 1960, ARCH NEUROL-CHICAGO, V3, P381, DOI 10.1001/archneur.1960.00450040031003; Corey JM, 2007, J BIOMED MATER RES A, V83A, P636, DOI 10.1002/jbm.a.31285; CRAVIOTO H, 1981, NEUROSURGERY, V8, P181, DOI 10.1227/00006123-198102000-00007; FARLEY H H, 1965, Minn Med, V48, P347; FREEMAN BS, 1969, PLAST RECONSTR SURG, V43, P174, DOI 10.1097/00006534-196902000-00011; Giniger E, 2002, DIFFERENTIATION, V70, P385, DOI 10.1046/j.1432-0436.2002.700801.x; Gould JS, 2013, FOOT ANKLE INT; Herbert TJ, 1998, J HAND SURG-BRIT EUR, V23B, P220, DOI 10.1016/S0266-7681(98)80178-2; HERNDON JH, 1976, J BONE JOINT SURG AM, V58, P369, DOI 10.2106/00004623-197658030-00013; Hirose K, 2010, EUR SPINE J, V19, P1746, DOI 10.1007/s00586-010-1428-4; Jimenez-Andrade JM, 2011, PAIN, V152, P2564, DOI 10.1016/j.pain.2011.07.020; Koch H, 2003, ANN PLAS SURG, V51, P45, DOI 10.1097/01.SAP.0000054187.72439.57; Koch H, 2004, FOOT ANKLE INT, V25, P476, DOI 10.1177/107110070402500706; Koch H, 2003, ANN PLAS SURG, V50, P354, DOI 10.1097/01.SAP.0000041486.24160.8C; Kreutzberg GW, 1996, ACT NEUR S, V66, P103; Lewin-Kowalik J, 2006, NEUROL MED-CHIR, V46, P62, DOI 10.2176/nmc.46.62; Lindqvist A, 2000, MUSCLE NERVE, V23, P1214, DOI 10.1002/1097-4598(200008)23:8<1214::AID-MUS9>3.0.CO;2-A; Luo LQ, 1997, CURR OPIN NEUROBIOL, V7, P81, DOI 10.1016/S0959-4388(97)80124-9; MASS DP, 1984, PLAST RECONSTR SURG, V74, P182, DOI 10.1097/00006534-198408000-00002; Mirsky R, 2002, J PHYSIOL-PARIS, V96, P17, DOI 10.1016/S0928-4257(01)00076-6; Mirsky R, 1999, BRAIN PATHOL, V9, P293; MUEHLEMAN C, 1990, Journal of Foot Surgery, V29, P260; Ogata T, 2006, MOL NEUROBIOL, V33, P51, DOI 10.1385/MN:33:1:051; Okuda T, 2006, J ORTHOP RES, V24, P1427, DOI 10.1002/jor.20196; Prabhakaran MP, 2013, BIOTECHNOL BIOENG; Rajput K, 2012, CLIN J PAIN, V28, P639, DOI 10.1097/AJP.0b013e31823d30a2; ROGISTER B, 1993, J NEUROSCI RES, V34, P32, DOI 10.1002/jnr.490340105; Sakai Y, 2005, J BIOMED MATER RES B, V73B, P355, DOI 10.1002/jbm.b.30219; Siddall PJ, 1999, BRAIN RES, V851, P281, DOI 10.1016/S0006-8993(99)02173-3; Stoll G, 1999, BRAIN PATHOL, V9, P313; Tay SC, 2005, ANN ACAD MED SINGAP, V34, P362; Thomsen L, 2010, CHIR MAIN, V29, P255, DOI 10.1016/j.main.2010.07.004; Touchette D, 2011, OTOLARYNG HEAD NECK, V145, P699, DOI 10.1177/0194599811405292; WALL PD, 1979, PAIN, V7, P103, DOI 10.1016/0304-3959(79)90002-2; WALL PD, 1974, EXP NEUROL, V43, P580, DOI 10.1016/0014-4886(74)90197-6; Wang CY, 2012, J BIOMAT SCI-POLYM E, V23, P167, DOI 10.1163/092050610X545805; Wang CY, 2011, ACTA BIOMATER, V7, P634, DOI 10.1016/j.actbio.2010.09.011; Wang HB, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/016001; WILLIAMS HB, 1984, CLIN PLAST SURG, V11, P79; Wu J, 1999, ANN PLAS SURG, V43, P661, DOI 10.1097/00000637-199912000-00016; Xu Y, 2013, TISSUE ENG C; Yan HD, 2012, J NEUROTRAUM, V29, P2791, DOI 10.1089/neu.2012.2502; Yin Q, 1998, J HAND SURG-BRIT EUR, V23B, P433, DOI 10.1016/S0266-7681(98)80117-4; Zeltser R, 2000, PAIN, V89, P19, DOI 10.1016/S0304-3959(00)00342-0; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6; Zochodne DW, 2001, BRAIN RES, V902, P40, DOI 10.1016/S0006-8993(01)02310-1	55	32	32	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93973	10.1371/journal.pone.0093973	http://dx.doi.org/10.1371/journal.pone.0093973			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705579	Green Submitted, Green Published, gold			2022-12-25	WOS:000334107500100
J	Cavalcanti, DMLP; Castro, LM; Neto, JCR; Seelaender, M; Neves, RX; Oliveira, V; Forti, FL; Iwai, LK; Gozzo, FC; Todiras, M; Schadock, I; Barros, CC; Bader, M; Ferro, ES				Cavalcanti, Diogo M. L. P.; Castro, Leandro M.; Rosa Neto, Jose C.; Seelaender, Marilia; Neves, Rodrigo X.; Oliveira, Vitor; Forti, Fabio L.; Iwai, Leo K.; Gozzo, Fabio C.; Todiras, Mihail; Schadock, Ines; Barros, Carlos C.; Bader, Michael; Ferro, Emer S.			Neurolysin Knockout Mice Generation and Initial Phenotype Characterization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Gluconeogenesis; Glucose Metabolism; Insulin; Peptidases; Peptides; Intracellular Peptides; Oligopeptidase	BRAIN SYNAPTIC-MEMBRANES; FALSE DISCOVERY RATE; THIMET OLIGOPEPTIDASE; ENDOPEPTIDASE 3.4.24.16; INTRACELLULAR PEPTIDES; SUBCELLULAR-DISTRIBUTION; CONVERTING-ENZYME; SKELETAL-MUSCLE; IN-VIVO; NEUROTENSIN	The oligopeptidase neurolysin (EC 3.4.24.16; Nln) was first identified in rat brain synaptic membranes and shown to ubiquitously participate in the catabolism of bioactive peptides such as neurotensin and bradykinin. Recently, it was suggested that Nln reduction could improve insulin sensitivity. Here, we have shown that Nln KO mice have increased glucose tolerance, insulin sensitivity, and gluconeogenesis. KO mice have increased liver mRNA for several genes related to gluconeogenesis. Isotopic label semiquantitative peptidomic analysis suggests an increase in specific intracellular peptides in gastrocnemius and epididymal adipose tissue, which likely is involved with the increased glucose tolerance and insulin sensitivity in the KO mice. These results suggest the exciting new possibility that Nln is a key enzyme for energy metabolism and could be a novel therapeutic target to improve glucose uptake and insulin sensitivity.	[Cavalcanti, Diogo M. L. P.; Rosa Neto, Jose C.; Seelaender, Marilia; Neves, Rodrigo X.] Univ Sao Paulo, Inst Biomed Sci, Dept Cell Biol & Dev, BR-05508900 Sao Paulo, Brazil; [Castro, Leandro M.; Ferro, Emer S.] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, Support Ctr Res Proteolysis & Cell Signaling, BR-05508900 Sao Paulo, Brazil; [Castro, Leandro M.; Oliveira, Vitor] Univ Fed Sao Paulo, Dept Biophys, BR-04039032 Sao Paulo, Brazil; [Forti, Fabio L.] Univ Sao Paulo, Inst Chem, Dept Biochem, Support Ctr Res Proteolysis & Cell Signaling, BR-05508000 Sao Paulo, Brazil; [Iwai, Leo K.] Butantan Inst, Special Lab Appl Toxinol, Ctr Toxins Immune Response & Cell Signaling, BR-05503000 Sao Paulo, Brazil; [Gozzo, Fabio C.] Univ Estadual Campinas, Inst Chem, BR-13083862 Campinas, SP, Brazil; [Todiras, Mihail; Schadock, Ines; Barros, Carlos C.; Bader, Michael] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Barros, Carlos C.] Univ Fed Pelotas, Dept Nutr, BR-96010610 Pelotas, RS, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Instituto Butantan; Universidade Estadual de Campinas; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Universidade Federal de Pelotas	Ferro, ES (corresponding author), Av Prof Lineu Prestes 1524,Sala 315, BR-05508900 Sao Paulo, Brazil.	eferro@usp.br	Iwai, Leo K/M-1734-2013; Oliveira, Vitor/AAT-5981-2020; Castro, Leandro M/E-5654-2014; Oliveira, Vitor/L-3709-2013; Castro, Leandro/ABI-5520-2020; Barros, Carlos Castilho/V-8659-2019; Ferro, Emer S/D-3908-2012; Barros, Carlos Castilho C/D-5378-2012; Castro, Leandro/O-6762-2019; Todiras, Mihail/AAT-4426-2020; rosa, jose cesar/C-4359-2014; FORTI, FABIO LUIS/F-8085-2012; Bader, Michael/K-2124-2013; Seelaender, Marilia Cerqueira Leite/B-9101-2011; Neto, Jose Cesar Rosa/I-8145-2015; Neto, Jose Rosa/G-6336-2012	Iwai, Leo K/0000-0002-1571-7763; Oliveira, Vitor/0000-0002-4662-1377; Castro, Leandro/0000-0002-7156-2006; Barros, Carlos Castilho/0000-0002-6926-734X; Ferro, Emer S/0000-0003-1651-9192; Barros, Carlos Castilho C/0000-0002-6926-734X; Castro, Leandro/0000-0002-7156-2006; Todiras, Mihail/0000-0002-9373-4753; FORTI, FABIO LUIS/0000-0002-2278-6396; Seelaender, Marilia Cerqueira Leite/0000-0002-9999-8020; Neto, Jose Cesar Rosa/0000-0001-7019-9762; Neto, Jose Rosa/0000-0001-7019-9762; Bader, Michael/0000-0003-4780-4164; Schadock, Ines/0000-0002-6717-6276; Manuel Lopes de Paiva Cavalcanti, Diogo/0000-0002-6395-7809	Brazilian National Research Council [559698/2009-7]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Projeto Tematico [04/04933-2]; Pro-Reitoria de Pesquisa, University of Sao Paulo through Support Center for Research in Proteolysis and Cell Signaling Process [2012.1.17607.1.2]; Brazilian National Research Council Ph.D. Fellowship [GM/GD-140650/2010-5, SWE-200678/2011-6]	Brazilian National Research Council(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Projeto Tematico; Pro-Reitoria de Pesquisa, University of Sao Paulo through Support Center for Research in Proteolysis and Cell Signaling Process; Brazilian National Research Council Ph.D. Fellowship	This work was supported by the Brazilian National Research Council Grants 559698/2009-7 (Rede GENOPROT), by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Projeto Tematico 04/04933-2 (to E. S. F.), and by the Pro-Reitoria de Pesquisa, University of Sao Paulo through Support Center for Research in Proteolysis and Cell Signaling Process 2012.1.17607.1.2.; Supported by Brazilian National Research Council Ph.D. Fellowship GM/GD-140650/2010-5 and SWE-200678/2011-6.; Supported by Brazilian National Research Council research fellowships.	[Anonymous], 2007, MATH STAT METASTATIS; Arkin MR, 2009, CURR OPIN CHEM BIOL, V13, P284, DOI 10.1016/j.cbpa.2009.05.125; Authier F, 2008, CELL MOL LIFE SCI, V65, P1880, DOI 10.1007/s00018-008-7479-6; BARELLI H, 1993, EUR J BIOCHEM, V211, P79, DOI 10.1111/j.1432-1033.1993.tb19872.x; BARELLI H, 1994, BRIT J PHARMACOL, V112, P127, DOI 10.1111/j.1476-5381.1994.tb13041.x; BARRETT AJ, 1995, METHOD ENZYMOL, V248, P529; Barros CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040573; Barros CC, 2012, LAB INVEST, V92, P1419, DOI 10.1038/labinvest.2012.105; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berti DA, 2012, PROTEOMICS, V12, P2668, DOI 10.1002/pmic.201200051; Blais PA, 2005, PEPTIDES, V26, P1317, DOI 10.1016/j.peptides.2005.03.026; Brown CK, 2001, P NATL ACAD SCI USA, V98, P3127, DOI 10.1073/pnas.051633198; Cardoso CC, 2010, BIOL CHEM, V391, P435, DOI 10.1515/BC.2010.040; Castro CHM, 2004, J CELL SCI, V117, P2853, DOI 10.1242/jcs.01133; Castro LM, 2014, J PROTEOMICS, V111, P238, DOI 10.1016/j.jprot.2014.03.043; Castro LM, 2010, AAPS J, V12, P608, DOI 10.1208/s12248-010-9224-y; Cayla C, 2007, FASEB J, V21, P1689, DOI 10.1096/fj.06-7175com; CHECLER F, 1986, J BIOL CHEM, V261, P1274; CHECLER F, 1983, J NEUROCHEM, V41, P375, DOI 10.1111/j.1471-4159.1983.tb04753.x; CHECLER F, 1984, J NEUROCHEM, V43, P1295, DOI 10.1111/j.1471-4159.1984.tb05386.x; Checler F, 2014, J NEUROCHEM, V129, P1, DOI 10.1111/jnc.12635; Corssmit EPM, 2001, METABOLISM, V50, P742, DOI 10.1053/meta.2001.24195; Cunha FM, 2008, J BIOL CHEM, V283, P24448, DOI 10.1074/jbc.M801252200; DAUCH P, 1992, J NEUROCHEM, V59, P1862, DOI 10.1111/j.1471-4159.1992.tb11021.x; DAUCH P, 1991, EUR J BIOCHEM, V202, P269, DOI 10.1111/j.1432-1033.1991.tb16372.x; DAUCH P, 1995, J BIOL CHEM, V270, P27266, DOI 10.1074/jbc.270.45.27266; DOULUT S, 1993, J MED CHEM, V36, P1369, DOI 10.1021/jm00062a009; Ferro E. S., 2014, EUPA OPEN PROTEOMICS, V3, P143, DOI [10.1016/j.euprot.2014.02.009, DOI 10.1016/J.EUPROT.2014.02.009]; Fontenele-Neto JD, 2001, J COMP NEUROL, V438, P399, DOI 10.1002/cne.1323; Fricker LD, 2012, J PROTEOME RES, V11, P1981, DOI 10.1021/pr2012076; Fricker LD, 2010, MOL BIOSYST, V6, P1355, DOI 10.1039/c003317k; Fritah A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032520; Garrido PAG, 1999, DNA CELL BIOL, V18, P323, DOI 10.1089/104454999315385; Gelman JS, 2011, J PROTEOME RES, V10, P1583, DOI 10.1021/pr100952f; Haffner SM, 1999, DIABETES CARE, V22, P562, DOI 10.2337/diacare.22.4.562; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Heimann AS, 2005, PHYSIOL GENOMICS, V20, P173, DOI 10.1152/physiolgenomics.00145.2004; Hernandez-Toro J, 2007, BIOINFORMATICS, V23, P2495, DOI 10.1093/bioinformatics/btm373; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jeske NA, 2006, J NEUROCHEM, V97, P13, DOI 10.1111/j.1471-4159.2006.03706.x; Jitrapakdee S, 2012, INT J BIOCHEM CELL B, V44, P33, DOI 10.1016/j.biocel.2011.10.001; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Kato A, 1997, J BIOL CHEM, V272, P15313, DOI 10.1074/jbc.272.24.15313; Krause DR, 1997, J CELL BIOCHEM, V66, P297, DOI 10.1002/(SICI)1097-4644(19970901)66:3<297::AID-JCB3>3.0.CO;2-K; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Massarelli EE, 1999, BRAIN RES, V851, P261, DOI 10.1016/S0006-8993(99)02135-6; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mest HJ, 2005, DIABETOLOGIA, V48, P616, DOI 10.1007/s00125-005-1707-5; MRAD JA, 1992, AM J PHYSIOL, V262, pR684, DOI 10.1152/ajpregu.1992.262.4.R684; Nader GA, 2001, J APPL PHYSIOL, V90, P1936, DOI 10.1152/jappl.2001.90.5.1936; NAGGERT JK, 1995, NAT GENET, V10, P135, DOI 10.1038/ng0695-135; Ng Y, 2008, CELL METAB, V7, P348, DOI 10.1016/j.cmet.2008.02.008; Norman MU, 2003, AM J PHYSIOL-HEART C, V284, pH1978, DOI 10.1152/ajpheart.01116.2002; OLIVEIRA EB, 1976, BIOCHEMISTRY-US, V15, P1967, DOI 10.1021/bi00654a026; Oliveira EB, 2007, AM J PHYSIOL-HEART C, V293, pH3550, DOI 10.1152/ajpheart.00784.2007; Panico K, 2013, J PROTEOME RES, V12, P5851, DOI 10.1021/pr400867j; Paschoalin T, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-44; Piliponsky AM, 2008, NAT MED, V14, P392, DOI 10.1038/nm1738; Rashid M, 2014, J NEUROCHEM, V129, P179, DOI 10.1111/jnc.12513; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Ray K, 2004, J BIOL CHEM, V279, P20480, DOI 10.1074/jbc.M400795200; Ray K, 2002, PROTEIN SCI, V11, P2237, DOI 10.1110/ps.0216302; Richter EA, 2013, PHYSIOL REV, V93, P993, DOI 10.1152/physrev.00038.2012; Rioli V, 2003, J BIOL CHEM, V278, P8547, DOI 10.1074/jbc.M212030200; Rioli V, 1998, BIOCHEM BIOPH RES CO, V250, P5, DOI 10.1006/bbrc.1998.8941; Russo LC, 2012, FEBS LETT, V586, P3287, DOI 10.1016/j.febslet.2012.07.002; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; SERIZAWA A, 1995, J BIOL CHEM, V270, P2092, DOI 10.1074/jbc.270.5.2092; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shrimpton CN, 2002, ENDOCR REV, V23, P647, DOI 10.1210/er.2001-0032; Smith AI, 2000, HYPERTENSION, V35, P626, DOI 10.1161/01.HYP.35.2.626; Tagore DM, 2009, NAT CHEM BIOL, V5, P23, DOI 10.1038/nchembio.126; Tan SX, 2010, BIOCHEM J, V432, P191, DOI 10.1042/BJ20100750; Tian R, 2005, CIRC RES, V96, P139, DOI 10.1161/01.RES.0000156076.17807.1F; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; Vincent B, 1996, J NEUROSCI, V16, P5049; Vincent B, 1997, BRIT J PHARMACOL, V121, P705, DOI 10.1038/sj.bjp.0701182; Vishesh A, 2008, DIABETES OBES METAB, V10, P973, DOI 10.1111/j.1463-1326.2008.00852.x; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Williamson DL, 2001, J APPL PHYSIOL, V91, P1955, DOI 10.1152/jappl.2001.91.5.1955; WOULFE J, 1992, EUR J NEUROSCI, V4, P1309, DOI 10.1111/j.1460-9568.1992.tb00156.x; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017	84	28	29	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15426	15440		10.1074/jbc.M113.539148	http://dx.doi.org/10.1074/jbc.M113.539148			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24719317	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000337465400026
J	Li, HY; Wang, J; Wu, YX; Zhang, L; Liu, ZP; Filep, JG; Potempa, LA; Wu, Y; Ji, SR				Li, Hai-Yun; Wang, Jing; Wu, Yue-Xin; Zhang, Lin; Liu, Zu-Pei; Filep, Janos G.; Potempa, Lawrence A.; Wu, Yi; Ji, Shang-Rong			Topological Localization of Monomeric C-reactive Protein Determines Proinflammatory Endothelial Cell Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Atherosclerosis; Endothelial Dysfunction; Inflammation; Innate Immunity; Pentraxins; C-Reactive Protein; Polarized Activation	COMPLEMENT ACTIVATION; FACTOR-H; DISEASE; ATHEROSCLEROSIS; PLATELETS; INFLAMMATION; MECHANISMS; PLAQUES; LESIONS; CANCER	Background: Monomeric C-reactive protein (mCRP) may contribute to atherogenesis by inducing endothelial activation. Results: mCRP induces much weaker endothelial cell (EC) responses from the basolateral than from the apical surfaces of ECs. Conclusion: Tissue-associated mCRP likely contributes little to EC activation. Significance: Topological localization is an important factor that defines the contribution of inflammatory mediators to chronic vascular inflammation. The activation of endothelial cells (ECs) by monomeric C-reactive protein (mCRP) has been implicated in contributing to atherogenesis. However, the potent proinflammatory actions of mCRP on ECs in vitro appear to be incompatible with the atheroprotective effects of mCRP in a mouse model. Because mCRP is primarily generated within inflamed tissues and is rapidly cleared from the circulation, we tested whether these discrepancies can be explained by topological differences in response to mCRP within blood vessels. In a Transwell culture model, the addition of mCRP to apical (luminal), but not basolateral (abluminal), surfaces of intact human coronary artery EC monolayers evoked a significant up-regulation of MCP-1, IL-8, and IL-6. Such polarized stimulation of mCRP was observed consistently regardless of EC type or experimental conditions (e.g. culture of ECs on filters or extracellular matrix-coated surfaces). Accordingly, we detected enriched lipid raft microdomains, the major surface sensors for mCRP on ECs, in apical membranes, leading to the preferential apical binding of mCRP and activation of ECs through the polarized induction of the phospholipase C, p38 MAPK, and NF-B signaling pathways. Furthermore, LPS and IL-1 induction of EC activation also exhibited topological dependence, whereas TNF- did not. Together, these results indicate that tissue-associated mCRP likely contributes little to EC activation. Hence, topological localization is an important, but often overlooked, factor that determines the contribution of mCRP and other proinflammatory mediators to chronic vascular inflammation.	[Li, Hai-Yun; Wang, Jing; Wu, Yue-Xin; Zhang, Lin; Liu, Zu-Pei; Wu, Yi; Ji, Shang-Rong] Lanzhou Univ, Sch Life Sci, Key Lab Cell Act & Stress Adaptat, Minist Educ China, Lanzhou 730000, Peoples R China; [Filep, Janos G.] Univ Montreal, Maisonneuve Rosemont Hosp, Res Ctr, Montreal, PQ H1T 2M4, Canada; [Potempa, Lawrence A.] Roosevelt Univ, Coll Pharm, Schaumburg, IL 60173 USA; [Wu, Yi] Lanzhou Univ, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China	Lanzhou University; Ministry of Education, China; Universite de Montreal; Lanzhou University	Wu, Y (corresponding author), Lanzhou Univ, Sch Life Sci, MOE Key Lab Cell Act & Stress Adaptat, Lanzhou 730000, Peoples R China.	wuy@lzu.edu.cn; jsr@lzu.edu.cn		Ji, Shang-Rong/0000-0001-8595-3756; Li, Haiyun/0000-0002-7458-7399; Wu, Yi/0000-0003-0365-5590	Ministry of Science and Technology of China [2011CB910500]; National Natural Science Foundation of China [30930024, 31222015, 31270813, 31170696]; Ministry of Education of China [PCSIRT: IRT1137, 121108, 20100211110006, lzujbky-2010-k03]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China)	This work was supported by Ministry of Science and Technology of China grant 2011CB910500; by National Natural Science Foundation of China grants 30930024, 31222015, 31270813, 31170696; and by Ministry of Education of China grants PCSIRT: IRT1137, 121108, 20100211110006, and lzujbky-2010-k03.	Allin KH, 2011, CRIT REV CL LAB SCI, V48, P155, DOI 10.3109/10408363.2011.599831; Allin KH, 2010, JNCI-J NATL CANCER I, V102, P202, DOI 10.1093/jnci/djp459; De La Torre R, 2013, J THROMB HAEMOST, V11, P2048, DOI 10.1111/jth.12415; Diehl EE, 2000, AM J MED SCI, V319, P79, DOI 10.1097/00000441-200002000-00002; Dunzendorfer S, 2004, FASEB J, V18, P1117, DOI 10.1096/fj.03-1263fje; Eisenhardt SU, 2009, CELL CYCLE, V8, P3885, DOI 10.4161/cc.8.23.10068; Eisenhardt SU, 2009, CIRC RES, V105, P128, DOI 10.1161/CIRCRESAHA.108.190611; Filep JG, 2009, CIRC RES, V105, P109, DOI 10.1161/CIRCRESAHA.109.202010; Habersberger J, 2012, CARDIOVASC RES, V96, P64, DOI 10.1093/cvr/cvs237; Ji SR, 2007, FASEB J, V21, P284, DOI 10.1096/fj.06-6722com; Ji SR, 2009, FASEB J, V23, P1806, DOI 10.1096/fj.08-116962; Ji SR, 2006, ARTERIOSCL THROM VAS, V26, P935, DOI 10.1161/01.ATV.0000206211.21895.73; Ji SR, 2006, INT J BIOCHEM CELL B, V38, P648, DOI 10.1016/j.biocel.2005.11.004; Khreiss T, 2005, CIRC RES, V97, P690, DOI 10.1161/01.RES.0000183881.11739.CB; Khreiss T, 2004, CIRCULATION, V109, P2016, DOI 10.1161/01.CIR.0000125527.41598.68; Lauer N, 2011, J IMMUNOL, V187, P4374, DOI 10.4049/jimmunol.1002488; Ma X, 2013, CHINESE SCI BULL, V58, P1642, DOI 10.1007/s11434-012-5591-3; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mihlan M, 2009, CELL DEATH DIFFER, V16, P1630, DOI 10.1038/cdd.2009.103; Mihlan M, 2011, FASEB J, V25, P4198, DOI 10.1096/fj.11-186460; Molins B, 2008, ARTERIOSCL THROM VAS, V28, P2239, DOI 10.1161/ATVBAHA.108.174359; Molins B, 2011, CARDIOVASC RES, V92, P328, DOI 10.1093/cvr/cvr226; Motie M, 1998, DRUG METAB DISPOS, V26, P977; MULLER WA, 1986, J CELL BIOL, V103, P2389, DOI 10.1083/jcb.103.6.2389; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schwedler SB, 2005, CIRCULATION, V112, P1016, DOI 10.1161/CIRCULATIONAHA.105.556530; Schwedler SB, 2003, NEPHROL DIAL TRANSPL, V18, P2300, DOI 10.1093/ndt/gfg407; Schwedler SB, 2009, CLIN CHEM, V55, P1728, DOI 10.1373/clinchem.2009.125732; Singh SK, 2008, ANN MED, V40, P110, DOI 10.1080/07853890701749225; Slevin M, 2010, BRAIN PATHOL, V20, P151, DOI 10.1111/j.1750-3639.2008.00256.x; Strang F, 2012, BRAIN PATHOL, V22, P337, DOI 10.1111/j.1750-3639.2011.00539.x; Triantafilou M, 2002, J CELL SCI, V115, P2603; Wang MY, 2014, CELL RES, V24, P505, DOI 10.1038/cr.2014.7; Wang MY, 2011, FASEB J, V25, P3186, DOI 10.1096/fj.11-182741; Yousuf O, 2013, J AM COLL CARDIOL, V62, P397, DOI 10.1016/j.jacc.2013.05.016; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	37	29	32	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14283	14290		10.1074/jbc.M114.555318	http://dx.doi.org/10.1074/jbc.M114.555318			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24711458	Green Published, hybrid			2022-12-25	WOS:000335984600053
J	Neumann, C; Garreis, F; Paulsen, F; Hammer, CM; Birke, MT; Scholz, M				Neumann, Carolin; Garreis, Fabian; Paulsen, Friedrich; Hammer, Christian M.; Birke, Marco T.; Scholz, Michael			Osteopontin Is Induced by TGF-beta 2 and Regulates Metabolic Cell Activity in Cultured Human Optic Nerve Head Astrocytes	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE ELEVATION; PRIMARY OPEN-ANGLE; TRABECULAR MESHWORK; GROWTH-FACTOR; EXTRACELLULAR-MATRIX; AQUEOUS-HUMOR; UP-REGULATION; MURINE MODEL; EXPRESSION; GLAUCOMA	The aqueous humor (AH) component transforming growth factor (TGF)-beta 2 is strongly correlated to primary open-angle glaucoma (POAG), and was shown to up-regulate glaucoma-associated extracellular matrix (ECM) components, members of the ECM degradation system and heat shock proteins (HSP) in primary ocular cells. Here we present osteopontin (OPN) as a new TGF-beta 2 responsive factor in cultured human optic nerve head (ONH) astrocytes. Activation was initially demonstrated by Oligo GEArray microarray and confirmed by semiquantitative (sq) RT-PCR, realtime RT-PCR and western blot. Expressions of most prevalent OPN receptors CD44 and integrin receptor subunits alpha V, alpha 4, alpha 5, alpha 6, alpha 9, beta 1, beta 3 and beta 5 by ONH astrocytes were shown by sqRT-PCR and immunofluorescence labeling. TGF-beta 2 treatment did not affect their expression levels. OPN did not regulate gene expression of described TGF-beta 2 targets shown by sqRT-PCR. In MTS-assays, OPN had a time- and dose-dependent stimulating effect on the metabolic activity of ONH astrocytes, whereas TGF-beta 2 significantly reduced metabolism. OPN signaling via CD44 mediated a repressive outcome on metabolic activity, whereas signaling via integrin receptors resulted in a pro-metabolic effect. In summary, our findings characterize OPN as a TGF-beta 2 responsive factor that is not involved in TGF-beta 2 mediated ECM and HSP modulation, but affects the metabolic activity of astrocytes. A potential involvement in a protective response to TGF-beta 2 triggered damage is indicated, but requires further investigation.	[Neumann, Carolin; Garreis, Fabian; Paulsen, Friedrich; Hammer, Christian M.; Scholz, Michael] Univ Erlangen Nurnberg, Dept Anat 2, D-91054 Erlangen, Germany; [Birke, Marco T.] Tufts Univ, Dept Ophthalmol, Boston, MA 02111 USA	University of Erlangen Nuremberg; Tufts University	Garreis, F (corresponding author), Univ Erlangen Nurnberg, Dept Anat 2, D-91054 Erlangen, Germany.	Fabian.garreis@anatomie2.med.uni-erlangen.de		Paulsen, Friedrich/0000-0002-0527-0953; Scholz, Michael/0000-0001-8440-6785	Muck Foundation, University Erlangen Nuremberg; Johannes and Frieda Marohn Foundation, University Erlangen Nuremberg; Deutsche Forschungsgemeinschaft (DFG); Friedrich-Alexander-University Erlangen-Nurnberg (FAU)	Muck Foundation, University Erlangen Nuremberg; Johannes and Frieda Marohn Foundation, University Erlangen Nuremberg; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Friedrich-Alexander-University Erlangen-Nurnberg (FAU)	FG was supported in part by the Muck Foundation, University Erlangen Nuremberg. MS was supported by the Johannes and Frieda Marohn Foundation, University Erlangen Nuremberg. The authors acknowledge support by Deutsche Forschungsgemeinschaft (DFG) and Friedrich-Alexander-University Erlangen-Nurnberg (FAU) within the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Asrar AM, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/493043; Anderson MG, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-20; Birke MT, 2010, INVEST OPHTH VIS SCI, V51, P5759, DOI 10.1167/iovs.10-5558; Chidlow G, 2008, INVEST OPHTH VIS SCI, V49, P762, DOI 10.1167/iovs.07-0726; Comi C, 2009, J ALZHEIMERS DIS; Del Rio P, 2011, GLIA, V59, P821, DOI 10.1002/glia.21155; Denhardt DT, 1998, J CELL BIOCHEM, P92, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A; Diekmann H, 2013, CELL TISSUE RES, V353, P327, DOI 10.1007/s00441-013-1596-8; Eitzman DT, 1997, ADV EXP MED BIOL, V425, P131; Fuchshofer R, 2005, INVEST OPHTH VIS SCI, V46, P568, DOI 10.1167/iovs.04-0649; Fuchshofer R, 2003, EXP EYE RES, V77, P757, DOI 10.1016/S0014-4835(03)00220-3; Fuchshofer R, 2012, CELL TISSUE RES, V347, P279, DOI 10.1007/s00441-011-1274-7; Gottanka J, 2005, INVEST OPHTH VIS SCI, V46, P4170, DOI 10.1167/iovs.05-0289; Gottanka J, 2004, INVEST OPHTH VIS SCI, V45, P153, DOI 10.1167/iovs.03-0796; Gross TS, 2005, J BONE MINER RES, V20, P250, DOI 10.1359/JBMR.041004; Hashimoto M, 2007, J NEUROSCI, V27, P3603, DOI 10.1523/JNEUROSCI.4805-06.2007; Heguy A, 2006, J MOL MED, V84, P318, DOI 10.1007/s00109-005-0008-2; Heiduschka P, 2010, EXP EYE RES, V91, P779, DOI 10.1016/j.exer.2010.09.001; Hernandez MR, 2008, PROG BRAIN RES, V173, P353, DOI 10.1016/S0079-6123(08)01125-4; Hernandez MR, 2000, PROG RETIN EYE RES, V19, P297, DOI 10.1016/S1350-9462(99)00017-8; HERNANDEZ MR, 1990, AM J OPHTHALMOL, V109, P180, DOI 10.1016/S0002-9394(14)75984-7; Howell GR, 2008, PROG BRAIN RES, V173, P303, DOI 10.1016/S0079-6123(08)01122-9; Iczkiewicz J, 2006, BRAIN RES, V1118, P239, DOI 10.1016/j.brainres.2006.08.036; Inman DM, 2006, INVEST OPHTH VIS SCI, V47, P986, DOI 10.1167/iovs.05-0925; Iyer P, 2012, INVEST OPHTH VIS SCI, V53, P4952, DOI 10.1167/iovs.12-9681; Jakobs TC, 2005, J CELL BIOL, V171, P313, DOI 10.1083/jcb.200506099; Jin JK, 2006, BRAIN RES, V1072, P227, DOI 10.1016/j.brainres.2005.12.013; Junglas B, 2009, EXP EYE RES, V88, P1065, DOI 10.1016/j.exer.2009.01.008; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Kohan M, 2009, AM J RESP CELL MOL, V41, P290, DOI 10.1165/rcmb.2008-0307OC; Lee MY, 1999, NEUROSCI LETT, V271, P81, DOI 10.1016/S0304-3940(99)00526-1; Lin YH, 2000, MOL CELL BIOL, V20, P2734, DOI 10.1128/MCB.20.8.2734-2742.2000; Lutjen-Drecoll E, 2005, EXP EYE RES, V81, P1, DOI 10.1016/j.exer.2005.02.008; Maetzler W, 2007, NEUROBIOL DIS, V25, P473, DOI 10.1016/j.nbd.2006.10.020; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Meller R, 2005, J CEREBR BLOOD F MET, V25, P217, DOI 10.1038/sj.jcbfm.9600022; Neumann C, 2008, INVEST OPHTH VIS SCI, V49, P1464, DOI 10.1167/iovs.07-1053; Nickells RW, 2012, ANNU REV NEUROSCI, V35, P153, DOI 10.1146/annurev.neuro.051508.135728; NODA M, 1988, J BIOL CHEM, V263, P13916; Okamoto H, 2007, MOL CELL BIOCHEM, V300, P1, DOI 10.1007/s11010-006-9368-3; Padanilam BJ, 1996, ENDOCRINOLOGY, V137, P2133, DOI 10.1210/en.137.5.2133; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Pena JDO, 2001, INVEST OPHTH VIS SCI, V42, P2303; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Picht G, 2001, GRAEF ARCH CLIN EXP, V239, P199, DOI 10.1007/s004170000252; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Sabo-Attwood T, 2011, AM J PATHOL, V178, P1975, DOI 10.1016/j.ajpath.2011.01.048; Saika S, 2003, INVEST OPHTH VIS SCI, V44, P1622, DOI 10.1167/iovs.02-0873; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; Scholz M, 2008, INVEST OPHTH VIS SCI, V49, P613, DOI 10.1167/iovs.07-0745; Schroeter M, 2006, BRAIN, V129, P1426, DOI 10.1093/brain/awl094; Tambuyzer BR, 2012, CELL BIOL INT, V36, P1233, DOI 10.1042/CBI20120172; Tektas OY, 2010, INVEST OPHTH VIS SCI, V51, P5083, DOI 10.1167/iovs.09-5101; TRIPATHI RC, 1994, EXP EYE RES, V59, P723, DOI 10.1006/exer.1994.1158; Vetrone SA, 2009, J CLIN INVEST, V119, P1583, DOI 10.1172/JCI37662; Wahl V, 2013, NEUROSCIENCE; Wang KX, 2008, CYTOKINE GROWTH FACT; Weber GF, 1996, SCIENCE, V271, P509, DOI 10.1126/science.271.5248.509; Wordinger RJ, 2007, INVEST OPHTH VIS SCI, V48, P1191, DOI 10.1167/iovs.06-0296; Yu AL, 2007, EXP EYE RES, V84, P694, DOI 10.1016/j.exer.2006.12.008; Yu AL, 2010, INVEST OPHTH VIS SCI, V51, P5718, DOI 10.1167/iovs.10-5679; Yu AL, 2009, INVEST OPHTH VIS SCI, V50, P1707, DOI 10.1167/iovs.08-1961; Zhang GX, 2004, WORLD J GASTROENTERO, V10, P205	63	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e92762	10.1371/journal.pone.0092762	http://dx.doi.org/10.1371/journal.pone.0092762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718314	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000019
J	Shi, XD; DiRenzo, D; Guo, LW; Franco, SR; Wang, BW; Seedial, S; Kent, KC				Shi, Xudong; DiRenzo, Daniel; Guo, Lian-Wang; Franco, Sarah R.; Wang, Bowen; Seedial, Stephen; Kent, K. Craig			TGF-beta/Smad3 Stimulates Stem Cell/Developmental Gene Expression and Vascular Smooth Muscle Cell De-Differentiation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; PHENOTYPIC MODULATION; PROGENITOR CELLS; DIFFERENTIATION; PROLIFERATION; SMAD3; PDGF; TRANSCRIPTION; RECRUITMENT	Atherosclerotic-associated diseases are the leading cause of death in the United States. Despite recent progress, interventional treatments for atherosclerosis can be complicated by restenosis resulting from neo-intimal hyperplasia. We have previously demonstrated that TGF-beta and its downstream signaling protein Smad3:1) are up-regulated following vascular injury, 2) together drive smooth muscle cell (SMC) proliferation and migration and 3) enhance the development of intimal hyperplasia. In order to determine a mechanism through which TGF-beta/Smad3 promote these effects, Affymetrix gene expression arrays were performed on primary rat SMCs infected with Smad3 and stimulated with TGF-beta or infected with GFP alone. More than 200 genes were differentially expressed (>2.0 fold change, p<0.05) in TGF-beta/Smad3 stimulated SMCs. We then performed GO term enrichment analysis using the DAVID bioinformatics database and found that TGF-beta/ Smad3 activated the expression of multiple genes related to either development or cell differentiation, several of which have been shown to be associated with multipotent stem or progenitor cells. Quantitative real-time PCR confirmed up-regulation of several developmental genes including FGF1, NGF, and Wnt11 (by 2.5, 6 and 7 fold, respectively) as well as stem/progenitor cell associated genes CD34 and CXCR4 (by 10 and 45 fold, respectively). In addition, up-regulation of these factors at protein levels were also confirmed by Western blotting, or by immunocytochemistry (performed for CXCR4 and NGF). Finally, TGF-beta/Smad3 down regulated transcription of SMC contractile genes as well as protein production of smooth muscle alpha actin, calponin, and smooth muscle myosin heavy chain. These combined results suggest that TGF-beta/Smad3 stimulation drives SMCs to a phenotypically altered state of de-differentiation through the up-regulation of developmental related genes.	[Shi, Xudong; DiRenzo, Daniel; Guo, Lian-Wang; Franco, Sarah R.; Wang, Bowen; Seedial, Stephen; Kent, K. Craig] Univ Wisconsin Hosp & Clin, Dept Surg, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison	Guo, LW (corresponding author), Univ Wisconsin Hosp & Clin, Dept Surg, Madison, WI 53792 USA.	guo@surgery.wisc.edu; kent@surgery.wisc.edu			National Heart, Lung, Blood Institute [HL-068673, HL-110853]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL110853, R01HL068673] Funding Source: NIH RePORTER	National Heart, Lung, Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a National Heart, Lung, Blood Institute R01 Grant (HL-068673, to K.C.K.) and a T32 training Grant (HL-110853, to K.C.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; Clement N, 2007, J CELL SCI, V120, P3352, DOI 10.1242/jcs.007872; CLOWES MM, 1994, J CLIN INVEST, V93, P644, DOI 10.1172/JCI117016; Cohen ED, 2012, DEVELOPMENT, V139, P1931, DOI 10.1242/dev.069377; Crcareva A, 2005, EXP HEMATOL, V33, P1459, DOI 10.1016/j.exphem.2005.09.001; de Haan G, 2003, DEV CELL, V4, P241, DOI 10.1016/S1534-5807(03)00018-2; Deaton RA, 2009, AM J PHYSIOL-HEART C, V296, pH1027, DOI 10.1152/ajpheart.01230.2008; Edlin RS, 2009, J VASC SURG, V49, P1289, DOI 10.1016/j.jvs.2008.11.096; Falk S, 2008, CELL STEM CELL, V2, P472, DOI 10.1016/j.stem.2008.03.006; Ferlosio A, 2012, ATHEROSCLEROSIS, V224, P51, DOI 10.1016/j.atherosclerosis.2012.07.016; FINA L, 1990, BLOOD, V75, P2417; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P655, DOI 10.1210/en.2004-0766; Hautmann MB, 1997, J BIOL CHEM, V272, P10948; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Hoggatt AM, 2000, J BIOL CHEM, V275, P31162, DOI 10.1074/jbc.M005595200; Hollenbeck ST, 2004, J SURG RES, V120, P288, DOI 10.1016/j.jss.2004.01.005; HOLYCROSS BJ, 1992, CIRC RES, V71, P1525, DOI 10.1161/01.RES.71.6.1525; Imamura H, 2010, ATHEROSCLEROSIS, V211, P114, DOI 10.1016/j.atherosclerosis.2010.02.040; Inoue T, 2011, JACC-CARDIOVASC INTE, V4, P1057, DOI 10.1016/j.jcin.2011.05.025; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kawai-Kowase K, 2007, AM J PHYSIOL-CELL PH, V292, pC59, DOI 10.1152/ajpcell.00394.2006; Krampera M, 2005, BLOOD, V106, P59, DOI 10.1182/blood-2004-09-3645; Kubo F, 2005, DEVELOPMENT, V132, P2759, DOI 10.1242/dev.01856; Kundi R, 2009, CARDIOVASC RES, V84, P326, DOI 10.1093/cvr/cvp220; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Ma XL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001894; Mack CP, 2011, ARTERIOSCL THROM VAS, V31, P1495, DOI 10.1161/ATVBAHA.110.221135; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Mau E, 2007, DEV BIOL, V305, P28, DOI 10.1016/j.ydbio.2007.01.031; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Nakayama N, 2004, DEVELOPMENT, V131, P229, DOI 10.1242/dev.00901; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pidkovka NA, 2007, CIRC RES, V101, P792, DOI 10.1161/CIRCRESAHA.107.152736; Raines EW, 2000, INT J EXP PATHOL, V81, P173, DOI 10.1046/j.1365-2613.2000.00155.x; Rodriguez-Menocal L, 2009, CARDIOVASC RES, V81, P46, DOI 10.1093/cvr/cvn265; Salmon M, 2012, CIRC RES, V111, P685, DOI 10.1161/CIRCRESAHA.112.269811; Schneider RP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2946; Seay U, 2005, J PHARMACOL EXP THER, V315, P1005, DOI 10.1124/jpet.105.091249; Serrano AG, 2010, BLOOD, V115, P3895, DOI 10.1182/blood-2009-10-247395; Si Y, 2012, ARTERIOSCL THROM VAS, V32, P943, DOI 10.1161/ATVBAHA.111.244921; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Spater D, 2006, DEVELOPMENT, V133, P3039, DOI 10.1242/dev.02471; Spits H, 2000, J EXP MED, V192, P1775, DOI 10.1084/jem.192.12.1775; Suwanabol PA, 2012, J VASC SURG, V56, P446, DOI 10.1016/j.jvs.2011.12.038; Suwanabol PA, 2012, AM J PHYSIOL-HEART C, V302, pH2211, DOI 10.1152/ajpheart.00966.2011; Suwanabol PA, 2011, J SURG RES, V167, P287, DOI 10.1016/j.jss.2010.12.020; Takahashi M, 2012, INT J MOL MED, V29, P357, DOI 10.3892/ijmm.2011.847; Tanaka K, 2008, FASEB J, V22, P428, DOI 10.1096/fj.06-6884com; Tang ZY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1867; Thomas JA, 2009, AM J PHYSIOL-HEART C, V296, pH442, DOI 10.1152/ajpheart.00165.2008; Tiano HF, 2002, CANCER RES, V62, P3395; Tsai S, 2009, AM J PHYSIOL-HEART C, V297, pH540, DOI 10.1152/ajpheart.91478.2007; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yoshida T, 2008, AM J PHYSIOL-CELL PH, V295, pC1175, DOI 10.1152/ajpcell.00288.2008; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zernecke A, 2005, CIRC RES, V96, P784, DOI 10.1161/01.RES.0000162100.52009.38; Zhang F, 2009, J BIOL CHEM, V284, P17564, DOI 10.1074/jbc.M109.013987; Zheng B, 2010, IUBMB LIFE, V62, P132, DOI 10.1002/iub.298; Zheng B, 2009, J BIOL CHEM, V284, P22773, DOI 10.1074/jbc.M109.026989; Zhou JL, 2005, MOL CELL BIOL, V25, P9874, DOI 10.1128/MCB.25.22.9874-9885.2005	63	31	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93995	10.1371/journal.pone.0093995	http://dx.doi.org/10.1371/journal.pone.0093995			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718260	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000063
J	Du, QS; Wang, SQ; Chen, D; Meng, JZ; Huang, RB				Du, Qi-Shi; Wang, Shu-Qing; Chen, Dong; Meng, Jian-Zong; Huang, Ri-Bo			In Depth Analysis on the Binding Sites of Adamantane Derivatives in HCV ( Hepatitis C Virus) p7 Channel Based on the NMR Structure	PLOS ONE			English	Article							LAMARCKIAN GENETIC ALGORITHM; COUPLED-CLUSTER SINGLES; CATION-PI INTERACTIONS; ION-CHANNEL; PROTEIN; DRUG; RATIONALIZATION; SENSITIVITY; AMANTADINE; PREDICTION	Background: The recently solved solution structure of HCV (hepatitis C virus) p7 ion channel provides a solid structure basis for drug design against HCV infection. In the p7 channel the ligand amantadine (or rimantadine) was determined in a hydrophobic pocket. However the pharmocophore (-NH2) of the ligand was not assigned a specific binding site. Results: The possible binding sites for amino group of adamantane derivatives is studied based on the NMR structure of p7 channel using QM calculation and molecular modeling. In the hydrophobic cavity and nearby three possible binding sites are proposed: His17, Phe20, and Trp21. The ligand binding energies at the three binding sites are studied using high level QM method CCSD(T)/6-311+G(d,p) and AutoDock calculations, and the interaction details are analyzed. The potential application of the binding sites for rational inhibitor design are discussed. Conclusions: Some useful viewpoints are concluded as follows. (1) The amino group (-NH2) of adamantane derivatives is protonated (-NH3+), and the positively charged cation may form cation-pi interactions with aromatic amino acids. (2) The aromatic amino acids (His17, Phe20, and Trp21) are the possible binding sites for the protonated amino group (-NH3+) of adamantane derivatives, and the cation-pi bond energies are 3 to 5 times stronger than the energies of common hydrogen bonds. (3) The higher inhibition potent of rimantadine than amantadine probably because of its higher pK(a) value (pK(a) = 10.40) and the higher positive charge in the amino group. The potential application of p7 channel structure for inhibitor design is discussed.	[Du, Qi-Shi; Chen, Dong; Huang, Ri-Bo] Guangxi Acad Sci, Natl Engn Res Ctr Nonfood Biorefinery, State Key Lab Nonfood Biomass & Enzyme Technol, Nanning, Guangxi, Peoples R China; [Wang, Shu-Qing] Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin, Peoples R China; [Chen, Dong; Meng, Jian-Zong; Huang, Ri-Bo] Guangxi Univ, Life Sci & Biotechnol Coll, Nanning, Guangxi, Peoples R China; [Du, Qi-Shi] Gordon Life Sci Inst, San Diego, CA USA	Tianjin Medical University; Guangxi University	Du, QS (corresponding author), Guangxi Acad Sci, Natl Engn Res Ctr Nonfood Biorefinery, State Key Lab Nonfood Biomass & Enzyme Technol, Nanning, Guangxi, Peoples R China.	du.qishi@aliyun.com			National Science Foundation of China (NSFC) [31370716, 31360207]; BaGui Scholar's Program Foundation	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); BaGui Scholar's Program Foundation	This work was supported by grants from the National Science Foundation of China (NSFC) under the contract numbers 31370716 and 31360207, and by the BaGui Scholar's Program Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Du QS, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-92; Du QS, 2012, J MOL GRAPH MODEL, V34, P38, DOI 10.1016/j.jmgm.2011.12.002; Du QS, 2012, J COMPUT CHEM, V33, P153, DOI 10.1002/jcc.21951; Dubuisson J, 2008, CELL MICROBIOL, V10, P821, DOI 10.1111/j.1462-5822.2007.01107.x; Foster TL, 2011, HEPATOLOGY, V54, P79, DOI 10.1002/hep.24371; Fuhrmann J, 2010, J COMPUT CHEM, V31, P1911, DOI 10.1002/jcc.21478; Fusco DN, 2012, ANNU REV MED, V63, P373, DOI 10.1146/annurev-med-042010-085715; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Griffin SDC, 2003, FEBS LETT, V535, P34, DOI 10.1016/S0014-5793(02)03851-6; Griffin S, 2008, HEPATOLOGY, V48, P1779, DOI 10.1002/hep.22555; Gu RX, 2011, J AM CHEM SOC, V133, P10817, DOI 10.1021/ja1114198; Huang RB, 2008, BIOCHEM BIOPH RES CO, V377, P1243, DOI 10.1016/j.bbrc.2008.10.148; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Leckband D, 2001, Q REV BIOPHYS, V34, P105, DOI 10.1017/S0033583501003687; LEE TJ, 1988, CHEM PHYS LETT, V150, P406, DOI 10.1016/0009-2614(88)80427-5; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liao SM, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-44; Mihm U, 2006, ANTIVIR THER, V11, P507; Montserret R, 2010, J BIOL CHEM, V285, P31446, DOI 10.1074/jbc.M110.122895; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; OuYang B, 2013, NATURE, V498, P521, DOI 10.1038/nature12283; Pavlovic D, 2003, P NATL ACAD SCI USA, V100, P6104, DOI 10.1073/pnas.1031527100; Pielak RM, 2010, PROTEIN CELL, V1, P246, DOI 10.1007/s13238-010-0025-y; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Premkumar A, 2004, FEBS LETT, V557, P99, DOI 10.1016/S0014-5793(03)01453-4; PURVIS GD, 1982, J CHEM PHYS, V76, P1910, DOI 10.1063/1.443164; Rosenberg MR, 2010, P NATL ACAD SCI USA, V107, P13866, DOI 10.1073/pnas.1002051107; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; SCUSERIA GE, 1989, J CHEM PHYS, V90, P3700, DOI 10.1063/1.455827; SCUSERIA GE, 1988, J CHEM PHYS, V89, P7382, DOI 10.1063/1.455269; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; SPECTOR R, 1988, J PHARMACOL EXP THER, V244, P516; Steinmann E, 2007, HEPATOLOGY, V46, P330, DOI 10.1002/hep.21686; StGelais C, 2009, J VIROL, V83, P7970, DOI 10.1128/JVI.00521-09; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Wang QY, 2013, CURR TOP MED CHEM, V13, P1141, DOI 10.2174/15680266113139990002; Warshel A, 2006, BBA-PROTEINS PROTEOM, V1764, P1647, DOI 10.1016/j.bbapap.2006.08.007; Wasley A, 2000, SEMIN LIVER DIS, V20, P1, DOI 10.1055/s-2000-9506; Wermuth G, 1998, PURE APPL CHEM, V70, P1129, DOI 10.1351/pac199870051129; Wozniak AL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001087; Zoulim F, 2003, REV MED VIROL, V13, P57, DOI 10.1002/rmv.371	46	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93613	10.1371/journal.pone.0093613	http://dx.doi.org/10.1371/journal.pone.0093613			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714586	Green Submitted, gold, Green Published			2022-12-25	WOS:000334160900040
J	Cohen, DD; Gomez-Arbelaez, D; Camacho, PA; Pinzon, S; Hormiga, C; Trejos-Suarez, J; Duperly, J; Lopez-Jaramillo, P				Dylan Cohen, Daniel; Gomez-Arbelaez, Diego; Anthony Camacho, Paul; Pinzon, Sandra; Hormiga, Claudia; Trejos-Suarez, Juanita; Duperly, John; Lopez-Jaramillo, Patricio			Low Muscle Strength Is Associated with Metabolic Risk Factors in Colombian Children: The ACFIES Study	PLOS ONE			English	Article							SHUTTLE-RUN TEST; INSULIN SENSITIVITY; PHYSICAL-ACTIVITY; SKELETAL-MUSCLE; MUSCULAR STRENGTH; BIRTH-WEIGHT; YOUNG MEN; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR RISK; HANDGRIP STRENGTH	Purpose: In youth, poor cardiorespiratory and muscular strength are associated with elevated metabolic risk factors. However, studies examining associations between strength and risk factors have been done exclusively in high income countries, and largely in Caucasian cohorts. The aim of this study was to assess these interactions in schoolchildren in Colombia, a middle income Latin American country. Methods: We measured body mass index, body composition, handgrip strength (HG), cardiorespiratory fitness (CRF) and metabolic risk factors in 669 low-middle socioeconomic status Colombian schoolchildren (mean age 11.52 +/- 1.13, 47% female). Associations between HG, CRF and metabolic risk factors were evaluated. Results: HG and CRF were inversely associated with blood pressure, HOMA index and a composite metabolic risk score (p < 0.001 for all) and HG was also inversely associated with triglycerides and C-reactive protein (CRP) (both p < 0.05). Associations between HG and risk factors were marginally weakened after adjusting for CRF, while associations between CRF and these factors were substantially weakened after adjusting for HG. Linear regression analyses showed inverse associations between HG and systolic BP (beta = 0.101; p = 0.047), diastolic BP (beta = 0.241; p >= 0.001), HOMA (beta = 0.164; p = 0.005), triglycerides (beta = 0.583; p = 0.026) and CRP (beta = 20.183; p = 0.037) but not glucose (p = 0.698) or HDL cholesterol (p = 0.132). The odds ratios for having clustered risk in the weakest quartile compared with the strongest quartile were 3.0 (95% confidence interval: 1.81-4.95). Conclusions: In Colombian schoolchildren both poorer handgrip strength/kg body mass and cardiorespiratory fitness were associated with a worse metabolic risk profile. Associations were stronger and more consistent between handgrip and risk factors than between cardiorespiratory fitness and these risk factors. Our findings indicate the addition of handgrip dynamometry to non-invasive youth health surveillance programs would improve the accuracy of the assessment of cardiometabolic health.	[Dylan Cohen, Daniel; Gomez-Arbelaez, Diego; Anthony Camacho, Paul; Hormiga, Claudia; Lopez-Jaramillo, Patricio] Fdn Oftalmol Santander FOSCAL, Direcc Invest, Santander, Colombia; [Dylan Cohen, Daniel; Gomez-Arbelaez, Diego; Pinzon, Sandra; Lopez-Jaramillo, Patricio] Univ Santander UDES, Fac Ciencias Salud, Santander, Colombia; [Duperly, John] Univ Los Andes, Fac Med, Bogota, Colombia	Universidad Industrial de Santander; Universidad de los Andes (Colombia)	Lopez-Jaramillo, P (corresponding author), Fdn Oftalmol Santander FOSCAL, Direcc Invest, Santander, Colombia.	jplopezj@gmail.com	Gómez-Arbeláez, Diego/K-1883-2013	Gómez-Arbeláez, Diego/0000-0001-6150-0066; Camacho, Paul Anthony/0000-0002-6233-9582; Duperly Sanchez, John/0000-0002-6401-8395; Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Trejos-Suarez, Juanita/0000-0002-0697-3386	mayor's office of the city of Bucaramanga (Colombia); Fundacion MAPFRE (Spain)	mayor's office of the city of Bucaramanga (Colombia); Fundacion MAPFRE (Spain)	The study was funded primarily by the mayor's office of the city of Bucaramanga (Colombia) and secondarily by a grant from the Fundacion MAPFRE (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000192; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Arsenault JE, 2011, BRIT J NUTR, V1, P1; Artero EG, 2012, J CARDIOPULM REHABIL, V32, P351, DOI 10.1097/HCR.0b013e3182642688; Artero EG, 2011, PEDIATR DIABETES, V12, P704, DOI 10.1111/j.1399-5448.2011.00769.x; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Benefice E, 1999, ANN HUM BIOL, V26, P443, DOI 10.1080/030144699282561; Benson AC, 2006, INT J PEDIATR OBES, V1, P222, DOI 10.1080/17477160600962864; Bergmann GG, 2013, J PHYS ACTIVITY HLTH; Brons C, 2008, J CLIN ENDOCR METAB, V93, P3885, DOI 10.1210/jc.2008-0630; Cohen DD, 2010, ACTA PAEDIATR, V99, P1065, DOI 10.1111/j.1651-2227.2010.01723.x; CONPES (Consejo Nacional de Politica Economica y Social Republica de Colombia Departamento Nacional de Planeacion), 2005, 3386 CONPES; Davis JN, 2011, MED SCI SPORT EXER, V43, P2195, DOI 10.1249/MSS.0b013e31821f5d4e; Dodds R, 2012, J NUTR HEALTH AGING, V16, P609, DOI 10.1007/s12603-012-0053-9; dos Santos FK, 2013, ANN HUM BIOL, V40, P15, DOI 10.3109/03014460.2012.720708; Fogelholm M, 2010, OBES REV, V11, P202, DOI 10.1111/j.1467-789X.2009.00653.x; Grontved A, 2013, BRIT J SPORTS MED; Janz KF, 2008, MED SCI SPORT EXER, V40, P767, DOI 10.1249/MSS.0b013e3181620ed1; Jensen CB, 2007, J CLIN ENDOCR METAB, V92, P1530, DOI 10.1210/jc.2006-2360; Jensen CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003738; Lee S, 2012, EUR J CLIN NUTR, V66, P1366, DOI 10.1038/ejcn.2012.142; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Martinez-Gomez D, 2011, SCAND J MED SCI SPOR, V21, P310, DOI 10.1111/j.1600-0838.2009.01036.x; Martinez-Gomez D, 2012, ATHEROSCLEROSIS, V221, P260, DOI 10.1016/j.atherosclerosis.2011.12.032; Moura-Dos-Santos M, 2013, AM J HUM BIOL, V25, P58, DOI 10.1002/ajhb.22341; Ng N, 2009, GLOBAL HLTH ACTION, Vs1, P17; Nightingale CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036236; Ortega FB, 2008, INT J OBESITY, V32, P1, DOI 10.1038/sj.ijo.0803774; Ortega FB, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7279; Petroski Edio Luiz, 2011, Rev. salud pública, V13, P219, DOI 10.1590/S0124-00642011000200004; Ridgway CL, 2011, INT J PEDIATR OBES, V6, pE590, DOI 10.3109/17477166.2010.526225; Ruiz JR, 2008, ARCH PEDIAT ADOL MED, V162, P462, DOI 10.1001/archpedi.162.5.462; Ruiz JR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a439; Ruiz JR, 2011, BRIT J SPORT MED, V45, P518, DOI 10.1136/bjsm.2010.075341; Sandercock G, 2012, J SPORT SCI, V30, P679, DOI 10.1080/02640414.2012.660185; Shaibi GQ, 2006, MED SCI SPORT EXER, V38, P1208, DOI 10.1249/01.mss.0000227304.88406.0f; Steene-Johannessen J, 2009, MED SCI SPORT EXER, V41, P1361, DOI 10.1249/MSS.0b013e31819aaae5; TANNER JM, 1976, ARCH DIS CHILD, V51, P170, DOI 10.1136/adc.51.3.170; Tomkinson Grant R, 2007, Med Sport Sci, V50, P46, DOI 10.1159/000101075; Tremblay Mark S, 2010, Health Rep, V21, P7; Trudeau F, 2003, CAN J APPL PHYSIOL, V28, P257, DOI 10.1139/h03-020; Unni US, 2009, EUR J CLIN NUTR, V63, P1206, DOI 10.1038/ejcn.2009.32; Whincup PH, 2002, BRIT MED J, V324, P635, DOI 10.1136/bmj.324.7338.635; Zimmet P, 2007, LANCET, V369, P2059, DOI 10.1016/S0140-6736(07)60958-1	44	94	100	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93150	10.1371/journal.pone.0093150	http://dx.doi.org/10.1371/journal.pone.0093150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714401	Green Published, gold, Green Submitted			2022-12-25	WOS:000334160900016
J	Lasecka, L; Baron, MD				Lasecka, Lidia; Baron, Michael D.			The Nairovirus Nairobi Sheep Disease Virus/Ganjam Virus Induces the Translocation of Protein Disulphide Isomerase-Like Oxidoreductases from the Endoplasmic Reticulum to the Cell Surface and the Extracellular Space	PLOS ONE			English	Article							CONGO-HEMORRHAGIC-FEVER; UUKUNIEMI VIRUS; DUGBE VIRUS; THIOL/DISULFIDE EXCHANGE; MEMBRANE-FUSION; GANJAM VIRUS; RNA SEGMENT; INTERMEDIATE COMPARTMENT; NUCLEOCAPSID PROTEIN; NOSOCOMIAL OUTBREAK	Nairobi sheep disease virus (NSDV) of the genus Nairovirus causes a haemorrhagic gastroenteritis in sheep and goats with mortality up to 90%; the virus is found in East and Central Africa, and in India, where the virus is called Ganjam virus. NSDV is closely related to the human pathogen Crimean-Congo haemorrhagic fever virus, which also causes a haemorrhagic disease. As with other nairoviruses, replication of NSDV takes place in the cytoplasm and the new virus particles bud into the Golgi apparatus; however, the effect of viral replication on cellular compartments has not been studied extensively. We have found that the overall structure of the endoplasmic reticulum (ER), the ER-Golgi intermediate compartment and the Golgi were unaffected by infection with NSDV. However, we observed that NSDV infection led to the loss of protein disulphide isomerase (PDI), an oxidoreductase present in the lumen of the endoplasmic reticulum (ER) and which assists during protein folding, from the ER. Further investigation showed that NSDV-infected cells have high levels of PDI at their surface, and PDI is also secreted into the culture medium of infected cells. Another chaperone from the PDI family, ERp57, was found to be similarly affected. Analysis of infected cells and expression of individual viral glycoproteins indicated that the NSDV PreGn glycoprotein is involved in redistribution of these soluble ER oxidoreductases. It has been suggested that extracellular PDI can activate integrins and tissue factor, which are involved respectively in pro-inflammatory responses and disseminated intravascular coagulation, both of which manifest in many viral haemorrhagic fevers. The discovery of enhanced PDI secretion from NSDV-infected cells may be an important finding for understanding the mechanisms underlying the pathogenicity of haemorrhagic nairoviruses.	[Lasecka, Lidia; Baron, Michael D.] Pirbright Inst, Woking, Surrey, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Baron, MD (corresponding author), Pirbright Inst, Woking, Surrey, England.	michael.baron@pirbright.ac.uk	Dykes, Lidia/HHM-9104-2022	Lasecka-Dykes, Lidia/0000-0003-3188-4198	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F00740X/1, BB/F006764/1]; BBSRC Institute Strategic Programme on Vector-borne Viral Diseases at The Pirbright Institute; BBSRC PhD studentship; BBSRC [BBS/E/I/00001718, BB/F00740X/1, BB/F006764/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001718, BB/F00740X/1, BB/F006764/1] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Institute Strategic Programme on Vector-borne Viral Diseases at The Pirbright Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC PhD studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants BB/F00740X/1 and BB/F006764/1 from the United Kingdom Biotechnology and Biological Sciences Research Council (BBSRC) and the BBSRC Institute Strategic Programme on Vector-borne Viral Diseases at The Pirbright Institute. LL was the recipient of a BBSRC PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrowicz P, 2008, HAMOSTASEOLOGIE, V28, P77; Altamura LA, 2007, J VIROL, V81, P6632, DOI 10.1128/JVI.02730-06; Andersson I, 2004, J MED VIROL, V72, P83, DOI 10.1002/jmv.10560; Andres G, 1998, J VIROL, V72, P8988; Bergeron E, 2007, J VIROL, V81, P13271, DOI 10.1128/JVI.01647-07; Bergeron E, 2010, J VIROL, V84, P216, DOI 10.1128/JVI.01859-09; Bertolotti-Ciarlet A, 2005, J VIROL, V79, P6152, DOI 10.1128/JVI.79.10.6152-6161.2005; Bi SG, 2011, P NATL ACAD SCI USA, V108, P10650, DOI 10.1073/pnas.1017954108; bin Tarif A, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-71; Bodur H, 2010, INT J INFECT DIS, V14, pE704, DOI 10.1016/j.ijid.2010.02.2240; BOOTH TF, 1991, VIRUS RES, V21, P199, DOI 10.1016/0168-1702(91)90033-R; BOSHELL J, 1970, INDIAN J MED RES, V58, P561; Bridgen A, 2002, VIROLOGY, V294, P364, DOI 10.1006/viro.2001.1324; BURNEY MI, 1980, AM J TROP MED HYG, V29, P941, DOI 10.4269/ajtmh.1980.29.941; Burt FJ, 1997, ARCH PATHOL LAB MED, V121, P839; Burt FJ, 1996, EPIDEMIOL INFECT, V116, P353, DOI 10.1017/S0950268800052687; Carter SD, 2012, J VIROL, V86, P10914, DOI 10.1128/JVI.01555-12; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; CASH P, 1985, J GEN VIROL, V66, P141, DOI 10.1099/0022-1317-66-1-141; Cho K, 2011, ANTIOXID REDOX SIGN, V15, P621, DOI 10.1089/ars.2010.3756; CLERX JPM, 1981, VIROLOGY, V108, P361, DOI 10.1016/0042-6822(81)90444-X; CLERX JPM, 1981, J GEN VIROL, V55, P165, DOI 10.1099/0022-1317-55-1-165; DANDAWAT.CN, 1969, INDIAN J MED RES, V57, P799; DAUBNEY R., 1931, PARASITOLOGY, V23, P507, DOI 10.1017/S0031182000013895; DAVIDWES.TS, 1974, J GEN VIROL, V23, P297, DOI 10.1099/0022-1317-23-3-297; DAVIES FG, 1978, J HYG-CAMBRIDGE, V81, P259, DOI 10.1017/S0022172400025092; DAVIES FG, 1978, J COMP PATHOL, V88, P519, DOI 10.1016/0021-9975(78)90005-1; DAVIES FG, 1978, J HYG-CAMBRIDGE, V81, P251, DOI 10.1017/S0022172400025080; DAVIES FG, 1982, J COMP PATHOL, V92, P15, DOI 10.1016/0021-9975(82)90039-1; DAVIES FG, 1976, J COMP PATHOL, V86, P497, DOI 10.1016/0021-9975(76)90058-X; Drosten C, 2002, J CLIN MICROBIOL, V40, P1122, DOI 10.1128/JCM.40.3.1122-1123.2002; Dunster L, 2002, EMERG INFECT DIS, V8, P1005, DOI 10.3201/eid0809.010510; ElAzazy OME, 1997, T ROY SOC TROP MED H, V91, P275, DOI 10.1016/S0035-9203(97)90072-9; ELLIS DS, 1981, ARCH VIROL, V70, P189, DOI 10.1007/BF01315125; Ergonul O, 2006, LANCET INFECT DIS, V6, P203, DOI 10.1016/S1473-3099(06)70435-2; Ergonul O, 2006, J INFECT DIS, V193, P941, DOI 10.1086/500836; Esmon CT, 2005, BRIT J HAEMATOL, V131, P417, DOI 10.1111/j.1365-2141.2005.05753.x; Fenouillet E, 2001, J INFECT DIS, V183, P744, DOI 10.1086/318823; Fenouillet E, 2007, ANTIOXID REDOX SIGN, V9, P1009, DOI 10.1089/ars.2007.1639; Fontana J, 2008, CELL MICROBIOL, V10, P2012, DOI 10.1111/j.1462-5822.2008.01184.x; Garrison AR, 2013, VIROLOGY, V444, P45, DOI 10.1016/j.virol.2013.05.030; GENTSCH J, 1977, J GEN VIROL, V34, P257, DOI 10.1099/0022-1317-34-2-257; Groocock CM, 1998, FOREIGN ANIMAL DIS; Guo Y, 2012, P NATL ACAD SCI USA, V109, P5046, DOI 10.1073/pnas.1200808109; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; HARRISONLAVOIE KJ, 1993, EMBO J, V12, P2847, DOI 10.1002/j.1460-2075.1993.tb05946.x; HEWLETT MJ, 1977, J VIROL, V21, P1085, DOI 10.1128/JVI.21.3.1085-1093.1977; Hoffstrom BG, 2010, NAT CHEM BIOL, V6, P900, DOI [10.1038/nchembio.467, 10.1038/NCHEMBIO.467]; Holzer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028594; Honig JE, 2004, VIROLOGY, V321, P29, DOI 10.1016/j.virol.2003.09.042; HOWARTH JA, 1965, J COMP PATHOL THERAP, V75, P437, DOI 10.1016/0021-9975(65)90024-1; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Ikegami T, 2005, J VIROL, V79, P12106, DOI 10.1128/JVI.79.18.12106-12111.2005; Jain S, 2007, J VIROL, V81, P2328, DOI 10.1128/JVI.01940-06; Jain S, 2009, J VIROL, V83, P241, DOI 10.1128/JVI.01407-08; Jain S, 2008, J VIROL, V82, P12039, DOI 10.1128/JVI.01406-08; Jantti J, 1997, J VIROL, V71, P1162; Jasuja R, 2012, J CLIN INVEST, V122, P2104, DOI 10.1172/JCI61228; Jordan PA, 2006, ANTIOXID REDOX SIGN, V8, P312, DOI 10.1089/ars.2006.8.312; Joshi MV, 2005, J MED ENTOMOL, V42, P204, DOI 10.1603/0022-2585(2005)042[0204:IOGVFT]2.0.CO;2; JOUBERT JR, 1985, S AFR MED J, V68, P722; Lahav J, 2002, BLOOD, V100, P2472, DOI 10.1182/blood-2001-12-0339; Levi M, 2013, INTERN EMERG MED, V8, P23, DOI 10.1007/s11739-012-0859-9; Mackenzie JM, 1999, J VIROL, V73, P9555, DOI 10.1128/JVI.73.11.9555-9567.1999; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; MANDEL R, 1993, P NATL ACAD SCI USA, V90, P4112, DOI 10.1073/pnas.90.9.4112; Marczinke BI, 2002, VIROLOGY, V303, P146, DOI 10.1006/viro.2002.1514; Markovic I, 2004, BLOOD, V103, P1586, DOI 10.1182/blood-2003-05-1390; Marriott A. C., 1996, The Bunyaviridae., P91; MARRIOTT AC, 1992, VIROLOGY, V190, P606, DOI 10.1016/0042-6822(92)90898-Y; Marriott AC, 1996, J GEN VIROL, V77, P1775, DOI 10.1099/0022-1317-77-8-1775; MATSUOKA Y, 1991, CURR TOP MICROBIOL, V169, P161; Montgomery RE, 1917, J COMP PATHOL, V30; Nabeth P, 2004, EMERG INFECT DIS, V10, P1881, DOI 10.3201/eid1010.040586; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nanda SK, 2006, J VIROL, V80, P7555, DOI 10.1128/JVI.02720-05; Netherton C, 2004, J VIROL, V78, P3710, DOI 10.1128/JVI.78.7.3710-3721.2004; Novoa RR, 2005, J VIROL, V79, P10852, DOI 10.1128/JVI.79.17.10852-10863.2005; Osterud B, 2001, SEMIN THROMB HEMOST, V27, P605, DOI 10.1055/s-2001-18866; Papa A, 2004, EMERG INFECT DIS, V10, P1465, DOI 10.3201/eid1008.040162; Papa A, 2010, CLIN MICROBIOL INFEC, V16, P843, DOI 10.1111/j.1469-0691.2009.02996.x; Papa A, 2002, EMERG INFECT DIS, V8, P50, DOI 10.3201/eid0801.010087; Papa A, 2006, J CLIN VIROL, V36, P272, DOI 10.1016/j.jcv.2006.04.007; PERSSON R, 1991, J CELL BIOL, V112, P257, DOI 10.1083/jcb.112.2.257; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PETTERSSON RF, 1975, J VIROL, V15, P386, DOI 10.1128/JVI.15.2.386-392.1975; PETTERSSON RF, 1973, VIROLOGY, V56, P608, DOI 10.1016/0042-6822(73)90062-7; Popescu NI, 2010, BLOOD, V116, P993, DOI 10.1182/blood-2009-10-249607; Popescu NI, 2010, THROMB RES, V125, pS38, DOI 10.1016/j.thromres.2010.01.034; Ramanathan HN, 2008, VIROLOGY, V374, P138, DOI 10.1016/j.virol.2007.12.030; Ramanathan HN, 2007, J VIROL, V81, P8634, DOI 10.1128/JVI.00418-07; Reinhardt C, 2008, J CLIN INVEST, V118, P1110, DOI 10.1172/JCI32376; Rodriguez F, 1996, VET REC, V139, P249, DOI 10.1136/vr.139.11.249; Rouiller I, 1998, J VIROL, V72, P2373, DOI 10.1128/JVI.72.3.2373-2387.1998; Rwambo PM, 1996, ARCH VIROL, V141, P1479, DOI 10.1007/BF01718249; Salanueva IJ, 2003, J VIROL, V77, P1368, DOI 10.1128/JVI.77.2.1368-1381.2003; Sanchez AJ, 2006, J VIROL, V80, P514, DOI 10.1128/JVI.80.1.514-525.2006; Sanchez AJ, 2002, J VIROL, V76, P7263, DOI 10.1128/JVI.76.14.7263-7275.2002; Saunders PM, 2011, TISSUE ANTIGENS, V78, P161, DOI 10.1111/j.1399-0039.2011.01735.x; Schmidt S, 2013, MOL IMMUNOL, V55, P49, DOI 10.1016/j.molimm.2012.11.006; Shi XH, 2004, J VIROL, V78, P5414, DOI 10.1128/JVI.78.10.5414-5422.2004; Simon M, 2009, VIROLOGY, V385, P313, DOI 10.1016/j.virol.2008.11.020; Strandin T, 2011, J GEN VIROL, V92, P1189, DOI 10.1099/vir.0.027896-0; Sudeep AB, 2009, INDIAN J MED RES, V130, P514; Swiatkowska M, 2008, FEBS J, V275, P1813, DOI 10.1111/j.1742-4658.2008.06339.x; TERADA K, 1995, J BIOL CHEM, V270, P20410, DOI 10.1074/jbc.270.35.20410; Terasaki K, 2011, P NATL ACAD SCI USA, V108, P804, DOI 10.1073/pnas.1013155108; UEDA K, 1992, JPN J VET RES, V40, P133; VAUX D, 1990, NATURE, V345, P495, DOI 10.1038/345495a0; Veijola J, 1999, J VIROL, V73, P6123, DOI 10.1128/JVI.73.7.6123-6127.1999; Vincent MJ, 2003, J VIROL, V77, P8640, DOI 10.1128/JVI.77.16.8640-8649.2003; Wan SW, 2012, J CELL BIOCHEM, V113, P1681, DOI 10.1002/jcb.24037; Wang Y, 2012, J VIROL, V86, P12294, DOI 10.1128/JVI.01627-12; WATRET GE, 1985, J GEN VIROL, V66, P2513, DOI 10.1099/0022-1317-66-11-2513; WEINBREN M. P., 1958, JOUR COMP PATHOL AND THERAP, V68, P174, DOI 10.1016/S0368-1742(58)80018-1; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; White WR, 2008, FOREIGN ANIMAL DIS, P335; Whitehouse CA, 2004, ANTIVIR RES, V64, P145, DOI 10.1016/j.antiviral.2004.08.001; Williams RJ, 2000, TROP MED INT HEALTH, V5, P99, DOI 10.1046/j.1365-3156.2000.00524.x; YOSHIMORI T, 1990, J BIOL CHEM, V265, P15984; Zhang YN, 2006, J BIOL CHEM, V281, P14622, DOI 10.1074/jbc.M512073200	121	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94656	10.1371/journal.pone.0094656	http://dx.doi.org/10.1371/journal.pone.0094656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714576	gold, Green Submitted, Green Published			2022-12-25	WOS:000334160900140
J	Morris, S; Karlsen, S; Chung, N; Hill, M; Chitty, LS				Morris, Stephen; Karlsen, Saffron; Chung, Nancy; Hill, Melissa; Chitty, Lyn S.			Model-Based Analysis of Costs and Outcomes of Non-Invasive Prenatal Testing for Down's Syndrome Using Cell Free Fetal DNA in the UK National Health Service	PLOS ONE			English	Article							MATERNAL PLASMA; ANEUPLOIDY; DIAGNOSIS; WOMEN; AMNIOCENTESIS; GENOME	Background: Non-invasive prenatal testing (NIPT) for Down's syndrome (DS) using cell free fetal DNA in maternal blood has the potential to dramatically alter the way prenatal screening and diagnosis is delivered. Before NIPT can be implemented into routine practice, information is required on its costs and benefits. We investigated the costs and outcomes of NIPT for DS as contingent testing and as first-line testing compared with the current DS screening programme in the UK National Health Service. Methods: We used a pre-existing model to evaluate the costs and outcomes associated with NIPT compared with the current DS screening programme. The analysis was based on a hypothetical screening population of 10,000 pregnant women. Model inputs were taken from published sources. The main outcome measures were number of DS cases detected, number of procedure-related miscarriages and total cost. Results: At a screening risk cut-off of 1:150 NIPT as contingent testing detects slightly fewer DS cases, has fewer procedure-related miscarriages, and costs the same as current DS screening (around UK 280,000) pound at a cost of 500 pound per NIPT. As first-line testing NIPT detects more DS cases, has fewer procedure-related miscarriages, and is more expensive than current screening at a cost of 50 pound per NIPT. When NIPT uptake increases, NIPT detects more DS cases with a small increase in procedure-related miscarriages and costs. Conclusions: NIPT is currently available in the private sector in the UK at a price of 400- pound 900 pound. If the NHS cost was at the lower end of this range then at a screening risk cut-off of 1:150 NIPT as contingent testing would be cost neutral or cost saving compared with current DS screening. As first-line testing NIPT is likely to produce more favourable outcomes but at greater cost. Further research is needed to evaluate NIPT under real world conditions.	[Morris, Stephen; Karlsen, Saffron] UCL, Dept Appl Hlth Res, London, England; [Chung, Nancy] Univ Exeter, NHS Fetal Anomaly Screening Programme, Exeter, Devon, England; [Hill, Melissa; Chitty, Lyn S.] UCL Inst Child Hlth, Clin & Mol Genet Unit, London, England; [Hill, Melissa; Chitty, Lyn S.] Great Ormond St Hosp Children NHS Fdn Trust, London, England; [Hill, Melissa; Chitty, Lyn S.] Univ Coll London Hosp NHS Fdn Trust, Fetal Med Unit, London, England	University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University College London Hospitals NHS Foundation Trust; University of London; University College London	Morris, S (corresponding author), UCL, Dept Appl Hlth Res, London, England.	steve.morris@ucl.ac.uk	Hill, Melissa/AIC-6192-2022	Morris, Stephen/0000-0002-5828-3563; chitty, lyn/0000-0002-4857-7138	National Institute for Health Research (NIHR) [RP-PG-0707-10107]; Central and East London NIHR Comprehensive Local Research Network; Great Ormond Street Hospital Children's Charity; NIHR Biomedical Research Centre at Great Ormond Street Hospital; National Institute for Health Research [NF-SI-0513-10141, RP-PG-0707-10107] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1253] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Central and East London NIHR Comprehensive Local Research Network; Great Ormond Street Hospital Children's Charity; NIHR Biomedical Research Centre at Great Ormond Street Hospital; National Institute for Health Research(National Institute for Health Research (NIHR)); Great Ormond Street Hospital Childrens Charity	This study was funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research scheme (the "RAPID'' project; RP-PG-0707-10107), the Central and East London NIHR Comprehensive Local Research Network, the Great Ormond Street Hospital Children's Charity and the NIHR Biomedical Research Centre at Great Ormond Street Hospital. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, OBSTET GYNECOL, V120, P1532, DOI 10.1097/01.AOG.0000423819.85283.f4; Antenatal Results and Choices, 2013, NON PREN TEST SYNDR; Ashoor G, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.029; Benn P, 2012, PRENATAL DIAG, V32, P1, DOI 10.1002/pd.2919; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Boon EMJ, 2013, PRENATAL DIAG, V33, P563, DOI 10.1002/pd.4111; Bray IC, 1998, PRENATAL DIAG, V18, P1045, DOI 10.1002/(SICI)1097-0223(1998100)18:10<1045::AID-PD403>3.3.CO;2-I; Chetty S, 2013, PRENATAL DIAG, V33, P542, DOI 10.1002/pd.4125; Chitty LS, 2006, BMJ-BRIT MED J, V332, P452, DOI 10.1136/bmj.38730.655197.AE; Chitty LS, 2012, AM J OBSTET GYNECOL, V206, P269, DOI 10.1016/j.ajog.2012.02.021; Cuckle H, 2013, PRENATAL DIAG, V33, P636, DOI 10.1002/pd.4157; Department of Health, 2011, 15423 DEP HLTH, P16211; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Futch T, 2013, PRENATAL DIAG, V33, P569, DOI 10.1002/pd.4123; Garfield SS, 2012, J MANAGED CARE MED, V15, P34; Gilbert RE, 2000, COST EFFECTIVENES SA; Gray JAM, 2004, NATL SYNDROME SCREEN; HESonline, MAT DAT 2010 11; Kagan KO, 2007, PRENATAL DIAG, V27, P34, DOI 10.1002/pd.1615; Langlois S, 2013, J OBSTET GYNAECOL CA, V35, P177, DOI 10.1016/S1701-2163(15)31025-2; Lewis C, 2013, PUBLIC HEALTH GENOM, V16, P223, DOI 10.1159/000353523; Liang DS, 2013, PRENATAL DIAG, V33, P409, DOI 10.1002/pd.4033; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Morris JK, 2002, J MED SCREEN, V9, P2, DOI 10.1136/jms.9.1.2; Morris JK, 2011, NATL SYNDROME CYTOGE; NHS Choices, 2013, TESTS SYNDR; NHS FASP. Screening for Down's syndrome: UK NSC policy recommenda-ations, 2011, 2011 2014 MOD BEST P; NHS Fetal Anomaly Screening Programme, 2012, DEC PLANN TOOL; Norton ME, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.021; Ohno M, 2013, PRENATAL DIAG, V33, P630, DOI 10.1002/pd.4156; ONS, 2010, LIV BIRT ENGL WAL CH; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Rowe R, 2008, PRENATAL DIAG, V28, P1245, DOI 10.1002/pd.2125; Song K, 2013, J MATERN-FETAL NEO M, V26, P1180, DOI 10.3109/14767058.2013.770464; Sparks A, 2012, AM J OBSTET GYNECOL, V206, pS314, DOI 10.1016/j.ajog.2011.10.725; Tabor A, 2010, FETAL DIAGN THER, V27, P1, DOI 10.1159/000271995; Wald NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058732; Wald NJ, 2003, J MED SCREEN, V10, P56, DOI 10.1258/096914103321824133; Wald NJ, 1998, HEALTH TECHNOL ASSES, V2, P1, DOI DOI 10.3310/HTA2010; Wright D, 2009, DQASS DETECTION RATE	40	82	84	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93559	10.1371/journal.pone.0093559	http://dx.doi.org/10.1371/journal.pone.0093559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714162	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900033
J	Li, W; Claypool, MD; Friera, AM; McLaughlin, J; Baltgalvis, KA; Smith, IJ; Kinoshita, T; White, K; Lang, W; Godinez, G; Payan, DG; Kinsella, TM				Li, Wei; Claypool, Mark D.; Friera, Annabelle M.; McLaughlin, John; Baltgalvis, Kristen A.; Smith, Ira J.; Kinoshita, Taisei; White, Kathy; Lang, Wayne; Godinez, Guillermo; Payan, Donald G.; Kinsella, Todd M.			Noninvasive Imaging of In Vivo MuRF1 Expression during Muscle Atrophy	PLOS ONE			English	Article							SKELETAL-MUSCLE; GLUCOCORTICOID-RECEPTOR; DISUSE; INVOLVE; DISEASE; MASS	Numerous human diseases can lead to atrophy of skeletal muscle, and loss of this tissue has been correlated with increased mortality and morbidity rates. Clinically addressing muscle atrophy remains an unmet medical need, and the development of preclinical tools to assist drug discovery and basic research in this effort is important for advancing this goal. In this report, we describe the development of a bioluminescent gene reporter rat, based on the zinc finger nuclease-targeted insertion of a bicistronic luciferase reporter into the 39 untranslated region of a muscle specific E3 ubiquitin ligase gene, MuRF1 (Trim63). In longitudinal studies, we noninvasively assess atrophy-related expression of this reporter in three distinct models of muscle loss (sciatic denervation, hindlimb unloading and dexamethasone-treatment) and show that these animals are capable of generating refined detail on in vivo MuRF1 expression with high temporal and anatomical resolution.	[Li, Wei; Claypool, Mark D.; Friera, Annabelle M.; McLaughlin, John; Baltgalvis, Kristen A.; Smith, Ira J.; Kinoshita, Taisei; White, Kathy; Lang, Wayne; Godinez, Guillermo; Payan, Donald G.; Kinsella, Todd M.] Rigel Pharmaceut Inc, Discovery Res, San Francisco, CA 94080 USA		Kinsella, TM (corresponding author), Rigel Pharmaceut Inc, Discovery Res, San Francisco, CA 94080 USA.	tkinsella@rigel.com			Rigel Pharmaceuticals Inc.	Rigel Pharmaceuticals Inc.	Financial support for this work was provided by Rigel Pharmaceuticals Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2004, NATURE, V428, P464, DOI 10.1038/428464a; Arbogast S, 2007, J APPL PHYSIOL, V102, P956, DOI 10.1152/japplphysiol.00538.2006; Baehr LM, 2011, J PHYSIOL-LONDON, V589, P4759, DOI 10.1113/jphysiol.2011.212845; Bodine S., 2013, INT J BIOCH CELL BIO; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Csukly K, 2006, J PHYSIOL-LONDON, V574, P319, DOI 10.1113/jphysiol.2006.109702; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Degens H, 2006, INT J SPORTS MED, V27, P94, DOI 10.1055/s-2005-837571; DESPLANCHES D, 1987, J APPL PHYSIOL, V63, P558, DOI 10.1152/jappl.1987.63.2.558; Files DC, 2012, AM J RESP CRIT CARE, V185, P825, DOI 10.1164/rccm.201106-1150OC; Foletta VC, 2011, PFLUG ARCH EUR J PHY, V461, P325, DOI 10.1007/s00424-010-0919-9; Glass D, 2010, ANN NY ACAD SCI, V1211, P25, DOI 10.1111/j.1749-6632.2010.05809.x; GRINDELAND RE, 1994, AM J PHYSIOL, V267, pR316, DOI 10.1152/ajpregu.1994.267.1.R316; Iannaccone PM, 2009, DIS MODEL MECH, V2, P206, DOI 10.1242/dmm.002733; Kelkar M, 2012, CURR OPIN PHARMACOL, V12, P592, DOI 10.1016/j.coph.2012.07.014; Labeit S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/693741; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Macpherson PCD, 2011, J CELL BIOCHEM, V112, P2149, DOI 10.1002/jcb.23136; Maguire KK, 2013, J CLIN INVEST, V123, P2298, DOI 10.1172/JCI68458; Marimuthu K, 2011, J APPL PHYSIOL, V110, P555, DOI 10.1152/japplphysiol.00962.2010; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Morey-Holton ER, 2002, J APPL PHYSIOL, V92, P1367, DOI 10.1152/japplphysiol.00969.2001; O'Neill K, 2010, J PATHOL, V220, P317, DOI 10.1002/path.2656; Prescher JA, 2010, CURR OPIN CHEM BIOL, V14, P80, DOI 10.1016/j.cbpa.2009.11.001; Radek KA, 2008, J APPL PHYSIOL, V104, P1295, DOI 10.1152/japplphysiol.00977.2007; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Tang HB, 2006, P NATL ACAD SCI USA, V103, P16977, DOI 10.1073/pnas.0601565103; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Waddell DS, 2008, AM J PHYSIOL-ENDOC M, V295, pE785, DOI 10.1152/ajpendo.00646.2007; Watson ML, 2012, AM J PHYSIOL-ENDOC M, V302, pE1210, DOI 10.1152/ajpendo.00512.2011; Willis MS, 2007, CIRC RES, V100, P456, DOI 10.1161/01.RES.0000259559.48597.32	34	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94032	10.1371/journal.pone.0094032	http://dx.doi.org/10.1371/journal.pone.0094032			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710205	Green Submitted, Green Published, gold			2022-12-25	WOS:000334159800091
J	Liu, XD; Gao, LH; Zhao, A; Zhang, R; Ji, BH; Wang, L; Zheng, YL; Zeng, BF; Valenzuela, RK; He, L; Ma, J				Liu, Xudong; Gao, Linghan; Zhao, Aman; Zhang, Rui; Ji, Baohu; Wang, Lei; Zheng, Yonglan; Zeng, Bingfang; Valenzuela, Robert K.; He, Lin; Ma, Jie			Identification of Duplication Downstream of BMP2 in a Chinese Family with Brachydactyly Type A2 (BDA2)	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; INDIAN HEDGEHOG; MISSENSE MUTATIONS; GENE-EXPRESSION; GROWTH-PLATE; BONE; ROR2; GDF5; TRANSCRIPTION; MECHANISMS	Brachydactyly type A2 (BDA2, MIM 112600) is characterized by the deviation and shortening of the middle phalange of the index finger and the second toe. Using genome-wide linkage analysis in a Chinese BDA2 family, we mapped the maximum candidate interval of BDA2 to a similar to 1.5 Mb region between D20S194 and D20S115 within chromosome 20p12.3 and found that the pairwise logarithm of the odds score was highest for marker D20S156 (Zmax = 6.09 at theta = 0). Based on functional and positional perspectives, the bone morphogenetic protein 2 (BMP2) gene was identified as the causal gene for BDA2 in this region, even though no point mutation was detected in BMP2. Through further investigation, we identified a 4,671 bp (Chr20: 6,809,218-6,813,888) genomic duplication downstream of BMP2. This duplication was located within the linked region, co-segregated with the BDA2 phenotype in this family, and was not found in the unaffected family members and the unrelated control individuals. Compared with the previously reported duplications, the duplication in this family has a different breakpoint flanked by the microhomologous sequence GATCA and a slightly different length. Some other microhomologous nucleotides were also found in the duplicated region. In summary, our findings support the conclusions that BMP2 is the causing gene for BDA2, that the genomic location corresponding to the duplication region is prone to structural changes associated with malformation of the digits, and that this tendency is probably caused by the abundance of microhomologous sequences in the region.	[Liu, Xudong; Zeng, Bingfang] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Orthopaed Surg, Shanghai 200030, Peoples R China; [Gao, Linghan; Zhao, Aman; Wang, Lei; He, Lin] Shanghai Jiao Tong Univ, Biox Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China; [Zhang, Rui; Ma, Jie] Xi An Jiao Tong Univ, Sch Med, Dept Genet & Mol Biol, Xian 710049, Shaanxi, Peoples R China; [Ji, Baohu; Ma, Jie] Univ Calif San Diego, Sch Med, Dept Psychiat, San Diego, CA 92103 USA; [Zheng, Yonglan] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Valenzuela, Robert K.] ASTAR, Human Genet Genome Inst Singapore, Singapore, Singapore; [Zhang, Rui] Xi An Jiao Tong Univ, Affiliated Hosp, Xian Hong Hui Hosp, Sch Med, Xian 710049, Shaanxi, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Xi'an Jiaotong University; University of California System; University of California San Diego; University of Chicago; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Xi'an Jiaotong University	He, L (corresponding author), Shanghai Jiao Tong Univ, Biox Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China.	helinhelin@gmail.com; majie.paper@gmail.com	Zheng, Yonglan/O-4112-2019; Zheng, Yonglan/C-4236-2011	Zheng, Yonglan/0000-0001-6597-7072; Zhang, Rui/0000-0002-8664-6915	National Natural Science Foundation of China [30700453, 81121001, 31371298, 81301151]; 973 Program [2010CB529600]; National Key Technology RD Program [2012BAI01B09]; Shanghai Municipal Commission of Science and Technology Program [09DJ1400601]; Shanghai Leading Academic Discipline Project [B205]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); National Key Technology RD Program(National Key Technology R&D Program); Shanghai Municipal Commission of Science and Technology Program; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the National Natural Science Foundation of China (No. 30700453; No. 81121001; No. 31371298; No. 81301151), the 973 Program (2010CB529600), the National Key Technology R&D Program (2012BAI01B09), the Shanghai Municipal Commission of Science and Technology Program 09DJ1400601, the Shanghai Leading Academic Discipline Project (B205). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams KL, 2004, J BIOL CHEM, V279, P15916, DOI 10.1074/jbc.M313531200; Akbarzadeh S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001873; Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Armour CM, 2002, J MED GENET, V39, P186, DOI 10.1136/jmg.39.3.186; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Baur ST, 2000, DEVELOPMENT, V127, P605; Bell J., 1951, TREASURY HUMAN INHER, P1; Chandler RL, 2007, MOL CELL BIOL, V27, P2934, DOI 10.1128/MCB.01609-06; Dathe K, 2009, AM J HUM GENET, V84, P483, DOI 10.1016/j.ajhg.2009.03.001; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Feng JQ, 2003, J BIOL CHEM, V278, P29130, DOI 10.1074/jbc.M212296200; FITCH N, 1979, J MED GENET, V16, P36, DOI 10.1136/jmg.16.1.36; Fritz DT, 2004, J BIOL CHEM, V279, P48950, DOI 10.1074/jbc.M409620200; Gao B, 2001, NAT GENET, V28, P386, DOI 10.1038/ng577; Gao B, 2009, NATURE, V458, P1196, DOI 10.1038/nature07862; Ghosh-Choudhury N, 2001, BIOCHEM BIOPH RES CO, V286, P101, DOI 10.1006/bbrc.2001.5351; Guo SZ, 2010, CELL MOL BIOL LETT, V15, P153, DOI 10.2478/s11658-009-0040-2; Hay E, 2001, J BIOL CHEM, V276, P29028, DOI 10.1074/jbc.M011265200; Johnson D, 2003, AM J HUM GENET, V72, P984, DOI 10.1086/374721; KAWABATA M, 1995, J BIOL CHEM, V270, P5625, DOI 10.1074/jbc.270.10.5625; Kimura-Yoshida C, 2004, DEVELOPMENT, V131, P57, DOI 10.1242/dev.00877; Kjaer KW, 2006, J MED GENET, V43, P225, DOI 10.1136/jmg.2005.034058; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kornak U, 2003, AM J HUM GENET, V73, P447, DOI 10.1086/377110; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lehmann K, 2007, AM J HUM GENET, V81, P388, DOI 10.1086/519697; Lehmann K, 2003, P NATL ACAD SCI USA, V100, P12277, DOI 10.1073/pnas.2133476100; Lehmann K, 2006, EUR J HUM GENET, V14, P1248, DOI 10.1038/sj.ejhg.5201708; Long FX, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008334; Ma G, 2011, CELL RES, V21, P1343, DOI 10.1038/cr.2011.76; Mackie EJ, 2008, INT J BIOCHEM CELL B, V40, P46, DOI 10.1016/j.biocel.2007.06.009; Minina E, 2002, DEV CELL, V3, P439, DOI 10.1016/S1534-5807(02)00261-7; Mohr O.L., 1919, NEW TYPE HEREDITARY, P5; Mundlos S, 2009, CLIN GENET, V76, P123, DOI 10.1111/j.1399-0004.2009.01238.x; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; Oldridge M, 2000, NAT GENET, V24, P275, DOI 10.1038/73495; Ovcharenko I, 2005, GENOME RES, V15, P137, DOI 10.1101/gr.3015505; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Ploger F, 2008, HUM MOL GENET, V17, P1222, DOI 10.1093/hmg/ddn012; Polinkovsky A, 1997, NAT GENET, V17, P18, DOI 10.1038/ng0997-18; Sammar M, 2004, GENES CELLS, V9, P1227, DOI 10.1111/j.1365-2443.2004.00799.x; Schwabe GC, 2000, AM J HUM GENET, V67, P822, DOI 10.1086/303084; Seemann P, 2005, J CLIN INVEST, V115, P2373, DOI 10.1172/JCI25118; Storm EE, 1999, DEV BIOL, V209, P11, DOI 10.1006/dbio.1999.9241; Styrkarsdottir U, 2003, PLOS BIOL, V1, P351, DOI 10.1371/journal.pbio.0000069; Su PQ, 2011, J MED GENET, V48, P312, DOI 10.1136/jmg.2010.084814; Sugiura T, 1999, BIOCHEM J, V338, P433, DOI 10.1042/0264-6021:3380433; Temtamy SA, 1978, GENETICS HAND MALFOR; Temtamy SA, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-15; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Uchikawa M, 2004, MECH DEVELOP, V121, P1145, DOI 10.1016/j.mod.2004.05.009; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Xing QH, 2003, AM J HUM GENET, V73, P377, DOI 10.1086/377007; Yoon BS, 2004, J CELL BIOCHEM, V93, P93, DOI 10.1002/jcb.20211; Zhao M, 2006, MOL CELL BIOL, V26, P6197, DOI 10.1128/MCB.02214-05	57	5	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94201	10.1371/journal.pone.0094201	http://dx.doi.org/10.1371/journal.pone.0094201			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710560	Green Submitted, gold, Green Published			2022-12-25	WOS:000334159800116
J	Marriott, AC; Dove, BK; Whittaker, CJ; Bruce, C; Ryan, KA; Bean, TJ; Rayner, E; Pearson, G; Taylor, I; Dowall, S; Plank, J; Newman, E; Barclay, WS; Dimmock, NJ; Easton, AJ; Hallis, B; Silman, NJ; Carroll, MW				Marriott, Anthony C.; Dove, Brian K.; Whittaker, Catherine J.; Bruce, Christine; Ryan, Kathryn A.; Bean, Thomas J.; Rayner, Emma; Pearson, Geoff; Taylor, Irene; Dowall, Stuart; Plank, Jenna; Newman, Edmund; Barclay, Wendy S.; Dimmock, Nigel J.; Easton, Andrew J.; Hallis, Bassam; Silman, Nigel J.; Carroll, Miles W.			Low Dose Influenza Virus Challenge in the Ferret Leads to Increased Virus Shedding and Greater Sensitivity to Oseltamivir	PLOS ONE			English	Article							A H1N1 VIRUS; APRIL 2009; MORTALITY; INFECTION; MODEL; TRANSMISSION; INHIBITOR; PROTECTS; PATHOGENESIS; EFFICACY	Ferrets are widely used to study human influenza virus infection. Their airway physiology and cell receptor distribution makes them ideal for the analysis of pathogenesis and virus transmission, and for testing the efficacy of anti-influenza interventions and vaccines. The 2009 pandemic influenza virus (H1N1pdm09) induces mild to moderate respiratory disease in infected ferrets, following inoculation with 10(6) plaque-forming units (pfu) of virus. We have demonstrated that reducing the challenge dose to 10(2) pfu delays the onset of clinical signs by 1 day, and results in a modest reduction in clinical signs, and a less rapid nasal cavity innate immune response. There was also a delay in virus production in the upper respiratory tract, this was up to 9-fold greater and virus shedding was prolonged. Progression of infection to the lower respiratory tract was not noticeably delayed by the reduction in virus challenge. A dose of 10(4) pfu gave an infection that was intermediate between those of the 10(6) pfu and 10(2) pfu doses. To address the hypothesis that using a more authentic low challenge dose would facilitate a more sensitive model for antiviral efficacy, we used the well-known neuraminidase inhibitor, oseltamivir. Oseltamivir-treated and untreated ferrets were challenged with high (10(6) pfu) and low (10(2) pfu) doses of influenza H1N1pdm09 virus. The low dose treated ferrets showed significant delays in innate immune response and virus shedding, delayed onset of pathological changes in the nasal cavity, and reduced pathological changes and viral RNA load in the lung, relative to untreated ferrets. Importantly, these observations were not seen in treated animals when the high dose challenge was used. In summary, low dose challenge gives a disease that more closely parallels the disease parameters of human influenza infection, and provides an improved pre-clinical model for the assessment of influenza therapeutics, and potentially, influenza vaccines.	[Marriott, Anthony C.; Dove, Brian K.; Whittaker, Catherine J.; Bruce, Christine; Ryan, Kathryn A.; Bean, Thomas J.; Rayner, Emma; Pearson, Geoff; Taylor, Irene; Dowall, Stuart; Plank, Jenna; Newman, Edmund; Hallis, Bassam; Silman, Nigel J.; Carroll, Miles W.] Publ Hlth England, Salisbury, Wilts, England; [Barclay, Wendy S.] Univ London Imperial Coll Sci Technol & Med, Div Infect Dis, London, England; [Dimmock, Nigel J.; Easton, Andrew J.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	Public Health England; Imperial College London; University of Warwick	Marriott, AC (corresponding author), Publ Hlth England, Salisbury, Wilts, England.	Anthony.marriott@phe.gov.uk		Marriott, Anthony/0000-0002-8862-9852; Barclay, Wendy/0000-0002-3948-0895; Ryan, Kathryn Ann/0000-0001-8608-1144	National Institute for Health Research, Centre for Health Protection Research [104663]; MRC [G0600504] Funding Source: UKRI; Medical Research Council [G0600504] Funding Source: researchfish	National Institute for Health Research, Centre for Health Protection Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by National Institute for Health Research, Centre for Health Protection Research, project number 104663. http://www.nihr.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD RH, 1966, P SOC EXP BIOL MED, V122, P800, DOI 10.3181/00379727-122-31255; Bodewes R, 2010, EXPERT REV VACCINES, V9, P59, DOI [10.1586/erv.09.148, 10.1586/ERV.09.148]; Boltz DA, 2008, J INFECT DIS, V197, P1315, DOI 10.1086/586711; CHEN KS, 1995, INT J EXP PATHOL, V76, P55; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dimmock NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049394; Dimmock NJ, 2012, ANTIVIR RES, V96, P376, DOI 10.1016/j.antiviral.2012.09.017; Dimmock NJ, 2006, J GEN VIROL, V87, P1259, DOI 10.1099/vir.0.81678-0; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Govorkova EA, 2007, ANTIMICROB AGENTS CH, V51, P1414, DOI 10.1128/AAC.01312-06; Govorkova EA, 2011, ANTIVIR RES, V91, P81, DOI 10.1016/j.antiviral.2011.05.008; Gustin KM, 2011, P NATL ACAD SCI USA, V108, P8432, DOI 10.1073/pnas.1100768108; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Killingley B, 2011, LANCET INFECT DIS, V11, P879, DOI 10.1016/S1473-3099(11)70142-6; Kirkeby S, 2009, VIRUS RES, V144, P225, DOI 10.1016/j.virusres.2009.05.004; Lednicky JA, 2010, COMPARATIVE MED, V60, P364; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Matsuoka Yumiko, 2009, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/9780471729259.mc15g03s13, 10.1002/9780471729259.mc15g02s13]; Mendel DB, 1998, ANTIMICROB AGENTS CH, V42, P640, DOI 10.1128/AAC.42.3.640; Mishin VR, 2005, VACCINE, V23, P2922, DOI 10.1016/j.vaccine.2004.11.058; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Pebody RG, 2010, EUROSURVEILLANCE, V15; REUMAN PD, 1989, J VIROL METHODS, V24, P27, DOI 10.1016/0166-0934(89)90004-9; RYAN DM, 1995, ANTIMICROB AGENTS CH, V39, P2583, DOI 10.1128/AAC.39.11.2583; Slomka MJ, 2010, INFLUENZA OTHER RESP, V4, P277, DOI 10.1111/j.1750-2659.2010.00149.x; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Smith JEH, 2011, NEW SYNTH HIST LIB, V67, P1, DOI 10.1007/978-94-007-0041-3_1; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Suguitan AL, 2014, INFLUENZA OTHER RESP, V8, P169, DOI 10.1111/irv.12220; Sweet C, 2002, ANTIMICROB AGENTS CH, V46, P996, DOI 10.1128/AAC.46.4.996-1004.2002; van den Brand JMA, 2010, J INFECT DIS, V201, P993, DOI 10.1086/651132; Ward P, 2005, J ANTIMICROB CHEMOTH, V55, P5, DOI 10.1093/jac/dki018	34	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94090	10.1371/journal.pone.0094090	http://dx.doi.org/10.1371/journal.pone.0094090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709834	gold, Green Submitted, Green Published			2022-12-25	WOS:000334159800100
J	Reece, JC; Martyushev, A; Petravic, J; Grimm, A; Gooneratne, S; Amaresena, T; De Rose, R; Loh, L; Davenport, MP; Kent, SJ				Reece, Jeanette C.; Martyushev, Alexey; Petravic, Janka; Grimm, Andrew; Gooneratne, Shayarana; Amaresena, Thakshila; De Rose, Robert; Loh, Liyen; Davenport, Miles P.; Kent, Stephen J.			Measuring Turnover of SIV DNA in Resting CD4+T Cells Using Pyrosequencing: Implications for the Timing of HIV Eradication Therapies	PLOS ONE			English	Article							CD4(+) T-CELLS; IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; HISTONE DEACETYLASE INHIBITORS; LATENT RESERVOIR; VALPROIC ACID; LIFELONG PERSISTENCE; INTRINSIC STABILITY; ANTIVIRAL THERAPY; LYMPHOCYTE ESCAPE	Resting CD4+ T cells are a reservoir of latent HIV-1. Understanding the turnover of HIV DNA in these cells has implications for the development of eradication strategies. Most studies of viral latency focus on viral persistence under antiretroviral therapy (ART). We studied the turnover of SIV DNA resting CD4+ T cells during active infection in a cohort of 20 SIV-infected pigtail macaques. We compared SIV sequences at two Mane-A1*084:01-restricted CTL epitopes using serial plasma RNA and resting CD4+ T cell DNA samples by pyrosequencing, and used a mathematical modeling approach to estimate SIV DNA turnover. We found SIV DNA turnover in resting CD4+ T cells was slow in animals with low chronic viral loads, consistent with the long persistence of latency seen under ART. However, in animals with high levels of chronic viral replication, turnover was high. SIV DNA half-life within resting CD4 cells correleated with viral load (p=0.0052) at the Gag KP9 CTL epitope. At a second CTL epitope in Tat (KVA10) there was a trend towards an association of SIV DNA half-life in resting CD4 cells and viral load (p=0.0971). Further, we found that the turnover of resting CD4+ T cell SIV DNA was higher for escape during early infection than for escape later in infection (p=0.0084). Our results suggest viral DNA within resting CD4 T cells is more labile and may be more susceptible to reactivation/eradication treatments when there are higher levels of virus replication and during early/acute infection.	[Reece, Jeanette C.; Gooneratne, Shayarana; Amaresena, Thakshila; De Rose, Robert; Loh, Liyen; Kent, Stephen J.] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia; [Martyushev, Alexey; Petravic, Janka; Grimm, Andrew; Davenport, Miles P.] Univ New S Wales, Ctr Vasc Res, Kensington, NSW 2033, Australia	University of Melbourne; University of New South Wales Sydney	Kent, SJ (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic 3010, Australia.	skent@unimelb.edu.au	Petravic, Janka/AAD-9192-2020; Kent, Stephen/AAL-5101-2020	Petravic, Janka/0000-0002-2263-2776; Kent, Stephen/0000-0002-8539-4891; Loh, Liyen/0000-0002-1676-0579; Reece, Jeanette/0000-0003-2897-0271; De Rose, Robert/0000-0003-4316-3910; Gooneratne, Shayarana/0000-0001-6839-4729; Davenport, Miles/0000-0002-4751-1831	Australian National Health and Medical Research Council; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007762] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the Australian National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananworanich J, 2013, CROI C RETR OPP INF; Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2012, P NATL ACAD SCI USA, V109, P9523, DOI 10.1073/pnas.1120248109; Archin NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009390; Archin NM, 2008, AIDS, V22, P1131, DOI 10.1097/QAD.0b013e3282fd6df4; Blankenberg D, 2011, BIOINFORMATICS, V27, P2426, DOI 10.1093/bioinformatics/btr398; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Blankson JN, 2000, J INFECT DIS, V182, P1636, DOI 10.1086/317615; Blazkova J, 2012, J INFECT DIS, V206, P765, DOI 10.1093/infdis/jis412; BUKRINSKY MI, 1991, SCIENCE, V254, P423, DOI 10.1126/science.1925601; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; De Rose R, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000055; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580; Kent SJ, 2013, LANCET INFECT DIS; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Koelsch KK, 2011, AIDS, V25, P2069, DOI 10.1097/QAD.0b013e32834b9658; Kumar R, 2002, J VIROL METHODS, V105, P233, DOI 10.1016/S0166-0934(02)00105-2; Lewden C, 2012, INT J EPIDEMIOL, V41, P433, DOI 10.1093/ije/dyr164; Loh L, 2008, AIDS RES HUM RETROV, V24, P1067, DOI 10.1089/aid.2007.0309; Mason RD, 2009, VIROLOGY, V388, P315, DOI 10.1016/j.virol.2009.03.020; Matalon S, 2011, MOL MED, V17, P466, DOI 10.2119/molmed.2011.00076; Mexas AM, 2012, AIDS, V26, P2295, DOI 10.1097/QAD.0b013e32835a5c2f; Monie D, 2005, J VIROL, V79, P5185, DOI 10.1128/JVI.79.8.5185-5202.2005; O'Connor SL, 2012, J VIROL, V86, P605, DOI 10.1128/JVI.05511-11; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Persaud D, 2013, NEW ENGL J MED, V369, P1828, DOI 10.1056/NEJMoa1302976; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Pierson TC, 2002, J VIROL, V76, P8518, DOI 10.1128/JVI.76.17.8518-8513.2002; Pierson TC, 2002, J VIROL, V76, P4138, DOI 10.1128/JVI.76.8.4138-4144.2002; Reece J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002615; Reece JC, 2013, J VIROL, V87, P4146, DOI 10.1128/JVI.02645-12; Routy JP, 2012, HIV MED, V13, P291, DOI 10.1111/j.1468-1293.2011.00975.x; Ruff CT, 2002, J VIROL, V76, P9481, DOI 10.1128/JVI.76.18.9481-9492.2002; Sankatsing SUC, 2003, ANTIVIR THER, V8, P137; Sexton A, 2009, J VIROL, V83, P7619, DOI 10.1128/JVI.00470-09; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Smith MZ, 2005, J VIROL, V79, P684, DOI 10.1128/JVI.79.2.684-695.2005; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; Tran TA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003305; Wind-Rotolo M, 2009, J INFECT DIS, V199, P1301, DOI 10.1086/597759; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Xing SF, 2012, J ANTIMICROB CHEMOTH, V67, P398, DOI 10.1093/jac/dkr496; Xing SF, 2011, J VIROL, V85, P6060, DOI 10.1128/JVI.02033-10; Zhou Y, 2005, J VIROL, V79, P2199, DOI 10.1128/JVI.79.4.2199-2210.2005	55	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93330	10.1371/journal.pone.0093330	http://dx.doi.org/10.1371/journal.pone.0093330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710023	gold, Green Published			2022-12-25	WOS:000334159800028
J	Villani, G; Shevelev, I; Orlando, E; Pospiech, H; Syvaoja, JE; Markkanen, E; Hubscher, U; Le Gac, NT				Villani, Giuseppe; Shevelev, Igor; Orlando, Eleonora; Pospiech, Helmut; Syvaoja, Juhani E.; Markkanen, Enni; Hubscher, Ulrich; Le Gac, Nicolas Tanguy			Gap-Directed Translesion DNA Synthesis of an Abasic Site on Circular DNA Templates by a Human Replication Complex	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; POLYMERASE-DELTA; PROTEIN-A; EPSILON; LAMBDA; BETA; ELONGATION; GENERATION; PRIMPOL; LESIONS	DNA polymerase epsilon(pol epsilon) is believed to be the leading strand replicase in eukaryotes whereas pols lambda and beta are thought to be mainly involved in re-synthesis steps of DNA repair. DNA elongation by the human pol e is halted by an abasic site (apurinic/apyrimidinic (AP) site). We have previously reported that human pols lambda,beta and eta can perform translesion synthesis (TLS) of an AP site in the presence of pol epsilon. In the case of pol lambda and beta, this TLS requires the presence of a gap downstream from the product synthetized by the epsilon replicase. However, since these studies were conducted exclusively with a linear DNA template, we decided to test whether the structure of the template could influence the capacity of the pols epsilon,lambda, beta and eta to perform TLS of an AP site. Therefore, we have investigated the replication of damaged ``minicircle'' DNA templates. In addition, replication of circular DNA requires, beyond DNA pols, the processivity clamp PCNA, the clamp loader replication factor C (RFC), and the accessory proteins replication protein A (RPA). Finally we have compared the capacity of unmodified versus monoubiquitinated PCNA in sustaining TLS by pols lambda and eta on a circular template. Our results indicate that in vitro gap-directed TLS synthesis by pols lambda and beta in the presence of pol epsilon, RPA and PCNA is unaffected by the structure of the DNA template. Moreover, monoubiquitination of PCNA does not affect TLS by pol lambda while it appears to slightly stimulate TLS by pol eta.	[Villani, Giuseppe; Orlando, Eleonora; Le Gac, Nicolas Tanguy] CNRS, Inst Pharmacol & Biol Struct, Toulouse, France; [Villani, Giuseppe; Orlando, Eleonora; Le Gac, Nicolas Tanguy] Univ Toulouse 3, Inst Pharmacol & Biol Struct, Toulouse, France; [Shevelev, Igor; Pospiech, Helmut] Leibniz Inst Age Res, Fritz Lipman Inst, Jena, Germany; [Shevelev, Igor; Pospiech, Helmut] Univ Oulu, Dept Biochem, Oulu, Finland; [Syvaoja, Juhani E.] Univ Eastern Finland, Inst Biomed, Kuopio, Finland; [Markkanen, Enni] Gray Inst Radiat Oncol & Biol, Dept Oncol, Dept Grp, Biochem Grp, Oxford, England; [Hubscher, Ulrich] Univ Zurich Irchel, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Finland National Institute for Health & Welfare; University of Oulu; University of Eastern Finland; University of Oxford; University of Zurich	Le Gac, NT (corresponding author), CNRS, Inst Pharmacol & Biol Struct, Toulouse, France.	ntlg@ipbs.fr	Markkanen, Enni/V-9784-2017; Pospiech, Helmut/J-8598-2015	Markkanen, Enni/0000-0001-7780-8233; 	Swiss National Science Foundation; Grant Electricite de France [NRB62013-07]; Academy of Finland [251576]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Grant Electricite de France; Academy of Finland(Academy of Finland)	EM and UH are supported by the Swiss National Science Foundation (http://www.snf.ch). GV was supported by the Grant Electricite de France NRB62013-07 (http://france.edf.com). JES was supported by grant 251576 from the Academy of Finland (http://www.aka.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker T. A., 2005, DNA REPLICATION; Bianchi J, 2013, MOL CELL, V52, P566, DOI 10.1016/j.molcel.2013.10.035; Blanca G, 2004, BIOCHEMISTRY-US, V43, P11605, DOI 10.1021/bi049050x; Chary P, 2012, CHEM RES TOXICOL, V25, P2744, DOI 10.1021/tx300368f; Eger S, 2011, CHEMBIOCHEM, V12, P2807, DOI 10.1002/cbic.201100444; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Garcia-Gomez S, 2013, MOL CELL, V52, P541, DOI 10.1016/j.molcel.2013.09.025; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; Haracska L, 2006, P NATL ACAD SCI USA, V103, P6477, DOI 10.1073/pnas.0510924103; Hendel A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002262; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hubscher U., 2010, DNA POLYM DISCOVERY; Indiani C, 2006, NAT REV MOL CELL BIO, V7, P751, DOI 10.1038/nrm2022; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kanuri M, 2002, J BIOL CHEM, V277, P18257, DOI 10.1074/jbc.M112419200; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Le Gac NT, 2004, J MOL BIOL, V336, P1023, DOI 10.1016/j.jmb.2004.01.005; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Locatelli GA, 2010, BIOCHEM J, V429, P573, DOI 10.1042/BJ20100405; Maga G, 2001, P NATL ACAD SCI USA, V98, P14298, DOI 10.1073/pnas.251193198; Mozzherin DJ, 1997, P NATL ACAD SCI USA, V94, P6126, DOI 10.1073/pnas.94.12.6126; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Shevelev I, 2003, NUCLEIC ACIDS RES, V31, P6916, DOI 10.1093/nar/gkg896; Shibutani S, 1997, J BIOL CHEM, V272, P13916, DOI 10.1074/jbc.272.21.13916; SYVAOJA J, 1990, P NATL ACAD SCI USA, V87, P6664, DOI 10.1073/pnas.87.17.6664; Tomer G, 1999, BIOCHEMISTRY-US, V38, P5948, DOI 10.1021/bi982599+; van Loon Barbara, 2009, V521, P345, DOI [10.1007/978-1-60327-817-5_19, 10.1007/978-1-60327-815-7_19]; Villani G, 2011, J BIOL CHEM, V286, P32094, DOI 10.1074/jbc.M111.246611; Wan L, 2013, EMBO REP, V14, P1104, DOI 10.1038/embor.2013.159; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08	31	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93908	10.1371/journal.pone.0093908	http://dx.doi.org/10.1371/journal.pone.0093908			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710081	Green Submitted, gold, Green Published			2022-12-25	WOS:000334159800068
J	Desarzens, S; Liao, WH; Mammi, C; Caprio, M; Faresse, N				Desarzens, Sebastien; Liao, Wan-Hui; Mammi, Caterina; Caprio, Massimiliano; Faresse, Nourdine			Hsp90 Blockers Inhibit Adipocyte Differentiation and Fat Mass Accumulation	PLOS ONE			English	Article							PHASE-II TRIAL; GLUCOCORTICOID-RECEPTOR FUNCTION; SHOCK-PROTEIN 90; MINERALOCORTICOID RECEPTOR; TISSUE DISTRIBUTION; CARBOXYL-TERMINUS; ANDROGEN RECEPTOR; OBESITY; MICE; 17-(ALLYLAMINO)-17-DEMETHOXYGELDANAMYCIN	Geldanamycin derivatives are benzoquinone ansamycin antibiotics that bind to Hsp90 and alter its function. The alteration of Hsp90 activity limits some cellular hormonal responses by inhibiting nuclear receptors activation. The nuclear receptors activity, such as PPAR gamma, the mineralocorticoid and glucocorticoid receptors (MR and GR) play a critical role in the conversion of preadipocytes to mature adipocytes. Given the importance of these nuclear receptors for adipogenesis, we investigated the effects of geldanamycin analogues (GA) on adipocyte differentiation and function. We found that early exposure of preadipocyte cells to GA inhibited their conversion into mature adipocytes by inhibiting the adipogenic transcriptional program and lipid droplets accumulation. Furthermore, GA altered the adipokines secretion profile of mature adipocyte. The anti-adipogenic effect of GA was also confirmed in mice fed a high fat diet. Biochemical analysis revealed that anti-adipogenic effects of geldanamycin analogues may result from the simultaneous inhibition of MR, GR and PPAR gamma activity. Taken together, our observations lead us to propose Hsp90 as a potent target for drug development in the control of obesity and its related metabolic complications.	[Desarzens, Sebastien; Liao, Wan-Hui; Faresse, Nourdine] Univ Zurich, Zurich, Switzerland; [Mammi, Caterina; Caprio, Massimiliano] IRCCS San Raffaele, Rome, Italy	University of Zurich; IRCCS San Raffaele Pisana; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Faresse, N (corresponding author), Univ Zurich, Zurich, Switzerland.	nourdine.faresse@uzh.ch	Mammi, Caterina/O-1047-2013; Caprio, Massimiliano/J-3020-2012	Caprio, Massimiliano/0000-0003-0722-7163; mammi, caterina/0000-0002-2687-4422	Swiss National Science Foundation [PZ00P3_142594]; National Centre of Competence in Research (NCCR) Kidney	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Centre of Competence in Research (NCCR) Kidney	The study was supported by funding form the Swiss National Science Foundation (Ambizone grant PZ00P3_142594) and the National Centre of Competence in Research (NCCR) Kidney. CH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamberger CM, 1997, MOL CELL ENDOCRINOL, V131, P233, DOI 10.1016/S0303-7207(97)00115-9; Briones AM, 2012, HYPERTENSION, V59, P1069, DOI 10.1161/HYPERTENSIONAHA.111.190223; Caprio M, 2007, FASEB J, V21, P2185, DOI 10.1096/fj.06-7970com; Caprio M, 2011, ENDOCRINOLOGY, V152, P113, DOI 10.1210/en.2010-0674; Egorin MJ, 2002, CANCER CHEMOTH PHARM, V49, P7, DOI 10.1007/s00280-001-0380-8; Egorin MJ, 2001, CANCER CHEMOTH PHARM, V47, P291, DOI 10.1007/s002800000242; Fan MY, 2005, MOL ENDOCRINOL, V19, P2901, DOI 10.1210/me.2005-0111; Faresse N, 2012, FASEB J, V26, P4373, DOI 10.1096/fj.12-209924; Faresse N, 2010, AM J PHYSIOL-RENAL, V299, pF1462, DOI 10.1152/ajprenal.00285.2010; Fu MG, 2005, MOL ENDOCRINOL, V19, P2437, DOI 10.1210/me.2004-0539; Goetz MP, 2005, J CLIN ONCOL, V23, P1078, DOI 10.1200/JCO.2005.09.119; GREEN H, 1979, J CELL PHYSIOL, V101, P169, DOI 10.1002/jcp.1041010119; Grem JL, 2005, J CLIN ONCOL, V23, P1885, DOI 10.1200/JCO.2005.12.085; Guo C, 2008, CIRCULATION, V117, P2253, DOI 10.1161/CIRCULATIONAHA.107.748640; He YH, 2013, BIOCHEM BIOPH RES CO, V436, P169, DOI 10.1016/j.bbrc.2013.05.068; Heath EI, 2008, CLIN CANCER RES, V14, P7940, DOI 10.1158/1078-0432.CCR-08-0221; Hirata A, 2009, CARDIOVASC RES, V84, P164, DOI 10.1093/cvr/cvp191; Hoppmann J, 2010, J ENDOCRINOL, V204, P153, DOI 10.1677/JOE-09-0292; Leal VD, 2013, CLIN CHIM ACTA, V419, P87, DOI 10.1016/j.cca.2013.02.003; Lee MJ, 2013, BIOCH BIOPHYS ACTA; Marzolla V, 2011, MOL CELLULAR ENDOCRI; McInnes KJ, 2012, DIABETES, V61, P1072, DOI 10.2337/db11-1136; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Morales JL, 2007, BIOCHEMISTRY-US, V46, P610, DOI 10.1021/bi062165b; Nguyen MT, 2013, CELL DEATH DIFFER, V20, P1654, DOI 10.1038/cdd.2013.129; Prins JB, 1997, CLIN SCI, V92, P3, DOI 10.1042/cs0920003; Ronnen EA, 2006, INVEST NEW DRUG, V24, P543, DOI 10.1007/s10637-006-9208-z; Sahin-Efe A, 2012, METABOLISM, V61, P1659, DOI 10.1016/j.metabol.2012.09.001; Sharp S, 2006, ADV CANCER RES, V95, P323, DOI 10.1016/S0065-230X(06)95009-X; Shemin D, 2011, CRIT CARE CLIN, V27, P379, DOI 10.1016/j.ccc.2010.12.003; Singh R, 2006, ENDOCRINOLOGY, V147, P141, DOI 10.1210/en.2004-1649; Solit DB, 2008, CLIN CANCER RES, V14, P8302, DOI 10.1158/1078-0432.CCR-08-1002; Steger DJ, 2010, GENE DEV, V24, P1035, DOI 10.1101/gad.1907110; Viau A, 2010, J CLIN INVEST, V120, P4065, DOI 10.1172/JCI42004; White UA, 2010, MOL CELL ENDOCRINOL, V318, P10, DOI 10.1016/j.mce.2009.08.023; Whitesell L, 1996, MOL ENDOCRINOL, V10, P705, DOI 10.1210/me.10.6.705; Zennaro MC, 2009, TRENDS ENDOCRIN MET, V20, P444, DOI 10.1016/j.tem.2009.05.006; Zhang HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032746	38	27	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94127	10.1371/journal.pone.0094127	http://dx.doi.org/10.1371/journal.pone.0094127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705830	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000334107500126
J	Nkum, BC; Micah, FB; Ankrah, TC; Nyan, O				Nkum, Bernard Cudjoe; Micah, Frank Botsi; Ankrah, Theophilus C.; Nyan, Ousman			Left Ventricular Hypertrophy and Insulin Resistance in Adults from an Urban Community in the Gambia: Cross-Sectional Study	PLOS ONE			English	Article							GROWTH-FACTOR-I; HYPERTENSIVE PATIENTS; METABOLIC SYNDROME; CARDIAC STRUCTURE; MASS INDEX; SENSITIVITY; ASSOCIATION; RAT; HYPERINSULINEMIA; TRIGLYCERIDE	Objective: To determine the association between left ventricular hypertrophy and insulin resistance in Gambians. Design: Cross-sectional study. Setting: Outpatient clinics of Royal Victoria Teaching Hospital and Medical Research Council Laboratories in Banjul. Participants: Three hundred and sixteen consecutive patients were enrolled from outpatient clinics. The data of 275 participants (89 males) were included in the analysis with a mean (+/- standard deviation) age of 53.7 (+/- 11.9) years. Interventions: A questionnaire was filled and anthropometric measurements were taken. 2-D guided M-mode echocardiography, standard 12-1ead electrocardiogram, fasting insulin and the oral glucose tolerance test were performed. Main Outcome Measures: The Penn formula was used to determine the left ventricular mass index, 125 g/m(2) in males and 110 g/m2 in females as the cut-off for left ventricular hypertrophy. Using the fasting insulin and fasting glucose levels, the insulin resistance was estimated by the homeostatic model assessment formula. Logistic regression analysis was used to determine the association between left ventricular hypertrophy and insulin resistance. Results: The mean Penn left ventricular mass index was 119.5 (+/- 54.3) and the prevalence of Penn left ventricular mass index left ventricular hypertrophy was 41%. The mean fasting glucose was 5.6 (+/- 2.5) mmol/l, fasting insulin was 6.39 (+/- 5.49) mu U/ml and insulin resistance was 1.58 (+/- 1.45). There was no association between Penn left ventricular mass index left ventricular hypertrophy and log of insulin resistance in univariate (OR = 0.98, 95% CI = 0.80 - 1.19, p = 0.819) and multivariate logistic regression (OR = 0.93, 95% CI = 0.76-1.15, p = 0.516) analysis. Conclusion: No association was found in this study between left ventricular hypertrophy and insulin resistance in Gambians and this does not support the suggestion that insulin is an independent determinant of left ventricular hypertrophy in hypertensives.	[Nkum, Bernard Cudjoe; Micah, Frank Botsi; Ankrah, Theophilus C.] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Med, Kumasi, Ghana; [Nyan, Ousman] Royal Victoria Teaching Hosp, Dept Med, Banjul, Gambia	Kwame Nkrumah University Science & Technology	Nkum, BC (corresponding author), Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Med, Kumasi, Ghana.	bcnkum@yahoo.co.uk			Medical Research Council (MRC), UK	Medical Research Council (MRC), UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Medical Research Council (MRC), UK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agabiti-Rosei E, 2006, J AM SOC NEPHROL, V17, pS104, DOI 10.1681/ASN.2005121336; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; ATTAH EB, 1977, AM HEART J, V94, P189, DOI 10.1016/S0002-8703(77)80279-2; Barud Wojciech, 2004, Ann Univ Mariae Curie Sklodowska Med, V59, P232; COSTA CHRM, 1995, HYPERTENSION, V26, P1085, DOI 10.1161/01.HYP.26.6.1085; DAEMEN MJAP, 1991, CIRC RES, V68, P450, DOI 10.1161/01.RES.68.2.450; Ebinc H, 2006, ACTA CARDIOL, V61, P398, DOI 10.2143/AC.61.4.2017299; *EXP COMM ART HYP, 1962, WHO TECHN REP SER, V231, P28; FERRANNINI E, 1991, DIABETOLOGIA, V34, P416, DOI 10.1007/BF00403180; Galvan AQ, 2000, CIRCULATION, V102, P2233; Grundy SM, 1998, AM J CARDIOL, V81, p18B, DOI 10.1016/S0002-9149(98)00033-2; HAMMOND IW, 1986, J AM COLL CARDIOL, V7, P639, DOI 10.1016/S0735-1097(86)80476-4; Homcy CJ, 1998, CIRCULATION, V97, P1890, DOI 10.1161/01.CIR.97.19.1890; Hsueh WA, 1999, AM J CARDIOL, V84, p21J; Ilercil A, 2002, DIABETES, V51, P1543, DOI 10.2337/diabetes.51.5.1543; ITO H, 1993, CIRCULATION, V87, P1715, DOI 10.1161/01.CIR.87.5.1715; Kahan T, 1998, J HYPERTENS, V16, pS23; LIND L, 1995, J HYPERTENS, V13, P433; Malmqvist K, 2001, J HYPERTENS, V19, P311, DOI 10.1097/00004872-200102000-00019; MAYET J, 1994, BMJ-BRIT MED J, V308, P1011, DOI 10.1136/bmj.308.6935.1011; Nickenig G, 1998, CIRCULATION, V98, P2453, DOI 10.1161/01.CIR.98.22.2453; NKUM BC, 2009, J SCI TECHNOL, V29, P130; Okada K, 2004, HYPERTENS RES, V27, P293, DOI 10.1291/hypres.27.293; Poornima IG, 2006, CIRC RES, V98, P596, DOI 10.1161/01.RES.0000207406.94146.c2; Rheeder P, 1999, AM J CARDIOL, V84, P233, DOI 10.1016/S0002-9149(99)00243-X; ROCCHINI AP, 1989, HYPERTENSION, V14, P367, DOI 10.1161/01.HYP.14.4.367; Ruilope LM, 2008, AM J HYPERTENS, V21, P500, DOI 10.1038/ajh.2008.16; Rutter MK, 2003, CIRCULATION, V107, P448, DOI 10.1161/01.CIR.0000045671.62860.98; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; SASSON Z, 1993, CIRCULATION, V88, P1431, DOI 10.1161/01.CIR.88.4.1431; Scherrer U, 1997, CIRCULATION, V96, P4104; SHARP SD, 1992, CARDIOLOGY, V81, P207, DOI 10.1159/000175806; Sherif K, 2000, AM J MED SCI, V320, P13, DOI 10.1097/00000441-200007000-00003; Top C, 2007, J INT MED RES, V35, P909, DOI 10.1177/147323000703500621; Urbina EM, 1999, AM HEART J, V138, P122, DOI 10.1016/S0002-8703(99)70256-5; Verdecchia P, 1999, CIRCULATION, V100, P1802, DOI 10.1161/01.CIR.100.17.1802; Whaley-Connell A, 2007, AM J PHYSIOL-ENDOC M, V293, pE355, DOI 10.1152/ajpendo.00632.2006	37	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93606	10.1371/journal.pone.0093606	http://dx.doi.org/10.1371/journal.pone.0093606			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705608	Green Published, Green Submitted, gold			2022-12-25	WOS:000334107500048
J	Zallocchi, M; Binley, K; Lad, Y; Ellis, S; Widdowson, P; Iqball, S; Scripps, V; Kelleher, M; Loader, J; Miskin, J; Peng, YW; Wang, WM; Cheung, LD; Delimont, D; Mitrophanous, KA; Cosgrove, D				Zallocchi, Marisa; Binley, Katie; Lad, Yatish; Ellis, Scott; Widdowson, Peter; Iqball, Sharifah; Scripps, Vicky; Kelleher, Michelle; Loader, Julie; Miskin, James; Peng, You-Wei; Wang, Wei-Min; Cheung, Linda; Delimont, Duane; Mitrophanous, Kyriacos A.; Cosgrove, Dominic			EIAV-Based Retinal Gene Therapy in the shaker1 Mouse Model for Usher Syndrome Type 1B: Development of UshStat	PLOS ONE			English	Article							LIGHT-DRIVEN TRANSLOCATION; MYOSIN-VIIA; TRANSDUCIN TRANSLOCATION; INDUCED DEGENERATION; ROD PHOTORECEPTORS; LENTIVIRAL VECTORS; STARGARDT DISEASE; PROTEIN; MUTATIONS; MICE	Usher syndrome type 1B is a combined deaf-blindness condition caused by mutations in the MYO7A gene. Loss of functional myosin VIIa in the retinal pigment epithelia (RPE) and/or photoreceptors leads to blindness. We evaluated the impact of subretinally delivered UshStat, a recombinant EIAV-based lentiviral vector expressing human MYO7A, on photoreceptor function in the shaker1 mouse model for Usher type 1B that lacks a functional Myo7A gene. Subretinal injections of EIAV-CMV-GFP, EIAV-RK-GFP (photoreceptor specific), EIAV-CMV-MYO7A (UshStat) or EIAV-CMV-Null (control) vectors were performed in shaker1 mice. GFP and myosin VIIa expression was evaluated histologically. Photoreceptor function in EIAV-CMV-MYO7A treated eyes was determined by evaluating a-transducin translocation in photoreceptors in response to low light intensity levels, and protection from light induced photoreceptor degeneration was measured. The safety and tolerability of subretinally delivered UshStat was evaluated in macaques. Expression of GFP and myosin VIIa was confirmed in the RPE and photoreceptors in shaker1 mice following subretinal delivery of the EIAV-CMV-GFP/MYO7A vectors. The EIAV-CMV-MYO7A vector protected the shaker1 mouse photoreceptors from acute and chronic intensity light damage, indicated by a significant reduction in photoreceptor cell loss, and restoration of the a-transducin translocation threshold in the photoreceptors. Safety studies in the macaques demonstrated that subretinal delivery of UshStat is safe and well-tolerated. Subretinal delivery of EIAV-CMV-MYO7A (UshStat) rescues photoreceptor phenotypes in the shaker1 mouse. In addition, subretinally delivered UshStat is safe and well-tolerated in macaque safety studies These data support the clinical development of UshStat to treat Usher type 1B syndrome.	[Zallocchi, Marisa; Peng, You-Wei; Wang, Wei-Min; Cheung, Linda; Delimont, Duane; Cosgrove, Dominic] Boys Town Natl Res Hosp, Omaha, NE 68131 USA; [Binley, Katie; Lad, Yatish; Ellis, Scott; Widdowson, Peter; Iqball, Sharifah; Scripps, Vicky; Kelleher, Michelle; Loader, Julie; Miskin, James; Mitrophanous, Kyriacos A.] Oxford BioMed UK Ltd, Oxford, England; [Cosgrove, Dominic] Univ Nebraska Med Ctr, Omaha, NE USA	Boys Town National Research Hospital; Oxford Biomedica (UK) Ltd; University of Nebraska System; University of Nebraska Medical Center	Cosgrove, D (corresponding author), Boys Town Natl Res Hosp, Omaha, NE 68131 USA.	Dominic.cosgrove@boystown.org	Zallocchi, Marisa/HHS-7445-2022		Foundation Fighting Blindness (NNRI) [NNPC-GT-0710-0054-BTNRH-FR]; National Institutes of Health [R01 DC004844, 5 P20 RR018788-08]; NCRR, NIH [5P20RR016469]; NIGMS, NIH [8P20GM103427]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018788, P20RR016469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004844] Funding Source: NIH RePORTER	Foundation Fighting Blindness (NNRI); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from the Foundation Fighting Blindness (NNRI Grant No.: NNPC-GT-0710-0054-BTNRH-FR) and the National Institutes of Health (R01 DC004844 and 5 P20 RR018788-08). Confocal microscopy was conducted at the Integrative Biological Imaging Facility, Creighton University, Omaha, NE (5P20RR016469, NCRR, NIH and 8P20GM103427, NIGMS, NIH). Oxford BioMedica (UK) Ltd provided support in the form of salaries for authors KB, YL, SE, PW, SI, VS, MK, JL, JM and KAM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adato A, 2002, EUR J HUM GENET, V10, P339, DOI 10.1038/sj.ejhg.5200831; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Balaggan KS, 2006, J GENE MED, V8, P275, DOI 10.1002/jgm.845; Binley K, 2013, INVEST OPHTH VIS SCI, V54, P4061, DOI 10.1167/iovs.13-11871; Binley K, 2012, HUM GENE THER, V23, P980, DOI 10.1089/hum.2012.008; Bitner-Glindzicz M, 2000, NAT GENET, V26, P56, DOI 10.1038/79178; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; Bork JM, 2001, AM J HUM GENET, V68, P26, DOI 10.1086/316954; Calvert PD, 2006, TRENDS CELL BIOL, V16, P560, DOI 10.1016/j.tcb.2006.09.001; Colella P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072027; Eudy JD, 1998, SCIENCE, V280, P1753, DOI 10.1126/science.280.5370.1753; Fields RR, 2002, AM J HUM GENET, V71, P607, DOI 10.1086/342098; Gibbs D, 2004, J CELL SCI, V117, P6473, DOI 10.1242/jcs.01580; Gibbs D, 2009, INVEST OPHTH VIS SCI, V50, P4386, DOI 10.1167/iovs.09-3471; Gruter O, 2005, GENE THER, V12, P942, DOI 10.1038/sj.gt.3302485; Hashimoto T, 2007, GENE THER, V14, P584, DOI 10.1038/sj.gt.3302897; Hasson T, 1997, CELL MOTIL CYTOSKEL, V37, P127, DOI 10.1002/(SICI)1097-0169(1997)37:2<127::AID-CM5>3.0.CO;2-5; Kerov V, 2005, J BIOL CHEM, V280, P41069, DOI 10.1074/jbc.M508849200; Kong J, 2008, GENE THER, V15, P1311, DOI 10.1038/gt.2008.78; Kong L, 2006, NEUROBIOL DIS, V21, P468, DOI 10.1016/j.nbd.2005.08.017; Kostic C, 2003, GENE THER, V10, P818, DOI 10.1038/sj.gt.3301948; Libby RT, 2001, INVEST OPHTH VIS SCI, V42, P770; Lillo C, 2003, ADV EXP MED BIOL, V533, P143; Liu XR, 1999, J NEUROSCI, V19, P6267; Lopes VS, 2013, GENE THER, V20, P824, DOI 10.1038/gt.2013.3; Lopes VS, 2011, HUM MOL GENET, V20, P2560, DOI 10.1093/hmg/ddr155; Peng YW, 2008, INVEST OPHTH VIS SCI, V49, P4647, DOI 10.1167/iovs.08-2011; Peng YW, 2011, INVEST OPHTH VIS SCI, V52, P6421, DOI 10.1167/iovs.10-6557; Redmond TM, 2007, MOL VIS, V13, P1813; Reiners J, 2005, MOL VIS, V11, P347; Riazuddin S, 2012, NAT GENETICS ONLINE, P1; Schwander M, 2009, J NEUROSCI, V29, P15810, DOI 10.1523/JNEUROSCI.4876-09.2009; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; Soni LE, 2005, CELL MOTIL CYTOSKEL, V62, P13, DOI 10.1002/cm.20080; Stewart HJ, 2009, GENE THER, V16, P805, DOI 10.1038/gt.2009.20; Tian M, 2014, EXP EYE RES, V118, P145, DOI 10.1016/j.exer.2013.10.021; Trapani I, 2013, EMBO MOL MED, P1; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Williams DS, 2012, ADV EXP MED BIOL, V723, P235, DOI 10.1007/978-1-4614-0631-0_31; Williams DS, 2011, BIOCHEM SOC T, V39, P1207, DOI 10.1042/BST0391207	43	68	73	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94272	10.1371/journal.pone.0094272	http://dx.doi.org/10.1371/journal.pone.0094272			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705452	gold, Green Published, Green Submitted			2022-12-25	WOS:000334107500138
J	Gawlak, G; Tian, YF; O'Donnell, JJ; Tian, XY; Birukova, AA; Birukov, KG				Gawlak, Grzegorz; Tian, Yufeng; O'Donnell, James J., III; Tian, Xinyong; Birukova, Anna A.; Birukov, Konstantin G.			Paxillin mediates stretch-induced Rho signaling and endothelial permeability via assembly of paxillin-p42/44MAPK-GEF-H1 complex	FASEB JOURNAL			English	Article						mechanotransduction; focal adhesions; cytoskeleton; guanine nucleotide exchange factors	FOCAL ADHESION KINASE; INDUCED LUNG INJURY; TGF-BETA ACTIVATION; CYCLIC STRETCH; SHEAR-STRESS; OXIDIZED PHOSPHOLIPIDS; CELL-ADHESION; FAK PHOSPHORYLATION; MECHANICAL STRETCH; BARRIER FUNCTION	Suboptimal ventilator support or regional ventilation heterogeneity in inflamed lungs causes excessive tissue distension, which triggers stretch-induced pathological signaling and may lead to vascular leak and lung dysfunction. Focal adhesions (FAs) are cell-substrate adhesive complexes participating in cellular mechanotransduction and regulation of the Rho GTPase pathway. Stretch-induced Rho regulation remains poorly understood. We used human lung endothelial cells (ECs) exposed to pathological cyclic stretch (CS) at 18% distension to test the hypothesis that FA protein paxillin participates in CS-induced Rho activation by recruiting the Rho-specific guanine nucleotide exchange factor GEF-H1. CS induced phosphorylation of paxillin and activated p42/44-MAP kinase, Rho GTPase, and paxillin/GEF-H1/p42/44-MAPK association. CS caused nearly 2-fold increase in EC permeability, which was attenuated by paxillin knockdown. Expression of the paxillin-Y31/118F phosphorylation mutant decreased the CS-induced paxillin/GEF-H1 association (16.3 +/- 4.1%), GEF-H1 activation (28.9 +/- 9.2%), and EC permeability (28.7 +/- 8.1%) but not CS-induced p42/44-MAPK activation. Inhibition of p42/44-MAPK suppressed CS-induced paxillin/GEF-H1 interactions (15.9 +/- 7.9%), GEF-H1 activation (11.7 +/- 4.3%), and disruption of EC monolayer. Expression of GEF-H1T678A lacking p42/44-MAPK phosphorylation site attenuated Rho activation (31.2 +/- 11.6%). We conclude that MAPK-dependent targeting of GEF-H1 to paxillin is involved in the regulation of CS-induced Rho signaling and EC permeability. This study proposes a novel concept of paxillin-GEF-H1-p42/44-MAPK module as a regulator of pathological mechanotransduction.	[Gawlak, Grzegorz; Tian, Yufeng; O'Donnell, James J., III; Tian, Xinyong; Birukova, Anna A.; Birukov, Konstantin G.] Univ Chicago, Dept Med, Lung Injury Ctr, Chicago, IL 60637 USA	University of Chicago	Birukov, KG (corresponding author), Univ Chicago, Dept Med, Lung Injury Ctr, Sect Pulm & Crit Med, 5841 S Maryland Ave,MC 6026, Chicago, IL 60637 USA.	kbirukov@medicine.bsd.uchicago.edu	Birukov, Konstantin/FJB-5755-2022		National Heart, Lung, and Blood Institute, U.S. National Institutes of Health [HL-76259, HL1-07920]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107920, R01HL076259, R01HL089257, R56HL107920] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank C. Turner (State University of New York, Syracuse, NY, USA) for providing paxillin constructs; G. Bokoch (Scripps, La Jolla, CA, USA) and K. Szaszi (St. Michael's Hospital, Toronto, ON, Canada) for providing GEF-H1 constructs and RhoA(G17A) mutant. This work was supported by Public Health Service grants HL-76259 and HL1-07920 from the National Heart, Lung, and Blood Institute, U.S. National Institutes of Health.	Abdulnour REE, 2006, AM J PHYSIOL-LUNG C, V291, pL345, DOI 10.1152/ajplung.00453.2005; Aijaz S, 2005, DEV CELL, V8, P777, DOI 10.1016/j.devcel.2005.03.003; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Birukov KG, 2003, AM J PHYSIOL-LUNG C, V285, pL785, DOI 10.1152/ajplung.00336.2002; Birukov KG, 2002, AM J RESP CELL MOL, V26, P453, DOI 10.1165/ajrcmb.26.4.4725; Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007; Birukova AA, 2006, AM J PATHOL, V168, P1749, DOI 10.2353/ajpath.2006.050431; Birukova AA, 2007, AM J PHYSIOL-LUNG C, V293, pL199, DOI 10.1152/ajplung.00020.2007; Birukova AA, 2011, EXP CELL RES, V317, P859, DOI 10.1016/j.yexcr.2010.11.011; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V299, pL652, DOI 10.1152/ajplung.00202.2009; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Chen KD, 1999, J BIOL CHEM, V274, P18393, DOI 10.1074/jbc.274.26.18393; Desai LP, 2007, AM J PHYSIOL-LUNG C, V293, pL769, DOI 10.1152/ajplung.00127.2007; DiPaolo BC, 2012, AM J PHYSIOL-LUNG C, V302, pL992, DOI 10.1152/ajplung.00175.2011; Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Guilluy C, 2011, NAT CELL BIOL, V13, P722, DOI 10.1038/ncb2254; Hammerschmidt S, 2004, AM J RESP CELL MOL, V30, P396, DOI 10.1165/rcmb.2003-0136OC; Heck JN, 2012, MOL BIOL CELL, V23, P2583, DOI 10.1091/mbc.E11-10-0876; Holinstat M, 2006, J BIOL CHEM, V281, P2296, DOI 10.1074/jbc.M511248200; Ikeda M, 1999, BIOCHEM BIOPH RES CO, V257, P668, DOI 10.1006/bbrc.1999.0532; Ingram AJ, 2000, KIDNEY INT, V58, P1431, DOI 10.1046/j.1523-1755.2000.00305.x; Jafari B., 2004, GENE, V363, P166; Jenkins RG, 2006, J CLIN INVEST, V116, P1606, DOI 10.1172/JCI27183; Kakiashvili E, 2009, J BIOL CHEM, V284, P11454, DOI 10.1074/jbc.M805933200; Kano Y, 2000, CIRC RES, V86, P425, DOI 10.1161/01.RES.86.4.425; Kito H, 2000, J APPL PHYSIOL, V89, P2391, DOI 10.1152/jappl.2000.89.6.2391; Liu MY, 1996, J BIOL CHEM, V271, P7066, DOI 10.1074/jbc.271.12.7066; Ly DL, 2013, AM J PHYSIOL-CELL PH, V304, pC115, DOI 10.1152/ajpcell.00290.2012; Matthay MA, 2003, AM J RESP CRIT CARE, V167, P1027, DOI 10.1164/rccm.200208-966WS; Mehta D, 2002, J PHYSIOL-LONDON, V539, P779, DOI 10.1113/jphysiol.2001.013289; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Naruse K, 1998, ONCOGENE, V17, P455, DOI 10.1038/sj.onc.1201950; Naruse K, 1998, FEBS LETT, V441, P111, DOI 10.1016/S0014-5793(98)01528-2; Nonas S, 2008, CRIT CARE, V12, DOI 10.1186/cc6805; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Parsons JT, 2000, ONCOGENE, V19, P5606, DOI 10.1038/sj.onc.1203877; Pimentel DR, 2001, CIRC RES, V89, P453, DOI 10.1161/hh1701.096615; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Sanchez-Esteban J, 2002, AM J PHYSIOL-LUNG C, V282, pL448, DOI 10.1152/ajplung.00399.2000; Schaller MD, 2001, ONCOGENE, V20, P6459, DOI 10.1038/sj.onc.1204786; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005; Shikata Y, 2005, EXP CELL RES, V304, P40, DOI 10.1016/j.yexcr.2004.11.001; Shikata Y, 2003, FASEB J, V17, P2240, DOI 10.1096/fj.03-0198com; Singleton PA, 2007, AM J RESP CELL MOL, V37, P222, DOI 10.1165/rcmb.2006-0327OC; Smith PG, 1998, EXP CELL RES, V239, P353, DOI 10.1006/excr.1997.3905; Su X, 2006, AM J PHYSIOL-LUNG C, V290, pL769, DOI 10.1152/ajplung.00334.2005; Tschumperlin DJ, 1999, J APPL PHYSIOL, V86, P2026, DOI 10.1152/jappl.1999.86.6.2026; Uhlig S, 2002, AM J PHYSIOL-LUNG C, V282, pL892, DOI 10.1152/ajplung.00124.2001; Waheed F, 2013, MOL BIOL CELL, V24, P1068, DOI 10.1091/mbc.E12-09-0661; Xu MY, 2009, AM J PATHOL, V174, P1264, DOI 10.2353/ajpath.2009.080160	55	25	27	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					3249	3260		10.1096/fj.13-245142	http://dx.doi.org/10.1096/fj.13-245142			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24706358	Green Published			2022-12-25	WOS:000337949400044
J	Hoffman, L; Chandrasekar, A; Wang, X; Putkey, JA; Waxham, MN				Hoffman, Laurel; Chandrasekar, Anuja; Wang, Xu; Putkey, John A.; Waxham, M. Neal			Neurogranin Alters the Structure and Calcium Binding Properties of Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-ENCODING NEUROGRANIN; C PHOSPHORYLATION SITE; IQ-MOTIF PROTEINS; CA2+ BINDING; TERMINAL DOMAIN; MESSENGER-RNA; KINASE; RC3/NEUROGRANIN; DYNAMICS; NEUROMODULIN	Neurogranin (Ng) is a member of the IQ motif class of calmodulin (CaM)-binding proteins, and interactions with CaM are its only known biological function. In this report we demonstrate that the binding affinity of Ng for CaM is weakened by Ca2+ but to a lesser extent (2-3-fold) than that previously suggested from qualitative observations. We also show that Ng induced a > 10-fold decrease in the affinity of Ca2+ binding to the C-terminal domain of CaM with an associated increase in the Ca2+ dissociation rate. We also discovered a modest, but potentially important, increase in the cooperativity in Ca2+ binding to the C-lobe of CaM in the presence of Ng, thus sharpening the threshold for the C-domain to become Ca2+-saturated. Domain mapping using synthetic peptides indicated that the IQ motif of Ng is a poor mimetic of the intact protein and that the acidic sequence just N-terminal to the IQ motif plays an important role in reproducing Ng-mediated decreases in the Ca2+ binding affinity of CaM. Using NMR, full-length Ng was shown to make contacts largely with residues in the C-domain of CaM, although contacts were also detected in residues in the N-terminal domain. Together, our results can be consolidated into a model where Ng contacts residues in the N- and C-lobes of both apo- and Ca2+-bound CaM and that although Ca2+ binding weakens Ng interactions with CaM, the most dramatic biochemical effect is the impact of Ng on Ca2+ binding to the C-terminal lobe of CaM.	[Hoffman, Laurel; Chandrasekar, Anuja; Waxham, M. Neal] Univ Texas Med Sch Houston, Dept Neurobiol & Anat, Houston, TX 77030 USA; [Wang, Xu; Putkey, John A.] Univ Texas Med Sch Houston, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Waxham, MN (corresponding author), Rm 7-254 Med Sch Bldg,6431 Fannin St, Houston, TX 77030 USA.	m.n.waxham@uth.tmc.edu		Wang, Xu/0000-0002-8266-098X; Waxham, M. Neal/0000-0003-4801-1190	National Institutes of Health [GM097553, GM104290]; UT Graduate Initiative in Theoretical and Computational Neuroscience; William Wheless III professorship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097553, R01GM104290] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UT Graduate Initiative in Theoretical and Computational Neuroscience; William Wheless III professorship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM097553 (NIGMS; to M. N. W.) and GM104290 (NIGMS; to M. N. W. and J. A. P.).; Supported by the UT Graduate Initiative in Theoretical and Computational Neuroscience. Present address: Cytokinetics, 280 East Grand Ave., South San Francisco, CA 94080.; Supported by the William Wheless III professorship. To whom correspondence should be addressed: Rm. 7.254 Medical School Bldg., 6431 Fannin St., Houston TX, 77030. Tel.: 713-500-5621; Fax: 713-500-0621; E-mail: m.n.waxham@uth.tmc.edu.	ALEXANDER KA, 1987, J BIOL CHEM, V262, P6108; ANDREASEN TJ, 1983, BIOCHEMISTRY-US, V22, P4615, DOI 10.1021/bi00289a001; APEL ED, 1990, BIOCHEMISTRY-US, V29, P2330, DOI 10.1021/bi00461a017; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; BASI GS, 1987, CELL, V49, P785, DOI 10.1016/0092-8674(87)90616-7; BAUDIER J, 1991, J BIOL CHEM, V266, P229; BIBER A, 1984, EXP BRAIN RES, V56, P323; Broadbelt K, 2006, SCHIZOPHR RES, V87, P6, DOI 10.1016/j.schres.2006.04.028; Chang JW, 1997, J NEUROPATH EXP NEUR, V56, P1105, DOI 10.1097/00005072-199710000-00004; CHAPMAN ER, 1991, J BIOL CHEM, V266, P207; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Coldren CD, 2009, NEUROGENETICS, V10, P89, DOI 10.1007/s10048-008-0157-x; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Cui YF, 2003, ANAL BIOCHEM, V315, P175, DOI 10.1016/S0003-2697(03)00007-1; Dominguez-Gonzalez I, 2007, BIOCHEM J, V404, P31, DOI 10.1042/BJ20061483; Ehrhardt MR, 1996, BIOCHEMISTRY-US, V35, P1599, DOI 10.1021/bi951267r; Evenas J, 2001, STRUCTURE, V9, P185, DOI 10.1016/S0969-2126(01)00575-5; Evenas J, 1999, J MOL BIOL, V289, P603, DOI 10.1006/jmbi.1999.2770; Faas GC, 2011, NAT NEUROSCI, V14, P301, DOI 10.1038/nn.2746; Gaertner TR, 2004, J BIOL CHEM, V279, P39374, DOI 10.1074/jbc.M405352200; George AJ, 2010, NEUROTOX RES, V17, P360, DOI 10.1007/s12640-009-9112-3; Gerendasy D, 1999, J NEUROSCI RES, V58, P107, DOI 10.1002/(SICI)1097-4547(19991001)58:1<107::AID-JNR11>3.0.CO;2-G; GERENDASY DD, 1994, J BIOL CHEM, V269, P22420; GERENDASY DD, 1995, J BIOL CHEM, V270, P6741, DOI 10.1074/jbc.270.12.6741; Gerendasy DD, 1997, MOL NEUROBIOL, V15, P131, DOI 10.1007/BF02740632; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; Gifford JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051026; Hoffman L, 2013, BIOCHEMISTRY-US, V52, P1198, DOI 10.1021/bi3016586; HUANG KP, 1993, ARCH BIOCHEM BIOPHYS, V305, P570, DOI 10.1006/abbi.1993.1463; Johnson JD, 1996, J BIOL CHEM, V271, P761, DOI 10.1074/jbc.271.2.761; KAKIUCHI S, 1982, J BIOCHEM-TOKYO, V92, P1041, DOI 10.1093/oxfordjournals.jbchem.a134019; KLEE CB, 1982, ADV PROTEIN CHEM, V35, P213, DOI 10.1016/S0065-3233(08)60470-2; Kleerekoper QK, 2009, J BIOL CHEM, V284, P7455, DOI 10.1074/jbc.M808067200; Kubota Y, 2008, J NEUROPHYSIOL, V99, P264, DOI 10.1152/jn.00876.2007; Kubota Y, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000987; Kumar V, 2013, SCI REP-UK, V3, DOI 10.1038/srep01392; LINSE S, 1991, J BIOL CHEM, V266, P8050; Malmendal A, 1999, J MOL BIOL, V293, P883, DOI 10.1006/jmbi.1999.3188; NeunerJehle M, 1996, BRAIN RES, V733, P149, DOI 10.1016/0006-8993(96)00786-X; OLWIN BB, 1985, BIOCHEMISTRY-US, V24, P8081, DOI 10.1021/bi00348a037; Peersen OB, 1997, PROTEIN SCI, V6, P794; Pohlack ST, 2011, MOL PSYCHIATR, V16, P1072, DOI 10.1038/mp.2011.66; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Putkey JA, 2003, J BIOL CHEM, V278, P49667, DOI 10.1074/jbc.C300372200; Putkey JA, 2008, J BIOL CHEM, V283, P1401, DOI 10.1074/jbc.M703831200; Ruano D, 2008, J PSYCHIATR RES, V42, P125, DOI 10.1016/j.jpsychires.2006.10.008; SANGAMESWARAN L, 1989, P NATL ACAD SCI USA, V86, P5651, DOI 10.1073/pnas.86.14.5651; SANGAMESWARAN L, 1993, MOL BRAIN RES, V19, P62, DOI 10.1016/0169-328X(93)90149-J; Shen YC, 2012, SCHIZOPHR RES, V137, P7, DOI 10.1016/j.schres.2012.01.011; Sorensen BR, 1998, BIOCHEMISTRY-US, V37, P4244, DOI 10.1021/bi9718200; Sorensen BR, 2002, BIOCHEMISTRY-US, V41, P15, DOI 10.1021/bi011718+; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Theoharis NT, 2008, BIOCHEMISTRY-US, V47, P112, DOI 10.1021/bi7013129; Tidow H, 2013, FEBS J, V280, P5551, DOI 10.1111/febs.12296; Wang X, 2013, J BIOL CHEM, V288, P2040, DOI 10.1074/jbc.M112.411314; Wang X, 2010, BIOCHEMISTRY-US, V49, P10287, DOI 10.1021/bi100500m; WATSON JB, 1990, J NEUROSCI RES, V26, P397, DOI 10.1002/jnr.490260402; Wu JF, 2003, J NEUROCHEM, V86, P1524, DOI 10.1046/j.1471-4159.2003.01963.x; Xiong LW, 2010, J BIOL CHEM, V285, P8094, DOI 10.1074/jbc.M109.065243; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; YAZAWA M, 1987, J BIOL CHEM, V262, P10951; Zhang MJ, 1998, BIOCHEM CELL BIOL, V76, P313, DOI 10.1139/bcb-76-2-3-313; Zhong L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041275; ZIAI R, 1986, P NATL ACAD SCI USA, V83, P8420, DOI 10.1073/pnas.83.21.8420	65	40	42	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14644	14655		10.1074/jbc.M114.560656	http://dx.doi.org/10.1074/jbc.M114.560656			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24713697	hybrid, Green Published			2022-12-25	WOS:000337248100021
J	Geist, MM; Pan, XY; Bender, S; Bartenschlager, R; Nickel, W; Fackler, OT				Geist, Miriam M.; Pan, Xiaoyu; Bender, Silke; Bartenschlager, Ralf; Nickel, Walter; Fackler, Oliver T.			Heterologous Src Homology 4 Domains Support Membrane Anchoring and Biological Activity of HIV-1 Nef	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Host-Pathogen Interactions; Human Immunodeficiency Virus; Membrane Trafficking; Plasma Membrane; Viral Protein; Nef; SH4 Domain	VIRUS TYPE-1 NEF; CD4 DOWN-REGULATION; T-CELL-ACTIVATION; PLASMA-MEMBRANE; VIRAL INFECTIVITY; VIRION INCORPORATION; SURFACE EXPRESSION; DILEUCINE MOTIF; PROTEIN COMPLEX; IN-VITRO	Background: HIV-1 Nef is a membrane-associated protein that acts as viral pathogenicity factor. Results: Nef function requires regulated membrane interactions along transport pathways to and from the plasma membrane. Conclusion: Nef function is determined by dynamic anterograde and endocytic transport cycles. Significance: Dynamic transport cycles provide the basis for the multifunctionality of Nef. The HIV-1 pathogenicity factor Nef enhances viral replication by modulation of multiple host cell transport and signaling pathways. Nef associates with membranes via an N-terminal Src homology 4 (SH4) domain, and membrane association is believed to be essential for its biological functions. At which subcellular site(s) Nef exerts its different functions and how kinetics of membrane interactions contribute to its biological activity are unknown. To address how specific characteristics of Nef membrane association affect its biological properties, the SH4 domain of Nef was replaced by heterologous membrane targeting domains. The use of a panel of heterologous SH4 domains resulted in chimeric Nef proteins with distinct steady state subcellular localization, membrane association efficiency, and anterograde transport routes. Irrespective of these modifications, cardinal Nef functions affecting host cell vesicular transport and actin dynamics were fully preserved. In contrast, stable targeting of Nef to the surface of mitochondria, peroxisomes, or the Golgi apparatus, and thus prevention of plasma membrane delivery, caused potent and broad loss of Nef activity. These results support the concept that Nef adopts its active conformation in the membrane-associated state but exclude that membrane-associated Nef simply acts by recruiting soluble factors independently of its local microenvironment. Rather than its steady state subcellular localization or membrane affinity, the ability to undergo dynamic anterograde and internalization cycles appear to determine Nef function. These results reveal that functional membrane interactions of Nef underlie critical spatiotemporal regulation and suggest that delivery to distinct subcellular sites via such transport cycles provides the basis for the multifunctionality of Nef.	[Geist, Miriam M.; Pan, Xiaoyu; Bender, Silke; Bartenschlager, Ralf; Fackler, Oliver T.] Univ Heidelberg Hosp, Dept Infect Dis, D-69120 Heidelberg, Germany; [Nickel, Walter] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Fackler, OT (corresponding author), Univ Heidelberg Hosp, Dept Infect Dis, Neuenheimer Feld 324, D-69120 Heidelberg, Germany.	oliver.fackler@med.uni-heidelberg.de	; Bartenschlager, Ralf/L-2582-2015	Fackler, Oliver Till/0000-0003-2982-4209; Bartenschlager, Ralf/0000-0001-5601-9307	Deutsche Forschungsgemeinschaft [TRR83]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft TRR83 projects 5 (to W. N.), 13 (to R. B.), and 15 (to O. T. F.).	Abraham L, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-39; Abraham L, 2012, J IMMUNOL, V189, P1898, DOI 10.4049/jimmunol.1200652; AIKEN C, 1994, CELL, V76, P853, DOI 10.1016/0092-8674(94)90360-3; AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; Akari H, 2000, J VIROL, V74, P2907, DOI 10.1128/JVI.74.6.2907-2912.2000; Akgun B, 2013, STRUCTURE, V21, P1822, DOI 10.1016/j.str.2013.08.008; Aldrovandi GM, 1998, J VIROL, V72, P7032, DOI 10.1128/JVI.72.9.7032-7039.1998; Alexander M, 2004, J VIROL, V78, P1685, DOI 10.1128/JVI.78.4.1685-1696.2004; Arhel N, 2009, J CLIN INVEST, V119, P2965, DOI 10.1172/JCI38994; Arold ST, 2001, TRENDS BIOCHEM SCI, V26, P356, DOI 10.1016/S0968-0004(01)01846-1; Baur AS, 1997, IMMUNITY, V6, P283, DOI 10.1016/S1074-7613(00)80331-3; BAUR AS, 1994, IMMUNITY, V1, P373, DOI 10.1016/1074-7613(94)90068-X; Bentham M, 2006, J GEN VIROL, V87, P563, DOI 10.1099/vir.0.81200-0; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Bresnahan PA, 1998, CURR BIOL, V8, P1235, DOI 10.1016/S0960-9822(07)00517-9; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Coates K, 1997, J BIOL CHEM, V272, P12289, DOI 10.1074/jbc.272.19.12289; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Fackler OT, 2006, VIROLOGY, V351, P322, DOI 10.1016/j.virol.2006.03.044; Fackler OT, 1999, MOL CELL, V3, P729, DOI 10.1016/S1097-2765(01)80005-8; FRANCHINI G, 1986, VIROLOGY, V155, P593, DOI 10.1016/0042-6822(86)90219-9; Fransen M, 2001, MOL CELL BIOL, V21, P4413, DOI 10.1128/MCB.21.13.4413-4424.2001; GARCIA JV, 1991, NATURE, V350, P508, DOI 10.1038/350508a0; Gerlach H, 2010, NAT CHEM BIOL, V6, P46, DOI [10.1038/NCHEMBIO.268, 10.1038/nchembio.268]; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Giese SI, 2006, VIROLOGY, V355, P175, DOI 10.1016/j.virol.2006.07.003; GOLDSMITH MA, 1995, J VIROL, V69, P4112, DOI 10.1128/JVI.69.7.4112-4121.1995; Greenberg ME, 1997, EMBO J, V16, P6964, DOI 10.1093/emboj/16.23.6964; GUY B, 1987, NATURE, V330, P266, DOI 10.1038/330266a0; Haller C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001212; Haller C, 2006, J BIOL CHEM, V281, P19618, DOI 10.1074/jbc.M513802200; Hanna Z, 1998, CELL, V95, P163, DOI 10.1016/S0092-8674(00)81748-1; Jia XF, 2012, NAT STRUCT MOL BIOL, V19, P701, DOI 10.1038/nsmb.2328; KAMINCHIK J, 1994, AIDS RES HUM RETROV, V10, P1003, DOI 10.1089/aid.1994.10.1003; KAMINCHIK J, 1991, J VIROL, V65, P583, DOI 10.1128/JVI.65.2.583-588.1991; Kasahara K, 2004, J CELL BIOL, V165, P641, DOI 10.1083/jcb.200403011; Kasahara K, 2007, EXP CELL RES, V313, P2651, DOI 10.1016/j.yexcr.2007.05.001; Keppler OT, 2006, J LEUKOCYTE BIOL, V79, P616, DOI 10.1189/jlb.0805461; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; KIRCHHOFF F, 1995, NEW ENGL J MED, V332, P228, DOI 10.1056/NEJM199501263320405; Krautkramer E, 2004, J VIROL, V78, P4085, DOI 10.1128/JVI.78.8.4085-4097.2004; Laguette N, 2009, J VIROL, V83, P7117, DOI 10.1128/JVI.01648-08; Lama J, 1999, CURR BIOL, V9, P622, DOI 10.1016/S0960-9822(99)80284-X; Madrid R, 2005, J BIOL CHEM, V280, P5032, DOI 10.1074/jbc.M401202200; Mangasarian A, 1997, IMMUNITY, V6, P67, DOI 10.1016/S1074-7613(00)80243-5; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; Morgan CR, 2011, BIOCHEMISTRY-US, V50, P3394, DOI 10.1021/bi200197e; Mossalam M, 2012, MOL PHARMACEUT, V9, P1449, DOI 10.1021/mp3000259; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; Noviello CM, 2008, J VIROL, V82, P1249, DOI 10.1128/JVI.00660-07; Pan XY, 2013, CELL MICROBIOL, V15, P1605, DOI 10.1111/cmi.12148; Pan XY, 2012, BLOOD, V119, P786, DOI 10.1182/blood-2011-08-373209; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; Peng B, 2001, IMMUNOL LETT, V78, P195, DOI 10.1016/S0165-2478(01)00250-4; Pevzner I, 2012, TRAFFIC, V13, P849, DOI 10.1111/j.1600-0854.2012.01349.x; Rahim MMA, 2009, J VIROL, V83, P11830, DOI 10.1128/JVI.01466-09; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Ritzerfeld J, 2011, GENOME RES, V21, P1955, DOI 10.1101/gr.116087.110; Rudolph JM, 2009, J VIROL, V83, P11528, DOI 10.1128/JVI.01423-09; Sato I, 2009, J CELL SCI, V122, P965, DOI 10.1242/jcs.034843; SAWAI ET, 1995, J BIOL CHEM, V270, P15307, DOI 10.1074/jbc.270.25.15307; Schindler M, 2006, CELL, V125, P1055, DOI 10.1016/j.cell.2006.04.033; Schmidt S, 2011, MBIO, V2, DOI 10.1128/mBio.00036-11; Schrager JA, 1999, P NATL ACAD SCI USA, V96, P8167, DOI 10.1073/pnas.96.14.8167; SCHWARTZ O, 1995, J VIROL, V69, P4053, DOI 10.1128/JVI.69.7.4053-4059.1995; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Sol-Foulon N, 2004, J BIOL CHEM, V279, P31398, DOI 10.1074/jbc.M401621200; Stolp B, 2012, P NATL ACAD SCI USA, V109, P18541, DOI 10.1073/pnas.1204322109; Stolp B, 2010, J VIROL, V84, P3935, DOI 10.1128/JVI.02467-09; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Suzuki H, 2002, J CELL SCI, V115, P1895; Thoulouze MI, 2006, IMMUNITY, V24, P547, DOI 10.1016/j.immuni.2006.02.016; Tokarev Andrey, 2011, Cell Logist, V1, P90; Tournaviti S, 2009, TRAFFIC, V10, P1047, DOI 10.1111/j.1600-0854.2009.00921.x; vantHof W, 1997, J CELL BIOL, V136, P1023, DOI 10.1083/jcb.136.5.1023; Welker R, 1998, J VIROL, V72, P8833, DOI 10.1128/JVI.72.11.8833-8840.1998; Witte V, 2008, J IMMUNOL, V181, P8425, DOI 10.4049/jimmunol.181.12.8425; Wolf D, 2008, CELL HOST MICROBE, V4, P398, DOI 10.1016/j.chom.2008.08.013; Wonderlich ER, 2008, J BIOL CHEM, V283, P3011, DOI 10.1074/jbc.M707760200; Xu XN, 1999, J EXP MED, V189, P1489, DOI 10.1084/jem.189.9.1489; ZAZOPOULOS E, 1992, P NATL ACAD SCI USA, V89, P6634, DOI 10.1073/pnas.89.14.6634	84	9	9	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14030	14044		10.1074/jbc.M114.563528	http://dx.doi.org/10.1074/jbc.M114.563528			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24706755	Green Published, hybrid			2022-12-25	WOS:000335984600033
J	Crompton, MJ; Dunstan, RH; Macdonald, MM; Gottfries, J; von Eiff, C; Roberts, TK				Crompton, Marcus J.; Dunstan, R. Hugh; Macdonald, Margaret M.; Gottfries, Johan; von Eiff, Christof; Roberts, Timothy K.			Small Changes in Environmental Parameters Lead to Alterations in Antibiotic Resistance, Cell Morphology and Membrane Fatty Acid Composition in Staphyloccus lugdunensis	PLOS ONE			English	Article							SMALL COLONY VARIANTS; LIPID-COMPOSITION; SUSCEPTIBILITY; BIOSYNTHESIS; TEMPERATURE; BACTERIA; SKIN	Staphylococcus lugdunensis has emerged as a major cause of community-acquired and nosocomial infections. This bacterium can rapidly adapt to changing environmental conditions to survive and capitalize on opportunities to colonize and infect through wound surfaces. It was proposed that S. lugdunensis would have underlying alterations in metabolic homeostasis to provide the necessary levels of adaptive protection. The aims of this project were to examine the impacts of subtle variations in environmental conditions on growth characteristics, cell size and membrane fatty acid composition in S. lugdunensis. Liquid broth cultures of S. lugdunensis were grown under varying combinations of pH (6-8), temperature (35-39(circle)C) and osmotic pressure (0-5% sodium chloride w/w) to reflect potential ranges of conditions encountered during transition from skin surfaces to invasion of wound sites. The cells were harvested at the mid-exponential phase of growth and assessed for antibiotic minimal inhibitory concentration (MIC), generation time, formation of small colony variants, cell size (by scanning electron microscopy) and membrane fatty acid composition. Stress regimes with elevated NaCl concentrations resulted in significantly higher antibiotic resistance (MIC) and three of the combinations with 5% NaCl had increased generation times (P < 0.05). It was found that all ten experimental growth regimes, including the control and centroid cultures, yielded significantly different profiles of plasma membrane fatty acid composition (P < 0.0001). Alterations in cell size (P < 0.01) were also observed under the range of conditions with the most substantial reduction occurring when cells were grown at 39(circle)C, pH 8 (514652 nm, mean 6 Standard Deviation) compared with cells grown under control conditions at 37(circle)C with pH 7 (702676 nm, P < 0.01). It was concluded that S. lugdunensis responded to slight changes in environmental conditions by altering plasma membrane fatty acid composition, growth rates and morphology to achieve optimal adaptations for survival in changing environments.	[Gottfries, Johan] Gothenburg Univ, Dept Chem, Gothenburg, Sweden; [von Eiff, Christof] Univ Munster, Inst Med Microbiol, D-48149 Munster, Germany; [Crompton, Marcus J.; Dunstan, R. Hugh; Macdonald, Margaret M.; Roberts, Timothy K.] Univ Newcastle, Sch Environm & Life Sci, Metab Res Grp, Callaghan, NSW 2308, Australia	University of Gothenburg; University of Munster; University of Newcastle	Dunstan, RH (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Metab Res Grp, Callaghan, NSW 2308, Australia.	hugh.dunstan@newcastle.edu.au	Roberts, Tim K/A-4286-2009; Gottfries, Johan/M-3445-2016	Gottfries, Johan/0000-0001-7135-4664	University of Newcastle; Harold Stannet Williams and Judith Mason research grant	University of Newcastle; Harold Stannet Williams and Judith Mason research grant	This work was supported by University of Newcastle funds for post-graduate research as well as the Harold Stannet Williams and Judith Mason research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.anz.com.au/resources/2/f/2fce2b804a47773887c8cfac93b0266b/MasonNatMedGuidelines.pdf?CACHEID = 2fce2b804a47773887c8cfac93b0266b The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, COMPR REV FOOD SCI F, V5, P71; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Baumert N, 2002, MICROB DRUG RESIST, V8, P253, DOI 10.1089/10766290260469507; Behme RJ, 1996, J CLIN MICROBIOL, V34, P3075, DOI 10.1128/JCM.34.12.3075-3084.1996; Bellamy R, 2002, CLIN INFECT DIS, V35, pE32, DOI 10.1086/341304; Bower CK, 1999, INT J FOOD MICROBIOL, V50, P33, DOI 10.1016/S0168-1605(99)00075-6; Brown GK, 2001, AUST VET J, V79, P554, DOI 10.1111/j.1751-0813.2001.tb10747.x; Butt HL, 1998, J MED MICROBIOL, V47, P577, DOI 10.1099/00222615-47-7-577; Casey AL, 2007, INT J ANTIMICROB AG, V29, pS23, DOI 10.1016/S0924-8579(07)72175-1; Celeste CJ, 2013, VET SURG, V42, P147, DOI 10.1111/j.1532-950X.2012.00966.x; Dowhan W, 2004, BBA-BIOMEMBRANES, V1666, P19, DOI 10.1016/j.bbamem.2004.04.010; Frank K. L., 2008, Clinical Microbiology Newsletter, V30, P55, DOI 10.1016/j.clinmicnews.2008.03.004; Frank KL, 2007, INFECT IMMUN, V75, P4728, DOI 10.1128/IAI.00640-07; FRENEY J, 1988, INT J SYST BACTERIOL, V38, P168, DOI 10.1099/00207713-38-2-168; HAZEL JR, 1990, PROG LIPID RES, V29, P167, DOI 10.1016/0163-7827(90)90002-3; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; KOMARATAT P, 1975, BIOCHIM BIOPHYS ACTA, V398, P464, DOI 10.1016/0005-2760(75)90197-6; Kriegeskorte A, 2011, PROTEOMICS, V11, P2476, DOI 10.1002/pmic.201000796; Laan EVDD, 2003, J BACTERIOL, V185, P3773, DOI 10.1128/JB.185.3773.3779.2003; Lenhardt R, 2006, ANESTHESIOLOGY, V105, P1117, DOI 10.1097/00000542-200612000-00011; LEPAGE G, 1986, J LIPID RES, V27, P114; McMahon MAS, 2007, APPL ENVIRON MICROB, V73, P211, DOI 10.1128/AEM.00578-06; Norris V, 2004, FEBS LETT, V561, P3, DOI 10.1016/S0014-5793(04)00135-8; Onyango LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029031; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Sado-Kamdem SL, 2009, INT J FOOD MICROBIOL, V129, P288, DOI 10.1016/j.ijfoodmicro.2008.12.010; Schneider LA, 2007, ARCH DERMATOL RES, V298, P413, DOI 10.1007/s00403-006-0713-x; Seggewiss J, 2006, J BACTERIOL, V188, P7765, DOI 10.1128/JB.00774-06; Seifert H, 2005, EMERG INFECT DIS, V11, P1283, DOI 10.3201/eid1108.041177; Singh VK, 2008, APPL ENVIRON MICROB, V74, P5882, DOI 10.1128/AEM.00882-08; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; van Voorst F, 2000, BIOCHEM J, V347, P601, DOI 10.1042/bj3470601; Veening JW, 2008, ANNU REV MICROBIOL, V62, P193, DOI 10.1146/annurev.micro.62.081307.163002; Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0; WALLACE RJ, 1986, J CLIN MICROBIOL, V24, P976, DOI 10.1128/JCM.24.6.976-981.1986; Wehrli PM, 2014, J CHEMOMETRICS	36	24	25	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e92296	10.1371/journal.pone.0092296	http://dx.doi.org/10.1371/journal.pone.0092296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714666	gold, Green Published, Green Submitted			2022-12-25	WOS:000334160900005
J	Wang, YS; Cheng, SL; Fang, HJ; Yu, GR; Xu, MJ; Dang, XS; Li, LS; Wang, L				Wang, Yongsheng; Cheng, Shulan; Fang, Huajun; Yu, Guirui; Xu, Minjie; Dang, Xusheng; Li, Linsen; Wang, Lei			Simulated Nitrogen Deposition Reduces CH4 Uptake and Increases N2O Emission from a Subtropical Plantation Forest Soil in Southern China	PLOS ONE			English	Article							QINGHAI-TIBETAN PLATEAU; GREENHOUSE-GAS FLUXES; ALPINE MEADOW SOIL; METHANE OXIDATION; SPRUCE FOREST; OXIDE FLUXES; ENVIRONMENTAL-FACTORS; CO2; RESPONSES; DENITRIFICATION	To date, few studies are conducted to quantify the effects of reduced ammonium (NH4+) and oxidized nitrate (NO3-) on soil CH4 uptake and N2O emission in the subtropical forests. In this study, NH4Cl and NaNO3 fertilizers were applied at three rates: 0, 40 and 120 kg N ha(-1) yr(-1). Soil CH4 and N2O fluxes were determined twice a week using the static chamber technique and gas chromatography. Soil temperature and moisture were simultaneously measured. Soil dissolved N concentration in 0-20 cm depth was measured weekly to examine the regulation to soil CH4 and N2O fluxes. Our results showed that one year of N addition did not affect soil temperature, soil moisture, soil total dissolved N (TDN) and NH4+-N concentrations, but high levels of applied NH4Cl and NaNO3 fertilizers significantly increased soil NO3 (-)-N concentration by 124% and 157%, respectively. Nitrogen addition tended to inhibit soil CH4 uptake, but significantly promoted soil N2O emission by 403% to 762%. Furthermore, NH4+-N fertilizer application had a stronger inhibition to soil CH4 uptake and a stronger promotion to soil N2O emission than NO3--N application. Also, both soil CH4 and N2O fluxes were driven by soil temperature and moisture, but soil inorganic N availability was a key integrator of soil CH4 uptake and N2O emission. These results suggest that the subtropical plantation soil sensitively responses to atmospheric N deposition, and inorganic N rather than organic N is the regulator to soil CH4 uptake and N2O emission.	[Wang, Yongsheng; Fang, Huajun; Yu, Guirui; Dang, Xusheng; Li, Linsen; Wang, Lei] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China; [Wang, Yongsheng; Cheng, Shulan; Xu, Minjie; Dang, Xusheng; Wang, Lei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Fang, HJ (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China.	fanghj@igsnrr.ac.cn	于, 贵瑞/C-1768-2014	于, 贵瑞/0000-0002-1859-8966	National Natural Science Foundation of China [31290222, 31130009, 31290221, 31070435, 41071166]; Development Plan Program of State Key Basic Research [2012CB41710, 32010CB833502, 2010CB833501]; Bingwei's Funds for Young Talents from Institute of Geographical Sciences and Natural Resources Research, CAS [2011RC202]; CAS Strategic Priority Program [XDA 05050600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Development Plan Program of State Key Basic Research; Bingwei's Funds for Young Talents from Institute of Geographical Sciences and Natural Resources Research, CAS; CAS Strategic Priority Program	This project was supported by National Natural Science Foundation of China (No. 31290222, 31130009, 31290221, 31070435, and 41071166), Development Plan Program of State Key Basic Research (No. 2012CB41710, 32010CB833502, and 2010CB833501), Bingwei's Funds for Young Talents from Institute of Geographical Sciences and Natural Resources Research, CAS, (No. 2011RC202) and CAS Strategic Priority Program (No. XDA 05050600). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson EL, 2010, ECOLOGY, V91, P3242, DOI 10.1890/09-2185.1; Basiliko N, 2009, CAN J FOREST RES, V39, P1220, DOI 10.1139/X09-043; Bijoor NS, 2008, GLOBAL CHANGE BIOL, V14, P2119, DOI 10.1111/j.1365-2486.2008.01617.x; Bodelier PLE, 2011, CURR OPIN ENV SUST, V3, P379, DOI 10.1016/j.cosust.2011.06.002; Bodelier PLE, 2004, FEMS MICROBIOL ECOL, V47, P265, DOI 10.1016/S0168-6496(03)00304-0; Borken W, 2002, SOIL BIOL BIOCHEM, V34, P1815, DOI 10.1016/S0038-0717(02)00171-2; Butterbach-Bahl K, 1998, ATMOS ENVIRON, V32, P559, DOI 10.1016/S1352-2310(97)00234-3; CASTRO MS, 1994, CAN J FOREST RES, V24, P9, DOI 10.1139/x94-002; Chan ASK, 2006, FEMS MICROBIOL ECOL, V57, P343, DOI 10.1111/j.1574-6941.2006.00127.x; Chen GC, 2012, SOIL BIOL BIOCHEM, V48, P175, DOI 10.1016/j.soilbio.2012.01.029; Department of Forest Resources Management S, 2010, FOR RESOUR MANAG, V1, P3; Dutaur L, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002734; Fang HJ, 2010, BIOGEOSCIENCES, V7, P395, DOI 10.5194/bg-7-395-2010; Fang HJ, 2014, GEODERMA, V213, P444, DOI 10.1016/j.geoderma.2013.08.006; Fang HJ, 2012, PLANT SOIL, V351, P177, DOI 10.1007/s11104-011-0942-4; Hu Zheng-hua, 2011, China Environmental Science, V31, P892; IPCC, 2001, ADV CLIM CHANG RES; Jang I, 2011, SOIL BIOL BIOCHEM, V43, P620, DOI 10.1016/j.soilbio.2010.11.032; Jassal RS, 2011, GEODERMA, V162, P182, DOI 10.1016/j.geoderma.2011.02.002; Kim YS, 2012, ATMOS ENVIRON, V46, P36, DOI 10.1016/j.atmosenv.2011.10.034; KING GM, 1994, NATURE, V370, P282, DOI 10.1038/370282a0; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; Lin S, 2012, AGR ECOSYST ENVIRON, V146, P168, DOI 10.1016/j.agee.2011.10.024; Lin XW, 2009, SOIL BIOL BIOCHEM, V41, P718, DOI 10.1016/j.soilbio.2009.01.007; Liu LL, 2009, ECOL LETT, V12, P1103, DOI 10.1111/j.1461-0248.2009.01351.x; Liu XJ, 2011, ENVIRON POLLUT, V159, P2251, DOI 10.1016/j.envpol.2010.08.002; Luo GJ, 2013, BIOGEOSCIENCES, V10, P3205, DOI 10.5194/bg-10-3205-2013; Martinson GO, 2013, BIOGEOCHEMISTRY, V112, P625, DOI 10.1007/s10533-012-9753-9; Matson P, 2002, AMBIO, V31, P113, DOI 10.1639/0044-7447(2002)031[0113:TGONDC]2.0.CO;2; Merino A, 2004, SOIL BIOL BIOCHEM, V36, P917, DOI 10.1016/j.soilbio.2004.02.006; Mohanty SR, 2006, APPL ENVIRON MICROB, V72, P1346, DOI 10.1128/AEM.72.2.1346-1354.2006; Nyerges G, 2009, FEMS MICROBIOL LETT, V297, P131, DOI 10.1111/j.1574-6968.2009.01674.x; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; Reay DS, 2004, SOIL BIOL BIOCHEM, V36, P2059, DOI 10.1016/j.soilbio.2004.06.002; Rowlings DW, 2012, GLOBAL CHANGE BIOL, V18, P726, DOI 10.1111/j.1365-2486.2011.02563.x; SFA (State Forestry Administration), 2007, CHIN FOR 1999 2005; Steinkamp R, 2001, SOIL BIOL BIOCHEM, V33, P145, DOI 10.1016/S0038-0717(00)00124-3; Steudler PA, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001394; Tang XL, 2006, GLOBAL CHANGE BIOL, V12, P546, DOI 10.1111/j.1365-2486.2006.01109.x; Topp E, 1997, CAN J SOIL SCI, V77, P167, DOI 10.4141/S96-107; Venterea RT, 2003, GLOBAL CHANGE BIOL, V9, P346, DOI 10.1046/j.1365-2486.2003.00591.x; Wang H, 2013, FOREST ECOL MANAG, V300, P4, DOI 10.1016/j.foreco.2012.04.005; Wang LF, 2008, SOIL SCI PLANT NUTR, V54, P786, DOI 10.1111/j.1747-0765.2008.00297.x; Wang YD, 2012, CAN J FOREST RES, V42, P657, DOI [10.1139/x2012-017, 10.1139/X2012-017]; Wang YS, 2003, ADV ATMOS SCI, V20, P842, DOI 10.1007/BF02915410; Wen XF, 2010, BIOGEOSCIENCES, V7, P357, DOI 10.5194/bg-7-357-2010; Werner C, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007388; Whalen SC, 2000, GEOMICROBIOL J, V17, P237; Xu XK, 2004, BIOL FERT SOILS, V40, P215, DOI 10.1007/s00374-004-0768-9; Xu YB, 2007, EUR J SOIL SCI, V58, P1293, DOI 10.1111/j.1365-2389.2007.00923.x; Xu YB, 2013, J SOIL SEDIMENT, V13, P699, DOI 10.1007/s11368-013-0650-1; Zhang JB, 2013, NATURE, V3, P1; Zhang JB, 2011, ENVIRON RES, V111, P643, DOI 10.1016/j.envres.2011.04.005; Zhang JB, 2009, SOIL BIOL BIOCHEM, V41, P2551, DOI 10.1016/j.soilbio.2009.09.016; Zhang W, 2008, PLANT SOIL, V306, P221, DOI 10.1007/s11104-008-9575-7; Zhang W, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002094; Zhang W, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009195; Zhu J, 2013, SOIL BIOL BIOCHEM, V57, P577, DOI 10.1016/j.soilbio.2012.09.017	58	34	44	11	158	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93571	10.1371/journal.pone.0093571	http://dx.doi.org/10.1371/journal.pone.0093571			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714387	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900036
J	Gu, CJ; Zheng, F; Long, LK; Wang, J; Ding, SJ				Gu, Chunjuan; Zheng, Fei; Long, Liangkun; Wang, Jing; Ding, Shaojun			Engineering the Expression and Characterization of Two Novel Laccase Isoenzymes from Coprinus comatus in Pichia pastoris by Fusing an Additional Ten Amino Acids Tag at N-Terminus	PLOS ONE			English	Article							MELANOCARPUS-ALBOMYCES LACCASE; TRAMETES-VERSICOLOR LACCASE; REDOX POTENTIAL LACCASE; MULTI-COPPER OXIDASE; HETEROLOGOUS EXPRESSION; SACCHAROMYCES-CEREVISIAE; MOLECULAR-CLONING; PLEUROTUS-ERYNGII; FUNGAL LACCASES; GENE	The detail understanding of physiological/biochemical characteristics of individual laccase isoenzymes in fungi is necessary for fundamental and application purposes, but our knowledge is still limited for most of fungi due to difficult to express laccases heterologously. In this study, two novel laccase genes, named lac3 and lac4, encoding proteins of 547 and 532-amino acids preceded by 28 and 16-residue signal peptides, respectively, were cloned from the edible basidiomycete Coprinus comatus. They showed 70% identity but much lower homology with other fungal laccases at protein level (less than 58%). Two novel laccase isoenzymes were successfully expressed in Pichia pastoris by fusing an additional 10 amino acids (Thr-Pro-Phe-Pro-Pro-Phe-Asn-Thr-Asn-Ser) tag at N-terminus, and the volumetric activities could be dramatically enhanced from undetectable level to 689 and 1465 IU/l for Lac3 and Lac4, respectively. Both laccases possessed the lowest Km and highest k(cat)/K-m value towards syringaldazine, followed by ABTS, guaiacol and 2,6-dimethylphenol similar as the low redox potential laccases from other microorganisms. Lac3 and Lac4 showed resistant to SDS, and retained 31.86% and 43.08% activity in the presence of 100 mM SDS, respectively. Lac3 exhibited higher decolorization efficiency than Lac4 for eleven out of thirteen different dyes, which may attribute to the relatively higher catalytic efficiency of Lac3 than Lac4 (in terms of k(cat/)K(m)) towards syringaldazine and ABTS. The mild synergistic decolorization by two laccases was observed for triphenylmethane dyes but not for anthraquinone and azo dyes.	[Gu, Chunjuan; Zheng, Fei; Long, Liangkun; Wang, Jing; Ding, Shaojun] Nanjing Forestry Univ, Coll Chem Engn, Dept Biol Engn, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University	Ding, SJ (corresponding author), Nanjing Forestry Univ, Coll Chem Engn, Dept Biol Engn, Nanjing, Jiangsu, Peoples R China.	dshaojun@hotmail.com			National Natural Science Foundation of China (NSFC) [30871987]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the National Natural Science Foundation of China (NSFC) (Grant No. 30871987) and the Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andberg M, 2009, FEBS J, V276, P6285, DOI 10.1111/j.1742-4658.2009.07336.x; Bai YG, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-33; Baker CJO, 2000, ABSTR PAP AM CHEM S, V219, pU281; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Bao SY, 2013, MOL BIOL REP, V40, P1927, DOI 10.1007/s11033-012-2249-9; Bleve G, 2008, APPL MICROBIOL BIOT, V79, P731, DOI 10.1007/s00253-008-1479-1; Bohlin C, 2006, APPL BIOCHEM BIOTECH, V129, P195, DOI 10.1385/ABAB:129:1:195; Brown MA, 2002, INORG CHIM ACTA, V331, P232, DOI 10.1016/S0020-1693(01)00814-3; Bulter T, 2003, APPL ENVIRON MICROB, V69, P987, DOI 10.1128/AEM.69.2.987-995.2003; CANTERS GW, 1993, FEBS LETT, V325, P39, DOI 10.1016/0014-5793(93)81410-2; Cassland P, 1999, APPL MICROBIOL BIOT, V52, P393, DOI 10.1007/s002530051537; CHILDS RE, 1975, BIOCHEM J, V145, P93, DOI 10.1042/bj1450093; Christenson A, 2006, BBA-BIOENERGETICS, V1757, P1634, DOI 10.1016/j.bbabio.2006.08.008; Ciullini I, 2008, BIORESOURCE TECHNOL, V99, P7003, DOI 10.1016/j.biortech.2008.01.019; Guo M, 2006, APPL MICROBIOL BIOT, V71, P848, DOI 10.1007/s00253-005-0210-8; Herter S, 2013, J MOL CATAL B-ENZYM, V90, P91, DOI 10.1016/j.molcatb.2013.01.020; Hilden K, 2013, APPL MICROBIOL BIOT, V97, P1589, DOI 10.1007/s00253-012-4011-6; Hoshida H, 2001, J BIOSCI BIOENG, V92, P372, DOI 10.1263/jbb.92.372; Jolivalt C, 2005, APPL MICROBIOL BIOT, V66, P450, DOI 10.1007/s00253-004-1717-0; Kiiskinen LL, 2004, MICROBIOL-SGM, V150, P3065, DOI 10.1099/mic.0.27147-0; Kilaru S, 2006, CURR GENET, V50, P45, DOI 10.1007/s00294-006-0074-1; Klonowska A, 2005, ENZYME MICROB TECH, V36, P34, DOI 10.1016/j.enzmictec.2004.03.022; Klonowska A, 2002, EUR J BIOCHEM, V269, P6119, DOI 10.1046/j.1432-1033.2002.03324.x; KOIKEDA S, 1993, J BIOL CHEM, V268, P18801; Kokol V, 2007, ENZYME MICROB TECH, V40, P1673, DOI 10.1016/j.enzmictec.2006.08.015; Koschorreck K, 2008, ARCH BIOCHEM BIOPHYS, V474, P213, DOI 10.1016/j.abb.2008.03.009; Kues U, 2011, CURR GENOMICS, V12, P72, DOI 10.2174/138920211795564377; Kunamneni A, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-32; Lin YQ, 2013, MOL BIOL REP, V40, P1487, DOI 10.1007/s11033-012-2191-x; Lu X, 2010, MYCOSCIENCE, V51, P68, DOI 10.1007/s10267-009-0002-6; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Mayer AM, 2002, PHYTOCHEMISTRY, V60, P551, DOI 10.1016/S0031-9422(02)00171-1; Murugesan K, 2009, APPL MICROBIOL BIOT, V82, P341, DOI 10.1007/s00253-008-1819-1; Piontek K, 2002, J BIOL CHEM, V277, P37663, DOI 10.1074/jbc.M204571200; Piscitelli Alessandra, 2010, Bioeng Bugs, V1, P252, DOI 10.4161/bbug.1.4.11438; Polak J, 2012, BIOTECHNOL PROGR, V28, P93, DOI 10.1002/btpr.713; Rodriguez E, 2008, J BIOTECHNOL, V134, P9, DOI 10.1016/j.jbiotec.2007.12.008; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Uthandi S, 2010, APPL ENVIRON MICROB, V76, P733, DOI 10.1128/AEM.01757-09; Wong KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066426; Yan KL, 2009, J MICROBIOL BIOTECHN, V19, P1421, DOI 10.4014/jmb.0901.0033; Yano A, 2009, MICROBIOL RES, V164, P642, DOI 10.1016/j.micres.2008.12.001; Zhao D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038817; Zheng F, 2013, J IND MICROBIOL BIOT, V40, P1083, DOI 10.1007/s10295-013-1312-4	44	37	40	4	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93912	10.1371/journal.pone.0093912	http://dx.doi.org/10.1371/journal.pone.0093912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710109	Green Submitted, Green Published, gold			2022-12-25	WOS:000334159800069
J	Hejblum, G; Lambotte, O; Galicier, L; Coppo, P; Marzac, C; Aumont, C; Fardet, L				Hejblum, Gilles; Lambotte, Olivier; Galicier, Lionel; Coppo, Paul; Marzac, Christophe; Aumont, Cedric; Fardet, Laurence			A Web-Based Delphi Study for Eliciting Helpful Criteria in the Positive Diagnosis of Hemophagocytic Syndrome in Adult Patients	PLOS ONE			English	Article							CLINICAL-FEATURES; LYMPHOHISTIOCYTOSIS; PATHOGENESIS; DISORDERS	The diagnosis of the reactive form of hemophagocytic syndrome in adults remains particularly difficult since none of the clinical or laboratory manifestations are specific. We undertook a study in order to elicit which features constitute helpful criteria for a positive diagnosis. In this Delphi study, the features investigated in the questionnaire and the experts invited to participate in the survey were issued from a bibliographic search. The questionnaire was iteratively proposed to experts via a web-based application with a feedback of the results observed at the preceding Delphi round. Experts were asked to label each investigated criterion in one of the following categories: absolutely required, important, of minor interest, or not assessable in the routine practice environment. A positive consensus was a priori defined as at least 75% answers observed in the categories absolutely required and important. The questionnaire investigated 26 criteria and 24 experts originating from 13 countries participated in the second and final Delphi round. A positive consensus was reached for the nine following criteria: unilineage cytopenia, bicytopenia, pancytopenia, presence of hemophagocytosis pictures on a bone marrow aspirate or on a tissue biopsy, high ferritin level, fever, organomegaly, presence of a predisposing underlying disease, and high level of lactate dehydrogenase. A negative consensus was reached for 13 criteria, and an absence of consensus was observed for 4 criteria. The study constitutes the first initiative to date for defining international guidelines devoted to the positive diagnosis of the reactive form of hemophagocytic syndrome.	[Hejblum, Gilles] INSERM, Inst Pierre Louis Epidemiol & Sante Publ, UMR S 1136, Paris, France; [Hejblum, Gilles] Univ Paris 06, Univ Sorbonne, Inst Pierre Louis Epidemiol & Sante Publ, UMR S 1136, Paris, France; [Hejblum, Gilles] Hop St Antoine, AP HP, F-75571 Paris, France; [Lambotte, Olivier] Hop Bicetre, AP HP, Serv Med Interne, Le Kremlin Bicetre, France; [Lambotte, Olivier] Univ Paris Sud, Fac Med Paris Sud 11, F-94275 Le Kremlin Bicetre, France; [Galicier, Lionel] Hop St Louis, AP HP, Paris, France; [Coppo, Paul] Hop St Antoine, AP HP, Serv Hematol, F-75571 Paris, France; [Coppo, Paul] Univ Paris 06, Univ Sorbonne, Fac Med Pierre & Marie Curie, Paris, France; [Marzac, Christophe] Hop St Antoine, AP HP, Serv Hematol Biol, F-75571 Paris, France; [Aumont, Cedric] Univ Paris 06, Univ Sorbonne, Grp Rech Clin 7, MyPAC, Paris, France; [Aumont, Cedric] Hop Bicetre, AP HP, Serv Hematol Biol, Le Kremlin Bicetre, France; [Fardet, Laurence] Hop St Antoine, AP HP, Serv Med Interne, F-75571 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Hejblum, G (corresponding author), INSERM, Inst Pierre Louis Epidemiol & Sante Publ, UMR S 1136, Paris, France.	gilles.hejblum@inserm.fr	Hejblum, Gilles/N-6337-2017; Lambotte, Olivier/GRT-0160-2022	Hejblum, Gilles/0000-0003-0127-1964; Aumont, Cedric/0000-0002-7118-4295				Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Dakley NC, 1969, DELPHI METHOD EXPT S; Davi S, 2011, J RHEUMATOL, V38, P764, DOI 10.3899/jrheum.100996; Debin M, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-138; Fardet L, 2008, ARTHRITIS RHEUM, V58, P1521, DOI 10.1002/art.23415; Fisman DN, 2000, EMERG INFECT DIS, V6, P601, DOI 10.3201/eid0606.000608; Fukaya S, 2008, RHEUMATOLOGY, V47, P1686, DOI 10.1093/rheumatology/ken342; Hejblum G, 2008, CHEST, V133, P1107, DOI 10.1378/chest.06-3014; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; HENTER JI, 1991, ACTA PAEDIATR SCAND, V80, P428, DOI 10.1111/j.1651-2227.1991.tb11878.x; Henter JI, 2004, CRIT REV ONCOL HEMAT, V50, P157, DOI 10.1016/j.critrevonc.2004.01.002; Imashuku S, 1997, INT J HEMATOL, V66, P135; Janka GE, 2007, BLOOD REV, V21, P245, DOI 10.1016/j.blre.2007.05.001; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Kleynberg Roman Leonid, 2012, Clin Adv Hematol Oncol, V10, P726; Larroche C, 2012, JOINT BONE SPINE, V79, P356, DOI 10.1016/j.jbspin.2011.10.015; Linstone H. A., 1975, DELPHI METHOD TECHNI; Rosado FGN, 2013, AM J CLIN PATHOL, V139, P713, DOI 10.1309/AJCP4ZDKJ4ICOUAT; Shih TH, 2008, FIELD METHOD, V20, P249, DOI 10.1177/1525822X08317085; Usmani GN, 2013, BRIT J HAEMATOL, V161, P609, DOI 10.1111/bjh.12293; Verbsky JW, 2006, ANN MED, V38, P20, DOI 10.1080/07853890500465189; WONG KF, 1992, AM J MED, V93, P177, DOI 10.1016/0002-9343(92)90048-G	22	52	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94024	10.1371/journal.pone.0094024	http://dx.doi.org/10.1371/journal.pone.0094024			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710079	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800088
J	Li, P; Liu, TT; Liu, JJ; Zhang, Q; Lou, FL; Kong, F; Cheng, GH; Bjorkholm, M; Zheng, CY; Xu, DW				Li, Ping; Liu, Tiantian; Liu, Jiajia; Zhang, Qing; Lou, Fenglan; Kong, Feng; Cheng, Guanghui; Bjorkholm, Magnus; Zheng, Chengyun; Xu, Dawei			Promoter Polymorphism in the Serotonin Transporter ( 5-HTT) Gene Is Significantly Associated with Leukocyte Telomere Length in Han Chinese	PLOS ONE			English	Article							BIASED ATTENTION; LIFE STRESS; DEPRESSION; POPULATION; MORTALITY; HALLMARKS; DEMENTIA	The serotonin transporter gene (5-HTT)-linked polymorphic region (5-HTTLPR) plays an important role in modulating mood and behavior by regulating 5-HTT expression and thereby controlling the concentration of serotonin (5-HT) in brain synapses: The homozygous shorter allele (S/S) in 5-HTTLPR results in lower 5-HTT expression coupled with stronger psychopathological reactions to stressful experiences compared to the homozygous long (L/L) and heterozygous (S/L) alleles. Psychological insults and mood disorders have been shown to cause accelerated telomere shortening, a marker of biological aging, however, it is currently unclear whether the allelic variants of 5-HTTLPR affect telomere length (TL) in the healthy population without mood disorders. In the present study, we determined the relationship between TL and the 5HTTLPR variants in healthy Han Chinese. The 5-HTTLPR genotyping and leukocyte TL analysis of 280 young female Han Chinese freshmen showed a significantly shorter TL in 149 of them carrying the 5-HTTLPR S/S version compared to those ( 131) with the L/S or L/ S plus L/L genotypes (mean = SD, 0.533 +/- 0.241 for S/ S vs 0.607 +/- 0.312 for L/ S, P = 0.034; or vs 0.604 +/- 0.313 for L/ S plus L/ L, P = 0.038). Similar results were achieved in the other cohort including 220 adult healthy individuals of different age, gender and profession (0.691=0.168 for S/ S vs 0.729 +/- 0.211 for L/ S, P = 0.046, or vs 0.725 +/- 0.213 for L/ S plus L/ L, P = 0.039). Taken together, shorter leukocyte TL is significantly associated with the 5-HTTLPR S/S allelic variant, which may be implicated in psychological stress-related health problems.	[Li, Ping; Liu, Jiajia; Zhang, Qing; Lou, Fenglan] Shandong Univ, Sch Nursing, Jinan 250100, Peoples R China; [Liu, Tiantian] Shandong Univ, Sch Med, Dept Microbiol, Jinan 250100, Peoples R China; [Kong, Feng; Cheng, Guanghui; Xu, Dawei] Shandong Univ, Hosp 2, Cent Res Lab, Jinan 250100, Peoples R China; [Zheng, Chengyun] Shandong Univ, Hosp 2, Dept Hematol, Jinan 250100, Peoples R China; [Liu, Jiajia; Bjorkholm, Magnus; Xu, Dawei] Karolinska Univ Hosp Solna, Dept Med, Div Hematol, Stockholm, Sweden; [Liu, Tiantian; Bjorkholm, Magnus; Xu, Dawei] Karolinska Univ Hosp Solna, Ctr Mol Med, Stockholm, Sweden; [Liu, Tiantian; Bjorkholm, Magnus; Xu, Dawei] Karolinska Inst, Stockholm, Sweden	Shandong University; Shandong University; Shandong University; Shandong University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Li, P (corresponding author), Shandong Univ, Sch Nursing, Jinan 250100, Peoples R China.	pingli12@sdu.edu.cn; Dawei.Xu@ki.se		Xu, Dawei/0000-0003-3141-4524	National Basic Research Program of China (973 Program) [2012CB911202]; Shandong Province Natural Science Foundation [Y2003C08, ZR2009DM022]; Independent Innovation Foundation of Shandong University [2012TS093]; National Natural Science Foundation of China [81071721]; Swedish Research Council; Karolinska Institutet Foundations	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); Independent Innovation Foundation of Shandong University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet Foundations(Karolinska Institutet)	The study was supported by grants from The National Basic Research Program of China (Grant No. 973 Program 2012CB911202), the Shandong Province Natural Science Foundation (Nos Y2003C08 and ZR2009DM022) and Independent Innovation Foundation of Shandong University (No 2012TS093), National Natural Science Foundation of China (No 81071721), Swedish Research Council, Karolinska Institutet Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NP, 2010, GERONTOLOGY, V56, P390, DOI 10.1159/000268620; Aviv A, 2006, INT J EPIDEMIOL, V35, P1424, DOI 10.1093/ije/dyl169; Aviv A, 2009, HYPERTENSION, V53, P590, DOI 10.1161/HYPERTENSIONAHA.109.128926; Barrett ELB, 2011, AGING CELL, V10, P913, DOI 10.1111/j.1474-9726.2011.00741.x; Beevers CG, 2007, J ABNORM PSYCHOL, V116, P208, DOI 10.1037/0021-843X.116.1.208; Beevers CG, 2009, J ABNORM PSYCHOL, V118, P670, DOI 10.1037/a0016198; Brocke B, 2006, MOL PSYCHIATR, V11, P1106, DOI 10.1038/sj.mp.4001908; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Damjanovic AK, 2007, J IMMUNOL, V179, P4249, DOI 10.4049/jimmunol.179.6.4249; Daniel M, 2012, GENE, V498, P135, DOI 10.1016/j.gene.2012.01.095; De Meyer T, 2011, PSYCHOSOM MED, V73, P524, DOI 10.1097/PSY.0b013e31822ed876; Deelen J, 2014, INT J EPIDEMIOL, V43, P878, DOI 10.1093/ije/dyt267; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Fox E, 2009, P R SOC B, V276, P1747, DOI 10.1098/rspb.2008.1788; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Geronimus AT, HUM NAT, V21, P19; Gibb BE, 2009, J CLIN CHILD ADOLESC, V38, P415, DOI 10.1080/15374410902851705; Halvorsen TL, 2000, J ENDOCRINOL, V166, P103, DOI 10.1677/joe.0.1660103; Homberg JR, 2011, BIOL PSYCHIAT, V69, P513, DOI 10.1016/j.biopsych.2010.09.024; Honig LS, 2012, ARCH NEUROL-CHICAGO, V69, P1332, DOI 10.1001/archneurol.2012.1541; Kiecolt-Glaser JK, 2010, BRAIN BEHAV IMMUN, V24, P529, DOI 10.1016/j.bbi.2010.02.002; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035567; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Li P, 2012, INT J BIOCHEM CELL B, V44, P1531, DOI 10.1016/j.biocel.2012.06.020; Li Q, 2006, MOL NEUROBIOL, V34, P51, DOI 10.1385/MN:34:1:51; Lin J, 2012, MUTAT RES-FUND MOL M, V730, P85, DOI 10.1016/j.mrfmmm.2011.08.003; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Martin-Ruiz C, 2006, ANN NEUROL, V60, P174, DOI 10.1002/ana.20869; Morla M, 2006, EUR RESPIR J, V27, P525, DOI 10.1183/09031936.06.00087005; Nicholls C, 2011, PROTEIN CELL, V2, P726, DOI 10.1007/s13238-011-1093-3; Osinsky R, 2008, EMOTION, V8, P584, DOI 10.1037/a0012826; Price LH, 2013, BIOL PSYCHIAT, V73, P15, DOI 10.1016/j.biopsych.2012.06.025; Shay JW, 2007, J PATHOL, V211, P114, DOI 10.1002/path.2090; Surtees PG, 2011, J GERONTOL A-BIOL, V66, P1152, DOI 10.1093/gerona/glr112; Takubo K, 2002, EXP GERONTOL, V37, P523, DOI 10.1016/S0531-5565(01)00218-2; Thomason ME, 2010, BIOL PSYCHOL, V85, P38, DOI 10.1016/j.biopsycho.2010.04.009; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Weischer M, 2013, JNCI-J NATL CANCER I, V105, P459, DOI 10.1093/jnci/djt016; Wikgren M, 2012, BIOL PSYCHIAT, V71, P294, DOI 10.1016/j.biopsych.2011.09.015; Wolkowitz OM, 2010, DEPRESS ANXIETY, V27, P327, DOI 10.1002/da.20686	42	5	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94442	10.1371/journal.pone.0094442	http://dx.doi.org/10.1371/journal.pone.0094442			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710073	gold, Green Published, Green Submitted			2022-12-25	WOS:000334159800147
J	Liu, YW; Cao, L; Chang, J; Lin, J; He, B; Rao, J; Zhang, Z; Zhang, XM				Liu, Yingwen; Cao, Lei; Chang, Jiang; Lin, Jia; He, Bing; Rao, Juan; Zhang, Zhi; Zhang, Xuemei			XPF-673C > T Polymorphism Effect on the Susceptibility to Esophageal Cancer in Chinese Population	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; NUCLEOTIDE EXCISION-REPAIR; DNA-REPAIR; GENETIC VARIANT; BREAST-CANCER; RISK; EXPRESSION; DAMAGE; ERCC1; XPF	Purpose: Xeroderma pigmentsum group F (XPF) plays a pivotal role in DNA nucleotide excision repair and has been linked to the development of various cancers. This study aims to assess the association of XPF genetic variants with the susceptibility to esophageal squamous cell carcinoma (ESCC) in Chinese population. Methods: This two-stage case-control study was conducted in a total of 1524 patients with ESCC and 1524 controls. Genotype of XPF -673C>T and 11985A>G variants were determined by polymerase chain reaction-based restriction fragment length polymorphism (PCR- RFLP). Logistic regression analysis was performed to estimate odd ratios (ORs) and 95% confidence intervals (95% CI). Results: Our case-control study showed that XPF -673TT genotype was associated with a decreased risk of ESCC compared with CC genotype in both case-control sets (Tangshan set: OR = 0.58; 95%CI = 0.34-0.99, P = 0.040; Beijing set: OR = 0.66; 95% CI = 0.46- 0.95, P = 0.027). Stratified analyses revealed that a multiplicative interaction between - 673C>T variant and age, sex or smoking status was evident (Gene-age: P-interaction = 0.002; Gene- sex: P-interaction = 0.002; Gene- smoking: P-interaction = 0.002). For XPF 11985A>G polymorphism, there was no significant difference of genotype distribution between ESCC cases and controls. Conclusion: These findings indicated that genetic variants in XPF might contribute to the susceptibility to ESCC.	[Liu, Yingwen; Cao, Lei; Lin, Jia; He, Bing; Rao, Juan; Zhang, Xuemei] Hebei United Univ, Coll Life Sci, Dept Mol Genet, Tangshan, Peoples R China; [Liu, Yingwen] Hebei United Univ, Coll Life Sci, Dept Epidemiol, Tangshan, Peoples R China; [Chang, Jiang] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Etiol & Carcinogenesis, Beijing 100730, Peoples R China; [Zhang, Zhi] Hebei United Univ, Affiliated Tangshan Gongren Hosp, Tangshan, Peoples R China	North China University of Science & Technology; North China University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; North China University of Science & Technology	Zhang, XM (corresponding author), Hebei United Univ, Coll Life Sci, Dept Mol Genet, Tangshan, Peoples R China.	jyxuemei@gmail.com	LIU, YING/GZL-7252-2022		National Natural Science Foundation of China [81272613]; Science Fund for Distinguished Young Scholars of Hebei Scientific Committee [H2012401022]; Leader Talent Cultivation Plan of Innovation Team in Hebei province [LJRC001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund for Distinguished Young Scholars of Hebei Scientific Committee; Leader Talent Cultivation Plan of Innovation Team in Hebei province	This study was supported by the National Natural Science Foundation of China (81272613 to X. Zhang), Science Fund for Distinguished Young Scholars of Hebei Scientific Committee (H2012401022 to X. Zhang) and Leader Talent Cultivation Plan of Innovation Team in Hebei province (LJRC001 to X. Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstralh DT, 2008, TRENDS GENET, V24, P70, DOI 10.1016/j.tig.2007.11.003; Berwick M, 2000, JNCI-J NATL CANCER I, V92, P874, DOI 10.1093/jnci/92.11.874; Bowles M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks284; Chen W, 2013, BREAST CANCER RES TR, V142, P637, DOI 10.1007/s10549-013-2775-8; Das D, 2012, STRUCTURE, V20, P667, DOI 10.1016/j.str.2012.02.009; FAN XJ, 2013, SICHUAN DA XUE XUE B, V44; Fareed KR, 2010, BRIT J CANCER, V102, P1600, DOI 10.1038/sj.bjc.6605686; Gaillard PHL, 2001, NUCLEIC ACIDS RES, V29, P872, DOI 10.1093/nar/29.4.872; Han JL, 2009, BREAST CANCER RES TR, V115, P613, DOI 10.1007/s10549-008-0089-z; Holmes RS, 2007, SEMIN RADIAT ONCOL, V17, P2, DOI 10.1016/j.semradonc.2006.09.003; Ji GX, 2013, TOXICOL LETT, V218, P144, DOI 10.1016/j.toxlet.2013.01.017; Lee JM, 2001, INT J CANCER, V95, P240, DOI 10.1002/1097-0215(20010720)95:4<240::AID-IJC1041>3.0.CO;2-1; Lieberman L, 2013, AM J PUBLIC HEALTH, V103, P1942, DOI 10.2105/AJPH.2013.301284; Liu Y, 2011, DNA REPAIR, V10, P684, DOI 10.1016/j.dnarep.2011.04.020; McNeil EM, 2012, NUCLEIC ACIDS RES, V40, P9990, DOI 10.1093/nar/gks818; Nathrath M, 2002, KLIN PADIATR, V214, P230, DOI 10.1055/s-2002-33189; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shaoa MH, 2008, LUNG CANCER, V60, P332, DOI 10.1016/j.lungcan.2007.10.023; Shi TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038606; Thrift AP, 2012, INT J CANCER, V131, pE759, DOI 10.1002/ijc.27420; Vaezi A, 2011, CLIN CANCER RES, V17, P5513, DOI 10.1158/1078-0432.CCR-11-0086; WANG M, 2010, ONCOGENE, V29; Wang YF, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-11; Ye B, 2013, GENET TEST MOL BIOMA; Yu D-K, 2010, FRONT MED-PRC, V4, P82, DOI [10.1007/s11684-010-0014-9, DOI 10.1007/S11684-010-0014-9]; Zhang JS, 2013, ASIAN PAC J CANCER P, V14, P1847, DOI 10.7314/APJCP.2013.14.3.1847; Zhang XJ, 2013, CARCINOGENESIS, V34, P2309, DOI 10.1093/carcin/bgt213; Zhong R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04147; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395; 2013, APPL BIOCH BIOTECHNO	30	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94136	10.1371/journal.pone.0094136	http://dx.doi.org/10.1371/journal.pone.0094136			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709955	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800104
J	Ranucci, M; Ballotta, A; La Rovere, MT; Castelvecchio, S				Ranucci, Marco; Ballotta, Andrea; La Rovere, Maria Teresa; Castelvecchio, Serenella		Surgical & Clinical Outcome Res SC	Postoperative Hypoxia and Length of Intensive Care Unit Stay after Cardiac Surgery: The Underweight Paradox?	PLOS ONE			English	Article							HEPARIN-COATED CIRCUITS; CARDIOPULMONARY BYPASS; RESPIRATORY SYSTEM; LUNG DYSFUNCTION; OBESE-PATIENTS; RISK PATIENTS; TRANSFUSION; COMPONENTS; MECHANICS; INJURY	Objective: Cardiac operations with cardiopulmonary bypass can be associated with postoperative lung dysfunction. The present study investigates the incidence of postoperative hypoxia after cardiac surgery, its relationship with the length of intensive care unit stay, and the role of body mass index in determining postoperative hypoxia and intensive care unit length of stay. Design: Single-center, retrospective study. Setting: University Hospital. Patients. Adult patients ( N = 5,023) who underwent cardiac surgery with CPB. Interventions: None. Measurements and main results: According to the body mass index, patients were attributed to six classes, and obesity was defined as a body mass index > 30. POH was defined as a PaO2/FiO2 ratio < 200 at the arrival in the intensive care unit. Postoperative hypoxia was detected in 1,536 patients ( 30.6%). Obesity was an independent risk factor for postoperative hypoxia ( odds ratio 2.4, 95% confidence interval 2.05-2.78, P = 0.001) and postoperative hypoxia was a determinant of intensive care unit length of stay. There is a significant inverse correlation between body mass index and PaO2/FiO2 ratio, with the risk of postoperative hypoxia increasing by 1.7 folds per each incremental body mass index class. The relationship between body mass index and intensive care unit length of stay is U-shaped, with longer intensive care unit stay in underweight patients and moderate-morbid obese patients. Conclusions: Obese patients are at higher risk for postoperative hypoxia, but this leads to a prolonged intensive care unit stay only for moderate-morbid obese patients. Obese patients are partially protected against the deleterious effects of hemodilution and transfusions. Underweight patients present the "paradox" of a better lung gas exchange but a longer intensive care unit stay. This is probably due to a higher severity of their cardiac disease.	[Ranucci, Marco; Ballotta, Andrea; Castelvecchio, Serenella] Fdn Salvatore Maugeri, IRCCS, Ist Sci Montescano, Dept Cardiothorac Vasc Anesthesia & Intens Care, Montescano, Italy; [La Rovere, Maria Teresa] Fdn Salvatore Maugeri, IRCCS, Ist Sci Montescano, Dept Cardiol, Montescano, Italy	Istituti Clinici Scientifici Maugeri IRCCS; Istituti Clinici Scientifici Maugeri IRCCS	Ranucci, M (corresponding author), Fdn Salvatore Maugeri, IRCCS, Ist Sci Montescano, Dept Cardiothorac Vasc Anesthesia & Intens Care, Montescano, Italy.	cardioanestesia@virgilio.it	Ranucci, Marco/K-1040-2016; La Rovere, Maria Teresa/D-6796-2019; , CASTELVECCHIO/J-9091-2016	Ranucci, Marco/0000-0002-4915-3572; La Rovere, Maria Teresa/0000-0002-1884-5058; , CASTELVECCHIO/0000-0001-5365-7063	IRCCS Policlinico San Donato	IRCCS Policlinico San Donato	This work was supported by local research funds at the IRCCS Policlinico San Donato. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, WHO TECH REP SER, V894, P1; Apostolakis E, 2010, J CARDIAC SURG, V25, P47, DOI 10.1111/j.1540-8191.2009.00823.x; Apostolakis EE, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-1; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Koch CG, 2006, CRIT CARE MED, V34, P1608, DOI 10.1097/01.CCM.0000217920.48559.D8; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Kress JP, 1999, AM J RESP CRIT CARE, V160, P883, DOI 10.1164/ajrccm.160.3.9902058; Leal-Noval SM, 2001, CHEST, V119, P1461, DOI 10.1378/chest.119.5.1461; Lin CK, 2012, RESPIROLOGY, V17, P402, DOI 10.1111/j.1440-1843.2011.02124.x; Lomivorotov VV, 2013, INTERACT CARDIOV TH, V16, P612, DOI 10.1093/icvts/ivs549; NAIMARK A, 1960, J APPL PHYSIOL, V15, P377, DOI 10.1152/jappl.1960.15.3.377; Ng CSH, 2002, CHEST, V121, P1269, DOI 10.1378/chest.121.4.1269; Pelosi P, 1996, CHEST, V109, P144, DOI 10.1378/chest.109.1.144; Ranucci M, 1996, ANN THORAC SURG, V61, P76, DOI 10.1016/0003-4975(95)00820-9; Ranucci M, 1999, J CARDIOTHOR VASC AN, V13, P280, DOI 10.1016/S1053-0770(99)90264-1; Ranucci M, 1999, ANN THORAC SURG, V67, P994, DOI 10.1016/S0003-4975(99)00062-4; Ranucci M, 1997, PERFUSION-UK, V12, P309, DOI 10.1177/026765919701200506; Ranucci M, 2009, ANN THORAC SURG, V87, P1311, DOI 10.1016/j.athoracsur.2008.09.076; RAY CS, 1983, AM REV RESPIR DIS, V128, P501, DOI 10.1164/arrd.1983.128.3.501; SAMPSON MG, 1983, AM J MED, V75, P81, DOI 10.1016/0002-9343(83)91171-3; Stephens RS, 2013, ANN THORAC SURG, V95, P1122, DOI 10.1016/j.athoracsur.2012.10.024; Szeles Tais Felix, 2008, Rev. Bras. Anestesiol., V58, P124, DOI 10.1590/S0034-70942008000200005; Tuinman PR, 2011, CRIT CARE, V15, DOI 10.1186/cc10032; Valentijn TM, 2013, SURG-J R COLL SURG E, V11, P169, DOI 10.1016/j.surge.2013.02.003; Weiss YG, 2000, J CARDIOTHOR VASC AN, V14, P506, DOI 10.1053/jcan.2000.9488; YAP JCH, 1995, J APPL PHYSIOL, V79, P1199, DOI 10.1152/jappl.1995.79.4.1199	27	44	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93992	10.1371/journal.pone.0093992	http://dx.doi.org/10.1371/journal.pone.0093992			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709952	Green Submitted, gold, Green Published			2022-12-25	WOS:000334159800083
J	Travers-Trolet, M; Shin, YJ; Shannon, LJ; Moloney, CL; Field, JG				Travers-Trolet, Morgane; Shin, Yunne-Jai; Shannon, Lynne J.; Moloney, Coleen L.; Field, John G.			Combined Fishing and Climate Forcing in the Southern Benguela Upwelling Ecosystem: An End-to-End Modelling Approach Reveals Dampened Effects	PLOS ONE			English	Article							INDIVIDUAL-BASED MODEL; MARINE ECOSYSTEMS; TROPHIC INTERACTIONS; MULTIPLE STRESSORS; BOTTOM-UP; FISHERIES; RESPONSES; IMPACTS; SYSTEMS; BIODIVERSITY	The effects of climate and fishing on marine ecosystems have usually been studied separately, but their interactions make ecosystem dynamics difficult to understand and predict. Of particular interest to management, the potential synergism or antagonism between fishing pressure and climate forcing is analysed in this paper, using an end-to-end ecosystem model of the southern Benguela ecosystem, built from coupling hydrodynamic, biogeochemical and multispecies fish models (ROMS-N(2)P(2)Z(2)D(2)-OSMOSE). Scenarios of different intensities of upwelling-favourable wind stress combined with scenarios of fishing top-predator fish were tested. Analyses of isolated drivers show that the bottom-up effect of the climate forcing propagates up the food chain whereas the top-down effect of fishing cascades down to zooplankton in unfavourable environmental conditions but dampens before it reaches phytoplankton. When considering both climate and fishing drivers together, it appears that top-down control dominates the link between top-predator fish and forage fish, whereas interactions between the lower trophic levels are dominated by bottom-up control. The forage fish functional group appears to be a central component of this ecosystem, being the meeting point of two opposite trophic controls. The set of combined scenarios shows that fishing pressure and upwelling-favourable wind stress have mostly dampened effects on fish populations, compared to predictions from the separate effects of the stressors. Dampened effects result in biomass accumulation at the top predator fish level but a depletion of biomass at the forage fish level. This should draw our attention to the evolution of this functional group, which appears as both structurally important in the trophic functioning of the ecosystem, and very sensitive to climate and fishing pressures. In particular, diagnoses considering fishing pressure only might be more optimistic than those that consider combined effects of fishing and environmental variability.	[Travers-Trolet, Morgane] IFREMER, Fisheries Lab, Sete, France; [Shin, Yunne-Jai] IRD, CRH UMR EME 212, Sete, France; [Shin, Yunne-Jai; Shannon, Lynne J.; Moloney, Coleen L.; Field, John G.] Univ Cape Town, Marine Res Inst, ZA-7700 Rondebosch, South Africa	Ifremer; Institut de Recherche pour le Developpement (IRD); University of Cape Town	Travers-Trolet, M (corresponding author), IFREMER, Fisheries Lab, Sete, France.	morgane.travers@ifremer.fr	Shannon, Lynne J/A-1612-2015; Shin, Yunne-Jai/A-7575-2012; Moloney, Coleen/B-4363-2009	Shannon, Lynne J/0000-0001-7842-0636; Shin, Yunne-Jai/0000-0002-7259-9265; Moloney, Coleen/0000-0001-6663-8814; Travers-Trolet, Morgane/0000-0003-1493-662X	EUR-OCEANS Network of Excellence (European Commission) [FP6-511106]; European Collaborative Project MEECE (European Commission) [FP7-212085]; EMIBIOS project through French Foundation for Research on Biodiversity (FRB) [APP-SCEN-2010-II]	EUR-OCEANS Network of Excellence (European Commission)(European CommissionEuropean Commission Joint Research Centre); European Collaborative Project MEECE (European Commission); EMIBIOS project through French Foundation for Research on Biodiversity (FRB)	This work was partially funded by the EUR-OCEANS Network of Excellence (contract of the European Commission No FP6-511106), by the European Collaborative Project MEECE (contract of the European Commission No FP7-212085) and by the EMIBIOS project through a grant from the French Foundation for Research on Biodiversity (FRB), "Modeling and Scenarios of Biodiversity" call for proposals, grant number APP-SCEN-2010-II. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Breitburg DL, 2005, MARINE CONSERVATION; Carr ME, 2001, DEEP-SEA RES PT II, V49, P59; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Crozier LG, 2008, EVOL APPL, V1, P252, DOI 10.1111/j.1752-4571.2008.00033.x; Cury P, 2003, RESPONSIBLE FISHERIES IN THE MARINE ECOSYSTEM, P103, DOI 10.1079/9780851996332.0103; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; CURY P, 1989, CAN J FISH AQUAT SCI, V46, P670, DOI 10.1139/f89-086; da Silva A.M., 1994, ATLAS SURFACE MARINE, V6; Daan N, 2005, ICES J MAR SCI, V62, P177, DOI 10.1016/j.icesjms.2004.08.020; Daskalov GM, 2007, P NATL ACAD SCI USA, V104, P10518, DOI 10.1073/pnas.0701100104; Drinkwater KF, 2005, ICES J MAR SCI, V62, P1327, DOI 10.1016/j.icesjms.2005.05.015; Duboz R, 2010, ECOL MODEL, V221, P840, DOI 10.1016/j.ecolmodel.2009.11.023; Dunlop ES, 2009, EVOL APPL, V2, P246, DOI 10.1111/j.1752-4571.2009.00087.x; Durant JM, 2005, ECOL LETT, V8, P952, DOI 10.1111/j.1461-0248.2005.00798.x; Frank KT, 2006, ECOL LETT, V9, P1096, DOI 10.1111/j.1461-0248.2006.00961.x; Freon P, 2009, PROG OCEANOGR, V83, P97, DOI 10.1016/j.pocean.2009.07.034; Fulton EA, 2010, J MARINE SYST, V81, P171, DOI 10.1016/j.jmarsys.2009.12.012; Goni R, 1998, OCEAN COAST MANAGE, V40, P37, DOI 10.1016/S0964-5691(98)00037-4; Griffith GP, 2012, CONSERV BIOL, V26, P1145, DOI 10.1111/j.1523-1739.2012.01937.x; Griffiths MH, 2000, S AFR J MARINE SCI, V22, P81, DOI 10.2989/025776100784125663; Halpern BS, 2008, OCEAN COAST MANAGE, V51, P203, DOI 10.1016/j.ocecoaman.2007.08.002; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Henderson PA, 2011, J EXP MAR BIOL ECOL, V400, P78, DOI 10.1016/j.jembe.2011.02.028; Hunt GL, 2006, PROG OCEANOGR, V68, P115, DOI 10.1016/j.pocean.2006.02.008; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kone V, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002427; Laugen AT, 2014, FISH FISH, V15, P65, DOI 10.1111/faf.12007; Link JS, 2010, ICES J MAR SCI, V67, P787, DOI 10.1093/icesjms/fsp258; Miller EF, 2011, ICES J MAR SCI, V68, P2123, DOI 10.1093/icesjms/fsr167; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; Palkovacs EP, 2011, TRENDS ECOL EVOL, V26, P616, DOI 10.1016/j.tree.2011.08.004; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Payne AL, 1995, BIOL FISHERIES S AFR, P15; Penven P, 2001, S AFR J SCI, V97, P472; Perry RI, 2010, J MARINE SYST, V79, P427, DOI 10.1016/j.jmarsys.2008.12.017; Planque B, 2010, J MARINE SYST, V79, P403, DOI 10.1016/j.jmarsys.2008.12.018; Prince ED, 2006, FISH OCEANOGR, V15, P451, DOI 10.1111/j.1365-2419.2005.00393.x; Rademeyer RA, 2008, AFR J MAR SCI, V30, P263, DOI 10.2989/AJMS.2008.30.2.7.557; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; Roy C, 2007, AFR J MAR SCI, V29, P309, DOI 10.2989/AJMS.2007.29.3.1.331; Sala E, 2006, TRENDS ECOL EVOL, V21, P479, DOI 10.1016/j.tree.2006.07.006; Shannon LJ, 2003, J MARINE SYST, V39, P83, DOI 10.1016/S0924-7963(02)00250-6; Shannon LJ, 2000, ICES J MAR SCI, V57, P720, DOI 10.1006/jmsc.2000.0716; Shannon L, 2009, CLIMATE CHANGE AND SMALL PELAGIC FISH, P158; Shin YJ, 2005, ICES J MAR SCI, V62, P384, DOI 10.1016/j.icesjms.2005.01.004; Shin YJ, 2004, CAN J FISH AQUAT SCI, V61, P414, DOI 10.1139/F03-154; Shin YJ, 2001, AQUAT LIVING RESOUR, V14, P65, DOI 10.1016/S0990-7440(01)01106-8; Townsend CR, 2008, J APPL ECOL, V45, P1810, DOI 10.1111/j.1365-2664.2008.01548.x; Travers M, 2007, PROG OCEANOGR, V75, P751, DOI 10.1016/j.pocean.2007.08.001; Travers M, 2010, PROG OCEANOGR, V84, P118, DOI 10.1016/j.pocean.2009.09.014; Travers M, 2009, ECOL MODEL, V220, P3089, DOI 10.1016/j.ecolmodel.2009.08.016; Travers M, 2009, COUPLAGE MODELES TRO; Travers-Trolet M, 2014, AFR J MAR SCI, V36, P11, DOI 10.2989/1814232X.2014.883326; Vinebrooke RD, 2004, OIKOS, V104, P451, DOI 10.1111/j.0030-1299.2004.13255.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Ware DM, 2005, SCIENCE, V308, P1280, DOI 10.1126/science.1109049; Watermeyer KE, 2008, AFR J MAR SCI, V30, P351, DOI 10.2989/AJMS.2008.30.2.11.561; Watermeyer KE, 2008, AFR J MAR SCI, V30, P383, DOI 10.2989/AJMS.2008.30.2.12.562; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146	63	53	54	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94286	10.1371/journal.pone.0094286	http://dx.doi.org/10.1371/journal.pone.0094286			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710351	Green Submitted, Green Published, gold			2022-12-25	WOS:000334159800132
J	McGillivray, A; Golden, NA; Gautam, US; Mehra, S; Kaushal, D				McGillivray, Amanda; Golden, Nadia Abrahams; Gautam, Uma Shankar; Mehra, Smriti; Kaushal, Deepak			The Mycobacterium tuberculosis Rv2745c Plays an Important Role in Responding to Redox Stress	PLOS ONE			English	Article							SIGMA-FACTOR; GENE-EXPRESSION; REGULATES EXPRESSION; 2-COMPONENT SYSTEM; IMMUNOPATHOLOGY; PATHOGENESIS; MACROPHAGES; CHAPERONE; PATHWAY; MPRAB	Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is the leading cause of death from an infectious disease worldwide. Over the course of its life cycle in vivo, Mtb is exposed to a plethora of environmental stress conditions. Temporal regulation of genes involved in sensing and responding to such conditions is therefore crucial for Mtb to establish an infection. The Rv2745c (clgR) gene encodes a Clp protease gene regulator that is induced in response to a variety of stress conditions and potentially plays a role in Mtb pathogenesis. Our isogenic mutant, Mtb:Delta Rv2745c, is significantly more sensitive to in vitro redox stress generated by diamide, relative to wild-type Mtb as well as to a complemented strain. Together with the fact that the expression of Rv2745c is strongly induced in response to redox stress, these results strongly implicate a role for ClgR in the management of intraphagosomal redox stress. Additionally, we observed that redox stress led to the dysregulation of the expression of the sigma(H)/sigma(E) regulon in the isogenic mutant, Mtb:Delta Rv2745c. Furthermore, induction of clgR in Mtb and Mtb:Delta Rv2745c (comp) did not lead to Clp protease induction, indicating that clgR has additional functions that need to be elucidated. Our data, when taken together with that obtained by other groups, indicates that ClgR plays diverse roles in multiple regulatory networks in response to different stress conditions. In addition to redox stress, the expression of Rv2745c correlates with the expression of genes involved in sulfate assimilation as well as in response to hypoxia and reaeration. Clearly, the Mtb Rv2745c-encoded ClgR performs different functions during stress response and is important for the pathogenicity of Mtb in-vivo, regardless of its induction of the Clp proteolytic pathway.	[McGillivray, Amanda; Golden, Nadia Abrahams; Gautam, Uma Shankar; Kaushal, Deepak] Tulane Natl Primate Res Ctr, Div Bacteriol, Covington, LA 70433 USA; [McGillivray, Amanda; Golden, Nadia Abrahams; Gautam, Uma Shankar; Kaushal, Deepak] Tulane Natl Primate Res Ctr, Div Parasitol, Covington, LA USA; [McGillivray, Amanda; Kaushal, Deepak] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA; [Mehra, Smriti] Tulane Natl Primate Res Ctr, Div Microbiol, Covington, LA USA	Tulane University; Tulane University; Tulane University; Tulane University	Kaushal, D (corresponding author), Tulane Natl Primate Res Ctr, Div Bacteriol, Covington, LA 70433 USA.	dkaushal@tulane.edu	GAUTAM, UMA/AAI-1531-2021; Uma S Gautam, MSc/H-3474-2019	Uma S Gautam, MSc/0000-0003-0326-6325	NIH [AI089323, HL106790, AI091457, RR026006, RR020159, RR000164/OD011104, C06AI058609]; Louisiana Board of Regents [LEQSF (2007-12)-ENHPKSFI-PRS]; Tulane Research Enhancement Fund; Tulane Center for Infectious Diseases; Tulane National Primate Research Center Office; Tulane Office of the Vice-President for Research; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR026006, P20RR020159] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI091457, R01AI089323] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Louisiana Board of Regents; Tulane Research Enhancement Fund; Tulane Center for Infectious Diseases; Tulane National Primate Research Center Office; Tulane Office of the Vice-President for Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the NIH grants AI089323, with additional support from NIH grants HL106790, AI091457, RR026006, RR020159, RR000164/ OD011104 and C06AI058609. Additionally, the authors also acknowledge the support from the Louisiana Board of Regents (LEQSF (2007-12)-ENHPKSFI-PRS), the Tulane Research Enhancement Fund, the Tulane Center for Infectious Diseases, the Tulane National Primate Research Center Office of the Director and a Bridge Award from the Tulane Office of the Vice-President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren D, 2008, J BIOL CHEM, V283, P31567, DOI 10.1074/jbc.M804877200; Arko-Mensah J, 2007, SCAND J IMMUNOL, V65, P148, DOI 10.1111/j.1365-3083.2006.01888.x; Ascenzi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069762; Barik S, 2010, MOL MICROBIOL, V75, P592, DOI 10.1111/j.1365-2958.2009.07008.x; Bellier A, 2004, J BACTERIOL, V186, P3238, DOI 10.1128/JB.186.10.3238-3248.2004; Bhat SA, 2012, FREE RADICAL BIO MED, V53, P1625, DOI 10.1016/j.freeradbiomed.2012.08.008; Dutta NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028958; Dutta NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010069; Dye C, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0365; Estorninho M, 2010, MICROBIOL-SGM, V156, P3445, DOI 10.1099/mic.0.042275-0; Fontan PA, 2009, J BACTERIOL, V191, P5628, DOI 10.1128/JB.00510-09; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Hatzios SK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002036; He HJ, 2006, J BACTERIOL, V188, P2134, DOI 10.1128/JB.188.6.2134-2143.2006; Hernandez-Abanto SM, 2006, ARCH MICROBIOL, V186, P459, DOI 10.1007/s00203-006-0160-2; Jeena PM, 2001, B WORLD HEALTH ORGAN, V79, P337; Jurgenson CT, 2008, BIOCHEMISTRY-US, V47, P10354, DOI 10.1021/bi800915j; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Kumar A, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002079; Larsen Michelle H, 2007, Curr Protoc Microbiol, VChapter 10, DOI 10.1002/9780471729259.mc10a02s6; Manganelli R, 2004, INFECT IMMUN, V72, P3038, DOI 10.1128/IAI.72.5.3038-3041.2004; Manganelli R, 2002, MOL MICROBIOL, V45, P365, DOI 10.1046/j.1365-2958.2002.03005.x; Mehra S, 2012, J INFECT DIS, V205, P1203, DOI 10.1093/infdis/jis102; Mehra S, 2010, J INFECT DIS, V202, P943, DOI 10.1086/654820; Mehra S, 2009, J BACTERIOL, V191, P3965, DOI 10.1128/JB.00064-09; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; Pang XH, 2007, J BACTERIOL, V189, P6213, DOI 10.1128/JB.00492-07; Personne Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060228; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Rohde KH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002769; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Sachdeva P, 2010, FEBS J, V277, P605, DOI 10.1111/j.1742-4658.2009.07479.x; Sherrid AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011622; Stewart GR, 2005, MOL MICROBIOL, V55, P1127, DOI 10.1111/j.1365-2958.2004.04450.x; Vandal OH, 2009, J BACTERIOL, V191, P4714, DOI 10.1128/JB.00305-09; Wang Y, 2011, J BIOL CHEM, V286, P31159, DOI 10.1074/jbc.M111.241802; World Health Organization, 2012, GLOB TUB REP 2012 IR, Vviii	38	20	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93604	10.1371/journal.pone.0093604	http://dx.doi.org/10.1371/journal.pone.0093604			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705585	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500047
J	Korneeva, VA; Trubetskov, MM; Korshunova, AV; Lushchekina, SV; Kolyadko, VN; Sergienko, OV; Lunin, VG; Panteleev, MA; Ataullakhanov, FI				Korneeva, Vera A.; Trubetskov, Mikhail M.; Korshunova, Alena V.; Lushchekina, Sofya V.; Kolyadko, Vladimir N.; Sergienko, Olga V.; Lunin, Vladimir G.; Panteleev, Mikhail A.; Ataullakhanov, Fazoil I.			Interactions Outside the Proteinase-binding Loop Contribute Significantly to the Inhibition of Activated Coagulation Factor XII by Its Canonical Inhibitor from Corn	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Blood Coagulation Factors; Enzyme Kinetics; Enzyme Mechanisms; Protease Inhibitor; Protein Expression; Protein-Protein Interactions; Serine Protease	TRYPSIN-INHIBITOR; HAGEMAN-FACTOR; ESCHERICHIA-COLI; REACTIVE-SITE; WEB SERVER; PEPTIDE; DOCKING; ELECTROSTATICS; PURIFICATION; CHYMOTRYPSIN	Background: Canonical inhibitors interact with cognate proteases through a protease-binding loop. Results: Protease-binding loop of corn Hageman factor inhibitor (CHFI) does not inhibit its cognate enzyme-activated coagulation factor XII (FXIIa). Conclusion: Nonloop regions of CHFI are required for specific inhibition of FXIIa. Significance: CHFI is the first canonical inhibitor whose protease-binding loop is not sufficient for cognate enzyme inhibition. Activated factor XII (FXIIa) is selectively inhibited by corn Hageman factor inhibitor (CHFI) among other plasma proteases. CHFI is considered a canonical serine protease inhibitor that interacts with FXIIa through its protease-binding loop. Here we examined whether the protease-binding loop alone is sufficient for the selective inhibition of serine proteases or whether other regions of a canonical inhibitor are involved. Six CHFI mutants lacking different N- and C-terminal portions were generated. CHFI-234, which lacks the first and fifth disulfide bonds and 11 and 19 amino acid residues at the N and C termini, respectively, exhibited no significant changes in FXIIa inhibition (K-i = 3.2 +/- 0.4 nm). CHFI-123, which lacks 34 amino acid residues at the C terminus and the fourth and fifth disulfide bridges, inhibited FXIIa with a K-i of 116 +/- 16 nm. To exclude interactions outside the FXIIa active site, a synthetic cyclic peptide was tested. The peptide contained residues 20-45 (Protein Data Bank code 1BEA), and a C29D substitution was included to avoid unwanted disulfide bond formation between unpaired cysteines. Surprisingly, the isolated protease-binding loop failed to inhibit FXIIa but retained partial inhibition of trypsin (K-i = 11.7 +/- 1.2 m) and activated factor XI (K-i = 94 +/- 11 m). Full-length CHFI inhibited trypsin with a K-i of 1.3 +/- 0.2 nm and activated factor XI with a K-i of 5.4 +/- 0.2 m. Our results suggest that the protease-binding loop is not sufficient for the interaction between FXIIa and CHFI; other regions of the inhibitor also contribute to specific inhibition.	[Korneeva, Vera A.; Trubetskov, Mikhail M.; Kolyadko, Vladimir N.; Panteleev, Mikhail A.; Ataullakhanov, Fazoil I.] Russian Acad Sci, Ctr Theoret Problems Physicochem Pharmacol, Lab Mol Mech Hemostasis, Moscow 119991, Russia; [Trubetskov, Mikhail M.; Panteleev, Mikhail A.; Ataullakhanov, Fazoil I.] Moscow MV Lomonosov State Univ, Dept Phys, Moscow 119992, Russia; [Korshunova, Alena V.; Panteleev, Mikhail A.; Ataullakhanov, Fazoil I.] HemaCore LLC, Res Dept, Moscow 125319, Russia; [Lushchekina, Sofya V.] Russian Acad Sci, Emanuel Inst Biochem Phys, Lab Comp Modeling Biomol Syst & Nanomat, Moscow 119334, Russia; [Sergienko, Olga V.] Russian Acad Agr Sci, Inst Agr Biotechnol, Lab Mol Diagnost & Genet Engn, Moscow 127550, Russia; [Lunin, Vladimir G.] Minist Hlth & Social Dev, Gamaleya Inst Epidemiol & Microbiol Russian Feder, Lab Biol Act Nanostruct, Moscow 123098, Russia; [Panteleev, Mikhail A.; Ataullakhanov, Fazoil I.] Minist Hlth Russian Federat, Sci Clin Ctr Pediat Hematol Oncol & Immunol, Div Res, Moscow 117997, Russia; [Panteleev, Mikhail A.; Ataullakhanov, Fazoil I.] Moscow Inst Phys & Technol, Dept Translat & Regenerat Med, Dolgoprudnyi 141700, Moscow Region, Russia	Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences; Russian Academy of Sciences; Lomonosov Moscow State University; Russian Academy of Sciences; Emanuel Institute of Biochemical Physics; All-Russia Research Institute of Agricultural Biotechnology; Ministry of Health of the Russian Federation; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS; Ministry of Health of the Russian Federation; Moscow Institute of Physics & Technology	Panteleev, MA (corresponding author), Natl Res Ctr Hematol, 4 Novyi Zykovskii Proezd, Moscow 125167, Russia.	mapanteleev@yandex.ru	Panteleev, Mikhail A/H-5491-2012; Lushchekina, Sofya/F-8469-2010; Ataullakhanov, Fazoil/J-8076-2012; Ataullakhanov, Fazoil/O-3458-2019; Zhivotova, Vera/E-4766-2014	Panteleev, Mikhail A/0000-0002-8128-7757; Lushchekina, Sofya/0000-0002-6922-020X; Trubetskov, Mikhail/0000-0003-2049-870X; Zhivotova, Vera/0000-0003-2937-1190; Kolyadko, Vladimir/0000-0003-4008-2461	Russian Foundation for Basic Research [14-04-00670, 12-04-00438]; Russian Academy of Sciences Presidium Basic Research Program "Molecular and Cellular Biology"; Fund UMA	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Academy of Sciences Presidium Basic Research Program "Molecular and Cellular Biology"; Fund UMA	This work was supported by Russian Foundation for Basic Research Grants 14-04-00670 and 12-04-00438 and by the Russian Academy of Sciences Presidium Basic Research Program "Molecular and Cellular Biology." This work was also supported by a grant from Fund UMA.	Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Behnke CA, 1998, BIOCHEMISTRY-US, V37, P15277, DOI 10.1021/bi9812266; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Brauer ABE, 2002, J BIOMOL STRUCT DYN, V20, P59, DOI 10.1080/07391102.2002.10506822; BURKHARD RK, 1979, J AGR FOOD CHEM, V27, P452, DOI 10.1021/jf60222a023; Chelliah V, 2006, J MOL BIOL, V357, P1669, DOI 10.1016/j.jmb.2006.01.001; Chen ZY, 1999, APPL ENVIRON MICROB, V65, P1320; Cheng TMK, 2007, PROTEINS, V68, P503, DOI 10.1002/prot.21419; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Dahl ACE, 2012, BIOINFORMATICS, V28, P2193, DOI 10.1093/bioinformatics/bts357; Faulkner MJ, 2008, P NATL ACAD SCI USA, V105, P6735, DOI 10.1073/pnas.0801986105; Fernandez JH, 2007, GENET MOL RES, V6, P846; Fradera X, 2012, ACTA CRYSTALLOGR F, V68, P404, DOI 10.1107/S1744309112009037; Froger Alexandrine, 2007, J Vis Exp, P253, DOI 10.3791/253; Gailani D, 2009, J THROMB HAEMOST, V7, P1840, DOI 10.1111/j.1538-7836.2009.03591.x; Hazegh-Azam M, 1998, PROTEIN EXPRES PURIF, V13, P143, DOI 10.1006/prep.1998.0882; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOJIMA Y, 1980, THROMB RES, V20, P149, DOI 10.1016/0049-3848(80)90381-3; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson RM, 2000, J MOL BIOL, V296, P325, DOI 10.1006/jmbi.1999.3389; Jimenez-Garcia B, 2013, BIOINFORMATICS, V29, P1698, DOI 10.1093/bioinformatics/btt262; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Krowarsch D, 2003, CELL MOL LIFE SCI, V60, P2427, DOI 10.1007/s00018-003-3120-x; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LEI MG, 1987, THROMB RES, V45, P87, DOI 10.1016/0049-3848(87)90259-3; Li JX, 2008, BIOCHIMIE, V90, P1356, DOI 10.1016/j.biochi.2008.04.005; Li JX, 2007, FASEB J, V21, P2466, DOI 10.1096/fj.06-7966com; Li JX, 2007, GENOMICS, V89, P413, DOI 10.1016/j.ygeno.2006.11.013; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Luckett S, 1999, J MOL BIOL, V290, P525, DOI 10.1006/jmbi.1999.2891; MAHONEY WC, 1984, J BIOL CHEM, V259, P8412; McBride JD, 2002, BIOPOLYMERS, V66, P79, DOI 10.1002/bip.10228; Mucsi Z, 2003, PROTEIN ENG, V16, P673, DOI 10.1093/protein/gzg090; OZAWA K, 1966, J BIOL CHEM, V241, P3955; Pauer HU, 2004, THROMB HAEMOSTASIS, V92, P503, DOI 10.1160/TH04-04-0250; Pham M, 2010, NEUROIMAGE, V49, P2907, DOI 10.1016/j.neuroimage.2009.11.061; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RATNOFF OD, 1955, J CLIN INVEST, V34, P602, DOI 10.1172/JCI103109; Raveh B, 2010, PROTEINS, V78, P2029, DOI 10.1002/prot.22716; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI [10.1093/nar/gkt953, 10.1093/nar/gkr987]; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; Sadovnichy V., 2013, LOMONOSOV SUPERCOMPU, P283; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salinas G, 2011, BIOTECHNOL J, V6, P686, DOI 10.1002/biot.201000335; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schmaier AH, 2007, J THROMB HAEMOST, V5, P2323, DOI 10.1111/j.1538-7836.2007.02770.x; SEEMULLER U, 1977, H-S Z PHYSIOL CHEM, V358, P1105, DOI 10.1515/bchm2.1977.358.2.1105; SWARTZ MJ, 1977, J BIOL CHEM, V252, P8105; Toledano MB, 2007, FEBS LETT, V581, P3598, DOI 10.1016/j.febslet.2007.07.002; Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055; Wu Y, 2007, P NATL ACAD SCI USA, V104, P19784, DOI 10.1073/pnas.0708251104; Yau JW, 2012, ACTA BIOMATER, V8, P4092, DOI 10.1016/j.actbio.2012.07.019	59	8	8	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14109	14120		10.1074/jbc.M114.553735	http://dx.doi.org/10.1074/jbc.M114.553735			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24706752	Green Published, hybrid			2022-12-25	WOS:000335984600039
J	Churkin, A; Avihoo, A; Shapira, M; Barash, D				Churkin, Alexander; Avihoo, Assaf; Shapira, Michal; Barash, Danny			RNAthermsw: Direct Temperature Simulations for Predicting the Location of RNA Thermometers	PLOS ONE			English	Article							SECONDARY STRUCTURE; MESSENGER-RNA; THERMOSENSOR; TRANSLATION; ELEMENTS; SERVER	The mechanism of RNA thermometers is a subject of growing interest. Also known as RNA thermosensors, these temperature-sensitive segments of the mRNA regulate gene expression by changing their secondary structure in response to temperature fluctuations. The detection of RNA thermometers in various genes of interest is valuable as it could lead to the discovery of new thermometers participating in fundamental processes such as preferential translation during heatshock. RNAthermsw is a user-friendly webserver for predicting the location of RNA thermometers using direct temperature simulations. It operates by analyzing dotted figures generated as a result of a moving window that performs successive energy minimization folding predictions. Inputs include the RNA sequence, window size, and desired temperature change. RNAthermsw can be freely accessed at http://www.cs.bgu.ac.il/similar to rnathemsw/RNAthemsw/ (with the slash sign at the end). The website contains a help page with explanations regarding the exact usage.	[Churkin, Alexander; Barash, Danny] Ben Gurion Univ Negev, Dept Comp Sci, IL-84105 Beer Sheva, Israel; [Avihoo, Assaf] Microsoft Res Israel, Herzliyya, Israel; [Shapira, Michal] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Barash, D (corresponding author), Ben Gurion Univ Negev, Dept Comp Sci, IL-84105 Beer Sheva, Israel.	dbarash@cs.bgu.ac.il		Shapira, Michal/0000-0002-6164-7874	Kreitman Foundation at Ben-Gurion University	Kreitman Foundation at Ben-Gurion University	This work was supported by the Kreitman Foundation at Ben-Gurion University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 2004, J BIOL CHEM, V279, P49919, DOI 10.1074/jbc.M404681200; Avihoo A, 2005, IEEE COMP SYST BIOIN, P235; Avihoo A, 2011, THESIS B GURION U BE; Chowdhury S, 2003, J BIOL CHEM, V278, P47915, DOI 10.1074/jbc.M306874200; Chowdhury S, 2006, EMBO J, V25, P2487, DOI 10.1038/sj.emboj.7601128; Chursov A, 2013, NUCLEIC ACIDS RES, V41, pW486, DOI 10.1093/nar/gkt486; DING Y, 2013, NATURE, DOI DOI 10.1038/NATURE12756; Giuliodori AM, 2010, MOL CELL, V37, P21, DOI 10.1016/j.molcel.2009.11.033; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hofacker IL, 2004, BIOINFORMATICS, V20, P186, DOI 10.1093/bioinformatics/btg388; Kortmann J, 2012, NAT REV MICROBIOL, V10, P255, DOI 10.1038/nrmicro2730; Kortmann J, 2011, NUCLEIC ACIDS RES, V39, P2855, DOI 10.1093/nar/gkq1252; Mandal M, 2004, NAT REV MOL CELL BIO, V5, P451, DOI 10.1038/nrm1403; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Mortimer Stefanie A, 2012, Curr Protoc Chem Biol, V4, P275, DOI 10.1002/9780470559277.ch120019; Narberhaus F, 2006, FEMS MICROBIOL REV, V30, P3, DOI 10.1111/j.1574-6976.2005.004.x; Nocker A, 2001, NUCLEIC ACIDS RES, V29, P4800, DOI 10.1093/nar/29.23.4800; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; Shah P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011308; Waldminghaus T, 2007, MOL GENET GENOMICS, V278, P555, DOI 10.1007/s00438-007-0272-7; Waldminghaus T, 2007, MOL MICROBIOL, V65, P413, DOI 10.1111/j.1365-2958.2007.05794.x; Waldminghaus T, 2009, RNA BIOL, V6, P455, DOI 10.4161/rna.6.4.9014; Wan Y, 2012, MOL CELL, V48, P169, DOI 10.1016/j.molcel.2012.08.008; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	27	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94340	10.1371/journal.pone.0094340	http://dx.doi.org/10.1371/journal.pone.0094340			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718440	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000106
J	Cusick, MF; Libbey, JE; Trede, NS; Fujinami, RS				Cusick, Matthew F.; Libbey, Jane E.; Trede, Nikolaus S.; Fujinami, Robert S.			Targeting Insulin-Like Growth Factor 1 Leads to Amelioration of Inflammatory Demyelinating Disease	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MYELIN PROTEOLIPID PROTEIN; MULTIPLE-SCLEROSIS; FACTOR-I; GLATIRAMER ACETATE; ZEBRAFISH SCREEN; IMMUNE-RESPONSES; SYSTEM; VIRUS	In patients with multiple sclerosis ( MS) and in mice with experimental autoimmune encephalomyelitis (EAE), proliferating autoreactive T cells play an important role in the pathogenesis of the disease. Due to the importance of these myelin-specific T cells, these cells have been therapeutic targets in a variety of treatments. Previously we found that Lenaldekar (LDK), a novel small molecule, could inhibit exacerbations in a preclinical model of MS when given at the start of an EAE exacerbation. In those studies, we found that LDK could inhibit human T cell recall responses and murine myelin responses in vitro. In these new studies, we found that LDK could inhibit myelin specific T cell responses through the insulin-like growth factor-1 receptor (IGF-1R) pathway. Alteration of this pathway led to marked reduction in T cell proliferation and expansion. Blocking this pathway could account for the observed decreases in clinical signs and inflammatory demyelinating disease, which was accompanied by axonal preservation. Our data indicate that IGF-1R could be a potential target for new therapies for the treatment of autoimmune diseases where autoreactive T cell expansion is a requisite for disease.	[Cusick, Matthew F.; Libbey, Jane E.; Fujinami, Robert S.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA; [Trede, Nikolaus S.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT USA; [Trede, Nikolaus S.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Trede, Nikolaus S.] Univ Utah, Dept Pediat, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Fujinami, RS (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA.	Robert.Fujinami@hsc.utah.edu		Cusick, Matthew/0000-0002-0383-9747	Emma Mary Deland Foundation; NIH [T32AI055434]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055434] Funding Source: NIH RePORTER	Emma Mary Deland Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this research was from the Emma Mary Deland Foundation (RSF) and NIH T32AI055434 (MFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed R, 1992, Semin Immunol, V4, P105; Aranami Toshimasa, 2008, Allergol Int, V57, P115, DOI 10.2332/allergolint.R-07-159; BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3; Blanchette F, 2008, J NEUROL, V255, P26, DOI 10.1007/s00415-008-1005-5; Brennan DC, 2013, REV MED VIROL, V23, P97, DOI 10.1002/rmv.1733; BROWN A, 1982, LAB INVEST, V46, P171; Cannella B, 2000, AM J PATHOL, V157, P933, DOI 10.1016/S0002-9440(10)64606-8; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cusick MF, 2012, J NEUROIMMUNOL, V244, P35, DOI 10.1016/j.jneuroim.2011.12.024; Donia M, 2009, J AUTOIMMUN, V33, P135, DOI 10.1016/j.jaut.2009.06.003; Frank JA, 2002, MULT SCLER, V8, P24, DOI 10.1191/1352458502ms768oa; Genoud S, 2005, J NEUROIMMUNOL, V168, P40, DOI 10.1016/j.jneuroim.2005.06.033; Graumann U, 2003, BRAIN PATHOL, V13, P554, DOI 10.1111/j.1750-3639.2003.tb00485.x; Hafler DA, 2004, J CLIN INVEST, V113, P788, DOI 10.1172/JCI200421357; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Karandikar NJ, 2002, J CLIN INVEST, V109, P641, DOI 10.1172/JCI200214380; Kirkman NJ, 2010, EPILEPSIA, V51, P454, DOI 10.1111/j.1528-1167.2009.02390.x; Lassmann H, 2010, EXP NEUROL, V225, P2, DOI 10.1016/j.expneurol.2009.10.009; Li W, 1998, J NEUROPATH EXP NEUR, V57, P426; Libbey JE, 2011, VACCINE, V29, P3356, DOI 10.1016/j.vaccine.2010.08.103; Libbey JE, 2010, J NEUROIMMUNE PHARM, V5, P168, DOI 10.1007/s11481-010-9215-x; Lovett-Racke AE, 1998, J CLIN INVEST, V101, P1797, DOI 10.1172/JCI1486; McMorris FA, 1996, BRAIN PATHOL, V6, P313, DOI 10.1111/j.1750-3639.1996.tb00858.x; Paintlia AS, 2010, GLIA, V58, P1669, DOI 10.1002/glia.21039; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Ridges S, 2012, BLOOD, V119, P5621, DOI 10.1182/blood-2011-12-398818; Sagnelli E, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/945950; Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3; SOBEL RA, 1990, J NEUROPATH EXP NEUR, V49, P468, DOI 10.1097/00005072-199009000-00002; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; Sun X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009380; Theil DJ, 2001, J NEUROVIROL, V7, P220; Tsunoda I, 1998, J NEUROPATH EXP NEUR, V57, P758, DOI 10.1097/00005072-199808000-00005; Tsunoda I, 1997, VIROLOGY, V228, P388, DOI 10.1006/viro.1996.8382; Tsunoda I, 2003, AM J PATHOL, V162, P1259, DOI 10.1016/S0002-9440(10)63922-3; Tsunoda I, 2001, J VIROL, V75, P7494, DOI 10.1128/JVI.75.16.7494-7505.2001; Tsunoda I, 1996, J NEUROPATH EXP NEUR, V55, P673, DOI 10.1097/00005072-199606000-00001; TUOHY VK, 1989, J IMMUNOL, V142, P1523; Ulfig N, 1998, CELL TISSUE RES, V291, P433, DOI 10.1007/s004410051013; Webster HD, 1997, MULT SCLER J, V3, P113, DOI 10.1177/135245859700300210; Wu Tianfu, 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P145	41	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94486	10.1371/journal.pone.0094486	http://dx.doi.org/10.1371/journal.pone.0094486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718491	gold, Green Submitted, Green Published			2022-12-25	WOS:000334339000127
J	Kaplan, I; McArt, SH; Thaler, JS				Kaplan, Ian; McArt, Scott H.; Thaler, Jennifer S.			Plant Defenses and Predation Risk Differentially Shape Patterns of Consumption, Growth, and Digestive Efficiency in a Guild of Leaf- Chewing Insects	PLOS ONE			English	Article							STRESS; TOMATO; HERBIVORES; RESISTANCE; JASMONATE; PREY; RESPONSES; TADPOLES; BEHAVIOR; LARVAE	Herbivores are squeezed between the two omnipresent threats of variable food quality and natural enemy attack, but these two factors are not independent of one another. The mechanisms by which organisms navigate the dual challenges of foraging while avoiding predation are poorly understood. We tested the effects of plant defense and predation risk on herbivory in an assemblage of leaf-chewing insects on Solanum lycopersicum (tomato) that included two Solanaceae specialists (Manduca sexta and Leptinotarsa decemlineata) and one generalist (Trichoplusia ni). Defenses were altered using genetic manipulations of the jasmonate phytohormonal cascade, whereas predation risk was assessed by exposing herbivores to cues from the predaceous stink bug, Podisus maculiventris. Predation risk reduced herbivore food intake by an average of 29% relative to predator-free controls. Interestingly, this predator-mediated impact on foraging behavior largely attenuated when quantified in terms of individual growth rate. Only one of the three species experienced lower body weight under predation risk and the magnitude of this effect was small (17% reduction) compared with effects on foraging behavior. Manduca sexta larvae, compensated for their predator-induced reduction in food intake by more effectively converting leaf tissue to body mass. They also had higher whole-body lipid content when exposed to predators, suggesting that individuals convert energy to storage forms to draw upon when risk subsides. In accordance with expectations based on insect diet breadth, plant defenses tended to have a stronger impact on consumption and growth in the generalist than the two specialists. These data both confirm the ecological significance of predators in the foraging behavior of herbivorous prey and demonstrate how sophisticated compensatory mechanisms allow foragers to partially offset the detrimental effects of reduced food intake. The fact that these mechanisms operated across a wide range of plant resistance phenotypes suggests that compensation is not always constrained by reduced food quality.	[Kaplan, Ian] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [McArt, Scott H.; Thaler, Jennifer S.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [McArt, Scott H.; Thaler, Jennifer S.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Cornell University; Cornell University	Kaplan, I (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	ikaplan@purdue.edu			National Research Initiative of the USDA Cooperative State Research, Education and Extension Service [2006-35302-17431]	National Research Initiative of the USDA Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This project was supported by the National Research Initiative of the USDA Cooperative State Research, Education and Extension Service, Grant no. 2006-35302-17431 to JST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; Anholt BR, 1998, EVOL ECOL, V12, P729, DOI 10.1023/A:1006589616931; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Beckerman AP, 1997, P NATL ACAD SCI USA, V94, P10735, DOI 10.1073/pnas.94.20.10735; Bernays EA, 1997, ECOL ENTOMOL, V22, P121, DOI 10.1046/j.1365-2311.1997.00042.x; Bronmark C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030467; Castellanos I, 2006, ANIM BEHAV, V72, P461, DOI 10.1016/j.anbehav.2006.02.005; Chapman RF., 2012, INSECTS STRUCTURE FU; Christianson D, 2010, ECOLOGY, V91, P1184, DOI 10.1890/09-0221.1; Coors A, 2008, J APPL ECOL, V45, P1820, DOI 10.1111/j.1365-2664.2008.01566.x; Cornell HV, 2003, AM NAT, V161, P507, DOI 10.1086/368346; Danner BJ, 2003, OECOLOGIA, V137, P352, DOI 10.1007/s00442-003-1362-9; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Denno R.F., 1983, VARIABLE PLANTS HERB; Erb M, 2012, TRENDS PLANT SCI, V17, P250, DOI 10.1016/j.tplants.2012.01.003; FRITZ RS, 1992, PLANT RESISTANCE HER; Gotthard K, 2000, J ANIM ECOL, V69, P896, DOI 10.1046/j.1365-2656.2000.00432.x; Griffin CAM, 2006, ECOL LETT, V9, P335, DOI 10.1111/j.1461-0248.2005.00880.x; Hawlena D, 2010, AM NAT, V176, P537, DOI 10.1086/656495; Hawlena D, 2010, P NATL ACAD SCI USA, V107, P15503, DOI 10.1073/pnas.1009300107; HOO CRS, 1984, ENVIRON ENTOMOL, V13, P843, DOI 10.1093/ee/13.3.843; Howe GA, 1996, PLANT CELL, V8, P2067, DOI 10.1105/tpc.8.11.2067; HSIAO TH, 1968, ANN ENTOMOL SOC AM, V61, P485, DOI 10.1093/aesa/61.2.485; Janssens L, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0350; Johansson F, 2009, J ANIM ECOL, V78, P772, DOI 10.1111/j.1365-2656.2009.01530.x; Kaplan I, 2010, OIKOS, V119, P1105, DOI 10.1111/j.1600-0706.2009.18311.x; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kennedy GG, 2003, ANNU REV ENTOMOL, V48, P51, DOI 10.1146/annurev.ento.48.091801.112733; Lavoie B, 2004, ENVIRON ENTOMOL, V33, P1062, DOI 10.1603/0046-225X-33.4.1062; Li L, 2004, PLANT CELL, V16, P126, DOI 10.1105/tpc.017954; Li L, 2002, P NATL ACAD SCI USA, V99, P6416, DOI 10.1073/pnas.072072599; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; McConn M, 1997, P NATL ACAD SCI USA, V94, P5473, DOI 10.1073/pnas.94.10.5473; MORAN N, 1980, J THEOR BIOL, V86, P247, DOI 10.1016/0022-5193(80)90004-1; OROZCOCARDENAS M, 1993, P NATL ACAD SCI USA, V90, P8273, DOI 10.1073/pnas.90.17.8273; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Preisser EL, 2009, J ANIM ECOL, V78, P1103, DOI 10.1111/j.1365-2656.2009.01602.x; Rayapuram C, 2006, PLANT CELL ENVIRON, V29, P1585, DOI 10.1111/j.1365-3040.2006.01534.x; Relyea RA, 2004, ENVIRON TOXICOL CHEM, V23, P1080, DOI 10.1897/03-259; Relyea RA, 2001, P NATL ACAD SCI USA, V98, P2491, DOI 10.1073/pnas.031076198; Relyea RA, 2003, ECOL APPL, V13, P1515, DOI 10.1890/02-5298; Relyea RA, 1999, ECOLOGY, V80, P2117, DOI 10.1890/0012-9658(1999)080[2117:QTRBPI]2.0.CO;2; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schmitz OJ, 1998, AM NAT, V151, P327, DOI 10.1086/286122; Schmitz OJ, 2001, ECOLOGY, V82, P2072, DOI 10.1890/0012-9658(2001)082[2072:EOTPSO]2.0.CO;2; Scott IM, 2010, J CHEM ECOL, V36, P490, DOI 10.1007/s10886-010-9780-8; Sheriff MJ, 2009, J ANIM ECOL, V78, P1249, DOI 10.1111/j.1365-2656.2009.01552.x; SLANSKY F, 1977, ECOL MONOGR, V47, P209, DOI 10.2307/1942617; Slansky F. J. R., 1985, COMPREHENSIVE INSECT, V8, P88; Slos S, 2008, FUNCT ECOL, V22, P637, DOI 10.1111/j.1365-2435.2008.01424.x; Stamp NE, 1993, CATERPILLARS ECOLOGI; Steiner UK, 2007, ANIM BEHAV, V74, P1473, DOI 10.1016/j.anbehav.2007.02.016; Steppuhn A, 2007, ECOL LETT, V10, P499, DOI 10.1111/j.1461-0248.2007.01045.x; Thaler JS, 2008, ENTOMOL EXP APPL, V128, P34, DOI 10.1111/j.1570-7458.2008.00737.x; Thaler JS, 2012, P NATL ACAD SCI USA, V109, P12075, DOI 10.1073/pnas.1208070109; Thaler JS, 2002, ECOL LETT, V5, P764, DOI 10.1046/j.1461-0248.2002.00388.x; Thaler JS, 2001, ECOL ENTOMOL, V26, P312, DOI 10.1046/j.1365-2311.2001.00324.x; Thaler JS, ECOLOGICAL IN PRESS; Tilmon KJ, 2008, EVOLUTIONARY BIOL HE; VANHANDEL E, 1988, J AM MOSQUITO CONTR, V4, P549; Waldbauer G. P., 1968, P229, DOI 10.1016/S0065-2806(08)60230-1; Warburg MS, 1997, OECOLOGIA, V112, P314, DOI 10.1007/s004420050314; White T. C. R., 1993, INADEQUATE ENV NITRO; YAMAMOTO ROBERT T., 1960, ANN ENT SOC AMER, V53, P503, DOI 10.1093/aesa/53.4.503; Zanette LY, 2011, SCIENCE, V334, P1398, DOI 10.1126/science.1210908	65	35	35	1	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93714	10.1371/journal.pone.0093714	http://dx.doi.org/10.1371/journal.pone.0093714			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718036	gold, Green Submitted, Green Published			2022-12-25	WOS:000334339000043
J	Fan, Z; Sehm, T; Rauh, M; Buchfelder, M; Eyupoglu, IY; Savaskan, NE				Fan, Zheng; Sehm, Tina; Rauh, Manfred; Buchfelder, Michael; Eyupoglu, Ilker Y.; Savaskan, Nicolai E.			Dexamethasone Alleviates Tumor-Associated Brain Damage and Angiogenesis	PLOS ONE			English	Article							TEMOZOLOMIDE-INDUCED APOPTOSIS; NEURONAL CELL-DEATH; VASCULAR-PERMEABILITY; MALIGNANT GLIOMAS; ENERGY-METABOLISM; KINASE INHIBITOR; GLIOBLASTOMA; RECEPTOR; CANCER; BEVACIZUMAB	Children and adults with the most aggressive form of brain cancer, malignant gliomas or glioblastoma, often develop cerebral edema as a life-threatening complication. This complication is routinely treated with dexamethasone (DEXA), a steroidal anti-inflammatory drug with pleiotropic action profile. Here we show that dexamethasone reduces murine and rodent glioma tumor growth in a concentration-dependent manner. Low concentrations of DEXA are already capable of inhibiting glioma cell proliferation and at higher levels induce cell death. Further, the expression of the glutamate antiporter xCT (system Xc(-); SLC7a11) and VEGFA is up-regulated after DEXA treatment indicating early cellular stress responses. However, in human gliomas DEXA exerts differential cytotoxic effects, with some human glioma cells (U251, T98G) resistant to DEXA, a finding corroborated by clinical data of dexamethasone non-responders. Moreover, DEXA-resistant gliomas did not show any xCT alterations, indicating that these gene expressions are associated with DEXA-induced cellular stress. Hence, siRNA-mediated xCT knockdown in glioma cells increased the susceptibility to DEXA. Interestingly, cell viability of primary human astrocytes and primary rodent neurons is not affected by DEXA. We further tested the pharmacological effects of DEXA on brain tissue and showed that DEXA reduces tumor-induced disturbances of the microenvironment such as neuronal cell death and tumor-induced angiogenesis. In conclusion, we demonstrate that DEXA inhibits glioma cell growth in a concentration and species-dependent manner. Further, DEXA executes neuroprotective effects in brains and reduces tumor-induced angiogenesis. Thus, our investigations reveal that DEXA acts pleiotropically and impacts tumor growth, tumor vasculature and tumor-associated brain damage.	[Fan, Zheng; Sehm, Tina; Buchfelder, Michael; Eyupoglu, Ilker Y.; Savaskan, Nicolai E.] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Neurosurg, D-91054 Erlangen, Bavaria, Germany; [Rauh, Manfred] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Pediat & Adolescent Med, D-91054 Erlangen, Bavaria, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Savaskan, NE (corresponding author), Univ Erlangen Nurnberg, Univ Hosp Erlangen, Dept Neurosurg, D-91054 Erlangen, Bavaria, Germany.	savaskan@gmx.net	Savaskan, Nicolai/D-2923-2018	Savaskan, Nicolai/0000-0003-1348-094X	Deutsche Forschungsgemeinschaft (DFG); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU); China Scholarship Council [CSC: 2011627126]; Deutsche Forschungsgemeinschaft [DFG Ey 94-2/1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU); China Scholarship Council(China Scholarship Council); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We acknowledge support by the Deutsche Forschungsgemeinschaft (DFG) and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme 'Open Access Publishing'. This study was in part supported by the China Scholarship Council (CSC: 2011627126) and the Deutsche Forschungsgemeinschaft (DFG Ey 94-2/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannai M, 2001, EUR J IMMUNOL, V31, P3361, DOI 10.1002/1521-4141(200111)31:11<3361::AID-IMMU3361>3.0.CO;2-Z; BARKS JDE, 1991, PEDIATR RES, V29, P558, DOI 10.1203/00006450-199106010-00008; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Benedetti S, 2003, GENE THER, V10, P188, DOI 10.1038/sj.gt.3301863; Bertorelli R, 1998, NEUROSCI LETT, V246, P41, DOI 10.1016/S0304-3940(98)00221-3; Carmeliet P, 2011, NAT REV DRUG DISCOV, V10, P417, DOI 10.1038/nrd3455; Cuneo KC, 2012, INT J RADIAT ONCOL, V82, P2018, DOI 10.1016/j.ijrobp.2010.12.074; Dardzinski BJ, 2000, PEDIATR RES, V48, P248, DOI 10.1203/00006450-200008000-00021; Darpolor MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016621; Das A, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-36; di Tomaso E, 2011, CANCER RES, V71, P19, DOI 10.1158/0008-5472.CAN-10-2602; Dietrich Jorg, 2011, Expert Rev Clin Pharmacol, V4, P233, DOI 10.1586/ecp.11.1; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Eyupoglu IY, 2013, NAT REV NEUROL, V9, P141, DOI 10.1038/nrneurol.2012.279; Eyupoglu IY, 2005, J NEUROSURG, V102, P738, DOI 10.3171/jns.2005.102.4.0738; Eyupoglu IY, 2003, BRAIN RES PROTOC, V11, P1, DOI 10.1016/S1385-299X(02)00186-1; Felszeghy K, 2004, NEUROIMMUNOMODULAT, V11, P404, DOI 10.1159/000080151; Feng Y, 2011, NEUROSCIENCE, V179, P223, DOI 10.1016/j.neuroscience.2011.01.050; Harada M, 2012, LEUKEMIA LYMPHOMA, V53, P2041, DOI 10.3109/10428194.2012.678004; Heiss JD, 1996, J CLIN INVEST, V98, P1400, DOI 10.1172/JCI118927; Hempen C, 2002, SUPPORT CARE CANCER, V10, P322, DOI 10.1007/s00520-001-0333-0; Hock SW, 2013, EVOLUTION MOL BIOL B, V638, P125; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jain RK, 2013, J CLIN ONCOL, V31, P2205, DOI 10.1200/JCO.2012.46.3653; JELSMAN R, 1967, J NEUROSURG, V27, P388, DOI 10.3171/jns.1967.27.5.0388; Kaal ECA, 2004, CURR OPIN ONCOL, V16, P593, DOI 10.1097/01.cco.0000142076.52721.b3; Kamoun WS, 2009, J CLIN ONCOL, V27, P2542, DOI 10.1200/JCO.2008.19.9356; Kfir-Erenfeld S, 2010, LEUKEMIA LYMPHOMA, V51, P1968, DOI 10.3109/10428194.2010.506570; Kloosterhof NK, 2013, GENE CHROMOSOME CANC, V52, P665, DOI 10.1002/gcc.22062; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; KROH H, 1988, Zentralblatt fuer Allgemeine Pathologie und Pathologische Anatomie, V134, P523; Lambert W, 2001, INVEST OPHTH VIS SCI, V42, P2315; Lewerenz J, 2011, ANTIOXID REDOX SIGN, V14, P1449, DOI 10.1089/ars.2010.3600; Li A, 2009, CANCER RES, V69, P2091, DOI 10.1158/0008-5472.CAN-08-2100; Limbourg FP, 2002, J CLIN INVEST, V110, P1729, DOI 10.1172/JCI200215481; Marantidou A, 2010, J NEURO-ONCOL, V100, P89, DOI 10.1007/s11060-010-0142-8; Miller J D, 1977, Neurosurgery, V1, P114; Narita Y, 2013, JPN J CLIN ONCOL, V43, P587, DOI 10.1093/jjco/hyt051; Noch E, 2009, CANCER BIOL THER, V8, P1791, DOI 10.4161/cbt.8.19.9762; Pace A, 2013, J NEURO-ONCOL, V111, P83, DOI 10.1007/s11060-012-0993-2; Rinne ML, 2013, EXPERT OPIN EMERG DR, V18, P137, DOI 10.1517/14728214.2013.794784; Robe PA, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-32; Savaskan NE, 2011, ONCOGENE, V30, P43, DOI 10.1038/onc.2010.391; Savaskan NE, 2010, ANN ANAT, V192, P309, DOI 10.1016/j.aanat.2010.07.003; Savaskan NE, 2008, NAT MED, V14, P629, DOI 10.1038/nm1772; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SILBERGELD DL, 1991, J NEURO-ONCOL, V10, P179, DOI 10.1007/BF00146880; Spaner DE, 2012, LEUKEMIA, V26, P1144, DOI 10.1038/leu.2011.329; STORRING FK, 1954, J PATHOL BACTERIOL, V68, P231, DOI 10.1002/path.1700680128; Sur P, 2005, GLIA, V50, P160, DOI 10.1002/glia.20168; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Tung S, 2013, BLOOD, V122, P969, DOI 10.1182/blood-2013-03-489468; TUOR UI, 1993, BRAIN RES, V604, P165, DOI 10.1016/0006-8993(93)90364-S; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; VECHT CJ, 1994, NEUROLOGY, V44, P675, DOI 10.1212/WNL.44.4.675; Villeneuve J, 2008, BRAIN PATHOL, V18, P401, DOI 10.1111/j.1750-3639.2008.00139.x; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wen PY, 2005, CANC NERVOUS SYSTEM, P243; Wenzel EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038188; YUAN F, 1994, CANCER RES, V54, P4564; Zuniga RM, 2010, J NEURO-ONCOL, V99, P237, DOI 10.1007/s11060-010-0121-0	62	39	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93264	10.1371/journal.pone.0093264	http://dx.doi.org/10.1371/journal.pone.0093264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714627	gold, Green Published, Green Submitted			2022-12-25	WOS:000334160900021
J	Kent, BP; Rinaldo, A; Yeh, FC; Verstynen, T				Kent, Brian P.; Rinaldo, Alessandro; Yeh, Fang-Cheng; Verstynen, Timothy			Mapping Topographic Structure in White Matter Pathways with Level Set Trees	PLOS ONE			English	Article							IN-VIVO; TRACTOGRAPHY; CONNECTIVITY; QUANTIFICATION; CLASSIFICATION; CONSISTENCY; STABILITY	Fiber tractography on diffusion imaging data offers rich potential for describing white matter pathways in the human brain, but characterizing the spatial organization in these large and complex data sets remains a challenge. We show that level set trees-which provide a concise representation of the hierarchical mode structure of probability density functions-offer a statistically-principled framework for visualizing and analyzing topography in fiber streamlines. Using diffusion spectrum imaging data collected on neurologically healthy controls (N = 30), we mapped white matter pathways from the cortex into the striatum using a deterministic tractography algorithm that estimates fiber bundles as dimensionless streamlines. Level set trees were used for interactive exploration of patterns in the endpoint distributions of the mapped fiber pathways and an efficient segmentation of the pathways that had empirical accuracy comparable to standard nonparametric clustering techniques. We show that level set trees can also be generalized to model pseudo-density functions in order to analyze a broader array of data types, including entire fiber streamlines. Finally, resampling methods show the reliability of the level set tree as a descriptive measure of topographic structure, illustrating its potential as a statistical descriptor in brain imaging analysis. These results highlight the broad applicability of level set trees for visualizing and analyzing high-dimensional data like fiber tractography output.	[Kent, Brian P.; Rinaldo, Alessandro] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Yeh, Fang-Cheng] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Verstynen, Timothy] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Verstynen, Timothy] Carnegie Mellon Univ, Ctr Neural Basis Computat, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University	Verstynen, T (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.	timothyv@andrew.cmu.edu	Yeh, Fang-Cheng/E-9698-2012	Yeh, Fang-Cheng/0000-0002-7946-2173; Verstynen, Timothy/0000-0003-4720-0336	Army Research Laboratory [W911NF-10-2-0022]; NSF CAREER [DMS 114967]; Division Of Mathematical Sciences [1149677] Funding Source: National Science Foundation	Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); NSF CAREER(National Science Foundation (NSF)NSF - Office of the Director (OD)); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This research was sponsored by the Army Research Laboratory and was accomplished under Cooperative Agreement Number W911NF-10-2-0022. The views and conclusions contained in this document are those of the authors and should not be interpreted as representing the official policies, either expressed or implied, of the Army Research Laboratory or the U. S. Government. The U. S. Government is authorized to reproduce and distribute reprints for Government purposes notwithstanding any copyright notation herein. This research was also supported by NSF CAREER grant DMS 114967. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, ADV NEURAL INFORM PR; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Azzalini A, 2007, STAT COMPUT, V17, P71, DOI 10.1007/s11222-006-9010-y; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Ben-Hur Asa, 2002, Pac Symp Biocomput, P6; Billingsley P., 2012, WILEY SERIES PROBABI; Brun A, 2004, LECT NOTES COMPUT SC, V3216, P368; Catani M, 2013, BRAIN; Catani M, 2012, CORTEX, V48, P273, DOI 10.1016/j.cortex.2011.12.001; Coifman RR, 2006, APPL COMPUT HARMON A, V21, P5, DOI 10.1016/j.acha.2006.04.006; Corouge I, 2004, 2004 2ND IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING: MACRO TO NANO, VOLS 1 and 2, P344; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; DEVROYE LP, 1977, ANN STAT, V5, P536, DOI 10.1214/aos/1176343851; Ding ZH, 2003, MAGNET RESON MED, V49, P716, DOI 10.1002/mrm.10415; Draganski B, 2008, J NEUROSCI, V28, P7143, DOI 10.1523/JNEUROSCI.1486-08.2008; Ester M., 1996, KDD, V96, P226; Ferraty F., 2006, SPR S STAT; Garyfallidis E, 2011, 17 ANN M ORG HUM BRA, P1; Gerig G, 2004, P ANN INT IEEE EMBS, V26, P4421; GRAYBIEL AM, 1978, P NATL ACAD SCI USA, V75, P5723, DOI 10.1073/pnas.75.11.5723; Greenberg AS, 2012, J NEUROSCI, V32, P2773, DOI 10.1523/JNEUROSCI.5419-11.2012; Guevara P, 2011, NEUROIMAGE, V54, P1975, DOI 10.1016/j.neuroimage.2010.10.028; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2006, RADIOGRAPHICS, V26, pS205, DOI 10.1148/rg.26si065510; Hartigan J., 1975, CLUSTERING ALGORITHM; HARTIGAN JA, 1981, J AM STAT ASSOC, V76, P388, DOI 10.2307/2287840; Hastie T, 2009, ELEMENTS STAT LEARNI, P510, DOI [978-0387848570, DOI 10.1007/978-0-387-84858-7]; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Jarbo K, 2012, NEUROIMAGE, V59, P1988, DOI 10.1016/j.neuroimage.2011.09.056; Jbabdi S, 2013, CURRENT OPINION NEUR, P1; Jonasson L, 2005, P INT SOC MAGN RES I; KPOTUFE S., 2011, P 28 INT C MACH LEAR, P225; Lazar M, 2003, HUM BRAIN MAPP, V18, P306, DOI 10.1002/hbm.10102; Li H, 2010, NEUROIMAGE, V49, P1249, DOI 10.1016/j.neuroimage.2009.08.017; Maier M, 2009, THEOR COMPUT SCI, V410, P1749, DOI 10.1016/j.tcs.2009.01.009; Makris N, 2009, CEREB CORTEX, V19, P777, DOI 10.1093/cercor/bhn124; Moberts B, 2005, IEEE VISUALIZATION 2005, PROCEEDINGS, P65; O'Donnell L, 2005, LECT NOTES COMPUT SC, V3749, P140; O'Donnell LJ, 2013, NEUROIMAGE; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Prasad G, 2011, MICCAI 2011 WORKSH C; Pyles JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061611; R Core Team, 2012, R LANG ENV STAT COMP, DOI 3-900051-07-0; RAGSDALE CW, 1990, P NATL ACAD SCI USA, V87, P6196, DOI 10.1073/pnas.87.16.6196; Rao P, 1983, NONPARAMETRIC FUNCTI; Richards JW, 2009, MON NOT R ASTRON SOC, V399, P1044, DOI 10.1111/j.1365-2966.2009.15349.x; Richards JW, 2009, ASTROPHYS J, V691, P32, DOI 10.1088/0004-637X/691/1/32; Rinaldo A, 2012, J MACH LEARN RES, V13, P905; Rinaldo A, 2010, ANN STAT, V38, P2678, DOI 10.1214/10-AOS797; Shimony JS, 2002, P INT SOC MAGN RES I; SMITH SP, 1980, PATTERN RECOGN, V12, P177, DOI 10.1016/0031-3203(80)90042-4; Tsai A, 2007, IEEE C COMP VIS PATT, P1, DOI [10.1109/CVPR.2007.383096., DOI 10.1109/CVPR.2007.383096]; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Verstynen TD, 2012, J NEUROPHYSIOLOGY; Verstynen T, 2011, J NEUROPHYSIOL, V105, P336, DOI 10.1152/jn.00698.2010; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang XG, 2011, NEUROIMAGE, V54, P290, DOI 10.1016/j.neuroimage.2010.07.050; Wang Y., 2012, J NANOMATER, V2012, P1, DOI DOI 10.1186/1687-6180-2012-40; Wassermann D, 2010, NEUROIMAGE, V51, P228, DOI 10.1016/j.neuroimage.2010.01.004; Wassermann D, 2008, MICCAI 2008 WORKSH M, V2, P1; Wassermann D, 2008, INT J BIOMED IMAGING, V2008, DOI 10.1155/2008/526906; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280; Wishart D., 1969, NUMERICAL TAXONOMY, P282; Xia Y, 2005, LECT NOTES COMPUT SC, V3749, P205; Yeh FC, 2011, NEUROIMAGE, V58, P91, DOI 10.1016/j.neuroimage.2011.06.021; Yeh FC, 2010, IEEE T MED IMAGING, V29, P1626, DOI 10.1109/TMI.2010.2045126; Yeh FC, 2010, 2INT SOC MAGNET RES; Zhang S, 2005, P INT SOC MAGN RES I, P2727; Zhang S, 2008, IEEE T VIS COMPUT GR, V14, P1044, DOI 10.1109/TVCG.2008.52; Zvitia O, 2008, I S BIOMED IMAGING, P692, DOI 10.1109/ISBI.2008.4541090	73	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93344	10.1371/journal.pone.0093344	http://dx.doi.org/10.1371/journal.pone.0093344			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714673	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900024
J	Liu, Y; Rao, U; McClure, J; Konopa, P; Manocheewa, S; Kim, M; Chen, L; Troyer, RM; Tebit, DM; Holte, S; Arts, EJ; Mullins, JI				Liu, Yi; Rao, Ushnal; McClure, Jan; Konopa, Philip; Manocheewa, Siriphan; Kim, Moon; Chen, Lennie; Troyer, Ryan M.; Tebit, Denis M.; Holte, Sarah; Arts, Eric J.; Mullins, James I.			Impact of Mutations in Highly Conserved Amino Acids of the HIV-1 Gag-p24 and Env-gp120 Proteins on Viral Replication in Different Genetic Backgrounds	PLOS ONE			English	Article							T-LYMPHOCYTE EPITOPES; DOUBLE-BLIND; VIRUS; FITNESS; VACCINE; ESCAPE; GAG; INFECTION; COMPENSATION; EVOLUTION	It has been hypothesized that a single mutation at a highly conserved amino acid site (HCS) can be severely deleterious to HIV in most if not all isolate-specific genetic backgrounds. Consequently, potentially universal HIV-1 vaccines exclusively targeting highly conserved regions of the viral proteome have been proposed. To test this hypothesis, we examined the impact of 10 Gag-p24 and 9 Env-gp120 HCS single mutations on viral fitness. In the original founder sequence of the subject in whom these mutations were identified, all Gag-p24 HCS mutations significantly reduced viral replication fitness, including 7 that were lethal. Similar results were obtained at 9/10 sites when the same mutations were introduced into the founder sequences of two epidemiologically unlinked subjects. In contrast, none of the 9 Env-gp120 HCS mutations were lethal in the original founder sequence, and four had no fitness cost. Hence, HCS mutations in Gag-p24 are likely to be severely deleterious in different HIV-1 subtype B backgrounds; however, some HCS mutations in both Gag-p24 and Env-gp120 fragments can be well tolerated. Therefore, when designing HIV-1 immunogens that are intended to force the virus to nonviable escape pathways, the fitness constraints on the HIV segments included should be considered beyond their conservation level.	[Liu, Yi; Rao, Ushnal; McClure, Jan; Konopa, Philip; Manocheewa, Siriphan; Kim, Moon; Chen, Lennie; Mullins, James I.] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Mullins, James I.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Troyer, Ryan M.; Tebit, Denis M.; Arts, Eric J.] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; [Holte, Sarah] Fred Hutchinson Canc Res Ctr, Program Biostat & Biomath, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Liu, Y (corresponding author), Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA.	yiliu197@uw.edu	Troyer, Ryan/ABE-2221-2021; Tebit, Denis/ABE-1824-2020	Troyer, Ryan/0000-0001-8908-5853; Tebit, Denis/0000-0002-4540-6245; Arts, Eric/0000-0002-4880-7968	National Institutes of Health [AI081569, AI47734, AI57005, AI27757]; Bill and Melinda Gates Foundation [43437]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049170, R37AI047734, P01AI057005, R21AI081569, R01AI047734, P30AI027757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health [AI081569 to Y.L., AI47734 and AI57005 to J.I.M., AI27757 to the University of Washington Center for AIDS Research Computational Biology Core led by J.I.M.], and the Bill and Melinda Gates Foundation [43437 to J.I.M.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2005, J VIROL, V79, P13239, DOI 10.1128/JVI.79.21.13239-13249.2005; Altfeld M, 2006, TRENDS IMMUNOL, V27, P504, DOI 10.1016/j.it.2006.09.007; Brockman MA, 2007, J VIROL, V81, P12608, DOI 10.1128/JVI.01369-07; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; CAHALL DL, 1975, INFECT IMMUN, V12, P833, DOI 10.1128/IAI.12.4.833-840.1975; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; HANSEN LJ, 1988, MOL CELL BIOL, V8, P5245, DOI 10.1128/MCB.8.12.5245; Herbeck JT, 2011, J VIROL, V85, P7523, DOI 10.1128/JVI.02697-10; Janes H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043396; Jones NA, 2004, J EXP MED, V200, P1243, DOI 10.1084/jem.20040511; Koval CE, 2006, VIROLOGY, V353, P184, DOI 10.1016/j.virol.2006.05.021; Lanxon-Cookson EC, 2013, J VIROL METHODS, V194, P7, DOI 10.1016/j.jviromet.2013.07.062; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; LIU Y, 2012, J VIROL MET IN PRESS; Liu Y, 2007, J VIROL, V81, P12179, DOI 10.1128/JVI.01277-07; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; Liu Y, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015639, 10.1371/journal.pone.0022241]; Llano A, 2009, HIV MOL IMMUNOL, V2009, P3, DOI DOI 10.1016/J.M0LIMM.2008.12.019; Ma JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-261; McClure J, 2007, JAIDS-J ACQ IMM DEF, V44, P254, DOI 10.1097/QAI.0b013e318030f5c5; PATARCA R, 1985, NATURE, V318, P390, DOI 10.1038/318390a0; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Schneidewind A, 2007, J VIROL, V81, P12382, DOI 10.1128/JVI.01543-07; Stech J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn646; Stekler Joanne, 2004, Curr HIV/AIDS Rep, V1, P68, DOI 10.1007/s11904-004-0010-2; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Wu HL, 2006, J VIROL, V80, P2380, DOI 10.1128/JVI.80.5.2380-2389.2006; Yoo SH, 1997, J MOL BIOL, V269, P780, DOI 10.1006/jmbi.1997.1051; Yusim K, 2002, J VIROL, V76, P8757, DOI 10.1128/JVI.76.17.8757-8768.2002	42	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94240	10.1371/journal.pone.0094240	http://dx.doi.org/10.1371/journal.pone.0094240			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713822	gold, Green Submitted, Green Published			2022-12-25	WOS:000334160900108
J	Oshio, T; Kawashima, R; Kawamura, YI; Hagiwara, T; Mizutani, N; Okada, T; Otsubo, T; Inagaki-Ohara, K; Matsukawa, A; Haga, T; Kakuta, S; Iwakura, Y; Hosokawa, S; Dohi, T				Oshio, Tomoyuki; Kawashima, Rei; Kawamura, Yuki I.; Hagiwara, Teruki; Mizutani, Noriko; Okada, Toshihiko; Otsubo, Takeshi; Inagaki-Ohara, Kyoko; Matsukawa, Akihiro; Haga, Tatsuya; Kakuta, Shigeru; Iwakura, Yoichiro; Hosokawa, Seijiro; Dohi, Taeko			Chemokine Receptor CCR8 Is Required for Lipopolysaccharide-Triggered Cytokine Production in Mouse Peritoneal Macrophages	PLOS ONE			English	Article							T-CELLS; CUTTING EDGE; RECRUITMENT; ACTIVATION; EXPRESSION; ROLES; IDENTIFICATION; ANTAGONISTS; INHIBITION; EOSINOPHIL	Chemokine (C-C motif) receptor 8 (CCR8), the chemokine receptor for chemokine (C-C motif) ligand 1 (CCL1), is expressed in T-helper type-2 lymphocytes and peritoneal macrophages (PM phi) and is involved in various pathological conditions, including peritoneal adhesions. However, the role of CCR8 in inflammatory responses is not fully elucidated. To investigate the function of CCR8 in macrophages, we compared cytokine secretion from mouse PM phi or bone marrow-derived macrophages (BMM phi) stimulated with various Toll-like receptor (TLR) ligands in CCR8 deficient (CCR8(-/-)) and wild-type (WT) mice. We found that CCR8(-/-) PM phi demonstrated attenuated secretion of tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, and IL-10 when stimulated with lipopolysaccharide (LPS). In particular, LPS-induced IL-10 production absolutely required CCR8. CCR8-dependent cytokine secretion was characteristic of PM phi but not BMM phi. To further investigate this result, we selected the small molecule compound R243 from a library of compounds with CCR8-antagonistic effects on CCL1-induced Ca2+ flux and CCL1-driven PM phi aggregation. Similar to CCR8(-/-) PM phi, R243 attenuated secretion of TNF-alpha, IL-6, and most strikingly IL-10 from WT PM phi, but not BMM phi. CCR8(-/-)PM phi and R243-treated WT PM phi both showed suppressed c-jun N-terminal kinase activity and nuclear factor-kappa B signaling after LPS treatment when compared with WT PM phi. A c-Jun signaling pathway inhibitor also produced an inhibitory effect on LPS-induced cytokine secretion that was similar to that of CCR8 deficiency or R243 treatment. As seen in CCR8(-/-) mice, administration of R243 attenuated peritoneal adhesions in vivo. R243 also prevented hapten-induced colitis. These results are indicative of cross talk between signaling pathways downstream of CCR8 and TLR-4 that induces cytokine production by PMQ. Through use of CCR8(-/-) mice and the new CCR8 inhibitor, R243, we identified a novel macrophage innate immune response pathway that involves a chemokine receptor.	[Oshio, Tomoyuki; Kawashima, Rei; Kawamura, Yuki I.; Hagiwara, Teruki; Mizutani, Noriko; Okada, Toshihiko; Otsubo, Takeshi; Inagaki-Ohara, Kyoko; Dohi, Taeko] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Res Inst, Dept Gastroenterol, Ichikawa, Chiba, Japan; [Oshio, Tomoyuki] Jichi Med Univ, Dept Dermatol, Shimotsuke, Tochigi, Japan; [Kawashima, Rei] Kitasato Univ, Grad Sch Med Sci, Sagamihara, Kanagawa 228, Japan; [Matsukawa, Akihiro] Okayama Univ, Dept Pathol & Expt Med, Okayama, Okayama, Japan; [Haga, Tatsuya] Gakushuin Univ, Dept Life Sci, Mejiro Ku, Tokyo 171, Japan; [Kakuta, Shigeru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomed Sci, Bunkyo Ku, Tokyo, Japan; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Div Expt Anim Immunol, Noda, Chiba 278, Japan; [Hosokawa, Seijiro] Waseda Univ, Fac Adv Sci & Engn, Dept Appl Chem, Shinjuku Ku, Tokyo, Japan	National Center for Global Health & Medicine - Japan; Jichi Medical University; Kitasato University; Okayama University; Gakushuin University; University of Tokyo; Waseda University	Dohi, T (corresponding author), Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Res Inst, Dept Gastroenterol, Ichikawa, Chiba, Japan.	dohi@ri.ncgm.go.jp	Iwakura, Yoichiro/E-5457-2011; Kakuta, Shigeru/L-2241-2018; Otsubo, Takeshi/G-6123-2014	Iwakura, Yoichiro/0000-0002-9934-5775; Kakuta, Shigeru/0000-0002-5900-1425; Matsukawa, Akihiro/0000-0002-5081-6089; Hosokawa, Seijiro/0000-0002-8036-532X	Research on Health Sciences focusing on Drug Innovation [KHC2206]; grants for Research on New Drug Development [H21-007]; Research on Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology; National Center for Global Health and Medicine [21-110, 22-205, 25-104]; Ministry of Health, Labor and Welfare	Research on Health Sciences focusing on Drug Innovation; grants for Research on New Drug Development; Research on Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by Research on Health Sciences focusing on Drug Innovation (KHC2206) grants and contracts, grants for Research on New Drug Development (H21-007) and Research on Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan, Grants-in-Aid for Scientific Research (B and C) and for Young Scientists (B) from the Ministry of Education, Culture, Sports, Science, and Technology, and by a grant from the National Center for Global Health and Medicine (21-110, 22-205, 25-104), Ministry of Health, Labor and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres PG, 2000, J IMMUNOL, V164, P6303, DOI 10.4049/jimmunol.164.12.6303; Cantor J, 2007, J IMMUNOL, V179, P5760, DOI 10.4049/jimmunol.179.9.5760; Chensue SW, 2001, J EXP MED, V193, P573, DOI 10.1084/jem.193.5.573; D'Ambrosio D, 1998, J IMMUNOL, V161, P5111; DANIELISSAKANI S, 1989, J BIOL CHEM, V264, P20240; Debes GF, 2011, NAT IMMUNOL, V12, P111, DOI 10.1038/ni0211-111; DEVI S, 1995, J IMMUNOL, V154, P5376; Gombert M, 2005, J IMMUNOL, V174, P5082, DOI 10.4049/jimmunol.174.8.5082; Goya I, 1998, J IMMUNOL, V160, P1975; Hoshino A, 2007, J IMMUNOL, V178, P5296, DOI 10.4049/jimmunol.178.8.5296; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Inngjerdingen M, 2000, J IMMUNOL, V164, P4048, DOI 10.4049/jimmunol.164.8.4048; Islam SA, 2011, NAT IMMUNOL, V12, P167, DOI 10.1038/ni.1984; JAKWAY JP, 1986, SCIENCE, V234, P743, DOI 10.1126/science.3095921; Jenkins TJ, 2007, J MED CHEM, V50, P566, DOI 10.1021/jm061118e; Karlsson AKC, 2011, BIOCHEM BIOPH RES CO, V407, P764, DOI 10.1016/j.bbrc.2011.03.097; KATAKAMI Y, 1988, IMMUNOLOGY, V64, P719; Kawashima R, 2012, J IMMUNOASS IMMUNOCH, V33, P291, DOI 10.1080/15321819.2011.638409; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Lattin J, 2007, J LEUKOCYTE BIOL, V82, P16, DOI 10.1189/jlb.0107051; Le YY, 2004, CELL MOL IMMUNOL, V1, P95; Lira SA, 2012, IMMUNOL RES, V54, P111, DOI 10.1007/s12026-012-8313-7; Matsukawa A, 2006, FASEB J, V20, P302, DOI 10.1096/fj.04-1728fje; Platt AM, 2010, J IMMUNOL, V184, P6843, DOI 10.4049/jimmunol.0903987; Popivanova BK, 2009, CANCER RES, V69, P7884, DOI 10.1158/0008-5472.CAN-09-1451; Reimer MK, 2011, CLIN VACCINE IMMUNOL, V18, P2050, DOI 10.1128/CVI.05275-11; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Tiffany HL, 1997, J EXP MED, V186, P165, DOI 10.1084/jem.186.1.165; Tokuyama H, 2005, INT IMMUNOL, V17, P1023, DOI 10.1093/intimm/dxh284; Triantafilou K, 2001, NAT IMMUNOL, V2, P338, DOI 10.1038/86342; Wang L, 2013, THORAX, V68, P506, DOI 10.1136/thoraxjnl-2012-203012; ZHANG XK, 1993, J IMMUNOL, V150, P1011; Zingoni A, 1998, J IMMUNOL, V161, P547	33	24	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94445	10.1371/journal.pone.0094445	http://dx.doi.org/10.1371/journal.pone.0094445			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714157	Green Published, gold, Green Submitted			2022-12-25	WOS:000334160900133
J	Pilot, M; Dabrowski, MJ; Hayrapetyan, V; Yavruyan, EG; Kopaliani, N; Tsingarska, E; Bujalska, B; Kaminski, S; Bogdanowicz, W				Pilot, Malgorzata; Dabrowski, Michal J.; Hayrapetyan, Vahram; Yavruyan, Eduard G.; Kopaliani, Natia; Tsingarska, Elena; Bujalska, Barbara; Kaminski, Stanislaw; Bogdanowicz, Wieslaw			Genetic Variability of the Grey Wolf Canis lupus in the Caucasus in Comparison with Europe and the Middle East: Distinct or Intermediary Population?	PLOS ONE			English	Article							COMPLETE MITOCHONDRIAL GENOMES; LINKAGE DISEQUILIBRIUM; DOMESTIC DOGS; WOLVES; DNA; HYBRIDIZATION; SIZE; PROGRAM; HISTORY; ORIGIN	Despite continuous historical distribution of the grey wolf (Canis lupus) throughout Eurasia, the species displays considerable morphological differentiation that resulted in delimitation of a number of subspecies. However, these morphological discontinuities are not always consistent with patterns of genetic differentiation. Here we assess genetic distinctiveness of grey wolves from the Caucasus (a region at the border between Europe and West Asia) that have been classified as a distinct subspecies C. l. cubanensis. We analysed their genetic variability based on mtDNA control region, microsatellite loci and genome-wide SNP genotypes (obtained for a subset of the samples), and found similar or higher levels of genetic diversity at all these types of loci as compared with other Eurasian populations. Although we found no evidence for a recent genetic bottleneck, genome-wide linkage disequilibrium patterns suggest a long-term demographic decline in the Caucasian population - a trend consistent with other Eurasian populations. Caucasian wolves share mtDNA haplotypes with both Eastern European and West Asian wolves, suggesting past or ongoing gene flow. Microsatellite data also suggest gene flow between the Caucasus and Eastern Europe. We found evidence for moderate admixture between the Caucasian wolves and domestic dogs, at a level comparable with other Eurasian populations. Taken together, our results show that Caucasian wolves are not genetically isolated from other Eurasian populations, share with them the same demographic trends, and are affected by similar conservation problems.	[Pilot, Malgorzata] Lincoln Univ, Sch Life Sci, Lincoln, England; [Dabrowski, Michal J.; Bujalska, Barbara; Bogdanowicz, Wieslaw] Polish Acad Sci, Museum & Inst Zool, PL-00679 Warsaw, Poland; [Hayrapetyan, Vahram] Armenian Natl Agrarian Univ, Stepanakert Branch, Stepanakert, Armenia; [Yavruyan, Eduard G.] Natl Acad Sci Armenia, Sci Ctr Zool & Hydroecol, Yerevan, Armenia; [Kopaliani, Natia] Ilia State Univ, Inst Ecol, Tbilisi, Georgia; [Tsingarska, Elena] BALKANI Wildlife Soc, Sofia, Bulgaria; [Kaminski, Stanislaw] Univ Warmia & Mazury, Dept Anim Genet, Olsztyn, Poland; [Dabrowski, Michal J.] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden	University of Lincoln; Polish Academy of Sciences; Museum & Institute of Zoology of the Polish Academy of Sciences; National Academy of Sciences of Armenia; Ilia State University; University of Warmia & Mazury; Uppsala University	Bogdanowicz, W (corresponding author), Polish Acad Sci, Museum & Inst Zool, PL-00679 Warsaw, Poland.	wieslawb@miiz.waw.pl	Dabrowski, Michal J./AAV-1219-2020; Kaminski, Stanislaw/AAB-5726-2022; Dabrowski, Michal/D-4369-2014	Dabrowski, Michal J./0000-0003-1269-6722; Pilot, Malgorzata/0000-0002-6057-5768; KAMINSKI, STANISLAW/0000-0003-3909-4959; Bogdanowicz, Wieslaw/0000-0003-1196-2494	Ministry of Science and Higher Education [N N303 566339]; National Science Centre (Poland) [2011/01/B/NZ8/02978]; Foundation for Polish Science	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Centre (Poland)(National Science Centre, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	This study was funded by the grant no. N N303 566339 from the Ministry of Science and Higher Education and the grant no. 2011/01/B/NZ8/02978 from the National Science Centre (Poland) to W. Bogdanowicz. M. Pilot was supported by the Foundation for Polish Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2007, J ZOOL SYST EVOL RES, V45, P163, DOI 10.1111/j.1439-0469.2006.00400.x; Aggarwal RK, 2003, GENOME BIOL, V4, pP6; Altobello G, 1921, FAUNA ABRUZZO MOLISE, P38; Andersone Z, 2002, MAMM BIOL, V67, P79, DOI 10.1078/1616-5047-00012; Bakeev Yu.N., 1978, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V83, P45; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Boyko AR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000451; Cabrera A, 1907, B REAL SOC ESPANOLA, V7; Cornuet JM, 1996, GENETICS, V144, P2001; Czarnomska SD, 2013, CONSERV GENET, V14, P573, DOI 10.1007/s10592-013-0446-2; Dabrowski MJ, 2014, MOL ECOL RESOUR, V14, P361, DOI 10.1111/1755-0998.12177; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fabbri E, 2007, MOL ECOL, V16, P1661, DOI 10.1111/j.1365-294X.2007.03262.x; Fabbri E, 2014, CONSERV GENET, V15, P187, DOI 10.1007/s10592-013-0530-7; Francisco LV, 1996, MAMM GENOME, V7, P359, DOI 10.1007/s003359900104; Freedman AH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004016; Gaubert P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042740; Godinho R, 2011, MOL ECOL, V20, P5154, DOI 10.1111/j.1365-294X.2011.05345.x; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Gurielidze Z, 2004, P I ZOOLOGY GEORGIAN, V22, P100; Hayes BJ, 2003, GENOME RES, V13, P635, DOI 10.1101/gr.387103; Hindrikson M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046465; HOLMES NG, 1995, ANIM GENET, V26, P132, DOI 10.1111/j.1365-2052.1995.tb02659.x; Iacolina L, 2010, MAMM BIOL, V75, P341, DOI 10.1016/j.mambio.2010.02.004; Ishiguro N, 2009, ZOOL SCI, V26, P765, DOI 10.2108/zsj.26.765; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Keis M, 2013, J BIOGEOGR, V40, P915, DOI 10.1111/jbi.12043; Khosravi R, 2013, ZOOL SCI, V30, P27, DOI 10.2108/zsj.30.27; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Konovalov DA, 2004, MOL ECOL NOTES, V4, P779, DOI 10.1111/j.1471-8286.2004.00796.x; Kopaliani N, 2014, J HEREDITY IN PRESS; KurtUn B., 1968, PLEISTOCENE MAMMALS; Lucchini V, 2004, MOL ECOL, V13, P523, DOI 10.1046/j.1365-294X.2004.02077.x; Mech L. David, 2003, P1; MECH LD, 1987, J MAMMAL, V68, P871, DOI 10.2307/1381570; Mech LD, 2010, IUCN 2012 IUCN RED L; Milne RI, 2002, ADV BOT RES, V38, P281, DOI 10.1016/S0065-2296(02)38033-9; Moura AE, 2014, CONSERV GENET, V15, P405, DOI 10.1007/s10592-013-0547-y; Musiani M., 2010, WORLD WOLVES NEW PER; Musiani M, 2007, MOL ECOL, V16, P4149, DOI 10.1111/j.1365-294X.2007.03458.x; Nowak Ronald M., 2003, P239; Ognev S. I., 1923, Biol Mitteil Timiriazeff Inst Moscow Zool Lief, V1, P102; OSTRANDER EA, 1993, GENOMICS, V16, P207, DOI 10.1006/geno.1993.1160; Ovenden JR, 2007, MOL ECOL, V16, P127, DOI 10.1111/j.1365-294X.2006.03132.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pilot M, 2014, HEREDITY, V112, P428, DOI 10.1038/hdy.2013.122; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Pilot M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039341; Pilot M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-104; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANG ENV STAT COMP; Randi E, 2000, CONSERV BIOL, V14, P464, DOI 10.1046/j.1523-1739.2000.98280.x; Randi E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086409; Randi E, 2011, MAMMAL REV, V41, P99, DOI 10.1111/j.1365-2907.2010.00176.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rueness EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016385; Sastre N, 2011, CONSERV GENET, V12, P701, DOI 10.1007/s10592-010-0177-6; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Sharma DK, 2004, P ROY SOC B-BIOL SCI, V271, pS1, DOI 10.1098/rsbl.2003.0071; SHIBUYA H, 1994, ANIM GENET, V25, P122, DOI 10.1111/j.1365-2052.1994.tb00094.x; Sillero-Zubiri C, 2004, CANIDS FOXES WOLVES; Sommer R, 2005, MAMM BIOL, V70, P227, DOI 10.1016/j.mambio.2004.12.001; Stronen AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076454; Sykes W.H., 1831, P ZOOL SOC LOND, V1830-1831, P99; Tarkhnishvili D, 2012, BIOL J LINN SOC, V105, P231, DOI 10.1111/j.1095-8312.2011.01788.x; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Thalmann O, 2013, SCIENCE, V342, P871, DOI 10.1126/science.1243650; Verardi A, 2006, MOL ECOL, V15, P2845, DOI 10.1111/j.1365-294X.2006.02995.x; Verginelli F, 2005, MOL BIOL EVOL, V22, P2541, DOI 10.1093/molbev/msi248; Vila C, 1999, MOL ECOL, V8, P2089, DOI 10.1046/j.1365-294x.1999.00825.x; Vila C, 2003, HEREDITY, V90, P17, DOI 10.1038/sj.hdy.6800175; vonHoldt BM, 2011, GENOME RES, V21, P1294, DOI 10.1101/gr.116301.110; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Weiss S, 2007, PHYLOGEOGRAPHY SO EU	77	25	25	0	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93828	10.1371/journal.pone.0093828	http://dx.doi.org/10.1371/journal.pone.0093828			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714198	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000334160900054
J	You, XD; Huang, PT; Zhang, C; Wang, MH; Zhang, Y; Hong, YR; Wei, SM; Liu, CM; Pu, ZX; Zhang, JM; Chen, SY				You, Xiangdong; Huang, Pintong; Zhang, Chao; Wang, Minghui; Zhang, Ying; Hong, Yurong; Wei, Shumei; Liu, Chunmei; Pu, Zhaoxia; Zhang, Jianmin; Chen, Shuyuan			Relationship between Enhanced Intensity of Contrast Enhanced Ultrasound and Microvessel Density of Aortic Atherosclerostic Plaque in Rabbit Model	PLOS ONE			English	Article							CAROTID PLAQUE; VASA VASORUM; INTRAPLAQUE NEOVASCULARIZATION; ANGIOGENESIS; SYMPTOMATOLOGY; QUANTIFICATION; ASSOCIATION	The aim of this study was to evaluate the relationship between enhanced intensity of contrast enhanced ultrasound and microvessel density of aortic atherosclerotic plaque in rabbit model. The abdominal aortas of thirty-six male New Zealand rabbits were damaged by balloon expansion and the animals were then fed a high fat diet for 12 weeks. Twenty-seven plaques on the near aortic wall were detected using conventional ultrasound examination. The maximum thickness of each plaque was recorded. CEUS was performed on these 27 plaques and the time-intensity curves (TICs) were analyzed offline. Using the quantitative ACQ software, features such as the arrival time (AT), time to peak (TTP), baseline intensity (BI), peak intensity (PI) and enhanced intensity (EI) (EI = PI-BI) were assessed. Inter-and intra-observer agreement of EI were assessed using the Bland-Altman test. After CEUS examination, the rabbits were sacrificed for pathological examination and CD34 monoclonal antibody immunohistochemical detection. Microvessel density (MVD) was counted under the microscope. The relationship between indexes of CEUS and the level of MVD was analyzed. There was a good positive linear correlation between EI and MVD (gamma = 0. 854, P < 0. 001), the intraclass correlations for inter-and intra-observer agreement for EI were 0.73 and 0.82 respectively, suggesting that EI may be act as a useful index for plaque risk stratification in animal models.	[You, Xiangdong; Huang, Pintong; Zhang, Chao; Wang, Minghui; Zhang, Ying; Hong, Yurong; Liu, Chunmei; Pu, Zhaoxia] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Ultrasonog, Hangzhou, Zhejiang, Peoples R China; [Wei, Shumei] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Pathol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Jianmin] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Neurol Surg, Hangzhou, Zhejiang, Peoples R China; [Chen, Shuyuan] Baylor Univ, Med Ctr Dallas, Baylor Res Inst, Dallas, TX USA	Zhejiang University; Zhejiang University; Zhejiang University; Baylor Scott & White Health; Baylor University; Baylor University Medical Center	Huang, PT (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Ultrasonog, Hangzhou, Zhejiang, Peoples R China.	huangpintong@126.com			National Natural Science Funds of China [81071164, 81271584]; Science and Technology Department of Zhejiang Province [2008C33012]; Zhejiang Nature Science Foundation [Y2080718]; Main International Project of Zhejiang Province of China [2009C14017]; Major Science and Technology Project in Medical and Health of Zhejiang Province [wkj2011-2-007]	National Natural Science Funds of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Zhejiang Province; Zhejiang Nature Science Foundation; Main International Project of Zhejiang Province of China; Major Science and Technology Project in Medical and Health of Zhejiang Province	This study was supported by grants from the National Natural Science Funds (Grant No. 81071164, 81271584) of China, Science and Technology Department of Zhejiang Province (2008C33012), Zhejiang Nature Science Foundation (Y2080718), the Main International Project of Zhejiang Province of China (No. 2009C14017), and Major Science and Technology Project in Medical and Health of Zhejiang Province (co-constructed Project by the Province and the Ministry) (wkj2011-2-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkus Z, 2014, ULTRASOUND MED BIOL, V40, P25, DOI 10.1016/j.ultrasmedbio.2013.09.010; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Coli S, 2008, J AM COLL CARDIOL, V52, P223, DOI 10.1016/j.jacc.2008.02.082; Dunmore BJ, 2007, J VASC SURG, V45, P155, DOI 10.1016/j.jvs.2006.08.072; Giannarelli C, 2010, JACC-CARDIOVASC IMAG, V3, P1256, DOI 10.1016/j.jcmg.2010.09.017; Giannoni MF, 2009, EUR J VASC ENDOVASC, V37, P722, DOI 10.1016/j.ejvs.2008.12.028; Hiyama T, 2010, NEUROL MED-CHIR, V50, P1056, DOI 10.2176/nmc.50.1056; Ho-Tin-Noe B, 2011, TRENDS CARDIOVAS MED, V21, P183, DOI 10.1016/j.tcm.2012.05.007; Huang PT, 2008, J CLIN ULTRASOUND, V36, P346, DOI 10.1002/jcu.20448; Huang PT, 2010, WORLD J CARDIOL, V2, P89, DOI 10.4330/wjc.v2.i4.89; Kockx MM, 2003, ARTERIOSCL THROM VAS, V23, P440, DOI 10.1161/01.ATV.0000057807.28754.7F; Lee SC, 2010, JACC-CARDIOVASC IMAG, V3, P1265, DOI 10.1016/j.jcmg.2010.08.017; McCarthy MJ, 1999, J VASC SURG, V30, P261, DOI 10.1016/S0741-5214(99)70136-9; Moguillansky D, 2011, EUR HEART J, V32, P646, DOI 10.1093/eurheartj/ehq197; Moreno PR, 2004, CIRCULATION, V110, P2032, DOI 10.1161/01.CIR.0000143233.87854.23; Moulton KS, 1999, CIRCULATION, V99, P1726, DOI 10.1161/01.CIR.99.13.1726; Pelisek J, 2012, CIRC J, V76, P1274, DOI 10.1253/circj.CJ-11-0768; Phillips P, 2004, EUR RADIOL, V14, pP4, DOI 10.1007/s10406-004-0075-4; Shah F, 2007, VASC MED, V12, P291, DOI 10.1177/1358863X07083363; Staub D, 2010, STROKE, V41, P41, DOI 10.1161/STROKEAHA.109.560342; Vavuranakis M, 2013, VASA, V42, P184, DOI 10.1024/0301-1526/a000267; Vicenzini E, 2007, STROKE, V38, P2841, DOI 10.1161/STROKEAHA.107.487918; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Xiong L, 2009, RADIOLOGY, V251, P583, DOI 10.1148/radiol.2512081829	24	13	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e92445	10.1371/journal.pone.0092445	http://dx.doi.org/10.1371/journal.pone.0092445			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713618	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900007
J	Zhu, F; Wang, WG; Hou, YY; Shi, JD; Liu, ZL; He, DM; Bai, CX; Li, SQ; Jiang, LY				Zhu, Fen; Wang, Weige; Hou, Yingyong; Shi, Jindong; Liu, Zilong; He, Deming; Bai, Chunxue; Li, Shanqun; Jiang, Liyan			MAML2 Rearrangement in Primary Pulmonary Mucoepidermoid Carcinoma and the Correlation with FLT1 Expression	PLOS ONE			English	Article							FUSION ONCOGENE; MECT1-MAML2; TRANSLOCATION; LUNG	Introduction: Primary pulmonary mucoepidermoid carcinoma (PMEC) is an uncommon neoplasm with remarkable resemblance to mucoepidermoid carcinoma of the salivary glands. The latter has been shown to harbor t(11,19) resulting in MECT1-MAML2 fusion, which may be of diagnostic and prognostic values. However, the importance of such feature in PMEC has not been well studied. Methods: We detected MAML2 rearrangement using fluorescence in situ hybridization (FISH) in tissue samples from 42 cases of PMEC and 40 of adenosquamous carcinoma (ASC), and the expression of potential downstream targets of MECT1-MAML2, including HES1, FLT1 and NR4A2 with immunohistochemistry (IHC). The findings were then examined regarding the clinicopathological parameters and patient outcomes. Results: FISH analysis revealed MAML2 rearrangement in 50% of the PMEC cases, and such property was prominent in considerable younger patients (33 versus 60 years; p = 0.001) and restricted to cases of low and intermediate grades. IHC analysis showed that FLT1 and HES1 were expressed at lower level in MAML2 rearranged group than MAML2 non-rearranged group (p, 0.001 and p = 0.023, respectively). Survival analysis showed significant correlation between MAML2 rearrangement and overall survival (p = 0.023) or disease-free survival (p = 0.027) as well as correlation between FLT1 and overall survival (p = 0.009). Conclusions: MAML2 rearrangement appears frequent in PMEC and specific with this tumor. Both the presence of MAML2 rearrangement and absence of FLT1 tend to confer a favorable clinical outcome. These findings suggest that molecular detection of MAML2 rearrangement combined with FLT1 may be of important clinical value for PMEC.	[Zhu, Fen; Liu, Zilong; Bai, Chunxue; Li, Shanqun] Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai 200433, Peoples R China; [Wang, Weige] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China; [Hou, Yingyong; He, Deming] Fudan Univ, Zhongshan Hosp, Dept Pathol, Shanghai 200433, Peoples R China; [Jiang, Liyan] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm Med, Shanghai 200030, Peoples R China; [Wang, Weige] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Shi, Jindong] Fudan Univ, Peoples Hosp Shanghai 5, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Shanghai Jiao Tong University; Fudan University; Fudan University	Li, SQ (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Pulm Med, Shanghai 200433, Peoples R China.	li.shanqun@zs-hospital.sh.cn; jiang_liyan2000@126.com.cn	Li, Shanqun/AAI-7205-2020	shanqun, li/0000-0002-8096-9780; Bai, Chunxue/0000-0001-5798-3130	Shanghai Committee of Science and Technology [13430720500]; Shanghai Leading Academic Discipline Project [B115]; National Natural Science Foundation of China [81372524]; Shanghai Committee of Health and Family Planning [20134007]	Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Health and Family Planning	Support was provided by Shanghai Committee of Science and Technology (NO. 13430720500) and Shanghai Leading Academic Discipline Project (NO. B115). National Natural Science Foundation of China (No. 81372524), Shanghai Committee of Health and Family Planning (No. 20134007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achcar RDD, 2009, HUM PATHOL, V40, P854, DOI 10.1016/j.humpath.2008.11.007; AUCLAIR PL, 1992, CANCER, V69, P2021, DOI 10.1002/1097-0142(19920415)69:8<2021::AID-CNCR2820690803>3.0.CO;2-7; Behboudi A, 2006, GENE CHROMOSOME CANC, V45, P470, DOI 10.1002/gcc.20306; Chin CH, 2008, RESPIROLOGY, V13, P275, DOI 10.1111/j.1440-1843.2007.01207.x; Coxon A, 2005, CANCER RES, V65, P7137, DOI 10.1158/0008-5472.CAN-05-1125; Enlund F, 2004, EXP CELL RES, V292, P21, DOI 10.1016/j.yexcr.2003.09.007; Garcia JJ, 2011, HUM PATHOL, V42, P2001, DOI 10.1016/j.humpath.2011.02.028; Han SW, 2008, LUNG CANCER, V61, P30, DOI 10.1016/j.lungcan.2007.11.014; Martins C, 2004, J MOL DIAGN, V6, P205, DOI 10.1016/S1525-1578(10)60511-9; Noda H, 2013, CANCER SCI, V104, P85, DOI 10.1111/cas.12039; O'Neill ID, 2009, ORAL ONCOL, V45, P2, DOI 10.1016/j.oraloncology.2008.03.012; Okabe M, 2006, CLIN CANCER RES, V12, P3902, DOI 10.1158/1078-0432.CCR-05-2376; Pirker R, 2012, LANCET ONCOL, V13, P33, DOI 10.1016/S1470-2045(11)70318-7; Rossi G, 2009, LUNG CANCER, V63, P159, DOI 10.1016/j.lungcan.2008.09.007; Seethala RR, 2009, HEAD NECK PATHOL, V3, P69, DOI 10.1007/s12105-009-0102-9; Seethala RR, 2010, AM J SURG PATHOL, V34, P1106, DOI 10.1097/PAS.0b013e3181de3021; Seethala RR., 2008, MODERN PATHOL, V21, p241A; Tonon G, 2003, NAT GENET, V33, P208, DOI 10.1038/ng1083; Travis WD., 2004, TRAVIS WB WHO CLASSI; Wu LZ, 2005, EMBO J, V24, P2391, DOI 10.1038/sj.emboj.7600719; Xi JJ, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-232; Zhu F, 2013, J THORAC ONCOL, V8, P1578, DOI 10.1097/JTO.0b013e3182a7d272	22	18	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94399	10.1371/journal.pone.0094399	http://dx.doi.org/10.1371/journal.pone.0094399			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714697	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900126
J	Hawkes, LA; Butler, PJ; Frappell, PB; Meir, JU; Milsom, WK; Scott, GR; Bishop, CM				Hawkes, Lucy A.; Butler, Patrick J.; Frappell, Peter B.; Meir, Jessica U.; Milsom, William K.; Scott, Graham R.; Bishop, Charles M.			Maximum Running Speed of Captive Bar-Headed Geese Is Unaffected by Severe Hypoxia	PLOS ONE			English	Article							HIGH-ALTITUDE; HEART-RATE; OXYGEN-CONSUMPTION; BRANTA-LEUCOPSIS; EXERCISE PERFORMANCE; SEA-LEVEL; BLOOD; FLIGHT; BIRDS; MIGRATION	While bar-headed geese are renowned for migration at high altitude over the Himalayas, previous work on captive birds suggested that these geese are unable to maintain rates of oxygen consumption while running in severely hypoxic conditions. To investigate this paradox, we re-examined the running performance and heart rates of bar-headed geese and barnacle geese (a low altitude species) during exercise in hypoxia. Bar-headed geese (n = 7) were able to run at maximum speeds (determined in normoxia) for 15 minutes in severe hypoxia (7% O-2; simulating the hypoxia at 8500 m) with mean heart rates of 466 +/- 8 beats min(-1). Barnacle geese (n = 10), on the other hand, were unable to complete similar trials in severe hypoxia and their mean heart rate (316 beats.min(-1)) was significantly lower than bar-headed geese. In bar-headed geese, partial pressures of oxygen and carbon dioxide in both arterial and mixed venous blood were significantly lower during hypoxia than normoxia, both at rest and while running. However, measurements of blood lactate in bar-headed geese suggested that anaerobic metabolism was not a major energy source during running in hypoxia. We combined these data with values taken from the literature to estimate (i) oxygen supply, using the Fick equation and (ii) oxygen demand using aerodynamic theory for bar-headed geese flying aerobically, and under their own power, at altitude. This analysis predicts that the maximum altitude at which geese can transport enough oxygen to fly without environmental assistance ranges from 6,800 m to 8,900 m altitude, depending on the parameters used in the model but that such flights should be rare.	[Hawkes, Lucy A.] Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales; [Butler, Patrick J.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Frappell, Peter B.] Univ Tasmania, Hobart, Tas, Australia; [Meir, Jessica U.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, Boston, MA USA; [Milsom, William K.] Univ British Columbia, Dept Zool, Vancouver, BC V5Z 1M9, Canada; [Scott, Graham R.] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Hawkes, Lucy A.; Bishop, Charles M.] Univ Exeter, Coll Life & Environm Sci, Penryn, Cornwall, England	Bangor University; University of Birmingham; University of Tasmania; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of British Columbia; McMaster University; University of Exeter	Hawkes, LA (corresponding author), Bangor Univ, Sch Biol Sci, Bangor, Gwynedd, Wales.	l.hawkes@exeter.ac.uk	Hawkes, Lucy/L-7407-2014	Hawkes, Lucy/0000-0002-6696-1862	Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom [BB/F015615/1]; Biotechnology and Biological Sciences Research Council [BB/F015615/1] Funding Source: researchfish; BBSRC [BB/F015615/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The project was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) of the United Kingdom [Grant number BB/F015615/1] to CMB and PJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beneke R, 2003, EUR J APPL PHYSIOL, V88, P361, DOI 10.1007/s00421-002-0713-2; Bishop CM, 2013, J THEOR BIOL, V323, P11, DOI 10.1016/j.jtbi.2013.01.002; BISHOP CM, 1995, J EXP BIOL, V198, P2153; Bishop CM, 2002, COMP BIOCHEM PHYS A, V133, P225, DOI 10.1016/S1095-6433(02)00157-5; Bishop CM, 1999, P ROY SOC B-BIOL SCI, V266, P2275, DOI 10.1098/rspb.1999.0919; Bishop Mary A., 1997, Wildfowl, V48, P118; BLACK CP, 1980, RESP PHYSIOL, V39, P217, DOI 10.1016/0034-5687(80)90046-8; Blum Arlene, 1998, ANNAPURNA WOMANS PLA; BOND CF, 1958, AM J PHYSIOL, V194, P519, DOI 10.1152/ajplegacy.1958.194.3.519; Brown WEL, 1923, P R SOC LOND B-CONTA, V94, P297, DOI 10.1098/rspb.1923.0006; Butler PJ, 2010, COMP BIOCHEM PHYS A, V156, P325, DOI 10.1016/j.cbpa.2010.01.016; BUTLER PJ, 1993, J EXP BIOL, V179, P159; Butler PJ, 1998, J AVIAN BIOL, V29, P536, DOI 10.2307/3677173; BUTLER PJ, 1991, J EXP BIOL, V160, P233; DAVIES CTM, 1979, EUR J APPL PHYSIOL O, V41, P233, DOI 10.1007/BF00429740; di Prampero PE, 1999, RESP PHYSIOL, V118, P103, DOI 10.1016/S0034-5687(99)00083-3; Eichhorn G, 2009, J ANIM ECOL, V78, P63, DOI 10.1111/j.1365-2656.2008.01485.x; FARACI FM, 1985, RESP PHYSIOL, V61, P21, DOI 10.1016/0034-5687(85)90025-8; FARACI FM, 1986, AM J PHYSIOL, V250, pR499, DOI 10.1152/ajpregu.1986.250.3.R499; FARACI FM, 1984, AM J PHYSIOL, V247, pR402, DOI 10.1152/ajpregu.1984.247.2.R402; FARACI FM, 1991, ANNU REV PHYSIOL, V53, P59, DOI 10.1146/annurev.ph.53.030191.000423; FARACI FM, 1984, AM J PHYSIOL, V247, pR69, DOI 10.1152/ajpregu.1984.247.1.R69; FEDAK MA, 1981, J APPL PHYSIOL, V51, P772, DOI 10.1152/jappl.1981.51.3.772; FEDDE MR, 1989, RESP PHYSIOL, V77, P239, DOI 10.1016/0034-5687(89)90010-8; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Hartman F. A., 1961, Condor, V66, P403; Hawkes LA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2114; Hawkes LA, 2011, P NATL ACAD SCI USA, V108, P9516, DOI 10.1073/pnas.1017295108; Lee SY, 2008, COMP BIOCHEM PHYS C, V148, P324, DOI 10.1016/j.cbpc.2008.05.009; Liechti F, 2002, J EXP BIOL, V205, P2461; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; Lundby C, 2001, HIGH ALT MED BIOL, V2, P369, DOI 10.1089/15270290152608543; MARGARIA R, 1963, J APPL PHYSIOL, V18, P371, DOI 10.1152/jappl.1963.18.2.371; Meir JU, 2013, J EXP BIOL, V216, P2172, DOI 10.1242/jeb.085282; Noakes TD, 2007, J PHYSIOL-LONDON, V585, P919, DOI 10.1113/jphysiol.2007.145110; NOLET BA, 1992, PHYSIOL ZOOL, V65, P1188, DOI 10.1086/physzool.65.6.30158275; Nudds RL, 2010, COMP BIOCHEM PHYS A, V156, P318, DOI 10.1016/j.cbpa.2010.01.023; Pennycuick CJ, 2008, THEOR ECOL SER, P1; PETSCHOW D, 1977, J APPL PHYSIOL, V42, P139, DOI 10.1152/jappl.1977.42.2.139; Piersma T, 1996, CONDOR, V98, P363, DOI 10.2307/1369154; Portugal SJ, 2012, BIOL LETTERS, V8, P469, DOI 10.1098/rsbl.2011.0975; Portugal SJ, 2009, J EXP BIOL, V212, P2941, DOI 10.1242/jeb.034546; Prop J, 2003, OIKOS, V103, P403, DOI 10.1034/j.1600-0706.2003.12042.x; RAYNER JMV, 1991, PHILOS T ROY SOC B, V334, P119, DOI 10.1098/rstb.1991.0101; RAYNER JMV, 1994, J ZOOL, V234, P537; RODKEY FL, 1979, AM J VET RES, V40, P887; RUIZ G, 1995, INT J BIOMETEOROL, V39, P103, DOI 10.1007/BF01212588; Schippers MP, 2012, CURR BIOL, V22, P2350, DOI 10.1016/j.cub.2012.10.043; Scott GR, 2007, AM J PHYSIOL-REG I, V293, pR379, DOI 10.1152/ajpregu.00161.2007; Scott GR, 2011, J EXP BIOL, V214, P2455, DOI 10.1242/jeb.052548; Scott GR, 2006, RESP PHYSIOL NEUROBI, V154, P284, DOI 10.1016/j.resp.2006.02.012; Scott GR, 2009, P R SOC B, V276, P3645, DOI 10.1098/rspb.2009.0947; Scott GR, 2009, AM J PHYSIOL-REG I, V297, pR1066, DOI 10.1152/ajpregu.00241.2009; SEEHERMAN HJ, 1981, RESP PHYSIOL, V44, P11, DOI 10.1016/0034-5687(81)90074-8; SNYDER GK, 1984, RESP PHYSIOL, V58, P151; STEPHENSON R, 1986, J EXP BIOL, V126, P341; Swan L. W., 1970, Nat. Hist., N.Y., V79, P68; SWAN LW, 1961, SCI AM, V205, P68, DOI 10.1038/scientificamerican1061-68; Tickle PG, 2010, COMP BIOCHEM PHYS A, V156, P309, DOI 10.1016/j.cbpa.2010.01.022; Verhulst S, 2002, AVIAN SCI, V2, P1; VOGEL JA, 1974, J APPL PHYSIOL, V36, P173, DOI 10.1152/jappl.1974.36.2.173; Vogel JA, 1974, J APPL PHYSL, V36; Ward S, 2002, J EXP BIOL, V205, P3347; WEST JB, 1983, J APPL PHYSIOL, V55, P688, DOI 10.1152/jappl.1983.55.3.688; WITHERS PC, 1977, J APPL PHYSIOL, V42, P120, DOI 10.1152/jappl.1977.42.1.120; WOAKES AJ, 1986, J EXP BIOL, V120, P215	66	24	24	0	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94015	10.1371/journal.pone.0094015	http://dx.doi.org/10.1371/journal.pone.0094015			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710001	gold, Green Published			2022-12-25	WOS:000334159800086
J	Li, WJ; Liu, J; Jackson, K; Shi, RH; Zhao, YF				Li, Wenjuan; Liu, Joan; Jackson, Kasey; Shi, Runhua; Zhao, Yunfeng			Sensitizing the Therapeutic Efficacy of Taxol with Shikonin in Human Breast Cancer Cells	PLOS ONE			English	Article							NF-KAPPA-B; PYRUVATE-KINASE; IN-VITRO; INHIBITION; PHOSPHORYLATION; AP-1; TRANSFORMATION; TRANSCRIPTION; PACLITAXEL; INDUCTION	Shikonin, a small-molecule natural product which inhibits the activity of pyruvate kinase M2 (PKM2), has been studied as an anti-cancer drug candidate in human cancer models. Here, our results demonstrate that shikonin is able to sensitize human breast cancer cells to chemotherapy by paclitaxel (taxol). Human breast adenocarcinoma MBA-MD-231 cells, which have higher levels of PKM2 expression and activity compared with MCF-7 cells, were selected to study further. The concentrations of shikonin and taxol were first selected at which they did not significantly induce cytotoxicity when treated alone, whereas the combination induced apoptosis. Surprisingly, PKM2 activity was decreased by shikonin, but not by the combination treatment. To identify the potential targets of this combination, human phospho-kinase antibody array analysis was performed and results indicated that the combination treatment inhibited the activation of ERK, Akt, and p70S6 kinases, which are known to contribute to breast cancer progression. Finally, how the combination affects breast cancer cell growth in vivo was tested using a xenograft tumor model. The results indicated that shikonin plus taxol prolonged animal survival and reduced tumor size than the vehicle treatment group. In summary, our results suggest that shikonin has a potential as an adjuvant for breast cancer therapy.	[Li, Wenjuan; Liu, Joan; Jackson, Kasey; Zhao, Yunfeng] LSU Hlth Sci Ctr Shreveport, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71103 USA; [Shi, Runhua] LSU Hlth Sci Ctr Shreveport, Feist Weiller Canc Ctr, Shreveport, LA USA; [Li, Wenjuan] Hebei Univ, Sch Basic Med, Baoding, Hebei, Peoples R China	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Hebei University	Zhao, YF (corresponding author), LSU Hlth Sci Ctr Shreveport, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71103 USA.	yzhao1@lsuhsc.edu			NIH [1R03CA167689]; NATIONAL CANCER INSTITUTE [R03CA167689] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by NIH Grant Number 1R03CA167689. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Chen J, 2011, ONCOGENE, V30, P4297, DOI 10.1038/onc.2011.137; Chen X, 2002, PHYTOTHER RES, V16, P199, DOI 10.1002/ptr.1100; Cooper SJ, 2007, CURR CANCER DRUG TAR, V7, P325, DOI 10.2174/156800907780809714; DONG ZG, 1994, P NATL ACAD SCI USA, V91, P609, DOI 10.1073/pnas.91.2.609; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Fahy BN, 2004, J AM COLL SURGEONS, V198, P591, DOI 10.1016/j.jamcollsurg.2003.12.005; Gao N, 2003, BIOCHEM BIOPH RES CO, V310, P1124, DOI 10.1016/j.bbrc.2003.09.132; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Hou Y, 2006, YAKUGAKU ZASSHI, V126, P1383, DOI 10.1248/yakushi.126.1383; Kane LP, 2002, MOL CELL BIOL, V22, P5962, DOI 10.1128/MCB.22.16.5962-5974.2002; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lim JY, 2012, WORLD J GASTROENTERO, V18, P4037, DOI 10.3748/wjg.v18.i30.4037; Liu GM, 2001, CANCER RES, V61, P5749; Mabuchi S, 2002, J BIOL CHEM, V277, P33490, DOI 10.1074/jbc.M204042200; Moody TW, 2001, BREAST CANCER RES TR, V68, P55, DOI 10.1023/A:1017994722130; Nguyen DM, 2004, J THORAC CARDIOV SUR, V127, P365, DOI 10.1016/j.jtcvs.2003.09.033; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu Z, 2004, J PHARMACOL SCI, V94, P166, DOI 10.1254/jphs.94.166; Yang HJ, 2009, INT J CANCER, V124, P2450, DOI 10.1002/ijc.24195	22	52	55	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94079	10.1371/journal.pone.0094079	http://dx.doi.org/10.1371/journal.pone.0094079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710512	gold, Green Published, Green Submitted			2022-12-25	WOS:000334159800096
J	Pankova, H; Raabova, J; Munzbergova, Z				Pankova, Hana; Raabova, Jana; Muenzbergova, Zuzana			Mycorrhizal Symbiosis and Local Adaptation in Aster amellus: A Field Transplant Experiment	PLOS ONE			English	Article							COEVOLUTION; FUNGI	Many plant populations have adapted to local soil conditions. However, the role of arbuscular mycorrhizal fungi is often overlooked in this context. Only a few studies have used reciprocal transplant experiments to study the relationships between soil conditions, mycorrhizal colonisation and plant growth. Furthermore, most of the studies were conducted under controlled greenhouse conditions. However, long-term field experiments can provide more realistic insights into this issue. We conducted a five-year field reciprocal transplant experiment to study the relationships between soil conditions, arbuscular mycorrhizal fungi and plant growth in the obligate mycotrophic herb Aster amellus. We conducted this study in two regions in the Czech Republic that differ significantly in their soil nutrient content, namely Czech Karst (region K) and Ceske Stredohori (region S). Plants that originated from region S had significantly higher mycorrhizal colonisation than plants from region K, indicating that the percentage of mycorrhizal colonisation has a genetic basis. We found no evidence of local adaptation in Aster amellus. Instead, plants from region S outperformed the plants from region K in both target regions. Similarly, plants from region S showed more mycorrhizal colonisation in all cases, which was likely driven by the lower nutrient content in the soil from that region. Thus, plant aboveground biomass and mycorrhizal colonisation exhibited corresponding differences between the two target regions and regions of origin. Higher mycorrhizal colonisation in the plants from region with lower soil nutrient content (region S) in both target regions indicates that mycorrhizal colonisation is an adaptive trait. However, lower aboveground biomass in the plants with lower mycorrhizal colonisation suggests that the plants from region K are in fact maladapted by their low inherent mycorrhizal colonization. We conclude that including mycorrhizal symbiosis in local adaptation studies may increase our understanding of the mechanisms by which plants adapt to their environment.	[Pankova, Hana; Muenzbergova, Zuzana] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Raabova, Jana] Natl Museum, Dept Bot, Prague, Czech Republic; [Muenzbergova, Zuzana] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; National Museum; Charles University Prague	Munzbergova, Z (corresponding author), Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic.	zuzmun@natur.cuni.cz	Münzbergová, Zuzana/F-6321-2013; Pánková, Hana/H-1617-2014	Münzbergová, Zuzana/0000-0002-4026-6220; Pánková, Hana/0000-0001-6012-541X	Grant Agency of the Czech Republic [P504/10/1486, P505/11/P482]; Academy of Sciences of the Czech Republic [RVO 67985939]; Ministry of Culture of the Czech Republic [DKRVO 2014/08, 00023272]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Ministry of Culture of the Czech Republic	The study was supported by Grant Agency of the Czech Republic (grants no P504/10/1486, P505/11/P482) and also partly by long-term research projects of the Academy of Sciences of the Czech Republic (RVO 67985939) and the Ministry of Culture of the Czech Republic (DKRVO 2014/08, National Museum, 00023272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker U, 2006, OECOLOGIA, V150, P506, DOI 10.1007/s00442-006-0534-9; Chylova T, 2008, PRESLIA, V80, P183; Cogni R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029220; Doubkova P, 2012, SOIL BIOL BIOCHEM, V44, P56, DOI 10.1016/j.soilbio.2011.09.011; Ehrenberger F., 1973, METHODEN ORGANISCHEN; Ellenberg H, 1996, VEGETATION MITTELEUR; Garrido JL, 2012, PLANT ECOL, V213, P1555, DOI 10.1007/s11258-012-0111-8; Giovannetti M., 1980, New Phytologist, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; Hereford J, 2009, AM NAT, V173, P579, DOI 10.1086/597611; Hoeksema JD, 2010, NEW PHYTOL, V187, P286, DOI 10.1111/j.1469-8137.2010.03305.x; Hufford KM, 2008, RESTOR ECOL, V16, P59, DOI 10.1111/j.1526-100X.2007.00262.x; Ji BM, 2010, ECOLOGY, V91, P3037, DOI 10.1890/09-1451.1; Johnson NC, 2010, NEW PHYTOL, V185, P631, DOI 10.1111/j.1469-8137.2009.03110.x; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Koorem K, 2012, BASIC APPL ECOL, V13, P663, DOI 10.1016/j.baae.2012.09.008; KOSKE RE, 1989, MYCOL RES, V92, P486, DOI 10.1016/S0953-7562(89)80195-9; Leimu R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004010; Lenssen JPM, 2004, J ECOL, V92, P696, DOI 10.1111/j.0022-0477.2004.00895.x; Macel M, 2007, ECOLOGY, V88, P424, DOI 10.1890/0012-9658(2007)88[424:CVSFIL]2.0.CO;2; Mandakova T, 2006, ANN BOT-LONDON, V98, P845, DOI 10.1093/aob/mcl165; Moore P.D., 1986, METHODS PLANT ECOLOG, VSecond edition; Munzbergova Z, 2011, PERSPECT PLANT ECOL, V13, P151, DOI 10.1016/j.ppees.2011.03.002; Nuismer SL, 2008, AM NAT, V171, P658, DOI 10.1086/587077; OLSEN STERLING R., 1954, U S DEPT AGRIC CIRC, V939, P1; Pankova H, 2008, OECOLOGIA, V157, P211, DOI 10.1007/s00442-008-1064-4; Pankova H, 2011, AM J BOT, V98, P850, DOI 10.3732/ajb.0900350; Raabova J, 2008, OECOLOGIA, V158, P463, DOI 10.1007/s00442-008-1156-1; Raabova J, 2007, BIOL CONSERV, V139, P348, DOI 10.1016/j.biocon.2007.07.007; Raabova J, 2011, BASIC APPL ECOL, V12, P152, DOI 10.1016/j.baae.2011.01.001; Schultz PA, 2001, AM J BOT, V88, P1650, DOI 10.2307/3558410; Thrall PH, 2007, TRENDS ECOL EVOL, V22, P120, DOI 10.1016/j.tree.2006.11.007; van Aarle IM, 2003, SOIL BIOL BIOCHEM, V35, P1557, DOI 10.1016/S0038-0717(03)00248-7; Wagner V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017580	35	9	9	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93967	10.1371/journal.pone.0093967	http://dx.doi.org/10.1371/journal.pone.0093967			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709748	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800079
J	Chueca, B; Pagan, R; Garcia-Gonzalo, D				Chueca, Beatriz; Pagan, Rafael; Garcia-Gonzalo, Diego			Differential Mechanism of Escherichia coli Inactivation by (+)-Limonene as a Function of Cell Physiological State and Drug's Concentration	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; ESSENTIAL OILS; BACTERICIDAL ANTIBIOTICS; SULFHYDRYL COMPOUND; OXIDATIVE STRESS; DNA-DAMAGE; LIMONENE; CONSTITUENTS; OXYGEN; DEATH	(+)-limonene is a lipophilic antimicrobial compound, extracted from citrus fruits' essential oils, that is used as a flavouring agent and organic solvent by the food industry. A recent study has proposed a common and controversial mechanism of cell death for bactericidal antibiotics, in which hydroxyl radicals ultimately inactivated cells. Our objective was to determine whether the mechanism of Escherichia coli MG1655 inactivation by (+)-limonene follows that of bactericidal antibiotics. A treatment with 2,000 mu L/L (+)-limonene inactivated 4 log(10) cycles of exponentially growing E. coli cells in 3 hours. On one hand, an increase of cell survival in the Delta acnB mutant (deficient in a TCA cycle enzyme), or in the presence of 2,2'-dipyridyl (inhibitor of Fenton reaction by iron chelation), thiourea, or cysteamine (hydroxyl radical scavengers) was observed. Moreover, the Delta recA mutant (deficient in an enzyme involved in SOS response to DNA damage) was more sensitive to (+)-limonene. Thus, this indirect evidence indicates that the mechanism of exponentially growing E. coli cells inactivation by 2,000 mu L/L (+)-limonene is due to the TCA cycle and Fenton-mediated hydroxyl radical formation that caused oxidative DNA damage, as observed for bactericidal drugs. However, several differences have been observed between the proposed mechanism for bactericidal drugs and for (+)-limonene. In this regard, our results demonstrated that E. coli inactivation was influenced by its physiological state and the drug's concentration: experiments with stationary-phase cells or 4,000 mu L/L (+)-limonene uncovered a different mechanism of cell death, likely unrelated to hydroxyl radicals. Our research has also shown that drug's concentration is an important factor influencing the mechanism of bacterial inactivation by antibiotics, such as kanamycin. These results might help in improving and spreading the use of (+)-limonene as an antimicrobial compound, and in clarifying the controversy about the mechanism of inactivation by bactericidal antibiotics.	[Chueca, Beatriz; Pagan, Rafael; Garcia-Gonzalo, Diego] Univ Zaragoza, Fac Vet, Dept Prod Anim & Ciencia Alimentos, Zaragoza, Spain	University of Zaragoza	Garcia-Gonzalo, D (corresponding author), Univ Zaragoza, Fac Vet, Dept Prod Anim & Ciencia Alimentos, Zaragoza, Spain.	Diego.Garcia@unizar.es	Gonzalo, Diego Garcia/AAE-8947-2021; Pagan, Rafael/H-4401-2011; Gonzalo, Diego Garcia/A-2766-2012	Gonzalo, Diego Garcia/0000-0002-7629-8101; Pagan, Rafael/0000-0002-0238-6328; Gonzalo, Diego Garcia/0000-0002-7629-8101	CICYT [AGL2012-32165]; European Social Fund; Aragonese Departamento de Ciencia, Tecnologia y Universidad; Spanish Ministerio de Educacion, Cultura y Deporte	CICYT(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); European Social Fund(European Social Fund (ESF)); Aragonese Departamento de Ciencia, Tecnologia y Universidad; Spanish Ministerio de Educacion, Cultura y Deporte(Spanish Government)	This study was financially supported by the CICYT (Project AGL2012-32165), European Social Fund and Aragonese Departamento de Ciencia, Tecnologia y Universidad; and Spanish Ministerio de Educacion, Cultura y Deporte that provided B. Chueca with a grant to carry out this investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Ouazzou A, 2011, INNOV FOOD SCI EMERG, V12, P320, DOI 10.1016/j.ifset.2011.04.004; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Braun JEF, 1996, MUTAT RES-DNA REPAIR, V364, P171, DOI 10.1016/S0921-8777(96)00030-4; Chee Hee Youn, 2009, Mycobiology, V37, P243, DOI 10.4489/MYCO.2009.37.3.243; Condon S, 1996, LETT APPL MICROBIOL, V22, P149, DOI 10.1111/j.1472-765X.1996.tb01130.x; Courcelle J, 2003, ANNU REV GENET, V37, P611, DOI 10.1146/annurev.genet.37.110801.142616; Crowell PL, 1999, J NUTR, V129, p775S, DOI 10.1093/jn/129.3.775S; Dambolena JS, 2008, TOXICON, V51, P37, DOI 10.1016/j.toxicon.2007.07.005; Dorman HJD, 2000, J APPL MICROBIOL, V88, P308, DOI 10.1046/j.1365-2672.2000.00969.x; Espina L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056769; Espina L, 2013, INT J FOOD MICROBIOL, V161, P23, DOI 10.1016/j.ijfoodmicro.2012.11.015; Espina L, 2011, FOOD CONTROL, V22, P896, DOI 10.1016/j.foodcont.2010.11.021; FARR SB, 1991, MICROBIOL REV, V55, P561, DOI 10.1128/MMBR.55.4.561-585.1991; Fisher K, 2008, TRENDS FOOD SCI TECH, V19, P156, DOI 10.1016/j.tifs.2007.11.006; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Friedman M, 2002, J FOOD PROTECT, V65, P1545, DOI 10.4315/0362-028X-65.10.1545; Guyton Kathryn Z, 2002, Curr Oncol Rep, V4, P464, DOI 10.1007/s11912-002-0057-4; HARTMAN PS, 1978, J BACTERIOL, V133, P769, DOI 10.1128/JB.133.2.769-774.1978; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; IMLAY JA, 1986, J BACTERIOL, V166, P519, DOI 10.1128/jb.166.2.519-527.1986; Jaroenkit P., 2011, International Journal of Medicinal and Aromatic Plants, V1, P234; Jones SFA, 1996, EUR J GASTROEN HEPAT, V8, P1227, DOI 10.1097/00042737-199612000-00018; KELNER MJ, 1990, J BIOL CHEM, V265, P1306; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Letain TE, 1997, MOL MICROBIOL, V24, P271, DOI 10.1046/j.1365-2958.1997.3331703.x; Liu JD, 2013, APPL MICROBIOL BIOT, V97, P6467, DOI 10.1007/s00253-013-4931-9; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Moeck GS, 1998, MOL MICROBIOL, V28, P675, DOI 10.1046/j.1365-2958.1998.00817.x; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; NOVOGRODSKY A, 1982, P NATL ACAD SCI-BIOL, V79, P1171, DOI 10.1073/pnas.79.4.1171; Raso J, 1998, APPL ENVIRON MICROB, V64, P465; REPINE JE, 1981, J BIOL CHEM, V256, P7094; Rolseth V, 2002, TOXICOLOGY, V170, P75, DOI 10.1016/S0300-483X(01)00537-6; Salih FM, 2002, J APPL MICROBIOL, V92, P920, DOI 10.1046/j.1365-2672.2002.01601.x; SIKKEMA J, 1994, J BIOL CHEM, V269, P8022; Somolinos M, 2010, J APPL MICROBIOL, V108, P1928, DOI 10.1111/j.1365-2672.2009.04597.x; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; Van Vuuren SF, 2007, FLAVOUR FRAG J, V22, P540, DOI 10.1002/ffj.1843; WALSH K, 1984, J BIOL CHEM, V259, P9646; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; ZUKERMAN I, 1951, NATURE, V168, P517, DOI 10.1038/168517a0	43	30	31	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94072	10.1371/journal.pone.0094072	http://dx.doi.org/10.1371/journal.pone.0094072			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705541	Green Published, Green Submitted, gold			2022-12-25	WOS:000334107500119
J	Basak, I; Pal, R; Patil, KS; Dunne, A; Ho, HP; Lee, S; Peiris, D; Maple-Grodem, J; Odell, M; Chang, EJ; Larsen, JP; Moller, SG				Basak, Indranil; Pal, Ramavati; Patil, Ketan S.; Dunne, Aisling; Ho, Hsin-Pin; Lee, Sungsu; Peiris, Diluka; Maple-Grodem, Jodi; Odell, Mark; Chang, Emmanuel J.; Larsen, Jan Petter; Moller, Simon G.			Arabidopsis AtPARK13, Which Confers Thermotolerance, Targets Misfolded Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE; NEUROPROTECTIVE ROLE; HTRA2; GENE; MUTATIONS; MITOCHONDRIA; DEGRADATION; OMI/HTRA2; THALIANA	Mutations in HTRA2/Omi/PARK13 have been implicated inParkinson disease (PD). PARK13 is a neuroprotective serine protease; however, little is known about how PARK13 confers stress protection and which protein targets are directly affected by PARK13. We have reported that Arabidopsis thaliana represents a complementary PD model, and here we demonstrate that AtPARK13, similar to human PARK13 (hPARK13), is a mitochondrial protease. We show that the expression/accumulation of AtPARK13 transcripts are induced by heat stress but not by other stress conditions, including oxidative stress and metals. Our data show that elevated levels of AtPARK13 confer thermotolerance in A. thaliana. Increased temperatures accelerate protein unfolding, and we demonstrate that although AtPARK13 can act on native protein substrates, unfolded proteins represent better AtPARK13 substrates. The results further show that AtPARK13 and hPARK13 can degrade the PD proteins alpha-synuclein (SNCA) and DJ-1/PARK7 directly, without autophagy involvement, and that misfolded SNCA and DJ-1 represent better substrates than their native counterparts. Comparative proteomic profiling revealed AtPARK13-mediated proteome changes, and we identified four proteins that show altered abundance in response to AtPARK13 overexpression and elevated temperatures. Our study not only suggests that AtPARK13 confers thermotolerance by degrading misfolded protein targets, but it also provides new insight into possible roles of this protease in neurodegeneration.	[Basak, Indranil; Pal, Ramavati; Patil, Ketan S.; Dunne, Aisling; Lee, Sungsu; Moller, Simon G.] St Johns Univ, Dept Biol Sci, New York, NY 11439 USA; [Ho, Hsin-Pin; Chang, Emmanuel J.] CUNY York Coll, Dept Chem, New York, NY 11451 USA; [Peiris, Diluka; Odell, Mark] Univ Westminster, Dept Mol & Appl Biosci, London W1W 6UW, England; [Maple-Grodem, Jodi; Larsen, Jan Petter; Moller, Simon G.] Stavanger Univ Hosp, Norwegian Ctr Movement Disorders, N-4068 Stavanger, Norway	Saint John's University; City University of New York (CUNY) System; University of Westminster; Stavanger University Hospital	Moller, SG (corresponding author), St Johns Univ, Dept Biol Sci, 8000 Utopia Pkwy, New York, NY 11439 USA.	mollers@stjohns.edu	Basak, Indranil/P-9279-2016; Basak, Indranil/AAH-2593-2020; Grødem, jodi M/H-5482-2012	Basak, Indranil/0000-0001-5009-2845; Maple-Grodem, Jodi/0000-0001-7142-0078; Moller, Simon/0000-0002-0460-3592	Norwegian Research Council; Western Norway Regional Health Authority; Norwegian Centre for Movement Disorders; Department of Biological Sciences at St. John's University	Norwegian Research Council(Research Council of NorwayEuropean Commission); Western Norway Regional Health Authority; Norwegian Centre for Movement Disorders; Department of Biological Sciences at St. John's University	This work was supported by grants from the Norwegian Research Council, the Western Norway Regional Health Authority, the Norwegian Centre for Movement Disorders, and the Department of Biological Sciences at St. John's University.	Bailey S, 2002, J BIOL CHEM, V277, P2006, DOI 10.1074/jbc.M105878200; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bogaerts V, 2008, HUM MUTAT, V29, P832, DOI 10.1002/humu.20713; Bonifati V, 2003, NEUROL SCI, V24, P159, DOI 10.1007/s10072-003-0108-0; Charng YY, 2007, PLANT PHYSIOL, V143, P251, DOI 10.1104/pp.106.091322; Chen JP, 2006, PLANT J, V48, P73, DOI 10.1111/j.1365-313X.2006.02855.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Fitzgerald JC, 2012, CELL DEATH DIFFER, V19, P257, DOI 10.1038/cdd.2011.90; Fulda M, 2002, PLANT J, V32, P93, DOI 10.1046/j.1365-313X.2002.01405.x; Hansen G, 2013, CELL MOL LIFE SCI, V70, P761, DOI 10.1007/s00018-012-1076-4; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hirt H., 2004, PLANT RESPONSES ABIO, V4, P73; Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kost B, 1998, PLANT J, V16, P393, DOI 10.1046/j.1365-313x.1998.00304.x; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Kruger R, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2009.11.021; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li B, 2010, CELL DEATH DIFFER, V17, P1773, DOI 10.1038/cdd.2010.55; Lin CH, 2011, HUM GENET, V130, P817, DOI 10.1007/s00439-011-1041-6; Liu MJ, 2007, BIOCHEM BIOPH RES CO, V362, P295, DOI 10.1016/j.bbrc.2007.07.118; Martin I, 2011, ANNU REV GENOM HUM G, V12, P301, DOI 10.1146/annurev-genom-082410-101440; Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004; Mesquita RO, 2012, GENET MOL BIOL, V35, P353, DOI 10.1590/S1415-47572012000200017; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Moisoi N, 2009, CELL DEATH DIFFER, V16, P449, DOI 10.1038/cdd.2008.166; Pliyev BK, 1999, BIOCHEMISTRY-MOSCOW+, V64, P738; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Schapira AHV, 2011, PARKINSONS DIS-US, V2011, DOI 10.4061/2011/159160; Selkoe DJ, 2004, NAT CELL BIOL, V6, P1054, DOI 10.1038/ncb1104-1054; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Truscott KN, 2011, IUBMB LIFE, V63, P955, DOI 10.1002/iub.526; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Wang CY, 2011, BRAIN RES, V1385, P293, DOI 10.1016/j.brainres.2011.02.037; Xu XM, 2011, CURR OPIN BIOTECH, V22, P300, DOI 10.1016/j.copbio.2010.11.007; Xu XM, 2010, J CELL SCI, V123, P1644, DOI 10.1242/jcs.063222; Yu F, 2005, PLANT PHYSIOL, V138, P1957, DOI 10.1104/pp.105.061234; Zelisko A, 2005, P NATL ACAD SCI USA, V102, P13699, DOI 10.1073/pnas.0503472102; Zhang XF, 2004, BIOCHEMISTRY-MOSCOW+, V69, P687, DOI 10.1023/B:BIRY.0000033743.09806.1a; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x; Zurawa-Janicka D, 2013, CELL STRESS CHAPERON, V18, P35, DOI 10.1007/s12192-012-0355-1	43	15	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14458	14469		10.1074/jbc.M114.548156	http://dx.doi.org/10.1074/jbc.M114.548156			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24719325	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000337248100003
J	Heraud, C; Griffiths, A; Pandruvada, SNM; Kilimann, MW; Pata, M; Vacher, J				Heraud, Celine; Griffiths, Adam; Pandruvada, Subramanya N. M.; Kilimann, Manfred W.; Pata, Monica; Vacher, Jean			Severe Neurodegeneration with Impaired Autophagy Mechanism Triggered by Ostm1 Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; mTOR; Neurodegeneration; Neurons; Transgenic Mice	AUTOSOMAL RECESSIVE OSTEOPETROSIS; LYSOSOMAL STORAGE DISEASE; MOUSE MODELS; AXONAL-TRANSPORT; REQUIRES OSTM1; INHIBITION; ASTROCYTES; ACTIVATION; REVEALS; DEFECT	Background: Although loss of the Ostm1 gene leads to the most severe form of osteopetrosis, Ostm1 is expressed in other tissues, including the CNS. Results: Independently of hematopoietic lineages, loss of Ostm1 results in acute neurodegeneration with enhanced autophagy. Conclusion: We present evidence for an Ostm1 cell-autonomous role in neurons. Significance: This study shows a novel molecular pathogenic mechanism for neurodegeneration-related diseases. Loss of Ostm1 leads to the most severe form of osteopetrosis in mice and humans. Because functional rescue of the osteopetrotic defect in these mice extended their lifespan from approximate to 3 weeks to 6 weeks, this unraveled a second essential role of Ostm1. We discovered that Ostm1 is highly expressed in the mouse brain in neurons, microglia, and astrocytes. At 3-4 weeks of age, mice with Ostm1 loss showed 3-10-fold stimulation of reactive gliosis, with an increased astrocyte cell population and microglia activation. This inflammatory response was associated with marked retinal photoreceptor degeneration and massive neuronal loss in the brain. Intracellular characterization of neurons revealed abnormal storage of carbohydrates, lipids, and ubiquitinated proteins, combined with marked accumulation of autophagosomes that causes frequent axonal swelling. Stimulation of autophagy was provided by specific markers and by significant down-regulation of the mammalian target of rapamycin signaling, identifying a cellular pathologic mechanism. A series of transgenic mouse lines specifically targeted to distinct central nervous system cell subpopulations determined that Ostm1 has a primary and autonomous role in neuronal homeostasis. Complete functional complementation demonstrated that the development of severe and rapid neurodegeneration in these mice is independent of the hematopoietic lineage and has clinical implications for treatment of osteopetrosis. Importantly, this study establishes a novel neurodegenerative mouse model critical for understanding the multistep pathogenic cascade of cellular autophagy disorders toward therapeutic strategy design.	[Heraud, Celine; Griffiths, Adam; Pandruvada, Subramanya N. M.; Pata, Monica; Vacher, Jean] Univ Montreal, Dept Med, Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Heraud, Celine; Griffiths, Adam; Pandruvada, Subramanya N. M.; Pata, Monica; Vacher, Jean] McGill Univ, Dept Med, Div Expt Med, Montreal, PQ H3A 1A3, Canada; [Kilimann, Manfred W.] Univ Gottingen, Med Ctr, Dept Otolaryngol, D-37075 Gottingen, Germany; [Kilimann, Manfred W.] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; University of Gottingen; Max Planck Society	Vacher, J (corresponding author), Clin Res Inst Montreal, 110 Ave Pins Ouest Montreal, Montreal, PQ H2W 1R7, Canada.	vacherj@ircm.qc.ca	pandruvada, subramanya/AAA-3072-2019; Pandruvada, Subramanya/E-4373-2012	Pandruvada, Subramanya/0000-0001-9568-7666; Heraud, Celine/0000-0002-9208-2335	Canadian Institutes of Health Research [86655]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grant 86655 (to J.V.).	Alroy J, 2007, ULTRASTRUCT PATHOL, V31, P333, DOI 10.1080/01913120701578098; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; Cao Y, 2006, J BIOL CHEM, V281, P20483, DOI 10.1074/jbc.M602180200; Chalhoub N, 2003, NAT MED, V9, P399, DOI 10.1038/nm842; Chiodo DC, 2007, NEUROPEDIATRICS, V38, P154, DOI 10.1055/s-2007-990267; de Luca C, 2005, J CLIN INVEST, V115, P3484, DOI 10.1172/JCI24059; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goebel HH, 2004, BRAIN PATHOL, V14, P61, DOI 10.1111/j.1750-3639.2004.tb00499.x; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Kasper D, 2005, EMBO J, V24, P1079, DOI 10.1038/sj.emboj.7600576; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Laird FM, 2008, J NEUROSCI, V28, P1997, DOI 10.1523/JNEUROSCI.4231-07.2008; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Lee S, 2011, J NEUROSCI, V31, P7817, DOI 10.1523/JNEUROSCI.6412-10.2011; Leisle L, 2011, EMBO J, V30, P2140, DOI 10.1038/emboj.2011.137; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Maranda B, 2008, J BONE MINER RES, V23, P296, DOI 10.1359/JBMR.071015; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Mazzolari E, 2009, AM J HEMATOL, V84, P473, DOI 10.1002/ajh.21447; Millecamps S, 2013, NAT REV NEUROSCI, V14, P161, DOI 10.1038/nrn3380; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Ott CE, 2013, BONE, V55, P292, DOI 10.1016/j.bone.2013.04.007; Pacheco CD, 2007, HUM MOL GENET, V16, P1495, DOI 10.1093/hmg/ddm100; Pangrazio A, 2006, J BONE MINER RES, V21, P1098, DOI 10.1359/JBMR.060403; Pata M, 2008, J BIOL CHEM, V283, P30522, DOI 10.1074/jbc.M805242200; Platt FM, 2012, J CELL BIOL, V199, P723, DOI 10.1083/jcb.201208152; Poet M, 2006, P NATL ACAD SCI USA, V103, P13854, DOI 10.1073/pnas.0606137103; Pressey SNR, 2010, J NEUROPATH EXP NEUR, V69, P1228, DOI 10.1097/NEN.0b013e3181ffe742; Prinetti A, 2009, GLYCOCONJUGATE J, V26, P623, DOI 10.1007/s10719-008-9179-8; Quarello P, 2004, J BONE MINER RES, V19, P1194, DOI 10.1359/JBMR.040407; Rajapurohitam V, 2001, BONE, V28, P513, DOI 10.1016/S8756-3282(01)00416-1; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rodriguez JJ, 2009, CELL DEATH DIFFER, V16, P378, DOI 10.1038/cdd.2008.172; Sobacchi C, 2013, NAT REV ENDOCRINOL, V9, P522, DOI 10.1038/nrendo.2013.137; Steward CG, 2003, NEUROPATH APPL NEURO, V29, P87, DOI 10.1046/j.1365-2990.2003.00474.x; Tolar J, 2004, NEW ENGL J MED, V351, P2839, DOI 10.1056/NEJMra040952; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Wada R, 2000, P NATL ACAD SCI USA, V97, P10954, DOI 10.1073/pnas.97.20.10954; Wartosch L, 2009, FASEB J, V23, P4056, DOI 10.1096/fj.09-130880; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047	45	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13912	13925		10.1074/jbc.M113.537233	http://dx.doi.org/10.1074/jbc.M113.537233			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24719316	hybrid, Green Published			2022-12-25	WOS:000335984600023
J	Amberbir, A; Medhin, G; Hanlon, C; Britton, J; Davey, G; Venn, A				Amberbir, Alemayehu; Medhin, Girmay; Hanlon, Charlotte; Britton, John; Davey, Gail; Venn, Andrea			Effects of Early Life Paracetamol Use on the Incidence of Allergic Disease and Sensitization: 5 Year Follow-Up of an Ethiopian Birth Cohort	PLOS ONE			English	Article							ACETAMINOPHEN USE; GLUTATHIONE LEVELS; ASTHMA; RISK; CHILDHOOD; CHILDREN; WHEEZE; ECZEMA; RHINOCONJUNCTIVITIS; ASSOCIATION	Introduction: The hypothesis that paracetamol, one of the most widely used medicines, may increase the risk of asthma and allergic disease is of obvious importance but prospective cohort data looking at dose and timing of exposure are lacking. Objective: The aim of the study is to investigate the role of paracetamol use in early life on the prevalence and incidence of wheeze, eczema, rhinitis and allergic sensitization, prospectively over 5 years in an Ethiopian birth cohort. Methods: In 2005/6 a birth cohort of 1006 newborns was established in Butajira, Ethiopia. Questionnaire data on allergic disease symptoms, paracetamol use and numerous potential confounders were collected at ages 1, 3 and 5, and allergen skin sensitivity measured at ages 3 and 5. Multivariate logistic regression was used to determine independent effects of paracetamol exposure on the incidence of each outcome between ages 3 and 5, and prevalence at age 5. Findings: Paracetamol use in the first 3 years of life was reported in 60% of children and was associated with increased incidence of wheeze, eczema, rhinitis and allergic sensitisation between ages 3 and 5 which was statistically significant for wheeze and eczema. High exposure (reported use in the past month at age 1 and 3) was associated with a more than 3-fold increased risk of new onset wheeze (adjusted odds ratio (OR) 3.64; 95% confidence interval, 1.34 to 9.90) compared to never users. Use in the past year at age 3 but not age 1 was associated with ORs at least as large as those for use in first year of life only. Significant positive dose-response effects of early life use were seen in relation to the prevalence of all outcomes at age 5. Conclusions: Use of paracetamol in early life is a strong risk factor for incident allergic disease in childhood.	[Amberbir, Alemayehu] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Amberbir, Alemayehu; Britton, John; Venn, Andrea] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Medhin, Girmay] Univ Addis Ababa, Aklilu Lemma Inst Pathobiol, Addis Ababa, Ethiopia; [Hanlon, Charlotte] Univ Addis Ababa, Dept Psychiat, Addis Ababa, Ethiopia; [Davey, Gail] Univ Brighton, Brighton & Sussex Med Sch, Brighton, E Sussex, England	University of London; London School of Hygiene & Tropical Medicine; University of Nottingham; Addis Ababa University; Addis Ababa University; University of Brighton; University of Sussex	Amberbir, A (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England.	alemayehu.amberbir@lshtm.ac.uk	Amberbir, Alemayehu/HGC-2647-2022; Hanlon, Charlotte/AAH-7769-2020	Hanlon, Charlotte/0000-0002-7937-3226; Medhin, Girmay/0000-0003-2146-4261	Asthma United Kingdom [07/036]; Medical Research Council [MR/K023195/1B] Funding Source: researchfish; Asthma UK [07/036] Funding Source: researchfish	Asthma United Kingdom; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	The study was funded by Asthma United Kingdom project grant (07/036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberbir A, 2011, CLIN EXP ALLERGY, V41, P1422, DOI 10.1111/j.1365-2222.2011.03831.x; Amberbir A, 2011, AM J RESP CRIT CARE, V183, P165, DOI 10.1164/rccm.201006-0989OC; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Barr RG, 2004, AM J RESP CRIT CARE, V169, P836, DOI 10.1164/rccm.200304-596OC; Beasley R, 2008, LANCET, V372, P1039, DOI 10.1016/S0140-6736(08)61445-2; Beasley RW, 2011, AM J RESP CRIT CARE, V183, P171, DOI 10.1164/rccm.201005-0757OC; Belyhun Y, 2010, CLIN EXP ALLERGY, V40, P619, DOI 10.1111/j.1365-2222.2010.03479.x; Berhane Y., 1999, ETHIOP J HEALTH DEV, V13, P1; Davey G, 2005, J ALLERGY CLIN IMMUN, V116, P863, DOI 10.1016/j.jaci.2005.05.045; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Etminan M, 2009, CHEST, V136, P1316, DOI 10.1378/chest.09-0865; Eyers S, 2011, CLIN EXP ALLERGY, V41, P482, DOI 10.1111/j.1365-2222.2010.03691.x; Farquhar H, 2010, CLIN EXP ALLERGY, V40, P32, DOI 10.1111/j.1365-2222.2009.03378.x; Hanlon C, 2009, TROP MED INT HEALTH, V14, P156, DOI 10.1111/j.1365-3156.2008.02198.x; Illi S, 2001, BMJ-BRIT MED J, V322, P390, DOI 10.1136/bmj.322.7283.390; Lesko SM, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e20; Lowe AJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4616; MICHELI L, 1994, ENVIRON HEALTH PERSP, V102, P63, DOI 10.1289/ehp.94102s963; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nassini R, 2010, FASEB J, V24, P4904, DOI 10.1096/fj.10-162438; Nuttall SL, 2003, J CLIN PHARM THER, V28, P289, DOI 10.1046/j.1365-2710.2003.00493.x; Nuttall SL, 2003, J CLIN PHARM THER, V28, P251, DOI 10.1046/j.1365-2710.2003.00492.x; Perzanowski MS, 2008, J ALLERGY CLIN IMMUN, V121, pS231, DOI 10.1016/j.jaci.2007.12.914; Peterson JD, 1998, P NATL ACAD SCI USA, V95, P3071, DOI 10.1073/pnas.95.6.3071; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; Rebordosa C, 2008, INT J EPIDEMIOL, V37, P583, DOI 10.1093/ije/dyn070; Shaheen SO, 2002, THORAX, V57, P958, DOI 10.1136/thorax.57.11.958; Yemaneberhan H, 1997, LANCET, V350, P85, DOI 10.1016/S0140-6736(97)01151-3	30	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93869	10.1371/journal.pone.0093869	http://dx.doi.org/10.1371/journal.pone.0093869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718577	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000334339000053
J	Sieradzka, D; Power, RA; Freeman, D; Cardno, AG; McGuire, P; Plomin, R; Meaburn, EL; Dudbridge, F; Ronald, A				Sieradzka, Dominika; Power, Robert A.; Freeman, Daniel; Cardno, Alastair G.; McGuire, Philip; Plomin, Robert; Meaburn, Emma L.; Dudbridge, Frank; Ronald, Angelica			Are Genetic Risk Factors for Psychosis Also Associated with Dimension-Specific Psychotic Experiences in Adolescence?	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BIPOLAR AFFECTIVE-DISORDER; SCHIZOPHRENIA; POPULATION; SCHIZOTYPY; SYMPTOMS; HERITABILITY; METAANALYSIS; GENOTYPE; TRAITS	Psychosis has been hypothesised to be a continuously distributed quantitative phenotype and disorders such as schizophrenia and bipolar disorder represent its extreme manifestations. Evidence suggests that common genetic variants play an important role in liability to both schizophrenia and bipolar disorder. Here we tested the hypothesis that these common variants would also influence psychotic experiences measured dimensionally in adolescents in the general population. Our aim was to test whether schizophrenia and bipolar disorder polygenic risk scores (PRS), as well as specific single nucleotide polymorphisms (SNPs) previously identified as risk variants for schizophrenia, were associated with adolescent dimension-specific psychotic experiences. Self-reported Paranoia, Hallucinations, Cognitive Disorganisation, Grandiosity, Anhedonia, and Parent-rated Negative Symptoms, as measured by the Specific Psychotic Experiences Questionnaire (SPEQ), were assessed in a community sample of 2, 152 16-year-olds. Polygenic risk scores were calculated using estimates of the log of odds ratios from the Psychiatric Genomics Consortium GWAS stage-1 mega-analysis of schizophrenia and bipolar disorder. The polygenic risk analyses yielded no significant associations between schizophrenia and bipolar disorder PRS and the SPEQ measures. The analyses on the 28 individual SNPs previously associated with schizophrenia found that two SNPs in TCF4 returned a significant association with the SPEQ Paranoia dimension, rs17512836 (p-value = 2.57x10(-4)) and rs9960767 (p-value = 6.23x10(-4)). Replication in an independent sample of 16-year-olds (N = 3,427) assessed using the Psychotic-Like Symptoms Questionnaire (PLIKS-Q), a composite measure of multiple positive psychotic experiences, failed to yield significant results. Future research with PRS derived from larger samples, as well as larger adolescent validation samples, would improve the predictive power to test these hypotheses further. The challenges of relating adult clinical diagnostic constructs such as schizophrenia to adolescent psychotic experiences at a genetic level are discussed.	[Sieradzka, Dominika; Meaburn, Emma L.; Ronald, Angelica] Univ London, Ctr Brain & Cognit Dev, London, England; [Power, Robert A.; Plomin, Robert] Kings Coll London, MRC, Social Genet & Dev Psychiat Ctr, Inst Psychiat, London, England; [Freeman, Daniel] Univ Oxford, Dept Psychiat, Oxford, England; [Cardno, Alastair G.] Univ Leeds, Acad Unit Psychiat & Behav Sci, Leeds, W Yorkshire, England; [McGuire, Philip] Kings Coll London, Inst Psychiat, London, England; [Dudbridge, Frank] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England	University of London; Birkbeck University London; University of London; King's College London; University of Oxford; University of Leeds; University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine	Sieradzka, D (corresponding author), Univ London, Ctr Brain & Cognit Dev, London, England.	dsiera01@mail.bbk.ac.uk	Freeman, Daniel/C-6851-2009; Ronald, Angelica/C-7812-2009	Freeman, Daniel/0000-0002-2541-2197; Ronald, Angelica/0000-0002-9576-2176; McGuire, Philip/0000-0003-4381-0532; Plomin, Robert/0000-0002-0756-3629; Meaburn, Emma/0000-0001-8096-9089; Power, Robert/0000-0003-0276-0399	Medical Research Council [G1100559, G0901245, G0500079, G19/2]; UK Medical Research Council; Wellcome Trust [092731]; Wellcome Trust Case Control Consortium 2 project [085475/B/08/Z, 085475/Z/08/Z]; Economic and Social Research Council; Economic and Social Research Council [1099627] Funding Source: researchfish; Medical Research Council [MC_PC_15018, G0902308, G9817803B, MR/K006215/1] Funding Source: researchfish; MRC [G0500079, G1100559, G19/2, G0901245, G0902308, MR/K006215/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Wellcome Trust Case Control Consortium 2 project; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council [G1100559 to A. R., G0901245, G0500079, G19/2 to R. P.] and the UK Medical Research Council and the Wellcome Trust [092731] to ALSPAC. Genome-wide genotyping was made possible by grants from the Wellcome Trust Case Control Consortium 2 project (085475/B/08/Z; 085475/Z/08/Z). D. S. was supported by the Economic and Social Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI 10.1176/appi.books.9780890425596; Bergen SE, 2012, CURR OPIN PSYCHIATR, V25, P76, DOI 10.1097/YCO.0b013e32835035dd; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; Cummings E, 2010, SCHIZOPHR RES, V122, P273, DOI 10.1016/j.schres.2010.05.022; Cyhlarova E, 2005, SCHIZOPHR RES, V80, P253, DOI 10.1016/j.schres.2005.07.037; Derks EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037852; DeRosse P, 2006, AM J PSYCHIAT, V163, P532, DOI 10.1176/appi.ajp.163.3.532; DeRosse P, 2006, SCHIZOPHR RES, V87, P28, DOI 10.1016/j.schres.2006.06.008; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Ericson M, 2011, BEHAV GENET, V41, P499, DOI 10.1007/s10519-010-9401-x; Fanous AH, 2005, AM J PSYCHIAT, V162, P1824, DOI 10.1176/appi.ajp.162.10.1824; Fanous AH, 2005, MOL PSYCHIATR, V10, P6, DOI 10.1038/sj.mp.4001571; Fanous AH, 2012, AM J PSYCHIAT, V169, P1309, DOI 10.1176/appi.ajp.2012.12020218; Fonseca-Pedrero E, 2009, SCHIZOPHR RES, V111, P53, DOI 10.1016/j.schres.2009.03.006; Fossati A, 2003, PERS INDIV DIFFER, V35, P1007, DOI 10.1016/S0191-8869(02)00314-8; Haworth CMA, 2013, TWIN RES HUM GENET, V16, P117, DOI 10.1017/thg.2012.91; Hur YM, 2012, PSYCHIAT RES, V199, P98, DOI 10.1016/j.psychres.2012.04.024; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kelleher I, 2012, BRIT J PSYCHIAT, V201, P26, DOI 10.1192/bjp.bp.111.101543; Laursen TM, 2007, J CLIN PSYCHIAT, V68, P1673, DOI 10.4088/JCP.v68n1106; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lehman EL, 1975, NONPARAMETRICS STAT; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; Lin CCH, 2007, BEHAV GENET, V37, P334, DOI 10.1007/s10519-006-9104-5; McGuffin P, 2003, ARCH GEN PSYCHIAT, V60, P497, DOI 10.1001/archpsyc.60.5.497; Paternoster L, 2011, HUM MOL GENET, V20, P4069, DOI 10.1093/hmg/ddr309; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Poulton R, 2000, ARCH GEN PSYCHIAT, V57, P1053, DOI 10.1001/archpsyc.57.11.1053; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Psychiatric GWAS Consortium Bipolar Disorder Working Group, 2011, Nat Genet, V43, P977, DOI 10.1038/ng.943; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Rijsdijk FV, 2011, AM J MED GENET B, V156B, P89, DOI 10.1002/ajmg.b.31145; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Ronald A, 2014, SCHIZOPHR B IN PRESS; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Trzaskowski M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058676; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; Vollema MG, 2000, SCHIZOPHRENIA BULL, V26, P565, DOI 10.1093/oxfordjournals.schbul.a033478; Welham J, 2009, PSYCHOL MED, V39, P625, DOI 10.1017/S0033291708003760; Wigman JTW, 2011, SCHIZOPHRENIA BULL, V37, P850, DOI 10.1093/schbul/sbp154; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Yang Jian, 2011, Am J Hum Genet, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Zammit S, 2014, SCHIZOPHR B IN PRESS; Zammit S, 2011, BRIT J PSYCHIAT, V199, P380, DOI 10.1192/bjp.bp.111.091421	47	45	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94398	10.1371/journal.pone.0094398	http://dx.doi.org/10.1371/journal.pone.0094398			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718684	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000334339000117
J	Sugiyama, K; Ebinuma, H; Nakamoto, N; Sakasegawa, N; Murakami, Y; Chu, P; Usui, S; Ishibashi, Y; Wakayama, Y; Taniki, N; Murata, H; Saito, Y; Fukasawa, M; Saito, K; Yamagishi, Y; Wakita, T; Takaku, H; Hibi, T; Saito, H; Kanai, T				Sugiyama, Kazuo; Ebinuma, Hirotoshi; Nakamoto, Nobuhiro; Sakasegawa, Noriko; Murakami, Yuko; Chu, Po-sung; Usui, Shingo; Ishibashi, Yuka; Wakayama, Yuko; Taniki, Nobuhito; Murata, Hiroko; Saito, Yoshimasa; Fukasawa, Masayoshi; Saito, Kyoko; Yamagishi, Yoshiyuki; Wakita, Takaji; Takaku, Hiroshi; Hibi, Toshifumi; Saito, Hidetsugu; Kanai, Takanori			Prominent Steatosis with Hypermetabolism of the Cell Line Permissive for Years of Infection with Hepatitis C Virus	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; RNA REPLICATION; LIPID DROPLET; CORE PROTEIN; CANCER; TRANSPORTERS; HEPATOCYTES; SECRETION; MEMBRANE; NRF2	Most of experiments for HCV infection have been done using lytic infection systems, in which HCV-infected cells inevitably die. Here, to elucidate metabolic alteration in HCV-infected cells in a more stable condition, we established an HCVpersistently- infected cell line, designated as HPI cells. This cell line has displayed prominent steatosis and supported HCV infection for more than 2 years, which is the longest ever reported. It enabled us to analyze metabolism in the HCV-infected cells integrally combining metabolomics and expression arrays. It revealed that rate- limiting enzymes for biosynthesis of cholesterol and fatty acids were up-regulated with actual increase in cholesterol, desmosterol (cholesterol precursor) and pool of fatty acids. Notably, the pentose phosphate pathway was facilitated with marked up-regulation of glucose-6-phosphate dehydrogenase, a rete-limiting enzyme, with actual increase in NADPH. In its downstream, enzymes for purine synthesis were also up-regulated resulting in increase of purine. Contrary to common cancers, the TCA cycle was preferentially facilitated comparing to glycolysis pathway with a marked increase of most of amino acids. Interestingly, some genes controlled by nuclear factor (erythroid-derived 2)-like 2 (Nrf2), a master regulator of antioxidation and metabolism, were constitutively up- regulated in HPI cells. Knockdown of Nrf2 markedly reduced steatosis and HCV infection, indicating that Nrf2 and its target genes play important roles in metabolic alteration and HCV infection. In conclusion, HPI cell is a bona fide HCV-persistently-infected cell line supporting HCV infection for years. This cell line sustained prominent steatosis in a hypermetabolic status producing various metabolites. Therefore, HPI cell is a potent research tool not only for persistent HCV infection but also for liver metabolism, overcoming drawbacks of the lytic infection systems.	[Sugiyama, Kazuo] Keio Univ, Sch Med, Ctr Study Chron Liver Dis, Tokyo, Japan; [Ebinuma, Hirotoshi; Nakamoto, Nobuhiro; Chu, Po-sung; Usui, Shingo; Ishibashi, Yuka; Wakayama, Yuko; Taniki, Nobuhito; Murata, Hiroko; Yamagishi, Yoshiyuki; Saito, Hidetsugu; Kanai, Takanori] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Sakasegawa, Noriko] Keio Univ, Sch Med, Grad Sch, Tokyo, Japan; [Murakami, Yuko; Saito, Yoshimasa; Saito, Hidetsugu] Keio Univ, Fac Pharm, Div Pharmacotherapeut, Tokyo, Japan; [Fukasawa, Masayoshi; Saito, Kyoko] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Tokyo, Japan; [Wakita, Takaji] Natl Inst Infect Dis, Tokyo, Japan; [Takaku, Hiroshi] Chiba Inst Technol, Dept Life & Environm Sci, Chiba, Japan; [Hibi, Toshifumi] Kitasato Univ, Kitasato Inst Hosp, Ctr Adv IBD Res & Treatment, Tokyo, Japan	Keio University; Keio University; Keio University; Keio University; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Chiba Institute of Technology; Kitasato University	Sugiyama, K (corresponding author), Keio Univ, Sch Med, Ctr Study Chron Liver Dis, Tokyo, Japan.	sygiyamkz@a8.keio.jp	Fukasawa, Masayoshi/ABD-7655-2020; Taniki, Nobuhito/ABT-6589-2022	Fukasawa, Masayoshi/0000-0002-0702-0691; Taniki, Nobuhito/0000-0003-3627-5412; Kanai, Takanori/0000-0002-1466-4532; Chu, Po-sung/0000-0002-8687-2760	Japan Society for the Promotion of Science (JSPS) KAKENHI [23590551]; Ministry of Health, Labor and Welfare of Japan; National Cancer Center Research and Development Fund	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Cancer Center Research and Development Fund(National Cancer Center - Japan)	This work was funded by the Japan Society for the Promotion of Science (JSPS) KAKENHI (23590551), a grant-in-aid for research on hepatitis from the Ministry of Health, Labor and Welfare of Japan, and the National Cancer Center Research and Development Fund. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Aleman S, 2013, CLIN INFECT DIS, V57, P230, DOI 10.1093/cid/cit234; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Bauhofer O, 2012, GASTROENTEROLOGY, V143, P429, DOI 10.1053/j.gastro.2012.04.018; Carvajal-Yepes M, 2011, J BIOL CHEM, V286, P8941, DOI 10.1074/jbc.M110.186684; Date T, 2012, MICROBIOL IMMUNOL, V56, P308, DOI 10.1111/j.1348-0421.2012.00437.x; DEFvd Putte, 2013, J HEPATOLOGY; Deng L, 2011, J VIROL, V85, P8556, DOI 10.1128/JVI.00146-11; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Ganan-Gomez I, 2013, FREE RADICAL BIOL ME; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; GOODMAN ZD, 1995, SEMIN LIVER DIS, V15, P70, DOI 10.1055/s-2007-1007264; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; HIJIKATA M, 1993, P NATL ACAD SCI USA, V90, P10773, DOI 10.1073/pnas.90.22.10773; HIJIKATA M, 1991, P NATL ACAD SCI USA, V88, P5547, DOI 10.1073/pnas.88.13.5547; Hirata Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002860; Hishiki T, 2010, J VIROL, V84, P12048, DOI 10.1128/JVI.01063-10; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Icard V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004233; Ikeda M, 2006, HEPATOLOGY, V44, P117, DOI 10.1002/hep.21232; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Ivanov AV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024957; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kato N, 2003, BIOCHEM BIOPH RES CO, V306, P756, DOI 10.1016/S0006-291X(03)01047-7; Lee JL, 2003, TOXICOL APPL PHARM, V192, P294, DOI 10.1016/S0041-008X(03)00301-6; LIANG TJ, 1993, HEPATOLOGY, V18, P1326, DOI 10.1016/0270-9139(93)90219-D; Lo M, 2008, J CELL PHYSIOL, V215, P593, DOI 10.1002/jcp.21366; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Masson J, 1999, PHARMACOL REV, V51, P439; Mitsuishi Y, 2012, KEAP1 NRF2 SYSTEM CA; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Miyoshi H, 2011, J HEPATOL, V54, P432, DOI 10.1016/j.jhep.2010.07.039; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Nishitsuji H, 2013, J VIROL, V87, P8169, DOI 10.1128/JVI.00974-13; Ogawa K, 2009, P JPN ACAD B-PHYS, V85, P217, DOI 10.2183/pjab.85.217; PARTIN JS, 1974, GASTROENTEROLOGY, V67, P107; Ploss A, 2010, P NATL ACAD SCI USA, V107, P3141, DOI 10.1073/pnas.0915130107; Rodgers MA, 2012, J AM CHEM SOC, V134, P6896, DOI 10.1021/ja207391q; Seronello S, 2010, J BIOL CHEM; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; Silberstein E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000910; Sugiyama K, 2009, J VIROL, V83, P6922, DOI 10.1128/JVI.02674-08; Uruno A, 2011, NITRIC OXIDE-BIOL CH, V25, P153, DOI 10.1016/j.niox.2011.02.007; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Yamazaki T, 2005, J BIOL CHEM, V280, P21506, DOI 10.1074/jbc.M412989200; Zerenturk EJ, 2013, PROG LIPID RES, V52, P666, DOI 10.1016/j.plipres.2013.09.002; Ziboh VA, 2000, AM J CLIN NUTR, V71, p361S, DOI 10.1093/ajcn/71.1.361s	56	27	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94460	10.1371/journal.pone.0094460	http://dx.doi.org/10.1371/journal.pone.0094460			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718268	Green Submitted, gold, Green Published			2022-12-25	WOS:000334339000123
J	Wei, CH; Lu, J; Xu, LY; Liu, G; Wang, ZG; Zhao, FP; Zhang, L; Han, X; Du, LX; Liu, CS				Wei, Caihong; Lu, Jian; Xu, Lingyang; Liu, Gang; Wang, Zhigang; Zhao, Fuping; Zhang, Li; Han, Xu; Du, Lixin; Liu, Chousheng			Genetic Structure of Chinese Indigenous Goats and the Special Geographical Structure in the Southwest China as a Geographic Barrier Driving the Fragmentation of a Large Population	PLOS ONE			English	Article							MULTIPLE MATERNAL ORIGINS; MITOCHONDRIAL-DNA; PHYLOGEOGRAPHIC STRUCTURE; DIVERSITY; LINEAGES; BREEDS; SHEEP	Background: China has numerous native domestic goat breeds, however, extensive studies are focused on the genetic within the fewer breeds and limited regions, the population demograogic history and origin of Chinese goats are still unclear. The roles of geographical structure have not been analyzed in Chinese goat domestic process. In this study, the genetic relationships of Chinese indigenous goat populations were evaluated using 30 microsatellite markers. Methodology/Principal Findings: Forty Chinese indigenous populations containing 2078 goats were sampled from different geographic regions of China. Moderate genetic diversity at the population level (H-S of 0.644) and high population diversity at the species level (H-T value of 0.737) were estimated. Significant moderate population differentiation was detected (F-ST value of 0.129). Significant excess homozygosity (F-IS of 0.105) and recent population bottlenecks were detected in thirty-six populations. Neighbour-joining tree, principal components analysis and Bayesian clusters all revealed that Chinese goat populations could be subdivided into at least four genetic clusters: Southwest China, South China, Northwest China and East China. It was observed that the genetic diversity of Northern China goats was highest among these clusters. The results here suggested that the goat populations in Southwest China might be the earliest domestic goats in China. Conclusions/Significance: Our results suggested that the current genetic structure of Chinese goats were resulted from the special geographical structure, especially in the Western China, and the Western goat populations had been separated by the geographic structure (Hengduan Mountains and Qinling Mountains-Huaihe River Line) into two clusters: the Southwest and Northwest. It also indicated that the current genetic structure was caused by the geographical origin mainly, in close accordance with the human's migration history throughout China. This study provides a fundamental genetic profile for the conservation of these populations and better to understand the domestication process and origin of Chinese goats.	[Wei, Caihong; Xu, Lingyang; Zhao, Fuping; Zhang, Li; Du, Lixin] Chinese Acad Agr Sci, Inst Anim Sci, Natl Ctr Mol Genet & Breeding Anim, Beijing 100193, Peoples R China; [Lu, Jian; Liu, Gang; Wang, Zhigang; Han, Xu; Liu, Chousheng] Natl Anim Husb Serv, Natl Ctr Preservat & Utilizat Genet Resources Ani, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Du, LX (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Natl Ctr Mol Genet & Breeding Anim, Beijing 100193, Peoples R China.	lxdu@263.net; liuchousheng@sina.com	Xu, Lingyang/W-8664-2019		National Key Technology R&D Program of China [2011BAD28B05-2]; Ministry of Agriculture [[2013] 36]	National Key Technology R&D Program of China(National Key Technology R&D Program); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi)	This work was supported by grant 2011BAD28B05-2 from the National Key Technology R&D Program of China and Ministry of Agriculture 2013 Protection Project of Animal Germplasm Resources (No. [2013] 36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Canon J, 2006, ANIM GENET, V37, P327, DOI 10.1111/j.1365-2052.2006.01461.x; Chen SY, 2005, MOL PHYLOGENET EVOL, V37, P804, DOI 10.1016/j.ympev.2005.06.014; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Cornuet JM, 1999, GENETICS, V153, P1989; Dalvit C, 2009, J ANIM SCI, V87, P3837, DOI 10.2527/jas.2008-1682; Di R, 2011, ANIM GENET, V42, P428, DOI 10.1111/j.1365-2052.2010.02072.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J, 2008, PHYLOGENY INFERENCE; Glowatzki-Mullis ML, 2009, J ANIM BREED GENET, V126, P164, DOI 10.1111/j.1439-0388.2008.00768.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Jin L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051649; Joshi MB, 2004, MOL BIOL EVOL, V21, P454, DOI 10.1093/molbev/msh038; Kijas JW, 2013, ANIM GENET, V44, P325, DOI 10.1111/age.12011; Kim KS, 2002, ASIAN AUSTRAL J ANIM, V15, P461, DOI 10.5713/ajas.2002.461; Kong QP, 2011, MOL BIOL EVOL, V28, P513, DOI 10.1093/molbev/msq219; Lai SJ, 2007, ANIM GENET, V38, P77, DOI 10.1111/j.1365-2052.2007.01555.x; Li JY, 2008, CZECH J ANIM SCI, V53, P315, DOI 10.17221/347-CJAS; Li MH, 2002, GENET SEL EVOL, V34, P729, DOI [10.1186/1297-9686-34-6-729, 10.1051/gse:2002032]; Li Xianglong, 1999, Acta Veterinaria et Zootechnica Sinica, V30, P313; Lin BZ, 2013, ANIM GENET, V44, P79, DOI 10.1111/j.1365-2052.2012.02358.x; Liu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031453; Liu YP, 2006, MOL PHYLOGENET EVOL, V38, P12, DOI 10.1016/j.ympev.2005.09.014; Luikart G, 2001, P NATL ACAD SCI USA, V98, P5927, DOI 10.1073/pnas.091591198; MacHugh DE, 2001, P NATL ACAD SCI USA, V98, P5382, DOI 10.1073/pnas.111163198; Meadow R.H., 1993, HARAPPAN CIVILIZATIO, V2nd, P295; Naderi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001012; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Nomura K, 2012, ANIM GENET, V43, P760, DOI 10.1111/j.1365-2052.2012.02334.x; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Poissant J, 2009, MOL ECOL RESOUR, V9, P1121, DOI 10.1111/j.1755-0998.2009.02575.x; PORTER V, 1996, GOATS WORLD; Pringle H, 1998, SCIENCE, V282, P1448, DOI 10.1126/science.282.5393.1448; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wu GS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r245; Wu YP, 2009, ANIM SCI J, V80, P372, DOI 10.1111/j.1740-0929.2009.00659.x; Xiang-Long L, 2004, J ANIM BREED GENET, V121, P350, DOI 10.1111/j.1439-0388.2004.00465.x; Yuan JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034955; Zhang LiYing, 2012, African Journal of Biotechnology, V11, P11671; Zhong T, 2013, TROP ANIM HEALTH PRO, V45, P1833, DOI 10.1007/s11250-013-0432-1	45	26	27	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94435	10.1371/journal.pone.0094435	http://dx.doi.org/10.1371/journal.pone.0094435			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718092	gold, Green Published, Green Submitted			2022-12-25	WOS:000334339000121
J	Botta, C; Langerholc, T; Cencic, A; Cocolin, L				Botta, Cristian; Langerholc, Tomaz; Cencic, Avrelija; Cocolin, Luca			In Vitro Selection and Characterization of New Probiotic Candidates from Table Olive Microbiota	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; LISTERIA-MONOCYTOGENES INFECTION; LACTOBACILLUS-PLANTARUM; CACO-2 CELLS; ADHESION; ASSAY; AGGREGATION; SURVIVAL; STRAINS; IMPACT	To date, only a few studies have investigated the complex microbiota of table olives in order to identify new probiotic microorganisms, even though this food matrix has been shown to be a suitable source of beneficial lactic acid bacteria (LAB). Two hundred and thirty eight LAB, belonging to Lactobacillus plantarum, Lactobacillus pentosus and Leuconostoc mesenteroides species, and isolated from Nocellara Etnea table olives, have been screened in this survey through an in vitro approach. A simulation of transit tolerance in the upper human gastrointestinal tract, together with autoaggregation and hydrophobicity, have been decisive in reducing the number of LAB to 17 promising probiotics. None of the selected strains showed intrinsic resistances towards a broad spectrum of antibiotics and were therefore accurately characterized on an undifferentiated and 3D functional model of the human intestinal tract made up of H4-1 epithelial cells. As far as the potential colonization of the intestinal tract is concerned, a high adhesion ratio was observed for Lb. plantarum O2T60C (over 9%) when tested in the 3D functional model, which closely mimics real intestinal conditions. The stimulation properties towards the epithelial barrier integrity and the in vitro inhibition of L. monocytogenes adhesion and invasion have also been assessed. Lb. plantarum S1T10A and S11T3E enhanced trans-epithelial electrical resistance (TEER) and therefore the integrity of the polarized epithelium in the 3D model. Moreover, S11T3E showed the ability to inhibit L. monocytogenes invasion in the undifferentiated epithelial model. The reduction in L. monocytogenes infection, together with the potential enhancement of barrier integrity and an adhesion ratio that was above the average in the 3D functional model (6.9%) would seem to suggest the Lb. plantarum S11T3E strain as the most interesting candidate for possible in vivo animal and human trials.	[Botta, Cristian; Cocolin, Luca] Univ Turin, Dept Forestry Agr & Food Sci, Turin, Italy; [Langerholc, Tomaz; Cencic, Avrelija] Univ Maribor, Fac Agr & Life Sci, Dept Microbiol Biochem Mol Biol & Biotechnol, SLO-2000 Maribor, Slovenia	University of Turin; University of Maribor	Cocolin, L (corresponding author), Univ Turin, Dept Forestry Agr & Food Sci, Turin, Italy.	lucasimone.cocolin@unito.it	Cocolin, Luca/H-5091-2012; Botta, Cristian/F-5885-2013	Cocolin, Luca/0000-0003-4799-7074; Botta, Cristian/0000-0003-1102-3294	EU [243471-PROBIOLIVES]	EU(European Commission)	The conducted research received funding from the EU (FP7/2007-2013), under grant agreement no. 243471-PROBIOLIVES (www.probiolives.eu). The information in this document only reflects the authors' views and the Community is not liable for any use that may be made of the information contained herein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RC, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-316; Archambaud C, 2012, P NATL ACAD SCI USA, V109, P16684, DOI 10.1073/pnas.1212809109; Argyri AA, 2013, FOOD MICROBIOL, V33, P282, DOI 10.1016/j.fm.2012.10.005; Arroyo-Lopez FN, 2008, INT J FOOD MICROBIOL, V128, P189, DOI 10.1016/j.ijfoodmicro.2008.08.018; Bautista-Gallego J, 2013, FOOD RES INT, V50, P135, DOI 10.1016/j.foodres.2012.10.004; BERGAMINI A, 1992, J VIROL METHODS, V40, P275, DOI 10.1016/0166-0934(92)90086-S; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Bevilacqua A, 2010, J FOOD SCI, V75, pM536, DOI 10.1111/j.1750-3841.2010.01793.x; Bories G, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.732; Botes M, 2008, ARCH MICROBIOL, V190, P573, DOI 10.1007/s00203-008-0408-0; Botta C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00245; Burkholder KM, 2010, INFECT IMMUN, V78, P5062, DOI 10.1128/IAI.00516-10; Cencic A, 2010, INT J FOOD MICROBIOL, V141, pS4, DOI 10.1016/j.ijfoodmicro.2010.03.026; Cocolin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069074; Collado MC, 2008, EUR FOOD RES TECHNOL, V226, P1065, DOI 10.1007/s00217-007-0632-x; Collado MC, 2009, CURR DRUG METAB, V10, P68, DOI 10.2174/138920009787048437; Corcoran BM, 2007, MICROBIOL-SGM, V153, P291, DOI 10.1099/mic.0.28966-0; Corr SC, 2007, FEMS IMMUNOL MED MIC, V50, P380, DOI 10.1111/j.1574-695X.2007.00264.x; CROW VL, 1995, INT DAIRY J, V5, P45, DOI 10.1016/0958-6946(94)P1598-8; DASHKEVICZ MP, 1989, APPL ENVIRON MICROB, V55, P11, DOI 10.1128/AEM.55.1.11-16.1989; de Vries MC, 2006, INT DAIRY J, V16, P1018, DOI 10.1016/j.idairyj.2005.09.003; Del Re B, 2000, LETT APPL MICROBIOL, V31, P438, DOI 10.1046/j.1365-2672.2000.00845.x; Dias FS, 2013, BIOSCI J, V29, P1678; Dicks LMT, 2010, BENEF MICROBES, V1, P11, DOI 10.3920/BM2009.0012; Dobson A, 2012, APPL ENVIRON MICROB, V78, P1, DOI 10.1128/AEM.05576-11; Dobson A, 2011, FEMS MICROBIOL ECOL, V76, P602, DOI 10.1111/j.1574-6941.2011.01069.x; Elkins CA, 2004, APPL ENVIRON MICROB, V70, P7200, DOI 10.1128/AEM.70.12.7200-7209.2004; Food and Agriculture Organization of the United Nations World Health Organization, 2002, GUIDELINES EVALUATIO; Hummel AS, 2007, APPL ENVIRON MICROB, V73, P730, DOI 10.1128/AEM.02105-06; Ivec M, 2007, ANTIVIR RES, V75, P266, DOI 10.1016/j.antiviral.2007.03.013; Jensen H, 2012, INT J FOOD MICROBIOL, V153, P216, DOI 10.1016/j.ijfoodmicro.2011.11.020; Karczewski J, 2010, AM J PHYSIOL-GASTR L, V298, pG851, DOI 10.1152/ajpgi.00327.2009; Klingberg TD, 2005, APPL ENVIRON MICROB, V71, P7528, DOI 10.1128/AEM.71.11.7528-7530.2005; Koo OK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029277; Kos B, 2003, J APPL MICROBIOL, V94, P981, DOI 10.1046/j.1365-2672.2003.01915.x; Langerholc T, 2011, TRENDS FOOD SCI TECH, V22, pS11, DOI 10.1016/j.tifs.2011.03.010; Lavermicocca P, 2006, DIGESTIVE LIVER D S2, V38; Lin WH, 2006, FOOD MICROBIOL, V23, P74, DOI 10.1016/j.fm.2005.01.013; Maragkoudakis PA, 2010, INT J FOOD MICROBIOL, V141, pS91, DOI 10.1016/j.ijfoodmicro.2009.12.024; Marteau P, 2003, BEST PRACT RES CL GA, V17, P725, DOI 10.1016/S1521-6918(03)00055-6; Moal VLL, 2013, MICROBIOL MOL BIOL R, V77, P380, DOI 10.1128/MMBR.00064-12; Nakamura S, 2012, ANAEROBE, V18, P19, DOI 10.1016/j.anaerobe.2011.11.006; Nanthakumar NN, 2000, P NATL ACAD SCI USA, V97, P6043, DOI 10.1073/pnas.97.11.6043; Nissen L, 2009, INT J FOOD MICROBIOL, V135, P288, DOI 10.1016/j.ijfoodmicro.2009.08.027; Ogawa M, 2001, INFECT IMMUN, V69, P1101, DOI 10.1128/IAI.69.2.1101-1108.2001; Ohland CL, 2010, AM J PHYSIOL-GASTR L, V298, pG807, DOI 10.1152/ajpgi.00243.2009; Oomen AG, 2003, ARCH ENVIRON CON TOX, V44, P281, DOI 10.1007/s00244-002-1278-0; Ortakci F, 2012, J DAIRY SCI, V95, P6274, DOI 10.3168/jds.2012-5476; Ouwehand AC, 2002, ANTON LEEUW INT J G, V82, P279, DOI 10.1023/A:1020620607611; Paolillo R, 2009, INT IMMUNOPHARMACOL, V9, P1265, DOI 10.1016/j.intimp.2009.07.008; Peres CM, 2012, TRENDS FOOD SCI TECH, V26, P31, DOI 10.1016/j.tifs.2012.01.006; Petrovic T, 2012, ARCH BIOL SCI, V64, P1473, DOI 10.2298/ABS1204473P; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Possemiers S, 2013, J AGR FOOD CHEM, V61, P9380, DOI 10.1021/jf402137r; Puertollano MA, 2002, CLIN DIAGN LAB IMMUN, V9; Rivera-Espinoza Y, 2010, FOOD MICROBIOL, V27, P1, DOI 10.1016/j.fm.2008.06.008; Rowan NJ, 2000, J CLIN MICROBIOL, V38, P2643, DOI 10.1128/JCM.38.7.2643-2648.2000; Saad N, 2013, LWT-FOOD SCI TECHNOL, V50, P1, DOI 10.1016/j.lwt.2012.05.014; Sanderson IR, 1996, P NATL ACAD SCI USA, V93, P7717, DOI 10.1073/pnas.93.15.7717; Teuber M, 1999, ANTON LEEUW INT J G, V76, P115, DOI 10.1023/A:1002035622988; Tien MT, 2006, J IMMUNOL, V176, P1228, DOI 10.4049/jimmunol.176.2.1228; TOBA T, 1991, LETT APPL MICROBIOL, V13, P102, DOI 10.1111/j.1472-765X.1991.tb00581.x; Torriani S, 2001, APPL ENVIRON MICROB, V67, P3450, DOI 10.1128/AEM.67.8.3450-3454.2001; Tsukatani T, 2008, J MICROBIOL METH, V75, P109, DOI 10.1016/j.mimet.2008.05.016; Tuo YF, 2013, J DAIRY SCI, V96, P4252, DOI 10.3168/jds.2013-6547; Williams NT, 2010, AM J HEALTH-SYST PH, V67, P449, DOI 10.2146/ajhp090168; Yamada F, 2006, J MICROBIOL METH, P66; Zhou JS, 2005, INT J FOOD MICROBIOL, V98, P211, DOI 10.1016/j.ijfoodmicro.2004.05.011	68	80	81	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94457	10.1371/journal.pone.0094457	http://dx.doi.org/10.1371/journal.pone.0094457			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714329	Green Published, gold, Green Submitted			2022-12-25	WOS:000334160900135
J	Liu, XF; Zhou, J; Abid, MDN; Yan, HH; Huang, H; Wan, LM; Feng, ZH; Chen, J				Liu, Xiaofeng; Zhou, Jie; Abid, Morad Dirhem Naji; Yan, Huanhuan; Huang, Hao; Wan, Limin; Feng, Zuohua; Chen, Juan			Berberine Attenuates Axonal Transport Impairment and Axonopathy Induced by Calyculin A in N2a Cells	PLOS ONE			English	Article							SPATIAL MEMORY RETENTION; PROTEIN PHOSPHATASE 2A; TAU-HYPERPHOSPHORYLATION; NEUROFILAMENT PROTEINS; NEUROBLASTOMA-CELLS; ALZHEIMERS-DISEASE; OKADAIC ACID; IN-VIVO; PHOSPHORYLATION; INHIBITION	Berberine is a primary component of the most functional extracts of Coptidis rhizome used in traditional Chinese medicine for centuries. Recent reports indicate that Berberine has the potential to prevent and treat Alzheimer's disease (AD). The previous studies reported that Calyculin A (CA) impaired the axonal transport in neuroblastoma-2a (N2a) cells. Berberine attenuated tau hyperphosphorylation and cytotoxicity induced by CA. Our study aimed at investigating the effects of Berberine on the axonal transport impairment induced by CA in N2a cells. The results showed that Berberine could protect the cell from CA -induced toxicity in metabolism and viability, as well as hyperphosphorylation of tau and neurofilaments (NFs). Furthermore, Berberine could reverse CA-induced axonal transport impairment significantly. Berberine also partially reversed the phosphorylation of the catalytic subunit of PP-2A at Tyrosine 307, a crucial site negatively regulating the activity of PP-2A, and reduced the levels of malondialdehyde and the activity of superoxide dismutase, markers of oxidative stress, induced by CA. The present work for the first time demonstrates that Berberine may play a role in protecting against CA-induced axonal transport impairment by modulating the activity of PP-2A and oxidative stress. Our findings also suggest that Berberine may be a potential therapeutic drug for AD.	[Liu, Xiaofeng; Zhou, Jie; Yan, Huanhuan; Huang, Hao; Wan, Limin; Feng, Zuohua; Chen, Juan] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Biochem & Mol Biol, Wuhan 430074, Peoples R China; [Abid, Morad Dirhem Naji] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Chen, J (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Biochem & Mol Biol, Wuhan 430074, Peoples R China.	chenjuanlinda@gmail.com			National Natural Science Foundation of China [81371416, 81371508, 31171027, 31000471]; Important National Science & Technology Specific Projects [2009ZX09301-014]; Hubei Province Natural Science Foundation [2011CDB365]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Important National Science & Technology Specific Projects; Hubei Province Natural Science Foundation(Natural Science Foundation of Hubei Province)	This work was supported in part by grants from the National Natural Science Foundation of China (Grant No. 81371416, 81371508, 31171027 and 31000471), the Important National Science & Technology Specific Projects (Grant No. 2009ZX09301-014) and the Hubei Province Natural Science Foundation (Grant No. 2011CDB365). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerley S, 2000, J CELL BIOL, V150, P165, DOI 10.1083/jcb.150.1.165; Arendt T, 1998, NEUROBIOL AGING, V19, P3, DOI 10.1016/S0197-4580(98)00003-7; Asai M, 2007, BIOCHEM BIOPH RES CO, V352, P498, DOI 10.1016/j.bbrc.2006.11.043; Bajaj NPS, 2000, AMYOTROPH LATERAL SC, V1, P319, DOI 10.1080/146608200300079563; Benitez-King G, 2003, EXP NEUROL, V182, P151, DOI 10.1016/S0014-4886(03)00085-2; Bennecib M, 2001, FEBS LETT, V490, P15, DOI 10.1016/S0014-5793(01)02127-5; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; Cash AD, 2003, AM J PATHOL, V162, P1623, DOI 10.1016/S0002-9440(10)64296-4; Chohan MO, 2006, FEBS LETT, V580, P3973, DOI 10.1016/j.febslet.2006.06.021; GONG CX, 1993, J NEUROCHEM, V61, P921, DOI 10.1111/j.1471-4159.1993.tb03603.x; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hung TM, 2008, J ETHNOPHARMACOL, V119, P74, DOI 10.1016/j.jep.2008.05.041; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Jung C, 2000, CELL MOTIL CYTOSKEL, V47, P120, DOI 10.1002/1097-0169(200010)47:2<120::AID-CM3>3.0.CO;2-6; Jung C, 2000, BRAIN RES, V856, P12, DOI 10.1016/S0006-8993(99)02314-8; KATO Y, 1988, DRUG EXP CLIN RES, V14, P723; Kins S, 2001, J BIOL CHEM, V276, P38193; Kobe Hitoshi, 2002, Journal of Nippon Medical School, V69, P542, DOI 10.1272/jnms.69.542; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Li SP, 2004, J PINEAL RES, V36, P186, DOI 10.1111/j.1600-079X.2004.00116.x; Liu Q, 2004, CELL MOL LIFE SCI, V61, P3057, DOI 10.1007/s00018-004-4268-8; Liu SJ, 2002, ACTA PHARMACOL SIN, V23, P183; MalchiodiAlbedi F, 1997, J NEUROSCI RES, V48, P425, DOI 10.1002/(SICI)1097-4547(19970601)48:5<425::AID-JNR4>3.0.CO;2-G; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Miller CCJ, 2002, CELL MOL LIFE SCI, V59, P323, DOI 10.1007/s00018-002-8425-7; Netzer WJ, 2003, P NATL ACAD SCI USA, V100, P12444, DOI 10.1073/pnas.1534745100; OLMSTED JB, 1970, P NATL ACAD SCI USA, V65, P129, DOI 10.1073/pnas.65.1.129; Pappolla MA, 1997, J NEUROSCI, V17, P1683; RICHARD S, 1989, J SUBMICR CYTOL PATH, V21, P461; Sang HC, 2001, NEUROSCI LETT, V312, P141, DOI 10.1016/S0304-3940(01)02206-6; Singh J, 2009, J ETHNOPHARMACOL, V123, P22, DOI 10.1016/j.jep.2009.02.038; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Strack S, 1997, MOL BRAIN RES, V49, P15, DOI 10.1016/S0169-328X(97)00117-4; Sun L, 2003, NEUROSCIENCE, V118, P1175, DOI 10.1016/S0306-4522(02)00697-8; Tanaka T, 1998, FEBS LETT, V426, P248, DOI 10.1016/S0014-5793(98)00346-9; Wang DL, 2004, J PINEAL RES, V37, P11, DOI 10.1111/j.1600-079X.2004.00130.x; Wang JZ, 1996, MOL BRAIN RES, V38, P200, DOI 10.1016/0169-328X(95)00316-K; Wataya T, 2002, J BIOL CHEM, V277, P4644, DOI 10.1074/jbc.M110913200; Xiong YF, 2011, J PINEAL RES, V50, P319, DOI 10.1111/j.1600-079X.2010.00846.x; Yabe JT, 2000, CELL MOTIL CYTOSKEL, V45, P249, DOI 10.1002/(SICI)1097-0169(200004)45:4<249::AID-CM1>3.0.CO;2-M; Yang XF, 2011, J PSYCHOPHARMACOL, V25, P1118, DOI 10.1177/0269881110367723; Yang Y, 2007, J NEUROCHEM, V102, P878, DOI 10.1111/j.1471-4159.2007.04603.x; Yu G, 2011, J ALZHEIMERS DIS, V24, P525, DOI 10.3233/JAD-2011-101779; Zhou J, 2010, LIFE SCI, V86, P532, DOI 10.1016/j.lfs.2010.02.009; Zhu FQ, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-78	47	18	19	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93974	10.1371/journal.pone.0093974	http://dx.doi.org/10.1371/journal.pone.0093974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713870	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900069
J	Matsudaira, K; Konishi, H; Miyoshi, K; Isomura, T; Inuzuka, K				Matsudaira, Ko; Konishi, Hiroaki; Miyoshi, Kota; Isomura, Tatsuya; Inuzuka, Kyoko			Potential Risk Factors of Persistent Low Back Pain Developing from Mild Low Back Pain in Urban Japanese Workers	PLOS ONE			English	Article							FEAR-AVOIDANCE BELIEFS; DISABILITY; PREVALENCE; OCCUPATION; EXPERIENCE; MANAGEMENT; SEVERITY; DISTRESS; BURDEN; CARE	Study Design: Two-year, prospective cohort data from the Japan epidemiological research of occupation-related back pain study in urban settings were used for this analysis. Objective: To examine the association between aggravated low back pain and psychosocial factors among Japanese workers with mild low back pain. Summary of Background Data: Although psychosocial factors are strongly indicated as yellow flags of low back pain (LBP) leading to disability, the association between aggravated LBP and psychosocial factors has not been well assessed in Japanese workers. Methods: At baseline, 5,310 participants responded to a self-administered questionnaire including questions about individual characteristics, ergonomic work demands, and work-related psychosocial factors (response rate: 86.5%), with 3,811 respondents completing the 1-year follow-up questionnaire. The target outcome was aggravation of mild LBP into persistent LBP during the follow-up period. Incidence was calculated for the participants with mild LBP during the past year at baseline. Logistic regression was used to explore risk factors associated with persistent LBP. Results: Of 1,675 participants who had mild LBP during the preceding year, 43 (2.6%) developed persistent LBP during the follow-up year. Multivariate analyses adjusted for individual factors and an ergonomic factor found statistically significant or almost significant associations of the following psychosocial factors with persistent LBP: interpersonal stress at work [adjusted odds ratio (OR): 1.96 and 95% confidence interval (95%CI): 1.00-3.82], job satisfaction (OR: 2.34, 95%CI: 1.21-4.54), depression (OR: 1.92, 95%CI: 1.00-3.69), somatic symptoms (OR: 2.78, 95%CI: 1.44-5.40), support from supervisors (OR: 2.01, 95%CI: 1.05-3.85), previous sick-leave due to LBP (OR: 1.94, 95%CI: 0.98-3.86) and family history of LBP with disability (OR: 1.98, 95%CI: 1.04-3.78). Conclusions: Psychosocial factors are important risk factors for persistent LBP in urban Japanese workers. It may be necessary to take psychosocial factors into account, along with physical work demands, to reduce LBP related disability.	[Matsudaira, Ko] Kanto Rosai Hosp, Clin Res Ctr Occupat Musculoskeletal Disorders, Kawasaki, Kanagawa, Japan; [Konishi, Hiroaki] Nagasaki Rosai Hosp, Dept Orthopaed Surg, Nagasaki, Japan; [Miyoshi, Kota] Yokohama Rosai Hosp, Spine Ctr, Yokohama, Kanagawa, Japan; [Isomura, Tatsuya; Inuzuka, Kyoko] CLINICAL STUDY SUPPORT Inc, Dept Clin Res, Nagoya, Aichi, Japan	Yokohama Rosai Hospital	Matsudaira, K (corresponding author), Univ Tokyo, Fac Med, Century Med & Res Ctr 22, Dept Med Res & Management Musculoskeletal Pain,Bu, Tokyo 113, Japan.	kohart801@gmail.com						Barsky AJ, 1999, ANN INTERN MED, V130, P910, DOI 10.7326/0003-4819-130-11-199906010-00016; Bernard B., 1997, MUSCULOSKELETAL DISO; BRINKMAN GL, 1963, AM REV RESPIR DIS, V87, P684; Coggon D, 2013, PAIN, V154, P856, DOI 10.1016/j.pain.2013.02.008; Crook J, 2002, J OCCUP REHABIL, V12, P277, DOI 10.1023/A:1020278708861; Currie SR, 2004, PAIN, V107, P54, DOI 10.1016/j.pain.2003.09.015; DEYO RA, 1992, JAMA-J AM MED ASSOC, V268, P760, DOI 10.1001/jama.268.6.760; Evans Subhadra, 2008, J Pain Manag, V1, P237; HARATANI T, 1993, JPN J IND HLTH S, V35, pS214; Henningsen P, 2007, LANCET, V369, P946, DOI 10.1016/S0140-6736(07)60159-7; Hoogendoorn WE, 2000, SPINE, V25, P2114, DOI 10.1097/00007632-200008150-00017; Isaac M, 1994, SCREENER SOMATOFORM; KAPLAN C, 1988, J GEN INTERN MED, V3, P177, DOI 10.1007/BF02596128; Kawakami N, 1995, INT J BEHAV MED, V2, P358, DOI 10.1207/s15327558ijbm0204_5; Kawakami N, 2005, PREV MED, V41, P471, DOI 10.1016/j.ypmed.2005.01.001; Kori SH, 1990, PAIN MANAG, V3, P35; Krismer M, 2007, BEST PRACT RES CL RH, V21, P77, DOI 10.1016/j.berh.2006.08.004; Linton SJ, 2001, J OCCUP REHABIL, V11, P53, DOI 10.1023/A:1016656225318; Linton SJ, 2000, NECK BACK PAIN SCI E, P57; Lynch AM, 2006, J PAIN, V7, P244, DOI 10.1016/j.jpain.2005.11.001; Maetzel A, 2002, BEST PRACT RES CL RH, V16, P23, DOI 10.1053/berh.2001.0204; Matsudaira K, 2012, SPINE, V37, P1324, DOI 10.1097/BRS.0b013e3182498382; Matsudaira K, 2011, OCCUP ENVIRON MED, V68, P191, DOI 10.1136/oem.2009.053645; Miller RP, 1991, CLIN J PAIN, V7, DOI DOI 10.1097/00002508-199103000-00053; Ministry of Health Labour and Welfare, 2010, SURV LIV COND; Muto S, 2006, IND HEALTH, V44, P123, DOI 10.2486/indhealth.44.123; Ogino Y, 2007, CEREB CORTEX, V17, P1139, DOI 10.1093/cercor/bhl023; Ono Y., 1996, JAPANESE J STRESS SC, V10, P273; Osborn Jody, 2010, Pain, V148, P268, DOI 10.1016/j.pain.2009.11.007; Papageorgiou AC, 1996, PAIN, V66, P181, DOI 10.1016/0304-3959(96)03022-9; Schmidt CO, 2007, SPINE, V32, P2005, DOI 10.1097/BRS.0b013e318133fad8; Shaw WS, 2001, DISABIL REHABIL, V23, P815; Shima S, 1985, SEISHIN IGAKU, V27, P717; Shimomitsu T, 2004, OCCUP MENTAL HLTH, V12, P25; Snook SH, 2004, J ELECTROMYOGR KINES, V14, P153, DOI 10.1016/j.jelekin.2003.09.006; Spielberger C.D., 1970, STAI MANUAL; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Waddell G, 2001, OCCUP MED-OXFORD, V51, P124, DOI 10.1093/occmed/51.2.124; Waddell G, 2004, THE BACK PAIN REVOLU, P241; Walker BF, 2004, J MANIP PHYSIOL THER, V27, P238, DOI 10.1016/j.jmpt.2004.02.002; Westman AE, 2011, CLIN J PAIN, V27, P567, DOI 10.1097/AJP.0b013e318219ab6c; Williams RM, 2007, DISABIL REHABIL, V29, P607, DOI 10.1080/09638280600841513; Yokoyama K, 1990, Nihon Koshu Eisei Zasshi, V37, P913	45	32	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93924	10.1371/journal.pone.0093924	http://dx.doi.org/10.1371/journal.pone.0093924			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7FA	24714616	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900061
J	Reynolds, SJ; Martin, GR; Dawson, A; Wearn, CP; Hughes, BJ				Reynolds, S. James; Martin, Graham R.; Dawson, Alistair; Wearn, Colin P.; Hughes, B. John			The Sub-Annual Breeding Cycle of a Tropical Seabird	PLOS ONE			English	Article							CIRCANNUAL RHYTHMS; SOOTY TERN; SUCCESS; POPULATION; ISLAND; MOLT; FUSCATA; REGIME; COLONY; OCEAN	Breeding periodicity allows organisms to synchronise breeding attempts with the most favourable ecological conditions under which to raise offspring. For most animal species, ecological conditions vary seasonally and usually impose an annual breeding schedule on their populations; sub-annual breeding schedules will be rare. We use a 16-year dataset of breeding attempts by a tropical seabird, the sooty tern (Onychoprion fuscatus), on Ascension Island to provide new insights about this classical example of a population of sub-annually breeding birds that was first documented in studies 60 years previously on the same island. We confirm that the breeding interval of this population has remained consistently sub-annual. By ringing>17000 birds and re-capturing a large sample of them at equivalent breeding stages in subsequent seasons, we reveal for the first time that many individual birds also consistently breed sub-annually (i.e. that sub-annual breeding is an individual as well as a population breeding strategy). Ascension Island sooty terns appear to reduce their courtship phase markedly compared with conspecifics breeding elsewhere. Our results provide rare insights into the ecological and physiological drivers of breeding periodicity, indicating that reduction of the annual cycle to just two life-history stages, breeding and moult, is a viable life-history strategy and that moult may determine the minimum time between breeding attempts.	[Reynolds, S. James; Martin, Graham R.; Hughes, B. John] Univ Birmingham, Sch Biosci, Coll Life & Environm Sci, Ctr Ornithol, Birmingham, W Midlands, England; [Reynolds, S. James] Land Forces Directorate, Army Ornithol Soc, Andover, Hants, England; [Dawson, Alistair] Ctr Ecol & Hydrol, Penicuik, Midlothian, Scotland; [Wearn, Colin P.] Royal Air Force, Headquarters Air Command, Royal Air Force Ornithol Soc, High Wycombe, Bucks, England	University of Birmingham; UK Centre for Ecology & Hydrology (UKCEH)	Reynolds, SJ (corresponding author), Univ Birmingham, Sch Biosci, Coll Life & Environm Sci, Ctr Ornithol, Birmingham, W Midlands, England.	J.Reynolds.2@bham.ac.uk; rasuk@btconnect.com	Reynolds, Silas James/AAM-1372-2020; Dawson, Alistair/B-4221-2012	Dawson, Alistair/0000-0001-6492-872X; Hughes, B. John/0000-0002-4537-065X	Army Ornithological Society (AOS); Royal Air Force Ornithological Society (RAFOS); Royal Naval Birdwatching Society (RNBWS); Royal Society for the Protection of Birds (RSPB); Natural Environment Research Council [CEH010021] Funding Source: researchfish	Army Ornithological Society (AOS); Royal Air Force Ornithological Society (RAFOS); Royal Naval Birdwatching Society (RNBWS); Royal Society for the Protection of Birds (RSPB); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The logistics for fieldwork including the ringing activities reported in this study were supported financially by the Army Ornithological Society (AOS), the Royal Air Force Ornithological Society (RAFOS), the Royal Naval Birdwatching Society (RNBWS) and the Royal Society for the Protection of Birds (RSPB). The funders had no role in the preparation of the manuscript for publication.	ASHMOLE N. P., 1963, IBIS, V103b, P297, DOI 10.1111/j.1474-919X.1963.tb06757.x; ASHMOLE N. PHILIP, 1963, POSTILLA [YALE PEABODY MUS], V76, P1; ASHMOLE NP, 1968, CONDOR, V70, P35, DOI 10.2307/1366507; ASHMOLE NP, 1965, P NATL ACAD SCI USA, V53, P311, DOI 10.1073/pnas.53.2.311; Baker J. R., 1938, P161; BROOKE MD, 1995, BIOL J LINN SOC, V56, P199, DOI 10.1006/bijl.1995.0061; CHAPIN JAMES P., 1959, AUK, V76, P153; CHAPIN JAMES P., 1954, AUK, V71, P1; CHASTEL O, 1995, IBIS, V137, P360, DOI 10.1111/j.1474-919X.1995.tb08033.x; Coulson John C., 2002, P87; Darwin Charles, 1844, GEOLOGICAL OBSERVATI; Dawson A, 1997, J BIOL RHYTHM, V12, P371, DOI 10.1177/074873049701200409; Dawson A, 2008, PHILOS T R SOC B, V363, P1621, DOI 10.1098/rstb.2007.0004; Dawson A, 2007, P ROY SOC B-BIOL SCI, V274, P721, DOI 10.1098/rspb.2006.0067; DEL HOYO J., 1996, HDB BIRDS WORLD, V3; DIAMOND AW, 1976, IBIS, V118, P414, DOI 10.1111/j.1474-919X.1976.tb02029.x; DIAMOND AW, 1986, J ZOOL, V210, P527; DINSMORE J J, 1972, Bulletin of the Florida State Museum Biological Sciences, V16, P129; FEARE CJ, 1976, J ZOOL, V179, P317; GWINNER E, 1977, ANNU REV ECOL SYST, V8, P381, DOI 10.1146/annurev.es.08.110177.002121; Hamer Keith C., 2002, P217; HARRINGTON BA, 1974, BIRD BANDING, V45, P115, DOI 10.2307/4512021; Hart-Davis D, 1972, ASCENSION STORY S AT; Hughes BJ, 2008, IBIS, V150, P122, DOI 10.1111/j.1474-919X.2008.00838.x; Hughes B. John, 2012, Bulletin of the African Bird Club, V19, P166; Immelmann K., 1971, P341; Jaquemet S, 2007, DEEP-SEA RES PT I, V54, P130, DOI 10.1016/j.dsr.2006.10.003; Jouventin P, 2002, P ROY SOC B-BIOL SCI, V269, P1955, DOI 10.1098/rspb.2002.2080; KING BR, 1992, EMU, V92, P1, DOI 10.1071/MU9920001; Lack D., 1954, P343; Le Corre M, 2001, J ZOOL, V254, P239, DOI 10.1017/S0952836901000759; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Newton I, 2011, J ORNITHOL, V152, P169, DOI 10.1007/s10336-011-0689-y; PARSONS J, 1976, IBIS, V118, P537; PRYSJONES RP, 1980, IBIS, V122, P76, DOI 10.1111/j.1474-919X.1980.tb00873.x; Ratcliffe N, 2008, IBIS, V150, P300, DOI 10.1111/j.1474-919X.2007.00778.x; RICKLEFS RE, 1966, EVOLUTION, V20, P235, DOI 10.1111/j.1558-5646.1966.tb03358.x; Schreiber E.A., 2002, P179; Schreiber EA, 2002, BIRDS N AM; SNOW DW, 1967, IBIS, V109, P14, DOI 10.1111/j.1474-919X.1967.tb00003.x; SNOW DW, 1965, AUK, V82, P591, DOI 10.2307/4083221; Stonehouse B., 1962, Ibis, V103b, P124, DOI 10.1111/j.1474-919X.1962.tb07242.x; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Williams T., 2012, PHYSL ADAPTATIONS BR; Wingfield JC, 2008, PHILOS T R SOC B, V363, P425, DOI 10.1098/rstb.2007.2149	45	15	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93582	10.1371/journal.pone.0093582	http://dx.doi.org/10.1371/journal.pone.0093582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714514	Green Published, Green Accepted, gold			2022-12-25	WOS:000334160900038
J	Taube, M; Pienkowska, JR; Jarmolowski, A; Kozak, M				Taube, Michal; Pienkowska, Joanna R.; Jarmolowski, Artur; Kozak, Maciej			Low-Resolution Structure of the Full-Length Barley (Hordeum vulgare) SGT1 Protein in Solution, Obtained Using Small-Angle X-Ray Scattering	PLOS ONE			English	Article							BIOLOGICAL MACROMOLECULES; ESSENTIAL COMPONENT; SECONDARY STRUCTURE; FUNCTIONAL-ANALYSIS; SELF-ASSOCIATION; DOMAIN; HSP90; ACCUMULATION; RESISTANCE; COMPLEXES	SGT1 is an evolutionarily conserved eukaryotic protein involved in many important cellular processes. In plants, SGT1 is involved in resistance to disease. In a low ionic strength environment, the SGT1 protein tends to form dimers. The protein consists of three structurally independent domains (the tetratricopeptide repeats domain (TPR), the CHORD-and SGT1-containing domain (CS), and the SGT1-specific domain (SGS)), and two less conserved variable regions (VR1 and VR2). In the present study, we provide the low-resolution structure of the barley (Hordeum vulgare) SGT1 protein in solution and its dimer/monomer equilibrium using small-angle scattering of synchrotron radiation, ab-initio modeling and circular dichroism spectroscopy. The multivariate curve resolution least-square method (MCR-ALS) was applied to separate the scattering data of the monomeric and dimeric species from a complex mixture. The models of the barley SGT1 dimer and monomer were formulated using rigid body modeling with ab-initio structure prediction. Both oligomeric forms of barley SGT1 have elongated shapes with unfolded inter-domain regions. Circular dichroism spectroscopy confirmed that the barley SGT1 protein had a modular architecture, with an alpha-helical TPR domain, a beta-sheet sandwich CS domain, and a disordered SGS domain separated by VR1 and VR2 regions. Using molecular docking and ab-initio protein structure prediction, a model of dimerization of the TPR domains was proposed.	[Taube, Michal; Kozak, Maciej] Adam Mickiewicz Univ, Fac Phys, Dept Macromol Phys, Poznan, Poland; [Pienkowska, Joanna R.] Adam Mickiewicz Univ, Fac Biol, Inst Expt BiFol, Dept Cell Biol, Poznan, Poland; [Jarmolowski, Artur] Adam Mickiewicz Univ, Fac Biol, Inst Mol Biol & Biotechnol, Dept Gene Express, Poznan, Poland	Adam Mickiewicz University	Kozak, M (corresponding author), Adam Mickiewicz Univ, Fac Phys, Dept Macromol Phys, Poznan, Poland.	mkozak@amu.edu.pl		Pienkowska, Joanna/0000-0003-0372-121X; Taube, Michal/0000-0002-8876-929X; Kozak, Maciej/0000-0003-3312-6518	Polish Ministry of Science and Higher Education [N N202 127237]; National Science Centre [2012/05/N/ST3/03087]; POLAPGEN-BD [UDA POIG.01.03.01-00-101/08]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Centre(National Science Centre, Poland); POLAPGEN-BD	This work was supported in part by grant N N202 127237 (MK) from the Polish Ministry of Science and Higher Education. The work was also supported by the grant (2012/05/N/ST3/03087) from National Science Centre (MT) and by POLAPGEN-BD (UDA POIG.01.03.01-00-101/08) grant (AJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Azevedo C, 2006, EMBO J, V25, P2007, DOI 10.1038/sj.emboj.7601084; Bansal PK, 2009, J BIOL CHEM, V284, P18692, DOI 10.1074/jbc.M109.012732; Bansal PK, 2009, J BIOL CHEM, V284, P3586, DOI 10.1074/jbc.M806281200; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bernado P, 2012, MOL BIOSYST, V8, P151, DOI 10.1039/c1mb05275f; Bieri S, 2004, PLANT CELL, V16, P3480, DOI 10.1105/tpc.104.026682; Blobel J, 2009, J AM CHEM SOC, V131, P4378, DOI 10.1021/ja808490b; Boter M, 2007, PLANT CELL, V19, P3791, DOI 10.1105/tpc.107.050427; Correia JD, 2007, P NATL ACAD SCI USA, V104, P6764, DOI 10.1073/pnas.0610926104; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Diebold ML, 2011, J STRUCT BIOL, V175, P178, DOI 10.1016/j.jsb.2011.02.001; Dubacq C, 2002, EUKARYOT CELL, V1, P568, DOI 10.1128/EC.1.4.568-582.2002; Dummler A, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-34; Filipek A, 1998, J NEUROCHEM, V70, P1793, DOI 10.1046/j.1471-4159.1998.70051793.x; Gray WM, 2003, PLANT CELL, V15, P1310, DOI 10.1105/tpc.010884; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; HUANG TC, 1993, J APPL CRYSTALLOGR, V26, P180, DOI 10.1107/S0021889892009762; Jaumot J, 2005, CHEMOMETR INTELL LAB, V76, P101, DOI 10.1016/j.chemolab.2004.12.007; Kadota Y, 2008, EMBO REP, V9, P1209, DOI 10.1038/embor.2008.185; Kinch L, 2011, PROTEINS, V79, P59, DOI 10.1002/prot.23181; Kitagawa K, 1999, MOL CELL, V4, P21, DOI 10.1016/S1097-2765(00)80184-7; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozak M, 2005, J APPL CRYSTALLOGR, V38, P555, DOI 10.1107/S0021889805010472; Kozak M, 2002, ACTA BIOCHIM POL, V49, P509; Krachler AM, 2010, PROTEINS, V78, P2131, DOI 10.1002/prot.22726; Lee YT, 2008, BIOCHEMISTRY-US, V47, P10921, DOI 10.1021/bi801233z; Lee YT, 2004, J BIOL CHEM, V279, P16511, DOI 10.1074/jbc.M400215200; Li YZ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001111; Main ERG, 2003, STRUCTURE, V11, P497, DOI 10.1016/S0969-2126(03)00076-5; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; Meldau S, 2011, PLANT SIGNAL BEHAV, V6, P1479, DOI 10.4161/psb.6.10.17708; Muroga Y, 2000, BIOPHYS CHEM, V83, P197, DOI 10.1016/S0301-4622(99)00141-6; Nowotny M, 2000, J BIOL CHEM, V275, P31178, DOI 10.1074/jbc.M001622200; Nyarko A, 2007, BIOCHEMISTRY-US, V46, P11331, DOI 10.1021/bi700735t; Pernot P, 2010, J PHYS CONF SER, V247, DOI 10.1088/1742-6596/247/1/012009; Petoukhov MV, 2007, CURR OPIN STRUC BIOL, V17, P562, DOI 10.1016/j.sbi.2007.06.009; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Round AR, 2008, J APPL CRYSTALLOGR, V41, P913, DOI 10.1107/S0021889808021018; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shirasu K, 2009, ANNU REV PLANT BIOL, V60, P139, DOI 10.1146/annurev.arplant.59.032607.092906; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Steensgaard P, 2004, EMBO REP, V5, P626, DOI 10.1038/sj.embor.7400154; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2000, J BIOL CHEM, V275, P14432, DOI 10.1074/jbc.275.19.14432; Svergun DI, 2003, REP PROG PHYS, V66, P1735, DOI 10.1088/0034-4885/66/10/R05; Svergun DI, 1997, PROTEINS, V27, P110; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Weaver AJ, 2000, J BIOL CHEM, V275, P23045, DOI 10.1074/jbc.M003410200; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Williamson TE, 2008, BIOPHYS J, V94, P4906, DOI 10.1529/biophysj.107.113167; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Xu D, 2011, PROTEINS, V79, P147, DOI 10.1002/prot.23111; Zhang MH, 2008, EMBO J, V27, P2789, DOI 10.1038/emboj.2008.190; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	62	7	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93313	10.1371/journal.pone.0093313	http://dx.doi.org/10.1371/journal.pone.0093313			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714665	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900023
J	Wessels, JM; Wu, L; Leyland, NA; Wang, HM; Foster, WG				Wessels, Jocelyn M.; Wu, Liang; Leyland, Nicholas A.; Wang, Hongmei; Foster, Warren G.			The Brain-Uterus Connection: Brain Derived Neurotrophic Factor (BDNF) and Its Receptor (Ntrk2) Are Conserved in the Mammalian Uterus	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; TYROSINE PROTEIN-KINASE; EUTOPIC ENDOMETRIUM; ENDOTHELIAL-CELLS; FACTOR EXPRESSION; TRKB; ACTIVATION; INNERVATION; RELEASE; COMPLEX	The neurotrophins are neuropeptides that are potent regulators of neurite growth and survival. Although mainly studied in the brain and nervous system, recent reports have shown that neurotrophins are expressed in multiple target tissues and cell types throughout the body. Additionally, dysregulation of neurotrophins has been linked to several disease conditions including Alzheimer's, Parkinson's, Huntington's, psychiatric disorders, and cancer. Brain derived neurotrophic factor (BDNF) is a member of the neurotrophin family that elicits its actions through the neurotrophic tyrosine receptor kinase type 2 (Ntrk2). Together BDNF and Ntrk2 are capable of activating the adhesion, angiogenesis, apoptosis, and proliferation pathways. These pathways are prominently involved in reproductive physiology, yet a cross-species examination of BDNF and Ntrk2 expression in the mammalian uterus is lacking. Herein we demonstrated the conserved nature of BDNF and Ntrk2 across several mammalian species by mRNA and protein sequence alignment, isolated BDNF and Ntrk2 transcripts in the uterus by Real-Time PCR, localized both proteins to the glandular and luminal epithelium, vascular smooth muscle, and myometrium of the uterus, determined that the major isoforms expressed in the human endometrium were pro-BDNF, and truncated Ntrk2, and finally demonstrated antibody specificity. Our findings suggest that BDNF and Ntrk2 are transcribed, translated, and conserved across mammalian species including human, mouse, rat, pig, horse, and the bat.	[Wessels, Jocelyn M.; Leyland, Nicholas A.; Foster, Warren G.] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada; [Wu, Liang; Wang, Hongmei] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China	McMaster University; Chinese Academy of Sciences; Institute of Zoology, CAS	Foster, WG (corresponding author), McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada.	fosterw@mcmaster.ca			Natural Sciences and Engineering Research Council; Canadian Institutes of Health Research (CIHR)	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Funding for this project was provided by an operating grant from the Natural Sciences and Engineering Research Council. Ms. Jocelyn Wessels received a Vanier scholarship from the Canadian Institutes of Health Research (CIHR) and is a student member of the CIHR Training Program in Reproduction, Early Development, and the Impact on Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 2002, J CLIN ENDOCR METAB, V87, P890, DOI 10.1210/jc.87.2.890; Anger DL, 2007, ENDOCRINE, V31, P167, DOI 10.1007/s12020-007-0025-8; Bao W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070616; Baxter GT, 1997, J NEUROSCI, V17, P2683; Browne AS, 2012, FERTIL STERIL, V98, P713, DOI 10.1016/j.fertnstert.2012.05.027; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Cassens C, 2010, J BIOL CHEM, V285, P28959, DOI 10.1074/jbc.M110.114835; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Donnez O, 2013, J ENDOMETR PELVIC PA, V5, P68, DOI 10.5301/je.5000155; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Garces MF, 2013, CLIN ENDOCRINOL OXF; Geiger TR, 2007, CANCER RES, V67, P6221, DOI 10.1158/0008-5472.CAN-07-0121; Gilmore JH, 2003, J NEUROIMMUNOL, V138, P49, DOI 10.1016/S0165-5728(03)00095-X; GOTZ R, 1992, J NEUROCHEM, V59, P432, DOI 10.1111/j.1471-4159.1992.tb09389.x; Gray K, 2008, FEBS LETT, V582, P907, DOI 10.1016/j.febslet.2008.02.026; Hahn C, 2006, J ALLERGY CLIN IMMUN, V117, P787, DOI 10.1016/j.jaci.2005.12.1339; Harel S, 2006, MOL HUM REPROD, V12, P357, DOI 10.1093/molehr/gal033; Huang YQ, 2011, ARCH GYNECOL OBSTET, V283, P775, DOI 10.1007/s00404-010-1718-4; Kaur P, 2007, J NEUROSCI RES, V85, P2441, DOI 10.1002/jnr.21370; Kawamura K, 2007, DEV BIOL, V311, P147, DOI 10.1016/j.ydbio.2007.08.026; Kawamura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049328; Kawamura K, 2011, ENDOCRINOLOGY, V152, P1090, DOI 10.1210/en.2010-1124; Kawamura K, 2009, ENDOCRINOLOGY, V150, P3774, DOI 10.1210/en.2009-0213; Kawamura N, 2010, ENDOCRINOLOGY, V151, P3006, DOI 10.1210/en.2009-1378; Kermani P, 2005, J CLIN INVEST, V115, P653, DOI 10.1172/JCI200522655; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; KLEIN R, 1992, NEURON, V8, P947, DOI 10.1016/0896-6273(92)90209-V; KLEIN R, 1991, CELL, V66, P395, DOI 10.1016/0092-8674(91)90628-C; Koshimizu H, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-27; Krizsan-Agbas D, 2003, EUR J NEUROSCI, V18, P2760, DOI 10.1111/j.1460-9568.2003.03029.x; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030246; Liu Y, 2012, SCIENCE, V338, P1357, DOI 10.1126/science.1228258; Lommatzsch M, 2006, PSYCHONEUROENDOCRINO, V31, P388, DOI 10.1016/j.psyneuen.2005.09.003; Lommatzsch M, 1999, AM J PATHOL, V155, P1183, DOI 10.1016/S0002-9440(10)65221-2; Maruyama E, 2007, INT J BIOCHEM CELL B, V39, P1930, DOI 10.1016/j.biocel.2007.05.012; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Metsis M, 2001, CELL MOL LIFE SCI, V58, P1014, DOI 10.1007/PL00000916; Meyer M, 2012, NEUROSCIENCE, V201, P267, DOI 10.1016/j.neuroscience.2011.11.034; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; Nakahashi T, 2000, FEBS LETT, V470, P113, DOI 10.1016/S0014-5793(00)01302-8; Nakamura K, 2006, CANCER RES, V66, P4249, DOI 10.1158/0008-5472.CAN-05-2789; Newman TA, 2013, HUM REPROD, V28, P2502, DOI 10.1093/humrep/det274; Noga O, 2008, CLIN EXP ALLERGY, V38, P473, DOI 10.1111/j.1365-2222.2007.02907.x; Noga O, 2003, CLIN EXP ALLERGY, V33, P649, DOI 10.1046/j.1365-2222.2003.01586.x; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Quinn MJ, 2002, AM J OBSTET GYNECOL, V187, P1515, DOI 10.1067/mob.2002.130007; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rost B, 2005, REGUL PEPTIDES, V124, P19, DOI 10.1016/j.regpep.2004.06.024; Russo N, 2012, GYNECOL ENDOCRINOL, V28, P492, DOI 10.3109/09513590.2011.633667; Schulte-Herbruggen O, 2007, J REPROD IMMUNOL, V74, P170, DOI 10.1016/j.jri.2006.10.003; Shibayama E, 1996, AM J PATHOL, V148, P1807; Solum DT, 2002, J NEUROSCI, V22, P2650, DOI 10.1523/JNEUROSCI.22-07-02650.2002; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035883; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Tervonen TA, 2006, EUR J NEUROSCI, V24, P1277, DOI 10.1111/j.1460-9568.2006.05010.x; Wang LH, 2005, J PHARMACOL EXP THER, V312, P1007, DOI 10.1124/jpet.104.077800; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; YAMAMOTO H, 1990, J NEUROSCI, V10, P3469; Zhang XP, 2007, BIOL REPROD, V77, P358, DOI 10.1095/biolreprod.106.058958; Zhang XM, 2010, FERTIL STERIL, V94, P730, DOI 10.1016/j.fertnstert.2009.03.026; Zhou H, 1997, J NEUROSCI RES, V49, P281, DOI 10.1002/(SICI)1097-4547(19970801)49:3<281::AID-JNR3>3.0.CO;2-8	65	36	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94036	10.1371/journal.pone.0094036	http://dx.doi.org/10.1371/journal.pone.0094036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714156	Green Submitted, gold, Green Published			2022-12-25	WOS:000334160900072
J	Boender, AJ; Koning, NA; van den Heuvel, JK; Luijendijk, MCM; van Rozen, AJ; la Fleur, SE; Adan, RAH				Boender, Arjen J.; Koning, Nivard A.; van den Heuvel, Jose K.; Luijendijk, Mieneke C. M.; van Rozen, Andrea J.; la Fleur, Susanne E.; Adan, Roger A. H.			AAV-Mediated Gene Transfer of the Obesity-Associated Gene Etv5 in Rat Midbrain Does Not Affect Energy Balance or Motivated Behavior	PLOS ONE			English	Article							MESOLIMBIC DOPAMINE SYSTEM; HYPOTHALAMUS; EXPRESSION; NEURONS; LOCI	Several genome-wide association studies have implicated the transcription factor E-twenty-six version 5 (Etv5) in the regulation of body mass index. Further substantiating the role of Etv5 in feeding behavior are the findings that targeted disruption of Etv5 in mice leads to decreased body weight gain and that expression of Etv5 is decreased in the ventral tegmental area and substantia nigra pars compacta (VTA/SNpc) after food restriction. As Etv5 has been suggested to influence dopaminergic neurotransmission by driving the expression of genes that are responsible for the synthesis and release of dopamine, we investigated if expression levels of Etv5 are dependent on nutritional state and subsequently influence the expression levels of tyrosine hydroxylase. While it was shown that Etv5 expression in the VTA/SNpc increases after central administration of leptin and that Etv5 was able to drive expression of tyrosine hydroxylase in vitro, AAVmediated gene transfer of Etv5 into the VTA/SNpc of rats did not alter expression of tyrosine hydroxylase in vivo. Moreover, AAV-mediated gene transfer of Etv5 in the VTA/SNpc did not affect measures of energy balance or performances in a progressive ratio schedule. Thus, these data do not support a role for increased expression of Etv5 in the VTA/SNpc in the regulation of feeding behavior.	[Boender, Arjen J.; Koning, Nivard A.; Luijendijk, Mieneke C. M.; van Rozen, Andrea J.; Adan, Roger A. H.] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands; [van den Heuvel, Jose K.; la Fleur, Susanne E.] Univ Amsterdam, Acad Med Ctr, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam	Adan, RAH (corresponding author), Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Translat Neurosci, Utrecht, Netherlands.	r.a.h.adan@umcutrecht.nl		Boender, Arjen/0000-0002-6018-3588	European Community [245009, 266408]	European Community(European Commission)	This work was funded by the European Community's Seventh Framework Programme (FP7/2007-2013 under grant agreement no 245009 and 266408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boender AJ, 2012, OBESITY, V20, P2420, DOI 10.1038/oby.2012.128; de Backer MWA, 2011, INT J OBESITY, V35, P629, DOI 10.1038/ijo.2010.169; de Backer MWA, 2010, J MOL ENDOCRINOL, V45, P341, DOI 10.1677/JME-10-0057; de Backer MWA, 2010, HUM GENE THER, V21, P673, DOI 10.1089/hum.2009.169; Flames N, 2009, NATURE, V458, P885, DOI 10.1038/nature07929; Kenny PJ, 2011, NEURON, V69, P664, DOI 10.1016/j.neuron.2011.02.016; Leinninger GM, 2011, CELL METAB, V14, P313, DOI 10.1016/j.cmet.2011.06.016; Leinninger GM, 2009, CELL METAB, V10, P89, DOI 10.1016/j.cmet.2009.06.011; Schlesser HN, 2008, BIOL REPROD, V78, P483, DOI 10.1095/biolreprod.107.062935; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Tiesjema B, 2007, J NEUROSCI, V27, P14139, DOI 10.1523/JNEUROSCI.3280-07.2007; Wang SR, 2010, J NEUROSCI, V30, P9224, DOI 10.1523/JNEUROSCI.1977-10.2010; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	14	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94159	10.1371/journal.pone.0094159	http://dx.doi.org/10.1371/journal.pone.0094159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710089	Green Submitted, gold, Green Published			2022-12-25	WOS:000334159800108
J	Chadha, S; Sharma, M				Chadha, Sonia; Sharma, Mradul			Transposable Elements as Stress Adaptive Capacitors Induce Genomic Instability in Fungal Pathogen Magnaporthe oryzae	PLOS ONE			English	Article							RICE-BLAST-FUNGUS; PWWP DOMAIN; GENETIC DIVERSITY; DNA-DAMAGE; PLANT; RETROTRANSPOSON; EVOLUTION; GRISEA; MUTATION; PROTEIN	A fundamental problem in fungal pathogenesis is to elucidate the evolutionary forces responsible for genomic rearrangements leading to races with fitter genotypes. Understanding the adaptive evolutionary mechanisms requires identification of genomic components and environmental factors reshaping the genome of fungal pathogens to adapt. Herein, Magnaporthe oryzae, a model fungal plant pathogen is used to demonstrate the impact of environmental cues on transposable elements (TE) based genome dynamics. For heat shock and copper stress exposed samples, eight TEs belonging to class I and II family were employed to obtain DNA profiles. Stress induced mutant bands showed a positive correlation with dose/duration of stress and provided evidences of TEs role in stress adaptiveness. Further, we demonstrate that genome dynamics differ for the type/family of TEs upon stress exposition and previous reports of stress induced MAGGY transposition has underestimated the role of TEs in M. oryzae. Here, we identified Pyret, MAGGY, Pot3, MINE, MgSINE, Grasshopper and MGLR3 as contributors of high genomic instability in M. oryzae in respective order. Sequencing of mutated bands led to the identification of LTR-retrotransposon sequences within regulatory regions of psuedogenes. DNA transposon Pot3 was identified in the coding regions of chromatin remodelling protein containing tyrosinase copperbinding and PWWP domains. LTR-retrotransposons Pyret and MAGGY are identified as key components responsible for the high genomic instability and perhaps these TEs are utilized by M. oryzae for its acclimatization to adverse environmental conditions. Our results demonstrate how common field stresses change genome dynamics of pathogen and provide perspective to explore the role of TEs in genome adaptability, signalling network and its impact on the virulence of fungal pathogens.	[Chadha, Sonia] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Mumbai 400085, Maharashtra, India; [Sharma, Mradul] Bhabha Atom Res Ctr, Astrophys Sci Div, Mumbai 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC); Bhabha Atomic Research Center (BARC)	Chadha, S (corresponding author), Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Mumbai 400085, Maharashtra, India.	schadha@barc.gov.in	Chadha, Sonia/AAJ-2483-2020	CHADHA, SONIA/0000-0003-2831-6907	Department of Atomic Energy, Government of India	Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE))	Funding was provided by Department of Atomic Energy, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qurainy F, 2011, PAK J BOT, V43, P2183; Atienzar FA, 2004, MUTAT RES-FUND MOL M, V552, P125, DOI 10.1016/j.mrfmmm.2004.06.009; Badyaev AV, 2005, P ROY SOC B-BIOL SCI, V272, P877, DOI 10.1098/rspb.2004.3045; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Behe MJ, 2010, Q REV BIOL, V85, P419, DOI 10.1086/656902; Bjedov I, 2003, SCIENCE, V300, P1404, DOI 10.1126/science.1082240; Boyko A, 2011, CURR OPIN PLANT BIOL, V14, P260, DOI 10.1016/j.pbi.2011.03.003; BRADSHAW AD, 1989, BIOL J LINN SOC, V37, P137, DOI 10.1111/j.1095-8312.1989.tb02099.x; Chadha S, 2005, GENOME, V48, P943, DOI 10.1139/g05-045; Chadha S, 2005, CURR SCI INDIA, V88, P1466; Chadha S, 2007, CURR SCI INDIA, V93, P688; Dasilva C, 2002, P NATL ACAD SCI USA, V99, P13636, DOI 10.1073/pnas.202284199; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; DOBINSON KF, 1993, MOL PLANT MICROBE IN, V6, P114, DOI 10.1094/MPMI-6-114; Eto Y, 2001, MOL GEN GENET, V264, P565, DOI 10.1007/s004380000343; Ewing AD, 2011, GENOME RES, V21, P985, DOI 10.1101/gr.114777.110; Falquet L, 2002, NUCLEIC ACIDS RES, V30, P235, DOI 10.1093/nar/30.1.235; Fedoroff NV, 2012, SCIENCE, V338, P758, DOI 10.1126/science.338.6108.758; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fudal I, 2005, FUNGAL GENET BIOL, V42, P761, DOI 10.1016/j.fgb.2005.05.001; Galhardo RS, 2007, CRIT REV BIOCHEM MOL, V42, P399, DOI 10.1080/10409230701648502; Hoffmann AA, 2008, NAT REV GENET, V9, P421, DOI 10.1038/nrg2339; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Hua-Van A, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-19; Huen MSY, 2010, MOL CELL, V37, P854, DOI 10.1016/j.molcel.2009.12.040; Ikeda K, 2002, MOL MICROBIOL, V45, P1355, DOI 10.1046/j.1365-2958.2002.03101.x; Ikeda K, 2001, MOL GENET GENOMICS, V266, P318, DOI 10.1007/s004380100560; Ishii T, 2001, NUCLEIC ACIDS RES, V29, P278, DOI 10.1093/nar/29.1.278; Jeon J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065416; KACHROO P, 1995, P NATL ACAD SCI USA, V92, P11125, DOI 10.1073/pnas.92.24.11125; Kang S, 2001, MOL PLANT MICROBE IN, V14, P671, DOI 10.1094/MPMI.2001.14.5.671; KANG S, 2000, PLANT PATHOLOGY J, V16, P1; Kumar A, 2004, BIOCHEM BIOPH RES CO, V318, P1025, DOI 10.1016/j.bbrc.2004.04.129; LEE WC, 1991, J CELL BIOL, V113, P1, DOI 10.1083/jcb.113.1.1; Letunic I, 2002, NUCLEIC ACIDS RES, V30, P242, DOI 10.1093/nar/30.1.242; Liu W, 2007, CHEMOSPHERE, V67, P1155, DOI 10.1016/j.chemosphere.2006.11.011; Lowe CB, 2007, P NATL ACAD SCI USA, V104, P8005, DOI 10.1073/pnas.0611223104; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Maeda T, 1999, CANCER LETT, V138, P183, DOI 10.1016/S0304-3835(99)00004-X; Mathioni SM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-49; McDonald BA, 2002, ANNU REV PHYTOPATHOL, V40, P349, DOI 10.1146/annurev.phyto.40.120501.101443; Nishimura M, 2000, MOL PLANT MICROBE IN, V13, P892, DOI 10.1094/MPMI.2000.13.8.892; Ou S H, 1987, RICE DIS; Shan EL, 2009, J CREATION, V23, P110; Shull V, 1996, CURR GENET, V30, P263, DOI 10.1007/s002940050131; Sinha H, 2008, GENETICS, V180, P1661, DOI 10.1534/genetics.108.092932; Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6; STEPHAN W, 1994, GENETICS, V136, P333, DOI 10.1093/genetics/136.1.333; Theodorakis CW, 2001, ENVIRON TOXICOL CHEM, V20, P317, DOI 10.1002/etc.5620200212; Thon MR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r16; Tosa Yukio, 1995, Annals of the Phytopathological Society of Japan, V61, P549, DOI 10.3186/jjphytopath.61.549; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Viaud MC, 2002, PLANT CELL, V14, P917, DOI 10.1105/tpc.010389; Wessler SR, 1996, CURR BIOL, V6, P959, DOI 10.1016/S0960-9822(02)00638-3; Xue MF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002869; Zeh DW, 2009, BIOESSAYS, V31, P715, DOI 10.1002/bies.200900026; Zhou EX, 2007, FUNGAL GENET BIOL, V44, P1024, DOI 10.1016/j.fgb.2007.02.003	58	30	32	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94415	10.1371/journal.pone.0094415	http://dx.doi.org/10.1371/journal.pone.0094415			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709911	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800142
J	Hu, ZX; Duan, SS; Xu, N; Mulholland, MR				Hu, Zhangxi; Duan, Shunshan; Xu, Ning; Mulholland, Margaret R.			Growth and Nitrogen Uptake Kinetics in Cultured Prorocentrum donghaiense	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; ALEXANDRIUM-CATENELLA DINOPHYCEAE; EAST CHINA; ORGANIC NITROGEN; AUREOCOCCUS-ANOPHAGEFFERENS; DINOFLAGELLATE BLOOMS; PEPTIDE HYDROLYSIS; LIMITED GROWTH; RED TIDE; EUTROPHICATION	We compared growth kinetics of Prorocentrum donghaiense cultures on different nitrogen (N) compounds including nitrate (NO3-), ammonium (NH4+), urea, glutamic acid (glu), dialanine (diala) and cyanate. P. donghaiense exhibited standard Monod-type growth kinetics over a range of N concentraions (0.5-500 mu mol NL-1 for NO3- and NH4+ , 0.5- 50 mu mol N L-1 for urea, 0.5-100 mu mol N L-1 for glu and cyanate, and 0.5-200 mu mol N L-1 for diala) for all of the N compounds tested. Cultures grown on glu and urea had the highest maximum growth rates (mu(m), 1.51=0.06 d(-1) and 1.50=0.05 d(-1), respectively). However, cultures grown on cyanate, NO3- , and NH4+ had lower half saturation constants (K-mu, 0.28-0.51 mu mol N L-1). N uptake kinetics were measured in NO3--deplete and -replete batch cultures of P. donghaiense. In NO3--deplete batch cultures, P. donghaiense exhibited Michaelis-Menten type uptake kinetics for NO3(-), NH4+, urea and algal amino acids; uptake was saturated at or below 50 mu mol N L-1. In NO3--replete batch cultures, NH4+, urea, and algal amino acid uptake kinetics were similar to those measured in NO3--deplete batch cultures. Together, our results demonstrate that P. donghaiense can grow well on a variety of N sources, and exhibits similar uptake kinetics under both nutrient replete and deplete conditions. This may be an important factor facilitating their growth during bloom initiation and development in N-enriched estuaries where many algae compete for bioavailable N and the nutrient environment changes as a result of algal growth.	[Hu, Zhangxi] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Peoples R China; [Hu, Zhangxi; Duan, Shunshan; Xu, Ning] Jinan Univ, Res Ctr Hydrobiol, Guangzhou, Guangdong, Peoples R China; [Mulholland, Margaret R.] Old Dominion Univ, Dept Ocean Earth & Atmospher Sci, Norfolk, VA USA	Chinese Academy of Sciences; Institute of Oceanology, CAS; Jinan University; Old Dominion University	Xu, N (corresponding author), Jinan Univ, Res Ctr Hydrobiol, Guangzhou, Guangdong, Peoples R China.	txuning@163.com; mmulholl@odu.edu	Mulholland, Margaret R/E-8480-2011	Mulholland, Margaret R/0000-0001-8819-189X	China Scholarship Council; NOAA; NSF; Natural Science Foundation of China (NSFC) [40776078, 40876074, 41176104]; Directorate For Geosciences [1155666] Funding Source: National Science Foundation	China Scholarship Council(China Scholarship Council); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); NSF(National Science Foundation (NSF)); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The authors acknowledge the financial support from the China Scholarship Council to Zhangxi Hu. In addition, this work was supported by NOAA and NSF grants to MRM, and Natural Science Foundation of China (NSFC) (Grant Numbers 40776078, 40876074, 41176104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN CM, 1964, BIOCHEMISTRY-US, V3, P1238, DOI 10.1021/bi00897a010; Anderson DM, 1997, NATURE, V388, P513, DOI 10.1038/41415; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Anderson DM, 2012, ANNU REV MAR SCI, V4, P143, DOI 10.1146/annurev-marine-120308-081121; Anderson DM, 2008, HARMFUL ALGAE, V8, P39, DOI 10.1016/j.hal.2008.08.017; ANTIA NJ, 1991, PHYCOLOGIA, V30, P1, DOI 10.2216/i0031-8884-30-1-1.1; Berman T, 2003, AQUAT MICROB ECOL, V31, P279, DOI 10.3354/ame031279; Bronk DA, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P385, DOI 10.1016/B978-0-12-372522-6.00008-6; Chai C, 2006, HYDROBIOLOGIA, V563, P313, DOI 10.1007/s10750-006-0021-7; Cochlan WP, 2008, HARMFUL ALGAE, V8, P111, DOI 10.1016/j.hal.2008.08.008; COCHLAN WP, 1991, J PHYCOL, V27, P673; COCHLAN WP, 1991, MAR ECOL PROG SER, V69, P103, DOI 10.3354/meps069103; Cochlan WP, 2003, AGU ANTARCTIC RES SE, V78, P159; Collos Y, 2004, J PHYCOL, V40, P96, DOI 10.1046/j.1529-8817.2004.03034.x; COWIE GL, 1992, MAR CHEM, V37, P223, DOI 10.1016/0304-4203(92)90079-P; Dugdale RC, 2007, ESTUAR COAST SHELF S, V73, P17, DOI 10.1016/j.ecss.2006.12.008; EPPLEY RW, 1969, J PHYCOL, V5, P375, DOI 10.1111/j.1529-8817.1969.tb02628.x; Fan CL, 2003, HARMFUL ALGAE, V2, P283, DOI 10.1016/S1568-9883(03)00047-7; Fu MZ, 2009, CONT SHELF RES, V29, P2178, DOI 10.1016/j.csr.2009.08.010; Glibert PM, 2006, ECOL STU AN, V189, P341, DOI 10.1007/978-3-540-32210-8_26; Glibert PM, 2012, HARMFUL ALGAE, V14, P231, DOI 10.1016/j.hal.2011.10.023; Gobler CJ, 2012, HARMFUL ALGAE, V17, P64, DOI 10.1016/j.hal.2012.03.001; Goldman J. C., 1983, NITROGEN MAR ENV, P233, DOI DOI 10.1016/B978-0-12-160280-2.50015-8; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Guillard R.R.L., 1973, HDB PHYCOLOGICAL MET, P289; GUILLARD RR, 1973, J PHYCOL, V9, P233; HARRISON PJ, 1989, MAR ECOL PROG SER, V52, P301, DOI 10.3354/meps052301; HEALEY FP, 1980, MICROBIAL ECOL, V5, P281, DOI 10.1007/BF02020335; HEIN M, 1995, MAR ECOL PROG SER, V118, P247, DOI 10.3354/meps118247; Heisler J, 2008, HARMFUL ALGAE, V8, P3, DOI 10.1016/j.hal.2008.08.006; Herndon J, 2007, HARMFUL ALGAE, V6, P260, DOI 10.1016/j.hal.2006.08.006; Hu ZX, 2012, HARMFUL ALGAE, V13, P72, DOI 10.1016/j.hal.2011.10.004; [胡章喜 Hu Zhangxi], 2010, [环境科学学报, Acta Scientiae Circumstantiae], V30, P1265; Jauzein C, 2008, AQUAT MICROB ECOL, V53, P271, DOI 10.3354/ame01249; Jeong Hae Jin, 2010, Ocean Science Journal, V45, P65, DOI 10.1007/s12601-010-0007-2; Kana TM, 2004, HARMFUL ALGAE, V3, P377, DOI 10.1016/j.hal.2004.06.008; Kudela RM, 2008, HARMFUL ALGAE, V7, P278, DOI 10.1016/j.hal.2007.12.016; Kudela RM, 2000, AQUAT MICROB ECOL, V21, P31, DOI 10.3354/ame021031; Li J, 2011, CHIN J OCEANOL LIMN, V29, P746, DOI 10.1007/s00343-011-0504-x; Li J, 2010, HARMFUL ALGAE, V9, P531, DOI 10.1016/j.hal.2010.03.007; Li J, 2009, MAR ECOL PROG SER, V383, P11, DOI 10.3354/meps07975; Lindehoff E, 2011, HARMFUL ALGAE, V12, P70, DOI 10.1016/j.hal.2011.09.001; Lomas MW, 1999, MAR BIOL, V133, P541, DOI 10.1007/s002270050494; Lu DD, 2005, HARMFUL ALGAE, V4, P493, DOI 10.1016/j.hal.2004.08.015; Lu Dou-ding, 2001, Chinese Journal of Oceanology and Limnology, V19, P337; Lu SH, 2004, HYDROBIOLOGIA, V512, P231, DOI 10.1023/B:HYDR.0000020331.75003.18; Maguer JF, 2007, J PHYCOL, V43, P295, DOI 10.1111/j.1529-8817.2007.00334.x; MONOD J., 1942, Research on the Glowth of Bacterial Cultures.; MONOD J, 1950, ANN I PASTEUR PARIS, V79, P390; Mulholland MR, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P303, DOI 10.1016/B978-0-12-372522-6.00007-4; Mulholland MR, 2009, LIMNOL OCEANOGR, V54, P856, DOI 10.4319/lo.2009.54.3.0856; Mulholland MR, 2002, LIMNOL OCEANOGR, V47, P1094, DOI 10.4319/lo.2002.47.4.1094; Paerl HW, 1997, LIMNOL OCEANOGR, V42, P1154, DOI 10.4319/lo.1997.42.5_part_2.1154; Parsons T. R., 1984, MANUAL CHEM BIOL MET, DOI [10.1016/B978-0-08-030287-4.50004-9, DOI 10.1016/C2009-0-07774-5]; Seeyave S, 2009, MAR ECOL PROG SER, V379, P91, DOI 10.3354/meps07898; Shen ZL, 2003, AMBIO, V32, P65; SMITH REH, 1982, J PHYCOL, V18, P275; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; Taylor GT, 2006, MAR ECOL PROG SER, V312, P67, DOI 10.3354/meps312067; TILMAN D, 1977, ECOLOGY, V58, P338, DOI 10.2307/1935608; Wang JH, 2009, SCI TOTAL ENVIRON, V407, P4012, DOI 10.1016/j.scitotenv.2009.02.040; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Yan T., 2002, 23 PICES, P21; Yu J, 2007, TERR ATMOS OCEAN SCI, V18, P1011, DOI 10.3319/TAO.2007.18.5.1011(Oc); Yuan XC, 2012, ESTUAR COAST, V35, P325, DOI 10.1007/s12237-011-9433-3; Zhou M, 2010, ENV SETTINGS HARMFUL, P133; Zhou MJ, 2008, CONT SHELF RES, V28, P1483, DOI 10.1016/j.csr.2007.02.009	67	14	17	6	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94030	10.1371/journal.pone.0094030	http://dx.doi.org/10.1371/journal.pone.0094030			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710151	Green Published, gold, Green Submitted			2022-12-25	WOS:000334159800090
J	Koval, OA; Tkachenko, AV; Fomin, AS; Semenov, DV; Nushtaeva, AA; Kuligina, EV; Zavjalov, EL; Richter, VA				Koval, Olga A.; Tkachenko, Anastasiya V.; Fomin, Alexandr S.; Semenov, Dmitry V.; Nushtaeva, Anna A.; Kuligina, Elena V.; Zavjalov, Eugeny L.; Richter, Vladimir A.			Lactaptin Induces p53-Independent Cell Death Associated with Features of Apoptosis and Autophagy and Delays Growth of Breast Cancer Cells in Mouse Xenografts	PLOS ONE			English	Article							HUMAN ALPHA-LACTALBUMIN; HUMAN-MILK; MOLECULAR-MECHANISMS; SELF-DIGESTION; TUMOR-CELLS; PROTEIN; DRUG; CHLOROQUINE; INHIBITION; COMBINATION	Lactaptin, the proteolytic fragment of human milk kappa-casein, induces the death of various cultured cancer cells. The mechanisms leading to cell death after lactaptin treatment have not been well characterized. In this study the in vivo and in vitro effects of a recombinant analogue of lactaptin (RL2) were examined. Following treatment with the recombinant analogue of lactaptin strong caspase -3, -7 activation was detected. As a consequence of caspase activation we observed the appearance of a sub-G1 population of cells with subdiploid DNA content. Dynamic changes in the mRNA and protein levels of apoptosis-related genes were estimated. No statistically reliable differences in p53 mRNA level or protein level were found between control and RL2-treated cells. We observed that RL2 constitutively suppressed bcl-2 mRNA expression and down regulated Bcl-2 protein expression in MDA-MB-231 cells. We demonstrated that RL2 penetrates cancer and non-transformed cells. Identification of the cellular targets of the lactaptin analogue revealed that alpha/beta-tubulin and alpha-actinin-1 were RL2-bound proteins. As the alteration in cellular viability in response to protein stimulus can be realized not only by way of apoptosis but also by autophagy, we examined the implications of autophagy in RL2-dependent cell death. We also found that RL2 treatment induces LC3-processing, which is a hallmark of autophagy. The autophagy inhibitor chloroquine enhanced RL2 cytotoxicity to MDA-MB-231 cells, indicating the pro- survival effect of RL2-dependent autophagy. The antitumour potential of RL2 was investigated in vivo in mouse xenografts bearing MDA-MB-231 cells. We demonstrated that the recombinant analogue of lactaptin significantly suppressed the growth of solid tumours. Our results indicate that lactaptin could be a new molecule for the development of anticancer drugs.	[Koval, Olga A.; Tkachenko, Anastasiya V.; Fomin, Alexandr S.; Semenov, Dmitry V.; Nushtaeva, Anna A.; Kuligina, Elena V.; Richter, Vladimir A.] RUS, Inst Chem Biol & Fundamental Med, SB, Novosibirsk, Russia; [Koval, Olga A.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Zavjalov, Eugeny L.] RUS, Inst Cytol & Genet, SB, Novosibirsk, Russia	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Novosibirsk State University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Koval, OA (corresponding author), RUS, Inst Chem Biol & Fundamental Med, SB, Novosibirsk, Russia.	o.koval@niboch.nsc.ru	Koval, Olga/G-8836-2013; Tkachenko, Anastasiya/H-9649-2016; Fomin, Alexandr/AAP-6413-2020; Richter, Vladimir/G-9750-2013; Nushtaeva, Anna/I-1547-2016; Semenov, Dmitry V/Q-9153-2017; Fomin, Alexander/U-5928-2019	Nushtaeva, Anna/0000-0001-9367-807X; Kuligina, Elena/0000-0003-3145-1878; Koval, Olga/0000-0001-7788-2249	Siberian Branch of the Russian Academy of Sciences under the Program "Science to Medicine'' [13]; Siberian Branch of the Russian Academy of Sciences under the Integration Project [94]; Russian Foundation for Basic Research [13-04-01313a, 13-04-011457a]; Russian Federal Target Programs [16.N08.12.1009]	Siberian Branch of the Russian Academy of Sciences under the Program "Science to Medicine''; Siberian Branch of the Russian Academy of Sciences under the Integration Project; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Federal Target Programs	The study was supported by the Siberian Branch of the Russian Academy of Sciences under the Program "Science to Medicine'' (Project no. 13) and Integration Project (no. 94), by grants from the Russian Foundation for Basic Research (Grant nos. 13-04-01313a and 13-04-011457a) and by a grant from Russian Federal Target Programs (Grant no. 16.N08.12.1009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Bedner E, 2000, EXP CELL RES, V259, P308, DOI 10.1006/excr.2000.4955; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brinkley M., 1992, BIOCONJUGATE CHEM, V1, P2; Bruck WM, 2014, BIOCHIMIE, V97, P138, DOI 10.1016/j.biochi.2013.10.007; Cao XC, 2013, CHINESE J CANCER RES, V25, P212, DOI 10.3978/j.issn.1000-9604.2013.04.01; Carew JS, 2007, BLOOD, V110, P313, DOI 10.1182/blood-2006-10-050260; Carew Jennifer S, 2012, Cancer Manag Res, V4, P357, DOI 10.2147/CMAR.S26133; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Edlund A, 1996, GENE, V174, P65, DOI 10.1016/0378-1119(96)00351-4; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Floris R, 2003, CURR PHARM DESIGN, V9, P1257, DOI 10.2174/1381612033454810; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Geng Y, 2010, NEURO-ONCOLOGY, V12, P473, DOI 10.1093/neuonc/nop048; Han J, 2013, J BIOL CHEM, V288, P20315, DOI 10.1074/jbc.M113.461350; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang JS, 2009, BIOL PHARM BULL, V32, P150, DOI 10.1248/bpb.32.150; Kanyshkova TG, 2003, EUR J BIOCHEM, V270, P3353, DOI 10.1046/j.1432-1033.2003.03715.x; Karantza-Wadsworth V, 2007, AUTOPHAGY, V3, P610, DOI 10.4161/auto.4867; Klionsky DJ, 2010, AUTOPHAGY, V6, P438, DOI 10.4161/auto.6.4.12244; Koval OA, 2012, BIOCHIMIE, V94, P2467, DOI 10.1016/j.biochi.2012.08.017; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liepke C, 2001, J CHROMATOGR B, V752, P369, DOI 10.1016/S0378-4347(00)00516-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; Meng XW, 2006, CURR OPIN CELL BIOL, V18, P668, DOI 10.1016/j.ceb.2006.10.008; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Morgner J, 2013, CELL CYCLE, V12, P2929, DOI 10.4161/cc.26213; Mossberg AK, 2007, INT J CANCER, V121, P1352, DOI 10.1002/ijc.22810; Nag S, 2013, J BIOMED RES, V27, P254, DOI 10.7555/JBR.27.20130030; Nakamura T, 2013, J BIOL CHEM, V288, P14408, DOI 10.1074/jbc.M112.437889; Nekipelaya VV, 2008, DOKL BIOCHEM BIOPHYS, V419, P58, DOI 10.1134/S1607672908020038; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Semenov DV, 2010, PROTEIN J, V29, P174, DOI 10.1007/s10930-010-9237-5; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; STROMQVIST M, 1995, J PEDIATR GASTR NUTR, V21, P288, DOI 10.1097/00005176-199510000-00006; Tallarida RJ, 2001, J PHARMACOL EXP THER, V298, P865; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Upreti M, 2008, MOL CANCER THER, V7, P2224, DOI 10.1158/1535-7163.MCT-07-2299; Wassmann K, 2001, CURR OPIN GENET DEV, V11, P83, DOI 10.1016/S0959-437X(00)00161-1; Yang C, 2008, AM J PHYSIOL-RENAL, V294, pF777, DOI 10.1152/ajprenal.00590.2007; Zinn RL, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-16	48	24	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93921	10.1371/journal.pone.0093921	http://dx.doi.org/10.1371/journal.pone.0093921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710119	Green Submitted, Green Published, gold			2022-12-25	WOS:000334159800070
J	Sharabi, O; Shirian, J; Grossman, M; Lebendiker, M; Sagi, I; Shifman, J				Sharabi, Oz; Shirian, Jason; Grossman, Moran; Lebendiker, Mario; Sagi, Irit; Shifman, Julia			Affinity- and Specificity-Enhancing Mutations Are Frequent in Multispecific Interactions between TIMP2 and MMPs	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERFACES; TISSUE INHIBITOR; MATRIX-METALLOPROTEINASES; CRYSTAL-STRUCTURE; 1-MATRIX METALLOPROTEINASE; COMPLEX; BINDING; DOMAIN; OPTIMIZATION; FLEXIBILITY	Multispecific proteins play a major role in controlling various functions such as signaling, regulation of transcription/translation, and immune response. Hence, a thorough understanding of the atomic-level principles governing multispecific interactions is important not only for the advancement of basic science but also for applied research such as drug design. Here, we study evolution of an exemplary multispecific protein, a Tissue Inhibitor of Matrix Metalloproteinases 2 (TIMP2) that binds with comparable affinities to more than twenty-six members of the Matrix Metalloproteinase (MMP) and the related ADAMs families. We postulate that due to its multispecific nature, TIMP2 is not optimized to bind to any individual MMP type, but rather embodies a compromise required for interactions with all MMPs. To explore this hypothesis, we perform computational saturation mutagenesis of the TIMP2 binding interface and predict changes in free energy of binding to eight MMP targets. Computational results reveal the non-optimality of the TIMP2 binding interface for all studied proteins, identifying many affinity-enhancing mutations at multiple positions. Several TIMP2 point mutants predicted to enhance binding affinity and/or binding specificity towards MMP14 were selected for experimental verification. Experimental results show high abundance of affinity-enhancing mutations in TIMP2, with some point mutations producing more than ten-fold improvement in affinity to MMP14. Our computational and experimental results collaboratively demonstrate that the TIMP2 sequence lies far from the fitness maximum when interacting with its target enzymes. This non-optimality of the binding interface and high potential for improvement might characterize all proteins evolved for binding to multiple targets.	[Sharabi, Oz; Shirian, Jason; Shifman, Julia] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel; [Grossman, Moran; Sagi, Irit] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Lebendiker, Mario] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Wolfson Ctr Struct Biol, Jerusalem, Israel	Hebrew University of Jerusalem; Weizmann Institute of Science; Hebrew University of Jerusalem	Shifman, J (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel.	jshifman@cc.huji.ac.il			Israel Science Foundation [1372/10]; Abisch-Frenkel Foundation	Israel Science Foundation(Israel Science Foundation); Abisch-Frenkel Foundation	This work was supported in part by the Israel Science Foundation (1372/10) and by the Abisch-Frenkel Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizner Y, 2014, STRUCTURE, V22, P636, DOI 10.1016/j.str.2014.01.012; Bahudhanapati H, 2011, J BIOL CHEM, V286, P31761, DOI 10.1074/jbc.M111.253328; Batra J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075836; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Butler GS, 1999, J BIOL CHEM, V274, P20391, DOI 10.1074/jbc.274.29.20391; Cho KI, 2006, PROTEINS, V65, P593, DOI 10.1002/prot.21056; DESMET J, 1992, NATURE, V356, P539, DOI 10.1038/356539a0; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; Erijman A, 2011, J STRUCT BIOL, V175, P171, DOI 10.1016/j.jsb.2011.04.005; Erijman A, 2011, BIOCHEMISTRY-US, V50, P602, DOI 10.1021/bi101563v; Ernst A, 2013, SCIENCE, V339, P590, DOI 10.1126/science.1230161; Fernandez-Catalan C, 1998, EMBO J, V17, P5238, DOI 10.1093/emboj/17.17.5238; Fromer M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000627; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Gordon DB, 2003, J COMPUT CHEM, V24, P232, DOI 10.1002/jcc.10121; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Grossman M, 2011, CURR OPIN STRUC BIOL, V21, P678, DOI 10.1016/j.sbi.2011.07.008; Grossman M, 2010, BIOCHEMISTRY-US, V49, P6184, DOI 10.1021/bi902141x; Hamze AB, 2007, PROTEIN SCI, V16, P1905, DOI 10.1110/ps.072978507; Huang W, 1996, FEBS LETT, V384, P155, DOI 10.1016/0014-5793(96)00304-3; Humphris EL, 2007, PLOS COMPUT BIOL, V3, P1591, DOI 10.1371/journal.pcbi.0030164; Iyer S, 2007, J BIOL CHEM, V282, P364, DOI 10.1074/jbc.M607625200; Lee MH, 2003, J BIOL CHEM, V278, P40224, DOI 10.1074/jbc.M305678200; Lippow SM, 2007, NAT BIOTECHNOL, V25, P1171, DOI 10.1038/nbt1336; Litwin S, 1992, THEORETICAL EXPT INS, P289; Maskos K, 2007, J MOL BIOL, V366, P1222, DOI 10.1016/j.jmb.2006.11.072; Murphy G, 2008, NAT CLIN PRACT RHEUM, V4, P128, DOI 10.1038/ncprheum0727; Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233; Nishida Y, 2008, CANCER RES, V68, P9096, DOI 10.1158/0008-5472.CAN-08-2522; Sammond DW, 2007, J MOL BIOL, V371, P1392, DOI 10.1016/j.jmb.2007.05.096; Sharabi O, 2013, BIOCHEM SOC T, V41, P1166, DOI 10.1042/BST20130121; Sharabi O, 2013, METHOD ENZYMOL, V523, P41, DOI 10.1016/B978-0-12-394292-0.00003-5; Sharabi O, 2011, PROTEINS, V79, P1487, DOI 10.1002/prot.22977; Wei S, 2005, J BIOL CHEM, V280, P32877, DOI 10.1074/jbc.C500220200; Wei S, 2003, J BIOL CHEM, V278, P9831, DOI 10.1074/jbc.M211793200; Wisniewska M, 2008, J MOL BIOL, V381, P1307, DOI 10.1016/j.jmb.2008.06.088; Xu D, 1997, PROTEIN ENG, V10, P999, DOI 10.1093/protein/10.9.999	39	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93712	10.1371/journal.pone.0093712	http://dx.doi.org/10.1371/journal.pone.0093712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710006	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800046
J	Olivetta, E; Tirelli, V; Chiozzini, C; Scazzocchio, B; Romano, I; Arenaccio, C; Sanchez, M				Olivetta, Eleonora; Tirelli, Valentina; Chiozzini, Chiara; Scazzocchio, Beatrice; Romano, Ignazio; Arenaccio, Claudia; Sanchez, Massimo			HIV-1 Nef Impairs Key Functional Activities in Human Macrophages through CD36 Downregulation	PLOS ONE			English	Article							B SCAVENGER RECEPTOR; HUMAN MONOCYTE/MACROPHAGES; IN-VITRO; ANTIRETROVIRAL THERAPY; PLASMODIUM-FALCIPARUM; BACTERIAL RECOGNITION; ALVEOLAR MACROPHAGES; PNEUMOCYSTIS-CARINII; INFECTED PATIENTS; INNATE IMMUNITY	Monocytes and macrophages utilize the class A and B scavenger receptors to recognize and perform phagocytosis of invading microbes before a pathogen-specific immune response is generated. HIV-1 Nef protein affects the innate immune system impairing oxidative burst response and phagocytic capacity of macrophages. Our data show that exogenous recombinant myristoylated Nef protein induces a marked CD36 downregulation in monocytes from Peripheral Blood Mononuclear Cells, in Monocyte-Derived Macrophages (MDMs) differentiated by cytokines and in MDMs contained in a mixed culture obtained expanding PBMCs under Human Erythroid Massive Amplification condition. Under the latter culture condition we identify three main populations after 6 days of expansion: lymphocytes (37.8+/-14.7%), erythroblasts (46.7+/-6.1%) and MDMs (15.7+/-7.5%). The Nef addition to the cell culture significantly downregulates CD36 expression in MDMs, but not in erythroid cells. Furthermore, CD36 inhibition is highly specific since it does not modify the expression levels of other MDM markers such as CD14, CD11c, CD86, CD68, CD206, Toll-like Receptor 2 and Toll-like Receptor 4. Similar results were obtained in MDMs infected with VSV-G pseudotyped HIV-1-expressing Nef. The reduced CD36 membrane expression is associated with decrease of correspondent CD36 mRNA transcript. Furthermore, Nef-induced CD36 downregulation is linked to both impaired scavenger activity with reduced capability to take up oxidized lipoproteins and to significant decreased phagocytosis of fluorescent beads and GFP-expressing Salmonella tiphymurium. In addition we observed that Nef induces TNF-alpha release in MDMs. Although these data suggest a possible involvement of TNF-alpha in mediating Nef activity, our results exclude a possible relationship between Nef-induced TNF-alpha release and Nef-mediated CD36 downregulation. The present work shows that HIV-1 Nef protein may have a role in the strategies elaborated by HIV-1 to alter pathogen disease outcomes, by modulating CD36 expression in macrophages, favoring the onset of opportunistic infections in HIV-1 infected people.	[Olivetta, Eleonora; Chiozzini, Chiara; Arenaccio, Claudia] Ist Super Sanita, Natl AIDS Ctr, I-00161 Rome, Italy; [Tirelli, Valentina; Romano, Ignazio; Sanchez, Massimo] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Scazzocchio, Beatrice] Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, I-00161 Rome, Italy; [Arenaccio, Claudia] Univ Roma TRE, Dept Sci, Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Italfarmaco; Roma Tre University	Sanchez, M (corresponding author), Ist Super Sanita, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	massimo.sanchez@iss.it	chiozzini, chiara/M-8906-2017; scazzocchio, beatrice/B-4110-2015; Tirelli, Valentina/AAB-2422-2019; Chiozzini, Chiara/AAH-1790-2021; Sanchez, Massimo/AAD-1746-2021; Scazzocchio, Beatrice/AAH-1395-2021; Arenaccio, Claudia/J-9914-2016; Olivetta, Eleonora/N-5736-2017	Tirelli, Valentina/0000-0001-6021-0833; Chiozzini, Chiara/0000-0002-4153-0927; Sanchez, Massimo/0000-0003-3696-7582; Scazzocchio, Beatrice/0000-0002-5123-3897; Arenaccio, Claudia/0000-0003-3297-2608; Olivetta, Eleonora/0000-0003-3296-5328	Istituto Superiore di Sanita, Rome, Italy	Istituto Superiore di Sanita, Rome, Italy	This work was supported by institutional funds from Istituto Superiore di Sanita, Rome, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Areschoug T, 2009, CELL MICROBIOL, V11, P1160, DOI 10.1111/j.1462-5822.2009.01326.x; Asztalos BF, 2010, J INFECT DIS, V202, P614, DOI 10.1086/654817; Baranova IN, 2008, J IMMUNOL, V181, P7147, DOI 10.4049/jimmunol.181.10.7147; Baranova IN, 2012, J IMMUNOL, V188, P1371, DOI 10.4049/jimmunol.1100350; Biggs TE, 1999, J MOL BIOL, V290, P21, DOI 10.1006/jmbi.1999.2849; Boccara F, 2008, AIDS, V22, pS19, DOI 10.1097/01.aids.0000327512.76126.6e; Boyer JF, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2133; Briggs SD, 2001, J BIOL CHEM, V276, P25605, DOI 10.1074/jbc.M103244200; Buechler C, 1999, BIOCHEM BIOPH RES CO, V262, P251, DOI 10.1006/bbrc.1999.1193; Capparelli R, 2010, J INFECT DIS, V201, P52, DOI 10.1086/648478; Collot-Teixeira S, 2007, CARDIOVASC RES, V75, P468, DOI 10.1016/j.cardiores.2007.03.010; Dennis CA, 2005, PROTEINS, V60, P658, DOI 10.1002/prot.20544; Dressman J, 2003, J CLIN INVEST, V111, P389, DOI 10.1172/JCI200316261; DUFF GW, 1982, J IMMUNOL METHODS, V52, P333, DOI 10.1016/0022-1759(82)90005-9; Duong M, 2006, HIV CLIN TRIALS, V7, P41, DOI 10.1310/7381-M1YD-RTV5-4RYT; Erdman LK, 2009, J IMMUNOL, V183, P6452, DOI 10.4049/jimmunol.0901374; ESPEVIK T, 1986, J IMMUNOL METHODS, V95, P99, DOI 10.1016/0022-1759(86)90322-4; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Federico M, 2001, BLOOD, V98, P2752, DOI 10.1182/blood.V98.9.2752; Feeney ER, 2013, J INFECT DIS, V207, P628, DOI 10.1093/infdis/jis723; Fujii Y, 1996, FEBS LETT, V393, P93, DOI 10.1016/0014-5793(96)00859-9; Ghiglione Y, 2011, CURR HIV RES, V9, P505, DOI 10.2174/157016211798842080; Han JH, 2000, J BIOL CHEM, V275, P1241, DOI 10.1074/jbc.275.2.1241; Han S, 2002, IMMUNOLOGY, V106, P53, DOI 10.1046/j.1365-2567.2002.01404.x; Hirano K, 2003, TRENDS CARDIOVAS MED, V13, P136, DOI 10.1016/S1050-1738(03)00026-4; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hume DA, 2006, CURR OPIN IMMUNOL, V18, P49, DOI 10.1016/j.coi.2005.11.008; Kedzierska K, 2003, J CLIN VIROL, V26, P247, DOI 10.1016/S1386-6532(02)00123-3; Kedzierska K, 2002, J IMMUNOL, V168, P2895, DOI 10.4049/jimmunol.168.6.2895; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Koziel H, 2000, AM J RESP CELL MOL, V23, P452, DOI 10.1165/ajrcmb.23.4.4084; Koziel H, 1998, AM J RESP CELL MOL, V18, P834, DOI 10.1165/ajrcmb.18.6.3059; Laguette N, 2010, MOL ASPECTS MED, V31, P418, DOI 10.1016/j.mam.2010.05.003; Lamers SL, 2012, INT REV IMMUNOL, V31, P432, DOI 10.3109/08830185.2012.737073; Masella R, 2004, J NUTR, V134, P785, DOI 10.1093/jn/134.4.785; Mazzolini J, 2010, BLOOD, V115, P4226, DOI 10.1182/blood-2009-12-259473; Meroni L, 2005, JAIDS-J ACQ IMM DEF, V38, P310; Migliaccio G, 2002, BLOOD CELL MOL DIS, V28, P169, DOI 10.1006/bcmd.2002.0502; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Munteanu A, 2005, FREE RADICAL BIO MED, V38, P1047, DOI 10.1016/j.freeradbiomed.2004.12.030; Olivetta E, 2005, BIOCHEM J, V390, P591, DOI 10.1042/BJ20042139; Olivetta E, 2003, J IMMUNOL, V170, P1716, DOI 10.4049/jimmunol.170.4.1716; Olivetta E, 2009, J CELL BIOCHEM, V106, P812, DOI 10.1002/jcb.22041; OQUENDO P, 1989, CELL, V58, P95, DOI 10.1016/0092-8674(89)90406-6; Percario Z, 2003, J LEUKOCYTE BIOL, V74, P821, DOI 10.1189/jlb.0403161; Petit JM, 2002, EUR J CLIN INVEST, V32, P354, DOI 10.1046/j.1365-2362.2002.00989.x; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Pitrak DL, 1998, J LAB CLIN MED, V132, P284, DOI 10.1016/S0022-2143(98)90041-5; Pou J, 2008, EXP BIOL MED, V233, P1572, DOI 10.3181/0805-RM-144; Renga B, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-274; Renga B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035924; Rios FJO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036632; Serghides L, 2002, AIDS, V16, P353, DOI 10.1097/00002030-200202150-00006; Shen LJ, 2001, J LIPID RES, V42, P813; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Smith TG, 2003, INFECT IMMUN, V71, P393, DOI 10.1128/IAI.71.1.393-400.2003; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; Tirelli V, 2011, STEM CELLS INT, V2011, DOI 10.4061/2011/602483; Torre D, 2002, CLIN DIAGN LAB IMMUN, V9, P983, DOI 10.1128/CDLI.9.5.983-986.2002; YAGI K, 1987, CHEM PHYS LIPIDS, V45, P337, DOI 10.1016/0009-3084(87)90071-5; Zamora C, 2012, CYTOKINE, V60, P257, DOI 10.1016/j.cyto.2012.06.020	64	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93699	10.1371/journal.pone.0093699	http://dx.doi.org/10.1371/journal.pone.0093699			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705461	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500059
J	Bhattacharya, D; Dwivedi, VP; Maiga, M; Maiga, M; Van Kaer, L; Bishai, WR; Das, G				Bhattacharya, Debapriya; Dwivedi, Ved Prakash; Maiga, Mamoudou; Maiga, Mariama; Van Kaer, Luc; Bishai, William R.; Das, Gobardhan			Small Molecule-directed Immunotherapy against Recurrent Infection by Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; SUPLATAST TOSILATE IPD-1151T; TUMOR-NECROSIS-FACTOR; TGF-BETA; IN-VIVO; TRANSCRIPTION FACTOR; LINEAGE COMMITMENT; IMMUNE-RESPONSES; TH1; GAMMA	Tuberculosis remains the biggest infectious threat to humanity with one-third of the population infected and 1.4 million deaths and 8.7 million new cases annually. Current tuberculosis therapy is lengthy and consists of multiple antimicrobials, which causes poor compliance and high treatment dropout, resulting in the development of drug-resistant variants of tuberculosis. Therefore, alternate methods to treat tuberculosis are urgently needed. Mycobacterium tuberculosis evades host immune responses by inducing T helper (Th)2 and regulatory T (Treg) cell responses, which diminish protective Th1 responses. Here, we show that animals (Stat-6(-/-)CD4-TGF beta RIIDN mice) that are unable to generate both Th2 cells and Tregs are highly resistant to M. tuberculosis infection. Furthermore, simultaneous inhibition of these two subsets of Th cells by therapeutic compounds dramatically reduced bacterial burden in different organs. This treatment was associated with the generation of protective Th1 immune responses. As these therapeutic agents are not directed to the harbored organisms, they should avoid the risk of promoting the development of drug-resistant M. tuberculosis variants.	[Bhattacharya, Debapriya; Dwivedi, Ved Prakash; Das, Gobardhan] Univ Kwazulu Natal, Coll Hlth Sci, Lab Med & Med Sci, ZA-4001 Durban, South Africa; [Maiga, Mamoudou; Maiga, Mariama; Bishai, William R.] Johns Hopkins Univ, Dept Med, Ctr TB Res, Baltimore, MD 21231 USA; [Van Kaer, Luc] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	University of Kwazulu Natal; Johns Hopkins University; Vanderbilt University	Das, G (corresponding author), Jawaharlal Neheru Univ, Special Ctr Mol Med, New Delhi 110067, India.	gobardhan.das07@gmail.com	Van Kaer, Luc/H-1033-2015	Van Kaer, Luc/0000-0001-5275-2309; Dwivedi, Ved Prakash/0000-0003-4321-2567	Wellcome Trust; Department of Biotechnology India Alliance; Department of Biotechnology; Council for Scientific and Industrial research-Open Source Drug Discovery (CSIR-OSDD) program Government of India; College of Health Sciences, University of KwaZulu Natal (Durban, South Africa)	Wellcome Trust(Wellcome TrustEuropean Commission); Department of Biotechnology India Alliance(Wellcome Trust DBT India Alliance); Department of Biotechnology; Council for Scientific and Industrial research-Open Source Drug Discovery (CSIR-OSDD) program Government of India; College of Health Sciences, University of KwaZulu Natal (Durban, South Africa)	This work was supported by grants from The Wellcome Trust, Department of Biotechnology India Alliance, Department of Biotechnology, Council for Scientific and Industrial research-Open Source Drug Discovery (CSIR-OSDD) program Government of India, and College of Health Sciences, University of KwaZulu Natal (Durban, South Africa).	Agger EM, 2001, VACCINE, V19, P2298, DOI 10.1016/S0264-410X(00)00519-3; BARNES PF, 1991, NEW ENGL J MED, V324, P1644, DOI 10.1056/NEJM199106063242307; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; Callahan JF, 2002, J MED CHEM, V45, P999, DOI 10.1021/jm010493y; Chen WJ, 2010, J MOL CELL BIOL, V2, P30, DOI 10.1093/jmcb/mjp004; CHENSUE SW, 1994, AM J PATHOL, V145, P1105; Demissie A, 2004, J IMMUNOL, V172, P6938, DOI 10.4049/jimmunol.172.11.6938; Dlugovitzky D, 1999, RESP MED, V93, P557, DOI 10.1016/S0954-6111(99)90155-5; Elo LL, 2010, IMMUNITY, V32, P852, DOI 10.1016/j.immuni.2010.06.011; Fenhalls G, 2000, INFECT IMMUN, V68, P2827, DOI 10.1128/IAI.68.5.2827-2836.2000; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Henneekes H., 2002, CURR MED CHEM ANTIIN, P41; Hernandez-Pando R, 2004, EUR J IMMUNOL, V34, P174, DOI 10.1002/eji.200324253; Jayaswal S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000839; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Kurokawa M, 2001, MEDIAT INFLAMM, V10, P333, DOI 10.1080/09629350120102352; Lienhardt C, 2002, EUR J IMMUNOL, V32, P1605, DOI 10.1002/1521-4141(200206)32:6<1605::AID-IMMU1605>3.0.CO;2-6; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Oda N, 1999, LIFE SCI, V65, P763, DOI 10.1016/S0024-3205(99)00303-3; Oertelt S, 2006, J IMMUNOL, V177, P1655, DOI 10.4049/jimmunol.177.3.1655; Ordway Diane J, 2005, Acta Med Port, V18, P27; Peng YF, 2004, P NATL ACAD SCI USA, V101, P4572, DOI 10.1073/pnas.0400810101; Raghuvanshi S, 2010, P NATL ACAD SCI USA, V107, P21653, DOI 10.1073/pnas.1007967107; Randolph DA, 2006, ANNU REV MED, V57, P381, DOI 10.1146/annurev.med.57.121304.131337; Rook GAW, 2005, NAT REV IMMUNOL, V5, P661, DOI 10.1038/nri1666; Rook GAW, 2004, TRENDS IMMUNOL, V25, P483, DOI 10.1016/j.it.2004.06.005; Rook GAW, 1996, ANNU REV MICROBIOL, V50, P259, DOI 10.1146/annurev.micro.50.1.259; Roy E, 2008, TUBERCULOSIS, V88, P197, DOI [10.1016/j.tube.2007.11.005, 10.1016/S1472-9792(08)70011-8]; Scott-Browne JP, 2007, J EXP MED, V204, P2159, DOI 10.1084/jem.20062105; Seah GT, 2000, J INFECT DIS, V181, P385, DOI 10.1086/315200; Shafiani S, 2013, IMMUNITY, V38, P1261, DOI 10.1016/j.immuni.2013.06.003; SNIDER DE, 1992, NEW ENGL J MED, V326, P703, DOI 10.1056/NEJM199203053261011; Sweeney KA, 2011, NAT MED, V17, P1261, DOI 10.1038/nm.2420; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Toossi Z, 1998, CLIN IMMUNOL IMMUNOP, V87, P107, DOI 10.1006/clin.1998.4528; van der Werf N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003215; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	41	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16508	16515		10.1074/jbc.M114.558098	http://dx.doi.org/10.1074/jbc.M114.558098			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24711459	Green Published, hybrid			2022-12-25	WOS:000337965700052
J	Larimore, J; Zlatic, SA; Gokhale, A; Tornieri, K; Singleton, KS; Mullin, AP; Tang, JX; Talbot, K; Faundez, V				Larimore, Jennifer; Zlatic, Stephanie A.; Gokhale, Avanti; Tornieri, Karine; Singleton, Kaela S.; Mullin, Ariana P.; Tang, Junxia; Talbot, Konrad; Faundez, Victor			Mutations in the BLOC-1 Subunits Dysbindin and Muted Generate Divergent and Dosage-dependent Phenotypes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Adaptor Proteins; Mouse Genetics; Protein Complexes; Schizophrenia; Synapses	HERMANSKY-PUDLAK-SYNDROME; LYSOSOME-RELATED ORGANELLES; SCHIZOPHRENIA SUSCEPTIBILITY GENE; WORKING-MEMORY; HEALTHY-INDIVIDUALS; BRAIN-DYSFUNCTION; PROTEIN COMPLEXES; MUTANT MICE; MOUSE MODEL; SNAPIN	Background: Genetic defects affecting subunits of protein complexes are presumed to generate identical diseases in mammals. Results: Two mouse mutants in genes belonging to the BLOC-1 complex have divergent brain and pigmentation phenotypes. Conclusion: Genetic defects affecting subunits of a complex manifest by partially overlapping clinical features. Significance: Disease resulting from mutations in protein complexes may generate a wide range of clinically presentations. Post-mortem analysis has revealed reduced levels of the protein dysbindin in the brains of those suffering from the neurodevelopmental disorder schizophrenia. Consequently, mechanisms controlling the cellular levels of dysbindin and its interacting partners may participate in neurodevelopmental processes impaired in that disorder. To address this question, we studied loss of function mutations in the genes encoding dysbindin and its interacting BLOC-1 subunits. We focused on BLOC-1 mutants affecting synapse composition and function in addition to their established systemic pigmentation, hematological, and lung phenotypes. We tested phenotypic homogeneity and gene dosage effects in the mouse null alleles muted (Bloc1s5(mu/mu)) and dysbindin (Bloc1s8(sdy/sdy)). Transcripts of NMDA receptor subunits and GABAergic interneuron markers, as well as expression of BLOC-1 subunit gene products, were affected differently in the brains of Bloc1s5(mu/mu) and Bloc1s8(sdy/sdy) mice. Unlike Bloc1s8(sdy/sdy), elimination of one or two copies of Bloc1s5 generated indistinguishable pallidin transcript phenotypes. We conclude that monogenic mutations abrogating the expression of a protein complex subunit differentially affect the expression of other complex transcripts and polypeptides as well as their downstream effectors. We propose that the genetic disruption of different subunits of protein complexes and combinations thereof diversifies phenotypic presentation of pathway deficiencies, contributing to the wide phenotypic spectrum and complexity of neurodevelopmental disorders.	[Larimore, Jennifer; Singleton, Kaela S.] Agnes Scott Coll, Dept Biol, Decatur, GA 30030 USA; [Zlatic, Stephanie A.; Gokhale, Avanti; Tornieri, Karine; Mullin, Ariana P.; Faundez, Victor] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA; [Faundez, Victor] Emory Univ, Ctr Social Translat Neurosci, Atlanta, GA 30322 USA; [Tang, Junxia] Univ Penn, Dept Psychiat, Ctr Neurobiol & Behav, Philadelphia, PA 19104 USA; [Talbot, Konrad] Cedars Sinai Med Ctr, Dept Neurosurg, Los Angeles, CA 90048 USA	Emory University; Emory University; University of Pennsylvania; Pennsylvania Medicine; Cedars Sinai Medical Center	Faundez, V (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.	vfaunde@emory.edu		Zlatic, Stephanie/0000-0003-0758-9500; Faundez, Victor/0000-0002-2114-5271; Singleton, Kaela/0000-0003-2610-5890; Talbot, Konrad/0000-0003-4549-0835	National Institutes of Health [GM077569, NS42599, R01 MH072880, PP MH064045]; Emory University Integrated Cellular Imaging Microscopy Core and Viral Cores of the Emory Neuroscience NINDS Core Facilities [P30NS055077]; Children's Hospital of Atlanta (CHOA) Children's Center for Neuroscience; NIEHS, National Institutes of Health [T32 1P50NS071669]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH072880, P50MH064045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS071669, P30NS055077, R01NS042599, R56NS042599] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emory University Integrated Cellular Imaging Microscopy Core and Viral Cores of the Emory Neuroscience NINDS Core Facilities; Children's Hospital of Atlanta (CHOA) Children's Center for Neuroscience; NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM077569 and NS42599 (to V. F.), R01 MH072880 and PP MH064045 (to K. T.), and Emory University Integrated Cellular Imaging Microscopy Core and Viral Cores of the Emory Neuroscience NINDS Core Facilities Grant P30NS055077. This work was also supported by funds from the Children's Hospital of Atlanta (CHOA) Children's Center for Neuroscience (to V. F.).; Supported by Graduate and Postdoctoral Training in Toxicology Training Grant T32 1P50NS071669 from the NIEHS, National Institutes of Health.	Ayalew M, 2012, MOL PSYCHIATR, V17, P887, DOI 10.1038/mp.2012.37; Bassett AS, 2010, AM J PSYCHIAT, V167, P899, DOI 10.1176/appi.ajp.2009.09071016; Birchler JA, 2012, P NATL ACAD SCI USA, V109, P14746, DOI 10.1073/pnas.1207726109; Bray NJ, 2005, HUM MOL GENET, V14, P1947, DOI 10.1093/hmg/ddi199; Carlson GC, 2011, P NATL ACAD SCI USA, V108, pE962, DOI 10.1073/pnas.1109625108; Carlsson A, 2001, ANNU REV PHARMACOL, V41, P237, DOI 10.1146/annurev.pharmtox.41.1.237; Cerasa A, 2011, NEUROIMAGE, V55, P508, DOI 10.1016/j.neuroimage.2010.12.042; Cheli VT, 2010, HUM MOL GENET, V19, P861, DOI 10.1093/hmg/ddp555; Chen M, 2005, MOL BIOL CELL, V16, P5103, DOI 10.1091/mbc.E05-02-0165; Ciciotte SL, 2003, BLOOD, V101, P4402, DOI 10.1182/blood-2003-01-0020; Cox MM, 2009, GENES BRAIN BEHAV, V8, P390, DOI 10.1111/j.1601-183X.2009.00477.x; Craddock N, 2010, BRIT J PSYCHIAT, V196, P92, DOI 10.1192/bjp.bp.109.073429; Davis GW, 2013, NEURON, V80, P718, DOI 10.1016/j.neuron.2013.09.044; Dell'Angelica EC, 1999, MOL CELL, V3, P11, DOI 10.1016/S1097-2765(00)80170-7; Dell'Angelica EC, 2009, CURR OPIN CELL BIOL, V21, P552, DOI 10.1016/j.ceb.2009.04.014; Dickman DK, 2012, J NEUROSCI, V32, P8716, DOI 10.1523/JNEUROSCI.5465-11.2012; Dickman DK, 2009, SCIENCE, V326, P1127, DOI 10.1126/science.1179685; Doherty JL, 2012, CLIN GENET, V81, P103, DOI 10.1111/j.1399-0004.2011.01773.x; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Ghiani CA, 2010, MOL PSYCHIATR, V15, P204, DOI 10.1038/mp.2009.58; Ghiani CA, 2011, ASN NEURO, V3, DOI 10.1042/AN20110010; Gokhale A, 2012, J NEUROSCI, V32, P3697, DOI 10.1523/JNEUROSCI.5640-11.2012; Gonzalez-Burgos G, 2012, SCHIZOPHRENIA BULL, V38, P950, DOI 10.1093/schbul/sbs010; Gwynn B, 2004, BLOOD, V104, P3181, DOI 10.1182/blood-2004-04-1538; Hoyle DJ, 2011, PIGM CELL MELANOMA R, V24, P275, DOI 10.1111/j.1755-148X.2010.00815.x; Huang LP, 1999, NAT GENET, V23, P329, DOI 10.1038/15507; Jentsch JD, 2009, NEUROPSYCHOPHARMACOL, V34, P2601, DOI 10.1038/npp.2009.90; Jia D, 2010, P NATL ACAD SCI USA, V107, P10442, DOI 10.1073/pnas.0913293107; Karayiorgou M, 2010, NAT REV NEUROSCI, V11, P402, DOI 10.1038/nrn2841; Karlsgodt KH, 2011, BIOL PSYCHIAT, V69, P28, DOI 10.1016/j.biopsych.2010.09.012; Larimore J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065069; Larimore J, 2011, MOL BIOL CELL, V22, P4854, DOI 10.1091/mbc.E11-07-0592; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Liodis P, 2007, J NEUROSCI, V27, P3078, DOI 10.1523/JNEUROSCI.3055-06.2007; Locke M, 2009, HUM MOL GENET, V18, P2344, DOI 10.1093/hmg/ddp167; Luciano M, 2009, GENES BRAIN BEHAV, V8, P218, DOI 10.1111/j.1601-183X.2008.00462.x; Malhotra D, 2012, CELL, V148, P1223, DOI 10.1016/j.cell.2012.02.039; Markov V, 2009, NEUROIMAGE, V47, P2016, DOI 10.1016/j.neuroimage.2009.05.067; Markov V, 2010, HUM BRAIN MAPP, V31, P266, DOI 10.1002/hbm.20862; Mechelli A, 2010, NEUROIMAGE, V49, P817, DOI 10.1016/j.neuroimage.2009.07.030; Moreno-De-Luca A, 2013, LANCET NEUROL, V12, P423, DOI 10.1016/S1474-4422(13)70011-5; Mullin AP, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.108; Mullin AP, 2011, MOL NEUROBIOL, V44, P53, DOI 10.1007/s12035-011-8183-3; Newell-Litwa K, 2010, J NEUROSCI, V30, P820, DOI 10.1523/JNEUROSCI.3400-09.2010; Newell-Litwa K, 2009, MOL BIOL CELL, V20, P1441, DOI 10.1091/mbc.E08-05-0456; Pan PY, 2009, NEURON, V61, P412, DOI 10.1016/j.neuron.2008.12.029; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Rapoport JL, 2012, MOL PSYCHIATR, V17, P1228, DOI 10.1038/mp.2012.23; Ruder C, 2005, MOL BIOL CELL, V16, P1245, DOI 10.1091/mbc.E04-09-0817; Saggu S, 2013, SCHIZOPHR RES, V146, P254, DOI 10.1016/j.schres.2013.01.037; Shao LS, 2011, P NATL ACAD SCI USA, V108, P18831, DOI 10.1073/pnas.1114569108; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Talbot K, 2009, HANDBOOK OF NEUROCHEMISTRY AND MOLECULAR NEUROBIOLOGY: SCHIZOPHRENIA, THIRD EDITION, P107, DOI 10.1007/978-0-387-30410-6_2.2; Talbot K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016886; Tang TTT, 2009, P NATL ACAD SCI USA, V106, P21395, DOI 10.1073/pnas.0910499106; Tognin S, 2011, J CHILD PSYCHOL PSYC, V52, P1287, DOI 10.1111/j.1469-7610.2011.02427.x; Tricoire L, 2011, J NEUROSCI, V31, P10948, DOI 10.1523/JNEUROSCI.0323-11.2011; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Van Den Bogaert A, 2003, AM J HUM GENET, V73, P1438, DOI 10.1086/379928; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; Veitia RA, 2008, TRENDS GENET, V24, P390, DOI 10.1016/j.tig.2008.05.005; Wei ML, 2006, PIGM CELL RES, V19, P19, DOI 10.1111/j.1600-0749.2005.00289.x; Winden KD, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.46; Wolf C, 2011, MOL PSYCHIATR, V16, P145, DOI 10.1038/mp.2009.129; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Yang Q, 2012, TRAFFIC, V13, P1160, DOI 10.1111/j.1600-0854.2012.01375.x; Ye X, 2014, CELL REP, V6, P24, DOI 10.1016/j.celrep.2013.12.008; Zhang Q, 2002, HUM MOL GENET, V11, P697, DOI 10.1093/hmg/11.6.697; Zhou B, 2012, CELL REPORTS, V2, P42, DOI 10.1016/j.celrep.2012.06.010	75	28	28	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14291	14300		10.1074/jbc.M114.553750	http://dx.doi.org/10.1074/jbc.M114.553750			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24713699	Green Published, hybrid			2022-12-25	WOS:000335984600054
J	Chen, XH; Motani, R; Cheng, L; Jiang, DY; Rieppel, O				Chen, Xiao-Hong; Motani, Ryosuke; Cheng, Long; Jiang, Da-yong; Rieppel, Olivier			A Carapace-Like Bony 'Body Tube' in an Early Triassic Marine Reptile and the Onset of Marine Tetrapod Predation	PLOS ONE			English	Article							TURTLE; SAUROPTERYGIA; EVOLUTION; ORIGIN; CHINA; ICHTHYOSAUR; VENTILATION; SKELETON; MUSCLE	Parahupehsuchus longus is a new species of marine reptile from the Lower Triassic of Yuan'an County, Hubei Province, China. It is unique among vertebrates for having a body wall that is completely surrounded by a bony tube, about 50 cm long and 6.5 cm deep, comprising overlapping ribs and gastralia. This tube and bony ossicles on the back are best interpreted as anti-predatory features, suggesting that there was predation pressure upon marine tetrapods in the Early Triassic. There is at least one sauropterygian that is sufficiently large to feed on Parahupehsuchus in the Nanzhang-Yuan'an fauna, together with six more species of potential prey marine reptiles with various degrees of body protection. Modern predators of marine tetrapods belong to the highest trophic levels in the marine ecosystem but such predators did not always exist through geologic time. The indication of marine-tetrapod feeding in the Nanzhang-Yuan'an fauna suggests that such a trophic level emerged for the first time in the Early Triassic. The recovery from the end-Permian extinction probably proceeded faster than traditionally thought for marine predators. Parahupehsuchus has superficially turtle-like features, namely expanded ribs without intercostal space, very short transverse processes, and a dorsal outgrowth from the neural spine. However, these features are structurally different from their turtle counterparts. Phylogeny suggests that they are convergent with the condition in turtles, which has a fundamentally different body plan that involves the folding of the body wall. Expanded ribs without intercostal space evolved at least twice and probably even more among reptiles.	[Chen, Xiao-Hong; Cheng, Long] Wuhan Ctr China Geol Survey, Wuhan, Hubei, Peoples R China; [Motani, Ryosuke] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Jiang, Da-yong] Peking Univ, Dept Geol, Minist Educ, Lab Orogen Belt & Crustal Evolut, Beijing 100871, Peoples R China; [Jiang, Da-yong] Peking Univ, Geol Museum, Beijing 100871, Peoples R China; [Rieppel, Olivier] Field Museum, Ctr Integrat Res, Chicago, IL USA	China Geological Survey; University of California System; University of California Davis; Peking University; Peking University; Field Museum of Natural History (Chicago)	Motani, R (corresponding author), Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA.	rmotani@ucdavis.edu	Motani, Ryosuke/K-2607-2015	Motani, Ryosuke/0000-0001-5022-1053	China Geological Survey Project [1212010611603, 1212011120148]; National Natural Science Foundation of China [40920124002, 41372016]	China Geological Survey Project(China Geological Survey); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the China Geological Survey Project 1212010611603 to Xiao-hong Chen, the China Geological Survey Projects 1212011120148 to Long Cheng, and the National Natural Science Foundation of China Projects 40920124002 and 41372016 to Da-yong Jiang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carroll RL, 1991, PHILOS T R SOC B, V28, P131; Chen XH, 2013, ACTA GEOL SIN-ENGL, V87, P672, DOI 10.1111/1755-6724.12078; Chen ZQ, 2012, NAT GEOSCI, V5, P375, DOI [10.1038/NGEO1475, 10.1038/ngeo1475]; Cheng L, 2012, J EARTH SCI-CHINA, V23, P33, DOI 10.1007/s12583-012-0231-z; Collin Rachel, 1997, P451, DOI 10.1016/B978-012155210-7/50024-7; DEBUFFRENIL V, 1985, ZOOMORPHOLOGY, V105, P336, DOI 10.1007/BF00312066; DEBUFFRENIL V, 1990, PALEOBIOLOGY, V16, P435, DOI 10.1017/S0094837300010174; Frobisch NB, 2013, P NATL ACAD SCI USA, V110, P1393, DOI 10.1073/pnas.1216750110; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Hirasawa T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3107; Hoffstetter R., 1969, P201; Holz M, 1999, J AFR EARTH SCI, V29, P51, DOI 10.1016/S0899-5362(99)00079-2; Houssaye A, 2009, INTEGR ZOOL, V4, P325, DOI 10.1111/j.1749-4877.2009.00146.x; Kim SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030501, 10.1371/journal.pone.0045068]; LAURENTI JN, SPECIMEN MEDICUM EXH; Li C, 2008, NATURE, V456, P497, DOI 10.1038/nature07533; Li C, 2014, GEOL MAG, V151, P100, DOI 10.1017/S001675681300023X; Li Jin-Ling, 2002, Vertebrata Palasiatica, V40, P241; Lyson TR, 2013, CURR BIOL, V23, P1113, DOI 10.1016/j.cub.2013.05.003; Motani Ryosuke., 2009, Evolution Education and Outreach, V2, P224; Munns SL, 2012, J EXP BIOL, V215, P845, DOI 10.1242/jeb.061952; Nagashima H, 2009, SCIENCE, V325, P193, DOI 10.1126/science.1173826; Newsome SD, 2010, MAR MAMMAL SCI, V26, P509, DOI 10.1111/j.1748-7692.2009.00354.x; Newsome SD, 2009, MAR ECOL PROG SER, V374, P229, DOI 10.3354/meps07747; Osborn HF, 1903, REPTILIAN SUBCLASSES, P449; Piscitelli MA, 2013, J MORPHOL, V274, P1425, DOI 10.1002/jmor.20192; Rieppel O, 1998, J VERTEBR PALEONTOL, V18, P545, DOI 10.1080/02724634.1998.10011082; Romer AS, 1956, OSTEOLOGY REPTILES, Vxxi; Rossmann T, 2002, NEUES JAHRB GEOL P-A, V224, P197; Ruben JA, 1997, SCIENCE, V278, P1267, DOI 10.1126/science.278.5341.1267; Schachner ER, 2011, ANAT REC, V294, P1532, DOI 10.1002/ar.21439; Scheyer TM, 2010, PALAEONTOL ELECTRON, V13; WALL WP, 1983, J PALEONTOL, V57, P197; Wang K., 1959, Acta Palaeontologica Sinica, V7, P367; Weishampel D.B., 2004, DINOSAURIA, Vxviii; Wu XC, 2003, NATURE, V426, P516, DOI 10.1038/426516a; Young C. c., 1965, Vertebrata Palasiatica, V9, P315; Young CC, 1972, AQUATIC REPTILES TRI, P17; Young CC, 1972, AQUATIC REPTILES TRI, P28	39	19	24	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94396	10.1371/journal.pone.0094396	http://dx.doi.org/10.1371/journal.pone.0094396			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718682	gold, Green Published, Green Submitted			2022-12-25	WOS:000334339000116
J	Wang, AY; Nie, WY; Li, HX; Hou, YH; Yu, Z; Fan, Q; Sun, RP				Wang, Aiyun; Nie, Wenying; Li, Haixia; Hou, Yuhua; Yu, Zhen; Fan, Qing; Sun, Ruopeng			Epigenetic Upregulation of Corticotrophin-Releasing Hormone Mediates Postnatal Maternal SeparationInduced Memory Deficiency	PLOS ONE			English	Article							EARLY-LIFE STRESS; LONG-TERM POTENTIATION; CPG-BINDING-PROTEIN; ENVIRONMENTAL ENRICHMENT; MOUSE HIPPOCAMPUS; DNA METHYLATION; SYNAPTIC PLASTICITY; HISTONE DEACETYLASE; FACTOR RECEPTORS; BDNF EXPRESSION	Accumulating evidences demonstrated that early postnatal maternal separation induced remarkable social and memory defects in the adult rodents. Early-life stress induced long-lasting functional adaptation of neuroendocrine hypothalamic-pituitary- adrenal axis, including neuropeptide corticotrophin- releasing hormone (CRH) in the brain. In the present study, a significantly increased hippocampal CRH was observed in the adult rats with postnatal maternal separation, and blockade of CRHR1 signaling significantly attenuated the hippocampal synaptic dysfunction and memory defects in the modeled rats. Postnatal maternal separation enduringly increased histone H3 acetylation and decreased cytosine methylation in Crh promoter region, resulting from the functional adaptation of several transcriptional factors, in the hippocampal CA1 of the modeled rats. Enriched environment reversed the epigenetic upregulation of CRH, and ameliorated the hippocampal synaptic dysfunction and memory defects in the adult rats with postnatal maternal separation. This study provided novel insights into the epigenetic mechanism underlying postnatal maternal separation- induced memory deficiency, and suggested environment enrichment as a potential approach for the treatment of this disorder.	[Wang, Aiyun; Nie, Wenying; Li, Haixia; Hou, Yuhua; Yu, Zhen; Fan, Qing; Sun, Ruopeng] Shandong Univ, Qilu Hosp, Dept Pediat, Jinan, Shandong, Peoples R China	Shandong University	Sun, RP (corresponding author), Shandong Univ, Qilu Hosp, Dept Pediat, Jinan, Shandong, Peoples R China.	rpsun01@163.com						Arai JA, 2011, BRAIN RES BULL, V85, P30, DOI 10.1016/j.brainresbull.2010.11.003; Blank T, 2003, J NEUROSCI, V23, P700, DOI 10.1523/JNEUROSCI.23-02-00700.2003; Blank T, 2002, J NEUROSCI, V22, P3788; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Branchi I, 2011, NEUROSCI LETT, V495, P168, DOI 10.1016/j.neulet.2011.03.038; Champagne FA, 2007, BEHAV NEUROSCI, V121, P1353, DOI 10.1037/0735-7044.121.6.1353; Chen J, 2012, J NEUROENDOCRINOL, V24, P1055, DOI 10.1111/j.1365-2826.2012.02306.x; Chen Y, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00013; Diehl LA, 2014, NEUROCHEM RES, V39, P384, DOI 10.1007/s11064-013-1230-x; Dong E, 2007, P NATL ACAD SCI USA, V104, P4676, DOI 10.1073/pnas.0700529104; Elliott E, 2010, NAT NEUROSCI, V13, P1351, DOI 10.1038/nn.2642; Faherty CJ, 2003, DEV BRAIN RES, V141, P55, DOI 10.1016/S0165-3806(02)00642-9; Feng JA, 2010, NAT NEUROSCI, V13, P1039, DOI 10.1038/nn0910-1039; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Hauger RL, 2009, ANN NY ACAD SCI, V1179, P120, DOI 10.1111/j.1749-6632.2009.05011.x; Hollrigel GS, 1998, NEUROSCIENCE, V84, P71, DOI 10.1016/S0306-4522(97)00499-5; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Ivy AS, 2010, J NEUROSCI, V30, P13005, DOI 10.1523/JNEUROSCI.1784-10.2010; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kimura H, 2003, J BIOL CHEM, V278, P4806, DOI 10.1074/jbc.M209923200; Kuzumaki N, 2011, HIPPOCAMPUS, V21, P127, DOI 10.1002/hipo.20775; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Levine A, 2012, NEUROBIOL DIS, V45, P488, DOI 10.1016/j.nbd.2011.09.005; Lian SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080638; Liu L, 2013, J BIOL CHEM, V288, P34719, DOI 10.1074/jbc.M113.506568; Lowery EG, 2010, NEUROPSYCHOPHARMACOL, V35, P1241, DOI 10.1038/npp.2009.209; Maras PM, 2012, TRENDS NEUROSCI, V35, P315, DOI 10.1016/j.tins.2012.01.005; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Morley-Fletcher S, 2003, EUR J NEUROSCI, V18, P3367, DOI 10.1111/j.1460-9568.2003.03070.x; Mueller BR, 2008, J NEUROSCI, V28, P9055, DOI 10.1523/JNEUROSCI.1424-08.2008; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Mychasiuk R, 2012, BEHAV BRAIN RES, V228, P294, DOI 10.1016/j.bbr.2011.11.036; Na ES, 2013, NEUROPSYCHOPHARMACOL, V38, P212, DOI 10.1038/npp.2012.116; Neigh GN, 2013, NEUROSCIENCE, V249, P139, DOI 10.1016/j.neuroscience.2012.09.075; Nithianantharajah J, 2004, NEUROBIOL LEARN MEM, V81, P200, DOI 10.1016/j.nlm.2004.02.002; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Ouyang HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062192; Perrin MH, 1999, ANN NY ACAD SCI, V885, P312, DOI 10.1111/j.1749-6632.1999.tb08687.x; Pita-Almenar JD, 2012, LEARN MEMORY, V19, P615, DOI 10.1101/lm.023259.111; Provencal N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071691; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Refojo D, 2011, SCIENCE, V333, P1903, DOI 10.1126/science.1202107; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Row BW, 2008, NEUROBIOL LEARN MEM, V89, P370, DOI 10.1016/j.nlm.2007.10.008; Sabatino L, 2012, ONCOGENE, V31, P5061, DOI 10.1038/onc.2012.3; Shipton OA, 2011, J NEUROSCI, V31, P1688, DOI 10.1523/JNEUROSCI.2610-10.2011; Shum FWF, 2007, LEARN MEMORY, V14, P304, DOI 10.1101/lm.530607; Skwara AJ, 2012, BEHAV BRAIN RES, V234, P1, DOI 10.1016/j.bbr.2012.06.003; Smith GK, 2014, HIPPOCAMPUS, V24, P354, DOI 10.1002/hipo.22229; Suri D, 2013, BIOL PSYCHIAT, V73, P658, DOI 10.1016/j.biopsych.2012.10.023; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Tao JF, 2009, P NATL ACAD SCI USA, V106, P4882, DOI 10.1073/pnas.0811648106; Thompson WR, 1954, CAN J PSYCHOLOGY, V8, P17, DOI 10.1037/h0083595; Tillerson JL, 2003, NEUROSCIENCE, V119, P899, DOI 10.1016/S0306-4522(03)00096-4; Typlt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081270; Valentino RJ, 2013, MOL PHARMACOL, V83, P737, DOI 10.1124/mol.112.083550; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wang HL, 1998, EUR J NEUROSCI, V10, P3428, DOI 10.1046/j.1460-9568.1998.00352.x; Wang XD, 2013, NAT NEUROSCI, V16, P706, DOI 10.1038/nn.3395; Xie L, 2013, J NEUROCHEM, V125, P457, DOI 10.1111/jnc.12210; Yoon HG, 2003, MOL CELL, V12, P723, DOI 10.1016/j.molcel.2003.08.008; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	64	41	44	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94394	10.1371/journal.pone.0094394	http://dx.doi.org/10.1371/journal.pone.0094394			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718660	gold, Green Published, Green Submitted			2022-12-25	WOS:000334339000115
J	Zhang, Z; Zhang, Y; Mou, Z; Chu, SF; Chen, XY; He, WB; Guo, XF; Yuan, YH; Takahashi, M; Chen, NH				Zhang, Zhao; Zhang, Yun; Mou, Zheng; Chu, Shifeng; Chen, Xiaoyu; He, Wenbin; Guo, Xiaofeng; Yuan, Yuhe; Takahashi, Masami; Chen, Naihong			Tyrosine 402 Phosphorylation of Pyk2 Is Involved in Ionomycin-Induced Neurotransmitter Release	PLOS ONE			English	Article							FOCAL ADHESION KINASE; ACTIVATED PROTEIN-KINASE; TRANSMITTER RELEASE; SYNAPTIC VESICLES; CEREBRAL-ISCHEMIA; SIGNALING EVENTS; NERVOUS-SYSTEM; SRC; PYK2/CAK-BETA; FAK	Protein tyrosine kinases, which are highly expressed in the central nervous system, are implicated in many neural processes. However, the relationship between protein tyrosine kinases and neurotransmitter release remains unknown. In this study, we found that ionomycin, a Ca2+ ionophore, concurrently induced asynchronous neurotransmitter release and phosphorylation of a non-receptor protein tyrosine kinase, proline-rich tyrosine kinase 2 (Pyk2), in clonal rat pheochromocytoma PC12 cells and cerebellar granule cells, whereas introduction of Pyk2 siRNA dramatically suppressed ionomycin-induced neurotransmitter release. Further study indicated that Tyr-402 (Y402) in Pyk2, instead of other tyrosine sites, underwent rapid phosphorylation after ionomycin induction in 1 min to 2 min. We demonstrated that the mutant of Pyk2 Y402 could abolish ionomycin-induced dopamine (DA) release by transfecting cells with recombinant Pyk2 and its mutants (Y402F, Y579F, Y580F, and Y881F). In addition, Src inhibition could prolong phosphorylation of Pyk2 Y402 and increase DA release. These findings suggested that Pyk2 was involved in ionomycin-induced neurotransmitter release through phosphorylation of Y402.	[Zhang, Zhao; Zhang, Yun; Mou, Zheng; Chu, Shifeng; Chen, Xiaoyu; He, Wenbin; Yuan, Yuhe; Chen, Naihong] Chinese Acad Sci, Inst Mat Med, Dept Pharmacol,State Key Lab Bioact Subst & Funct, Beijing Key Lab New Drug Mech & Pharmacol Evaluat, Beijing, Peoples R China; [Zhang, Zhao; Zhang, Yun; Mou, Zheng; Chu, Shifeng; Chen, Xiaoyu; He, Wenbin; Yuan, Yuhe; Chen, Naihong] Chinese Acad Sci, Ctr Neurosci, Beijing, Peoples R China; [Zhang, Zhao; Zhang, Yun; Mou, Zheng; Chu, Shifeng; Chen, Xiaoyu; He, Wenbin; Yuan, Yuhe; Chen, Naihong] Peking Union Med Coll, Beijing 100021, Peoples R China; [He, Wenbin; Guo, Xiaofeng] Shanxi Univ Tradit Chinese Med, Basic Med Coll, Taiyuan, Peoples R China; [Takahashi, Masami] Kitasato Univ, Sch Med, Dept Biochem, Sagamihara, Kanagawa 228, Japan	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Kitasato University	Takahashi, M (corresponding author), Kitasato Univ, Sch Med, Dept Biochem, Sagamihara, Kanagawa 228, Japan.	masami@med.kitasato-u.ac.jp; chennh@imm.ac.cn			National Natural Science Foundation of China [81274122, 81073078, 81001487, 81373510, 81373998, 90713045]; National Key Sci-Tech Major Special Item [2012ZX09301002-004, 2012ZX09103101-006]; National 863 Program of China [2012AA020303]; Program for Changjiang Scholars and Innovative Research Team in University [IRT1007]; Beijing Natural Science Foundation [7131013]; Research Fund for the Doctoral Program of Higher Education of China [20121106130001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Sci-Tech Major Special Item; National 863 Program of China(National High Technology Research and Development Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by grants from the National Natural Science Foundation of China Grants (No. 81274122, No. 81073078, No. 81001487, No. 81373510, No. 81373998, Key Program No. 90713045), National Key Sci-Tech Major Special Item (No. 2012ZX09301002-004, No. 2012ZX09103101-006), National 863 Program of China (No. 2012AA020303), Program for Changjiang Scholars and Innovative Research Team in University (No. IRT1007), the Beijing Natural Science Foundation (7131013), and the Research Fund for the Doctoral Program of Higher Education of China (20121106130001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atluri PP, 1998, J NEUROSCI, V18, P8214; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; AVRAHAM S, 1995, J BIOL CHEM, V270, P27742, DOI 10.1074/jbc.270.46.27742; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; Bruzzaniti A, 2009, MOL CELL BIOL, V29, P3644, DOI 10.1128/MCB.00851-08; BURGAYA F, 1995, EUR J NEUROSCI, V7, P1810, DOI 10.1111/j.1460-9568.1995.tb00700.x; Cheung HH, 2000, J CEREBR BLOOD F MET, V20, P505, DOI 10.1097/00004647-200003000-00009; Cummings DD, 1996, J NEUROSCI, V16, P5312; Derkinderen P, 1998, EUR J NEUROSCI, V10, P1667, DOI 10.1046/j.1460-9568.1998.00174.x; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Girault JA, 1999, TRENDS NEUROSCI, V22, P257, DOI 10.1016/S0166-2236(98)01358-7; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Gurd JW, 1997, NEUROCHEM INT, V31, P635, DOI 10.1016/S0197-0186(97)00022-3; Gwag BJ, 1999, NEUROSCIENCE, V90, P1339, DOI 10.1016/S0306-4522(98)00508-9; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; Herzog H, 1996, GENOMICS, V32, P484, DOI 10.1006/geno.1996.0149; HIRANO AA, 1988, J NEUROCHEM, V50, P1447, DOI 10.1111/j.1471-4159.1988.tb03029.x; Huang YQ, 2001, NEURON, V29, P485, DOI 10.1016/S0896-6273(01)00220-3; HUNTER T, 1987, CELL, V50, P823, DOI 10.1016/0092-8674(87)90509-5; Ivankovic-Dikic I, 2000, NAT CELL BIOL, V2, P574, DOI 10.1038/35023515; Jensen K, 2000, BRAIN RES, V880, P198, DOI 10.1016/S0006-8993(00)02746-3; JESSELL TM, 1993, CELL, V72, P1, DOI 10.1016/S0092-8674(05)80025-X; Katagiri T, 2000, J BIOL CHEM, V275, P19645, DOI 10.1074/jbc.M909828199; Kirischuk S, 2003, J PHYSIOL-LONDON, V548, P753, DOI 10.1113/jphysiol.2002.037036; Lakkakorpi PT, 2003, J BIOL CHEM, V278, P11502, DOI 10.1074/jbc.M206579200; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Lim ST, 2009, J BIOL CHEM; Lipinski CA, 2010, EXPERT OPIN THER TAR, V14, P95, DOI 10.1517/14728220903473194; LLINAS R, 1995, NEUROPHARMACOLOGY, V34, P1443, DOI 10.1016/0028-3908(95)00150-5; Menegon A, 1999, EUR J NEUROSCI, V11, P3777, DOI 10.1046/j.1460-9568.1999.00798.x; Ohnishi H, 2001, P NATL ACAD SCI USA, V98, P10930, DOI 10.1073/pnas.191368198; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Pandey P, 1999, J BIOL CHEM, V274, P10140, DOI 10.1074/jbc.274.15.10140; Park SY, 2004, J BIOL CHEM, V279, P33315, DOI 10.1074/jbc.M313527200; Salgia R, 1996, J BIOL CHEM, V271, P31222, DOI 10.1074/jbc.271.49.31222; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; Sudhof TC, 2013, NEURON, V80, P675, DOI 10.1016/j.neuron.2013.10.022; Sun CK, 2008, CARCINOGENESIS, V29, P2096, DOI 10.1093/carcin/bgn203; Tian DH, 2000, J NEUROSCI, V20, P6478, DOI 10.1523/JNEUROSCI.20-17-06478.2000; Wright S, 2007, NEUROBIOL AGING, V28, P226, DOI 10.1016/j.neurobiolaging.2005.12.002; Yu H, 1996, J BIOL CHEM, V271, P29993, DOI 10.1074/jbc.271.47.29993	45	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94574	10.1371/journal.pone.0094574	http://dx.doi.org/10.1371/journal.pone.0094574			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718602	Green Published, Green Submitted, gold			2022-12-25	WOS:000334339000132
J	Bhattacharjee, K; Joshi, SR				Bhattacharjee, Kaushik; Joshi, Santa Ram			NEMiD: A Web-Based Curated Microbial Diversity Database with Geo-Based Plotting	PLOS ONE			English	Article							GRADIENTS; RESOURCE	The majority of the Earth's microbes remain unknown, and that their potential utility cannot be exploited until they are discovered and characterized. They provide wide scope for the development of new strains as well as biotechnological uses. The documentation and bioprospection of microorganisms carry enormous significance considering their relevance to human welfare. This calls for an urgent need to develop a database with emphasis on the microbial diversity of the largest untapped reservoirs in the biosphere. The data annotated in the North-East India Microbial database (NEMiD) were obtained by the isolation and characterization of microbes from different parts of the Eastern Himalayan region. The database was constructed as a relational database management system (RDBMS) for data storage in MySQL in the back-end on a Linux server and implemented in an Apache/PHP environment. This database provides a base for understanding the soil microbial diversity pattern in this megabiodiversity hotspot and indicates the distribution patterns of various organisms along with identification. The NEMiD database is freely available at www.mblabnehu.info/nemid/.	[Bhattacharjee, Kaushik; Joshi, Santa Ram] North Eastern Hill Univ, Dept Biotechnol & Bioinformat, Microbiol Lab, Shillong, Meghalaya, India	North Eastern Hill University	Joshi, SR (corresponding author), North Eastern Hill Univ, Dept Biotechnol & Bioinformat, Microbiol Lab, Shillong, Meghalaya, India.	srjoshi2006@yahoo.co.in	Joshi/F-2097-2015; Bhattacharjee, Dr. Kaushik/C-7676-2013	Bhattacharjee, Dr. Kaushik/0000-0002-2866-2239; Joshi, Santa Ram/0000-0001-8080-484X	Department of Electronics & Information Technology, Ministry of Communications & Information Technology, Government of India, New Delhi [DIT/R&D/BIO/15(14)/2008]	Department of Electronics & Information Technology, Ministry of Communications & Information Technology, Government of India, New Delhi	This work was funded by the Department of Electronics & Information Technology, Ministry of Communications & Information Technology, Government of India, New Delhi [Grant number No. DIT/R&D/BIO/15(14)/2008]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aithal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034613; Bedathur SJ, 2003, INFORM SYST, V28, P347, DOI 10.1016/S0306-4379(02)00073-X; Bhattacharjee K, 2012, BIOINFORMATION, V8, P548, DOI 10.6026/97320630008548; Bisby FA, 2000, SCIENCE, V289, P2309, DOI 10.1126/science.289.5488.2309; Chen T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq013; Demain AL, 2000, BIOTECHNOL ADV, V18, P499, DOI 10.1016/S0734-9750(00)00049-5; Devi Lamabam Sophiya, 2012, Mycobiology, V40, P151, DOI 10.5941/MYCO.2012.40.3.151; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Griffen AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019051; Guo AY, 2005, BIOINFORMATICS, V21, P2568, DOI 10.1093/bioinformatics/bti334; Holdener III A. T., 2008, AJAX DEFINITIVE GUID; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kumar A, 2010, CURR SCI INDIA, V99, P98; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Lyngwi NA, 2013, REV BIOL TROP, V61, P467; Mahe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043117; Majhi MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063083; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Triplet T, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq011; Ulrich LE, 2010, NUCLEIC ACIDS RES, V38, pD401, DOI 10.1093/nar/gkp940; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ware DH, 2002, PLANT PHYSIOL, V130, P1606, DOI 10.1104/pp.015248; Xu QF, 2006, BIOINFORMATICS, V22, P2876, DOI 10.1093/bioinformatics/btl490; Zhao XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066557	24	6	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94088	10.1371/journal.pone.0094088	http://dx.doi.org/10.1371/journal.pone.0094088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714636	Green Published, gold			2022-12-25	WOS:000334160900080
J	Merckel, LG; Verkooijen, HM; Peters, NHGM; Mann, RM; Veldhuis, WB; Storm, RK; Weits, T; Duvivier, KM; van Dalen, T; Mali, WPTM; Peeters, PHM; van den Bosch, MAAJ				Merckel, Laura G.; Verkooijen, Helena M.; Peters, Nicky H. G. M.; Mann, Ritse M.; Veldhuis, Wouter B.; Storm, Remmert K.; Weits, Teun; Duvivier, Katya M.; van Dalen, Thijs; Mali, Willem P. Th M.; Peeters, Petra H. M.; van den Bosch, Maurice A. A. J.			The Added Diagnostic Value of Dynamic Contrast-Enhanced MRI at 3.0 T in Nonpalpable Breast Lesions	PLOS ONE			English	Article							MAMMOGRAPHY; GUIDELINES; ACCURACY; CANCER	Objective: To investigate the added diagnostic value of 3.0 Tesla breast MRI over conventional breast imaging in the diagnosis of in situ and invasive breast cancer and to explore the role of routine versus expert reading. Materials and Methods: We evaluated MRI scans of patients with nonpalpable BI-RADS 3-5 lesions who underwent dynamic contrast-enhanced 3.0 Tesla breast MRI. Initially, MRI scans were read by radiologists in a routine clinical setting. All histologically confirmed index lesions were re-evaluated by two dedicated breast radiologists. Sensitivity and specificity for the three MRI readings were determined, and the diagnostic value of breast MRI in addition to conventional imaging was assessed. Interobserver reliability between the three readings was evaluated. Results: MRI examinations of 207 patients were analyzed. Seventy-eight of 207 (37.7%) patients had a malignant lesion, of which 33 (42.3%) patients had pure DCIS and 45 (57.7%) invasive breast cancer. Sensitivity of breast MRI was 66.7% during routine, and 89.3% and 94.7% during expert reading. Specificity was 77.5% in the routine setting, and 61.0% and 33.3% during expert reading. In the routine setting, MRI provided additional diagnostic information over clinical information and conventional imaging, as the Area Under the ROC Curve increased from 0.76 to 0.81. Expert MRI reading was associated with a stronger improvement of the AUC to 0.87. Interobserver reliability between the three MRI readings was fair and moderate. Conclusions: 3.0 T breast MRI of nonpalpable breast lesions is of added diagnostic value for the diagnosis of in situ and invasive breast cancer.	[Merckel, Laura G.; Peters, Nicky H. G. M.; Veldhuis, Wouter B.; Duvivier, Katya M.; Mali, Willem P. Th M.; van den Bosch, Maurice A. A. J.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Verkooijen, Helena M.] Univ Med Ctr Utrecht, Imaging Div, Utrecht, Netherlands; [Mann, Ritse M.] Radboud Univ Nijmegen, Med Ctr, Dept Radiol, NL-6525 ED Nijmegen, Netherlands; [Storm, Remmert K.] Albert Schweitzer Hosp, Dept Radiol, Dordrecht, Netherlands; [Weits, Teun] Diakonessen Hosp, Dept Radiol, Utrecht, Netherlands; [van Dalen, Thijs] Diakonessen Hosp, Dept Surg, Utrecht, Netherlands; [Peeters, Petra H. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Duvivier, Katya M.] Vrije Univ Amsterdam, Med Ctr, Dept Radiol, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Albert Schweitzer Ziekenhuis; Diakonessenhuis; Diakonessenhuis; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam	Merckel, LG (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	L.G.Merckel-2@umcutrecht.nl	Mann, R.M./L-4502-2015; Mali, Willem PThM/I-1123-2014; Merckel, Laura/ABE-2750-2020	Mann, R.M./0000-0001-8111-1930; Mali, Willem PThM/0000-0003-4391-0904; Veldhuis, Wouter/0000-0002-9798-6843				Altman D.G., 1990, PRACTICAL STAT MED R, DOI DOI 10.1201/9780429258589; BASSETT LW, 1992, RADIOL CLIN N AM, V30, P93; Berg WA, 2004, RADIOLOGY, V233, P830, DOI 10.1148/radiol.2333031484; DeMartini Wendy, 2008, Top Magn Reson Imaging, V19, P143, DOI 10.1097/RMR.0b013e31818a40a5; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Grobbee DE, 2008, CLIN EPIDEMIOLOGY; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hrung JM, 1999, ACAD RADIOL, V6, P387, DOI 10.1016/S1076-6332(99)80189-5; Ikeda DM, 2001, J MAGN RESON IMAGING, V13, P889, DOI 10.1002/jmri.1127; Ikeda O, 1999, ACTA RADIOL, V40, P585, DOI 10.3109/02841859909175592; Jansen SA, 2008, MED PHYS, V35, P3102, DOI 10.1118/1.2936220; Kottner J, 2011, J CLIN EPIDEMIOL, V64, P96, DOI 10.1016/j.jclinepi.2010.03.002; Kuhl CK, 2006, RADIOLOGY, V239, P666, DOI 10.1148/radiol.2392050509; Malur S, 2001, BREAST CANCER RES, V3, P55, DOI 10.1186/bcr271; Mann RM, 2008, EUR RADIOL, V18, P1307, DOI 10.1007/s00330-008-0863-7; Medeiros LR, 2011, BREAST CANCER RES TR, V126, P273, DOI 10.1007/s10549-010-1326-9; Mussurakis S, 1996, BRIT J RADIOL, V69, P1009, DOI 10.1259/0007-1285-69-827-1009; Newell D, 2010, EUR RADIOL, V20, P771, DOI 10.1007/s00330-009-1616-y; Peters NHGM, 2011, EUR J CANCER, V47, P879, DOI 10.1016/j.ejca.2010.11.035; Peters NHGM, 2008, RADIOLOGY, V246, P116, DOI 10.1148/radiol.2461061298; Pinker K, 2014, INVEST RADIOL; Rosen EL, 2007, BREAST J, V13, P545, DOI 10.1111/j.1524-4741.2007.00513.x; Sardanelli F, 2010, EUR J CANCER, V46, P1296, DOI 10.1016/j.ejca.2010.02.015; Schnall MD, 2006, RADIOLOGY, V238, P42, DOI 10.1148/radiol.2381042117; Shimauchi A, 2011, RADIOLOGY, V258, P696, DOI 10.1148/radiol.10100409; Turnbull LW, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14010; Veltman J, 2010, EUR J RADIOL, V74, P514, DOI 10.1016/j.ejrad.2009.03.053; Veronesi U, 2010, ONCOLOGIST, V15, P1248, DOI 10.1634/theoncologist.2010-0123; Wedegartner U, 2001, EUR RADIOL, V11, P1645, DOI 10.1007/s003300100885	29	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94233	10.1371/journal.pone.0094233	http://dx.doi.org/10.1371/journal.pone.0094233			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713637	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900107
J	Poretsky, R; Rodriguez-R, LM; Luo, CW; Tsementzi, D; Konstantinidis, KT				Poretsky, Rachel; Rodriguez-R, Luis M.; Luo, Chengwei; Tsementzi, Despina; Konstantinidis, Konstantinos T.			Strengths and Limitations of 16S rRNA Gene Amplicon Sequencing in Revealing Temporal Microbial Community Dynamics	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; DIVERSITY; PATTERNS; PROCHLOROCOCCUS; CLASSIFICATION; VARIABILITY; RESILIENCE; REDUNDANCY; RESISTANCE; HABITATS	This study explored the short-term planktonic microbial community structure and resilience in Lake Lanier (GA, USA) while simultaneously evaluating the technical aspects of identifying taxa via 16S rRNA gene amplicon and metagenomic sequence data. 16S rRNA gene amplicons generated from four temporally discrete samples were sequenced with 454 GS-FLX-Ti yielding similar to 40,000 rRNA gene sequences from each sample and representing similar to 300 observed OTUs. Replicates obtained from the same biological sample clustered together but several biases were observed, linked to either the PCR or sequencing-preparation steps. In comparisons with companion whole-community shotgun metagenome datasets, the estimated number of OTUs at each timepoint was concordant, but 1.5 times and similar to 10 times as many phyla and genera, respectively, were identified in the metagenomes. Our analyses showed that the 16S rRNA gene captures broad shifts in community diversity over time, but with limited resolution and lower sensitivity compared to metagenomic data. We also identified OTUs that showed marked shifts in abundance over four close timepoints separated by perturbations and tracked these taxa in the metagenome vs. 16S rRNA amplicon data. A strong summer storm had less of an effect on community composition than did seasonal mixing, which revealed a distinct succession of organisms. This study provides insights into freshwater microbial communities and advances the approaches for assessing community diversity and dynamics in situ.	[Poretsky, Rachel; Tsementzi, Despina; Konstantinidis, Konstantinos T.] Georgia Inst Technol, Sch Civil & Environm Engn, Atlanta, GA 30332 USA; [Rodriguez-R, Luis M.; Luo, Chengwei; Konstantinidis, Konstantinos T.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Rodriguez-R, Luis M.; Luo, Chengwei; Konstantinidis, Konstantinos T.] Georgia Inst Technol, Ctr Bioinformat Computat Genom, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Poretsky, R (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	microbe@uic.edu	Konstantinidis, Kostas/ABE-7113-2020; Rodriguez-R, Luis M./S-6996-2018	Konstantinidis, Kostas/0000-0002-0954-4755; Rodriguez-R, Luis M./0000-0001-7603-3093; Tsementzi, Despina/0000-0002-4578-1918	U.S. Department of Energy [DE-SC0006662]; U.S. National Science Foundation [1241046]; Direct For Biological Sciences [1241046] Funding Source: National Science Foundation	U.S. Department of Energy(United States Department of Energy (DOE)); U.S. National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported in part by the U.S. Department of Energy (Award DE-SC0006662) and by U.S. National Science Foundation (Award 1241046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, J BACTERIOL, V186, P2629, DOI 10.1128/JB.186.9.2629-2635.2004; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Bazinet AL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-92; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/NMETH.2276, 10.1038/nmeth.2276]; Burke C, 2011, P NATL ACAD SCI USA, V108, P14288, DOI 10.1073/pnas.1101591108; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Corzo A, 1999, J PLANKTON RES, V21, P1575, DOI 10.1093/plankt/21.8.1575; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Crump BC, 2007, ECOLOGY, V88, P1365, DOI 10.1890/06-0387; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Eiler A, 2012, ISME J, V6, P330, DOI 10.1038/ismej.2011.113; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Gilbert JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015545; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; GOOD IJ, 1956, BIOMETRIKA, V43, P45; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Kalyuzhnaya MG, 2008, NAT BIOTECHNOL, V26, P1029, DOI 10.1038/nbt.1488; Kent AD, 2004, MICROB ECOL, V48, P550, DOI 10.1007/s00248-004-0244-y; Kent AD, 2007, ISME J, V1, P38, DOI 10.1038/ismej.2007.6; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Konstantinidis KT, 2007, CURR OPIN MICROBIOL, V10, P504, DOI 10.1016/j.mib.2007.08.006; Konstantinidis KT, 2006, PHILOS T R SOC B, V361, P1929, DOI 10.1098/rstb.2006.1920; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Luo C, NUC ACIDS RES; Luo CW, 2012, ISME J, V6, P898, DOI 10.1038/ismej.2011.147; McDonald IR, 2005, INT J SYST EVOL MICR, V55, P1827, DOI 10.1099/ijs.0.63716-0; Methe BA, 1999, HYDROBIOLOGIA, V401, P77, DOI 10.1023/A:1003782209607; Miller CS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r44; Nemergut DR, 2011, ENVIRON MICROBIOL, V13, P135, DOI 10.1111/j.1462-2920.2010.02315.x; Newton RJ, 2011, ENVIRON MICROBIOL, V13, P887, DOI 10.1111/j.1462-2920.2010.02387.x; Newton RJ, 2011, MICROBIOL MOL BIOL R, V75, P14, DOI 10.1128/MMBR.00028-10; Oh S, 2011, APPL ENVIRON MICROB, V77, P6000, DOI 10.1128/AEM.00107-11; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Portillo MC, 2012, ENVIRON MICROBIOL, V14, P2417, DOI 10.1111/j.1462-2920.2012.02785.x; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Rodriguez-Brito B, 2010, ISME J, V4, P739, DOI 10.1038/ismej.2010.1; Rodriguez-R LM, 2014, BIOINFORMATICS, V30, P629, DOI 10.1093/bioinformatics/btt584; Rossello-Mora R, 2001, FEMS MICROBIOL REV, V25, P39, DOI 10.1016/S0168-6445(00)00040-1; Shade A, 2007, LIMNOL OCEANOGR, V52, P487, DOI 10.4319/lo.2007.52.2.0487; Shade A, 2012, ISME J, V6, P2153, DOI 10.1038/ismej.2012.56; Shade A, 2011, ENVIRON MICROBIOL, V13, P2752, DOI 10.1111/j.1462-2920.2011.02546.x; Shah N, 2011, BIOCOMPUT-PAC SYM, P165; Shakya M, 2013, ENVIRON MICROBIOL, V15, P1882, DOI 10.1111/1462-2920.12086; Sharpton TJ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001061; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Stenuite S, 2009, J PLANKTON RES, V31, P1531, DOI 10.1093/plankt/fbp090; Steven B, 2012, ENV MICROBIOL REP, V4, P248, DOI 10.1111/j.1758-2229.2012.00328.x; Strous M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00410; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Yannarell AC, 2003, MICROB ECOL, V46, P391, DOI 10.1007/s00248-003-1008-9; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275; Zwisler W, 2003, AQUAT MICROB ECOL, V31, P211, DOI 10.3354/ame031211	62	316	324	3	148	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93827	10.1371/journal.pone.0093827	http://dx.doi.org/10.1371/journal.pone.0093827			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714158	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900053
J	Beigel, F; Friedrich, M; Probst, C; Sotlar, K; Goke, B; Diegelmann, J; Brand, S				Beigel, Florian; Friedrich, Matthias; Probst, Corina; Sotlar, Karl; Goeke, Burkhard; Diegelmann, Julia; Brand, Stephan			Oncostatin M Mediates STAT3-Dependent Intestinal Epithelial Restitution via Increased Cell Proliferation, Decreased Apoptosis and Upregulation of SERPIN Family Members	PLOS ONE			English	Article							CROHNS-DISEASE; PROTEIN-KINASE; GROWTH-FACTOR; SIGNALING PATHWAY; GENE-EXPRESSION; ACTIVATION; INTERLEUKIN-6; LYMPHOCYTES; FRACTALKINE; MIGRATION	Objective: Oncostatin M (OSM) is produced by activated T cells, monocytes, and dendritic cells and signals through two distinct receptor complexes consisting of gp130 and LIFR (I) or OSMR-beta and gp130 (II), respectively. Aim of this study was to analyze the role of OSM in intestinal epithelial cells (IEC) and intestinal inflammation. Methods: OSM expression and OSM receptor distribution was analyzed by PCR and immunohistochemistry experiments, signal transduction by immunoblotting. Gene expression studies were performed by microarray analysis and RT-PCR. Apoptosis was measured by caspases-3/7 activity. IEC migration and proliferation was studied in wounding and water soluble tetrazolium assays. Results: The IEC lines Caco-2, DLD-1, SW480, HCT116 and HT-29 express mRNA for the OSM receptor subunits gp130 and OSMR-b, while only HCT116, HT-29 and DLD-1 cells express LIFR mRNA. OSM binding to its receptor complex activates STAT1, STAT3, ERK-1/2, SAPK/JNK-1/2, and Akt. Microarray analysis revealed 79 genes that were significantly up-regulated (adj.-p <= 0.05) by OSM in IEC. Most up-regulated genes belong to the functional categories "immunity and defense'' (p=2.1x10(-7)), "apoptosis'' (p=3.7x10(-4)) and "JAK/STAT cascade'' (p=3.4x10(-6)). Members of the SERPIN gene family were among the most strongly up-regulated genes. OSM significantly increased STAT3- and MEK1-dependent IEC cell proliferation (p < 0.05) and wound healing (p=3.9x10(-5)). OSM protein expression was increased in colonic biopsies of patients with active inflammatory bowel disease (IBD). Conclusions: OSM promotes STAT3-dependent intestinal epithelial cell proliferation and wound healing in vitro. Considering the increased OSM expression in colonic biopsy specimens of patients with active IBD, OSM upregulation may modulate a barrier-protective host response in intestinal inflammation. Further in vivo studies are warranted to elucidate the exact role of OSM in intestinal inflammation and the potential of OSM as a drug target in IBD.	[Beigel, Florian; Friedrich, Matthias; Probst, Corina; Goeke, Burkhard; Diegelmann, Julia; Brand, Stephan] Univ Munich, Univ Hosp Munich Grosshadern, Dept Med 2, Munich, Germany; [Sotlar, Karl] Univ Munich, Inst Pathol, D-80539 Munich, Germany; [Friedrich, Matthias; Diegelmann, Julia] Univ Munich, Clin Prevent Dent & Parodontol, Munich, Germany	University of Munich; University of Munich; University of Munich	Brand, S (corresponding author), Univ Munich, Univ Hosp Munich Grosshadern, Dept Med 2, Munich, Germany.	stephan.brand@med.uni-muenchen.de			Deutsche Forschungsgemeinschaft (DFG) [BE 4490/2-1, BR 1912/6-1]; Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium) [2010_EKES.32]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium)	This work is supported by grants from the Deutsche Forschungsgemeinschaft (DFG, BE 4490/2-1) to F. Beigel. S. Brand is supported by grants from the Deutsche Forschungsgemeinschaft (DFG, BR 1912/6-1) and the Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium 2010; 2010_EKES.32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battle T. E., 2002, Current Molecular Medicine (Hilversum), V2, P381, DOI 10.2174/1566524023362456; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Benko S, 2010, J IMMUNOL, V185, P1681, DOI 10.4049/jimmunol.0903900; Bonacchi A, 2001, J BIOL CHEM, V276, P9945, DOI 10.1074/jbc.M010303200; Boniface K, 2007, J IMMUNOL, V178, P4615, DOI 10.4049/jimmunol.178.7.4615; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Boutten A, 1998, AM J RESP CELL MOL, V18, P511, DOI 10.1165/ajrcmb.18.4.2772; Brand S, 2006, J CELL BIOCHEM, V97, P709, DOI 10.1002/jcb.20672; Brand S, 2006, AM J PHYSIOL-GASTR L, V290, pG827, DOI 10.1152/ajpgi.00513.2005; Brand S, 2006, AM J GASTROENTEROL, V101, P99, DOI 10.1111/j.1572-0241.2005.00361.x; Brand S, 2005, EXP CELL RES, V310, P117, DOI 10.1016/j.yexcr.2005.07.006; Brand S, 2002, GASTROENTEROLOGY, V122, P166, DOI 10.1053/gast.2002.30329; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Brand S, 2005, EXP CELL RE IN PRESS; BROWN TJ, 1987, J IMMUNOL, V139, P2977; Calabrese F, 2008, THORAX, V63, P795, DOI 10.1136/thx.2007.088583; Camilleri M, 2012, NEUROGASTROENT MOTIL, V24, P503, DOI 10.1111/j.1365-2982.2012.01921.x; Dambacher J, 2009, GUT, V58, P1207, DOI 10.1136/gut.2007.130112; Dambacher J, 2007, GUT, V56, P1257, DOI 10.1136/gut.2006.118679; de Chambrun GP, 2010, NAT REV GASTRO HEPAT, V7, P15, DOI 10.1038/nrgastro.2009.203; de Koning PJA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022645; Diegelmann J, 2012, J BIOL CHEM; Diegelmann J, 2012, J BIOL CHEM, V287, P286, DOI 10.1074/jbc.M111.294355; DIGNASS AU, 1993, GASTROENTEROLOGY, V105, P1323, DOI 10.1016/0016-5085(93)90136-Z; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Dumas A, 2012, J CELL MOL MED, V16, P1274, DOI 10.1111/j.1582-4934.2011.01412.x; Fearon U, 2006, ARTHRITIS RHEUM-US, V54, P3152, DOI 10.1002/art.22161; Fridell YWC, 1996, MOL CELL BIOL, V16, P135; Hoffmann DC, 2011, J BIOL CHEM, V286, P28889, DOI 10.1074/jbc.M111.249979; Hohensinner PJ, 2009, FASEB J, V23, P774, DOI 10.1096/fj.08-108035; Hommes D, 2002, GASTROENTEROLOGY, V122, P7, DOI 10.1053/gast.2002.30770; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kanda J, 2009, INT J HEMATOL, V90, P545, DOI 10.1007/s12185-009-0443-x; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Lannan EA, 2012, ENDOCRINOLOGY, V153, P3701, DOI 10.1210/en.2012-1020; Matthews VB, 2005, EXP CELL RES, V306, P252, DOI 10.1016/j.yexcr.2005.02.010; McLoughlin RM, 2005, P NATL ACAD SCI USA, V102, P9589, DOI 10.1073/pnas.0501794102; Migita K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3333; Mosley B, 1996, J BIOL CHEM, V271, P32635, DOI 10.1074/jbc.271.51.32635; Mozaffarian A, 2008, J IMMUNOL, V181, P7243, DOI 10.4049/jimmunol.181.10.7243; Muehlhoefer A, 2000, J IMMUNOL, V164, P3368, DOI 10.4049/jimmunol.164.6.3368; Nagaishi T, 2008, MUCOSAL IMMUNOL, V1, pS39, DOI 10.1038/mi.2008.50; Nakamura K, 2004, HEPATOLOGY, V39, P635, DOI 10.1002/hep.20086; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Nosaka T, 1999, EMBO J, V18, P4754, DOI 10.1093/emboj/18.17.4754; Paul-Pletzer K, 2006, DRUG TODAY, V42, P559, DOI 10.1358/dot.2006.42.9.1025692; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Quarta S, 2010, J PATHOL, V221, P343, DOI 10.1002/path.2708; Rega G, 2005, CIRCULATION, V111, P1938, DOI 10.1161/01.CIR.0000161823.55935.BE; RICHARDS CD, 1992, J IMMUNOL, V148, P1731; Roda G, 2009, INFLAMM BOWEL DIS, V15, P1775, DOI 10.1002/ibd.21023; Sanchez AL, 2003, J INTERF CYTOK RES, V23, P193, DOI 10.1089/107999003765027393; Schreiber S, 2002, GUT, V51, P379, DOI 10.1136/gut.51.3.379; Shin SH, 2012, INT WOUND J; Taga T, 1997, ANN MED, V29, P63, DOI 10.3109/07853899708998744; Tanaka M, 2004, REV PHYSIOL BIOCH P, V149, P39, DOI 10.1007/s10254-003-0013-1; THOMA B, 1994, J BIOL CHEM, V269, P6215; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Uchiyama K, 2012, AM J PHYSIOL-GASTR L, V302, pG1163, DOI 10.1152/ajpgi.00292.2011; Vidalino L, 2009, AUTOIMMUN REV, V9, P108, DOI 10.1016/j.autrev.2009.03.011; Waetzig GH, 2002, J IMMUNOL, V168, P5342, DOI 10.4049/jimmunol.168.10.5342; Wahl AF, 2001, ANN RHEUM DIS, V60, pIII75; Weiss TW, 2003, CARDIOVASC RES, V59, P628, DOI 10.1016/S0008-6363(03)00463-2; Woo JK, 2012, ONCOGENE, V31, P2187, DOI 10.1038/onc.2011.410	64	39	40	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93498	10.1371/journal.pone.0093498	http://dx.doi.org/10.1371/journal.pone.0093498			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710357	Green Submitted, gold, Green Published			2022-12-25	WOS:000334159800036
J	Chekabab, SM; Jubelin, G; Dozois, CM; Harel, J				Chekabab, Samuel Mohammed; Jubelin, Gregory; Dozois, Charles M.; Harel, Josee			PhoB Activates Escherichia coli O157: H7 Virulence Factors in Response to Inorganic Phosphate Limitation	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; ACANTHAMOEBA-CASTELLANII; REGULON; GENE; PST; EXPRESSION; REGULATOR; SYSTEM; OPERON; PROTEIN	Enterohemorrhagic Escherichia coli (EHEC), an emerging food-and water-borne hazard, is highly pathogenic to humans. In the environment, EHEC must survive phosphate (Pi) limitation. The response to such Pi starvation is an induction of the Pho regulon including the Pst system that senses Pi variation. The interplay between the virulence of EHEC, Pho-Pst system and environmental Pi remains unknown. To understand the effects of Pi deprivation on the molecular mechanisms involved in EHEC survival and virulence under Pho regulon control, we undertook transcriptome profiling of the EDL933 wild-type strain grown under high Pi and low Pi conditions and its isogenic triangle phoB mutant grown in low Pi conditions. The differentially expressed genes included 1067 Pi-dependent genes and 603 PhoB-dependent genes. Of these 131 genes were both Pi and PhoB-dependent. Differentially expressed genes that were selected included those involved in Pi homeostasis, cellular metabolism, acid stress, oxidative stress and RpoS-dependent stress responses. Differentially expressed virulence systems included the locus of enterocyte effacement (LEE) encoding the type-3 secretion system (T3SS) and its effectors, as well as BP-933W prophage encoded Shiga toxin 2 genes. Moreover, PhoB directly regulated LEE and stx2 gene expression through binding to specific Pho boxes. However, in Pi-rich medium, constitutive activation of the Pho regulon decreased LEE gene expression and reduced adherence to HeLa cells. Together, these findings reveal that EHEC has evolved a sophisticated response to Pi limitation involving multiple biochemical strategies that contribute to its ability to respond to variations in environmental Pi and to coordinating the virulence response.	[Chekabab, Samuel Mohammed; Harel, Josee] Univ Montreal, Fac Med Vet, Res Grp Infect Dis Swine, St Hyacinthe, PQ J2S 7C6, Canada; [Jubelin, Gregory] INRA Clermont Ferrand Theix, Unite Microbiol UR454, St Genes Champanelle, France; [Dozois, Charles M.] Inst Armand Frappier, INRS, Laval, PQ, Canada	Universite de Montreal; INRAE; University of Quebec; Institut national de la recherche scientifique (INRS)	Harel, J (corresponding author), Univ Montreal, Fac Med Vet, Res Grp Infect Dis Swine, St Hyacinthe, PQ J2S 7C6, Canada.	josee.harel@umontreal.ca	Harel, Josée/H-1933-2011	Harel, Josée/0000-0002-7822-3795; JUBELIN, Gregory/0000-0002-9902-0663; Chekabab, Samuel M/0000-0002-5636-4095	Natural Sciences and Engineering Research [250129-07, 25120-13]; Centre de Recherche en Infectiologie Porcine et Aviaire from Fonds de Recherche du Quebec Nature et technologies [RS-170946]	Natural Sciences and Engineering Research(Natural Sciences and Engineering Research Council of Canada (NSERC)); Centre de Recherche en Infectiologie Porcine et Aviaire from Fonds de Recherche du Quebec Nature et technologies	This work was supported by Discovery grants (250129-07) to C. M. D. and (25120-13) to J.H. from the Natural Sciences and Engineering Research and the strategic grant (RS-170946) Centre de Recherche en Infectiologie Porcine et Aviaire from Fonds de Recherche du Quebec Nature et technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Arribas-Bosacoma R, 2007, J MOL BIOL, V366, P626, DOI 10.1016/j.jmb.2006.11.038; Baek JH, 2006, FEMS MICROBIOL LETT, V264, P104, DOI 10.1111/j.1574-6968.2006.00440.x; Bertrand N, 2010, INFECT IMMUN, V78, P5324, DOI 10.1128/IAI.00452-10; Bhatt S, 2011, TRENDS MICROBIOL, V19, P217, DOI 10.1016/j.tim.2011.01.004; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Bougdour A, 2006, GENE DEV, V20, P884, DOI 10.1101/gad.1400306; Carruthers MD, 2010, FEMS MICROBIOL LETT, V312, P15, DOI 10.1111/j.1574-6968.2010.02098.x; Chan FY, 1996, J BACTERIOL, V178, P3974, DOI 10.1128/jb.178.13.3974-3977.1996; Chekabab SM, 2013, FEMS MICROBIOL LETT, V341, P1, DOI 10.1111/1574-6968.12078; Chekabab SM, 2012, MICROBIOLOGYOPEN, V1, P427, DOI 10.1002/mbo3.40; Cheng C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050682; Cheng C, 2009, INFECT IMMUN, V77, P1936, DOI 10.1128/IAI.01246-08; Crepin S, 2012, INFECT IMMUN, V80, P2802, DOI 10.1128/IAI.00162-12; Crepin S, 2011, VET MICROBIOL, V153, P82, DOI 10.1016/j.vetmic.2011.05.043; Crepin S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-568; DAIGLE F, 1995, INFECT IMMUN, V63, P4924, DOI 10.1128/IAI.63.12.4924-4927.1995; Danhorn T, 2004, J BACTERIOL, V186, P4492, DOI 10.1128/JB.186.14.4492-4501.2004; Dasanayake D, 2011, MOL MICROBIOL, V81, P734, DOI 10.1111/j.1365-2958.2011.07727.x; de Sablet T, 2008, MICROBIOL-SGM, V154, P176, DOI 10.1099/mic.0.2007/009704-0; Deng WY, 2005, INFECT IMMUN, V73, P2135, DOI 10.1128/IAI.73.4.2135-2146.2005; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Elliott SJ, 2000, INFECT IMMUN, V68, P6115, DOI 10.1128/IAI.68.11.6115-6126.2000; FISHER SL, 1995, J BIOL CHEM, V270, P23143, DOI 10.1074/jbc.270.39.23143; Gao R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003927; Gao R, 2013, P NATL ACAD SCI USA, V110, P672, DOI 10.1073/pnas.1214587110; Ghosh D, 2009, APPL ENVIRON MICROB, V75, P7142, DOI 10.1128/AEM.00950-09; Gobert AP, 2007, J IMMUNOL, V178, P8168, DOI 10.4049/jimmunol.178.12.8168; Graveline R, 2011, ETUDE MECANISMES MOL; Graveline R, 2011, MOL MICROBIOL, V81, P1286, DOI 10.1111/j.1365-2958.2011.07761.x; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60, DOI 10.1093/oxfordjournals.epirev.a036079; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Haack KR, 2003, INFECT IMMUN, V71, P384, DOI 10.1128/IAI.71.1.384-392.2003; Hancock D, 2001, INT J FOOD MICROBIOL, V66, P71, DOI 10.1016/S0168-1605(00)00487-6; HASHIMOTOGOTOH T, 1981, GENE, V16, P227, DOI 10.1016/0378-1119(81)90079-2; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Herold S, 2004, INT J MED MICROBIOL, V294, P115, DOI 10.1016/j.ijmm.2004.06.023; Hsieh YJ, 2010, CURR OPIN MICROBIOL, V13, P198, DOI 10.1016/j.mib.2010.01.014; Imamovic L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032393; JANS DA, 1983, BIOCHEM J, V211, P717, DOI 10.1042/bj2110717; Kang HY, 2002, INFECT IMMUN, V70, P1739, DOI 10.1128/IAI.70.4.1739-1749.2002; KAYNE LH, 1993, J CLIN INVEST, V91, P915, DOI 10.1172/JCI116313; Kendall MM, 2010, MOL MICROBIOL, V76, P1306, DOI 10.1111/j.1365-2958.2010.07174.x; Lamarche MG, 2008, J BACTERIOL, V190, P5256, DOI 10.1128/JB.01536-07; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Lamarche MG, 2010, CURR MICROBIOL, V60, P356, DOI 10.1007/s00284-009-9549-x; Lamarche MG, 2005, INFECT IMMUN, V73, P4138, DOI 10.1128/IAI.73.7.4138-4145.2005; Lemann Jacob Jr., 1993, P46; LITTLE JW, 1995, REGULATION GENE EXPR, P453; Loewen PC, 1998, CAN J MICROBIOL, V44, P707, DOI 10.1139/cjm-44-8-707; Magid J., 1996, HUMIC SUBSTANCES TER, P429; Mandel MJ, 2005, J BACTERIOL, V187, P434, DOI 10.1128/JB.187.2.434-442.2005; MCDANIEL TK, 1995, P NATL ACAD SCI USA, V92, P1664, DOI 10.1073/pnas.92.5.1664; Mellies JL, 2007, INFECT IMMUN, V75, P4199, DOI 10.1128/IAI.01927-06; Muhldorfer I, 1996, INFECT IMMUN, V64, P495; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Oshima T, 2002, MOL MICROBIOL, V46, P281, DOI 10.1046/j.1365-2958.2002.03170.x; PARKINSON JS, 1993, CELL, V73, P857, DOI 10.1016/0092-8674(93)90267-T; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Pieper R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066462; Pratt JT, 2010, MOL MICROBIOL, V77, P1595, DOI 10.1111/j.1365-2958.2010.07310.x; Ptashne M, 1992, GENETIC SWITCH PHAGE; RAO NN, 1990, MOL MICROBIOL, V4, P1083, DOI 10.1111/j.1365-2958.1990.tb00682.x; Rozanov DV, 1998, J BACTERIOL, V180, P6306; Shkilnyj P, 2007, J BACTERIOL, V189, P3115, DOI 10.1128/JB.01857-06; Sperandio V, 2000, MOL MICROBIOL, V38, P781, DOI 10.1046/j.1365-2958.2000.02168.x; STROCKBINE NA, 1986, INFECT IMMUN, V53, P135, DOI 10.1128/IAI.53.1.135-140.1986; Suziedeliene E, 1999, J BACTERIOL, V181, P2084; Tree JJ, 2009, TRENDS MICROBIOL, V17, P361, DOI 10.1016/j.tim.2009.06.001; Tyler JS, 2004, J BACTERIOL, V186, P7670, DOI 10.1128/JB.186.22.7670-7679.2004; Unkmeir A, 2000, INFECT IMMUN, V68, P4856, DOI 10.1128/IAI.68.9.4856-4864.2000; Wagner PL, 2001, J BACTERIOL, V183, P2081, DOI 10.1128/JB.183.6.2081-2085.2001; Waldor MK, 2005, CURR OPIN MICROBIOL, V8, P459, DOI 10.1016/j.mib.2005.06.001; WALTON J, 1979, CLIN SCI, V56, P407, DOI 10.1042/cs0560407; Wanner Barry L., 1994, Biodegradation, V5, P175, DOI 10.1007/BF00696458; WANNER BL, 1992, J BACTERIOL, V174, P2124, DOI 10.1128/JB.174.7.2124-2130.1992; Wanner BL, 1996, ESCHERICHIA COLI SAL, P1357, DOI DOI 10.1007/978-3-642-75969-7_16; Yang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047314; Yoshida Y, 2012, GENE, V502, P27, DOI 10.1016/j.gene.2012.03.064; Yoshida Y, 2010, MOL GENET GENOMICS, V284, P197, DOI 10.1007/s00438-010-0559-y; Zaborina O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040043; Zubkov MV, 2007, ENVIRON MICROBIOL, V9, P2079, DOI 10.1111/j.1462-2920.2007.01324.x	82	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94285	10.1371/journal.pone.0094285	http://dx.doi.org/10.1371/journal.pone.0094285			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710330	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000334159800131
J	Gabay, Y; Fine, M; Barkay, Z; Benayahu, Y				Gabay, Yasmin; Fine, Maoz; Barkay, Zahava; Benayahu, Yehuda			Octocoral Tissue Provides Protection from Declining Oceanic pH	PLOS ONE			English	Article							CORAL; ACIDIFICATION; CALCIFICATION; RESPONSES	Increase in anthropogenic pCO(2) alters seawater chemistry and could lead to reduced calcification or skeleton dissolution of calcifiers and thereby weaken coral-reef structure. Studies have suggested that the complex and diverse responses in stony coral growth and calcification, as a result of elevated pCO(2), can be explained by the extent to which their soft tissues cover the underlying skeleton. This study compared the effects of decreased pH on the microstructural features of both in hospite (within the colony) and isolated sclerites (in the absence of tissue protection) of the zooxanthellate reef-dwelling octocoral Ovabunda macrospiculata. Colonies and isolated sclerites were maintained under normal (8.2) and reduced (7.6 and 7.3) pH conditions for up to 42 days. Both in hospite and isolated sclerites were then examined under SEM and ESEM microscopy in order to detect any microstructural changes. No differences were found in the microstructure of the in hospite sclerites between the control and the pH treatments. In stark contrast, the isolated sclerites revealed dissolution damage related to the acidity of the water. These findings suggest a protective role of the octocoral tissue against adverse pH conditions, thus maintaining them unharmed at high pCO(2). In light of the competition for space with the less resilient reef calcifiers, octocorals may thus have a significant advantage under greater than normal acidic conditions.	[Gabay, Yasmin; Barkay, Zahava; Benayahu, Yehuda] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Gabay, Yasmin; Fine, Maoz] Interuniv Inst Marine Sci, Elat, Israel; [Fine, Maoz] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Tel Aviv University; Bar Ilan University	Gabay, Y (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.	yasminga@post.tau.ac.il	Fine, Maoz/S-5582-2019	Fine, Maoz/0000-0003-4911-4562	Israel Cohen Chair in Environmental Zoology; Israel Science Foundation	Israel Cohen Chair in Environmental Zoology; Israel Science Foundation(Israel Science Foundation)	This research was in part supported by the Israel Cohen Chair in Environmental Zoology to Y. Benayahu and an Israel Science Foundation grant to M. Fine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonovich D, 2012, MAR BIODIVERS, V42, P173, DOI 10.1007/s12526-011-0102-3; Albright R, 2010, P NATL ACAD SCI USA, V107, P20400, DOI 10.1073/pnas.1007273107; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Bramanti L, 2013, GLOBAL CHANGE BIOL, V19, P1897, DOI 10.1111/gcb.12171; Cerrano C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01457; Cohen AL, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002411; Fabricius K, 2001, SOFT CORALS SEA FANS; Fine M, 2007, SCIENCE, V315, P1811, DOI 10.1126/science.1137094; Gabay Y, 2013, ECOL EVOL, V3, P465, DOI 10.1002/ece3.351; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Jeng MS, 2011, CORAL REEFS, V30, P925, DOI 10.1007/s00338-011-0765-z; Jokiel PL, 2008, CORAL REEFS, V27, P473, DOI 10.1007/s00338-008-0380-9; Jury CP, 2010, GLOBAL CHANGE BIOL, V16, P1632, DOI 10.1111/j.1365-2486.2009.02057.x; Krief S, 2010, GEOCHIM COSMOCHIM AC, V74, P4988, DOI 10.1016/j.gca.2010.05.023; Marubini F, 2008, CORAL REEFS, V27, P491, DOI 10.1007/s00338-008-0375-6; Renegar DA, 2005, MAR ECOL PROG SER, V293, P69, DOI 10.3354/meps293069; Ries J, 2011, NAT CLIM CHANGE, V1, P294, DOI 10.1038/nclimate1204; Ries JB, 2011, J EXP MAR BIOL ECOL, V403, P54, DOI 10.1016/j.jembe.2011.04.006; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Rodolfo-Metalpa R, 2010, MAR ECOL-EVOL PERSP, V31, P447, DOI 10.1111/j.1439-0485.2009.00354.x; Schneider K, 2006, LIMNOL OCEANOGR, V51, P1284, DOI 10.4319/lo.2006.51.3.1284; Sheppard C, 1992, MARINE ECOLOGY ARABI, P359; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; Stemmer K, 2013, ORG DIVERS EVOL, V13, P135, DOI 10.1007/s13127-012-0119-x; Tentori E, 2006, BIOL BULL-US, V211, P193, DOI 10.2307/4134593; [No title captured]; [No title captured]; [No title captured]	29	32	32	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e91553	10.1371/journal.pone.0091553	http://dx.doi.org/10.1371/journal.pone.0091553			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710022	Green Submitted, Green Published, gold			2022-12-25	WOS:000334159800008
J	Tanner, SA; Berner, AZ; Rigozzi, E; Grattepanche, F; Chassard, C; Lacroix, C				Tanner, Sabine A.; Berner, Annina Zihler; Rigozzi, Eugenia; Grattepanche, Franck; Chassard, Christophe; Lacroix, Christophe			In Vitro Continuous Fermentation Model ( PolyFermS) of the Swine Proximal Colon for Simultaneous Testing on the Same Gut Microbiota	PLOS ONE			English	Article							REAL-TIME PCR; CONTINUOUS-CULTURE; INTESTINAL MICROBIOTA; BACTERIAL COMMUNITIES; FIBER FERMENTATION; FECAL MICROBIOTA; FECES; STARCH; PIGS; FEED	In vitro gut modeling provides a useful platform for a fast and reproducible assessment of treatment- related changes. Currently, pig intestinal fermentation models are mainly batch models with important inherent limitations. In this study we developed a novel in vitro continuous fermentation model, mimicking the porcine proximal colon, which we validated during 54 days of fermentation. This model, based on our recent PolyFermS design, allows comparing different treatment effects on the same microbiota. It is composed of a first- stage inoculum reactor seeded with immobilized fecal swine microbiota and used to constantly inoculate ( 10% v/v) five second- stage reactors, with all reactors fed with fresh nutritive chyme medium and set to mimic the swine proximal colon. Reactor effluents were analyzed for metabolite concentrations and bacterial composition by HPLC and quantitative PCR, and microbial diversity was assessed by 454 pyrosequencing. The novel PolyFermS featured stable microbial composition, diversity and metabolite production, consistent with bacterial activity reported for swine proximal colon in vivo. The constant inoculation provided by the inoculum reactor generated reproducible microbial ecosystems in all second- stage reactors, allowing the simultaneous investigation and direct comparison of different treatments on the same porcine gut microbiota. Our data demonstrate the unique features of this novel PolyFermS design for the swine proximal colon. The model provides a tool for efficient, reproducible and costeffective screening of environmental factors, such as dietary additives, on pig colonic fermentation.	[Tanner, Sabine A.; Berner, Annina Zihler; Rigozzi, Eugenia; Grattepanche, Franck; Chassard, Christophe; Lacroix, Christophe] ETH, Inst Food Nutr & Hlth, Lab Food Biotechnol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Lacroix, C (corresponding author), ETH, Inst Food Nutr & Hlth, Lab Food Biotechnol, Zurich, Switzerland.	christophe.lacroix@hest.ethz.ch	Lacroix, Christophe/B-5139-2016	Lacroix, Christophe/0000-0003-4360-2020	Commission of Technology and Innovation of Switzerland (CTI) [11962.1 PFLS-LS]	Commission of Technology and Innovation of Switzerland (CTI)	This study was carried out thanks to the financial support of the Commission of Technology and Innovation of Switzerland (CTI-Project Nr. 11962.1 PFLS-LS) (URL: http://www.kti.admin.ch/?lang = en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartosch S, 2004, APPL ENVIRON MICROB, V70, P3575, DOI 10.1128/AEM.70.6.3575-3581.2004; Berner AZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077772; Bindelle J, 2007, ANIM FEED SCI TECH, V132, P111, DOI 10.1016/j.anifeedsci.2006.03.009; Bird AR, 2009, DIGEST DIS SCI, V54, P947, DOI 10.1007/s10620-008-0451-3; Buzoianu SG, 2012, APPL ENVIRON MICROB, V78, P4217, DOI 10.1128/AEM.00307-12; Chassard C, 2013, CURR OPIN CLIN NUTR, V16, P453, DOI 10.1097/MCO.0b013e3283619e63; Cinquin C, 2004, MICROB ECOL, V48, P128, DOI 10.1007/s00248-003-2022-7; Cinquin C, 2006, FEMS MICROBIOL ECOL, V57, P324, DOI 10.1111/j.1574-6941.2006.00117.x; Cleusix V, 2010, J APPL MICROBIOL, V108, P181, DOI 10.1111/j.1365-2672.2009.04408.x; Dostal A, 2013, FEMS MICROBIOL ECOL, V83, P161, DOI 10.1111/j.1574-6941.2012.01461.x; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Grieshop CM, 2000, SWINE NUTR, P107; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Haenen D, 2013, J NUTR, V143, P274, DOI 10.3945/jn.112.169672; Hippe H, 1999, INT J SYST BACTERIOL, V49, P779, DOI 10.1099/00207713-49-2-779; Hosseini E, 2011, NUTR REV, V69, P245, DOI 10.1111/j.1753-4887.2011.00388.x; Jha R, 2011, ANIM FEED SCI TECH, V165, P191, DOI 10.1016/j.anifeedsci.2010.10.002; Jonathan MC, 2012, FOOD CHEM, V133, P889, DOI 10.1016/j.foodchem.2012.01.110; Jost T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044595; KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502; Kim HB, 2012, P NATL ACAD SCI USA, V109, P15485, DOI 10.1073/pnas.1205147109; Kim HB, 2011, VET MICROBIOL, V153, P124, DOI 10.1016/j.vetmic.2011.05.021; Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103; Le Blay G, 2010, BRIT J NUTR, V103, P403, DOI 10.1017/S0007114509991796; Lee TT, 2011, J AGR FOOD CHEM, V59, P7353, DOI 10.1021/jf200402u; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Li RW, 2012, INFECT IMMUN, V80, P2150, DOI 10.1128/IAI.00141-12; Lin B, 2011, FOOD HYDROCOLLOID, V25, P180, DOI 10.1016/j.foodhyd.2010.02.006; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Macfarlane GT, 2007, CURR OPIN BIOTECH, V18, P156, DOI 10.1016/j.copbio.2007.01.011; Macfarlane GT, 1998, MICROB ECOL, V35, P180, DOI 10.1007/s002489900072; Messens W, 2010, VET MICROBIOL, V141, P73, DOI 10.1016/j.vetmic.2009.08.002; Michel C, 1998, ANAEROBE, V4, P257, DOI 10.1006/anae.1998.0178; Mozzetti V, 2012, BENEF MICROBES, V3, P261, DOI 10.3920/BM2012.0025; Nyannor EKD, 2007, J ANIM SCI, V85, P1946, DOI 10.2527/jas.2007-0037; Payne AN, 2012, TRENDS BIOTECHNOL, V30, P17, DOI 10.1016/j.tibtech.2011.06.011; Pinloche E, 2012, J ANIM SCI, V90, P353, DOI 10.2527/jas.53800; Pluske JR, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-1; Poroyko V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012459; Possemiers S, 2004, FEMS MICROBIOL ECOL, V49, P495, DOI 10.1016/j.femsec.2004.05.002; Rajilic-Stojanovic M, 2010, MICROBIOL-SGM, V156, P3270, DOI 10.1099/mic.0.042044-0; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Riboulet-Bisson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031113; Ricca DM, 2010, ANAEROBE, V16, P516, DOI 10.1016/j.anaerobe.2010.03.010; Russell WR, 2013, CURR OPIN MICROBIOL, V16, P246, DOI 10.1016/j.mib.2013.07.002; Sakata T, 2003, P NUTR SOC, V62, P73, DOI 10.1079/PNS2002211; Stevenson DM, 2007, APPL MICROBIOL BIOT, V75, P165, DOI 10.1007/s00253-006-0802-y; Van den Abbeele P, 2010, APPL ENVIRON MICROB, V76, P5237, DOI 10.1128/AEM.00759-10; von Heimendahl E, 2010, J ANIM SCI, V88, P972, DOI 10.2527/jas.2009-2370; Wang JP, 2011, J ANIM SCI, V89, P2768, DOI 10.2527/jas.2009-1800; Williams BA, 2005, ANIM RES, V54, P191, DOI 10.1051/animres:2005011; Zhu WY, 2003, ANAEROBE, V9, P175, DOI 10.1016/S1075-9964(03)00083-0	53	48	48	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94123	10.1371/journal.pone.0094123	http://dx.doi.org/10.1371/journal.pone.0094123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709947	gold, Green Published, Green Submitted			2022-12-25	WOS:000334159800103
J	Wu, ZH				Wu, Zhenghua			SSVEP Extraction Based on the Similarity of Background EEG	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACES; VISUAL-EVOKED POTENTIALS; BCI; IMPLEMENTATION; COMMUNICATION; PHASE	Steady-state Visual Evoked Potential (SSVEP) outperforms the other types of ERPs for Brain-computer Interface (BCI), and thus it is widely employed. In order to apply SSVEP-based BCI to real life situations, it is important to improve the accuracy and transfer rate of the system. Aimed at this target, many SSVEP extraction methods have been proposed. All these methods are based directly on the properties of SSVEP, such as power and phase. In this study, we first filtered out the target frequencies from the original EEG to get a new signal and then computed the similarity between the original EEG and the new signal. Based on this similarity, SSVEP in the original EEG can be identified. This method is referred to as SOB (Similarity of Background). The SOB method is used to detect SSVEP in 1s-length and 3s-length EEG segments respectively. The accuracy of detection is compared with its peers computed by the widely-used Power Spectrum (PS) method and the Canonical Coefficient (CC) method. The comparison results illustrate that the SOB method can lead to a higher accuracy than the PS method and CC method when detecting a short period SSVEP signal.	[Wu, Zhenghua] Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu 610054, Sichuan, Peoples R China; [Wu, Zhenghua] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Key Lab Neuro Informat, Minist Educ, Chengdu 610054, Sichuan, Peoples R China	University of Electronic Science & Technology of China; University of Electronic Science & Technology of China	Wu, ZH (corresponding author), Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu 610054, Sichuan, Peoples R China.	wzhzxwz@sina.com			Science and Technology Bureau of Sichuan Province [2013GZ0017]	Science and Technology Bureau of Sichuan Province	The work was supported by Science and Technology Bureau of Sichuan Province (#2013GZ0017), and the grant number is 40,000 $. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison BZ, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/1/013001; Allison BZ, 2012, J NEUROSCI METH, V209, P299, DOI 10.1016/j.jneumeth.2012.06.022; ALLISON BZ, 2005, 3 INT BRAIN COMP INT; Birbaumer N, 2007, J PHYSIOL-LONDON, V579, P621, DOI 10.1113/jphysiol.2006.125633; Cheng M, 2002, IEEE T BIO-MED ENG, V49, P1181, DOI 10.1109/TBME.2002.803536; DAVILA CE, 1994, IEEE T BIO-MED ENG, V41, P197, DOI 10.1109/10.284933; Diez PF, 2013, IFMBE PROC, V33, P1154; Friman O, 2007, IEEE T BIO-MED ENG, V54, P742, DOI 10.1109/TBME.2006.889160; Gao XR, 2003, IEEE T NEUR SYS REH, V11, P137, DOI 10.1109/TNSRE.2003.814449; Gary G.M., 2013, INT J AUTONOMOUS ADA, V6, P1; Gary G. M., 2013, BIOL MED PHYS BIOMED, V25, P269; Hwang HJ, 2012, J NEUROSCI METH, V208, P59, DOI 10.1016/j.jneumeth.2012.04.011; Lee PL, 2010, ANN BIOMED ENG, V38, P2383, DOI 10.1007/s10439-010-9964-y; Lin ZL, 2007, IEEE T BIO-MED ENG, V54, P1172, DOI 10.1109/TBME.2006.889197; Lopez MA, 2009, NEURAL PROCESS LETT, V29, P179, DOI 10.1007/s11063-009-9102-8; Lopez-Gordo MA, 2010, NEURAL PROCESS LETT, V32, P1, DOI 10.1007/s11063-010-9139-8; Luo A, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026010; McCullagh Paul, 2013, Universal Access in Human-Computer Interaction. Design Methods, Tools, and Interaction Techniques for eInclusion. 7th International Conference, UAHCI 2013 Held as Part of HCI International 2013. Proceedings. LNCS 8009, P530, DOI 10.1007/978-3-642-39188-0_57; Ortiz-Rosario A., 2013, REV NEUROSCIENCES, V24, P455; Ortner R, 2011, IEEE T NEUR SYS REH, V19, P1, DOI 10.1109/TNSRE.2010.2076364; Volosyak I, 2011, IEEE T NEUR SYS REH, V19, P232, DOI 10.1109/TNSRE.2011.2121919; Wang YJ, 2004, P ANN INT IEEE EMBS, V26, P4507; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Wu ZH, 2008, J NEURAL ENG, V5, P36, DOI 10.1088/1741-2560/5/1/004; Yin EW, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026012; Zhu DH, 2011, LECT NOTES COMPUT SC, V6766, P645, DOI 10.1007/978-3-642-21663-3_70	26	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93884	10.1371/journal.pone.0093884	http://dx.doi.org/10.1371/journal.pone.0093884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709951	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800063
J	Jaberi-Douraki, M; Pietropaolo, M; Khadra, A				Jaberi-Douraki, Majid; Pietropaolo, Massimo; Khadra, Anmar			Predictive Models of Type 1 Diabetes Progression: Understanding T-Cell Cycles and Their Implications on Autoantibody Release	PLOS ONE			English	Article							CLASS-II TETRAMERS; AUTOIMMUNITY; IMMUNE; COMPETITION; ACTIVATION; IMMUNOLOGY; EPITOPES; RECEPTOR; IDENTIFICATION; PROLIFERATION	Defining the role of T-cell avidity and killing efficacy in forming immunological response(s), leading to relapse-remission and autoantibody release in autoimmune type 1 diabetes (T1D), remains incompletely understood. Using competition-based population models of T-and B-cells, we provide a predictive tool to determine how these two parametric quantities, namely, avidity and killing efficacy, affect disease outcomes. We show that, in the presence of T-cell competition, successive waves along with cyclic fluctuations in the number of T-cells are exhibited by the model, with the former induced by transient bistability and the latter by transient periodic orbits. We hypothesize that these two immunological processes are responsible for making T1D a relapsing-remitting disease within prolonged but limited durations. The period and the number of peaks of these two processes differ, making them potential candidates to determine how plausible waves and cyclic fluctuations are in producing such effects. By assuming that T-cell and B-cell avidities are correlated, we demonstrate that autoantibodies associated with the higher avidity T-cell clones are first to be detected, and they reach their detectability level faster than those associated with the low avidity clones, independent of what T-cell killing efficacies are. Such outcomes are consistent with experimental observations in humans and they provide a rationale for observing rapid and slow progressors of T1D in high risk subjects. Our analysis of the models also reveals that it is possible to improve disease outcomes by unexpectedly increasing the avidity of certain subclones of T-cells. The decline in the number of beta-cells in these cases still occurs, but it terminates early, leaving sufficient number of functioning beta-cells in operation and the affected individual asymptomatic. These results indicate that the models presented here are of clinical relevance because of their potential use in developing predictive algorithms of rapid and slow progression to clinical T1D.	[Jaberi-Douraki, Majid; Khadra, Anmar] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [Pietropaolo, Massimo] Univ Michigan, Immunogenet Lab, Ann Arbor, MI 48109 USA	McGill University; University of Michigan System; University of Michigan	Khadra, A (corresponding author), McGill Univ, Dept Physiol, Montreal, PQ, Canada.	anmar.khadra@mcgill.ca			National Institutes of Health [R01 DK53456, R01 DK56200, R21 DK073724]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK073724, R01DK056200, R01DK053456, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (grants R01 DK53456, R01 DK56200, and R21 DK073724). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HK, 2011, B MATH BIOL, V73, P33, DOI 10.1007/s11538-010-9519-2; Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Arazi A, 2010, J THEOR BIOL, V267, P426, DOI 10.1016/j.jtbi.2010.08.033; Arazi A, 2013, SEMIN IMMUNOL, V25, P193, DOI 10.1016/j.smim.2012.11.003; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; BONIFACIO E, 1995, J IMMUNOL, V155, P5419; Borg H, 1997, CLIN CHEM, V43, P2358; Borghans JAM, 1999, P NATL ACAD SCI USA, V96, P10782, DOI 10.1073/pnas.96.19.10782; Delitala M, 2013, COMPUT MATH APPL, V66, P1010, DOI 10.1016/j.camwa.2013.06.026; DeNiro M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050360; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Galea I, 2012, EUR J IMMUNOL, V42, P256, DOI 10.1002/eji.201142010; Hawa M, 1997, DIABETES, V46, P1270, DOI 10.2337/diabetes.46.8.1270; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; James EA, 2009, J VISUALIZED EXPT JO; Janeway C., 2001, IMMUNOBIOLOGY, V5th; Kawasaki E, 2012, ENDOCR J, V59, P531, DOI 10.1507/endocrj.EJ12-0069; Khadra A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014796; Khadra A, 2009, J THEOR BIOL, V256, P126, DOI 10.1016/j.jtbi.2008.09.019; Lejeune O, 2008, MATH COMPUT MODEL, V47, P649, DOI 10.1016/j.mcm.2007.02.026; Liu Y, 2008, ANN NY ACAD SCI, V1150, P245, DOI 10.1196/annals.1447.035; Mahaffy JM, 2007, SIAM J APPL MATH, V67, P915, DOI 10.1137/060661144; Mallone R, 2005, BLOOD, V106, P2798, DOI 10.1182/blood-2004-12-4848; Maree AFM, 2006, INT IMMUNOL, V18, P1067, DOI 10.1093/intimm/dxl040; Margulies DH, 1997, CURR OPIN IMMUNOL, V9, P390, DOI 10.1016/S0952-7915(97)80086-6; Miao DM, 2007, FRONT BIOSCI-LANDMRK, V12, P1889, DOI 10.2741/2195; Morran MP, 2008, MT SINAI J MED, V75, P314, DOI 10.1002/msj.20052; Morran MP, 2010, ENDOCRINOLOGY, V151, P2528, DOI 10.1210/en.2009-1257; Nelson P, 2009, MATH BIOSCI ENG, V6, P753, DOI 10.3934/mbe.2009.6.753; Oling V, 2005, J AUTOIMMUN, V25, P235, DOI 10.1016/j.jaut.2005.09.018; Parham P, 2009, IMMUNE SYSTEM, V3rd; Peakman M, 1999, J CLIN INVEST, V104, P1449, DOI 10.1172/JCI7936; Peakman M, 2001, DIABETES, V50, P1749, DOI 10.2337/diabetes.50.8.1749; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Pietropaolo M, 2002, DIABETOLOGIA, V45, P66, DOI 10.1007/s125-002-8246-5; Pietropaolo M, 2008, DIABETES, V57, P2872, DOI 10.2337/db07-1691; Pietropaolo M, 2007, DIABETES, V56, P1189, DOI 10.2337/db06-0880; Pietropaolo M, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012831; Reijonen H, 2002, DIABETES, V51, P1375, DOI 10.2337/diabetes.51.5.1375; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Scherer A, 2006, PLOS COMPUT BIOL, V2, P948, DOI 10.1371/journal.pcbi.0020109; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Standifer NE, 2006, DIABETES, V55, P3061, DOI 10.2337/db06-0066; Trudeau JD, 2003, J CLIN INVEST, V111, P217, DOI 10.1172/JCI200316409; Uibo R, 2008, ADV IMMUNOL, V100, P39, DOI 10.1016/S0065-2776(08)00803-1; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; Velthuis JH, 2010, DIABETES, V59, P1721, DOI 10.2337/db09-1486; Vendrame F, 2010, DIABETES, V59, P947, DOI 10.2337/db09-0498; Viola A, 1996, SCIENCE, V273, P104, DOI 10.1126/science.273.5271.104; von Herrath M, 2007, NAT REV IMMUNOL, V7, P988, DOI 10.1038/nri2192; Wells AD, 1997, J CLIN INVEST, V100, P3173, DOI 10.1172/JCI119873; Wenzlau JM, 2008, ANN NY ACAD SCI, V1150, P256, DOI 10.1196/annals.1447.029	54	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93326	10.1371/journal.pone.0093326	http://dx.doi.org/10.1371/journal.pone.0093326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705439	gold, Green Published, Green Submitted			2022-12-25	WOS:000334107500031
J	Totrov, M				Totrov, Maxim			Estimated Secondary Structure Propensities within V1/V2 Region of HIV gp120 Are an Important Global Antibody Neutralization Sensitivity Determinant	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN TRIMER; VARIABLE REGIONS; VACCINE EFFICACY; AMINO-ACIDS; FREE-ENERGY; V2 DOMAIN; PROTEIN; LOOP; CONFORMATION	Background: Neutralization sensitivity of HIV-1 virus to antibodies and anti-sera varies greatly between the isolates. Significant role of V1/V2 domain as a global neutralization sensitivity regulator has been suggested. Recent X-ray structures revealed presence of well-defined tertiary structure within this domain but also demonstrated partial disorder and conformational heterogeneity. Methods: Correlations of neutralization sensitivity with the conformational propensities for beta-strand and alpha-helix formation over the entire folded V1/V2 domain as well as within sliding 5-residue window were investigated. Analysis was based on a set of neutralization data for 106 HIV isolates for which consistent neutralization sensitivity measurements against multiple pools of human immune sera have been previously reported. Results: Significant correlation between beta-sheet formation propensity of the folded segments of V1/V2 domain and neutralization sensitivity was observed. Strongest correlation peaks localized to the beta-strands B and C. Correlation persisted when subsets of HIV isolates belonging to clades B, C and circulating recombinant form BC where analyzed individually or in combinations. Conclusions: Observed correlations suggest that stability of the beta-sheet structure and/or degree of structural disorder in the V1/V2 domain is an important determinant of the global neutralization sensitivity of HIV-1 virus. While specific mechanism is to yet to be investigated, plausible hypothesis is that less ordered V1/V2s may have stronger masking effect on various neutralizing epitopes, perhaps effectively occupying larger volume and thereby occluding antibody access.	Molsoft LLC, San Diego, CA 92121 USA		Totrov, M (corresponding author), Molsoft LLC, San Diego, CA 92121 USA.	max@molsoft.com		totrov, maxim/0000-0001-8594-274X	NIAID [5P01AI100151]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI100151] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a subcontract of the NIAID grant 5P01AI100151. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Abagyan R, 2013, ICM USER MANUAL; Cao J, 1997, J VIROL, V71, P9808, DOI 10.1128/JVI.71.12.9808-9812.1997; Ching LK, 2008, J VIROL, V82, P949, DOI 10.1128/JVI.02143-07; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; Cohen J., 2003, APPL MULTIPLE REGRES; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Edgington E.S., 2007, RANDOMIZATION TESTS; Gallo SA, 2003, BBA-BIOMEMBRANES, V1614, P36, DOI 10.1016/S0005-2736(03)00161-5; Haim H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002101; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Karasavvas N, 2012, AIDS RES HUM RETROV, V28, P1444, DOI 10.1089/aid.2012.0103; Krachmarov CP, 2006, J VIROL, V80, P7127, DOI 10.1128/JVI.02619-05; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Liu L, 2011, P NATL ACAD SCI USA, V108, P20148, DOI 10.1073/pnas.1104840108; Magnus C, 2013, J IMMUNOL METHODS; Mao YD, 2013, P NATL ACAD SCI USA, V110, P12438, DOI 10.1073/pnas.1307382110; Mayr LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070859; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; MUNOZ V, 1995, J MOL BIOL, V245, P275, DOI 10.1006/jmbi.1994.0023; Nakamura GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039045; NEMETHY G, 1966, J PHYS CHEM-US, V70, P998, DOI 10.1021/j100876a008; O'Rourke SM, 2012, J VIROL, V86, P12105, DOI 10.1128/JVI.01352-12; O'Rourke SM, 2010, J VIROL, V84, P11200, DOI 10.1128/JVI.00790-10; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pinter A, 2004, J VIROL, V78, P5205, DOI 10.1128/JVI.78.10.5205-5215.2004; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Rusert P, 2011, J EXP MED, V208, P1419, DOI 10.1084/jem.20110196; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; SMITH CK, 1994, BIOCHEMISTRY-US, V33, P5510, DOI 10.1021/bi00184a020; Stamatatos L, 1998, J VIROL, V72, P7840, DOI 10.1128/JVI.72.10.7840-7845.1998; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang J, 1996, J AM CHEM SOC, V118, P995, DOI 10.1021/ja953347o; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; WILLIAMS RW, 1987, BIOCHIM BIOPHYS ACTA, V916, P200, DOI 10.1016/0167-4838(87)90109-9; WYATT R, 1993, J VIROL, V67, P4557, DOI 10.1128/JVI.67.8.4557-4565.1993; Xue B, 2012, CELL MOL LIFE SCI, V69, P1211, DOI 10.1007/s00018-011-0859-3; Xue B, 2010, PROTEIN PEPTIDE LETT, V17, P932, DOI 10.2174/092986610791498984; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	47	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94002	10.1371/journal.pone.0094002	http://dx.doi.org/10.1371/journal.pone.0094002			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705879	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500108
J	Villumsen, KR; Neumann, L; Ohtani, M; Strom, HK; Raida, MK				Villumsen, Kasper Romer; Neumann, Lukas; Ohtani, Maki; Strom, Helene Kragelund; Raida, Martin Kristian			Oral and Anal Vaccination Confers Full Protection against Enteric Redmouth Disease (ERM) in Rainbow Trout	PLOS ONE			English	Article							ONCORHYNCHUS-MYKISS WALBAUM; YERSINIA-RUCKERI BACTERINS; SALMO-GAIRDNERI RICHARDSON; RED MOUTH-DISEASE; VIBRIO-ANGUILLARUM; BIOTYPE 2; GENE-EXPRESSION; IMMUNE-RESPONSE; ANTIGEN UPTAKE; TELEOST FISH	The effect of oral vaccines against bacterial fish diseases has been a topic for debate for decades. Recently both M-like cells and dendritic cells have been discovered in the intestine of rainbow trout. It is therefore likely that antigens reaching the intestine can be taken up and thereby induce immunity in orally vaccinated fish. The objective of this project was to investigate whether oral and anal vaccination of rainbow trout induces protection against an experimental waterborne infection with the pathogenic enterobacteria Yersinia ruckeri O1 biotype 1 the causative agent of enteric redmouth disease (ERM). Rainbow trout were orally vaccinated with AquaVac ERM Oral (MERCK Animal Health) or an experimental vaccine bacterin of Y. ruckeri O1. Both vaccines were tested with and without a booster vaccination four months post the primary vaccination. Furthermore, two groups of positive controls were included, one group receiving the experimental oral vaccine in a 50 times higher dose, and the other group receiving a single dose administered anally in order to bypass the stomach. Each group was bath challenged with 6.3X10(8) CFU/ml Y. ruckeri, six months post the primary vaccination. The challenge induced significant mortality in all the infected groups except for the groups vaccinated anally with a single dose or orally with the high dose of bacterin. Both of these groups had 100% survival. These results show that a low dose of Y. ruckeri bacterin induces full protection when the bacterin is administered anally. Oral vaccination also induces full protection, however, at a dose 50 times higher than if the fish were to be vaccinated anally. This indicates that much of the orally fed antigen is digested in the stomach before it reaches the second segment of the intestine where it can be taken up as immunogenic antigens and presented to lymphocytes.	[Villumsen, Kasper Romer; Neumann, Lukas; Ohtani, Maki; Strom, Helene Kragelund; Raida, Martin Kristian] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Res Grp Fish Dis & Immunol,Sect Vet Clin Microbio, Copenhagen, Denmark	University of Copenhagen	Raida, MK (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Res Grp Fish Dis & Immunol,Sect Vet Clin Microbio, Copenhagen, Denmark.	mr@sund.ku.dk	Villumsen, Kasper Rømer/L-2471-2019	Villumsen, Kasper Rømer/0000-0002-0616-4095	Danish Research Council [11-105095]	Danish Research Council(Det Frie Forskningsrad (DFF))	This work was funded by a Sapere Aude Grant 11-105095 from the Danish Research Council, entitled: "Understanding Key Mechanisms in Mucosal Immunity: Development of a New Immersion Vaccine''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMEND DF, 1983, J FISH DIS, V6, P337, DOI 10.1111/j.1365-2761.1983.tb00085.x; ANDERSON DP, 1972, PROG FISH CULT, V34, P226, DOI 10.1577/1548-8659(1972)34[226:CSOHRD]2.0.CO;2; ANDERSON DP, 1974, J FISH RES BOARD CAN, V31, P214, DOI 10.1139/f74-035; ANTIPA R, 1980, J FISH DIS, V3, P161, DOI 10.1111/j.1365-2761.1980.tb00199.x; Arias CR, 2007, J AQUAT ANIM HEALTH, V19, P35, DOI 10.1577/H06-011.1; Austin DA, 2003, SYST APPL MICROBIOL, V26, P127, DOI 10.1078/072320203322337416; Bullock G.L., 1984, ENTERIC REDMOUTH DIS; BUSCH RA, 1978, MAR FISH REV, V40, P42; BUSCH RA, 1975, J FISH RES BOARD CAN, V32, P2429, DOI 10.1139/f75-279; Cagirgan H, 1998, J APPL ICHTHYOL, V14, P239, DOI 10.1111/j.1439-0426.1998.tb00649.x; Cain KD, 2000, FISH SHELLFISH IMMUN, V10, P651, DOI 10.1006/fsim.2000.0280; Chettri JK, 2012, DEV COMP IMMUNOL, V36, P463, DOI 10.1016/j.dci.2011.08.014; Chettri JK, 2013, VET IMMUNOL IMMUNOP, V154, P42, DOI 10.1016/j.vetimm.2013.04.001; DAVIDSON GA, 1993, DEV COMP IMMUNOL, V17, P373, DOI 10.1016/0145-305X(93)90008-E; Deshmukh S, 2012, VET IMMUNOL IMMUNOP, V145, P379, DOI 10.1016/j.vetimm.2011.12.014; Duff DCB, 1942, J IMMUNOL, V44, P87; Evenhuis JP, 2014, DEV COMP IMMUNOL, V44, P145, DOI 10.1016/j.dci.2013.12.004; Evenhuis JP, 2012, VET IMMUNOL IMMUNOP, V146, P8, DOI 10.1016/j.vetimm.2012.01.008; EWING WH, 1978, INT J SYST BACTERIOL, V28, P37, DOI 10.1099/00207713-28-1-37; Fouz B, 2006, J FISH DIS, V29, P339, DOI 10.1111/j.1365-2761.2006.00723.x; Fuglem B, 2010, DEV COMP IMMUNOL, V34, P768, DOI 10.1016/j.dci.2010.02.007; GEORGOPOULOU U, 1986, DEV COMP IMMUNOL, V10, P529, DOI 10.1016/0145-305X(86)90174-6; Gravningen K, 1998, J APPL ICHTHYOL, V14, P163, DOI 10.1111/j.1439-0426.1998.tb00636.x; Hansen JD, 2005, P NATL ACAD SCI USA, V102, P6919, DOI 10.1073/pnas.0500027102; Horne MT, 1999, FISH DISEASES AND DISORDERS, VOL 3, P455; JOBLING M, 1981, J FISH BIOL, V19, P439, DOI 10.1111/j.1095-8649.1981.tb05847.x; JOHNSON KA, 1983, J FISH DIS, V6, P331, DOI 10.1111/j.1365-2761.1983.tb00084.x; JOHNSON KA, 1983, J FISH DIS, V6, P473, DOI 10.1111/j.1365-2761.1983.tb00101.x; Khimmakthong U, 2013, MICROB PATHOGENESIS, V59-60, P33, DOI 10.1016/j.micpath.2013.03.001; Merck-animal-health, 2014, AQUAVAC ERM OR; Newman Stephen G., 1993, Annual Review of Fish Diseases, V3, P145, DOI 10.1016/0959-8030(93)90033-8; Plant KP, 2011, DEV COMP IMMUNOL, V35, P1256, DOI 10.1016/j.dci.2011.03.007; Press CM, 1996, J FISH DIS, V19, P215, DOI 10.1111/j.1365-2761.1996.tb00128.x; Raida MK, 2008, VACCINE, V26, P1050, DOI 10.1016/j.vaccine.2007.12.029; Raida MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018832; Raida MK, 2008, FISH SHELLFISH IMMUN, V25, P533, DOI 10.1016/j.fsi.2008.07.008; ROBOHM RA, 1986, DEV COMP IMMUNOL, V10, P145; ROSS AJ, 1965, J FISH RES BOARD CAN, V22, P713, DOI 10.1139/f65-063; ROSS AJ, 1966, CAN J MICROBIOL, V12, P763, DOI 10.1139/m66-103; Ruckner R. R., 1966, Bulletin Office International des Epizooties, V65, P825; Salinas I, 2011, DEV COMP IMMUNOL, V35, P1346, DOI 10.1016/j.dci.2011.11.009; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Stevenson RMW, 1997, DEV BIOLOGICALS, V90, P117; TATNER MF, 1987, AQUACULTURE, V62, P173, DOI 10.1016/0044-8486(87)90164-5; TATNER MF, 1984, AQUACULTURE, V41, P193, DOI 10.1016/0044-8486(84)90282-5; Tebbit G. L., 1981, Developments in Biological Standardization, V49, P395; Tobar JA, 2011, VACCINE, V29, P2336, DOI 10.1016/j.vaccine.2010.12.107; Tobback E, 2007, J FISH DIS, V30, P257, DOI 10.1111/j.1365-2761.2007.00816.x; Tobback E, 2010, DIS AQUAT ORGAN, V90, P175, DOI 10.3354/dao02230; Vandenberg Grant W., 2004, Animal Health Research Reviews, V5, P301, DOI 10.1079/AHR200488; Welch TJ, 2011, APPL ENVIRON MICROB, V77, P3493, DOI 10.1128/AEM.02997-10; Wheeler RW, 2009, DIS AQUAT ORGAN, V84, P25, DOI 10.3354/dao02039; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913	53	33	33	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93845	10.1371/journal.pone.0093845	http://dx.doi.org/10.1371/journal.pone.0093845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705460	Green Published, Green Submitted, gold			2022-12-25	WOS:000334107500077
J	Zhu, FR; Zheng, YJ; Ding, YQ; Liu, Y; Zhang, XH; Wu, RR; Guo, XF; Zhao, JP				Zhu, Furong; Zheng, Yingjun; Ding, Yu-qiang; Liu, Yong; Zhang, Xianghui; Wu, Renrong; Guo, Xiaofeng; Zhao, Jingping			Minocycline and Risperidone Prevent Microglia Activation and Rescue Behavioral Deficits Induced by Neonatal Intrahippocampal Injection of Lipopolysaccharide in Rats	PLOS ONE			English	Article							IN-VITRO; SCHIZOPHRENIA; MICE; NEUROINFLAMMATION; MODEL; METHAMPHETAMINE; HYPERLOCOMOTION	Background: Various signs of activation of microglia have been reported in schizophrenia, and it is hypothesized that microglia activation is closely associated with the neuropathology of schizophrenia. Methods: Neonatal intrahippocampal injection of lipopolysaccharide (LPS), an activator of microglia, was performed in rats at postnatal day 7 (P7), and they were separately given saline, risperidone (0.5 mg/kg), minocycline (40 mg/kg) or a combination of both of them at P42 for consecutive 14 days. Behavioral changes ( locomotion activity, social interaction, novel object recognition and prepulse inhibition) were examined and the number of microglia was assessed by using immunohistochemistry in adulthood. Results: The adult rats in LPS-injected group showed obvious behavioral alteration ( e. g. deficits in social interaction, novel object recognition and prepulse inhibition) and a dramatic increase of number of activated microglial cells in the hippocampus and other brain regions such as cerebral cortex and thalamus compared to those in saline-injected group. Interestingly, application of either minocycline, risperidone or both of them significantly rescued behavioral deficits and attenuated microglia activation. Conclusion: Our results suggest that inhibition of microglia activation may be one of mechanisms underlying the antipsychotic effect of minocycline and risperidone.	[Zhu, Furong; Zheng, Yingjun; Ding, Yu-qiang; Liu, Yong; Zhang, Xianghui; Wu, Renrong; Guo, Xiaofeng; Zhao, Jingping] Cent S Univ, Key Lab Psychiat & Mental Hlth Hunan Prov, Natl Technol Inst Psychiat, Xiangya Hosp 2,Mental Hlth Inst, Changsha, Hunan, Peoples R China; [Zheng, Yingjun] Guangzhou Med Univ, Affiliated Hosp, Guangzhou Brain Hosp, Dept Gen Psychiat, Guangzhou, Guangdong, Peoples R China; [Ding, Yu-qiang] Tongji Univ, Sch Med, Dept Anat & Neurobiol, Shanghai 200092, Peoples R China	Central South University; Guangzhou Medical University; Tongji University	Zhao, JP (corresponding author), Cent S Univ, Key Lab Psychiat & Mental Hlth Hunan Prov, Natl Technol Inst Psychiat, Xiangya Hosp 2,Mental Hlth Inst, Changsha, Hunan, Peoples R China.	zhaojingpingcsu@163.com	zhao, jing/B-3868-2019	Ding, Yu-Qiang/0000-0003-1202-4635	Natural Science Foundation of China (NSFC) [81071093]; National Research and Development Program for Health Professions [201002003]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Research and Development Program for Health Professions	The present study was supported by Natural Science Foundation of China (NSFC, 81071093), National Research and Development Program for Health Professions (Project No. 201002003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Amann LC, 2010, BRAIN RES BULL, V83, P147, DOI 10.1016/j.brainresbull.2010.04.008; Bayer TA, 1999, NEUROSCI LETT, V271, P126, DOI 10.1016/S0304-3940(99)00545-5; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Chaves C, 2009, BRAZ J MED BIOL RES, V42, P1002, DOI 10.1590/S0100-879X2009001100002; Feleder C, 2010, BIOL PSYCHIAT, V67, P386, DOI 10.1016/j.biopsych.2009.09.028; Fujita Y, 2008, PROG NEURO-PSYCHOPH, V32, P336, DOI 10.1016/j.pnpbp.2007.08.031; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Jhamnani K, 2013, J NEUROPSYCH CLIN N, V25, pE6, DOI 10.1176/appi.neuropsych.11120376; Kato T, 2007, SCHIZOPHR RES, V92, P108, DOI 10.1016/j.schres.2007.01.019; Kato TA, 2011, SCHIZOPHR RES, V129, P172, DOI 10.1016/j.schres.2011.03.019; Lee M, 2013, CURR PROTEIN PEPT SC, V14, P21, DOI 10.2174/1389203711314010005; Lee SY, 2010, NEUROCHEM INT, V57, P600, DOI 10.1016/j.neuint.2010.07.008; Levkovitz Y, 2010, J CLIN PSYCHIAT, V71, P138, DOI 10.4088/JCP.08m04666yel; MacDowell KS, 2013, INT J NEUROPSYCHOPH, V16, P121, DOI 10.1017/S1461145711001775; Manitz MP, 2013, SCHIZOPHR RES, V143, P221, DOI 10.1016/j.schres.2012.10.028; Mizoguchi H, 2008, PSYCHOPHARMACOLOGY, V196, P233, DOI 10.1007/s00213-007-0955-0; Monji A, 2013, PROG NEURO-PSYCHOPH, V42, P115, DOI 10.1016/j.pnpbp.2011.12.002; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; Radewicz K, 2000, J NEUROPATH EXP NEUR, V59, P137, DOI 10.1093/jnen/59.2.137; Ratnayake U, 2012, BRAIN BEHAV IMMUN, V26, P1288, DOI 10.1016/j.bbi.2012.08.011; Richtand NM, 2011, J PSYCHIATR RES, V45, P1194, DOI 10.1016/j.jpsychires.2011.02.007; SamsDodd F, 1997, PSYCHOPHARMACOLOGY, V132, P303, DOI 10.1007/s002130050349; Schneider T, 2005, NEUROPSYCHOPHARMACOL, V30, P80, DOI 10.1038/sj.npp.1300518; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Tseng KY, 2009, BEHAV BRAIN RES, V204, P295, DOI 10.1016/j.bbr.2008.11.039; Van Amersfoort ES, 2003, CLIN MICROBIOL REV, V16, P379, DOI 10.1128/CMR.16.3.379-414.2003; van Berckel BN, 2008, BIOL PSYCHIAT, V64, P820, DOI 10.1016/j.biopsych.2008.04.025; Zhang L, 2007, NEUROPSYCHOPHARMACOL, V32, P2004, DOI 10.1038/sj.npp.1301313; Zhang L, 2006, PROG NEURO-PSYCHOPH, V30, P1381, DOI 10.1016/j.pnpbp.2006.05.015	29	67	69	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93966	10.1371/journal.pone.0093966	http://dx.doi.org/10.1371/journal.pone.0093966			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705495	Green Submitted, Green Published, gold			2022-12-25	WOS:000334107500098
J	Moktan, H; Guiraldelli, MF; Eyster, CA; Zhao, WX; Lee, CY; Mather, T; Camerini-Otero, RD; Sung, P; Zhou, DHH; Pezza, RJ				Moktan, Hem; Guiraldelli, Michel F.; Eyster, Craig A.; Zhao, Weixing; Lee, Chih-Ying; Mather, Timothy; Camerini-Otero, R. Daniel; Sung, Patrick; Zhou, Donghua H.; Pezza, Roberto J.			Solution Structure and DNA-binding Properties of the Winged Helix Domain of the Meiotic Recombination HOP2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR STRUCTURE DETERMINATION; CHROMOSOME SEGREGATION; HOP2-MND1 COMPLEX; OPERATOR COMPLEX; CHEMICAL-SHIFTS; MEIOSIS; MND1; INSIGHTS; REVEALS; RAD51	The HOP2 protein is required for efficient double-strand break repair which ensures the proper synapsis of homologous chromosomes and normal meiotic progression. We previously showed that in vitro HOP2 shows two distinctive activities: when it is incorporated into a HOP2-MND1 heterodimer, it stimulates DMC1 and RAD51 recombination activities, and the purified HOP2 alone is proficient in promoting strand invasion. The structural and biochemical basis of HOP2 action in recombination are poorly understood; therefore, they are the focus of this work. Herein, we present the solution structure of the amino-terminal portion of mouse HOP2, which contains a typical winged helix DNA-binding domain. Together with NMR spectral changes in the presence of double-stranded DNA, protein docking on DNA, and mutation analysis to identify the amino acids involved in DNA coordination, our results on the three-dimensional structure of HOP2 provide key information on the fundamental structural and biochemical requirements directing the interaction of HOP2 with DNA. These results, in combination with mutational experiments showing the role of a coiled-coil structural feature involved in HOP2 self-association, allow us to explain important aspects of the function of HOP2 in recombination.	[Moktan, Hem; Zhou, Donghua H.] Oklahoma State Univ, Dept Phys, Stillwater, OK 74078 USA; [Guiraldelli, Michel F.; Eyster, Craig A.; Lee, Chih-Ying; Pezza, Roberto J.] Oklahoma Med Res Fdn, Cell Cycle & Canc Biol Program, Oklahoma City, OK 73104 USA; [Zhao, Weixing; Sung, Patrick] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Mather, Timothy] Oklahoma Med Res Fdn, Cardiovasc Biol Program, Oklahoma City, OK 73104 USA; [Mather, Timothy] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Camerini-Otero, R. Daniel] NIDDK, Genet & Biochem Branch, NIH, Bethesda, MD 20892 USA; [Pezza, Roberto J.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73126 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma Medical Research Foundation; Yale University; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Oklahoma System; University of Oklahoma Health Sciences Center	Pezza, RJ (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Roberto-Pezza@omrf.org		zhao, weixing/0000-0001-5746-3696; Zhou, Donghua/0000-0002-6638-4014	NIGMS, National Institutes of Health [1P20GM103636]; Oklahoma Center for the Advancement of Science and Technology Grant [HR10-48S]; National Institutes of Health [GM097713]; Oklahoma Center for the Advancement of Science and Technology [HR12-050]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK052033] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Oklahoma Center for the Advancement of Science and Technology Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science and Technology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIGMS, National Institutes of Health Award 1P20GM103636 and by Oklahoma Center for the Advancement of Science and Technology Grant HR10-48S (to R. J. P.). This work was also supported by National Institutes of Health Grant GM097713 (to D. H. Z.) and Oklahoma Center for the Advancement of Science and Technology Grant HR12-050 (to D. H. Z.).	Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; BascomSlack CA, 1997, ADV GENET, V35, P253, DOI 10.1016/S0065-2660(08)60452-6; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Blanco AG, 2002, STRUCTURE, V10, P701, DOI 10.1016/S0969-2126(02)00761-X; Boudet J, 2007, NUCLEIC ACIDS RES, V35, P4384, DOI 10.1093/nar/gkm448; Boura E, 2010, ACTA CRYSTALLOGR D, V66, P1351, DOI 10.1107/S0907444910042228; Chen YK, 2004, P NATL ACAD SCI USA, V101, P10572, DOI 10.1073/pnas.0404195101; Chi P, 2007, GENE DEV, V21, P1747, DOI 10.1101/gad.1563007; COSTA RH, 1989, MOL CELL BIOL, V9, P1415, DOI 10.1128/MCB.9.4.1415; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Finnin MS, 1997, EMBO J, V16, P1992, DOI 10.1093/emboj/16.8.1992; Gajiwala KS, 2000, NATURE, V403, P916, DOI 10.1038/35002634; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Garnett JA, 2008, J MOL BIOL, V379, P284, DOI 10.1016/j.jmb.2008.03.007; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Huang YJ, 2005, J AM CHEM SOC, V127, P1665, DOI 10.1021/ja047109h; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jin CW, 1999, J MOL BIOL, V289, P683, DOI 10.1006/jmbi.1999.2819; Kitano K, 2010, STRUCTURE, V18, P177, DOI 10.1016/j.str.2009.12.011; Ko J, 2011, NUCLEIC ACIDS RES, V39, pW210, DOI 10.1093/nar/gkr352; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leu JY, 1998, CELL, V94, P375, DOI 10.1016/S0092-8674(00)81480-4; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Petukhova GV, 2005, NAT STRUCT MOL BIOL, V12, P449, DOI 10.1038/nsmb923; Petukhova GV, 2003, DEV CELL, V5, P927, DOI 10.1016/S1534-5807(03)00369-1; Pezza RJ, 2007, GENE DEV, V21, P1758, DOI 10.1101/gad.1562907; Pezza RJ, 2006, J BIOL CHEM, V281, P18426, DOI 10.1074/jbc.M601073200; Pezza RJ, 2014, NUCLEIC ACIDS RES, V42, P2346, DOI 10.1093/nar/gkt1234; Raman S, 2010, J AM CHEM SOC, V132, P202, DOI 10.1021/ja905934c; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shen Y, 2009, J BIOMOL NMR, V43, P63, DOI 10.1007/s10858-008-9288-5; Spronk CAEM, 2004, PROG NUCL MAG RES SP, V45, P315, DOI 10.1016/j.pnmrs.2004.08.003; Tang Yuefeng, 2010, Journal of Structural and Functional Genomics, V11, P223, DOI 10.1007/s10969-010-9095-6; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; Van Melckebeke H, 2003, J MOL BIOL, V333, P711, DOI 10.1016/j/jmb.2003.09.005; Zhang APP, 2010, NATURE, V466, P883, DOI 10.1038/nature09200; Zhao WX, 2014, NUCLEIC ACIDS RES, V42, P906, DOI 10.1093/nar/gkt924; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	43	10	10	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14682	14691		10.1074/jbc.M114.548180	http://dx.doi.org/10.1074/jbc.M114.548180			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24711446	Green Published, hybrid			2022-12-25	WOS:000337248100025
J	Kopecka, M; Kosek, D; Kukacka, Z; Rezabkova, L; Man, P; Novak, P; Obsil, T; Obsilova, V				Kopecka, Miroslava; Kosek, Dalibor; Kukacka, Zdenek; Rezabkova, Lenka; Man, Petr; Novak, Petr; Obsil, Tomas; Obsilova, Veronika			Role of the EF-hand-like Motif in the 14-3-3 Protein- mediated Activation of Yeast Neutral Trehalase Nth1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Calcium; Enzyme Mechanisms; Mass Spectrometry (MS); Protein Cross-linking; Protein Structure; 14-3-3; Bmh; H; D Exchange; SAXS; Neutral Trehalase	STRUCTURAL BASIS; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; 14-3-3-PROTEINS; PHOSPHORYLATION; GENE; MACROMOLECULES; INHIBITION; METABOLISM; CALCIUM	Background: The yeast neutral trehalase Nth1 is activated by the 14-3-3 protein binding. Results: The 14-3-3 protein induces a structural rearrangement of Nth1 with changes within the EF-hand like motif being essential for the activation process. Conclusion: The EF-hand-like motif-containing domain is crucial for the 14-3-3-dependent activation of Nth1. Significance: Structural basis of the mechanism of Nth1 activation. Trehalases hydrolyze the non-reducing disaccharide trehalose amassed by cells as a universal protectant and storage carbohydrate. Recently, it has been shown that the activity of neutral trehalase Nth1 from Saccharomyces cerevisiae is mediated by the 14-3-3 protein binding that modulates the structure of both the catalytic domain and the region containing the EF-hand-like motif, whose role in the activation of Nth1 is unclear. In this work, the structure of the Nth114-3-3 complex and the importance of the EF-hand-like motif were investigated using site-directed mutagenesis, hydrogen/deuterium exchange coupled to mass spectrometry, chemical cross-linking, and small angle x-ray scattering. The low resolution structural views of Nth1 alone and the Nth114-3-3 complex show that the 14-3-3 protein binding induces a significant structural rearrangement of the whole Nth1 molecule. The EF-hand-like motif-containing region forms a separate domain that interacts with both the 14-3-3 protein and the catalytic trehalase domain. The structural integrity of the EF-hand like motif is essential for the 14-3-3 protein-mediated activation of Nth1, and calcium binding, although not required for the activation, facilitates this process by affecting its structure. Our data suggest that the EF-hand like motif-containing domain functions as the intermediary through which the 14-3-3 protein modulates the function of the catalytic domain of Nth1.	[Kopecka, Miroslava; Kosek, Dalibor; Rezabkova, Lenka; Obsil, Tomas; Obsilova, Veronika] Acad Sci Czech Republ, Inst Physiol, Vvi, CR-14220 Prague, Czech Republic; [Kukacka, Zdenek; Man, Petr; Novak, Petr] Acad Sci Czech Republ, Inst Microbiol, Vvi, CR-14220 Prague, Czech Republic; [Kopecka, Miroslava] Charles Univ Prague, Fac Med 2, Prague 15006, Czech Republic; [Kosek, Dalibor; Rezabkova, Lenka; Obsil, Tomas] Charles Univ Prague, Dept Phys & Macromol Chem, Prague 12843, Czech Republic; [Kukacka, Zdenek; Man, Petr; Novak, Petr] Charles Univ Prague, Dept Biochem, Prague 12843, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; Charles University Prague; Charles University Prague; Charles University Prague	Obsilova, V (corresponding author), Acad Sci Czech Republ, Inst Physiol, Vvi, Videnska 1083, CR-14220 Prague, Czech Republic.	obsilova@biomed.cas.cz	Rezabkova, Lenka/O-8229-2017; Kukacka, Zdenek/J-8816-2014; Novak, Petr/F-9655-2014; Alblova, Miroslava/A-4436-2015; Obsilova, Veronika/B-7116-2012; Man, Petr/H-2451-2014; Obsil, Tomas/B-7142-2012; Košek, Dalibor/AAD-4715-2021	Rezabkova, Lenka/0000-0002-7274-8080; Kukacka, Zdenek/0000-0001-7569-843X; Novak, Petr/0000-0001-8688-529X; Alblova, Miroslava/0000-0002-8073-8544; Obsilova, Veronika/0000-0003-4887-0323; Man, Petr/0000-0002-1485-2197; Obsil, Tomas/0000-0003-4602-1272; 	Czech Science Foundation [P207/11/0455]; Grant Agency of Charles University [644313, 800413]; Academy of Sciences of the Czech Republic Research Project of the Institute of Physiology [RVO: 67985823]; Academy of Sciences of the Czech Republic Research Project of the Institute of Microbiology [RVO: 61388971]; Academy of Sciences of the Czech Republic [OPPK CZ.2.16/3.1.00/24023]	Czech Science Foundation(Grant Agency of the Czech Republic); Grant Agency of Charles University; Academy of Sciences of the Czech Republic Research Project of the Institute of Physiology; Academy of Sciences of the Czech Republic Research Project of the Institute of Microbiology; Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	This work was supported by Czech Science Foundation Project P207/11/0455; Grant Agency of Charles University Grants 644313 and 800413; and Academy of Sciences of the Czech Republic Research Projects RVO: 67985823 of the Institute of Physiology and RVO: 61388971 of the Institute of Microbiology. Access to MS facilities was supported by Academy of Sciences of the Czech Republic Project OPPK CZ.2.16/3.1.00/24023.	Alizadeh P, 1996, FEBS LETT, V391, P273, DOI 10.1016/0014-5793(96)00751-X; Amaral FC, 1997, ARCH MICROBIOL, V167, P202, DOI 10.1007/s002030050436; Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; Behm CA, 1997, INT J PARASITOL, V27, P215, DOI 10.1016/S0020-7519(96)00151-8; Dam J, 2005, BIOPHYS J, V89, P619, DOI 10.1529/biophysj.105.059568; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Engen JR, 2009, ANAL CHEM, V81, P7870, DOI 10.1021/ac901154s; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Franco A, 2003, BIOCHEM J, V376, P209, DOI 10.1042/BJ20030825; Gibson RP, 2007, ANGEW CHEM INT EDIT, V46, P4115, DOI 10.1002/anie.200604825; Goodwin T. W., 1946, BIOCHEM JOUR, V40, P628; Iacob RE, 2012, J AM SOC MASS SPECTR, V23, P1003, DOI 10.1007/s13361-012-0377-z; Jules M, 2008, APPL ENVIRON MICROB, V74, P605, DOI 10.1128/AEM.00557-07; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; KOPP M, 1993, J BIOL CHEM, V268, P4766; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Macakova E, 2013, BBA-GEN SUBJECTS, V1830, P4491, DOI 10.1016/j.bbagen.2013.05.025; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; NWAKA S, 1995, FEBS LETT, V360, P286, DOI 10.1016/0014-5793(95)00105-I; Nwaka S, 1998, PROG NUCLEIC ACID RE, V58, P197; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Oesterreicher TJ, 2001, GENE, V270, P211, DOI 10.1016/S0378-1119(01)00474-7; ORITZ CH, 1983, J BACTERIOL, V153, P644, DOI 10.1128/JB.153.2.644-651.1983; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; Panni S, 2008, FEMS YEAST RES, V8, P53, DOI 10.1111/j.1567-1364.2007.00312.x; Paul G, 2009, GENOMICS, V94, P287, DOI 10.1016/j.ygeno.2009.07.004; Pernambuco MB, 1996, MICROBIOL-SGM, V142, P1775, DOI 10.1099/13500872-142-7-1775; Pisackova J, 2013, CRYST GROWTH DES, V13, P844, DOI 10.1021/cg301551v; Rashidi Hooman H., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P175; Rezabkova L, 2011, J BIOL CHEM, V286, P43527, DOI 10.1074/jbc.M111.273573; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Schepers W, 2012, J BIOL CHEM, V287, P44130, DOI 10.1074/jbc.M112.421503; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; UNO I, 1983, J BIOL CHEM, V258, P867; VANHEUSDEN GPH, 1995, EUR J BIOCHEM, V229, P45; Veisova D, 2012, BIOCHEM J, V443, P663, DOI 10.1042/BJ20111615; Veisova D, 2010, BIOCHEMISTRY-US, V49, P3853, DOI 10.1021/bi100273k; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wilson MA, 2000, J MOL BIOL, V301, P1237, DOI 10.1006/jmbi.2000.4029; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Young MM, 2000, P NATL ACAD SCI USA, V97, P5802, DOI 10.1073/pnas.090099097	47	21	22	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13948	13961		10.1074/jbc.M113.544551	http://dx.doi.org/10.1074/jbc.M113.544551			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24713696	hybrid, Green Published			2022-12-25	WOS:000335984600026
J	Huo, XL; Min, JJ; Pan, CY; Zhao, CC; Pan, LL; Gui, FF; Jin, L; Wang, XT				Huo, Xin-long; Min, Jing-jing; Pan, Cai-yu; Zhao, Cui-cui; Pan, Lu-lu; Gui, Fei-fei; Jin, Lu; Wang, Xiao-tong			Efficacy of Lovastatin on Learning and Memory Deficits Caused by Chronic Intermittent Hypoxia-Hypercapnia: Through Regulation of NR2B-Containing NMDA Receptor-ERK Pathway	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; GLUTAMATE NEUROTOXICITY; COGNITIVE FUNCTION; CORTICAL-NEURONS; PROTEIN-KINASES; LIPID RAFTS; CELL-DEATH; CHOLESTEROL; TRAFFICKING; RAS	Background: Chronic intermittent hypoxia- hypercapnia (CIHH) exposure leads to learnning and memory deficits in rats. Overactivation of N-methyl-D-aspartate receptors(NMDARs) can lead to the death of neurons through a process termed excitotoxicity, which is involved in CIHH-induced cognitive deficits. Excessively activated NR2B (GluN2B)-containing NMDARs was reported as the main cause of excitotoxicity. The ERK1/2 (extracellular signal-regulated kinase 1/2) signaling cascade acts as a key component in NMDARs-dependent neuronal plasticity and survival. Ca2+/calmodulin-dependent protein kinase II (CaMKII), synapse-associated protein 102 ( SAP102) and Ras GTPase-activating protein (SynGAP) have been shown to be involved in the regulation of NMDAR-ERK signalling cascade. Recent studies revealed statins (the HMG-CoA reductase inhibitor) have effect on the expression of NMDARs. The present study intends to explore the potential effect of lovastatin on CIHH-induced cognitive deficits and the NR2B-ERK signaling pathway. Methods and Findings: Eighty male Sprague Dawley rats were randomly divided into five groups. Except for those in the control group, the rats were exposed to chronic intermittent hypoxia-hypercapnia (CIHH) ( 9,11% O-2, 5.5,6.5% CO2) for 4 weeks. After lovastatin administration, the rats performed better in the Morris water maze test. Electron microscopy showed alleviated hippocampal neuronal synaptic damage. Further observation suggested that either lovastatin or ifenprodil (a selective NR2B antagonist) administration similarly downregulated NR2B subunit expression leading to a suppression of CaMKII/SAP102/SynGAP signaling cascade, which in turn enhanced the phosphorylation of ERK1/2. The phosphorylated ERK1/2 induced signaling cascade involving cAMP-response element-binding protein (CREB) phosphorylation and brainderived neurotrophic factor (BDNF) activation, which is responsible for neuroprotection. Conclusions: These findings suggest that the ameliorative cognitive deficits caused by lovastatin are due to the downregulation of excessive NR2B expression accompanied by increased expression of ERK signaling cascade. The effect of NR2B in upregulating pERK1/2 maybe due, at least in part, to inactivation of CaMKII/SAP102/SynGAP signaling cascade.	[Huo, Xin-long; Min, Jing-jing; Pan, Cai-yu; Zhao, Cui-cui; Pan, Lu-lu; Gui, Fei-fei; Jin, Lu; Wang, Xiao-tong] Wenzhou Med Univ, Affiliated Hosp 2, Ctr Neurol & Rehabil, Wenzhou, Peoples R China		Wang, XT (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Ctr Neurol & Rehabil, Wenzhou, Peoples R China.	doctorhxl@163.com			Medical Science Research Foundation of Zhejiang Province [Y205233]; Wenzhou City Science and Technology Bureau [Y2005A001]	Medical Science Research Foundation of Zhejiang Province; Wenzhou City Science and Technology Bureau	This research was supported by the Medical Science Research Foundation of Zhejiang Province grant (NO: Y205233) and by Wenzhou City Science and Technology Bureau grant (NO: Y2005A001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamodt S M, 1999, Adv Neurol, V79, P133; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chalovich EM, 2006, J BIOL CHEM, V281, P17870, DOI 10.1074/jbc.M602632200; Chen BS, 2011, J NEUROSCI, V31, P89, DOI 10.1523/JNEUROSCI.1034-10.2011; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131; Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003; Eisner MD, 2008, AM J MED, V121, P789, DOI 10.1016/j.amjmed.2008.04.030; Elias GM, 2007, TRENDS CELL BIOL, V17, P343, DOI 10.1016/j.tcb.2007.07.005; Etnier J, 1999, CHEST, V116, P953, DOI 10.1378/chest.116.4.953; Follesa P, 1996, J NEUROSCI, V16, P2172; Frank C, 2008, EXP NEUROL, V212, P407, DOI 10.1016/j.expneurol.2008.04.019; Gambrill AC, 2011, J NEUROPHYSIOLX, V14, P2425; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Harvey BH, 2012, PHARMACOL BIOCHEM BE, V100, P775, DOI 10.1016/j.pbb.2011.06.014; He X, 2006, J NEUROPATH EXP NEUR, V65, P652, DOI 10.1097/01.jnen.0000225906.82428.69; Hering H, 2003, J NEUROSCI, V23, P3262; Hetman M, 2006, CURR TOP MED CHEMX, V40, P775; Himi T, 2003, J NEUROSCI RES, V71, P679, DOI 10.1002/jnr.10510; Hindley A, 2002, J CELL SCI, V115, P1575; Hota SK, 2007, NEUROCHEM INT, V51, P384, DOI 10.1016/j.neuint.2007.04.003; Incalzi RA, 2003, J NEUROL, V250, P325, DOI 10.1007/s00415-003-1005-4; Jin KL, 2002, J NEUROCHEM, V80, P119, DOI 10.1046/j.0022-3042.2001.00678.x; Jonsson N, 2001, STROKE, V32, P1112, DOI 10.1161/01.STR.32.5.1112; Kannan M, 2010, NEUROBIOL AGING, V31, P1543, DOI 10.1016/j.neurobiolaging.2008.09.004; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kocsis B, 2012, BIOL PSYCHIAT, V71, P987, DOI 10.1016/j.biopsych.2011.10.002; Koudinov AR, 2001, FASEB J, V15, P1858, DOI 10.1096/fj.00-0815fje; Kozora E, 2000, CHEST, V117, p249S, DOI 10.1378/chest.117.5_suppl_1.249S; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Krysiak R, 2003, DRUGS, V63, P1821, DOI 10.2165/00003495-200363170-00005; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Liesker JJW, 2004, RESP MED, V98, P351, DOI 10.1016/j.rmed.2003.11.004; Maiti P, 2008, J CHEM NEUROANAT, V36, P227, DOI 10.1016/j.jchemneu.2008.07.003; Makino K, 1997, ONCOGENE, V14, P2425, DOI 10.1038/sj.onc.1201087; Marti-Fabregas J, 2004, STROKE, V35, P1117, DOI 10.1161/01.STR.0000125863.93921.3f; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRISETT RA, 1990, EUR J PHARMACOL, V176, P103, DOI 10.1016/0014-2999(90)90138-V; Nakazawa T, 2007, J NEUROCHEM, V100, P1018, DOI 10.1111/j.1471-4159.2006.04274.x; Oh JS, 2004, J BIOL CHEM, V279, P17980, DOI 10.1074/jbc.M314109200; OLNEY JW, 1971, EXP BRAIN RES, V14, P61; Pike LJ, 2009, J LIPID RES, V50, pS323, DOI 10.1194/jlr.R800040-JLR200; Ponce J, 2008, STROKE, V39, P1269, DOI 10.1161/STROKEAHA.107.498923; Gonzalez-Moro JMR, 2009, INT J CLIN PRACT, V63, P742, DOI 10.1111/j.1742-1241.2009.02040.x; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Stanika RI, 2009, P NATL ACAD SCI USA, V106, P9854, DOI 10.1073/pnas.0903546106; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Vizi ES, 2013, BRAIN RES BULL, V93, P32, DOI 10.1016/j.brainresbull.2012.10.005; Wang CX, 2005, CNS NEUROL DISORD-DR, V4, P143, DOI 10.2174/1568007053544183; Wang XT, 2007, J WENZHOU MED COLL, V5, P003; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Won SJ, 2002, J BIOCHEM MOL BIOL, V35, P67, DOI 10.5483/BMBRep.2002.35.1.067; Wroge CM, 2012, J NEUROSCI, V32, P6732, DOI 10.1523/JNEUROSCI.6371-11.2012; Yang Q, 2010, NEUROCHEM RES, V35, P1353, DOI 10.1007/s11064-010-0191-6; Yang XY, 2011, CHINESE J PATHOPHYSI, V3, P029; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Zheng GQ, 2008, MED HYPOTHESES, V71, P111, DOI 10.1016/j.mehy.2008.01.025; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	63	22	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94278	10.1371/journal.pone.0094278	http://dx.doi.org/10.1371/journal.pone.0094278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718106	Green Published, Green Submitted, gold			2022-12-25	WOS:000334339000101
J	Liu, WN; Yu, WN; Hou, LY; Wang, XY; Zheng, F; Wang, WX; Liang, D; Yang, HL; Jin, Y; Xie, XM				Liu, Weina; Yu, Wangning; Hou, Lingyu; Wang, Xiaoyu; Zheng, Fei; Wang, Weixuan; Liang, Di; Yang, Hailun; Jin, Yi; Xie, Xiangming			Analysis of miRNAs and Their Targets during Adventitious Shoot Organogenesis of Acacia crassicarpa	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; APICAL MERISTEM; PLANT MICRORNAS; TRANSCRIPTION FACTORS; REGULATORY ROLES; LEAF DEVELOPMENT; DOWN-REGULATION; ZYGOTIC EMBRYO; SMALL RNAS; IN-VITRO	Organogenesis is an important process for plant regeneration by tissue or cell mass differentiation to regenerate a complete plant. MicroRNAs (miRNAs) play an essential role in regulating plant development by mediating target genes at transcriptional and post-transcriptional levels, but the diversity of miRNAs and their potential roles in organogenesis of Acacia crassicarpa have rarely been investigated. In this study, approximately 10 million sequence reads were obtained from a small RNA library, from which 189 conserved miRNAs from 57 miRNA families, and 7 novel miRNAs from 5 families, were identified from A. crassicarpa organogenetic tissues. Target prediction for these miRNAs yielded 237 potentially unique genes, of which 207 received target Gene Ontology annotations. On the basis of a bioinformatic analysis, one novel and 13 conserved miRNAs were selected to investigate their possible roles in A. crassicarpa organogenesis by qRT-PCR. The stage-specific expression patterns of the miRNAs provided information on their possible regulatory functions, including shoot bud formation, modulated function after transfer of the culture to light, and regulatory roles during induction of organogenesis. This study is the first to investigate miRNAs associated with A. crassicarpa organogenesis. The results provide a foundation for further characterization of miRNA expression profiles and roles in the regulation of diverse physiological pathways during adventitious shoot organogenesis of A. crassicarpa.	[Liu, Weina; Yu, Wangning; Hou, Lingyu; Wang, Xiaoyu; Zheng, Fei; Wang, Weixuan; Liang, Di; Yang, Hailun; Jin, Yi; Xie, Xiangming] Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China	Beijing Forestry University	Jin, Y (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Beijing, Peoples R China.	wizard.jin@163.com; xxm1005@126.com			National Natural Science Foundation of China [31070635]; Public Welfare Project from Ministry of Agriculture of the People's Republic of China [201103027]; Fundamental Research Funds for the Central University [TD2012-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Welfare Project from Ministry of Agriculture of the People's Republic of China; Fundamental Research Funds for the Central University	This work was supported by the National Natural Science Foundation of China (No. 31070635), Public Welfare Project from Ministry of Agriculture of the People's Republic of China (No. 201103027), and the Fundamental Research Funds for the Central University (No. TD2012-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RS, 2007, P NATL ACAD SCI USA, V104, P16371, DOI 10.1073/pnas.0707653104; Axtell MJ, 2008, BBA-GENE REGUL MECH, V1779, P725, DOI 10.1016/j.bbagrm.2008.02.007; Beilharz VC, 2004, STUD MYCOL, P471; Benson EE, 2000, IN VITRO CELL DEV-PL, V36, P141, DOI 10.1007/s11627-000-0029-z; Carraro N, 2006, PLANT MOL BIOL, V60, P811, DOI 10.1007/s11103-005-2761-6; Che P, 2002, PLANT CELL, V14, P2771, DOI 10.1105/tpc.006668; Che P, 2007, PLANTA, V226, P1183, DOI 10.1007/s00425-007-0565-4; DEWAN A, 1992, PLANT CELL REP, V12, P18, DOI 10.1007/BF00232415; Ehrenreich IM, 2008, PLANT SIGNAL BEHAV, V3, P829, DOI 10.4161/psb.3.10.5914; ENGELMANN F, 1991, EUPHYTICA, V57, P227, DOI 10.1007/BF00039669; Fahlgren N, 2006, CURR BIOL, V16, P939, DOI 10.1016/j.cub.2006.03.065; Hasson A, 2011, PLANT CELL, V23, P54, DOI 10.1105/tpc.110.081448; HE L, 2004, NAT REV GENET, V5, P522; Irish VF, 2008, TRENDS PLANT SCI, V13, P430, DOI 10.1016/j.tplants.2008.05.006; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kidner CA, 2005, CURR OPIN PLANT BIOL, V8, P38, DOI 10.1016/j.pbi.2004.11.008; Kinoshita N, 2012, PLANT CELL, V24, P3590, DOI 10.1105/tpc.112.097006; Li TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043451; Lin YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060337; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Luo YC, 2006, FEBS LETT, V580, P5111, DOI 10.1016/j.febslet.2006.08.046; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Martin KP, 2003, PLANT CELL TISS ORG, V72, P79, DOI 10.1023/A:1021229422172; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; MIDGLEY S, 2000, AUSTR TREE RESOURCES, V6, P1; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Nag A, 2009, P NATL ACAD SCI USA, V106, P22534, DOI 10.1073/pnas.0908718106; Oh TJ, 2008, NEW PHYTOL, V179, P67, DOI 10.1111/j.1469-8137.2008.02448.x; Ohler U, 2004, RNA, V10, P1309, DOI 10.1261/rna.5206304; Ong SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S13; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Pan Zhigang, 1994, Forest Research, V7, P498; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rodriguez RE, 2010, DEVELOPMENT, V137, P103, DOI 10.1242/dev.043067; Ru P, 2006, CELL RES, V16, P457, DOI 10.1038/sj.cr.7310057; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Sire C, 2009, FEBS LETT, V583, P1039, DOI 10.1016/j.febslet.2009.02.024; Sugiyama M, 1999, CURR OPIN PLANT BIOL, V2, P61, DOI 10.1016/S1369-5266(99)80012-0; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; TRANTHANHVAN M, 1973, PLANTA, V115, P87, DOI 10.1007/BF00388609; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vernoux T, 2005, CURR OPIN GENET DEV, V15, P388, DOI 10.1016/j.gde.2005.06.008; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang L, 2011, J EXP BOT, V62, P761, DOI 10.1093/jxb/erq307; Wang Y, 2009, INT J MOL SCI, V10, P116, DOI 10.3390/ijms10010116; Williams L, 2005, DEVELOPMENT, V132, P3657, DOI 10.1242/dev.01942; Willmann MR, 2011, PLANT PHYSIOL, V155, P1871, DOI 10.1104/pp.110.171355; Worm J, 2009, NUCLEIC ACIDS RES, V37, P5784, DOI 10.1093/nar/gkp577; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Wu XM, 2011, PLANTA, V233, P495, DOI 10.1007/s00425-010-1312-9; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Yang MC, 2005, CYTOKINE GROWTH F R, V16, P387, DOI 10.1016/j.cytogfr.2005.02.008; Yao DL, 2013, PROPAG ORNAM PLANTS, V13, P86; Yin ZJ, 2008, GENE, V414, P60, DOI 10.1016/j.gene.2008.02.007; Zhang JH, 2012, PLANTA, V236, P647, DOI 10.1007/s00425-012-1643-9; Zhang XM, 2011, MOL CELL, V42, P356, DOI 10.1016/j.molcel.2011.04.010; Zhu HL, 2011, CELL, V145, P242, DOI 10.1016/j.cell.2011.03.024	66	15	16	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93438	10.1371/journal.pone.0093438	http://dx.doi.org/10.1371/journal.pone.0093438			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718555	Green Published, Green Submitted, gold			2022-12-25	WOS:000334339000033
J	Sanchez-Bayo, F; Goka, K				Sanchez-Bayo, Francisco; Goka, Koichi			Pesticide Residues and Bees - A Risk Assessment	PLOS ONE			English	Article							HONEYBEES APIS-MELLIFERA; COLONY COLLAPSE DISORDER; NEONICOTINOID INSECTICIDES; HYMENOPTERA APIDAE; SYSTEMIC INSECTICIDES; POLLINATOR DECLINES; CONTAMINATED POLLEN; EXPOSURE; TOXICITY; BUMBLEBEES	Bees are essential pollinators of many plants in natural ecosystems and agricultural crops alike. In recent years the decline and disappearance of bee species in the wild and the collapse of honey bee colonies have concerned ecologists and apiculturalists, who search for causes and solutions to this problem. Whilst biological factors such as viral diseases, mite and parasite infections are undoubtedly involved, it is also evident that pesticides applied to agricultural crops have a negative impact on bees. Most risk assessments have focused on direct acute exposure of bees to agrochemicals from spray drift. However, the large number of pesticide residues found in pollen and honey demand a thorough evaluation of all residual compounds so as to identify those of highest risk to bees. Using data from recent residue surveys and toxicity of pesticides to honey and bumble bees, a comprehensive evaluation of risks under current exposure conditions is presented here. Standard risk assessments are complemented with new approaches that take into account time-cumulative effects over time, especially with dietary exposures. Whilst overall risks appear to be low, our analysis indicates that residues of pyrethroid and neonicotinoid insecticides pose the highest risk by contact exposure of bees with contaminated pollen. However, the synergism of ergosterol inhibiting fungicides with those two classes of insecticides results in much higher risks in spite of the low prevalence of their combined residues. Risks by ingestion of contaminated pollen and honey are of some concern for systemic insecticides, particularly imidacloprid and thiamethoxam, chlorpyrifos and the mixtures of cyhalothrin and ergosterol inhibiting fungicides. More attention should be paid to specific residue mixtures that may result in synergistic toxicity to bees.	[Sanchez-Bayo, Francisco] Univ Sydney, Fac Agr & Environm, Eveleigh, NSW, Australia; [Goka, Koichi] Natl Inst Environm Sci, Tsukuba, Ibaraki, Japan	University of Sydney; National Institute for Environmental Studies - Japan	Sanchez-Bayo, F (corresponding author), Univ Sydney, Fac Agr & Environm, Eveleigh, NSW, Australia.	sanchezbayo@mac.com						Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; Balayiannis G, 2008, ARCH ENVIRON CON TOX, V55, P462, DOI 10.1007/s00244-007-9126-x; Bernal J, 2010, J ECON ENTOMOL, V103, P1964, DOI 10.1603/EC10235; Biddinger DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072587; Blacquiere T, 2012, ECOTOXICOLOGY, V21, P973, DOI 10.1007/s10646-012-0863-x; Blasco C, 2003, J AGR FOOD CHEM, V51, P8132, DOI 10.1021/jf034870m; Buczek K., 2009, Annales Universitatis Mariae Curie-Sklodowska. Sectio DD, Medicina Veterinaria, V64, P1; Byrne FJ, 2014, PEST MANAG SCI, V70, P470, DOI 10.1002/ps.3596; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Chauzat MP, 2009, ENVIRON ENTOMOL, V38, P514, DOI 10.1603/022.038.0302; Chauzat MP, 2007, PEST MANAG SCI, V63, P1100, DOI 10.1002/ps.1451; Chauzat MP, 2011, ENVIRON TOXICOL CHEM, V30, P103, DOI 10.1002/etc.361; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Choudhary A, 2008, ENVIRON MONIT ASSESS, V144, P143, DOI 10.1007/s10661-007-9952-3; Choudhary A, 2008, B ENVIRON CONTAM TOX, V80, P417, DOI 10.1007/s00128-008-9426-5; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Decourtye A, 2004, PESTIC BIOCHEM PHYS, V78, P83, DOI 10.1016/j.pestbp.2003.10.001; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Dively GP, 2012, J AGR FOOD CHEM, V60, P4449, DOI 10.1021/jf205393x; EPA, 2012, WHIT PAP SUPP PROP R, P275; Fox DR, 2012, INTEGR ENVIRON ASSES, V8, P764, DOI 10.1002/ieam.1350; Geoghegan T., 2013, PREDICTING HONEYBEE, P174; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Girolami V, 2012, J APPL ENTOMOL, V136, P17, DOI 10.1111/j.1439-0418.2011.01648.x; Goka K, 2006, POPUL ECOL, V48, P285, DOI 10.1007/s10144-006-0010-8; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Graystock P, 2013, J APPL ECOL, V50, P1207, DOI 10.1111/1365-2664.12134; GREIGSMITH PW, 1994, CROP PROT, V13, P567, DOI 10.1016/0261-2194(94)90002-7; Halm MP, 2006, ENVIRON SCI TECHNOL, V40, P2448, DOI 10.1021/es051392i; Heard TA, 1999, ANNU REV ENTOMOL, V44, P183, DOI 10.1146/annurev.ento.44.1.183; HELSON BV, 1994, ARCH ENVIRON CON TOX, V27, P107, DOI 10.1007/BF00203895; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Higes M, 2010, ENV MICROBIOL REP, V2, P243, DOI 10.1111/j.1758-2229.2009.00099.x; Hsieh YN, 1998, PESTIC SCI, V53, P149, DOI 10.1002/(SICI)1096-9063(199806)53:2&lt;149::AID-PS758&gt;3.0.CO;2-Z; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; JOHANSEN CA, 1984, ENVIRON ENTOMOL, V13, P1386, DOI 10.1093/ee/13.5.1386; Johnson RM, 2010, APIDOLOGIE, V41, P312, DOI 10.1051/apido/2010018; Kenta T, 2007, BIOL CONSERV, V134, P298, DOI 10.1016/j.biocon.2006.07.023; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kovac H, 2010, J INSECT PHYSIOL, V56, P1834, DOI 10.1016/j.jinsphys.2010.08.002; Landis Wayne G., 2011, Integrated Environmental Assessment and Management, V7, pVI, DOI 10.1002/ieam.249; Laurino D, 2013, B INSECTOL, V66, P119; Maini S, 2010, B INSECTOL, V63, P153; Marletto Franco, 2003, Bulletin of Insectology, V56, P155; Mattila HR, 2001, INSECT SOC, V48, P88, DOI 10.1007/PL00001764; Mineau P, 2008, ENVIRON ENTOMOL, V37, P546, DOI 10.1603/0046-225X(2008)37[546:UROBMI]2.0.CO;2; MOFFETT JO, 1970, J ECON ENTOMOL, V63, P475, DOI 10.1093/jee/63.2.475; Mommaerts V, 2011, PESTICIDES IN THE MODERN WORLD - PESTS CONTROL AND PESTICIDES EXPOSURE AND TOXICITY ASSESSMENT, P507; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Moncharmont FXD, 2003, ENVIRON TOXICOL CHEM, V22, P3088, DOI 10.1897/02-578; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Jacob CRO, 2013, B ENVIRON CONTAM TOX, V90, P69, DOI 10.1007/s00128-012-0892-4; Oliveira RA, 2014, ENVIRON TOXICOL, V29, P1122, DOI 10.1002/tox.21842; Osborne JL, 2012, NATURE, V491, P43, DOI 10.1038/nature11637; Pettis JS, 2012, NATURWISSENSCHAFTEN, V99, P153, DOI 10.1007/s00114-011-0881-1; Pilling D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093730; PILLING ED, 1993, PESTIC SCI, V39, P293, DOI 10.1002/ps.2780390407; Pohorecka K, 2012, J APIC SCI, V56, P115, DOI 10.2478/v10289-012-0029-3; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Rennich K., 2012, 2011 2012 NATL HONEY; Rissato SR, 2007, FOOD CHEM, V101, P1719, DOI 10.1016/j.foodchem.2005.10.034; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Sanchez-Bayo F, 2009, ECOTOXICOLOGY, V18, P343, DOI 10.1007/s10646-008-0290-1; Schmuck R., 2001, Pflanzenschutz-Nachrichten Bayer, V54, P161; Schmuck R, 2003, PEST MANAG SCI, V59, P279, DOI 10.1002/ps.626; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; Scott-Dupree CD, 2009, J ECON ENTOMOL, V102, P177, DOI 10.1603/029.102.0125; Serra-Bonvehi J, 2010, PEST MANAG SCI, V66, P1230, DOI 10.1002/ps.1999; Stoner KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077550; Stoner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039114; Suchail S, 2004, PEST MANAG SCI, V60, P291, DOI 10.1002/ps.772; Suchail S, 2004, PEST MANAG SCI, V60, P1056, DOI 10.1002/ps.895; Suchail S, 2001, ENVIRON TOXICOL CHEM, V20, P2482, DOI [10.1002/etc.5620201113, 10.1897/1551-5028(2001)020&lt;2482:DBAACT&gt;2.0.CO;2]; Tapparo A, 2012, ENVIRON SCI TECHNOL, V46, P2592, DOI 10.1021/es2035152; Tasei JN, 2002, HONEY BEES: ESTIMATING THE ENVIRONMENTAL IMPACT OF CHEMICALS, P101, DOI 10.1201/9780203218655.ch7; Tasei JN, 2001, J ECON ENTOMOL, V94, P623, DOI 10.1603/0022-0493-94.3.623; Teeters BS, 2012, ENVIRON TOXICOL CHEM, V31, P1349, DOI 10.1002/etc.1830; Tennekes HA, 2012, J ENV ANAL TOXICOL S, VS4, pS4; Tennekes HA, 2013, TOXICOLOGY, V309, P39, DOI 10.1016/j.tox.2013.04.007; Thompson Helen, 2003, Bulletin of Insectology, V56, P175; Thompson HM, 2010, PEST MANAG SCI, V66, P1157, DOI 10.1002/ps.1994; Thompson HM, 1999, ECOTOXICOLOGY, V8, P147, DOI 10.1023/A:1026444029579; Thompson HM, 2001, APIDOLOGIE, V32, P305, DOI 10.1051/apido:2001131; Tomlin C.D.S., 2009, E PESTICIDE MANUAL; Underwood R., 2007, BEE CULTURE, V35, P13; van der Sluijs JP, 2013, CURR OPIN ENV SUST, V5, P293, DOI 10.1016/j.cosust.2013.05.007; Van Wijngaarden RPA, 2005, ECOTOXICOLOGY, V14, P355, DOI 10.1007/s10646-004-6371-x; vanEngelsdorp D, 2010, J ECON ENTOMOL, V103, P1517, DOI 10.1603/EC09429; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Vieira RF, 1999, PESTIC SCI, V55, P412, DOI 10.1002/(SICI)1096-9063(199904)55:4&lt;412::AID-PS892&gt;3.0.CO;2-L; Villa S, 2000, ECOTOXICOLOGY, V9, P287, DOI 10.1023/A:1026522112328; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williams GR, 2010, BIOESSAYS, V32, P845, DOI 10.1002/bies.201000075; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077547	99	458	470	21	578	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94482	10.1371/journal.pone.0094482	http://dx.doi.org/10.1371/journal.pone.0094482			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718419	Green Published, gold			2022-12-25	WOS:000334339000126
J	Boer, MC; van Meijgaarden, KE; Joosten, SA; Ottenhoff, THM				Boer, Mardi C.; van Meijgaarden, Krista E.; Joosten, Simone A.; Ottenhoff, Tom H. M.			CD8(+) Regulatory T Cells, and Not CD4(+) T Cells, Dominate Suppressive Phenotype and Function after In Vitro Live Mycobacterium bovis-BCG Activation of Human Cells	PLOS ONE			English	Article							IMMUNE-RESPONSES; ACTIVE TUBERCULOSIS; LATENT INFECTION; VACCINATION; BLOOD; TH17	Mycobacterium bovis bacillus Calmette-Guerin (M. bovis BCG), the only currently available vaccine against tuberculosis, has been reported to induce regulatory T cells in humans. The activity of regulatory T cells may not only dampen immunogenicity and protective efficacy of tuberculosis-vaccines, but also hamper diagnosis of infection of tuberculosis, when using immune (e.g. IFN gamma-release) assays. Still, in settings of infectious diseases and vaccination, most studies have focused on CD4(+) regulatory T cells, and not CD8(+) regulatory T-cells. Here, we present a comparative analysis of the suppressive phenotype and function of CD4(+) versus CD8(+) T cells after in vitro live BCG activation of human cells. Moreover, as BCG is administered as a (partly) live vaccine, we also compared the ability of live versus heatkilled BCG in activating CD4(+) and CD8(+) regulatory T cell responses. BCG-activated CD8(+) T cells consistently expressed higher levels of regulatory T cell markers, and after live BCG activation, density and (co-)expression of markers were significantly higher, compared to CD4(+) T cells. Furthermore, selection on CD25-expression after live BCG activation enriched for CD8(+) T cells, and selection on co-expression of markers further increased CD8(+) enrichment. Ultimately, only T cells activated by live BCG were functionally suppressive and this suppressive activity resided predominantly in the CD8(+) T cell compartment. These data highlight the important contribution of live BCG-activated CD8(+) Treg cells to immune regulation and emphasize their possible negative impact on immunity and protection against tuberculosis, following BCG vaccination.	[Boer, Mardi C.; van Meijgaarden, Krista E.; Joosten, Simone A.; Ottenhoff, Tom H. M.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ottenhoff, THM (corresponding author), Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.	T.H.M.Ottenhoff@lumc.nl	Joosten, Simone A/F-1357-2011; Joosten, Simone/E-4731-2011	Joosten, Simone A/0000-0002-9878-0863; 	EC FP7 NEWTBVAC [HEALTH.F3.2009 241745]; EC FP7 ADITEC [HEALTH. 2011.1.4-4 280873]; EC FP7 EURIPRED [INFRASTRUCTURES.2012.1 312661]; Netherlands Organization for Scientific Research [916.86.115]; Gisela Thier Foundation of the Leiden University Medical Center; Netherlands Leprosy Foundation	EC FP7 NEWTBVAC; EC FP7 ADITEC; EC FP7 EURIPRED; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Gisela Thier Foundation of the Leiden University Medical Center; Netherlands Leprosy Foundation	The authors acknowledge EC FP7 NEWTBVAC contract no. HEALTH.F3.2009 241745, EC FP7 ADITEC contract no. HEALTH. 2011.1.4-4 280873, EC FP7 EURIPRED contract no. INFRASTRUCTURES.2012.1 312661 (the text represents the authors' views and does not necessarily represent a position of the Commission who will not be liable for the use made of such information), The Netherlands Organization for Scientific Research (VENI grant 916.86.115), the Gisela Thier Foundation of the Leiden University Medical Center and the Netherlands Leprosy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkoc T, 2010, PEDIAT ALLERG IMM-UK, V21, P1059, DOI 10.1111/j.1399-3038.2010.01051.x; Boer MC, 2013, EUR J IMMUNOL, V43, P1925, DOI 10.1002/eji.201243286; Boor PPC, 2011, EUR J IMMUNOL, V41, P1663, DOI 10.1002/eji.201041229; Boussiotis VA, 2000, J CLIN INVEST, V105, P1317, DOI 10.1172/JCI9918; Britten CM, 2012, IMMUNITY, V37, P1, DOI 10.1016/j.immuni.2012.07.010; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Caccamo N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005528; Chiacchio T, 2009, CLIN EXP IMMUNOL, V156, P463, DOI 10.1111/j.1365-2249.2009.03908.x; de Cassan SC, 2010, CLIN VACCINE IMMUNOL, V17, P1066, DOI 10.1128/CVI.00047-10; du Plessis N, 2013, AM J RESP CRIT CARE, V188, P724, DOI 10.1164/rccm.201302-0249OC; GELUK A, 1992, J IMMUNOL, V149, P2864; Griffiths KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023463; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Hougardy JM, 2007, AM J RESP CRIT CARE, V176, P409, DOI 10.1164/rccm.200701-084OC; Hussey GD, 2002, IMMUNOLOGY, V105, P314, DOI 10.1046/j.1365-2567.2002.01366.x; Joosten SA, 2007, P NATL ACAD SCI USA, V104, P8029, DOI 10.1073/pnas.0702257104; Joosten SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000782; Joosten SA, 2008, HUM IMMUNOL, V69, P760, DOI 10.1016/j.humimm.2008.07.017; Kapp JA, 2008, HUM IMMUNOL, V69, P715, DOI 10.1016/j.humimm.2008.07.018; Levesque SA, 2007, BRIT J PHARMACOL, V152, P141, DOI 10.1038/sj.bjp.0707361; Lewinsohn DA, 2003, AM J RESP CRIT CARE, V168, P1346, DOI 10.1164/rccm.200306-837OC; Li L, 2011, IMMUNOBIOLOGY, V216, P477, DOI 10.1016/j.imbio.2010.09.003; Lin MY, 2007, INFECT IMMUN, V75, P3523, DOI 10.1128/IAI.01999-06; Lin MY, 2009, INFECT IMMUN, V77, P5071, DOI 10.1128/IAI.00457-09; Marchant A, 1999, J IMMUNOL, V163, P2249; Matsumiya M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067922; MODLIN RL, 1986, NATURE, V322, P459, DOI 10.1038/322459a0; Murray RA, 2006, J IMMUNOL, V177, P5647, DOI 10.4049/jimmunol.177.8.5647; Neefjes J, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00031; Orme IM, 2010, TUBERCULOSIS, V90, P329, DOI 10.1016/j.tube.2010.06.002; OTTENHOFF THM, 1986, NATURE, V322, P462, DOI 10.1038/322462a0; Ottenhoff THM, 2012, TRENDS MICROBIOL, V20, P419, DOI 10.1016/j.tim.2012.06.002; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Perreau M, 2013, EUR J IMMUNOL, V43, P939, DOI 10.1002/eji.201243090; Rozot V, 2013, EUR J IMMUNOL, V43, P1568, DOI 10.1002/eji.201243262; Semple PL, 2013, AM J RESP CRIT CARE, V187, P1249, DOI 10.1164/rccm.201210-1934OC; van Dissel JT, 2010, VACCINE, V28, P3571, DOI 10.1016/j.vaccine.2010.02.094; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Ye ZJ, 2011, CLIN VACCINE IMMUNOL, V18, P1608, DOI 10.1128/CVI.05214-11	41	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94192	10.1371/journal.pone.0094192	http://dx.doi.org/10.1371/journal.pone.0094192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714620	Green Submitted, gold, Green Published			2022-12-25	WOS:000334160900102
J	Lin, CW; Huang, YP; Chiu, YH; Ho, YT; Pan, SL				Lin, Chia-Wei; Huang, Ya-Ping; Chiu, Yueh-Hsia; Ho, Yu-Tsun; Pan, Shin-Liang			Increased Risk of Ischemic Stroke in Young Patients with Ankylosing Spondylitis: A Population-Based Longitudinal Follow-Up Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ENDOTHELIAL FUNCTION; ATHEROSCLEROSIS; PREVALENCE; RECOMMENDATIONS; MANIFESTATIONS; INFLAMMATION; MANAGEMENT; PROFILE; UPDATE	Background: Prospective data on the association between ischemic stroke and ankylosing spondylitis (AS) in the young are sparse. The purpose of this population-based, age- and sex-matched longitudinal follow-up study was to investigate the risk of developing ischemic stroke in young patients with AS. Methods: A total of 4562 patients aged 18- to 45-year-old with at least two ambulatory visits in 2001 with a principal diagnosis of AS were enrolled in the AS group. The non-AS group consisted of 22810 age- and sex-matched, randomly sampled subjects without AS. The two-year ischemic stroke-free survival rate for each group were calculated using the Kaplan-Meier method. Cox proportional hazards regression analysis was used to estimate the hazard ratio of ischemic stroke after adjusting for demographic and clinical covariates. Results: During follow-up, 21 patients in the AS group and 53 in the non-AS group developed ischemic stroke. The ischemic stroke-free survival rate over the 2 year follow-up was lower in the AS group than the non-AS group (p = 0.0021). The crude hazard ratio of ischemic stroke for the AS group was 1.98 (95% CI, 1.20-3.29; p = 0.0079) and the adjusted hazard ratio after controlling for demographic and comorbid medical disorders was 1.93 (95% CI, 1.16-3.20; p = 0.0110). Conclusion: Our study showed an increased risk of developing ischemic stroke in young patients with AS.	[Lin, Chia-Wei; Ho, Yu-Tsun; Pan, Shin-Liang] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Huang, Ya-Ping] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Yu Lin Branch, Yunlin, Taiwan; [Chiu, Yueh-Hsia] Chang Gung Univ, Dept & Grad Inst Hlth Care Management, Tao Yuan, Taiwan; [Pan, Shin-Liang] Natl Taiwan Univ, Coll Med, Dept Phys Med & Rehabil, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; Chang Gung University; National Taiwan University	Pan, SL (corresponding author), Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.	panslcb@gmail.com		lin, chiawei/0000-0002-6577-0116; Chiu, Sherry Yueh-Hsia/0000-0002-7207-7088; PAN, SHIN-LIANG/0000-0001-6451-4666	Department of Health (DOH), Executive Yuan, Republic of China [DOH93-TD-M-113-030, DOH94-TD-M-113-004, DOH95-TD-M-113-002]; National Science Council, Executive Yuan, Republic of China [NSC101-2314-B-002-088]	Department of Health (DOH), Executive Yuan, Republic of China; National Science Council, Executive Yuan, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by grants DOH93-TD-M-113-030, DOH94-TD-M-113-004, and DOH95-TD-M-113-002 from the Department of Health (DOH), Executive Yuan, Republic of China and grant NSC101-2314-B-002-088 from the National Science Council, Executive Yuan, Republic of China. This study used the complete National Health Insurance Research Database provided by the Bureau of National Health Insurance, Department of Health. The conclusions in our study are not necessarily those of the Department of Health, Executive Yuan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avierinos JF, 2003, STROKE, V34, P1339, DOI 10.1161/01.STR.0000072274.12041.FF; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Bodnar N, 2011, J RHEUMATOL, V38, P723, DOI 10.3899/jrheum.100668; Braun J, 2011, ANN RHEUM DIS, V70, P896, DOI 10.1136/ard.2011.151027; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Bremander A, 2011, ARTHRIT CARE RES, V63, P550, DOI 10.1002/acr.20408; Cece H, 2011, CLIN INVEST MED, V34, pE225, DOI 10.25011/cim.v34i4.15364; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; CHOU CT, 1994, J RHEUMATOL, V21, P302; Cohen A, 1997, STROKE, V28, P1574, DOI 10.1161/01.STR.28.8.1574; Divecha H, 2005, CLIN SCI, V109, P171, DOI 10.1042/CS20040326; El Maghraoui A, 2011, EUR J INTERN MED, V22, P554, DOI 10.1016/j.ejim.2011.06.006; Gonzalez-Juanatey C, 2009, MEDICINE, V88, P358, DOI 10.1097/MD.0b013e3181c10773; GRATACOS J, 1994, BRIT J RHEUMATOL, V33, P927; Hamdi W, 2012, J RHEUMATOL, V39, P322, DOI 10.3899/jrheum.110792; Han CL, 2006, J RHEUMATOL, V33, P2167; Huang YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064155; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Lange U, 2000, Eur J Med Res, V5, P507; Mathieu S, 2011, ARTHRIT CARE RES, V63, P557, DOI 10.1002/acr.20364; ONEILL TW, 1992, ANN RHEUM DIS, V51, P705, DOI 10.1136/ard.51.6.705; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Peters MJL, 2010, J RHEUMATOL, V37, P161, DOI 10.3899/jrheum.090667; Peters MJ, 2004, SEMIN ARTHRITIS RHEU, V34, P585, DOI 10.1016/j.semarthrit.2004.07.010; RIBEIRO P, 1984, EUR HEART J, V5, P419, DOI 10.1093/oxfordjournals.eurheartj.a061676; Roman MJ, 2007, CIRCULATION, V116, P2346, DOI 10.1161/CIRCULATIONAHA.106.678334; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sari I, 2006, RHEUMATOLOGY, V45, P283, DOI 10.1093/rheumatology/kei145; Stoll G, 2006, STROKE, V37, P1923, DOI 10.1161/01.STR.0000226901.34927.10; Szabo SM, 2011, ARTHRITIS RHEUM-US, V63, P3294, DOI 10.1002/art.30581; van den Berg R, 2012, RHEUMATOLOGY, V51, P1388, DOI 10.1093/rheumatology/kes066; Verma S, 2002, CIRCULATION, V105, P546, DOI 10.1161/hc0502.104540; Wu CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049343	33	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94027	10.1371/journal.pone.0094027	http://dx.doi.org/10.1371/journal.pone.0094027			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714094	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900071
J	Yu, HT; Jiang, W; Du, H; Xing, Y; Bai, GZ; Zhang, Y; Li, Y; Jiang, H; Zhang, Y; Wang, JP; Wang, PZ; Bai, XF				Yu, Haitao; Jiang, Wei; Du, Hong; Xing, Yuan; Bai, Guangzhen; Zhang, Ye; Li, Yu; Jiang, Hong; Zhang, Ying; Wang, Jiuping; Wang, Pingzhong; Bai, Xuefan			Involvement of the Akt/NF-kappa B Pathways in the HTNV-Mediated Increase of IL-6, CCL5, ICAM-1, and VCAM-1 in HUVECs	PLOS ONE			English	Article							HANTAVIRUS PULMONARY SYNDROME; HEMORRHAGIC-FEVER; ANTIINFLAMMATORY ACTIVITY; INCREASED PERMEABILITY; HUMAN CYTOMEGALOVIRUS; RELA/P65 SUBUNIT; VIRUS-INFECTION; RENAL SYNDROME; IN-VITRO; EXPRESSION	Background: Hantaan virus (HTNV) infection causes a severe form of HFRS(hemorrhagic fever with renal syndrome) in Asia. Although HTNV has been isolated for nearly forty years, the pathogenesis of HFRS is still unknown, and little is known regarding the signaling pathway that is activated by the virus. Methodology/Principal Findings: Cardamonin was selected as a NF-kappa B inhibitor, and indirect immunofluorescence assays were used to detect the effect of cardamonin on HTNV-infected HUVECs. The effect of cardamonin on the HTNV-induced phosphorylation of Akt and DNA-binding activity of NF-kB were determined using Western blot analysis and electrophoretic mobility shift assays (EMSAs), respectively. Then, flow cytometric and quantitative real-time PCR analyses were performed to quantify the expression levels of the adhesion molecules ICAM-1 and VCAM-1, and the concentrations of IL-6, IL-8, and CCL5 in HUVEC supernatants were examined using ELISA. The results showed that cardamonin did not effect the proliferation of HUVECs or the replication of HTNV in HUVECs. Instead, cardamonin inhibited the phosphorylation of Akt and nuclear transduction of NF-kB and further reduced the expression of the adhesion molecules ICAM-1 and VCAM-1 in HTNV-infected HUVECs. Cardamonin also inhibited the secretion of IL-6 and CCL5, but not IL-8 Conclusion/Significance: HTNV replication may not be dependent upon the ability of the virus to activate NF-kB in HUVECs. The Akt/NF-kappa B pathways may be involved in the pathogenesis of HFRS; therefore, cardamonin may serve as a potential beneficial agent for HFRS therapy.	[Yu, Haitao; Jiang, Wei; Du, Hong; Zhang, Ye; Jiang, Hong; Zhang, Ying; Wang, Jiuping; Wang, Pingzhong; Bai, Xuefan] Fourth Mil Med Univ, Tangdu Hosp, Dept Infect Dis, Xian 710032, Shaanxi Provinc, Peoples R China; [Xing, Yuan] Fourth Mil Med Univ, Dept Physiol, Xian 710032, Shaanxi Provinc, Peoples R China; [Bai, Guangzhen] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710032, Shaanxi Provinc, Peoples R China; [Li, Yu] Shaanxi Prov Peoples Hosp, Dept Infect Dis, Xian, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Xi'an Medical University	Wang, PZ (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Infect Dis, Xian 710032, Shaanxi Provinc, Peoples R China.	wangpz63@126.com; xfbai@fmmu.edu.cn	Gaobo, Huang/AAP-9975-2020		National Basic Research Program of China (973 Program) [2012CB518905]; National Natural Science Foundation of China [30901346, 81071370]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program) (No. 2012CB518905) and National Natural Science Foundation of China (No. 30901346, No. 81071370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amici C, 2001, J BIOL CHEM, V276, P28759, DOI 10.1074/jbc.M103408200; Ashcroft M, 2002, ONCOGENE, V21, P1955, DOI 10.1038/sj.onc.1205276; Balwani S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046528; Benedict CA, 2004, J VIROL, V78, P741, DOI 10.1128/JVI.78.2.741-750.2004; Bernasconi D, 2005, J BIOL CHEM, V280, P24127, DOI 10.1074/jbc.M413726200; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Caposio P, 2007, CELL MICROBIOL, V9, P2040, DOI 10.1111/j.1462-5822.2007.00936.x; COSGRIFF TM, 1991, REV INFECT DIS, V13, P97; Dai C, 2013, MOL CELL BIOCHEM, V374, P1, DOI 10.1007/s11010-012-1488-3; Gavrilovskaya IN, 2008, J VIROL, V82, P5797, DOI 10.1128/JVI.02397-07; Geimonen E, 2002, P NATL ACAD SCI USA, V99, P13837, DOI 10.1073/pnas.192298899; Gustems M, 2006, J VIROL, V80, P9899, DOI 10.1128/JVI.00640-06; Gustin JA, 2004, J BIOL CHEM, V279, P1615, DOI 10.1074/jbc.M306976200; Han QY, 2010, EUR J CLIN MICROBIOL, V29, P1507, DOI 10.1007/s10096-010-1032-x; Hayasaka D, 2007, VIRUS RES, V123, P120, DOI 10.1016/j.virusres.2006.08.006; Jiang H, 2008, VIROLOGY, V380, P52, DOI 10.1016/j.virol.2008.07.002; Kane LP, 2002, MOL CELL BIOL, V22, P5962, DOI 10.1128/MCB.22.16.5962-5974.2002; Kanerva M, 1998, REV MED VIROL, V8, P67, DOI 10.1002/(SICI)1099-1654(199804/06)8:2&lt;67::AID-RMV217&gt;3.0.CO;2-U; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kariwa H, 2007, COMP IMMUNOL MICROB, V30, P341, DOI 10.1016/j.cimid.2007.05.011; Kim YJ, 2010, INT IMMUNOPHARMACOL, V10, P1127, DOI 10.1016/j.intimp.2010.06.017; KITAMURA T, 1983, JPN J MED SCI BIOL, V36, P17, DOI 10.7883/yoken1952.36.17; LEE HW, 1978, J INFECT DIS, V137, P298, DOI 10.1093/infdis/137.3.298; Lee JH, 2006, J PHARMACOL EXP THER, V316, P271, DOI 10.1124/jpet.105.092486; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lyck R, 2003, BLOOD, V102, P3675, DOI 10.1182/blood-2003-02-0358; MacNeil A, 2011, VIRUS RES, V162, P138, DOI 10.1016/j.virusres.2011.09.017; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mori M, 1999, J INFECT DIS, V179, P295, DOI 10.1086/314597; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Nakabayashi H, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-453; NICHOL ST, 1993, SCIENCE, V262, P914, DOI 10.1126/science.8235615; Niikura M, 2004, ARCH VIROL, V149, P1279, DOI 10.1007/s00705-004-0306-y; NOLTE KB, 1995, HUM PATHOL, V26, P110, DOI 10.1016/0046-8177(95)90123-X; Outinen TK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-132; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Qi BT, 2006, VIRAL IMMUNOL, V19, P565, DOI 10.1089/vim.2006.19.565; Ren GL, 2005, BIOCHEM BIOPH RES CO, V335, P1051, DOI 10.1016/j.bbrc.2005.07.170; Sadeghi M, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-65; Saksida A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-142; Santoro MG, 2003, EMBO J, V22, P2552, DOI 10.1093/emboj/cdg267; SCHMALJOHN CS, 1985, SCIENCE, V227, P1041, DOI 10.1126/science.2858126; Sen T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048770; Shah A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052060; Shah A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-52; Sheikh AM, 2005, CARDIOVASC RES, V65, P263, DOI 10.1016/j.cardiores.2004.09.017; Sundstrom JB, 2001, J VIROL, V75, P6070, DOI 10.1128/JVI.75.13.6070-6085.2001; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Tsoyi K, 2010, ATHEROSCLEROSIS, V213, P115, DOI 10.1016/j.atherosclerosis.2010.07.061; Vapalahti O, 1996, J GEN VIROL, V77, P3063, DOI 10.1099/0022-1317-77-12-3063; Wang PZ, 2012, J INT MED RES, V40, P648, DOI 10.1177/147323001204000227; Xu Zhe, 2007, J Infect, V55, pe1, DOI 10.1016/j.jinf.2007.01.003; Yu HT, 2012, VIRAL IMMUNOL, V25, P387, DOI 10.1089/vim.2012.0005; ZAKI SR, 1995, AM J PATHOL, V146, P552; Zhang Y, 2008, APMIS, V116, P1089, DOI 10.1111/j.1600-0463.2008.01011.x	58	16	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93810	10.1371/journal.pone.0093810	http://dx.doi.org/10.1371/journal.pone.0093810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714064	gold, Green Published, Green Submitted			2022-12-25	WOS:000334160900051
J	Jiang, HL; Deng, XX; Wang, JA; Wang, J; Peng, J; Zhou, TT				Jiang, Hailan; Deng, Xiaoxia; Wang, Jungang; Wang, Jing; Peng, Jun; Zhou, Tingting			Effects of Gibberellic Acid and N, N-Dimethyl Piperidinium Chloride on the Dose of and Physiological Responses to Prometryn in Black Nightshade (Solanum nigrum L.)	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; LIPID-PEROXIDATION; OXIDATIVE DAMAGE; WEED MANAGEMENT; COTTON; ANTIOXIDANT; ENZYMES; GLUTATHIONE; STRESS; METABOLISM	The use of gibberellic acid (GA(3)) and N, N-dimethyl piperidinium chloride (DPC) in combination with prometryn would likely increase the control of black nightshade in cotton fields. Experiments were designed to investigate the physiological and biochemical responses of black nightshade at the three-to four-leaf stage to prometryn applied at different rates, either alone or in combination with GA(3) or DPC, in a greenhouse environment. These studies demonstrated that prometryn applied in combination with DPC at low rates (7.2 g ai ha(-1)) led to increased fresh weight and visible injury of black nightshade compared with prometryn applied alone or in combination with GA(3); however, at rates of 36, 180, and 900 g ai ha(-1), prometryn in combination with DPC caused the least visible injury among all treatments and prometryn in combination with GA(3) caused the greatest visible injury. These results suggest that black nightshade suffered more severe damage when prometryn was applied in combination with GA(3), which is supported by the reduced soluble protein content, lower antioxidant enzyme activities, and higher malondialdehyde (MDA) content in the plants treated with prometryn plus GA(3). These results indicate that the application of GA(3) in combination with prometryn to black nightshade may have the potential to lower the levels of prometryn tolerance in these plants.	[Jiang, Hailan; Deng, Xiaoxia; Wang, Jungang; Wang, Jing; Peng, Jun; Zhou, Tingting] Shihezi Univ, Coll Agr, Shihezi, Xinjiang, Peoples R China; [Jiang, Hailan; Deng, Xiaoxia] Kuerle Agr Technol Extens Ctr, Kuerle, Xinjiang, Peoples R China	Shihezi University	Wang, JA (corresponding author), Shihezi Univ, Coll Agr, Shihezi, Xinjiang, Peoples R China.	jungangwang98@163.com			Special Fund for Agro-scientific Research in the Public Interest [201303022]; corps doctoral Fund [2013BB004]; National Natural Science Foundation Project of China [31260435]	Special Fund for Agro-scientific Research in the Public Interest; corps doctoral Fund; National Natural Science Foundation Project of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest (201303022), corps doctoral Fund (2013BB004) and National Natural Science Foundation Project of China (31260435). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Bailly C, 1996, PHYSIOL PLANTARUM, V97, P104, DOI 10.1111/j.1399-3054.1996.tb00485.x; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Byrd Jr J., 2000, 2000 P BELTW COTT C, V2, P1455; Chance M, 1955, METHOD ENZYMOL, V2, P764, DOI DOI 10.1016/S0076-6879(55)02300-8; Davey MW, 2000, J SCI FOOD AGR, V80, P825, DOI [10.1002/(SICI)1097-0010(20000515)80:7<825::AID-JSFA598>3.0.CO;2-6, 10.1002/(SICI)1097-0010(20000515)80:7&lt;825::AID-JSFA598&gt;3.0.CO;2-6]; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Dunk P, 2002, WEED SCI, V50, P642; Economou G, 2005, PHYTOPARASITICA, V33, P406, DOI 10.1007/BF02981309; [冯国艺 Feng Guoyi], 2012, [棉花学报, Cotton Science], V24, P44; FRIDOVICH I, 1986, ARCH BIOCHEM BIOPHYS, V247, P1, DOI 10.1016/0003-9861(86)90526-6; Gausman HW, 1979, P 6 ANN M PLANT GROW, P117; GREEN JM, 1989, WEED TECHNOL, V3, P217, DOI 10.1017/S0890037X00031717; Gurinderbir SC, 2012, WEED TECHNOL, V26, P638; GUY CL, 1990, ANNU REV PLANT PHYS, V41, P187, DOI 10.1146/annurev.pp.41.060190.001155; Hake K., 1991, PHYSL TODAY, V2; HATZIOS K K, 1985, Reviews of Weed Science, V1, P1; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hernandez JA, 2001, PLANT PHYSIOL, V127, P817, DOI 10.1104/pp.010188; Holm LG., 1991, WORLDS WORST WEEDS D, P430; Jerry LC, 2002, WEED TECHNOL, V16, P712; Kaloumenos NS, 2005, WEED TECHNOL, V19, P207, DOI 10.1614/WT-04-188; Keeling JW, 2011, WEED TECHNOL, V25, P178, DOI 10.1614/WT-D-10-00110.1; KENYON WH, 1985, PLANT PHYSIOL, V79, P862, DOI 10.1104/pp.79.3.862; Ma XW, 2008, PLANT GROWTH REGUL, V56, P77, DOI 10.1007/s10725-008-9287-2; Ma YH, 2008, PLANT SCI, V175, P761, DOI 10.1016/j.plantsci.2008.07.010; Molassiotis A, 2006, ENVIRON EXP BOT, V56, P54, DOI 10.1016/j.envexpbot.2005.01.002; Nemat MM, 2008, PLANT BIOSYST, V142, P5; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Parida AK, 2004, J PLANT PHYSIOL, V161, P531, DOI 10.1078/0176-1617-01084; Porterfield D, 2002, WEED SCI, V50, P642, DOI 10.1614/0043-1745(2002)050[0642:WMWCFA]2.0.CO;2; Reddy AR, 1996, PLANT GROWTH REGUL, V20, P179, DOI 10.1007/BF00043305; Sairam RK, 2002, PLANT SCI, V162, P897, DOI 10.1016/S0168-9452(02)00037-7; Scott BC, 2007, WEED TECHNOL, V21, P45; Scott BC, 2008, WEED TECHNOL, V22, P160; Shah K, 2001, PLANT SCI, V161, P1135, DOI 10.1016/S0168-9452(01)00517-9; Shrestha A, 2005, WEED SCI, V53, P802, DOI 10.1614/WS-04-181R1.1; Thomas WE, 2006, WEED TECHNOL, V20, P6, DOI 10.1614/WT-04-257R1.1; Walter ET, 2006, WEED TECHNOL, V20, P6; Wang ZhengGui, 2010, Journal of Agro-Environment Science, V29, P1027; Wuolo A, 2002, NATTSKATTA AR PROBLE; Zhang Dingyi, 2007, Chinese Journal of Applied and Environmental Biology, V13, P294; [张明生 Zhang Mingsheng], 2004, [南京农业大学学报, Journal of Nanjing Agricultural University], V27, P123	44	3	4	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93654	10.1371/journal.pone.0093654	http://dx.doi.org/10.1371/journal.pone.0093654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709895	Green Published, gold, Green Submitted			2022-12-25	WOS:000334159800042
J	Kabir, A; Merrill, RD; Shamim, AA; Klemn, RDW; Labrique, AB; Christian, P; West, KP; Nasser, M				Kabir, Alamgir; Merrill, Rebecca D.; Shamim, Abu Ahmed; Klemn, Rolf D. W.; Labrique, Alain B.; Christian, Parul; West, Keith P., Jr.; Nasser, Mohammed			Canonical Correlation Analysis of Infant's Size at Birth and Maternal Factors: A Study in Rural Northwest Bangladesh	PLOS ONE			English	Article							BETA-CAROTENE SUPPLEMENTATION; VITAMIN-A; ANTHROPOMETRIC MEASUREMENTS; INTRAUTERINE GROWTH; NUTRITIONAL-STATUS; WEIGHT; MORTALITY; NEWBORN; CIRCUMFERENCE; PREGNANCY	This analysis was conducted to explore the association between 5 birth size measurements ( weight, length and head, chest and mid-upper arm [MUAC] circumferences) as dependent variables and 10 maternal factors as independent variables using canonical correlation analysis (CCA). CCA considers simultaneously sets of dependent and independent variables and, thus, generates a substantially reduced type 1 error. Data were from women delivering a singleton live birth (n = 14506) while participating in a double-masked, cluster-randomized, placebo-controlled maternal vitamin A or b-carotene supplementation trial in rural Bangladesh. The first canonical correlation was 0.42 (P < 0.001), demonstrating a moderate positive correlation mainly between the 5 birth size measurements and 5 maternal factors (preterm delivery, early pregnancy MUAC, infant sex, age and parity). A significant interaction between infant sex and preterm delivery on birth size was also revealed from the score plot. Thirteen percent of birth size variability was explained by the composite score of the maternal factors (Redundancy, R-Y/(X) = 0.131). Given an ability to accommodate numerous relationships and reduce complexities of multiple comparisons, CCA identified the 5 maternal variables able to predict birth size in this rural Bangladesh setting. CCA may offer an efficient, practical and inclusive approach to assessing the association between two sets of variables, addressing the innate complexity of interactions.	[Kabir, Alamgir; Nasser, Mohammed] Rajshahi Univ, Dept Stat, Rajshahi 6205, Bangladesh; [Kabir, Alamgir] Icddr b, Dhaka, Bangladesh; [Merrill, Rebecca D.; Klemn, Rolf D. W.; Labrique, Alain B.; Christian, Parul; West, Keith P., Jr.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Ctr Human Nutr, Dept Int Hlth, Baltimore, MD USA; [Shamim, Abu Ahmed] JiVitA Maternal & Child Hlth & Nutr Res Project, Gaibandha, Bangladesh	University of Rajshahi; International Centre for Diarrhoeal Disease Research (ICDDR); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kabir, A (corresponding author), Rajshahi Univ, Dept Stat, Rajshahi 6205, Bangladesh.	alamgir.kabir@icddrb.org	Kabir, Alamgir/H-3430-2019	Kabir, Alamgir/0000-0002-3762-8307; Abu Ahmed, Shamim/0000-0002-7071-8558; Labrique, Alain/0000-0003-2502-7819	Bill and Melinda Gates Foundation, Seattle, WA Global Control of Micronutrient Deficiency [614]; Micronutrients for Health Cooperative Agreement [HRN-A-00-97-00015]; Global Research Activity Cooperative Agreement [GHS-A-00-03-00019-00]; Johns Hopkins University; Office of Health, Infectious Diseases and Nutrition; US Agency for International Development, Washington, DC; Sight and Life Research Institute (Baltimore, MD); Nutrilite Health Institute (Nutrilite Division, Access Business Group, LLC, Buena Park, CA); Canadian International Development Agency (CIDA), Ottawa, Canada; Ministry of Health and Family Welfare of the Government of the People's Republic of Bangladesh	Bill and Melinda Gates Foundation, Seattle, WA Global Control of Micronutrient Deficiency; Micronutrients for Health Cooperative Agreement; Global Research Activity Cooperative Agreement; Johns Hopkins University(Johns Hopkins University); Office of Health, Infectious Diseases and Nutrition(United States Agency for International Development (USAID)); US Agency for International Development, Washington, DC(United States Agency for International Development (USAID)); Sight and Life Research Institute (Baltimore, MD); Nutrilite Health Institute (Nutrilite Division, Access Business Group, LLC, Buena Park, CA); Canadian International Development Agency (CIDA), Ottawa, Canada; Ministry of Health and Family Welfare of the Government of the People's Republic of Bangladesh	Supported by a grant from the Bill and Melinda Gates Foundation, Seattle, WA Global Control of Micronutrient Deficiency, grant 614); Micronutrients for Health Cooperative Agreement (HRN-A-00-97-00015); Global Research Activity Cooperative Agreement (GHS-A-00-03-00019-00) between Johns Hopkins University and the Office of Health, Infectious Diseases and Nutrition; and the US Agency for International Development, Washington, DC. Additional direct or in-kind support was provided by the Sight and Life Research Institute (Baltimore, MD); Nutrilite Health Institute (Nutrilite Division, Access Business Group, LLC, Buena Park, CA); the Canadian International Development Agency (CIDA), Ottawa, Canada; and the National Integrated Population and Health Program of the Ministry of Health and Family Welfare of the Government of the People's Republic of Bangladesh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, J DHAKA MEDI COLL; BAGGALEY AR, 1981, EVALUATION REV, V5, P123, DOI 10.1177/0193841X8100500106; Bartlett MS, 1941, BIOMETRIKA, V32, P29; Bhargava A, 2000, AM J PHYS ANTHROPOL, V111, P89, DOI 10.1002/(SICI)1096-8644(200001)111:1&lt;89::AID-AJPA6&gt;3.0.CO;2-X; Black J.T, 1992, MULTIVARIATE DATA AN; Bruguier A, 2008, NEUROIMAGE, V41, P35, DOI 10.1016/j.neuroimage.2008.01.062; Christian P, 2013, AM J CLIN NUTR, V97, P188, DOI 10.3945/ajcn.112.042275; Dhar B, 2002, J HEALTH POPUL NUTR, V20, P36; Elshibly EM, 2009, PEDIATR INT, V51, P326, DOI 10.1111/j.1442-200X.2008.02756.x; Feleke Y, 1999, E AFR MED J, V76, P468; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; FISH LJ, 1988, MEAS EVAL COUNS DEV, V21, P130, DOI 10.1080/07481756.1988.12022895; FORNELL C, 1978, J MARKET RES SOC, V20, P166; Gonzalez I, 2008, J STAT SOFTW, V23, P1; Gunnsteinsson S, 2010, J HEALTH POPUL NUTR, V28, P509; Henson, 2000, MULTIPLE LINEAR REGR, V26, P11; Hosain GMM, 2006, J TROP PEDIATRICS, V52, P87, DOI 10.1093/tropej/fmi066; Institute of Medicine (Subcommittees on Nutritional Status and Weight Gain During Pregnancy and Dietary Intake and Nutrient Supplements During Pregnancy Committee on Nutritional Status During Pregnancy and Lactation Food and Nutrition Board), 1990, NUTR PREGN 1; Karim E, 1997, ANN HUM BIOL, V24, P387, DOI 10.1080/03014469700005152; Khatun S, 2008, J BIOSOC SCI, V40, P321, DOI 10.1017/S0021932007002532; Klemm RDW, 2008, PEDIATRICS, V122, pE242, DOI 10.1542/peds.2007-3448; Labrique AB, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-102; LAMBERT ZV, 1975, J MARKETING RES, V12, P468, DOI 10.2307/3151100; Leal MDC, 2006, REV SAUDE PUBL, V40, P466, DOI 10.1590/S0034-89102006000300015; Lindley AA, 1999, EARLY HUM DEV, V56, P17, DOI 10.1016/S0378-3782(99)00033-X; Liu J, 2009, ENVIRON RES, V109, P193, DOI 10.1016/j.envres.2008.11.002; Maxwell S, 1992, ADV SOCIAL SCI METHO, V2, P137; MCCORMICK MC, 1985, NEW ENGL J MED, V312, P82, DOI 10.1056/NEJM198501103120204; Naylor MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010395; NEGGERS Y, 1995, OBSTET GYNECOL, V85, P192, DOI 10.1016/0029-7844(94)00364-J; Ogbonna C, 2007, ACTA OBSTET GYN SCAN, V86, P26, DOI 10.1080/00016340600935664; Rahman A, 2009, AM J EPIDEMIOL, V169, P304, DOI 10.1093/aje/kwn332; Raum E, 2001, INT J EPIDEMIOL, V30, P81, DOI 10.1093/ije/30.1.81; Sherry A, 2005, J PERS ASSESS, V84, P37, DOI 10.1207/s15327752jpa8401_09; Silva LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037356; STEWART D, 1968, PSYCHOL BULL, V70, P160, DOI 10.1037/h0026143; STOCH MB, 1963, ARCH DIS CHILD, V38, P546, DOI 10.1136/adc.38.202.546; Storms Michelle R, 2004, J Perinatol, V24, P236, DOI 10.1038/sj.jp.7211065; Thame M, 1997, EUR J CLIN NUTR, V51, P134, DOI 10.1038/sj.ejcn.1600357; THOMPSON B, 1991, MEAS EVAL COUNS DEV, V24, P80; Thompson B, 1998, ANNM AM ED RES ASS S, P102; Tripathi A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-111; West KP, 2011, JAMA-J AM MED ASSOC, V305, P1986, DOI 10.1001/jama.2011.656; Yunis KA, 2007, PAEDIATR PERINAT EP, V21, P387, DOI 10.1111/j.1365-3016.2007.00827.x	44	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94243	10.1371/journal.pone.0094243	http://dx.doi.org/10.1371/journal.pone.0094243			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710082	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800127
J	Kowno, M; Watanabe-Susaki, K; Ishimine, H; Komazaki, S; Enomoto, K; Seki, Y; Wang, YY; Ishigaki, Y; Ninomiya, N; Noguchi, TAK; Kokubu, Y; Ohnishi, K; Nakajima, Y; Kato, K; Intoh, A; Takada, H; Yamakawa, N; Wang, PC; Asashima, M; Kurisaki, A				Kowno, Megumi; Watanabe-Susaki, Kanako; Ishimine, Hisako; Komazaki, Shinji; Enomoto, Kei; Seki, Yasuhiro; Wang, Ying Ying; Ishigaki, Yohei; Ninomiya, Naoto; Noguchi, Taka-aki K.; Kokubu, Yuko; Ohnishi, Keigoh; Nakajima, Yoshiro; Kato, Kaoru; Intoh, Atsushi; Takada, Hitomi; Yamakawa, Norio; Wang, Pi-Chao; Asashima, Makoto; Kurisaki, Akira			Prohibitin 2 Regulates the Proliferation and Lineage-Specific Differentiation of Mouse Embryonic Stem Cells in Mitochondria	PLOS ONE			English	Article							DOMINANT OPTIC ATROPHY; NUCLEAR EXPORT; CRISTAE MORPHOGENESIS; OPA1; PLURIPOTENCY; REPRESSION; EFFICIENT; APOPTOSIS; ESTROGEN; PROTEIN	Background: The pluripotent state of embryonic stem (ES) cells is controlled by a network of specific transcription factors. Recent studies also suggested the significant contribution of mitochondria on the regulation of pluripotent stem cells. However, the molecules involved in these regulations are still unknown. Methodology/ Principal Findings: In this study, we found that prohibitin 2 (PHB2), a pleiotrophic factor mainly localized in mitochondria, is a crucial regulatory factor for the homeostasis and differentiation of ES cells. PHB2 was highly expressed in undifferentiated mouse ES cells, and the expression was decreased during the differentiation of ES cells. Knockdown of PHB2 induced significant apoptosis in pluripotent ES cells, whereas enhanced expression of PHB2 contributed to the proliferation of ES cells. However, enhanced expression of PHB2 strongly inhibited ES cell differentiation into neuronal and endodermal cells. Interestingly, only PHB2 with intact mitochondrial targeting signal showed these specific effects on ES cells. Moreover, overexpression of PHB2 enhanced the processing of a dynamin-like GTPase (OPA1) that regulates mitochondrial fusion and cristae remodeling, which could induce partial dysfunction of mitochondria. Conclusions/ Significance: Our results suggest that PHB2 is a crucial mitochondrial regulator for homeostasis and lineagespecific differentiation of ES cells.	[Kowno, Megumi; Ishimine, Hisako; Ishigaki, Yohei; Noguchi, Taka-aki K.; Kokubu, Yuko; Ohnishi, Keigoh; Wang, Pi-Chao; Kurisaki, Akira] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Watanabe-Susaki, Kanako; Ishimine, Hisako; Wang, Ying Ying; Nakajima, Yoshiro; Takada, Hitomi; Yamakawa, Norio; Asashima, Makoto; Kurisaki, Akira] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki, Japan; [Komazaki, Shinji] Saitama Med Sch, Dept Anat, Moroyama, Saitama 35004, Japan; [Enomoto, Kei; Ninomiya, Naoto] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Meguro Ku, Tokyo 113, Japan; [Seki, Yasuhiro; Intoh, Atsushi; Asashima, Makoto] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci Biol, Meguro Ku, Tokyo, Japan; [Wang, Ying Ying] Japan Soc Promot Sci, Tsukuba, Ibaraki, Japan; [Kato, Kaoru] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Tsukuba, Ibaraki, Japan; [Asashima, Makoto] Univ Tsukuba, Life Sci Ctr, Tsukuba Adv Res Alliance, Tsukuba, Ibaraki, Japan	University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST); Saitama Medical University; University of Tokyo; University of Tokyo; Japan Society for the Promotion of Science; National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Kurisaki, A (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	akikuri@hotmail.com	Asashima, Makoto/O-8389-2018; wang, yan/GSE-6489-2022; wang, yingying/GRS-3058-2022; Enomoto, Kei/GQP-7270-2022; Katoh, Kaoru/M-7526-2018	Asashima, Makoto/0000-0002-0012-026X; Enomoto, Kei/0000-0001-6210-8699; Katoh, Kaoru/0000-0001-6590-413X	 [17510165];  [20610008]	; 	This work was supported by Grant-in-Aid for Scientific Research (17510165 and 20610008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akama K, 2011, BBA-PROTEINS PROTEOM, V1814, P265, DOI 10.1016/j.bbapap.2010.10.009; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Artal-Sanz M, 2009, TRENDS ENDOCRIN MET, V20, P394, DOI 10.1016/j.tem.2009.04.004; Baharvand H, 2006, PROTEOMICS, V6, P3544, DOI 10.1002/pmic.200500844; Chen CT, 2012, BBA-GEN SUBJECTS, V1820, P571, DOI 10.1016/j.bbagen.2011.09.013; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Comelli M, 2011, MITOCHONDRION, V11, P315, DOI 10.1016/j.mito.2010.12.007; Czarnecka AM, 2006, CANCER BIOL THER, V5, P714, DOI 10.4161/cbt.5.7.2975; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0; Feng RP, 2013, BIOCHEM J, V450, P459, DOI 10.1042/BJ20120924; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; Heron-Milhavet L, 2008, J CELL PHYSIOL, V214, P158, DOI 10.1002/jcp.21177; Hogan B, 1994, MANIPULATING MOUSE E; Hom JR, 2011, DEV CELL, V21, P469, DOI 10.1016/j.devcel.2011.08.008; Intoh A, 2009, BIOMED CHROMATOGR, V23, P607, DOI 10.1002/bmc.1159; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; Kunisada Y, 2012, STEM CELL RES, V8, P274, DOI 10.1016/j.scr.2011.10.002; Kurisaki A, 2006, MOL CELL BIOL, V26, P1318, DOI 10.1128/MCB.26.4.1318-1332.2006; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; Merkwirth C, 2008, GENE DEV, V22, P476, DOI 10.1101/gad.460708; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Montano MM, 1999, P NATL ACAD SCI USA, V96, P6947, DOI 10.1073/pnas.96.12.6947; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Ng HH, 2011, NAT CELL BIOL, V13, P490, DOI 10.1038/ncb0511-490; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Park SE, 2005, MOL CELL BIOL, V25, P1989, DOI 10.1128/MCB.25.5.1989-1999.2005; Rastogi S, 2006, J BIOL CHEM, V281, P2951, DOI 10.1074/jbc.M508669200; Rehman J, 2010, J MOL MED, V88, P981, DOI 10.1007/s00109-010-0678-2; Sun LG, 2011, CELL SIGNAL, V23, P1686, DOI 10.1016/j.cellsig.2011.06.005; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thuaud F, 2013, CHEM BIOL, V20, P316, DOI 10.1016/j.chembiol.2013.02.006; Voccoli V, 2009, BRAIN RES, V1252, P15, DOI 10.1016/j.brainres.2008.11.026; Wang S, 1999, MOL CELL BIOL, V19, P7447; Wang S, 2002, ONCOGENE, V21, P8388, DOI 10.1038/sj.onc.1205944; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Watanabe M, 2000, EMBO REP, V1, P176, DOI 10.1093/embo-reports/kvd029; Yoshida-Koide U, 2004, BIOCHEM BIOPH RES CO, V313, P475, DOI 10.1016/j.bbrc.2003.11.138; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	44	25	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e81552	10.1371/journal.pone.0081552	http://dx.doi.org/10.1371/journal.pone.0081552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709813	gold, Green Submitted, Green Published			2022-12-25	WOS:000334159800001
J	Creswell, J; Khowaja, S; Codlin, A; Hashmi, R; Rasheed, E; Khan, M; Durab, I; Mergenthaler, C; Hussain, O; Khan, F; Khan, AJ				Creswell, Jacob; Khowaja, Saira; Codlin, Andrew; Hashmi, Rabia; Rasheed, Erum; Khan, Mubashir; Durab, Irfan; Mergenthaler, Christina; Hussain, Owais; Khan, Faisal; Khan, Aamir J.			An Evaluation of Systematic Tuberculosis Screening at Private Facilities in Karachi, Pakistan	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; CARE; HEALTH; DELAY; COMMUNITIES; DIAGNOSIS; SYMPTOMS; DISTRICT; COUGH; MIX	Background: In Pakistan, like many Asian countries, a large proportion of healthcare is provided through the private sector. We evaluated a systematic screening strategy to identify people with tuberculosis in private facilities in Karachi and assessed the approaches' ability to diagnose patients earlier in their disease progression. Methods and Findings: Lay workers at 89 private clinics and a large hospital outpatient department screened all attendees for tuberculosis using a mobile phone-based questionnaire during one year. The number needed to screen to detect a case of tuberculosis was calculated. To evaluate early diagnosis, we tested for differences in cough duration and smear grading by screening facility. 529,447 people were screened, 1,010 smear-positive tuberculosis cases were detected and 942 (93.3%) started treatment, representing 58.7% of all smear-positive cases notified in the intervention area. The number needed to screen to detect a smear-positive case was 124 (prevalence 806/100,000) at the hospital and 763 ( prevalence 131/100,000) at the clinics; however, ten times the number of individuals were screened in clinics. People with smear-positive TB detected at the hospital were less likely to report cough lasting 2-3 weeks (RR 0.66 95% Cl [0.49-0.90]) and more likely to report cough duration > 3 weeks (RR 1.10 95% Cl [1.03-1.18]). Smear-positive cases at the clinics were less likely to have a +3 grade (RR 0.76 95% Cl [0.63-0.92]) and more likely to have +1 smear grade (RR 1.24 95% Cl [1.02-1.51]). Conclusions: Tuberculosis screening at private facilities is acceptable and can yield large numbers of previously undiagnosed cases. Screening at general practitioner clinics may find cases earlier than at hospitals although more people must be screened to identify a case of tuberculosis. Limitations include lack of culture testing, therefore underestimating true TB prevalence. Using more sensitive and specific screening and diagnostic tests such as chest x-ray and Xpert MTB/RIF may improve results.	[Creswell, Jacob; Mergenthaler, Christina] Stop TB Partnership, Geneva, Switzerland; [Khowaja, Saira; Codlin, Andrew; Hashmi, Rabia; Rasheed, Erum; Khan, Mubashir; Durab, Irfan; Hussain, Owais; Khan, Faisal; Khan, Aamir J.] Interact Res & Dev, Karachi, Pakistan		Creswell, J (corresponding author), Stop TB Partnership, Geneva, Switzerland.	creswellj@who.int		Creswell, Jacob/0000-0002-4885-940X; Hussain, Owais/0000-0002-5449-1867	Foreign Affairs, Trade and Development of Canada	Foreign Affairs, Trade and Development of Canada	TB REACH, an initiative of the Stop TB Partnership, is funded by Foreign Affairs, Trade and Development of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.acdi-cida.gc.ca/home.	ALUOCH JA, 1985, TUBERCLE, V66, P237, DOI 10.1016/0041-3879(85)90061-3; Arantes G R, 1980, Rev Saude Publica, V14, P185, DOI 10.1590/S0034-89101980000200004; Asch S, 1998, AM J RESP CRIT CARE, V157, P1244, DOI 10.1164/ajrccm.157.4.9709071; Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; Cambodia National Tuberculosis Control Program, 2002, NAT TUB PREV SURV; Cattamanchi A, 2010, J CLIN MICROBIOL, V48, P2433, DOI 10.1128/JCM.00208-10; Claassens MM, 2013, INT J TUBERC LUNG D, V17, P608, DOI 10.5588/ijtld.12.0506; Codlin AJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-331; Den Boon S, 2008, EPIDEMIOL INFECT, V136, P1342, DOI 10.1017/S0950268807000106; Dowdy DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077517; Eang MT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-469; Khan AJ, 2012, LANCET INFECT DIS, V12, P608, DOI 10.1016/S1473-3099(12)70116-0; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; KRIVINKA R, 1974, B WORLD HEALTH ORGAN, V51, P59; Lienhardt C, 2001, INT J TUBERC LUNG D, V5, P233; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Lonnroth K, 2006, B WORLD HEALTH ORGAN, V84, P876; Lonnroth K, 2004, B WORLD HEALTH ORGAN, V82, P580; Ministry of Health Department of Health Government of Myanmar, 2011, REP NAT TB PREV SURV; Ngadaya ES, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-112; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Pantoja A, 2009, INT J TUBERC LUNG D, V13, P698; Qadeer E., 2013, PREVALENCE PULMONARY; Raviglione MC, 2006, LANCET, V367, P952, DOI 10.1016/S0140-6736(06)68392-X; Rieder H, 2004, TOMANS TUBERCULOSIS; Rojpibulstit M, 2006, INT J TUBERC LUNG D, V10, P422; Salim MAH, 2006, B WORLD HEALTH ORGAN, V84, P479, DOI 10.2471/BLT.05.023929; Santha T, 2005, INT J TUBERC LUNG D, V9, P61; Shapiro AE, 2013, SYSTEMATIC REV NUMBE; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Thomas Aleyamma, 2008, Indian J Tuberc, V55, P77; Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7; Uplekar M, 2013, INT J TUBERC LUNG D, V17, P1248, DOI 10.5588/ijtld.13.0199; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2013, SYST SCREEN ACT TUB	35	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93858	10.1371/journal.pone.0093858	http://dx.doi.org/10.1371/journal.pone.0093858			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705600	gold, Green Published, Green Submitted			2022-12-25	WOS:000334107500080
J	Downs, LM; Mellersh, CS				Downs, Louise M.; Mellersh, Cathryn S.			An Intronic SINE Insertion in FAM161A that Causes Exon-Skipping Is Associated with Progressive Retinal Atrophy in Tibetan Spaniels and Tibetan Terriers	PLOS ONE			English	Article							RECESSIVE RETINITIS-PIGMENTOSA; LEBER CONGENITAL AMAUROSIS; CONE-ROD DYSTROPHY; GENE-THERAPY; INDIAN FAMILY; DNA-SEQUENCE; MUTATIONS; DOGS; LOCUS; PHOTORECEPTOR	Progressive retinal atrophy (PRA) in dogs is characterised by the degeneration of the photoreceptor cells of the retina, resulting in vision loss and eventually complete blindness. The condition affects more than 100 dog breeds and is known to be genetically heterogeneous between breeds. Around 19 mutations have now been identified that are associated with PRA in around 49 breeds, but for the majority of breeds the mutation(s) responsible have yet to be identified. Using genome-wide association with 22 Tibetan Spaniel PRA cases and 10 controls, we identified a novel PRA locus, PRA3, on CFA10 (p(raw) = 2.01 x 10(-5), p(genome) = 0.014), where a 3.8 Mb region was homozygous within 12 cases. Using targeted next generation sequencing, a short interspersed nuclear element insertion was identified near a splice acceptor site in an intron of a provocative gene, FAM161A. Analysis of mRNA from an affected dog revealed that the SINE causes exon skipping, resulting in a frame shift, leading to a downstream premature termination codon and possibly a truncated protein product. This mutation segregates with the disease in 22 out of 35 cases tested (63%). Of the PRA controls, none are homozygous for the mutation, 15% carry the mutation and 85% are homozygous wildtype. This mutation was also identified in Tibetan Terriers, although our results indicate that PRA is genetically heterogeneous in both Tibetan Spaniels and Tibetan Terriers.	[Downs, Louise M.; Mellersh, Cathryn S.] Anim Hlth Trust, Genet Ctr, Kennel Club, Newmarket, Suffolk, England	Animal Health Trust	Mellersh, CS (corresponding author), Anim Hlth Trust, Genet Ctr, Kennel Club, Newmarket, Suffolk, England.	cathryn.mellersh@aht.org.uk		Burmeister, Louise/0000-0002-6551-055X	Petplan Charitable Trust [10-06]; Kennel Club Charitable Trust	Petplan Charitable Trust; Kennel Club Charitable Trust	The work was supported by the the Petplan Charitable Trust (grant no 10-06; http://www.petplantrust.org/) and by private donations from dog breeders and owners. The Kennel Club Genetics Centre at the Animal Health Trust is maintained by funding from the Kennel Club Charitable Trust (http://www.thekennelclub.org.uk/our-resources/kennel-club-charitable-trust/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Andre C, 2008, PRAT MED CHIR ANIM, V43, P75; Astle W, 2009, STAT SCI, V24, P451, DOI 10.1214/09-STS307; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bandah-Rozenfeld D, 2010, AM J HUM GENET, V87, P382, DOI 10.1016/j.ajhg.2010.07.022; Beggs AH, 2010, P NATL ACAD SCI USA, V107, P14697, DOI 10.1073/pnas.1003677107; Beltran WA, 2012, P NATL ACAD SCI USA, V109, P2132, DOI 10.1073/pnas.1118847109; BJERKAS E, 1994, VET REC, V134, P377, DOI 10.1136/vr.134.15.377; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Clark LA, 2006, P NATL ACAD SCI USA, V103, P1376, DOI 10.1073/pnas.0506940103; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; den Hollander AI, 2007, NAT GENET, V39, P889, DOI 10.1038/ng2066; Di Gioia SA, 2012, HUM MOL GENET; Downs LL, 2012, TRAV GENRE SOC, P169; Downs LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021452; Fairbanks D.J., 1999, GENETICS CONTINUITY; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Gomez-Baldo L, 2010, CELL CYCLE, V9, P1143, DOI 10.4161/cc.9.6.11018; Grall A, 2012, NAT GENET, V44, P140, DOI 10.1038/ng.1056; GRONDAHL J, 1987, CLIN GENET, V31, P255; Gu SM, 1999, J MED GENET, V36, P705; HAIM M, 1992, ACTA OPHTHALMOL, V70, P178; Howell JM, 1997, NEUROMUSCULAR DISORD, V7, P325; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Kumar A, 2004, MOL VIS, V10, P399; Langmann T, 2010, AM J HUM GENET, V87, P376, DOI 10.1016/j.ajhg.2010.07.018; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mellersh CS, 2006, GENOMICS, V88, P293, DOI 10.1016/j.ygeno.2006.05.004; MINNICK MF, 1992, GENE, V110, P235, DOI 10.1016/0378-1119(92)90654-8; Miyadera K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051598; Mount JD, 2002, BLOOD, V99, P2670, DOI 10.1182/blood.V99.8.2670; PAGON RA, 1988, SURV OPHTHALMOL, V33, P137, DOI 10.1016/0039-6257(88)90085-9; PARRY HB, 1953, BRIT J OPHTHALMOL, V37, P487, DOI 10.1136/bjo.37.8.487; Petersen-Jones S, 2005, J SMALL ANIM PRACT, V46, P371, DOI 10.1111/j.1748-5827.2005.tb00333.x; Ponder KP, 2002, P NATL ACAD SCI USA, V99, P13102, DOI 10.1073/pnas.192353499; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; REED R, 1988, GENE DEV, V2, P1268, DOI 10.1101/gad.2.10.1268; REED R, 1985, CELL, V41, P95, DOI 10.1016/0092-8674(85)90064-9; Roy-Engel AM, 2002, GENOME RES, V12, P1333, DOI 10.1101/gr.384802; Rozen S, 2000, Methods Mol Biol, V132, P365; Sidjanin DJ, 2002, HUM MOL GENET, V11, P1823, DOI 10.1093/hmg/11.16.1823; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thorvaldsdottir H, 2012, BRIEF BIOINFORM; Veske A, 1999, GENOMICS, V57, P57, DOI 10.1006/geno.1999.5754; Zach F, 2012, HUM MOL GENET	48	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93990	10.1371/journal.pone.0093990	http://dx.doi.org/10.1371/journal.pone.0093990			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705771	Green Submitted, gold, Green Published			2022-12-25	WOS:000334107500105
J	Williams, RM; Nayeem, S; Dolash, BD; Sooter, LJ				Williams, Ryan M.; Nayeem, Sara; Dolash, Bridget D.; Sooter, Letha J.			The Effect of DNA-Dispersed Single-Walled Carbon Nanotubes on the Polymerase Chain Reaction	PLOS ONE			English	Article							BAND-GAP FLUORESCENCE; RECOGNITION; SEPARATION; SPECTROSCOPY; ENRICHMENT; BIOSENSORS	The unique properties of single-wall carbon nanotubes (SWCNT) make them useful in many new technologies and applications. The interaction of DNA and SWCNT is of interest for many uses, including molecular sensors. This study determined polymerase chain reaction (PCR) efficiency in amplifying a 76 base pair DNA sequence in the presence of SWCNT, of heterogeneous "Mix'' and (6,5)-enriched chiralities, associated with three DNA sequences. The dependence of PCR efficiency on the concentration of DNA: SWCNT preparations was measured, as well as their age and level of dispersion (less than one month or between four and ten months). Additionally, the ability to directly amplify the DNA sequence associated with the SWCNT scaffold was investigated. In PCRs with DNA: SWCNT preparations less than one month old, concentrations greater than or equal to 0.1 mg/mL inhibited the PCR reaction. In PCRs with older preparations, no inhibition was seen at 0.01 or 0.1 mg/mL, with amplification at 1 mg/mL in some samples. Additionally, our studies showed that the DNA directly associated with the SWCNT can be amplified using PCR. This work provides an inhibitory concentration of DNA-dispersed SWCNT in PCR reactions for different preparations as well as a basis for future DNA: SWCNT studies that require PCR amplification. This will be useful for future studies focused on the use of SWCNT in molecular sensing technologies.	[Williams, Ryan M.; Nayeem, Sara; Dolash, Bridget D.; Sooter, Letha J.] W Virginia Univ, Morgantown, WV 26506 USA	West Virginia University	Sooter, LJ (corresponding author), W Virginia Univ, Morgantown, WV 26506 USA.	lsooter@hsc.wvu.edu			National Science Foundation Cooperative Agreements [NSF-1003907, NSF-0554328]; Department of Defense Cooperative Agreement [W911NF-09-2-0044]; West Virginia University; American Foundation for Pharmaceutical Education	National Science Foundation Cooperative Agreements(National Science Foundation (NSF)); Department of Defense Cooperative Agreement; West Virginia University; American Foundation for Pharmaceutical Education	This work was supported by National Science Foundation Cooperative Agreements (NSF-1003907 and NSF-0554328) (http://www.nsf.gov/). This work was also supported by a Department of Defense Cooperative Agreement (W911NF-09-2-0044 (http://www.defense.gov/). The work was also supported by West Virginia University (http://www.wvu.edu/). RMW was supported in part by a fellowship from the American Foundation for Pharmaceutical Education (http://www.afpenet.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajayan PM, 1999, CHEM REV, V99, P1787, DOI 10.1021/cr970102g; Albertorio F, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/39/395101; Avouris P, 2008, NAT PHOTONICS, V2, P341, DOI 10.1038/nphoton.2008.94; Coleman JN, 2006, CARBON, V44, P1624, DOI 10.1016/j.carbon.2006.02.038; Cui DX, 2004, NANOTECHNOLOGY, V15, P154, DOI 10.1088/0957-4484/15/1/030; Heller DA, 2005, ADV MATER, V17, P2793, DOI 10.1002/adma.200500477; Huang HD, 2011, TRAC-TREND ANAL CHEM, V30, P1109, DOI 10.1016/j.trac.2011.03.014; Huang XY, 2005, ANAL CHEM, V77, P6225, DOI 10.1021/ac0508954; Huy GD, 2011, BIOPROC BIOSYST ENG, V34, P189, DOI 10.1007/s00449-010-0460-4; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Jeng ES, 2006, NANO LETT, V6, P371, DOI 10.1021/nl051829k; Khandurina J, 2000, ANAL CHEM, V72, P2995, DOI 10.1021/ac991471a; Kim SN, 2008, NANO LETT, V8, P4415, DOI 10.1021/nl802332v; Kim YS, 2007, BIOSENS BIOELECTRON, V22, P2525, DOI 10.1016/j.bios.2006.10.004; Lahiji RR, 2007, SMALL, V3, P1912, DOI 10.1002/smll.200700184; Langan TJ, 2012, ELECTROPHORESIS, V33, P866, DOI 10.1002/elps.201100411; O'Connell MJ, 2002, SCIENCE, V297, P593, DOI 10.1126/science.1072631; SAITO R, 1992, APPL PHYS LETT, V60, P2204, DOI 10.1063/1.107080; So HM, 2005, J AM CHEM SOC, V127, P11906, DOI 10.1021/ja053094r; So HM, 2008, SMALL, V4, P197, DOI 10.1002/smll.200700664; Tu XM, 2011, J AM CHEM SOC, V133, P12998, DOI 10.1021/ja205407q; Tu XM, 2009, NATURE, V460, P250, DOI 10.1038/nature08116; Wang J, 2005, ELECTROANAL, V17, P7, DOI 10.1002/elan.200403113; Weisman RB, 2010, ANAL BIOANAL CHEM, V396, P1015, DOI 10.1007/s00216-009-3062-8; Yi CQ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/2/025102; Zhang YN, 2010, NANOSCALE, V2, P1919, DOI 10.1039/c0nr00222d; Zhang ZZ, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/35/355706; Zhang ZZ, 2008, BIOTECHNIQUES, V44, P537, DOI 10.2144/000112692; Zheng M, 2003, NAT MATER, V2, P338, DOI 10.1038/nmat877	30	21	22	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94117	10.1371/journal.pone.0094117	http://dx.doi.org/10.1371/journal.pone.0094117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705714	Green Submitted, gold, Green Published			2022-12-25	WOS:000334107500124
J	Kunchithapautham, K; Atkinson, C; Rohrer, B				Kunchithapautham, Kannan; Atkinson, Carl; Rohrer, Baerbel			Smoke Exposure Causes Endoplasmic Reticulum Stress and Lipid Accumulation in Retinal Pigment Epithelium through Oxidative Stress and Complement Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; CIGARETTE-SMOKE; BRUCHS MEMBRANE; CHOROIDAL NEOVASCULARIZATION; REGULATORY PROTEINS; ALTERNATIVE PATHWAY; GEOGRAPHIC ATROPHY; APOLIPOPROTEIN-E	Age-related macular degeneration (AMD) is a complex disease caused by genetic and environmental factors, including genetic variants in complement components and smoking. Smoke exposure leads to oxidative stress, complement activation, endoplasmic reticulum (ER) stress, and lipid dysregulation, which have all been proposed to be associated with AMD pathogenesis. Here we examine the effects of smoke exposure on the retinal pigment epithelium (RPE). Mice were exposed to cigarette smoke or filtered air for 6 months. RPE cells grown as stable monolayers were exposed to 5% cigarette smoke extract (CSE). Effects of smoke were determined by biochemical, molecular, and histological measures. Effects of the alternative pathway (AP) of complement and complement C3a anaphylatoxin receptor signaling were analyzed using knock-out mice or specific inhibitors. ER stress markers were elevated after smoke exposure in RPE of intact mice, which was eliminated in AP-deficient mice. To examine this relationship further, RPE monolayers were exposed to CSE. Short term smoke exposure resulted in production and release of complement C3, the generation of C3a, oxidative stress, complement activation on the cell membrane, and ER stress. Long term exposure to CSE resulted in lipid accumulation, and secretion. All measures were reversed by blocking C3a complement receptor (C3aR), alternative complement pathway signaling, and antioxidant therapy. Taken together, our results provide clear evidence that smoke exposure results in oxidative stress and complement activation via the AP, resulting in ER stress-mediated lipid accumulation, and further suggesting that oxidative stress and complement act synergistically in the pathogenesis of AMD.	[Kunchithapautham, Kannan; Rohrer, Baerbel] Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; [Atkinson, Carl] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Rohrer, Baerbel] Ralph H Johnson Vet Affairs Med Ctr, Res Serv, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Rohrer, B (corresponding author), 167 Ashley Ave, Charleston, SC 29425 USA.	rohrer@musc.edu			National Institutes of Health [C06RR015455]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019320] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091944] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Affairs(US Department of Veterans Affairs)	Animal studies were conducted in a facility constructed with support from the National Institutes of Health Grant C06RR015455.	Ablonczy Z, 2007, EXP EYE RES, V85, P762, DOI 10.1016/j.exer.2007.08.010; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Bandyopadhyay M, 2012, INVEST OPHTH VIS SCI, V53, P1953, DOI 10.1167/iovs.11-8638; Bertram KM, 2009, AM J PHYSIOL-CELL PH, V297, pC1200, DOI 10.1152/ajpcell.00126.2009; Brown MM, 2005, CAN J OPHTHALMOL, V40, P277, DOI 10.1016/S0008-4182(05)80070-5; Chakravarthy U, 2007, OPHTHALMOLOGY, V114, P1157, DOI 10.1016/j.ophtha.2006.09.022; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; Coffey PJ, 2007, P NATL ACAD SCI USA, V104, P16651, DOI 10.1073/pnas.0705079104; Colgan SM, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001742; Curcio CA, 2001, INVEST OPHTH VIS SCI, V42, P265; Damiano F, 2010, BIOCHEM J, V429, P603, DOI 10.1042/BJ20091827; Damman J, 2011, NEPHROL DIAL TRANSPL, V26, P2345, DOI 10.1093/ndt/gfq717; Davis KS, 2010, OTOLARYNG HEAD NECK, V143, P152, DOI 10.1016/j.otohns.2010.02.022; Dithmar S, 2000, INVEST OPHTH VIS SCI, V41, P2035; Ebrahimi KB, 2013, J PATHOL, V229, P729, DOI 10.1002/path.4128; Ebrahimi KB, 2011, J LIPIDS, V2011, DOI 10.1155/2011/802059; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Espinosa-Heidmann DG, 2006, INVEST OPHTH VIS SCI, V47, P729, DOI 10.1167/iovs.05-0719; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Fett AL, 2012, HISTOL HISTOPATHOL, V27, P357, DOI 10.14670/HH-27.357; Freund KB, 2010, RETINA-J RET VIT DIS, V30, P1333, DOI 10.1097/IAE.0b013e3181e7976b; Haeri Mohammad, 2012, J Ophthalmic Vis Res, V7, P45; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haimovici R, 2001, INVEST OPHTH VIS SCI, V42, P1592; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Huang YX, 2008, J IMMUNOL, V181, P8068, DOI 10.4049/jimmunol.181.11.8068; Ishida BY, 2004, J LIPID RES, V45, P263, DOI 10.1194/jlr.M300306-JLR200; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Johnson LV, 2011, P NATL ACAD SCI USA, V108, P18277, DOI 10.1073/pnas.1109703108; Joseph K, 2013, J BIOL CHEM, V288, P12753, DOI 10.1074/jbc.M112.421891; Kelsen SG, 2012, PULM PHARMACOL THER, V25, P447, DOI 10.1016/j.pupt.2012.07.005; KEW RR, 1985, J CLIN INVEST, V75, P1000, DOI 10.1172/JCI111760; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Kitamura M, 2008, AM J PHYSIOL-RENAL, V295, pF323, DOI 10.1152/ajprenal.00050.2008; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klos A, 2013, PHARMACOL REV, V65, P500, DOI 10.1124/pr.111.005223; Kunchithapautham K, 2012, ADV EXP MED BIOL, V723, P23, DOI 10.1007/978-1-4614-0631-0_4; LILES MR, 1991, ARCH OPHTHALMOL-CHIC, V109, P1285, DOI 10.1001/archopht.1991.01080090111033; Lin JH, 2010, ADV EXP MED BIOL, V664, P115, DOI 10.1007/978-1-4419-1399-9_14; Lin Y., 2012, C53 COPD PATHOGENESI, pA4561; Lohr HR, 2006, EXP EYE RES, V83, P380, DOI 10.1016/j.exer.2006.01.014; Lois N, 2008, BRIT J OPHTHALMOL, V92, P1304, DOI 10.1136/bjo.2008.141168; Luo C, 2011, MOL VIS, V17, P1588; Matsumoto M, 1997, P NATL ACAD SCI USA, V94, P8720, DOI 10.1073/pnas.94.16.8720; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mitchell P, 2002, ARCH OPHTHALMOL-CHIC, V120, P1357, DOI 10.1001/archopht.120.10.1357; Mogilenko DA, 2012, J BIOL CHEM, V287, P5954, DOI 10.1074/jbc.M111.289322; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; Mulligan RM, 2009, AM J RHINOL ALLERGY, V23, pE1, DOI 10.2500/ajra.2009.23.3400; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; PLATEL D, 1994, EUR CYTOKINE NETW, V5, P405; Roybal CN, 2004, J BIOL CHEM, V279, P14844, DOI 10.1074/jbc.M312948200; ROZANOWSKA M, 1995, J BIOL CHEM, V270, P18825, DOI 10.1074/jbc.270.32.18825; Rudolf M, 2009, J HISTOCHEM CYTOCHEM, V57, P731, DOI 10.1369/jhc.2009.953448; Salminen A, 2010, MOL MED, V16, P535, DOI 10.2119/molmed.2010.00070; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Sanai M, 2011, AFR J BIOTECHNOL, V10, P19211, DOI 10.5897/AJB11.254; TATE DJ, 1993, ARCH OPHTHALMOL-CHIC, V111, P963, DOI 10.1001/archopht.1993.01090070083023; Thurman JM, 2006, J CLIN INVEST, V116, P357, DOI 10.1172/JCI24521; Thurman JM, 2013, J CLIN INVEST, V123, P2218, DOI 10.1172/JCI65861; Thurman JM, 2009, J BIOL CHEM, V284, P16939, DOI 10.1074/jbc.M808166200; Tweed JO, 2012, TRENDS ENDOCRIN MET, V23, P334, DOI 10.1016/j.tem.2012.03.006; van der Vaart H, 2004, THORAX, V59, P713, DOI 10.1136/thx.2003.012468; Vogt SD, 2011, EXP EYE RES, V93, P413, DOI 10.1016/j.exer.2011.06.002; von Leithner PL, 2009, AM J PATHOL, V175, P412, DOI 10.2353/ajpath.2009.080927; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005304; Wang L, 2009, INVEST OPHTH VIS SCI, V50, P870, DOI 10.1167/iovs.08-2376; Wang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010329; Whitcup SM, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/348092; Woodell A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067894; Yang P, 2009, INVEST OPHTH VIS SCI, V50, P3473, DOI 10.1167/iovs.08-3202; Yin W, 2008, THROMB RES, V122, P221, DOI 10.1016/j.thromres.2007.11.005; Yu AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048501; Yu MZ, 2012, INVEST OPHTH VIS SCI, V53, P7684, DOI 10.1167/iovs.12-10069; Zarbin MA, 2010, RETINA-J RET VIT DIS, V30, P1350, DOI 10.1097/IAE.0b013e3181f57e30; Zipfel PF, 2010, ADV EXP MED BIOL, V703, P9, DOI 10.1007/978-1-4419-5635-4_2	78	105	106	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14534	14546		10.1074/jbc.M114.564674	http://dx.doi.org/10.1074/jbc.M114.564674			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24711457	Green Published, hybrid			2022-12-25	WOS:000337248100012
J	Buzatu, DA; Moskal, TJ; Williams, AJ; Cooper, WM; Mattes, WB; Wilkes, JG				Buzatu, Dan A.; Moskal, Ted J.; Williams, Anna J.; Cooper, Willie Mae; Mattes, William B.; Wilkes, Jon G.			An Integrated Flow Cytometry-Based System for RealTime, High Sensitivity Bacterial Detection and Identification	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; FOOD MATRIX INTERFERENCE; SAMPLE PREPARATION; PCR DETECTION; SAFETY; COMBINATION; SALMONELLA; PATHOGENS; ANTIBODY; CULTURE	Foodborne illnesses occur in both industrialized and developing countries, and may be increasing due to rapidly evolving food production practices. Yet some primary tools used to assess food safety are decades, if not centuries, old. To improve the time to result for food safety assessment a sensitive flow cytometer based system to detect microbial contamination was developed. By eliminating background fluorescence and improving signal to noise the assays accurately measure bacterial load or specifically identify pathogens. These assays provide results in minutes or, if sensitivity to one cell in a complex matrix is required, after several hours enrichment. Conventional assessments of food safety require 48 to 56 hours. The assays described within are linear over 5 orders of magnitude with results identical to culture plates, and report live and dead microorganisms. This system offers a powerful approach to real-time assessment of food safety, useful for industry self-monitoring and regulatory inspection.	[Buzatu, Dan A.; Williams, Anna J.; Cooper, Willie Mae; Wilkes, Jon G.] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Moskal, Ted J.] Vivione Biosci, Pine Bluff, AR USA; [Mattes, William B.] PharmPoint Consulting, Poolesville, MD USA	US Food & Drug Administration (FDA)	Buzatu, DA (corresponding author), US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.	dan.buzatu@fda.hhs.gov		Mattes, William/0000-0001-8653-4289				ALHITI MMA, 1983, J APPL BACTERIOL, V55, P173, DOI 10.1111/j.1365-2672.1983.tb02662.x; ALSHARIF R, 2002, BACTERIAL DETECTION; American Society for Microbiology Center for Disease Control Association of Public Health Laboratories, 2011, SENT LAB GUID; Andrews W.H., 2011, BACTERIOLOGICAL ANAL; bioMerieux Inc, 2009, VIDAS ECO VIDAS ICE; Buzatu DA, 2013, FOOD MICROBIOL, V36, P416, DOI 10.1016/j.fm.2013.07.007; Center for Disease Control and Prevention, 2011, EST FOODB ILLN US; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Clarke RG, 1998, J APPL MICROBIOL, V84, P577, DOI 10.1046/j.1365-2672.1998.00384.x; DuPont, 2005, BAX ENR MED E COL, VO157, pH7; Food and Drug Administration (FDA), 2012, BACT AN MAN BAM; GarciadeLomas J, 1997, PEDIATR INFECT DIS J, V16, pS43, DOI 10.1097/00006454-199703001-00004; Holland JL, 2000, J CLIN MICROBIOL, V38, P4108, DOI 10.1128/JCM.38.11.4108-4113.2000; Jordan J, 2002, INSIDE LAB MANAGEMEN, V2002, P19; Kaferstein F, 1999, B WORLD HEALTH ORGAN, V77, P347; Lindqvist R, 1997, LETT APPL MICROBIOL, V24, P306, DOI 10.1046/j.1472-765X.1997.00069.x; Malorny B, 2004, APPL ENVIRON MICROB, V70, P7046, DOI 10.1128/AEM.70.12.7046-7052.2004; MCCLELLAND RG, 1994, APPL ENVIRON MICROB, V60, P4255, DOI 10.1128/AEM.60.12.4255-4262.1994; McKillip JL, 2002, J FOOD PROTECT, V65, P1775, DOI 10.4315/0362-028X-65.11.1775; NABER SP, 1994, NEW ENGL J MED, V331, P1212, DOI 10.1056/NEJM199411033311808; Oliver JD, 2005, J MICROBIOL, V43, P93; Olson ED, 2011, HEALTH AFFAIR, V30, P915, DOI 10.1377/hlthaff.2010.1265; Pitcher DG, 2000, J INFECTION, V40, P116, DOI 10.1053/jinf.2000.0635; ROSSEN L, 1992, INT J FOOD MICROBIOL, V17, P37, DOI 10.1016/0168-1605(92)90017-W; Seo KH, 1998, INT J FOOD MICROBIOL, V44, P115, DOI 10.1016/S0168-1605(98)00129-9; STEEN HB, 1979, SCIENCE, V204, P403, DOI 10.1126/science.441727; STEEN HB, 1982, CYTOMETRY, V2, P249; Stokstad E, 2011, SCIENCE, V331, P270, DOI 10.1126/science.331.6015.270; Taylor DA, 2011, ENVIRON HEALTH PERSP, V119, P119; Taylor MR, 2011, NEW ENGL J MED, V365, DOI 10.1056/NEJMp1109388; Tetracore Inc, 2012, DOM PREP PROD BIOTHR; Toops D, 2012, 2012 FOOD IND OUTLOO; Vaisanen OM, 1998, J APPL MICROBIOL, V84, P1069; Wilkes JG, 2012, FOOD MICROBIOL, V30, P281, DOI 10.1016/j.fm.2011.11.002	34	34	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94254	10.1371/journal.pone.0094254	http://dx.doi.org/10.1371/journal.pone.0094254			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718659	Green Published, Green Submitted, gold			2022-12-25	WOS:000334339000096
J	Duyvestyn, JM; Taylor, SJ; Dagger, SA; Orandle, M; Morse, HC; Thien, CBF; Langdon, WY				Duyvestyn, Johanna M.; Taylor, Samuel J.; Dagger, Samantha A.; Orandle, Marlene; Morse, Herbert C., III; Thien, Christine B. F.; Langdon, Wallace Y.			Dasatinib Targets B-Lineage Cells but Does Not Provide an Effective Therapy for Myeloproliferative Disease in c-Cbl RING Finger Mutant Mice	PLOS ONE			English	Article							JUVENILE MYELOMONOCYTIC LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; ACQUIRED UNIPARENTAL DISOMY; HEMATOPOIETIC STEM-CELLS; SRC-FAMILY KINASES; LYN-DEFICIENT MICE; INHIBITOR DASATINIB; AUTOIMMUNE-DISEASE; MYELOID NEOPLASMS; TYROSINE KINASES	This study aimed to determine whether the multi-kinase inhibitor dasatinib would provide an effective therapy for myeloproliferative diseases (MPDs) involving c-Cbl mutations. These mutations, which occur in the RING finger and linker domains, abolish the ability of c-Cbl to function as an E3 ubiquitin ligase and downregulate activated protein tyrosine kinases. Here we analyzed the effects of dasatinib in a c-Cbl RING finger mutant mouse that develops an MPD with a phenotype similar to the human MPDs. The mice are characterized by enhanced tyrosine kinase signaling resulting in an expansion of hematopoietic stem cells, multipotent progenitors and cells within the myeloid lineage. Since c-Cbl is a negative regulator of c-Kit and Src signaling we reasoned that dasatinib, which targets these kinases, would be an effective therapy. Furthermore, two recent studies showed dasatinib to be effective in inhibiting the in vitro growth of cells from leukemia patients with c-Cbl RING finger and linker domain mutations. Surprisingly we found that dasatinib did not provide an effective therapy for c-Cbl RING finger mutant mice since it did not suppress any of the hematopoietic lineages that promote MPD development. Thus we conclude that dasatinib may not be an appropriate therapy for leukemia patients with c-Cbl mutations. We did however find that dasatinib caused a marked reduction of pre-B cells and immature B cells which correlated with a loss of Src activity. This study is therefore the first to provide a detailed characterization of in vivo effects of dasatinib in a hematopoietic disorder that is driven by protein tyrosine kinases other than BCR-ABL.	[Duyvestyn, Johanna M.; Taylor, Samuel J.; Dagger, Samantha A.; Thien, Christine B. F.; Langdon, Wallace Y.] Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA, Australia; [Orandle, Marlene] NIAID, Infect Dis Pathogenesis Sect, Comparat Med Branch, NIH, Rockville, MD USA; [Morse, Herbert C., III] NIAID, Virol & Cellular Immunol Sect, Immunogenet Lab, NIH, Rockville, MD USA	University of Western Australia; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Langdon, WY (corresponding author), Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA, Australia.	wally.langdon@uwa.edu.au	Thien, Christine/GQP-0424-2022	Morse, Herbert/0000-0002-9331-3705; Thien, Christine/0000-0003-3884-5546; Taylor, Samuel/0000-0002-9468-8752	National Health and Medical Research Council [572516, 634414]; Cancer Council of WA; Medical and the Health Research Infrastructure Fund; Intramural Research Program of the NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000858] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council of WA(Cancer Council Western Australia); Medical and the Health Research Infrastructure Fund; Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Health and Medical Research Council Project Grants 572516 and 634414, the Cancer Council of WA, and the Medical and the Health Research Infrastructure Fund, and in part by the Intramural Research Program of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrein PC, 2011, CLIN CANCER RES, V17, P2977, DOI 10.1158/1078-0432.CCR-10-2879; Bunda S, 2013, CANCER RES, V73, P2540, DOI 10.1158/0008-5472.CAN-12-3425; Chan CM, 2012, CLIN CANCER RES, V18, P3580, DOI 10.1158/1078-0432.CCR-11-3359; Coluccia AML, 2008, BLOOD, V112, P1346, DOI 10.1182/blood-2007-10-116590; Dargart JL, 2012, ANTIVIR RES, V95, P49, DOI 10.1016/j.antiviral.2012.05.003; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Dunbar AJ, 2008, CANCER RES, V68, P10349, DOI 10.1158/0008-5472.CAN-08-2754; Dunn EF, 2011, ONCOGENE, V30, P561, DOI 10.1038/onc.2010.430; Gauld SB, 2004, ONCOGENE, V23, P8001, DOI 10.1038/sj.onc.1208075; Grand FH, 2009, BLOOD, V113, P6182, DOI 10.1182/blood-2008-12-194548; HIBBS ML, 1995, CELL, V83, P301, DOI 10.1016/0092-8674(95)90171-X; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kales SC, 2010, CANCER RES, V70, P4789, DOI 10.1158/0008-5472.CAN-10-0610; Kamath AV, 2008, CANCER CHEMOTH PHARM, V61, P365, DOI 10.1007/s00280-007-0478-8; Kohlmann A, 2010, J CLIN ONCOL, V28, P3858, DOI 10.1200/JCO.2009.27.1361; Kuwahara K, 2012, J IMMUNOL, V189, P3472, DOI 10.4049/jimmunol.1200649; Lennartsson J, 1999, ONCOGENE, V18, P5546, DOI 10.1038/sj.onc.1202929; Levis M, 2011, BLOOD, V117, P6987, DOI 10.1182/blood-2011-03-340273; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Linnekin D, 1997, J BIOL CHEM, V272, P27450, DOI 10.1074/jbc.272.43.27450; Loh ML, 2009, BLOOD, V114, P1859, DOI 10.1182/blood-2009-01-198416; Makishima H, 2012, LEUKEMIA, V26, P1547, DOI 10.1038/leu.2012.7; Makishima H, 2009, J CLIN ONCOL, V27, P6109, DOI 10.1200/JCO.2009.23.7503; McCaig AM, 2011, BRIT J HAEMATOL, V153, P199, DOI 10.1111/j.1365-2141.2010.08507.x; Mohapatra B, 2013, BBA-MOL CELL RES, V1833, P122, DOI 10.1016/j.bbamcr.2012.10.010; Muramatsu H, 2010, BLOOD, V115, P1969, DOI 10.1182/blood-2009-06-226340; NISHIZUMI H, 1995, IMMUNITY, V3, P549, DOI 10.1016/1074-7613(95)90126-4; O'Laughlin-Bunner B, 2001, BLOOD, V98, P343, DOI 10.1182/blood.V98.2.343; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Porkka K, 2008, BLOOD, V112, P1005, DOI 10.1182/blood-2008-02-140665; Rathinam C, 2008, GENE DEV, V22, P992, DOI 10.1101/gad.1651408; Rathinam C, 2010, CANCER CELL, V18, P341, DOI 10.1016/j.ccr.2010.09.008; Robinson LJ, 2005, EXP HEMATOL, V33, P469, DOI 10.1016/j.exphem.2005.01.004; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Schittenhelm MM, 2006, CANCER RES, V66, P473, DOI 10.1158/0008-5472.CAN-05-2050; Schnittger S, 2012, HAEMATOL-HEMATOL J, V97, P1890, DOI 10.3324/haematol.2012.065375; Taylor SJ, 2012, BLOOD, V120, P4049, DOI 10.1182/blood-2012-06-436675; Thien CBF, 2001, MOL CELL, V7, P355, DOI 10.1016/S1097-2765(01)00183-6; Thien CBF, 2005, EMBO J, V24, P3807, DOI 10.1038/sj.emboj.7600841; Timokhina I, 1998, EMBO J, V17, P6250, DOI 10.1093/emboj/17.21.6250; Vitali R, 2009, INT J CANCER, V125, P2547, DOI 10.1002/ijc.24606	42	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94717	10.1371/journal.pone.0094717	http://dx.doi.org/10.1371/journal.pone.0094717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718698	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000138
J	Morfeld, KA; Lehnhardt, J; Alligood, C; Bolling, J; Brown, JL				Morfeld, Kari A.; Lehnhardt, John; Alligood, Christina; Bolling, Jeff; Brown, Janine L.			Development of a Body Condition Scoring Index for Female African Elephants Validated by Ultrasound Measurements of Subcutaneous Fat	PLOS ONE			English	Article							REPRODUCTIVE DISORDERS; BLUBBER THICKNESS; CONDITION SCORES; DAIRY-COW; OBESITY; HORSES; SYSTEM; RELIABILITY; PROVISION; AGREEMENT	Obesity-related health and reproductive problems may be contributing to non-sustainability of zoo African elephant (Loxodonta africana) populations. However, a major constraint in screening for obesity in elephants is lack of a practical method to accurately assess body fat. Body condition scoring (BCS) is the assessment of subcutaneous fat stores based on visual evaluation and provides an immediate appraisal of the degree of obesity of an individual. The objective of this study was to develop a visual BCS index for female African elephants and validate it using ultrasound measures of subcutaneous fat. To develop the index, standardized photographs were collected from zoo (n = 50) and free-ranging (n = 57) female African elephants for identifying key body regions and skeletal features, which were then used to visually determine body fat deposition patterns. This information was used to develop a visual BCS method consisting of a list of body regions and the physical criteria for assigning an overall score on a 5-point scale, with 1 representing the lowest and 5 representing the highest levels of body fat. Results showed that as BCS increased, ultrasound measures of subcutaneous fat thickness also increased (P<0.01), indicating the scores closely coincide with physical measures of fat reserves. The BCS index proved to be reliable and repeatable based on high intra- and inter-assessor agreement across three assessors. In comparing photographs of wild vs. captive African elephants, the median BCS in the free-ranging individuals (BCS = 3, range 1-5) was lower (P<0.001) than that of the zoo population (BCS = 4, range 2-5). In sum, we have developed the first validated BCS index for African elephants. This tool can be used to examine which factors impact body condition in zoo and free-ranging elephants, providing valuable information on how it affects health and reproductive potential of individual elephants.	[Morfeld, Kari A.; Brown, Janine L.] Natl Zool Pk, Smithsonian Conservat Biol Inst, Front Roya, VA USA; [Lehnhardt, John; Bolling, Jeff] Natl Elephant Ctr, Fellsmere, FL USA; [Alligood, Christina] Disneys Anim Kingdom, Bay Lake, FL USA	Walt Disney Company	Morfeld, KA (corresponding author), Natl Zool Pk, Smithsonian Conservat Biol Inst, Front Roya, VA USA.	morfeldk@si.edu			Morris Animal Foundation; Shared Earth Foundation; FBB Capital Partners; Wolcott Fund; Siemens Medical Solutions Diagnostics	Morris Animal Foundation; Shared Earth Foundation; FBB Capital Partners; Wolcott Fund; Siemens Medical Solutions Diagnostics	Morris Animal Foundation, Shared Earth Foundation, FBB Capital Partners, Wolcott Fund, Siemens Medical Solutions Diagnostics. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZA, 2011, AZA STAND EL MAN CAR; Bishop CJ, 2009, J WILDLIFE MANAGE, V73, P462, DOI 10.2193/2008-015; Bray George A., 1997, Human Reproduction (Oxford), V12, P26; Brown JL, 2004, ZOO BIOL, V23, P309, DOI 10.1002/zoo.20006; Burkholder WJ, 2000, J AM VET MED ASSOC, V217, P650, DOI 10.2460/javma.2000.217.650; Carter RA, 2009, VET J, V179, P204, DOI 10.1016/j.tvjl.2008.02.029; Chang RJ, 2007, NAT CLIN PRACT ENDOC, V3, P688, DOI 10.1038/ncpendmet0637; CLARK AM, 1995, HUM REPROD, V10, P2705, DOI 10.1093/oxfordjournals.humrep.a135772; Clingerman KJ, 2012, J AM ASSOC LAB ANIM, V51, P31; Clubb R, 2009, ANIM WELFARE, V18, P237; Clubb R., 2002, REV WELFARE ZOO ELEP, P303; Clubb R, 2008, SCIENCE, V322, P1649, DOI 10.1126/science.1164298; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Cook RC, 2001, J WILDLIFE MANAGE, V65, P973, DOI 10.2307/3803046; de Knegt HJ, 2011, J ANIM ECOL, V80, P270, DOI 10.1111/j.1365-2656.2010.01764.x; Deurenberg P, 1999, BEST PRACT RES CL EN, V13, P1, DOI 10.1053/beem.1999.0003; DOMECQ JJ, 1995, J DAIRY SCI, V78, P2308, DOI 10.3168/jds.S0022-0302(95)76857-6; Dow TL, 2011, ZOO BIOL, V30, P699, DOI 10.1002/zoo.20377; EDMONSON AJ, 1989, J DAIRY SCI, V72, P68, DOI 10.3168/jds.S0022-0302(89)79081-0; Ellis KJ, 2000, ENDOCRINOLOGIST, V10, p57S, DOI 10.1097/00019616-200010041-00012; FANELLI MT, 1984, AM J CLIN NUTR, V39, P703, DOI 10.1093/ajcn/39.5.703; Faust L., 2011, TECHNICAL REPORT ZOO; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Frank N, 2006, JAVMA-J AM VET MED A, V228, P1383, DOI 10.2460/javma.228.9.1383; Freeman EW, 2009, ZOO BIOL, V28, P1, DOI 10.1002/zoo.20187; GALES NJ, 1987, AUST J ZOOL, V35, P207, DOI 10.1071/ZO9870207; Ganswindt A, 2010, HORM BEHAV, V57, P506, DOI 10.1016/j.yhbeh.2010.02.009; Gustine DD, 2010, RANGIFER, V27, P249; Hall AJ, 2007, MAR MAMMAL SCI, V23, P650, DOI 10.1111/j.1748-7692.2007.00132.x; HENNEKE DR, 1983, EQUINE VET J, V15, P371, DOI 10.1111/j.2042-3306.1983.tb01826.x; Hile ME, 1997, J ZOO WILDLIFE MED, V28, P424; Hill JW, 2008, AM J PHYSIOL-ENDOC M, V294, pE827, DOI 10.1152/ajpendo.00670.2007; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Irvine L. M., 2003, CURR OBSTET GYNAECOL, V13, P179, DOI [DOI 10.1016/S0957-5847(03)00005-2, 10.1016/S0957-5847(03)00005-2]; Kearns CF, 2002, EQUINE VET J, V34, P485; Keele M., 2011, AZA PUBLICATION; Laflamme D, 1997, CANINE PRACT, V22, P10; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lassen J, 2003, J DAIRY SCI, V86, P4123, DOI 10.3168/jds.S0022-0302(03)74026-0; Lewis KD, 2010, ZOO BIOL, V29, P221, DOI 10.1002/zoo.20291; Li G, 2012, VET MED-RES REP, V3, P71, DOI 10.2147/VMRR.S34665; Lievense AM, 2002, RHEUMATOLOGY, V41, P1155, DOI 10.1093/rheumatology/41.10.1155; Lund E. M., 2006, International Journal of Applied Research in Veterinary Medicine, V4, P177; Lund E. M., 2005, International Journal of Applied Research in Veterinary Medicine, V3, P88; Mason GJ, 2010, ZOO BIOL, V29, P256, DOI [10.1002/zoo.20303, 10.1002/zoo.20256]; Mellish JAE, 2004, J ZOO WILDLIFE MED, V35, P116, DOI 10.1638/03-028; Miller PB, 2008, J REPROD MED, V53, P315; Nguyen NT, 2008, J AM COLL SURGEONS, V207, P928, DOI 10.1016/j.jamcollsurg.2008.08.022; Norman RJ, 1998, REPROD FERT DEVELOP, V10, P55, DOI 10.1071/R98010; OTTO KL, 1991, J DAIRY SCI, V74, P852, DOI 10.3168/jds.S0022-0302(91)78234-9; Pasquali R, 2003, HUM REPROD UPDATE, V9, P359, DOI 10.1093/humupd/dmg024; Phythian CJ, 2012, VET J, V193, P257, DOI 10.1016/j.tvjl.2011.12.006; POOLE JH, 1989, ANIM BEHAV, V37, P140, DOI 10.1016/0003-3472(89)90014-6; Proctor CM, 2010, ZOO BIOL, V29, P127, DOI 10.1002/zoo.20238; Schroder UJ, 2006, J DAIRY SCI, V89, P1, DOI 10.3168/jds.S0022-0302(06)72064-1; Speaker Kristin J., 2012, BMC Physiology, V12, P8, DOI 10.1186/1472-6793-12-8; Stephenson TR, 1998, CAN J ZOOL, V76, P717, DOI 10.1139/cjz-76-4-717; Treiber K, 2012, 7 CRISS ZOOL NUTR S, P1; Vick MM, 2006, REPROD FERT DEVELOP, V18, P609, DOI 10.1071/RD06016; VOLZ PA, 1984, MED SCI SPORT EXER, V16, P97, DOI 10.1249/00005768-198401000-00020; WAGNER JJ, 1988, J ANIM SCI, V66, P603; Wemmer C, 2006, ZOO BIOL, V25, P187, DOI 10.1002/zoo.20099; WESTERVELT RG, 1976, J ANIM SCI, V43, P781, DOI 10.2527/jas1976.434781x; Wiese R. J., 2006, International Zoo Yearbook, V40, P80, DOI 10.1111/j.1748-1090.2006.00080.x; Wijeyamohan S, 2012, CURR SCI INDIA, V102, P26; WILDMAN EE, 1982, J DAIRY SCI, V65, P495, DOI 10.3168/jds.S0022-0302(82)82223-6; WILKINSON MJA, 1991, J NUTR, V121, pS47, DOI 10.1093/jn/121.suppl_11.S47	68	33	35	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93802	10.1371/journal.pone.0093802	http://dx.doi.org/10.1371/journal.pone.0093802			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718304	gold, Green Submitted, Green Published			2022-12-25	WOS:000334339000047
J	Blum, KS; Karaman, S; Proulx, ST; Ochsenbein, AM; Luciani, P; Leroux, JC; Wolfrum, C; Detmar, M				Blum, Katrin S.; Karaman, Sinem; Proulx, Steven T.; Ochsenbein, Alexandra M.; Luciani, Paola; Leroux, Jean-Christophe; Wolfrum, Christian; Detmar, Michael			Chronic High-Fat Diet Impairs Collecting Lymphatic Vessel Function in Mice	PLOS ONE			English	Article							LYMPHEDEMA; HYPERPLASIA; ADIPOSE; LYMPHANGIOGENESIS; DYNAMICS; TISSUE; MODEL; FLOW	Lymphatic vessels play an essential role in intestinal lipid uptake, and impairment of lymphatic vessel function leads to enhanced adipose tissue accumulation in patients with lymphedema and in genetic mouse models of lymphatic dysfunction. However, the effects of obesity on lymphatic function have been poorly studied. We investigated if and how adipose tissue accumulation influences lymphatic function. Using a lymphatic specific tracer, we performed in vivo near-infrared (NIR) imaging to assess the function of collecting lymphatic vessels in mice fed normal chow or high-fat diet (HFD). Histological and whole mount analyses were performed to investigate the morphological changes in initial and the collecting lymphatic vessels. HFD was associated with impaired collecting lymphatic vessel function, as evidenced by reduced frequency of contractions and diminished response to mechanostimulation. Moreover, we found a significant negative correlation between collecting lymphatic vessel function and body weight. Whole mount analyses showed an enlargement of contractile collecting lymphatic vessels of the hind limb. In K14-VEGF-C mice, HFD resulted in a reduced spreading of the tracer within dermal lymphatic vessels. These findings indicate that adipose tissue expansion due to HFD leads to a functional impairment of the lymphatic vasculature, predominantly in collecting lymphatic vessels.	[Blum, Katrin S.; Karaman, Sinem; Proulx, Steven T.; Ochsenbein, Alexandra M.; Luciani, Paola; Leroux, Jean-Christophe; Detmar, Michael] ETH, Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland; [Wolfrum, Christian] ETH, Swiss Fed Inst Technol, Inst Food Nutr & Hlth, Schwerzenbach, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Detmar, M (corresponding author), ETH, Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland.	michael.detmar@pharma.ethz.ch	Karaman, Sinem/C-4428-2017; Luciani, Paola/M-3450-2018; Leroux, Jean-Christophe/N-4202-2015	Karaman, Sinem/0000-0002-0719-1773; Luciani, Paola/0000-0001-9664-0149; Leroux, Jean-Christophe/0000-0001-5601-1292; Wolfrum, Christian/0000-0002-3862-6805; Proulx, Steven/0000-0003-2154-8502	Swiss National Science Foundation [31003A_130627, 310030B_137087]; Advanced European Research Council Grant LYVICAM; Fondation Leducq Transatlantic Networks of Excellence in Cardiovascular Research; German Research Foundation [DFG: BL 1136/1-1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Advanced European Research Council Grant LYVICAM; Fondation Leducq Transatlantic Networks of Excellence in Cardiovascular Research; German Research Foundation(German Research Foundation (DFG))	This work was supported by Swiss National Science Foundation grants 31003A_130627 and 310030B_137087, Advanced European Research Council Grant LYVICAM, and Fondation Leducq Transatlantic Networks of Excellence in Cardiovascular Research (to MD). KSB received a research fellowship from the German Research Foundation (DFG: BL 1136/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; BILANCINI S, 1995, ANGIOLOGY, V46, P333, DOI 10.1177/000331979504600408; Blum KS, 2013, BREAST CANCER RES TR, V139, P81, DOI 10.1007/s10549-013-2537-7; Brorson Hakan, 2009, Lymphatic Research and Biology, V7, P3, DOI 10.1089/lrb.2008.1022; Cueni Leah N., 2008, Lymphatic Research and Biology, V6, P109, DOI 10.1089/lrb.2008.1008; Dixon JB, 2010, TRENDS ENDOCRIN MET, V21, P480, DOI 10.1016/j.tem.2010.04.003; Gogineni A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068755; Greene AK, 2012, NEW ENGL J MED, V366, P2136, DOI 10.1056/NEJMc1201684; Harvey NL, 2008, ANN NY ACAD SCI, V1131, P82, DOI 10.1196/annals.1413.007; Harvey NL, 2005, NAT GENET, V37, P1072, DOI 10.1038/ng1642; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Lim HY, 2009, AM J PATHOL, V175, P1328, DOI 10.2353/ajpath.2009.080963; Lohela M, 2008, AM J PATHOL, V173, P1891, DOI 10.2353/ajpath.2008.080378; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Proulx ST, 2013, ANGIOGENESIS; Proulx ST, 2013, BIOMATERIALS, V34, P5128, DOI 10.1016/j.biomaterials.2013.03.034; Quick CM, 2007, AM J PHYSIOL-REG I, V292, pR1510, DOI 10.1152/ajpregu.00258.2006; Rutkowski JM, 2006, MICROVASC RES, V72, P161, DOI 10.1016/j.mvr.2006.05.009; Rutkowski JM, 2010, AM J PATHOL, V176, P1122, DOI 10.2353/ajpath.2010.090733; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Vasileiou AM, 2011, INT J OBESITY, V35, P1247, DOI 10.1038/ijo.2010.273; Weitman ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070703; Wittenberg T, 2011, EUR J VASC ENDOVASC, V41, P849, DOI 10.1016/j.ejvs.2011.02.015; Zawieja SD, 2012, AM J PHYSIOL-HEART C, V302, pH643, DOI 10.1152/ajpheart.00606.2011; Zhou QA, 2010, ARTHRITIS RHEUM-US, V62, P1881, DOI 10.1002/art.27464	26	91	95	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94713	10.1371/journal.pone.0094713	http://dx.doi.org/10.1371/journal.pone.0094713			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714646	gold, Green Published, Green Submitted			2022-12-25	WOS:000334160900143
J	Boratynski, Z; Brito, JC; Campos, JC; Karala, M; Mappes, T				Boratynski, Zbyszek; Brito, Jose Carlos; Campos, Joao Carlos; Karala, Maija; Mappes, Tapio			Large Spatial Scale of the Phenotype-Environment Color Matching in Two Cryptic Species of African Desert Jerboas (Dipodidae: Jaculus)	PLOS ONE			English	Article							NATURAL-SELECTION; GENETIC-BASIS; EVOLUTION; ADAPTATION; CRYPSIS; HABITS; OWL	We tested the camouflage hypothesis, or the linkage between animal (Saharan rodent) and habitat coloration, on the largest geographical scale yet conducted. We aimed to determine whether phenotypic variation is explained by micro-habitat variation and/or genetic polymorphism to determine 1) the strength of linkage between fur color and local substrate color, and 2) the divergence in fur coloration between two genetic clades, representing cryptic species, throughout the complete range of the African desert jerboas (Jaculus jaculus). We used a combination of museum and field-collected specimens, remote sensing tools, satellite and digital photography and molecular genetic and phylogenetic methods to investigate the above hypotheses. Along with showing that the two divergent genetic clades of jerboas occur sympatrically throughout their African distribution, we showed significant covariation between dorsal fur coloration of the animals and the color of their habitat. We also described significant phenotypic divergence in fur color, consistent with genetic divergence between the sympatric clades. The linkage between environment and phenotype supports the idea that the selection promoting cryptic coloration is persistent in contemporary populations of jerboas, however the phenotypic divergence indicates that it has different strengths (or optima) in the two clades. The mosaic distribution of micro-habitats occupied by geographically sympatric clades suggests that it may influence both ecological and evolutionary dynamics between these two cryptic species.	[Boratynski, Zbyszek; Karala, Maija; Mappes, Tapio] Univ Jyvaskyla, Dept Biol & Environm Sci, Div Ecol & Evolutionary Biol, Jyvaskyla, Finland; [Boratynski, Zbyszek; Brito, Jose Carlos; Campos, Joao Carlos] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO InBIO, Vairao, Portugal; [Brito, Jose Carlos; Campos, Joao Carlos] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal	University of Jyvaskyla; Universidade do Porto; Universidade do Porto	Boratynski, Z (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Div Ecol & Evolutionary Biol, Jyvaskyla, Finland.	boratyns@jyu.fi	Mappes, Tapio/B-9780-2013; Boratyński, Zbyszek/AAF-2389-2020; Campos, João/L-7901-2013; Brito, José C./A-7831-2010	Boratyński, Zbyszek/0000-0003-4668-4922; Campos, João/0000-0002-9144-4680; Brito, José C./0000-0001-5444-8132; Mappes, Tapio/0000-0002-5936-7355	National Geographic Society [7629-04, 8412-08]; Fundacao para a Ciencia e Tecnologia, through the EU program COMPETE [PTDC/BIA-BEC/099934/2008]; Academy of Finland [132190]; University of Jyvaskyla; Centre of Excellence in Evolutionary Research; Fundacao para a Ciencia e Tecnologia [SFRH/BPD/84822/2012, SFRH/BD/87885/2012]; North Portugal Regional Operational Programme, under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF) [ON.2]	National Geographic Society(National Geographic Society); Fundacao para a Ciencia e Tecnologia, through the EU program COMPETE; Academy of Finland(Academy of Finland); University of Jyvaskyla; Centre of Excellence in Evolutionary Research; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); North Portugal Regional Operational Programme, under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF)	Fieldwork was supported by National Geographic Society (7629-04 and 8412-08) and Fundacao para a Ciencia e Tecnologia (PTDC/BIA-BEC/099934/2008), through the EU program COMPETE. Laboratory work was supported by the Academy of Finland (132190 to TM), the University of Jyvaskyla (mobility grant to ZB) and the Centre of Excellence in Evolutionary Research. Logistic support for fieldwork was given by Pedro Lopes Lda. (Trimble GPS), Off Road Power Shop and A. Araujo (P. N. Banc d'Arguin), and S.M.O. Lehlou (Ministry of Environment, Mauritania). Museum samples were kindly provided by the Smithsonian Institution, National Museum of Natural History, Division of Mammals, Washington D. C., USA. ZB and JCC are financed by Fundacao para a Ciencia e Tecnologia (SFRH/BPD/84822/2012 and SFRH/BD/87885/2012, respectively), and JCB by project "Biodiversity, Ecology and Global Change'' cofinanced by North Portugal Regional Operational Programme 2007/2013 (ON.2 - O Novo Norte), under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviles JM, 2013, OECOLOGIA, V173; Ben Faleh A, 2012, BIOL J LINN SOC, V107, P27, DOI 10.1111/j.1095-8312.2012.01920.x; Blair W. F., 1947, Contributions from the Laboratory of Vertebrate Biology of the University of Michigan, V87, P1; Bond AB, 1998, NATURE, V395, P594, DOI 10.1038/26961; Boratynski Z, 2012, BIOL J LINN SOC, V105, P435, DOI 10.1111/j.1095-8312.2011.01791.x; Boratynski Z, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-355; Brito JC, 2014, BIOL REV, V89, P215, DOI 10.1111/brv.12049; Caro T, 2005, BIOSCIENCE, V55, P125, DOI 10.1641/0006-3568(2005)055[0125:TASOCI]2.0.CO;2; Chander G, 2009, REMOTE SENS ENVIRON, V113, P893, DOI 10.1016/j.rse.2009.01.007; Coyne JA, 2004, SPECIATION, V37; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darwin C., 1877, DIFFERENT FORMS FLOW; Dice L, 1947, CONTRIBUTION LAB VER, P50115; ENDLER JA, 1988, PHILOS T R SOC B, V319, P505, DOI 10.1098/rstb.1988.0062; ESRI, 2008, ARCM 9 3 REDL; Gharaibeh, 1997, THESIS TEXAS TU, P354, DOI DOI 10.5281/ZENODO.4016016; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HALDANE JBS, 1948, J GENET, V48, P277, DOI 10.1007/BF02986626; Hendrie CA, 1998, J ZOOL, V245, P439, DOI 10.1017/S0952836998008073; HETH G, 1988, OECOLOGIA, V74, P617, DOI 10.1007/BF00380062; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Hoekstra HE, 2005, HEREDITY, V94, P217, DOI 10.1038/sj.hdy.6800600; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; HOOPER ET, 1972, J MAMMAL, V53, P574, DOI 10.2307/1379047; KAUFMAN DW, 1974, J MAMMAL, V55, P271, DOI 10.2307/1378997; Leonardi G, 2006, J ARID ENVIRON, V65, P677, DOI 10.1016/j.jaridenv.2005.10.007; Linnen CR, 2013, SCIENCE, V339, P1312, DOI 10.1126/science.1233213; Merilaita S, 1999, BIOL J LINN SOC, V67, P151, DOI 10.1111/j.1095-8312.1999.tb01858.x; Merilaita S, 2001, P ROY SOC B-BIOL SCI, V268, P1925, DOI 10.1098/rspb.2001.1747; Mullen LM, 2009, P ROY SOC B-BIOL SCI, V276, P3809, DOI 10.1098/rspb.2009.1146; Nachman MW, 2005, GENETICA, V123, P125, DOI 10.1007/s10709-004-2723-y; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Ng J, 2013, EVOLUTION, V67, P573, DOI 10.1111/j.1558-5646.2012.01795.x; NORRIS KS, 1964, ECOLOGY, V45, P565; Novembre J, 2009, NAT REV GENET, V10, P745, DOI 10.1038/nrg2632; RICE WR, 1990, EVOLUTION, V44, P1140, DOI 10.1111/j.1558-5646.1990.tb05221.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Schmidt DF, 2008, ANNOTATED GAZETTEER; Singaravelan N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008708; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; TURNER JOHN R. G., 1967, J LINN SOC LONDON ZOOL, V46, P255; Vignieri SN, 2010, EVOLUTION, V64, P2153, DOI 10.1111/j.1558-5646.2010.00976.x	45	24	25	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94342	10.1371/journal.pone.0094342	http://dx.doi.org/10.1371/journal.pone.0094342			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714509	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900119
J	Lahlali, R; McGregor, L; Song, T; Gossen, BD; Narisawa, K; Peng, G				Lahlali, Rachid; McGregor, Linda; Song, Tao; Gossen, Bruce D.; Narisawa, Kazuhiko; Peng, Gary			Heteroconium chaetospira Induces Resistance to Clubroot via Upregulation of Host Genes Involved in Jasmonic Acid, Ethylene, and Auxin Biosynthesis	PLOS ONE			English	Article							ROOT ENDOPHYTIC FUNGUS; PLASMODIOPHORA-BRASSICAE; CHINESE-CABBAGE; SYSTEMIC RESISTANCE; PIRIFORMOSPORA-INDICA; MUTUALISTIC SYMBIOSIS; PLANT; EXPRESSION; SUPPRESSION; ARABIDOPSIS	An endophytic fungus, Heteroconium chaetospira isolate BC2HB1 (Hc), suppressed clubroot (Plasmodiophora brassicae -Pb) on canola in growth-cabinet trials. Confocal microscopy demonstrated that Hc penetrated canola roots and colonized cortical tissues. Based on qPCR analysis, the amount of Hc DNA found in canola roots at 14 days after treatment was negatively correlated (r = 0.92, P<0.001) with the severity of clubroot at 5 weeks after treatment at a low (2x10(5) spores pot(-1)) but not high (2x10(5) spores pot(-1)) dose of pathogen inoculum. Transcript levels of nine B. napus (Bn) genes in roots treated with Hc plus Pb, Pb alone and a nontreated control were analyzed using qPCR supplemented with biochemical analysis for the activity of phenylalanine ammonia lyases (PAL). These genes encode enzymes involved in several biosynthetic pathways related potentially to plant defence. Hc plus Pb increased the activity of PAL but not that of the other two genes (BnCCR and BnOPCL) involved also in phenylpropanoid biosynthesis, relative to Pb inoculation alone. In contrast, expression of several genes involved in the jasmonic acid (BnOPR2), ethylene (BnACO), auxin (BnAAO1), and PR-2 protein (BnPR-2) biosynthesis were upregulated by 63, 48, 3, and 3 fold, respectively, by Hc plus Pb over Pb alone. This indicates that these genes may be involved in inducing resistance in canola by Hc against clubroot. The upregulation of BnAAO1 appears to be related to both pathogenesis of clubroot and induced defence mechanisms in canola roots. This is the first report on regulation of specific host genes involved in induced plant resistance by a non-mycorrhizal endophyte.	[Lahlali, Rachid; McGregor, Linda; Song, Tao; Gossen, Bruce D.; Peng, Gary] Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada; [Narisawa, Kazuhiko] Ibaraki Univ, Coll Agr, Ibaraki, Japan	Agriculture & Agri Food Canada; Ibaraki University	Peng, G (corresponding author), Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada.	Gary.Peng@agr.gc.ca	Gossen, Bruce/W-3414-2019	Gossen, Bruce/0000-0001-5869-930X; Peng, Gary/0000-0002-9072-7187; Lahlali, Rachid/0000-0002-1299-5733	Canola Council of Canada/SaskCanola [CARP 2008-16]; Saskatchewan Agriculture Development Fund [20090359]	Canola Council of Canada/SaskCanola; Saskatchewan Agriculture Development Fund	Canola Council of Canada (http://www.canolacouncil.org/)/SaskCanola (http://www.saskcanola.com)(CARP 2008-16) and Saskatchewan Agriculture Development Fund (http://www.agriculture.gov.sk.ca/ADF) (Project 20090359) provided partial funding support to this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando S, 2006, MOL PLANT PATHOL, V7, P223, DOI 10.1111/J.1364-3703.2006.00333.X; Martin-Rodriguez JA, 2011, NEW PHYTOL, V190, P193, DOI 10.1111/j.1469-8137.2010.03610.x; Arie Tsutomu, 1999, Pesticide Science, V55, P602, DOI 10.1002/(SICI)1096-9063(199905)55:5&lt;602::AID-PS964&gt;3.0.CO;2-C; Cardinali A., 2006, PHYTOCHEM ADV RES, V661, P23; Chabannes M, 2001, PLANT J, V28, P257, DOI 10.1046/j.1365-313X.2001.01140.x; Clarke BB, 2006, PLANT DIS, V90, P994, DOI 10.1094/PD-90-0994; Cordier C, 1998, MOL PLANT MICROBE IN, V11, P1017, DOI 10.1094/MPMI.1998.11.10.1017; Deshmukh S, 2006, P NATL ACAD SCI USA, V103, P18450, DOI 10.1073/pnas.0605697103; Diederichsen E, 2009, J PLANT GROWTH REGUL, V28, P265, DOI 10.1007/s00344-009-9100-0; Ding XH, 2008, PLANT CELL, V20, P228, DOI 10.1105/tpc.107.055657; DIXON RA, 1995, PLANT CELL, V7, P1085, DOI 10.1105/tpc.7.7.1085; Doan TT, 2008, 5 INT S BRASS 16 INT, V867, P173; Donald EC, 2006, ACTA HORTIC, P283, DOI 10.17660/ActaHortic.2006.706.33; Flors V, 2008, PLANT J, V54, P81, DOI 10.1111/j.1365-313X.2007.03397.x; Fracetto GGM, 2013, SYMBIOSIS, V60, P155, DOI 10.1007/s13199-013-0251-1; Garcia-Garrido JM, 2002, J EXP BOT, V53, P1377, DOI 10.1093/jexbot/53.373.1377; Grunwald U, 2004, PLANT MOL BIOL, V55, P553, DOI 10.1007/s11103-004-1303-y; HAHLBROCK K, 1989, ANNU REV PLANT PHYS, V40, P347, DOI 10.1146/annurev.pp.40.060189.002023; Hashiba T, 2005, FEMS MICROBIOL LETT, V252, P191, DOI 10.1016/j.femsle.2005.08.039; Hirai M, 2006, BREEDING SCI, V56, P223, DOI 10.1270/jsbbs.56.223; Howard RJ, 2010, CAN J PLANT PATHOL, V32, P43, DOI 10.1080/07060661003621761; Hwang SF, 2012, MOL PLANT PATHOL, V13, P105, DOI 10.1111/j.1364-3703.2011.00729.x; Jaschke D, 2010, PLANT PATHOL, V59, P100, DOI 10.1111/j.1365-3059.2009.02199.x; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; Jumpponen A, 1998, NEW PHYTOL, V140, P295, DOI 10.1046/j.1469-8137.1998.00265.x; Kazan K, 2009, TRENDS PLANT SCI, V14, P373, DOI 10.1016/j.tplants.2009.04.005; Lahlali R., 2014, Plant Pathology, V63, P447, DOI 10.1111/ppa.12112; Lahlali R, 2013, PHYTOPATHOLOGY, V103, P245, DOI 10.1094/PHYTO-06-12-0123-R; Lahlali R, 2011, BIOCONTROL SCI TECHN, V21, P1351, DOI 10.1080/09583157.2011.618263; Lahlali R, 2012, CAN J PLANT PATHOL, V34, P320; Lee YC, 2011, MOL PLANT MICROBE IN, V24, P421, DOI 10.1094/MPMI-05-10-0110; Lehtonen MJ, 2008, PHYTOPATHOLOGY, V98, P1190, DOI 10.1094/PHYTO-98-11-1190; Li J, 2005, PHYSIOL MOL PLANT P, V67, P220, DOI 10.1016/j.pmpp.2006.02.002; Liu JY, 2007, PLANT J, V50, P529, DOI 10.1111/j.1365-313X.2007.03069.x; Lovelock DA, 2013, AUSTRALAS PLANT PATH, V42, P141, DOI 10.1007/s13313-012-0167-x; Ludwig-Muller J, 2009, J PLANT GROWTH REGUL, V28, P229, DOI 10.1007/s00344-009-9089-4; Mano Y, 2012, J EXP BOT, V63, P2853, DOI 10.1093/jxb/ers091; McDonald MR, 2004, ACTA HORTIC, P25, DOI 10.17660/ActaHortic.2004.635.3; Morita Soichiro, 2003, Journal of General Plant Pathology, V69, P71, DOI 10.1007/s10327-002-0005-z; Narisawa K, 2005, PLANT DIS, V89, P285, DOI 10.1094/PD-89-0285; Narisawa K, 1998, PLANT PATHOL, V47, P206, DOI 10.1046/j.1365-3059.1998.00225.x; Narisawa K, 2000, PLANT PATHOL, V49, P141, DOI 10.1046/j.1365-3059.2000.00425.x; Narisawa Kazuhiko, 2007, Mycoscience, V48, P274, DOI 10.1007/s10267-007-0364-6; Ohki Takehiro, 2002, Mycoscience, V43, P191, DOI 10.1007/s102670200027; Peng G, 2011, PLANT PATHOL, V60, P566, DOI 10.1111/j.1365-3059.2010.02400.x; Peng G, 2014, CAN J PLANT PATHOL, V36, P99, DOI 10.1080/07060661.2013.860398; Petti C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-224; Pieterse CMJ, 2000, PHYSIOL MOL PLANT P, V57, P123, DOI 10.1006/pmpp.2000.0291; Pieterse CMJ, 1999, TRENDS PLANT SCI, V4, P52, DOI 10.1016/S1360-1385(98)01364-8; Potlakayala SD, 2007, PHYTOPATHOLOGY, V97, P794, DOI 10.1094/PHYTO-97-7-0794; Pozo MJ, 2007, CURR OPIN PLANT BIOL, V10, P393, DOI 10.1016/j.pbi.2007.05.004; SCHREINER RP, 1993, NEW PHYTOL, V123, P99, DOI 10.1111/j.1469-8137.1993.tb04535.x; Sharma K, 2011, PHYTOPATHOLOGY, V101, P1424, DOI 10.1094/PHYTO-04-11-0124; Souza CD, 2008, NEW PHYTOL, V179, P987, DOI 10.1111/j.1469-8137.2008.02534.x; Strelkov SE, 2006, CAN J PLANT PATHOL, V28, P467, DOI 10.1080/07060660609507321; Sundelin T, 2010, PLANT DIS, V94, P432, DOI 10.1094/PDIS-94-4-0432; Turner JG, 2002, PLANT CELL, V14, pS153, DOI 10.1105/tpc.000679; Umamaheswari Chandrasekaran, 2009, Archives of Phytopathology and Plant Protection, V42, P1187, DOI 10.1080/03235400701652383; Usuki F, 2007, MYCOLOGIA, V99, P175, DOI 10.3852/mycologia.99.2.175; Usuki Fumiaki, 2002, Journal of General Plant Pathology, V68, P326, DOI 10.1007/PL00013098; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Van Loon LC, 1999, PHYSIOL MOL PLANT P, V55, P85, DOI 10.1006/pmpp.1999.0213; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Wang KLC, 2002, PLANT CELL, V14, pS131, DOI 10.1105/tpc.001768; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; WILSON D, 1995, OIKOS, V73, P274, DOI 10.2307/3545919; Yonezawa Miho, 2004, Mycoscience, V45, P367, DOI 10.1007/s10267-004-0201-0; Zhao JW, 2009, MOL PLANT PATHOL, V10, P635, DOI [10.1111/J.1364-3703.2009.00558.X, 10.1111/j.1364-3703.2009.00558.x]	68	44	52	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94144	10.1371/journal.pone.0094144	http://dx.doi.org/10.1371/journal.pone.0094144			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714177	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900094
J	Bari, V; Valencia, JF; Vallverdu, M; Girardengo, G; Marchi, A; Bassani, T; Caminal, P; Cerutti, S; George, AL; Brink, PA; Crotti, L; Schwartz, PJ; Porta, A				Bari, Vlasta; Valencia, Jose F.; Vallverdu, Montserrat; Girardengo, Giulia; Marchi, Andrea; Bassani, Tito; Caminal, Pere; Cerutti, Sergio; George, Alfred L., Jr.; Brink, Paul A.; Crotti, Lia; Schwartz, Peter J.; Porta, Alberto			Multiscale Complexity Analysis of the Cardiac Control Identifies Asymptomatic and Symptomatic Patients in Long QT Syndrome Type 1	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; AUTONOMIC NERVOUS-SYSTEM; POWER SPECTRUM ANALYSIS; INTERVAL VARIABILITY; REPOLARIZATION LABILITY; PERIOD VARIABILITY; NONLINEAR MEASURES; T INTERVAL; ENTROPY; STRESS	The study assesses complexity of the cardiac control directed to the sinus node and to ventricles in long QT syndrome type 1 (LQT1) patients with KCNQ1-A341V mutation. Complexity was assessed via refined multiscale entropy (RMSE) computed over the beat-to-beat variability series of heart period (HP) and QT interval. HP and QT interval were approximated respectively as the temporal distance between two consecutive R-wave peaks and between the R-wave apex and T-wave end. Both measures were automatically taken from 24-hour electrocardiographic Holter traces recorded during daily activities in non mutation carriers (NMCs, n = 14) and mutation carriers (MCs, n = 34) belonging to a South African LQT1 founder population. The MC group was divided into asymptomatic (ASYMP, n = 11) and symptomatic (SYMP, n = 23) patients according to the symptom severity. Analyses were carried out during daytime (DAY, from 2PM to 6PM) and nighttime (NIGHT, from 12PM to 4AM) off and on beta-adrenergic blockade (BBoff and BBon). We found that the complexity of the HP variability at short time scale was under vagal control, being significantly increased during NIGHT and BBon both in ASYMP and SYMP groups, while the complexity of both HP and QT variability at long time scales was under sympathetic control, being smaller during NIGHT and BBon in SYMP subjects. Complexity indexes at long time scales in ASYMP individuals were smaller than those in SYMP ones regardless of therapy (i.e. BBoff or BBon), thus suggesting that a reduced complexity of the sympathetic regulation is protective in ASYMP individuals. RMSE analysis of HP and QT interval variability derived from routine 24-hour electrocardiographic Holter recordings might provide additional insights into the physiology of the cardiac control and might be fruitfully exploited to improve risk stratification in LQT1 population.	[Bari, Vlasta] Grp Osped San Donato Fdn, Milan, Italy; [Bari, Vlasta; Marchi, Andrea; Cerutti, Sergio] Politecn Milan, Dept Elect Informat & Bioengn, I-20133 Milan, Italy; [Valencia, Jose F.] Univ San Buenaventura, Dept Elect Engn, Cali, Colombia; [Vallverdu, Montserrat; Caminal, Pere] Univ Politecn Cataluna, Biomed Engn Res Ctr, Dept Automat Control, E-08028 Barcelona, Spain; [Girardengo, Giulia; Crotti, Lia; Schwartz, Peter J.] IRCCS Ist Auxologico Italiano, Ctr Diagnost San Carlo, Ctr Cardiac Arrhythmias Genet Origin, Milan, Italy; [Marchi, Andrea] IRCCS Humanitas Clin & Res Ctr, Dept Anesthesia & Intens Care, Rozzano, Italy; [Bassani, Tito] IRCCS Humanitas Clin & Res Ctr, Rozzano, Italy; [George, Alfred L., Jr.] Vanderbilt Univ, Dept Med & Pharmacol, Nashville, TN 37235 USA; [Brink, Paul A.] Univ Stellenbosch, Dept Internal Med, ZA-7600 Stellenbosch, South Africa; [Crotti, Lia] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Porta, Alberto] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Porta, Alberto] IRCCS Galeazzi Orthoped Inst, Milan, Italy	IRCCS Policlinico San Donato; Polytechnic University of Milan; Universitat Politecnica de Catalunya; IRCCS Istituto Auxologico Italiano; IRCCS Humanitas Research Hospital; IRCCS Humanitas Research Hospital; Vanderbilt University; Stellenbosch University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Milan; IRCCS Istituto Ortopedico Galeazzi	Porta, A (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Milan, Italy.	alberto.porta@unimi.it	Bari, Vlasta/J-8591-2016; Porta, Alberto/K-4390-2016; Crotti, Lia/AAB-3914-2019; Bassani, Tito/B-2050-2017; Schwartz, Peter J/J-4267-2016; Marchi, Andrea/J-7205-2016; Cerutti, Sergio/A-3155-2009	Bari, Vlasta/0000-0002-5346-2677; Porta, Alberto/0000-0002-6720-9824; Bassani, Tito/0000-0003-3312-1565; Schwartz, Peter J/0000-0003-0367-1048; Marchi, Andrea/0000-0001-5846-4164; Valencia, Jose Fernando/0000-0003-2997-2121; crotti, lia/0000-0001-8739-6527; Brink, Paul/0000-0001-8538-5824	Telethon [GGP09247]; National Institutes of Health [HL068880]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068880] Funding Source: NIH RePORTER	Telethon(Fondazione Telethon); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the Telethon grant GGP09247 to Peter J. Schwartz, Lia Crotti and Alberto Porta and by the National Institutes of Health grant HL068880 to Alfred L. George Jr, Peter J. Schwartz, and Lia Crotti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Bar KB, 2008, J CLIN PSYCHOPHARM, V28, P694, DOI 10.1097/JCP.0b013e31818a6d25; Baumert M, 2008, AM J PHYSIOL-HEART C, V295, pH962, DOI 10.1152/ajpheart.00301.2008; Baumert M, 2012, COMPUT BIOL MED, V42, P347, DOI 10.1016/j.compbiomed.2011.03.019; Baumert M, 2011, AM J PHYSIOL-HEART C, V300, pH1412, DOI 10.1152/ajpheart.01184.2010; Bazett HC, 1920, HEART-J STUD CIRC, V7, P353; Berger RD, 1997, CIRCULATION, V96, P1557, DOI 10.1161/01.CIR.96.5.1557; Boettger MK, 2010, ANN NONINVAS ELECTRO, V15, P165, DOI 10.1111/j.1542-474X.2010.00358.x; Brink PA, 2005, CIRCULATION, V112, P2602, DOI 10.1161/CIRCULATIONAHA.105.572453; Brink PA, 2009, HEART RHYTHM, V6, pS25, DOI 10.1016/j.hrthm.2009.08.036; BROWNE KF, 1983, PACE, V6, P1050, DOI 10.1111/j.1540-8159.1983.tb04443.x; Camm AJ, 1996, CIRCULATION, V93, P1043; Cooke WH, 1999, J PHYSIOL-LONDON, V517, P617, DOI 10.1111/j.1469-7793.1999.0617t.x; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Crotti L, 2007, CIRCULATION, V116, P2366, DOI 10.1161/CIRCULATIONAHA.107.726950; Crotti L, 2012, J AM COLL CARDIOL, V60, P2515, DOI 10.1016/j.jacc.2012.08.1009; deJager T, 1996, J MED GENET, V33, P567, DOI 10.1136/jmg.33.7.567; Valencia JF, 2009, IEEE T BIO-MED ENG, V56, P2202, DOI 10.1109/TBME.2009.2021986; Furlan R, 2000, CIRCULATION, V101, P886, DOI 10.1161/01.CIR.101.8.886; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Lewis MJ, 2007, PHYSIOL MEAS, V28, P731, DOI 10.1088/0967-3334/28/6/011; Maestri R, 2007, J CARDIOVASC ELECTR, V18, P425, DOI 10.1111/j.1540-8167.2007.00728.x; Magnano AR, 2002, J AM COLL CARDIOL, V39, P1820, DOI 10.1016/S0735-1097(02)01852-1; MONTANO N, 1994, CIRCULATION, V90, P1826, DOI 10.1161/01.CIR.90.4.1826; Negoescu R, 1997, INTEGR PHYS BEH SCI, V32, P220, DOI 10.1007/BF02688620; PARLOW J, 1995, HYPERTENSION, V25, P1058, DOI 10.1161/01.HYP.25.5.1058; Piccirillo G, 2001, CLIN SCI, V101, P429, DOI 10.1042/CS20000310; Piccirillo G, 2006, TRANSL RES, V148, P72, DOI 10.1016/j.trsl.2006.02.001; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; Porta A, 2007, CHAOS, V17, DOI 10.1063/1.2404630; Porta A, 1998, MED BIOL ENG COMPUT, V36, P27, DOI 10.1007/BF02522854; Porta A, 1998, MED BIOL ENG COMPUT, V36, P35, DOI 10.1007/BF02522855; Porta A, 2000, MED BIOL ENG COMPUT, V38, P180, DOI 10.1007/BF02344774; Porta A, 2007, J APPL PHYSIOL, V103, P1143, DOI 10.1152/japplphysiol.00293.2007; Porta A, 2011, J ELECTROCARDIOL, V44, P662, DOI 10.1016/j.jelectrocard.2011.08.002; Porta A, 2010, AM J PHYSIOL-HEART C, V298, pH1406, DOI 10.1152/ajpheart.01206.2009; Porta A, 2009, PHILOS T R SOC A, V367, P1215, DOI 10.1098/rsta.2008.0292; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Sauer AJ, 2007, J AM COLL CARDIOL, V49, P329, DOI 10.1016/j.jacc.2006.08.057; Schwartz PJ, 2008, J AM COLL CARDIOL, V51, P920, DOI 10.1016/j.jacc.2007.09.069; Schwartz PJ, 2011, CIRCULATION, V124, P2181, DOI 10.1161/CIRCULATIONAHA.111.062182; Schwartz PJ, 2011, HEART RHYTHM, V8, P548, DOI 10.1016/j.hrthm.2010.12.035; SCHWARTZ PJ, 1975, AM HEART J, V89, P378, DOI 10.1016/0002-8703(75)90089-7; Schwartz PJ, 2001, CIRCULATION, V103, P89; Turianikova Z, 2011, PHYSIOL MEAS, V32, DOI 10.1088/0967-3334/32/9/006; Yeragani VK, 2000, PSYCHIAT RES, V93, P225, DOI 10.1016/S0165-1781(00)00119-0; Yeragani VK, 2000, NEUROPSYCHOBIOLOGY, V41, P113, DOI 10.1159/000026642; Yeragania VK, 2003, PSYCHIAT RES, V117, P177, DOI 10.1016/S0165-1781(02)00319-0	48	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93808	10.1371/journal.pone.0093808	http://dx.doi.org/10.1371/journal.pone.0093808			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705789	Green Submitted, Green Published, gold			2022-12-25	WOS:000334107500067
J	Missana, M; Grigutsch, M; Grossmann, T				Missana, Manuela; Grigutsch, Maren; Grossmann, Tobias			Developmental and Individual Differences in the Neural Processing of Dynamic Expressions of Pain and Anger	PLOS ONE			English	Article							FACIAL EXPRESSIONS; BRAIN ACTIVITY; EMOTIONAL EXPRESSIONS; INFANT TEMPERAMENT; PERSPECTIVE-TAKING; AFFECTIVE STYLE; EMPATHY; RECOGNITION; ATTENTION; EEG	We examined the processing of facial expressions of pain and anger in 8-month-old infants and adults by measuring event-related brain potentials (ERPs) and frontal EEG alpha asymmetry. The ERP results revealed that while adults showed a late positive potential (LPP) to emotional expressions that was enhanced to pain expressions, reflecting increased evaluation and emotional arousal to pain expressions, infants showed a negative component (Nc) to emotional expressions that was enhanced to angry expressions, reflecting increased allocation of attention to angry faces. Moreover, infants and adults showed opposite patterns in their frontal asymmetry responses to pain and anger, suggesting developmental differences in the motivational processes engendered by these facial expressions. These findings are discussed in the light of associated individual differences in infant temperament and adult dispositional empathy.	[Missana, Manuela; Grossmann, Tobias] Max Planck Inst Human Cognit & Brain Sci, Early Social Dev Grp, Leipzig, Germany; [Grigutsch, Maren] Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany	Max Planck Society; Max Planck Society	Missana, M (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Early Social Dev Grp, Leipzig, Germany.	missana@cbs.mpg.de	Grossmann, Tobias/H-6364-2019; Lowe, Lauryn/U-9710-2019	Grossmann, Tobias/0000-0002-1116-6423				Ambadar Z, 2005, PSYCHOL SCI, V16, P403, DOI 10.1111/j.0956-7976.2005.01548.x; [Anonymous], 2009, EXPRESS EMOT MAN; Benuzzi F, 2008, J NEUROSCI, V28, P923, DOI 10.1523/JNEUROSCI.4012-07.2008; Botvinick M, 2005, NEUROIMAGE, V25, P312, DOI 10.1016/j.neuroimage.2004.11.043; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; BURNHAM DK, 1979, J EXP CHILD PSYCHOL, V28, P191, DOI 10.1016/0022-0965(79)90083-3; Burnham DK, 1987, PERCEPTUAL DEV EARLY, P143; Buss KA, 2003, BEHAV NEUROSCI, V117, P11, DOI 10.1037/0735-7044.117.1.11; Campos JJ, 2003, ANN NY ACAD SCI, V1000, P110, DOI 10.1196/annals.1280.040; Carver CS, 2009, PSYCHOL BULL, V135, P183, DOI 10.1037/a0013965; Craig K. D., 2001, HDB PAIN ASSESSMENT, P153; Davidson R.J., 1984, EMOTIONS COGNITION B; DAVIDSON RJ, 1982, SCIENCE, V218, P1235, DOI 10.1126/science.7146906; DAVIDSON RJ, 1994, DEV PSYCHOPATHOL, V6, P741, DOI 10.1017/S0954579400004764; DAVIDSON RJ, 1988, INT J NEUROSCI, V39, P71, DOI 10.3109/00207458808985694; Davidson RJ, 1998, COGNITION EMOTION, V12, P307, DOI 10.1080/026999398379628; Davis M.H., 1980, JSAS CATALOG SELECTE; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Decety J, 2008, NEUROPSYCHOLOGIA, V46, P2607, DOI 10.1016/j.neuropsychologia.2008.05.026; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Decety J, 2012, DEV COGN NEUROS-NETH, V2, P1, DOI 10.1016/j.dcn.2011.05.003; Decety J, 2010, DEV NEUROSCI-BASEL, V32, P257, DOI 10.1159/000317771; Eisenberg N, 2000, ANNU REV PSYCHOL, V51, P665, DOI 10.1146/annurev.psych.51.1.665; EISENBERG N, 1994, J PERS SOC PSYCHOL, V66, P776, DOI 10.1037/0022-3514.66.4.776; Eisenberg N., 2004, HDB SELF REGULATION, V3rd ed., DOI DOI 10.1146/ANNUREV-PSYCH-113011-143750; Eisenberg N., 2006, HDB CHILD PSYCHOL VO, V(6th ed., pp., P646, DOI 10.1002/9780470147658.chpsy0311; Ekman P., 1975, UNMASKING FACE; Fan Y, 2008, NEUROPSYCHOLOGIA, V46, P160, DOI 10.1016/j.neuropsychologia.2007.07.023; FOX NA, 1991, AM PSYCHOL, V46, P863, DOI 10.1037/0003-066X.46.8.863; Frith C, 2009, PHILOS T R SOC B, V364, P3453, DOI 10.1098/rstb.2009.0142; Gartstein MA, 2003, INFANT BEHAV DEV, V26, P64, DOI 10.1016/S0163-6383(02)00169-8; Geangu E, 2010, INFANT BEHAV DEV, V33, P279, DOI 10.1016/j.infbeh.2010.03.004; Goldman RI, 2002, NEUROREPORT, V13, P2487, DOI 10.1097/00001756-200212200-00022; Gonzalez-Roldan AM, 2011, PAIN, V152, P853, DOI 10.1016/j.pain.2010.12.037; Goubert L, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P153; Goubert L, 2009, PAIN, V143, P5, DOI 10.1016/j.pain.2009.02.023; Grossmann T, 2007, BRAIN COGNITION, V64, P30, DOI 10.1016/j.bandc.2006.10.002; Grossmann T, 2012, DEVELOPMENTAL SCI, V15, P830, DOI 10.1111/j.1467-7687.2012.01179.x; GWIAZDA J, 1989, CAN J PSYCHOL, V43, P109, DOI 10.1037/h0084217; Harmon-Jones E, 2003, PSYCHOPHYSIOLOGY, V40, P838, DOI 10.1111/1469-8986.00121; Harmon-Jones E, 2001, J PERS SOC PSYCHOL, V80, P797, DOI 10.1037/0022-3514.80.5.797; Harmon-Jones E, 2010, BIOL PSYCHOL, V84, P451, DOI 10.1016/j.biopsycho.2009.08.010; Harwood NK, 1999, AM J MENT RETARD, V104, P270, DOI 10.1352/0895-8017(1999)104<0270:ROFEEF>2.0.CO;2; Jackson PL, 2006, PAIN, V125, P5, DOI 10.1016/j.pain.2006.09.013; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kobiella A, 2008, COGNITION EMOTION, V22, P134, DOI 10.1080/02699930701394256; Kotsoni E, 2001, PERCEPTION, V30, P1115, DOI 10.1068/p3155; LABARBERA JD, 1976, CHILD DEV, V47, P535, DOI 10.2307/1128816; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; LoBue V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022694; Martinos M, 2012, J CHILD PSYCHOL PSYC, V53, P1118, DOI 10.1111/j.1469-7610.2012.02599.x; Mohr P, 2007, PERS INDIV DIFFER, V43, P507, DOI 10.1016/j.paid.2006.12.019; Morrison I, 2007, NEUROIMAGE, V37, P642, DOI 10.1016/j.neuroimage.2007.03.079; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; Nelson CA, 1996, DEV PSYCHOBIOL, V29, P577; Ohman A, 2001, J PERS SOC PSYCHOL, V80, P381, DOI 10.1037//0022-3514.80.3.381; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Paulus C., 2009, SAARBRUCKER PERSONLI; Peltola MJ, 2009, SOC COGN AFFECT NEUR, V4, P134, DOI 10.1093/scan/nsn046; Pichon S, 2008, SOC NEUROSCI-UK, V3, P199, DOI 10.1080/17470910701394368; PRKACHIN KM, 1995, J NONVERBAL BEHAV, V19, P191, DOI 10.1007/BF02173080; Reicherts P, 2012, PAIN, V153, P1959, DOI 10.1016/j.pain.2012.06.017; Richards JE, 2003, DEVELOPMENTAL SCI, V6, P312, DOI 10.1111/1467-7687.00287; Roth-Hanania R, 2011, INFANT BEHAV DEV, V34, P447, DOI 10.1016/j.infbeh.2011.04.007; Saarela MV, 2007, CEREB CORTEX, V17, P230, DOI 10.1093/cercor/bhj141; SCHNEIRLA T, 1959, NEBRASKA S MOTIVATIO; Schupp HT, 2004, EMOTION, V4, P189, DOI 10.1037/1528-3542.4.2.189; Schupp HT, 2003, NEUROREPORT, V14, P1107, DOI 10.1097/00001756-200306110-00002; SERRANO JM, 1992, DEV PSYCHOBIOL, V25, P411, DOI 10.1002/dev.420250603; Simon D, 2008, PAIN, V135, P55, DOI 10.1016/j.pain.2007.05.008; Simon D, 2006, PAIN, V126, P309, DOI 10.1016/j.pain.2006.08.033; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NEUROSCI BIOBEHAV R, V30, P855, DOI 10.1016/j.neubiorev.2006.06.011; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Stroganova TA, 1999, CLIN NEUROPHYSIOL, V110, P997, DOI 10.1016/S1388-2457(98)00009-1; Vaish A, 2004, DEVELOPMENTAL SCI, V7, P261, DOI 10.1111/j.1467-7687.2004.00344.x; Vaish A, 2008, PSYCHOL BULL, V134, P383, DOI 10.1037/0033-2909.134.3.383; Walle EA, 2012, EMOT REV, V4, P413, DOI 10.1177/1754073912445812; Williams ACD, 2002, BEHAV BRAIN SCI, V25, P439, DOI 10.1017/S0140525X02000080; Yamada M, 2009, PAIN, V143, P71, DOI 10.1016/j.pain.2009.01.028; ZAHNWAXLER C, 1992, DEV PSYCHOL, V28, P126, DOI 10.1037/0012-1649.28.1.126	86	24	26	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93728	10.1371/journal.pone.0093728	http://dx.doi.org/10.1371/journal.pone.0093728			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6MJ	24705497	Green Published, gold			2022-12-25	WOS:000334107500060
J	Moore, BS; Mirshahi, UL; Yost, EA; Stepanchick, AN; Bedrin, MD; Styer, AM; Jackson, KK; Still, CD; Breitwieser, GE; Gerhard, GS; Carey, DJ; Mirshahi, T				Moore, Bryn S.; Mirshahi, Uyenlinh L.; Yost, Evan A.; Stepanchick, Ann N.; Bedrin, Michael D.; Styer, Amanda M.; Jackson, Kathryn K.; Still, Christopher D.; Breitwieser, Gerda E.; Gerhard, Glenn S.; Carey, David J.; Mirshahi, Tooraj			Long-Term Weight-Loss in Gastric Bypass Patients Carrying Melanocortin 4 Receptor Variants	PLOS ONE			English	Article							PROOPIOMELANOCORTIN-DERIVED AGONISTS; PHARMACOLOGICAL CHARACTERIZATION; MUTATIONS; OBESITY; POLYMORPHISMS; GENE; ASSOCIATION; INHERITANCE; PREVALENCE; PHENOTYPE	Background: The melanocortin 4 receptor (MC4R) critically regulates feeding and satiety. Rare variants in MC4R are predominantly found in obese individuals. Though some rare variants in MC4R discovered in patients have defects in localization, ligand binding and signaling to cAMP, many have no recognized defects. Subjects/Methods: In our cohort of 1433 obese subjects that underwent Roux-en-Y Gastric Bypass (RYGB) surgery, we found fifteen variants of MC4R. We matched rare variant carriers to patients with the MC4R reference alleles for gender, age, starting BMI and T2D to determine the variant effect on weight-loss post-RYGB. In vitro, we determined expression of mutant receptors by ELISA and western blot, and cAMP production by microscopy. Results: While carrying a rare MC4R allele is associated with obesity, carriers of rare variants exhibited comparable weight-loss after RYGB to non-carriers. However, subjects carrying three of these variants, V95I, I137T or L250Q, lost less weight after surgery. In vitro, the R305Q mutation caused a defect in cell surface expression while only the I137T and C326R mutations showed impaired cAMP signaling. Despite these apparent differences, there was no correlation between in vitro signaling and pre- or post-surgery clinical phenotype. Conclusions: These data suggest that subtle differences in receptor signaling conferred by rare MC4R variants combined with additional factors predispose carriers to obesity. In the absence of complete MC4R deficiency, these differences can be overcome by the powerful weight-reducing effects of bariatric surgery. In a complex disorder such as obesity, genetic variants that cause subtle defects that have cumulative effects can be overcome after appropriate clinical intervention.	[Moore, Bryn S.; Mirshahi, Uyenlinh L.; Yost, Evan A.; Stepanchick, Ann N.; Bedrin, Michael D.; Styer, Amanda M.; Jackson, Kathryn K.; Breitwieser, Gerda E.; Gerhard, Glenn S.; Carey, David J.; Mirshahi, Tooraj] Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA; [Still, Christopher D.; Mirshahi, Tooraj] Geisinger Obes Inst, Geisinger Clin, Danville, PA USA		Mirshahi, T (corresponding author), Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA.	tmirshahi@geisinger.edu		Moore, Bryn/0000-0002-8758-7611; Breitwieser, Gerda/0000-0001-9081-0362	Geisinger Clinic and National Institutes of Health [DK092775, DK072488]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK092775, P30DK072488] Funding Source: NIH RePORTER	Geisinger Clinic and National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Geisinger Clinic and National Institutes of Health DK092775 to TM, and DK072488 to GSG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Aslan IR, 2011, OBES SURG, V21, P930, DOI 10.1007/s11695-010-0295-8; Biebermann H, 2003, DIABETES, V52, P2984, DOI 10.2337/diabetes.52.12.2984; Branson R, 2003, NEW ENGL J MED, V348, P1096, DOI 10.1056/NEJMoa021971; Buch TRH, 2009, J BIOL CHEM, V284, P26411, DOI 10.1074/jbc.M109.039339; Calton MA, 2009, HUM MOL GENET, V18, P1140, DOI 10.1093/hmg/ddn431; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; de Felipe P, 2004, TRAFFIC, V5, P616, DOI 10.1111/j.1398-9219.2004.00205.x; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.56.062904.144924; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Gu W, 1999, DIABETES, V48, P635, DOI 10.2337/diabetes.48.3.635; Hatoum IJ, 2012, J CLIN ENDOCR METAB, V97, pE1023, DOI 10.1210/jc.2011-3432; Hinney A, 2003, J CLIN ENDOCR METAB, V88, P4258, DOI 10.1210/jc.2003-030233; Lubrano-Berthelier C, 2006, J CLIN ENDOCR METAB, V91, P1811, DOI 10.1210/jc.2005-1411; Lubrano-Berthelier C, 2003, HUM MOL GENET, V12, P145, DOI 10.1093/hmg/ddg016; Mirshahi UL, 2011, J CLIN ENDOCR METAB, V96, pE2088, DOI 10.1210/jc.2011-1549; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Proneth B, 2006, CHEM BIOL DRUG DES, V67, P215, DOI 10.1111/j.1747-0285.2006.00362.x; Reinehr T, 2009, OBESITY, V17, P382, DOI 10.1038/oby.2008.422; Rouskas K, 2012, OBESITY, V20, P2278, DOI 10.1038/oby.2012.77; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Scott WR, 2011, AM J PHYSIOL-REG I, V301, pR15, DOI 10.1152/ajpregu.00038.2011; Sekine-Aizawa Y, 2004, P NATL ACAD SCI USA, V101, P17114, DOI 10.1073/pnas.0407563101; Srisai D, 2011, ENDOCRINOLOGY, V152, P890, DOI 10.1210/en.2010-0716; Still CD, 2014, OBESITY, V22, P888, DOI 10.1002/oby.20529; Stutzmann F, 2008, DIABETES, V57, P2511, DOI 10.2337/db08-0153; Stutzmann F, 2007, HUM MOL GENET, V16, P1837, DOI 10.1093/hmg/ddm132; Tao YX, 2010, ENDOCR REV, V31, P506, DOI 10.1210/er.2009-0037; Tao YX, 2005, J CLIN ENDOCR METAB, V90, P5632, DOI 10.1210/jc.2005-0519; Tao YX, 2003, ENDOCRINOLOGY, V144, P4544, DOI 10.1210/en.2003-0524; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Valette M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048221; van den Berg L, 2011, OBESITY, V19, P604, DOI 10.1038/oby.2010.259; Wang ZQ, 2011, BBA-MOL BASIS DIS, V1812, P1190, DOI 10.1016/j.bbadis.2011.06.008; Wickremesekera K, 2005, OBES SURG, V15, P474, DOI 10.1381/0960892053723402; Xiang ZM, 2006, BIOCHEMISTRY-US, V45, P7277, DOI 10.1021/bi0600300; Xiang ZM, 2010, BIOCHEMISTRY-US, V49, P4583, DOI 10.1021/bi100068u; Zechner JF, 2013, GASTROENTEROLOGY, V144, P580, DOI 10.1053/j.gastro.2012.11.022	43	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93629	10.1371/journal.pone.0093629	http://dx.doi.org/10.1371/journal.pone.0093629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705671	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500050
J	Sher, YP; Wang, LJ; Chuang, LL; Tsai, MH; Kuo, TT; Huang, CC; Chuang, EY; Lai, LC				Sher, Yuh-Pyng; Wang, Li-Ju; Chuang, Li-Ling; Tsai, Mong-Hsun; Kuo, Ting-Ting; Huang, Cheng-Chung; Chuang, Eric Y.; Lai, Liang-Chuan			ADAM9 Up-Regulates N-Cadherin via miR-218 Suppression in Lung Adenocarcinoma Cells	PLOS ONE			English	Article							CANCER PROGRESSION; BETA-CATENIN; TUMOR-GROWTH; GENES; MICRORNA-218; INVASION; EXPRESSION; MIGRATION; SLIT2; IDENTIFICATION	Lung cancer is the leading cause of cancer death worldwide, and brain metastasis is a major cause of morbidity and mortality in lung cancer. CDH2 (N-cadherin, a mesenchymal marker of the epithelial-mesenchymal transition) and ADAM9 (a type I transmembrane protein) are related to lung cancer brain metastasis; however, it is unclear how they interact to mediate this metastasis. Because microRNAs regulate many biological functions and disease processes (e. g., cancer) by down-regulating their target genes, microRNA microarrays were used to identify ADAM9-regulated miRNAs that target CDH2 in aggressive lung cancer cells. Luciferase assays and western blot analysis showed that CDH2 is a target gene of miR-218. MiR-218 was generated from pri-mir-218-1, which is located in SLIT2, in non-invasive lung adenocarcinoma cells, whereas its expression was inhibited in aggressive lung adenocarcinoma. The down-regulation of ADAM9 up-regulated SLIT2 and miR-218, thus down-regulating CDH2 expression. This study revealed that ADAM9 activates CDH2 through the release of miR-218 inhibition on CDH2 in lung adenocarcinoma.	[Sher, Yuh-Pyng; Kuo, Ting-Ting; Huang, Cheng-Chung] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Sher, Yuh-Pyng] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Wang, Li-Ju; Lai, Liang-Chuan] Natl Taiwan Univ, Grad Inst Physiol, Taipei 10764, Taiwan; [Chuang, Li-Ling] Chang Gung Univ, Dept Phys Therapy, Taoyuan, Taiwan; [Chuang, Li-Ling] Chang Gung Univ, Grad Inst Rehabil Sci, Taoyuan, Taiwan; [Tsai, Mong-Hsun] Natl Taiwan Univ, Inst Biotechnol, Taipei 10764, Taiwan; [Chuang, Eric Y.] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei 10764, Taiwan; [Tsai, Mong-Hsun; Chuang, Eric Y.; Lai, Liang-Chuan] Natl Taiwan Univ, Ctr Genom Med, Bioinformat & Biostat Core, Taipei 10764, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Taiwan University; Chang Gung University; Chang Gung University; National Taiwan University; National Taiwan University; National Taiwan University	Lai, LC (corresponding author), Natl Taiwan Univ, Grad Inst Physiol, Taipei 10764, Taiwan.	llai@ntu.edu.tw	Lai, Liang-Chuan/B-4768-2009	Lai, Liang-Chuan/0000-0002-3913-5338; TSAI, MONG-HSUN/0000-0001-8777-5818; Chuang, Li-Ling/0000-0001-8171-4811; Sher, Yuh-Pyng/0000-0002-6062-7556	National Science Council, Taiwan [101-2325-B-039-008, 101-2320-B-002-015]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This research was supported by grants 101-2325-B-039-008 and 101-2320-B-002-015 from the National Science Council, Taiwan, ROC.(http://web1.nsc.gov.tw/mp.aspx?mp=7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alajez NM, 2011, CANCER RES, V71, P2381, DOI 10.1158/0008-5472.CAN-10-2754; Barbieri CE, 2006, CANCER RES, V66, P7589, DOI 10.1158/0008-5472.CAN-06-2020; Bonomi P, 2002, SEMIN ONCOL, V29, P78, DOI 10.1053/sonc.2002.31528; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Chen WF, 2013, INT J COLORECTAL DIS, V28, P933, DOI 10.1007/s00384-013-1641-9; Chen YT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017876, 10.1371/journal.pone.0021428, 10.1371/journal.pone.0017844, 10.1371/journal.pone.0024144, 10.1371/journal.pone.0027163, 10.1371/journal.pone.0027333]; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Coleman RE, 2006, CLIN CANCER RES, V12, p6243S, DOI 10.1158/1078-0432.CCR-06-0931; Dallol A, 2002, CANCER RES, V62, P5874; Davidson MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012560; Dwyer MA, 2010, CANCER RES, V70, P9298, DOI 10.1158/0008-5472.CAN-10-0226; Felli N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056824; Fritzsche FR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-179; Fry JL, 2010, CANCER RES, V70, P8187, DOI 10.1158/0008-5472.CAN-09-4231; Gao P, 2013, ONCOGENE, V32, P491, DOI 10.1038/onc.2012.61; Goossens K, 2013, STEM CELLS DEV, V22, P1907, DOI 10.1089/scd.2012.0708; Grinberg-Rashi H, 2009, CLIN CANCER RES, V15, P1755, DOI 10.1158/1078-0432.CCR-08-2124; Guaiquil V, 2009, MOL CELL BIOL, V29, P2694, DOI 10.1128/MCB.01460-08; Guan H, 2013, J CLIN ENDOCRINOL ME; Hassan MQ, 2012, J BIOL CHEM, V287, P42084, DOI 10.1074/jbc.M112.377515; Hayama M, 2013, ANN THORAC CARDIOVAS; He H, 2013, ONCOL REP, V30, P651, DOI 10.3892/or.2013.2516; He XQ, 2012, MOL MED, V18, P1491, DOI 10.2119/molmed.2012.00304; Hulit J, 2007, CANCER RES, V67, P3106, DOI 10.1158/0008-5472.CAN-06-3401; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Josson S, 2011, PROSTATE, V71, P232, DOI 10.1002/pros.21237; Kausar H, 2013, CANCER LETT, V332, P35, DOI 10.1016/j.canlet.2013.01.008; Kinoshita T, 2012, ONCOTARGET, V3, P1386, DOI 10.18632/oncotarget.709; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JR, 2012, INT J MOL SCI, V13, P16053, DOI 10.3390/ijms131216053; Lu TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042390; Marlow R, 2008, CANCER RES, V68, P7819, DOI 10.1158/0008-5472.CAN-08-1357; Meert AP, 2001, BMC CANCER, V1, DOI 10.1186/1471-2407-1-5; Micocci KC, 2013, BIOCHIMIE, V95, P1371, DOI 10.1016/j.biochi.2013.03.001; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Nath D, 2000, J CELL SCI, V113, P2319; Ng YH, 2012, ENDOCRINOLOGY, V153, P925, DOI 10.1210/en.2011-1488; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Pattyn F, 2003, NUCLEIC ACIDS RES, V31, P122, DOI 10.1093/nar/gkg011; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; REID RA, 1990, NUCLEIC ACIDS RES, V18, P5896, DOI 10.1093/nar/18.19.5896; Sher YP, 2009, ONCOGENE, V28, P3286, DOI 10.1038/onc.2009.187; Shintani Y, 2004, CANCER RES, V64, P4190, DOI 10.1158/0008-5472.CAN-03-3235; Small EM, 2010, CIRC RES, V107, P1336, DOI 10.1161/CIRCRESAHA.110.227926; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Tseng RC, 2010, CANCER RES, V70, P543, DOI 10.1158/0008-5472.CAN-09-2084; Tu Y, 2013, CANC RES; Vincent-Chong VK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054705; Wingo PA, 1999, J NATL CANCER I, V91, P675, DOI 10.1093/jnci/91.8.675; Wu DW, 2010, CANCER RES, V70, P10392, DOI 10.1158/0008-5472.CAN-10-2341; Yamashita S, 2006, CANCER SCI, V97, P64, DOI 10.1111/j.1349-7006.2006.00136.x	54	29	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94065	10.1371/journal.pone.0094065	http://dx.doi.org/10.1371/journal.pone.0094065			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705471	gold, Green Published, Green Submitted			2022-12-25	WOS:000334107500117
J	Wei, W; Ge, JB; Zou, Y; Lin, L; Cai, Y; Liu, XB; Zhu, WQ				Wei, Wei; Ge, Jun-Bo; Zou, Yu; Lin, Li; Cai, Ying; Liu, Xue-Bo; Zhu, Wen-Qing			Anatomical Characteristics of Pulmonary Veins for the Prediction of Postoperative Recurrence after Radiofrequency Catheter Ablation of Atrial Fibrillation	PLOS ONE			English	Article							ASSOCIATION	Background: The relationship between focal pulmonary vein potential and atrial fibrillation (AF) has been confirmed. Pulmonary vein (PV) isolation and circumferential pulmonary vein ablation have been the most commonly used procedures of radiofrequency ablation. However, few studies have investigated the relationship between anatomical characteristics of PV and AF recurrences after radiofrequency ablation. Methodology: For 267 AF patients treated by radiofrequency catheter ablation, the anatomic structure characteristics of pulmonary veins were assessed by multi-slice spiral computed tomography while the values of left atrial diameter (LAD) were measured with transesophageal ultrasonic cardiogram. After radiofrequency catheter ablation, postoperative recurrence was evaluated during a 10-month term follow-up. Principal Findings: During follow-up, postoperative recurrence occurred in 44 patients. The mean diameters of LAD, left superior PV, right superior PV, all left PV, and all superior PV were significantly larger in patients with postoperative recurrence (Recurrence vs. Non-recurrence group; 43.9 +/- 6.4 mm vs. 40.7 +/- 5.6 mm; 18.4 +/- 2.1 mm vs. 17.1 +/- 3.1 mm; 18.2 +/- 2.8 mm vs. 17.2 mm +/- 3.9 mm; 16.4 +/- 1.5 mm vs. 15.6 +/- 2.5 mm; 18.3 +/- 2.1 mm vs. 17.1 +/- 3.0 mm; respectively; all P <0.05). Multivariable survival analysis showed that the type and the course of AF, LAD, and the diameters of all superior PV were the independent risk factors for the postoperative recurrence after radiofrequency catheter ablation. Conclusions: The enlargements of all superior PV and LAD, long course of diseases, and persistent AF were the independent risk factors for the postoperative recurrence after radiofrequency catheter ablation.	[Wei, Wei; Ge, Jun-Bo; Zou, Yu; Lin, Li; Cai, Ying; Liu, Xue-Bo] Tongji Univ, Sch Med, Dept Cardiovasc Med, Shanghai 200092, Peoples R China; [Wei, Wei; Ge, Jun-Bo; Zou, Yu; Zhu, Wen-Qing] Fudan Univ, Zhongshan Hosp, Dept Cardiovasc Med, Shanghai 200433, Peoples R China	Tongji University; Fudan University	Liu, XB (corresponding author), Tongji Univ, Sch Med, Dept Cardiovasc Med, Shanghai 200092, Peoples R China.	lxb1350@easthospital.cn; zhu.wenqing@zs-hospital.sh.cn						Anselmino M, 2011, J CARDIOVASC ELECTR, V22, P1, DOI 10.1111/j.1540-8167.2010.01853.x; Berruezo A, 2007, EUR HEART J, V28, P836, DOI 10.1093/eurheartj/ehm027; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Estes NAM, 2008, CIRCULATION, V117, P1101, DOI 10.1161/CIRCULATIONAHA.107.187192; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Kubala M, 2011, PACE, V34, P837, DOI 10.1111/j.1540-8159.2011.03070.x; NATHAN H, 1966, CIRCULATION, V34, P412, DOI 10.1161/01.CIR.34.3.412; Nedios S, 2011, J INTERV CARD ELECTR, V32, P87, DOI 10.1007/s10840-011-9591-z; Roten L, 2012, CURR CARDIOL REV, V8, P327, DOI 10.2174/157340312803760802; VAZIRI SM, 1994, CIRCULATION, V89, P724, DOI 10.1161/01.CIR.89.2.724; Zaca V, 2007, CAN J CARDIOL, V23, P869, DOI 10.1016/S0828-282X(07)70841-3; Zhuang JH, 2012, EUROPACE, V14, P638, DOI 10.1093/europace/eur364	12	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93817	10.1371/journal.pone.0093817	http://dx.doi.org/10.1371/journal.pone.0093817			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705909	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500070
J	Wang, JM; Huang, FC; Kuo, MHJ; Wang, ZF; Tseng, TY; Chang, LC; Yen, SJ; Chang, TC; Lin, JJ				Wang, Jing-Ming; Huang, Fong-Chun; Kuo, Margaret Hsin-Jui; Wang, Zi-Fu; Tseng, Ting-Yuan; Chang, Lien-Cheng; Yen, Shao-Jung; Chang, Ta-Chau; Lin, Jing-Jer			Inhibition of Cancer Cell Migration and Invasion through Suppressing the Wnt1-mediating Signal Pathway by G-quadruplex Structure Stabilizers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROMOTER REGION; WNT1 EXPRESSION; DNA; GENE; NUCLEOLIN; PARALLEL; TELOMERASE; ACTIVATION; SENESCENCE; CARCINOMA	WNT1 encodes a multifunctional signaling glycoprotein that is highly expressed in several malignant tumors. Patients with Wnt1-positive cancer are usually related to advanced metastasis. Here, we found that a stretch of G-rich sequences located at the WNT1 promoter region is capable of forming G-quadruplex structures. The addition of G-quadruplex structure stabilizers, BMVC and BMVC4, raises the melting temperature of the oligonucleotide formed by the WNT1 promoter G-rich sequences. Significantly, the expression of WNT1 was repressed by BMVC or BMVC4 in a G-quadruplex-dependent manner, suggesting that they can be used to modulate WNT1 expression. The role of G-quadruplex stabilizers on Wnt1-mediated cancer migration and invasion was further analyzed. The protein levels of beta-catenin, a mediator of the Wnt-mediated signaling pathway, and the downstream targets MMP7 and survivin were down-regulated upon BMVC or BMVC4 treatments. Moreover, the migration and invasion activities of cancer cells were inhibited by BMVC and BMVC4, and the inhibitory effects can be reversed by WNT1-overexpression. Thus the Wnt1 expression and its downstream signaling pathways can be regulated through the G-quadruplex sequences located at its promoter region. These findings provide a novel approach for future drug development to inhibit migration and invasion of cancer cells.	[Wang, Jing-Ming; Chang, Lien-Cheng; Lin, Jing-Jer] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan; [Huang, Fong-Chun; Yen, Shao-Jung; Lin, Jing-Jer] Natl Taiwan Univ, Inst Biochem & Mol Biol, Coll Med, Taipei 100, Taiwan; [Kuo, Margaret Hsin-Jui; Wang, Zi-Fu; Tseng, Ting-Yuan; Chang, Ta-Chau] Acad Sinica, Inst Atom & Mol Sci, Taipei 106, Taiwan; [Wang, Zi-Fu; Chang, Ta-Chau] Natl Taiwan Univ, Dept Chem, Taipei 106, Taiwan; [Tseng, Ting-Yuan; Chang, Ta-Chau] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Chang, Lien-Cheng] Minist Hlth & Welf, Food & Drug Adm, Taipei 115, Taiwan	National Yang Ming Chiao Tung University; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; National Yang Ming Chiao Tung University	Chang, TC (corresponding author), Acad Sinica, Inst Atom & Mol Sci, POB 23-166, Taipei 106, Taiwan.	tcchang@po.iams.sinica.edu.tw; jingjerlin@ntu.edu.tw	Chang, Ta-Chau/F-7921-2012; Lin, Jing-Jer/G-8068-2015	Chang, Ta-Chau/0000-0001-5878-8556; LIN, JING-JER/0000-0001-8250-7398	Academia Sinica [AS-98-TP-A04, AS-102-TP-A07]; National Science Council [100-2311-B-002-016, 100-2311-B-010-001]; National Health Research Institute [NHRI-EX101-10050SI]	Academia Sinica(Academia Sinica - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan)	This work was supported by Academia Sinica AS-98-TP-A04 and AS-102-TP-A07, the National Science Council (100-2311-B-002-016 and 100-2311-B-010-001), and the National Health Research Institute (NHRI-EX101-10050SI).	BALAGURUMOORTHY P, 1992, NUCLEIC ACIDS RES, V20, P4061, DOI 10.1093/nar/20.15.4061; Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen GP, 2004, CANCER-AM CANCER SOC, V101, P1345, DOI 10.1002/cncr.20518; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; CULLEN BR, 1992, METHOD ENZYMOL, V216, P362; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; De Armond R, 2005, BIOCHEMISTRY-US, V44, P16341, DOI 10.1021/bi051618u; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Ewan K, 2010, CANCER RES, V70, P5963, DOI 10.1158/0008-5472.CAN-10-1028; Feigon J, 1995, METHOD ENZYMOL, V261, P225; Fenby BT, 2008, BBA-GENE REGUL MECH, V1779, P115, DOI 10.1016/j.bbagrm.2007.11.008; Fernando H, 2006, BIOCHEMISTRY-US, V45, P7854, DOI 10.1021/bi0601510; Gonzalez V, 2010, BIOCHEMISTRY-US, V49, P9706, DOI 10.1021/bi100509s; He BA, 2005, ONCOGENE, V24, P3054, DOI 10.1038/sj.onc.1208511; He WC, 2012, J AM SOC NEPHROL, V23, P294, DOI 10.1681/ASN.2011050490; He WC, 2010, J BIOL CHEM, V285, P24665, DOI 10.1074/jbc.M109.091256; Hsu STD, 2009, J AM CHEM SOC, V131, P13399, DOI 10.1021/ja904007p; Huang FC, 2008, MOL CANCER RES, V6, P955, DOI 10.1158/1541-7786.MCR-07-0260; Huang FC, 2012, BRIT J PHARMACOL, V167, P393, DOI 10.1111/j.1476-5381.2012.01997.x; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Kang CC, 2013, INTEGR BIOL-UK, V5, P1217, DOI 10.1039/c3ib40058a; Kim YC, 2008, CANCER RES, V68, P10145, DOI 10.1158/0008-5472.CAN-08-2992; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kuryavyi V, 2010, NUCLEIC ACIDS RES, V38, P6757, DOI 10.1093/nar/gkq558; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Lin CT, 2011, J PHYS CHEM B, V115, P2360, DOI 10.1021/jp107623n; Maizels N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003468; Masiero S, 2010, ORG BIOMOL CHEM, V8, P2683, DOI 10.1039/c003428b; Nakashima T, 2008, ONCOL REP, V19, P203; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; NUSSE R, 1990, MOL CELL BIOL, V10, P4170, DOI 10.1128/MCB.10.8.4170; Palumbo SL, 2008, NUCLEIC ACIDS RES, V36, P1755, DOI 10.1093/nar/gkm1069; Palumbo SL, 2009, J AM CHEM SOC, V131, P10878, DOI 10.1021/ja902281d; PATEL DJ, 1974, BIOPOLYMERS, V13, P1943, DOI 10.1002/bip.1974.360131003; Phan AT, 2007, J AM CHEM SOC, V129, P4386, DOI 10.1021/ja068739h; Phan AT, 2003, J AM CHEM SOC, V125, P15021, DOI 10.1021/ja037616j; Polakis P, 2012, EMBO J, V31, P2737, DOI 10.1038/emboj.2012.126; Qin Y, 2007, NUCLEIC ACIDS RES, V35, P7698, DOI 10.1093/nar/gkm538; Qin Y, 2010, BIOCHEMISTRY-US, V49, P4208, DOI 10.1021/bi100330w; Rimerman RA, 2000, J BIOL CHEM, V275, P14736, DOI 10.1074/jbc.M910241199; Sack U, 2011, MOL BIOL CELL, V22, P3344, DOI 10.1091/mbc.E10-09-0739; Siddiqui-Jain A., 2002, P NATL ACAD SCI USA, V34, P11593; STARNAUD R, 1993, MOL CELL BIOL, V13, P1590, DOI 10.1128/MCB.13.3.1590; Sun DK, 2011, NUCLEIC ACIDS RES, V39, P1256, DOI 10.1093/nar/gkq926; Sun DY, 2005, NUCLEIC ACIDS RES, V33, P6070, DOI 10.1093/nar/gki917; Tao WK, 2001, GENE DEV, V15, P1796, DOI 10.1101/gad.894301; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Tsai YL, 2011, NUCLEIC ACIDS RES, V39, pE114, DOI 10.1093/nar/gkr499; Uribe DJ, 2011, BIOCHEMISTRY-US, V50, P3796, DOI 10.1021/bi101633b; Wei PC, 2013, NUCLEIC ACIDS RES, V41, P1533, DOI 10.1093/nar/gks1232; Wei W, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-76; Wong SCC, 2002, J PATHOL, V196, P145, DOI 10.1002/path.1035; Xu LF, 2000, GENE DEV, V14, P585; Xu X, 2011, J THORAC ONCOL, V6, P716, DOI 10.1097/JTO.0b013e31820c5189; Xu Y, 2006, NUCLEIC ACIDS RES, V34, P949, DOI 10.1093/nar/gkj485	60	30	31	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14612	14623		10.1074/jbc.M114.548230	http://dx.doi.org/10.1074/jbc.M114.548230			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24713700	Green Published, hybrid			2022-12-25	WOS:000337248100018
J	Ohashi, K; Enomoto, T; Joki, Y; Shibata, R; Ogura, Y; Kataoka, Y; Shimizu, Y; Kambara, T; Uemura, Y; Yuasa, D; Matsuo, K; Hayakawa, S; Hiramatsu-Ito, M; Murohara, T; Ouchi, N				Ohashi, Koji; Enomoto, Takashi; Joki, Yusuke; Shibata, Rei; Ogura, Yasuhiro; Kataoka, Yoshiyuki; Shimizu, Yuuki; Kambara, Takahiro; Uemura, Yusuke; Yuasa, Daisuke; Matsuo, Kazuhiro; Hayakawa, Satoko; Hiramatsu-Ito, Mizuho; Murohara, Toyoaki; Ouchi, Noriyuki			Neuron-derived Neurotrophic Factor Functions as a Novel Modulator That Enhances Endothelial Cell Function and Revascularization Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt; Angiogenesis; Apoptosis; Endothelial Cell; Ischemia; Nitric Oxide Synthase; Neuron-derived Neurotrophic Factor	ACTIVATED PROTEIN-KINASE; NITRIC-OXIDE SYNTHASE; ADIPONECTIN STIMULATES ANGIOGENESIS; COLLATERAL VESSEL DEVELOPMENT; FOLLISTATIN-LIKE 1; GROWTH-FACTOR; MOUSE MODEL; IN-VIVO; PROMOTES ANGIOGENESIS; METABOLIC SYNDROME	Background: Tissue ischemia stimulates production of secreted factors that regulate angiogenesis. Results: Neuron-derived neurotrophic factor (NDNF) is up-regulated in endothelial cells in ischemic limbs of mice. NDNF stimulates endothelial cell function and promotes ischemia-induced revascularization through NOS-dependent mechanisms. Conclusion: NDNF functions as a novel modulator that stimulates revascularization processes. Significance: NDNF represents a novel therapeutic target for ischemic vascular diseases. Strategies to stimulate revascularization are valuable for cardiovascular diseases. Here we identify neuron-derived neurotrophic factor (NDNF)/epidermacan as a secreted molecule that is up-regulated in endothelial cells in ischemic limbs of mice. NDNF was secreted from cultured human endothelial cells, and its secretion was stimulated by hypoxia. NDNF promoted endothelial cell network formation and survival in vitro through activation of Akt/endothelial NOS (eNOS) signaling involving integrin v3. Conversely, siRNA-mediated knockdown of NDNF in endothelial cells led to reduction of cellular responses and basal Akt signaling. Intramuscular overexpression of NDNF led to enhanced blood flow recovery and capillary density in ischemic limbs of mice, which was accompanied by enhanced phosphorylation of Akt and eNOS. The stimulatory actions of NDNF on perfusion recovery in ischemic muscles of mice were abolished by eNOS deficiency or NOS inhibition. Furthermore, siRNA-mediated reduction of NDNF in muscles of mice resulted in reduction of perfusion recovery and phosphorylation of Akt and eNOS in response to ischemia. Our data indicate that NDNF acts as an endogenous modulator that promotes endothelial cell function and ischemia-induced revascularization through eNOS-dependent mechanisms. Thus, NDNF can represent a therapeutic target for the manipulation of ischemic vascular disorders.	[Ohashi, Koji; Ouchi, Noriyuki] Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Nagoya, Aichi 4668550, Japan; [Enomoto, Takashi; Joki, Yusuke; Shibata, Rei; Ogura, Yasuhiro; Kataoka, Yoshiyuki; Shimizu, Yuuki; Kambara, Takahiro; Uemura, Yusuke; Yuasa, Daisuke; Matsuo, Kazuhiro; Hayakawa, Satoko; Hiramatsu-Ito, Mizuho; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan	Nagoya University; Nagoya University	Ouchi, N (corresponding author), Nagoya Univ, Grad Sch Med, Dept Mol Cardiol, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	nouchi@med.nagoya-u.ac.jp	OHASHI, Koji/I-7307-2014; Murohara, Toyoaki/M-4958-2014; OUCHI, Noriyuki/I-7306-2014	Enomoto, Takashi/0000-0002-7370-8013; Hiramatsu-Ito, Mizuho/0000-0003-1740-1794	Akeda Science Foundation; Uehara Memorial Foundation; Daiichi-Sankyo Foundation of Life Science; SENSHIN Medical Research Foundation; Cardiovascular Research Fund, Tokyo, Japan	Akeda Science Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Daiichi-Sankyo Foundation of Life Science; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Cardiovascular Research Fund, Tokyo, Japan	This work was supported by a grant-in-aid for scientific research; a grant-in-aid for challenging exploratory research; and grants from the Akeda Science Foundation, the Uehara Memorial Foundation, the Daiichi-Sankyo Foundation of Life Science, and the SENSHIN Medical Research Foundation (to N. O.).; Supported by a Grant-in-aid for Young Scientists B and by the Cardiovascular Research Fund, Tokyo, Japan.	Asano T, 2007, CIRC J, V71, P405, DOI 10.1253/circj.71.405; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Cantarella G, 2002, FASEB J, V16, P1307, DOI 10.1096/fj.01-1000fje; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Cikos S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-113; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Emanueli C, 2002, CIRCULATION, V106, P2257, DOI 10.1161/01.CIR.0000033971.56802.C5; Emanueli C, 2001, CIRCULATION, V103, P125; Enomoto T, 2011, J BIOL CHEM, V286, P34552, DOI 10.1074/jbc.M111.277319; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Galasso G, 2006, CIRC RES, V98, P254, DOI 10.1161/01.RES.0000200740.57764.52; Goukassian DA, 2007, CIRCULATION, V115, P752, DOI 10.1161/CIRCULATIONAHA.106.647255; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Grundy SM, 2004, ARTERIOSCL THROM VAS, V24, pE13, DOI 10.1161/01.ATV.0000111245.75752.C6; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kermani P, 2007, TRENDS CARDIOVAS MED, V17, P140, DOI 10.1016/j.tcm.2007.03.002; Kirchmair R, 2004, CIRCULATION, V109, P777, DOI 10.1161/01.CIR.0000112574.07422.C1; Kireeva ML, 1998, J BIOL CHEM, V273, P3090, DOI 10.1074/jbc.273.5.3090; Kuang XL, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-137; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Losordo DW, 2004, CIRCULATION, V109, P2487, DOI 10.1161/01.CIR.0000128595.79378.FA; Luo ZY, 2000, J CLIN INVEST, V106, P493, DOI 10.1172/JCI9419; Matsuda S, 2012, J CELL PHYSIOL, V227, P2123, DOI 10.1002/jcp.22942; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Ogura Y, 2012, CIRCULATION, V126, P1728, DOI 10.1161/CIRCULATIONAHA.112.115089; Ohashi K, 2010, J BIOL CHEM, V285, P22291, DOI 10.1074/jbc.M110.123794; Ohashi K, 2009, MOL CELL BIOL, V29, P3487, DOI 10.1128/MCB.00126-09; Oshima Y, 2008, CIRCULATION, V117, P3099, DOI 10.1161/CIRCULATIONAHA.108.767673; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; PIALI L, 1995, J CELL BIOL, V130, P451, DOI 10.1083/jcb.130.2.451; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Schgoer W, 2009, CIRC RES, V105, P994, DOI 10.1161/CIRCRESAHA.109.199513; Schiekofer S, 2005, ARTERIOSCL THROM VAS, V25, P1603, DOI 10.1161/01.ATV.0000171994.89106.ca; Shibata R, 2004, J BIOL CHEM, V279, P28670, DOI 10.1074/jbc.M402558200; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Simons M, 2005, CIRCULATION, V111, P1556, DOI 10.1161/01.CIR.0000159345.00591.8F; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Takemura Y, 2004, HYPERTENSION, V43, P880, DOI 10.1161/01.HYP.0000120124.27641.03; Turhan H, 2005, CORONARY ARTERY DIS, V16, P281, DOI 10.1097/00019501-200508000-00004; Yilmaz MB, 2003, INT J OBESITY, V27, P1541, DOI 10.1038/sj.ijo.0802474	49	31	34	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14132	14144		10.1074/jbc.M114.555789	http://dx.doi.org/10.1074/jbc.M114.555789			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24706764	Green Published, hybrid			2022-12-25	WOS:000335984600041
J	Lopez, E; Domenech, A; Ferrandiz, MJ; Frias, MJ; Ardanuy, C; Ramirez, M; Garcia, E; Linares, J; de la Campa, AG				Lopez, Elena; Domenech, Arnau; Ferrandiz, Maria-Jose; Frias, Maria Joao; Ardanuy, Carmen; Ramirez, Mario; Garcia, Ernesto; Linares, Josefina; de la Campa, Adela G.			Induction of Prophages by Fluoroquinolones in Streptococcus pneumoniae: Implications for Emergence of Resistance in Genetically-Related Clones	PLOS ONE			English	Article							TOPOISOMERASE; BACTERIOPHAGE; DISEASE; GENES; DEATH; SUSCEPTIBILITY; PNEUMOCOCCUS; EVOLUTION; INFECTION; CARRIAGE	Antibiotic resistance in Streptococcus pneumoniae has increased worldwide by the spread of a few clones. Fluoroquinolone resistance occurs mainly by alteration of their intracellular targets, the type II DNA topoisomerases, which is acquired either by point mutation or by recombination. Increase in fluoroquinolone-resistance may depend on the balance between antibiotic consumption and the cost that resistance imposes to bacterial fitness. In addition, pneumococcal prophages could play an important role. Prophage induction by fluoroquinolones was confirmed in 4 clinical isolates by using Southern blot hybridization. Clinical isolates (105 fluoroquinolone-resistant and 160 fluoroquinolone-susceptible) were tested for lysogeny by using a PCR assay and functional prophage carriage was studied by mitomycin C induction. Fluoroquinoloneresistant strains harbored fewer inducible prophages (17/43) than fluoroquinolone-susceptible strains (49/70) (P= 0.0018). In addition, isolates of clones associated with fluoroquinolone resistance [CC156 (3/25); CC63 (2/20), and CC81 (1/19)], had lower frequency of functional prophages than isolates of clones with low incidence of fluoroquinolone resistance [CC30 (4/ 21), CC230 (5/20), CC62 (9/21), and CC180 (21/30)]. Likewise, persistent strains from patients with chronic respiratory diseases subjected to fluoroquinolone treatment had a low frequency of inducible prophages (1/11). Development of ciprofloxacin resistance was tested with two isogenic strains, one lysogenic and the other non-lysogenic: emergence of resistance was only observed in the non-lysogenic strain. These results are compatible with the lysis of lysogenic isolates receiving fluoroquinolones before the development of resistance and explain the inverse relation between presence of inducible prophages and fluoroquinolone-resistance.	[Lopez, Elena; Ferrandiz, Maria-Jose; de la Campa, Adela G.] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain; [Lopez, Elena; Domenech, Arnau; Ferrandiz, Maria-Jose; Ardanuy, Carmen; Garcia, Ernesto; Linares, Josefina; de la Campa, Adela G.] ISCIII, Ciber Enfermedades Resp, Madrid, Spain; [Domenech, Arnau; Ardanuy, Carmen; Linares, Josefina] Univ Barcelona, Hosp Univ Bellvitge, IDIBELL, Dept Microbiol, Barcelona, Spain; [Frias, Maria Joao; Ramirez, Mario] Univ Lisbon, Fac Med, Inst Microbiol, Inst Mol Med, P-1699 Lisbon, Portugal; [Garcia, Ernesto] CSIC, Ctr Invest Biol, Madrid, Spain; [de la Campa, Adela G.] CSIC, Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Universidade de Lisboa; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC)	de la Campa, AG (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid, Spain.	agcampa@isciii.es	Ferrandiz, Maria-Jose/K-2820-2014; Ramirez, Mario/B-4993-2008; de la Campa, Adela G/K-1654-2014; Liñares, Josefina/N-9450-2014; Ardanuy, Carmen/C-4463-2015	Ferrandiz, Maria-Jose/0000-0003-1428-9506; Ramirez, Mario/0000-0002-4084-6233; de la Campa, Adela G/0000-0002-3598-2548; Frias, Maria Joao/0000-0002-8060-1206; Partearroyo Lacaba, Olvido/0000-0002-1692-4481; Domenech, Arnau/0000-0002-0829-511X; Ardanuy, Carmen/0000-0003-0225-607X	Plan Nacional [BIO2008-02154, SAF2009-10824, BIO2011-25343]; FIS of Ministerio de Economiy Competitividad [PI 0901904]; FPU of Ministerio de Educacion, Spain	Plan Nacional; FIS of Ministerio de Economiy Competitividad; FPU of Ministerio de Educacion, Spain(German Research Foundation (DFG))	This study was supported by grants BIO2008-02154, SAF2009-10824 and BIO2011-25343 from Plan Nacional and PI 0901904 by FIS of Ministerio de Economiy Competitividad. CIBER de Enfermedades Respiratorias (CIBERES) is an initiative of ISCIII. A. D. was supported by a grant from FPU of Ministerio de Educacion, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUSTRIAN R, 1981, REV INFECT DIS, V3, pS1; Balsalobre L, 2003, ANTIMICROB AGENTS CH, V47, P2072, DOI 10.1128/AAC.47.7.2072-2081.2003; Balsalobre L, 2008, ANTIMICROB AGENTS CH, V52, P822, DOI 10.1128/AAC.00731-07; Balsalobre L, 2013, ANTIMICROB AGENTS CH, V57, P254, DOI 10.1128/AAC.01357-12; Balsalobre L, 2011, ANTIMICROB AGENTS CH, V55, P1097, DOI 10.1128/AAC.00783-10; BERNHEIMER HP, 1979, J BACTERIOL, V138, P618, DOI 10.1128/JB.138.2.618-624.1979; Chen DK, 1999, NEW ENGL J MED, V341, P233, DOI 10.1056/NEJM199907223410403; Cirz RT, 2007, J BACTERIOL, V189, P531, DOI 10.1128/JB.01464-06; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; de la Campa AG, 2009, EMERG INFECT DIS, V15, P905, DOI 10.3201/eid1506.080684; de la Campa AG, 2004, EMERG INFECT DIS, V10, P1751, DOI 10.3201/eid1010.040382; Domenech A, 2012, J CLIN MICROBIOL, V50, P4047, DOI 10.1128/JCM.02056-12; Domenech A, 2011, J ANTIMICROB CHEMOTH, V66, P487, DOI 10.1093/jac/dkq480; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; Ferrandiz MJ, 2014, ANTIMICROB AGENTS CH, V58, P247, DOI 10.1128/AAC.01706-13; Frias MJ, 2009, J BACTERIOL, V191, P5428, DOI 10.1128/JB.00477-09; Ingrey KT, 2003, INFECT IMMUN, V71, P3028, DOI 10.1128/IAI.71.6.3028-3033.2003; Jacobs MR, 2003, J ANTIMICROB CHEMOTH, V52, P229, DOI 10.1093/jac/dkg321; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; MARTIN B, 1995, MOL MICROBIOL, V15, P367, DOI 10.1111/j.1365-2958.1995.tb02250.x; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Meessen-Pinard M, 2012, APPL ENVIRON MICROB, V78, P7662, DOI 10.1128/AEM.02275-12; Prudhomme M, 2006, SCIENCE, V313, P89, DOI 10.1126/science.1127912; Ramirez M, 1999, J BACTERIOL, V181, P3618, DOI 10.1128/JB.181.12.3618-3625.1999; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Romero P, 2009, APPL ENVIRON MICROB, V75, P1642, DOI 10.1128/AEM.02155-08; Rozen DE, 2007, ANTIMICROB AGENTS CH, V51, P412, DOI 10.1128/AAC.01161-06; Selva L, 2009, P NATL ACAD SCI USA, V106, P1234, DOI 10.1073/pnas.0809600106; Stanhope MJ, 2005, ANTIMICROB AGENTS CH, V49, P4315, DOI 10.1128/AAC.49.10.4315-4326.2005; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; Yasmin A, 2010, J BACTERIOL, V192, P1122, DOI 10.1128/JB.01293-09	32	16	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94358	10.1371/journal.pone.0094358	http://dx.doi.org/10.1371/journal.pone.0094358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718595	Green Published, gold			2022-12-25	WOS:000334339000110
J	Lubke, KT; Croy, I; Hoenen, M; Gerber, J; Pause, BM; Hummel, T				Luebke, Katrin T.; Croy, Ilona; Hoenen, Matthias; Gerber, Johannes; Pause, Bettina M.; Hummel, Thomas			Does Human Body Odor Represent a Significant and Rewarding Social Signal to Individuals High in Social Openness?	PLOS ONE			English	Article							CHEMOSENSORY CUES; ACTIVATION; RECOGNITION; EXPERT; COMMON; SKILLS	Across a wide variety of domains, experts differ from novices in their response to stimuli linked to their respective field of expertise. It is currently unknown whether similar patterns can be observed with regard to social expertise. The current study therefore focuses on social openness, a central social skill necessary to initiate social contact. Human body odors were used as social cues, as they inherently signal the presence of another human being. Using functional MRI, hemodynamic brain responses to body odors of women reporting a high (n = 14) or a low (n = 12) level of social openness were compared. Greater activation within the inferior frontal gyrus and the caudate nucleus was observed in high socially open individuals compared to individuals low in social openness. With the inferior frontal gyrus being a crucial part of the human mirror neuron system, and the caudate nucleus being implicated in social reward, it is discussed whether human body odor might constitute more of a significant and rewarding social signal to individuals high in social openness compared to individuals low in social openness process.	[Luebke, Katrin T.; Hoenen, Matthias; Pause, Bettina M.] Univ Dusseldorf, Dept Expt Psychol, Dusseldorf, Germany; [Croy, Ilona; Hummel, Thomas] Univ Dresden, Sch Med, Dept Otorhinolaryngol, Dresden, Germany; [Gerber, Johannes] Univ Dresden, Sch Med, Dept Neuroradiol, Dresden, Germany	Heinrich Heine University Dusseldorf; Technische Universitat Dresden; Technische Universitat Dresden	Lubke, KT (corresponding author), Univ Dusseldorf, Dept Expt Psychol, Dusseldorf, Germany.	katrin.luebke@hhu.de	Gerber, Johannes/U-4918-2019; Hoenen, Matthias/I-1029-2019	Gerber, Johannes/0000-0001-7465-8700; Hoenen, Matthias/0000-0002-5791-9486; Croy, Ilona/0000-0002-0361-5559				Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Arsalidou M, 2012, HUM BRAIN MAPP; Ashbaugh AR, 2005, COGNITIVE THER RES, V29, P387, DOI 10.1007/s10608-005-2413-9; Baker SR, 2002, BRIT J CLIN PSYCHOL, V41, P243, DOI 10.1348/014466502760379118; Batson CD, 2009, SOCIAL NEUROSCIENCE OF EMPATHY, P3; Bzdok D, 2011, BRAIN STRUCT FUNCT, V215, P209, DOI 10.1007/s00429-010-0287-4; Cacioppo JT, 2009, J COGNITIVE NEUROSCI, V21, P83, DOI 10.1162/jocn.2009.21007; Caldu X, 2007, ANN NY ACAD SCI, V1118, P43, DOI 10.1196/annals.1412.007; Chakrabarti B, 2006, SOC NEUROSCI-UK, V1, P364, DOI 10.1080/17470910601041317; Chen D, 2000, PERCEPT MOTOR SKILL, V91, P771, DOI 10.2466/pms.2000.91.3.771; Cohen MX, 2009, NAT NEUROSCI, V12, P32, DOI 10.1038/nn.2228; Croy I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009362; D'Argembeau A, 2008, NEUROIMAGE, V40, P398, DOI 10.1016/j.neuroimage.2007.11.025; Dimoka A, 2011, NEUROIMAGE, V54, pS263, DOI 10.1016/j.neuroimage.2010.05.007; Domes G, 2010, PSYCHONEUROENDOCRINO, V35, P83, DOI 10.1016/j.psyneuen.2009.06.016; Doty RL, 2009, PHYSIOL BEHAV, V97, P213, DOI 10.1016/j.physbeh.2009.02.032; Duan XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032532; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Focquaert F, 2010, BRAIN RES BULL, V83, P214, DOI 10.1016/j.brainresbull.2010.08.008; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Hampel S, 2011, J ANXIETY DISORD, V25, P545, DOI 10.1016/j.janxdis.2011.01.001; Hoenig K, 2011, NEUROIMAGE, V56, P1714, DOI 10.1016/j.neuroimage.2011.02.065; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Hummel T, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00786; Kanning U. P, 2009, ISK; Kaplan JT, 2006, SOC NEUROSCI-UK, V1, P175, DOI 10.1080/17470910600985605; Kim J, 2008, NEUROSCI LETT, V445, P236, DOI 10.1016/j.neulet.2008.09.018; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Kobal G., 2003, HDB OLFACTION GUSTAT, P229; Lebreton M, 2009, EUR J NEUROSCI, V29, P2247, DOI 10.1111/j.1460-9568.2009.06782.x; Lubke KT, 2012, BEHAV BRAIN RES, V228, P375, DOI 10.1016/j.bbr.2011.12.018; Lundstrom JN, 2008, CEREB CORTEX, V18, P1466, DOI 10.1093/cercor/bhm178; Lundstrom JN, 2010, VITAM HORM, V83, P1, DOI 10.1016/S0083-6729(10)83001-8; Lundstrom JN, 2009, HUM BRAIN MAPP, V30, P2571, DOI 10.1002/hbm.20686; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Maldjian JA, 2004, NEUROIMAGE, V21, P450, DOI 10.1016/j.neuroimage.2003.09.032; Mallet P, 1998, J GEN PSYCHOL, V125, P47, DOI 10.1080/00221309809595576; Mujica-Parodi LR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006415; Pause BM, 2012, CHEMOSENS PERCEPT, V5, P55, DOI 10.1007/s12078-011-9108-2; Pause BM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010342; Pause BM, 2009, INT J PSYCHOPHYSIOL, V74, P88, DOI 10.1016/j.ijpsycho.2009.07.008; Pause BM, 2004, CHEM SENSES, V29, P797, DOI 10.1093/chemse/bjh245; Pause BM, 2004, PHYSIOL BEHAV, V83, P21, DOI 10.1016/j.physbeh.2004.07.019; Porter RH, 1998, GENETICA, V104, P259, DOI 10.1023/A:1026404319384; Prehn-Kristensen A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005987; Rilling JK, 2012, PSYCHONEUROENDOCRINO, V37, P447, DOI 10.1016/j.psyneuen.2011.07.013; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Rizzolatti G, 2008, CURR OPIN NEUROBIOL, V18, P179, DOI 10.1016/j.conb.2008.08.001; Semrud-Clikeman M, 2011, NEUROPSYCHOBIOLOGY, V64, P47, DOI 10.1159/000325075; Sugranyes G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025322; SuÓ H.-M., 2005, HDB PERSONLICHKEITSP, P350; Wei GX, 2010, BRAIN RES, V1341, P52, DOI 10.1016/j.brainres.2009.08.014; Wintermann GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074655; Wright MJ, 2011, NEUROSCI LETT, V500, P216, DOI 10.1016/j.neulet.2011.06.045; Wyatt TD, 2004, SCENT HUMAN ATTRACTI, P270; Zhou W, 2011, NEUROIMAGE, V55, P1401, DOI 10.1016/j.neuroimage.2010.12.064; Zhou W, 2009, PSYCHOL SCI, V20, P1118, DOI 10.1111/j.1467-9280.2009.02413.x; Zhou W, 2009, PSYCHOL SCI, V20, P177, DOI 10.1111/j.1467-9280.2009.02263.x; Zhou W, 2008, J NEUROSCI, V28, P14416, DOI 10.1523/JNEUROSCI.3148-08.2008	60	22	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94314	10.1371/journal.pone.0094314	http://dx.doi.org/10.1371/journal.pone.0094314			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24718308	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000104
J	Prisco, AR; Bukowy, JD; Hoffmann, BR; Karcher, JR; Exner, EC; Greene, AS				Prisco, Anthony R.; Bukowy, John D.; Hoffmann, Brian R.; Karcher, Jamie R.; Exner, Eric C.; Greene, Andrew S.			Automated Quantification Reveals Hyperglycemia Inhibits Endothelial Angiogenic Function	PLOS ONE			English	Article							ADVANCED GLYCATION ENDPRODUCTS; TUBE FORMATION; CLINICAL-RELEVANCE; BASEMENT-MEMBRANE; IN-VITRO; CELLS; DYSFUNCTION; ADIPONECTIN; SECRETION; MIGRATION	Objective: Diabetes Mellitus (DM) has reached epidemic levels globally. A contributing factor to the development of DM is high blood glucose (hyperglycemia). One complication associated with DM is a decreased angiogenesis. The Matrigel tube formation assay (TFA) is the most widely utilized in vitro assay designed to assess angiogeneic factors and conditions. In spite of the widespread use of Matrigel TFAs, quantification is labor-intensive and subjective, often limiting experiential design and interpretation of results. This study describes the development and validation of an open source software tool for high throughput, morphometric analysis of TFA images and the validation of an in vitro hyperglycemic model of DM. Approach and Results: Endothelial cells mimic angiogenesis when placed onto a Matrigel coated surface by forming tubelike structures. The goal of this study was to develop an open-source software algorithm requiring minimal user input (Pipeline v1.3) to automatically quantify tubular metrics from TFA images. Using Pipeline, the ability of endothelial cells to form tubes was assessed after culture in normal or high glucose for 1 or 2 weeks. A significant decrease in the total tube length and number of branch points was found when comparing groups treated with high glucose for 2 weeks versus normal glucose or 1 week of high glucose. Conclusions: Using Pipeline, it was determined that hyperglycemia inhibits formation of endothelial tubes in vitro. Analysis using Pipeline was more accurate and significantly faster than manual analysis. The Pipeline algorithm was shown to have additional applications, such as detection of retinal vasculature.	[Prisco, Anthony R.; Bukowy, John D.; Hoffmann, Brian R.; Karcher, Jamie R.; Exner, Eric C.; Greene, Andrew S.] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA; [Prisco, Anthony R.; Bukowy, John D.; Hoffmann, Brian R.; Karcher, Jamie R.; Exner, Eric C.; Greene, Andrew S.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Greene, AS (corresponding author), Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA.	agreene@mcw.edu	Greene, Andrew S/B-9696-2015	Exner, Eric/0000-0003-0129-5536; Greene, Andrew/0000-0002-3191-2112	NIH [HL082798]; MSTP Institutional Training Fellowship from NIGMS [T32 GM80202]; NHLBI [T32 HL94273]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL082798, T32HL094273, T32HL007852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080202] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MSTP Institutional Training Fellowship from NIGMS; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant HL082798 and a gift from the Kern Family Foundation. AP was supported in part by an MSTP Institutional Training Fellowship from NIGMS (T32 GM80202). BH was supported by a post-doctoral training fellowship from NHLBI (T32 HL94273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adya R, 2012, J VASC RES, V49, P534, DOI 10.1159/000338279; Alfred G, 1998, MODERN DIFFERENTIAL; Avogaro A, 2011, DIABETES CARE, V34, pS285, DOI 10.2337/dc11-s239; Bagley RG, 2003, CANCER RES, V63, P5866; Basta G, 2004, CARDIOVASC RES, V63, P582, DOI 10.1016/j.cardiores.2004.05.001; Bettinger CJ, 2008, ADV MATER, V20, P99, DOI 10.1002/adma.200702487; Blair RJ, 1997, J CLIN INVEST, V99, P2691, DOI 10.1172/JCI119458; Bramich DM, 2008, MON NOT R ASTRON SOC, V386, pL77, DOI 10.1111/j.1745-3933.2008.00464.x; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Chu LY, 2013, BLOOD, V122, P1822, DOI 10.1182/blood-2013-01-482315; Davis DR, 2010, J MOL CELL CARDIOL, V49, P312, DOI 10.1016/j.yjmcc.2010.02.019; Devices M, 2010, USING ANGIOGENESIS T; Douma K, 2011, QUANTIFYING MICROVAS; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Esposito C, 2001, KIDNEY INT, V59, P1842, DOI 10.1046/j.1523-1755.2001.0590051842.x; Faibish M, 2011, MOL CANCER THER, V10, P742, DOI 10.1158/1535-7163.MCT-10-0868; Feener EP, 1997, LANCET, V350, pSI9; Funk SD, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/569654; Green PS, 2000, J NEUROCYTOL, V29, P419, DOI 10.1023/A:1007173509470; Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Kaur J, 2010, BIOCHEM BIOPH RES CO, V391, P1762, DOI 10.1016/j.bbrc.2009.12.150; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; KOLLURU GK, 2012, INT J VASC MED, DOI DOI 10.1155/2012/918267; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; Kunimasa K, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1093/ecam/nep024; Luppi P, 2008, DIABETOLOGIA, V51, P1534, DOI 10.1007/s00125-008-1032-x; Matsumura T, 1997, J IMMUNOL, V158, P3408; Meerwaldt R, 2008, EUR J VASC ENDOVASC, V36, P125, DOI 10.1016/j.ejvs.2008.01.030; Meerwaldt R, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-29; Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d; Odstrcilik J, 2013, IET IMAGE PROCESS, V7, P373, DOI 10.1049/iet-ipr.2012.0455; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; POLONSKY KS, 1988, NEW ENGL J MED, V318, P1231, DOI 10.1056/NEJM198805123181903; Potenza MA, 2009, CURR MED CHEM, V16, P94, DOI 10.2174/092986709787002853; Shen JS, 2007, MOL GENET METAB, V92, P137, DOI 10.1016/j.ymgme.2007.06.003; Shimo T, 1999, J BIOCHEM-TOKYO, V126, P137, DOI 10.1093/oxfordjournals.jbchem.a022414; Soda Y, 2011, P NATL ACAD SCI USA, V108, P4274, DOI 10.1073/pnas.1016030108; Sudhakar A, 2003, P NATL ACAD SCI USA, V100, P4766, DOI 10.1073/pnas.0730882100; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Wang S, 2012, CURR DIABETES REP, V12, P355, DOI 10.1007/s11892-012-0289-0; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Zhao T, 2010, AM J PHYSIOL-ENDOC M, V299, pE110, DOI 10.1152/ajpendo.00192.2010	45	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94599	10.1371/journal.pone.0094599	http://dx.doi.org/10.1371/journal.pone.0094599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718615	Green Submitted, gold, Green Published			2022-12-25	WOS:000334339000134
J	Sala, M; Casacci, LP; Balletto, E; Bonelli, S; Barbero, F				Sala, Marco; Casacci, Luca Pietro; Balletto, Emilio; Bonelli, Simona; Barbero, Francesca			Variation in Butterfly Larval Acoustics as a Strategy to Infiltrate and Exploit Host Ant Colony Resources	PLOS ONE			English	Article							LARGE-BLUE; SOCIAL PARASITE; MACULINEA-REBELI; POLYMORPHIC GROWTH; COMMUNICATION; SPECIFICITY; BEHAVIOR; ADOPTION; LEPIDOPTERA; CATERPILLARS	About 10,000 arthropods live as ants' social parasites and have evolved a number of mechanisms allowing them to penetrate and survive inside the ant nests. Many of them can intercept and manipulate their host communication systems. This is particularly important for butterflies of the genus Maculinea, which spend the majority of their lifecycle inside Myrmica ant nests. Once in the colony, caterpillars of Maculinea "predatory species'' directly feed on the ant larvae, while those of "cuckoo species'' are fed primarily by attendance workers, by trophallaxis. It has been shown that Maculinea cuckoo larvae are able to reach a higher social status within the colony's hierarchy by mimicking the acoustic signals of their host queen ants. In this research we tested if, when and how myrmecophilous butterflies may change sound emissions depending on their integration level and on stages of their life cycle. We studied how a Maculinea predatory species (M. teleius) can acoustically interact with their host ants and highlighted differences with respect to a cuckoo species (M. alcon). We recorded sounds emitted by Maculinea larvae as well as by their Myrmica hosts, and performed playback experiments to assess the parasites' capacity to interfere with the host acoustic communication system. We found that, although varying between and within butterfly species, the larval acoustic emissions are more similar to queens' than to workers' stridulations. Nevertheless playback experiments showed that ant workers responded most strongly to the sounds emitted by the integrated (i.e. post-adoption) larvae of the cuckoo species, as well as by those of predatory species recorded before any contact with the host ants (i.e. in pre-adoption), thereby revealing the role of acoustic signals both in parasite integration and in adoption rituals. We discuss our findings in the broader context of parasite adaptations, comparing effects of acoustical and chemical mimicry.	[Sala, Marco; Casacci, Luca Pietro; Balletto, Emilio; Bonelli, Simona; Barbero, Francesca] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy	University of Turin	Casacci, LP (corresponding author), Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy.	luca.casacci@unito.it	Casacci, Luca Pietro/AAA-4295-2020; Barbero, Francesca/J-3555-2016	Casacci, Luca Pietro/0000-0003-3083-7357; Barbero, Francesca/0000-0003-2667-0435; BALLETTO, Emilio/0000-0003-1168-2791; Bonelli, Simona/0000-0001-5185-8136	DLR-BMBF (Germany); NERC (UK); DEFRA (UK); ANR (France); Formas (Sweden); Swedish EPA (Sweden); Italian Ministry of Education, University and Research (MIUR)	DLR-BMBF (Germany); NERC (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); DEFRA (UK)(Department for Environment, Food & Rural Affairs (DEFRA)); ANR (France)(French National Research Agency (ANR)); Formas (Sweden)(Swedish Research Council Formas); Swedish EPA (Sweden); Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This research was carried out within the project CLIMIT (Climate Change Impacts on Insects and their Mitigation; Settele & Kuhn, 2009; Thomas, Simcox & Clarke, 2009) funded by DLR-BMBF (Germany), NERC and DEFRA (UK), ANR (France), Formas (Sweden), and Swedish EPA (Sweden) through the FP6 BiodivERsA Eranet, as well as by the project 'A multitaxa approach to study the impact of climate change on the biodiversity of Italian ecosystems' of the Italian Ministry of Education, University and Research (MIUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akino T, 1999, P ROY SOC B-BIOL SCI, V266, P1419, DOI 10.1098/rspb.1999.0796; Als TD, 2001, ANIM BEHAV, V62, P99, DOI 10.1006/anbe.2001.1716; Barbero F., 2012, Psyche (Cambridge), V2012, DOI 10.1155/2012/725237; Barbero F, 2009, J EXP BIOL, V212, P4084, DOI 10.1242/jeb.032912; Barbero F, 2009, SCIENCE, V323, P782, DOI 10.1126/science.1163583; Belt T, 1874, THE NATURALIST IN NI; Bonelli Simona, 2005, P65; Braune P, 2005, BEHAV ECOL SOCIOBIOL, V58, P587, DOI 10.1007/s00265-005-0944-4; Casacci LP, 2013, CURR BIOL, V23, P323, DOI 10.1016/j.cub.2013.01.010; DEVRIES PJ, 1991, ANT - PLANT INTERACTIONS, P143; DEVRIES PJ, 1993, BIOL J LINN SOC, V49, P229, DOI 10.1111/j.1095-8312.1993.tb00902.x; Donisthorpe H, 1927, THE GUESTS OF BRITIS; ELMES GW, 1991, J ZOOL, V223, P447, DOI 10.1111/j.1469-7998.1991.tb04775.x; Elmes GW, 2002, OECOLOGIA, V130, P525, DOI 10.1007/s00442-001-0857-5; Elmes GW, 1996, BIODIVERSITY RES ITS, P38; Fiedler K, 1990, NOTA LEPIDOPTEROLOGI, V12, P246; Giraud T, 2002, P NATL ACAD SCI USA, V99, P6075, DOI 10.1073/pnas.092694199; Hickling R, 2000, J ACOUST SOC AM, V108, P1920, DOI 10.1121/1.1290515; HILL CJ, 1993, J AUST ENTOMOL SOC, V32, P283; HOLLDOBLER B, 1985, BEHAV ECOL SOCIOBIOL, V18, P45; HOLLDOBLER B, 1985, Israel Journal of Entomology, V19, P89; Holldobler B, 2001, MG BEH ECOL, P92; Holldobler B., 1990, pi; Holldobler B, 2009, THE SUPERORGANISM TH; Hunt JH, 2013, INSECT SOC, V60, P403, DOI 10.1007/s00040-013-0311-9; Jang YW, 1996, ANIM BEHAV, V51, P1095, DOI 10.1006/anbe.1996.0111; Kirchner WH, 1997, EXS, V84, P273; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Lenoir A., 1982, SOCIAL INSECTS TROPI, V1, P157; Manly B., 1994, MULTIVARIATE STATIST; MARKL H, 1965, SCIENCE, V149, P1392, DOI 10.1126/science.149.3690.1392; MARKL H, 1978, BEHAV ECOL SOCIOBIOL, V4, P183, DOI 10.1007/BF00354979; MARKL H, 1967, Z VERGL PHYSIOL, V57, P299, DOI 10.1007/BF00303001; Markl H., 1973, Proceedings Congr Int Un Study Soc Ins, V7, P258; Nash DR, 2008, SCIENCE, V319, P88, DOI 10.1126/science.1149180; Nowbahari E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006573; Nowicki P, 2009, OECOLOGIA, V161, P227, DOI 10.1007/s00442-009-1373-2; Patricelli D, 2010, SOCIOBIOLOGY, V55, P861; Roces F, 2001, J ACOUST SOC AM, V109, P3080, DOI 10.1121/1.1370085; Santos JC, 2005, SOCIOBIOLOGY, V46, P27; Schonrogge K, 2004, J CHEM ECOL, V30, P91, DOI 10.1023/B:JOEC.0000013184.18176.a9; Schurian Klaus G., 1994, Nachrichten des Entomologischen Vereins Apollo, V14, P339; Scott-Phillips TC, 2008, J EVOLUTION BIOL, V21, P387, DOI 10.1111/j.1420-9101.2007.01497.x; Settele J, 2011, J EXP BIOL, V214, P1407, DOI 10.1242/jeb.035329; TAYLOR RW, 1978, SCIENCE, V201, P979, DOI 10.1126/science.201.4360.979; THOMAS JA, 1992, OECOLOGIA, V91, P101, DOI 10.1007/BF00317247; THOMAS JA, 1984, BIOL CONSERV, V28, P325, DOI 10.1016/0006-3207(84)90040-5; Thomas JA, 2004, NATURE, V432, P283, DOI 10.1038/432283a; Thomas JA, 1998, P ROY SOC B-BIOL SCI, V265, P1895, DOI 10.1098/rspb.1998.0517; Thomas JA, 1998, ECOL ENTOMOL, V23, P457, DOI 10.1046/j.1365-2311.1998.00153.x; Thomas JA, 2002, OECOLOGIA, V132, P531, DOI 10.1007/s00442-002-1002-9; Thomas Jeremy A., 2005, P479, DOI 10.1079/9780851998121.0479; Thomas Jeremy A., 2010, Communicative & Integrative Biology, V3, P169; WASMANN E., 1894, KRITISCHES VERZEICHN; Wheeler W, 1910, AM NAT, V91, P5927; Witek M, 2006, OECOLOGIA, V148, P729, DOI 10.1007/s00442-006-0404-5; Witek M, 2013, BIOL J LINN SOC, V109, P699, DOI 10.1111/bij.12074	57	30	30	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94341	10.1371/journal.pone.0094341	http://dx.doi.org/10.1371/journal.pone.0094341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718496	Green Published, gold			2022-12-25	WOS:000334339000107
J	Wei, CY; Xiao, TF; Zhang, P; Wang, ZS; Chen, XW; Zhang, LH; Yao, MX; Chen, RS; Wang, H				Wei, Chunyan; Xiao, Tengfei; Zhang, Peng; Wang, Zhensheng; Chen, Xiaowei; Zhang, Lianhui; Yao, Meixue; Chen, Runsheng; Wang, Heng			Deep Profiling of the Novel Intermediate-Size Noncoding RNAs in Intraerythrocytic Plasmodium falciparum	PLOS ONE			English	Article							SYSTEMATIC IDENTIFICATION; COMPARATIVE GENOMICS; MALARIA PARASITES; ANTISENSE RNA; TRANSCRIPTOME; FEATURES; REVEALS; INTERFERENCE; EXPRESSION; SEQUENCES	Intermediate-size noncoding RNAs (is-ncRNAs) have been shown to play important regulatory roles in the development of several eukaryotic organisms. However, they have not been thoroughly explored in Plasmodium falciparum, which is the most virulent malaria parasite infecting human being. By using Illumina/Solexa paired-end sequencing of an is-ncRNA-specific library, we performed a systematic identification of novel is-ncRNAs in intraerythrocytic P. falciparum, strain 3D7. A total of 1,198 novel is-ncRNA candidates, including antisense, intergenic, and intronic is-ncRNAs, were identified. Bioinformatics analyses showed that the intergenic is-ncRNAs were the least conserved among different Plasmodium species, and antisense is-ncRNAs were more conserved than their sense counterparts. Twenty-two novel snoRNAs were identified, and eight potential novel classes of P. falciparum is-ncRNAs were revealed by clustering analysis. The expression of randomly selected novel is-ncRNAs was confirmed by RT-PCR and northern blotting assays. An obvious different expressional profile of the novel is-ncRNA between the early and late intraerythrocytic developmental stages of the parasite was observed. The expression levels of the antisense RNAs correlated with those of their cis-encoded sense RNA counterparts, suggesting that these is-ncRNAs are involved in the regulation of gene expression of the parasite. In conclusion, we accomplished a deep profiling analysis of novel is-ncRNAs in P. falciparum, analysed the conservation and structural features of these novel is-ncRNAs, and revealed their differential expression patterns during the development of the parasite. These findings provide important information for further functional characterisation of novel is-ncRNAs during the development of P. falciparum.	[Wei, Chunyan; Wang, Zhensheng; Zhang, Lianhui; Yao, Meixue; Wang, Heng] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Microbiol & Parasitol, Beijing 100730, Peoples R China; [Wei, Chunyan; Wang, Zhensheng; Zhang, Lianhui; Yao, Meixue; Wang, Heng] Peking Union Med Coll, Sch Basic Med, Beijing 100021, Peoples R China; [Xiao, Tengfei; Zhang, Peng; Chen, Xiaowei; Chen, Runsheng] Chinese Acad Sci, Inst Biophys, Lab Bioinformat & Noncoding RNA, Beijing 100080, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; Institute of Biophysics, CAS	Chen, RS (corresponding author), Chinese Acad Sci, Inst Biophys, Lab Bioinformat & Noncoding RNA, Beijing 100080, Peoples R China.	crs@sun5.ibp.ac.cn; hengwang@pumc.edu.cn			National Basic Research Program of China [2007CB513100]; National Science Foundation of China [30700761]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China [2007CB513100] and the National Science Foundation of China [30700761]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-383; Arisue N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017775; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baum J, 2009, NUCLEIC ACIDS RES, V37, P3788, DOI 10.1093/nar/gkp239; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Broadbent KM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r56; Brosnan CA, 2009, CURR OPIN CELL BIOL, V21, P416, DOI 10.1016/j.ceb.2009.04.001; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Carrieri C, 2012, NATURE, V491, P454, DOI 10.1038/nature11508; Chakrabarti K, 2007, RNA, V13, P1923, DOI 10.1261/rna.751807; Deng W, 2006, GENOME RES, V16, P20, DOI 10.1101/gr.4139206; Frazer KA, 2001, GENOME RES, V11, P1651, DOI 10.1101/gr.198201; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gardner PP, 2011, NUCLEIC ACIDS RES, V39, pD141, DOI 10.1093/nar/gkq1129; Gilmore SJ, 2012, AUSTRALAS J DERMATOL, V54, P1; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Goodrich JA, 2009, CRIT REV BIOCHEM MOL, V44, P3, DOI [10.1080/10409230802593995, 10.1080/10409230802593995 ]; Gunasekera AM, 2004, MOL BIOCHEM PARASIT, V136, P35, DOI 10.1016/j.molbiopara.2004.02.007; Hastings ML, 2000, J BIOL CHEM, V275, P11507, DOI 10.1074/jbc.275.15.11507; Hertel J, 2008, BIOINFORMATICS, V24, P158, DOI 10.1093/bioinformatics/btm464; Kolev NG, 2011, EUKARYOT CELL, V10, P1156, DOI 10.1128/EC.05114-11; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lee C, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-37; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Li AQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048066; Li DD, 2011, NUCLEIC ACIDS RES, V39, P3792, DOI 10.1093/nar/gkq1317; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; Mishra PC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-68; Mourier T, 2008, GENOME RES, V18, P281, DOI 10.1101/gr.6836108; Mu JB, 2010, CURR GENOMICS, V11, P279, DOI 10.2174/138920210791233081; Nagano T, 2011, CELL, V145, P178, DOI 10.1016/j.cell.2011.03.014; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Raabe CA, 2010, NUCLEIC ACIDS RES, V38, P608, DOI 10.1093/nar/gkp895; Radfar A, 2009, NAT PROTOC, V4, P1899, DOI 10.1038/nprot.2009.198; Radke JR, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-26; Rathjen T, 2006, FEBS LETT, V580, P5185, DOI 10.1016/j.febslet.2006.08.063; Rougeulle C, 2002, TRENDS GENET, V18, P434, DOI 10.1016/S0168-9525(02)02749-X; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Schattner P, 2004, NUCLEIC ACIDS RES, V32, P4281, DOI 10.1093/nar/gkh768; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Silva JC, 2011, PARASITOLOGY, V138, P1737, DOI 10.1017/S0031182010001575; Sims JS, 2009, EUKARYOT CELL, V8, P327, DOI 10.1128/EC.00340-08; Spadafora C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-96; Spielmann T, 2006, MOL BIOL CELL, V17, P3613, DOI 10.1091/mbc.E06-04-0291; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Ullu E, 2004, CELL MICROBIOL, V6, P509, DOI 10.1111/j.1462-5822.2004.00399.x; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang YF, 2011, NUCLEIC ACIDS RES, V39, P5203, DOI 10.1093/nar/gkr102; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Will S, 2007, PLOS COMPUT BIOL, V3, P680, DOI 10.1371/journal.pcbi.0030065; Xiao TF, 2012, RNA, V18, P626, DOI 10.1261/rna.030965.111; Xue XY, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-47; Yan DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021652; Zhang Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-61; Zhang Y, 2009, NUCLEIC ACIDS RES, V37, P6562, DOI 10.1093/nar/gkp704	60	10	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e92946	10.1371/journal.pone.0092946	http://dx.doi.org/10.1371/journal.pone.0092946			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713982	Green Published, gold			2022-12-25	WOS:000334160900010
J	Dietrich, S; Wiegand, S; Liesegang, H				Dietrich, Sascha; Wiegand, Sandra; Liesegang, Heiko			TraV: A Genome Context Sensitive Transcriptome Browser	PLOS ONE			English	Article							RNA-SEQ; READ ALIGNMENT; VISUALIZATION; PLATFORM; TOOL	Next-generation sequencing (NGS) technologies like Illumina and ABI Solid enable the investigation of transcriptional activities of genomes. While read mapping tools have been continually improved to enable the processing of the increasing number of reads generated by NGS technologies, analysis and visualization tools are struggling with the amount of data they are presented with. Current tools are capable of handling at most two to three datasets simultaneously before they are limited by available memory or due to processing overhead. In order to process fifteen transcriptome sequencing experiments of Bacillus licheniformis DSM13 obtained in a previous study, we developed TraV, a RNA-Seq analysis and visualization tool. The analytical methods are designed for prokaryotic RNA-seq experiments. TraV calculates single nucleotide activities from the mapping information to visualize and analyze multiple transcriptome sequencing experiments. The use of nucleotide activities instead of single read mapping information is highly memory efficient without incurring a processing overhead. TraV is available at http://appmibio.uni-goettingen.de/index.php?sec=serv.	[Dietrich, Sascha; Wiegand, Sandra; Liesegang, Heiko] Univ Gottingen, Norddeutsches Zentrum Mikrobielle Genomforsch, Inst Mikrobiol & Genet, Abt Angew & Genom Mikrobiol, D-37073 Gottingen, Germany	University of Gottingen	Liesegang, H (corresponding author), Univ Gottingen, Norddeutsches Zentrum Mikrobielle Genomforsch, Inst Mikrobiol & Genet, Abt Angew & Genom Mikrobiol, D-37073 Gottingen, Germany.	hlieseg@gwdg.de		Wiegand, Sandra/0000-0001-5403-4896; Liesegang, Heiko/0000-0003-1792-2047	Bundesministerium fur Bildung und Forschung [FKZ-0315387]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work has been funded by the Bundesministerium fur Bildung und Forschung (FKZ-0315387). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breaker RR, 2011, MOL CELL, V43, P867, DOI 10.1016/j.molcel.2011.08.024; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; De Lay N, 2013, J BIOL CHEM, V288, P7996, DOI 10.1074/jbc.R112.441386; Filiatrault MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029335; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hardcastle TJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-422; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Malone JH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-34; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Milne I., 2012, BRIEF BIOINFORM; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P20130, DOI 10.1073/pnas.1112724108; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Niedringhaus TP, 2011, ANAL CHEM, V83, P4327, DOI 10.1021/ac2010857; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Philipp EER, 2012, BIOINFORMATICS, V28, P777, DOI 10.1093/bioinformatics/bts056; Popendorf K, 2012, BIOINFORMATICS, V28, P1276, DOI 10.1093/bioinformatics/bts122; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Schmidtke C, 2012, NUCLEIC ACIDS RES, V40, P2020, DOI 10.1093/nar/gkr904; Serganov A, 2013, CELL, V152, P17, DOI 10.1016/j.cell.2012.12.024; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wang Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-102; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wiegand S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-667; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109	27	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93677	10.1371/journal.pone.0093677	http://dx.doi.org/10.1371/journal.pone.0093677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709941	gold, Green Published, Green Submitted			2022-12-25	WOS:000334159800043
J	Echeverria, C; Montorfano, I; Hermosilla, T; Armisen, R; Velasquez, LA; Cabello-Verrugio, C; Varela, D; Simon, F				Echeverria, Cesar; Montorfano, Ignacio; Hermosilla, Tamara; Armisen, Ricardo; Velasquez, Luis A.; Cabello-Verrugio, Claudio; Varela, Diego; Simon, Felipe			Endotoxin Induces Fibrosis in Vascular Endothelial Cells through a Mechanism Dependent on Transient Receptor Protein Melastatin 7 Activity	PLOS ONE			English	Article							ANGIOTENSIN-II; CALCIUM-CHANNEL; EXTRACELLULAR-MATRIX; OXIDATIVE STRESS; MESENCHYMAL TRANSITION; MOLECULAR-MECHANISMS; LIVER FIBROSIS; TRPM7; DYSFUNCTION; EXPRESSION	The pathogenesis of systemic inflammatory diseases, including endotoxemia-derived sepsis syndrome, is characterized by endothelial dysfunction. It has been demonstrated that the endotoxin lipopolysaccharide (LPS) induces the conversion of endothelial cells (ECs) into activated fibroblasts through endothelial-to-mesenchymal transition mechanism. Fibrogenesis is highly dependent on intracellular Ca2+ concentration increases through the participation of calcium channels. However, the specific molecular identity of the calcium channel that mediates the Ca2+ influx during endotoxin-induced endothelial fibrosis is still unknown. Transient receptor potential melastatin 7 (TRPM7) is a calcium channel that is expressed in many cell types, including ECs. TRPM7 is involved in a number of crucial processes such as the conversion of fibroblasts into activated fibroblasts, or myofibroblasts, being responsible for the development of several characteristics of them. However, the role of the TRPM7 ion channel in endotoxin-induced endothelial fibrosis is unknown. Thus, our aim was to study whether the TRPM7 calcium channel participates in endotoxin- induced endothelial fibrosis. Using primary cultures of ECs, we demonstrated that TRPM7 is a crucial protein involved in endotoxin- induced endothelial fibrosis. Suppression of TRPM7 expression protected ECs from the fibrogenic process stimulated by endotoxin. Downregulation of TRPM7 prevented the endotoxin-induced endothelial markers decrease and fibrotic genes increase in ECs. In addition, TRPM7 downregulation abolished the endotoxin-induced increase in ECM proteins in ECs. Furthermore, we showed that intracellular Ca2+ levels were greatly increased upon LPS challenge in a mechanism dependent on TRPM7 expression. These results demonstrate that TRPM7 is a key protein involved in the mechanism underlying endotoxin-induced endothelial fibrosis.	[Echeverria, Cesar; Montorfano, Ignacio; Cabello-Verrugio, Claudio; Simon, Felipe] Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Santiago, Chile; [Echeverria, Cesar; Montorfano, Ignacio; Cabello-Verrugio, Claudio; Simon, Felipe] Univ Andres Bello, Fac Med, Santiago, Chile; [Simon, Felipe] Millennium Inst Immunol & Immunotherapy, Santiago, Chile; [Hermosilla, Tamara; Varela, Diego] Univ Chile, Fac Med, Ctr Estud Mol Celula, Santiago 7, Chile; [Hermosilla, Tamara; Armisen, Ricardo; Varela, Diego] Univ Chile, Fac Med, Inst Ciencias Biomed, Santiago, Chile; [Armisen, Ricardo] Univ Chile, Fac Med, Ctr Invest & Tratamiento Canc, Santiago, Chile; [Velasquez, Luis A.] Univ Andres Bello, Fac Med, CIMIS, Santiago, Chile; [Velasquez, Luis A.] Univ Santiago Chile, Ctr Para Desarrollo Nanociencia & Nanotecnol, Santiago, Chile	Universidad Andres Bello; Universidad Andres Bello; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad Andres Bello; Universidad de Santiago de Chile	Simon, F (corresponding author), Univ Andres Bello, Fac Ciencias Biol, Dept Ciencias Biol, Santiago, Chile.	fsimon@unab.cl	Armisen, Ricardo/A-7409-2012; Cabello-Verrugio, Claudio/AAD-1454-2020; Varela, Diego/AAG-7489-2019; Echeverría, César/AAH-4994-2019	Armisen, Ricardo/0000-0003-2567-0521; Cabello-Verrugio, Claudio/0000-0001-7273-2102; Varela, Diego/0000-0002-9352-414X; Echeverría, César/0000-0001-5431-7183; Simon, Felipe/0000-0002-2653-9798; Velasquez, Luis/0000-0002-9479-1792	Fondo Nacional de Desarrollo Cientifico y Tecnologico - Fondecyt [1121078, 1120240, 1120286, 1120712, 1120380]; Millennium Institute on Immunology and Immunotherapy [P09-016-F]; Centro para el Desarrollo de la Nanociencia y Nanotecnologia (CEDENNA) [FB0807]; Association-Francaise Contre Les Myopathies [AFM 16670];  [UNAB-DI-281-13/R];  [UNAB-DI-67-12/I]	Fondo Nacional de Desarrollo Cientifico y Tecnologico - Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Institute on Immunology and Immunotherapy; Centro para el Desarrollo de la Nanociencia y Nanotecnologia (CEDENNA); Association-Francaise Contre Les Myopathies(Association Francaise contre les Myopathies); ; 	This work was supported by research grants from Fondo Nacional de Desarrollo Cientifico y Tecnologico - Fondecyt 1121078 (FS), 1120240 (DV), 1120286 (RA), 1120712 (LAV), and 1120380 (CCV). Millennium Institute on Immunology and Immunotherapy P09-016-F. Centro para el Desarrollo de la Nanociencia y Nanotecnologia (CEDENNA) FB0807 (LAV). Association-Francaise Contre Les Myopathies AFM 16670 (CCV). UNAB-DI-281-13/R (CCV). UNAB-DI-67-12/I (CE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Becerra A, 2011, CARDIOVASC RES, V91, P677, DOI 10.1093/cvr/cvr135; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Cabello-Verrugio C, 2012, J CELL MOL MED, V16, P752, DOI 10.1111/j.1582-4934.2011.01354.x; Cabello-Verrugio C, 2011, BIOCHEM BIOPH RES CO, V410, P665, DOI 10.1016/j.bbrc.2011.06.051; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Colston JT, 2002, J BIOL CHEM, V277, P23477, DOI 10.1074/jbc.M108676200; Dauphinee SM, 2006, LAB INVEST, V86, P9, DOI 10.1038/labinvest.3700366; Du JY, 2010, CIRC RES, V106, P992, DOI 10.1161/CIRCRESAHA.109.206771; Echeverria C, 2013, J CELL MOL MED, V17, P800, DOI 10.1111/jcmm.12066; Morales MG, 2012, INT J BIOCHEM CELL B, V44, P1993, DOI 10.1016/j.biocel.2012.07.028; Grandel U, 2003, CRIT REV IMMUNOL, V23, P267, DOI 10.1615/CritRevImmunol.v23.i4.20; Hermosilla T, 2011, CHANNELS, V5, P280, DOI 10.4161/chan.5.3.15833; Hermosura MC, 2007, BBA-MOL BASIS DIS, V1772, P822, DOI 10.1016/j.bbadis.2007.02.008; HOOK M, 1990, CELL DIFFER DEV, V32, P433, DOI 10.1016/0922-3371(90)90060-A; Huet O, 2011, FRONT BIOSCI-LANDMRK, V16, P1986, DOI 10.2741/3835; Ivaska J, 2000, CELL MOL LIFE SCI, V57, P16, DOI 10.1007/s000180050496; Karima R, 1999, MOL MED TODAY, V5, P123, DOI 10.1016/S1357-4310(98)01430-0; Kim BJ, 2011, BASIC CLIN PHARMACOL, V109, P233, DOI 10.1111/j.1742-7843.2011.00706.x; Kimura C, 2001, AM J PHYSIOL-HEART C, V281, pH745, DOI 10.1152/ajpheart.2001.281.2.H745; Kozak JA, 2003, BIOPHYS J, V84, P922, DOI 10.1016/S0006-3495(03)74909-1; Kumaran C, 2002, AM J PHYSIOL-HEART C, V282, pH1855, DOI 10.1152/ajpheart.00747.2001; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Marchand A, 2012, ADV EXP MED BIOL, V740, P795, DOI 10.1007/978-94-007-2888-2_35; Matsuda H, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.07.496; Matsuda Naoyuki, 2007, Journal of Smooth Muscle Research, V43, P117, DOI 10.1540/jsmr.43.117; McNeill MS, 2007, J INVEST DERMATOL, V127, P2020, DOI 10.1038/sj.jid.5700710; Mohamad HE, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-4; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Nunez-Villena F, 2011, ANTIOXID REDOX SIGN, V15, P2425, DOI 10.1089/ars.2010.3825; Ohyama T, 2012, BRIT J PHARMACOL, V165, P1173, DOI 10.1111/j.1476-5381.2011.01599.x; Park HS, 2006, CARDIOVASC RES, V72, P447, DOI 10.1016/j.cardiores.2006.09.012; Peters K, 2003, CARDIOVASC RES, V60, P49, DOI 10.1016/S0008-6363(03)00397-3; Pinsky MR, 2004, AM J MED SCI, V328, P220, DOI 10.1097/00000441-200410000-00005; Potenta S, 2008, BRIT J CANCER, V99, P1375, DOI 10.1038/sj.bjc.6604662; Ramires FJA, 1998, J MOL CELL CARDIOL, V30, P475, DOI 10.1006/jmcc.1997.0612; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Rivers EP, 2008, CRIT CARE CLIN, V24, pS1, DOI 10.1016/j.ccc.2008.04.002; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sahni J, 2010, CELL CYCLE, V9, P3565, DOI 10.4161/cc.9.17.12798; Schletter J, 1995, ARCH MICROBIOL, V164, P383, DOI 10.1007/BF02529735; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Seccia TM, 2008, J HYPERTENS, V26, P2022, DOI 10.1097/HJH.0b013e328309f00a; Shivakumar K, 2001, J MOL CELL CARDIOL, V33, P373, DOI 10.1006/jmcc.2000.1309; Simon F, 2008, ENDOTHELIUM-J ENDOTH, V15, P175, DOI 10.1080/10623320802174480; Simon F, 2013, CELL SIGNAL, V25, P1614, DOI 10.1016/j.cellsig.2013.03.023; Simon F, 2009, J HYPERTENS, V27, P1202, DOI 10.1097/HJH.0b013e328329e31c; Singh B, 2012, FEMS MICROBIOL REV, V36, P1122, DOI 10.1111/j.1574-6976.2012.00340.x; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Targos B, 2005, ACTA BIOCHIM POL, V52, P397, DOI 10.18388/abp.2005_3452; Tran POT, 1999, EXP CELL RES, V246, P319, DOI 10.1006/excr.1998.4239; Wei CL, 2010, CAN J PHYSIOL PHARM, V88, P105, DOI 10.1139/Y09-118; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Winters BD, 2010, CRIT CARE MED, V38, P1276, DOI 10.1097/CCM.0b013e3181d8cc1d; Wuensch T, 2010, DIABETES, V59, P844, DOI 10.2337/db09-1100; Wykes RCE, 2007, J IMMUNOL, V179, P4045, DOI 10.4049/jimmunol.179.6.4045; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yang KL, 2008, BIOCHEM BIOPH RES CO, V365, P484, DOI 10.1016/j.bbrc.2007.10.203; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127	63	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94146	10.1371/journal.pone.0094146	http://dx.doi.org/10.1371/journal.pone.0094146			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710004	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800106
J	Evans, DW; Kleinpeter, FL; Slane, MM; Boomer, KB				Evans, David W.; Kleinpeter, F. Lee; Slane, Mylissa M.; Boomer, K. B.			Adaptive and Maladaptive Correlates of Repetitive Behavior and Restricted Interests in Persons with Down Syndrome and Developmentally-Matched Typical Children: A Two-Year Longitudinal Sequential Design	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; PRADER-WILLI-SYNDROME; CHILDHOOD RITUALS; AUTISM; STEREOTYPIES; ANNOTATION; MODELS	We examined the course of repetitive behavior and restricted interests (RBRI) in children with and without Down syndrome (DS) over a two-year time period. Forty-two typically-developing children and 43 persons with DS represented two mental age (MA) levels: `` younger'' 2-4 years; `` older'' 5-11 years. For typically developing younger children some aspects of RBRI increased from Time 1 to Time 2. In older children, these aspects remained stable or decreased over the two-year period. For participants with DS, RBRI remained stable or increased over time. Time 1 RBRI predicted Time 2 adaptive behavior (measured by the Vineland Scales) in typically developing children, whereas for participants with DS, Time 1 RBRI predicted poor adaptive outcome (Child Behavior Checklist) at Time 2. The results add to the body of literature examining the adaptive and maladaptive nature of repetitive behavior.	[Evans, David W.; Slane, Mylissa M.] Geisinger Bucknell Autism & Dev Med Inst, Dev Neuropsychol Lab, Lewisburg, PA 17837 USA; [Evans, David W.] Bucknell Univ, Dept Neurosci, Lewisburg, PA 17837 USA; [Kleinpeter, F. Lee] River Parishes Community Coll, Dept Psychol, Sorrento, LA USA; [Boomer, K. B.] Bucknell Univ, Dept Math, Lewisburg, PA 17837 USA	Bucknell University; Bucknell University	Evans, DW (corresponding author), Geisinger Bucknell Autism & Dev Med Inst, Dev Neuropsychol Lab, Lewisburg, PA 17837 USA.	dwevans@bucknell.edu						Achenbach T. M., 1991, MANUAL SELF REPORT 1; [Anonymous], 1928, INFANCY HUMAN GROWTH; [Anonymous], 1974, INFANT CHILD CULTURE; Berkson G, 2002, AM J MENT RETARD, V107, P468, DOI 10.1352/0895-8017(2002)107<0468:EDOSAS>2.0.CO;2; Bishop SL, 2006, CHILD NEUROPSYCHOL, V12, P247, DOI 10.1080/09297040600630288; Bodfish JW, 2000, J AUTISM DEV DISORD, V30, P237, DOI 10.1023/A:1005596502855; Bolton D, 1996, J CHILD PSYCHOL PSYC, V37, P131, DOI 10.1111/j.1469-7610.1996.tb01384.x; Bolton D, 2002, BRIT J DEV PSYCHOL, V20, P479, DOI 10.1348/026151002760390819; Boyd BA, 2010, AUTISM RES, V3, P78, DOI 10.1002/aur.124; Boyd BA, 2009, RES AUTISM SPECT DIS, V3, P959, DOI 10.1016/j.rasd.2009.05.003; Cevikaslan A, 2013, CHILD PSYCHIAT HUMAN; CICCHETTI D, 1984, CHILD DEV, V55, P1, DOI 10.2307/1129830; DULANEY S, 1994, ETHOS, V22, P243, DOI 10.1525/eth.1994.22.3.02a00010; Dykens E, 2003, CNS DRUGS, V17, P167, DOI 10.2165/00023210-200317030-00003; Eilam D, 2006, NEUROSCI BIOBEHAV R, V30, P456, DOI 10.1016/j.neubiorev.2005.08.003; Esbensen AJ, 2009, J AUTISM DEV DISORD, V39, P57, DOI 10.1007/s10803-008-0599-x; Evans DA, 2000, S DAK REV, V38, P21; Evans DW, 2011, BEHAV BRAIN RES, V224, P174, DOI 10.1016/j.bbr.2011.05.025; Evans DW, 1997, CHILD DEV, V68, P58, DOI 10.2307/1131925; Evans DW, 2004, BRAIN COGNITION, V55, P220, DOI 10.1016/s0278-2626(03)00274-4; Evans DW, 2002, CHILD PSYCHIAT HUM D, V33, P43, DOI 10.1023/A:1016516205827; Evans DW, 1999, CHILD PSYCHIAT HUM D, V29, P261, DOI 10.1023/A:1021392931450; Evans DW, 2000, CHILD DEV, V71, P288, DOI 10.1111/1467-8624.00144; Evans DW, 2006, DEV PSYCHOPATHOL, P404; Fiske AP, 1997, J NERV MENT DIS, V185, P211, DOI 10.1097/00005053-199704000-00001; Garner JP, 2005, ILAR J, V46, P106, DOI 10.1093/ilar.46.2.106; Garner JP, 2003, ANIM BEHAV, V66, P711, DOI 10.1006/anbe.2002.2254; Garner JP, 2002, BEHAV BRAIN RES, V136, P83, DOI 10.1016/S0166-4328(02)00111-0; Glenn S, 2007, INTELLECT DEV DISAB, V45, P246, DOI 10.1352/1934-9556(2007)45[246:TOPRAC]2.0.CO;2; Greaves N, 2005, J INTELL DISABIL RES, V50, P92; Janowsky J, 1996, 5 7 YEAR SHIFT AGE R; Judge P, 2011, BEHAV BRAIN RES, V222, P54; Kagan J., 1981, 2 YEAR; King R, 1991, PATHWAYS GROWTH ESSE; Leekam S, 2007, J CHILD PSYCHOL PSYC, V48, P1131, DOI 10.1111/j.1469-7610.2007.01778.x; Leekam SR, 2011, PSYCHOL BULL, V137, P562, DOI 10.1037/a0023341; LEONARD HL, 1990, J AM ACAD CHILD PSY, V29, P17, DOI 10.1097/00004583-199001000-00004; Lewis M, 2009, J NEURODEV DISORD, V1, P114, DOI 10.1007/s11689-009-9019-6; Lewis MH, 2007, BEHAV BRAIN RES, V176, P66, DOI 10.1016/j.bbr.2006.08.023; Lutz C, 2003, AM J PRIMATOL, V60, P1, DOI 10.1002/ajp.10075; Marks I, 1987, FEARS PHOBIAS RITUAL; Militerni R, 2002, EUR CHILD ADOLES PSY, V11, P210, DOI 10.1007/s00787-002-0279-x; Moreno-De-Luca A, 2013, LANCET NEUROL, V12, P423, DOI 10.1016/S1474-4422(13)70011-5; Moss J, 2009, J AUTISM DEV DISORD, V39, P572, DOI 10.1007/s10803-008-0655-6; NILER ER, 1989, BEHAV RES THER, V27, P213, DOI 10.1016/0005-7967(89)90039-9; Piaget Jean, 1952, ORIGINS INTELLIGENCE; Pietrefesa AS, 2007, BRAIN COGNITION, V65, P36, DOI 10.1016/j.bandc.2006.02.007; Schultz RT, 1999, CHILD ADOL PSYCH CL, V8, P513; South M, 2007, AUTISM, V11, P437, DOI 10.1177/1362361307079606; Sparrow S., 2016, VINELAND ADAPTIVE BE; Sparrow S.S., 1993, VINELAND SCREENER OV; THELEN E, 1979, ANIM BEHAV, V27, P699, DOI 10.1016/0003-3472(79)90006-X; Tregay J, 2009, BRIT J DEV PSYCHOL, V27, P283, DOI 10.1348/026151008X299737; Turner M, 1999, J CHILD PSYCHOL PSYC, V40, P839, DOI 10.1111/1469-7610.00502; Werner H., 1948, COMP PSYCHOL MENTAL; White SH, 1996, 5 7 YEAR SHIFT AGE R; Wigren M, 2003, J INTELL DISABIL RES, V47, P428, DOI 10.1046/j.1365-2788.2003.00515.x; Zelazo P., 1997, ANN CHILD DEV RES AN, V12, P119; ZIGLER E, 1967, SCIENCE, V155, P292, DOI 10.1126/science.155.3760.292; Zohar AH, 1997, J CHILD PSYCHOL PSYC, V38, P993, DOI 10.1111/j.1469-7610.1997.tb01616.x	60	30	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93951	10.1371/journal.pone.0093951	http://dx.doi.org/10.1371/journal.pone.0093951			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7EP	24710387	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800075
J	Somboonna, N; Wilantho, A; Jankaew, K; Assawamakin, A; Sangsrakru, D; Tangphatsornruang, S; Tongsima, S				Somboonna, Naraporn; Wilantho, Alisa; Jankaew, Kruawun; Assawamakin, Anunchai; Sangsrakru, Duangjai; Tangphatsornruang, Sithichoke; Tongsima, Sissades			Microbial Ecology of Thailand Tsunami and Non-Tsunami Affected Terrestrials	PLOS ONE			English	Article							INDIAN-OCEAN TSUNAMI; PHANG-NGA; RAST SERVER; SEQUENCE; IDENTIFICATION; EARTHQUAKE; DIVERSITY; INFECTION; COMMUNITY; SEDIMENTS	The effects of tsunamis on microbial ecologies have been ill-defined, especially in Phang Nga province, Thailand. This ecosystem was catastrophically impacted by the 2004 Indian Ocean tsunami as well as the 600 year-old tsunami in Phra Thong island, Phang Nga province. No study has been conducted to elucidate their effects on microbial ecology. This study represents the first to elucidate their effects on microbial ecology. We utilized metagenomics with 16S and 18S rDNAbarcoded pyrosequencing to obtain prokaryotic and eukaryotic profiles for this terrestrial site, tsunami affected (S1), as well as a parallel unaffected terrestrial site, non-tsunami affected (S2). S1 demonstrated unique microbial community patterns than S2. The dendrogram constructed using the prokaryotic profiles supported the unique S1 microbial communities. S1 contained more proportions of archaea and bacteria domains, specifically species belonging to Bacteroidetes became more frequent, in replacing of the other typical floras like Proteobacteria, Acidobacteria and Basidiomycota. Pathogenic microbes, including Acinetobacter haemolyticus, Flavobacterium spp. and Photobacterium spp., were also found frequently in S1. Furthermore, different metabolic potentials highlighted this microbial community change could impact the functional ecology of the site. Moreover, the habitat prediction based on percent of species indicators for marine, brackish, freshwater and terrestrial niches pointed the S1 to largely comprise marine habitat indicating-species.	[Somboonna, Naraporn] Chulalongkorn Univ, Fac Sci, Dept Microbiol, Bangkok, Thailand; [Wilantho, Alisa; Sangsrakru, Duangjai; Tangphatsornruang, Sithichoke; Tongsima, Sissades] Natl Ctr Genet Engn & Biotechnol, Genome Inst, Pathum Thani, Thailand; [Jankaew, Kruawun] Chulalongkorn Univ, Fac Sci, Dept Geol, Bangkok, Thailand; [Assawamakin, Anunchai] Mahidol Univ, Fac Pharm, Dept Pharmacol, Bangkok 10700, Thailand	Chulalongkorn University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chulalongkorn University; Mahidol University	Somboonna, N (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Microbiol, Bangkok, Thailand.	Naraporn.S@chula.ac.th	Tangphatsornruang, Sithichoke/G-3633-2010; Tongsima, Sissades/F-4891-2011	Tangphatsornruang, Sithichoke/0000-0003-2673-0012; Tongsima, Sissades/0000-0002-1491-1839	Faculty of Science, Chulalongkorn University [A1B1-NS (RES-A1B1-NS-01)]; Thai Aviation Refuelling Co., Ltd.	Faculty of Science, Chulalongkorn University(Chulalongkorn University); Thai Aviation Refuelling Co., Ltd.	The research was supported by Research Funds from the Faculty of Science, Chulalongkorn University, Under the A1B1-NS (RES-A1B1-NS-01), and Thai Aviation Refuelling Co., Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen K, 2012, MOL ECOL, V21, P1966, DOI 10.1111/j.1365-294X.2011.05261.x; Appeltans W, 2012, WORLD REGISTER MARIN; Auld RR, 2013, J MICROBIOL METH, V93, P108, DOI 10.1016/j.mimet.2013.01.023; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bailly J, 2007, ISME J, V1, P632, DOI 10.1038/ismej.2007.68; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Banning EC, 2010, FEMS MICROBIOL ECOL, V73, P254, DOI 10.1111/j.1574-6941.2010.00897.x; Boszke L, 2007, J ENVIRON SCI HEAL A, V42, P847, DOI 10.1080/10934520701373018; Brunak S, 2002, SCIENCE, V298, P1333; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; Chastel C, 2007, Bull Soc Pathol Exot, V100, P139; Collivignarelli C, 2008, ENVIRON MONIT ASSESS, V147, P191, DOI 10.1007/s10661-007-0111-7; Collivignarelli C, 2008, ENVIRON MONIT ASSESS, V142, P345, DOI 10.1007/s10661-007-9934-5; Grant S, 2006, APPL ENVIRON MICROB, V72, P135, DOI 10.1128/AEM.72.1.135-143.2006; Grotiuz G, 2006, J CLIN MICROBIOL, V44, P3838, DOI 10.1128/JCM.00407-06; HemphillHaley E, 1996, HOLOCENE, V6, P439, DOI 10.1177/095968369600600406; HEMPHILLHALEY E, 1995, GEOL SOC AM BULL, V107, P367, DOI 10.1130/0016-7606(1995)107<0367:DEFEIS>2.3.CO;2; HENRY EA, 1994, ARCH MICROBIOL, V161, P62, DOI 10.1007/BF00248894; Huang LN, 2002, FEMS MICROBIOL LETT, V214, P235, DOI 10.1016/S0378-1097(02)00881-9; Humblot C, 2009, APPL ENVIRON MICROB, V75, P4354, DOI 10.1128/AEM.00451-09; Huusom AJ, 2012, FORENSIC SCI MED PAT, V8, P114, DOI 10.1007/s12024-011-9283-0; Jankaew K, 2008, NATURE, V455, P1228, DOI 10.1038/nature07373; Jaszek M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/497492; Kendall MM, 2006, INT J SYST EVOL MICR, V56, P1525, DOI 10.1099/ijs.0.64216-0; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD28, DOI 10.1093/nar/gkq967; Lukaszewski Z, 2012, ECOTOX ENVIRON SAFE, V80, P184, DOI 10.1016/j.ecoenv.2012.02.026; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; Manichanh C, 2008, NUCLEIC ACIDS RES, V36, P5180, DOI 10.1093/nar/gkn496; Maurice CF, 2013, CELL, V152, P39, DOI 10.1016/j.cell.2012.10.052; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Meyer M, 2008, NAT PROTOC, V3, P267, DOI 10.1038/nprot.2007.520; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Osorio CR, 2000, DIS AQUAT ORGAN, V40, P177, DOI 10.3354/dao040177; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Prummongkol S, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.1101; Qadri M, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-8; Redel H, 2013, J INFECT DIS, V207, P1105, DOI 10.1093/infdis/jit005; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rosa LH, 2009, ANTON LEEUW INT J G, V95, P227, DOI 10.1007/s10482-009-9306-y; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sawai Y, 2009, MAR MICROPALEONTOL, V73, P70, DOI 10.1016/j.marmicro.2009.07.003; Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Somboonna N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S29; Sri-Aroon P, 2010, SE ASIAN J TROP MED, V41, P48; Starliper CE, 2011, J ADV RES, V2, P97, DOI 10.1016/j.jare.2010.04.001; Taberlet P, 2012, MOL ECOL, V21, P1816, DOI 10.1111/j.1365-294X.2011.05317.x; Tharnpoophasiam Prapin, 2006, Southeast Asian J Trop Med Public Health, V37 Suppl 3, P216; Vezzi A, 2005, SCIENCE, V307, P1459, DOI 10.1126/science.1103341; Wada K, 2012, J OCCUP HEALTH, V54, P255, DOI 10.1539/joh.11-0270-FS; Yooseph S, 2010, NATURE, V468, P60, DOI 10.1038/nature09530; Yoshida K, 2000, J MED MICROBIOL, V49, P1003, DOI 10.1099/0022-1317-49-11-1003; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418; Zinger L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024570	58	14	15	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94236	10.1371/journal.pone.0094236	http://dx.doi.org/10.1371/journal.pone.0094236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710002	Green Published, gold, Green Submitted			2022-12-25	WOS:000334159800125
J	Souza-Silva, FA; Torres, LM; Santos-Alves, JR; Tang, ML; Sanchez, BAM; Sousa, TN; Fontes, CJF; Nogueira, PA; Rocha, RS; Brito, CFA; Adams, JH; Kano, FS; Carvalho, LH				Souza-Silva, Flavia A.; Torres, Leticia M.; Santos-Alves, Jessica R.; Tang, Michaelis Loren; Sanchez, Bruno A. M.; Sousa, Tais N.; Fontes, Cor J. F.; Nogueira, Paulo A.; Rocha, Roberto S.; Brito, Cristiana F. A.; Adams, John H.; Kano, Flora S.; Carvalho, Luzia H.			Duffy Antigen Receptor for Chemokine (DARC) Polymorphisms and Its Involvement in Acquisition of Inhibitory Anti-Duffy Binding Protein II (DBPII) Immunity	PLOS ONE			English	Article							PLASMODIUM-VIVAX; NEGATIVE INDIVIDUALS; MALARIA; ANTIBODIES; EXPRESSION; IDENTIFICATION; INVASION; GENE; TRANSMISSION; INFECTION	The Plasmodium vivax Duffy binding protein (PvDBP) and its erythrocytic receptor, the Duffy antigen receptor for chemokines (DARC), are involved in the major P. vivax erythrocyte invasion pathway. An open cohort study to analyze DARC genotypes and their relationship to PvDBP immune responses was carried out in 620 volunteers in an agricultural settlement of the Brazilian Amazon. Three cross-sectional surveys were conducted at 6-month intervals, comprising 395, 410, and 407 subjects, respectively. The incidence rates of P. vivax infection was 2.32 malaria episodes per 100 person-months under survey (95% confidence interval [CI] of 1.92-2.80/100 person-month) and, of P. falciparum, 0.04 per 100 person-months (95% CI of 0.007-0.14/100 person-month). The distribution of DARC genotypes was consistent with the heterogeneous ethnic origins of the Amazon population, with a predominance of non-silent DARC alleles:FY*A > FY*B. The 12-month follow-up study demonstrated no association between DARC genotypes and total IgG antibodies as measured by ELISA targeting PvDBP (region II, DBPII or regions II-IV, DBPII-IV). The naturally acquired DBPII specific binding inhibitory antibodies (BIAbs) tended to be more frequent in heterozygous individuals carrying a DARC-silent allele (FY*B-ES). These results provide evidence that DARC polymorphisms may influence the naturally acquired inhibitory anti-Duffy binding protein II immunity.	[Souza-Silva, Flavia A.; Torres, Leticia M.; Santos-Alves, Jessica R.; Tang, Michaelis Loren; Sousa, Tais N.; Rocha, Roberto S.; Brito, Cristiana F. A.; Kano, Flora S.; Carvalho, Luzia H.] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Rene Rachou, Lab Malaria, Belo Horizonte, MG, Brazil; [Sanchez, Bruno A. M.] Univ Fed Mato Grosso, Sinop, MT, Brazil; [Fontes, Cor J. F.] Univ Fed Mato Grosso, Julio Muller Univ Hosp, Cuiaba, MT, Brazil; [Nogueira, Paulo A.] FIOCRUZ Amazonia, Ctr Pesquisas Leonidas & Maria Deane, Manaus, AM, Brazil; [Adams, John H.] Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL USA	Fundacao Oswaldo Cruz; Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso; Fundacao Oswaldo Cruz; State University System of Florida; University of South Florida	Carvalho, LH (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Rene Rachou, Lab Malaria, Belo Horizonte, MG, Brazil.	lhcarvalho@cpqrr.fiocruz.br	Sanchez, Bruno A M/F-8543-2017; Fontes, Cor JF/G-7331-2018; Kano, Flora/N-7749-2017; Kano, Flora S./AAS-3215-2020; Nogueira, Paulo/AAK-8822-2020; Adams, John/G-1800-2015; de Sousa, Tais Nobrega/AAG-6225-2019; Carvalho, Luzia H/AAW-3461-2021; Adams, John H./ABB-8458-2020	Fontes, Cor JF/0000-0003-2756-0588; Kano, Flora/0000-0002-2364-9772; Nogueira, Paulo/0000-0001-9677-7225; Adams, John/0000-0003-3707-7979; de Sousa, Tais Nobrega/0000-0002-6874-9427; Adams, John H./0000-0003-3707-7979; Sanchez, Bruno Antonio Marinho/0000-0001-9097-0112	Research Foundation of Minas Gerais State (FAPEMIG); Research Foundation of Amazonas State (FAPEAM); Brazilian National Research Council (CNPq); Oswaldo Cruz Foundation (FIOCRUZ, PAPES VI); Malaria Network/Support Program for Centers of Excellence - Pronex Malaria/CNPq/DECIT/MS; CAPES; PIBIC/Fiocruz; CNPq; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064478] Funding Source: NIH RePORTER	Research Foundation of Minas Gerais State (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Research Foundation of Amazonas State (FAPEAM)(Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM)); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Oswaldo Cruz Foundation (FIOCRUZ, PAPES VI); Malaria Network/Support Program for Centers of Excellence - Pronex Malaria/CNPq/DECIT/MS; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PIBIC/Fiocruz; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Research Foundation of Minas Gerais State (FAPEMIG), Research Foundation of Amazonas State (FAPEAM), The Brazilian National Research Council (CNPq), Oswaldo Cruz Foundation (FIOCRUZ, PAPES VI) and Malaria Network/Support Program for Centers of Excellence - Pronex Malaria/CNPq/DECIT/MS; scholarships from CAPES (FAS, LMT), PIBIC/Fiocruz (JRS, MLT), CNPq (LHC, CJFF, CFAB) are also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JH, 1990, CELL, V63, P141, DOI 10.1016/0092-8674(90)90295-P; Afenyi-Annan A, 2008, TRANSFUSION, V48, P917, DOI 10.1111/j.1537-2995.2007.01622.x; Badakere S S, 1970, Indian J Med Sci, V24, P562; Cavasini CE, 2007, T ROY SOC TROP MED H, V101, P1042, DOI 10.1016/j.trstmh.2007.04.011; Ceravolo IP, 2008, SCAND J IMMUNOL, V67, P270, DOI 10.1111/j.1365-3083.2007.02059.x; Ceravolo IP, 2009, CLIN EXP IMMUNOL, V156, P502, DOI 10.1111/j.1365-2249.2009.03931.x; Ceravolo IP, 2005, AM J TROP MED HYG, V72, P675, DOI 10.4269/ajtmh.2005.72.675; CHITNIS CE, 1994, J EXP MED, V180, P497, DOI 10.1084/jem.180.2.497; Cole-Tobian J, 2003, MOL BIOCHEM PARASIT, V127, P121, DOI 10.1016/S0166-6851(02)00327-4; da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P624, DOI 10.4269/ajtmh.2008.79.624; de Castro MC, 2006, P NATL ACAD SCI USA, V103, P2452, DOI 10.1073/pnas.0510576103; DVORAK JA, 1975, SCIENCE, V187, P748, DOI 10.1126/science.803712; FANG XD, 1991, MOL BIOCHEM PARASIT, V44, P125, DOI 10.1016/0166-6851(91)90228-X; Fraser T, 1997, INFECT IMMUN, V65, P2772, DOI 10.1128/IAI.65.7.2772-2777.1997; Genton B, 2008, PLOS MED, V5, P881, DOI 10.1371/journal.pmed.0050127; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Gilson PR, 2009, INT J PARASITOL, V39, P91, DOI 10.1016/j.ijpara.2008.09.007; Herrera S, 2005, AM J TROP MED HYG, V73, P44, DOI 10.4269/ajtmh.2005.73.44; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; IWAMOTO S, 1995, BLOOD, V85, P622, DOI 10.1182/blood.V85.3.622.bloodjournal853622; Jia XL, 2002, J IMMUNOL, V169, P3200, DOI 10.4049/jimmunol.169.6.3200; Kano FS, 2012, TROP MED INT HEALTH, V17, P989, DOI 10.1111/j.1365-3156.2012.03016.x; Kasehagen LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000336; King CL, 2008, P NATL ACAD SCI USA, V105, P8363, DOI 10.1073/pnas.0800371105; King CL, 2011, P NATL ACAD SCI USA, V108, P20113, DOI 10.1073/pnas.1109621108; Maestre A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011437; MALLINSON G, 1995, BRIT J HAEMATOL, V90, P823, DOI 10.1111/j.1365-2141.1995.tb05202.x; Mangold KA, 2005, J CLIN MICROBIOL, V43, P2435, DOI 10.1128/JCM.43.5.2435-2440.2005; McMorran BJ, 2012, SCIENCE, V338, P1348, DOI 10.1126/science.1228892; Menard D, 2010, P NATL ACAD SCI USA, V107, P5967, DOI 10.1073/pnas.0912496107; Michon P, 2000, INFECT IMMUN, V68, P3164, DOI 10.1128/IAI.68.6.3164-3171.2000; Michon P, 2001, FEBS LETT, V495, P111, DOI 10.1016/S0014-5793(01)02370-5; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Moise KJ, 2000, EUR J OBSTET GYN R B, V92, P75, DOI 10.1016/S0301-2115(00)00428-0; Ntumngia FB, 2012, INFECT IMMUN, V80, P1203, DOI 10.1128/IAI.05924-11; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Ryan JR, 2006, AM J TROP MED HYG, V75, P575, DOI 10.4269/ajtmh.2006.75.575; Sampath S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003420; Smolarek D, 2010, TRANSFUS CLIN BIOL, V17, P184, DOI 10.1016/j.tracli.2010.05.003; Sousa TN, 2007, VOX SANG, V92, P373, DOI 10.1111/j.1423-0410.2007.00902.x; Souza-Silva FA, 2010, AM J TROP MED HYG, V82, P185, DOI 10.4269/ajtmh.2010.08-0580; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; Walton RT, 2008, CELL HOST MICROBE, V4, P3, DOI 10.1016/j.chom.2008.06.006; WEINSTEIN L, 1975, AM J OBSTET GYNECOL, V121, P643, DOI 10.1016/0002-9378(75)90467-6; Woolley I J, 2009, Immunohematology, V25, P63; Woolley IJ, 2000, TRANSFUSION, V40, P949, DOI 10.1046/j.1537-2995.2000.40080949.x; Xainli J, 2003, INFECT IMMUN, V71, P2508, DOI 10.1128/IAI.71.5.2508-2515.2003; Zimmerman PA, 1999, P NATL ACAD SCI USA, V96, P13973, DOI 10.1073/pnas.96.24.13973	49	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93782	10.1371/journal.pone.0093782	http://dx.doi.org/10.1371/journal.pone.0093782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710306	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800051
J	Gu, Y; Lu, KM; Yang, GH; Cen, Z; Yu, L; Lin, L; Hao, J; Yang, ZG; Peng, JB; Cui, SJ; Huang, J				Gu, Ying; Lu, Kangmo; Yang, Guanghui; Cen, Zhong; Yu, Li; Lin, Lin; Hao, Jing; Yang, Zhigang; Peng, Jiabao; Cui, Shujian; Huang, Jian			Mutation Spectrum of Six Genes in Chinese Phenylketonuria Patients Obtained through Next-Generation Sequencing	PLOS ONE			English	Article							PHENYLALANINE-HYDROXYLASE DEFICIENCY; GTP CYCLOHYDROLASE-I; DIAGNOSIS	Background: The identification of gene variants plays an important role in the diagnosis of genetic diseases. Methodology/Principal Findings: To develop a rapid method for the diagnosis of phenylketonuria (PKU) and tetrahydrobiopterin (BH4) deficiency, we designed a multiplex, PCR-based primer panel to amplify all the exons and flanking regions (50 bp average) of six PKU-associated genes (PAH, PTS, GCH1, QDPR, PCBD1 and GFRP). The Ion Torrent Personal Genome Machine (PGM) System was used to detect mutations in all the exons of these six genes. We tested 93 DNA samples from blood specimens from 35 patients and their parents (32 families) and 26 healthy adults. Using strict bioinformatic criteria, this sequencing data provided, on average, 99.14% coverage of the 39 exons at more than 70-fold mean depth of coverage. We found 23 previously documented variants in the PAH gene and six novel mutations in the PAH and PTS genes. A detailed analysis of the mutation spectrum of these patients is described in this study. Conclusions/Significance: These results were confirmed by Sanger sequencing. In conclusion, benchtop next-generation sequencing technology can be used to detect mutations in monogenic diseases and can detect both point mutations and indels with high sensitivity, fidelity and throughput at a lower cost than conventional methods in clinical applications.	[Gu, Ying] Maternal & Child Hlth Care Hosp, Prenatal Diag Ctr, Lianyungang, Jiangsu, Peoples R China; [Lu, Kangmo] Chengdu Womens & Childrens Hosp, Prenatal Diag Ctr, Chengdu, Jiangsu, Peoples R China; [Yang, Guanghui; Cen, Zhong; Lin, Lin; Hao, Jing; Yang, Zhigang; Peng, Jiabao; Cui, Shujian] Shanghai Find Biotech Co Ltd, Shanghai, Peoples R China; [Yu, Li] Life Technol Co, Shanghai, Peoples R China; [Huang, Jian] Natl Engn Ctr Biochip Shanghai, Shanghai, Peoples R China; [Huang, Jian] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Dis & Hlth Genom, Shanghai, Peoples R China	Thermo Fisher Scientific	Huang, J (corresponding author), Natl Engn Ctr Biochip Shanghai, Shanghai, Peoples R China.	huangjchgc@hotmail.com			National High Technology Research and Development Program of China (863 Program) [2012AA02A205]; Chinese National Key Program on Basic Research (973 Program) [2010CB529206, 2014CB965002]; National Natural Science Foundation of China [81272306]; Program of Shanghai Subject Chief Scientist [12XD1421400, 11JC1408800, 13431902000, 12DZ942500]; Shanghai Find Bio-Tech Co Ltd.; Life Technologies Company; National Engineering Center for Biochip at Shanghai	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Chinese National Key Program on Basic Research (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Subject Chief Scientist; Shanghai Find Bio-Tech Co Ltd.; Life Technologies Company; National Engineering Center for Biochip at Shanghai	The authors gratefully acknowledge grant support from the National High Technology Research and Development Program of China (863 Program, 2012AA02A205), the Chinese National Key Program on Basic Research (973 Program, 2010CB529206 and 2014CB965002), the National Natural Science Foundation of China (81272306) and the Program of Shanghai Subject Chief Scientist (12XD1421400, 11JC1408800, 13431902000 and 12DZ942500). Shanghai Find Bio-Tech Co Ltd., provided support in the form of salaries for authors GY, ZC, LL, JH, ZY, JP, & SC. Life Technologies Company provided support in the form of a salary for author LY. National Engineering Center for Biochip at Shanghai provided support in the form of a salary for author JH. Otherwise, these organisations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Blau N, 2004, MOL GENET METAB, V82, P101, DOI 10.1016/j.ymgme.2004.03.006; Blau N, 2011, MOL GENET METAB, V104, pS2, DOI 10.1016/j.ymgme.2011.08.017; Boland JF, 2013, HUM GENET, V132, P1153, DOI 10.1007/s00439-013-1321-4; Chen GQ, 2006, J APPL CLIN PEDIAT, V21, P483; Chiu YH, 2012, J HUM GENET, V57, P145, DOI 10.1038/jhg.2011.146; Costa JL, 2013, HUM MUTAT, V34, P629, DOI 10.1002/humu.22272; DWORNICZAK B, 1991, GENOMICS, V11, P242, DOI 10.1016/0888-7543(91)90129-3; Elliott Aaron M, 2012, J Biomol Tech, V23, P24, DOI 10.7171/jbt.12-2301-003; Gu Xue-Fan, 2004, Zhonghua Yufang Yixue Zazhi, V38, P99; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Li L, 2009, CHINESE J CHILD HLTH, V17, P464; Mitchell JJ, 2011, GENET MED, V13, P697, DOI 10.1097/GIM.0b013e3182141b48; NIEDERWIESER A, 1984, EUR J PEDIATR, V141, P208, DOI 10.1007/BF00572762; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Song F, 2005, MOL GENET METAB, V86, pS107, DOI 10.1016/j.ymgme.2005.09.001; Thony B, 2006, HUM MUTAT, V27, P870, DOI 10.1002/humu.20366; Treff NR, 2013, FERTIL STERIL, V99, P1377, DOI 10.1016/j.fertnstert.2012.12.018; Wang Q, 2006, CHINESE J BIRTH HLTH, V14, P111; Yousem SA, 2013, CHEST, V143, P1679, DOI 10.1378/chest.12-1917; Zhou YA, 2012, GENET MOL BIOL, V35, P709, DOI 10.1590/S1415-47572012005000069; Zy L., 2005, HEILONG JIANG MED J, V29, P554	22	20	21	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94100	10.1371/journal.pone.0094100	http://dx.doi.org/10.1371/journal.pone.0094100			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705691	Green Published, Green Submitted, gold			2022-12-25	WOS:000334107500123
J	Puljic, VM; Licina, MLK; Kavic, M; Blazic, TN				Puljic, Vlatka Matkovic; Licina, Mirjana Lana Kosanovic; Kavic, Marija; Blazic, Tatjana Nemeth			Repeat HIV Testing at Voluntary Testing and Counseling Centers in Croatia: Successful HIV Prevention or Failure to Modify Risk Behaviors?	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; MEN; SEX; ZAGREB; SEROCONVERSION; INTERVENTIONS; PREDICTORS; IMPROVE	HIV testing plays a critical role in preventing the spread of the virus and identifying infected individuals in need of care. Voluntary counseling and testing centers (VCTs) not only conduct testing but they also provide counseling. Since a proportion of people who test negative for HIV on their previous visit will return for retesting, the frequency of retesting and the characteristics of those who retest may provide insights into the efficacy of testing and counseling strategies. In this cross-sectional, retrospective study of 1,482 VCT clients in Croatia in 2010, 44.3% had been tested for HIV before. The rate of repeat HIV testing is lower in Croatia than in other countries. Men who have sex with men (MSM) clients, those with three or more sexual partners in the last 12 months, consistent condom users with steady partners, and intravenous drug users were more likely to be repeat testers. This finding suggests that clients presenting for repeat HIV testing are those who self-identify as being at a higher risk of infection. Our data showed that testing positive for HIV was not associated with repeat testing. However, the effects of repeat testing on HIV epidemiology needs to be explored.	[Puljic, Vlatka Matkovic; Kavic, Marija] Univ Hosp Infect Dis, Zagreb, Croatia; [Licina, Mirjana Lana Kosanovic] Inst Publ Hlth Dr Andrija Stampar, Zagreb, Croatia; [Blazic, Tatjana Nemeth] Natl Inst Publ Hlth, Zagreb, Croatia		Puljic, VM (corresponding author), Univ Hosp Infect Dis, Zagreb, Croatia.	vlatka.m@gmail.com	Puljic, Vlatka Matkovic/V-1443-2019	Matkovic, Vlatka/0000-0001-9938-2253				[Anonymous], 2002, INCR ACC HIV TEST CO; Begovac J, 2008, AIDS BEHAV, V12, pS48, DOI 10.1007/s10461-008-9398-9; Begovac J, 2006, COLLEGIUM ANTROPOL, V30, P17; Bozicevic I, 2012, SEX TRANSM INFECT, V88, P539, DOI 10.1136/sextrans-2011-050374; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; U.S. Public Health Service, 2001, MMWR Recomm Rep, V50, P1; Chen Z, 1998, SEX TRANSM DIS, V25, P539, DOI 10.1097/00007435-199811000-00008; Croatian Institute of Public Health, 2009, HDB HIV COUNS TEST; Croatian Institute of Public Health Ministry of Health and Social Welfare Croatia, 2011, IZVJ OS LIJ ZBOG ZLO; Europaisches Zentrum fur die Pravention und die Kontrolle von Krankheiten, 2010, HIV TEST INCR UPT EF; Gjenero-Margan I, 2006, COLLEGIUM ANTROPOL, V30, P11; Glavak Tkalic R., 2012, SUBSTANCE ABUSE GEN; Gumy C, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-422; Hightow LB, 2004, SEX TRANSM DIS, V31, P455, DOI 10.1097/01.olq.0000135984.27593.5f; Johnson A. Satcher, 2010, Morbidity and Mortality Weekly Report, V59, P1550; Joint United Nations Programme on HIV/ AIDS, 2000, TOOLS EV HIV VOL COU; Kalichman SC, 2008, J CLIN PSYCHOL MED S, V15, P127, DOI 10.1007/s10880-008-9116-9; Kosanovic ML, 2006, COLLEGIUM ANTROPOL, V30, P115; Kozul K, 2010, COLLEGIUM ANTROPOL, V34, P509; Leaity S, 2000, AIDS, V14, P547, DOI 10.1097/00002030-200003310-00010; Lorente N, 2012, AIDS CARE, V24, P1039, DOI 10.1080/09540121.2012.668171; Lyons MS, 2009, CURR HIV RES, V7, P580, DOI 10.2174/157016209789973646; MacKellar DA, 2002, J ACQ IMMUN DEF SYND, V29, P76, DOI 10.1097/00042560-200201010-00011; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; MCFARLAND W, 1995, AM J EPIDEMIOL, V142, P719, DOI 10.1093/oxfordjournals.aje.a117702; Nemeth Blazic T, 2008, INCREASED ACCESS VOL; Ryder K, 2005, AIDS BEHAV, V9, P459, DOI 10.1007/s10461-005-9032-z; Stulhofer A, 2008, AIDS BEHAV, V12, P505, DOI 10.1007/s10461-007-9327-3; Stulhofer A, 2007, INT FAM PLAN PERSPEC, V33, P58, DOI 10.1363/3305807; Van Loon S, 2004, 15 INT AIDS C 2004; Williams-Roberts H, 2010, VIRULENCE, V1, P68, DOI 10.4161/viru.1.2.10570; Wimonsate W, 2011, AIDS BEHAV, V15, P693, DOI 10.1007/s10461-010-9755-3	32	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93734	10.1371/journal.pone.0093734	http://dx.doi.org/10.1371/journal.pone.0093734			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE6MJ	24705595	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500062
J	Salehi, MH; Kamalidehghan, B; Houshmand, M; Meng, GY; Sadeghizadeh, M; Aryani, O; Nafissi, S				Salehi, Mohammad Hossein; Kamalidehghan, Behnam; Houshmand, Massoud; Meng, Goh Yong; Sadeghizadeh, Majid; Aryani, Omid; Nafissi, Shahriar			Gene Expression Profiling of Mitochondrial Oxidative Phosphorylation (OXPHOS) Complex I in Friedreich Ataxia (FRDA) Patients	PLOS ONE			English	Article							ELECTRON-TRANSPORT CHAIN; IRON-SULFUR CLUSTERS; REPEAT EXPANSION; MAMMALIAN-CELLS; FRATAXIN; TRANSCRIPTION; BIOGENESIS; DEFICIENCY; PROTEIN; COEXPRESSION	Friedreich ataxia (FRDA) is the most frequent progressive autosomal recessive disorder associated with unstable expansion of GAA trinucleotide repeats in the first intron of the FXN gene, which encodes for the mitochondrial frataxin protein. The number of repeats correlates with disease severity, where impaired transcription of the FXN gene results in reduced expression of the frataxin protein. Gene expression studies provide insights into disease pathogenicity and identify potential biomarkers, an important goal of translational research in neurodegenerative diseases. Here, using real-time PCR (RT-PCR), the expression profiles of mitochondrial (mtDNA) and nuclear DNA (nDNA) genes that encode for the mitochondrial subunits of respiratory oxidative phosphorylation (OXPHOS) complex I in the blood panels of 21 FRDA patients and 24 healthy controls were investigated. Here, the expression pattern of mtDNA-encoded complex I subunits was distinctly different from the expression pattern of nDNA-encoded complex I subunits, where significant (p<0.05) down-regulation of the mitochondrial ND2, ND4L, and ND6 complex I genes, compared to controls, were observed. In addition, the expression pattern of one nDNA-encoded gene, NDUFA1, was significantly (p<0.05) down-regulated compared to control. These findings suggest, for the first time, that the regulation of complex I subunit expression in FRDA is complex, rather than merely being a reflection of global co-regulation, and may provide important clues toward novel therapeutic strategies for FRDA and mitochondrial complex I deficiency.	[Salehi, Mohammad Hossein; Sadeghizadeh, Majid] Tarbiat Modares Univ, Dept Mol Genet, Tehran, Iran; [Kamalidehghan, Behnam] UM, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Houshmand, Massoud] Natl Inst Genet Engn & Biotechnol, Dept Med Genet, Tehran, Iran; [Houshmand, Massoud; Aryani, Omid] Special Med Ctr, Dept Med Genet, Tehran, Iran; [Meng, Goh Yong] Univ Putra Malaysia, Fac Vet Med, Dept Preclin Sci, Serdang, Malaysia; [Meng, Goh Yong] Univ Putra Malaysia, Inst Trop Agr, Serdang, Malaysia; [Nafissi, Shahriar] Univ Tehran Med Sci, Shariati Hosp, Dept Neurol, Tehran, Iran	Tarbiat Modares University; Universiti Malaya; Universiti Putra Malaysia; Universiti Putra Malaysia; Tehran University of Medical Sciences	Houshmand, M (corresponding author), Natl Inst Genet Engn & Biotechnol, Dept Med Genet, Tehran, Iran.	massoudh@nigeb.ac.ir	Houshmand, Massoud/AEG-9909-2022; Goh, Y.M./B-2382-2010; nafissi, shahriar/A-1839-2013; Nafissi, Shahriar/AAS-1597-2020; Nafissi, Shahriar/AAX-9954-2020; Kamalidehghan, Behnam/B-5401-2013	Goh, Y.M./0000-0003-1237-2170; Nafissi, Shahriar/0000-0003-4763-4310; Kamalidehghan, Behnam/0000-0001-8530-8124; Houshmand, Massoud/0000-0002-2198-223X; , Masoud/0000-0001-7687-7464	 [187]		This work was supported by a grant(Project 187) from MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Chantrel-Groussard K, 2001, HUM MOL GENET, V10, P2061, DOI 10.1093/hmg/10.19.2061; Condo I, 2007, HUM MOL GENET, V16, P1534, DOI 10.1093/hmg/ddm102; Cossee M, 1997, P NATL ACAD SCI USA, V94, P7452, DOI 10.1073/pnas.94.14.7452; Cossee M, 1999, ANN NEUROL, V45, P200, DOI 10.1002/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U; Diaz F, 2011, SEMIN FETAL NEONAT M, V16, P197, DOI 10.1016/j.siny.2011.05.004; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Garbian Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009985; Grossman LI, 2004, TRENDS GENET, V20, P578, DOI 10.1016/j.tig.2004.09.002; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Heidari MM, 2009, CELL MOL NEUROBIOL, V29, P225, DOI 10.1007/s10571-008-9315-9; Heidari MM, 2009, CAN J NEUROL SCI, V36, P26, DOI 10.1017/S0317167100006260; Karthikeyan G, 2003, HUM MOL GENET, V12, P3331, DOI 10.1093/hmg/ddg349; KING MP, 1993, J BIOL CHEM, V268, P10228; Koutnikova H, 1997, NAT GENET, V16, P345, DOI 10.1038/ng0897-345; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mateo I, 2004, ACTA NEUROL SCAND, V109, P75, DOI 10.1034/j.1600-0404.2003.00190.x; McKenzie M, 2013, MITOCHONDRIAL DNA MU, P25; Mishmar D, 2006, GENE, V378, P11, DOI 10.1016/j.gene.2006.03.015; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; Napoli E, 2006, ANTIOXID REDOX SIGN, V8, P506, DOI 10.1089/ars.2006.8.506; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Pianese L, 2004, J NEUROL NEUROSUR PS, V75, P1061, DOI 10.1136/jnnp.2003.028605; Puccio H, 2000, HUM MOL GENET, V9, P887, DOI 10.1093/hmg/9.6.887; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Rouault TA, 2012, DIS MODEL MECH, V5, P155, DOI 10.1242/dmm.009019; Shoichet SA, 2002, HUM MOL GENET, V11, P815, DOI 10.1093/hmg/11.7.815; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Tan G, 2001, HUM MOL GENET, V10, P2099, DOI 10.1093/hmg/10.19.2099; Tucker EJ, 2011, IUBMB LIFE, V63, P669, DOI 10.1002/iub.495; van Waveren C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-18; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537	44	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94069	10.1371/journal.pone.0094069	http://dx.doi.org/10.1371/journal.pone.0094069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705504	Green Submitted, gold, Green Published			2022-12-25	WOS:000334107500118
J	Wang, JK; Teng, IJ; Lo, TJ; Moore, S; Yeo, YH; Teng, YC; Kaul, M; Chen, CC; Zuo, AH; Chou, FP; Yang, XY; Tseng, IC; Johnson, MD; Lin, CY				Wang, Jehng-Kang; Teng, I-Jou; Lo, Ting-Jen; Moore, Sean; Yeo, Yee Hui; Teng, Yun-Chung; Kaul, Malvika; Chen, Chiann-Chyi; Zuo, Annie Hong; Chou, Fen-Pai; Yang, Xiaoyu; Tseng, I-Chu; Johnson, Michael D.; Lin, Chen-Yong			Matriptase Autoactivation Is Tightly Regulated by the Cellular Chemical Environments	PLOS ONE			English	Article							AUTOSOMAL RECESSIVE ICHTHYOSIS; SERINE-PROTEASE; LIVING CELLS; GOLGI PH; ACTIVATION; MITOCHONDRIAL; CONTRIBUTES; REQUIRES; MUTATION; HYPOXIA	The ability of cells to rapidly detect and react to alterations in their chemical environment, such as pH, ionic strength and redox potential, is essential for cell function and survival. We present here evidence that cells can respond to such environmental alterations by rapid induction of matriptase autoactivation. Specifically, we show that matriptase autoactivation can occur spontaneously at physiological pH, and is significantly enhanced by acidic pH, both in a cellfree system and in living cells. The acid-accelerated autoactivation can be attenuated by chloride, a property that may be part of a safety mechanism to prevent unregulated matriptase autoactivation. Additionally, the thio-redox balance of the environment also modulates matriptase autoactivation. Using the cell-free system, we show that matriptase autoactivation is suppressed by cytosolic reductive factors, with this cytosolic suppression being reverted by the addition of oxidizing agents. In living cells, we observed rapid induction of matriptase autoactivation upon exposure to toxic metal ions known to induce oxidative stress, including CoCl2 and CdCl2. The metal-induced matriptase autoactivation is suppressed by N-acetylcysteine, supporting the putative role of altered cellular redox state in metal induced matriptase autoactivation. Furthermore, matriptase knockdown rendered cells more susceptible to CdCl2-induced cell death compared to control cells. This observation implies that the metal-induced matriptase autoactivation confers cells with the ability to survive exposure to toxic metals and/or oxidative stress. Our results suggest that matriptase can act as a cellular sensor of the chemical environment of the cell that allows the cell to respond to and protect itself from changes in the chemical milieu.	[Wang, Jehng-Kang] Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan; [Teng, I-Jou; Lo, Ting-Jen; Yeo, Yee Hui] Natl Def Med Ctr, Dept Med, Taipei, Taiwan; [Moore, Sean] Univ Maryland, Geenebaum Canc Ctr, Baltimore, MD 21201 USA; [Teng, Yun-Chung] Natl Yang Ming Univ, Dept Biomed Engn, Taipei 112, Taiwan; [Kaul, Malvika; Chen, Chiann-Chyi] Rutgers Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ USA; [Zuo, Annie Hong; Chou, Fen-Pai; Yang, Xiaoyu; Tseng, I-Chu; Johnson, Michael D.; Lin, Chen-Yong] Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA	National Defense Medical Center; National Defense Medical Center; University System of Maryland; University of Maryland Baltimore; National Yang Ming Chiao Tung University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Georgetown University	Lin, CY (corresponding author), Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA.	lincy@georgetown.edu	Yeo, Y/GWV-3316-2022; Feng-Pai, Chou/AGS-4250-2022	johnson, Michael/0000-0001-6260-7586	National Cancer Institute (NCI) [RO1 CA 123223]; Taiwan Department of Defense [MAB-102-8]; NATIONAL CANCER INSTITUTE [R01CA123223, P30CA051008] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000101] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Taiwan Department of Defense; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was supported by National Cancer Institute (NCI) Grants RO1 CA 123223 (to MDJ and CYL), and Taiwan Department of Defense Grant MAB-102-8 (to JKW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen YW, 2014, J INVEST DERMATOL, V134, P405, DOI 10.1038/jid.2013.320; Chen YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062826; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Chou FP, 2013, AM J PATHOL, V183, P1306, DOI 10.1016/j.ajpath.2013.06.024; Clark EB, 2010, J BIOL CHEM, V285, P27130, DOI 10.1074/jbc.M110.153213; Desilets A, 2008, J BIOL CHEM, V283, P10535, DOI 10.1074/jbc.M707012200; Ercal N, 2002, FREE RADICAL BIO MED, V32, P906, DOI 10.1016/S0891-5849(02)00781-5; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Gatenby RA, 2007, BRIT J CANCER, V97, P646, DOI 10.1038/sj.bjc.6603922; Glitsch M, 2011, PHYSIOLOGY, V26, P252, DOI 10.1152/physiol.00005.2011; Hung RJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1159, DOI 10.1152/ajpcell.00400.2003; Inouye K, 2010, J BIOCHEM, V147, P485, DOI 10.1093/jb/mvp190; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; Lin CY, 1997, J BIOL CHEM, V272, P9147; List K, 2007, J BIOL CHEM, V282, P36714, DOI 10.1074/jbc.M705521200; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; McQueney MS, 1997, J BIOL CHEM, V272, P13955, DOI 10.1074/jbc.272.21.13955; MENON GK, 1985, J INVEST DERMATOL, V84, P508, DOI 10.1111/1523-1747.ep12273485; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Politzer P, 2007, J MOL MODEL, V13, P305, DOI 10.1007/s00894-006-0154-7; Richter C, 1998, BIOCHEM J, V335, P481, DOI 10.1042/bj3350481; SEKSEK O, 1995, J BIOL CHEM, V270, P4967, DOI 10.1074/jbc.270.10.4967; STAMPFER MR, 1985, P NATL ACAD SCI USA, V82, P2394, DOI 10.1073/pnas.82.8.2394; Szabo R, 2011, ONCOGENE, V30, P2003, DOI 10.1038/onc.2010.586; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; TANNOCK IF, 1989, CANCER RES, V49, P4373; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Xu H, 2012, AM J PHYSIOL-CELL PH, V302, pC453, DOI 10.1152/ajpcell.00344.2011; Xu ZH, 2011, J MED CHEM, V54, P7567, DOI 10.1021/jm200920s	41	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93899	10.1371/journal.pone.0093899	http://dx.doi.org/10.1371/journal.pone.0093899			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705933	Green Submitted, Green Published, gold			2022-12-25	WOS:000334107500090
J	Pitsawong, W; Hoben, JP; Miller, AF				Pitsawong, Warintra; Hoben, John P.; Miller, Anne-Frances			Understanding the Broad Substrate Repertoire of Nitroreductase Based on Its Kinetic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Enzyme Kinetics; Enzyme Mechanisms; Flavin; Flavoproteins; Reductase; Nitroreductase; Substrate Specificity	PENTAERYTHRITOL TETRANITRATE REDUCTASE; ESCHERICHIA-COLI NITROREDUCTASE; P-HYDROXYBENZOATE HYDROXYLASE; ENTEROBACTER-CLOACAE; BAMBERGER REARRANGEMENT; NITROAROMATIC COMPOUNDS; IRON ENZYMES; SPECIFICITY; IDENTIFICATION; RESISTANCE	Background: Nitroreductase reduces a broad range of nitroaromatics. Results: Steady-state and pre-steady-state kinetics were combined with tests for aminoaromatic product formation. Conclusion: Both half-reactions occur via a simple mechanism lacking detectable gating steps consistent with the broad substrate repertoire. Significance: Nitroreductase does not generate p-aminobenzoic acid and, therefore, appears not to reduce nitro groups to amines. The oxygen-insensitive nitroreductase from Enterobacter cloacae (NR) catalyzes two-electron reduction of nitroaromatics to the corresponding nitroso compounds and, subsequently, to hydroxylamine products. NR has an unusually broad substrate repertoire, which may be related to protein dynamics (flexibility) and/or a simple non-selective kinetic mechanism. To investigate the possible role of mechanism in the broad substrate repertoire of NR, the kinetics of oxidation of NR by para-nitrobenzoic acid (p-NBA) were investigated using stopped-flow techniques at 4 degrees C. The results revealed a hyperbolic dependence on the p-NBA concentration with a limiting rate of 1.90 +/- 0.09 s(-1), indicating one-step binding before the flavin oxidation step. There is no evidence for a distinct binding step in which specificity might be enforced. The reduction of p-NBA is rate-limiting in steady-state turnover (1.7 +/- 0.3 s(-1)). The pre-steady-state reduction kinetics of NR by NADH indicate that NADH reduces the enzyme with a rate constant of 700 +/- 20 s(-1) and a dissociation constant of 0.51 +/- 0.04 mm. Thus, we demonstrate simple transient kinetics in both the reductive and oxidative half-reactions that help to explain the broad substrate repertoire of NR. Finally, we tested the ability of NR to reduce para-hydroxylaminobenzoic acid, demonstrating that the corresponding amine does not accumulate to significant levels even under anaerobic conditions. Thus E. cloacae NR is not a good candidate for enzymatic production of aromatic amines.	[Pitsawong, Warintra; Hoben, John P.; Miller, Anne-Frances] Univ Kentucky, Dept Chem, Lexington, KY 40506 USA	University of Kentucky	Miller, AF (corresponding author), Univ Kentucky, Dept Chem, Lexington, KY 40506 USA.	afm@uky.edu	Miller, Anne-Frances/M-7703-2017; pitsawong, warintra/G-1760-2018	pitsawong, warintra/0000-0001-5438-1783	Department of Chemistry of the University of Kentucky; Research Challenge Trust Fund Fellowship	Department of Chemistry of the University of Kentucky; Research Challenge Trust Fund Fellowship	This work was supported by the Vice President for Research of the University of Kentucky, the Center for Pharmaceutical Development (to A.-F. M.), the Department of Chemistry of the University of Kentucky, and a Research Challenge Trust Fund Fellowship (to W. P.).	Bollinger JM, 2006, J INORG BIOCHEM, V100, P586, DOI 10.1016/j.jinorgbio.2006.01.022; BRYANT C, 1991, J BIOL CHEM, V266, P4119; BRYANT C, 1991, J BIOL CHEM, V266, P4126; Campbell GRO, 2006, P NATL ACAD SCI USA, V103, P4634, DOI 10.1073/pnas.0509384103; Cleland W W, 1979, Methods Enzymol, V63, P500; Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME, P129; Defoin A, 2004, SYNTHESIS-STUTTGART, P706, DOI 10.1055/s-2004-815964; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; ELKOMMOS ME, 1987, ANALYST, V112, P1253, DOI 10.1039/an9871201253; Frederick KK, 2005, BIOCHEMISTRY-US, V44, P13304, DOI 10.1021/bi051119t; French CE, 1996, J BACTERIOL, V178, P6623, DOI 10.1128/jb.178.22.6623-6627.1996; Friedman JE, 2006, J BIOL CHEM, V281, P2812, DOI 10.1074/jbc.M510365200; Gamage NU, 2005, J BIOL CHEM, V280, P41482, DOI 10.1074/jbc.M508289200; GASPARIC J, 1977, MIKROCHIM ACTA, V1, P241; GOLDMAN P, 1986, BIOCHEM PHARMACOL, V35, P43, DOI 10.1016/0006-2952(86)90553-8; Goodwin A, 1998, MOL MICROBIOL, V28, P383, DOI 10.1046/j.1365-2958.1998.00806.x; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Haynes CA, 2002, J BIOL CHEM, V277, P11513, DOI 10.1074/jbc.M111334200; Hou L, 2007, J BIOL CHEM, V282, P23264, DOI 10.1074/jbc.M700868200; Jarrom D, 2009, BIOCHEMISTRY-US, V48, P7665, DOI 10.1021/bi900674m; Johansson E, 2003, J MED CHEM, V46, P4009, DOI 10.1021/jm030843b; Khan H, 2002, J BIOL CHEM, V277, P21906, DOI 10.1074/jbc.M200637200; Kim HY, 2005, APPL MICROBIOL BIOT, V68, P766, DOI 10.1007/s00253-005-1950-1; KNOX RJ, 1993, CANCER METAST REV, V12, P195, DOI 10.1007/BF00689810; KNOX RJ, 1993, BIOCHEM PHARMACOL, V46, P797, DOI 10.1016/0006-2952(93)90487-H; Koder RL, 1998, BBA-PROTEIN STRUCT M, V1387, P395, DOI 10.1016/S0167-4838(98)00151-4; Koder RL, 2002, BIOCHEMISTRY-US, V41, P14197, DOI 10.1021/bi025805t; Koder RL, 1998, PROTEIN EXPRES PURIF, V13, P53, DOI 10.1006/prep.1997.0866; Linwu SW, 2012, BIOCHEM PHARMACOL, V83, P1690, DOI 10.1016/j.bcp.2012.03.003; LIU D, 1984, APPL ENVIRON MICROB, V47, P1295, DOI 10.1128/AEM.47.6.1295-1298.1984; Lovering AL, 2001, J MOL BIOL, V309, P203, DOI 10.1006/jmbi.2001.4653; Lu ZB, 2011, PROTEINS, V79, P3099, DOI 10.1002/prot.23137; Manina G, 2010, MOL MICROBIOL, V77, P1172, DOI 10.1111/j.1365-2958.2010.07277.x; Mast N, 2003, BIOCHEMISTRY-US, V42, P14284, DOI 10.1021/bi035512f; Nivinskas H, 2001, ARCH BIOCHEM BIOPHYS, V385, P170, DOI 10.1006/abbi.2000.2127; OGATA Y, 1958, J AM CHEM SOC, V80, P3591, DOI 10.1021/ja01547a026; Palfey BA, 1999, BIOCHEMISTRY-US, V38, P1153, DOI 10.1021/bi9826613; Perez-Reinado E, 2008, ENVIRON MICROBIOL, V10, P3174, DOI 10.1111/j.1462-2920.2008.01585.x; Prosser GA, 2010, BIOCHEM PHARMACOL, V79, P678, DOI 10.1016/j.bcp.2009.10.008; Race PR, 2005, J BIOL CHEM, V280, P13256, DOI 10.1074/jbc.M409652200; Schenzle A, 1999, J BACTERIOL, V181, P1444, DOI 10.1128/JB.181.5.1444-1450.1999; Smallcombe SH, 1995, J MAGN RESON SER A, V117, P295, DOI 10.1006/jmra.1995.0759; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; SONE T, 1981, J CHEM SOC PERK T 2, P298, DOI 10.1039/p29810000298; SPAIN JC, 1995, ANNU REV MICROBIOL, V49, P523, DOI 10.1146/annurev.mi.49.100195.002515; Tomatis PE, 2008, P NATL ACAD SCI USA, V105, P20605, DOI 10.1073/pnas.0807989106; Upcroft P, 2001, CLIN MICROBIOL REV, V14, P150, DOI 10.1128/CMR.14.1.150-164.2001; WHITMORE GF, 1986, BIOCHEM PHARMACOL, V35, P97, DOI 10.1016/0006-2952(86)90565-4; Xu G, 2001, CLIN CANCER RES, V7, P3314; Yanto Y, 2010, ORG BIOMOL CHEM, V8, P1826, DOI 10.1039/b926274a; Yasutake Y, 2004, J MOL BIOL, V344, P325, DOI 10.1016/j.jmb.2004.09.035; YOST Y, 1969, J MED CHEM, V12, P961, DOI 10.1021/jm00305a077; Zhao R, 2011, TETRAHEDRON LETT, V52, P3805, DOI 10.1016/j.tetlet.2011.05.054	53	32	34	1	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15203	15214		10.1074/jbc.M113.547117	http://dx.doi.org/10.1074/jbc.M113.547117			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24706760	hybrid, Green Published			2022-12-25	WOS:000337465400007
J	Pustelny, K; Zdzalik, M; Stach, N; Stec-Niemczyk, J; Cichon, P; Czarna, A; Popowicz, G; Mak, P; Drag, M; Salvesen, GS; Wladyka, B; Potempa, J; Dubin, A; Dubin, G				Pustelny, Katarzyna; Zdzalik, Michal; Stach, Natalia; Stec-Niemczyk, Justyna; Cichon, Przemyslaw; Czarna, Anna; Popowicz, Grzegorz; Mak, Pawel; Drag, Marcin; Salvesen, Guy S.; Wladyka, Benedykt; Potempa, Jan; Dubin, Adam; Dubin, Grzegorz			Staphylococcal SplB Serine Protease Utilizes a Novel Molecular Mechanism of Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Crystal Structure; Enzyme Inactivation; Protease; Serine Protease; Staphylococcus aureus; Signal Peptide; Zymogen Activation	PROTEOLYTIC-ENZYMES; ENZYMATIC-ACTIVITY; CRYSTAL-STRUCTURES; AUREUS; CHYMOTRYPSINOGEN; METALLOPROTEASE; SPECIFICITY; INHIBITION; REFINEMENT; PROPEPTIDE	Staphylococcal SplB protease belongs to the chymotrypsin family. Chymotrypsin zymogen is activated by proteolytic processing at the N terminus, resulting in significant structural rearrangement at the active site. Here, we demonstrate that the molecular mechanism of SplB protease activation differs significantly and we characterize the novel mechanism in detail. Using peptide and protein substrates we show that the native signal peptide, or any N-terminal extension, has an inhibitory effect on SplB. Only precise N-terminal processing releases the full proteolytic activity of the wild type analogously to chymotrypsin. However, comparison of the crystal structures of mature SplB and a zymogen mimic show no rearrangement at the active site whatsoever. Instead, only the formation of a unique hydrogen bond network, distant form the active site, by the new N-terminal glutamic acid of mature SplB is observed. The importance of this network and influence of particular hydrogen bond interactions at the N terminus on the catalytic process is demonstrated by evaluating the kinetics of a series of mutants. The results allow us to propose a consistent model where changes in the overall protein dynamics rather than structural rearrangement of the active site are involved in the activation process.	[Pustelny, Katarzyna; Stec-Niemczyk, Justyna; Czarna, Anna; Mak, Pawel; Wladyka, Benedykt; Dubin, Adam] Jagiellonian Univ, Dept Analyt Biochem, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Pustelny, Katarzyna] Jagiellonian Univ, Dept Cell Biochem, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Zdzalik, Michal; Stach, Natalia; Cichon, Przemyslaw; Potempa, Jan; Dubin, Grzegorz] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Czarna, Anna; Popowicz, Grzegorz] Max Planck Inst Biochem, NMR Grp, D-82152 Martinsried, Germany; [Popowicz, Grzegorz] Helmholtz Zentrum Munchen, Deutsch Forschungszentrum Gesundheit & Umwelt, D-85764 Neuherberg, Germany; [Drag, Marcin] Wroclaw Univ Technol, Div Bioorgan Chem, Fac Chem, PL-50370 Wroclaw, Poland; [Drag, Marcin; Salvesen, Guy S.] Sanford Burnham Med Res Inst, Program Cell Death Res, La Jolla, CA 92037 USA; [Potempa, Jan] Univ Louisville, Sch Dent, Ctr Oral Hlth & Syst Dis, Louisville, KY 40202 USA; [Mak, Pawel; Wladyka, Benedykt; Dubin, Grzegorz] Malopolska Ctr Biotechnol, PL-30387 Krakow, Poland	Jagiellonian University; Jagiellonian University; Jagiellonian University; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Wroclaw University of Science & Technology; Sanford Burnham Prebys Medical Discovery Institute; University of Louisville; Jagiellonian University	Dubin, G (corresponding author), Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Ul Gronostajowa 7, PL-30387 Krakow, Poland.	grzegorz.dubin@uj.edu.pl	Potempa, Jan/AAA-6850-2021; Władyka, Benedykt/T-7039-2019; Dubin, Grzegorz/J-8168-2014; Popowicz, Grzegorz/G-4769-2017	Władyka, Benedykt/0000-0002-9075-3529; Dubin, Grzegorz/0000-0002-5535-5760; Popowicz, Grzegorz/0000-0003-2818-7498; Pustelny, Katarzyna/0000-0001-8430-8608; Mak, Pawel/0000-0002-5222-3922; Czarna, Anna/0000-0003-1068-0671; Potempa, Jan/0000-0002-3600-7461	Foundation for Polish Science-PARENT-BRIDGE Programme; Polish Ministry of Science and Higher Education [N N301 032834]; National Science Center [UMO-2011/01/D/NZ1/01169, UMO-2011/01/N/NZ1/00208]; European Union [POIG.02.01.00-12-064/08, POIG.02.01.00-12-167/08]; Foundation for Polish Science	Foundation for Polish Science-PARENT-BRIDGE Programme; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Center(National Science Centre, Poland); European Union(European Commission); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	This work was supported by the Foundation for Polish Science-PARENT-BRIDGE Programme (to K. P.) and in part by Grants N N301 032834 (to G. D.) from the Polish Ministry of Science and Higher Education, UMO-2011/01/D/NZ1/01169 (to G. D.) and UMO-2011/01/N/NZ1/00208 (to M. Z.) from the National Science Center. The research was carried out with the equipment purchased from support of the European Union structural funds (Grants POIG.02.01.00-12-064/08 and POIG.02.01.00-12-167/08).; Supported by the Foundation for Polish Science.	Bajaj SP, 2006, J BIOL CHEM, V281, P24873, DOI 10.1074/jbc.M509971200; Baker D, 1993, CURR OPIN CELL BIOL, V5, P966, DOI 10.1016/0955-0674(93)90078-5; BERTHOLD H, 1992, BIOTECHNOL LETT, V14, P245, DOI 10.1007/BF01022318; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; DRAPEAU GR, 1978, J BACTERIOL, V136, P607, DOI 10.1128/JB.136.2.607-613.1978; Dubin G, 2008, J MOL BIOL, V379, P343, DOI 10.1016/j.jmb.2008.03.059; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 1997, JOINT CCP4 ESF EACBM, V33, P22; Fersht A., 1985, ENZYME STRUCTURE MEC; Filipek R, 2004, BIOCHEMISTRY-US, V43, P14306, DOI 10.1021/bi048661m; FREER ST, 1970, BIOCHEMISTRY-US, V9, P1997, DOI 10.1021/bi00811a022; Khan AR, 1998, PROTEIN SCI, V7, P815; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Leslie A. G., 1992, JOIN CCP4 ESF EAMCB, V26; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; NEURATH H, 1976, P NATL ACAD SCI USA, V73, P3825, DOI 10.1073/pnas.73.11.3825; Nickerson NN, 2007, J BIOL CHEM, V282, P34129, DOI 10.1074/jbc.M705672200; Papageorgiou AC, 2000, PROTEIN SCI, V9, P610; Popowicz GM, 2006, J MOL BIOL, V358, P270, DOI 10.1016/j.jmb.2006.01.098; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; RUDENKO G, 1995, STRUCTURE, V3, P1249, DOI 10.1016/S0969-2126(01)00260-X; Rzychon M, 2003, MOL MICROBIOL, V49, P1051, DOI 10.1046/j.1365-2958.2003.03613.x; STEER ML, 1987, NEW ENGL J MED, V316, P144; STRAUSBERG S, 1993, BIOCHEMISTRY-US, V32, P8112, DOI 10.1021/bi00083a009; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vath GM, 1997, BIOCHEMISTRY-US, V36, P1559, DOI 10.1021/bi962614f; Wadyka B., 2008, CELL MOL BIOL LETT, V13, P212; WANG DC, 1985, J MOL BIOL, V185, P595, DOI 10.1016/0022-2836(85)90074-9; WILKES SH, 1973, EUR J BIOCHEM, V34, P459, DOI 10.1111/j.1432-1033.1973.tb02780.x; WINTHER JR, 1991, P NATL ACAD SCI USA, V88, P9330, DOI 10.1073/pnas.88.20.9330	33	11	11	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15544	15553		10.1074/jbc.M113.507616	http://dx.doi.org/10.1074/jbc.M113.507616			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24713703	Green Published, hybrid			2022-12-25	WOS:000337465400037
J	Li, XW; Rees, JS; Xue, P; Zhang, H; Hamaia, SW; Sanderson, B; Funk, PE; Farndale, RW; Lilley, KS; Perrett, S; Jackson, AP				Li, Xue-Wen; Rees, Johanna S.; Xue, Peng; Zhang, Hong; Hamaia, Samir W.; Sanderson, Bailey; Funk, Phillip E.; Farndale, Richard W.; Lilley, Kathryn S.; Perrett, Sarah; Jackson, Antony P.			New Insights into the DT40 B Cell Receptor Cluster Using a Proteomic Proximity Labeling Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; SIGNAL AMPLIFICATION; PROTEIN COMPLEXES; IN-SITU; LYMPHOCYTE; ACTIVATION; IDENTIFICATION; SEQUENCE; ADHESION; REQUIREMENT	In the vertebrate immune system, each B-lymphocyte expresses a surface IgM-class B cell receptor (BCR). When cross-linked by antigen or anti-IgM antibody, the BCR accumulates with other proteins into distinct surface clusters that activate cell signaling, division, or apoptosis. However, the molecular composition of these clusters is not well defined. Here we describe a quantitative assay we call selective proteomic proximity labeling using tyramide (SPPLAT). It allows proteins in the immediate vicinity of a target to be selectively biotinylated, and hence isolated for mass spectrometry analysis. Using the chicken B cell line DT40 as a model, we use SPPLAT to provide the first proteomic analysis of any BCR cluster using proximity labeling. We detect known components of the BCR cluster, including integrins, together with proteins not previously thought to be BCR-associated. In particular, we identify the chicken B-lymphocyte allotypic marker chB6. We show that chB6 moves to within about 30 - 40 nm of the BCR following BCR cross-linking, and we show that cross-linking chB6 activates cell binding to integrin substrates laminin and gelatin. Our work provides new insights into the nature and composition of the BCR cluster, and confirms SPPLAT as a useful research tool in molecular and cellular proteomics.	[Li, Xue-Wen; Xue, Peng; Zhang, Hong; Perrett, Sarah; Jackson, Antony P.] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Rees, Johanna S.; Hamaia, Samir W.; Farndale, Richard W.; Lilley, Kathryn S.; Jackson, Antony P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Rees, Johanna S.; Lilley, Kathryn S.] Univ Cambridge, Cambridge Ctr Prote, Cambridge CB2 1QR, England; [Sanderson, Bailey; Funk, Phillip E.] Depaul Univ, Dept Biol Sci, Chicago, IL 60604 USA; [Li, Xue-Wen] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Cambridge; University of Cambridge; DePaul University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Perrett, S (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	sarah.perrett@cantab.net; apj10@cam.ac.uk	Perrett, Sarah/AAS-9483-2020; Lilley, Kathryn/ABF-5787-2020	Perrett, Sarah/0000-0003-0137-0997; Lilley, Kathryn/0000-0003-0594-6543; Jackson, Antony Philip/0000-0002-2895-7387; Rees, Johanna/0000-0003-2066-8617	Chinese Ministry of Science and Technology 973 Program [2012CB911000, 2013CB910700]; National Natural Science Foundation of China [31110103914, 31070656, 31000342, 31270794]; Biotechnology and Biological Sciences Research Council (UK) [BB/J021091, H024085/1]; Medical Research Council (UK) [G0500707]; Wellcome Trust [094470/Z/10/Z]; DePaul University Research Council; Chinese Academy of Sciences [2010T1S11]; BBSRC [BB/H024085/1, BB/J021091/1] Funding Source: UKRI; MRC [G0500707] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H024085/1, BB/J021091/1] Funding Source: researchfish; British Heart Foundation [RG/09/003/27122] Funding Source: researchfish; Medical Research Council [G0500707] Funding Source: researchfish	Chinese Ministry of Science and Technology 973 Program(Ministry of Science and Technology, ChinaNational Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); DePaul University Research Council; Chinese Academy of Sciences(Chinese Academy of Sciences); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by grants from the Chinese Ministry of Science and Technology 973 Program (2012CB911000 and 2013CB910700) and the National Natural Science Foundation of China (31110103914, 31070656, 31000342, and 31270794).; Supported by Grants BB/J021091 and H024085/1 from the Biotechnology and Biological Sciences Research Council (UK).; Supported by Grant G0500707 from the Medical Research Council (UK) and Grant 094470/Z/10/Z from the Wellcome Trust.; Supported by the DePaul University Research Council.; Supported by a Chinese Academy of Sciences Visiting Professorship for Senior International Scientists Grant 2010T1S11. To whom correspondence may be addressed: Dept. of Biochemistry, University of Cambridge, Tennis Court Rd., Cambridge CB2 1QW, United Kingdom. Tel.: 44-1223-765951; E-mail: apj10@cam.ac.uk.	Allalou A, 2009, COMPUT METH PROG BIO, V94, P58, DOI 10.1016/j.cmpb.2008.08.006; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; Arana E, 2008, J CELL SCI, V121, P2279, DOI 10.1242/jcs.017905; Avram D, 2004, PROTEOMICS, V4, P2397, DOI 10.1002/pmic.200300755; BOBROW MN, 1989, J IMMUNOL METHODS, V125, P279, DOI 10.1016/0022-1759(89)90104-X; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; BUCHBERG AM, 1990, MOL CELL BIOL, V10, P4658, DOI 10.1128/MCB.10.9.4658; BUERSTEDDE JM, 1991, CELL, V67, P179, DOI 10.1016/0092-8674(91)90581-I; Caloca MJ, 2008, J BIOL CHEM, V283, P36454, DOI 10.1074/jbc.M803814200; Cheng PC, 2001, SEMIN IMMUNOL, V13, P107, DOI 10.1006/smim.2000.0302; Chiampanichayakul S, 2002, INT IMMUNOL, V14, P1407, DOI 10.1093/intimm/dxf112; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; de Wet B, 2011, J BIOL CHEM, V286, P4072, DOI 10.1074/jbc.M110.165415; DeFranco AL, 1997, CURR OPIN IMMUNOL, V9, P296, DOI 10.1016/S0952-7915(97)80074-X; Earnshaw JC, 1999, CYTOMETRY, V35, P176, DOI 10.1002/(SICI)1097-0320(19990201)35:2<176::AID-CYTO10>3.0.CO;2-S; FELLER SM, 1994, TRENDS BIOCHEM SCI, V19, P453, DOI 10.1016/0968-0004(94)90129-5; Fragoso R, 2003, J IMMUNOL, V170, P913, DOI 10.4049/jimmunol.170.2.913; Funk PE, 2003, CELL IMMUNOL, V226, P95, DOI 10.1016/j.cellimm.2003.11.009; Funk PE, 2003, ARCH IMMUNOL THER EX, V51, P389; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P1697, DOI 10.1074/mcp.M500190-MCP200; Guo FK, 2009, BLOOD, V114, P2909, DOI 10.1182/blood-2009-04-214676; Gupta N, 2003, MOL BIOL CELL, V14, P432, DOI 10.1091/mbc.02-05-0078; Gupta N, 2006, NAT IMMUNOL, V7, P625, DOI 10.1038/ni1337; Hall SL, 2009, MOL CELL PROTEOMICS, V8, P1295, DOI 10.1074/mcp.M800394-MCP200; Hamaia SW, 2012, J BIOL CHEM, V287, P26019, DOI 10.1074/jbc.M112.353144; Harwood NE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002360; Hotchin NA, 1995, J CELL BIOL, V131, P1857, DOI 10.1083/jcb.131.6.1857; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Igyarto BZ, 2008, POULTRY SCI, V87, P351, DOI 10.3382/ps.2007-00365; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Jiang SL, 2012, PROTEOMICS, V12, P54, DOI 10.1002/pmic.201100551; Kivens WJ, 1998, MOL CELL BIOL, V18, P5291, DOI 10.1128/MCB.18.9.5291; Kolesnikova TV, 2001, BMC BIOCHEM, V2, DOI 10.1186/1472-2091-2-10; Kurosaki T, 2011, MOL IMMUNOL, V48, P1287, DOI 10.1016/j.molimm.2010.12.007; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; McCarthy FM, 2006, PROTEOMICS, V6, P2759, DOI 10.1002/pmic.200500648; MOINGEON P, 1989, IMMUNOL REV, V111, P111, DOI 10.1111/j.1600-065X.1989.tb00544.x; Niiro H, 2004, J IMMUNOL, V173, P5601, DOI 10.4049/jimmunol.173.9.5601; Pierce SK, 2002, NAT REV IMMUNOL, V2, P96, DOI 10.1038/nri726; Rees JS, 2011, METHODS, V54, P407, DOI 10.1016/j.ymeth.2011.06.004; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Saci A, 2005, MOL CELL, V17, P205, DOI 10.1016/j.molcel.2004.12.012; Saeki K, 2003, EMBO J, V22, P3015, DOI 10.1093/emboj/cdg293; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Schofer C, 1997, HISTOCHEM CELL BIOL, V108, P313, DOI 10.1007/s004180050171; Schusser B, 2013, P NATL ACAD SCI USA, V110, P20170, DOI 10.1073/pnas.1317106110; Shenoi H, 1999, J IMMUNOL, V162, P7120; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Spaargaren M, 2003, J EXP MED, V198, P1539, DOI 10.1084/jem.20011866; Speel EJM, 1999, J HISTOCHEM CYTOCHEM, V47, P281, DOI 10.1177/002215549904700302; Spessotto P, 2001, CANCER RES, V61, P339; Stoddart A, 2005, MOL BIOL CELL, V16, P2339, DOI 10.1091/mbc.e05-01-0025; Stoddart A, 2002, IMMUNITY, V17, P451, DOI 10.1016/S1074-7613(02)00416-8; TAKATA M, 1995, J EXP MED, V182, P907, DOI 10.1084/jem.182.4.907; Tolar P, 2009, IMMUNOL REV, V232, P34, DOI 10.1111/j.1600-065X.2009.00833.x; Treanor B, 2012, IMMUNOLOGY, V136, P21, DOI 10.1111/j.1365-2567.2012.03564.x; Tregaskes CA, 1996, IMMUNOGENETICS, V44, P212, DOI 10.1007/BF02602587; Tsuji T, 2004, J MEMBRANE BIOL, V200, P115, DOI 10.1007/s00232-004-0696-5; VANKOOYK Y, 1989, NATURE, V342, P811, DOI 10.1038/342811a0; Veillette A, 2003, CURR OPIN IMMUNOL, V15, P277, DOI 10.1016/S0952-7915(03)00041-4; VEROMAA T, 1988, HYBRIDOMA, V7, P41, DOI 10.1089/hyb.1988.7.41; Vilen BJ, 1999, IMMUNITY, V10, P239, DOI 10.1016/S1074-7613(00)80024-2; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Williams MG, 2001, PROTEINS, P92; Xie P, 2004, J EXP MED, V199, P661, DOI 10.1084/jem.20031255; Yanagi S, 1996, J BIOL CHEM, V271, P30487, DOI 10.1074/jbc.271.48.30487; Yang W, 2008, PROTEOMICS, V8, P832, DOI 10.1002/pmic.200700650; Yasuda Tomoharu, 2004, Methods Mol Biol, V271, P261; Zheng YZ, 2009, J PROTEOMICS, V72, P12, DOI 10.1016/j.jprot.2008.09.003	72	80	81	1	49	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14434	14447		10.1074/jbc.M113.529578	http://dx.doi.org/10.1074/jbc.M113.529578			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24706754	Green Published, hybrid			2022-12-25	WOS:000337248100001
J	Rotzer, V; Breit, A; Waschke, J; Spindler, V				Roetzer, Vera; Breit, Andreas; Waschke, Jens; Spindler, Volker			Adducin Is Required for Desmosomal Cohesion in Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PEMPHIGUS-VULGARIS-IGG; CELL CARCINOMA LINE; ACTIN CYTOSKELETON; DESMOGLEIN 3; INOSITOL 1,4,5-TRISPHOSPHATE; INTRACELLULAR CALCIUM; DJM-1 CELLS; RHO GTPASES; SH2 DOMAIN	Adducin is a protein organizing the cortical actin cytoskeleton and a target of RhoA and PKC signaling. However, the role for intercellular cohesion is unknown. We found that adducin silencing induced disruption of the actin cytoskeleton, reduced intercellular adhesion of human keratinocytes, and decreased the levels of the desmosomal adhesion molecule desmoglein (Dsg) 3 by reducing its membrane incorporation. Because loss of cell cohesion and Dsg3 depletion is observed in the autoanti-body-mediated blistering skin disease pemphigus vulgaris (PV), we applied antibody fractions of PV patients. A rapid phosphorylation of adducin at serine 726 was detected in response to these autoantibodies. To mechanistically link autoantibody binding and adducin phosphorylation, we evaluated the role of several disease-relevant signaling molecules. Adducin phosphorylation at serine 726 was dependent on Ca2+ influx and PKC but occurred independent of p38 MAPK and PKA. Adducin phosphorylation is protective, because phosphorylation-deficient mutants resulted in loss of cell cohesion and Dsg3 fragmentation. Thus, PKC elicits both positive and negative effects on cell adhesion, since its contribution to cell dissociation in pemphigus is well established. We additionally evaluated the effect of RhoA on adducin phosphorylation because RhoA activation was shown to block pemphigus autoantibody-induced cell dissociation. Our data demonstrate that the protective effect of RhoA activation was dependent on the presence of adducin and its phosphorylation at serine 726. These experiments provide novel mechanisms for regulation of desmosomal adhesion by RhoA- and PKC-mediated adducin phosphorylation in keratinocytes.	[Roetzer, Vera; Waschke, Jens; Spindler, Volker] Univ Munich, Inst Anat & Cell Biol, D-80336 Munich, Germany; [Breit, Andreas] Univ Munich, Walther Straub Inst Pharmacol & Toxicol, D-80336 Munich, Germany	University of Munich; University of Munich	Waschke, J (corresponding author), Pettenkoferstr 11, D-80336 Munich, Germany.	jens.waschke@med.uni-muenchen.de; volker.spindler@med.uni-muenchen.de	Spindler, Volker/G-1704-2019	Spindler, Volker/0000-0002-1302-5421	Deutsche Forschungsgemeinschaft [DFG SP1300-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant DFG SP1300-1 (to V. S.).	Amagai M, 2012, J INVEST DERMATOL, V132, P776, DOI 10.1038/jid.2011.390; Amano M, 1996, SCIENCE, V271, P648, DOI 10.1126/science.271.5249.648; Bass-Zubek AE, 2008, J CELL BIOL, V181, P605, DOI 10.1083/jcb.200712133; Baubet V, 2000, P NATL ACAD SCI USA, V97, P7260, DOI 10.1073/pnas.97.13.7260; Baumgartner W, 2003, J CELL SCI, V116, P1001, DOI 10.1242/jcs.00322; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Chen CL, 2007, J CELL SCI, V120, P1157, DOI 10.1242/jcs.03408; Chen CL, 2011, TRAFFIC, V12, P1327, DOI 10.1111/j.1600-0854.2011.01245.x; Cirillo N, 2010, EXP CELL RES, V316, P580, DOI 10.1016/j.yexcr.2009.10.005; DONG LQ, 1995, J BIOL CHEM, V270, P25534, DOI 10.1074/jbc.270.43.25534; ESAKI C, 1995, J INVEST DERMATOL, V105, P329, DOI 10.1111/1523-1747.ep12319948; Evans JV, 2012, J CELL SCI, V125, P6185, DOI 10.1242/jcs.121046; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; GARDNER K, 1987, NATURE, V328, P359, DOI 10.1038/328359a0; Gliem M, 2010, AM J PHYSIOL-CELL PH, V299, pC606, DOI 10.1152/ajpcell.00075.2010; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hartlieb E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053739; Head JA, 2003, MOL BIOL CELL, V14, P3216, DOI 10.1091/mbc.e02-11-0753; Heupel WM, 2008, J IMMUNOL, V181, P1825, DOI 10.4049/jimmunol.181.3.1825; Hobbs RP, 2012, J INVEST DERMATOL, V132, P482, DOI 10.1038/jid.2011.318; HUGHES CA, 1995, J BIOL CHEM, V270, P18990, DOI 10.1074/jbc.270.32.18990; KAISER HW, 1989, J CELL BIOL, V109, P557, DOI 10.1083/jcb.109.2.557; Kimura K, 1998, J BIOL CHEM, V273, P5542, DOI 10.1074/jbc.273.10.5542; Kimura TE, 2007, J INVEST DERMATOL, V127, P775, DOI 10.1038/sj.jid.5700643; Kirkbride KC, 2012, CYTOSKELETON, V69, P625, DOI 10.1002/cm.21051; Kroger C, 2013, J CELL BIOL, V201, P681, DOI 10.1083/jcb.201208162; Kuhlman PA, 1996, J BIOL CHEM, V271, P7986, DOI 10.1074/jbc.271.14.7986; Kusumi A, 1999, CURR OPIN CELL BIOL, V11, P582, DOI 10.1016/S0955-0674(99)00020-4; Li XL, 1998, J BIOL CHEM, V273, P19329, DOI 10.1074/jbc.273.30.19329; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Matsuoka Y, 1996, J BIOL CHEM, V271, P25157, DOI 10.1074/jbc.271.41.25157; Matsuoka Y, 2000, CELL MOL LIFE SCI, V57, P884, DOI 10.1007/PL00000731; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Naydenov NG, 2010, MOL BIOL CELL, V21, P3506, DOI 10.1091/mbc.E10-03-0259; Nieto-Pelegrin E, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-11; OKAMURA H, 1995, J BIOL CHEM, V270, P26613, DOI 10.1074/jbc.270.44.26613; Osada K, 1997, J INVEST DERMATOL, V108, P482, DOI 10.1111/1523-1747.ep12289726; Sako Y, 1998, J CELL BIOL, V140, P1227, DOI 10.1083/jcb.140.5.1227; Sato M, 2000, LAB INVEST, V80, P1583, DOI 10.1038/labinvest.3780168; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; SEISHIMA M, 1995, J INVEST DERMATOL, V104, P33, DOI 10.1111/1523-1747.ep12613469; Spindler V, 2007, AM J PATHOL, V171, P906, DOI 10.2353/ajpath.2007.070028; Spindler V, 2014, CELL COMMUN ADHES, V21, P77, DOI 10.3109/15419061.2013.877000; Spindler V, 2013, J CLIN INVEST, V123, P800, DOI 10.1172/JCI60139; Spindler V, 2011, AM J PATHOL, V179, P1905, DOI 10.1016/j.ajpath.2011.06.043; Spindler V, 2011, ANN ANAT, V193, P177, DOI 10.1016/j.aanat.2011.02.003; Spindler V, 2010, J IMMUNOL, V185, P6831, DOI 10.4049/jimmunol.1002675; Stahley SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087809; TAYLOR KA, 1994, BIOPHYS J, V67, P1976, DOI 10.1016/S0006-3495(94)80680-0; Tsang SM, 2012, EXP CELL RES, V318, P2269, DOI 10.1016/j.yexcr.2012.07.002; Tsunoda K, 2003, J IMMUNOL, V170, P2170, DOI 10.4049/jimmunol.170.4.2170; Waschke J, 2005, J CLIN INVEST, V115, P3157, DOI 10.1172/JCI23475; Waschke J, 2008, HISTOCHEM CELL BIOL, V130, P21, DOI 10.1007/s00418-008-0420-0; Waschke J, 2006, J CELL BIOL, V175, P721, DOI 10.1083/jcb.200605125; Waschke J, 2014, MED RES REV, V34, P1127, DOI 10.1002/med.21310; Yamamoto Y, 2007, J BIOL CHEM, V282, P17866, DOI 10.1074/jbc.M607963200	57	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14925	14940		10.1074/jbc.M113.527127	http://dx.doi.org/10.1074/jbc.M113.527127			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24711455	hybrid, Green Published			2022-12-25	WOS:000337248100043
J	Holand, K; Boller, D; Hagel, C; Dolski, S; Treszl, A; Pardo, OE; Cwiek, P; Salm, F; Leni, Z; Shepherd, PR; Styp-Rekowska, B; Djonov, V; von Bueren, AO; Frei, K; Arcaro, A				Hoeland, Katrin; Boller, Danielle; Hagel, Christian; Dolski, Silvia; Treszl, Andras; Pardo, Olivier E.; Cwiek, Paulina; Salm, Fabiana; Leni, Zaira; Shepherd, Peter R.; Styp-Rekowska, Beata; Djonov, Valentin; von Bueren, Andre O.; Frei, Karl; Arcaro, Alexandre			Targeting Class I-A PI3K Isoforms Selectively Impairs Cell Growth, Survival, and Migration in Glioblastoma	PLOS ONE			English	Article							BRAIN-TUMORS; PIK3CA GENE; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; ANTITUMOR-ACTIVITY; MALIGNANT GLIOMAS; PATIENT SURVIVAL; KINASE-B; MUTATIONS; PATHWAY	The phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway is frequently activated in human cancer and plays a crucial role in glioblastoma biology. We were interested in gaining further insight into the potential of targeting PI3K isoforms as a novel anti-tumor approach in glioblastoma. Consistent expression of the PI3K catalytic isoform PI3K p11 alpha was detected in a panel of glioblastoma patient samples. In contrast, PI3K p11 beta expression was only rarely detected in glioblastoma patient samples. The expression of a module comprising the epidermal growth factor receptor (EGFR)/PI3K p110 alpha/phosphorylated ribosomal S6 protein (p-S6) was correlated with shorter patient survival. Inhibition of PI3K p11 alpha activity impaired the anchorage-dependent growth of glioblastoma cells and induced tumor regression in vivo. Inhibition of PI3K p11 alpha or PI3K p110 alpha also led to impaired anchorage-independent growth, a decreased migratory capacity of glioblastoma cells, and reduced the activation of the Akt/mTOR pathway. These effects were selective, because targeting of PI3K p11 delta d did not result in a comparable impairment of glioblastoma tumorigenic properties. Together, our data reveal that drugs targeting PI3K p110a can reduce growth in a subset of glioblastoma tumors characterized by the expression of EGFR/PI3K p110 alpha/p-S6.	[Hoeland, Katrin; Cwiek, Paulina; Salm, Fabiana; Leni, Zaira; Arcaro, Alexandre] Univ Bern, Dept Clin Res, Bern, Switzerland; [Boller, Danielle; Arcaro, Alexandre] Univ Childrens Hosp Zurich, Div Clin Chem & Biochem, Zurich, Switzerland; [Hagel, Christian] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany; [Dolski, Silvia; Frei, Karl] Univ Zurich Hosp, Dept Neurosurg, CH-8091 Zurich, Switzerland; [Treszl, Andras] Univ Med Ctr Hamburg Eppendorf, Ctr Med Expt, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Pardo, Olivier E.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Shepherd, Peter R.] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Styp-Rekowska, Beata; Djonov, Valentin] Univ Bern, Inst Anat, Bern, Switzerland; [von Bueren, Andre O.] Univ Med Ctr Goettingen, Dept Pediat & Adolescent Med, Div Pediat Hematol & Oncol, Gottingen, Germany	University of Bern; University Children's Hospital Zurich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Zurich; University Zurich Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Imperial College London; University of Auckland; University of Bern; University of Gottingen	Arcaro, A (corresponding author), Univ Bern, Dept Clin Res, Bern, Switzerland.	alexandre.arcaro@dkf.unibe.ch	Pardo, Oliver/AEM-2071-2022; von Bueren, Andre/AAF-2065-2020; Arcaro, Alexandre/G-1711-2010	Pardo, Oliver/0000-0003-2223-1435; Arcaro, Alexandre/0000-0001-9107-2947; Bronnimann, Paulina/0000-0001-7574-8214; Djonov, Valentin/0000-0002-5062-1169; Cwiek, Paulina/0000-0002-0964-6364; von Bueren, Andre/0000-0003-4197-6264	Oncosuisse [OCS-01501-02-2004]; Krebsliga Zurich; European Union [259348]	Oncosuisse; Krebsliga Zurich; European Union(European Commission)	Oncosuisse (OCS-01501-02-2004); Krebsliga Zurich; European Union's Seventh Framework Programme (FP7/2007-2013, grant agreement no259348). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan D, 2010, NEURO-ONCOLOGY, V12, P882, DOI 10.1093/neuonc/noq052; Arcaro A, 2007, BIOCHEM J, V406, P57, DOI 10.1042/BJ20070309; Belkaid A, 2006, FEBS LETT, V580, P3746, DOI 10.1016/j.febslet.2006.05.071; Bowers DC, 2000, CANCER RES, V60, P4277; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Carew JS, 2011, TARGET ONCOL, V6, P17, DOI 10.1007/s11523-011-0167-8; CBTRUS, CENTR BRAIN TUM REG; Chakravarti A, 2002, CANCER RES, V62, P200; Chakravarti A, 2004, J CLIN ONCOL, V22, P1926, DOI 10.1200/JCO.2004.07.193; Chaussade C, 2007, BIOCHEM J, V404, P449, DOI 10.1042/BJ20070003; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Choe G, 2003, CANCER RES, V63, P2742; Condliffe AM, 2005, BLOOD, V106, P1432, DOI 10.1182/blood-2005-03-0944; DeAngelis LM, 2001, NEW ENGL J MED, V344, P114, DOI 10.1056/NEJM200101113440207; Endersby R, 2011, CANCER RES, V71, P4106, DOI 10.1158/0008-5472.CAN-10-3597; Ermoian RP, 2002, CLIN CANCER RES, V8, P1100; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Gallia GL, 2006, MOL CANCER RES, V4, P709, DOI 10.1158/1541-7786.MCR-06-0172; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Gymnopoulos M, 2007, P NATL ACAD SCI USA, V104, P5569, DOI 10.1073/pnas.0701005104; Hagedorn M, 2005, P NATL ACAD SCI USA, V102, P1643, DOI 10.1073/pnas.0408622102; Halatsch ME, 2006, CANCER TREAT REV, V32, P74, DOI 10.1016/j.ctrv.2006.01.003; Hartmann C, 2005, ACTA NEUROPATHOL, V109, P639, DOI 10.1007/s00401-005-1000-1; Holand K, 2011, CURR CANCER DRUG TAR, V11, P894, DOI 10.2174/156800911797264743; Hui ABY, 2001, LAB INVEST, V81, P717, DOI 10.1038/labinvest.3780280; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jamieson S, 2011, BIOCHEM J, V438, P53, DOI 10.1042/BJ20110502; Janku F, 2012, CANC RES; Jia SD, 2008, NATURE, V454, P776, DOI 10.1038/nature07091; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Katso RM, 2006, MOL BIOL CELL, V17, P3729, DOI 10.1091/mbc.E05-11-1083; Kim B, 2010, J NEUROL SCI, V294, P112, DOI 10.1016/j.jns.2010.03.019; Knobbe CB, 2005, NEUROPATH APPL NEURO, V31, P486, DOI 10.1111/j.1365-2990.2005.00660.x; Knobbe CB, 2003, BRAIN PATHOL, V13, P507; Koul D, 2012, CLIN CANCER RES, V18, P184, DOI 10.1158/1078-0432.CCR-11-1558; Lee JC, 2006, PLOS MED, V3, P2264, DOI 10.1371/journal.pmed.0030485; Lino MM, 2011, J NEURO-ONCOL, V103, P417, DOI 10.1007/s11060-010-0442-z; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Luk SK, 2012, EUR J CANCER, V48, P149, DOI 10.1016/j.ejca.2011.09.006; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Maira SM, 2012, MOL CANCER THER, V11, P317, DOI 10.1158/1535-7163.MCT-11-0474; McBride SM, 2010, J NEURO-ONCOL, V97, P33, DOI 10.1007/s11060-009-0004-4; Mizoguchi M, 2004, BRAIN PATHOL, V14, P372, DOI 10.1111/j.1750-3639.2004.tb00080.x; Mueller W, 2005, ACTA NEUROPATHOL, V109, P654, DOI 10.1007/s00401-005-1001-0; Mure H, 2010, NEURO-ONCOLOGY, V12, P221, DOI 10.1093/neuonc/nop026; Nicholas MK, 2006, CLIN CANCER RES, V12, P7261, DOI 10.1158/1078-0432.CCR-06-0874; Nilsson KPR, 2010, AM J PATHOL, V176, P563, DOI 10.2353/ajpath.2010.080797; Puputti M, 2006, MOL CANCER RES, V4, P927, DOI 10.1158/1541-7786.MCR-06-0085; Rodak R, 2005, J NEUROSURG, V102, P1055, DOI 10.3171/jns.2005.102.6.1055; Sadhu C, 2003, J IMMUNOL, V170, P2647, DOI 10.4049/jimmunol.170.5.2647; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; VAN MEIR E, 1990, CANCER RES, V50, P6683; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Weigelt B, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00109; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Zhang SY, 2010, CLIN CANCER RES, V16, P4325, DOI 10.1158/1078-0432.CCR-09-2990	59	31	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94132	10.1371/journal.pone.0094132	http://dx.doi.org/10.1371/journal.pone.0094132			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718026	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000334339000080
J	Kim, TN; Lee, JE; Lee, EJ; Won, JC; Noh, JH; Ko, KS; Rhee, BD; Kim, DJ				Kim, Tae Nyun; Lee, Joo Eun; Lee, Eun Ju; Won, Jong Chul; Noh, Jung Hyun; Ko, Kyung Soo; Rhee, Byoung Doo; Kim, Dong-Jun			Prevalence of and Factors Associated with Lens Opacities in a Korean Adult Population with and without Diabetes: The 2008-2009 Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							POSTERIOR SUBCAPSULAR CATARACTS; AGE-RELATED CATARACT; CLASSIFICATION-SYSTEM-III; TANJONG-PAGAR SURVEY; ANGELES-LATINO-EYE; RISK-FACTORS; BARBADOS EYE; NUCLEAR; EPIDEMIOLOGY; SINGAPORE	Objective: We examined the prevalence of and factors associated with lens opacities in a Korean adult population with and without diabetes. Research Design and Methods: Among the 11,163 adults (>= 19 years old) from the fourth Korea National Health and Nutrition Examination Survey in 2008-2009, the data from laboratory tests, nutritional surveys, and slit-lamp examinations of 10,248 persons (4,397 men, 5,851 women) were examined. Cataract was defined as the presence of any nuclear, cortical, subcapsular, or mixed cataract in at least one eye, using the Lens Opacities Classification System III. Results: The weighted prevalence of cataracts were 23.5% [ 95% confidence interval (CI), 21.7-25.4] in a Korean adult population (19-39 years old, 1.8% [ 1.3-2.5], 40-64 years old, 25.2% [ 22.5-28.1],>= 65 years old, 87.8% [ 85.4-89.9]) and 54.7% [ 50.1-59.2] in a diabetic population(19-39 years old, 11.6% [ 4.5-26.5], 40-64 years old, 41.1% [ 35.4-47.0], >= 65 years old, 88.3% [ 83.5-91.8]). In a logistic regression analysis, age, myopia, and the presence of diabetes were independent risk factors. For young (age 19-39 years) and middle aged (age 40-65 years) adults with diabetes, the OR of having a lens opacity is 5.04 [ 1.41-17.98] and 1.47 [ 1.11-1.94], respectively, as those without diabetes, whereas for adults aged 65 and older, there was no difference in the prevalence of cataract. Conclusions: According to these national survey data, similar to 24% of Korean adults and similar to 55% of people with diabetes have cataracts. The presence of diabetes was independently associated with cataracts in young and middle aged adults.	[Kim, Tae Nyun; Lee, Eun Ju] Inje Univ, Coll Med, Haeundae Paik Hosp, Dept Internal Med, Pusan, South Korea; [Kim, Tae Nyun; Noh, Jung Hyun; Ko, Kyung Soo; Rhee, Byoung Doo] Inje Univ, Cardiovasc & Metab Dis Ctr, Pusan, South Korea; [Lee, Joo Eun] Inje Univ, Haeundae Paik Hosp, Coll Med, Dept Ophthalmol, Pusan, South Korea; [Noh, Jung Hyun; Kim, Dong-Jun] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med, Koyang, South Korea; [Won, Jong Chul; Ko, Kyung Soo; Rhee, Byoung Doo] Inje Univ, Coll Med, Sanggye Paik Hosp, Dept Internal Med, Seoul, South Korea	Inje University; Inje University; Inje University; Inje University; Inje University	Kim, DJ (corresponding author), Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med, Koyang, South Korea.	djkim@paik.ac.kr	Kim, Tae Nyun/AAV-5521-2020; Noh, Junghyun/AAU-8113-2020	Kim, Tae Nyun/0000-0001-6568-2469; Won, Jong Chul/0000-0002-2219-4083; Noh, Junghyun/0000-0002-7964-0515	Inje University research grant	Inje University research grant	This work was supported by a 2010 Inje University research grant. The relevant grant number is one. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, Ophthalmology, V98, P786; Chen SJ, 2008, ACTA DIABETOL, V45, P7, DOI 10.1007/s00592-007-0012-9; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Delcourt C, 2000, AM J EPIDEMIOL, V151, P497; Foster PJ, 2003, BRIT J OPHTHALMOL, V87, P1112, DOI 10.1136/bjo.87.9.1112; HILLER R, 1986, AM J EPIDEMIOL, V124, P916, DOI 10.1093/oxfordjournals.aje.a114481; HIRVELA H, 1995, OPHTHALMOLOGY, V102, P108; Jeganathan VSE, 2008, DIABETES CARE, V31, P1905, DOI 10.2337/dc08-0342; KARBASSI M, 1993, OPTOMETRY VISION SCI, V70, P923, DOI 10.1097/00006324-199311000-00009; Kim Seong Il, 2006, Korean J Ophthalmol, V20, P201; Klein B E, 1995, Ophthalmic Epidemiol, V2, P49, DOI 10.3109/09286589509071451; Klein BEK, 1998, AM J OPHTHALMOL, V126, P782, DOI 10.1016/S0002-9394(98)00280-3; Leske MC, 1999, OPHTHALMOLOGY, V106, P35, DOI 10.1016/S0161-6420(99)90003-9; Leske MC, 1997, ARCH OPHTHALMOL-CHIC, V115, P105, DOI 10.1001/archopht.1997.01100150107018; LESKE MC, 1991, ARCH OPHTHALMOL-CHIC, V109, P244, DOI 10.1001/archopht.1991.01080020090051; McCarty CA, 1999, AM J OPHTHALMOL, V128, P446, DOI 10.1016/S0002-9394(99)00218-4; Miglior S, 1994, Ophthalmic Epidemiol, V1, P93, DOI 10.3109/09286589409052365; Murtha T, 2007, CURR OPIN OPHTHALMOL, V18, P13, DOI 10.1097/ICU.0b013e32801129fc; Negahban Kambiz, 2002, Curr Opin Ophthalmol, V13, P419, DOI 10.1097/00055735-200212000-00013; Obrosova IG, 2010, DIABETES-METAB RES, V26, P172, DOI 10.1002/dmrr.1075; Pan CW, 2013, OPHTHALMOLOGY, V120, P284, DOI 10.1016/j.ophtha.2012.07.065; Park S, 2013, OPTOMETRY VISION SCI, V90, P1019, DOI 10.1097/OPX.0b013e31829cae62; Park Y, 2006, ANN NY ACAD SCI, V1079, P31, DOI 10.1196/annals.1375.005; Pierscionek BK, 1996, OPHTHALMIC RES, V28, P88, DOI 10.1159/000267879; Raman R, 2010, INVEST OPHTH VIS SCI, V51, P6253, DOI 10.1167/iovs.10-5414; Richter GM, 2012, OPHTHALMOLOGY, V119, P2040, DOI 10.1016/j.ophtha.2012.05.001; Richter GM, 2012, OPHTHALMOLOGY, V119, P547, DOI 10.1016/j.ophtha.2011.09.005; Rotimi Charles, 2003, Ethnicity & Disease, V13; Rowe N G, 2000, Ophthalmic Epidemiol, V7, P103; Seah SKL, 2002, OPHTHALMOLOGY, V109, P2058, DOI 10.1016/S0161-6420(02)01221-6; Taylor HR, 1999, EYE, V13, P445, DOI 10.1038/eye.1999.119; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421	33	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94189	10.1371/journal.pone.0094189	http://dx.doi.org/10.1371/journal.pone.0094189			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718421	Green Submitted, Green Published, gold			2022-12-25	WOS:000334339000086
J	Zhou, YF; Ueda, T; Muller, M				Zhou, Yufan; Ueda, Takuya; Mueller, Matthias			Signal Recognition Particle and SecA Cooperate during Export of Secretory Proteins with Highly Hydrophobic Signal Sequences	PLOS ONE			English	Article							ESCHERICHIA-COLI; MEMBRANE-PROTEINS; DEPENDENT TRANSLOCATION; INNER MEMBRANE; PURIFIED COMPONENTS; IN-VITRO; SRP; INSERTION; PATHWAY; SECYEG	The Sec translocon of bacterial plasma membranes mediates the linear translocation of secretory proteins as well as the lateral integration of membrane proteins. Integration of many membrane proteins occurs co-translationally via the signal recognition particle (SRP)-dependent targeting of ribosome-associated nascent chains to the Sec translocon. In contrast, translocation of classical secretory proteins across the Sec translocon is a post-translational event requiring no SRP but the motor protein SecA. Secretory proteins were, however, reported to utilize SRP in addition to SecA, if the hydrophobicity of their signal sequences exceeds a certain threshold value. Here we have analyzed transport of this subgroup of secretory proteins across the Sec translocon employing an entirely defined in vitro system. We thus found SecA to be both necessary and sufficient for translocation of secretory proteins with hydrophobic signal sequences, whereas SRP and its receptor improved translocation efficiency. This SRP-mediated boost of translocation is likely due to the early capture of the hydrophobic signal sequence by SRP as revealed by site-specific photo cross-linking of ribosome nascent chain complexes.	[Zhou, Yufan; Mueller, Matthias] Univ Freiburg, Inst Biochem & Mol Biol, Zentrum Biochem & Mol Zellforsch, D-79106 Freiburg, Germany; [Zhou, Yufan] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Ueda, Takuya] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Chiba, Japan	University of Freiburg; University of Freiburg; University of Tokyo	Muller, M (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, Zentrum Biochem & Mol Zellforsch, Hugstetter Str 55, D-79106 Freiburg, Germany.	matthias.mueller@biochemie.uni-freiburg.de	Zhou, Yufan/AFR-9024-2022; Ueda, Takuya/K-5217-2014	Ueda, Takuya/0000-0002-7760-8271	Deutsche Forschungsgemeinschaft [Forschergruppe 967]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Forschergruppe 967 of the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonoaea R, 2008, BIOCHEMISTRY-US, V47, P5649, DOI 10.1021/bi800233w; Ataide SF, 2011, SCIENCE, V331, P881, DOI 10.1126/science.1196473; Beck K, 2000, EMBO J, V19, P134, DOI 10.1093/emboj/19.1.134; Bibi E, 2012, TRENDS BIOCHEM SCI, V37, P1, DOI 10.1016/j.tibs.2011.09.004; Braig D, 2011, MOL BIOL CELL, V22, P2309, DOI 10.1091/mbc.E11-02-0152; CASADABAN MJ, 1979, P NATL ACAD SCI USA, V76, P4530, DOI 10.1073/pnas.76.9.4530; Deitermann S, 2005, J BIOL CHEM, V280, P39077, DOI 10.1074/jbc.M509647200; DEUTSCHE.MP, 1974, J BACTERIOL, V118, P621, DOI 10.1128/JB.118.2.621-627.1974; Eisner G, 2003, J CELL BIOL, V163, P35, DOI 10.1083/jcb.200306069; Holzapfel E, 2009, BIOCHEMISTRY-US, V48, P5096, DOI 10.1021/bi900520d; Huber D, 2005, J BACTERIOL, V187, P2983, DOI 10.1128/JB.187.9.2983-2991.2005; Huber D, 2011, MOL CELL, V41, P343, DOI 10.1016/j.molcel.2010.12.028; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Koch HG, 1999, MOL BIOL CELL, V10, P2163, DOI 10.1091/mbc.10.7.2163; Kudva R, 2013, RES MICROBIOL, V164, P505, DOI 10.1016/j.resmic.2013.03.016; Kuhn P, 2011, TRAFFIC, V12, P563, DOI 10.1111/j.1600-0854.2011.01167.x; Kuruma Y, 2005, BIOTECHNOL PROGR, V21, P1243, DOI 10.1021/bp049553u; Moser Michael, 2007, V390, P63; Neumann-Haefelin C, 2000, EMBO J, V19, P6419, DOI 10.1093/emboj/19.23.6419; Nishiyama K, 2010, BIOCHEM BIOPH RES CO, V394, P733, DOI 10.1016/j.bbrc.2010.03.061; Qi HY, 1999, J BIOL CHEM, V274, P8993, DOI 10.1074/jbc.274.13.8993; Schierle CF, 2003, J BACTERIOL, V185, P5706, DOI 10.1128/JB.185.19.5706-5713.2003; Scotti PA, 1999, J BIOL CHEM, V274, P29883, DOI 10.1074/jbc.274.42.29883; Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802; Shimohata N, 2005, J BACTERIOL, V187, P3997, DOI 10.1128/JB.187.12.3997-4004.2005; Tian HP, 2000, P NATL ACAD SCI USA, V97, P4730, DOI 10.1073/pnas.090087297; van der Laan M, 2004, J BIOL CHEM, V279, P1659, DOI 10.1074/jbc.M306527200; Welte T, 2012, MOL BIOL CELL, V23, P464, DOI 10.1091/mbc.E11-07-0590; WOOD H, 1992, NUCLEIC ACIDS RES, V20, P5919, DOI 10.1093/nar/20.22.5919; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Zhang X, 2010, SCIENCE, V328, P757, DOI 10.1126/science.1186743	31	9	9	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e92994	10.1371/journal.pone.0092994	http://dx.doi.org/10.1371/journal.pone.0092994			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717922	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000023
J	Keefe, CC; Goldman, MM; Zhang, K; Clarke, N; Reitz, RE; Welt, CK				Keefe, Candace C.; Goldman, Mildred M.; Zhang, Ke; Clarke, Nigel; Reitz, Richard E.; Welt, Corrine K.			Simultaneous Measurement of Thirteen Steroid Hormones in Women with Polycystic Ovary Syndrome and Control Women Using Liquid Chromatography-Tandem Mass Spectrometry	PLOS ONE			English	Article							ANDROGEN OVERPRODUCTION; THECA CELLS; TESTOSTERONE; CATHETERIZATION; RESPONSES; EXCESS	Background: The measurement of adrenal and ovarian androgens in women with PCOS has been difficult based on poor specificity and sensitivity of assays in the female range. Methods: Women with PCOS (NIH criteria; n = 52) and control subjects with 25-35 day menstrual cycles, no evidence of hyperandrogenism and matched for BMI (n = 42) underwent morning blood sampling. Liquid chromatography-tandem mass spectrometry (LC-MS/MS) was used to simultaneously measure 13 steroids from a single blood sample to measure adrenal and ovarian steroids. Androgen and progesterone results were compared in the same samples using RIA. Results: Testosterone, androstenedione, progesterone and 17OH progesterone levels were higher when measured using RIA compared to LC-MS/MS, although the testosterone RIA demonstrated the best agreement with the LC-MS/MS using a Bland-Altman analysis. Results using LC-MS/MS demonstrated that the concentration of androgens and their precursors were higher in women with PCOS than controls [median (2.5, 97.5th % ile); 1607 (638, 3085) vs. 1143 (511, 4784) ng/dL; p = 0.03]. Women with PCOS had higher testosterone [49 (16, 125) vs. 24 (10, 59) ng/dL], androstenedione [203 (98, 476) vs. 106 (69, 223) ng/dL] and 17OH progesterone levels [80 (17, 176) vs. 44 (17, 142) ng/dL] compared to controls (all P<0.02), but no differences in serum concentrations of the adrenal steroids DHEAS, cortisol, corticosterone and their 11 deoxy precursors. Women with PCOS also had an increase in the product: precursor ratio for 3 beta-hydroxysteroid dehydrogenase [22% (6, 92) vs. 20% (4, 43); p = 0.009]. Conclusion: LC-MS/MS was superior to RIA in measuring androstenedione, progesterone and 17OH progesterone levels, while testosterone measurements were better matched in the two assays. Androgen levels were higher in women with PCOS in the absence of a difference in adrenal-predominant steroids. These data support previous findings that the ovary is an important source for the androgen excess in women with PCOS.	[Keefe, Candace C.; Welt, Corrine K.] Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02114 USA; [Goldman, Mildred M.; Zhang, Ke; Clarke, Nigel; Reitz, Richard E.] Quest Diagnost Nichols Inst, Steroids Dept, San Juan Capistrano, CA USA	Harvard University; Massachusetts General Hospital; Nichols Institute	Welt, CK (corresponding author), Massachusetts Gen Hosp, Reprod Endocrine Unit, Boston, MA 02114 USA.	cwelt@partners.org		Welt, Corrine/0000-0002-8219-5504	National Institutes of Health [1R01HD065029, ADA 1-10-CT-57, 1 UL1 RR025758]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065029] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding came from the National Institutes of Health 1R01HD065029 (CKW), ADA 1-10-CT-57 (CKW) and the 1 UL1 RR025758 Harvard Clinical and Translational Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; BARNES RB, 1989, NEW ENGL J MED, V320, P559, DOI 10.1056/NEJM198903023200904; Fanelli F, 2011, STEROIDS, V76, P244, DOI 10.1016/j.steroids.2010.11.005; GillingSmith C, 1997, CLIN ENDOCRINOL, V47, P93, DOI 10.1046/j.1365-2265.1997.2321049.x; GILLINGSMITH C, 1994, J CLIN ENDOCR METAB, V79, P1158, DOI 10.1210/jc.79.4.1158; Hamdine O, 2013, FERTIL STERIL, V100, P867, DOI 10.1016/j.fertnstert.2013.05.031; ISAACS D, 1983, J CLIN PATHOL, V36, P1193, DOI 10.1136/jcp.36.10.1193; Janse F, 2011, EUR J ENDOCRINOL, V165, P925, DOI 10.1530/EJE-11-0482; Jaque J, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-5; Kasum M, 2013, GYNECOL ENDOCRINOL, V29, P744, DOI 10.3109/09513590.2013.798280; KIRSCHNER MA, 1971, J CLIN ENDOCR METAB, V33, P199, DOI 10.1210/jcem-33-2-199; Kumar A, 2005, CLIN ENDOCRINOL, V62, P644, DOI 10.1111/j.1365-2265.2005.02256.x; Legro RS, 2010, J CLIN ENDOCR METAB, V95, P5305, DOI 10.1210/jc.2010-1123; Naessen T, 2010, FERTIL STERIL, V94, P2228, DOI 10.1016/j.fertnstert.2009.12.081; Nelson VL, 1999, MOL ENDOCRINOL, V13, P946, DOI 10.1210/me.13.6.946; Nelson VL, 2001, J CLIN ENDOCR METAB, V86, P5925, DOI 10.1210/jc.86.12.5925; Pasquali R, 2011, CLIN ENDOCRINOL, V74, P424, DOI 10.1111/j.1365-2265.2010.03956.x; RODIN A, 1994, NEW ENGL J MED, V330, P460, DOI 10.1056/NEJM199402173300703; Rosencrantz MA, 2011, J CLIN ENDOCR METAB, V96, P1106, DOI 10.1210/jc.2010-2200; Rosner W, 2007, J CLIN ENDOCR METAB, V92, P405, DOI 10.1210/jc.2006-1864; Simon JA, 2002, FERTIL STERIL, V77, pS77; Taylor AE, 1997, J CLIN ENDOCR METAB, V82, P2248, DOI 10.1210/jc.82.7.2248; Vassiliadi DA, 2009, J CLIN ENDOCR METAB, V94, P3558, DOI 10.1210/jc.2009-0837; Vogeser M, 2007, EXP CLIN ENDOCR DIAB, V115, P559, DOI 10.1055/s-2007-981458; WAJCHENBERG BL, 1986, J CLIN ENDOCR METAB, V63, P1204, DOI 10.1210/jcem-63-5-1204; Welt CK, 2006, J CLIN ENDOCR METAB, V91, P4361, DOI 10.1210/jc.2006-1191; Welt CK, 1999, J CLIN ENDOCR METAB, V84, P2163, DOI 10.1210/jc.84.6.2163; Zawadski J., 1992, POLYCYSTIC OVARY SYN, P377	28	67	72	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93805	10.1371/journal.pone.0093805	http://dx.doi.org/10.1371/journal.pone.0093805			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713888	Green Published, gold, Green Submitted			2022-12-25	WOS:000334160900049
J	Kitsera, N; Gasteiger, K; Luhnsdorf, B; Allgayer, J; Epe, B; Carell, T; Khobta, A				Kitsera, Nataliya; Gasteiger, Karola; Luehnsdorf, Bork; Allgayer, Julia; Epe, Bernd; Carell, Thomas; Khobta, Andriy			Cockayne Syndrome: Varied Requirement of Transcription-Coupled Nucleotide Excision Repair for the Removal of Three Structurally Different Adducts from Transcribed DNA	PLOS ONE			English	Article							UV-SENSITIVE SYNDROME; RNA-POLYMERASE-II; MOLECULAR-BASIS; DAMAGE; PROTEINS; LESION; CELLS; AAF; CSA	Hereditary defects in the transcription-coupled nucleotide excision repair (TC-NER) pathway of damaged DNA cause severe neurodegenerative disease Cockayne syndrome (CS) however the origin and chemical nature of the underlying DNA damage had remained unknown. To find out to which degree the structural properties of DNA lesions determine the extent of transcription arrest in human CS cells we performed quantitative host cell reactivation analyses of expression vectors containing various synthetic adducts. We found that a single 3-(deoxyguanosin-N-2-yl)-2- acetylaminofluorene adduct (dG(N-2)-AAF) constitutes an unsurmountable obstacle to transcription in both CS-A and CS-B cells and is removed exclusively by the CSA and CSB-dependent pathway. In contrast contribution of the CS proteins to the removal of two other transcription-blocking DNA lesions - N-(deoxyguanosin-8-yl)-2-acetylaminofluorene (dG(C8)-AAF) and cyclobutane thymine-thymine (TT) dimer - is only minor (TT dimer) or none (dG(C8)-AAF). The unique properties of dG(N-2)-AAF identify this adduct as a prototype for a new class of DNA lesions that escape the alternative global genome repair and could be critical for the CS pathogenesis.	[Kitsera, Nataliya; Luehnsdorf, Bork; Allgayer, Julia; Epe, Bernd; Khobta, Andriy] Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55122 Mainz, Germany; [Gasteiger, Karola; Carell, Thomas] Univ Munich, Dept Chem & Biochem, Munich, Germany	Johannes Gutenberg University of Mainz; University of Munich	Khobta, A (corresponding author), Johannes Gutenberg Univ Mainz, Inst Pharm & Biochem, D-55122 Mainz, Germany.	khobta@uni-mainz.de	Carell, Thomas/G-4799-2012; Khobta, Andriy/B-6622-2014	Carell, Thomas/0000-0001-7898-2831; Khobta, Andriy/0000-0001-9165-3557	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [KH 263/1, KH 263/2]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	This research was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) (KH 263/1 and KH 263/2). The funder's website:www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgayer J, 2013, NUCLEIC ACIDS RES, V41, P8559, DOI 10.1093/nar/gkt620; Anindya R, 2007, MOL CELL, V28, P386, DOI 10.1016/j.molcel.2007.10.008; Bonala RR, 2005, CHEM RES TOXICOL, V18, P457, DOI 10.1021/tx0497907; Cleaver JE, 2013, MECH AGEING DEV, V134, P284, DOI 10.1016/j.mad.2013.02.005; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Cui XS, 1999, MUTAT RES-GEN TOX EN, V442, P9, DOI 10.1016/S1383-5718(99)00053-4; Donahue BA, 1996, J BIOL CHEM, V271, P10588, DOI 10.1074/jbc.271.18.10588; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Gillet LCJ, 2005, NUCLEIC ACIDS RES, V33, P1961, DOI 10.1093/nar/gki335; Gillet LCJ, 2002, ORG LETT, V4, P4205, DOI 10.1021/ol026474f; Gool AJ, 1997, EMBO J, V16, P5955; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hess MT, 1997, P NATL ACAD SCI USA, V94, P6664, DOI 10.1073/pnas.94.13.6664; Horibata K, 2004, P NATL ACAD SCI USA, V101, P15410, DOI 10.1073/pnas.0404587101; Khobta A, 2013, MECH AGEING DEV, V134, P253, DOI 10.1016/j.mad.2013.03.001; Khobta A, 2010, NUCLEIC ACIDS RES, V38, P4285, DOI 10.1093/nar/gkq170; Laugel V, 2010, HUM MUTAT, V31, P113, DOI 10.1002/humu.21154; Luhnsdorf B, 2012, ANAL BIOCHEM, V425, P47, DOI 10.1016/j.ab.2012.03.001; MAYNE LV, 1982, CANCER RES, V42, P1473; Mu H, 2012, NUCLEIC ACIDS RES, V40, P9675, DOI 10.1093/nar/gks788; Nardo T, 2009, P NATL ACAD SCI USA, V106, P6209, DOI 10.1073/pnas.0902113106; OHANDLEY SF, 1993, BIOCHEMISTRY-US, V32, P2481, DOI 10.1021/bi00061a005; Scharer OD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012609; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Tornaletti S, 2005, MUTAT RES-FUND MOL M, V577, P131, DOI 10.1016/j.mrfmmm.2005.03.014; vanOosterwijk MF, 1996, MOL CELL BIOL, V16, P4436; Vermeulen W, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012625; Wang ZW, 2001, ORG LETT, V3, P565, DOI 10.1021/ol006968h; Yeo JE, 2012, CHEM RES TOXICOL, V25, P2462, DOI 10.1021/tx3003033; Zaliznyak T, 2006, CHEM RES TOXICOL, V19, P745, DOI 10.1021/tx060002i	31	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94405	10.1371/journal.pone.0094405	http://dx.doi.org/10.1371/journal.pone.0094405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713864	Green Submitted, gold, Green Published			2022-12-25	WOS:000334160900129
J	Park, YJ; Baek, JH; Lee, S; Kim, C; Rhee, H; Kim, H; Seo, JS; Park, HR; Yoon, DE; Nam, JY; Kim, HI; Kim, JG; Yoon, H; Kang, HW; Cho, JY; Song, ES; Sung, GH; Yoo, YB; Lee, CS; Lee, BM; Kong, WS				Park, Young-Jin; Baek, Jeong Hun; Lee, Seonwook; Kim, Changhoon; Rhee, Hwanseok; Kim, Hyungtae; Seo, Jeong-Sun; Park, Hae-Ran; Yoon, Dae-Eun; Nam, Jae-Young; Kim, Hong-Il; Kim, Jong-Guk; Yoon, Hyeokjun; Kang, Hee-Wan; Cho, Jae-Yong; Song, Eun-Sung; Sung, Gi-Ho; Yoo, Young-Bok; Lee, Chang-Soo; Lee, Byoung-Moo; Kong, Won-Sik			Whole Genome and Global Gene Expression Analyses of the Model Mushroom Flammulina velutipes Reveal a High Capacity for Lignocellulose Degradation	PLOS ONE			English	Article							CARBON CATABOLITE REPRESSION; FRUITING BODY DEVELOPMENT; SACCHAROMYCES-CEREVISIAE; ALCOHOL-DEHYDROGENASE; ASPERGILLUS-NIDULANS; MITOCHONDRIAL GENOME; PROTEIN EXPRESSION; HYPHAL WALL; RNA GENES; SEQUENCE	Flammulina velutipes is a fungus with health and medicinal benefits that has been used for consumption and cultivation in East Asia. F. velutipes is also known to degrade lignocellulose and produce ethanol. The overlapping interests of mushroom production and wood bioconversion make F. velutipes an attractive new model for fungal wood related studies. Here, we present the complete sequence of the F. velutipes genome. This is the first sequenced genome for a commercially produced edible mushroom that also degrades wood. The 35.6-Mb genome contained 12,218 predicted protein-encoding genes and 287 tRNA genes assembled into 11 scaffolds corresponding with the 11 chromosomes of strain KACC42780. The 88.4-kb mitochondrial genome contained 35 genes. Well-developed wood degrading machinery with strong potential for lignin degradation (69 auxiliary activities, formerly FOLymes) and carbohydrate degradation (392 CAZymes), along with 58 alcohol dehydrogenase genes were highly expressed in the mycelium, demonstrating the potential application of this organism to bioethanol production. Thus, the newly uncovered wood degrading capacity and sequential nature of this process in F. velutipes, offer interesting possibilities for more detailed studies on either lignin or (hemi-) cellulose degradation in complex wood substrates. The mutual interest in wood degradation by the mushroom industry and (ligno-) cellulose biomass related industries further increase the significance of F. velutipes as a new model.	[Park, Young-Jin; Park, Hae-Ran; Yoon, Dae-Eun; Nam, Jae-Young; Kim, Hong-Il; Lee, Chang-Soo] Konkuk Univ, Dept Biomed Chem, Chungju, South Korea; [Baek, Jeong Hun; Lee, Seonwook; Kim, Changhoon; Rhee, Hwanseok; Kim, Hyungtae; Seo, Jeong-Sun] Macrogen Inc, Seoul, South Korea; [Kim, Jong-Guk; Yoon, Hyeokjun] Kyungpook Natl Univ, Dept Life Sci & Biotechnol, Taegu 702701, South Korea; [Kang, Hee-Wan] Hankyong Natl Univ, Grad Sch Biotechnol & Informat Technol, Ansung, South Korea; [Cho, Jae-Yong] Sangji Univ, Dept Pharmaceut Engn, Wonju, South Korea; [Song, Eun-Sung; Lee, Byoung-Moo] Natl Acad Agr Sci, Rural Dev Adm, Suwon, South Korea; [Sung, Gi-Ho; Yoo, Young-Bok; Kong, Won-Sik] Rural Dev Adm, Natl Inst Hort & Herbal Sci, Mushroom Res Div, Eumsung, South Korea; [Seo, Jeong-Sun] Seoul Natl Univ, Med Res Ctr, GMI, Seoul, South Korea	Konkuk University; Macrogen, Inc.; Kyungpook National University; Hankyong National University; Sangji University; Rural Development Administration (RDA), Republic of Korea; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Seoul National University (SNU)	Lee, CS (corresponding author), Konkuk Univ, Dept Biomed Chem, Chungju, South Korea.	cslee@kku.ac.kr; lbmoo@korea.kr; wskong@korea.kr	Seo, Jeong-Sun/J-2763-2012	Kong, Won-Sik/0000-0001-6800-2545	next generation Biogreen 21 Program [PJ008216]; Rural Development Administration, Republic of Korea	next generation Biogreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This work was supported by a grant from the next generation Biogreen 21 Program (Grant number PJ008216), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amore A, 2013, CURR GENOMICS, V14, P230, DOI 10.2174/1389202911314040002; Ando A, 2001, CURR GENET, V39, P190, DOI 10.1007/s002940100193; ARST HN, 1973, MOL GEN GENET, V126, P111, DOI 10.1007/BF00330988; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baldrian P, 2008, FEMS MICROBIOL REV, V32, P501, DOI 10.1111/j.1574-6976.2008.00106.x; Bao DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058294; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BOTTOM CB, 1979, CARBOHYD RES, V77, P169, DOI 10.1016/S0008-6215(00)83803-3; BRUNS TD, 1992, MOL BIOL EVOL, V9, P836; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen BZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058780; CIRIACY M, 1975, MOL GEN GENET, V138, P157, DOI 10.1007/BF02428119; de Smidt O, 2008, FEMS YEAST RES, V8, P967, DOI 10.1111/j.1567-1364.2008.00387.x; Dequard-Chablat M, 2011, MOL BIOL EVOL, V28, P2063, DOI 10.1093/molbev/msr025; DOWZER CEA, 1991, MOL CELL BIOL, V11, P5701, DOI 10.1128/MCB.11.11.5701; FELDMANN H, 1994, EMBO J, V13, P5795, DOI 10.1002/j.1460-2075.1994.tb06923.x; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Foreman PK, 2003, J BIOL CHEM, V278, P31988, DOI 10.1074/jbc.M304750200; Formighieri EF, 2008, MYCOL RES, V112, P1136, DOI 10.1016/j.mycres.2008.04.014; Frijters ACJ, 1997, THEOR APPL GENET, V94, P390, DOI 10.1007/s001220050428; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gonzalez E, 2000, J BIOL CHEM, V275, P35876, DOI 10.1074/jbc.M003035200; Gray MW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011403; Haridas S, 2010, FEMS MICROBIOL LETT, V308, P29, DOI 10.1111/j.1574-6968.2010.01979.x; HYNES MJ, 1977, MOL GEN GENET, V150, P193, DOI 10.1007/BF00695399; Joh JH, 2009, J MICROBIOL BIOTECHN, V19, P774, DOI 10.4014/jmb.0809.548; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kong Won-Sik, 2004, Mycobiology, V32, P11; Kubicek CP, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-19; Kues U, 2000, MICROBIOL MOL BIOL R, V64, P316, DOI 10.1128/MMBR.64.2.316-353.2000; Larroy C, 2002, EUR J BIOCHEM, V269, P5738, DOI 10.1046/j.1432-1033.2002.03296.x; Larroy C, 2002, BIOCHEM J, V361, P163, DOI 10.1042/0264-6021:3610163; Leonowicz A, 1999, FUNGAL GENET BIOL, V27, P175, DOI 10.1006/fgbi.1999.1150; Levasseur A, 2008, FUNGAL GENET BIOL, V45, P638, DOI 10.1016/j.fgb.2008.01.004; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lockington RA, 2001, MOL MICROBIOL, V40, P1311, DOI 10.1046/j.1365-2958.2001.02474.x; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; LUTSTORF U, 1968, ARCH BIOCHEM BIOPHYS, V126, P933, DOI 10.1016/0003-9861(68)90487-6; Maehara T, 2013, FUNGAL BIOL-UK, V117, P220, DOI 10.1016/j.funbio.2013.02.002; Maehara T, 2010, BIOSCI BIOTECH BIOCH, V74, P1126, DOI 10.1271/bbb.100021; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martinez AT, 2005, INT MICROBIOL, V8, P195; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Matheny PB, 2006, MYCOLOGIA, V98, P982, DOI 10.3852/mycologia.98.6.982; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mizuno R, 2009, BIOSCI BIOTECH BIOCH, V73, P2240, DOI 10.1271/bbb.90332; Mizuno R, 2009, BIOSCI BIOTECH BIOCH, V73, P1671, DOI 10.1271/bbb.90099; MOL PC, 1990, MYCOL RES, V94, P472, DOI 10.1016/S0953-7562(10)80006-1; Moore D., 1998, FUNGAL MORPHOGENESIS; Morin E, 2012, P NATL ACAD SCI USA, V109, P17501, DOI 10.1073/pnas.1206847109; Mouhamadou B, 2008, FUNGAL GENET BIOL, V45, P1219, DOI 10.1016/j.fgb.2008.06.006; Noguchi Y, 2009, APPL MICROBIOL BIOT, V85, P141, DOI 10.1007/s00253-009-2236-9; Ohm RA, 2010, NAT BIOTECHNOL, V28, P957, DOI 10.1038/nbt.1643; Okamura, 2009, MUSHROOM SCI BIOTECH, V8, P109; Okamura T, 2001, BIOSCI BIOTECH BIOCH, V65, P1596, DOI 10.1271/bbb.65.1596; PAL M, 1995, WORLD J MICROB BIOT, V11, P541, DOI 10.1007/BF00286370; Park YJ, 2010, MICROBIOL RES, V165, P321, DOI 10.1016/j.micres.2009.06.003; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Psurtseva NV, 2005, INT J MED MUSHROOMS, V7, P449, DOI DOI 10.1615/INTJMEDMUSHROOMS.V7.I3.870; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raudaskoski M, 2010, EUKARYOT CELL, V9, P847, DOI 10.1128/EC.00319-09; Sakamoto Y, 2002, MYCOL RES, V106, P222, DOI 10.1017/S095375620100541X; Sakamoto Y, 2007, FUNGAL GENET BIOL, V44, P14, DOI 10.1016/j.fgb.2006.06.002; Sakamoto Y, 2010, MYCOSCIENCE, V51, P163, DOI 10.1007/s10267-010-0032-0; Santana MF, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-720; SHIDA M, 1981, J BIOCHEM, V90, P1093, DOI 10.1093/oxfordjournals.jbchem.a133561; Soderlund C, 2000, GENOME RES, V10, P1772, DOI 10.1101/gr.GR-1375R; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Stricker AR, 2008, APPL MICROBIOL BIOT, V78, P211, DOI 10.1007/s00253-007-1322-0; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Todd RB, 2000, MOL GEN GENET, V263, P561, DOI 10.1007/s004380051202; van Peer AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022249; van Peij NNME, 1998, MOL MICROBIOL, V27, P131, DOI 10.1046/j.1365-2958.1998.00666.x; van Zyl WH, 2007, ADV BIOCHEM ENG BIOT, V108, P205, DOI 10.1007/10_2007_061; vanIersel MFM, 1997, APPL ENVIRON MICROB, V63, P4079, DOI 10.1128/AEM.63.10.4079-4082.1997; WALTON JD, 1986, CELL, V46, P857, DOI 10.1016/0092-8674(86)90067-X; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang Y, 2008, FEMS MICROBIOL LETT, V280, P34, DOI 10.1111/j.1574-6968.2007.01048.x; WEHNER EP, 1993, MOL GEN GENET, V237, P351, DOI 10.1007/BF00279438; WESSELS JGH, 1993, ADV MICROB PHYSIOL, V34, P147, DOI 10.1016/S0065-2911(08)60029-6; WESSELS JGH, 1972, BIOCHIM BIOPHYS ACTA, V273, P346, DOI 10.1016/0304-4165(72)90226-7; Yamada M, 2005, APPL MICROBIOL BIOT, V67, P240, DOI 10.1007/s00253-004-1776-2; Yamada M, 2008, FEMS MICROBIOL LETT, V289, P130, DOI 10.1111/j.1574-6968.2008.01361.x; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Yoon H, 2012, J GEN APPL MICROBIOL, V58, P331	93	81	112	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93560	10.1371/journal.pone.0093560	http://dx.doi.org/10.1371/journal.pone.0093560			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714189	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900034
J	Swedish, KA; Goldstone, SE				Swedish, Kristin A.; Goldstone, Stephen E.			Prevention of Anal Condyloma with Quadrivalent Human Papillomavirus Vaccination of Older Men Who Have Sex with Men	PLOS ONE			English	Article							HPV INFECTION; RISK-FACTORS; DISEASE; WOMEN; RECURRENCE; CLEARANCE; ACUMINATA; NEOPLASIA; EFFICACY; COHORT	Background: The quadrivalent human papillomavirus vaccine (qHPV) is FDA-approved for use in males 9 to 26 years old to prevent anogenital condyloma. The objective of this study is to determine if qHPV is effective at preventing anal condyloma among men who have sex with men (MSM) aged 26 years and older. Methods: This post-hoc analysis of a nonconcurrent cohort study evaluated 210 patients without history of anal condyloma and 103 patients with previously-treated anal condyloma recurrence-free for at least 12 months prior to vaccination/time zero. We determined the rate of anal condyloma development in vaccinated versus unvaccinated patients. Results: 313 patients with mean age 42 years were followed for median 981 days. During 773.6 person-years follow-up, condyloma developed in 10 (8.6%) vaccinated patients (incidence of 3.7 per 100 person-years) and 37 (18.8%) unvaccinated patients (incidence 7.3 per 100 person-years; p = 0.05). Multivariable hazards ratio showed that qHPV was associated with decreased risk of anal condyloma development (HR 0.45; 95% CI 0.22-0.92; p = 0.03). History of anal condyloma was associated with increased risk of anal condyloma development (HR 2.28; 95% CI 1.28-4.05; p = 0.005), as was infection with oncogenic HPV (HR 3.87; 95% CI 1.66-9.03; p = 0.002). Conclusions: Among MSM 26 years of age and older with and without history of anal condyloma, qHPV reduces the risk of anal condyloma development. A randomized controlled trial is needed to confirm these findings in this age group.	[Swedish, Kristin A.] Montefiore Med Ctr, Dept Internal Med, Bronx, NY 10467 USA; [Goldstone, Stephen E.] Icahn Sch Med Mt Sinai, Dept Surg, New York, NY 10029 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai	Goldstone, SE (corresponding author), Icahn Sch Med Mt Sinai, Dept Surg, New York, NY 10029 USA.	goldstone.stephen@gmail.com						Anic GM, 2012, J INFECT DIS, V205, P789, DOI 10.1093/infdis/jir851; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P630; Chesson HW, 2012, VACCINE, V30, P6016, DOI 10.1016/j.vaccine.2012.07.056; Chin-Hong PV, 2004, J INFECT DIS, V190, P2070, DOI 10.1086/425906; D'Ambrogio A, 2009, SEX TRANSM DIS, V36, P536, DOI 10.1097/OLQ.0b013e3181a866a3; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Goldstone SE, 2013, VACCINE, V31, P3849, DOI 10.1016/j.vaccine.2013.06.057; Goodman MT, 2008, J INFECT DIS, V197, P957, DOI 10.1086/529207; Howley PM, 2007, FIELDS VIROLOGY, V2, P2299; Jin F, 2007, SEX TRANSM DIS, V34, P488, DOI 10.1097/01.olq.0000245960.52668.e5; Joura EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1401; Lee Mortensen Gitte, 2010, BMC Res Notes, V3, P280, DOI 10.1186/1756-0500-3-280; Mistrangelo M, 2010, COLORECTAL DIS, V12, P799, DOI 10.1111/j.1463-1318.2009.01960.x; Palefsky JM, 2011, NEW ENGL J MED, V365, P1576, DOI 10.1056/NEJMoa1010971; Shvetsov YB, 2009, CLIN INFECT DIS, V48, P536, DOI 10.1086/596758; Swedish KA, 2012, CLIN INFECT DIS, V54, P891, DOI 10.1093/cid/cir1036; Swedish KA, 2011, DIS COLON RECTUM, V54, P1003, DOI 10.1097/DCR.0b013e31821d6cb9; Thomas EA, 2011, VACCINE, V29, P570, DOI 10.1016/j.vaccine.2010.09.101; Van den Eeden SK, 1998, SEX TRANSM DIS, V25, P278, DOI 10.1097/00007435-199807000-00002	19	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93393	10.1371/journal.pone.0093393	http://dx.doi.org/10.1371/journal.pone.0093393			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714693	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900025
J	Yang, CY; Li, F; Du, BW; Chen, B; Wang, F; Wang, MK				Yang, Chunyan; Li, Fu; Du, Baowen; Chen, Bin; Wang, Fei; Wang, Mingkui			Isolation and Characterization of New Phenolic Compounds with Estrogen Biosynthesis-Inhibiting and Antioxidation Activities from Broussonetia papyrifera Leaves	PLOS ONE			English	Article							AROMATASE INHIBITORS; LIQUID-CHROMATOGRAPHY; CELL-LINE; IDENTIFICATION; ALPHA; CONSTITUENTS; GLYCOSIDES; EXTRACT	Broussonetia papyrifera leaves (BPL) as a traditional Chinese medicine are also used in livestock feed for stimulating reproduction, adipose tissue and muscle development; however, the mechanism of their action is still unknown. Through estrogen biosynthesis-guided fractionation in human ovarian granulosa-like KGN cells, five new phenolic glycosides, broussoside A-E(1-5), along with fifteen known dietary phenolic compounds, were isolated from the n-butanol extract of BPL, and their structures were elucidated on the basis of NMR spectra analysis and chemical evidence. New compounds 3, 4, 5 and the known compounds 9 and 10 were found to potently inhibit estrogen biosynthesis in KGN cells. In addition, compounds 9, 17, 18, and 20 showed strong antioxidant activity against ABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6sulfonic acid) diammonium salt) and DPPH (1, 1'-diphenyl-2-picryl-hydrazyl radical) assays. These findings suggest that BPL may improve meat quality through the regulation of estrogen biosynthesis. Furthermore, they may be useful for the discovery of potential aromatase modulators from natural products. Finally, they could be considered as a new source for natural antioxidants.	[Yang, Chunyan; Li, Fu; Du, Baowen; Chen, Bin; Wang, Fei; Wang, Mingkui] Chinese Acad Sci, Key Lab Mt Ecol Restorat & Bioresource Utilizat &, Chengdu, Peoples R China; [Yang, Chunyan; Li, Fu; Du, Baowen; Chen, Bin; Wang, Fei; Wang, Mingkui] Chinese Acad Sci, Chengdu Inst Biol, Key Lab Sichuan Prov, Chengdu, Peoples R China; [Yang, Chunyan] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, F (corresponding author), Chinese Acad Sci, Key Lab Mt Ecol Restorat & Bioresource Utilizat &, Chengdu, Peoples R China.	wangfei@cib.ac.cn; wangmk@cib.ac.cn		Wang, Fei/0000-0002-2513-502X	National New Drug Innovation 441 Major Project of 442 China [2011ZX09307-002-02]; National Natural Science Foundation of China 443 [20932007, 21372214]	National New Drug Innovation 441 Major Project of 442 China; National Natural Science Foundation of China 443	This work was supported by the National New Drug Innovation 441 Major Project of 442 China (2011ZX09307-002-02) and National Natural Science Foundation of China 443 (Grants 20932007 and 21372214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alu'datt MH, 2013, FOOD CHEM, V139, P93, DOI 10.1016/j.foodchem.2012.12.061; Bao L, 2010, NAT PROD RES DEV, V22, P939; [鲍玲 Bao Ling], 2010, [天然产物研究与开发, Natural Product R & D], V22, P934; Bhattacharya P, 2013, REV BRAS FARMACOGN, V23, P342, DOI 10.1590/S0102-695X2013005000020; BHAUMIK PK, 1987, PHYTOCHEMISTRY, V26, P3090, DOI 10.1016/S0031-9422(00)84606-3; Bonfield K, 2012, BIOORGAN MED CHEM, V20, P2603, DOI 10.1016/j.bmc.2012.02.042; Cooke PS, 2004, EXP BIOL MED, V229, P1127, DOI 10.1177/153537020422901107; Dawidowicz AL, 2013, EUR FOOD RES TECHNOL, V236, P1099, DOI 10.1007/s00217-013-1982-1; Du QZ, 2012, FOOD CHEM, V131, P1181, DOI 10.1016/j.foodchem.2011.09.095; Gao DF, 2011, FOOD CHEM, V124, P432, DOI 10.1016/j.foodchem.2010.06.048; Gerothanassis IP, 1998, J AGR FOOD CHEM, V46, P4185, DOI 10.1021/jf9804591; GOLLAPUDI SR, 1989, PHYTOCHEMISTRY, V28, P3556, DOI 10.1016/0031-9422(89)80394-2; KIM SY, 1994, J AM OIL CHEM SOC, V71, P633, DOI 10.1007/BF02540592; Kisiel W, 2000, FITOTERAPIA, V71, P269, DOI 10.1016/S0367-326X(99)00158-6; Krafczyk N, 2008, J AGR FOOD CHEM, V56, P3368, DOI 10.1021/jf703701n; Lee D, 2001, J NAT PROD, V64, P1286, DOI 10.1021/np010288l; Lee JH, 2013, FOOD CHEM, V136, P843, DOI 10.1016/j.foodchem.2012.08.057; Liu YB, 2012, J FUNCT FOODS, V4, P116, DOI 10.1016/j.jff.2011.08.006; Lu DF, 2012, J AGR FOOD CHEM, V60, P8411, DOI 10.1021/jf3022817; McInnes KJ, 2008, BREAST CANCER RES TR, V112, P429, DOI 10.1007/s10549-007-9883-2; Minglu X, 2011, J HENAN I SCI TECHNO, P51; Mun'im A, 2003, BIOSCI BIOTECH BIOCH, V67, P410, DOI 10.1271/bbb.67.410; Nair VD, 2013, IND CROP PROD, V45, P406, DOI 10.1016/j.indcrop.2013.01.008; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Ouyang MA, 2007, J AGR FOOD CHEM, V55, P6460, DOI 10.1021/jf0709808; Pineda B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053902; Reyes JM, 2012, SMALL RUMINANT RES, V106, P178, DOI 10.1016/j.smallrumres.2012.03.017; Ryu HW, 2010, J AGR FOOD CHEM, V58, P202, DOI 10.1021/jf903068k; Sarkar A, 2012, J MOL MODEL, V18, P2621, DOI 10.1007/s00894-011-1274-2; Sashidhara KV, 2013, EUR J MED CHEM, V60, P497, DOI 10.1016/j.ejmech.2012.12.019; Shi J, 2010, MOLECULES, V15, P3556, DOI 10.3390/molecules15053556; Shibano M, 2008, J NAT MED-TOKYO, V62, P349, DOI 10.1007/s11418-008-0244-1; Shoeb M, 2007, J NAT MED, V61, P164, DOI 10.1007/s11418-006-0117-4; Stauffer F, 2012, BIOORG MED CHEM LETT, V22, P1860, DOI 10.1016/j.bmcl.2012.01.076; Suvannang N, 2011, MOLECULES, V16, P3597, DOI 10.3390/molecules16053597; Tang WW, 2012, FITOTERAPIA, V83, P513, DOI 10.1016/j.fitote.2011.12.016; Tarola AM, 2013, FOOD ANAL METHOD, V6, P227, DOI 10.1007/s12161-012-9431-5; ter Veld MGR, 2006, J AGR FOOD CHEM, V54, P4407, DOI 10.1021/jf052864f; Xiong Y, 2009, CHINA FOREST SCI TEC, V23, P42; Xu ML, 2010, FOOD SCI BIOTECHNOL, V19, P677, DOI 10.1007/s10068-010-0095-x; Yang CY, 2013, NAT PROD RES, V27, P2055, DOI 10.1080/14786419.2013.811660; Yang CY, 2012, J SEP SCI, V35, P977, DOI 10.1002/jssc.201101104; Yang LJ, 2013, J ETHNOPHARMACOL, V145, P715, DOI 10.1016/j.jep.2012.11.031; Yang YH, 2012, AQUACULTURE, V350, P1, DOI 10.1016/j.aquaculture.2012.04.031; Yao Y, 2011, INT J MOL SCI, V12, P6445, DOI 10.3390/ijms12106445; Yi B, 2011, MOLECULES, V16, P10157, DOI 10.3390/molecules161210157; Zheng ZP, 2008, FOOD CHEM, V106, P529, DOI 10.1016/j.foodchem.2007.06.037; Zhu LF, 2012, J AGR FOOD CHEM, V60, P12170, DOI 10.1021/jf302726t	48	9	12	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94198	10.1371/journal.pone.0094198	http://dx.doi.org/10.1371/journal.pone.0094198			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714659	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900104
J	Konarev, PV; Kachalova, GS; Ryazanova, AY; Kubareva, EA; Karyagina, AS; Bartunik, HD; Svergun, DI				Konarev, Petr V.; Kachalova, Galina S.; Ryazanova, Alexandra Yu; Kubareva, Elena A.; Karyagina, Anna S.; Bartunik, Hans D.; Svergun, Dmitri I.			Flexibility of the Linker between the Domains of DNA Methyltransferase SsoII Revealed by Small-Angle X-Ray Scattering: Implications for Transcription Regulation in SsoII Restriction-Modification System	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PROMOTER REGION; BIOLOGICAL MACROMOLECULES; HHAI METHYLTRANSFERASE; MOLECULAR-BIOLOGY; EXPRESSION; BINDING; METHYLATION; PROTEINS; COMPLEX	Cytosine-5)-DNA methyltransferase SsoII (M. SsoII) consists of a methyltransferase domain (residues 72-379) and an N-terminal region (residues 1-71) which regulates transcription in SsoII restriction-modification system. Small-angle X-ray scattering (SAXS) is employed here to study the low resolution structure of M.SsoII and its complex with DNA containing the methylation site. The shapes reconstructed ab initio from the SAXS data reveal two distinct protein domains of unequal size. The larger domain matches the crystallographic structure of a homologous DNA methyltransferase HhaI (M.HhaI), and the cleft in this domain is occupied by DNA in the model of the complex reconstructed from the SAXS data. This larger domain can thus be identified as the methyltransferase domain whereas the other domain represents the N-terminal region. Homology modeling of the M.SsoII structure is performed by using the model of M.HhaI for the methyltransferase domain and representing the N-terminal region either as a flexible chain of dummy residues or as a rigid structure of a homologous protein (phage 434 repressor) connected to the methyltransferase domain by a short flexible linker. Both models are compatible with the SAXS data and demonstrate high mobility of the N-terminal region. The linker flexibility might play an important role in the function of M.SsoII as a transcription factor.	[Konarev, Petr V.; Svergun, Dmitri I.] DESY, European Mol Biol Lab, Hamburg Outstat, Hamburg, Germany; [Kachalova, Galina S.; Bartunik, Hans D.] Russian Acad Sci, Bach Inst Biochem, Moscow, Russia; [Ryazanova, Alexandra Yu; Kubareva, Elena A.; Karyagina, Anna S.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Karyagina, Anna S.] NF Gamalei Inst Epidemiol & Microbiol, Moscow, Russia; [Karyagina, Anna S.] Russian Acad Sci, Inst Agr Biotechnol, Moscow, Russia	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Research Center of Biotechnology RAS; Russian Academy of Sciences; Lomonosov Moscow State University; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS; All-Russia Research Institute of Agricultural Biotechnology; Russian Academy of Sciences	Svergun, DI (corresponding author), DESY, European Mol Biol Lab, Hamburg Outstat, Hamburg, Germany.	svergun@embl-hamburg.de	kachalova, galina/AAD-9742-2019; Kubareva, Elena A/I-3184-2012; Kachalova, Galina S/J-9437-2015; Ryazanova, Alexandra/E-9427-2012; Karyagina, Anna/I-7159-2012; Konarev, Petr V/W-1380-2017	Kachalova, Galina S/0000-0002-8240-6287; Ryazanova, Alexandra/0000-0002-3503-779X; Karyagina, Anna/0000-0002-2580-3489; Konarev, Petr/0000-0002-5606-1596; Svergun, Dmitri/0000-0003-0830-5696	Max-Planck-Gesellschaft zur Forderung der Wissenschaften; Russian Foundation for Basic Research [13-04-00615_a, 12-04-32103]; Max-Planck fellowship; German Ministry of Education and Science (BMBF) project BIOSCAT [05K20912]	Max-Planck-Gesellschaft zur Forderung der Wissenschaften(Max Planck Society); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Max-Planck fellowship(Max Planck Society); German Ministry of Education and Science (BMBF) project BIOSCAT(Federal Ministry of Education & Research (BMBF))	This work was supported by Max-Planck-Gesellschaft zur Forderung der Wissenschaften and by Russian Foundation for Basic Research (grant nos. 13-04-00615_a and 12-04-32103). A.Yu.R. was a recipient of a Max-Planck fellowship. D. I. S. and P. V. K. acknowledge support from the German Ministry of Education and Science (BMBF) project BIOSCAT, Grant 05K20912. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball N, 2009, ACTA CRYSTALLOGR D, V65, P900, DOI 10.1107/S0907444909020514; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Beletskaya IV, 2000, NUCLEIC ACIDS RES, V28, P3817, DOI 10.1093/nar/28.19.3817; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Burenina OY, 2013, ACTA NATURAE, V5, P70, DOI 10.32607/20758251-2013-5-2-70-80; Butler D, 2001, J BACTERIOL, V183, P4668, DOI 10.1128/JB.183.15.4668-4673.2001; Dong AP, 2004, BIOL CHEM, V385, P373, DOI 10.1515/bchm.385.13.373.57208; DUBEY AK, 1992, NUCLEIC ACIDS RES, V20, P1579, DOI 10.1093/nar/20.7.1579; FRIEDMAN S, 1993, J BACTERIOL, V175, P6293, DOI 10.1128/JB.175.19.6293-6298.1993; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Jeltsch A, 2002, CHEMBIOCHEM, V3, P275, DOI 10.1002/1439-7633(20020402)3:4<274::AID-CBIC274>3.0.CO;2-S; Karyagina A, 1997, NUCLEIC ACIDS RES, V25, P2114, DOI 10.1093/nar/25.11.2114; Karyagina A. S., 2003, Biophysics, V48, pS45; KARYAGINA AS, 1995, GENE, V157, P93, DOI 10.1016/0378-1119(94)00667-H; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Kobayashi I, 2004, NUCL ACID M, V14, P19; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kubareva EA, 2002, BIOTECHNIQUES, V33, P526, DOI 10.2144/02333st02_11839a; MALONE T, 1995, J MOL BIOL, V253, P618, DOI 10.1006/jmbi.1995.0577; McGeehan JE, 2011, J MOL BIOL, V409, P177, DOI 10.1016/j.jmb.2011.03.033; McGeehan JE, 2005, J MOL BIOL, V346, P689, DOI 10.1016/j.jmb.2004.12.025; Nagornykh M O, 2008, Genetika, V44, P606; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; NARDONE G, 1984, J BIOL CHEM, V259, P357; NIKOLSKAYA II, 1984, BIOCHEM INT, V9, P771; O'Driscoll J, 2005, MOL MICROBIOL, V57, P1532, DOI 10.1111/j.1365-2958.2005.04769.x; O'Gara M, 1999, J MOL BIOL, V287, P201, DOI 10.1006/jmbi.1999.2608; OGara M, 1996, J MOL BIOL, V261, P634, DOI 10.1006/jmbi.1996.0489; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Porod G., 1982, SMALL ANGLE XRAY SCA, P17, DOI DOI 10.1002/ACTP.1985.010360520; Protsenko A, 2009, NUCLEIC ACIDS RES, V37, P5322, DOI 10.1093/nar/gkp579; REINISCH KM, 1995, CELL, V82, P143, DOI 10.1016/0092-8674(95)90060-8; Roberts RJ, 2010, NUCLEIC ACIDS RES, V38, pD234, DOI 10.1093/nar/gkp874; RODGERS DW, 1993, STRUCTURE, V1, P227, DOI 10.1016/0969-2126(93)90012-6; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; RUBIN RA, 1977, J BIOL CHEM, V252, P7265; Ryazanova AY, 2011, ANALYST, V136, P1227, DOI 10.1039/c0an00545b; Ryazanova AY, 2010, MOL BIOL+, V44, P807, DOI 10.1134/S0026893310050183; Ryazanova AY, 2011, NUCLEOS NUCLEOT NUCL, V30, P632, DOI 10.1080/15257770.2011.584339; Ryazanova AY, 2012, METHYLATION DNA RNA, P29; Sawaya MR, 2005, STRUCTURE, V13, P1837, DOI 10.1016/j.str.2005.08.017; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Shilov I, 1998, NUCLEIC ACIDS RES, V26, P2659, DOI 10.1093/nar/26.11.2659; SOM S, 1993, EMBO J, V12, P4297, DOI 10.1002/j.1460-2075.1993.tb06114.x; Som S, 1997, J BACTERIOL, V179, P964, DOI 10.1128/jb.179.3.964-967.1997; Streeter SD, 2004, NUCLEIC ACIDS RES, V32, P6445, DOI 10.1093/nar/gkh975; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2000, J BIOL CHEM, V275, P14432, DOI 10.1074/jbc.275.19.14432; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Thomas CB, 2006, NUCLEIC ACIDS RES, V34, P806, DOI 10.1093/nar/gkj486; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vorob'eva OV, 2002, RUSS J BIOORG CHEM+, V28, P363, DOI 10.1023/A:1020463810179; Vorob'eva OV, 2000, MOL BIOL+, V34, P921, DOI 10.1023/A:1026640212498	56	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93453	10.1371/journal.pone.0093453	http://dx.doi.org/10.1371/journal.pone.0093453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710319	Green Submitted, gold, Green Published			2022-12-25	WOS:000334159800034
J	Miyagawa, K; Yamazaki, M; Kawai, M; Nishino, J; Koshimizu, T; Ohata, Y; Tachikawa, K; Mikuni-Takagaki, Y; Kogo, M; Ozono, K; Michigami, T				Miyagawa, Kazuaki; Yamazaki, Miwa; Kawai, Masanobu; Nishino, Jin; Koshimizu, Takao; Ohata, Yasuhisa; Tachikawa, Kanako; Mikuni-Takagaki, Yuko; Kogo, Mikihiko; Ozono, Keiichi; Michigami, Toshimi			Dysregulated Gene Expression in the Primary Osteoblasts and Osteocytes Isolated from Hypophosphatemic Hyp Mice	PLOS ONE			English	Article							X-LINKED HYPOPHOSPHATEMIA; VITAMIN-D METABOLISM; PHOSPHATE HOMEOSTASIS; INORGANIC-PHOSPHATE; MINERAL METABOLISM; TARGETED ABLATION; DIETARY PHOSPHATE; FGF23 EXPRESSION; IN-VITRO; PEX GENE	Osteocytes express multiple genes involved in mineral metabolism including PHEX, FGF23, DMP1 and FAM20C. In Hyp mice, a murine model for X-linked hypophosphatemia (XLH),Phex deficiency results in the overproduction of FGF23 in osteocytes, which leads to hypophosphatemia and impaired vitamin D metabolism. In this study, to further clarify the abnormality in osteocytes of Hyp mice, we obtained detailed gene expression profiles in osteoblasts and osteocytes isolated from the long bones of 20-week-old Hyp mice and wild-type (WT) control mice. The expression of Fgf23, Dmp1, and Fam20c was higher in osteocytic cells than in osteoblastic cells in both genotypes, and was up-regulated in Hyp cells. Interestingly, the up-regulation of these genes in Hyp bones began before birth. On the other hand, the expression of Slc20a1 encoding the sodium/phosphate (Na+/Pi) co-transporter Pit1 was increased in osteoblasts and osteocytes from adult Hyp mice, but not in Hyp fetal bones. The direct effects of extracellular Pi and 1,25-dihydroxyvitamin D-3 [ 1,25( OH) D-2(3)] on isolated osteoblastic and osteocytic cells were also investigated. Twenty-four-hour treatment with 10(-8) M 1,25(OH)(2)D-3 increased the expression of Fgf23 in WT osteoblastic cells but not in osteocytic cells. Dmp1 expression in osteocytic cells was increased due to the 24-hour treatment with 10 mM Pi and was suppressed by 10(-8) M 1,25(OH)(2)D-3 in WT osteocytic cells. We also found the up-regulation of the genes for FGF1, FGF2, their receptors, and Egr-1 which is a target of FGF signaling, in Hyp osteocytic cells, suggesting the activation of FGF/FGFR signaling. These results implicate the complex gene dysregulation in osteoblasts and osteocytes of Hyp mice, which might contribute to the pathogenesis.	[Miyagawa, Kazuaki; Yamazaki, Miwa; Kawai, Masanobu; Nishino, Jin; Koshimizu, Takao; Ohata, Yasuhisa; Tachikawa, Kanako; Michigami, Toshimi] Osaka Med Ctr, Dept Bone & Mineral Res, Osaka, Japan; [Miyagawa, Kazuaki; Yamazaki, Miwa; Kawai, Masanobu; Nishino, Jin; Koshimizu, Takao; Ohata, Yasuhisa; Tachikawa, Kanako; Michigami, Toshimi] Res Inst Maternal & Child Hlth, Izumi Ku, Osaka, Japan; [Ohata, Yasuhisa; Ozono, Keiichi] Osaka Univ, Grad Sch Med, Dept Pediat, Suita, Osaka, Japan; [Miyagawa, Kazuaki; Nishino, Jin; Kogo, Mikihiko] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg 1, Suita, Osaka, Japan; [Mikuni-Takagaki, Yuko] Kanagawa Dent Coll, Dept Mol & Cellular Biol Mineralized Tissues, Yokosuka, Kanagawa 238, Japan	Osaka Medical Center for Cancer & Cardiovascular Diseases; Osaka University; Osaka University; Kanagawa Dental College	Michigami, T (corresponding author), Osaka Med Ctr, Dept Bone & Mineral Res, Osaka, Japan.	michigami@mch.pref.osaka.jp	Kogo, Mikihiko/ABD-7080-2020; Ohata, Yasuhisa/AAJ-4615-2020; Michigami, Toshimi/AAU-2326-2021	Kogo, Mikihiko/0000-0002-4556-2491; Ohata, Yasuhisa/0000-0001-6084-6620; Kawai, Masanobu/0000-0003-4466-1559; Miyagawa, Kazuaki/0000-0003-4014-1847	Japan Society for the Promotion of Science [23591227]; Grants-in-Aid for Scientific Research [23791216, 23591227] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from Japan Society for the Promotion of Science (No. 23591227). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for the study.	Beck GR, 2003, J BIOL CHEM, V278, P41921, DOI 10.1074/jbc.M304470200; Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997; Beck L, 1997, J CLIN INVEST, V99, P1200, DOI 10.1172/JCI119276; Bonewald LF, 2008, BONE, V42, P606, DOI 10.1016/j.bone.2007.12.224; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Cornet A, 1998, J NEUROSCI RES, V53, P742, DOI 10.1002/(SICI)1097-4547(19980915)53:6<742::AID-JNR11>3.0.CO;2-#; Endo I, 2008, BONE, V42, P1235, DOI 10.1016/j.bone.2008.02.014; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Ferrari SL, 2005, J CLIN ENDOCR METAB, V90, P1519, DOI 10.1210/jc.2004-1039; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Igwe JC, 2011, CONNECT TISSUE RES, V52, P401, DOI 10.3109/03008207.2010.546536; Ito N, 2007, J BONE MINER METAB, V25, P419, DOI 10.1007/s00774-007-0779-3; Ito N, 2013, J STEROID BIOCHEM, V136, P183, DOI 10.1016/j.jsbmb.2012.09.029; Kato K, 2006, J BIOL CHEM, V281, P18370, DOI 10.1074/jbc.M602469200; Kimata M, 2010, BONE, V47, P938, DOI 10.1016/j.bone.2010.08.006; Kyono A, 2012, J BONE MINER METAB, V30, P19, DOI 10.1007/s00774-011-0288-2; Li H, 2011, AM J PHYSIOL-ENDOC M, V300, pE508, DOI 10.1152/ajpendo.00499.2010; Liu SG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1636, DOI 10.1152/ajpendo.00396.2007; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; Liu SG, 2009, MOL ENDOCRINOL, V23, P1505, DOI 10.1210/me.2009-0085; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; MIKUNITAKAGAKI Y, 1995, J BONE MINER RES, V10, P231, DOI 10.1002/jbmr.5650100209; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nishida Y, 2006, KIDNEY INT, V70, P2141, DOI 10.1038/sj.ki.5002000; Pereira RC, 2009, BONE, V45, P1161, DOI 10.1016/j.bone.2009.08.008; Perwad F, 2005, ENDOCRINOLOGY, V146, P5358, DOI 10.1210/en.2005-0777; Quarles LD, 2008, J CLIN INVEST, V118, P3820, DOI 10.1172/JCI36479; Rafaelsen SH, 2013, J BONE MINER RES, V28, P1378, DOI 10.1002/jbmr.1850; REINHARDT TA, 1990, ENDOCRINOLOGY, V127, P942, DOI 10.1210/endo-127-2-942; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Sabbagh Y, 2000, HUM MUTAT, V16, P1; Saini V, 2013, J BIOL CHEM, V288, P20122, DOI 10.1074/jbc.M112.441360; Segawa H, 2003, PFLUG ARCH EUR J PHY, V446, P585, DOI 10.1007/s00424-003-1084-1; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Stern AR, 2012, BIOTECHNIQUES, V52, P361, DOI 10.2144/0000113876; Strom TM, 1997, HUM MOL GENET, V6, P165, DOI 10.1093/hmg/6.2.165; Tagliabracci VS, 2012, SCIENCE, V336, P1150, DOI 10.1126/science.1217817; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Ubaidus S, 2009, J ELECTRON MICROSC, V58, P381, DOI 10.1093/jmicro/dfp032; Virkki LV, 2007, AM J PHYSIOL-RENAL, V293, pF643, DOI 10.1152/ajprenal.00228.2007; Wang XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002708; White KE, 2005, AM J HUM GENET, V76, P361, DOI 10.1086/427956; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yuan B, 2008, J CLIN INVEST, V118, P722, DOI 10.1172/JCI32702; Yuan BZ, 2013, J BONE MINER RES, V28, P56, DOI 10.1002/jbmr.1738	51	38	37	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93840	10.1371/journal.pone.0093840	http://dx.doi.org/10.1371/journal.pone.0093840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710520	gold, Green Submitted, Green Published			2022-12-25	WOS:000334159800056
J	Prager, SM; Esquivel, I; Trumble, JT				Prager, Sean M.; Esquivel, Isaac; Trumble, John T.			Factors Influencing Host Plant Choice and Larval Performance in Bactericera cockerelli	PLOS ONE			English	Article							ZEBRA CHIP DISEASE; HEMIPTERA TRIOZIDAE; LIFE-HISTORY; POTATO; SELECTION; PREFERENCE; LEPIDOPTERA; HOMOPTERA; MEMORY; TOMATO	Among the many topics of interest to ecologists studying associations between phytophagous insects and their host plants are the influence of natal host plant on future oviposition decisions and the mechanisms of generalist versus specialist host selection behavior. In this study, we examined the oviposition preferences, behavior and larval development of the tomato/potato psyllid, Bactericera cockerelli. By rearing psyllids with two distinct geographically-linked haplotypes on different host plants, we were able to examine the role of natal host plant and potential local adaptation on host plant usage. Choice bioassays among three host species demonstrated that psyllids from California had clear preferences that were influenced by natal plant. We further found that patterns in choice bioassays corresponded to observed feeding and movement responses. No-choice bioassays demonstrated that there is little to no association between development and host-plant choice for oviposition, while also indicating that host choice varies between haplotypes. These findings support the concept that mothers do not always choose oviposition sites optimally and also add support for the controversial Hopkins' host selection principle.	[Prager, Sean M.; Esquivel, Isaac; Trumble, John T.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Prager, SM (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	sprager@ucr.edu		Esquivel, Isaac/0000-0002-2242-0466	USDA SCRI [2009-34381-20036]; California Department of Food and Agriculture (CDFA) Speciality Crop Block [SCB11052]	USDA SCRI(United States Department of Agriculture (USDA)); California Department of Food and Agriculture (CDFA) Speciality Crop Block	This research was partially funded by a USDA SCRI grant (2009-34381-20036) and a California Department of Food and Agriculture (CDFA) Speciality Crop Block Grant SCB11052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Barron AB, 2001, J INSECT BEHAV, V14, P725, DOI 10.1023/A:1013033332535; Berdegue M, 1996, ENTOMOL EXP APPL, V78, P253, DOI 10.1111/j.1570-7458.1996.tb00789.x; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Bernays EA, 2001, ANNU REV ENTOMOL, V46, P703, DOI 10.1146/annurev.ento.46.1.703; Blackiston DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001736; Butler Casey D., 2012, Terrestrial Arthropod Reviews, V5, P87, DOI 10.1163/187498312X634266; Butler CD, 2012, ENTOMOL EXP APPL, V142, P247, DOI 10.1111/j.1570-7458.2012.01219.x; Butler CD, 2011, J ECON ENTOMOL, V104, P586, DOI 10.1603/EC10285; Casteel CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035191; Clark KE, 2011, ECOL ENTOMOL, V36, P117, DOI 10.1111/j.1365-2311.2010.01248.x; CORBET SA, 1985, ECOL ENTOMOL, V10, P143, DOI 10.1111/j.1365-2311.1985.tb00543.x; Crawley M. J., 1983, Herbivory. The dynamics of animal--plant interactions.; Crosslin JM, 2009, AM J POTATO RES, V86, P183, DOI 10.1007/s12230-009-9070-6; Dukas R, 2008, ANNU REV ENTOMOL, V53, P145, DOI 10.1146/annurev.ento.53.103106.093343; Dunlap AS, 2012, BEHAV PROCESS, V89, P86, DOI 10.1016/j.beproc.2011.10.005; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Forister ML, 2013, OIKOS, V122, P657, DOI 10.1111/j.1600-0706.2013.00251.x; Fox J., 2019, R COMPANION APPL REG, V3rd ed; Funk DJ, 2002, GENETICA, V116, P251, DOI 10.1023/A:1021236510453; Futuyma D.J., 1983, COEVOLUTION; Gao F, 2009, INSECT SCI, V16, P399, DOI 10.1111/j.1744-7917.2009.01261.x; Hansen AK, 2008, APPL ENVIRON MICROB, V74, P5862, DOI 10.1128/AEM.01268-08; Hansen AK, 2013, MOL ECOL; HODKINSON ID, 1974, B ENTOMOL RES, V64, P325, DOI 10.1017/S0007485300031217; Hopkins AD, 1916, EC INVESTIGATIONS SC, P353; JAENIKE J, 1978, THEOR POPUL BIOL, V14, P350, DOI 10.1016/0040-5809(78)90012-6; JAENIKE J, 1983, OECOLOGIA, V58, P320, DOI 10.1007/BF00385230; Jallow MFA, 2004, CROP PROT, V23, P955, DOI 10.1016/j.cropro.2004.02.008; Janz N, 2005, J INSECT BEHAV, V18, P767, DOI 10.1007/s10905-005-8739-z; Johnson SN, 2006, ECOL ENTOMOL, V31, P395, DOI 10.1111/j.1365-2311.2006.00776.x; KAROWE DN, 1990, EVOLUTION, V44, P1637, DOI 10.1111/j.1558-5646.1990.tb03852.x; KNOWLTON GEORGE F., 1934, JOUR ECON ENT, V27, P547, DOI 10.1093/jee/27.2.547; Liefting LW, 2008, PLANT DIS, V92, P1474, DOI 10.1094/PDIS-92-10-1474A; Liefting LW, 2009, PLANT DIS, V93, P208, DOI 10.1094/PDIS-93-3-0208; Liu D, 2006, ENTOMOL EXP APPL, V118, P177, DOI 10.1111/j.1570-7458.2006.00383.x; Liu D, 2006, B ENTOMOL RES, V96, P197, DOI 10.1079/BER2005416; Liu D, 2007, ENTOMOL EXP APPL, V123, P35, DOI 10.1111/j.1570-7458.2007.00521.x; Liu DG, 2005, CROP PROT, V24, P111, DOI 10.1016/j.cropro.2004.07.001; Liu DG, 2004, J ECON ENTOMOL, V97, P1078, DOI 10.1603/0022-0493(2004)097[1078:TPBRTT]2.0.CO;2; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; Martin Nicholas A., 2008, Weta, V35, P12; Matkin OA, 1957, UC TYPE SOIL MIXES; Matsubayashi KW, 2010, ENTOMOL EXP APPL, V134, P1, DOI 10.1111/j.1570-7458.2009.00916.x; Mayhew PJ, 2001, TRENDS ECOL EVOL, V16, P165, DOI 10.1016/S0169-5347(00)02099-1; Mayhew PJ, 1997, OIKOS, V79, P417, DOI 10.2307/3546884; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Mery F, 2010, EVOL ECOL, V24, P571, DOI 10.1007/s10682-009-9336-y; MITTER C, 1991, TRENDS ECOL EVOL, V6, P290, DOI 10.1016/0169-5347(91)90007-K; MOPPER S, 1995, EVOLUTION, V49, P810, DOI [10.2307/2410404, 10.1111/j.1558-5646.1995.tb02317.x]; Munyaneza JE, 2013, PLANT DIS, V97, P1654, DOI 10.1094/PDIS-06-13-0641-PDN; Munyaneza JE, 2013, PLANT DIS, V97, P1244, DOI 10.1094/PDIS-03-13-0247-PDN; MUNYANEZA JE, 2007, SUBTROPICAL PLANT SC, V59, P30; NANTHAGOPAL R, 1989, CROP PROT, V8, P133, DOI 10.1016/0261-2194(89)90089-6; Oksanen J., 2013, VEGAN COMMUNITY ECOL; Oksanen J., 2011, MULTIVARIATE ANAL EC; PHILLIPS WM, 1977, ENTOMOL EXP APPL, V21, P71, DOI 10.1007/BF00300343; PLETSCH D. J., 1947, Bull. Mont. agric. Exp. Stn., V446; Prager SM, 2013, PEST MANAG SCI, V69, P1131, DOI 10.1002/ps.3475; Price PW, 2011, INSECT ECOLOGY; Ray S, 1999, NEUROSCI LETT, V259, P37, DOI 10.1016/S0304-3940(98)00892-1; Rietdorf K, 2002, PHYSIOL ENTOMOL, V27, P223, DOI 10.1046/j.1365-3032.2002.00289.x; Scheirs J, 2000, P ROY SOC B-BIOL SCI, V267, P2065, DOI 10.1098/rspb.2000.1250; Scheirs J, 2002, OIKOS, V96, P187, DOI 10.1034/j.1600-0706.2002.960121.x; SMITH MA, 1979, ANIM BEHAV, V27, P365, DOI 10.1016/0003-3472(79)90170-2; Swisher KD, 2013, AM J POTATO RES, V90, P570, DOI 10.1007/s12230-013-9330-3; Swisher KD, 2012, ENVIRON ENTOMOL, V41, P1019, DOI 10.1603/EN12066; Thomas K. L., 2011, New Zealand Plant Protection, V64, P259; Thoming G, 2013, ECOLOGY, V94, P1744, DOI 10.1890/12-0907.1; THOMPSON JN, 1988, ENTOMOL EXP APPL, V47, P3, DOI 10.1007/BF00186709; TULLY T, 1994, J NEUROSCI, V14, P68; Underwood NC, 1998, OECOLOGIA, V114, P376, DOI 10.1007/s004420050460; VALLADARES G, 1991, J ANIM ECOL, V60, P227, DOI 10.2307/5456; Van Klinken RD, 2000, ECOL ENTOMOL, V25, P413, DOI 10.1046/j.1365-2311.2000.00274.x; vanEmden HF, 1996, PHYSIOL ENTOMOL, V21, P325, DOI 10.1111/j.1365-3032.1996.tb00873.x; Venables W.N., 2002, MODERN APPL STAT S; Wallis CM, 2013, PHYTOPATHOLOGY, V103, P154; WALLIS R. L., 1955, Technical Bulletin. United States Department of Agriculture; WALLIS RL, 1951, J ECON ENTOMOL, V44, P815, DOI 10.1093/jee/44.5.815; White I.M., 1985, Bulletin of the British Museum (Natural History) Entomology, V50, P153; WIKLUND C, 1981, OIKOS, V36, P163, DOI 10.2307/3544441; WIKLUND C, 1975, OECOLOGIA, V18, P185, DOI 10.1007/BF00345421; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Yang XB, 2010, J ECON ENTOMOL, V103, P1729, DOI 10.1603/EC10083; Yang XB, 2009, ENVIRON ENTOMOL, V38, P1661, DOI 10.1603/022.038.0619; ZHANG ML, 1993, J CHEM ECOL, V19, P1109, DOI 10.1007/BF00987372	89	24	26	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94047	10.1371/journal.pone.0094047	http://dx.doi.org/10.1371/journal.pone.0094047			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710468	gold, Green Published, Green Submitted			2022-12-25	WOS:000334159800095
J	Hresko, RC; Kraft, TE; Tzekov, A; Wildman, SA; Hruz, PW				Hresko, Richard C.; Kraft, Thomas E.; Tzekov, Anatoly; Wildman, Scott A.; Hruz, Paul W.			Isoform-selective Inhibition of Facilitative Glucose Transporters ELUCIDATION OF THE MOLECULAR MECHANISM OF HIV PROTEASE INHIBITOR BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENTS; INSULIN-RESISTANCE; SCANNING-MUTAGENESIS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; LIGAND-BINDING; CYTOCHALASIN-B; GLUT1; SURFACE; CELLS	Pharmacologic HIV protease inhibitors (PIs) and structurally related oligopeptides are known to reversibly bind and inactivate the insulin-responsive facilitative glucose transporter 4 (GLUT4). Several PIs exhibit isoform selectivity with little effect on GLUT1. The ability to target individual GLUT isoforms in an acute and reversible manner provides novel means both to investigate the contribution of individual GLUTs to health and disease and to develop targeted treatment of glucose-dependent diseases. To determine the molecular basis of transport inhibition, a series of chimeric proteins containing transmembrane and cytosolic domains from GLUT1 and GLUT4 and/or point mutations were generated and expressed in HEK293 cells. Structural integrity was confirmed via measurement of N-[2-[2[ 2-[(N-biotinylcaproylamino) ethoxy) ethoxyl]-4-[2-(trifluoromethyl)- 3H-diazirin-3-yl] benzoyl]-1,3-bis(mannopyranosyl- 4-yloxy)-2-propylamine (ATB-BMPA) labeling of the chimeric proteins in low density microsome fractions isolated from stably transfected 293 cells. Functional integrity was assessed via measurement of zero-trans 2-deoxyglucose (2-DOG) uptake. ATB-BMPA labeling studies and 2-DOG uptake revealed that transmembrane helices 1 and 5 contain amino acid residues that influence inhibitor access to the transporter binding domain. Substitution of Thr-30 and His-160 in GLUT1 to the corresponding positions in GLUT4 is sufficient to completely transform GLUT1 into GLUT4 with respect to indinavir inhibition of 2-DOG uptake and ATB-BMPA binding. These data provide a structural basis for the selectivity of PIs toward GLUT4 over GLUT1 that can be used in ongoing novel drug design.	[Hruz, Paul W.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Wildman, Scott A.] Washington Univ, Sch Med, Dept Biochem, St Louis, MO 63110 USA; [Hruz, Paul W.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Hruz, PW (corresponding author), Washington Univ, Sch Med, Dept Pediat, 660 S Euclid Ave,Campus Box 8208, St Louis, MO 63110 USA.	hruz_p@kids.wustl.edu		Kraft, Thomas/0000-0002-5528-3197; Wildman, Scott/0000-0002-8598-0751; Hruz, Paul/0000-0002-1478-3355	National Institutes of Health [DK064572, HL092798]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK064572 and HL092798.	Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; Caffrey DR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-381; Chan DA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002394; CLARK AE, 1990, BIOCHEM J, V269, P615, DOI 10.1042/bj2690615; CZECH MP, 1993, J CELL BIOL, V123, P127, DOI 10.1083/jcb.123.1.127; De Zutter JK, 2013, J BIOL CHEM, V288, P20734, DOI 10.1074/jbc.M113.469023; GORGA FR, 1981, BIOCHEMISTRY-US, V20, P5108, DOI 10.1021/bi00521a003; Haspel HC, 1999, J MEMBRANE BIOL, V169, P45, DOI 10.1007/PL00005900; HELLWIG B, 1991, MOL PHARMACOL, V40, P383; Hertel J, 2004, J BIOL CHEM, V279, P55147, DOI 10.1074/jbc.M410826200; HOLMAN GD, 1990, J BIOL CHEM, V265, P18172; Hresko RC, 2011, DIABETES, V60, pA409; Hresko RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025237; Hruz PW, 2006, JAIDS-J ACQ IMM DEF, V43, P624, DOI 10.1097/01.qai.0000245883.66509.b4; Hruz PW, 2011, BEST PRACT RES CL EN, V25, P459, DOI 10.1016/j.beem.2010.10.017; Hruz PW, 2011, ANTIMICROB AGENTS CH, V55, P1377, DOI 10.1128/AAC.01184-10; Hruz PW, 2001, MOL MEMBR BIOL, V18, P183; Iancu CV, 2013, P NATL ACAD SCI USA, V110, P17862, DOI 10.1073/pnas.1311485110; INUKAI K, 1994, BIOCHEM J, V302, P355, DOI 10.1042/bj3020355; Klepper J, 2007, DEV MED CHILD NEUROL, V49, P707, DOI 10.1111/j.1469-8749.2007.00707.x; Koumanov F, 1998, BIOCHEM J, V330, P1209, DOI 10.1042/bj3301209; Lachaal M, 1996, J BIOL CHEM, V271, P5225; Madej MG, 2014, P NATL ACAD SCI USA, V111, pE719, DOI 10.1073/pnas.1400336111; McBrayer SK, 2012, BLOOD, V119, P4686, DOI 10.1182/blood-2011-09-377846; Michau A, 2013, J BIOL CHEM, V288, P31080, DOI 10.1074/jbc.M113.469189; MUECKLER M, 1994, J BIOL CHEM, V269, P20533; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Mueckler M, 2009, BIOCHEMISTRY-US, V48, P5934, DOI 10.1021/bi900521n; Murata H, 2000, J BIOL CHEM, V275, P20251, DOI 10.1074/jbc.C000228200; Murata H, 2002, AIDS, V16, P859, DOI 10.1097/00002030-200204120-00005; Noel LE, 1997, BIOCHEMISTRY-US, V36, P5465, DOI 10.1021/bi9630624; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; PIPER RC, 1991, AM J PHYSIOL, V260, pC570, DOI 10.1152/ajpcell.1991.260.3.C570; Quistgaard EM, 2013, NAT STRUCT MOL BIOL, V20, P766, DOI 10.1038/nsmb.2569; Rudich A, 2003, DIABETOLOGIA, V46, P649, DOI 10.1007/s00125-003-1080-1; Schurmann A, 1997, BIOCHEMISTRY-US, V36, P12897, DOI 10.1021/bi971173c; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smirnova I, 2011, BIOCHEMISTRY-US, V50, P9684, DOI 10.1021/bi2014294; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; TAMORI Y, 1994, J BIOL CHEM, V269, P2982; TORDJMAN KM, 1989, P NATL ACAD SCI USA, V86, P7761, DOI 10.1073/pnas.86.20.7761; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03	43	13	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16100	16113		10.1074/jbc.M113.528430	http://dx.doi.org/10.1074/jbc.M113.528430			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24706759	hybrid, Green Published			2022-12-25	WOS:000337965700018
J	Peters, DE; Szabo, R; Friis, S; Shylo, NA; Sales, KU; Holmbeck, K; Bugge, TH				Peters, Diane E.; Szabo, Roman; Friis, Stine; Shylo, Natalia A.; Sales, Katiuchia Uzzun; Holmbeck, Kenn; Bugge, Thomas H.			The Membrane-anchored Serine Protease Prostasin (CAP1/PRSS8) Supports Epidermal Development and Postnatal Homeostasis Independent of Its Enzymatic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEOLYTIC CASCADE; BARRIER FUNCTION; ACTIVATION; MUTATIONS; CHANNELS; CLOSURE; CELL	The membrane-anchored serine protease prostasin (CAP1/PRSS8) is part of a cell surface proteolytic cascade that is essential for epithelial barrier formation and homeostasis. Here, we report the surprising finding that prostasin executes these functions independent of its own enzymatic activity. Prostasin null (Prss8(-/-)) mice lack barrier formation and display fatal postnatal dehydration. In sharp contrast, mice homozygous for a point mutation in the Prss8 gene, which causes the substitution of the active site serine within the catalytic histidine-aspartate-serine triad with alanine and renders prostasin catalytically inactive (Prss8(Cat-/Cat-) mice), develop barrier function and are healthy when followed for up to 20 weeks. This striking difference could not be explained by genetic modifiers or by maternal effects, as these divergent phenotypes were displayed by Prss8(-/-) and Prss8Cat(-/Cat-) mice born within the same litter. Furthermore, Prss8Cat(-/Cat-) mice were able to regenerate epidermal covering following cutaneous wounding. This study provides the first demonstration that essential in vivo functions of prostasin are executed by a non-enzymatic activity of this unique membrane-anchored serine protease.	[Peters, Diane E.; Szabo, Roman; Friis, Stine; Shylo, Natalia A.; Sales, Katiuchia Uzzun; Bugge, Thomas H.] Natl Inst Dent & Craniofacial Res, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Peters, Diane E.] Tufts Univ, Sch Med, Program Pharmacol & Expt Therapeut, Boston, MA 02111 USA; [Friis, Stine] Univ Copenhagen, Dept Cellular & Mol Med, Fac Hlth Sci, DK-2200 Copenhagen, Denmark; [Holmbeck, Kenn] Natl Inst Dent & Craniofacial Res, Connect Tissue Remodeling Sect, NIH, Bethesda, MD 20892 USA; [Sales, Katiuchia Uzzun] Natl Inst Dent & Craniofacial Res, Clin Res Core, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Tufts University; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Bugge, TH (corresponding author), Natl Inst Dent & Craniofacial Res, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, NIH, 30 Convent Dr,Rm 211, Bethesda, MD 20892 USA.	thomas.bugge@nih.gov	sales, katiuchia u/J-4880-2012	Shylo, Natalia/0000-0002-0466-896X; Peters, Diane/0000-0003-4185-6203; sales, katiuchia/0000-0002-3768-5790	NIDCR Intramural Research Program; Harboe Foundation; Lundbeck Foundation; Foundation of 17.12.1981; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000676, ZIADE000699] Funding Source: NIH RePORTER	NIDCR Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Harboe Foundation; Lundbeck Foundation(Lundbeckfonden); Foundation of 17.12.1981; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the NIDCR Intramural Research Program (to K. H. and T. H. B.), by The Harboe Foundation, The Lundbeck Foundation, and the Foundation of 17.12.1981 (to S. F.).	Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Buzza MS, 2013, J BIOL CHEM, V288, P10328, DOI 10.1074/jbc.M112.443432; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; DONATE LE, 1994, PROTEIN SCI, V3, P2378, DOI 10.1002/pro.5560031222; Frateschi S, 2012, AM J PATHOL, V181, P605, DOI 10.1016/j.ajpath.2012.05.007; Friis S, 2013, J BIOL CHEM, V288, P19028, DOI 10.1074/jbc.M113.469932; Hummler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055796; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2007, J BIOL CHEM, V282, P36714, DOI 10.1074/jbc.M705521200; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Nemes Z, 1999, EXP MOL MED, V31, P5, DOI 10.1038/emm.1999.2; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Planes C, 2010, EMBO MOL MED, V2, P26, DOI 10.1002/emmm.200900050; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; Sales KU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023261; Sanford LP, 2000, METH MOL B, V158, P217; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spacek DV, 2010, EXP DERMATOL, V19, P527, DOI 10.1111/j.1600-0625.2009.01054.x; Szabo R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002937; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247	24	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14740	14749		10.1074/jbc.M113.541318	http://dx.doi.org/10.1074/jbc.M113.541318			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24706745	hybrid, Green Published			2022-12-25	WOS:000337248100030
J	Choi, BH; Pagano, M; Dai, W				Choi, Byeong Hyeok; Pagano, Michele; Dai, Wei			Plk1 Protein Phosphorylates Phosphatase and Tensin Homolog ( PTEN) and Regulates Its Mitotic Activity during the Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Cycle; Cell Signaling; Chromatin; Mitosis; PTEN; Kinase; Phosphorylation; Plk1	POLO-LIKE KINASE-1; TUMOR-SUPPRESSOR; SPLICE VARIANT; CANCER-THERAPY; NUCLEAR PTEN; CHECKPOINT; STABILITY; G2; POLO-LIKE-KINASE-1; CENTROSOMES	Background: PTEN localizes to the nucleus, whose molecular regulation remains unknown. Results: Plk1 phosphorylates PTEN on Ser-380 and regulates its function in mitosis. Conclusion: Plk1 is an important regulator of PTEN during the cell cycle. Significance: PTEN plays a key role in regulating mitotic progression. PTEN is a well known tumor suppressor through the negative regulation of the PI3K signaling pathway. Here we report that PTEN plays an important role in regulating mitotic timing, which is associated with increased PTEN phosphorylation in the C-terminal tail and its localization to chromatin. Pulldown analysis revealed that Plk1 physically interacted with PTEN. Biochemical studies showed that Plk1 phosphorylates PTEN in vitro in a concentration-dependent manner and that the phosphorylation was inhibited by Bi2635, a Plk1-specific inhibitor. Deletional and mutational analyses identified that Plk1 phosphorylated Ser-380, Thr-382, and Thr-383, but not Ser-385, a cluster of residues known to affect the PTEN stability. Interestingly, a combination of molecular and genetic analyses revealed that only Ser-380 was significantly phosphorylated in vivo and that Plk1 regulated the phosphorylation, which was associated with the accumulation of PTEN on chromatin. Moreover, expression of phospho-deficient mutant, but not wild-type PTEN, caused enhanced mitotic exit. Taken together, our studies identify Plk1 as an important regulator of PTEN during the cell cycle.	[Choi, Byeong Hyeok; Dai, Wei] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA; [Choi, Byeong Hyeok; Dai, Wei] NYU, Sch Med, Dept Biochem, Tuxedo Pk, NY 10987 USA; [Choi, Byeong Hyeok; Dai, Wei] NYU, Sch Med, Dept Mol Pharmacol, Tuxedo Pk, NY 10987 USA; [Pagano, Michele] NYU, Sch Med, Inst Canc, Dept Pathol, New York, NY 10016 USA; [Pagano, Michele] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA	New York University; New York University; New York University; New York University; Howard Hughes Medical Institute; New York University	Dai, W (corresponding author), Dept Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	wei.dai@nyumc.org		Dai, Wei/0000-0003-0169-8327; pagano, michele/0000-0003-3210-2442; Choi, Byeong Hyeok/0000-0002-8866-1131	United States Public Service Awards [CA090658, CA150512]; National Institutes of Health NIEHS Center Grant [ES000260, R01-GM057587, R21-AG032560]; NATIONAL CANCER INSTITUTE [R01CA090658, R37CA076584, R01CA150512, P30CA016087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260, R01ES020591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032560] Funding Source: NIH RePORTER	United States Public Service Awards; National Institutes of Health NIEHS Center Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by United States Public Service Awards CA090658 and CA150512 (to W. D.) and National Institutes of Health NIEHS Center Grant ES000260 and Grants R01-GM057587 and R21-AG032560 (to M. P.).	Al-Khouri AM, 2005, J BIOL CHEM, V280, P35195, DOI 10.1074/jbc.M503045200; Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Berger AH, 2011, J PATHOL, V223, P137, DOI 10.1002/path.2800; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Choi BH, 2013, CELL CYCLE, V12, P3442, DOI 10.4161/cc.26465; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Eldridge AG, 2006, CELL, V124, P367, DOI 10.1016/j.cell.2005.10.038; Fairley JA, 2012, MOL CELL, V45, P541, DOI 10.1016/j.molcel.2011.11.030; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Johmura Y, 2011, P NATL ACAD SCI USA, V108, P11446, DOI 10.1073/pnas.1106223108; Ko MA, 2005, NAT GENET, V37, P883, DOI 10.1038/ng1605; Liu XS, 2010, EMBO REP, V11, P626, DOI 10.1038/embor.2010.90; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Loncarek J, 2010, CURR BIOL, V20, P1277, DOI 10.1016/j.cub.2010.05.050; Lu LY, 2008, MOL CELL BIOL, V28, P6870, DOI 10.1128/MCB.00392-08; Lu PD, 2004, EMBO J, V23, P169, DOI 10.1038/sj.emboj.7600030; Miller SJ, 2002, FEBS LETT, V528, P145, DOI 10.1016/S0014-5793(02)03274-X; Odriozola L, 2007, J BIOL CHEM, V282, P23306, DOI 10.1074/jbc.M611240200; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Simizu S, 2000, NAT CELL BIOL, V2, P852, DOI 10.1038/35041102; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Soung NK, 2006, MOL CELL BIOL, V26, P8316, DOI 10.1128/MCB.00671-06; Soung NK, 2009, DEV CELL, V16, P539, DOI 10.1016/j.devcel.2009.02.004; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Wang X, 2008, DEV CELL, V14, P331, DOI 10.1016/j.devcel.2007.12.007; Wang XJ, 2008, CELL RES, V18, P807, DOI 10.1038/cr.2008.83; Xu DZ, 2010, J BIOL CHEM, V285, P39935, DOI 10.1074/jbc.M110.166462; Yang YL, 2008, CANCER RES, V68, P4077, DOI 10.1158/0008-5472.CAN-07-6182; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012; Yin Y, 2008, ONCOGENE, V27, P5443, DOI 10.1038/onc.2008.241	42	41	45	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14066	14074		10.1074/jbc.M114.558155	http://dx.doi.org/10.1074/jbc.M114.558155			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24706748	Green Published, hybrid			2022-12-25	WOS:000335984600036
J	Gazeau, F; van Rijswijk, P; Pozzato, L; Middelburg, JJ				Gazeau, Frederic; van Rijswijk, Pieter; Pozzato, Lara; Middelburg, Jack J.			Impacts of Ocean Acidification on Sediment Processes in Shallow Waters of the Arctic Ocean	PLOS ONE			English	Article							SEAWATER ACIDIFICATION; CARBON; CO2; NITROGEN; ALKALINITY; RATES; UNDERSATURATION; NITRIFICATION; PHYSIOLOGY	Despite the important roles of shallow-water sediments in global biogeochemical cycling, the effects of ocean acidification on sedimentary processes have received relatively little attention. As high-latitude cold waters can absorb more CO2 and usually have a lower buffering capacity than warmer waters, acidification rates in these areas are faster than those in sub-tropical regions. The present study investigates the effects of ocean acidification on sediment composition, processes and sediment-water fluxes in an Arctic coastal system. Undisturbed sediment cores, exempt of large dwelling organisms, were collected, incubated for a period of 14 days, and subject to a gradient of pCO(2) covering the range of values projected for the end of the century. On five occasions during the experimental period, the sediment cores were isolated for flux measurements (oxygen, alkalinity, dissolved inorganic carbon, ammonium, nitrate, nitrite, phosphate and silicate). At the end of the experimental period, denitrification rates were measured and sediment samples were taken at several depth intervals for solid-phase analyses. Most of the parameters and processes (i.e. mineralization, denitrification) investigated showed no relationship with the overlying seawater pH, suggesting that ocean acidification will have limited impacts on the microbial activity and associated sediment-water fluxes on Arctic shelves, in the absence of active bio-irrigating organisms. Only following a pH decrease of 1 pH unit, not foreseen in the coming 300 years, significant enhancements of calcium carbonate dissolution and anammox rates were observed. Longer-term experiments on different sediment types are still required to confirm the limited impact of ocean acidification on shallow Arctic sediment processes as observed in this study.	[Gazeau, Frederic] Sorbonne Univ, Univ Paris 06, Lab Oceanog Villefranche, Observ Oceanol, Villefranche Sur Mer, France; [Gazeau, Frederic] CNRS, Inst Natl Sci Univers, Lab Oceanog Villefranche, Observ Oceanol, Villefranche Sur Mer, France; [van Rijswijk, Pieter; Pozzato, Lara; Middelburg, Jack J.] Royal Netherlands Inst Sea Res, Dept Ecosyst Studies, Yerseke, Netherlands; [Middelburg, Jack J.] Univ Utrecht, Fac Geosci, Utrecht, Netherlands	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University	Gazeau, F (corresponding author), Sorbonne Univ, Univ Paris 06, Lab Oceanog Villefranche, Observ Oceanol, Villefranche Sur Mer, France.	f.gazeau@obs-vlfr.fr	Gazeau, Frédéric/G-3050-2011; Middelburg, Jack/B-4951-2011	Gazeau, Frédéric/0000-0001-8807-4597; Middelburg, Jack/0000-0003-3601-9072	Netherlands Organization of Scientific Research; Darwin Centre for Biogeosciences; European Community [211384]	Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); Darwin Centre for Biogeosciences; European Community(European Commission)	This research has received support from the Netherlands Organization of Scientific Research, the Darwin Centre for Biogeosciences and is a contribution to the "European Project on Ocean Acidification" (EPOCA) which received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 211384. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2006, CORAL REEFS, V25, P123, DOI 10.1007/s00338-005-0069-2; Andersson AJ, 2003, GEOLOGY, V31, P513, DOI 10.1130/0091-7613(2003)031<0513:SOSCAI>2.0.CO;2; Andersson AJ, 2014, NAT CLIM CHANGE, V4, P56, DOI 10.1038/NCLIMATE2050; BARNES DJ, 2000, P 9 INT COR REEF S; Barry J. P., 2010, GUIDE BEST PRACTICES; Bates NR, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004862; Beman JM, 2011, P NATL ACAD SCI USA, V108, P208, DOI 10.1073/pnas.1011053108; Berner R.A., 1980, EARLY DIAGENESIS THE; Burdige DJ, 2006, GEOCHEMISTRY MARINE, DOI DOI 10.2307/J.CTV131BW7S; Caldeira K, 2007, GEOPHYS RES LETT, V34, P3; Chierici M, 2009, BIOGEOSCIENCES, V6, P2421, DOI 10.5194/bg-6-2421-2009; Cyronak T, 2013, LIMNOL OCEANOGR, V58, P131, DOI 10.4319/lo.2013.58.1.0131; Darby DA, 1990, ARCTICS SEAS CLIMATO, P657; Dashfield SL, 2008, J EXP MAR BIOL ECOL, V365, P46, DOI 10.1016/j.jembe.2008.07.039; den Camp HJMO, 2006, BIOCHEM SOC T, V34, P174, DOI 10.1042/BST0340174; Dickson A. G., 2007, PICES SPECIAL PUBLIC, DOI DOI 10.1159/000331784; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Donohue PJC, 2012, AQUAT BIOL, V15, P73, DOI 10.3354/ab00408; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Forster S, 2003, J MAR RES, V61, P335, DOI 10.1357/002224003322201223; Gattuso JP, 2006, BIOGEOSCIENCES, V3, P489, DOI 10.5194/bg-3-489-2006; Gattuso J.-P., 2011, OCEAN ACIDIFICATION, P1; Gihring TM, 2010, LIMNOL OCEANOGR, V55, P740, DOI 10.4319/lo.2009.55.2.0740; Gribsholt B, 2005, LIMNOL OCEANOGR, V50, P1945, DOI 10.4319/lo.2005.50.6.1945; Hauck J, 2013, GLOBAL BIOGEOCHEM CY, V27, P11, DOI 10.1029/2011GB004211; Herman PMJ, 2000, MAR ECOL PROG SER, V204, P79, DOI 10.3354/meps204079; Hu XP, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003859; Huesemann MH, 2002, MAR POLLUT BULL, V44, P142, DOI 10.1016/S0025-326X(01)00194-1; Kitidis V, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049095; Knap A., 1996, 19 JGOFS UNESCO; Krumins V, 2013, BIOGEOSCIENCES, V10, P371, DOI 10.5194/bg-10-371-2013; Meysman FJR, 2006, LIMNOL OCEANOGR, V51, P142, DOI 10.4319/lo.2006.51.1.0142; Middelburg JJ, 2009, BIOGEOSCIENCES, V6, P1273, DOI 10.5194/bg-6-1273-2009; Middelburg JJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049725; NIEUWENHUIZE J, 1994, MAR CHEM, V45, P217, DOI 10.1016/0304-4203(94)90005-1; Olafsson J, 2009, BIOGEOSCIENCES, V6, P2661, DOI 10.5194/bg-6-2661-2009; Orr J. C., 2011, RECENT FUTURE CHANGE, P41; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Pempkowiak J., 2006, ANN ENV PROT, V8, P79; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; Rao AMF, 2012, LIMNOL OCEANOGR, V57, P809, DOI 10.4319/lo.2012.57.3.0809; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Soetaert K, 2007, MAR CHEM, V105, P30, DOI 10.1016/j.marchem.2006.12.012; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Tait K, 2013, ESTUAR COAST, P1; Thomas H, 2009, BIOGEOSCIENCES, V6, P267, DOI 10.5194/bg-6-267-2009; Van den Meersche K, 2004, LIMNOL OCEANOGR, V49, P862, DOI 10.4319/lo.2004.49.3.0862; WEISS RF, 1980, MAR CHEM, V8, P347, DOI 10.1016/0304-4203(80)90024-9; Widdicombe S, 2007, MAR ECOL PROG SER, V341, P111, DOI 10.3354/meps341111; Widdicombe S, 2009, MAR ECOL PROG SER, V379, P59, DOI 10.3354/meps07894; Wolf-Gladrow DA, 2007, MAR CHEM, V106, P287, DOI 10.1016/j.marchem.2007.01.006; Wood HL, 2009, BIOGEOSCIENCES, V6, P2015, DOI 10.5194/bg-6-2015-2009; Yamamoto-Kawai M, 2009, SCIENCE, V326, P1098, DOI 10.1126/science.1174190; Yates KK, 2006, ESTUARIES COASTS, V29, P24, DOI 10.1007/BF02784696	56	26	26	4	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94068	10.1371/journal.pone.0094068	http://dx.doi.org/10.1371/journal.pone.0094068			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718610	Green Published, Green Submitted, gold			2022-12-25	WOS:000334339000074
J	Kooij, PW; Liberti, J; Giampoudakis, K; Schiott, M; Boomsma, JJ				Kooij, Pepijn W.; Liberti, Joanito; Giampoudakis, Konstantinos; Schiott, Morten; Boomsma, Jacobus J.			Differences in Forage-Acquisition and Fungal Enzyme Activity Contribute to Niche Segregation in Panamanian Leaf-Cutting Ants	PLOS ONE			English	Article							ATTA-CEPHALOTES L; L HYMENOPTERA-FORMICIDAE; HABITAT SEGREGATION; INSECT HERBIVORES; WASTE MANAGEMENT; SUBSTRATE; SELECTION; DIET; RETICULITERMES; DEGRADATION	The genera Atta and Acromyrmex are often grouped as leaf-cutting ants for pest management assessments and ecological surveys, although their mature colony sizes and foraging niches may differ substantially. Few studies have addressed such interspecific differences at the same site, which prompted us to conduct a comparative study across six sympatric leafcutting ant species in Central Panama. We show that foraging rates during the transition between dry and wet season differ about 60 fold between genera, but are relatively constant across species within genera. These differences appear to match overall differences in colony size, especially when Atta workers that return to their nests without leaves are assumed to carry liquid food. We confirm that Panamanian Atta specialize primarily on tree-leaves whereas Acromyrmex focus on collecting flowers and herbal leaves and that species within genera are similar in these overall foraging strategies. Species within genera tended to be spaced out over the three habitat categories that we distinguished (forest, forest edge, open grassland), but each of these habitats normally had only a single predominant Atta and Acromyrmex species. We measured activities of twelve fungus garden decomposition enzymes, belonging to the amylases, cellulases, hemicellulases, pectinases and proteinases, and show that average enzyme activity per unit of fungal mass in Atta gardens is lower than in Acromyrmex gardens. Expression profiles of fungal enzymes in Atta also appeared to be more specialized than in Acromyrmex, possibly reflecting variation in forage material. Our results suggest that species-and genus-level identities of leaf-cutting ants and habitat-specific foraging profiles may give predictable differences in the expression of fungal genes coding for decomposition enzymes.	[Kooij, Pepijn W.; Liberti, Joanito; Giampoudakis, Konstantinos; Schiott, Morten; Boomsma, Jacobus J.] Univ Copenhagen, Dept Biol, Ctr Social Evolut, Copenhagen, Denmark	University of Copenhagen	Kooij, PW (corresponding author), Univ Copenhagen, Dept Biol, Ctr Social Evolut, Copenhagen, Denmark.	pkooij@bio.ku.dk	Schiøtt, Morten/H-4118-2012; Boomsma, Jacobus J/M-2785-2014; Kooij, Pepijn W/E-3755-2019; Liberti, Joanito/AFT-0264-2022; Schiøtt, Morten/AAJ-8945-2021	Schiøtt, Morten/0000-0002-4309-8090; Boomsma, Jacobus J/0000-0002-3598-1609; Kooij, Pepijn W/0000-0002-2619-0813; Liberti, Joanito/0000-0002-4158-2591; Schiøtt, Morten/0000-0002-4309-8090	Danish National Research Foundation [DNRF57]	Danish National Research Foundation(Danmarks Grundforskningsfond)	Funding was provided by the Danish National Research Foundation (DNRF57). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali JG, 2012, TRENDS PLANT SCI, V17, P293, DOI 10.1016/j.tplants.2012.02.006; Aylward FO, 2013, APPL ENVIRON MICROB, V79, P3770, DOI 10.1128/AEM.03833-12; BASS M, 1995, PHYSIOL ENTOMOL, V20, P1, DOI 10.1111/j.1365-3032.1995.tb00793.x; BERISH CW, 1986, AM MIDL NAT, V115, P268, DOI 10.2307/2425863; Bernays EA, 1997, ECOLOGY, V78, P1157, DOI 10.1890/0012-9658(1997)078[1157:IHDRFB]2.0.CO;2; Bot ANM, 2001, ETHOL ECOL EVOL, V13, P225, DOI 10.1080/08927014.2001.9522772; CHERRETT JM, 1972, J ANIM ECOL, V41, P647, DOI 10.2307/3200; CHERRETT JM, 1968, J ANIM ECOL, V37, P387, DOI 10.2307/2955; CHERRETT JM, 1976, ANN APPL BIOL, V84, P124, DOI 10.1111/j.1744-7348.1976.tb01741.x; CREWE RM, 1972, J INSECT PHYSIOL, V18, P31, DOI 10.1016/0022-1910(72)90062-5; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; DEVASCONCELOS HL, 1990, INSECT SOC, V37, P131, DOI 10.1007/BF02224026; Farji-Brener AG, 2000, STUD NEOTROP FAUNA E, V35, P131, DOI 10.1076/0165-0521(200008)35:2;1-9;FT131; Farji-Brener AG, 2001, OIKOS, V92, P169, DOI 10.1034/j.1600-0706.2001.920120.x; Florencio M, 2013, FRESHW SCI, V32, P650, DOI 10.1899/12-105.1; FOWLER HG, 1989, ENVIRON MANAGE, V13, P671, DOI 10.1007/BF01868306; Grell MN, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-928; Guo ZQ, 2012, FUND APPL LIMNOL, V181, P241, DOI 10.1127/1863-9135/2012/0397; Hart AG, 2002, BEHAV ECOL, V13, P224, DOI 10.1093/beheco/13.2.224; Holldobler B, 2011, LEAFCUTTER ANTS; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Houseman RM, 2001, ENVIRON ENTOMOL, V30, P673, DOI 10.1603/0046-225X-30.4.673; HOWARD JJ, 1988, ECOLOGY, V69, P250, DOI 10.2307/1943180; Husson F, 2013, FACTOMINER MULTIVARI; Ibanez R, 2002, ENVIRON MONIT ASSESS, V80, P65, DOI 10.1023/A:1020378926399; Kacurakova M, 2000, CARBOHYD POLYM, V43, P195, DOI 10.1016/S0144-8617(00)00151-X; Kambara K, 2009, SOCIOBIOLOGY, V54, P65; Kooij PW, 2011, INSECT SOC, V58, P145, DOI 10.1007/s00040-010-0127-9; Kooij PW, FUNGAL ADAPTAT UNPUB; Licht HHD, 2010, EVOLUTION, V64, P2055, DOI 10.1111/j.1558-5646.2010.00948.x; Licht HHD, 2010, ECOL ENTOMOL, V35, P259, DOI 10.1111/j.1365-2311.2010.01193.x; LITTLEDYKE M, 1976, B ENTOMOL RES, V66, P205, DOI 10.1017/S0007485300006647; Mayhe-Nunes Antonio, 1998, Ecotropicos, V11, P45; Mehdiabadi NJ, 2010, MYRMECOL NEWS, V13, P37; Mendes Thais D., 2012, Insects, V3, P228, DOI 10.3390/insects3010228; Mikheyev AS, 2007, MOL ECOL, V16, P209, DOI 10.1111/j.1365-294X.2006.03134.x; Mikheyev AS, 2010, AM NAT, V175, pE126, DOI 10.1086/652472; Moller IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017506; Murakami T, 2000, BEHAV ECOL SOCIOBIOL, V48, P276, DOI 10.1007/s002650000243; Nagamoto NS, 2011, J BIOL RES-THESSALON, V16, P308; North RD, 1999, PHYSIOL ENTOMOL, V24, P127, DOI 10.1046/j.1365-3032.1999.00122.x; ORTEGA S, 1987, J EXP MAR BIOL ECOL, V113, P247, DOI 10.1016/0022-0981(87)90104-3; Pinheiro J, 2016, NLME LINEAR NONLINEA, DOI DOI 10.1016/S0006-3207(01)00201-4; PORTER SD, 1980, BIOTROPICA, V12, P232, DOI 10.2307/2387983; QUINLAN RJ, 1979, ECOL ENTOMOL, V4, P151, DOI 10.1111/j.1365-2311.1979.tb00570.x; R Core Team, 2021, R LANG ENV STAT COMP; Rohde K, 2006, NONEQUILIBRIUM ECOLO; Ronhede S, 2004, MYCOL RES, V108, P101, DOI 10.1017/S0953756203008931; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Suzuki R, 2011, PVCLUST HIERARCHICAL; TYRRELL HF, 1975, J DAIRY SCI, V58, P1151, DOI 10.3168/jds.S0022-0302(75)84694-7; Villesen P, 2002, P ROY SOC B-BIOL SCI, V269, P1541, DOI 10.1098/rspb.2002.2044; Warnes G, 2016, R PACKAGE VERSION 3; WEBER NA, 1966, SCIENCE, V153, P587, DOI 10.1126/science.153.3736.587; WEBER NA, 1969, ECOLOGY, V50, P141; WEBER NA, 1972, AM ZOOL, V12, P577; Weber NA, 1958, P 10 INT C ENT, V2, P459; Wetterer JK, 1998, FLA ENTOMOL, V81, P61, DOI 10.2307/3495996; WETTERER JK, 1995, OECOLOGIA, V104, P409, DOI 10.1007/BF00341337; Wirth R, 2003, HERBIVORY LEAF CUTTI	61	19	21	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94284	10.1371/journal.pone.0094284	http://dx.doi.org/10.1371/journal.pone.0094284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718261	gold, Green Submitted, Green Published			2022-12-25	WOS:000334339000102
J	Liu, XP; Tu, XY; He, HM; Chen, C; Xue, FS				Liu, XingPing; Tu, XiaoYun; He, HaiMin; Chen, Chao; Xue, FangSen			Evidence for Inbreeding Depression and Pre-Copulatory, but Not Post Copulatory Inbreeding Avoidance in the Cabbage Beetle Colaphellus bowringi	PLOS ONE			English	Article							MATE CHOICE; NO EVIDENCE; CALLOSOBRUCHUS-MACULATUS; MATING-BEHAVIOR; FEMALE FITNESS; FIELD CRICKET; LIFE-SPAN; EVOLUTION; FERTILIZATION; COLEOPTERA	Inbreeding is known to have adverse effects on fitness-related traits in a range of insect species. A series of theoretical and experimental studies have suggested that polyandrous insects could avoid the cost of inbreeding via pre-copulatory mate choice and/or post-copulatory mechanisms. We looked for evidence of pre-copulatory inbreeding avoidance using female mate preference trials, in which females were given the choice of mating with either of two males, a sibling and a nonsibling. We also tested for evidence of post- copulatory inbreeding avoidance by conducting double mating experiments, in which four sibling females were mated with two males sequentially, either two siblings, two non-siblings or a sibling and a non-sibling in either order. We identified substantial inbreeding depression: offspring of females mated to full siblings had lower hatching success, slower development time from egg to adult, lower survival of larval and pupal stages, and lower adult body mass than the offspring of females mated to non-sibling males. We also found evidence of pre-copulatory inbreeding avoidance, as females preferred to mate with non-sibling males. However, we did not find any evidence of postcopulatory inbreeding avoidance: egg hatching success of females mating to both sibling and non- sibling males were consistent with sperm being used without bias in relation to mate relatedness. Our results suggest that this cabbage beetle has evolved a pre-copulatory mechanism to avoid matings between close relative, but that polyandry is apparently not an inbreeding avoidance mechanism in C. bowringi.	[Liu, XingPing; He, HaiMin; Chen, Chao; Xue, FangSen] Jiangxi Agr Univ, Inst Entomol, Nanchang, Jiangxi, Peoples R China; [Tu, XiaoYun] Jiangxi Normal Univ, Life & Sci Coll, Nanchang, Jiangxi, Peoples R China	Jiangxi Agricultural University	Xue, FS (corresponding author), Jiangxi Agr Univ, Inst Entomol, Nanchang, Jiangxi, Peoples R China.	xue_fangsen@hotmail.com			National Natural Science Foundation of of P.R. China [31000173, 30460074]	National Natural Science Foundation of of P.R. China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the National Natural Science Foundation of of P.R. China to XPL (Project no. 31000173) and to FSX (Project no. 30460074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala-Honkola O, 2011, EVOLUTION, V65, P2699, DOI 10.1111/j.1558-5646.2011.01317.x; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Bechsgaard JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051176; BOORMAN E, 1976, ECOL ENTOMOL, V1, P145, DOI 10.1111/j.1365-2311.1976.tb01217.x; Bretman A, 2011, MOL ECOL, V20, P3045, DOI 10.1111/j.1365-294X.2011.05140.x; Bretman A, 2009, MOL ECOL, V18, P3340, DOI 10.1111/j.1365-294X.2009.04301.x; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Cook PA, 1997, PHILOS T R SOC B, V352, P771, DOI 10.1098/rstb.1997.0061; Cornell SJ, 2007, P ROY SOC B-BIOL SCI, V274, P2873, DOI 10.1098/rspb.2007.0926; Drayton JM, 2011, BEHAV ECOL, V22, P486, DOI 10.1093/beheco/arr005; Edvardsson M, 2008, ANIM BEHAV, V75, P1519, DOI 10.1016/j.anbehav.2007.10.005; Fox CW, 2007, B ENTOMOL RES, V97, P49, DOI 10.1017/S0007485307004737; Fox CW, 2013, J EVOLUTION BIOL, V26, P88, DOI 10.1111/jeb.12027; Fox CW, 2012, J EVOLUTION BIOL, V25, P29, DOI 10.1111/j.1420-9101.2011.02400.x; Fox CW, 2009, HEREDITY, V103, P62, DOI 10.1038/hdy.2009.31; Fox CW, 2006, ENTOMOL EXP APPL, V121, P137, DOI 10.1111/j.1570-8703.2006.00465.x; Fox CW, 2011, EVOL ECOL, V25, P25, DOI 10.1007/s10682-010-9376-3; Haikola S, 2004, EVOL ECOL, V18, P113, DOI 10.1023/B:EVEC.0000021062.97769.66; Harano T, 2011, ECOL RES, V26, P327, DOI 10.1007/s11284-010-0787-y; Jennions MD, 2004, EVOLUTION, V58, P2472; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kokko H, 2006, EVOLUTION, V60, P467, DOI 10.1554/05-613.1; Kuriwada T, 2011, ETHOLOGY, V117, P822, DOI 10.1111/j.1439-0310.2011.01937.x; Lihoreau M, 2007, BEHAV ECOL, V18, P880, DOI 10.1093/beheco/arm046; Lihoreau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003365; Liu XP, 2013, ENTOMOL EXP APPL, V146, P379, DOI 10.1111/eea.12037; Liu XP, 2014, INSECT SCI, V21, P515, DOI 10.1111/1744-7917.12051; Liu XP, 2011, J INSECT BEHAV, V24, P83, DOI 10.1007/s10905-010-9237-5; Liu XP, 2010, ANIM BEHAV, V79, P1391, DOI 10.1016/j.anbehav.2010.03.019; Liu XP, 2010, INSECT SCI, V17, P61, DOI 10.1111/j.1744-7917.2009.01285.x; Messina FJ, 2013, ANN ENTOMOL; Michalczyk L, 2011, SCIENCE, V333, P1739, DOI 10.1126/science.1207314; Michalczyk L, 2010, P ROY SOC B-BIOL SCI, V277, P3483, DOI 10.1098/rspb.2010.0514; Okada K, 2011, J EVOLUTION BIOL, V24, P363, DOI 10.1111/j.1420-9101.2010.02170.x; Parker GA, 2006, PHILOS T R SOC B, V361, P235, DOI 10.1098/rstb.2005.1785; Polkki M, 2012, BIOL LETTERS, V8, P423, DOI 10.1098/rsbl.2011.1135; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Ruf D, 2010, BEHAV ECOL, V21, P1301, DOI 10.1093/beheco/arq148; Simmons LW, 2006, MOL ECOL, V15, P3817, DOI 10.1111/j.1365-294X.2006.03035.x; SIMMONS LW, 1991, ANIM BEHAV, V41, P493, DOI 10.1016/S0003-3472(05)80852-8; Tabadkani SM, 2012, NATURWISSENSCHAFTEN, V99, P779, DOI 10.1007/s00114-012-0961-x; Teng ZQ, 2007, EVOLUTION, V61, P470, DOI 10.1111/j.1558-5646.2007.00030.x; Thornhill R., 1983, pi; Tien NSH, 2011, EXP APPL ACAROL, V54, P119, DOI 10.1007/s10493-011-9431-y; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Valtonen TM, 2011, GENETICA, V139, P525, DOI 10.1007/s10709-011-9574-0; Welke K, 2009, BEHAV ECOL, V20, P1056, DOI 10.1093/beheco/arp097; Xue Fang-Sen, 2002, Acta Entomologica Sinica, V45, P494; Xue FS, 2002, J INSECT PHYSIOL, V48, P279, DOI 10.1016/S0022-1910(01)00172-X; XUE FS, 1993, J APPL ENTOMOL, V116, P170; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250	52	16	16	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94389	10.1371/journal.pone.0094389	http://dx.doi.org/10.1371/journal.pone.0094389			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718627	gold, Green Published			2022-12-25	WOS:000334339000113
J	Grayson, KL; Mitchell, NJ; Monks, JM; Keall, SN; Wilson, JN; Nelson, NJ				Grayson, Kristine L.; Mitchell, Nicola J.; Monks, Joanne M.; Keall, Susan N.; Wilson, Joanna N.; Nelson, Nicola J.			Sex Ratio Bias and Extinction Risk in an Isolated Population of Tuatara (Sphenodon punctatus)	PLOS ONE			English	Article							CLIMATE-CHANGE; TEMPERATURE; CONSERVATION; VIABILITY; DYNAMICS; ISLAND; CONSEQUENCES; GENERATIONS; DIMORPHISM; ALLOCATION	Understanding the mechanisms underlying population declines is critical for preventing the extinction of endangered populations. Positive feedbacks can hasten the process of collapse and create an 'extinction vortex,' particularly in small, isolated populations. We provide a case study of a male-biased sex ratio creating the conditions for extinction in a natural population of tuatara (Sphenodon punctatus) on North Brother Island in the Cook Strait of New Zealand. We combine data from long term mark-recapture surveys, updated model estimates of hatchling sex ratio, and population viability modeling to measure the impacts of sex ratio skew. Results from the mark-recapture surveys show an increasing decline in the percentage of females in the adult tuatara population. Our monitoring reveals compounding impacts on female fitness through reductions in female body condition, fecundity, and survival as the male-bias in the population has increased. Additionally, we find that current nest temperatures are likely to result in more male than female hatchlings, owing to the pattern of temperature-dependent sex determination in tuatara where males hatch at warmer temperatures. Anthropogenic climate change worsens the situation for this isolated population, as projected temperature increases for New Zealand are expected to further skew the hatchling sex ratio towards males. Population viability models predict that without management intervention or an evolutionary response, the population will ultimately become entirely comprised of males and functionally extinct. Our study demonstrates that sex ratio bias can be an underappreciated threat to population viability, particularly in populations of long-lived organisms that appear numerically stable.	[Grayson, Kristine L.; Keall, Susan N.; Wilson, Joanna N.; Nelson, Nicola J.] Victoria Univ Wellington, Allan Wilson Ctr Mol Ecol & Evolut, Sch Biol Sci, Wellington, New Zealand; [Mitchell, Nicola J.] Univ Western Australia, Ctr Evolutionary Biol, Sch Anim Biol, Crawley, WA, Australia; [Monks, Joanne M.] Dept Conservat, Sci & Capabil Grp, Christchurch, New Zealand	Victoria University Wellington; University of Western Australia	Grayson, KL (corresponding author), Victoria Univ Wellington, Allan Wilson Ctr Mol Ecol & Evolut, Sch Biol Sci, Wellington, New Zealand.	klg8y@virginia.edu	Mitchell, Nicola J/K-5277-2012; Mitchell, Nicola/AAE-4132-2020	Mitchell, Nicola J/0000-0003-0744-984X; Nelson, Nicola/0000-0002-1641-6030; Monks, Jo/0000-0001-9391-380X; Grayson, Kristine/0000-0003-1710-0457	Allan Wilson Centre for Molecular Ecology and Evolution; School of Biological Sciences at Victoria University of Wellington; US National Science Foundation [OISE-0965096]	Allan Wilson Centre for Molecular Ecology and Evolution; School of Biological Sciences at Victoria University of Wellington; US National Science Foundation(National Science Foundation (NSF))	This work was supported by the Allan Wilson Centre for Molecular Ecology and Evolution and the School of Biological Sciences at Victoria University of Wellington. Funding was also provided by grants from the US National Science Foundation (International Research Fellowship OISE-0965096 to KLG), Dallas Zoo, (http://www.dallaszoo.com/), Toledo Zoo (http://www.toledozoo.org/), and St. Louis Zoo (http://www.stlzoo.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTS AC, 1994, ZOO BIOL, V13, P479, DOI 10.1002/zoo.1430130510; Armbruster P, 1999, ANIM CONSERV, V2, P69, DOI 10.1111/j.1469-1795.1999.tb00050.x; Arnqvist Goran, 2005, pUnpaginated; Bernardo J, 1996, AM ZOOL, V36, P83; Brook BW, 2002, CONSERV ECOL, V6; BULL JJ, 1980, Q REV BIOL, V55, P3, DOI 10.1086/411613; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Clout MN, 2002, BIOL CONSERV, V107, P13, DOI 10.1016/S0006-3207(01)00267-1; CLUTTONBROCK TH, 1995, ANIM BEHAV, V49, P1345, DOI 10.1006/anbe.1995.0166; Cree A., 1991, Tuatara, V31, P9; CREE A, 1994, NEW ZEAL J ZOOL, V21, P351, DOI 10.1080/03014223.1994.9518005; Dale S, 2001, OIKOS, V92, P344, DOI 10.1034/j.1600-0706.2001.920217.x; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; Doody JS, 2006, EVOL ECOL, V20, P307, DOI 10.1007/s10682-006-0003-2; Ewen JG, 2011, J ANIM ECOL, V80, P448, DOI 10.1111/j.1365-2656.2010.01774.x; Freed LA, 2009, EVOL ECOL RES, V11, P731; Freedberg S, 2006, EVOL ECOL RES, V8, P1499; GAZE P, 2001, TUATARA RECOVERY PLA; Gilpin M.E., 1986, P19; GINSBERG JR, 1994, CONSERV BIOL, V8, P157, DOI 10.1046/j.1523-1739.1994.08010157.x; Gruber MAM, 2007, CONSERVATION TUATARA; Herrel A, 2010, BIOL J LINN SOC, V100, P287, DOI 10.1111/j.1095-8312.2010.01433.x; Hoare JM, 2006, ANIM CONSERV, V9, P456, DOI 10.1111/j.1469-1795.2006.00061.x; Hu JH, 2013, BIOL CONSERV, V166, P23, DOI 10.1016/j.biocon.2013.06.011; JANZEN FJ, 1994, P NATL ACAD SCI USA, V91, P7487, DOI 10.1073/pnas.91.16.7487; Kendall WL, 1997, ECOLOGY, V78, P563; KORPELAINEN H, 1990, BIOL REV, V65, P147, DOI 10.1111/j.1469-185X.1990.tb01187.x; Kvarnemo C, 1996, TRENDS ECOL EVOL, V11, P404, DOI 10.1016/0169-5347(96)10056-2; LACY RC, 1993, WILDLIFE RES, V20, P45, DOI 10.1071/WR9930045; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; Le Galliard JF, 2005, P NATL ACAD SCI USA, V102, P18231, DOI 10.1073/pnas.0505172102; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lopez-Sepulcre A, 2009, J ANIM ECOL, V78, P219, DOI 10.1111/j.1365-2656.2008.01475.x; MacAvoy ES, 2007, CONSERV GENET, V8, P305, DOI 10.1007/s10592-006-9170-5; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Marcott SA, 2013, SCIENCE, V339, P1198, DOI 10.1126/science.1228026; Miller KA, 2012, CONSERV BIOL, V26, P790, DOI 10.1111/j.1523-1739.2012.01902.x; Mitchell NJ, 2010, SEX DEV, V4, P129, DOI 10.1159/000282494; Mitchell NJ, 2008, P ROY SOC B-BIOL SCI, V275, P2185, DOI 10.1098/rspb.2008.0438; Mitchell Nicola J, 2006, Front Zool, V3, P9, DOI 10.1186/1742-9994-3-9; Mitchell NJ, 2010, GLOBAL CHANGE BIOL, V16, P60, DOI 10.1111/j.1365-2486.2009.01964.x; Moore JA, 2008, CONSERV GENET, V9, P1243, DOI 10.1007/s10592-007-9452-6; Moore JA, 2009, J HERPETOL, V43, P570, DOI 10.1670/08-290.1; MROSOVSKY N, 1982, BIOL CONSERV, V23, P309, DOI 10.1016/0006-3207(82)90087-8; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; Nelson NJ, 2010, HERPETOL CONSERV BIO, V5, P324; Nelson NJ, 2004, INT CONGR SER, V1275, P250, DOI 10.1016/j.ics.2004.08.093; Nelson NJ, 2002, J BIOGEOGR, V29, P633, DOI 10.1046/j.1365-2699.2002.00712.x; O'Grady JJ, 2008, ANIM CONSERV, V11, P442, DOI 10.1111/j.1469-1795.2008.00201.x; PULLIAM HR, 1992, ECOL APPL, V2, P165, DOI 10.2307/1941773; Rankin DJ, 2011, AM NAT, V177, P780, DOI 10.1086/659947; Reisinger A., 2010, GLOBAL LOCAL CLIMATE; Robertson BC, 2006, BIOL LETTERS, V2, P229, DOI 10.1098/rsbl.2005.0430; Schwanz LE, 2008, PHYSIOL BIOCHEM ZOOL, V81, P826, DOI 10.1086/590220; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; THOMPSON MB, 1992, J ROY SOC NEW ZEAL, V22, P123, DOI 10.1080/03036758.1992.10420810; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Valenzuela N., 2004, TEMPERATURE DEPENDEN; Wapstra E, 2009, J ANIM ECOL, V78, P84, DOI 10.1111/j.1365-2656.2008.01470.x; Wedekind C, 2002, ANIM CONSERV, V5, P13, DOI 10.1017/S1367943002001026; Woerner LLB, 2009, AGGRESSION COMPETITI; Wratt D.S., 2004, CLIMATE CHANGE EFFEC	62	47	47	1	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94214	10.1371/journal.pone.0094214	http://dx.doi.org/10.1371/journal.pone.0094214			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714691	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900106
J	Zhang, YF; Yu, B; Sui, YJ; Gao, X; Yang, H; Ma, TH				Zhang, Yaofang; Yu, Bo; Sui, Yujie; Gao, Xin; Yang, Hong; Ma, Tonghui			Identification of Resveratrol Oligomers as Inhibitors of Cystic Fibrosis Transmembrane Conductance Regulator by High-Throughput Screening of Natural Products from Chinese Medicinal Plants	PLOS ONE			English	Article							CFTR CHLORIDE CHANNEL; EPSILON-VINIFERIN; STILBENE DERIVATIVES; TRANS-RESVERATROL; CHOLERA-TOXIN; PHARMACOKINETICS; MECHANISM; DISCOVERY; GROWTH	Inhibitors of cystic fibrosis transmembrane conductance regulator (CFTR) have been widely used for characterizing CFTR function in epithelial fluid transport and in diseases such as secretory diarrhea, polycystic kidney disease and cystic fibrosis. Few small molecule CFTR inhibitors have been discovered so far from combinatorial compound library. In the present study, we used a high throughput screening (HTS)-based natural product discovery strategy to identify new CFTR inhibitors from Chinese medicinal herbs. By screening 40,000 small molecule fractions from 500 herbal plants, we identified 42 positive fractions from 5 herbs and isolated two compounds that inhibited CFTR conductance from Chinese wild grapevine (Vitis amurensis Rupr). Mass spectrometry (MS) and nuclear magnetic resonance (NMR) studies determined the two active compounds as trans-epsilon-viniferin (TV) and r-2-viniferin (RV), respectively. Both compounds dose-dependently blocked CFTR-mediated iodide influx with IC50 around 20 mu M. Further analysis by excised inside-out patch-clamp indicated strong inhibition of protein kinase A (PKA)-activated CFTR chloride currents by TV and RV. In ex vivo studies, TV and RV inhibited CFTR-mediated short-circuit CI- currents in isolated rat colonic mucosa in a dose-dependent manner. In a closed-loop mouse model, intraluminal applications of TV (2.5 mu g) and RV (4.5 mu g) significantly reduced cholera toxin-induced intestinal fluid secretion. The present study identified two resveratrol oligomers as new CFTR inhibitors and validates our high-throughput screening method for discovery of bioactive compounds from natural products with complex chemical ingredients such as herbal plants.	[Zhang, Yaofang; Yu, Bo; Yang, Hong] Liaoning Normal Univ, Sch Life Sci, Liaoning Prov Key Lab Biotechnol & Drug Discovery, Dalian, Peoples R China; [Sui, Yujie; Ma, Tonghui] Dalian Med Univ, Coll Basic Med Sci, Dalian, Peoples R China; [Gao, Xin] Yanbian Univ, Sch Med, Yanji, Peoples R China	Liaoning Normal University; Dalian Medical University; Yanbian University	Yang, H (corresponding author), Liaoning Normal Univ, Sch Life Sci, Liaoning Prov Key Lab Biotechnol & Drug Discovery, Dalian, Peoples R China.	hyanglnnu@gmail.com; tonghuima@dlmedu.edu.cn		Ma, Tonghui/0000-0001-9338-1030	National Natural Science Fund [81173109, 30973577]; Special Fund for Doctorate Disciplines Construction in Universities [20112136110002]	National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Special Fund for Doctorate Disciplines Construction in Universities	This work was supported by National Natural Science Fund (No. 81173109; 30973577), Special Fund for Doctorate Disciplines Construction in Universities (20112136110002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; Bavaresco L, 1999, DRUG EXP CLIN RES, V25, P57; Brown VA, 2010, CANCER RES, V70, P9003, DOI 10.1158/0008-5472.CAN-10-2364; Catalgol B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00141; CHAO AC, 1994, EMBO J, V13, P1065, DOI 10.1002/j.1460-2075.1994.tb06355.x; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; Frizzell RA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009563; Frombaum M, 2012, BIOCHIMIE, V94, P269, DOI 10.1016/j.biochi.2011.11.001; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; Galietta LVJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1734, DOI 10.1152/ajpcell.2001.281.5.C1734; Gonzalez-Sarrias A, 2011, J AGR FOOD CHEM, V59, P8632, DOI 10.1021/jf201561e; Greger R, 2000, ANNU REV PHYSIOL, V62, P467, DOI 10.1146/annurev.physiol.62.1.467; He CY, 2004, CHEM RES CHINESE U, V20, P334; Hwang TC, 1999, TRENDS PHARMACOL SCI, V20, P448, DOI 10.1016/S0165-6147(99)01386-3; Jakab RL, 2011, AM J PHYSIOL-GASTR L, V300, pG82, DOI 10.1152/ajpgi.00245.2010; Kapetanovic IM, 2011, CANCER CHEMOTH PHARM, V68, P593, DOI 10.1007/s00280-010-1525-4; Kim JY, 2012, PHYTOMEDICINE, V19, P150, DOI 10.1016/j.phymed.2011.06.015; Kopeikin Z, 2010, J GEN PHYSIOL, V136, P659, DOI 10.1085/jgp.201010518; Kunzelmann K, 1999, Rev Physiol Biochem Pharmacol, V137, P1; la Porte C, 2010, CLIN PHARMACOKINET, V49, P449, DOI 10.2165/11531820-000000000-00000; Landrault N, 2002, J AGR FOOD CHEM, V50, P2046, DOI 10.1021/jf010794g; Li HY, 2009, BIODRUGS, V23, P203, DOI 10.2165/11313570-000000000-00000; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Luzhetskyy A, 2007, CURR OPIN INVEST DR, V8, P608; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Ma TH, 2002, J BIOL CHEM, V277, P37235, DOI 10.1074/jbc.M205932200; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; Privat C, 2002, J AGR FOOD CHEM, V50, P1213, DOI 10.1021/jf010676t; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; RIORDAN JR, 1989, SCIENCE, V245, P1066; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Venkatasubramanian J, 2010, CURR OPIN GASTROEN, V26, P123, DOI 10.1097/MOG.0b013e3283358a45; Verkman AS, 2013, CURR PHARM DESIGN, V19, P3529, DOI 10.2174/13816128113199990321; Vitrac X, 2005, J AGR FOOD CHEM, V53, P5664, DOI 10.1021/jf050122g; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Wang XF, 2004, EXP PHYSIOL, V89, P417, DOI 10.1113/expphysiol.2003.027003; Yang H, 2003, J BIOL CHEM, V278, P35079, DOI 10.1074/jbc.M303098200; Yang S, 2013, PHARMAZIE, V68, P772, DOI 10.1691/ph.2013.3548; Zegarra-Moran O, 2002, BRIT J PHARMACOL, V137, P504, DOI 10.1038/sj.bjp.0704882; Zghonda N, 2011, BIOSCI BIOTECH BIOCH, V75, P1259, DOI 10.1271/bbb.110022; Zhang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081589	41	18	22	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94302	10.1371/journal.pone.0094302	http://dx.doi.org/10.1371/journal.pone.0094302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714160	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900113
J	Bertolusso, R; Tian, B; Zhao, Y; Vergara, L; Sabree, A; Iwanaszko, M; Lipniacki, T; Brasier, AR; Kimmel, M				Bertolusso, Roberto; Tian, Bing; Zhao, Yingxin; Vergara, Leoncio; Sabree, Aqeeb; Iwanaszko, Marta; Lipniacki, Tomasz; Brasier, Allan R.; Kimmel, Marek			Dynamic Cross Talk Model of the Epithelial Innate Immune Response to Double-Stranded RNA Stimulation: Coordinated Dynamics Emerging from Cell-Level Noise	PLOS ONE			English	Article							NF-KAPPA-B; INDUCIBLE GENE-I; INTERFERON ANTIVIRAL RESPONSE; RIG-I; TRANSCRIPTION FACTOR; UBIQUITIN LIGASE; ACTIVATION; RECOGNITION; EXPRESSION; ADAPTER	We present an integrated dynamical cross-talk model of the epithelial innate immune reponse (IIR) incorporating RIG-I and TLR3 as the two major pattern recognition receptors (PRR) converging on the RelA and IRF3 transcriptional effectors. bioPN simulations reproduce biologically relevant gene-and protein abundance measurements in response to time course, gene silencing and dose-response perturbations both at the population and single cell level. Our computational predictions suggest that RelA and IRF3 are under auto-and cross-regulation. We predict, and confirm experimentally, that RIG-I mRNA expression is controlled by IRF7. We also predict the existence of a TLR3-dependent, IRF3-independent transcription factor (or factors) that control(s) expression of MAVS, IRF3 and members of the IKK family. Our model confirms the observed dsRNA dose-dependence of oscillatory patterns in single cells, with periods of 1-3 hr. Model fitting to time series, matched by knockdown data suggests that the NF-kB module operates in a different regime (with different coefficient values) than in the TNF alpha-stimulation experiments. In future studies, this model will serve as a foundation for identification of virus-encoded IIR antagonists and examination of stochastic effects of viral replication. Our model generates simulated time series, which reproduce the noisy oscillatory patterns of activity (with 1-3 hour period) observed in individual cells. Our work supports the hypothesis that the IIR is a phenomenon that emerged by evolution despite highly variable responses at an individual cell level.	[Bertolusso, Roberto; Sabree, Aqeeb; Kimmel, Marek] Rice Univ, Dept Stat, Houston, TX 77251 USA; [Tian, Bing; Zhao, Yingxin; Brasier, Allan R.] UTMB, Dept Internal Med, Galveston, TX USA; [Zhao, Yingxin; Brasier, Allan R.] UTMB, Sealy Ctr Mol Med, Galveston, TX USA; [Zhao, Yingxin; Brasier, Allan R.] UTMB, Inst Translat Sci, Galveston, TX USA; [Vergara, Leoncio] UTMB, Ctr Biomed Engn, Galveston, TX USA; [Iwanaszko, Marta; Kimmel, Marek] Silesian Tech Univ, Syst Engn Grp, Gliwice, Poland; [Lipniacki, Tomasz] Polish Acad Sci, Inst Fundamental Technol Res, Warsaw, Poland	Rice University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Silesian University of Technology; Polish Academy of Sciences; Institute of Fundamental Technological Research of the Polish Academy of Sciences	Kimmel, M (corresponding author), Rice Univ, Dept Stat, Houston, TX 77251 USA.	kimmel@rice.edu	Lipniacki, Tomasz/AAC-6744-2019	Lipniacki, Tomasz/0000-0002-3488-2561; Brasier, Allan/0000-0002-5012-4090	National Institutes of Health [GM086885, AI062885]; National Science Center (Poland) [DEC-2012/04/A/ST7/00353]; EPSRC; Institute for Advanced Study at the Warwick University, UK; EPSRC [EP/J006653/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/J006653/1] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Center (Poland)(National Science Centre, Poland); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Institute for Advanced Study at the Warwick University, UK; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants GM086885 (RB, TL, AS, MI, ARB, MK) and AI062885 (ARB). MK was partly supported by DEC-2012/04/A/ST7/00353 grant from the National Science Center (Poland), and by EPSRC and the Institute for Advanced Study at the Warwick University, UK, grants supporting his stay as a Fellow of the IAS at the Systems Biology Center at WU in the fall of 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Balachandran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002165; Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; Bertolusso R, 2011, COMPUTATIONAL MODELS; Brasier A.R., 2008, CELLULAR SIGNALING I, P119; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Brasier AR, 2011, J VIROL, V85, P11752, DOI 10.1128/JVI.05360-11; Bryne JC, 2008, NUCLEIC ACIDS RES, V36, pD102, DOI 10.1093/nar/gkm955; Cheong R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.30; Chkrebtii O, 2013, BAYESIAN UNCERTAINTY; Clemens MJ, 1997, INT J BIOCHEM CELL B, V29, P945, DOI 10.1016/S1357-2725(96)00169-0; Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607; Du CJ, 2010, CYTOM PART A, V77A, P1137, DOI 10.1002/cyto.a.20993; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Forbus J, 2006, PROTEOMICS, V6, P2656, DOI 10.1002/pmic.200500652; Fujita PA, 2011, NUCL ACIDS RES; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Girolami M, 2008, THEOR COMPUT SCI, V408, P4, DOI 10.1016/j.tcs.2008.07.005; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Gutenkunst RN, 2007, ANN NY ACAD SCI, V1115, P203, DOI 10.1196/annals.1407.003; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Imaizumi T, 2004, LIFE SCI, V75, P1171, DOI 10.1016/j.lfs.2004.01.030; Iwanaszko M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-182; Jaksik R, 2012, GENE, V492, P375, DOI 10.1016/j.gene.2011.10.050; Kalita MK, 2011, J BIOL CHEM, V286, P37741, DOI 10.1074/jbc.M111.280925; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Lipniacki T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-376; Liu P, 2008, J BIOL CHEM, V283, P23169, DOI 10.1074/jbc.M802729200; Liu P, 2007, J VIROL, V81, P1401, DOI 10.1128/JVI.01740-06; Liu P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008079; Lu RQ, 2002, J BIOL CHEM, V277, P16592, DOI 10.1074/jbc.M111440200; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; mieja J, 2008, BIOINFORMATICS, V24, P2363; Ning SB, 2005, J BIOL CHEM, V280, P12262, DOI 10.1074/jbc.M404260200; Nowak DE, 2008, MOL CELL BIOL, V28, P3623, DOI 10.1128/MCB.01152-07; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; RHOADS RE, 1993, J BIOL CHEM, V268, P3017; Saitoh T, 2005, J IMMUNOL, V174, P1507, DOI 10.4049/jimmunol.174.3.1507; Sandelin A, 2004, NUCLEIC ACIDS RES, V1, P32; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seckute J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt540; Sen A, 2009, J VIROL, V83, P10322, DOI 10.1128/JVI.01186-09; Sen GC, 2005, CYTOKINE GROWTH F R, V16, P1, DOI 10.1016/j.cytogfr.2005.01.006; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Su ZZ, 2007, J CELL PHYSIOL, V213, P502, DOI 10.1002/jcp.21128; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Tian B, 2013, J VIROL, V87, P7075, DOI 10.1128/JVI.03399-12; Waterfall JJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.150601; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xu T, 2010, SCI SIGNALLING, V3; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhao XL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000299; Zhao YX, 2013, METHODS, V61, P313, DOI 10.1016/j.ymeth.2013.02.001; Zhao YX, 2013, MOL CELL PROTEOMICS, V12, P1513, DOI 10.1074/mcp.M112.023465	69	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93396	10.1371/journal.pone.0093396	http://dx.doi.org/10.1371/journal.pone.0093396			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710104	Green Published, gold			2022-12-25	WOS:000334159800030
J	Hofstede, SN; van Bodegom-Vos, L; Wentink, MM; Vleggeert-Lankamp, CLA; Vlieland, TPMV; Marang-van de Mheen, PJ				Hofstede, Stefanie N.; van Bodegom-Vos, Leti; Wentink, Manon M.; Vleggeert-Lankamp, Carmen L. A.; Vlieland, Thea P. M. Vliet; Marang-van de Mheen, Perla J.		DISC Study Grp	Most Important Factors for the Implementation of Shared Decision Making in Sciatica Care: Ranking among Professionals and Patients	PLOS ONE			English	Article							SURGERY; DISC; FACILITATORS; MANAGEMENT; BARRIERS	Introduction: Due to the increasing specialization of medical professionals, patients are treated by multiple disciplines. To ensure that delivered care is patient-centered, it is crucial that professionals and the patient together decide on treatment (shared decision making (SDM)). However, it is not known how SDM should be integrated in multidisciplinary practice. This study determines the most important factors for SDM implementation in sciatica care, as it is known that a prior inventory of factors is crucial to develop a successful implementation strategy. Methods: 246 professionals (general practitioners, physical therapists, neurologists, neurosurgeons, orthopedic surgeons) (30% response) and 155 patients (96% response) responded to an internet-based survey. Respondents ranked barriers and facilitators identified in previous interviews, on their importance using Maximum Difference Scaling. Feeding back the personal top 5 most important factors, each respondent indicated whether these factors were barriers or facilitators. Hierarchical Bayes estimation was used to estimate the relative importance (RI) of each factor. Results: Professionals assigned the highest importance to: quality of professional-patient relationship (RI 4.87; CI 4.75-4.99); importance of quick recovery of patient (RI 4.83; CI 4.69-4.97); and knowledge about treatment options (RI 6.64; CI 4.534.74), which were reported as barrier and facilitator. Professionals working in primary care had a different ranking than those working in hospital care. Patients assigned the highest importance to: correct diagnosis by professionals (barrier, RI 8.19; CI 7.99-8.38); information provision about treatment options and potential harm and benefits (RI 7.87; CI 7.65-8.08); and explanation of the professional about the care trajectory (RI 7.16; CI 6.94-7.38), which were reported as barrier and facilitator. Conclusions: Knowledge, information provision and a good relationship are the most important conditions for SDM perceived by both patients and professionals. These conditions are not restricted to one specific disease or health care system, because they are mostly professional or patient dependent and require healthcare professional training.	[Hofstede, Stefanie N.; van Bodegom-Vos, Leti; Wentink, Manon M.; Marang-van de Mheen, Perla J.] Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands; [Vleggeert-Lankamp, Carmen L. A.] Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands; [Vlieland, Thea P. M. Vliet] Leiden Univ, Med Ctr, Dept Orthopaed, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Marang-van de Mheen, PJ (corresponding author), Leiden Univ, Med Ctr, Dept Med Decis Making, Leiden, Netherlands.	p.j.marang@lumc.nl	assendelft, willem/AAW-1854-2021; Assendelft, W.J.J./H-8008-2014; Vleggeert-Lankamp, Carmen/AGX-9660-2022; de Mheen, Perla J. Marang-van/I-2783-2015; van Bodegom-Vos, Leti/J-8087-2015; Vlieland, Thea Vliet/AAJ-8119-2020	assendelft, willem/0000-0002-2966-3778; Assendelft, W.J.J./0000-0002-2966-3778; Vleggeert-Lankamp, Carmen/0000-0001-9597-7225; de Mheen, Perla J. Marang-van/0000-0003-1439-0989; van Bodegom-Vos, Leti/0000-0002-8486-6404; Vlieland, Thea Vliet/0000-0001-6322-3859; Hofstede, Stefanie/0000-0002-7181-9959	Netherlands Organization for Health Research and Development [171203003]; Netherlands Organization for Scientific Research (NWO) Incentive Fund Open Access Publications	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research (NWO) Incentive Fund Open Access Publications	This research project is supported by a grant from the Netherlands Organization for Health Research and Development (grant number 171203003). Funding was obtained from the Netherlands Organization for Scientific Research (NWO) Incentive Fund Open Access Publications. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHERKIN DC, 1994, SPINE, V19, P1201, DOI 10.1097/00007632-199405310-00001; Cohen S, 2004, MARK RES, V16, P32; Cohen Steven H., 2002, C P AMST NETH; DEGNER LF, 1992, J CLIN EPIDEMIOL, V45, P941, DOI 10.1016/0895-4356(92)90110-9; Dobrow MJ, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1090; Elwyn G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5146; Flynn TN, 2007, J HEALTH ECON, V26, P171, DOI 10.1016/j.jhealeco.2006.04.002; Gravel K, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-16; Hofstede SN, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-95; Jacobs WCH, 2011, EUR SPINE J, V20, P513, DOI 10.1007/s00586-010-1603-7; Jessup RL, 2007, AUST HEALTH REV, V31, P330, DOI 10.1071/AH070330; Konstantinou K, 2008, SPINE, V33, P2464, DOI 10.1097/BRS.0b013e318183a4a2; Legare F, 2011, J EVAL CLIN PRACT, V17, P554, DOI 10.1111/j.1365-2753.2010.01515.x; Legare F, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006732.pub2; Legare F, 2008, PATIENT EDUC COUNS, V73, P526, DOI 10.1016/j.pec.2008.07.018; Lurie JD, 2008, SPINE, V33, P2663, DOI 10.1097/BRS.0b013e31818cb0db; McIntosh E, 2002, HLTH EC STUD GROUP M; OCONNOR A, 2009, COCHRANE DB SYST REV, V10; Peul WC, 2008, BRIT MED J, V336, P1355, DOI 10.1136/bmj.a143; Quality Institute for Health Care CBO, 2008, GUID LUMB RAD SYNDR; Rajakumar R., 2014, PRIM HLTH CARE RES D, P1; Sawtooth Software, 2009, CBC HB SYSTEM HIERAR; Sawtooth Software I, 2013, MAXDIFF SYST VERS 8; Sawtooth Software I, 2012, SSI WEB V8 1 SOFTW W; Van Beek E, 2010, REDUCTION VARIATION; Veroff D, 2013, HEALTH AFFAIR, V32, P285, DOI 10.1377/hlthaff.2011.0941; Vroomen PCAJ, 2002, BRIT J GEN PRACT, V52, P119; Webster BS, 2005, J GEN INTERN MED, V20, P1132, DOI 10.1111/j.1525-1497.2005.0230.x; Wiebe ER, 2012, CAN FAM PHYSICIAN, V58, pE225; Wirth R, 2011, USING MAXDIFF EVALUA	30	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94176	10.1371/journal.pone.0094176	http://dx.doi.org/10.1371/journal.pone.0094176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7EP	24710328	Green Submitted, Green Published, gold			2022-12-25	WOS:000334159800112
J	Shiheido, H; Chen, C; Hikida, M; Watanabe, T; Shimizu, J				Shiheido, Hirokazu; Chen, Chen; Hikida, Masaki; Watanabe, Takeshi; Shimizu, Jun			Modulation of the Human T Cell Response by a Novel Non-Mitogenic Anti-CD3 Antibody	PLOS ONE			English	Article							OKT3 MONOCLONAL-ANTIBODY; ANTIGEN RECEPTOR; IN-VITRO; IMMUNOSUPPRESSIVE PROPERTIES; ACTIVATION; RECIPIENTS; REJECTION; PROLIFERATION; EXPANSION; RELEASE	The agonistic anti-human CD3 epsilon antibody ( Ab), OKT3, has been used to control acute transplant rejection. The in vivo administration of OKT3 was previously shown to induce the partial depletion of T cells and unresponsiveness ( anergy) in the remaining CD4(+) T cells. However, this therapy is also associated with the systemic release of several cytokines, which leads to a series of adverse side effects. We established a novel anti-human CD3 epsilon Ab, 20-2b2, which recognized a close, but different determinant on the CD epsilon molecule from that recognized by OKT3. 20-2b2 was non-mitogenic for human CD4(+) T cells, could inhibit the activation of T cells in vitro, and induced T cell anergy in in vivo experiments using humanized mice. Cytokine release in humanized mice induced by the administration of 20-2b2 was significantly less than that induced by OKT3. Our results indicated that the CD epsilon molecule is still an attractive, effective, and useful target for the modulation of T cell responses. The establishment of other Abs that recognize CD3e, even though the determinant recognized by those Abs may be close to or different from that recognized by OKT3, may represent a novel approach for the development of safer Ab therapies using anti-CD3 Abs, in addition to the modification of OKT3 in terms of the induction of cytokine production.	[Shiheido, Hirokazu; Chen, Chen; Hikida, Masaki; Watanabe, Takeshi; Shimizu, Jun] Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan	Kyoto University	Shimizu, J (corresponding author), Kyoto Univ, Grad Sch Med, Ctr Innovat Immunoregulat Technol & Therapeut, Kyoto, Japan.	jun@ak.med.kyoto-u.ac.jp		Shimizu, Jun/0000-0002-6461-4648; Shiheido, Hirokazu/0000-0002-1415-2019	Ministry of Education, Culture, Sports, Science and Technology of Japan; Astellas Pharma Inc. in the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Grants-in-Aid for Scientific Research [24111009] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Astellas Pharma Inc. in the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Special Coordination Funds by the Ministry of Education, Culture, Sports, Science and Technology of Japan and Astellas Pharma Inc. in the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; ABRAMOWICZ D, 1989, TRANSPLANTATION, V47, P606, DOI 10.1097/00007890-198904000-00008; ALEGRE ML, 1994, TRANSPLANTATION, V57, P1537; Bisikirska B, 2005, J CLIN INVEST, V115, P2904, DOI 10.1172/JCI23961; BOLT S, 1993, EUR J IMMUNOL, V23, P403, DOI 10.1002/eji.1830230216; CANTRELL DA, 1985, P NATL ACAD SCI USA, V82, P8158, DOI 10.1073/pnas.82.23.8158; Chatenoud L, 2004, CURR OPIN PHARMACOL, V4, P403, DOI 10.1016/j.coph.2004.03.012; CHATENOUD L, 1990, TRANSPLANTATION, V49, P697, DOI 10.1097/00007890-199004000-00009; Cole MS, 1999, TRANSPLANTATION, V68, P563, DOI 10.1097/00007890-199908270-00020; COSIMI AB, 1981, NEW ENGL J MED, V305, P308, DOI 10.1056/NEJM198108063050603; COSIMI AB, 1981, TRANSPLANTATION, V32, P535, DOI 10.1097/00007890-198112000-00018; DIETRICH J, 1994, EMBO J, V13, P2156, DOI 10.1002/j.1460-2075.1994.tb06492.x; Fleischer B, 1996, INFECT IMMUN, V64, P987, DOI 10.1128/IAI.64.3.987-994.1996; Friend PJ, 1999, TRANSPLANTATION, V68, P1632, DOI 10.1097/00007890-199912150-00005; Grakoui A, 1998, INT IMMUNOL, V10, P969, DOI 10.1093/intimm/10.7.969; Herold KC, 2003, J CLIN INVEST, V111, P409, DOI 10.1172/JCI200316090; HIRSCH R, 1989, J IMMUNOL, V142, P737; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; Kaufman A, 2009, DIABETES-METAB RES, V25, P302, DOI 10.1002/dmrr.933; Kuhn C, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001830; Li J, 2006, INT IMMUNOPHARMACOL, V6, P880, DOI 10.1016/j.intimp.2005.12.009; LUTON F, 1994, J IMMUNOL, V153, P63; Martin A, 2013, CLIN IMMUNOL, V148, P136, DOI 10.1016/j.clim.2013.04.011; Nishida E, 2011, IMMUNOL LETT, V136, P163, DOI 10.1016/j.imlet.2011.01.006; Nishioka T, 2008, IMMUNOL LETT, V121, P97, DOI 10.1016/j.imlet.2008.09.003; OHASHI PS, 1985, NATURE, V316, P606, DOI 10.1038/316606a0; Popma SH, 2005, INT IMMUNOPHARMACOL, V5, P155, DOI 10.1016/j.intimp.2004.09.023; Schwartz RH, 1996, J EXP MED, V184, P1, DOI 10.1084/jem.184.1.1; Shiheido H, 2014, EUR J IMMUNOL, V44, P1770, DOI 10.1002/eji.201344146; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; VIGERAL P, 1986, TRANSPLANTATION, V41, P730, DOI 10.1097/00007890-198606000-00013; WEISS A, 1984, J EXP MED, V160, P1284, DOI 10.1084/jem.160.5.1284; Xu DL, 2000, CELL IMMUNOL, V200, P16, DOI 10.1006/cimm.2000.1617; 1985, N ENGL J MED, V313, P337	34	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94324	10.1371/journal.pone.0094324	http://dx.doi.org/10.1371/journal.pone.0094324			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710513	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800135
J	Qi, HS; Li, SS; Zhao, SM; Huang, D; Xia, ML; Wen, JP				Qi, Haishan; Li, Shanshan; Zhao, Sumin; Huang, Di; Xia, Menglei; Wen, Jianping			Model-Driven Redox Pathway Manipulation for Improved Isobutanol Production in Bacillus subtilis Complemented with Experimental Validation and Metabolic Profiling Analysis	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; ESCHERICHIA-COLI; OVEREXPRESSION; BIOSYNTHESIS; GENES; YIELD; BUTANOL; UDHA	To rationally guide the improvement of isobutanol production, metabolic network and metabolic profiling analysis were performed to provide global and profound insights into cell metabolism of isobutanol-producing Bacillus subtilis. The metabolic flux distribution of strains with different isobutanol production capacity (BSUL03, BSUL04 and BSUL05) drops a hint of the importance of NADPH on isobutanol biosynthesis. Therefore, the redox pathways were redesigned in this study. To increase NADPH concentration, glucose-6-phosphate isomerase was inactivated (BSUL06) and glucose-6-phosphate dehydrogenase was overexpressed (BSUL07) successively. As expected, NADPH pool size in BSUL07 was 4.4-fold higher than that in parental strain BSUL05. However, cell growth, isobutanol yield and production were decreased by 46%, 22%, and 80%, respectively. Metabolic profiling analysis suggested that the severely imbalanced redox status might be the primary reason. To solve this problem, gene udhA of Escherichia coli encoding transhydrogenase was further overexpressed (BSUL08), which not only well balanced the cellular ratio of NAD(P)H/NAD(P)(+), but also increased NADH and ATP concentration. In addition, a straightforward engineering approach for improving NADPH concentrations was employed in BSUL05 by overexpressing exogenous gene pntAB and obtained BSUL09. The performance for isobutanol production by BSUL09 was poorer than BSUL08 but better than other engineered strains. Furthermore, in fed-batch fermentation the isobutanol production and yield of BSUL08 increased by 11% and 19%, up to the value of 6.12 g/L and 0.37 C-mol isobutanol/C-mol glucose (63% of the theoretical value), respectively, compared with parental strain BSUL05. These results demonstrated that model-driven complemented with metabolic profiling analysis could serve as a useful approach in the strain improvement for higher bio-productivity in further application.	[Qi, Haishan; Li, Shanshan; Zhao, Sumin; Huang, Di; Xia, Menglei; Wen, Jianping] Tianjin Univ, Minist Educ, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China; [Qi, Haishan; Li, Shanshan; Zhao, Sumin; Huang, Di; Xia, Menglei; Wen, Jianping] Tianjin Univ, Sch Chem Engn & Technol, Dept Biochem Engn, Tianjin 300072, Peoples R China; [Wen, Jianping] Collaborat Innovat Ctr Chem Sci & Engn, Tianjin, Peoples R China	Tianjin University; Tianjin University	Wen, JP (corresponding author), Tianjin Univ, Minist Educ, Key Lab Syst Bioengn, Tianjin 300072, Peoples R China.	jpwen@tju.edu.cn	Wen, Jianping/A-1866-2015		National Basic Research Program of China ("973'' Program) [2013CB733600]; Key Program of National Natural Science Foundation of China [21236005]; Specialized Research Fund for the Doctoral Program of Higher Education [20110032130005]; Programme of Introducing Talents of Discipline to Universities [B06006]	National Basic Research Program of China ("973'' Program)(National Basic Research Program of China); Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Programme of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project)	This research was financially supported by the National Basic Research Program of China ("973'' Program: 2013CB733600), the Key Program of National Natural Science Foundation of China (21236005), Specialized Research Fund for the Doctoral Program of Higher Education (20110032130005) and the Programme of Introducing Talents of Discipline to Universities (B06006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Atsumi S, 2010, APPL MICROBIOL BIOT, V85, P651, DOI 10.1007/s00253-009-2085-6; Atsumi S, 2009, APPL ENVIRON MICROB, V75, P6306, DOI 10.1128/AEM.01160-09; Baez A, 2011, APPL MICROBIOL BIOT, V90, P1681, DOI 10.1007/s00253-011-3173-y; Bartek T, 2010, BIOTECHNOL PROGR, V26, P361, DOI 10.1002/btpr.345; Bastian S, 2011, METAB ENG, V13, P345, DOI 10.1016/j.ymben.2011.02.004; Bi CH, 2009, APPL ENVIRON MICROB, V75, P5743, DOI 10.1128/AEM.01180-09; Blombach B, 2011, APPL ENVIRON MICROB, V77, P3300, DOI 10.1128/AEM.02972-10; Borden JR, 2007, APPL ENVIRON MICROB, V73, P3061, DOI 10.1128/AEM.02296-06; BOWLES LK, 1985, APPL ENVIRON MICROB, V50, P1165, DOI 10.1128/AEM.50.5.1165-1170.1985; Canonaco F, 2001, FEMS MICROBIOL LETT, V204, P247, DOI 10.1111/j.1574-6968.2001.tb10892.x; Chemler JA, 2010, METAB ENG, V12, P96, DOI 10.1016/j.ymben.2009.07.003; Chen X, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-21; Chin JW, 2009, BIOTECHNOL BIOENG, V102, P209, DOI 10.1002/bit.22060; Fuhrer T, 2009, J BACTERIOL, V191, P2112, DOI 10.1128/JB.01523-08; Ghosh A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027316; Gyan S, 2006, J BACTERIOL, V188, P7062, DOI 10.1128/JB.00601-06; Higashide W, 2011, APPL ENVIRON MICROB, V77, P2727, DOI 10.1128/AEM.02454-10; Jia XQ, 2012, APPL BIOCHEM BIOTECH, V168, P1, DOI 10.1007/s12010-011-9268-1; Karabektas M, 2009, RENEW ENERG, V34, P1554, DOI 10.1016/j.renene.2008.11.003; Kim YM, 2011, BIOTECHNOL BIOENG, V108, P2941, DOI 10.1002/bit.23259; Lee HC, 2010, J BIOTECHNOL, V149, P24, DOI 10.1016/j.jbiotec.2010.06.011; Lee WH, 2007, APPL MICROBIOL BIOT, V76, P329, DOI 10.1007/s00253-007-1016-7; Lerondel G, 2006, J BACTERIOL, V188, P4727, DOI 10.1128/JB.00167-06; Li SS, 2012, BIOTECHNOL LETT, V34, P2253, DOI 10.1007/s10529-012-1041-1; Li SS, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-101; Li SS, 2011, APPL MICROBIOL BIOT, V91, P577, DOI 10.1007/s00253-011-3280-9; Lim SJ, 2002, J BIOSCI BIOENG, V93, P543, DOI 10.1016/S1389-1723(02)80235-3; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; Maugeri DA, 2003, MOL BIOCHEM PARASIT, V130, P117, DOI 10.1016/S0166-6851(03)00173-7; Nielsen DR, 2009, METAB ENG, V11, P262, DOI 10.1016/j.ymben.2009.05.003; PRASAD C, 1974, J BACTERIOL, V118, P1111, DOI 10.1128/JB.118.3.1111-1122.1974; Romero S, 2007, APPL ENVIRON MICROB, V73, P5190, DOI 10.1128/AEM.00625-07; Ruhl M, 2010, BIOTECHNOL BIOENG, V105, P795, DOI 10.1002/bit.22591; Sanchez AM, 2006, BIOTECHNOL PROGR, V22, P420, DOI 10.1021/bp050375u; Sauer U, 1997, NAT BIOTECHNOL, V15, P448, DOI 10.1038/nbt0597-448; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Selvarasu S, 2012, BIOTECHNOL BIOENG, V109, P1415, DOI 10.1002/bit.24445; Shi AQ, 2013, METAB ENG, V16, P1, DOI 10.1016/j.ymben.2012.11.008; Shimizu K, 2009, BIOCHEM ENG J, V46, P235, DOI 10.1016/j.bej.2009.06.006; Siedler S, 2011, APPL MICROBIOL BIOT, V92, P929, DOI 10.1007/s00253-011-3374-4; Singh A, 2011, METAB ENG, V13, P76, DOI 10.1016/j.ymben.2010.10.006; Singh A, 2009, METAB ENG, V11, P347, DOI 10.1016/j.ymben.2009.07.002; Trinh CT, 2011, APPL ENVIRON MICROB, V77, P4894, DOI 10.1128/AEM.00382-11; Veit A, 2008, MICROB BIOTECHNOL, V1, P382, DOI 10.1111/j.1751-7915.2008.00033.x; Villas-Boas SG, 2005, YEAST, V22, P1155, DOI 10.1002/yea.1308; von Kamp A, 2006, BIOINFORMATICS, V22, P1930, DOI 10.1093/bioinformatics/btl267; Wang ZW, 2011, BIORESOURCE TECHNOL, V102, P3934, DOI 10.1016/j.biortech.2010.11.120; Winder CL, 2008, ANAL CHEM, V80, P2939, DOI 10.1021/ac7023409; Zhang YHP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000456	51	18	21	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93815	10.1371/journal.pone.0093815	http://dx.doi.org/10.1371/journal.pone.0093815			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705866	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500069
J	Campos-Salinas, J; Cavazzuti, A; O'Valle, F; Forte-Lago, I; Caro, M; Beverley, SM; Delgado, M; Gonzalez-Rey, E				Campos-Salinas, Jenny; Cavazzuti, Antonio; O'Valle, Francisco; Forte-Lago, Irene; Caro, Marta; Beverley, Stephen M.; Delgado, Mario; Gonzalez-Rey, Elena			Therapeutic Efficacy of Stable Analogues of Vasoactive Intestinal Peptide against Pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLASE-ACTIVATING POLYPEPTIDE; LEISHMANIA-MAJOR; ANTIMICROBIAL PEPTIDES; FORMULATION DESIGN; SCORING FUNCTION; MICE; VIP; NEUROPEPTIDES; PROTEIN; MODEL	Vasoactive intestinal peptide (VIP) is an anti-inflammatory neuropeptide recently identified as a potential antimicrobial peptide. To overcome the metabolic limitations of VIP, we modified the native peptide sequence and generated two stable synthetic analogues (VIP51 and VIP51(6-30)) with better antimicrobial profiles. Herein we investigate the effects of both VIP analogues on cell viability, membrane integrity, and ultrastructure of various bacterial strains and Leishmania species. We found that the two VIP derivatives kill various non-pathogenic and pathogenic Gram-positive and Gram-negative bacteria as well as the parasite Leishmania major through a mechanism that depends on the interaction with certain components of the microbial surface, the formation of pores, and the disruption of the surface membrane. The cytotoxicity of the VIP derivatives is specific for pathogens, because they do not affect the viability of mammalian cells. Docking simulations indicate that the chemical changes made in the analogues are critical to increase their antimicrobial activities. Consequently, we found that the native VIP is less potent as an antibacterial and fails as a leishmanicidal. Noteworthy from a therapeutic point of view is that treatment with both derivatives increases the survival and reduces bacterial load and inflammation in mice with polymicrobial sepsis. Moreover, treatment with VIP51(6-30) is very effective at reducing lesion size and parasite burden in a model of cutaneous leishmaniasis. These results indicate that the VIP analogues emerge as attractive alternatives for treating drug-resistant infectious diseases and provide key insights into a rational design of novel agents against these pathogens.	[Campos-Salinas, Jenny; Cavazzuti, Antonio; Forte-Lago, Irene; Caro, Marta; Delgado, Mario; Gonzalez-Rey, Elena] CSIC, Inst Parasitol & Biomed, Granada 18016, Spain; [O'Valle, Francisco] Med Sch Granada, Dept Pathol Anat, Granada 18012, Spain; [Beverley, Stephen M.] Washington Univ, Dept Mol Microbiol, Sch Med, St Louis, MO 63110 USA; [Gonzalez-Rey, Elena] Med Sch Seville, Dept Biochem & Mol Biol, Seville 41009, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Washington University (WUSTL)	Gonzalez-Rey, E (corresponding author), CSIC, Inst Parasitol & Biomed, PT Ciencias Salud, Avd Conocimiento, Granada 18016, Spain.	elenag@ipb.csic.es	Forte-Lago, Irene/ABG-9980-2020; GONZALEZ-REY, ELENA/L-3296-2014; Delgado, Mario/P-1524-2016; Caro, Marta/ABG-9963-2020; OValle, Francisco/AAA-9151-2019	GONZALEZ-REY, ELENA/0000-0003-3917-9020; Delgado, Mario/0000-0003-1893-5982; Forte Lago, Irene/0000-0002-3998-0398; Caro, Marta/0000-0003-3385-4734; Beverley, Stephen/0000-0001-5319-0811	National Institutes of Health [RO1 AI031078]; Excellence Grants from Junta de Andalucia [P09/CTS-4705]; European Cost Action [BM0802]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI031078] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Excellence Grants from Junta de Andalucia(Junta de Andalucia); European Cost Action; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI031078 (to S. M. B.). This work was also supported by Excellence Grants from Junta de Andalucia (P09/CTS-4705) (to E. G.-R.) and European Cost Action (BM0802) (to E. G.-R.).	Abad C, 2003, GASTROENTEROLOGY, V124, P961, DOI 10.1053/gast.2003.50141; AFONSO LCC, 1993, INFECT IMMUN, V61, P2952, DOI 10.1128/IAI.61.7.2952-2959.1993; Augustyniak D, 2012, CURR PROTEIN PEPT SC, V13, P723, DOI 10.2174/138920312804871139; Baltzer SA, 2011, J MOL MICROB BIOTECH, V20, P228, DOI 10.1159/000331009; Brogden KA, 2005, NAT IMMUNOL, V6, P558, DOI 10.1038/ni1209; Ceraudo E, 2008, MOL ENDOCRINOL, V22, P147, DOI 10.1210/me.2007-0361; Chorny A, 2008, AM J PATHOL, V172, P1297, DOI 10.2353/ajpath.2008.070969; da Silva LM, 2009, P NATL ACAD SCI USA, V106, P7583, DOI 10.1073/pnas.0901698106; Delgado M, 2009, CELL DEATH DIFFER, V16, P406, DOI 10.1038/cdd.2008.161; Delgado M, 2003, FASEB J, V17, P1922, DOI 10.1096/fj.02-1029fje; Delgado M, 2003, FASEB J, V17, P944, DOI 10.1096/fj.02-0799fje; Delgado M, 1999, J IMMUNOL, V162, P1200; Delgado M, 2004, PHARMACOL REV, V56, P249, DOI 10.1124/pr.56.2.7; Delgado M, 2001, NAT MED, V7, P563, DOI 10.1038/87887; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1197, DOI 10.1164/rccm.200204-302OC; El Karim IA, 2008, J NEUROIMMUNOL, V200, P11, DOI 10.1016/j.jneuroim.2008.05.014; Epand RF, 2005, MOL MEMBR BIOL, V22, P457, DOI 10.1080/09687860500370562; Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000; Gonzalez-Rey E, 2006, AM J PATHOL, V168, P1179, DOI 10.2353/ajpath.2006.051081; Hancock REW, 1997, LANCET, V349, P418, DOI 10.1016/S0140-6736(97)80051-7; Harmar AJ, 2012, BRIT J PHARMACOL, V166, P4, DOI 10.1111/j.1476-5381.2012.01871.x; He J, 2007, ANTIMICROB AGENTS CH, V51, P1351, DOI 10.1128/AAC.01270-06; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hotez P, 2007, TRENDS PARASITOL, V23, P511, DOI 10.1016/j.pt.2007.08.015; Iyer R, 2002, NATURE, V419, P715, DOI 10.1038/nature01000; Kihara N, 2003, GUT, V52, P713, DOI 10.1136/gut.52.5.713; Kleczka B, 2007, J BIOL CHEM, V282, P10498, DOI 10.1074/jbc.M700023200; Kulkarni MM, 2006, MOL MICROBIOL, V62, P1484, DOI 10.1111/j.1365-2958.2006.05459.x; Ma DQ, 1997, J BIOL CHEM, V272, P3799, DOI 10.1074/jbc.272.6.3799; Mayer M. L., 2011, ADV MOL CELLULAR MIC, P195; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P7385; McGwire BS, 2010, EXP PARASITOL, V126, P397, DOI 10.1016/j.exppara.2010.02.006; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Mor A, 2009, FEBS J, V276, P6474, DOI 10.1111/j.1742-4658.2009.07358.x; Naderer T, 2004, CURR MOL MED, V4, P649, DOI 10.2174/1566524043360069; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Nevot M, 2006, MICROB ECOL, V51, P501, DOI 10.1007/s00248-006-9065-5; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Ohta K, 2011, J NEUROIMMUNOL, V233, P37, DOI 10.1016/j.jneuroim.2010.11.009; Onoue S, 2004, EUR J BIOCHEM, V271, P1757, DOI 10.1111/j.1432-1033.2004.04086.x; Onoue S, 2008, N-S ARCH PHARMACOL, V377, P579, DOI 10.1007/s00210-007-0232-0; Onoue S, 2013, EUR J PHARM SCI, V49, P382, DOI 10.1016/j.ejps.2013.04.009; Onoue S, 2011, INT J PHARMACEUT, V410, P54, DOI 10.1016/j.ijpharm.2011.03.021; Onoue S, 2009, EUR J PHARM BIOPHARM, V73, P95, DOI 10.1016/j.ejpb.2009.05.013; Pulido D, 2012, ANTIMICROB AGENTS CH, V56, P2378, DOI 10.1128/AAC.06107-11; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; SAID SI, 1970, SCIENCE, V169, P1217, DOI 10.1126/science.169.3951.1217; SAID SI, 1991, TRENDS ENDOCRIN MET, V2, P107, DOI 10.1016/S1043-2760(05)80006-2; Spath GF, 2003, SCIENCE, V301, P1241, DOI 10.1126/science.1087499; Sun QQ, 2003, J NEUROSCI, V23, P2751; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vaudry D, 2000, PHARMACOL REV, V52, P269; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	56	30	35	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14583	14599		10.1074/jbc.M114.560573	http://dx.doi.org/10.1074/jbc.M114.560573			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24706753	Green Published, hybrid			2022-12-25	WOS:000337248100016
J	Anderson, LG; White, PCL; Stebbing, PD; Stentiford, GD; Dunn, AM				Anderson, Lucy G.; White, Piran C. L.; Stebbing, Paul D.; Stentiford, Grant D.; Dunn, Alison M.			Biosecurity and Vector Behaviour: Evaluating the Potential Threat Posed by Anglers and Canoeists as Pathways for the Spread of Invasive Non-Native Species and Pathogens	PLOS ONE			English	Article							CRAYFISH PLAGUE; GYRODACTYLUS-SALARIS; MEDIATED DISPERSAL; OVERLAND DISPERSAL; RISK-ASSESSMENT; GREAT-BRITAIN; WATER; TRANSMISSION; ZOOPLANKTON; SURVIVAL	Invasive non-native species ( INNS) endanger native biodiversity and are a major economic problem. The management of pathways to prevent their introduction and establishment is a key target in the Convention on Biological Diversity's Aichi biodiversity targets for 2020. Freshwater environments are particularly susceptible to invasions as they are exposed to multiple introduction pathways, including non-native fish stocking and the release of boat ballast water. Since many freshwater INNS and aquatic pathogens can survive for several days in damp environments, there is potential for transport between water catchments on the equipment used by recreational anglers and canoeists. To quantify this biosecurity risk, we conducted an online questionnaire with 960 anglers and 599 canoeists to investigate their locations of activity, equipment used, and how frequently equipment was cleaned and/or dried after use. Anglers were also asked about their use and disposal of live bait. Our results indicate that 64% of anglers and 78.5% of canoeists use their equipment/boat in more than one catchment within a fortnight, the survival time of many of the INNS and pathogens considered in this study and that 12% of anglers and 50% of canoeists do so without either cleaning or drying their kit between uses. Furthermore, 8% of anglers and 28% of canoeists had used their equipment overseas without cleaning or drying it after each use which could facilitate both the introduction and secondary spread of INNS in the UK. Our results provide a baseline against which to evaluate the effectiveness of future biosecurity awareness campaigns, and identify groups to target with biosecurity awareness information. Our results also indicate that the biosecurity practices of these groups must improve to reduce the likelihood of inadvertently spreading INNS and pathogens through these activities.	[Anderson, Lucy G.; Dunn, Alison M.] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England; [White, Piran C. L.] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; [Stebbing, Paul D.; Stentiford, Grant D.] Ctr Environm Fisheries & Aquaculture Sci Cefas, Weymouth, England	University of Leeds; University of York - UK; Centre for Environment Fisheries & Aquaculture Science	Dunn, AM (corresponding author), Univ Leeds, Sch Biol, Leeds, W Yorkshire, England.	a.dunn@leeds.ac.uk	Stentiford, Grant/I-5567-2019; White, Piran Crawfurd Limond/AAH-6851-2021	Stentiford, Grant/0000-0001-6597-5413; White, Piran Crawfurd Limond/0000-0002-7496-5775; Dunn, Alison/0000-0002-4855-1077; Anderson, Lucy/0000-0002-9744-0349	CASE-Studentship from Biotechnology and Biological Sciences Research Council; Centre for Environment, Fisheries and Aquaculture Science; BBSRC	CASE-Studentship from Biotechnology and Biological Sciences Research Council; Centre for Environment, Fisheries and Aquaculture Science; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a CASE-Studentship from the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk) and the Centre for Environment, Fisheries and Aquaculture Science (www.cefas.defra.gov.uk) awarded to LA. The major funder (BBSRC) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-authors PS and GS are employed by the case-partner, Cefas.	AHNE W, 1982, ZBL VET MED B, V29, P457; Ahne W., 1976, FISCH UMWELT, V2, P121; Baruch-Mordo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015681; Briski E, 2012, J APPL ECOL, V49, P1124, DOI 10.1111/j.1365-2664.2012.02186.x; British Canoe Union, 2011, WAT LEIS PART SURV; Caplat P, 2011, ENVIRON MANAGE, V48, P878, DOI 10.1007/s00267-011-9747-8; Chan FT, 2012, BIOL INVASIONS; CSIRO, 2009, BIOS INV SPEC; Drake DAR, 2010, ECOL APPL, V20, P2286, DOI 10.1890/09-2005.1; Dresser C, 2013, BIOL INVASIONS, V15, P1049, DOI 10.1007/s10530-012-0349-z; E.S.R.I, 2012, ARCGIS; Environment Agency, 2004, OUR NAT FISH MIGR FR; Environment Agency, 2011, BIOD MOST WANT; Fielding N, 2011, FRESHWATER BIOL ASS, V54; Gallardo B, 2013, J APPL ECOL, V50, P757, DOI 10.1111/1365-2664.12079; Gallardo B, 2012, BIOL INVASIONS, V14, P1265, DOI 10.1007/s10530-011-0154-0; Gates KK, 2009, FISHERIES MANAG ECOL, V16, P448, DOI 10.1111/j.1365-2400.2009.00694.x; Gatlin MR, 2012, BIOL INVASIONS; GB Non Native Species Secretariat, 2011, GB NONN ORG RISK ASS; Gozlan RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053200; Hatcher M. J., 2011, PARASITES ECOLOGICAL; Havel JE, 2004, LIMNOL OCEANOGR, V49, P1229, DOI 10.4319/lo.2004.49.4_part_2.1229; Jacobs MJ, 2007, HYDROBIOLOGIA, V583, P119, DOI 10.1007/s10750-006-0487-3; Jerde CL, 2012, AQUAT INVASIONS, V7, P135, DOI 10.3391/ai.2012.7.1.015; Johnson LE, 2001, ECOL APPL, V11, P1789, DOI 10.1890/1051-0761(2001)011[1789:ODOAIS]2.0.CO;2; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Keller RP, 2007, AM MIDL NAT, V158, P321, DOI 10.1674/0003-0031(2007)158[321:FBSTTF]2.0.CO;2; Keller RP, 2009, CONSERV BIOL, V23, P1526, DOI 10.1111/j.1523-1739.2009.01249.x; Kelly NE, 2013, BIOL INVASIONS, V15, P509, DOI 10.1007/s10530-012-0303-0; Kilian JV, 2012, BIOL INVASIONS; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; MacNeil C, 2010, AQUAT INVASIONS, V5, P441, DOI 10.3391/ai.2010.5.4.15; Madgwick G, 2011, BRIT WILDLIFE; Martens Andreas, 2008, Lauterbornia, V62, P41; Ministry for Primary Industries, 2008, CHECK CLEAN DRY; Nakano H, 1998, FISH PATHOL, V33, P65, DOI 10.3147/jsfp.33.65; Nazir J, 2012, DIS AQUAT ORGAN, V98, P177, DOI 10.3354/dao02443; Oidtmann B, 2002, DIS AQUAT ORGAN, V52, P159, DOI 10.3354/dao052159; Oidtmann B, 2000, DIS FRESHWATER CRAYF, P9; Oidtmann BC, 2011, AQUACULTURE, V320, P22, DOI 10.1016/j.aquaculture.2011.07.032; Okamura B, 2011, FRESHWATER BIOL, V56, P627, DOI 10.1111/j.1365-2427.2011.02578.x; Olstad K, 2006, PARASITOLOGY, V133, P33, DOI 10.1017/S0031182006009966; Padilla DK, 2004, FRONT ECOL ENVIRON, V2, P131, DOI 10.1890/1540-9295(2004)002[0131:BBWAAO]2.0.CO;2; Peeler EJ, 2011, FRESHWATER BIOL, V56, P705, DOI 10.1111/j.1365-2427.2011.02572.x; Peeler EJ, 2004, PREV VET MED, V64, P175, DOI 10.1016/j.prevetmed.2004.05.005; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Poznanska M, 2013, HYDROBIOLOGIA, V700, P47, DOI 10.1007/s10750-012-1218-6; Prenter J, 2004, TRENDS ECOL EVOL, V19, P385, DOI 10.1016/j.tree.2004.05.002; R Core Team, 2018, R LANG ENV STAT COMP; Rahel FJ, 2007, FRESHWATER BIOL, V52, P696, DOI 10.1111/j.1365-2427.2006.01708.x; REYNOLDS JD, 1988, BIOL CONSERV, V45, P279, DOI 10.1016/0006-3207(88)90059-6; RICCIARDI A, 1995, CAN J FISH AQUAT SCI, V52, P470, DOI 10.1139/f95-048; Secretariat of the Convention on Biological Diversity, 2011, STRAT PLAN BIOD 2011; Shimizu T, 2006, FISH PATHOL, V41, P153, DOI 10.3147/jsfp.41.153; Stasko AD, 2012, AQUAT ECOL, V46, P9, DOI 10.1007/s10452-011-9378-4; Strayer DL, 2010, AQUAT SCI, V72, P127, DOI 10.1007/s00027-010-0128-9; TAUGBOL T, 1993, BIOL CONSERV, V63, P75, DOI 10.1016/0006-3207(93)90076-D; University of Bristol, 2013, BRIST ONL SURV; White PCL, 2005, J APPL ECOL, V42, P421, DOI 10.1111/j.1365-2664.2005.01032.x; Williams AE, 2001, AQUAT CONSERV, V11, P357, DOI 10.1002/aqc.466; Williams F., 2010, EC COST INVASIVE NON; Winfield IJ, 2011, HYDROBIOLOGIA, V660, P93, DOI 10.1007/s10750-010-0397-2	63	63	66	1	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e92788	10.1371/journal.pone.0092788	http://dx.doi.org/10.1371/journal.pone.0092788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717714	Green Published, gold			2022-12-25	WOS:000334339000020
J	Boudarham, J; Roche, N; Pradon, D; Delouf, E; Bensmail, D; Zory, R				Boudarham, Julien; Roche, Nicolas; Pradon, Didier; Delouf, Eric; Bensmail, Djamel; Zory, Raphael			Effects of Quadriceps Muscle Fatigue on Stiff-Knee Gait in Patients with Hemiparesis	PLOS ONE			English	Article							BOTULINUM TOXIN INJECTION; MOTONEURON FIRING RATES; RECTUS FEMORIS ACTIVITY; CEREBRAL-PALSY; SPASTIC PARESIS; STROKE PATIENTS; VOLUNTARY CONTRACTIONS; HEMIPLEGIC PATIENTS; LOWER-EXTREMITY; STRETCH REFLEX	The relationship between neuromuscular fatigue and locomotion has never been investigated in hemiparetic patients despite the fact that, in the clinical context, patients report to be more spastic or stiffer after walking a long distance or after a rehabilitation session. The aim of this study was to evaluate the effects of quadriceps muscle fatigue on the biomechanical gait parameters of patients with a stiff-knee gait (SKG). Thirteen patients and eleven healthy controls performed one gait analysis before a protocol of isokinetic quadriceps fatigue and two after (immediately after and after 10 minutes of rest). Spatiotemporal parameters, sagittal knee and hip kinematics, rectus femoris (RF) and vastus lateralis (VL) kinematics and electromyographic (EMG) activity were analyzed. The results showed that quadriceps muscle weakness, produced by repetitive concentric contractions of the knee extensors, induced an improvement of spatiotemporal parameters for patients and healthy subjects. For the patient group, the increase in gait velocity and step length was associated with i) an increase of sagittal hip and knee flexion during the swing phase, ii) an increase of the maximal normalized length of the RF and VL and of the maximal VL lengthening velocity during the pre-swing and swing phases, and iii) a decrease in EMG activity of the RF muscle during the initial pre-swing phase and during the latter 2/3 of the initial swing phase. These results suggest that quadriceps fatigue did not alter the gait of patients with hemiparesis walking with a SKG and that neuromuscular fatigue may play the same functional role as an anti-spastic treatment such as botulinum toxin-A injection. Strength training of knee extensors, although commonly performed in rehabilitation, does not seem to be a priority to improve gait of these patients.	[Boudarham, Julien; Roche, Nicolas; Pradon, Didier; Delouf, Eric; Bensmail, Djamel; Zory, Raphael] CHU Raymond Poincare, GRCTH, EA4497, CIC IT 805, Garches, France; [Zory, Raphael] Univ Nice Sophia Antipolis, LAMHESS, EA 6309, F-06189 Nice, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Universite Cote d'Azur	Boudarham, J (corresponding author), CHU Raymond Poincare, GRCTH, EA4497, CIC IT 805, Garches, France.	julien.boudarham@yahoo.fr	roche, nicolas/R-6080-2018; Bensmail, Djamel/R-6035-2018	Bensmail, Djamel/0000-0001-9360-9330				Amann M, 2011, J PHYSIOL-LONDON, V589, P5299, DOI 10.1113/jphysiol.2011.213769; Annaswamy TM, 1999, ARCH PHYS MED REHAB, V80, P930, DOI 10.1016/S0003-9993(99)90085-0; Arif M., 2010, ENG INTELL SYST ELEC, V2, P93; BIGLANDRITCHIE B, 1983, J PHYSIOL-LONDON, V340, P335, DOI 10.1113/jphysiol.1983.sp014765; BIGLANDRITCHIE BR, 1986, J PHYSIOL-LONDON, V379, P451, DOI 10.1113/jphysiol.1986.sp016263; Biro A, 2007, EXP BRAIN RES, V177, P157, DOI 10.1007/s00221-006-0656-7; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Boudarham J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066421; Byrne CA, 2005, J ELECTROMYOGR KINES, V15, P564, DOI 10.1016/j.jelekin.2005.03.002; Caty GD, 2008, ARCH PHYS MED REHAB, V89, P284, DOI 10.1016/j.apmr.2007.08.155; CRENNA P, 1999, PATHOPHYSIOLOGY, V5, P283; Feldmann RG, 1980, SPASTICITY DISORDERE, P485; Froyd C, 2013, J PHYSIOL-LONDON, V591, P1339, DOI 10.1113/jphysiol.2012.245316; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Goldberg SR, 2006, J BIOMECH, V39, P689, DOI 10.1016/j.jbiomech.2005.01.015; Granacher U, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-56; Helbostad JL, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-56; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hsu AL, 2003, ARCH PHYS MED REHAB, V84, P1185, DOI 10.1016/S0003-9993(03)00030-3; Hu M, 2006, BIOL SPORT, V23, P327; Hunter SK, 2004, EXERC SPORT SCI REV, V32, P44, DOI 10.1097/00003677-200404000-00002; Hutin E, 2012, GAIT POSTURE, V36, P205, DOI 10.1016/j.gaitpost.2012.02.016; Hutin E, 2010, NEUROREHAB NEURAL RE, V24, P442, DOI 10.1177/1545968309354535; Jackson ND, 2009, J ELECTROMYOGR KINES, V19, P75, DOI 10.1016/j.jelekin.2007.06.016; Judge JO, 1996, J GERONTOL A-BIOL, V51, pM303, DOI 10.1093/gerona/51A.6.M303; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Kalezic I, 2004, J PHYSIOL-LONDON, V556, P283, DOI 10.1113/jphysiol.2003.053249; KERRIGAN DC, 1991, AM J PHYS MED REHAB, V70, P294; Knorr S, 2012, DISABIL REHABIL, V34, P2291, DOI 10.3109/09638288.2012.683233; Knuppe AE, 2013, GAIT POSTURE, V37, P345, DOI 10.1016/j.gaitpost.2012.07.034; KNUTSSON E, 1980, SCAND J REHABIL MED, V12, P93; Lampire N, 2013, CLIN BIOMECH, V28, P164, DOI 10.1016/j.clinbiomech.2012.12.006; Lelas JL, 2003, GAIT POSTURE, V17, P106, DOI 10.1016/S0966-6362(02)00060-7; Lewek MD, 2007, J NEUROPHYSIOL, V98, P3153, DOI 10.1152/jn.00726.2007; Longpre HS, 2013, CLIN BIOMECH, V28, P441, DOI 10.1016/j.clinbiomech.2013.02.010; Lukacs M, 2008, CLIN NEUROPHYSIOL, V119, P2555, DOI 10.1016/j.clinph.2008.08.005; Marque P, 2001, J NEUROL NEUROSUR PS, V70, P36, DOI 10.1136/jnnp.70.1.36; Martin PG, 2006, J NEUROSCI, V26, P4796, DOI 10.1523/JNEUROSCI.5487-05.2006; Merletti R., 1999, J ELECTROMYOGR KINES, V9, P1; Moore BD, 2002, J ELECTROMYOGR KINES, V12, P351, DOI 10.1016/S1050-6411(02)00032-9; Moreau NG, 2008, ARCH PHYS MED REHAB, V89, P2011, DOI 10.1016/j.apmr.2008.03.012; Moreau NG, 2009, CLIN BIOMECH, V24, P355, DOI 10.1016/j.clinbiomech.2009.01.012; Murdock GH, 2012, EUR J APPL PHYSIOL, V112, P439, DOI 10.1007/s00421-011-1990-4; Nadeau S, 1999, CLIN BIOMECH, V14, P125, DOI 10.1016/S0268-0033(98)00062-X; NAKAMURA R, 1988, TOHOKU J EXP MED, V154, P111, DOI 10.1620/tjem.154.111; Niogi S, 2010, FRONT NEUROANAT, V4, DOI [10.3389/neuro.05.002.2010, 10.3389/fneur.2010.00149]; OLNEY SJ, 1996, GAIT POSTURE, V4, P136, DOI 10.1016/0966-6362(96)01063-6; Orendurff MS, 2004, J REHABIL RES DEV, V41, P829, DOI 10.1682/JRRD.2003.10.0150; Parijat P, 2008, GAIT POSTURE, V28, P568, DOI 10.1016/j.gaitpost.2008.04.001; Perry J., 1992, GAIT ANAL NORMAL PAT; Piazza SJ, 1996, J BIOMECH, V29, P723, DOI 10.1016/0021-9290(95)00144-1; Pincivero DM, 2001, MED SCI SPORT EXER, V33, P334; Poulain B., 2003, Annales de Readaptation et de Medecine Physique, V46, P265, DOI 10.1016/S0168-6054(03)00114-4; Reinbolt JA, 2008, J BIOMECH, V41, P2362, DOI 10.1016/j.jbiomech.2008.05.030; Robertson JVG, 2009, GAIT POSTURE, V29, P108, DOI 10.1016/j.gaitpost.2008.07.005; Rosales RL, 1996, MUSCLE NERVE, V19, P488, DOI 10.1002/(SICI)1097-4598(199604)19:4<488::AID-MUS9>3.0.CO;2-8; Rossi A, 2003, CLIN NEUROPHYSIOL, V114, P279, DOI 10.1016/S1388-2457(02)00334-6; Rudomin P, 1999, EXP BRAIN RES, V129, P1, DOI 10.1007/s002210050933; Shiavi R, 1987, J Rehabil Res Dev, V24, P24; Sibley KM, 2008, GAIT POSTURE, V27, P387, DOI 10.1016/j.gaitpost.2007.05.007; Stampacchia G, 2004, ARCH ITAL BIOL, V142, P265; Staszkiewicz R, 2010, ACTA BIOENG BIOMECH, V12, P13; Stoquart GG, 2008, ARCH PHYS MED REHAB, V89, P56, DOI 10.1016/j.apmr.2007.08.131; Sung DH, 2000, ARCH PHYS MED REHAB, V81, P910, DOI 10.1053/apmr.2000.5615; Tok F, 2012, AM J PHYS MED REHAB, V91, P321, DOI 10.1097/PHM.0b013e3182465feb; Trompetto C, 2006, MOVEMENT DISORD, V21, P777, DOI 10.1002/mds.20801; van der Krogt MM, 2012, GAIT POSTURE, V36, P113, DOI 10.1016/j.gaitpost.2012.01.017; van der Krogt MM, 2010, J REHABIL MED, V42, P656, DOI 10.2340/16501977-0579; VANINGENSCHENAU GJ, 1995, J PHYSIOL-LONDON, V484, P247, DOI 10.1113/jphysiol.1995.sp020662	70	21	22	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94138	10.1371/journal.pone.0094138	http://dx.doi.org/10.1371/journal.pone.0094138			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718087	Green Published, Green Submitted, gold			2022-12-25	WOS:000334339000081
J	Jimenez-Franco, MV; Martinez, JE; Calvo, JF				Jimenez-Franco, Maria V.; Martinez, Jose E.; Calvo, Jose F.			Lifespan Analyses of Forest Raptor Nests: Patterns of Creation, Persistence and Reuse	PLOS ONE			English	Article							BUZZARD BUTEO-BUTEO; TERRITORIAL OCCUPANCY; HIERAAETUS-PENNATUS; CONSERVATION; COMPETITION; POPULATION; DEMOGRAPHY; FIDELITY; DENSITY; EAGLES	Structural elements for breeding such as nests are key resources for the conservation of bird populations. This is especially true when structural elements require a specific and restricted habitat, or if the construction of nests is costly in time and energy. The availability of nesting-platforms is influenced by nest creation and persistence. In a Mediterranean forest in southeastern Spain, nesting-platforms are the only structural element for three forest-dwelling raptor species: booted eagle Aquila pennata, common buzzard Buteo buteo and northern goshawk Accipiter gentilis. From 1998 to 2013, we tracked the fate of 157 nesting-platforms built and reused by these species with the aim of determining the rates of creation and destruction of nesting-platforms, estimating nest persistence by applying two survival analyses, describing the pattern of nest reuse and testing the effects of nest use on breeding success. Nest creation and destruction rates were low (0.14 and 0.05, respectively). Using Kaplan Meier survival estimates and Cox proportional-hazards regression models we found that median nest longevity was 12 years and that this was not significantly affected by nest characteristics, nest-tree dimensions, nest-builder species, or frequency of use of the platform. We also estimated a transition matrix, considering the different stages of nest occupation (vacant or occupied by one of the focal species), to obtain the fundamental matrix and the average life expectancies of nests, which varied from 17.9 to 19.7 years. Eighty six percent of nests were used in at least one breeding attempt, 67.5% were reused and 17.8% were successively occupied by at least two of the study species. The frequency of nest use had no significant effects on the breeding success of any species. We conclude that nesting-platforms constitute an important resource for forest raptors and that their longevity is sufficiently high to allow their reuse in multiple breeding attempts.	[Jimenez-Franco, Maria V.; Martinez, Jose E.; Calvo, Jose F.] Univ Murcia, Dept Ecol & Hidrol, Murcia, Spain; [Martinez, Jose E.] Bonellis Eagle Study & Conservat Grp, Murcia, Spain	University of Murcia	Jimenez-Franco, MV (corresponding author), Univ Murcia, Dept Ecol & Hidrol, Murcia, Spain.	mvjimenez@um.es	Jiménez-Franco, Maria Victoria/M-2041-2014; Calvo, José Francisco/C-7076-2009	Jiménez-Franco, Maria Victoria/0000-0002-7254-0431; Calvo, José Francisco/0000-0002-3813-4333; Martinez, Jose Enrique/0000-0002-1200-5795	Spanish Ministerio de Educacion y Ciencia [REN2002-324 01884/GLO]; FEDER funds; Consejeria de Agricultura y Agua of the Region of Murcia; FPU grant from the Spanish Ministerio de Educacion y Ciencia [AP2009-2073]	Spanish Ministerio de Educacion y Ciencia(Spanish Government); FEDER funds(European Commission); Consejeria de Agricultura y Agua of the Region of Murcia; FPU grant from the Spanish Ministerio de Educacion y Ciencia(National Health and Medical Research Council (NHMRC) of AustraliaGerman Research Foundation (DFG))	This work was funded by the Spanish Ministerio de Educacion y Ciencia (project REN2002-324 01884/GLO, partially financed by FEDER funds) and the Consejeria de Agricultura y Agua of the Region of Murcia. MVJF is supported by a FPU grant from the Spanish Ministerio de Educacion y Ciencia (reference AP2009-2073). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorklund H, 2013, ANIM CONSERV, V16, P546, DOI 10.1111/acv.12028; BRAULT S, 1993, ECOLOGY, V74, P1444, DOI 10.2307/1940073; Brostrom G., 2011, GLMMML GEN LINEAR MO; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Burnham KK, 2009, IBIS, V151, P514, DOI 10.1111/j.1474-919X.2009.00939.x; Caswell H., 2004, Animal Biodiversity and Conservation, V27, P471; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Caswell H, 2009, OIKOS, V118, P1763, DOI 10.1111/j.1600-0706.2009.17620.x; Cockle KL, 2011, FRONT ECOL ENVIRON, V9, P377, DOI 10.1890/110013; Edworthy AB, 2013, J WILDLIFE MANAGE, V77, P770, DOI 10.1002/jwmg.526; Edworthy AB, 2012, ECOL APPL, V22, P1733, DOI 10.1890/11-1594.1; ERCKMANN WJ, 1990, CONDOR, V92, P113, DOI 10.2307/1368389; Fergusson-Lees J, 2001, RAPTORS BIRDS PREY W; Ferreira M, 2013, BIOL CONSERV, V165, P179, DOI 10.1016/j.biocon.2013.05.029; Fox G.A., 2001, DESIGN ANAL ECOLOGIC, V2nd, P253; Fujiwara M, 2001, NATURE, V414, P537, DOI 10.1038/35107054; Fuller MR., 1987, RAPTOR MANAGEMENT TE, P37; Hakkarainen H, 2004, OECOLOGIA, V141, P420, DOI 10.1007/s00442-004-1656-6; HICKEY JOSEPH J., 1942, AUK, V59, P176; Jimenez-Franco MV, 2014, J ZOOL, V292, P64, DOI 10.1111/jzo.12085; Jimenez-Franco MV, 2013, J ORNITHOL, V154, P311, DOI 10.1007/s10336-012-0895-2; Jimenez-Franco MV, 2011, OECOLOGIA, V166, P507, DOI 10.1007/s00442-010-1857-0; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kochert MN, 2012, J RAPTOR RES, V46, P239, DOI 10.3356/JRR-12-00001.1; KOSTRZEWA A, 1991, ETHOL ECOL EVOL, V3, P127, DOI 10.1080/08927014.1991.9525379; Kruger O, 2002, OIKOS, V96, P441, DOI 10.1034/j.1600-0706.2002.960306.x; Kruger O, 2002, ECOGRAPHY, V25, P523, DOI 10.1034/j.1600-0587.2002.250502.x; Lebreton JD, 1995, J APPL STAT, V22, P1009, DOI 10.1080/02664769524766; Libois E, 2012, BIOL CONSERV, V155, P39, DOI 10.1016/j.biocon.2012.05.020; Lindenmayer DB, 2010, CAN J FOREST RES, V40, P48, DOI 10.1139/X09-185; Lohmus Asko, 2006, Proceedings of the Estonian Academy of Sciences Biology Ecology, V55, P31; Margalida A, 1999, BIRD STUDY, V46, P224, DOI 10.1080/00063659909461134; Margalida A, 2007, J ORNITHOL, V148, P309, DOI 10.1007/s10336-007-0133-5; Martinez JE, 2006, RAPACES DIURNAS NOCT; Martinez JE, 2002, THESIS U MURCIA; Martinez JE, 2007, BIODIVERS CONSERV, V16, P3481, DOI 10.1007/s10531-006-9053-6; Martinez JE, 2006, J ORNITHOL, V147, P612, DOI 10.1007/s10336-006-0086-0; Martinez JE, 2006, IBIS, V148, P807, DOI 10.1111/j.1474-919X.2006.00586.x; Martinez JE, 2013, ACTA OECOL, V48, P47, DOI 10.1016/j.actao.2013.01.017; McCulloch C. E., 2000, GEN LINEAR MIXED MOD; Mitsopoulos ID, 2014, EUR J FOREST RES, V133, P73, DOI 10.1007/s10342-013-0740-z; NEWTON I, 1994, BIOL CONSERV, V70, P265, DOI 10.1016/0006-3207(94)90172-4; Newton I., 1979, POPULATION ECOLOGY R; Ontiveros D, 2008, J ORNITHOL, V149, P253, DOI 10.1007/s10336-007-0268-4; Pagan I, 2009, J ZOOL, V279, P36, DOI 10.1111/j.1469-7998.2009.00587.x; Penteriani V, 2002, AUK, V119, P1132, DOI 10.1642/0004-8038(2002)119[1132:ISRTCN]2.0.CO;2; Penteriani Vincenzo, 2011, P126; PETTY SJ, 1998, FORESTRY COMMISSION, V118; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Redmond LJ, 2007, CONDOR, V109, P463, DOI 10.1650/0010-5422(2007)109[463:NRBEKA]2.0.CO;2; Rendell WB, 1996, CONDOR, V98, P142, DOI 10.2307/1369517; Robledano F., 2006, LIBRO ROJO VERTEBRAD; Santangeli A, 2012, ANIM CONSERV, V15, P571, DOI 10.1111/j.1469-1795.2012.00551.x; Sergio F, 2011, SCIENCE, V331, P327, DOI 10.1126/science.1199422; Steenhof K., 1987, RAPTOR MANAGEMENT TE, P157; Stubben C, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i11; Therneau T. M, 2015, SURVIVAL SURVIVAL AN; Wesolowski T, 2012, BIOL CONSERV, V153, P118, DOI 10.1016/j.biocon.2012.04.017; White C.M., 1994, NEW WORLD VULTURES G; Zhou T, 2009, PROG NAT SCI-MATER, V19, P1253, DOI 10.1016/j.pnsc.2009.03.006; [No title captured]; [No title captured]	62	16	16	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93628	10.1371/journal.pone.0093628	http://dx.doi.org/10.1371/journal.pone.0093628			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717935	gold, Green Published, Green Submitted			2022-12-25	WOS:000334339000041
J	Xie, SB; Chen, M; Yan, B; He, XF; Chen, XW; Li, DW				Xie, Songbo; Chen, Miao; Yan, Bing; He, Xianfei; Chen, Xiwen; Li, Dengwen			Identification of a Role for the PI3K/AKT/mTOR Signaling Pathway in Innate Immune Cells	PLOS ONE			English	Article							TISSUE-RESIDENT MACROPHAGES; CYTOKINE PRODUCTION; INDUCED IL-12; PI3K; RECEPTOR; KINASE; CANCER; ACCUMULATION; MIGRATION; RESPONSES	The innate immune system is the first line of host defense against infection and involves several different cell types. Here we investigated the role of the phosphatidylinositol 3 kinase (PI3K) signaling pathway in innate immune cells. By blocking this pathway with pharmacological inhibitors, we found that the production of proinflammatory cytokines was drastically suppressed in monocytes and macrophages. Further study revealed that the suppression was mainly related to the mammalian target of rapamycin (mTOR)/p70(S6K) signaling. In addition, we found that the PI3K pathway was involved in macrophage motility and neovascularization. Our data provide a rationale that inhibition of the PI3K signaling pathway could be an attractive approach for the management of inflammatory disorders.	[Xie, Songbo; Chen, Miao; Yan, Bing; He, Xianfei; Chen, Xiwen; Li, Dengwen] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China	Nankai University	Chen, XW (corresponding author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China.	xiwenchen@nankai.edu.cn; dwli@nankai.edu.cn	Xie, Songbo/AAD-9850-2020		National Natural Science Foundation of China [31171334, 31371382]; Tianjin Natural Science Foundation [13JCZDJC30300]; 111 project of the Ministry of Education of China [B08011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Natural Science Foundation(Natural Science Foundation of Tianjin); 111 project of the Ministry of Education of China(Ministry of Education, China - 111 Project)	This work was supported by grants from the National Natural Science Foundation of China (31171334 and 31371382), the Tianjin Natural Science Foundation (13JCZDJC30300), and the 111 project of the Ministry of Education of China (B08011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2013, ANTI-CANCER AGENT ME, V13, P1014, DOI 10.2174/18715206113139990117; Araki N, 2003, J CELL SCI, V116, P247, DOI 10.1242/jcs.00235; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Carnero A, 2008, CURR CANCER DRUG TAR, V8, P187, DOI 10.2174/156800908784293659; CERAMI A, 1992, CLIN IMMUNOL IMMUNOP, V62, pS3, DOI 10.1016/0090-1229(92)90035-M; Chanput W, 2013, FOOD FUNCT, V4, P266, DOI 10.1039/c2fo30156c; Chiba T, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/759103; Curat CA, 2004, DIABETES, V53, P1285, DOI 10.2337/diabetes.53.5.1285; Desmedt M, 1998, J IMMUNOL, V160, P5300; Dituri F, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/947858; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fortin CF, 2011, EUR J IMMUNOL, V41, P1709, DOI 10.1002/eji.201040945; Goldbach-Mansky R, 2012, CLIN EXP IMMUNOL, V167, P391, DOI 10.1111/j.1365-2249.2011.04533.x; Hammond MD, 2012, TRANSL STROKE RES, V3, pS125, DOI 10.1007/s12975-012-0174-9; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hortner M, 2002, J IMMUNOL, V169, P1219, DOI 10.4049/jimmunol.169.3.1219; Jimenez S, 2011, J BIOL CHEM, V286, P18414, DOI 10.1074/jbc.M110.209718; KAPLAN DR, 1987, CELL, V50, P1021, DOI 10.1016/0092-8674(87)90168-1; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Li DW, 2011, PROTEIN CELL, V2, P150, DOI 10.1007/s13238-011-1015-4; McGillicuddy FC, 2011, DIABETES, V60, P1688, DOI 10.2337/db10-1278; Moulton KS, 2003, P NATL ACAD SCI USA, V100, P4736, DOI 10.1073/pnas.0730843100; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Ohl K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/432595; Ozaita A, 2007, J NEUROCHEM, V102, P1105, DOI 10.1111/j.1471-4159.2007.04642.x; Polumuri SK, 2007, J IMMUNOL, V179, P236, DOI 10.4049/jimmunol.179.1.236; Reale M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-13; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Shi XJ, 2012, CELL CYCLE, V11, P1554, DOI 10.4161/cc.19954; Solana R, 2012, SEMIN IMMUNOL, V24, P331, DOI 10.1016/j.smim.2012.04.008; Soond DR, 2010, BLOOD, V115, P2203, DOI 10.1182/blood-2009-07-232330; Stewart CR, 2005, BIOCHEMISTRY-US, V44, P9108, DOI 10.1021/bi050497v; Thorley AJ, 2007, J IMMUNOL, V178, P463, DOI 10.4049/jimmunol.178.1.463; Trifilo MJ, 2003, J VIROL, V77, P4004, DOI 10.1128/JVI.77.7.4004-4014.2003; Utsugi M, 2009, J IMMUNOL, V182, P5225, DOI 10.4049/jimmunol.0801352; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; WHITMAN M, 1985, NATURE, V315, P239, DOI 10.1038/315239a0; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xie C, 2007, INT IMMUNOL, V19, P509, DOI 10.1093/intimm/dxm017; Xie SB, 2014, ATHEROSCLEROSIS, V233, P403, DOI 10.1016/j.atherosclerosis.2014.01.009; Zajac E, 2013, BLOOD, V122, P4054, DOI 10.1182/blood-2013-05-501494	42	146	146	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94496	10.1371/journal.pone.0094496	http://dx.doi.org/10.1371/journal.pone.0094496			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718556	Green Submitted, Green Published, gold			2022-12-25	WOS:000334339000128
J	Talati, M; West, J; Zaynagetdinov, R; Hong, CC; Han, W; Blackwell, T; Robinson, L; Blackwell, TS; Lane, K				Talati, Megha; West, James; Zaynagetdinov, Rinat; Hong, Charles C.; Han, Wei; Blackwell, Tom; Robinson, Linda; Blackwell, Timothy S.; Lane, Kirk			BMP Pathway Regulation of and by Macrophages	PLOS ONE			English	Article							PULMONARY-HYPERTENSION; RECEPTOR; INFLAMMATION; MUTATIONS; GENE	Pulmonary arterial hypertension (PAH) is a disease of progressively increasing pulmonary vascular resistance, associated with mutations of the type 2 receptor for the BMP pathway, BMPR2. The canonical signaling pathway for BMPR2 is through the SMAD family of transcription factors. BMPR2 is expressed in every cell type, but the impact of BMPR2 mutations affecting SMAD signaling, such as Bmpr2(delx4+), had only previously been investigated in smooth muscle and endothelium. In the present study, we created a mouse with universal doxycycline-inducible expression of Bmpr2(delx4+) in order to determine if broader expression had an impact relevant to the development of PAH. We found that the most obvious phenotype was a dramatic, but patchy, increase in pulmonary inflammation. We crossed these double transgenic mice onto an NF-kB reporter strain, and by luciferase assays on live mice, individual organs and isolated macrophages, we narrowed down the origin of the inflammatory phenotype to constitutive activation of tissue macrophages. Study of bone marrow-derived macrophages from mutant and wild-type mice suggested a baseline difference in differentiation state in Bmpr2 mutants. When activated with LPS, both mutant and wild-type macrophages secrete BMP pathway inhibitors sufficient to suppress BMP pathway activity in smooth muscle cells (SMC) treated with conditioned media. Functionally, co-culture with macrophages results in a BMP signaling-dependent increase in scratch closure in cultured SMC. We conclude that SMAD signaling through BMP is responsible, in part, for preventing macrophage activation in both live animals and in cells in culture, and that activated macrophages secrete BMP inhibitors in sufficient quantity to cause paracrine effect on vascular smooth muscle.	[Talati, Megha; West, James; Zaynagetdinov, Rinat; Hong, Charles C.; Han, Wei; Blackwell, Tom; Robinson, Linda; Blackwell, Timothy S.; Lane, Kirk] Vanderbilt Univ, Dept Med, Nashville, TN 37235 USA; [Hong, Charles C.] Vet Affairs Tennessee Valley Healthcare Syst, Dept Med Res, Nashville, TN USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	West, J (corresponding author), Vanderbilt Univ, Dept Med, Nashville, TN 37235 USA.	j.west@vanderbilt.edu	West, James/E-2960-2010	West, James/0000-0002-6004-0202	National Institutes of Health [HL82694, HL095797]; Vanderbilt Allergy, Pulmonary, and Critical Care Division; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104040, R01HL082694, R01HL095797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Allergy, Pulmonary, and Critical Care Division; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health RO1 Grants HL82694 and HL095797 and Vanderbilt Allergy, Pulmonary, and Critical Care Division internal funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldred MA, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9398; Austin Eric D, 2011, Pulm Circ, V1, P389, DOI 10.4103/2045-8932.87308; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Burton VJ, 2010, BLOOD; Chamoto K, 2011, J CELL PHYSL; Choi KC, 2006, NAT IMMUNOL, V7, P1057, DOI 10.1038/ni1383; Cuny GD, 2008, BIOORG MED CHEM LETT, V18, P4388, DOI 10.1016/j.bmcl.2008.06.052; Davies RJ, 2012, AM J PHYSL LUNG CELL; Dorfmuller P, 2003, EUR RESPIR J, V22, P358, DOI 10.1183/09031936.03.00038903; Hagen M, 2007, AM J PHYSIOL-LUNG C, V292, pL1473, DOI 10.1152/ajplung.00197.2006; Hassoun PM, 2009, J AM COLL CARDIOL, V54, pS10, DOI 10.1016/j.jacc.2009.04.006; Johnson JA, 2011, AM J PHYSL LUNG CELL; Konstantinidis G, 2011, CELL PHYSIOL BIOCHEM, V28, P1031, DOI 10.1159/000335790; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Lane Kirk L, 2011, Pulm Circ, V1, P72; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Majka SM, 2008, AM J PHYSIOL-LUNG C, V295, pL1028, DOI 10.1152/ajplung.90449.2008; Majka S, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-84; Menon S, 2011, INT J CLIN PRACT, V65, P19, DOI 10.1111/j.1742-1241.2010.02604.x; Price LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075415; Sadikot RT, 2003, J IMMUNOL, V170, P1091, DOI 10.4049/jimmunol.170.2.1091; Sadikot RT, 2001, AM J RESP CRIT CARE, V164, P873, DOI 10.1164/ajrccm.164.5.2008059; Song YL, 2005, CIRCULATION, V112, P553, DOI 10.1161/CIRCULATIONAHA.104.492488; Stacher E, 2012, AM J RESP CRIT CARE, V186, P261, DOI 10.1164/rccm.201201-0164OC; Tada Y, 2007, AM J PHYSIOL-LUNG C, V292, pL1556, DOI 10.1152/ajplung.00305.2006; Tamosiuniene R, 2011, CIRC RES, V109, P867, DOI 10.1161/CIRCRESAHA.110.236927; West J, 2004, CIRC RES, V94, P1109, DOI 10.1161/01.RES.0000126047.82846.20; Yull FE, 2003, J HISTOCHEM CYTOCHEM, V51, P741, DOI 10.1177/002215540305100605	29	22	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94119	10.1371/journal.pone.0094119	http://dx.doi.org/10.1371/journal.pone.0094119			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713633	Green Submitted, gold, Green Published			2022-12-25	WOS:000334160900087
J	Wang, LY; Liu, Y; Wang, HM; Liu, X; Chen, J; Wang, MH; Wang, JF; Huang, H				Wang, Luyun; Liu, Yang; Wang, Huamin; Liu, Xun; Chen, Jie; Wang, Mong-Heng; Wang, Jingfeng; Huang, Hui			Epoxyeicosatrienoic Acids Attenuating Hypotonic-Induced Apoptosis of IMCD Cells via gamma-ENaC Inhibition	PLOS ONE			English	Article							SOLUBLE EPOXIDE HYDROLASE; ACTIVATED PROTEIN-KINASE; COLLECTING DUCT CELLS; ENDOTHELIAL-CELLS; MEDIATED REGULATION; ARACHIDONIC-ACID; HEME OXYGENASE-1; APICAL MEMBRANE; CATION CHANNEL; BETA-ENAC	Inner medulla collecting duct (IMCD) cells are the key part for urinary concentration. Hypotonic stress may trigger apoptosis of IMCD cells and induce renal injury. Epoxyeicosatrienoic acids (EETs) play an important role in anti-apoptosis, but their roles in hypotonic-induced apoptosis of IMCD cells are still unclear. Here we found increasing exogenous 11, 12-EET or endogenous EETs with Ad-CMV-CYP2C23-EGFP transfection decreased apoptosis of IMCD cells induced by hypotonic stress. Moreover, up-regulation of c-ENaC induced by hypotonic stress was abolished by elevation of exogenous or endogenous EETs. Collectively, this study illustrated that EETs attenuated hypotonic-induced apoptosis of IMCD cells, and that regulation of gamma-ENAC may be a possible mechanism contributing to the anti-apoptotic effect of EETs in response to hypotonic stress.	[Wang, Luyun; Liu, Yang; Chen, Jie; Wang, Jingfeng; Huang, Hui] Guangdong Prov Key Lab Arrhythmia & Elect, Guangzhou, Guangdong, Peoples R China; [Liu, Yang; Wang, Jingfeng; Huang, Hui] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Cardiol, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Luyun] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Crit Care Med, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Huamin] Guangzhou Univ Chinese Med, Affiliated Hosp, Zhongshan City Hosp Chinese Med, Zhongshan, Peoples R China; [Liu, Xun] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Internal Med, Div Nephrol, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Jie] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Radiotherapy, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Mong-Heng] Georgia Regents Univ, Dept Physiol, Augusta, GA USA	Sun Yat Sen University; Sun Yat Sen University; Guangzhou University of Chinese Medicine; Sun Yat Sen University; Sun Yat Sen University; University System of Georgia; Augusta University	Huang, H (corresponding author), Guangdong Prov Key Lab Arrhythmia & Elect, Guangzhou, Guangdong, Peoples R China.	huanghui765@hotmail.com	wang, jing/GRS-7509-2022		NSFC [91029742, 81170647, 81370837, 81370866, 81070612]; Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China [132030]; Yat-sen Scholarship for Young Scientists, the Science & technology star of Zhujiang (Guangzhou) [2011016]; AHA [AHASE0054]	NSFC(National Natural Science Foundation of China (NSFC)); Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China(Fok Ying Tung Education Foundation); Yat-sen Scholarship for Young Scientists, the Science & technology star of Zhujiang (Guangzhou); AHA(American Heart Association)	This work was supported in part by NSFC [91029742, 81170647 and 81370837 to HH], Fok Ying-Tong Education Foundation for Young Teachers in the Higher Education Institutions of China [132030], Yat-sen Scholarship for Young Scientists, the Science & technology star of Zhujiang (Guangzhou)[2011016] to HH, NSFC [81370866 and 81070612] to XL, AHA Grant-in-Aid grant (AHASE0054) to MHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM NG, 1995, INVEST OPHTH VIS SCI, V36, P2202; Bi Y, 2013, ARCH MED SCI, V9, P314, DOI 10.5114/aoms.2012.31410; Bondarava M, 2009, PFLUG ARCH EUR J PHY, V458, P675, DOI 10.1007/s00424-009-0649-z; Bortner CD, 2011, CELL PHYSIOL BIOCHEM, V28, P1079, DOI 10.1159/000335864; Bortner CD, 2003, J BIOL CHEM, V278, P39176, DOI 10.1074/jbc.M303516200; Bouvry D, 2006, AM J RESP CELL MOL, V35, P519, DOI 10.1165/rcmb.2005-0478OC; Capdevila J, 2013, CURR OPIN NEPHROL HY, V22, P163, DOI 10.1097/MNH.0b013e32835d911e; Chen GZ, 2012, AM J PHYSIOL-ENDOC M, V303, pE563, DOI 10.1152/ajpendo.00591.2011; Chen LD, 2013, PROSTAG OTH LIPID M, V104, P42, DOI 10.1016/j.prostaglandins.2012.12.001; Ecelbarger CA, 2000, AM J PHYSIOL-RENAL, V279, pF46, DOI 10.1152/ajprenal.2000.279.1.F46; Fauci Braunwald, HARRISONS PRINCIPLES, VII, P2738; Feng WJ, 2013, INT J MOL MED, V32, P685, DOI 10.3892/ijmm.2013.1435; Gao CJ, 2012, J TRAUMA ACUTE CARE, V72, P150, DOI 10.1097/TA.0b013e318230e25d; GRUNEWALD JM, 1993, KIDNEY INT, V44, P509, DOI 10.1038/ki.1993.275; Hager H, 2001, AM J PHYSIOL-RENAL, V280, pF1093, DOI 10.1152/ajprenal.2001.280.6.F1093; Husted RF, 1996, AM J PHYSIOL-RENAL, V271, pF433, DOI 10.1152/ajprenal.1996.271.2.F433; Krotz F, 2004, ARTERIOSCL THROM VAS, V24, P595, DOI 10.1161/01.ATV.0000116219.09040.8c; Kultz D, 1998, J EXP BIOL, V201, P3015; Larsen BT, 2006, AM J PHYSIOL-HEART C, V290, pH491, DOI 10.1152/ajpheart.00927.2005; LIGHT DB, 1988, AM J PHYSIOL, V255, pF278, DOI 10.1152/ajprenal.1988.255.2.F278; LIGHT DB, 1989, J CLIN INVEST, V84, P352, DOI 10.1172/JCI114162; Liu XL, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-8; Liu YM, 2013, MOL PHARMACOL, V84, P925, DOI 10.1124/mol.113.088302; Marunaka Y, 1997, JPN J PHYSIOL, V47, P499, DOI 10.2170/jjphysiol.47.499; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Miyazaki H, 2008, BIOCHEM BIOPH RES CO, V366, P506, DOI 10.1016/j.bbrc.2007.11.144; Niisato N, 2007, BIOCHEM BIOPH RES CO, V358, P819, DOI 10.1016/j.bbrc.2007.04.192; Niisato N, 2012, AM J PHYSIOL-RENAL, V303, pF240, DOI 10.1152/ajprenal.00198.2011; Ohsawa R, 2010, J CELL PHYSIOL, V223, P764, DOI 10.1002/jcp.22088; Orlov SN, 2013, AM J PHYSIOL-CELL PH, V305, pC361, DOI 10.1152/ajpcell.00040.2013; Pavlov TS, 2011, AM J PHYSIOL-RENAL, V301, pF672, DOI 10.1152/ajprenal.00597.2010; Pidkovka N, 2013, J BIOL CHEM, V288, P5223, DOI 10.1074/jbc.M112.407981; Quan S, 2004, KIDNEY INT, V65, P1628, DOI 10.1111/j.1523-1755.2004.00562.x; Saito T, 2008, EXP PHYSIOL, V93, P1147, DOI 10.1113/expphysiol.2008.042663; STOKES JB, 1987, AM J PHYSIOL, V253, pF251, DOI 10.1152/ajprenal.1987.253.2.F251; Sun P, 2012, HYPERTENSION, V59, P339, DOI 10.1161/HYPERTENSIONAHA.111.178475; Taniguchi J, 2005, VASC PHARMACOL, V43, P47, DOI 10.1016/j.vph.2005.03.005; Taruno A, 2008, AM J PHYSIOL-RENAL, V294, pF177, DOI 10.1152/ajprenal.00250.2007; Taruno A, 2007, AM J PHYSIOL-RENAL, V293, pF128, DOI 10.1152/ajprenal.00011.2007; Volk KA, 1995, J CLIN INVEST, V96, P2748, DOI 10.1172/JCI118344; Wang XX, 2014, MOL PHARMACOL, V85, P105, DOI 10.1124/mol.113.087122; Wang Y, 2005, J PHARMACOL EXP THER, V314, P522, DOI 10.1124/jpet.105.083477; Xu XZ, 2011, ADV DRUG DELIVER REV, V63, P597, DOI 10.1016/j.addr.2011.03.006; Xu XZ, 2010, DIABETES, V59, P997, DOI 10.2337/db09-1241; Yang SL, 2007, AM J PHYSIOL-HEART C, V293, pH142, DOI 10.1152/ajpheart.00783.2006; Ye Q, 2003, HYPERTENSION, V41, P675, DOI 10.1161/01.HYP.0000047204.72286.34; Yin JJ, 2013, INT J ENDOCRINOL MET, V11, P184, DOI 10.5812/ijem.8088; Zhang Wei, 2010, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V22, P385; Zhao G, 2012, HUM GENE THER, V23, P688, DOI 10.1089/hum.2011.135	49	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94400	10.1371/journal.pone.0094400	http://dx.doi.org/10.1371/journal.pone.0094400			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713619	gold, Green Submitted, Green Published			2022-12-25	WOS:000334160900127
J	Wang, YY; Zhao, J; Yang, JH; Zhou, ZX; Chen, GL; Liu, Y				Wang, Yingyong; Zhao, Jian; Yang, Jianhuan; Zhou, Zhixin; Chen, Guoling; Liu, Yang			Morphology, Molecular Genetics, and Bioacoustics Support Two New Sympatric Xenophrys Toads ( Amphibia: Anura: Megophryidae) in Southeast China	PLOS ONE			English	Article							PHYLOGENY; DIVERSITY; EVOLUTION; IDENTITY; FROGS	Given their recent worldwide declines and extinctions, characterization of species-level diversity is of critical importance for large-scale biodiversity assessments and conservation of amphibians. This task is made difficult by the existence of cryptic species complexes, species groups comprising closely related and morphologically analogous species. The combination of morphology, genetic, and bioacoustic analyses permits robust and accurate species identification. Using these methods, we discovered two undescribed Xenophrys species, namely Xenophrys lini sp. nov. and Xenophrys cheni sp. nov. from the middle range of Luoxiao Mountains, southeast China. These two new species can be reliably distinguished from other known congeners by morphological and morphometric differences, distinctness in male advertisement calls, and substantial genetic distances (> 3.6%) based on the mitochondrial 16s and 12s rRNA genes. The two new species, together with X. jinggangensis, are sympatric in the middle range of Luoxiao Mountains but may be isolated altitudinally and ecologically. Our study provides a first step to help resolve previously unrecognized cryptic biodiversity and provides insights into the understanding of Xenophrys diversification in the mountain complexes of southeast China.	[Wang, Yingyong; Zhao, Jian; Chen, Guoling; Liu, Yang] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Jianhuan] Kadoorie Farm & Bot Garden, Hong Kong, Hong Kong, Peoples R China; [Zhou, Zhixin] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China	Sun Yat Sen University; Chinese Academy of Sciences; Institute of Zoology, CAS	Liu, Y (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	liuy353@mail.sysu.edu.cn	Zhou, Zhixin/GSD-7016-2022; Zhou, Zhixin/AAK-6744-2020	Zhou, Zhixin/0000-0002-4055-9672	Chinese National Science AMP; Technology Basic Work Program; The Comprehensive Scientific Survey of Biodiversity from Luoxiao Range Region in China [2013FY111500]; Hundred Talent Program ("Bai Ren Ji Hua") from Sun Yat-sen University	Chinese National Science AMP; Technology Basic Work Program; The Comprehensive Scientific Survey of Biodiversity from Luoxiao Range Region in China; Hundred Talent Program ("Bai Ren Ji Hua") from Sun Yat-sen University	This work was partially supported by the Chinese National Science & Technology Basic Work Program, "The Comprehensive Scientific Survey of Biodiversity from Luoxiao Range Region in China (2013FY111500)" to Y.Y. Wang and the Hundred Talent Program ("Bai Ren Ji Hua") from Sun Yat-sen University to Y. Liu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aowphol A, 2013, ZOOTAXA, V3702, P101, DOI 10.11646/zootaxa.3702.2.1; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Delorme Magali, 2006, Alytes (Paris), V24, P6; Fei L, 2009, FAUNA SINICA AMPHIBI; Felsenstein J., 2004, INFERRING PHYLOGENIE; Frost DR, 2011, AMPHIBIAN SPECIES WO; Funk WC, 2012, P ROY SOC B-BIOL SCI, V279, P1806, DOI 10.1098/rspb.2011.1653; Gosner K. L., 1960, Herpetologica, V16, P183; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hanken J, 1999, TRENDS ECOL EVOL, V14, P7, DOI 10.1016/S0169-5347(98)01534-1; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hu JH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084529, 10.1371/journal.pone.0108582]; Hu JH, 2012, ASIAN HERPETOL RES, V3, P163, DOI 10.3724/SP.J.1245.2012.00163; Hu JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019817; Huang ZH, 2007, JIANGXI SCI, V25, P643; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jiang JP, 2005, HERPETOL J, V15, P1; Karraker NE, 2010, BIOL CONSERV, V143, P1079, DOI 10.1016/j.biocon.2010.01.020; Lehtinen RM, 2011, J ZOOL, V283, P117, DOI 10.1111/j.1469-7998.2010.00752.x; Li Cheng, 2008, Acta Zootaxonomica Sinica, V33, P104; Liang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013575; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Mahony S, 2013, ZOOTAXA, V3722, P143, DOI 10.11646/zootaxa.3722.2.2; Mahony Stephen, 2011, Zootaxa, V2734, P23; Mayr E., 1942, P1; Mayr E., 1963, ANIMAL SPECIES EVOLU; Mo XY, 2010, CURR ZOOL, V56, P432, DOI 10.1093/czoolo/56.4.432; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Rao Ding-Qi, 1997, Asiatic Herpetological Research, V7, P93; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sambrook J., 1989, MOL CLONING LAB MANU; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vences M, 2005, PHILOS T R SOC B, V360, P1859, DOI 10.1098/rstb.2005.1717; Vences Miguel, 2007, Amphibian Biology, V7, P2613; Vredenburg VT, 2007, J ZOOL, V271, P361, DOI 10.1111/j.1469-7998.2006.00258.x; Waddell PJ, 1997, MOL PHYLOGENET EVOL, V8, P398, DOI 10.1006/mpev.1997.0452; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Wang Ying-Yong, 2012, Zootaxa, V3546, P53; Wilkins MR, 2013, TRENDS ECOL EVOL, V28, P156, DOI 10.1016/j.tree.2012.10.002; Zhang P, 2013, MOL BIOL EVOL, V30, P1899, DOI 10.1093/molbev/mst091; Zou DL, 1985, J NANCHANG U NATURAL, V1, P51	52	34	37	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93075	10.1371/journal.pone.0093075	http://dx.doi.org/10.1371/journal.pone.0093075			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714161	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900013
J	Olden, A; Ovaskainen, O; Kotiaho, JS; Laaka-Lindberg, S; Halme, P				Olden, Anna; Ovaskainen, Otso; Kotiaho, Janne S.; Laaka-Lindberg, Sanna; Halme, Panu			Bryophyte Species Richness on Retention Aspens Recovers in Time but Community Structure Does Not	PLOS ONE			English	Article							BOREAL FOREST; EPIPHYTIC BRYOPHYTES; MICROCLIMATIC GRADIENTS; TREE RETENTION; GROWTH; DIVERSITY; CONSERVATION; FINLAND; EDGES; REPRODUCTION	Green-tree retention is a forest management method in which some living trees are left on a logged area. The aim is to offer `lifeboats' to support species immediately after logging and to provide microhabitats during and after forest re-establishment. Several studies have shown immediate decline in bryophyte diversity after retention logging and thus questioned the effectiveness of this method, but longer term studies are lacking. Here we studied the epiphytic bryophytes on European aspen (Populus tremula L.) retention trees along a 30-year chronosequence. We compared the bryophyte flora of 102 `retention aspens' on 14 differently aged retention sites with 102 `conservation aspens' on 14 differently aged conservation sites. We used a Bayesian community-level modelling approach to estimate the changes in bryophyte species richness, abundance (area covered) and community structure during 30 years after logging. Using the fitted model, we estimated that two years after logging both species richness and abundance of bryophytes declined, but during the following 20-30 years both recovered to the level of conservation aspens. However, logging-induced changes in bryophyte community structure did not fully recover over the same time period. Liverwort species showed some or low potential to benefit from lifeboating and high potential to re-colonise as time since logging increases. Most moss species responded similarly, but two cushion-forming mosses benefited from the logging disturbance while several weft- or mat-forming mosses declined and did not re-colonise in 20-30 years. We conclude that retention trees do not function as equally effective lifeboats for all bryophyte species but are successful in providing suitable habitats for many species in the long-term. To be most effective, retention cuts should be located adjacent to conservation sites, which may function as sources of re-colonisation and support the populations of species that require old-growth forests.	[Olden, Anna; Kotiaho, Janne S.; Halme, Panu] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Ovaskainen, Otso] Univ Helsinki, Dept Biosci, Metapopulat Res Grp, Helsinki, Finland; [Laaka-Lindberg, Sanna] Univ Helsinki, Bot Unit, Finnish Nat Hist Museum LUOMUS, Helsinki, Finland	University of Jyvaskyla; University of Helsinki; University of Helsinki	Olden, A (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland.	anna.m.olden@jyu.fi	Ovaskainen, Otso/D-9119-2012; Ovaskainen, Otso/AGN-4838-2022	Ovaskainen, Otso/0000-0001-9750-4421; Ovaskainen, Otso/0000-0001-9750-4421; Kotiaho, Janne/0000-0002-4732-784X; Olden, Anna/0000-0003-0570-5002	Koneen Saatio foundation [27-6152]; Metsamiesten Saatio; Societas pro Fauna et Flora Fennica; Suomen Biologian Seura Vanamo ry; Academy of Finland [250444]; European Research Council [205905]	Koneen Saatio foundation; Metsamiesten Saatio; Societas pro Fauna et Flora Fennica; Suomen Biologian Seura Vanamo ry; Academy of Finland(Academy of Finland); European Research Council(European Research Council (ERC)European Commission)	This study was funded by Koneen Saatio foundation (http://www.koneensaatio.fi/en/, grant 27-6152 to A.O.), Metsamiesten Saatio (http://mmsaatio.fi/www/fi/index.php, small grant to A.O), Societas pro Fauna et Flora Fennica (http://www.societasfff.fi/?lang = en, small grant to A.O), Suomen Biologian Seura Vanamo ry (http://www.vanamo.fi/, small grant to A.O), Academy of Finland (http://www.aka.fi/en-GB/A/, grant 250444 to O.O.) and the European Research Council (http://erc.europa.eu/, ERC Starting Grant 205905 to O.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahti T., 1968, Annales Botanici Fennici, Helsinki, V5, P168; Bates JW, 1998, OIKOS, V82, P223, DOI 10.2307/3546962; Beese WJ, 1999, FOREST ECOL MANAG, V115, P231, DOI 10.1016/S0378-1127(98)00402-2; Bengtsson J, 2000, FOREST ECOL MANAG, V132, P39, DOI 10.1016/S0378-1127(00)00378-9; Brosofske KD, 1997, ECOL APPL, V7, P1188, DOI 10.1890/1051-0761(1997)007[1188:HEOMGF]2.0.CO;2; Brown JH, 2001, OECOLOGIA, V126, P321, DOI 10.1007/s004420000536; BUSBY JR, 1978, ECOL MONOGR, V48, P95, DOI 10.2307/2937294; CAJANDER A. K., 1926, ADA FORESTALIA FENNICA, V29, P1; Caners RT, 2013, FOREST ECOL MANAG, V303, P184, DOI 10.1016/j.foreco.2013.04.019; Caners RT, 2010, BOTANY, V88, P315, DOI 10.1139/B09-089; Caruso A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027936; CHEN JQ, 1995, ECOL APPL, V5, P74, DOI 10.2307/1942053; FAO, 2010, 163 FAO; Franklin J.F., 1989, AM FORESTS, V95, P37; Franklin J.F., 1997, CREATING FORESTRY 21, P111; Gignac LD, 2005, BRYOLOGIST, V108, P50, DOI 10.1639/0007-2745(2005)108[50:EOFSAH]2.0.CO;2; Gustafsson L, 2012, BIOSCIENCE, V62, P633, DOI 10.1525/bio.2012.62.7.6; Gustafsson L, 2010, SCAND J FOREST RES, V25, P295, DOI 10.1080/02827581.2010.497495; HUNTER ML, 1993, BIOL CONSERV, V65, P115, DOI 10.1016/0006-3207(93)90440-C; Hylander K, 2005, J APPL ECOL, V42, P518, DOI 10.1111/j.1365-2664.2005.01033.x; Hylander K, 2012, J APPL ECOL, V49, P1316, DOI 10.1111/j.1365-2664.2012.02218.x; Jairus K, 2009, J APPL ECOL, V46, P930, DOI 10.1111/j.1365-2664.2009.01672.x; Jalonen J, 2001, FOREST ECOL MANAG, V146, P25, DOI 10.1016/S0378-1127(00)00446-1; Johansson Tord, 1996, Silva Fennica, V30, P437; Kouki Jari, 2004, Journal for Nature Conservation (Jena), V12, P41, DOI 10.1016/j.jnc.2003.08.002; Kuuluvainen T, 2012, CAN J FOREST RES, V42, P1185, DOI [10.1139/X2012-064, 10.1139/x2012-064]; Kuusinen M, 1996, LICHENOLOGIST, V28, P443, DOI 10.1006/lich.1996.0043; Kuusinen M, 1999, ECOGRAPHY, V22, P729, DOI 10.1111/j.1600-0587.1999.tb00522.x; Lankia H, 2012, J VEG SCI, V23, P1159, DOI 10.1111/j.1654-1103.2012.01426.x; Lindenmayer DB, 2012, CONSERV LETT, V5, P421, DOI 10.1111/j.1755-263X.2012.00257.x; Lindenmayer D.B., 2002, CONSERVING FOREST BI; Lobel S, 2012, J APPL ECOL, V49, P1334, DOI 10.1111/j.1365-2664.2012.02201.x; Lobel S, 2009, J ECOL, V97, P176, DOI 10.1111/j.1365-2745.2008.01459.x; Lohmus A, 2010, BIOL CONSERV, V143, P891, DOI 10.1016/j.biocon.2009.12.036; Lohmus P, 2006, CAN J FOREST RES, V36, P1319, DOI 10.1139/X06-032; Lundstrom J, 2013, FOREST ECOL MANAG, V293, P49, DOI 10.1016/j.foreco.2012.12.027; Martikainen Petri, 2001, Ecological Bulletins, V49, P205; Nelson CR, 2005, CAN J BOT, V83, P610, DOI [10.1139/B05-036, 10.1139/b05-036]; Ojala E, 2000, CAN J BOT, V78, P529, DOI 10.1139/cjb-78-4-529; Ovaskainen O, 2011, ECOLOGY, V92, P289, DOI 10.1890/10-1251.1; Perhans K, 2009, BIOL CONSERV, V142, P1125, DOI 10.1016/j.biocon.2008.12.033; Proctor MCF, 2007, BRYOLOGIST, V110, P595, DOI 10.1639/0007-2745(2007)110[595:DIBAR]2.0.CO;2; Roberge JM, 2011, J APPL ECOL, V48, P650, DOI 10.1111/j.1365-2664.2011.01963.x; Rosenvald R, 2008, FOREST ECOL MANAG, V255, P1, DOI 10.1016/j.foreco.2007.09.016; Snall T, 2003, OIKOS, V103, P566, DOI 10.1034/j.1600-0706.2003.12551.x; Svancara LK, 2005, BIOSCIENCE, V55, P989, DOI 10.1641/0006-3568(2005)055[0989:PVECAR]2.0.CO;2; Syrjanen K., 2010, 2010 RED LIST FINNIS, P208; Syrjanen K, 2009, SUOMEN UNHANALAISET, P183; Ulvinen T., 2002, SUOMEN SAMMALET LEVI; Ulvinen T., 2009, SUOMEN UHANALAISET S, P309	50	14	14	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93786	10.1371/journal.pone.0093786	http://dx.doi.org/10.1371/journal.pone.0093786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710329	Green Published, gold			2022-12-25	WOS:000334159800052
J	Yang, M; Geng, XM; Grace, J; Lu, C; Zhu, Y; Zhou, Y; Lei, GC				Yang, Meng; Geng, Xuemeng; Grace, John; Lu, Cai; Zhu, Yi; Zhou, Yan; Lei, Guangchun			Spatial and Seasonal CH4 Flux in the Littoral Zone of Miyun Reservoir near Beijing: The Effects of Water Level and Its Fluctuation	PLOS ONE			English	Article							METHANE EMISSIONS; EMERGENT MACROPHYTES; BOREAL LAKES; SOIL REDOX; WETLANDS; OXIDATION; HYDROPOWER; EFFLUX; STANDS; RICE	Wetlands, and especially their littoral zones, are considered to be CH4 emissions hotspots. The recent creation of reservoirs has caused a rapid increase in the area of the world's littoral zones. To investigate the effects of water depth and water level fluctuation on CH4 fluxes, and how these are coupled with vegetation and nutrients, we used static closed chamber and gas chromatography techniques to measure CH4 fluxes in the littoral zone of a large reservoir near Beijing, China, from November 2011 to October 2012. We found that CH4 flux decreased significantly along a transect from open water to dry land, from 3.1 mg m (-2) h (-1) at the deep water site to approximately 1.3 mg m (-2) h (-1) at the shallow water site, and less than 0.01 mg m 22 h 21 in the non-flooded area. Water level influenced CH4 flux by affecting soil properties including soil redox potential, soil carbon and nitrogen, and bulk density. The largest emission of all was from the seasonally flooded site after a flooding event ( up to 21.1 mg m (-2) h (-1)), which may have been caused by vegetation decomposition. Submerged sites had greater emissions, while the driest site had lower emissions. Immediately after the monthly measurements had been made, we removed the aboveground vegetation to enable an assessment of the gas transportation per unit of biomass. Removal of biomass decreased emissions by up to 53%. These results indicated the dominant effect of water depth on CH4 flux through effects of soil conditions, plant species composition and distribution. This study suggests that temporally flooded wetlands, including littoral zones, contribute significantly to the global CH4 burden. However, the current challenge is to capture their spatial extent and temporal variation in the fluxes.	[Yang, Meng; Geng, Xuemeng; Lu, Cai; Zhu, Yi; Zhou, Yan; Lei, Guangchun] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China; [Grace, John] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland	Beijing Forestry University; University of Edinburgh	Lei, GC (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China.	guangchun.lei@foxmail.com	Guangchun, Lei/ABC-8081-2021; Grace, John/N-9280-2013		China National Forestry Public Welfare Fund [200804005]	China National Forestry Public Welfare Fund	This research was supported by China National Forestry Public Welfare Fund (No. 200804005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril G, 2013, J S AM EARTH SCI, V44, P104, DOI 10.1016/j.jsames.2012.11.007; Allaire SE, 2008, J ENVIRON MONITOR, V10, P1326, DOI 10.1039/b809461f; [Anonymous], 2011, CHINAS LARGEST INLAN; Bergier I., 2011, OECOL AUST, V15, P666, DOI [10.4257/oeco.2011.1503.17, DOI 10.4257/0EC0.2011.1503.17, DOI 10.4257/OECO.2011.1503.17]; Bergstrom I, 2007, ATMOS ENVIRON, V41, P339, DOI 10.1016/j.atmosenv.2006.08.014; Bernal B, 2013, BIOGEOCHEMISTRY, V115, P77, DOI 10.1007/s10533-012-9819-8; Bhullar GS, 2013, J PLANT ECOL, V6, P298, DOI 10.1093/jpe/rts045; Boon PI, 1997, HYDROBIOLOGIA, V357, P73, DOI 10.1023/A:1003126601466; Bridgham SD, 2013, GLOBAL CHANGE BIOL, V19, P1325, DOI 10.1111/gcb.12131; [曹荣龙 CAO Ronglong], 2008, [测绘科学, Science of Surveying and Mapping], V33, P158; Chaudhari P.R., 2013, INT J SCI RES PUBLIC, V3, P1; Chen H, 2009, ATMOS ENVIRON, V43, P4995, DOI 10.1016/j.atmosenv.2009.07.001; Chen X, 2009, GAZETTE MINISTRY WAT; Cheng HL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078838, 10.1371/journal.pone.0053878]; Chowdhury TR, 2013, APPL SOIL ECOL, V65, P8, DOI 10.1016/j.apsoil.2012.12.014; Cunha-Santino Marcela Bianchessi da, 2010, Acta Limnol. Bras., V22, P237, DOI 10.4322/actalb.02202012; Demarty M, 2011, BIOGEOSCIENCES, V8, P41, DOI 10.5194/bg-8-41-2011; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Duan XN, 2006, J FRESHWATER ECOL, V21, P139, DOI 10.1080/02705060.2006.9664106; Fazli H.C., 2013, ASIA PAC J MOL BIOL, V21, P3; Gao Z. Q., 1989, BEIJING CHRONICLES W, VIII; Gauci V, 2010, ATMOS ENVIRON, V44, P2157, DOI 10.1016/j.atmosenv.2010.02.034; Gorres CM, 2013, FEMS MICROBIOL ECOL, V85, P227, DOI 10.1111/1574-6941.12115; Gunkel G, 2009, CLEAN-SOIL AIR WATER, V37, P726, DOI 10.1002/clen.200900062; Haynes WM, 2012, CRC HDB CHEM PHYS 20; Hirota M, 2004, SOIL BIOL BIOCHEM, V36, P737, DOI 10.1016/j.soilbio.2003.12.009; Hu YA, 2013, NAT CLIM CHANGE, V3, P708, DOI 10.1038/NCLIMATE1831; [黄佳芳 Huang Jiafang], 2011, [植物学报, Chinese Bulletin of Botany], V46, P534; Huang Y, 2002, NUTR CYCL AGROECOSYS, V64, P157, DOI 10.1023/A:1021132330268; Juutinen S, 2003, GLOBAL CHANGE BIOL, V9, P413, DOI 10.1046/j.1365-2486.2003.00595.x; Juutinen S, 2004, METHANE FLUXES THEIR; Kammann C, 2001, ENVIRON POLLUT, V115, P261, DOI 10.1016/S0269-7491(01)00103-8; Kankaala P, 2005, GLOBAL CHANGE BIOL, V11, P145, DOI 10.1111/j.1365-2486.2004.00888.x; KLUDZE HK, 1995, SOIL SCI SOC AM J, V59, P939, DOI 10.2136/sssaj1995.03615995005900030045x; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Koh HS, 2009, HYDROBIOLOGIA, V630, P271, DOI 10.1007/s10750-009-9821-x; Kolka RK, 2007, ECOLOGY FRESHWATER E; Kundzewicz ZW, 2007, CONTRIBUTION WORKING; Laanbroek HJ, 2010, ANN BOT-LONDON, V105, P141, DOI 10.1093/aob/mcp201; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; Li CF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034642, 10.1371/journal.pone.0030026, 10.1371/journal.pone.0047442]; Li SY, 2012, NAT HAZARDS, V62, P1343, DOI 10.1007/s11069-012-0127-3; Light HM, 1993, HYDROLOGY VEGETATION; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Liu DY, 2011, BIOGEOSCIENCES, V8, P329, DOI 10.5194/bg-8-329-2011; Makinen K., 2010, Water Alternatives, V3, P91; Mander U, 2011, WETLANDS, V31, P1023, DOI 10.1007/s13157-011-0218-z; MOORE TR, 1991, ATMOS OCEAN, V29, P102, DOI 10.1080/07055900.1991.9649395; Petrescu AMR, 2008, BIOGEOSCIENCES, V5, P111, DOI 10.5194/bg-5-111-2008; Petrescu AMR, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003610; Pierobon E, 2010, J LIMNOL, V69, P225, DOI 10.4081/jlimnol.2010.225; Sakin E., 2012, African Journal of Biotechnology, V11, P1373; Schimel J, 2000, NATURE, V403, P375, DOI 10.1038/35000325; Swamy YV, 2012, ATMOSFERA, V25, P107; WANG ZP, 1993, SOIL SCI SOC AM J, V57, P382, DOI 10.2136/sssaj1993.03615995005700020016x; Wildi W., 2010, TERRE ENV, V88, P187; Yamamoto A, 2009, LIMNOLOGY, V10, P228, DOI 10.1007/s10201-009-0284-6; [杨萌 YANG Meng], 2011, [湿地科学, Wetland Science], V9, P191; Zheng H, 2011, HYDROL PROCESS, V25, P1391, DOI 10.1002/hyp.7903	59	20	23	6	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94275	10.1371/journal.pone.0094275	http://dx.doi.org/10.1371/journal.pone.0094275			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710279	Green Published, gold, Green Submitted			2022-12-25	WOS:000334159800130
J	Ye, D; Hu, YK; Song, MH; Pan, X; Xie, XF; Liu, GF; Ye, XH; Dong, M				Ye, Duo; Hu, Yukun; Song, Minghua; Pan, Xu; Xie, Xiufang; Liu, Guofang; Ye, Xuehua; Dong, Ming			Clonality-Climate Relationships along Latitudinal Gradient across China: Adaptation of Clonality to Environments	PLOS ONE			English	Article							PLANT-SPECIES DIVERSITY; GLOBAL PATTERNS; LIFE; TRAITS; ECOLOGY; STRESS; LADAKH	Plant clonality, the ability of a plant species to reproduce itself vegetatively through ramets (shoot-root units), occurs in many plant species and is considered to be more frequent in cold or wet environments. However, a deeper understanding on the clonality-climate relationships along large geographic gradients is still scarce. In this study we revealed the clonality-climate relationships along latitudinal gradient of entire China spanning from tropics to temperate zones using clonality data for 4015 vascular plant species in 545 terrestrial communities. Structural equation modeling (SEM) showed that, in general, the preponderance of clonality increased along the latitudinal gradient towards cold, dry or very wet environments. However, the distribution of clonality in China was significantly but only weakly correlated with latitude and four climatic factors (mean annual temperature, temperature seasonality, mean annual precipitation, precipitation seasonality). Clonality of woody and herbaceous species had opposite responses to climatic variables. More precisely, woody clonality showed higher frequency in wet or climatically stable environments, while herbaceous clonality preferred cold, dry or climatically instable environments. Unexplained variation in clonality may be owed to the influences of other environmental conditions and to different clonal strategies and underlying traits adopted by different growth forms and phylogenetic lineages. Therefore, in-depth research in terms of more detailed clonal growth form, phylogeny and additional environmental variables are encouraged to further understand plant clonality response to climatic and/or edaphic conditions.	[Ye, Duo; Hu, Yukun; Pan, Xu; Xie, Xiufang; Liu, Guofang; Ye, Xuehua; Dong, Ming] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Dong, Ming] Hangzhou Normal Univ, Coll Life & Environm Sci, Key Lab Hangzhou City Ecosyst Protect & Restorat, Hangzhou, Zhejiang, Peoples R China; [Song, Minghua] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China; [Ye, Duo; Hu, Yukun; Pan, Xu; Xie, Xiufang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Hangzhou Normal University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, GF (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	liugf@ibcas.ac.cn; dongmingchina@126.com	Ye, Xuehua/I-3116-2013	Ye, Xuehua/0000-0002-5625-9877	NSFC [31261120580, 39825106, 31100333]; Innovative R & D grant of Hangzhou Normal University [PD12002002004001]	NSFC(National Natural Science Foundation of China (NSFC)); Innovative R & D grant of Hangzhou Normal University	This project was supported by the NSFC grant (grant no. 31261120580, 39825106) and the Innovative R & D grant of Hangzhou Normal University (grant no. PD12002002004001) to MD, and by the NSFC grants (grant no. 31100333) to GL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheplick GP, 1997, OIKOS, V79, P581, DOI 10.2307/3546902; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; de Bello F, 2011, PRESLIA, V83, P315; deKroon H, 1996, OECOLOGIA, V106, P73, DOI 10.1007/BF00334409; Del Tredici P, 2001, BOT REV, V67, P121, DOI 10.1007/BF02858075; DONG M, 1994, OIKOS, V70, P99, DOI 10.2307/3545704; Dong M., 1996, SURVEY OBSERVATION A; DORNBOS DL, 1989, CROP SCI, V29, P476, DOI 10.2135/cropsci1989.0011183X002900020047x; Editorial Committee of Flora Reipublicae Popularis Sinicae, 1961, FLORA REIPUBLICAE PO; Evette A, 2009, FOLIA GEOBOT, V44, P95, DOI 10.1007/s12224-009-9039-8; Fischer M, 2001, EVOL ECOL, V15, P565, DOI 10.1023/A:1016013721469; Fogel BN, 2004, J ECOL, V92, P589, DOI 10.1111/j.0022-0477.2004.00903.x; Grace JB, 2006, ECOL APPL, V16, P503, DOI 10.1890/1051-0761(2006)016[0503:ASEMAO]2.0.CO;2; Herben T, 2014, ANN BOT-LONDON, V114, P377, DOI 10.1093/aob/mct308; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hosaka N, 2005, NORTHEAST NAT, V12, P11, DOI 10.1656/1092-6194(2005)012[0011:TESOCG]2.0.CO;2; Jackson J. B. C., 1985, POPULATION BIOL EVOL; Klimes L, 2003, BASIC APPL ECOL, V4, P317, DOI 10.1078/1439-1791-00163; Klimes L, 1997, ECOLOGY AND EVOLUTION OF CLONAL PLANTS, P1; Klimesova J, 2012, POL POLAR RES, V33, P421, DOI 10.2478/v10183-012-0019-y; Klimesova J, 2011, PLANT ECOL DIVERS, V4, P373, DOI 10.1080/17550874.2011.586734; Klimesova J, 2011, FOLIA GEOBOT, V46, P191, DOI 10.1007/s12224-010-9076-3; Klimesova J, 2009, J VEG SCI, V20, P511, DOI 10.1111/j.1654-1103.2009.01050.x; Kroon H.D., 1997, ECOLOGY EVOLUTION CL; Lamb EG, 2008, ECOLOGY, V89, P216, DOI 10.1890/07-0393.1; Lamb EG, 2011, CAN J PLANT SCI, V91, P603, DOI [10.4141/CJPS2010-035, 10.4141/cjps2010-035]; Liu JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061060; McCullagh P, 1989, GEN LINEAR MODELS; Mikesell JE, 1997, INT J PLANT SCI, V158, P306, DOI 10.1086/297442; Moles AT, 2007, GLOBAL ECOL BIOGEOGR, V16, P109, DOI 10.1111/j.1466-8238.2006.00259.x; Moles AT, 2009, J ECOL, V97, P923, DOI 10.1111/j.1365-2745.2009.01526.x; Muthen, 2010, STAT ANAL LATENT VAR; Oborny B, 2000, ECOLOGY, V81, P3291; Oborny B., 1995, ABSTR BOT, V11, P115; PRACH K, 1994, SPEC FEAT VEGET SCI, V4, P307; R Development Core Team, 2012, R LANG ENV STAT COMP; SHAVER GR, 1976, FLORA, V165, P247; SIMON EW, 1976, NEW PHYTOL, V77, P301, DOI 10.1111/j.1469-8137.1976.tb01519.x; Song M., 2001, ACTA ECOL SIN, V21, P1095; Song MH, 2002, J VEG SCI, V13, P237, DOI 10.1111/j.1654-1103.2002.tb02044.x; Song MH, 2002, ECOL RES, V17, P705, DOI 10.1046/j.1440-1703.2002.00527.x; Sosnova M, 2010, AQUAT BOT, V92, P33, DOI 10.1016/j.aquabot.2009.09.005; Stuefer JF, 2001, EVOL ECOL, V15, P223, DOI 10.1023/A:1016017822027; Suzuki Jun-ichirou, 1999, Plant Species Biology, V14, P11, DOI 10.1046/j.1442-1984.1999.00002.x; vanGroenendael JM, 1996, PHILOS T ROY SOC B, V351, P1331, DOI 10.1098/rstb.1996.0116; Wellstein C, 2011, FOLIA GEOBOT, V46, P255, DOI 10.1007/s12224-010-9075-4; Woodward FI, 1997, J ECOL, V85, P899, DOI 10.2307/2960610; Yu FH, 2008, ANN BOT-LONDON, V102, P571, DOI 10.1093/aob/mcn119; Zobel M, 2010, OIKOS, V119, P802, DOI 10.1111/j.1600-0706.2010.18296.x	49	34	37	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94009	10.1371/journal.pone.0094009	http://dx.doi.org/10.1371/journal.pone.0094009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709992	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800085
J	Ellison, A; Ball, KL; Moseley, P; Dowsett, J; Smith, DT; Weis, S; Lane, AR				Ellison, Amanda; Ball, Keira L.; Moseley, Peter; Dowsett, James; Smith, Daniel T.; Weis, Susanne; Lane, Alison R.			Functional Interaction between Right Parietal and Bilateral Frontal Cortices during Visual Search Tasks Revealed Using Functional Magnetic Imaging and Transcranial Direct Current Stimulation	PLOS ONE			English	Article							EYE FIELDS; PREFRONTAL CORTEX; WORKING-MEMORY; NEURAL SYSTEMS; ATTENTION; MODULATION; TMS; INVOLVEMENT; ACTIVATION; MECHANISMS	The existence of a network of brain regions which are activated when one undertakes a difficult visual search task is well established. Two primary nodes on this network are right posterior parietal cortex (rPPC) and right frontal eye fields. Both have been shown to be involved in the orientation of attention, but the contingency that the activity of one of these areas has on the other is less clear. We sought to investigate this question by using transcranial direct current stimulation (tDCS) to selectively decrease activity in rPPC and then asking participants to perform a visual search task whilst undergoing functional magnetic resonance imaging. Comparison with a condition in which sham tDCS was applied revealed that cathodal tDCS over rPPC causes a selective bilateral decrease in frontal activity when performing a visual search task. This result demonstrates for the first time that premotor regions within the frontal lobe and rPPC are not only necessary to carry out a visual search task, but that they work together to bring about normal function.	[Ellison, Amanda; Ball, Keira L.; Moseley, Peter; Smith, Daniel T.; Weis, Susanne; Lane, Alison R.] Univ Durham, Dept Psychol, Durham DH1 3LE, England; [Dowsett, James] Carl von Ossietzky Univ Oldenburg, Dept Psychol, D-26111 Oldenburg, Germany	Durham University; Carl von Ossietzky Universitat Oldenburg	Ellison, A (corresponding author), Univ Durham, Dept Psychol, Durham DH1 3LE, England.	amanda.ellison@durham.ac.uk	Smith, Daniel T./L-1365-2019; Smith, Daniel T/A-2230-2009	Smith, Daniel T./0000-0001-7030-6994; Smith, Daniel T/0000-0001-7030-6994; Dowsett, James/0000-0002-0949-8939; Moseley, Peter/0000-0002-9284-2509	Durham University NeuroImaging Collective	Durham University NeuroImaging Collective	Durham University NeuroImaging Collective. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashbridge E, 1997, NEUROPSYCHOLOGIA, V35, P1121, DOI 10.1016/S0028-3932(97)00003-1; Bai SW, 2012, BRAIN STIMUL, V5, P408, DOI 10.1016/j.brs.2011.07.004; Ball K, 2013, BRAIN STIMUL, V6, P959, DOI 10.1016/j.brs.2013.06.001; Baudewig J, 2001, MAGN RESON MED, V45, P196, DOI 10.1002/1522-2594(200102)45:2<196::AID-MRM1026>3.0.CO;2-1; Chang CF, 2013, HUM BRAIN MAPP, V34, P869, DOI 10.1002/hbm.21476; Cohen JY, 2007, J NEUROPHYSIOL, V98, P2580, DOI 10.1152/jn.00522.2007; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Corbetta M, 1998, PHILOS T ROY SOC B, V353, P1353, DOI 10.1098/rstb.1998.0289; Donner TH, 2002, NEUROIMAGE, V15, P16, DOI 10.1006/nimg.2001.0951; Ellison A, 2003, SUPPL CLIN NEUROPHYS, V56, P321; Ellison A, 2008, BRAIN STIMUL, V1, P259; Ellison A, 2007, CEREB CORTEX, V17, P2579, DOI 10.1093/cercor/bhl165; Ellison A, 2006, EXP BRAIN RES, V175, P618, DOI 10.1007/s00221-006-0582-8; Ellison A, 2009, NEUROPSYCHOLOGIA, V47, P1609, DOI 10.1016/j.neuropsychologia.2008.12.013; Fregni F, 2006, ARTHRITIS RHEUM-US, V54, P3988, DOI 10.1002/art.22195; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Higo T, 2011, P NATL ACAD SCI USA, V108, P4230, DOI 10.1073/pnas.1013361108; Kalla R, 2008, NEUROREPORT, V19, P1067, DOI 10.1097/WNR.0b013e328304d9c4; Lane AR, 2012, BRAIN STIMUL, V5, P11, DOI 10.1016/j.brs.2011.01.005; Lane AR, 2011, J COGNITIVE NEUROSCI, V23, P1964, DOI 10.1162/jocn.2010.21576; Malhotra P, 2009, BRAIN, V132, P645, DOI 10.1093/brain/awn350; Morgan HM, 2013, BRAIN STIMUL, V6, P122, DOI 10.1016/j.brs.2012.03.001; Muggleton N, 2007, NEUROPSYCHOLOGIA, V45, P1582, DOI 10.1016/j.neuropsychologia.2006.11.021; Muggleton NG, 2011, J NEUROPHYSIOL, V105, P2891, DOI 10.1152/jn.01149.2009; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P2220, DOI 10.1016/S1388-2457(03)00235-9; Peterchev AV, 2012, BRAIN STIMUL, V5, P435, DOI 10.1016/j.brs.2011.10.001; Rogalewski A, 2004, EUR J NEUROSCI, V20, P313, DOI 10.1111/j.0953-816X.2004.03450.x; Rossi AF, 2007, J NEUROSCI, V27, P11306, DOI 10.1523/JNEUROSCI.2939-07.2007; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Slotnick SD, 2003, BEHAV RES METH INS C, V35, P322, DOI 10.3758/BF03202559; Smith DT, 2005, NEUROPSYCHOLOGIA, V43, P1288, DOI 10.1016/j.neuropsychologia.2004.12.003; Stagg CJ, 2009, EUR J NEUROSCI, V30, P1412, DOI 10.1111/j.1460-9568.2009.06937.x; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Szczepanski SM, 2010, J NEUROSCI, V30, P148, DOI 10.1523/JNEUROSCI.3862-09.2010; Talairach J., 1988, COPLANAR STEREOTAXIC; Tseng P, 2012, J NEUROSCI, V32, P10554, DOI 10.1523/JNEUROSCI.0362-12.2012; Tseng P, 2010, NEUROPSYCHOLOGIA, V48, P1063, DOI 10.1016/j.neuropsychologia.2009.12.005; Venkatakrishnan A, 2011, IEEE ENG MED BIO, P8102, DOI 10.1109/IEMBS.2011.6091998; Woodman GF, 2007, CEREBRAL CORTEX S1, V1, pi118	44	22	22	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93767	10.1371/journal.pone.0093767	http://dx.doi.org/10.1371/journal.pone.0093767			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705681	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000334107500065
J	Tojo, M; Fujita, T; Ainoda, Y; Nagamatsu, M; Hayakawa, K; Mezaki, K; Sakurai, A; Masui, Y; Yazaki, H; Takahashi, H; Miyoshi-Akiyama, T; Totsuka, K; Kirikae, T; Ohmagari, N				Tojo, Masayoshi; Fujita, Takahiro; Ainoda, Yusuke; Nagamatsu, Maki; Hayakawa, Kayoko; Mezaki, Kazuhisa; Sakurai, Aki; Masui, Yoshinori; Yazaki, Hirohisa; Takahashi, Hiroshi; Miyoshi-Akiyama, Tohru; Totsuka, Kyoichi; Kirikae, Teruo; Ohmagari, Norio			Evaluation of an Automated Rapid Diagnostic Assay for Detection of Gram-Negative Bacteria and Their Drug-Resistance Genes in Positive Blood Cultures	PLOS ONE			English	Article							NUCLEIC-ACID TEST; MOLECULAR DIAGNOSIS; STREAM INFECTIONS; IDENTIFICATION; ORGANISMS; SEPSIS; THERAPY; MARKERS; SYSTEM; IMPACT	We evaluated the performance of the Verigene Gram-Negative Blood Culture Nucleic Acid Test (BC-GN; Nanosphere, Northbrook, IL, USA), an automated multiplex assay for rapid identification of positive blood cultures caused by 9 Gramnegative bacteria (GNB) and for detection of 9 genes associated with beta-lactam resistance. The BC-GN assay can be performed directly from positive blood cultures with 5 minutes of hands-on and 2 hours of run time per sample. A total of 397 GNB positive blood cultures were analyzed using the BC-GN assay. Of the 397 samples, 295 were simulated samples prepared by inoculating GNB into blood culture bottles, and the remaining were clinical samples from 102 patients with positive blood cultures. Aliquots of the positive blood cultures were tested by the BC-GN assay. The results of bacterial identification between the BC-GN assay and standard laboratory methods were as follows: Acinetobacter spp. (39 isolates for the BC-GN assay/39 for the standard methods), Citrobacter spp. (7/7), Escherichia coli (87/87), Klebsiella oxytoca (13/13), and Proteus spp. (11/11); Enterobacter spp. (29/30); Klebsiella pneumoniae (62/72); Pseudomonas aeruginosa (124/125); and Serratia marcescens (18/21); respectively. From the 102 clinical samples, 104 bacterial species were identified with the BC-GN assay, whereas 110 were identified with the standard methods. The BC-GN assay also detected all beta-lactam resistance genes tested (233 genes), including 54 bla(CTX-M), 119 bla(IMP), 8 bla(KPC), 16 bla(NDM), 24 bla(OXA-23), 1 bla(OXA-24/40), 1 bla(OXA-48), 4 bla(OXA-58), and 6 bla(VIM). The data shows that the BC-GN assay provides rapid detection of GNB and beta-lactam resistance genes in positive blood cultures and has the potential to contributing to optimal patient management by earlier detection of major antimicrobial resistance genes.	[Tojo, Masayoshi; Nagamatsu, Maki; Hayakawa, Kayoko; Ohmagari, Norio] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Res Inst, Tokyo, Japan; [Tojo, Masayoshi; Nagamatsu, Maki; Miyoshi-Akiyama, Tohru; Kirikae, Teruo] Natl Ctr Global Hlth & Med, Res Inst, Dept Infect Dis, Tokyo, Japan; [Fujita, Takahiro; Ainoda, Yusuke; Totsuka, Kyoichi] Tokyo Womens Med Univ, Dept Infect Dis, Tokyo, Japan; [Mezaki, Kazuhisa] Natl Ctr Global Hlth & Med, Dept Clin Lab, Tokyo, Japan; [Sakurai, Aki] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Pulm Med, Chiba, Japan; [Masui, Yoshinori] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Internal Med, Chiba, Japan; [Yazaki, Hirohisa] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Takahashi, Hiroshi] East West Diagnost Theranost LLC, San Francisco, CA USA	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; Tokyo Women's Medical University; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Kirikae, T (corresponding author), Natl Ctr Global Hlth & Med, Res Inst, Dept Infect Dis, Tokyo, Japan.	tkirikae@ri.ncgm.go.jp	Ohmagari, Norio/GLN-5290-2022; Hayakawa, Kayoko/GNW-2394-2022	Ohmagari, Norio/0000-0002-4622-8970; Ainoda, Yusuke/0000-0002-1009-8414	National Center for Global Health and Medicine [24-207]; East-West Diagnostics/Theranostics, LLC	National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan); East-West Diagnostics/Theranostics, LLC	This work was supported by the grant of National Center for Global Health and Medicine (24-207). East-West Diagnostics/Theranostics, LLC provided support in the form of salaries for author HT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alby K, 2013, J CLIN MICROBIOL, V51, P3869, DOI 10.1128/JCM.01587-13; Altun O, 2013, J CLIN MICROBIOL, V51, P4130, DOI 10.1128/JCM.01835-13; Beal SG, 2013, J CLIN MICROBIOL, V51, P3988, DOI 10.1128/JCM.01889-13; Buchan BW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001478; Bush K., 2010, ANTIMICROB AGENTS CH, V54, P969, DOI [DOI 10.1128/AAC.01009-09, 10.1128/aac.01009-09]; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Clinical Laboratory Standards Institute, 2009, M07A7 CLIN LAB STAND; European Centre for disease prevention and Control (ECDC), 2012, HEALTHC ASS INF, P212; Fujita S, 2011, J CLIN MICROBIOL, V49, P1483, DOI 10.1128/JCM.01976-10; Gaieski DF, 2010, CRIT CARE MED, V38, P1045, DOI 10.1097/CCM.0b013e3181cc4824; Kouyama Y, 2012, J INFECT CHEMOTHER, V18, P522, DOI 10.1007/s10156-012-0374-y; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; La Scola B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008041; Leggieri N, 2010, CURR OPIN INFECT DIS, V23, P311, DOI 10.1097/QCO.0b013e32833bfc44; Liesenfeld O, 2014, EUR J MICRO IN PRESS; Mancini N, 2008, J MED MICROBIOL, V57, P601, DOI 10.1099/jmm.0.47732-0; Mestas J, 2014, J CLIN MICROBIOL, V52, P283, DOI 10.1128/JCM.02322-13; Morgan M, 2010, J CLIN MICROBIOL, V48, P2268, DOI 10.1128/JCM.00166-10; Nagao M, 2012, CLIN MICROBIOL INFEC; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Petti C, 2011, MANUAL CLIN MICROBIO, V10th, P15; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Samuel LP, 2013, J CLIN MICROBIOL, V51, P1188, DOI 10.1128/JCM.02982-12; Sango A, 2013, J CLIN MICROBIOL, V51, P4008, DOI 10.1128/JCM.01951-13; Seki M, 2013, J MED MICROBIOL, V62, P801, DOI 10.1099/jmm.0.051334-0; Shorr AF, 2011, CRIT CARE MED, V39, P46, DOI 10.1097/CCM.0b013e3181fa41a7; Sievert DM, 2013, INFECT CONT HOSP EP, V34, P1, DOI 10.1086/668770; Sontakke S, 2009, J MICROBIOL METH, V76, P217, DOI 10.1016/j.mimet.2008.11.002; Sullivan KV, 2013, J CLIN MICROBIOL, V51, P3579, DOI 10.1128/JCM.01224-13; Tissari P, 2010, LANCET, V375, P224, DOI 10.1016/S0140-6736(09)61569-5; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Wojewoda CM, 2013, J CLIN MICROBIOL, V51, P2072, DOI 10.1128/JCM.00831-13; Zhang CX, 2009, INT J SYST EVOL MICR, V59, P1603, DOI 10.1099/ijs.0.65718-0	33	37	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94064	10.1371/journal.pone.0094064	http://dx.doi.org/10.1371/journal.pone.0094064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705449	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500116
J	Bastiaans, E; Bastiaans, MJ; Morinaga, G; Gaytan, JGC; Marshall, JC; Bane, B; de la Cruz, FM; Sinervo, B				Bastiaans, Elizabeth; Jane Bastiaans, Mary; Morinaga, Gen; Castaneda Gaytan, Jose Gamaliel; Marshall, Jonathon C.; Bane, Brendan; Mendez de la Cruz, Fausto; Sinervo, Barry			Female Preference for Sympatric vs. Allopatric Male Throat Color Morphs in the Mesquite Lizard (Sceloporus grammicus) Species Complex	PLOS ONE			English	Article							2 CHROMOSOME RACES; KEELED EARLESS LIZARDS; VISUAL MATE CHOICE; MALE TREE LIZARDS; SEXUAL SELECTION; HYBRID ZONE; IGUANID LIZARD; BEHAVIORAL-RESPONSES; GEOGRAPHIC-VARIATION; COURTSHIP REJECTION	Color polymorphic sexual signals are often associated with alternative reproductive behaviors within populations, and the number, frequency, or type of morphs present often vary among populations. When these differences lead to assortative mating by population, the study of such polymorphic taxa may shed light on speciation mechanisms. We studied two populations of a lizard with polymorphic throat color, an important sexual signal. Males in one population exhibit orange, yellow, or blue throats; whereas males in the other exhibit orange, yellow, or white throats. We assessed female behavior when choosing between allopatric and sympatric males. We asked whether females discriminated more when the allopatric male was of an unfamiliar morph than when the allopatric male was similar in coloration to the sympatric male. We found that female rejection of allopatric males relative to sympatric males was more pronounced when males in a pair were more different in throat color. Our findings may help illuminate how behavioral responses to color morph differences between populations with polymorphic sexual signals contribute to reproductive isolation.	[Bastiaans, Elizabeth; Morinaga, Gen; Bane, Brendan; Sinervo, Barry] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Jane Bastiaans, Mary] Nanoopt Mat Inc, Carson, CA USA; [Castaneda Gaytan, Jose Gamaliel] Univ Juarez Estado Durango, Fac Ciencias Biol, Durango, Mexico; [Marshall, Jonathon C.] Weber State Univ, Dept Zool, Ogden, UT 84408 USA; [Mendez de la Cruz, Fausto] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Lab Herpetol, Mexico City 04510, DF, Mexico	University of California System; University of California Santa Cruz; Utah System of Higher Education; Weber State University; Universidad Nacional Autonoma de Mexico	Bastiaans, E (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, Falcon Hts, MN 55108 USA.	ejbastiaans@gmail.com	DURANGO, UNIVERSIDAD J/F-1212-2018; Mendez, Fausto/HGD-1205-2022; Mendez, Fausto R./O-3512-2018; Marshall, Jonathon C./AGG-8101-2022	DURANGO, UNIVERSIDAD J/0000-0002-1896-0937; Mendez, Fausto R./0000-0002-5084-1276; Bastiaans, Elizabeth/0000-0002-7322-1088; Marshall, Jonathon/0000-0003-0955-4889	National Science Foundation [IOS-1110497]; Science, Technology, Engineering, Society, and Policy Institute, UC Santa Cruz	National Science Foundation(National Science Foundation (NSF)); Science, Technology, Engineering, Society, and Policy Institute, UC Santa Cruz	This work was funded by the National Science Foundation (www.nsf.gov) Doctoral Dissertation Improvement Grant IOS-1110497 to EB. Research fellowship from the Science, Technology, Engineering, Society, and Policy Institute, UC Santa Cruz, to EB (www.ucsc.edu).	Abell AJ, 1997, BEHAV ECOL SOCIOBIOL, V41, P217, DOI 10.1007/s002650050382; Alonzo SH, 2010, J EVOLUTION BIOL, V23, P2614, DOI 10.1111/j.1420-9101.2010.02130.x; Andrews RM, 1997, COPEIA, P108, DOI 10.2307/1447845; AREVALO E, 1993, COPEIA, P352; Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Bastiaans E., 2013, THESIS U CALIFORNIA; Bastiaans E, 2013, BEHAV ECOL, V24, P968, DOI 10.1093/beheco/art010; Bleay C, 2007, P ROY SOC B-BIOL SCI, V274, P2019, DOI 10.1098/rspb.2007.0361; Bleay C, 2007, BEHAV ECOL, V18, P304, DOI 10.1093/beheco/arl101; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Calsbeek R, 2002, P NATL ACAD SCI USA, V99, P14897, DOI 10.1073/pnas.242645199; CARPENTER C C, 1978, Milwaukee Public Museum Contributions in Biology and Geology, P1; COOPER WE, 1987, ANIM BEHAV, V35, P1177, DOI 10.1016/S0003-3472(87)80174-4; COOPER WE, 1988, ETHOLOGY, V77, P265; COOPER WE, 1987, ANIM BEHAV, V35, P526, DOI 10.1016/S0003-3472(87)80277-4; Corl A, 2012, COPEIA, P593, DOI 10.1643/CH-11-166; Corl A, 2010, P NATL ACAD SCI USA, V107, P4254, DOI 10.1073/pnas.0909480107; Coyne JA, 2004, SPECIATION, V37; DENARDO DF, 1993, HORM BEHAV, V27, P184, DOI 10.1006/hbeh.1993.1014; Dijkstra PD, 2009, BEHAV ECOL, V20, P593, DOI 10.1093/beheco/arp036; Downes SJ, 2002, BEHAV ECOL SOCIOBIOL, V52, P444, DOI 10.1007/s00265-002-0538-3; DUVALL D, 1979, J EXP ZOOL, V210, P321, DOI 10.1002/jez.1402100215; Egger B, 2008, HYDROBIOLOGIA, V615, P37, DOI 10.1007/s10750-008-9564-0; Elmer KR, 2009, EVOLUTION, V63, P2750, DOI 10.1111/j.1558-5646.2009.00736.x; Encina-Dominguez JA, 2008, B SOC BOT MEX, V83, P13; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; Engstrom-Ost J, 2007, BEHAV ECOL, V18, P393, DOI 10.1093/beheco/arl097; Ersts PJ, 2012, GEOGRAPHIC DISTANCE; Feldman CR, 2011, MOL PHYLOGENET EVOL, V61, P714, DOI 10.1016/j.ympev.2011.08.008; Forsman A, 2008, ECOLOGY, V89, P34, DOI 10.1890/07-0572.1; GARLAND T, 1990, FUNCT ECOL, V4, P243, DOI 10.2307/2389343; Gonzalez-Voyer A, 2013, J EVOLUTION BIOL, V26, P647, DOI 10.1111/jeb.12084; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; HALL W., 1973, THESIS HARVARD U CAM; Hall WP, 2009, CYTOGENET GENOME RES, V127, P143, DOI 10.1159/000304050; Hamilton PS, 2005, ANIM BEHAV, V69, P219, DOI 10.1016/j.anbehav.2004.03.011; Hardwick KM, 2013, CURR ZOOL, V59, P20, DOI 10.1093/czoolo/59.1.20; Healey M, 2007, ANIM BEHAV, V74, P337, DOI 10.1016/j.anbehav.2006.09.017; Hernandez-Salinas U, 2010, HERPETOLOGICA, V66, P12, DOI 10.1655/08-053.1; Hews DK, 2004, ANIM BEHAV, V68, P1201, DOI 10.1016/j.anbehav.2003.11.024; Hochberg ME, 2003, EVOLUTION, V57, P154, DOI 10.1554/0014-3820(2003)057[0154:SMS]2.0.CO;2; HOVER EL, 1985, COPEIA, P933; Huyghe K, 2007, INTEGR COMP BIOL, V47, P211, DOI 10.1093/icb/icm043; Jimenez-Cruz E, 2005, SOUTHWEST NAT, V50, P178, DOI 10.1894/0038-4909(2005)050[0178:RCOSGS]2.0.CO;2; Korzan WJ, 2007, BEHAV ECOL, V18, P318, DOI 10.1093/beheco/arl093; Kozak GM, 2013, J EVOLUTION BIOL, V26, P130, DOI 10.1111/jeb.12034; Kraaijeveld K, 2011, BIOL REV, V86, P367, DOI 10.1111/j.1469-185X.2010.00150.x; Lancaster LT, 2007, ECOL LETT, V10, P798, DOI 10.1111/j.1461-0248.2007.01069.x; Lancaster LT, 2010, EVOLUTION, V64, P1607, DOI 10.1111/j.1558-5646.2010.00941.x; Lancaster LT, 2009, BEHAV ECOL, V20, P993, DOI 10.1093/beheco/arp088; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; LARA-GONGORA G., 1983, B MARYLAND HERPETOLO, V19, P1; Leache AD, 2002, SYST BIOL, V51, P44, DOI 10.1080/106351502753475871; Lemos-Espinal JA, 1998, GREAT BASIN NAT, V58, P375; Lopez P, 2003, BEHAV ECOL SOCIOBIOL, V55, P73, DOI 10.1007/s00265-003-0675-3; Lukhtanov VA, 2005, NATURE, V436, P385, DOI 10.1038/nature03704; Maan ME, 2011, ECOL LETT, V14, P591, DOI 10.1111/j.1461-0248.2011.01606.x; Marshall JC, 2006, EVOLUTION, V60, P1050; Marshall JC, 2001, MOL ECOL, V10, P435, DOI 10.1046/j.1365-294x.2001.01232.x; MARTINS EP, 1991, ANIM BEHAV, V41, P403, DOI 10.1016/S0003-3472(05)80841-3; MARTINS EP, 1993, AM NAT, V142, P994, DOI 10.1086/285585; Martins EP, 1998, ANIM BEHAV, V56, P1113, DOI 10.1006/anbe.1998.0872; McLean CA, 2014, BIOL REV, V89, P860, DOI 10.1111/brv.12083; Mendelson TC, 2012, TRENDS ECOL EVOL, V27, P421, DOI 10.1016/j.tree.2012.04.001; Mendez de la Cruz F, 1989, THESIS U NACL AUTONO; Miles DB, 2007, FUNCT ECOL, V21, P653, DOI 10.1111/j.1365-2435.2007.01304.x; Neff BD, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0045; NOBLE G. K., 1933, ANN NEW YORK ACAD SCI, V35, P25, DOI 10.1111/j.1749-6632.1933.tb55365.x; Norman GR, 2008, BIOSTATISTICS BARE E, V3rd; Olsson M, 2013, SEMIN CELL DEV BIOL, V24, P529, DOI 10.1016/j.semcdb.2013.04.001; Perez i de Lanuza G, 2012, BEHAV ECOL; Pizzatto L, 2012, BIOL J LINN SOC, V107, P210, DOI 10.1111/j.1095-8312.2012.01936.x; Pryke SR, 2010, EVOLUTION, V64, P1301, DOI 10.1111/j.1558-5646.2009.00897.x; Pryke SR, 2006, P ROY SOC B-BIOL SCI, V273, P949, DOI 10.1098/rspb.2005.3362; Quinn VS, 2000, P ROY SOC B-BIOL SCI, V267, P755, DOI 10.1098/rspb.2000.1067; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Ramirez-Bautista A, 2004, WEST N AM NATURALIST, V64, P175; Ramirez-Bautista A, 2012, ECOL EVOL, V2, P1903, DOI 10.1002/ece3.310; RAND MS, 1990, AM MIDL NAT, V124, P352, DOI 10.2307/2426184; RAND MS, 1988, AM ZOOL, V28, pA153; REED KM, 1995, EVOLUTION, V49, P37, DOI 10.1111/j.1558-5646.1995.tb05956.x; REED KM, 1995, EVOLUTION, V49, P61, DOI 10.1111/j.1558-5646.1995.tb05958.x; REED KM, 1995, EVOLUTION, V49, P48, DOI 10.1111/j.1558-5646.1995.tb05957.x; Reynolds RG, 2007, EVOLUTION, V61, P2253, DOI 10.1111/j.1558-5646.2007.00174.x; Ritchie MG, 2007, ANNU REV ECOL EVOL S, V38, P79, DOI 10.1146/annurev.ecolsys.38.091206.095733; Robertson JM, 2009, BIOL J LINN SOC, V98, P243, DOI 10.1111/j.1095-8312.2009.01291.x; Ronald KL, 2012, ANIM BEHAV, V84, P1283, DOI 10.1016/j.anbehav.2012.09.015; Runemark A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-269; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 1999, ECOL LETT, V2, P367; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Simmons LW, 2001, EVOLUTION, V55, P1386, DOI 10.1111/j.0014-3820.2001.tb00660.x; Sinervo A, 2001, J HERED, V92, P198, DOI 10.1093/jhered/92.2.198; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Sinervo B, 2006, P NATL ACAD SCI USA, V103, P7372, DOI 10.1073/pnas.0510260103; SITES JW, 1983, EVOLUTION, V37, P54, DOI 10.1111/j.1558-5646.1983.tb05513.x; SITES JW, 1995, EVOLUTION, V49, P9, DOI 10.1111/j.1558-5646.1995.tb05955.x; SITES JW, 1983, EVOLUTION, V37, P38, DOI 10.1111/j.1558-5646.1983.tb05512.x; SITES JW, 1981, J HERPETOL, V15, P59, DOI 10.2307/1563647; Speck F. G., 1924, Copeia Northampton, V128, P35; Sullivan BK, 2007, FUNCT ECOL, V21, P666, DOI 10.1111/j.1365-2435.2007.01244.x; Summers K, 1999, P ROY SOC B-BIOL SCI, V266, P2141, DOI 10.1098/rspb.1999.0900; Swierk L, 2013, ANIM BEHAV; Swierk L, 2012, BEHAV ECOL SOCIOBIOL, V66, P1033, DOI 10.1007/s00265-012-1351-2; Templeton JJ, 2012, BIOL LETTERS, V8, P924, DOI 10.1098/rsbl.2012.0830; THOEN C, 1986, ANIM BEHAV, V34, P1805, DOI 10.1016/S0003-3472(86)80266-4; THOMPSON CW, 1991, ANIM BEHAV, V42, P745, DOI 10.1016/S0003-3472(05)80120-4; THOMPSON CW, 1991, COPEIA, P493; TOKARZ RR, 1995, HERPETOLOGICAL MONOGRAPHS, NO 9, 1995, P17, DOI 10.2307/1466994; Uetz GW, 2009, ANIM BEHAV, V78, P299, DOI 10.1016/j.anbehav.2009.04.023; van der Sluijs I, 2008, PHILOS T R SOC B, V363, P2871, DOI 10.1098/rstb.2008.0045; van der Sluijs I, 2008, BEHAV ECOL, V19, P177, DOI 10.1093/beheco/arm120; Vercken E, 2008, ECOSCIENCE, V15, P320, DOI 10.2980/15-3-3135; Vercken E, 2008, HERPETOL J, V18, P223; Villanueva-Diaz J, 2007, CLIMATIC CHANGE, V83, P117, DOI 10.1007/s10584-006-9144-0; VINEGAR MB, 1972, COPEIA, P660; WESTEBERHARD MJ, 1986, P NATL ACAD SCI USA, V83, P1388, DOI 10.1073/pnas.83.5.1388; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; Zoppoth P, 2013, J EVOLUTION BIOL, V26, P577, DOI 10.1111/jeb.12074; Zuniga-Vega JJ, 2008, AMPHIBIA-REPTILIA, V29, P127, DOI 10.1163/156853808783431550	124	30	30	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93197	10.1371/journal.pone.0093197	http://dx.doi.org/10.1371/journal.pone.0093197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718297	Green Published, Green Submitted, gold			2022-12-25	WOS:000334339000028
J	DelGiorno, KE; Tam, JW; Hall, JC; Thotakura, G; Crawford, HC; van der Velden, AWM				DelGiorno, Kathleen E.; Tam, Jason W.; Hall, Jason C.; Thotakura, Gangadaar; Crawford, Howard C.; van der Velden, Adrianus W. M.			Persistent Salmonellosis Causes Pancreatitis in a Murine Model of Infection	PLOS ONE			English	Article							TO-DUCTAL METAPLASIA; NF-KAPPA-B; TYPHOID CARRIERS; CANCER; TYPHIMURIUM; CELLS; CARCINOMA; EPIDEMIOLOGY; MACROPHAGE; GALLSTONES	Pancreatitis, a known risk factor for the development of pancreatic ductal adenocarcinoma, is a serious, widespread medical condition usually caused by alcohol abuse or gallstone-mediated ductal obstruction. However, many cases of pancreatitis are of an unknown etiology. Pancreatitis has been linked to bacterial infection, but causality has yet to be established. Here, we found that persistent infection of mice with the bacterial pathogen Salmonella enterica serovar Typhimurium (S. Typhimurium) was sufficient to induce pancreatitis reminiscent of the human disease. Specifically, we found that pancreatitis induced by persistent S. Typhimurium infection was characterized by a loss of pancreatic acinar cells, acinar-toductal metaplasia, fibrosis and accumulation of inflammatory cells, including CD11b(+) F4/80(+), CD11b(+) Ly6C(int) Ly6G(+) and CD11b(+) Ly6C(hi) Ly6G(-) cells. Furthermore, we found that S. Typhimurium colonized and persisted in the pancreas, associated with pancreatic acinar cells in vivo, and could invade cultured pancreatic acinar cells in vitro. Thus, persistent infection of mice with S. Typhimurium may serve as a useful model for the study of pancreatitis as it relates to bacterial infection. Increased knowledge of how pathogenic bacteria can cause pancreatitis will provide a more integrated picture of the etiology of the disease and could lead to the development of new therapeutic approaches for treatment and prevention of pancreatitis and pancreatic ductal adenocarcinoma.	[DelGiorno, Kathleen E.; Tam, Jason W.; Crawford, Howard C.; van der Velden, Adrianus W. M.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [DelGiorno, Kathleen E.; Hall, Jason C.; Crawford, Howard C.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [van der Velden, Adrianus W. M.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Tam, Jason W.; van der Velden, Adrianus W. M.] SUNY Stony Brook, Ctr Infect Dis, Stony Brook, NY 11794 USA; [DelGiorno, Kathleen E.; Hall, Jason C.; Thotakura, Gangadaar; Crawford, Howard C.] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Mayo Clinic	Crawford, HC (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	a.vandervelden@stonybrook.edu; crawford.howard@mayo.edu	DelGiorno, Kathy/AAJ-9911-2021	DelGiorno, Kathy/0000-0002-5749-8394	NIH [R21AI092165, R01AI101221, P01AI055621-Benach, R01CA159222, R01CA136754, T32AI007539]; NATIONAL CANCER INSTITUTE [R01CA159222, R01CA136754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101221, P01AI055621, R21AI092165, T32AI007539] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants awarded to AWMvdV (R21AI092165, R01AI101221 and P01AI055621-Benach) and HCC (R01CA159222 and R01CA136754). JWT was supported by the NIH under award number T32AI007539. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAWADHI NZ, 1989, AM J GASTROENTEROL, V84, P1570; ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; ANDRENSANDBERG A, 1994, INT J PANCREATOL, V15, P229; Andrews-Polymenis HL, 2010, INFECT IMMUN, V78, P2356, DOI 10.1128/IAI.00096-10; Blank A, 2003, DIGEST DIS SCI, V48, P1472, DOI 10.1023/A:1024795202768; CAYGILL CPJ, 1995, EUR J CANCER PREV, V4, P187, DOI 10.1097/00008469-199504000-00010; CAYGILL CPJ, 1994, LANCET, V343, P83, DOI 10.1016/S0140-6736(94)90816-8; Crawford HC, 2002, J CLIN INVEST, V109, P1437, DOI 10.1172/JCI200215051; Daniluk J, 2012, J CLIN INVEST, V122, P1519, DOI 10.1172/JCI59743; Delrue LJ, 2010, ABDOM IMAGING, V35, P349, DOI 10.1007/s00261-009-9522-y; Deng SX, 2008, WORLD J GASTROENTERO, V14, P782, DOI 10.3748/wjg.14.782; Ding SP, 2003, WORLD J GASTROENTERO, V9, P584, DOI 10.3748/wjg.v9.i3.584; Dougan G, 2011, IMMUNOL REV, V240, P196, DOI 10.1111/j.1600-065X.2010.00999.x; Dutta U, 2000, AM J GASTROENTEROL, V95, P784, DOI 10.1111/j.1572-0241.2000.01860.x; EDWARDS CN, 1991, AM J GASTROENTEROL, V86, P1665; ELZAYADI A, 1991, HEPATO-GASTROENTEROL, V38, P337; EZPELETA C, 1992, CLIN INFECT DIS, V15, P1050, DOI 10.1093/clind/15.6.1050; Fagenholz PJ, 2007, ANN EPIDEMIOL, V17, P491, DOI 10.1016/j.annepidem.2007.02.002; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; FILIPE MI, 1994, INT J CANCER, V57, P324, DOI 10.1002/ijc.2910570306; Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4; Fortunato F, 2006, AM J PHYSIOL-GASTR L, V290, pG232, DOI 10.1152/ajpgi.00040.2005; Frey CF, 2006, PANCREAS, V33, P336, DOI 10.1097/01.mpa.0000236727.16370.99; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; GARG P, 1992, POSTGRAD MED J, V68, P294, DOI 10.1136/pgmj.68.798.294; GIBB AP, 1991, J ANTIMICROB CHEMOTH, V28, P318, DOI 10.1093/jac/28.2.318; Gonzalez-Escobedo G, 2011, NAT REV MICROBIOL, V9, P9, DOI 10.1038/nrmicro2490; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; HALEVY A, 1987, BRIT J SURG, V74, P150, DOI 10.1002/bjs.1800740227; Hamaguchi H, 1999, INT J PANCREATOL, V26, P189, DOI 10.1385/IJGC:26:3:189; HERMANS P, 1991, SCAND J INFECT DIS, V23, P201, DOI 10.3109/00365549109023401; Kadappu Krishna Kishor, 2002, Indian J Gastroenterol, V21, P32; Kullas AL, 2012, CELL HOST MICROBE, V12, P791, DOI 10.1016/j.chom.2012.10.018; KUNE GA, 1972, MED J AUSTRALIA, V1, P417, DOI 10.5694/j.1326-5377.1972.tb106538.x; Lambotte O, 2001, J INFECTION, V42, P161, DOI 10.1053/jinf.2000.0783; LINDHOLT J, 1985, ACTA CHIR SCAND, V151, P703; Liou GY, 2013, J CELL BIOL, V202, P563, DOI 10.1083/jcb.201301001; Morris JP, 2010, NAT REV CANCER, V10, P683, DOI 10.1038/nrc2899; MURPHY S, 1991, LANCET, V338, P571, DOI 10.1016/0140-6736(91)91134-G; Parenti DM, 1996, PANCREAS, V13, P356, DOI 10.1097/00006676-199611000-00005; PETTERSSON T, 1970, Annals of Clinical Research, V2, P157; Pezzilli Raffaele, 2003, JOP, V4, P200; Prouty AM, 2002, INFECT IMMUN, V70, P2640, DOI 10.1128/IAI.70.5.2640-2649.2002; RENNER F, 1991, LANCET, V337, P1611, DOI 10.1016/0140-6736(91)93310-6; RUSSELL IJ, 1976, JAMA-J AM MED ASSOC, V235, P753, DOI 10.1001/jama.235.7.753; Schmid SW, 1999, GUT, V45, P311, DOI 10.1136/gut.45.2.311; Sevastos N, 2001, AM J GASTROENTEROL, V96, P3450, DOI 10.1111/j.1572-0241.2001.05348.x; Shukla VK, 2000, DIGEST DIS SCI, V45, P900, DOI 10.1023/A:1005564822630; STRAND CL, 1978, AM SURGEON, V44, P174; Tenner S, 1997, GASTROENTEROLOGY, V113, P899, DOI 10.1016/S0016-5085(97)70185-9; Tsolis RM, 2011, INFECT IMMUN, V79, P1806, DOI 10.1128/IAI.01369-10; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Vaccaro MI, 2000, DIGEST DIS SCI, V45, P915, DOI 10.1023/A:1005521007609; Vaishnavi C, 2005, MICROBIOL IMMUNOL, V49, P107, DOI 10.1111/j.1348-0421.2005.tb03709.x; van der Velden AWM, 2000, INFECT IMMUN, V68, P5702, DOI 10.1128/IAI.68.10.5702-5709.2000; Vazquez-Torres A, 1999, NATURE, V401, P804, DOI 10.1038/44593; Wang F, 2013, CANC LETT; WESTBLOM TU, 1988, SOUTH MED J, V81, P1200, DOI 10.1097/00007611-198809000-00036; Whitcomb DC, 2004, AM J PHYSIOL-GASTR L, V287, pG315, DOI 10.1152/ajpgi.00115.2004; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Zaharik ML, 2004, INFECT IMMUN, V72, P5522, DOI 10.1128/IAI.72.9.5522-5525.2004	63	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e92807	10.1371/journal.pone.0092807	http://dx.doi.org/10.1371/journal.pone.0092807			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717768	Green Submitted, Green Published, gold			2022-12-25	WOS:000334339000021
J	Holden, AR; Koch, JB; Griswold, T; Erwin, DM; Hall, J				Holden, Anna R.; Koch, Jonathan B.; Griswold, Terry; Erwin, Diane M.; Hall, Justin			Leafcutter Bee Nests and Pupae from the Rancho La Brea Tar Pits of Southern California: Implications for Understanding the Paleoenvironment of the Late Pleistocene	PLOS ONE			English	Article							MIDDLE EOCENE; HYMENOPTERA; LEAF; COLEOPTERA; FOSSIL; EVOLUTION; BEETLES; CLIMATE; APOIDEA	The Rancho La Brea Tar Pits is the world's richest and most important Late Pleistocene fossil locality and best renowned for numerous fossil mammals and birds excavated over the past century. Less researched are insects, even though these specimens frequently serve as the most valuable paleoenvironemental indicators due to their narrow climate restrictions and life cycles. Our goal was to examine fossil material that included insect-plant associations, and thus an even higher potential for significant paleoenviromental data. Micro-CT scans of two exceptionally preserved leafcutter bee nest cells from the Rancho La Brea Tar Pits in Los Angeles, California reveal intact pupae dated between, similar to 23,000-40,000 radiocarbon years BP. Here identified as best matched to Megachile (Litomegachile) gentilis Cresson (Hymenoptera: Megachilidae) based on environmental niche models as well as morphometrics, the nest cells (LACMRLP 388E) document rare preservation and life-stage. The result of complex plant-insect interactions, they offer new insights into the environment of the Late Pleistocene in southern California. The remarkable preservation of the nest cells suggests they were assembled and nested in the ground where they were excavated. The four different types of dicotyledonous leaves used to construct the cells were likely collected in close proximity to the nest and infer a wooded or riparian habitat with sufficient pollen sources for larval provisions. LACMRLP 388E is the first record of fossil Megachile Latreille cells with pupae. Consequently, it provides a pre-modern age location for a Nearctic group, whose phylogenetic relationships and biogeographic history remain poorly understood. Megachile gentilis appears to respond to climate change as it has expanded its distribution across elevation gradients over time as estimated by habitat suitability comparisons between low and high elevations; it currently inhabits mesic habitats which occurred at a lower elevation during the Last Glacial Maximum,21,000 years ago. Nevertheless, the broad ecological niche of M. gentilis appears to have remained stable.	[Holden, Anna R.] Nat Hist Museum Los Angeles Cty, Entomol Sect, Los Angeles, CA 90007 USA; [Koch, Jonathan B.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Koch, Jonathan B.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Griswold, Terry] Utah State Univ, USDA ARS, Pollinating Insect Res Unit, Logan, UT 84322 USA; [Erwin, Diane M.] Univ Calif Berkeley, Museum Paleontol, Berkeley, CA 94720 USA; [Hall, Justin] Nat Hist Museum Los Angeles Cty, Dinosaur Inst, Los Angeles, CA USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; United States Department of Agriculture (USDA); Utah System of Higher Education; Utah State University; University of California System; University of California Berkeley	Holden, AR (corresponding author), Nat Hist Museum Los Angeles Cty, Entomol Sect, Los Angeles, CA 90007 USA.	aholden@nhm.org	Koch, Jonathan/AAH-4591-2020	Koch, Jonathan/0000-0002-6654-7370; Griswold, Terry/0000-0003-3952-9393	Annie M. Alexander Endowment	Annie M. Alexander Endowment	The Annie M. Alexander Endowment provided funding for Diane M. Erwin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOTT HJ, 1963, AM J BOT, V50, P821, DOI 10.2307/2440201; ARNOTT HOWARD J., 1964, BOT GAZ, V125, P13, DOI 10.1086/336238; Baldwin B.G., 2012, JEPSON MANUAL VASCUL; Berry E. W., 1916, 91 US GEOL SURV, V91, P1, DOI [DOI 10.3133/PP91, 10.3133/pp91]; Berry EW, 1931, AM J SCI, V21, P301; Bischoff JL, 2001, QUATERNARY RES, V55, P14, DOI 10.1006/qres.2000.2183; BROOKS H. K., 1955, PSYCHE, V62, P1, DOI 10.1155/1955/76727; Bzdyk EL, 2012, ZOOKEYS, P31, DOI 10.3897/zookeys.221.3234; Cane JH, 2007, ANN ENTOMOL SOC AM, V100, P350, DOI 10.1603/0013-8746(2007)100[350:SAMUFN]2.0.CO;2; CANE JH, 1983, J KANSAS ENTOMOL SOC, V56, P199; CANE JH, 1984, COMP BIOCHEM PHYS B, V78, P769, DOI 10.1016/0305-0491(84)90132-9; Cockerell TDA, 1908, B AM MUS NAT HIST, V24, P59; Coltrain JB, 2004, PALAEOGEOGR PALAEOCL, V205, P199, DOI 10.1016/j.palaeo.2003.12.008; Coope GR, 2004, PHILOS T R SOC B, V359, P209, DOI 10.1098/rstb.2003.1393; DOYEN JT, 1980, PAN-PAC ENTOMOL, V56, P1; Engel Michael S., 1999, American Museum Novitates, V3276, P1; Engel MS, 2004, NATURE, V427, P627, DOI 10.1038/nature02291; Engel MS, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)506[0001:AEBIRA]2.0.CO;2; Engel MS, 2001, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2001)259<0001:AMOTBA>2.0.CO;2; Friscia AR, 2008, PALAIOS, V23, P35, DOI 10.2110/palo.2005.p05-143r; Gustafsson MH, 1955, BOT J LINN SOC, V118, P1; Heusser L, 1998, PALEOCEANOGRAPHY, V13, P252, DOI 10.1029/98PA00670; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Holden AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067119; Hurd PD, 1955, B CALIFORNIA INSECT, V3, P1; Jacobs DK, 2004, ANNU REV EARTH PL SC, V32, P601, DOI 10.1146/annurev.earth.32.092203.122436; Kim JY, 2007, NATURWISSENSCHAFTEN, V94, P981, DOI 10.1007/s00114-007-0277-4; KIM JY, 1992, ANN ENTOMOL SOC AM, V85, P85, DOI 10.1093/aesa/85.1.85; Krombein K. V., 1967, TRAP NESTING WASPS B, Vvi; Latreille P. A., 1802, HIST NATURELLE GEN P; LEWIS SE, 1994, J PALEONTOL, V68, P172, DOI 10.1017/S0022336000025713; Litman JR, 2011, P ROY SOC B-BIOL SCI, V278, P3593, DOI 10.1098/rspb.2011.0365; Michener C.D., 2007, BEES WORLD, Vsecond; MICHENER CHARLES D., 1953, UNIV KANSAS SCI BULL, V35, P1659; Michez Denis, 2012, Systematics Association Special Volume Series, V81, P103; MILLER SE, 1981, P ENTOMOL SOC WASH, V83, P625; MITCHELL THEODORE B., 1935, TRANS AMER ENT SOC, V61, P1; Munz P., 1959, CALIFORNIA FLORA; O'Toole C., 1991, BEES OF THE WORLD; PACKER L, 1987, J KANSAS ENTOMOL SOC, V60, P280; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; R Core Team, 2012, R LANG ENV STAT COMP; Robert C, 2004, QUATERNARY SCI REV, V23, P1029, DOI 10.1016/j.quascirev.2003.11.005; Sarzetti LC, 2008, PALAEONTOLOGY, V51, P933, DOI 10.1111/j.1475-4983.2008.00787.x; Shaw C.A., 1982, Curator, V25, P63; Shaw C.A., 1986, CALIFORNIA GEOLOGY U, V39, p123; Sheffield Cory S., 2013, Journal of Melittology, V19, P1; Stock C, 1992, RANCHO LA BREA RECOR; Strickler K, 1991, J KANSAS ENTOMOL SOC, V69, P26; Wappler T, 2003, J PALEONTOL, V77, P908, DOI 10.1666/0022-3360(2003)077<0908:TMEBFO>2.0.CO;2; Warter JK, 1979, ABS ANN M S CA ACAD, V87, P44; Wedmann S, 2009, NATURWISSENSCHAFTEN, V96, P703, DOI 10.1007/s00114-009-0525-x	54	3	3	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94724	10.1371/journal.pone.0094724	http://dx.doi.org/10.1371/journal.pone.0094724			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718701	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000139
J	Li, YJ; Lu, JP; Peng, ZK; Tan, GJ; Liu, N; Huang, DM; Zhang, ZL; Duan, CJ; Tang, XW; Tang, FQ				Li, Yuejin; Lu, Jinping; Peng, Zhengke; Tan, Gongjun; Liu, Na; Huang, Damao; Zhang, Zhenlin; Duan, Chaojun; Tang, Xiaowei; Tang, Faqing			N,N '-Dinitrosopiperazine-Mediated AGR2 Is Involved in Metastasis of Nasopharyngeal Carcinoma	PLOS ONE			English	Article							CATHEPSIN-B PROMOTES; BREAST-CANCER; SALTED FISH; PANCREATIC-CANCER; NITROSO-COMPOUNDS; NODE METASTASIS; EXPRESSION; CHINESE; RISK; BIOMARKER	Nasopharyngeal carcinoma (NPC) has a high metastatic character in the clinic, but its mechanism is not clear. As a carcinogen with organ specificity for the nasopharyngeal epithelium, N,N '-Dinitrosopiperazine (DNP) is involved in NPC metastasis. Herein, our data revealed that anterior gradient 2 (AGR2) was overexpressed in human NPC tissues, particularly in cervical lymph node metastatic NPC (LMNPC). High AGR2 expression was associated with NPC metastasis. Importantly, DNP induced AGR2 expression, and increased cell motility and invasion in the NPC cell line 6-10B. However, DNP-mediated cell motility and invasion was dramatically decreased when transfected with siRNA-AGR2. Further, AGR2 directly regulated cathepsin (CTS) B and D by binding them in vitro. These results indicate that DNP induces AGR2 expression, regulates CTSB and CTSD, increases cell motility and invasion, and promotes NPC tumor metastasis. Therefore, DNP-mediated AGR2 expression may be an important factor in prolific NPC metastasis.	[Li, Yuejin; Lu, Jinping; Peng, Zhengke; Tan, Gongjun; Zhang, Zhenlin; Tang, Faqing] Jinan Univ, Zhuhai Peoples Hosp, Zhuhai Hosp, Clin Lab, Zhuhai, Guangdong, Peoples R China; [Li, Yuejin; Lu, Jinping; Peng, Zhengke; Tan, Gongjun; Zhang, Zhenlin; Tang, Faqing] Jinan Univ, Zhuhai Peoples Hosp, Zhuhai Hosp, Med Res Ctr, Zhuhai, Guangdong, Peoples R China; [Liu, Na; Huang, Damao; Duan, Chaojun] Cent South Univ, Xiangya Hosp, Med Res Ctr, Changsha, Hunan, Peoples R China; [Liu, Na; Huang, Damao; Duan, Chaojun] Cent South Univ, Xiangya Hosp, Clin Lab, Changsha, Hunan, Peoples R China; [Tang, Xiaowei] Cent South Univ, Changsha, Hunan, Peoples R China	Jinan University; Jinan University; Central South University; Central South University; Central South University	Tang, FQ (corresponding author), Jinan Univ, Zhuhai Peoples Hosp, Zhuhai Hosp, Clin Lab, Zhuhai, Guangdong, Peoples R China.	tangfaqing33@hotmail.com	LI, Yue/GRS-8071-2022		National Natural Science Foundation of China [81372282, 81071718, 30973400, 30670990]; Program for New Century Excellent Talents in University, NCET [NCET-06-0685]; Guangdong Natural Science Foundation [S2013010013360]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University, NCET(Program for New Century Excellent Talents in University (NCET)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported in part by the National Natural Science Foundation of China (81372282, 81071718, 30973400 30670990), Program for New Century Excellent Talents in University, NCET (NCET-06-0685), Guangdong Natural Science Foundation (S2013010013360). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DE, 2010, CANCER BIOL THER, V9, P23, DOI 10.4161/cbt.9.1.10378; Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; [Anonymous], BREAST CANC RES, V12, pR32; Armstrong RW, 1998, INT J CANCER, V77, P228, DOI 10.1002/(SICI)1097-0215(19980717)77:2&lt;228::AID-IJC11&gt;3.0.CO;2-7; Barraclough DL, 2009, AM J PATHOL, V175, P1848, DOI 10.2353/ajpath.2009.090246; BARTSCH H, 1992, PHARMACOGENETICS, V2, P272, DOI 10.1097/00008571-199212000-00005; Brychtova V, 2011, CANCER LETT, V304, P1, DOI 10.1016/j.canlet.2010.12.023; Bu HJ, 2011, PROSTATE, V71, P575, DOI 10.1002/pros.21273; Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Chan ATC, 2010, ANN ONCOL, V21, P308, DOI 10.1093/annonc/mdq277; Chen Z C, 1991, IARC Sci Publ, P434; Cheng AL, 2008, J PROTEOME RES, V7, P2415, DOI 10.1021/pr7008548; Chew MMS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-574; Chua DTT, 1998, INT J RADIAT ONCOL, V41, P379, DOI 10.1016/S0360-3016(98)00063-7; Chung Kyukwang, 2012, Osaka City Med J, V58, P13; Czyzewska J, 2008, FOLIA HISTOCHEM CYTO, V46, P57, DOI 10.2478/v10042-008-0007-6; del Casar JM, 2008, J CANCER RES CLIN, V134, P153, DOI 10.1007/s00432-007-0264-3; Dumartin L, 2011, CANCER RES, V71, P7091, DOI 10.1158/0008-5472.CAN-11-1367; Gallicchio L, 2006, INT J CANCER, V119, P1125, DOI 10.1002/ijc.21946; Gan Y, 2008, CELL DEATH DIFFER, V15, P1481, DOI 10.1038/cdd.2008.73; Henderson B E, 1978, IARC Sci Publ, P251; Herszenyi L, 2008, EUR J CANCER PREV, V17, P438, DOI 10.1097/CEJ.0b013e328305a130; Huang D P, 1978, IARC Sci Publ, P315; Jakszyn P, 2006, WORLD J GASTROENTERO, V12, P4296, DOI 10.3748/wjg.v12.i27.4296; Jia WH, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-446; Kaneko I, 2007, WORLD J GASTROENTERO, V13, P3829; Kong QL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000940; Li CS, 2011, ONCOL REP, V26, P869, DOI 10.3892/or.2011.1344; Li YM, 2012, CHINA FOUNDRY, V9, P6; LIEBOWITZ D, 1994, SEMIN ONCOL, V21, P376; LIJINSKY W, 1993, CANCER LETT, V74, P101, DOI 10.1016/0304-3835(93)90050-J; Lively S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-75; Lodillinsky C, 2009, J UROLOGY, V182, P749, DOI 10.1016/j.juro.2009.03.076; Malla RR, 2013, MOL CARCINOGEN, V52, P777, DOI 10.1002/mc.21915; Nouh MA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-1; Ohri SS, 2008, INT J ONCOL, V32, P491; Paksoy M, 2011, J CANCER RES CLIN, V137, P1371, DOI 10.1007/s00432-011-1007-z; Park K, 2011, EXP MOL MED, V43, P91, DOI 10.3858/emm.2011.43.2.011; Peng ZK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062908; Pizzi M, 2012, APPL IMMUNOHISTO M M, V20, P31, DOI 10.1097/PAI.0b013e3182233f9f; Poirier S, 1987, IARC Sci Publ, P415; PRESTONMARTIN S, 1989, CANCER SURV, V8, P459; Ramachandran V, 2008, CANCER RES, V68, P7811, DOI 10.1158/0008-5472.CAN-08-1320; Salmans ML, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3408; Sevenich L, 2011, ONCOGENE, V30, P54, DOI 10.1038/onc.2010.387; Simons Malcolm J, 2011, Chin J Cancer, V30, P79; Szajda SD, 2008, HEPATO-GASTROENTEROL, V55, P388; Szajda Slawomir Dariusz, 2006, Pol Arch Med Wewn, V116, P1150; Tang F, 2001, Zhonghua Bing Li Xue Za Zhi, V30, P125; Tang FQ, 2009, CANCER SCI, V100, P216, DOI 10.1111/j.1349-7006.2008.01028.x; Tang FQ, 2011, J BIOL CHEM, V286, P36956, DOI 10.1074/jbc.M111.259234; Wang X, 2008, RADIOTHER ONCOL, V89, P28, DOI 10.1016/j.radonc.2008.07.014; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wickramasinghe NS, 2005, ARCH BIOCHEM BIOPHYS, V436, P187, DOI 10.1016/j.abb.2005.01.023; Withana NP, 2012, CANCER RES, V72, P1199, DOI 10.1158/0008-5472.CAN-11-2759; Wu D, 2012, HISTOL HISTOPATHOL, V27, P79, DOI 10.14670/HH-27.79; Wu Dan, 2010, Nan Fang Yi Ke Da Xue Xue Bao, V30, P1330; Yu B, 2004, ZHONGHUA WEI CHANG W, V8, P507; Yu M C, 1990, FEMS Microbiol Immunol, V2, P235; YU MC, 1989, INT J CANCER, V43, P1077, DOI 10.1002/ijc.2910430621; YU MC, 1989, BRIT J CANCER, V60, P198, DOI 10.1038/bjc.1989.250; YU MC, 1986, CANCER RES, V46, P956; Yuan JM, 2000, INT J CANCER, V85, P358, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;358::AID-IJC11&gt;3.0.CO;2-E; ZHENG X, 1994, ACTA OTO-LARYNGOL, V114, P98, DOI 10.3109/00016489409126024; Zou J, 2000, J Radiat Res, V41 Suppl, P53; ZOU XN, 1994, INT J CANCER, V59, P155, DOI 10.1002/ijc.2910590202; Zweitzig DR, 2007, MOL CELL BIOCHEM, V306, P255, DOI 10.1007/s11010-007-9562-y	67	9	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e92081	10.1371/journal.pone.0092081	http://dx.doi.org/10.1371/journal.pone.0092081			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717913	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000013
J	Nie, HY; Liu, C; Cheng, TC; Li, QY; Wu, YQ; Zhou, MT; Zhang, YX; Xia, QY				Nie, Hongyi; Liu, Chun; Cheng, Tingcai; Li, Qiongyan; Wu, Yuqian; Zhou, Mengting; Zhang, Yinxia; Xia, Qingyou			Transcriptome Analysis of Integument Differentially Expressed Genes in the Pigment Mutant (quail) during Molting of Silkworm, Bombyx mori	PLOS ONE			English	Article							TRANSLUCENT LARVAL SKIN; CUTICULAR PROTEIN GENES; OMMOCHROME BIOSYNTHESIS; TOBACCO HORNWORM; TRANSPORTER GENE; ABC TRANSPORTER; MELANIN; IDENTIFICATION; MUTATIONS; YELLOW	In the silkworm Bombyx mori, pigment mutants with diverse body colors have been maintained throughout domestication for about 5000 years. The silkworm larval body color is formed through the mutual interaction of melanin, ommochromes, pteridines and uric acid. These pigments/compounds are synthesized by the cooperative action of various genes and enzymes. Previous reports showed that melanin, ommochrome and pteridine are increased in silkworm quail (q) mutants. To understand the pigment increase and alterations in pigment synthesis in q mutant, transcriptome profiles of the silkworm integument were investigated at 16 h after head capsule slippage in the fourth molt in q mutants and wild-type (Dazao). Compared to the wild-type, 1161 genes were differentially expressed in the q mutant. Of these modulated genes, 62.4% (725 genes) were upregulated and 37.6% (436 genes) were downregulated in the q mutant. The molecular function of differently expressed genes was analyzed by Blast2GO. The results showed that upregulated genes were mainly involved in protein binding, small molecule binding, transferase activity, nucleic acid binding, specific DNA-binding transcription factor activity and chromatin binding, while exclusively down-expressed genes functioned in oxidoreductase activity, cofactor binding, tetrapyrrole binding, peroxidase activity and pigment binding. We focused on genes related to melanin, pteridine and ommochrome biosynthesis; transport of uric acid; and juvenile hormone metabolism because of their importance in integument coloration during molting. This study identified differently expressed genes implicated in silkworm integument formation and pigmentation using silkworm q mutant. The results estimated the number and types of genes that drive new integument formation.	[Nie, Hongyi; Liu, Chun; Cheng, Tingcai; Li, Qiongyan; Wu, Yuqian; Zhou, Mengting; Zhang, Yinxia; Xia, Qingyou] State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China; [Nie, Hongyi; Liu, Chun; Cheng, Tingcai; Li, Qiongyan; Wu, Yuqian; Zhou, Mengting; Zhang, Yinxia; Xia, Qingyou] Southwest Univ, Minist Agr, Key Sericultural Lab, Chongqing, Peoples R China	Ministry of Agriculture & Rural Affairs; Southwest University - China	Xia, QY (corresponding author), State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn		cheng, tingcai/0000-0002-3862-0817	National Basic Research Program of China [2012CB114600]; Program for New Century Excellent Talents [110699]; National Natural Science Foundation of China [31372380]; Fundamental Research Funds for the Central Universities of China [XDJK2013A026]; Doctorial Innovation Fund of Southwest University [ky2010001]	National Basic Research Program of China(National Basic Research Program of China); Program for New Century Excellent Talents(Program for New Century Excellent Talents in University (NCET)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Doctorial Innovation Fund of Southwest University	Funding provided by the National Basic Research Program of China (No. 2012CB114600); Program for New Century Excellent Talents (No. NCET-110699); the National Natural Science Foundation of China (No. 31372380); the Fundamental Research Funds for the Central Universities of China (No. XDJK2013A026); the Doctorial Innovation Fund of Southwest University (No. ky2010001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MS, 2012, DEV GENES EVOL, V222, P89, DOI 10.1007/s00427-012-0392-x; Andersen S.O., 2005, P145; ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J; Andersen SO, 2010, INSECT BIOCHEM MOLEC, V40, P166, DOI 10.1016/j.ibmb.2009.10.007; ASHIDA M, 1995, P NATL ACAD SCI USA, V92, P10698, DOI 10.1073/pnas.92.23.10698; Chen L, 2013, INT J MOL SCI, V14, P17055, DOI 10.3390/ijms140817055; Chen P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071984; Cheng D, 2008, INSECT BIOCHEM MOLEC, V38, P1130, DOI 10.1016/j.ibmb.2008.09.013; Dai FY, 2010, J BIOL CHEM, V285, P19553, DOI 10.1074/jbc.M109.096743; FUKAMIZO T, 1985, INSECT BIOCHEM, V15, P141, DOI 10.1016/0020-1790(85)90001-0; Futahashi R, 2006, INSECT BIOCHEM MOLEC, V36, P63, DOI 10.1016/j.ibmb.2005.11.002; Futahashi R, 2005, DEV GENES EVOL, V215, P519, DOI 10.1007/s00427-005-0014-y; Futahashi R, 2008, SCIENCE, V319, P1061, DOI 10.1126/science.1149786; Futahashi R, 2012, P NATL ACAD SCI USA, V109, P12626, DOI 10.1073/pnas.1207114109; Futahashi R, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-46; Futahashi R, 2010, EVOL DEV, V12, P157, DOI 10.1111/j.1525-142X.2010.00401.x; Futahashi R, 2008, GENETICS, V180, P1995, DOI 10.1534/genetics.108.096388; Futahashi R, 2008, INSECT BIOCHEM MOLEC, V38, P1138, DOI 10.1016/j.ibmb.2008.05.007; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; Han D, 2002, BIOCHEM J, V368, P333; HAYASHI Y, 1960, NATURE, V186, P1053, DOI 10.1038/1861053a0; HORI M, 1982, J COMP PHYSIOL, V147, P1, DOI 10.1007/BF00689284; Hu YG, 2013, ARCH INSECT BIOCHEM, V83, P41, DOI 10.1002/arch.21096; Ito K, 2010, J BIOL CHEM, V285, P5624, DOI 10.1074/jbc.M109.035741; Kato T, 2006, PIGM CELL RES, V19, P337, DOI 10.1111/j.1600-0749.2006.00316.x; Kim J, 2006, BIOCHEM J, V398, P451, DOI 10.1042/BJ20060424; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Kiuchi T, 2011, INSECT BIOCHEM MOLEC, V41, P680, DOI 10.1016/j.ibmb.2011.04.011; Komoto N, 2003, INSECT BIOCHEM MOLEC, V33, P417, DOI 10.1016/S0965-1748(03)00006-7; Komoto N, 2009, INSECT BIOCHEM MOLEC, V39, P152, DOI 10.1016/j.ibmb.2008.10.003; Kozlova T, 2009, DEV DYNAM, V238, P701, DOI 10.1002/dvdy.21860; Li S, 2005, INSECT BIOCHEM MOLEC, V35, P1235, DOI 10.1016/j.ibmb.2005.06.005; Linzen B., 1974, ADV INSECT PHYSL, P117, DOI DOI 10.1016/S0065-2806(08)60130-7; Liu C, 2010, P NATL ACAD SCI USA, V107, P12980, DOI 10.1073/pnas.1001725107; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mackenzie SM, 2000, GENETICA, V108, P239, DOI 10.1023/A:1004115718597; Meng Y, 2009, J BIOL CHEM, V284, P11698, DOI 10.1074/jbc.M900485200; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; OHASHI M, 1983, INSECT BIOCHEM, V13, P123, DOI 10.1016/0020-1790(83)90074-4; Ohashi M, 1983, J SERICULTURAL SCI J, P52; Osanai-Futahashi M, 2012, J BIOL CHEM, V287, P17706, DOI 10.1074/jbc.M111.321331; Phillips J. P., 1980, GENET BIOL DROSOPHIL, P542; RETTENMEYER CW, 1970, ANNU REV ENTOMOL, V15, P43, DOI 10.1146/annurev.en.15.010170.000355; SAFRANEK L, 1975, J INSECT PHYSIOL, V21, P1931, DOI 10.1016/0022-1910(75)90225-5; Sato K, 2008, GENETICS, V179, P875, DOI 10.1534/genetics.107.082784; Sawada H, 1997, J SERICULTURAL SCI J, P66; Shinoda T, 2003, P NATL ACAD SCI USA, V100, P11986, DOI 10.1073/pnas.2134232100; Sugumaran M, 1998, ADV INSECT PHYSIOL, V27, P229, DOI 10.1016/S0065-2806(08)60014-4; Sugumaran M, 2009, PIGM CELL MELANOMA R, V22, P523, DOI 10.1111/j.1755-148X.2009.00608.x; Tatematsu K, 2011, GENES CELLS, V16, P331, DOI 10.1111/j.1365-2443.2011.01490.x; tenHave JFM, 1995, MOL GEN GENET, V249, P673, DOI 10.1007/BF00418037; True JR, 2003, TRENDS ECOL EVOL, V18, P640, DOI 10.1016/j.tree.2003.09.006; Wang L, 2013, INSECT BIOCH MOL BIO; WATT WB, 1968, EVOLUTION, V22, P437, DOI 10.1111/j.1558-5646.1968.tb03985.x; WATT WB, 1969, P NATL ACAD SCI USA, V63, P767, DOI 10.1073/pnas.63.3.767; WIERNASZ DC, 1989, EVOLUTION, V43, P1672, DOI 10.1111/j.1558-5646.1989.tb02617.x; Wiernasz DC, 1995, ANIMAL BEHAV; Willis J.H., 2005, P79; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849; Xia AH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-195; Yamada M, 2000, DEVELOPMENT, V127, P5083; Yao QO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014058	62	20	24	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94185	10.1371/journal.pone.0094185	http://dx.doi.org/10.1371/journal.pone.0094185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718369	Green Published, Green Submitted, gold			2022-12-25	WOS:000334339000085
J	Bhuiyan, TR; Islam, MMT; Uddin, T; Chowdhury, MI; Janzon, A; Adamsson, J; Lundin, SB; Qadri, F; Lundgren, A				Bhuiyan, Taufiqur R.; Islam, M. M. Towhidul; Uddin, Taher; Chowdhury, Mohiul I.; Janzon, Anders; Adamsson, Jenni; Lundin, Samuel B.; Qadri, Firdausi; Lundgren, Anna			Th1 and Th17 Responses to Helicobacter pylori in Bangladeshi Infants, Children and Adults	PLOS ONE			English	Article							T-CELL RESPONSES; IMMUNE-RESPONSES; GASTRITIS; EXPRESSION; IL-17; CD4(+); INTERLEUKIN-17; INFECTION; SPECIFICITY; VACCINATION	Both Th1 and Th17 cells are important components of the immune response to Helicobacter pylori (Hp) in adults, but less is known about T cell responses to Hp during early childhood, when the infection is often acquired. We investigated Th1 and Th17 type responses to Hp in adults, children and infants in Bangladesh, where Hp is highly endemic. IL-17 and IFN-gamma mRNA levels in gastric biopsies from Hp-infected Bangladeshi adults were analyzed and compared to levels in infected and uninfected Swedish controls. Since biopsies could not be collected from infants and children, cytokine responses in Bangladeshi infants (6-12 months), children (3-5 years) and adults (> 19 years) were instead compared by stimulating peripheral blood mononuclear cells (PBMCs) with a Hp membrane preparation (MP) and analyzing culture supernatants by ELISA and cytometric bead array. We found significantly higher expression of IL-17 and IFN-gamma mRNA in gastric mucosa of Hp-infected Bangladeshi and Swedish adults compared to uninfected Swedish controls. PBMCs from all age groups produced IL-17 and IFN-gamma after MP stimulation, but little Th2 cytokines. IL-17 and IFN-gamma were primarily produced by CD4(+) T cells, since CD4(+) T cell depleted PBMCs produced reduced amounts of these cytokines. Infant cells produced significantly more IL-17, but similar levels of IFN-gamma, compared to adult cells after MP stimulation. In contrast, polyclonal stimulation induced lower levels IL-17 and IFN-gamma in infant compared to adult PBMCs and CD4(+) T cells. The strong IL-17 production in infants after MP stimulation was paralleled by significantly higher production of the IL-17 promoting cytokine IL-1 beta from infant compared to adult PBMCs and monocytes. In conclusion, these results show that T cells can produce high levels of IL-17 and IFN-gamma in response to Hp from an early age and indicate a potential role for IL-1 beta in promoting Th17 responses to Hp during infancy.	[Bhuiyan, Taufiqur R.; Islam, M. M. Towhidul; Uddin, Taher; Chowdhury, Mohiul I.; Qadri, Firdausi] Int Ctr Diarrhoeal Dis Res, Bangladesh Icddr, Dhaka 1000, Bangladesh; [Janzon, Anders; Adamsson, Jenni; Lundin, Samuel B.; Lundgren, Anna] Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden	University of Gothenburg	Lundgren, A (corresponding author), Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden.	anna.lundgren@microbio.gu.se	UDDIN, TAHER/AAX-8663-2021; Qadri, Firdausi/AAF-4583-2019; Al, Mamun M./AAF-5850-2019	, Mohiul/0000-0001-5534-2161	Swedish Agency for Research and Economic Cooperation (SAREC) [INT-ICDDR,B-HN-01-AV]; Marianne and Markus Wallenberg Foundation; International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)	Swedish Agency for Research and Economic Cooperation (SAREC); Marianne and Markus Wallenberg Foundation; International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)	This work was supported by the Swedish Agency for Research and Economic Cooperation (SAREC) (grant INT-ICDDR,B-HN-01-AV), the Marianne and Markus Wallenberg Foundation through the support to GUVAX as well as the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTMAN M, 1978, MOL GEN GENET, V164, P171, DOI 10.1007/BF00267382; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Bhuiyan TR, 2008, FEMS IMMUNOL MED MIC, V54, P70, DOI 10.1111/j.1574-695X.2008.00449.x; Bhuiyan TR, 2010, J INFECT DIS, V202, P1676, DOI 10.1086/657085; Bhuiyan TR, 2009, PEDIATR INFECT DIS J, V28, P79, DOI 10.1097/INF.0b013e31818a5d9d; Caruso R, 2008, EUR J IMMUNOL, V38, P470, DOI 10.1002/eji.200737635; Corbett NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015041; de Melo FF, 2012, MICROBES INFECT, V14, P341, DOI 10.1016/j.micinf.2011.11.008; DElios MM, 1997, EUR J IMMUNOL, V27, P1751, DOI 10.1002/eji.1830270723; Delyria ES, 2009, GASTROENTEROLOGY, V136, P247, DOI 10.1053/j.gastro.2008.09.017; DITOMMASO A, 1995, INFECT IMMUN, V63, P1102, DOI 10.1128/IAI.63.3.1102-1106.1995; Eaton KA, 2001, J IMMUNOL, V166, P7456, DOI 10.4049/jimmunol.166.12.7456; Flach CF, 2011, INFECT IMMUN, V79, P879, DOI 10.1128/IAI.00756-10; Frenck RW, 2003, MICROBES INFECT, V5, P705, DOI 10.1016/S1286-4579(03)00112-6; Gray BM, 2013, INFECT IMMUN, V81, P740, DOI 10.1128/IAI.01269-12; Harris PR, 2008, GASTROENTEROLOGY, V134, P491, DOI 10.1053/j.gastro.2007.11.006; Janzon A, 2009, HELICOBACTER, V14, P237, DOI 10.1111/j.1523-5378.2009.00692.x; KARTTUNEN R, 1990, CLIN EXP IMMUNOL, V82, P485; Khamri W, 2010, INFECT IMMUN, V78, P845, DOI 10.1128/IAI.00524-09; Kindlund B, 2009, HELICOBACTER, V14, P192, DOI 10.1111/j.1523-5378.2009.00673.x; Kolls JK, 2010, CYTOKINE GROWTH F R, V21, P443, DOI 10.1016/j.cytogfr.2010.11.002; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Leach S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051718; Lee WW, 2010, BLOOD, V115, P530, DOI 10.1182/blood-2009-08-236521; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Lindgren A, 2010, J INNATE IMMUN, V2, P294, DOI 10.1159/000286238; Lindholm C, 1998, INFECT IMMUN, V66, P5964, DOI 10.1128/IAI.66.12.5964-5971.1998; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundgren A, 2003, INFECT IMMUN, V71, P1755, DOI 10.1128/IAI.71.4.1755-1762.2003; Lundgren A, 2005, INFECT IMMUN, V73, P5612, DOI 10.1128/IAI.73.9.5612-5619.2005; Lundgren A, 2012, VACCINE, V30, P3897, DOI 10.1016/j.vaccine.2012.03.082; Lundin BS, 2007, CLIN IMMUNOL, V125, P205, DOI 10.1016/j.clim.2007.07.011; Luzza F, 2000, J IMMUNOL, V165, P5332, DOI 10.4049/jimmunol.165.9.5332; Luzza F, 2001, DIGEST LIVER DIS, V33, P14, DOI 10.1016/S1590-8658(01)80130-4; Marchant A, 2005, CLIN EXP IMMUNOL, V141, P10, DOI 10.1111/j.1365-2249.2005.02799.x; Mattsson A, 1998, CLIN DIAGN LAB IMMUN, V5, P288, DOI 10.1128/CDLI.5.3.288-293.1998; Mizuno T, 2005, WORLD J GASTROENTERO, V11, P6305, DOI 10.3748/wjg.v11.i40.6305; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; O'Keeffe J, 2008, HELICOBACTER, V13, P1, DOI 10.1111/j.1523-5378.2008.00559.x; Otani K, 2009, BIOCHEM BIOPH RES CO, V382, P252, DOI 10.1016/j.bbrc.2009.02.107; Ottsjo LS, 2013, INFECT IMMUN, V81, P1532, DOI 10.1128/IAI.01407-12; Quiding-Jarbrink M, 2001, CLIN EXP IMMUNOL, V123, P81, DOI 10.1046/j.1365-2249.2001.01427.x; Rahman M, 2003, J CLIN MICROBIOL, V41, P2008, DOI 10.1128/JCM.41.5.2008-2014.2003; Robinson K, 2010, ADV M C M, P94, DOI 10.1079/9781845935948.0094; Schaub B, 2008, ALLERGY, V63, P1438, DOI 10.1111/j.1398-9995.2008.01685.x; Serelli-Lee V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039199; Serrano C, 2013, MUCOSAL IMMUNOL, V6, P950, DOI 10.1038/mi.2012.133; Shi Y, 2010, J IMMUNOL, V184, P5121, DOI 10.4049/jimmunol.0901115; Shiomi S, 2008, HELICOBACTER, V13, P518, DOI 10.1111/j.1523-5378.2008.00629.x; Sundquist M, 2010, EXPERT REV GASTROENT, V4, P733, DOI 10.1586/EGH.10.71; Velin D, 2009, GASTROENTEROLOGY, V136, P2237, DOI 10.1053/j.gastro.2009.02.077; Zu YL, 2000, ULTRASTRUCT PATHOL, V24, P319, DOI 10.1080/019131200750035049	52	24	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93943	10.1371/journal.pone.0093943	http://dx.doi.org/10.1371/journal.pone.0093943			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714675	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900064
J	Duncan, MJ; Kline, CE; Vandelanotte, C; Sargent, C; Rogers, NL; Di Milia, L				Duncan, Mitch J.; Kline, Christopher E.; Vandelanotte, Corneel; Sargent, Charli; Rogers, Naomi L.; Di Milia, Lee			Cross-Sectional Associations between Multiple Lifestyle Behaviors and Health-Related Quality of Life in the 10,000 Steps Cohort	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; SELF-RATED HEALTH; PHYSICAL-ACTIVITY; SLEEP DURATION; CARDIOVASCULAR-DISEASE; SITTING TIME; NATIONAL-HEALTH; HEART-DISEASE; RISK; WOMEN	Background: The independent and combined influence of smoking, alcohol consumption, physical activity, diet, sitting time, and sleep duration and quality on health status is not routinely examined. This study investigates the relationships between these lifestyle behaviors, independently and in combination, and health-related quality of life (HRQOL). Methods: Adult members of the 10,000 Steps project (n = 159,699) were invited to participate in an online survey in November-December 2011. Participant socio-demographics, lifestyle behaviors, and HRQOL (poor self-rated health; frequent unhealthy days) were assessed by self-report. The combined influence of poor lifestyle behaviors were examined, independently and also as part of two lifestyle behavior indices, one excluding sleep quality (Index 1) and one including sleep quality (Index 2). Adjusted Cox proportional hazard models were used to examine relationships between lifestyle behaviors and HRQOL. Results: A total of 10,478 participants provided complete data for the current study. For Index 1, the Prevalence Ratio (p value) of poor self-rated health was 1.54 (p = 0.001), 2.07 (p <= 0.001), 3.00 (p <= 0.001), 3.61 (p <= 0.001) and 3.89 (p <= 0.001) for people reporting two, three, four, five and six poor lifestyle behaviors, compared to people with 0-1 poor lifestyle behaviors. For Index 2, the Prevalence Ratio (p value) of poor self-rated health was 2.26 (p = 0.007), 3.29 (p <= 0.001), 4.68 (p <= 0.001), 6.48 (p <= 0.001), 7.91 (p <= 0.001) and 8.55 (p <= 0.001) for people reporting two, three, four, five, six and seven poor lifestyle behaviors, compared to people with 0-1 poor lifestyle behaviors. Associations between the combined lifestyle behavior index and frequent unhealthy days were statistically significant and similar to those observed for poor self-rated health. Conclusions: Engaging in a greater number of poor lifestyle behaviors was associated with a higher prevalence of poor HRQOL. This association was exacerbated when sleep quality was included in the index.	[Duncan, Mitch J.; Vandelanotte, Corneel] Cent Queensland Univ, Ctr Phys Act Studies, Inst Hlth & Social Sci Res, Rockhampton, Qld 4702, Australia; [Kline, Christopher E.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Sargent, Charli] Cent Queensland Univ, Appleton Inst Behav Sci, Adelaide, SA, Australia; [Rogers, Naomi L.; Di Milia, Lee] Cent Queensland Univ, Sch Business & Law, Rockhampton, Qld 4702, Australia; [Di Milia, Lee] Cent Queensland Univ, Sch Inst Hlth & Social Sci Res, Rockhampton, Qld 4702, Australia	Central Queensland University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central Queensland University; Central Queensland University; Central Queensland University	Duncan, MJ (corresponding author), Cent Queensland Univ, Ctr Phys Act Studies, Inst Hlth & Social Sci Res, Rockhampton, Qld 4702, Australia.	m.duncan@cqu.edu.au	Vandelanotte, Corneel/ABF-5580-2020; Kline, Christopher/B-1477-2012; Di Milia, Lee/A-6810-2008; Sargent, Charli/U-7393-2019; Duncan, Mitch/V-1708-2019	Kline, Christopher/0000-0003-1025-9430; Di Milia, Lee/0000-0001-7681-5589; Duncan, Mitch/0000-0002-9166-6195; Sargent, Charli/0000-0001-5340-4701; Vandelanotte, Corneel/0000-0002-4445-8094	Queensland Health; CQUniversity Health CRN; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL082610] Funding Source: NIH RePORTER	Queensland Health; CQUniversity Health CRN; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Queensland Health provided funding to Central Queensland University for the development of 10,000 Steps. 10,000 is a joint Australian, State, and Territory Government Initiative under the National Partnership Agreement on Preventive Health. This manuscript was supported by the CQUniversity Health CRN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman NG, 2012, SLEEP MED, V13, P1261, DOI 10.1016/j.sleep.2012.08.005; Andresen EM, 2003, J EPIDEMIOL COMMUN H, V57, P339, DOI 10.1136/jech.57.5.339; Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P1175; [Anonymous], 2000, MEAS HLTH DAYS; Artinian NT, 2010, CIRCULATION, V122, P406, DOI 10.1161/CIR.0b013e3181e8edf1; Atkinson G, 2007, PHYSIOL BEHAV, V90, P229, DOI 10.1016/j.physbeh.2006.09.015; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Buysse DJ, 2006, SLEEP, V29, P1155, DOI 10.1093/sleep/29.9.1155; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Byles J, 2006, J AM GERIATR SOC, V54, P1341, DOI 10.1111/j.1532-5415.2006.00837.x; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Chandola T, 2010, SLEEP, V33, P739, DOI 10.1093/sleep/33.6.739; Chau JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080000; Chau JY, 2011, BRIT J SPORT MED, V45, P1216, DOI 10.1136/bjsports-2011-090214; Chee MWL, 2013, ANN ACAD MED SINGAP, V42, P105; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Davies CA, 2012, PREV MED, V55, P46, DOI 10.1016/j.ypmed.2012.05.003; Ding D, PREVENTIVE IN PRESS; Duncan MJ, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-16; Eguchi E, 2012, EUR HEART J, V33, P467, DOI 10.1093/eurheartj/ehr429; Ernstsen L, 2011, AGE AGEING, V40, P105, DOI 10.1093/ageing/afq141; Ford ES, 2011, AM J PUBLIC HEALTH, V101, P1922, DOI [10.2105/AJPH.2011.300167, 10.2105//AJPH.2011.300167]; Ford ES, 2001, OBES RES, V9, P21, DOI 10.1038/oby.2001.4; George ES, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-20; Grandner MA, 2010, SLEEP MED REV, V14, P191, DOI 10.1016/j.smrv.2009.07.006; Haseli-Mashhadi N, 2009, BMC PUBLIC HEALTH, V9, DOI [10.1186/1471-2458-9-130, 10.1186/1471-2458-9-368]; Hoevenaar-Blom MP, 2011, SLEEP, V34, P1487, DOI 10.5665/sleep.1382; Hoevenaar-Blom MP, 2013, EUR J PREV CARDIOL; Holliday EG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082305, 10.1371/journal.pone.0053830]; Hyman DJ, 2007, ARCH INTERN MED, V167, P1152, DOI 10.1001/archinte.167.11.1152; King AC, 2013, ANN BEHAV MED, V46, P157, DOI 10.1007/s12160-013-9501-y; Kline CE, 2013, SLEEP, V36, P1279, DOI 10.5665/sleep.2946; Li CY, 2008, VALUE HEALTH, V11, P689, DOI 10.1111/j.1524-4733.2007.00307.x; Loef M, 2012, PREV MED, V55, P163, DOI 10.1016/j.ypmed.2012.06.017; Luyster FS, 2012, SLEEP, V35, P727, DOI 10.5665/sleep.1846; Magee CA, 2012, J SLEEP RES, V21, P441, DOI 10.1111/j.1365-2869.2011.00993.x; Magee CA, 2011, SLEEP MED, V12, P346, DOI 10.1016/j.sleep.2010.09.013; Magee CA, 2010, J AGING HEALTH, V22, P1235, DOI 10.1177/0898264310372780; Martinez-Gomez D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-47; Moriarty David G, 2003, Health Qual Life Outcomes, V1, P37, DOI 10.1186/1477-7525-1-37; Mummery W, 2008, 10 INT C BEH MED TOK; National Health and Medical Research Council, 2009, AUSTR GUID RED HLTH; Newschaffer C. J., 1998, VALIDATION BEHAV RIS; Noar SM, 2008, PREV MED, V46, P275, DOI 10.1016/j.ypmed.2007.08.001; Odegaard AO, 2011, CIRCULATION, V124, P2847, DOI 10.1161/CIRCULATIONAHA.111.048843; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Parekh S, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-108; Patel AV, 2010, AM J EPIDEMIOL, V172, P419, DOI 10.1093/aje/kwq155; Prochaska JJ, 2008, PREV MED, V46, P260, DOI 10.1016/j.ypmed.2007.07.035; Prochaska JJ, 2008, PREV MED, V46, P181, DOI 10.1016/j.ypmed.2008.02.001; Rabin BA, 2006, AM J PREV MED, V31, pS24, DOI 10.1016/j.amepre.2006.06.009; Rosenkranz RR, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1071; Sabanayagam C, 2010, SLEEP, V33, P1037, DOI 10.1093/sleep/33.8.1037; Smith KJ, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-29; Sodergren M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-551; Tsai J, 2010, PREV MED, V51, P268, DOI 10.1016/j.ypmed.2010.07.010; Vallance JK, 2013, MENTAL HLTH PHYS ACT; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; Vandelanotte C, 2008, PREV MED, V46, P232, DOI 10.1016/j.ypmed.2007.07.008	60	55	56	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94184	10.1371/journal.pone.0094184	http://dx.doi.org/10.1371/journal.pone.0094184			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7FA	24714564	Green Published, gold, Green Accepted			2022-12-25	WOS:000334160900100
J	Hira, SK; Mishra, AK; Ray, B; Manna, PP				Hira, Sumit Kumar; Mishra, Avnish Kumar; Ray, Biswajit; Manna, Partha Pratim			Targeted Delivery of Doxorubicin-Loaded Poly (epsilon-caprolactone)-b-Poly (N-vinylpyrrolidone) Micelles Enhances Antitumor Effect in Lymphoma	PLOS ONE			English	Article							DRUG-DELIVERY; INTRACELLULAR RELEASE; BLOCK-COPOLYMERS; CELLS; POLYMERIZATION; NANOPARTICLES; COMBINATION; APOPTOSIS; TISSUE	Background: The present study was motivated by the need to design a safe nano-carrier for the delivery of doxorubicin which could be tolerant to normal cells. PCL63-b-PNVP90 was loaded with doxorubicin (6 mg/ml), and with 49.8% drug loading efficiency; it offers a unique platform providing selective immune responses against lymphoma. Methods: In this study, we have used micelles of amphiphilic PCL63-b-PNVP90 block copolymer as nano-carrier for controlled release of doxorubicin (DOX). DOX is physically entrapped and stabilized in the hydrophobic cores of the micelles and biological roles of these micelles were evaluated in lymphoma. Results: DOX loaded PCL63-b-PNVP90 block copolymer micelles (DOX-PCL63-b-PNVP90) shows enhanced growth inhibition and cytotoxicity against human (K-562, JE6.1 and Raji) and mice lymphoma cells (Dalton's lymphoma, DL). DOX-PCL63-b-PNVP90 demonstrates higher levels of tumoricidal effect against DOX-resistant tumor cells compared to free DOX. DOX-PCL63- b-PNVP90 demonstrated effective drug loading and a pH-responsive drug release character besides exhibiting sustained drug release performance in in-vitro and intracellular drug release experiments. Conclusion: Unlike free DOX, DOX-PCL63-b-PNVP90 does not show cytotoxicity against normal cells. DOX-PCL63-b-PNVP90 prolonged the survival of tumor (DL) bearing mice by enhancing the apoptosis of the tumor cells in targeted organs like liver and spleen.	[Hira, Sumit Kumar; Manna, Partha Pratim] Banaras Hindu Univ, Dept Zool, Fac Sci, Immunobiol Lab, Varanasi 221005, Uttar Pradesh, India; [Mishra, Avnish Kumar; Ray, Biswajit] Banaras Hindu Univ, Dept Chem, Fac Sci, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU)	Ray, B (corresponding author), Banaras Hindu Univ, Dept Chem, Fac Sci, Varanasi 221005, Uttar Pradesh, India.	biswajitray2003@yahoo.co.in; pp_manna@yahoo.com	Ray, Biswajit/I-9968-2018; HIRA, SUMIT KUMAR/J-9271-2014	HIRA, SUMIT KUMAR/0000-0001-6113-4721; Manna, Partha Pratim/0000-0003-2939-0818	Department of Biotechnology (DBT), New Delhi, India [BT/PR11490/BRB/10/675/2008]; Department of Science and Technology, Government of India [SR/S1/PC-25/2006]; CSIR, New Delhi, India	Department of Biotechnology (DBT), New Delhi, India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India(Department of Science & Technology (India)); CSIR, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	Present work is supported by a grant from Department of Biotechnology (DBT), New Delhi, India, No. BT/PR11490/BRB/10/675/2008(PPM). BR gratefully acknowledges the financial support from the Department of Science and Technology, Government of India, through grant no. SR/S1/PC-25/2006. SKH and AKM are recipients of junior & senior research fellowship from CSIR, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; Chaudhuri P, 2009, ACS NANO, V3, P2505, DOI 10.1021/nn900318y; Chung TW, 2004, POLYMER, V45, P1591, DOI 10.1016/j.polymer.2003.12.074; Dash TK, 2012, MOL PHARMACEUT, V9, P2365, DOI 10.1021/mp3001952; Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gamen S, 2000, EXP CELL RES, V258, P223, DOI 10.1006/excr.2000.4924; Gao Y, 2011, ACS NANO, V5, P9788, DOI 10.1021/nn2033105; GOLDIE H, 1951, CANCER RES, V11, P73; Jeon HJ, 2009, J POLYM SCI POL CHEM, V47, P3078, DOI 10.1002/pola.23396; Kam NWS, 2006, ANGEW CHEM INT EDIT, V45, P577, DOI 10.1002/anie.200503389; KLEIN E, 1954, CANCER RES, V14, P139; Leiva A, 2007, J COLLOID INTERF SCI, V310, P136, DOI 10.1016/j.jcis.2007.01.013; Lele BS, 2002, MACROMOLECULES, V35, P6714, DOI 10.1021/ma020433h; Li Y, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/5/055106; Lorenzo E, 2002, J BIOL CHEM, V277, P10883, DOI 10.1074/jbc.M107442200; Matsumura Y, 2004, BRIT J CANCER, V91, P1775, DOI 10.1038/sj.bjc.6602204; Mishra AK, 2011, MACROMOLECULES, V44, P2465, DOI 10.1021/ma102453h; Patel VK, 2010, POLYM BULL, V65, P97, DOI 10.1007/s00289-009-0185-1; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Reddy LH, 2007, J CONTROL RELEASE, V124, P20, DOI 10.1016/j.jconrel.2007.08.018; Rihova B, 2003, J CONTROL RELEASE, V91, P1, DOI 10.1016/S0168-3659(03)00235-9; Sun HL, 2010, BIOMACROMOLECULES, V11, P848, DOI 10.1021/bm1001069; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; Tolcher AW, 1999, J CLIN ONCOL, V17, P478, DOI 10.1200/JCO.1999.17.2.478; Torchilin V, 2011, ADV DRUG DELIVER REV, V63, P131, DOI 10.1016/j.addr.2010.03.011; Wang YC, 2011, BIOCONJUGATE CHEM, V22, P1939, DOI 10.1021/bc200139n; Weiss B, 2007, BIOCONJUGATE CHEM, V18, P1087, DOI 10.1021/bc060342f; Xu G, 2002, CLIN CANCER RES, V8, P2605	30	55	56	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94309	10.1371/journal.pone.0094309	http://dx.doi.org/10.1371/journal.pone.0094309			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714166	Green Published, gold, Green Submitted			2022-12-25	WOS:000334160900114
J	Itahashi, T; Yamada, T; Watanabe, H; Nakamura, M; Jimbo, D; Shioda, S; Toriizuka, K; Kato, N; Hashimoto, R				Itahashi, Takashi; Yamada, Takashi; Watanabe, Hiromi; Nakamura, Motoaki; Jimbo, Daiki; Shioda, Seiji; Toriizuka, Kazuo; Kato, Nobumasa; Hashimoto, Ryuichiro			Altered Network Topologies and Hub Organization in Adults with Autism: A Resting-State fMRI Study	PLOS ONE			English	Article							BRAIN FUNCTIONAL NETWORKS; SUPERIOR TEMPORAL SULCUS; MIRROR NEURON SYSTEM; SPECTRUM QUOTIENT AQ; GRAY-MATTER VOLUME; INHIBITORY CONTROL; MODULAR ORGANIZATION; ANATOMICAL NETWORKS; DEFAULT MODE; CONNECTIVITY	Recent functional magnetic resonance imaging (fMRI) studies on autism spectrum condition (ASC) have identified dysfunctions in specific brain networks involved in social and non-social cognition that persist into adulthood. Although increasing numbers of fMRI studies have revealed atypical functional connectivity in the adult ASC brain, such functional alterations at the network level have not yet been fully characterized within the recently developed graph-theoretical framework. Here, we applied a graph-theoretical analysis to resting-state fMRI data acquired from 46 adults with ASC and 46 age- and gender-matched controls, to investigate the topological properties and organization of autistic brain network. Analyses of global metrics revealed that, relative to the controls, participants with ASC exhibited significant decreases in clustering coefficient and characteristic path length, indicating a shift towards randomized organization. Furthermore, analyses of local metrics revealed a significantly altered organization of the hub nodes in ASC, as shown by analyses of hub disruption indices using multiple local metrics and by a loss of '' hubness '' in several nodes (e. g., the bilateral superior temporal sulcus, right dorsolateral prefrontal cortex, and precuneus) that are critical for social and non-social cognitive functions. In particular, local metrics of the anterior cingulate cortex consistently showed significant negative correlations with the Autism-Spectrum Quotient score. Our results demonstrate altered patterns of global and local topological properties that may underlie impaired social and non-social cognition in ASC.	[Itahashi, Takashi; Toriizuka, Kazuo] Showa Univ, Sch Med, Dept Pharmacognosy & Phytochem, Tokyo 142, Japan; [Yamada, Takashi; Watanabe, Hiromi; Nakamura, Motoaki; Kato, Nobumasa; Hashimoto, Ryuichiro] Showa Univ, Sch Med, Dept Psychiat, Tokyo 142, Japan; [Nakamura, Motoaki] Kinko Hosp, Kanagawa Psychiat Ctr, Kanagawa, Japan; [Jimbo, Daiki; Shioda, Seiji] Showa Univ, Sch Med, Dept Anat, Tokyo 142, Japan; [Hashimoto, Ryuichiro] Tokyo Metropolitan Univ, Grad Sch Humanities, Dept Language Sci, Tokyo 158, Japan	Showa University; Showa University; Showa University	Hashimoto, R (corresponding author), Showa Univ, Sch Med, Dept Psychiat, Tokyo 142, Japan.	dbridges50@gmail.com		Itahashi, Takashi/0000-0001-7606-7090; Hashimoto, Ryu-ichiro/0000-0002-9661-3412	Japan Society for the Promotion of Science (JSPS) [25870738]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [23118003]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	A part of this study is the result of "Development of BMI Technologies for Clinical Application" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan. This work was also supported by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Young Scientists (B) (25870738 to T. I.) and by a Grant-in-Aid for Scientific Research on Innovative Areas (23118003; Adolescent Mind & Self-Regulation to R. H.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DA, 2013, P NATL ACAD SCI USA, V110, P12060, DOI 10.1073/pnas.1302982110; Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Achard S, 2012, P NATL ACAD SCI USA, V109, P20608, DOI 10.1073/pnas.1208933109; Alexander-Bloch AF, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00147; Allen G, 2004, BIOL PSYCHIAT, V56, P269, DOI 10.1016/j.biopsych.2004.06.005; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5, DOI 10.1176/appi.books.9780890425596; Aoki Y, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-25; Arons MH, 2012, J NEUROSCI, V32, P14966, DOI 10.1523/JNEUROSCI.2215-12.2012; Ashburner J, 2008, AM J OCCUP THER, V62, P564, DOI 10.5014/ajot.62.5.564; Assaf M, 2010, NEUROIMAGE, V53, P247, DOI 10.1016/j.neuroimage.2010.05.067; Bakhtiari R, 2012, NEUROIMAGE-CLIN, V1, P48, DOI 10.1016/j.nicl.2012.09.001; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Barttfeld P, 2012, NEUROPSYCHOLOGIA, V50, P3653, DOI 10.1016/j.neuropsychologia.2012.09.047; Barttfeld P, 2011, NEUROPSYCHOLOGIA, V49, P254, DOI 10.1016/j.neuropsychologia.2010.11.024; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blakemore SJ, 2008, NAT REV NEUROSCI, V9, P267, DOI 10.1038/nrn2353; Boddaert N, 2004, NEUROIMAGE, V23, P364, DOI 10.1016/j.neuroimage.2004.06.016; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Bruno J, 2012, NEUROBIOL DIS, V48, P329, DOI 10.1016/j.nbd.2012.07.009; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cao H, 2014, NEUROIMAGE, V84, P888, DOI 10.1016/j.neuroimage.2013.09.013; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Christ SE, 2007, J AUTISM DEV DISORD, V37, P1155, DOI 10.1007/s10803-006-0259-y; Courchesne E, 2011, BRAIN RES, V1380, P138, DOI 10.1016/j.brainres.2010.09.101; Di Martino A, 2014, Mol Psychiatry, V19, P659, DOI 10.1038/mp.2013.78; Di Martino A, 2013, BIOL PSYCHIAT, V74, P623, DOI 10.1016/j.biopsych.2013.02.011; Di Martino A, 2009, BIOL PSYCHIAT, V65, P63, DOI 10.1016/j.biopsych.2008.09.022; Dickstein DP, 2013, J AM ACAD CHILD PSY, V52, P279, DOI 10.1016/j.jaac.2012.12.012; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Dowell LR, 2009, NEUROPSYCHOLOGY, V23, P563, DOI 10.1037/a0015640; Duerden EG, 2013, BRAIN RES, V1533, P80, DOI 10.1016/j.brainres.2013.08.021; Dunn MA, 2008, J AUTISM DEV DISORD, V38, P52, DOI 10.1007/s10803-007-0359-3; Dziuk MA, 2007, DEV MED CHILD NEUROL, V49, P734, DOI 10.1111/j.1469-8749.2007.00734.x; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Fan Y, 2011, NEUROIMAGE, V54, P1862, DOI 10.1016/j.neuroimage.2010.07.025; Foldy C, 2013, NEURON, V78, P498, DOI 10.1016/j.neuron.2013.02.036; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2011, CEREB CORTEX, V21, P145, DOI 10.1093/cercor/bhq071; GAYMARD B, 1993, ANN NEUROL, V34, P404, DOI 10.1002/ana.410340317; Greimel E, 2012, NEUROPSYCHOLOGIA, V50, P3440, DOI 10.1016/j.neuropsychologia.2012.09.029; Hadjikhani N, 2006, CEREB CORTEX, V16, P1276, DOI 10.1093/cercor/bh069; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Holroyd CB, 2012, TRENDS COGN SCI, V16, P122, DOI 10.1016/j.tics.2011.12.008; Hua X, 2013, HUM BRAIN MAPP, V34, P425, DOI 10.1002/hbm.21441; Hwang K, 2013, CEREB CORTEX, V23, P2380, DOI 10.1093/cercor/bhs227; Hyde KL, 2010, HUM BRAIN MAPP, V31, P556, DOI 10.1002/hbm.20887; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; Jakab A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060982; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kana RK, 2007, BIOL PSYCHIAT, V62, P198, DOI 10.1016/j.biopsych.2006.08.004; Kana RK, 2012, SOCIAL COGNITIVE AFF; Kleinhans NM, 2012, BRAIN RES, V1479, P1, DOI 10.1016/j.brainres.2012.07.056; Kosaka H, 2010, NEUROIMAGE, V50, P1357, DOI 10.1016/j.neuroimage.2010.01.085; Lai MC, 2010, BIOL PSYCHIAT, V68, P1092, DOI 10.1016/j.biopsych.2010.06.027; Lane AE, 2010, J AUTISM DEV DISORD, V40, P112, DOI 10.1007/s10803-009-0840-2; Langen M, 2009, BIOL PSYCHIAT, V66, P327, DOI 10.1016/j.biopsych.2009.03.017; Li H, 2012, HUM BRAIN MAPP; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; Matsuoka K, 2006, PSYCHIAT CLIN NEUROS, V60, P332, DOI 10.1111/j.1440-1819.2006.01510.x; Matsuzaki J, 2012, NEUROREPORT, V23, P113, DOI 10.1097/WNR.0b013e32834ebf44; Menon V, 2013, TRENDS COGN SCI, V17, P627, DOI 10.1016/j.tics.2013.09.015; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Mosconi MW, 2009, PSYCHOL MED, V39, P1559, DOI 10.1017/S0033291708004984; Mostofsky SH, 2009, BRAIN, V132, P2413, DOI 10.1093/brain/awp088; Muller RA, 2007, MENT RETARD DEV D R, V13, P85, DOI 10.1002/mrdd.20141; Muller RA, 2004, BIOL PSYCHIAT, V56, P323, DOI 10.1016/j.biopsych.2004.06.007; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nakano M, 2014, PROG NEURO-PSYCHOPH, V48, P51, DOI 10.1016/j.pnpbp.2013.09.011; Nebel MB, 2012, HUM BRAIN MAPP; Nelson HE., 1982, NATL ADULT READING T; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pelphrey KA, 2008, ANN NY ACAD SCI, V1145, P283, DOI 10.1196/annals.1416.007; Peters JM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-54; Power JD, 2013, NEURON, V79, P798, DOI 10.1016/j.neuron.2013.07.035; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Redcay E, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00573; Redies C, 2012, BRAIN RES, V1470, P130, DOI 10.1016/j.brainres.2012.06.020; Rizzolatti G, 2008, CURR OPIN NEUROBIOL, V18, P179, DOI 10.1016/j.conb.2008.08.001; Rizzolatti G, 2009, NAT CLIN PRACT NEURO, V5, P24, DOI 10.1038/ncpneuro0990; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Rudie JD, 2013, NEUROIMAGE-CLIN, V2, P79, DOI 10.1016/j.nicl.2012.11.006; Rudie JD, 2012, CEREB CORTEX, V22, P1025, DOI 10.1093/cercor/bhr171; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Shih P, 2011, BIOL PSYCHIAT, V70, P270, DOI 10.1016/j.biopsych.2011.03.040; Solomon M, 2009, NEUROPSYCHOLOGIA, V47, P2515, DOI 10.1016/j.neuropsychologia.2009.04.019; Supekar K, 2013, CELL REP, V5, P738, DOI 10.1016/j.celrep.2013.10.001; Takarae Y, 2007, PSYCHIAT RES-NEUROIM, V156, P117, DOI 10.1016/j.pscychresns.2007.03.008; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tsiaras V, 2011, COMPUT BIOL MED, V41, P1166, DOI 10.1016/j.compbiomed.2011.04.004; Uddin Lucina Q, 2013, Front Hum Neurosci, V7, P458, DOI 10.3389/fnhum.2013.00458; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; von dem Hagen EAH, 2013, SOC COGN AFFECT NEUR, V8, P694, DOI 10.1093/scan/nss053; Wakabayashi A, 2006, J AUTISM DEV DISORD, V36, P263, DOI 10.1007/s10803-005-0061-2; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021976; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Watanabe T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039561; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Williams DL, 2013, AUTISM RES, V6, P288, DOI 10.1002/aur.1291; Yamasaki S, 2010, BIOL PSYCHIAT, V68, P1141, DOI 10.1016/j.biopsych.2010.07.012; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang JR, 2011, BIOL PSYCHIAT, V70, P334, DOI 10.1016/j.biopsych.2011.05.018; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	121	91	96	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94115	10.1371/journal.pone.0094115	http://dx.doi.org/10.1371/journal.pone.0094115			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714805	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900086
J	Kim, HJ; Jin, Y; Kim, HJ				Kim, Hyoung Jin; Jin, Yingji; Kim, Hong-Jin			The Concentration of Carbon Source in the Medium Affects the Quality of Virus-Like Particles of Human Papillomavirus Type 16 Produced in Saccharomyces cerevisiae	PLOS ONE			English	Article							L1 PROTEIN; IMMUNOGENICITY; VACCINES; MANUFACTURE; PSEUDOVIRUS; GLUTATHIONE; EXPRESSION; REACTIVITY; SYSTEMS; STRESS	There is accumulating evidence that virus-like particles (VLPs) recombinantly produced in Saccharomyces cerevisiae (S. cerevisiae) are characterized by low structural stability, and that this is associated with reduced antigenicity and immunogenicity. However, little attention has been devoted to methods of improving the quality of the VLPs. Here, we investigated the effect of carbon source concentration in the medium on the antigenicity and immunogenicity of human papillomavirus (HPV) type 16 L1 VLPs expressed in S. cerevisiae from the galactose promoter. Media containing 2, 4, 6, and 8% carbon source, composed of both glucose and galactose in equal proportion, were used. VLP antigenicity was enhanced in cultures grown on media with 6 or 8% carbon source, compared to those from cultures with less than 6% carbon source. Moreover, the VLPs obtained from these cultures induced higher anti-HPV16 L1 IgG titers and neutralizing antibody titers in immunized mice than those purified from cultures with less than 6% carbon source. Our results indicate that the concentration of the carbon source in the medium plays a crucial role in determining the antigenicity and immunogenicity of HPV type16 L1 VLPs.	[Kim, Hyoung Jin; Jin, Yingji; Kim, Hong-Jin] Chung Ang Univ, Coll Pharm, Virol Lab, Seoul 156756, South Korea	Chung Ang University	Kim, HJ (corresponding author), Chung Ang Univ, Coll Pharm, Virol Lab, Seoul 156756, South Korea.	hongjink@cau.ac.kr			National Research Foundation of Korea; Korean Government [NRF-2009-353-E00026]	National Research Foundation of Korea(National Research Foundation of Korea); Korean Government(Korean Government)	This work was supported by a National Research Foundation of Korea Grant funded by the Korean Government [NRF-2009-353-E00026], http://www.nrf.re.kr/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azizi A, 2007, J PEPT SCI, V13, P776, DOI 10.1002/psc.896; Buck CB, 2005, J VIROL, V79, P2839, DOI 10.1128/JVI.79.5.2839-2846.2005; Chang DY, 2012, BIOTECHNOL BIOPROC E, V17, P755, DOI 10.1007/s12257-012-0067-5; Choi YR, 2013, PROTEIN EXPRES PURIF, V89, P162, DOI 10.1016/j.pep.2013.03.007; Cobbold C, 2007, J GEN VIROL, V88, P77, DOI 10.1099/vir.0.82257-0; Crisci E, 2012, VET IMMUNOL IMMUNOP, V148, P211, DOI 10.1016/j.vetimm.2012.04.026; Foged C, 2011, THER DELIV, V2, P1057, DOI 10.4155/TDE.11.68; Grant CM, 1996, CURR GENET, V29, P511, DOI 10.1007/BF02426954; Kim HJ, 2013, BIOTECHNOL LETT, V35, P413, DOI 10.1007/s10529-012-1097-y; Kim HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035893; Kim HJ, 2011, PROTEIN EXPRES PURIF, V80, P52, DOI 10.1016/j.pep.2011.06.010; Kim HJ, 2010, J BIOTECHNOL, V150, P31, DOI 10.1016/j.jbiotec.2010.07.032; Kim HJ, 2010, PROTEIN EXPRES PURIF, V70, P68, DOI 10.1016/j.pep.2009.08.005; Kim SY, 2011, PROTEIN EXPRES PURIF, V76, P103, DOI 10.1016/j.pep.2010.11.003; Kushnir N, 2012, VACCINE, V31, P58, DOI 10.1016/j.vaccine.2012.10.083; Kwag HL, 2012, J MICROBIOL, V50, P813, DOI 10.1007/s12275-012-2292-1; Mukherjee S, 2008, J MOL BIOL, V381, P229, DOI 10.1016/j.jmb.2008.05.079; Mulder AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033235; MURRAY K, 1988, VACCINE, V6, P164, DOI 10.1016/S0264-410X(88)80022-7; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; Pattenden LK, 2005, TRENDS BIOTECHNOL, V23, P523, DOI 10.1016/j.tibtech.2005.07.011; Peixoto C, 2007, J BIOTECHNOL, V127, P452, DOI 10.1016/j.jbiotec.2006.08.002; Perrie Y, 2008, INT J PHARMACEUT, V364, P272, DOI 10.1016/j.ijpharm.2008.04.036; Rizk RZ, 2008, J GEN VIROL, V89, P117, DOI 10.1099/vir.0.83145-0; Shi L, 2005, J PHARM SCI-US, V94, P1538, DOI 10.1002/jps.20377; SILBER R, 1992, BLOOD, V80, P2038; Stanley D, 2010, J APPL MICROBIOL, V109, P13, DOI 10.1111/j.1365-2672.2009.04657.x; Tanyalcin T, 2000, HEPATOL RES, V18, P104, DOI 10.1016/S1386-6346(99)00088-1; Thones N, 2008, J VIROL, V82, P5472, DOI 10.1128/JVI.02482-07; Xie XX, 2013, ARCH VIROL, V158, P193, DOI 10.1007/s00705-012-1465-x; Zhao QJ, 2013, TRENDS BIOTECHNOL, V31, P654, DOI 10.1016/j.tibtech.2013.09.002; Zhao YP, 2003, BIOTECHNOL LETT, V25, P1151, DOI 10.1023/A:1024577414157	32	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94467	10.1371/journal.pone.0094467	http://dx.doi.org/10.1371/journal.pone.0094467			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714383	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900136
J	Haase, N; Rugor, J; Przybyl, L; Qadri, F; Muller, DN; Dechend, R				Haase, Nadine; Rugor, Julianna; Przybyl, Lukasz; Qadri, Fatimunnisa; Mueller, Dominik N.; Dechend, Ralf			Relaxin Does Not Improve Angiotensin II-Induced Target-Organ Damage	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; INDUCED CARDIAC INJURY; EMERGING ROLE; HORMONE RELAXIN; HEART-FAILURE; PREGNANT RATS; NITRIC-OXIDE; HUMAN RENIN; FIBROSIS; DISEASE	Relaxin is a corpus-luteum produced protein hormone with vasodilatatory, anti-fibrotic, and angiogenic properties that are opposite to angiotensin (Ang) II. We investigated whether or not relaxin ameliorates Ang II-induced target-organ damage. We used double transgenic rats harboring both human renin and angiotensinogen genes (dTGR) that develop severe hypertension, target-organ damage, and die untreated within 7-8 weeks. Recombinant relaxin at a low (26 mu g/kg/d) and a high dose (240 mu g/kg/d) was given to 4 week-old dTGR and age-matched Sprague-Dawley rats (SD). Systolic blood pressure increased progressively in untreated dTGRs from 162 +/- 3 mmHg at week 5 to 225 +/- 5 mmHg at week 7. Relaxin had no effect on blood pressure whereas SD rats were normotensive (106 +/- 1 mmHg). Untreated and relaxin-treated dTGR had similarly severe cardiac hypertrophy indices. Relaxin did not ameliorate albuminuria and did not prevent matrix-protein deposition in the heart and kidney in dTGR. Finally, relaxin treatment did not reduce mortality. These data suggest that pharmacological doses of relaxin do not reverse severe effects of Ang II.	[Haase, Nadine; Rugor, Julianna; Przybyl, Lukasz; Qadri, Fatimunnisa; Mueller, Dominik N.; Dechend, Ralf] Max Delbrueck Ctr Mol Med, Expt & Clin Res Ctr, Berlin, Germany; [Haase, Nadine; Rugor, Julianna; Przybyl, Lukasz; Qadri, Fatimunnisa; Mueller, Dominik N.; Dechend, Ralf] Fac Med Charite, Berlin, Germany; [Dechend, Ralf] HELIOS Klin, Dept Cardiol & Nephrol, Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helios Kliniken	Dechend, R (corresponding author), Max Delbrueck Ctr Mol Med, Expt & Clin Res Ctr, Berlin, Germany.	ralf.dechend@charite.de	Bader, Michael/K-2124-2013; Przybyl, Lukasz/GYA-0002-2022	Muller, Dominik N/0000-0003-3650-5644; Przybyl, Lukasz/0000-0001-9777-8879; Haase, Nadine/0000-0003-0727-1738	Novartis	Novartis(Novartis)	The work was funded by grant in aid by Novartis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bathgate RAD, 2013, PHYSIOL REV, V93, P405, DOI 10.1152/physrev.00001.2012; Bennett RG, 2009, TRANSL RES, V154, P1, DOI 10.1016/j.trsl.2009.03.007; Chan SL, 2013, FASEB J, V27, P3917, DOI 10.1096/fj.13-230797; Conrad KP, 2011, AM J PHYSIOL-REG I, V301, pR267, DOI 10.1152/ajpregu.00156.2011; Conrad KP, 2011, SEMIN NEPHROL, V31, P15, DOI 10.1016/j.semnephrol.2010.10.003; Conrad KP, 2004, AM J PHYSIOL-REG I, V287, pR250, DOI 10.1152/ajpregu.00672.2003; Danielson LA, 2003, J APPL PHYSIOL, V95, P1509, DOI 10.1152/japplphysiol.00545.2003; Debrah DO, 2005, HYPERTENSION, V46, P745, DOI 10.1161/01.HYP.0000184230.52059.33; Dechend R, 2001, CIRCULATION, V104, P576, DOI 10.1161/hc3001.092039; Du XJ, 2003, CARDIOVASC RES, V57, P395, DOI 10.1016/S0008-6363(02)00663-6; Fiebeler A, 2001, HYPERTENSION, V37, P787, DOI 10.1161/01.HYP.37.2.787; Fischer R, 2008, HYPERTENSION, V51, P540, DOI 10.1161/HYPERTENSIONAHA.107.103143; GANT NF, 1973, J CLIN INVEST, V52, P2682, DOI 10.1172/JCI107462; GRIGGS KC, 1993, AM J PHYSIOL, V265, pF309, DOI 10.1152/ajprenal.1993.265.2.F309; Hernandez-Montfort Jaime A, 2013, Curr Heart Fail Rep, V10, P198, DOI 10.1007/s11897-013-0148-6; Hewitson TD, 2010, ENDOCRINOLOGY, V151, P4938, DOI 10.1210/en.2010-0286; Hewitson TD, 2009, ANN NY ACAD SCI, V1160, P289, DOI 10.1111/j.1749-6632.2008.03795.x; Hultstrom M, 2012, J HYPERTENS, V30, P1087, DOI 10.1097/HJH.0b013e328352b89a; Kvakan H, 2009, CIRCULATION, V119, P2904, DOI 10.1161/CIRCULATIONAHA.108.832782; Lekgabe ED, 2005, HYPERTENSION, V46, P412, DOI 10.1161/01.HYP.0000171930.00697.2f; Luft FC, 1999, HYPERTENSION, V33, P212, DOI 10.1161/01.HYP.33.1.212; McGuane JT, 2011, ENDOCRINOLOGY, V152, P2786, DOI 10.1210/en.2010-1126; McGuane JT, 2011, HYPERTENSION, V57, P1151, DOI 10.1161/HYPERTENSIONAHA.110.165027; Mervaala EMA, 2001, HYPERTENSION, V37, P414, DOI 10.1161/01.HYP.37.2.414; Muller DN, 2000, AM J PATHOL, V157, P111, DOI 10.1016/S0002-9440(10)64523-3; Muller DN, 2000, HYPERTENSION, V35, P193, DOI 10.1161/01.HYP.35.1.193; Muller DN, 2002, AM J PATHOL, V161, P1679, DOI 10.1016/S0002-9440(10)64445-8; OLSON JL, 1986, KIDNEY INT, V29, P849, DOI 10.1038/ki.1986.76; Parikh A, 2013, CIRC RES, V113, P313, DOI 10.1161/CIRCRESAHA.113.301646; Samuel CS, 2007, CELL MOL LIFE SCI, V64, P1539, DOI 10.1007/s00018-007-6543-y; Samuel CS, 2011, LAB INVEST, V91, P675, DOI 10.1038/labinvest.2010.198; Samuel CS, 2009, CURR OPIN NEPHROL HY, V18, P9, DOI 10.1097/MNH.0b013e32831b7096; Samuel CS, 2006, KIDNEY INT, V69, P1498, DOI 10.1038/sj.ki.5000264; Sasser JM, 2011, HYPERTENSION, V58, P197, DOI 10.1161/HYPERTENSIONAHA.110.164392; Shagdarsuren E, 2005, CIRC RES, V97, P716, DOI 10.1161/01.RES.0000182677.89816.38; Teerlink JR, 2013, LANCET, V381, P29, DOI 10.1016/S0140-6736(12)61855-8; Teerlink JR, 2009, LANCET, V373, P1429, DOI 10.1016/S0140-6736(09)60622-X; Unemori E, 2009, ANN NY ACAD SCI, V1160, P381, DOI 10.1111/j.1749-6632.2009.03838.x; van Drongelen J, 2013, PEPTIDES, V49, P41, DOI 10.1016/j.peptides.2013.08.020; Wellner M, 2005, PHYSIOL GENOMICS, V20, P256, DOI 10.1152/physiolgenomics.00165.2004; Wenzel K, 2011, HYPERTENSION, V58, P77, DOI 10.1161/HYPERTENSIONAHA.111.171348; Wong SE, 2013, PROTEIN PEPTIDE LETT, V20, P1029; Xu Q, 2008, ENDOCRINOLOGY, V149, P476, DOI 10.1210/en.2007-1220; Yoshida T, 2013, AM J PHYSIOL-RENAL, V305, pF1169, DOI 10.1152/ajprenal.00654.2012	44	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93743	10.1371/journal.pone.0093743	http://dx.doi.org/10.1371/journal.pone.0093743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710077	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000334159800047
J	Tan, XL; Wang, S; Ridsdill-Smith, J; Liu, TX				Tan, Xiao-Ling; Wang, Su; Ridsdill-Smith, James; Liu, Tong-Xian			Direct and Indirect Impacts of Infestation of Tomato Plant by Myzus persicae ( Hemiptera: Aphididae) on Bemisia tabaci ( Hemiptera: Aleyrodidae)	PLOS ONE			English	Article							INDUCED VOLATILE EMISSIONS; PHLOEM-FEEDING INSECTS; MEDIATED INTERACTIONS; INTERSPECIFIC COMPETITION; MACROSIPHUM-EUPHORBIA; INDUCED RESISTANCE; SPODOPTERA-EXIGUA; DEFENSE RESPONSES; NATURAL ENEMIES; ORAL SECRETION	The impacts of infestation by the green peach aphid (Myzus persicae) on sweetpotato whitefly (Bemisia tabaci) settling on tomato were determined in seven separate experiments with whole plants and with detached leaves through manipulation of four factors: durations of aphid infestation, density of aphids, intervals between aphid removal after different durations of infestation and the time of whitefly release, and leaf positions on the plants. The results demonstrated that B. tabaci preferred to settle on the plant leaves that had not been infested by aphids when they had a choice. The plant leaves on which aphids were still present ( direct effect) had fewer whiteflies than those previously infested by aphids ( indirect effect). The whiteflies were able to settle on the plant which aphids had previously infested, and also could settle on leaves with aphids if no uninfested plants were available. Tests of direct factors revealed that duration of aphid infestation had a stronger effect on whitefly landing preference than aphid density; whitefly preference was the least when 20 aphids fed on the leaves for 72 h. Tests of indirect effects revealed that the major factor that affected whitefly preference for a host plant was the interval between the time of aphid removal after infestation and the time of whitefly release. The importance of the four factors that affected the induced plant defense against whiteflies can be arranged in the following order: time intervals between aphid removal and whitefly release. durations of aphid infestation > density of aphids > leaf positions on the plants. In conclusion, the density of aphid infestation and time for which they were feeding influenced the production of induced compounds by tomatoes, the whitefly responses to the plants, and reduced interspecific competition.	[Tan, Xiao-Ling; Ridsdill-Smith, James; Liu, Tong-Xian] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Tan, Xiao-Ling; Ridsdill-Smith, James; Liu, Tong-Xian] Northwest A&F Univ, Key Lab Crop Pest Management Losses Plateau, Minist Agr, Yangling, Shaanxi, Peoples R China; [Wang, Su] Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China; [Ridsdill-Smith, James] Univ Western Australia M092, Crawley, WA, Australia	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Beijing Academy of Agriculture & Forestry; University of Western Australia	Liu, TX (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	txliu@nwsuaf.edu.cn	wang, su/AAC-6313-2019; tan, xiao/GZL-0264-2022	Ridsdill-Smith, James/0000-0003-0660-1934	National Basic Research Program of China [2012CB114105, 2013CB127600]; China Agriculture Research System [CARS-25-B-06]	National Basic Research Program of China(National Basic Research Program of China); China Agriculture Research System	Funding of this research was partially supported by each of the following grants: the National Basic Research Program of China (973 Projects No. 2012CB114105 and No. 2013CB127600), China Agriculture Research System (CARS-25-B-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2000, OIKOS, V89, P70, DOI 10.1034/j.1600-0706.2000.890108.x; Alborn HT, 1997, SCIENCE, V276, P945, DOI 10.1126/science.276.5314.945; Anderson KE, 2009, OIKOS, V118, P1633, DOI 10.1111/j.1600-0706.2009.17437.x; Beale MH, 2006, P NATL ACAD SCI USA, V103, P10509, DOI 10.1073/pnas.0603998103; BERLINGER MJ, 1986, AGR ECOSYST ENVIRON, V17, P69, DOI 10.1016/0167-8809(86)90028-9; Bhattarai KK, 2007, MOL PLANT MICROBE IN, V20, P276, DOI 10.1094/MPMI-20-3-0276; Bleeker PM, 2009, PLANT PHYSIOL, V151, P925, DOI 10.1104/pp.109.142661; Botha CEJ, 2004, S AFR J BOT, V70, P249, DOI 10.1016/S0254-6299(15)30242-8; Brunissen L, 2009, ENTOMOL EXP APPL, V132, P30, DOI 10.1111/j.1570-7458.2009.00862.x; Choh Y, 2004, J CHEM ECOL, V30, P1305, DOI 10.1023/B:JOEC.0000037741.13402.19; Cory JS, 2006, TRENDS ECOL EVOL, V21, P278, DOI 10.1016/j.tree.2006.02.005; de Vos M, 2010, CURR OPIN PLANT BIOL, V13, P366, DOI 10.1016/j.pbi.2010.05.001; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Dicke M, 2009, NAT CHEM BIOL, V5, P317, DOI 10.1038/nchembio.169; Dugravot S, 2007, ENTOMOL EXP APPL, V123, P271, DOI 10.1111/j.1570-7458.2007.00542.x; Elliot SL, 2000, ECOL LETT, V3, P228; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Erb M, 2011, J ECOL, V99, P7, DOI 10.1111/j.1365-2745.2010.01757.x; Gianoli E, 1997, J CHEM ECOL, V23, P2695, DOI 10.1023/A:1022554708782; Goggin FL, 2007, CURR OPIN PLANT BIOL, V10, P399, DOI 10.1016/j.pbi.2007.06.004; Goggin FL, 2001, ENVIRON ENTOMOL, V30, P101, DOI 10.1603/0046-225X-30.1.101; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Hunter MD, 2002, AGR FOREST ENTOMOL, V4, P81, DOI 10.1046/j.1461-9563.2002.00138.x; Inbar M, 1999, ENVIRON ENTOMOL, V28, P353, DOI 10.1093/ee/28.3.353; Inbar M, 2001, OIKOS, V94, P228, DOI 10.1034/j.1600-0706.2001.940203.x; Inbar M, 2008, ANNU REV ENTOMOL, V53, P431, DOI 10.1146/annurev.ento.53.032107.122456; Kaplan I, 2011, OECOLOGIA, V166, P627, DOI 10.1007/s00442-010-1885-9; Karban R., 1997, INDUCED RESPONSES HE, DOI 10.7208/chicago/9780226424972.001.0001; Kessler A, 2011, FUNCT ECOL, V25, P348, DOI 10.1111/j.1365-2435.2010.01818.x; Korth KL, 1997, PLANT PHYSIOL, V115, P1299, DOI 10.1104/pp.115.4.1299; Kost C, 2006, J ECOL, V94, P619, DOI 10.1111/j.1365-2745.2006.01120.x; LIU TX, 1994, J ENTOMOL SCI, V29, P55, DOI 10.18474/0749-8004-29.1.55; Lucas-Barbosa D, 2011, PHYTOCHEMISTRY, V72, P1647, DOI 10.1016/j.phytochem.2011.03.013; Luo C, 2010, CROP PROT, V29, P429, DOI 10.1016/j.cropro.2009.10.001; Ma DY, 2007, CROP PROT, V26, P612, DOI 10.1016/j.cropro.2006.04.027; Mayer RT, 2002, ARCH INSECT BIOCHEM, V51, P151, DOI 10.1002/arch.10065; McAuslane HJ, 2000, ENTOMOL EXP APPL, V97, P283, DOI 10.1023/A:1004051527347; MCCALL PJ, 1994, J CHEM ECOL, V20, P3039, DOI 10.1007/BF02033709; Messina FJ, 2002, OECOLOGIA, V131, P43, DOI 10.1007/s00442-001-0859-3; MORAN NA, 1990, ECOLOGY, V71, P1050, DOI 10.2307/1937373; Murugan M., 2006, Journal of Vegetable Science, V12, P43, DOI 10.1300/J484v12n03_05; Naranjo SE, 2009, BIOL CONTROL, V51, P458, DOI 10.1016/j.biocontrol.2009.08.006; Nombela G, 2009, B ENTOMOL RES, V99, P183, DOI 10.1017/S0007485308006214; Nombela G, 1987, BEMISIA BIONOMICS MA, P357; Nunez-Farfan J, 2007, ANNU REV ECOL EVOL S, V38, P541, DOI 10.1146/annurev.ecolsys.38.091206.095822; Ohgushi T, 2005, ANNU REV ECOL EVOL S, V36, P81, DOI 10.1146/annurev.ecolsys.36.091704.175523; Orians C, 2005, J CHEM ECOL, V31, P2231, DOI 10.1007/s10886-005-7099-7; Pare PW, 1999, PLANT PHYSIOL, V121, P325, DOI 10.1104/pp.121.2.325; Quiroz A, 1997, J CHEM ECOL, V23, P2599, DOI 10.1023/B:JOEC.0000006669.34845.0d; Rahbe Y, 2003, PLANT SCI, V164, P441, DOI 10.1016/S0168-9452(02)00402-8; Rodriguez-Saona C, 2003, J CHEM ECOL, V29, P2539, DOI 10.1023/A:1026314102866; Sarmento RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023757; Sarmento RA, 2011, ECOL LETT, V14, P229, DOI 10.1111/j.1461-0248.2010.01575.x; Sauge MH, 2002, ENTOMOL EXP APPL, V102, P29, DOI 10.1023/A:1015282702657; Shiojiri K, 2006, OECOLOGIA, V149, P214, DOI 10.1007/s00442-006-0441-0; Smith CM, 2007, ENTOMOL EXP APPL, V122, P1, DOI 10.1111/j.1570-7458.2006.00503.x; Stratmann JW, 2003, TRENDS PLANT SCI, V8, P247, DOI 10.1016/S1360-1385(03)00106-7; Thompson GA, 2006, J EXP BOT, V57, P755, DOI 10.1093/jxb/erj135; Turlings TCJ, 1998, PLANTA, V207, P146, DOI 10.1007/s004250050466; Turlings TCJ, 2000, J CHEM ECOL, V26, P189, DOI 10.1023/A:1005449730052; Voelckel C, 2004, ECOL LETT, V7, P770, DOI 10.1111/j.1461-0248.2004.00633.x; Walling LL, 2008, PLANT PHYSIOL, V146, P859, DOI 10.1104/pp.107.113142; Wise MJ, 2009, EVOL ECOL, V23, P347, DOI 10.1007/s10682-007-9230-4; Wool D, 1996, PHYTOPARASITICA, V24, P39, DOI 10.1007/BF02981452; Xue M, 2010, ENVIRON ENTOMOL, V39, P883, DOI 10.1603/EN09307; Yang JW, 2011, J ECOL, V99, P46, DOI 10.1111/j.1365-2745.2010.01756.x; Zhang LP, 2005, J APPL ENTOMOL, V129, P443, DOI 10.1111/j.1439-0418.2005.00991.x; Zhang PJ, 2009, P NATL ACAD SCI USA, V106, P21202, DOI 10.1073/pnas.0907890106; Zhang SZ, 2013, ENTOMOL EXP APPL, V147, P293, DOI 10.1111/eea.12067; Zhang ZP, 1997, PLANTA, V203, P436, DOI 10.1007/s004250050211; Zhu-Salzman K, 2008, PLANT PHYSIOL, V146, P852, DOI 10.1104/pp.107.112177; Zhu-Salzman Keyan, 2005, Insect Science, V12, P3, DOI 10.1111/j.1672-9609.2005.00002.x	72	9	12	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94310	10.1371/journal.pone.0094310	http://dx.doi.org/10.1371/journal.pone.0094310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710393	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800133
J	Svahn, KS; Goransson, U; Chryssanthou, E; Olsen, B; Sjolin, J; Stromstedt, AA				Svahn, K. Stefan; Goransson, Ulf; Chryssanthou, Erja; Olsen, Bjorn; Sjolin, Jan; Stromstedt, Adam A.			Induction of Gliotoxin Secretion in Aspergillus fumigatus by Bacteria-Associated Molecules	PLOS ONE			English	Article							PATHOGEN RECOGNITION; LIPOTEICHOIC ACID; CANDIDA-ALBICANS; INNATE; MICE; PEPTIDOGLYCAN; PENICILLIUM; SYSTEM	Aspergillus fumigatus is the most common causative agent of mold diseases in humans, giving rise to life-threatening infections in immunocompromised individuals. One of its secreted metabolites is gliotoxin, a toxic antimicrobial agent. The aim of this study was to determine whether the presence of pathogen-associated molecular patterns in broth cultures of A. fumigatus could induce gliotoxin production. Gliotoxin levels were analyzed by ultra-performance liquid chromatography and mass spectrometry. The presence of a bacteria-derived lipopolysaccharide, peptidoglycan, or lipoteichoic acid in the growth media at a concentration of 5 mu g/ml increased the gliotoxin concentration in the media by 37%, 65%, and 35%, respectively. The findings reveal a correlation between the concentrations of pathogen-associated molecular patterns and gliotoxin secretion. This shows that there is a yet uncharacterized detection system for such compounds within fungi. Inducing secondary metabolite production by such means in fungi is potentially relevant for drug discovery research. Our results also give a possible explanation for the increased virulence of A. fumigatus during bacterial co-infection, one that is important for the transition from colonization to invasiveness in this pulmonary disease.	[Svahn, K. Stefan; Goransson, Ulf; Stromstedt, Adam A.] Uppsala Univ, Dept Med Chem, Uppsala, Sweden; [Chryssanthou, Erja] Karolinska Univ Hosp, Dept Clin Microbiol, Stockholm, Sweden; [Chryssanthou, Erja] Karolinska Inst, Stockholm, Sweden; [Olsen, Bjorn; Sjolin, Jan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Uppsala University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Uppsala University	Stromstedt, AA (corresponding author), Uppsala Univ, Dept Med Chem, Uppsala, Sweden.	adam.stromstedt@fkog.uu.se	Strömstedt, Adam/I-8820-2018	Strömstedt, Adam/0000-0001-9070-6944; Goransson, Ulf/0000-0002-5005-9612; Olsen, Bjorn/0000-0002-4646-691X	Swedish Governmental Agency for Innovation Systems - VINNOVA	Swedish Governmental Agency for Innovation Systems - VINNOVA(Vinnova)	This work has been financially supported by the Swedish Governmental Agency for Innovation Systems - VINNOVA (http://www.vinnova.se/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACKUS MP, 1955, MYCOLOGIA, V47, P429, DOI 10.2307/3755661; Baxter CG, 2013, THORAX, V68, P652, DOI 10.1136/thoraxjnl-2012-202412; Ben-Ami R, 2010, BRIT J HAEMATOL, V150, P406, DOI 10.1111/j.1365-2141.2010.08283.x; Bonnett CR, 2006, INFECT IMMUN, V74, P6528, DOI 10.1128/IAI.00909-06; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Comera C, 2007, MICROBES INFECT, V9, P47, DOI 10.1016/j.micinf.2006.10.009; Fleming A, 1929, BRIT J EXP PATHOL, V10, P226; Forseth RR, 2011, J AM CHEM SOC, V133, P9678, DOI 10.1021/ja2029987; GALE D, 1957, J BACTERIOL, V73, P616, DOI 10.1128/JB.73.5.616-624.1957; Grice CM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00026; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Houbraken J, 2011, IMA FUNGUS, V2, P87, DOI 10.5598/imafungus.2011.02.01.12; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kobayashi DY, 2009, ANNU REV PHYTOPATHOL, V47, P63, DOI 10.1146/annurev-phyto-080508-081729; Kousha M, 2011, EUR RESPIR REV, V20, P156, DOI 10.1183/09059180.00001011; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Maffei ME, 2012, NAT PROD REP, V29, P1288, DOI 10.1039/c2np20053h; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; NEELY AN, 1986, INFECT IMMUN, V52, P200, DOI 10.1128/IAI.52.1.200-204.1986; Otte JM, 2003, J GASTROENTEROL, V38, P717, DOI 10.1007/s00535-003-1136-5; Pardo J, 2006, J CELL BIOL, V174, P509, DOI 10.1083/jcb.200604044; Pettit RK, 2011, MICROB BIOTECHNOL, V4, P471, DOI 10.1111/j.1751-7915.2010.00196.x; Pettit RK, 2009, APPL MICROBIOL BIOT, V83, P19, DOI 10.1007/s00253-009-1916-9; Philippe B, 2003, INFECT IMMUN, V71, P3034, DOI 10.1128/IAI.71.6.3034-3042.2003; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rao XJ, 2010, DEV COMP IMMUNOL, V34, P1119, DOI 10.1016/j.dci.2010.06.007; Ray A, 2013, BIOCHIMIE, V95, P33, DOI 10.1016/j.biochi.2012.06.007; RODRIGUEZ PL, 1992, J VIROL, V66, P1971, DOI 10.1128/JVI.66.4.1971-1976.1992; Roeder A, 2004, TRENDS MICROBIOL, V12, P44, DOI 10.1016/j.tim.2003.11.003; Scharf DH, 2012, APPL MICROBIOL BIOT, V93, P467, DOI 10.1007/s00253-011-3689-1; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Svahn K. Stefan, 2012, Infection Ecology & Epidemiology, V2, P11591, DOI 10.3402/iee.v2i0.11591; TROWN PW, 1972, ANTIMICROB AGENTS CH, V2, P261, DOI 10.1128/AAC.2.4.261; Xu XL, 2008, CELL HOST MICROBE, V4, P28, DOI 10.1016/j.chom.2008.05.014; Yoshimura A, 1999, J IMMUNOL, V163, P1	35	15	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93685	10.1371/journal.pone.0093685	http://dx.doi.org/10.1371/journal.pone.0093685			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705440	Green Submitted, Green Published, gold			2022-12-25	WOS:000334107500056
J	Jin, Y; Nair, A; van Veen, HW				Jin, Yoonhee; Nair, Asha; van Veen, Hendrik W.			Multidrug Transport Protein NorM from Vibrio cholerae Simultaneously Couples to Sodium- and Proton-Motive Force	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC TRANSPORTER; STAPHYLOCOCCUS-AUREUS; MATE FAMILY; EFFLUX PUMP; EXTRUSION; RESISTANCE; BINDING; DISRUPTION; ANTIPORTER; PRINCIPLES	Membrane transporters belonging to the multidrug and toxic compound extrusion family mediate the efflux of unrelated pharmaceuticals from the interior of the cell in organisms ranging from bacteria to human. These proteins are thought to fall into two classes that couple substrate efflux to the influx of either Na+ or H+. We studied the energetics of drug extrusion by NorM from Vibrio cholerae in proteoliposomes in which purified NorM protein was functionally reconstituted in an inside-out orientation. We establish that NorM simultaneously couples to the sodium-motive force and proton-motive force, and biochemically identify protein regions and residues that play important roles in Na+ or H+ binding. As the positions of protons are not available in current medium and high-resolution crystal structures of multidrug and toxic compound extrusion transporters, our findings add a previously unrecognized parameter to mechanistic models based of these structures.	[Jin, Yoonhee; Nair, Asha; van Veen, Hendrik W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	van Veen, HW (corresponding author), Tennis Court Rd, Cambridge CB2 1PD, England.	hwv20@cam.ac.uk	van Veen, Hendrik W./A-4162-2008	van Veen, Hendrik W./0000-0002-9658-8077; V Nair, Asha/0000-0002-2037-1138	Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BB/K017713/1] Funding Source: researchfish; BBSRC [BB/K017713/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC).	AMBUDKAR SV, 1984, J BIOL CHEM, V259, P6142; Becker ML, 2010, PHARMACOGENET GENOM, V20, P38, DOI 10.1097/FPC.0b013e328333bb11; Brown MH, 1999, MOL MICROBIOL, V31, P394, DOI 10.1046/j.1365-2958.1999.01162.x; deRuyter PGGA, 1996, J BACTERIOL, V178, P3434, DOI 10.1128/jb.178.12.3434-3439.1996; Fluman N, 2012, MOL CELL, V47, P777, DOI 10.1016/j.molcel.2012.06.018; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Hashimoto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059525; He GX, 2004, J BACTERIOL, V186, P262, DOI 10.1128/JB.186.1.262-265.2004; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Kaatz GW, 2005, ANTIMICROB AGENTS CH, V49, P1857, DOI 10.1128/AAC.49.5.1857-1864.2005; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; Lu M, 2013, NAT STRUCT MOL BIOL, V20, P1310, DOI 10.1038/nsmb.2687; Lu M, 2013, P NATL ACAD SCI USA, V110, P2099, DOI 10.1073/pnas.1219901110; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Matsushima S, 2009, DRUG METAB DISPOS, V37, P555, DOI 10.1124/dmd.108.023911; McAleese F, 2005, ANTIMICROB AGENTS CH, V49, P1865, DOI 10.1128/AAC.49.5.1865-1871.2005; Nakamura T, 2010, BIOCHEM PHARMACOL, V80, P1762, DOI 10.1016/j.bcp.2010.08.019; Omote H, 2006, TRENDS PHARMACOL SCI, V27, P587, DOI 10.1016/j.tips.2006.09.001; Otsuka M, 2005, J BACTERIOL, V187, P1552, DOI 10.1128/JB.187.5.1552-1558.2005; Putman M, 1999, BIOCHEMISTRY-US, V38, P1002, DOI 10.1021/bi981863w; Schaedler TA, 2012, J BIOL CHEM, V287, P27682, DOI 10.1074/jbc.M112.372334; Schaedler TA, 2010, FASEB J, V24, P3653, DOI 10.1096/fj.10-156927; Steed PR, 2013, BIOCHEMISTRY-US, V52, P5790, DOI 10.1021/bi4008935; Tanaka Y, 2013, NATURE, V496, P247, DOI 10.1038/nature12014; Tanihara Y, 2007, BIOCHEM PHARMACOL, V74, P359, DOI 10.1016/j.bcp.2007.04.010; Tsuda M, 2009, MOL PHARMACOL, V75, P1280, DOI 10.1124/mol.109.056242; van Veen HW, 2010, NATURE, V467, P926, DOI 10.1038/467926a; Vanni S, 2012, BIOCHEMISTRY-US, V51, P1281, DOI 10.1021/bi2015184; Venter H, 2003, NATURE, V426, P866, DOI 10.1038/nature02173; Venter H, 2008, BIOCHEM PHARMACOL, V75, P866, DOI 10.1016/j.bcp.2007.10.022; Wang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038715; Woebking B, 2008, BIOCHEMISTRY-US, V47, P10904, DOI 10.1021/bi800778d; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	34	43	43	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14624	14632		10.1074/jbc.M113.546770	http://dx.doi.org/10.1074/jbc.M113.546770			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24711447	Green Published, hybrid			2022-12-25	WOS:000337248100019
J	Mohammadi, T; Sijbrandi, R; Lutters, M; Verheul, J; Martin, NI; den Blaauwen, T; de Kruijff, B; Breukink, E				Mohammadi, Tamimount; Sijbrandi, Robert; Lutters, Mandy; Verheul, Jolanda; Martin, Nathaniel I.; den Blaauwen, Tanneke; de Kruijff, Ben; Breukink, Eefjan			Specificity of the Transport of Lipid II by FtsW in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIVISION PROTEIN FTSW; CELL-DIVISION; BACTERIAL-MEMBRANES; IDENTIFICATION; PHOSPHOLIPIDS; TRANSLOCATION; PRECURSORS; PBP3; WALL	Synthesis of biogenic membranes requires transbilayer movement of lipid-linked sugar molecules. This biological process, which is fundamental in prokaryotic cells, remains as yet not clearly understood. In order to obtain insights into the molecular basis of its mode of action, we analyzed the structure-function relationship between Lipid II, the important building block of the bacterial cell wall, and its inner membrane-localized transporter FtsW. Here, we show that the predicted transmembrane helix 4 of Escherichia coli FtsW (this protein consists of 10 predicted transmembrane segments) is required for the transport activity of the protein. We have identified two charged residues (Arg(145) and Lys(153)) within this segment that are specifically involved in the flipping of Lipid II. Mutating these two amino acids to uncharged ones affected the transport activity of FtsW. This was consistent with loss of in vivo activity of the mutants, as manifested by their inability to complement a temperature-sensitive strain of FtsW. The transport activity of FtsW could be inhibited with a Lipid II variant having an additional size of 420 Da. Reducing the size of this analog by about 274 Da resulted in the resumption of the transport activity of FtsW. This suggests that the integral membrane protein FtsW forms a size-restricted porelike structure, which accommodates Lipid II during transport across the bacterial cytoplasmic membrane.	[Mohammadi, Tamimount; Sijbrandi, Robert; Lutters, Mandy; de Kruijff, Ben; Breukink, Eefjan] Univ Utrecht, Dept Chem, Fac Sci, NL-3584 CH Utrecht, Netherlands; [den Blaauwen, Tanneke] Univ Amsterdam, Swammerdam Inst Life Sci, Fac Sci, NL-1098 XH Amsterdam, Netherlands; [Martin, Nathaniel I.] Univ Utrecht, Dept Med Chem & Chem Biol, Utrecht Inst Pharmaceut Sci, Fac Sci, NL-3584 CG Utrecht, Netherlands; [Sijbrandi, Robert; Verheul, Jolanda] Acad Technol Gezondheid & Milieu, Avans Hogesch, NL-4818 AJ Breda, Netherlands	Utrecht University; University of Amsterdam; Utrecht University	Breukink, E (corresponding author), Univ Utrecht, Dept Chem, Fac Sci, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	e.j.breukink@uu.nl	Breukink, Eefjan/I-3039-2016	Breukink, Eefjan/0000-0002-7311-0660; den Blaauwen, Tanneke/0000-0002-5403-5597	European Commission EUR-INTAFAR [KSHM-CT-2004-512138]; ZonMW [20500001]; EU [FP7-Health-2007-B-223431]	European Commission EUR-INTAFAR; ZonMW(Netherlands Organization for Health Research and Development); EU(European Commission)	This work was supported by European Commission EUR-INTAFAR Grant KSHM-CT-2004-512138, ZonMW Project 20500001, and EU Project FP7-Health-2007-B-223431.	Bonardi F, 2011, P NATL ACAD SCI USA, V108, P7775, DOI 10.1073/pnas.1101705108; Breukink E, 2003, J BIOL CHEM, V278, P19898, DOI 10.1074/jbc.M301463200; D'Ulisse V, 2007, MICROBIOL-SGM, V153, P124, DOI 10.1099/mic.0.2006/000265-0; den Blaauwen T, 2003, MOL MICROBIOL, V47, P539, DOI 10.1046/j.1365-2958.2003.03316.x; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Ehlert K, 1996, J BACTERIOL, V178, P6766, DOI 10.1128/jb.178.23.6766-6771.1996; Fraipont C, 2011, MICROBIOL-SGM, V157, P251, DOI 10.1099/mic.0.040071-0; Goddard-Borger ED, 2007, ORG LETT, V9, P3797, DOI 10.1021/ol701581g; ISHINO F, 1989, J BACTERIOL, V171, P5523, DOI 10.1128/jb.171.10.5523-5530.1989; KHATTAR MM, 1994, J BACTERIOL, V176, P7140, DOI 10.1128/JB.176.23.7140-7147.1994; Kol MA, 2004, BIOCHEMISTRY-US, V43, P2673, DOI 10.1021/bi036200f; Koppelman CM, 2004, MOL MICROBIOL, V51, P645, DOI 10.1046/j.1365-2958.2003.03876.x; Lara B, 2002, FEMS MICROBIOL LETT, V216, P23, DOI 10.1111/j.1574-6968.2002.tb11409.x; Menon I, 2011, CURR BIOL, V21, P149, DOI 10.1016/j.cub.2010.12.031; Mercer KLN, 2002, J BACTERIOL, V184, P904, DOI 10.1128/jb.184.4.904-912.2002; Mohammadi T, 2011, EMBO J, V30, P1425, DOI 10.1038/emboj.2011.61; Pastoret S, 2004, J BACTERIOL, V186, P8370, DOI 10.1128/JB.186.24.8370-8379.2004; Pera NP, 2010, ORG BIOMOL CHEM, V8, P2425, DOI 10.1039/c000819b; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; TASCHNER PEM, 1988, J BACTERIOL, V170, P1533, DOI 10.1128/jb.170.4.1533-1540.1988; van Dam V, 2007, MOL MICROBIOL, V64, P1105, DOI 10.1111/j.1365-2958.2007.05722.x; van der Ploeg R, 2013, MOL MICROBIOL, V87, P1074, DOI 10.1111/mmi.12150; Wang L, 1998, J BACTERIOL, V180, P2810, DOI 10.1128/JB.180.11.2810-2816.1998; Williamson P, 2011, CURR BIOL, V21, pR168, DOI 10.1016/j.cub.2011.01.030; Zhang L, 2007, ANGEW CHEM INT EDIT, V46, P1798, DOI 10.1002/anie.200604222	25	55	57	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14707	14718		10.1074/jbc.M114.557371	http://dx.doi.org/10.1074/jbc.M114.557371			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24711460	Green Published, hybrid			2022-12-25	WOS:000337248100027
J	Attard, MRG; Parr, WCH; Wilson, LAB; Archer, M; Hand, SJ; Rogers, TL; Wroe, S				Attard, Marie R. G.; Parr, William C. H.; Wilson, Laura A. B.; Archer, Michael; Hand, Suzanne J.; Rogers, Tracey L.; Wroe, Stephen			Virtual Reconstruction and Prey Size Preference in the Mid Cenozoic Thylacinid, Nimbacinus dicksoni (Thylacinidae, Marsupialia)	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; QUOLL DASYURUS-MACULATUS; ESTIMATED BITING FORCES; PREDATORY BEHAVIOR; FEEDING-BEHAVIOR; DNA PHYLOGENY; BITE FORCE; SKULL; DIET; BIOMECHANICS	Thylacinidae is an extinct family of Australian and New Guinean marsupial carnivores, comprizing 12 known species, the oldest of which are late Oligocene (similar to 24 Ma) in age. Except for the recently extinct thylacine (Thylacinus cynocephalus), most are known from fragmentary craniodental material only, limiting the scope of biomechanical and ecological studies. However, a particularly well-preserved skull of the fossil species Nimbacinus dicksoni, has been recovered from middle Miocene (similar to 16-11.6 Ma) deposits in the Riversleigh World Heritage Area, northwestern Queensland. Here, we ask whether N. dicksoni was more similar to its recently extinct relative or to several large living marsupials in a key aspect of feeding ecology, i.e., was N. dicksoni a relatively small or large prey specialist. To address this question we have digitally reconstructed its skull and applied three-dimensional Finite Element Analysis to compare its mechanical performance with that of three extant marsupial carnivores and T. cynocephalus. Under loadings adjusted for differences in size that simulated forces generated by both jaw closing musculature and struggling prey, we found that stress distributions and magnitudes in the skull of N. dicksoni were more similar to those of the living spotted-tailed quoll (Dasyurus maculatus) than to its recently extinct relative. Considering the Finite Element Analysis results and dental morphology, we predict that N. dicksoni likely occupied a broadly similar ecological niche to that of D. maculatus, and was likely capable of hunting vertebrate prey that may have exceeded its own body mass.	[Attard, Marie R. G.; Parr, William C. H.; Wilson, Laura A. B.; Rogers, Tracey L.] Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Attard, Marie R. G.; Wroe, Stephen] Univ New England, Sch Environm & Rural Sci, Funct Evolut & Anat Res Lab, Armidale, NSW 2351, Australia; [Archer, Michael; Hand, Suzanne J.] Univ New S Wales, Evolut Earth & Life Sci Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia	University of New South Wales Sydney; University of New England; University of New South Wales Sydney	Attard, MRG (corresponding author), Univ New S Wales, Evolut & Ecol Res Ctr, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia.	marie.attard@une.edu.au	Wilson, Laura AB/A-4881-2012; Rogers, Tracey L/C-3419-2008; Attard, Marie/AAT-9996-2021; Hand, Suzanne J/C-3853-2008	Wilson, Laura AB/0000-0002-3779-8277; Attard, Marie/0000-0002-8509-3677; Wroe, Stephen/0000-0002-6365-5915; Hand, Suzanne/0000-0002-4940-3391; Rogers, Tracey/0000-0002-7141-4177; Archer, Michael/0000-0002-0304-4039	Australian Research Council [DP0666374, DP0987985, LP100200486, DP1094569]; Postgraduate Writing and Skills Transfer Award; Evolution and Ecology Research Centre, University of New South Wales; Swiss National Science Foundation [PBZHP3_141470]	Australian Research Council(Australian Research Council); Postgraduate Writing and Skills Transfer Award; Evolution and Ecology Research Centre, University of New South Wales; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was funded by Australian Research Council grants to S. Wroe (DP0666374 and DP0987985), and to M. Archer, and S .J. Hand (LP100200486 and DP1094569). M. Attard is supported by the Postgraduate Writing and Skills Transfer Award sponsored by the Evolution and Ecology Research Centre, University of New South Wales. L. Wilson is supported by the Swiss National Science Foundation (PBZHP3_141470). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	ARCHER M, 1991, RIVERSLEIGH STORY AN; ARCHER M, 2002, EVOLUTION AUSTR 110; Archer M., 2006, ALCHERINGA AUSTRALAS, V30, P1, DOI DOI 10.1080/03115510609506851; Attard MRG, 2011, J ZOOL, V285, P292, DOI 10.1111/j.1469-7998.2011.00844.x; Bailey C, 2003, TIGER TALES STORIES; BELCHER CA, 1995, WILDLIFE RES, V22, P341, DOI 10.1071/WR9950341; Bell PR, 2009, ANAT REC, V292, P1338, DOI 10.1002/ar.20978; Benazzi S, 2011, J HUM EVOL, V61, P75, DOI 10.1016/j.jhevol.2011.02.005; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; Bradshaw CJA, 2005, ECOGRAPHY, V28, P181, DOI 10.1111/j.0906-7590.2005.04088.x; Braithwaite RW, 1995, MAMMALS AUSTR NATL P, P65; Breul R, 1999, ANN ANAT, V181, P55, DOI 10.1016/S0940-9602(99)80090-9; Chamoli U, 2011, THESIS U NEW S WALES; Chamoli U, 2011, J THEOR BIOL, V283, P217, DOI 10.1016/j.jtbi.2011.05.020; Christiansen P, 2007, ECOLOGY, V88, P347, DOI 10.1890/0012-9658(2007)88[347:BFAEAT]2.0.CO;2; Clausen P, 2008, J BIOMECH, V41, P3184, DOI 10.1016/j.jbiomech.2008.08.019; COOK SD, 1982, J DENT RES, V61, P25, DOI 10.1177/00220345820610010501; Dawson JP, 2007, WILDLIFE RES, V34, P342, DOI 10.1071/WR05101; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; Dumont ER, 2003, J EXP BIOL, V206, P2117, DOI 10.1242/jeb.00375; Dumont ER, 2005, ANAT REC PART A, V283A, P319, DOI 10.1002/ar.a.20165; Edgar R., 1995, MAMMALS AUSTR, P67; Ellis JL, 2008, J ANAT, V212, P769, DOI 10.1111/j.1469-7580.2008.00911.x; Figueirido B, 2013, EVOLUTION, V67, P1975, DOI 10.1111/evo.12059; Figueirido B, 2011, BIOL LETTERS, V7, P937, DOI 10.1098/rsbl.2011.0364; FLEAY DAVID, 1932, VICTORIAN NAT, V49, P63; Glen AS, 2006, J ZOOL, V269, P241, DOI 10.1111/j.1469-7998.2006.00046.x; Goswami A, 2011, P ROY SOC B-BIOL SCI, V278, P1831, DOI 10.1098/rspb.2010.2031; Greaves GN, 2011, NAT MATER, V10, P823, DOI [10.1038/NMAT3134, 10.1038/nmat3134]; Groves C. P., 2005, MAMMAL SPECIES WORLD, P23; GUILER E R, 1970, Australian Journal of Zoology, V18, P49, DOI 10.1071/ZO9700049; Guiler ER, 1985, THYLACINE TRAGEDY TA; Hickman DM, 1998, ORAL SURG ORAL MED O, V85, P18, DOI 10.1016/S1079-2104(98)90392-4; HYLANDER WL, 1979, AM J PHYS ANTHROPOL, V51, P433, DOI 10.1002/ajpa.1330510317; Jones M, 1997, ECOLOGY, V78, P2569; Jones M., 1995, THESIS U TASMANIA HO; Jones ME, 1998, J ZOOL, V246, P239, DOI 10.1111/j.1469-7998.1998.tb00152.x; Jones ME, 1998, J ANIM ECOL, V67, P410, DOI 10.1046/j.1365-2656.1998.00203.x; Jones Menna E., 2003, P285; Krajewski C, 1997, P ROY SOC B-BIOL SCI, V264, P911, DOI 10.1098/rspb.1997.0126; KRAJEWSKI C, 1992, P ROY SOC B-BIOL SCI, V250, P19, DOI 10.1098/rspb.1992.0125; LOWENSTEIN JM, 1981, NATURE, V291, P409, DOI 10.1038/291409a0; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Mitteroecker P, 2009, EVOL BIOL, V36, P235, DOI 10.1007/s11692-009-9055-x; Moazen M, 2008, J ANAT, V213, P499, DOI 10.1111/j.1469-7580.2008.00980.x; MUIRHEAD J, 1990, Memoirs of the Queensland Museum, V28, P203; Muirhead J, 1998, J VERTEBR PALEONTOL, V18, P612, DOI 10.1080/02724634.1998.10011088; Muirhead Jeanette, 1997, Memoirs of the Queensland Museum, V41, P367; Murray Peter, 2000, Beagle, V16, P145; Murray Peter F., 1997, Records of the South Australian Museum (Adelaide), V30, P43; Myers TJ, 2001, AUST J ZOOL, V49, P99, DOI 10.1071/ZO01009; Nalla RK, 2003, NAT MATER, V2, P164, DOI 10.1038/nmat832; Oakwood M., 1997, THESIS AUSTR NATL U; Oldfield CC, 2012, J ZOOL, V286, P163, DOI 10.1111/j.1469-7998.2011.00862.x; Owen D, 2005, TASMANIAN DEVIL UNIQ; Paddle R., 2000, LAST TASMANIAN TIGER; Parr WCH, 2012, J THEOR BIOL, V301, P1, DOI 10.1016/j.jtbi.2012.01.030; PELLIS S M, 1984, Australian Mammalogy, V7, P5; PELLIS SM, 1987, ETHOLOGY, V75, P177; Pollock A. B., 1999, Australian Zoologist, V31, P388; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; Ross CF, 2005, ANAT REC PART A, V283A, P253, DOI 10.1002/ar.a.20177; SARICH V, 1982, CARNIVOROUS MARSUPIA, P445; Slater GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013870; Strahan R., 1995, MAMMALS AUSTR, V2nd; Strait DS, 2010, ANAT REC, V293, P583, DOI 10.1002/ar.21122; Szalay F.S., 1982, P621; TAYLOR R J, 1986, Papers and Proceedings of the Royal Society of Tasmania, V120, P7; THOMAS RH, 1989, NATURE, V340, P465, DOI 10.1038/340465a0; THOMASON JJ, 1991, CAN J ZOOL, V69, P2326, DOI 10.1139/z91-327; THRESHER RW, 1973, J BIOMECH, V6, P443, DOI 10.1016/0021-9290(73)90003-1; Travouillon KJ, 2009, PALAEOGEOGR PALAEOCL, V276, P24, DOI 10.1016/j.palaeo.2009.02.025; Tsafnat N, 2011, J ANAT, V218, P40, DOI 10.1111/j.1469-7580.2010.01289.x; Tseng ZJ, 2009, BIOL J LINN SOC, V96, P51, DOI 10.1111/j.1095-8312.2008.01095.x; Turnbull W. D., 1970, Fieldiana (Geol.), V18, P147; Walmsley CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053873; Wroe S, 2008, J ZOOL, V274, P332, DOI 10.1111/j.1469-7998.2007.00389.x; Wroe S, 1996, J PALEONTOL, V70, P1032, DOI 10.1017/S0022336000038737; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Wroe S, 2001, AUST J ZOOL, V49, P603, DOI 10.1071/ZO01044; Wroe S, 2001, AUST J ZOOL, V49, P487, DOI 10.1071/ZO00032; Wroe S, 1999, AUST J ZOOL, V47, P489, DOI 10.1071/ZO99006; Wroe S, 1998, J PALEONTOL, V72, P738, DOI 10.1017/S0022336000040439; Wroe S, 2006, EVOLUTION BIOGEOGRAP, P517; Wroe S, 2007, P ROY SOC B-BIOL SCI, V274, P2819, DOI 10.1098/rspb.2007.0906; Wroe S, 2007, EVOLUTION, V61, P1251, DOI 10.1111/j.1558-5646.2007.00101.x; Wroe Stephen, 2003, P102; Wroe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066888; Wroe S, 2010, P ROY SOC B-BIOL SCI, V277, P3579, DOI 10.1098/rspb.2010.0509; Young MT, 2012, NATURWISSENSCHAFTEN, V99, P637, DOI 10.1007/s00114-012-0944-y; Zar J. H., 1996, BIOSTAT ANAL, P353	92	24	24	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93088	10.1371/journal.pone.0093088	http://dx.doi.org/10.1371/journal.pone.0093088			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24718109	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000026
J	Canto, E; Planella, EG; Zamora-Atenza, C; Nieto, JC; Gordillo, J; Ortiz, MA; Meton, I; Serrano, E; Vegas, E; Garcia-Bosch, O; Juarez, C; Vidal, S				Canto, Elisabet; Garcia Planella, Esther; Zamora-Atenza, Carlos; Camilo Nieto, Juan; Gordillo, Jordi; Angels Ortiz, Ma; Meton, Isidoro; Serrano, Elena; Vegas, Esteban; Garcia-Bosch, Orlando; Juarez, Candido; Vidal, Silvia			Interleukin-19 Impairment in Active Crohn's Disease Patients	PLOS ONE			English	Article							KERATINOCYTE GROWTH-FACTOR; CUTTING EDGE; POTENTIAL ROLE; TH2 CYTOKINES; TNF-ALPHA; IL-19; EXPRESSION; CELLS; IL-20; MICE	The exact function of interleukin-19 (IL-19) on immune response is poorly understood. In mice, IL-19 up-regulates TNF alpha and IL-6 expression and its deficiency increases susceptibility to DSS-induced colitis. In humans, IL-19 favors a Th2 response and is elevated in several diseases. We here investigate the expression and effects of IL-19 on cells from active Crohn's disease (CD) patient. Twenty-three active CD patients and 20 healthy controls (HC) were included. mRNA and protein IL-19 levels were analyzed in monocytes. IL-19 effects were determined in vitro on the T cell phenotype and in the production of cytokines by immune cells. We observed that unstimulated and TLR-activated monocytes expressed significantly lower IL-19 mRNA in active CD patients than in HC (logFC = -1.97 unstimulated; -1.88 with Pam3CSK4; and -1.91 with FSL-1; p< 0.001). These results were confirmed at protein level. Exogenous IL-19 had an anti-inflammatory effect on HC but not on CD patients. IL-19 decreased TNF alpha production in PBMC (850.7 +/- 75.29 pg/ml vs 2626.0 +/- 350 pg/ml; p<0.01) and increased CTLA4 expression (22.04 +/- 1.55% vs 13.98 +/- 2.05%; p<0.05) and IL-4 production (32.5 +/- 8.9 pg/ml vs 13.5 +/- 2.9 pg/ml; p< 0.05) in T cells from HC. IL-10 regulated IL-19 production in both active CD patients and HC. We observed that three of the miRNAs that can modulate IL-19 mRNA expression, were up-regulated in monocytes from active CD patients. These results suggested that IL-19 had an anti-inflammatory role in this study. Defects in IL-19 expression and the lack of response to this cytokine could contribute to inflammatory mechanisms in active CD patients.	[Canto, Elisabet; Zamora-Atenza, Carlos; Camilo Nieto, Juan; Angels Ortiz, Ma; Vidal, Silvia] IIB St Pau, Biomed Res Inst St Pau, Dept Immunol, Barcelona, Spain; [Garcia Planella, Esther; Gordillo, Jordi] Hosp Santa Creu & Sant Pau, Dept Digest Pathol, Barcelona, Spain; [Meton, Isidoro] Univ Barcelona, Fac Pharm, Dept Biochem & Mol Biol, Barcelona, Spain; [Serrano, Elena] IIB St Pau, Biomed Res Inst St Pau, PSCT Platforms, Barcelona, Spain; [Vegas, Esteban] Univ Barcelona, Fac Biol, Dept Stat, Barcelona, Spain; [Garcia-Bosch, Orlando] Hosp St Joan Despi Moises Broggi, Dept Digest, Barcelona, Spain; [Juarez, Candido] Hosp Santa Creu & Sant Pau, Dept Immunol, Barcelona, Spain; [Juarez, Candido; Vidal, Silvia] Univ Autonoma Barcelona, E-08193 Barcelona, Spain	University of Barcelona; University of Barcelona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona	Canto, E (corresponding author), IIB St Pau, Biomed Res Inst St Pau, Dept Immunol, Barcelona, Spain.	ecanto@santpau.cat	Vegas, Esteban/G-4231-2015; Metón, Isidoro/G-9027-2015	Vegas, Esteban/0000-0002-6869-4075; Metón, Isidoro/0000-0003-2301-2365; zamora, carlos/0000-0003-2962-678X; Vidal, Silvia/0000-0002-3909-6682; CANTO, ELISABET/0000-0002-1782-1855; Nieto Sachica, Juan Camilo/0000-0002-3400-1488	Ministerio de Economia i competitividad, Instituto de Salud Carlos III [PS09/132]; Fondo Investigaciones Sanitarias	Ministerio de Economia i competitividad, Instituto de Salud Carlos III; Fondo Investigaciones Sanitarias(Instituto de Salud Carlos III)	Ministerio de Economia i competitividad PS09/132 Instituto de Salud Carlos III. Silvia Vidal was supported by "Fondo Investigaciones Sanitarias" and participant in the Program for Stabilization of Investigators of the "Direccio d'Estrategia i Coordinacio del Departament Salut de la Generalitat de Catalunya". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanara T, 2010, SCAND J RHEUMATOL, V39, P118, DOI 10.3109/03009740903170823; Azuma YT, 2010, INFLAMM BOWEL DIS, V16, P1017, DOI 10.1002/ibd.21151; Beltran CJ, 2009, EUR CYTOKINE NETW, V20, P94, DOI [10.1684/ecn.2009.0142, 10.1684/ecn.2009.0151]; Bianchini R, 2011, EUR J IMMUNOL, V41, P2269, DOI 10.1002/eji.201040943; Canto E, 2006, CLIN IMMUNOL, V119, P156, DOI 10.1016/j.clim.2005.12.005; Chen YY, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/294320; De Tena JG, 2006, J CLIN IMMUNOL, V26, P233, DOI 10.1007/s10875-006-9016-4; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; England RN, 2013, AM J PHYSL CELL PHYS; England RN, 2012, INT J INFLAMM, V2012, DOI 10.1155/2012/253583; Gabunia K, 2011, AM J PHYSIOL-CELL PH, V300, pC896, DOI 10.1152/ajpcell.00439.2010; Gallagher G, 2004, INT IMMUNOPHARMACOL, V4, P615, DOI 10.1016/j.intimp.2004.01.005; Gallagher G, 2000, GENES IMMUN, V1, P442, DOI 10.1038/sj.gene.6363714; Gallagher G, 2010, CYTOKINE GROWTH F R, V21, P345, DOI 10.1016/j.cytogfr.2010.08.005; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guarnieri DJ, 2008, ANN MED, V40, P197, DOI 10.1080/07853890701771823; Hofmann SR, 2012, KLIN PADIATR, V224, P53, DOI 10.1055/s-0031-1291359; Hsing CH, 2008, SHOCK, V29, P7, DOI 10.1097/shk.0b013e318067de40; Hsing CH, 2007, NEPHROL DIAL TRANSPL, V22, P2230, DOI 10.1093/ndt/gfm179; Hsing CH, 2008, CYTOKINE, V44, P221, DOI 10.1016/j.cyto.2008.06.007; Hsu YH, 2012, RHEUMATOLOGY, V51, P434, DOI 10.1093/rheumatology/ker127; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; Jordan WJ, 2005, EUR J IMMUNOL, V35, P1576, DOI 10.1002/eji.200425317; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kunz S, 2006, EXP DERMATOL, V15, P991, DOI 10.1111/j.1600-0625.2006.00516.x; Li HH, 2005, BRIT J DERMATOL, V153, P591, DOI 10.1111/j.1365-2133.2005.06665.x; Liao SC, 2004, J IMMUNOL, V173, P6712, DOI 10.4049/jimmunol.173.11.6712; Liao YC, 2002, J IMMUNOL, V169, P4288, DOI 10.4049/jimmunol.169.8.4288; Nimmo ER, 2012, INFLAMM BOWEL DIS, V18, P889, DOI 10.1002/ibd.21912; Novak JP, 2002, J BIOL CHEM, V277, P47517, DOI 10.1074/jbc.M205114200; Oral HB, 2006, EUR J IMMUNOL, V36, P380, DOI 10.1002/eji.200425523; Pace E, 2012, ALLERGY, V67, P878, DOI 10.1111/j.1398-9995.2012.02842.x; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sakurai N, 2008, RHEUMATOLOGY, V47, P815, DOI 10.1093/rheumatology/ken061; Schaefer JS, 2011, J IMMUNOL, V187, P5834, DOI 10.4049/jimmunol.1100922; Strober W, 1998, ANN INTERN MED, V128, P848, DOI 10.7326/0003-4819-128-10-199805150-00009; Sun DP, 2013, CYTOKINE, V62, P360, DOI 10.1016/j.cyto.2013.03.017; Wahl C, 2009, J IMMUNOL, V182, P802, DOI 10.4049/jimmunol.182.2.802; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Yeh CH, 2011, ANN THORAC SURG, V92, P1252, DOI 10.1016/j.athoracsur.2011.04.061; Zdanov A, 2010, CYTOKINE GROWTH F R, V21, P325, DOI 10.1016/j.cytogfr.2010.08.003	41	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93910	10.1371/journal.pone.0093910	http://dx.doi.org/10.1371/journal.pone.0093910			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718601	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000056
J	Gruninger, RJ; Thibault, J; Capeness, MJ; Till, R; Mosimann, SC; Sockett, RE; Selinger, BL; Lovering, AL				Gruninger, Robert J.; Thibault, John; Capeness, Michael J.; Till, Robert; Mosimann, Steven C.; Sockett, R. Elizabeth; Selinger, Brent L.; Lovering, Andrew L.			Structural and Biochemical Analysis of a Unique Phosphatase from Bdellovibrio bacteriovorus Reveals Its Structural and Functional Relationship with the Protein Tyrosine Phosphatase Class of Phytase	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; INOSITOL POLYPHOSPHATASE; SUBSTRATE-BINDING; SPECIFICITY; DIVERSITY; STEREOSPECIFICITY	Bdellovibrio bacteriovorus is an unusual delta-proteobacterium that invades and preys on other Gram-negative bacteria and is of potential interest as a whole cell therapeutic against pathogens of man, animals and crops. PTPs (protein tyrosine phosphatases) are an important class of enzyme involved in desphosphorylating a variety of substrates, often with implications in cell signaling. The B. bacteriovorus open reading frame Bd1204 is predicted to encode a PTP of unknown function. Bd1204 is both structurally and mechanistically related to the PTP- like phytase (PTPLP) class of enzymes and possesses a number of unique properties not observed in any other PTPLPs characterized to date. Bd1204 does not display catalytic activity against some common protein tyrosine phosphatase substrates but is highly specific for hydrolysis of phosphomonoester bonds of inositol hexakisphosphate. The structure reveals that Bd1204 has the smallest and least electropositive active site of all characterized PTPLPs to date yet possesses a unique substrate specificity characterized by a strict preference for inositol hexakisphosphate. These two active site features are believed to be the most significant contributors to the specificity of phytate degrading enzymes. We speculate that Bd1204 may be involved in phosphate acquisition outside of prey.	[Gruninger, Robert J.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Capeness, Michael J.; Till, Robert; Sockett, R. Elizabeth] Univ Nottingham, Sch Med, Sch Life Sci, Ctr Genet & Genom,QMC, Nottingham, England; [Thibault, John; Selinger, Brent L.] Univ Lethbridge, Dept Biol Sci, Lethbridge, AB T1K 3M4, Canada; [Mosimann, Steven C.] Univ Lethbridge, Dept Chem & Biochem, Lethbridge, AB T1K 3M4, Canada; [Lovering, Andrew L.] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Lovering, Andrew L.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	Agriculture & Agri Food Canada; University of Nottingham; University of Lethbridge; University of Lethbridge; University of Birmingham; University of Birmingham	Lovering, AL (corresponding author), Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.	a.lovering@bham.ac.uk		Lovering, Andrew/0000-0002-1856-7975	NSERC; BBSRC [BB/G013632/1, BB/J015229/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G013632/1, BB/J015229/1] Funding Source: researchfish	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	LBS and SBM are supported by funding from NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bohm K, 2010, FEBS J, V277, P1284, DOI 10.1111/j.1742-4658.2010.07559.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gruninger RJ, 2008, FEBS J, V275, P3783, DOI 10.1111/j.1742-4658.2008.06524.x; Gruninger RJ, 2012, J BIOL CHEM, V287, P9722, DOI 10.1074/jbc.M111.309872; Gruninger RJ, 2009, J MOL BIOL, V392, P75, DOI 10.1016/j.jmb.2009.05.079; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang HQ, 2011, ENVIRON MICROBIOL, V13, P747, DOI 10.1111/j.1462-2920.2010.02379.x; Idriss EE, 2002, MICROBIOL-SGM, V148, P2097, DOI 10.1099/00221287-148-7-2097; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karunker I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061850; Kostrewa D, 1999, J MOL BIOL, V288, P965, DOI 10.1006/jmbi.1999.2736; Lambert C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008599; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Laskowski RA, 1997, TRENDS BIOCHEM SCI, V22, P488, DOI 10.1016/S0968-0004(97)01140-7; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Lim BL, 2007, ISME J, V1, P321, DOI 10.1038/ismej.2007.40; Mullaney EJ, 2003, BIOCHEM BIOPH RES CO, V312, P179, DOI 10.1016/j.bbrc.2003.09.176; Nakashima BA, 2007, MICROB ECOL, V53, P82, DOI 10.1007/s00248-006-9147-4; Oh BC, 2004, APPL MICROBIOL BIOT, V63, P362, DOI 10.1007/s00253-003-1345-0; Pasternak Z, 2013, ISME J, V7, P756, DOI 10.1038/ismej.2012.149; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Puhl AA, 2008, BIOCHEM CELL BIOL, V86, P322, DOI 10.1139/o08-095; Puhl AA, 2008, INT J BIOCHEM CELL B, V40, P2053, DOI 10.1016/j.biocel.2008.02.003; Puhl AA, 2007, PROTEIN SCI, V16, P1368, DOI 10.1110/ps.062738307; Puhl AA, 2009, APPL MICROBIOL BIOT, V82, P95, DOI 10.1007/s00253-008-1734-5; Rao DECS, 2009, CRIT REV BIOTECHNOL, V29, P182, DOI 10.1080/07388550902919571; Shapland EB, 2011, J BACTERIOL, V193, P4361, DOI 10.1128/JB.00185-11; Sockett RE, 2004, NAT REV MICROBIOL, V2, P669, DOI 10.1038/nrmicro959; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328	34	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94403	10.1371/journal.pone.0094403	http://dx.doi.org/10.1371/journal.pone.0094403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718691	Green Published, Green Submitted, gold			2022-12-25	WOS:000334339000119
J	Gaiad, TP; Araujo, KPC; Serrao, JC; Miglino, MA; Ambrosio, CE				Gaiad, Thais P.; Araujo, Karla P. C.; Serrao, Julio C.; Miglino, Maria A.; Ambrosio, Carlos Eduardo			Motor Physical Therapy Affects Muscle Collagen Type I and Decreases Gait Speed in Dystrophin-Deficient Dogs	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; FIBROSIS; MODELS; RANGE; GENE	Golden Retriever Muscular Dystrophy (GRMD) is a dystrophin-deficient canine model genetically homologous to Duchenne Muscular Dystrophy (DMD) in humans. Muscular fibrosis secondary to cycles of degeneration/regeneration of dystrophic muscle tissue and muscular weakness leads to biomechanical adaptation that impairs the quality of gait. Physical therapy (PT) is one of the supportive therapies available for DMD, however, motor PT approaches have controversial recommendations and there is no consensus regarding the type and intensity of physical therapy. In this study we investigated the effect of physical therapy on gait biomechanics and muscular collagen deposition types I and III in dystrophin-deficient dogs. Two dystrophic dogs (treated dogs-TD) underwent a PT protocol of active walking exercise, 3 x/week, 40 minutes/day, 12 weeks. Two dystrophic control dogs (CD) maintained their routine of activities of daily living. At t0 (pre) and t1 (post-physical therapy), collagen type I and III were assessed by immunohistochemistry and gait biomechanics were analyzed. Angular displacement of shoulder, elbow, carpal, hip, stifle and tarsal joint and vertical (Fy), mediolateral (Fz) and craniocaudal (Fx) ground reaction forces (GRF) were assessed. Wilcoxon test was used to verify the difference of biomechanical variables between t0 and t1, considering p<.05. Type I collagen of endomysium suffered the influence of PT, as well as gait speed that had decreased from t0 to t1 (p<.000). The PT protocol employed accelerates morphological alterations on dystrophic muscle and promotes a slower velocity of gait. Control dogs which maintained their routine of activities of daily living seem to have found a better balance between movement and preservation of motor function.	[Gaiad, Thais P.] Univ Jequitinhonha & Mucuri Valley UFVJM, Fac Biol Sci & Hlth, Dept Phys Therapy, Diamantina, MG, Brazil; [Araujo, Karla P. C.; Miglino, Maria A.] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Surg, BR-09500900 Sao Paulo, Brazil; [Serrao, Julio C.] Univ Sao Paulo, Sch Phys Educ & Sports, Dept Biodynam, BR-09500900 Sao Paulo, Brazil; [Ambrosio, Carlos Eduardo] Univ Sao Paulo, Sch Anim Sci & Food Engn, Dept Vet Med, Pirassununga, SP, Brazil	Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade de Sao Paulo	Ambrosio, CE (corresponding author), Univ Sao Paulo, Sch Anim Sci & Food Engn, Dept Vet Med, Pirassununga, SP, Brazil.	ceambrosio@usp.br	SERRÃO, JULIO CERCA/G-8499-2015; Ambrosio, Carlos Eduardo/F-3402-2010; Miglino, Maria Angelica/B-9519-2012	SERRÃO, JULIO CERCA/0000-0002-3646-3387; Ambrosio, Carlos Eduardo/0000-0002-8224-5022; Miglino, Maria Angelica/0000-0003-4979-115X	FAPESP (Fundacao de Amparo a pesquisa do Estado de Sao Paulo) [06/61561-6]	FAPESP (Fundacao de Amparo a pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research was supported by FAPESP (Fundacao de Amparo a pesquisa do Estado de Sao Paulo) process no 06/61561-6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhadi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052202; Alexakis C, 2007, AM J PHYSIOL-CELL PH, V293, pC661, DOI 10.1152/ajpcell.00061.2007; Ambrosio CE, 2009, GENET MOL RES, V8, P389, DOI 10.4238/vol8-2gmr581; Ansved T, 2003, CURR OPIN CLIN NUTR, V6, P435, DOI 10.1097/00075197-200307000-00013; Araujo KPC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061367; Barthelemy I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048478; Barthelemy I, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-75; Barthelemy I, 2009, NEUROMUSCULAR DISORD, V19, P788, DOI 10.1016/j.nmd.2009.07.014; Besancon MF, 2004, AM J VET RES, V65, P1497, DOI 10.2460/ajvr.2004.65.1497; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Carter GT, 2008, AM J PHYS MED RE S11, V81, P151; Collins CA, 2003, INT J EXP PATHOL, V84, P165, DOI 10.1046/j.1365-2613.2003.00354.x; Cozzi F, 2001, ACTA NEUROPATHOL, V101, P469; Cup EH, 2007, ARCH PHYS MED REHAB, V88, P1452, DOI 10.1016/j.apmr.2007.07.024; Desguerre I, 2009, J NEUROPATH EXP NEUR, V68, P762, DOI 10.1097/NEN.0b013e3181aa31c2; Doglio L, 2011, EUR J PHYS REHAB MED, V47, P587; Eagle M, 2002, NEUROMUSCULAR DISORD, V12, P926, DOI 10.1016/S0960-8966(02)00140-2; Gaiad TP, 2009, BRAZ J PHYS THER, V13, P244, DOI 10.1590/S1413-35552009005000032; Gaiad TP, 2011, RES VET SCI, V91, P188, DOI 10.1016/j.rvsc.2011.01.007; Gaiad TP, 2012, MUSCULAR DYSTROPHY, P535, DOI [10.5772/30329, DOI 10.5772/30329]; Ganea R, 2012, J CHILD NEUROL, V27, P30, DOI 10.1177/0883073811413581; Gillette RL, 2008, VET J, V178, P165, DOI 10.1016/j.tvjl.2008.01.009; Howell JM, 1997, NEUROMUSCULAR DISORD, V7, P325; Huang P, 2009, FASEB J, V23, P2539, DOI 10.1096/fj.09-129833; Huebner KD, 2008, AM J PHYSIOL-HEART C, V294, pH1550, DOI 10.1152/ajpheart.01253.2007; Kerkis I, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-35; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Kornegay JN, 2012, MAMM GENOME, V23, P85, DOI 10.1007/s00335-011-9382-y; Lee DV, 2004, J EXP BIOL, V207, P1715, DOI 10.1242/jeb.00947; Marsh AP, 2010, NEUROMUSCULAR DISORD, V20, P16, DOI 10.1016/j.nmd.2009.10.007; McLoon LK, 2008, AM J PHYSIOL-HEART C, V294, pH1505, DOI 10.1152/ajpheart.00176.2008; Meij BP, 2006, VET SURG, V35, P168, DOI 10.1111/j.1532-950X.2006.00128.x; Nguyen F, 2002, J COMP PATHOL, V126, P100, DOI 10.1053/jcpa.2001.0526; Passerini L, 2002, NEUROMUSCULAR DISORD, V12, P828, DOI 10.1016/S0960-8966(02)00071-8; Shin JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059875; Shin JH, 2013, MOL THER, V21, P750, DOI 10.1038/mt.2012.283; Strober Jonathan B, 2006, NeuroRx, V3, P225; Thibaud JL, 2007, NEUROMUSCULAR DISORD, V17, P575, DOI 10.1016/j.nmd.2007.03.013; VALENTINE BA, 1990, J NEUROL SCI, V97, P1, DOI 10.1016/0022-510X(90)90095-5; van der Walt AM, 2008, J S AFR VET ASSOC, V79, P175; Zhou L, 2010, J NEUROPATH EXP NEUR, V69, P771, DOI 10.1097/NEN.0b013e3181e9a34b	41	10	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93500	10.1371/journal.pone.0093500	http://dx.doi.org/10.1371/journal.pone.0093500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713872	Green Published, gold, Green Submitted			2022-12-25	WOS:000334160900029
J	Natoli, C; Brocco, D; Sperduti, I; Nuzzo, A; Tinari, N; De Tursi, M; Grassadonia, A; Mazzilli, L; Iacobelli, S; Gamucci, T; Vici, P				Natoli, Clara; Brocco, Davide; Sperduti, Isabella; Nuzzo, Antonio; Tinari, Nicola; De Tursi, Michele; Grassadonia, Antonino; Mazzilli, Lorenzo; Iacobelli, Stefano; Gamucci, Teresa; Vici, Patrizia		Follow-UP Study Grp	Breast Cancer '' Tailored Follow-up '' in Italian Oncology Units: A Web-Based Survey	PLOS ONE			English	Article							AMERICAN-SOCIETY; ADJUVANT THERAPY; CARE; GUIDELINES; WOMEN; SURVEILLANCE; RECURRENCE; DISEASE; UPDATE; EXPERIENCE	Purpose: Breast cancer follow-up procedures after primary treatment are still a controversial issue. Aim of this study was to investigate, through a web-based survey, surveillance methodologies selected by Italian oncologists in everyday clinical practice. Methods: Referents of Italian medical oncology units were invited to participate to the study via e-mail through the SurveyMonkey website. Participants were asked how, in their institution, exams of disease staging and follow-up are planned in asymptomatic women and if surveillance continues beyond the 5th year. Results: Between February and May 2013, 125 out of 233 (53.6%) invited referents of Italian medical oncology units agreed to participate in the survey. Ninety-seven (77.6%) referents state that modalities of breast cancer follow-up are planned according to the risk of disease progression at diagnosis and only 12 (9.6%) oncology units apply the minimal follow-up procedures according to international guidelines. Minimal follow-up is never applied in high risk asymptomatic women. Ninety-eight (78.4%) oncology units continue follow-up in all patients beyond 5 years. Conclusions: Our survey shows that 90.4% of participating Italian oncology units declare they do not apply the minimal breast cancer follow-up procedures after primary treatment in asymptomatic women, as suggested by national and international guidelines. Interestingly, about 80.0% of interviewed referents performs the so called '' tailored follow-up '', high intensity for high risk, low intensity for low risk patients. There is an urgent need of randomized clinical trials able to determine the effectiveness of risk-based follow-up modalities, their ideal frequency and persistence in time.	[Natoli, Clara; Brocco, Davide; Tinari, Nicola; De Tursi, Michele; Grassadonia, Antonino; Iacobelli, Stefano] Univ G Dannunzio, Dept Expt & Clin Sci, Chieti, Italy; [Sperduti, Isabella] Regina Elena Inst Canc Res, Unit Biostat, Rome, Italy; [Nuzzo, Antonio] Floraspe Renzetti Hosp, Dept Oncol, Lanciano, Italy; [Mazzilli, Lorenzo] SS Annunziata Hosp, Clin Governance Unit, Chieti, Italy; [Gamucci, Teresa] SS Trinita Hosp, Dept Oncol, Sora, Italy; [Vici, Patrizia] Regina Elena Inst Canc Res, Div Med Oncol B, Rome, Italy	G d'Annunzio University of Chieti-Pescara; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Natoli, C (corresponding author), Univ G Dannunzio, Dept Expt & Clin Sci, Chieti, Italy.	natoli@unich.it	Natoli, Clara/E-1378-2013; GORI, Stefania/AAB-4802-2022; Madeddu, Clelia/C-2347-2014; GORI, Stefania/N-8827-2016; Brocco, Davide/ABC-5304-2021; Brunello, Antonella/F-4224-2014; DE TURSI, MICHELE/L-3427-2016; Biglia, Nicoletta/F-8801-2013; Ferro, Antonella/AAA-8241-2020; Sperduti, Isabella/K-8902-2016; riccardi, ferdinando/K-7370-2016	Natoli, Clara/0000-0001-7295-0230; GORI, Stefania/0000-0001-6320-405X; GORI, Stefania/0000-0001-6320-405X; Brunello, Antonella/0000-0003-2583-5226; DE TURSI, MICHELE/0000-0002-1411-1946; Biglia, Nicoletta/0000-0003-1009-5309; Ferro, Antonella/0000-0003-4109-6769; Sperduti, Isabella/0000-0001-5115-3099; riccardi, ferdinando/0000-0002-2852-2770; Landriscina, Matteo/0000-0003-0591-9799; Vici, Patrizia/0000-0001-7528-9783; Tonini, Giuseppe/0000-0003-4442-8677; Tinari, Nicola/0000-0001-8449-5407; ORDITURA, Michele/0000-0001-9105-8563	Consorzio Interuniversitario Nazionale per Bio-Oncologia (CINBO); Gruppo Interdisciplinare Cure Oncologiche (GICO), ASL Lanciano-Vasto-Chieti, Italy	Consorzio Interuniversitario Nazionale per Bio-Oncologia (CINBO); Gruppo Interdisciplinare Cure Oncologiche (GICO), ASL Lanciano-Vasto-Chieti, Italy	Supported by the Consorzio Interuniversitario Nazionale per Bio-Oncologia (CINBO) and by the Gruppo Interdisciplinare Cure Oncologiche (GICO), ASL Lanciano-Vasto-Chieti, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Associazione Italiana Oncologia Medica, LIN GUID TUM MAMM; Azim HA, 2011, ANN ONCOL, V22, P1939, DOI 10.1093/annonc/mdq683; Barni S, 2011, TUMORI J, V97, P559, DOI 10.1700/989.10711; Bell RJ, 2013, INTERN MED J; Bell RJ, 2013, ANZ J SURG, V83, P129, DOI 10.1111/j.1445-2197.2012.06229.x; Brennan ME, 2010, ASIA-PAC J CLIN ONCO, V6, P116, DOI 10.1111/j.1743-7563.2010.01286.x; Ciatto S, 2004, EUR J CANCER, V40, P1496, DOI 10.1016/j.ejca.2004.03.010; Collins RF, 2004, CANCER TREAT REV, V30, P19, DOI 10.1016/S0305-7372(03)00141-5; Davies C, 2013, LANCET, V381, P805, DOI 10.1016/S0140-6736(12)61963-1; de Bock GH, 2004, BRIT J CANCER, V90, P1144, DOI 10.1038/sj.bjc.6601655; Del Barco S, 2013, CLIN TRANSL ONCOL; DELTURCO MR, 1994, JAMA-J AM MED ASSOC, V271, P1593, DOI 10.1001/jama.1994.03510440053032; Donnelly P, 2007, ANN ONCOL, V18, P1467, DOI 10.1093/annonc/mdm193; Gamucci T, 2013, J CANCER RES CLIN, V139, P853, DOI 10.1007/s00432-013-1388-2; GHEZZI P, 1994, JAMA-J AM MED ASSOC, V271, P1587, DOI 10.1001/jama.1994.03510440047031; Goss PE, 2003, NEW ENGL J MED, V349, P1793, DOI 10.1056/NEJMoa032312; Grandjean I, 2012, EUR J ONCOL NURS, V16, P281, DOI 10.1016/j.ejon.2011.07.004; Grunfeld E, 2005, CAN MED ASSOC J, V172, P1319, DOI 10.1503/cmaj.045062; Grunfeld E, 2010, J ONCOL PRACT, V6, P174, DOI 10.1200/JOP.200009; Hahn EE, 2013, CANCER; Hall PS, 2011, PHARMACOECONOMICS, V29, P415, DOI 10.2165/11588340-000000000-00000; Harrell JC, 2012, BREAST CANCER RES TR, V132, P523, DOI 10.1007/s10549-011-1619-7; Hayes DF, 2007, NEW ENGL J MED, V356, P2505, DOI 10.1056/NEJMcp067260; Jatoi I, 2011, J CLIN ONCOL, V29, P2301, DOI 10.1200/JCO.2010.32.3550; Khatcheressian JL, 2006, J CLIN ONCOL, V24, P5091, DOI 10.1200/JCO.2006.08.8575; Khatcheressian JL, 2013, J CLIN ONCOL, V31, P961, DOI 10.1200/JCO.2012.45.9859; Kobayashi T, 2012, BREAST CANCER-TOKYO, V19, P218, DOI 10.1007/s12282-012-0347-0; Kokko R, 2005, BREAST CANCER RES TR, V93, P255, DOI 10.1007/s10549-005-5199-2; Leoni M, 2013, TUMORI, V99, P30, DOI 10.1700/1248.13784; Margenthaler JA, 2013, ANN SURG ONCOL; Margenthaler JA, 2012, J ONCOL PRACT, V8, P79, DOI 10.1200/JOP.2011.000289; Metzger O, 2013, J CLIN ONCOL, V31, P3083, DOI 10.1200/JCO.2012.46.1574; Minicozzi P, 2013, J CANCER RES CLIN, V139, P1569, DOI 10.1007/s00432-013-1478-1; Montgomery DA, 2007, BRIT J CANCER, V96, P1625, DOI 10.1038/sj.bjc.6603771; Nabholtz Jean-Marc A, 2008, Ther Clin Risk Manag, V4, P189; National Comprehensive Cancer Network, 2013, BREAST CANC; Neuman HB, 2013, ANN SURG ONCOL; NICE, EARL LOC ADV BREAST; Ogawa Y, 2013, INT J CLIN ONCOL, V18, P447, DOI 10.1007/s10147-012-0401-0; Ohno S, 2012, BREAST CANCER-TOKYO, V19, P212, DOI 10.1007/s12282-011-0277-2; Palli D, 1999, JAMA-J AM MED ASSOC, V281, P1586, DOI 10.1001/jama.281.17.1586; Rojas MP, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001768.pub2; Mendoza ESR, 2013, J CANCER RES CLIN, V139, P645, DOI 10.1007/s00432-012-1367-z; Saphner T, 1996, J CLIN ONCOL, V14, P2738, DOI 10.1200/JCO.1996.14.10.2738; Schaapveld M, 2008, BREAST CANCER RES TR, V110, P189, DOI 10.1007/s10549-007-9709-2; Senkus E, 2013, ANN ONCOL; Smith TJ, 1999, J CLIN ONCOL, V17, P1080, DOI 10.1200/JCO.1999.17.3.1080; Somerfield MR, 1997, J CLIN ONCOL, V15, P2149; Stopeck AT, 2012, CLIN EXP METASTAS, V29, P807, DOI 10.1007/s10585-012-9496-y; Strasser-Weippl K, 2013, BREAST, V22, pS171, DOI 10.1016/j.breast.2013.07.033; Taggart F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-238; van Hezewijk M, 2011, EJSO-EUR J SURG ONC, V37, P217, DOI 10.1016/j.ejso.2011.01.001	52	6	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94063	10.1371/journal.pone.0094063	http://dx.doi.org/10.1371/journal.pone.0094063			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714591	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900078
J	Wang, XL; Luo, FL; Zhao, HG				Wang, Xiaolong; Luo, Fuling; Zhao, Hengguang			Paraquat-Induced Reactive Oxygen Species Inhibit Neutrophil Apoptosis via a p38 MAPK/NF-kappa B-IL-6/TNF-alpha Positive-Feedback Circuit	PLOS ONE			English	Article							NF-KAPPA-B; HYDROGEN-PEROXIDE; ACTIVATION; LUNG; SUPPRESSION; HYPOXIA; KINASE	Paraquat (PQ), a widely used herbicide and potent reactive oxygen species (ROS) inducer, can injure multiple tissues and organs, especially the lung. However, the underlying mechanism is still poorly understood. According to previous reports, neutrophil aggregation and excessive ROS production might play pivotal pathogenetic roles. In the present study, we found that PQ could prolong neutrophil lifespan and induce ROS generation in a concentration-independent manner. Activated nuclear factor-kappa B (NF-kappa B), p38 mitogen-activated kinase (p38 MAPK), and myeloid cell leukemia sequence 1 (Mcl-1) but not Akt signaling pathways were involved in this process, as well as increasing levels of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and IL-1 beta. Furthermore, the proinflammatory mediators IL-6 and TNF-alpha could in turn promote ROS generation, creating a vicious cycle. The existence of such a feedback loop is supported by our finding that neutrophil apoptosis is attenuated by PQ in a concentration-independent manner and could partially explain the clinical dilemma why oxygen therapy will exacerbate PQ induced tissue injury.	[Wang, Xiaolong] Chongqing Med Univ, Affiliated Hosp 2, Emergency Dept, Chongqing, Peoples R China; [Luo, Fuling] Chongqing Med Univ, Affiliated Hosp 1, Dept Pharm, Chongqing, Peoples R China; [Zhao, Hengguang] Chongqing Med Univ, Affiliated Hosp 1, Dept Dermatol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Zhao, HG (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Dermatol, Chongqing, Peoples R China.	zhgdoc@hotmail.com			Natural Science Foundation Project of CQ CSTC [cstc2012jjA0315]; Sanitary Science Foundation of CQ [2013-2-036]	Natural Science Foundation Project of CQ CSTC(Natural Science Foundation Project of CQ CSTC); Sanitary Science Foundation of CQ	This study was supported by Natural Science Foundation Project of CQ CSTC (to Hengguang Zhao, No. cstc2012jjA0315) and Sanitary Science Foundation of CQ (to Xiaolong Wang, No. 2013-2-036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirshahrokhi K, 2013, INT IMMUNOPHARMACOL, V17, P210, DOI 10.1016/j.intimp.2013.06.005; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Choi M, 2003, BLOOD, V102, P2259, DOI 10.1182/blood-2002-09-2960; Corasaniti MT, 1998, PHARMACOL TOXICOL, V83, P1, DOI 10.1111/j.1600-0773.1998.tb01434.x; Derouet M, 2004, J BIOL CHEM, V279, P26915, DOI 10.1074/jbc.M313875200; Dimmeler S, 1997, J EXP MED, V185, P601, DOI 10.1084/jem.185.4.601; Dinis-Oliveira RJ, 2006, XENOBIOTICA, V36, P724, DOI 10.1080/00498250600790331; Dinis-Oliveira RJ, 2006, PEDIATR EMERG CARE, V22, P537, DOI 10.1097/01.pec.0000223179.07633.8a; Edwards MG, 2003, PHYSIOL GENOMICS, V13, P119, DOI 10.1152/physiolgenomics.00172.2002; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hampton MB, 1997, FEBS LETT, V414, P552, DOI 10.1016/S0014-5793(97)01068-5; Hashimoto S, 2000, AM J RESP CRIT CARE, V161, P237, DOI 10.1164/ajrccm.161.1.9810007; Haslett C, 1997, BRIT MED BULL, V53, P669; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; Hoffer E, 1996, TOXICOL LETT, V84, P7, DOI 10.1016/0378-4274(95)03446-3; Holland JA, 1998, ENDOTHELIUM-NEW YORK, V6, P113, DOI 10.3109/10623329809072198; Korn SH, 2001, J BIOL CHEM, V276, P35693, DOI 10.1074/jbc.M104321200; Kulisz A, 2002, AM J PHYSIOL-LUNG C, V282, pL1324, DOI 10.1152/ajplung.00326.2001; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee W L, 2001, Curr Opin Crit Care, V7, P1, DOI 10.1097/00075198-200102000-00001; Leuenroth SJ, 2000, SURGERY, V128, P171, DOI 10.1067/msy.2000.107609; Lundqvist-Gustafsson H, 1999, J LEUKOCYTE BIOL, V65, P196, DOI 10.1002/jlb.65.2.196; Maianski NA, 2003, ACTA HAEMATOL-BASEL, V111, P56, DOI 10.1159/000074486; Martin TR, 2003, CRIT CARE MED, V31, pS184, DOI 10.1097/01.CCM.0000057841.33876.B1; MatuteBello G, 1997, AM J RESP CRIT CARE, V156, P1969, DOI 10.1164/ajrccm.156.6.96-12081; Melino G, 1997, NATURE, V388, P432, DOI 10.1038/41237; Miskolci V, 2007, MOL MED, V13, P134, DOI 10.2119/2006-00072.Miskolci; Moulding DA, 2001, J LEUKOCYTE BIOL, V70, P783; Nick JA, 1999, J CLIN INVEST, V103, P851, DOI 10.1172/JCI5257; Parsey MV, 1999, CLIN IMMUNOL, V91, P219, DOI 10.1006/clim.1999.4693; Peng J, 2004, J BIOL CHEM, V279, P32626, DOI 10.1074/jbc.M404596200; Rygiel TP, 2008, J CELL SCI, V121, P1183, DOI 10.1242/jcs.017194; SLATER AFG, 1995, BBA-MOL BASIS DIS, V1271, P59, DOI 10.1016/0925-4439(95)00010-2; Strassheim D, 2004, AM J PHYSIOL-CELL PH, V286, pC683, DOI 10.1152/ajpcell.00296.2003; Tesoriere L., 2013, BR J NUTR, P1; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Yum HK, 2001, J IMMUNOL, V167, P6601, DOI 10.4049/jimmunol.167.11.6601; Zhang B, 2003, J BIOL CHEM, V278, P28443, DOI 10.1074/jbc.M210727200	39	40	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93837	10.1371/journal.pone.0093837	http://dx.doi.org/10.1371/journal.pone.0093837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714343	Green Submitted, gold, Green Published			2022-12-25	WOS:000334160900055
J	Yi, N; Ma, WZ; Pei, JF; Ouyang, Q; Tang, C; Lai, LH				Yi, Ning; Ma, Wenzhe; Pei, Jianfeng; Ouyang, Qi; Tang, Chao; Lai, Luhua			Synergistic and Antagonistic Drug Combinations Depend on Network Topology	PLOS ONE			English	Article							DISCOVERY; IDENTIFICATION; INHIBITION; TARGET	Drug combinations may exhibit synergistic or antagonistic effects. Rational design of synergistic drug combinations remains a challenge despite active experimental and computational efforts. Because drugs manifest their action via their targets, the effects of drug combinations should depend on the interaction of their targets in a network manner. We therefore modeled the effects of drug combinations along with their targets interacting in a network, trying to elucidate the relationships between the network topology involving drug targets and drug combination effects. We used three-node enzymatic networks with various topologies and parameters to study two-drug combinations. These networks can be simplifications of more complex networks involving drug targets, or closely connected target networks themselves. We found that the effects of most of the combinations were not sensitive to parameter variation, indicating that drug combinational effects largely depend on network topology. We then identified and analyzed consistent synergistic or antagonistic drug combination motifs. Synergistic motifs encompass a diverse range of patterns, including both serial and parallel combinations, while antagonistic combinations are relatively less common and homogenous, mostly composed of a positive feedback loop and a downstream link. Overall our study indicated that designing novel synergistic drug combinations based on network topology could be promising, and the motifs we identified could be a useful catalog for rational drug combination design in enzymatic systems.	[Yi, Ning; Pei, Jianfeng; Ouyang, Qi; Tang, Chao; Lai, Luhua] Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China; [Lai, Luhua] Peking Univ, Coll Chem & Mol Engn, State Key Lab Struct Chem Unstable & Stable Speci, BNLMS, Beijing 100871, Peoples R China; [Ouyang, Qi; Tang, Chao; Lai, Luhua] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Ouyang, Qi; Tang, Chao] Peking Univ, Sch Phys, Beijing 100871, Peoples R China; [Ma, Wenzhe] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA	Peking University; Chinese Academy of Sciences; Peking University; Peking University; Peking University; Harvard University; Harvard Medical School	Lai, LH (corresponding author), Peking Univ, Ctr Quantitat Biol, Beijing 100871, Peoples R China.	lhlai@pku.edu.cn	Ma, Wenzhe/N-3320-2017; Pei, Jianfeng/U-9790-2019	Pei, Jianfeng/0000-0002-8482-1185; Tang, Chao/0000-0003-1474-3705	Ministry of Science and Technology of China [2012AA020308, 2012AA020301]; National Natural Science Foundation of China [90913021, 91313302, 81273436]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Ministry of Science and Technology of China (No. 2012AA020308, 2012AA020301) National Natural Science Foundation of China (No. 90913021, 91313302, 81273436). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo RP, 2007, NAT REV DRUG DISCOV, V6, P871, DOI 10.1038/nrd2381; BLACK ML, 1963, J MED CHEM, V6, P145, DOI 10.1021/jm00338a014; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Chait R, 2007, NATURE, V446, P668, DOI 10.1038/nature05685; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cokol M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.71; Feala JD, 2010, WIRES SYST BIOL MED, V2, P181, DOI 10.1002/wsbm.51; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Galassi M., 2011, GNU SCI LIB REFERENC; GRECO WR, 1995, PHARMACOL REV, V47, P331; Jansen G, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.95; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Kraatz BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012838; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Li S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S10; Liu YB, 2010, BIOINFORMATICS, V26, P587, DOI 10.1093/bioinformatics/btp697; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Molhoek KR, 2005, J TRANSL MED, V3, P1, DOI 10.1186/1479-5876-3-39; Morita M, 2007, INT J ONCOL, V30, P187; Severyn B, 2011, ACS CHEM BIOL, V6, P1391, DOI 10.1021/cb2003225; Tan X, 2012, NAT BIOTECHNOL, V30, P1125, DOI 10.1038/nbt.2391; VOGT MW, 1987, SCIENCE, V235, P1376, DOI 10.1126/science.2435003; Wang HS, 2011, CANCER RES, V71, P5535, DOI 10.1158/0008-5472.CAN-10-4351; Xu S, 2013, MOL CANC THER; Yan H, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-50; YAN L, 2012, PLOS ONE, V0007; Yang K, 2007, PLOS COMPUT BIOL, V3, P523, DOI 10.1371/journal.pcbi.0030055; Yang K, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.60; Yao G, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.19; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; Yeh PJ, 2009, NAT REV MICROBIOL, V7, P460, DOI 10.1038/nrmicro2133; Zou J, 2012, MOL BIOSYST, V8, P3185, DOI 10.1039/c2mb25267h	35	42	47	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93960	10.1371/journal.pone.0093960	http://dx.doi.org/10.1371/journal.pone.0093960			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713621	gold, Green Published, Green Submitted			2022-12-25	WOS:000334160900067
J	Nakamura, I; Zakharia, K; Banini, BA; Mikhail, DS; Kim, TH; Yang, JD; Moser, CD; Shaleh, HM; Thornburgh, SR; Walters, I; Roberts, LR				Nakamura, Ikuo; Zakharia, Kais; Banini, Bubu A.; Mikhail, Dalia S.; Kim, Tae Hyo; Yang, Ju Dong; Moser, Catherine D.; Shaleh, Hassan M.; Thornburgh, Sarah R.; Walters, Ian; Roberts, Lewis R.			Brivanib Attenuates Hepatic Fibrosis In Vivo and Stellate Cell Activation In Vitro by Inhibition of FGF, VEGF and PDGF Signaling	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HEPATOCELLULAR-CARCINOMA; TRANSGENIC MICE; LIVER FIBROSIS; TGF-BETA; INCREASED EXPRESSION; FACTOR RECEPTOR-2; BASIC FIBROBLAST; DUAL INHIBITOR; DISCOVERY	Background and Aims: Brivanib is a selective inhibitor of vascular endothelial growth factor receptor (VEGFR) and fibroblast growth factor receptor (FGFR) tyrosine kinases, which are both involved in mechanisms of liver fibrosis. We hypothesized that inhibition of VEGFR and FGFR by brivanib would inhibit liver fibrosis. We therefore examined the effect of brivanib on liver fibrosis in three mouse models of fibrosis. Methods: In vivo, we induced liver fibrosis by bile duct ligation (BDL), chronic carbon tetrachloride (CCl4), and chronic thioacetamide (TAA) administration. Liver fibrosis was examined by immunohistochemistry and Western immunoblotting. In vitro, we used LX-2 human hepatic stellate cells (HSCs) to assess the effect of brivanib on stellate cell proliferation and activation. Results: After in vivo induction with BDL, CCl4, and TAA, mice treated with brivanib showed reduced liver fibrosis and decreased expression of collagen I alpha 1 and alpha-smooth muscle actin in the liver. In vitro, brivanib decreased proliferation of HSCs induced by platelet-derived growth factor (PDGF), VEGF, and FGF. Brivanib also decreased stellate cell viability and inhibited PDGFBB-induced phosphorylation of its cognate receptor. Conclusion: Brivanib reduces liver fibrosis in three different animal models and decreases human hepatic stellate cell activation. Brivanib may represent a novel therapeutic approach to treatment of liver fibrosis and prevention of liver cancer.	[Nakamura, Ikuo; Zakharia, Kais; Banini, Bubu A.; Mikhail, Dalia S.; Kim, Tae Hyo; Yang, Ju Dong; Moser, Catherine D.; Shaleh, Hassan M.; Thornburgh, Sarah R.; Roberts, Lewis R.] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA; [Walters, Ian] Bristol Myers Squibb, Wallingford, CT USA	Mayo Clinic; Bristol-Myers Squibb	Roberts, LR (corresponding author), Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA.	roberts.lewis@mayo.edu		Roberts, Lewis/0000-0001-7885-8574	Bristol Myers Squibb; NATIONAL CANCER INSTITUTE [R01CA165076] Funding Source: NIH RePORTER	Bristol Myers Squibb(Bristol-Myers Squibb); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant Support was received from Bristol Myers Squibb. Dr Ian Walters (employee of Bristol Myers Squibb) played a role in study design and in review/editing of the manuscript, but had no role in data collection and analysis or in the decision to publish.	Ayers M, 2007, CANCER RES, V67, P6899, DOI 10.1158/0008-5472.CAN-06-4555; BARTOK I, 1981, HUM PATHOL, V12, P794; Bhide RS, 2010, MOL CANCER THER, V9, P369, DOI 10.1158/1535-7163.MCT-09-0472; Bhide RS, 2006, J MED CHEM, V49, P2143, DOI 10.1021/jm051106d; Cai ZW, 2008, J MED CHEM, V51, P1976, DOI 10.1021/jm7013309; Campbell JS, 2005, P NATL ACAD SCI USA, V102, P3389, DOI 10.1073/pnas.0409722102; Czochra P, 2006, J HEPATOL, V45, P419, DOI 10.1016/j.jhep.2006.04.010; Fibbi G, 1999, HEPATOLOGY, V29, P868, DOI 10.1002/hep.510290343; Finn RS, 2012, CLIN CANCER RES, V18, P2090, DOI 10.1158/1078-0432.CCR-11-1991; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Huynh H, 2008, CLIN CANCER RES, V14, P6146, DOI 10.1158/1078-0432.CCR-08-0509; Jeong WI, 2006, HEPATOLOGY, V44, P1441, DOI 10.1002/hep.21419; JHAPPAN C, 1990, CELL, V61, P1137, DOI 10.1016/0092-8674(90)90076-Q; Kahraman A, 2008, HEPATOLOGY, V47, P1317, DOI 10.1002/hep.22136; Kim SO, 1996, CANCER RES, V56, P3831; Liu XJ, 2006, LIVER INT, V26, P8, DOI 10.1111/j.1478-3231.2005.01192.x; Liu YQ, 2009, LAB INVEST, V89, P209, DOI 10.1038/labinvest.2008.127; Mise M, 1996, HEPATOLOGY, V23, P455; MULLER A, 1988, EXP PATHOL-JENA, V34, P229; Nicholes K, 2002, AM J PATHOL, V160, P2295, DOI 10.1016/S0002-9440(10)61177-7; Pinzani M, 1998, LIVER, V18, P2; Pinzani M, 2002, FRONT BIOSCI-LANDMRK, V7, pD1720, DOI 10.2741/pinzani; Sokolovic A, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-3; Torimura T, 1998, HUM PATHOL, V29, P986, DOI 10.1016/S0046-8177(98)90205-2; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yang JD, 2011, SEMIN CANCER BIOL, V21, P35, DOI 10.1016/j.semcancer.2010.10.007; Yu CD, 2003, AM J PATHOL, V163, P1653, DOI 10.1016/S0002-9440(10)63522-5	27	43	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e92273	10.1371/journal.pone.0092273	http://dx.doi.org/10.1371/journal.pone.0092273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710173	Green Published, gold			2022-12-25	WOS:000334159800012
J	Wang, LM; Li, LH; Chen, X; Tian, X; Wang, XK; Luo, GP				Wang, Limei; Li, Longhui; Chen, Xi; Tian, Xin; Wang, Xiaoke; Luo, Geping			Biomass Allocation Patterns across China's Terrestrial Biomes	PLOS ONE			English	Article							ORGANIC-MATTER; ROOT BIOMASS; SHOOT RATIOS; CARBON; FORESTS; GROWTH; PLANTS; WATER	Root to shoot ratio (RS) is commonly used to describe the biomass allocation between below-and aboveground parts of plants. Determining the key factors influencing RS and interpreting the relationship between RS and environmental factors is important for biological and ecological research. In this study, we compiled 2088 pairs of root and shoot biomass data across China's terrestrial biomes to examine variations in the RS and its responses to biotic and abiotic factors including vegetation type, soil texture, climatic variables, and stand age. The median value of RS (RSm) for grasslands, shrublands, and forests was 6.0, 0.73, and 0.23, respectively. The range of RS was considerably wide for each vegetation type. RS values for all three major vegetation types were found to be significantly correlated to mean annual precipitation (MAP) and potential water deficit index (PWDI). Mean annual temperature (MAT) also significantly affect the RS for forests and grasslands. Soil texture and forest origin altered the response of RS to climatic factors as well. An allometric formula could be used to well quantify the relationship between aboveground and belowground biomass, although each vegetation type had its own inherent allometric relationship.	[Wang, Limei; Li, Longhui; Chen, Xi; Luo, Geping] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Peoples R China; [Tian, Xin] Chinese Acad Forestry, Inst Forest Informat Resource Tech, Beijing, Peoples R China; [Wang, Xiaoke] Chinese Acad Sci, Res Ctr Ecoenvironm Sci, State Key Lab Urban & Reg Ecol, Beijing Urban Ecosyst Res Stn, Beijing, Peoples R China	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Forestry; Chinese Academy of Sciences; Research Center for Eco-Environmental Sciences (RCEES)	Li, LH (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Peoples R China.	lhli@ms.xjb.ac.cn; tianxin@caf.ac.cn	Li, Longhui/I-5797-2018; Li, L./C-7214-2013	Li, Longhui/0000-0001-9983-6681; 	National Natural Science Foundation of China [41171094, 41101379]; "Hundred Talent" Project of the Chinese Academy of Sciences [Y174051001]; one of National Basic Research Program of China [2013CB733404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Hundred Talent" Project of the Chinese Academy of Sciences(Chinese Academy of Sciences); one of National Basic Research Program of China	This study was funded by the National Natural Science Foundation of China (grant number 41171094), the "Hundred Talent" Project of the Chinese Academy of Sciences (grant number Y174051001), one of National Basic Research Program of China (grant number 2013CB733404), and the National Natural Science Foundation of China (grant number 41101379). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren GI, 2003, ANN BOT-LONDON, V92, P795, DOI 10.1093/aob/mcg203; Binkley D, 2004, FOREST ECOL MANAG, V193, P5, DOI 10.1016/j.foreco.2004.01.019; BROWN S, 1982, BIOTROPICA, V14, P161, DOI 10.2307/2388024; Cairns MA, 1997, OECOLOGIA, V111, P1, DOI 10.1007/s004420050201; Camila AC, 2011, PLOS ONE, V6; Cheng DL, 2007, ANN BOT-LONDON, V99, P95, DOI 10.1093/aob/mcl206; Crawley M. J, 2002, STAT COMPUTING INTRO; Enquist BJ, 2002, SCIENCE, V295, P1517, DOI 10.1126/science.1066360; Ericsson T, 1996, BIOMASS BIOENERG, V11, P115, DOI 10.1016/0961-9534(96)00032-3; FAO Food and Agriculture Organization of the United Nations, 1998, CROP EVAPOTRANSPIRAT; Friedlingstein P, 1999, GLOBAL CHANGE BIOL, V5, P755, DOI 10.1046/j.1365-2486.1999.00269.x; GHOLZ HL, 1991, ECOL MONOGR, V61, P33, DOI 10.2307/1942998; GOWER ST, 1992, ECOL MONOGR, V62, P43, DOI 10.2307/2937170; Hui DF, 2006, NEW PHYTOL, V169, P85, DOI 10.1111/j.1469-8137.2005.01569.x; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Kang MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069561; Kellomaki S, 2001, TREE PHYSIOL, V16, P765; Li LH, 2006, FIELD CROP RES, V96, P133, DOI 10.1016/j.fcr.2005.06.003; Li LH, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002038; Luo YJ, 2013, ANN FOREST SCI, V70, P589, DOI 10.1007/s13595-013-0296-6; Luo YJ, 2012, FOREST ECOL MANAG, V269, P19, DOI 10.1016/j.foreco.2012.01.005; Matsui Y, 2003, WATER RES, V37, P4413, DOI 10.1016/S0043-1354(03)00423-8; McConnaughay KDM, 1999, ECOLOGY, V80, P2581, DOI 10.1890/0012-9658(1999)080[2581:BAIPOO]2.0.CO;2; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Niklas KJ, 2006, NEW PHYTOL, V171, P27, DOI 10.1111/j.1469-8137.2006.01760.x; Niklas KJ, 2005, ANN BOT-LONDON, V95, P315, DOI 10.1093/aob/mci028; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P595, DOI 10.1071/PP99173; Read JJ, 1996, ANN BOT-LONDON, V77, P487, DOI 10.1006/anbo.1996.0059; Reich PB, 2002, PLANT ROOTS HIDDEN H, V3rd, P205; Schenk HJ, 2002, J ECOL, V90, P480, DOI 10.1046/j.1365-2745.2002.00682.x; Snowdon P., 2000, 17 NCAS AUSTR GREENH; Stearns S.C., 1992, pi; Vogt KA, 1998, PLANT SOIL, V200, P71, DOI 10.1023/A:1004313515294; Wang XP, 2008, FOREST ECOL MANAG, V255, P4007, DOI 10.1016/j.foreco.2008.03.055; Yang YH, 2010, GLOBAL ECOL BIOGEOGR, V19, P268, DOI 10.1111/j.1466-8238.2009.00502.x; Yang YH, 2009, J VEG SCI, V20, P177, DOI 10.1111/j.1654-1103.2009.05566.x; Yu Q, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032162, 10.1371/journal.pone.0050902]	37	24	33	11	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93566	10.1371/journal.pone.0093566	http://dx.doi.org/10.1371/journal.pone.0093566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710503	Green Submitted, Green Published, gold			2022-12-25	WOS:000334159800038
J	Ye, GP; Zhu, YX; Liu, J; Chen, XX; Huang, KH				Ye, Gengping; Zhu, Yongxing; Liu, Jin; Chen, Xingxiang; Huang, Kehe			Preparation of Glycerol-Enriched Yeast Culture and Its Effect on Blood Metabolites and Ruminal Fermentation in Goats	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; DAIRY-COWS; RUMEN FERMENTATION; EARLY LACTATION; PERFORMANCE; LAMBS; ACCUMULATION; AMMONIA; INVITRO; SHEEP	The aim of this study was to isolate a glycerol-producing yeast strain from nature to prepare glycerol-enriched yeast culture (GY), and preliminarily evaluate the effects of GY on blood metabolites and ruminal fermentation in goats. During the trial, six isolates were isolated from unprocessed honey, and only two isolates with higher glycerol yield were identified by analysis of 26S ribosomal DNA sequences. One of the two isolates was identified as Saccharomyces cerevisiae, a direct-fed microbe permitted by the FDA. This isolate was used to prepare GY. The fermentation parameters were optimized through single-factor and orthogonal design methods to maximize the glycerol yield and biomass. The final GY contained 38.7 +/- 0.6 g/L glycerol and 12.6 +/- 0.5 g/L biomass. In vivo, eight castrated male goats with ruminal fistula were used in a replicated 464 Latin square experiment with four consecutive periods of 15 d. Treatments were as follows: control, LGY, MGY, and HGY with 0, 100, 200, and 300 mL GY per goat per day, respectively. The GY was added in two equal portions at 08: 00 and 17: 00 through ruminal fistula. Samples of blood and ruminal fluid were collected on the last one and two days of each period, respectively. Results showed that the plasma concentrations of triglyceride and total cholesterol were not affected by the supplemented GY. Compared with the control, goats supplemented with MGY and HGY had significantly higher(P < 0.05) concentrations of plasma glucose and total protein, ruminal volatile fatty acid and molar proportion of propionate, and significantly lower (P < 0.05) ruminal pH and ammonia nitrogen. These parameters changed linearly with increasing GY supplementation level (P < 0.05). In conclusion, GY has great potential to be developed as a feed additive with dual effects of glycerol and yeast for ruminants.	[Ye, Gengping; Zhu, Yongxing; Liu, Jin; Chen, Xingxiang; Huang, Kehe] Nanjing Agr Univ, Inst Nutr & Metab Disorders Domest Anim & Fowls, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Huang, KH (corresponding author), Nanjing Agr Univ, Inst Nutr & Metab Disorders Domest Anim & Fowls, Nanjing, Jiangsu, Peoples R China.	khhuang@njau.edu.cn			science and technology support plan project of Jiangsu Province, China [BE2011364]; Research Fund for the Doctoral Program of Higher Education of China [20110097110014, 20120097130002]; Priority Academic Program Development of Jiangsu Higher Education Institutions	science and technology support plan project of Jiangsu Province, China; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Priority Academic Program Development of Jiangsu Higher Education Institutions	The project was supported by science and technology support plan project of Jiangsu Province, China (Grant number BE2011364), the Research Fund for the Doctoral Program of Higher Education of China (Grant number 20110097110014, 20120097130002), and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshaikh MA, 2002, ASIAN AUSTRAL J ANIM, V15, P352, DOI 10.5713/ajas.2002.352; [Anonymous], 2011, AM J BIOCH MOL BIOL, DOI DOI 10.3923/AJBMB.2011.158.167; BERTICS SJ, 1992, J DAIRY SCI, V75, P1914, DOI 10.3168/jds.S0022-0302(92)77951-X; BRODERICK GA, 1980, J DAIRY SCI, V63, P64, DOI 10.3168/jds.S0022-0302(80)82888-8; Chaucheyras-Durand F, 2001, REPROD NUTR DEV, V41, P57, DOI 10.1051/rnd:2001112; Chung YH, 2007, J DAIRY SCI, V90, P5682, DOI 10.3168/jds.2007-0426; Cori C F, 1935, Science, V82, P134, DOI 10.1126/science.82.2119.134-a; Donkin SS, 2007, TRI-STATE DAIRY NUTRITION CONFERENCE, PROCEEDINGS, P97; ERASMUS LJ, 1992, J DAIRY SCI, V75, P3056, DOI 10.3168/jds.S0022-0302(92)78069-2; FORD EJH, 1980, RES VET SCI, V29, P346, DOI 10.1016/S0034-5288(18)32640-7; GARTON GA, 1961, J GEN MICROBIOL, V25, P215, DOI 10.1099/00221287-25-2-215; Goff J. P., 2001, Journal of Dairy Science, V84, P153; Gunn P. J., 2010, Professional Animal Scientist, V26, P298; Haddad SG, 2005, ANIM FEED SCI TECH, V118, P343, DOI 10.1016/j.anifeedsci.2004.10.003; Hippen AR, 2008, FLOR RUM NUTR S, P1; JOHNS A. T., 1953, New Zealand Journal of Science and Technology, Section A, V35, P262; Kalmus P, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-32; Khalid MF, 2011, AFR J AGR RES, V6, P5198; Krehbiel CR, 2008, J ANIM SCI S, V86, P392, DOI DOI 10.2527/JAS.2007-0788; Kurtzman C. P., 1998, P3, DOI 10.1016/B978-044481312-1/50004-6; LAMBERT M, 1950, CAN J RES B, V28, P83, DOI 10.1139/cjr50b-013; Liu YQ, 2002, BIOTECHNOL LETT, V24, P1137, DOI 10.1023/A:1016170600048; Looke M, 2011, BIOTECHNIQUES, V50, P325, DOI 10.2144/000113672; NAGODAWITHANA TW, 1976, APPL ENVIRON MICROB, V31, P158, DOI 10.1128/AEM.31.2.158-162.1976; nal F, 2010, KAFKAS U VET FAK DER, V16, P799; OMORI T, 1995, J FERMENT BIOENG, V79, P560, DOI 10.1016/0922-338X(95)94748-G; Petrovska B, 1999, CAN J MICROBIOL, V45, P695, DOI 10.1139/cjm-45-8-695; REED RH, 1987, APPL ENVIRON MICROB, V53, P2119, DOI 10.1128/AEM.53.9.2119-2123.1987; REID R. L., 1960, AUSTRALIAN JOUR AGRIC RES, V11, P42, DOI 10.1071/AR9600042; REMOND B, 1993, ANIM FEED SCI TECH, V41, P121, DOI 10.1016/0377-8401(93)90118-4; RUSSELL JB, 1992, J ANIM SCI, V70, P3551, DOI 10.2527/1992.70113551x; SATTER LD, 1974, BRIT J NUTR, V32, P199, DOI 10.1079/BJN19740073; Taqarort N, 2008, WORLD J MICROB BIOT, V24, P3031, DOI 10.1007/s11274-008-9849-5; Wang C, 2009, ANIM FEED SCI TECH, V151, P12, DOI 10.1016/j.anifeedsci.2008.10.009; Yalcin S, 2011, ASIAN AUSTRAL J ANIM, V24, P1377, DOI 10.5713/ajas.2011.11060; Zhuge J, 2001, APPL MICROBIOL BIOT, V55, P686, DOI 10.1007/s002530100596	36	7	9	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94410	10.1371/journal.pone.0094410	http://dx.doi.org/10.1371/journal.pone.0094410			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709881	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800141
J	Aydinonat, D; Penn, DJ; Smith, S; Moodley, Y; Hoelzl, F; Knauer, F; Schwarzenberger, F				Aydinonat, Denise; Penn, Dustin J.; Smith, Steve; Moodley, Yoshan; Hoelzl, Franz; Knauer, Felix; Schwarzenberger, Franz			Social Isolation Shortens Telomeres in African Grey Parrots (Psittacus erithacus erithacus)	PLOS ONE			English	Article							QUANTITATIVE PCR; DNA-DAMAGE; LIFE-STYLE; STRESS; LENGTH; DYNAMICS; MORTALITY; STEREOTYPIES; DYSFUNCTION; SENESCENCE	Telomeres, the caps of eukaryotic chromosomes, control chromosome stability and cellular senescence, but aging and exposure to chronic stress are suspected to cause attrition of telomere length. We investigated the effect of social isolation on telomere length in the highly social and intelligent African Grey parrot (Psittacus erithacus erithacus). Our study population consisted of single-housed (n = 26) and pair-housed (n = 19) captive individuals between 0.75 to 45 years of age. Relative telomere length of erythrocyte DNA was measured by quantitative real-time PCR. We found that telomere length declined with age (p<0.001), and socially isolated parrots had significantly shorter telomeres compared to pair-housed birds (p<0.001) - even among birds of similar ages. Our findings provide the first evidence that social isolation affects telomere length, which supports the hypothesis that telomeres provide a biomarker indicating exposure to chronic stress.	[Aydinonat, Denise; Schwarzenberger, Franz] Univ Vet Med, Dept Biomed Sci, Vienna, Austria; [Aydinonat, Denise; Penn, Dustin J.; Smith, Steve; Moodley, Yoshan] Univ Vet Med, Konrad Lorenz Inst Ethol, Dept Integrat Biol & Evolut, Vienna, Austria; [Hoelzl, Franz; Knauer, Felix] Univ Vet Med, Res Inst Wildlife Ecol, Dept Integrat Biol & Evolut, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Penn, DJ (corresponding author), Univ Vet Med, Konrad Lorenz Inst Ethol, Dept Integrat Biol & Evolut, Vienna, Austria.	dustin.penn@vetmeduni.ac.at	Schwarzenberger, Franz/A-9236-2013	Schwarzenberger, Franz/0000-0002-2961-0545; Smith, Steve/0000-0002-1318-0018; Hoelzl, Franz/0000-0001-9717-4338; Moodley, Yoshan/0000-0003-4216-2924	University of Veterinary Medicine, Vienna (Austria)	University of Veterinary Medicine, Vienna (Austria)	This Study was supported by funds from the University of Veterinary Medicine, Vienna (Austria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett ELB, 2013, MOL ECOL, V22, P249, DOI 10.1111/mec.12110; Barton K, 2020, MUMIN MULTIMODEL INF; Beery AK, 2012, BIOL LETTERS, V8, P1063, DOI 10.1098/rsbl.2012.0747; Bize P, 2009, P R SOC B, V276, P1679, DOI 10.1098/rspb.2008.1817; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Brouwer K., 2000, International Zoo Yearbook, V37, P299, DOI 10.1111/j.1748-1090.2000.tb00735.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Carroll JE, 2013, PSYCHOSOM MED, V75, P171, DOI 10.1097/PSY.0b013e31828233bf; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Correia-Melo Clara, 2014, Longev Healthspan, V3, P1, DOI 10.1186/2046-2395-3-1; Criscuolo F, 2009, J AVIAN BIOL, V40, P342, DOI 10.1111/j.1600-048X.2008.04623.x; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Damjanovic AK, 2007, J IMMUNOL, V179, P4249, DOI 10.4049/jimmunol.179.6.4249; DAVIS CS, 1991, VET CLIN N AM-SMALL, V21, P1281, DOI 10.1016/S0195-5616(91)50138-8; Dickens MJ, 2013, GEN COMP ENDOCR, V191, P177, DOI 10.1016/j.ygcen.2013.06.014; Drury SS, 2012, MOL PSYCHIATR, V17, P719, DOI 10.1038/mp.2011.53; Ehrlenbach S, 2009, INT J EPIDEMIOL, V38, P1725, DOI 10.1093/ije/dyp273; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Foote CG, 2013, MOL ECOL RESOUR, V13, P417, DOI 10.1111/1755-0998.12079; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Garner JP, 2006, APPL ANIM BEHAV SCI, V96, P153, DOI 10.1016/j.applanim.2005.09.009; Garner JP, 2003, BEHAV BRAIN RES, V145, P125, DOI 10.1016/S0166-4328(03)00115-3; Haussmann MF, 2005, BIOL LETTERS, V1, P212, DOI 10.1098/rsbl.2005.0301; Haussmann MF, 2003, P ROY SOC B-BIOL SCI, V270, P1387, DOI 10.1098/rspb.2003.2385; Heidbreder CA, 2000, NEUROSCIENCE, V100, P749, DOI 10.1016/S0306-4522(00)00336-5; Henriques CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003214; Hewitt G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1708; Ilmonen P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002143; Joeng KS, 2004, NAT GENET, V36, P607, DOI 10.1038/ng1356; Johnstone CP, 2012, J COMP PHYSIOL B, V182, P861, DOI 10.1007/s00360-012-0656-9; Juniper T, 1998, PARROTS GUIDE PARROT; Kikusui T, 2006, PHILOS T R SOC B, V361, P2215, DOI 10.1098/rstb.2006.1941; Kotrschal A, 2007, BIOL LETTERS, V3, P128, DOI 10.1098/rsbl.2006.0594; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; Meehan CL, 2004, DEV PSYCHOBIOL, V44, P209, DOI 10.1002/dev.20007; Monaghan P, 2006, TRENDS ECOL EVOL, V21, P47, DOI 10.1016/j.tree.2005.11.007; Nalapareddy K, 2008, EXP GERONTOL, V43, P998, DOI 10.1016/j.exger.2008.09.002; Opresko PL, 2005, NUCLEIC ACIDS RES, V33, P1230, DOI 10.1093/nar/gki273; Pauliny A, 2006, MOL ECOL, V15, P1681, DOI 10.1111/j.1365-294X.2006.02862.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Price LH, 2013, BIOL PSYCHIAT, V73, P15, DOI 10.1016/j.biopsych.2012.06.025; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Sanders JL, 2013, EPIDEMIOL REV, V35, P112, DOI 10.1093/epirev/mxs008; Schmid R, 2006, APPL ANIM BEHAV SCI, V98, P293, DOI 10.1016/j.applanim.2005.09.002; Serra M, 2003, J NEUROCHEM, V85, P257, DOI 10.1046/j.1471-4159.2003.01680.x; Simon NM, 2006, BIOL PSYCHIAT, V60, P432, DOI 10.1016/j.biopsych.2006.02.004; Smith S, 2011, HEREDITY, V107, P372, DOI 10.1038/hdy.2011.14; Song ZF, 2010, AGING CELL, V9, P607, DOI 10.1111/j.1474-9726.2010.00583.x; Turbill C, 2012, BIOL LETTERS, V8, P304, DOI 10.1098/rsbl.2011.0758; Ujvari B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007493; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Vallejo AN, 2004, TRENDS MOL MED, V10, P119, DOI 10.1016/j.molmed.2004.01.002; van Zeeland YRA, 2009, APPL ANIM BEHAV SCI, V121, P75, DOI 10.1016/j.applanim.2009.09.006; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; Wolkowitz OM, 2010, DEPRESS ANXIETY, V27, P327, DOI 10.1002/da.20686; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	61	38	38	6	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93839	10.1371/journal.pone.0093839	http://dx.doi.org/10.1371/journal.pone.0093839			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705445	Green Published, Green Submitted, gold			2022-12-25	WOS:000334107500075
J	Leingartner, A; Hoiss, B; Krauss, J; Steffan-Dewenter, I				Leingaertner, Annette; Hoiss, Bernhard; Krauss, Jochen; Steffan-Dewenter, Ingolf			Combined Effects of Extreme Climatic Events and Elevation on Nutritional Quality and Herbivory of Alpine Plants	PLOS ONE			English	Article							MANIPULATION EXPERIMENTS; GLOBAL CHANGE; RESPONSES; DROUGHT; SNOWMELT; ECOSYSTEMS; ABUNDANCE; NITROGEN; INSECTS; EUROPE	Climatic extreme events can cause the shift or disruption of plant-insect interactions due to altered plant quality, e. g. leaf carbon to nitrogen ratios, and phenology. However, the response of plant-herbivore interactions to extreme events and climatic gradients has been rarely studied, although climatic extremes will increase in frequency and intensity in the future and insect herbivores represent a highly diverse and functionally important group. We set up a replicated climate change experiment along elevational gradients in the German Alps to study the responses of three plant guilds and their herbivory by insects to extreme events (extreme drought, advanced and delayed snowmelt) versus control plots under different climatic conditions on 15 grassland sites. Our results indicate that elevational shifts in CN (carbon to nitrogen) ratios and herbivory depend on plant guild and season. CN ratios increased with altitude for grasses, but decreased for legumes and other forbs. In contrast to our hypotheses, extreme climatic events did not significantly affect CN ratios and herbivory. Thus, our study indicates that nutritional quality of plants and antagonistic interactions with insect herbivores are robust against seasonal climatic extremes. Across the three functional plant guilds, herbivory increased with nitrogen concentrations. Further, increased CN ratios indicate a reduction in nutritional plant quality with advancing season. Although our results revealed no direct effects of extreme climatic events, the opposing responses of plant guilds along elevation imply that competitive interactions within plant communities might change under future climates, with unknown consequences for plant-herbivore interactions and plant community composition.	[Leingaertner, Annette; Hoiss, Bernhard; Krauss, Jochen; Steffan-Dewenter, Ingolf] Univ Wurzburg, Bioctr, Dept Anim Ecol & Trop Biol, D-97070 Wurzburg, Germany	University of Wurzburg	Leingartner, A (corresponding author), Univ Wurzburg, Bioctr, Dept Anim Ecol & Trop Biol, D-97070 Wurzburg, Germany.	annette.leingaertner@uni-wuerzburg.de	Krauss, Jochen/C-6216-2014	Krauss, Jochen/0000-0003-2304-9117; Steffan-Dewenter, Ingolf/0000-0003-1359-3944	Bavarian Climate Programme; FAZIT-STIFTUNG; German Research Foundation (DFG); University of Wuerzburg	Bavarian Climate Programme; FAZIT-STIFTUNG; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This study was pursued within the framework of the joint research centre FORKAST and was funded by the "Bavarian Climate Programme 2020''. [http://www.bayceer.uni-bayreuth.de/forkast/, http://www.stmwfk.bayern.de/start/] Annette Leingartner was partly funded by the FAZIT-STIFTUNG. [http://www.fazit-stiftung.de/] This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts R, 2009, FUNCT ECOL, V23, P680, DOI 10.1111/j.1365-2435.2009.01566.x; Bale JS, 2010, J EXP BIOL, V213, P980, DOI 10.1242/jeb.037911; Behmer ST, 2009, ANNU REV ENTOMOL, V54, P165, DOI 10.1146/annurev.ento.54.110807.090537; Beier C, 2004, ECOSYSTEMS, V7, P583, DOI 10.1007/s10021-004-0178-8; Beier C, 2012, ECOL LETT, V15, P899, DOI 10.1111/j.1461-0248.2012.01793.x; Beniston M, 2003, CLIMATIC CHANGE, V59, P5, DOI 10.1023/A:1024458411589; Beniston M, 2012, J HYDROL, V412, P291, DOI 10.1016/j.jhydrol.2010.06.046; Butof A, 2012, GLOBAL CHANGE BIOL, V18, P127, DOI 10.1111/j.1365-2486.2011.02539.x; Cornelius C, 2013, J EXP BOT, V64, P241, DOI 10.1093/jxb/ers321; Crawley MJ., 2007, R BOOK; de Sassi C, 2012, ECOLOGY, V93, P1892, DOI 10.1890/11-1839.1; Dunne JA, 2004, ECOLOGY, V85, P904, DOI 10.1890/03-8003; Dunne JA, 2003, ECOL MONOGR, V73, P69, DOI 10.1890/0012-9615(2003)073[0069:SMFPRT]2.0.CO;2; Field C. B., 2012, SPECIAL REPORT WORKI, P1, DOI DOI 10.1017/CBO9781139177245; Garibaldi Lucas A., 2011, Oecologia (Berlin), V167, P117, DOI 10.1007/s00442-011-1978-0; Gutbrodt B, 2011, OIKOS, V120, P1732, DOI 10.1111/j.1600-0706.2011.19558.x; Hansen AH, 2006, OECOLOGIA, V147, P1, DOI 10.1007/s00442-005-0233-y; Hill JK, 2011, ANNU REV ENTOMOL, V56, P143, DOI 10.1146/annurev-ento-120709-144746; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; Huberty AF, 2004, ECOLOGY, V85, P1383, DOI 10.1890/03-0352; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Jentsch A, 2011, J ECOL, V99, P689, DOI 10.1111/j.1365-2745.2011.01817.x; Korner C, 2007, TRENDS ECOL EVOL, V22, P569, DOI 10.1016/j.tree.2007.09.006; KORNER C, 1989, OECOLOGIA, V81, P379, DOI 10.1007/BF00377088; Korner C, 2003, ALPINE PLANT LIFE FU, DOI DOI 10.1007/978-3-030-59538-8; Kreyling J, 2010, BASIC APPL ECOL, V11, P65, DOI 10.1016/j.baae.2009.07.008; Laghari AN, 2012, HYDROLOG SCI J, V57, P103, DOI 10.1080/02626667.2011.637040; Lloret F, 2012, GLOBAL CHANGE BIOL, V18, P797, DOI 10.1111/j.1365-2486.2011.02624.x; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; Pauli H, 2012, SCIENCE, V336, P353, DOI 10.1126/science.1219033; Pellissier L, 2012, ECOL EVOL, V2, P1818, DOI 10.1002/ece3.296; R Core Team, 2012, R LANG ENV STAT COMP; Raisanen J, 2012, CLIM DYNAM, V38, P2575, DOI 10.1007/s00382-011-1076-3; Rasmann S, 2013, FUNCT ECOL; Rowell DP, 2009, J CLIMATE, V22, P2813, DOI 10.1175/2008JCLI2713.1; Roy BA, 2004, ECOLOGY, V85, P2570, DOI 10.1890/03-0182; Sardans J, 2012, PERSPECT PLANT ECOL, V14, P33, DOI 10.1016/j.ppees.2011.08.002; Sardans J, 2008, GLOBAL CHANGE BIOL, V14, P2304, DOI 10.1111/j.1365-2486.2008.01656.x; Sarkar D., 2019, NLME LINEAR NONLINEA; Smith MD, 2011, J ECOL, V99, P656, DOI 10.1111/j.1365-2745.2011.01798.x; Stewart IT, 2009, HYDROL PROCESS, V23, P78, DOI 10.1002/hyp.7128; Strong D.R., 1984, INSECTS PLANTS COMMU; Torp M, 2010, ECOSYSTEMS, V13, P741, DOI 10.1007/s10021-010-9351-4; Tylianakis JM, 2008, ECOL LETT, V11, P1351, DOI 10.1111/j.1461-0248.2008.01250.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Welker JM, 2005, OIKOS, V109, P167, DOI 10.1111/j.0030-1299.2005.13264.x; WHITE TCR, 1984, OECOLOGIA, V63, P90, DOI 10.1007/BF00379790; Wipf S, 2006, GLOBAL CHANGE BIOL, V12, P1496, DOI 10.1111/j.1365-2486.2006.01185.x; Wipf S, 2010, POLAR RES-SWEDEN, V29, P95, DOI 10.1111/j.1751-8369.2010.00153.x	50	14	14	2	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93881	10.1371/journal.pone.0093881	http://dx.doi.org/10.1371/journal.pone.0093881			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705715	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500083
J	Moser, B; Janik, S; Schiefer, AI; Mullauer, L; Bekos, C; Scharrer, A; Mildner, M; Renyi-Vamos, F; Klepetko, W; Ankersmit, HJ				Moser, Bernhard; Janik, Stefan; Schiefer, Ana-Iris; Muellauer, Leonhard; Bekos, Christine; Scharrer, Anke; Mildner, Michael; Renyi-Vamos, Ferenc; Klepetko, Walter; Ankersmit, Hendrik Jan			Expression of RAGE and HMGB1 in Thymic Epithelial Tumors, Thymic Hyperplasia and Regular Thymic Morphology	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; MYASTHENIA-GRAVIS; SOLUBLE RECEPTOR; THERAPEUTIC TARGET; DENDRITIC CELLS; T-CELLS; PATHOGENESIS; THYMOMA; CLASSIFICATION; BLOCKADE	Recently, a role of the receptor for advanced glycation endproducts (RAGE) in myasthenia gravis was described. RAGE and its ligand high mobility group box 1 (HMGB1) play key roles in autoimmunity and cancer. To test whether these molecules are involved in patients with thymic abnormalities we applied immunohistochemical analysis in 33 cases of thymic epithelial tumors, comprising 27 thymomas and 6 thymic carcinomas, and 21 nonneoplastic thymuses. Both molecules were detected in neoplastic epithelial cells: RAGE staining was most intense in WHO type B2 thymomas and thymic carcinomas (p<0.001). HMGB1 nuclear staining was strongest in A and AB, and gradually less in B1 = B2>B3> thymic carcinoma (p<0.001). Conversely, HMGB1 cytoplasmic staining intensities were as follows: A and AB (none), B1 (strong), B2 (moderate), B3 and thymic carcinoma (weak); (p<0.001). Fetal thymic tissue showed a distinct expression of RAGE and HMGB1 in subcapsular cortical epithelial cells which was found in 50% of myasthenic patients. Furthermore RAGE and HMGB1 were expressed in thymocytes, macrophages, Hassall's corpuscles, thymic medulla, and germinal center cells in myasthenic patients. Immunohistochemistry results were complemented by systemic measurements (immunosorbent assay): serum levels of soluble RAGE were significantly reduced in patients with epithelial tumors (p = 0.008); and in invasive tumors (p = 0.008). Whereas RAGE was equally reduced in thymic hyperplasia and epithelial tumors (p = 0.003), HMGB1 was only elevated in malignancies (p = 0.036). Results were most pronounced in thymic carcinomas. Thus, RAGE and HMGB1 are involved in the (patho-) physiology of thymus, as evidenced by differentiated thymic and systemic expression patterns that may act as diagnostic or therapeutic targets in autoimmune disease and cancer.	[Moser, Bernhard; Janik, Stefan; Bekos, Christine; Klepetko, Walter; Ankersmit, Hendrik Jan] Med Univ Vienna, Div Surg, Dept Thorac Surg, Vienna, Austria; [Schiefer, Ana-Iris; Muellauer, Leonhard; Scharrer, Anke] Med Univ Vienna, Dept Pathol, Vienna, Austria; [Bekos, Christine; Ankersmit, Hendrik Jan] Med Univ Vienna, Christian Doppler Lab Diag & Regenerat Cardiac &, Vienna, Austria; [Mildner, Michael] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Renyi-Vamos, Ferenc] Natl Inst Oncol, Dept Gen & Thorac Surg, Budapest, Hungary	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; National Institute of Oncology Hungary	Moser, B (corresponding author), Med Univ Vienna, Div Surg, Dept Thorac Surg, Vienna, Austria.	bernhard.moser@meduniwien.ac.at	Moser, Bernhard/ABA-9436-2020; Schiefer, Ana-Iris/AAX-8123-2020; Müllauer, Leonhard/GSN-9884-2022	Moser, Bernhard/0000-0002-6037-5475; Müllauer, Leonhard/0000-0002-3399-078X; Mildner, Michael/0000-0002-6892-925X; Ankersmit, Hendrik Jan/0000-0002-8761-3517; Bekos, Christine/0000-0003-4038-6860	FOLAB - Research Laboratories of the Department of Surgery, Medical University Vienna; Christian Doppler Laboratory for the Diagnosis and Regeneration of Cardiac and Thoracic Diseases	FOLAB - Research Laboratories of the Department of Surgery, Medical University Vienna; Christian Doppler Laboratory for the Diagnosis and Regeneration of Cardiac and Thoracic Diseases	Funding sources: FOLAB - Research Laboratories of the Department of Surgery, Medical University Vienna. Christian Doppler Laboratory for the Diagnosis and Regeneration of Cardiac and Thoracic Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeron S, 2005, J BIOL CHEM, V280, P31314, DOI 10.1074/jbc.M503063200; BURNET M, 1957, BRIT MED J, V1, P779, DOI 10.1136/bmj.1.5022.779; Calder AE, 2011, NEUROIMMUNOMODULAT, V18, P281, DOI 10.1159/000329496; Castleman B, 1955, ATLAS TUMOR PATHOLOG; Cataldegirmen G, 2005, J EXP MED, V201, P473, DOI 10.1084/jem.20040934; Cavalcante P, 2011, MUSCLE NERVE, V44, P467, DOI 10.1002/mus.22103; Chen G, 2002, CANCER, V95, P420, DOI 10.1002/cncr.10665; COSGROVE D, 1992, INT IMMUNOL, V4, P707, DOI 10.1093/intimm/4.6.707; Detterbeck F, 2010, J THORAC ONCOL, V5, P1, DOI 10.1097/JTO.0b013e3181c59224; Detterbeck FC, 2011, J THORAC ONCOL, V6, pS1710, DOI 10.1097/JTO.0b013e31821e8cff; Dougan M, 2008, J EXP MED, V205, P267, DOI 10.1084/jem.20080136; Duwe BV, 2005, CHEST, V128, P2893, DOI 10.1378/chest.128.4.2893; Engels EA, 2010, J THORAC ONCOL, V5, pS260, DOI 10.1097/JTO.0b013e3181f1f62d; Fujii Y, 2011, THORAC SURG CLIN, V21, P125, DOI 10.1016/j.thorsurg.2010.08.002; Gao Ke, 2008, Zhonghua Yixue Yichuanxue Zazhi, V25, P311; Halayko AJ, 2009, CAN J PHYSIOL PHARM, V87, P743, DOI 10.1139/Y09-054; Hiwatashi K, 2008, ANN SURG ONCOL, V15, P923, DOI 10.1245/s10434-007-9698-8; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Hohlfeld R, 2008, J NEUROIMMUNOL, V201, P21, DOI 10.1016/j.jneuroim.2008.05.020; Imai K, 2000, LANCET, V356, P1795, DOI 10.1016/S0140-6736(00)03231-1; Jablonska-Mestanova V, 2013, BRATISL MED J, V114, P402, DOI 10.4149/BLL_2013_086; Jiao L, 2011, CANCER EPIDEM BIOMAR, V20, P1430, DOI 10.1158/1055-9965.EPI-11-0066; Jiao L, 2011, CANCER RES, V71, P3582, DOI 10.1158/0008-5472.CAN-10-2573; Johnson SB, 2001, ONCOLOGIST, V6, P239, DOI 10.1634/theoncologist.6-3-239; Kalea AZ, 2011, FRONT BIOSCI-LANDMRK, V16, P2756, DOI 10.2741/3884; Kang R, 2013, CLIN CANCER RES, V19, P4046, DOI 10.1158/1078-0432.CCR-13-0495; KONDO K, 1990, AM J SURG PATHOL, V14, P1139, DOI 10.1097/00000478-199012000-00006; Kuniyasu H, 2003, ONCOL REP, V10, P445; Lara PN, 2000, CANCER TREAT REV, V26, P127; LE PT, 1991, J EXP MED, V174, P1147, DOI 10.1084/jem.174.5.1147; Leclerc Estelle, 2010, Cardiovasc Psychiatry Neurol, V2010, P539581, DOI 10.1155/2010/539581; Li Ronghua, 2010, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V24, P823; Lin LG, 2012, J CANCER RES CLIN, V138, P11, DOI 10.1007/s00432-011-1067-0; Little AJ, 2013, NUCLEIC ACIDS RES, V41, P3289, DOI 10.1093/nar/gks1461; Livesey KM, 2012, CANCER RES, V72, P1996, DOI 10.1158/0008-5472.CAN-11-2291; Ma CY, 2012, SCAND J IMMUNOL, V75, P614, DOI 10.1111/j.1365-3083.2012.02691.x; Marx A, 2013, AUTOIMMUN REV, V12, P875, DOI 10.1016/j.autrev.2013.03.007; Miyata T, 1996, J CLIN INVEST, V98, P1088, DOI 10.1172/JCI118889; Moser B, 2007, AM J TRANSPLANT, V7, P293, DOI 10.1111/j.1600-6143.2006.01617.x; Moser B, 2007, J IMMUNOL, V179, P8051, DOI 10.4049/jimmunol.179.12.8051; Moser B, 2014, THORAC CARDIOV SURG, V62, P153, DOI 10.1055/s-0032-1322611; Moser B, 2012, BIOCHEM BIOPH RES CO, V420, P96, DOI 10.1016/j.bbrc.2012.02.121; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Omatsu M, 2012, GEN THORAC CARDIOVAS, V60, P803, DOI 10.1007/s11748-012-0160-x; PAPATESTAS AE, 1971, AM J MED, V50, P465, DOI 10.1016/0002-9343(71)90336-6; Papoudou-Bai A, 2012, IN VIVO, V26, P985; Pisetsky DS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2440; Pullerits R, 2005, ARTHRITIS RES THER, V7, pR817, DOI 10.1186/ar1749; Raica M, 2007, Rom J Morphol Embryol, V48, P101; Raica M, 2006, ANN ANAT, V188, P345, DOI 10.1016/j.aanat.2006.01.012; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Roithmaier S, 2007, J HEART LUNG TRANSPL, V26, P845, DOI 10.1016/j.healun.2007.05.019; Rosai J, 1976, ATLAS TUMOR PATHOLOG; Ruffini E, 2011, J THORAC ONCOL, V6, P614, DOI 10.1097/JTO.0b013e318207cd74; Sasahira T, 2005, VIRCHOWS ARCH, V446, P411, DOI 10.1007/s00428-005-1210-x; Savchenko AS, 2006, CELL TISSUE RES, V325, P455, DOI 10.1007/s00441-006-0202-8; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Sims GP, 2001, J IMMUNOL, V167, P1935, DOI 10.4049/jimmunol.167.4.1935; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Strobel P, 2005, SURG TODAY, V35, P805, DOI 10.1007/s00595-005-3047-y; Tafani M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-32; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; THOMAS L, 1982, YALE J BIOL MED, V55, P329; Urbonaviciute V, 2011, J INTERN MED, V270, P309, DOI 10.1111/j.1365-2796.2011.02432.x; Vincent A, 2002, NAT REV IMMUNOL, V2, P797, DOI 10.1038/nri916; Wang XL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036663, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0040084, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0045036, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045380]; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886; Weksler B, 2012, ANN THORAC SURG, V93, P884, DOI 10.1016/j.athoracsur.2011.05.089; Xu XC, 2013, INT J IMMUNOPATH PH, V26, P485, DOI 10.1177/039463201302600222; Yan SS, 2003, NAT MED, V9, P287, DOI 10.1038/nm831; Zhu XJ, 2013, CELL BIOCHEM BIOPHYS, V66, P843, DOI 10.1007/s12013-013-9515-x; Zuckerman NS, 2010, EUR J IMMUNOL, V40, P1150, DOI 10.1002/eji.200939914	73	26	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94118	10.1371/journal.pone.0094118	http://dx.doi.org/10.1371/journal.pone.0094118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705787	Green Published, Green Submitted, gold			2022-12-25	WOS:000334107500125
J	Miyashita, A; Kizaki, H; Kawasaki, K; Sekimizu, K; Kaito, C				Miyashita, Atsushi; Kizaki, Hayato; Kawasaki, Kiyoshi; Sekimizu, Kazuhisa; Kaito, Chikara			Primed Immune Responses to Gram-negative Peptidoglycans Confer Infection Resistance in Silkworms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Antimicrobial Peptides; Immunology; Insect; Invertebrates; Jun N-terminal Kinase (JNK); Peptidoglycan; Silkworm; Tolerance	STAPHYLOCOCCUS-AUREUS VIRULENCE; DROSOPHILA; RECOGNITION; MEMORY; LARVAE; MODEL; IDENTIFICATION; PROTECTION; BACTERIA; INSECT	Background: Primed immune responses contribute to vertebrate host defense. Results: Silkworms acquire resistance to a pathogen by a preinjection of its heat-killed cells or its cell surface peptidoglycans. The amount of antimicrobial peptides is increased at the second round of infection. Conclusion: Invertebrates acquire infection resistance by peptidoglycan recognition and antimicrobial peptide increase. Significance: Molecular mechanisms of invertebrate primed immunity were revealed. A heightened immune response, in which immune responses are primed by repeated exposure to a pathogen, is an important characteristic of vertebrate adaptive immunity. In the present study, we examined whether invertebrate animals also exhibit a primed immune response. The LD50 of Gram-negative enterohemorrhagic Escherichia coli O157:H7 Sakai in silkworms was increased 100-fold by pre-injection of heat-killed Sakai cells. Silkworms pre-injected with heat-killed cells of a Gram-positive bacterium, Staphylococcus aureus, did not have resistance to Sakai. Silkworms preinjected with enterohemorrhagic E. coli peptidoglycans, cell surface components of bacteria, were resistant to Sakai infection. Silkworms preinjected with S. aureus peptidoglycans, however, were not resistant to Sakai. Silkworms preinjected with heat-killed Sakai cells showed persistent resistance to Sakai infection even after pupation. Repeated injection of heat-killed Sakai cells into the silkworms induced earlier and greater production of antimicrobial peptides than a single injection of heat-killed Sakai cells. These findings suggest that silkworm recognition of Gram-negative peptidoglycans leads to a primed immune reaction and increased resistance to a second round of bacterial infection.	[Miyashita, Atsushi; Kizaki, Hayato; Sekimizu, Kazuhisa; Kaito, Chikara] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Kawasaki, Kiyoshi] Doshisha Womens Coll, Fac Pharmaceut Sci, Microbiol Lab, Kyotanabe 6100395, Japan	University of Tokyo	Kaito, C (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, 3-1,7 Chome, Tokyo 1130033, Japan.	kaito@mol.f.u-tokyo.ac.jp	Kaito, Chikara/W-1815-2019; Kaito, Chikara/G-1248-2017	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386; Miyashita, Atsushi/0000-0002-9076-0569	Japan Society for the Promotion of Science [25-8664]; Mochida Memorial Foundation; Genome Pharmaceuticals Institute;  [23249009];  [24590519];  [25117507]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mochida Memorial Foundation; Genome Pharmaceuticals Institute; ; ; 	This work was supported by Grants-in-aid for Scientific Research 23249009, 24590519, 25117507 and Japan Society for the Promotion of Science research fellowships for young scientists Grant 25-8664 (to A. M.). This study was also supported in part by the Mochida Memorial Foundation and the Genome Pharmaceuticals Institute.	Babayan SA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001297; Fernandez J, 1998, ELECTROPHORESIS, V19, P1036, DOI 10.1002/elps.1150190619; Hanada Y, 2011, J BIOL CHEM, V286, P39360, DOI 10.1074/jbc.M111.278416; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Hossain MS, 2006, J BIOCHEM, V140, P439, DOI 10.1093/jb/mvj171; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kaito C, 2002, MICROB PATHOGENESIS, V32, P183, DOI 10.1006/mpat.2002.0494; Kaito C, 2007, DRUG DISCOV THER, V1, P89; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kurata S, 2010, INT IMMUNOL, V22, P143, DOI 10.1093/intimm/dxp128; Kurtz J, 2003, NATURE, V425, P37, DOI 10.1038/425037a; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Litman GW, 2010, NAT REV IMMUNOL, V10, P543, DOI 10.1038/nri2807; Lund FE, 2010, NAT REV IMMUNOL, V10, P236, DOI 10.1038/nri2729; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Miyashita A, 2012, FEMS MICROBIOL LETT, V333, P59, DOI 10.1111/j.1574-6968.2012.02599.x; Miyazaki S, 2012, FEMS MICROBIOL LETT, V326, P116, DOI 10.1111/j.1574-6968.2011.02439.x; Parthasarathy R, 2007, MECH DEVELOP, V124, P23, DOI 10.1016/j.mod.2006.09.002; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Rabani M, 2011, NAT BIOTECHNOL, V29, P436, DOI 10.1038/nbt.1861; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199; Weaver CT, 2009, NAT REV IMMUNOL, V9, P883, DOI 10.1038/nri2660; Woodland DL, 2004, TRENDS IMMUNOL, V25, P98, DOI 10.1016/j.it.2003.11.009	27	18	19	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14412	14421		10.1074/jbc.M113.525139	http://dx.doi.org/10.1074/jbc.M113.525139			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24706746	hybrid, Green Published			2022-12-25	WOS:000335984600066
J	Sasi, SP; Song, J; Park, D; Enderling, H; McDonald, JT; Gee, H; Garrity, B; Shtifman, A; Yan, XH; Walsh, K; Natarajan, M; Kishore, R; Goukassian, DA				Sasi, Sharath P.; Song, Jin; Park, Daniel; Enderling, Heiko; McDonald, J. Tyson; Gee, Hannah; Garrity, Brittany; Shtifman, Alexander; Yan, Xinhua; Walsh, Kenneth; Natarajan, Mohan; Kishore, Raj; Goukassian, David A.			TNF-TNFR2/p75 Signaling Inhibits Early and Increases Delayed Nontargeted Effects in Bone Marrow-derived Endothelial Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cytokine; DNA Damage Response; Radiation Biology; Receptors; Tumor Necrosis Factor (TNF); Nontargeted Effects	NECROSIS-FACTOR-ALPHA; INDUCED GENOMIC INSTABILITY; MEDIATED INTERCELLULAR COMMUNICATION; GLOBAL GENE-EXPRESSION; IONIZING-RADIATION; TNF-ALPHA; HUMAN FIBROBLASTS; IN-VIVO; KAPPA-B; CHROMOSOMAL INSTABILITY	Background: Ionizing radiation can induce DNA damage in nonirradiated (N-IR) cells via nontargeted effects (NTE). Results: TNF- and IL-1 mediate NTE in N-IR bone marrow-derived EPCs, and neutralizing TNF- diminishes NTE in WT and p55 knock-out BM-EPCs. Conclusion: TNF-TNFR2/p75 signaling alters accumulation of inflammatory cytokines that attenuate NTE in N-IR EPCs. Significance: TNFR2/p75 may represent a gene target for mitigation of delayed RBR in BM-EPCs. TNF-, a pro-inflammatory cytokine, is highly expressed after being irradiated (IR) and is implicated in mediating radiobiological bystander responses (RBRs). Little is known about specific TNF receptors in regulating TNF-induced RBR in bone marrow-derived endothelial progenitor cells (BM-EPCs). Full body -IR WT BM-EPCs showed a biphasic response: slow decay of p-H2AX foci during the initial 24 h and increase between 24 h and 7 days post-IR, indicating a significant RBR in BM-EPCs in vivo. Individual TNF receptor (TNFR) signaling in RBR was evaluated in BM-EPCs from WT, TNFR1/p55KO, and TNFR2/p75KO mice, in vitro. Compared with WT, early RBR (1-5 h) were inhibited in p55KO and p75KO EPCs, whereas delayed RBR (3-5 days) were amplified in p55KO EPCs, suggesting a possible role for TNFR2/p75 signaling in delayed RBR. Neutralizing TNF in -IR conditioned media (CM) of WT and p55KO BM-EPCs largely abolished RBR in both cell types. ELISA protein profiling of WT and p55KO EPC -IR-CM over 5 days showed significant increases in several pro-inflammatory cytokines, including TNF-, IL-1 (Interleukin-1 alpha), RANTES (regulated on activation, normal T cell expressed and secreted), and MCP-1. In vitro treatments with murine recombinant (rm) TNF- and rmIL-1, but not rmMCP-1 or rmRANTES, increased the formation of p-H2AX foci in nonirradiated p55KO EPCs. We conclude that TNF-TNFR2 signaling may induce RBR in naive BM-EPCs and that blocking TNF-TNFR2 signaling may prevent delayed RBR in BM-EPCs, conceivably, in bone marrow milieu in general.	[Sasi, Sharath P.; Song, Jin; Park, Daniel; Gee, Hannah; Garrity, Brittany; Shtifman, Alexander; Yan, Xinhua; Goukassian, David A.] Steward Res & Specialty Projects Corp, Cardiovasc Res Ctr, Brighton, MA 02135 USA; [Enderling, Heiko; McDonald, J. Tyson; Yan, Xinhua] GeneSys Res Inst, Ctr Canc Syst Biol, Boston, MA 02135 USA; [Enderling, Heiko] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Integrated Math Oncol, Tampa, FL 33612 USA; [Enderling, Heiko; McDonald, J. Tyson; Shtifman, Alexander; Yan, Xinhua; Goukassian, David A.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Walsh, Kenneth; Goukassian, David A.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Natarajan, Mohan] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Kishore, Raj] Northwestern Univ, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; Tufts University; Boston University; University of Texas System; University of Texas Health San Antonio; Northwestern University	Goukassian, DA (corresponding author), Tufts Univ, Sch Med, GeneSys Res Inst, 736 Cambridge St,CBR 340, Brighton, MA 02135 USA.	david.goukassian@tufts.edu	Enderling, Heiko/AAA-2423-2021	Enderling, Heiko/0000-0002-9696-6410; Goukassian, David/0000-0001-5270-5270; McDonald, John/0000-0003-4300-6827	National Aeronautic and Space Administration [NNJ10ZSA001N]; AHA [14GRNT18860032, 10GRNT4710003]; NHLBI [HL106098]; NIH [HL091983]; NASA [NNX11AK26G]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL106098, R01HL091983] Funding Source: NIH RePORTER	National Aeronautic and Space Administration(National Aeronautics & Space Administration (NASA)); AHA(American Heart Association); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA(National Aeronautics & Space Administration (NASA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This material is based upon work supported by the National Aeronautic and Space Administration under Grant No. NNJ10ZSA001N and AHA Grant No. 14GRNT18860032 to D. A. G. and in part by grants from AHA 10GRNT4710003 and NHLBI HL106098 to X. Y., NIH HL091983 to R. K. and NASA NNX11AK26G to Dr. L. Hlatky.	Amundson SA, 2008, CANCER RES, V68, P415, DOI 10.1158/0008-5472.CAN-07-2120; Ansari R, 2007, RADIAT RES, V167, P80, DOI 10.1667/RR0616.1; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Averbeck D, 2010, MUTAT RES-FUND MOL M, V687, P7, DOI 10.1016/j.mrfmmm.2010.01.004; Azzam EI, 2003, CANCER RES, V63, P7128; Azzam EI, 2001, P NATL ACAD SCI USA, V98, P473, DOI 10.1073/pnas.011417098; Barbara JAJ, 1996, IMMUNOL CELL BIOL, V74, P434, DOI 10.1038/icb.1996.73; BROCKHAUS M, 1990, P NATL ACAD SCI USA, V87, P3127, DOI 10.1073/pnas.87.8.3127; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Burdak-Rothkamm S, 2007, ONCOGENE, V26, P993, DOI 10.1038/sj.onc.1209863; Burr KL, 2010, RADIAT RES, V173, P760, DOI 10.1667/RR1937.1; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Coward WR, 2002, J IMMUNOL, V169, P5287, DOI 10.4049/jimmunol.169.9.5287; Daigle JL, 2001, CANCER RES, V61, P8859; Djordjevic B, 2000, BIOESSAYS, V22, P286, DOI 10.1002/(SICI)1521-1878(200003)22:3<286::AID-BIES10>3.3.CO;2-J; Fadini GP, 2006, STROKE, V37, P2277, DOI 10.1161/01.STR.0000236064.19293.79; Fischer-Rasokat U, 2009, CIRC-HEART FAIL, V2, P417, DOI 10.1161/CIRCHEARTFAILURE.109.855023; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Ghandhi SA, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-63; Gill M, 2001, CIRC RES, V88, P167; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Goukassian DA, 2007, CIRCULATION, V115, P752, DOI 10.1161/CIRCULATIONAHA.106.647255; Hei TK, 2008, J PHARM PHARMACOL, V60, P943, DOI 10.1211/jpp.60.8.0001; Higuchi Y, 2004, CIRCULATION, V109, P1892, DOI 10.1161/01.CIR.0000124227.00670.AB; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hubackova S, 2012, AGING-US, V4, P932, DOI 10.18632/aging.100520; Ihnatko R, 2007, GEN PHYSIOL BIOPHYS, V26, P159; Ivanov VN, 2010, CELL SIGNAL, V22, P1076, DOI 10.1016/j.cellsig.2010.02.010; Iwaguro H, 2002, CIRCULATION, V105, P732, DOI 10.1161/hc0602.103673; JACOBSEN SEW, 1994, STEM CELLS, V12, P111; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawamoto A, 2001, CIRCULATION, V103, P634; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Kojda G, 1999, CARDIOVASC RES, V42, P206, DOI 10.1016/S0008-6363(98)00315-0; Ksontini R, 1998, ARCH SURG-CHICAGO, V133, P558, DOI 10.1001/archsurg.133.5.558; Lee CM, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-30; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Little JB, 2006, HEALTH PHYS, V91, P416, DOI 10.1097/01.HP.0000232847.23192.3e; Little JB, 2006, MUTAT RES-FUND MOL M, V597, P113, DOI 10.1016/j.mrfmmm.2005.12.001; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Lorimore SA, 2003, ONCOGENE, V22, P7058, DOI 10.1038/sj.onc.1207044; Lorimore SA, 2001, ONCOGENE, V20, P7085, DOI 10.1038/sj.onc.1204903; Meng YR, 2010, CANCER RES, V70, P1534, DOI 10.1158/0008-5472.CAN-09-2995; Mitchell SA, 2004, INT J RADIAT BIOL, V80, P465, DOI 10.1080/09553000410001725116; Modarai B, 2005, CIRCULATION, V111, P2645, DOI 10.1161/CIRCULATIONAHA.104.492678; Morgan WF, 2003, RADIAT RES, V159, P567, DOI 10.1667/0033-7587(2003)159[0567:NADEOE]2.0.CO;2; Morgan WF, 2007, MUTAT RES-FUND MOL M, V616, P159, DOI 10.1016/j.mrfmmm.2006.11.009; Mothersill C, 2006, RADIAT RES, V165, P26, DOI 10.1667/RR3488.1; Mothersill C, 1997, INT J RADIAT BIOL, V71, P421, DOI 10.1080/095530097144030; Mothersill C, 1998, RADIAT RES, V149, P256, DOI 10.2307/3579958; Mungrue IN, 2002, J CLIN INVEST, V109, P735, DOI 10.1172/JCI200213265; NAGASAWA H, 1992, CANCER RES, V52, P6394; Narayanan PK, 1999, RADIAT RES, V152, P57, DOI 10.2307/3580049; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pandey R, 2005, INT J RADIAT BIOL, V81, P801, DOI 10.1080/09553000500531886; Pastorino F, 2008, J CONTROL RELEASE, V126, P85, DOI 10.1016/j.jconrel.2007.11.010; Pierce DA, 2000, RADIAT RES, V154, P178, DOI 10.1667/0033-7587(2000)154[0178:RRCRAL]2.0.CO;2; Rastogi S, 2012, RADIAT RES, V177, P244, DOI 10.1667/RR2805.1; Ribatti D, 2007, LEUKEMIA RES, V31, P439, DOI 10.1016/j.leukres.2006.10.014; RISAU W, 1995, FASEB J, V9, P926, DOI 10.1096/fasebj.9.10.7615161; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rzeszowska-Wolny J, 2009, EUR J PHARMACOL, V625, P156, DOI 10.1016/j.ejphar.2009.07.028; Sasi SP, 2012, ONCOGENE, V31, P4117, DOI 10.1038/onc.2011.567; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Schaue D, 2012, RADIAT RES, V178, P505, DOI 10.1667/RR3031.1; Seed TM, 2002, ADV SPACE RES, V30, P945, DOI 10.1016/S0273-1177(02)00159-X; Sethi G, 2008, FRONT BIOSCI-LANDMRK, V13, P5094, DOI 10.2741/3066; Sharma Arishya, 2012, Methods Mol Biol, V920, P613, DOI 10.1007/978-1-61779-998-3_40; SHERMAN ML, 1991, J CLIN INVEST, V87, P1794, DOI 10.1172/JCI115199; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Shintani S, 2001, CIRCULATION, V103, P2776, DOI 10.1161/hc2301.092122; Sowa MB, 2010, INT J RADIAT BIOL, V86, P102, DOI 10.3109/09553000903419957; STEIN O, 1980, BIOCHIM BIOPHYS ACTA, V620, P631, DOI 10.1016/0005-2760(80)90155-1; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Todd P, 1999, MUTAT RES-FUND MOL M, V430, P211, DOI 10.1016/S0027-5107(99)00132-3; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Valdiglesias V, 2013, MUTAT RES-REV MUTAT, V753, P24, DOI 10.1016/j.mrrev.2013.02.001; van Ramshorst J, 2009, JAMA-J AM MED ASSOC, V301, P1997, DOI 10.1001/jama.2009.685; VANDENABEELE P, 1995, TRENDS CELL BIOL, V5, P392, DOI 10.1016/S0962-8924(00)89088-1; VANOS R, 1993, INT J RADIAT BIOL, V64, P761, DOI 10.1080/09553009314552011; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034; Watson GE, 2000, CANCER RES, V60, P5608; Watson GE, 2001, INT J RADIAT BIOL, V77, P409, DOI 10.1080/09553000010028476; Westbrook AM, 2012, MUTAGENESIS, V27, P77, DOI 10.1093/mutage/ger063; Wright EG, 1998, INT J RADIAT BIOL, V74, P681, DOI 10.1080/095530098140943; Wright EG, 2006, MUTAT RES-FUND MOL M, V597, P119, DOI 10.1016/j.mrfmmm.2005.03.035; Yang HY, 2007, RADIAT RES, V168, P292, DOI 10.1667/RR0864.1; Yang HY, 2011, INT J RADIAT BIOL, V87, P311, DOI 10.3109/09553002.2010.537431; Yang HY, 2005, ONCOGENE, V24, P2096, DOI 10.1038/sj.onc.1208439; Yang JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020219; Zhou HN, 2005, P NATL ACAD SCI USA, V102, P14641, DOI 10.1073/pnas.0505473102	96	11	11	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14178	14193		10.1074/jbc.M114.567743	http://dx.doi.org/10.1074/jbc.M114.567743			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24711449	Green Published, hybrid			2022-12-25	WOS:000335984600045
J	Ge, H; Liu, G; Xiang, YF; Wang, Y; Guo, CW; Chen, NH; Zhang, YJ; Wang, YF; Kitazato, K; Xu, J				Ge, Hu; Liu, Ge; Xiang, Yang-Fei; Wang, Yu; Guo, Chao-Wan; Chen, Nan-Hao; Zhang, Ying-Jun; Wang, Yi-Fei; Kitazato, Kaio; Xu, Jun			The Mechanism of Poly-Galloyl-Glucoses Preventing Influenza A Virus Entry into Host Cells	PLOS ONE			English	Article							RECEPTOR-BINDING PROPERTIES; MOLECULAR-DYNAMICS; HUMAN INFECTION; HEMAGGLUTININ; FUSION; ORIGIN; AMBER	Hemagglutinin (HA) is essential for Influenza A virus infection, but its diversity of subtypes presents an obstacle to developing broad-spectrum HA inhibitors. In this study, we investigated the molecular mechanisms by which poly-galloyl glucose (pGG) analogs inhibit influenza hemagglutinin (HA) in vitro and in silico. We found that (1) star-shaped pGG analogs exhibit HA-inhibition activity by interacting with the conserved structural elements of the receptor binding domain (RBD); (2) HA inhibition depends on the number of galloyl substituents in a pGG analog; the best number is four; and when PGG binds with two HA trimers at their conserved receptor binding domains (loop 130, loop 220, and 190-alpha-helix), PGG acts as a molecular glue by aggregating viral particles so as to prevent viral entry into host cells (this was revealed via an in silico simulation on the binding of penta- galloyl-glucose (PGG) with HA). pGGs are also effective on a broad-spectrum influenza A subtypes (including H1, H3, H5, H7); this suggests that pGG analogs can be applied to most influenza A subtypes as a prophylactic against influenza viral infections.	[Ge, Hu; Wang, Yu; Chen, Nan-Hao; Xu, Jun] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510275, Guangdong, Peoples R China; [Ge, Hu; Wang, Yu; Chen, Nan-Hao; Xu, Jun] Sun Yat Sen Univ, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Ge; Guo, Chao-Wan; Kitazato, Kaio] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Microbiol & Immunol, Div Mol Pharmacol Infect Agents, Nagasaki 852, Japan; [Xiang, Yang-Fei; Wang, Yi-Fei] Jinan Univ, Natl Engn Res Ctr Genet Med, Guangdong Prov Key Lab Bioengn Med, Div Biomed,Res & Dev Ctr, Guangzhou, Guangdong, Peoples R China; [Xiang, Yang-Fei] Jinan Univ, Coll Pharm, Guangzhou, Guangdong, Peoples R China; [Zhang, Ying-Jun] Chinese Acad Sci, Kunming Inst Bot, Kunming, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Nagasaki University; Jinan University; Jinan University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Wang, YF (corresponding author), Jinan Univ, Natl Engn Res Ctr Genet Med, Guangdong Prov Key Lab Bioengn Med, Div Biomed,Res & Dev Ctr, Guangzhou, Guangdong, Peoples R China.	twang-yf@163.com; kkholi@nagasaki-u.ac.jp; junxu@biochemomes.com	Guo, Chaowan/AAF-3876-2022; Guo, Chaowan/AFI-6708-2022	Wang, Yi-fei/0000-0002-9918-2865	National High Technology Research and Development Program of China (863 Program) [2012AA020307]; Guangdong Recruitment Program of Creative Research Groups; National Natural Science Foundation of China [81173470, 81274170]; Special Funding Program for the National Supercomputer Center in Guangzhou [2012Y2-00048/2013Y2-00045, 201200000037]; Tokyo Biochemical Research Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan [22590274]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Guangdong Recruitment Program of Creative Research Groups; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Funding Program for the National Supercomputer Center in Guangzhou; Tokyo Biochemical Research Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the National High Technology Research and Development Program of China (863 Program) (No. 2012AA020307), Guangdong Recruitment Program of Creative Research Groups, and the National Natural Science Foundation of China (No. 81173470, 81274170), and the Special Funding Program for the National Supercomputer Center in Guangzhou (2012Y2-00048/2013Y2-00045, 201200000037). This study was also supported partly by Grant-in-aid from the Tokyo Biochemical Research Foundation and a Grant-in-Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 22590274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Fleury D, 1999, NAT STRUCT BIOL, V6, P530, DOI 10.1038/9299; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Ge H, 2010, NAT PROD REP, V27, P1758, DOI 10.1039/c0np00005a; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Gu QO, 2010, MOLECULES, V15, P5031, DOI 10.3390/molecules15075031; Gyemant G, 2009, BBA-PROTEINS PROTEOM, V1794, P291, DOI 10.1016/j.bbapap.2008.10.012; Ha Y, 2001, P NATL ACAD SCI USA, V98, P11181, DOI 10.1073/pnas.201401198; He Q, 2006, FOOD CHEM, V95, P250, DOI 10.1016/j.foodchem.2004.11.055; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Ichiki H, 2007, J NAT MED-TOKYO, V61, P146, DOI 10.1007/s11418-006-0111-x; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kageyama-Yahara N, 2010, FEBS LETT, V584, P111, DOI 10.1016/j.febslet.2009.11.007; Kato S, 2010, BIOL PHARM BULL, V33, P1878, DOI 10.1248/bpb.33.1878; Knipe DM, 2007, FIELDS VIROLOGY; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li XQ, 2011, J NANOMATER, V2011, DOI 10.1155/2011/270974; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Liu G, 2011, ARCH VIROL, V156, P1359, DOI 10.1007/s00705-011-0989-9; Lorieau JL, 2012, P NATL ACAD SCI USA, V109, P19994, DOI 10.1073/pnas.1213801109; Luo GX, 1996, VIROLOGY, V226, P66, DOI 10.1006/viro.1996.0628; Matrosovich M, 2003, REV MED VIROL, V13, P85, DOI 10.1002/rmv.372; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; NAKAYAMA M, 1993, ANTIVIR RES, V21, P289, DOI 10.1016/0166-3542(93)90008-7; Nandi T, 2008, BIOINFORMATION, V2, P240, DOI 10.6026/97320630002240; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Pan DB, 2012, J MOL MODEL, V18, P4355, DOI 10.1007/s00894-012-1423-2; Reid AH, 2003, EMERG INFECT DIS, V9, P1249; Richard T, 2005, BBA-GEN SUBJECTS, V1726, P238, DOI 10.1016/j.bbagen.2005.07.017; Russell RJ, 2004, VIROLOGY, V325, P287, DOI 10.1016/j.virol.2004.04.040; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007789; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Srinivasan A, 2008, P NATL ACAD SCI USA, V105, P2800, DOI 10.1073/pnas.0711963105; Sriwilaijaroen N, 2012, P JPN ACAD B-PHYS, V88, P226, DOI 10.2183/pjab.88.226; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Watanabe T, 2011, J VIROL, V85, P13195, DOI 10.1128/JVI.00859-11; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO/GIP, 2013, CUM NUMB CONF HUM CA; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; Xiong XL, 2013, NATURE, V497, P392, DOI 10.1038/nature12144; Xu J, 2013, SCI CHINA CHEM, V56, P71, DOI 10.1007/s11426-012-4761-0; Yamada K, 2009, ANTIVIR RES, V83, P35, DOI 10.1016/j.antiviral.2009.03.002; Yen HL, 2012, NATURE, V486, P332, DOI 10.1038/nature11192; Zhang JH, 2009, PHARM RES-DORDR, V26, P2066, DOI 10.1007/s11095-009-9932-0; Zhang W, 2013, SCIENCE, V340, P1463, DOI 10.1126/science.1236787; Zhou RH, 2001, J CHEM PHYS, V115, P2348, DOI 10.1063/1.1385159	56	5	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94392	10.1371/journal.pone.0094392	http://dx.doi.org/10.1371/journal.pone.0094392			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718639	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000114
J	Lovati, AB; Romano, CL; Monti, L; Vassena, C; Previdi, S; Drago, L				Lovati, Arianna B.; Romano, Carlo L.; Monti, Lorenzo; Vassena, Christian; Previdi, Sara; Drago, Lorenzo			Does PGE1 Vasodilator Prevent Orthopaedic Implant-Related Infection in Diabetes? Preliminary Results in a Mouse Model	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; PROSTAGLANDIN E-1; PERIPHERAL-BLOOD; FOOT INFECTIONS; BONE-FORMATION; FACTOR-ALPHA; ANGIOGENESIS; STIMULATION; DISEASE; OSTEOMYELITIS	Background: Implant-related infections are characterized by bacterial colonization and biofilm formation on the prosthesis. Diabetes represents one of the risk factors that increase the chances of prosthetic infections because of related severe peripheral vascular disease. Vasodilatation can be a therapeutic option to overcome diabetic vascular damages and increase the local blood supply. In this study, the effect of a PGE(1) vasodilator on the incidence of surgical infections in diabetic mice was investigated. Methodology: A S. aureus implant-related infection was induced in femurs of diabetic mice, then differently treated with a third generation cephalosporin alone or associated with a PGE(1) vasodilator. Variations in mouse body weight were evaluated as index of animal welfare. The femurs were harvested after 28 days and underwent both qualitative and quantitative analysis as micro-CT, histological and microbiological analyses. Results: The analysis performed in this study demonstrated the increased host response to implant-related infection in diabetic mice treated with the combination of a PGE(1) and antibiotic. In this group, restrained signs of infections were identified by micro-CT and histological analysis. On the other hand, the diabetic mice treated with the antibiotic alone showed a severe infection and inability to successfully respond to the standard antimicrobial treatment. Conclusions: The present study revealed interesting preliminary results in the use of a drug combination of antibiotic and vasodilator to prevent implant-related Staphylococcus aureus infections in a diabetic mouse model.	[Lovati, Arianna B.] IRCCS Galeazzi Orthopaed Inst, Cell & Tissue Engn Lab, Milan, Italy; [Romano, Carlo L.; Monti, Lorenzo] IRCCS Galeazzi Orthopaed Inst, Dipartimento Chirurg Ricostrutt & Infez Osteoarti, Milan, Italy; [Vassena, Christian; Drago, Lorenzo] IRCCS Galeazzi Orthopaed Inst, Lab Clin Chem & Microbiol, Milan, Italy; [Previdi, Sara] Ist Ric Farmacol Mario Negri, Dept Oncol, Lab Canc Cachexia AIRC Start Up, Milan, Italy; [Drago, Lorenzo] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	IRCCS Istituto Ortopedico Galeazzi; IRCCS Istituto Ortopedico Galeazzi; IRCCS Istituto Ortopedico Galeazzi; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Milan	Lovati, AB (corresponding author), IRCCS Galeazzi Orthopaed Inst, Cell & Tissue Engn Lab, Milan, Italy.	arianna.lovati@grupposandonato.it	Lovati, Arianna Barbara/J-8213-2016; Monti, Lorenzo/AAB-2967-2020; ROMANO, CARLO LUCA/C-4310-2017	Lovati, Arianna Barbara/0000-0002-5230-9718; ROMANO, CARLO LUCA/0000-0001-6726-0593; Lorenzo, Drago/0000-0002-5206-540X	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	The entire work was funded by the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAMINE T, 1992, BONE, V13, P11, DOI 10.1016/8756-3282(92)90356-2; Akbari CM, 1999, J VASC SURG, V30, P373, DOI 10.1016/S0741-5214(99)70154-0; BAGDADE JD, 1978, DIABETES, V27, P677, DOI 10.2337/diabetes.27.6.677; Bernthal NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012580; Bertoni AG, 2001, DIABETES CARE, V24, P1044, DOI 10.2337/diacare.24.6.1044; Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P45, DOI 10.1007/s11999-009-0945-0; Chae JK, 2000, ARTERIOSCL THROM VAS, V20, P2573, DOI 10.1161/01.ATV.20.12.2573; Clover AJP, 2003, BRIT J PLAST SURG, V56, P314, DOI 10.1016/S0007-1226(03)00230-3; CREUTZIG A, 1991, THERAPIE, V46, P241; Cross SE, 1996, ANTIMICROB AGENTS CH, V40, P1703, DOI 10.1128/AAC.40.7.1703; Dooper MMBW, 2002, IMMUNOLOGY, V107, P152, DOI 10.1046/j.1365-2567.2002.01474.x; Eneroth M, 1999, J DIABETES COMPLICAT, V13, P254, DOI 10.1016/S1056-8727(99)00065-3; Faries PL, 2004, AM J SURG, V187, p34S, DOI 10.1016/S0002-9610(03)00302-7; Farrokhnia F, 2012, WORLD J GASTRO SURG, V4, P284, DOI 10.4240/wjgs.v4.i12.284; Fulkerson E, 2006, J BONE JOINT SURG AM, V88A, P1231, DOI 10.2106/JBJS.E.00004; Funao H, 2012, INFECT IMMUN, V80, P733, DOI 10.1128/IAI.06166-11; GEE MH, 1987, CIRC RES, V61, P420, DOI 10.1161/01.RES.61.3.420; GOODSON WH, 1977, J SURG RES, V22, P221, DOI 10.1016/0022-4804(77)90137-8; HIGH WB, 1987, BONE, V8, P363, DOI 10.1016/8756-3282(87)90068-8; Iino G, 2008, INT J ORAL MAX IMPL, V23, P835; Ishikawa O, 1998, EUR J PHARMACOL, V344, P95, DOI 10.1016/S0014-2999(97)01575-6; Isner JM, 1999, J CLIN INVEST, V103, P1231, DOI 10.1172/JCI6889; JEE WSS, 1985, CALCIFIED TISSUE INT, V37, P148, DOI 10.1007/BF02554834; Jee WSS, 1997, BONE, V21, P297, DOI 10.1016/S8756-3282(97)00147-6; Jung CJ, 2012, J INFECT DIS, V205, P1066, DOI 10.1093/infdis/jis021; King GL, 1996, ENDOCRIN METAB CLIN, V25, P255, DOI 10.1016/S0889-8529(05)70324-8; Kuss M, 2003, VASA-J VASCULAR DIS, V32, P145, DOI 10.1024/0301-1526.32.3.145; Lankinen P, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-41; Lipsky BA, 1997, CLIN INFECT DIS, V25, P1318, DOI 10.1086/516148; Lipsky BA, 2007, DIABETES CARE, V30, P2171, DOI 10.2337/dc07-0935; Lovati AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067628; Makino H, 2004, HYPERTENS RES, V27, P85, DOI 10.1291/hypres.27.85; MARHOFFER W, 1993, DIABETES RES CLIN PR, V19, P183, DOI 10.1016/0168-8227(93)90112-I; Mehrabi MR, 2003, BIOMED PHARMACOTHER, V57, P173, DOI 10.1016/S0753-3322(03)00026-X; Mehrabi MR, 2001, J HEART LUNG TRANSPL, V20, P465, DOI 10.1016/S1053-2498(00)00317-X; Miller SC, 2008, PHARM RES-DORDR, V25, P2889, DOI 10.1007/s11095-008-9706-0; MILLER SC, 1993, BONE, V14, P143, DOI 10.1016/8756-3282(93)90241-2; Moreschi Jr. Dorival, 2007, J. vasc. bras., V6, P316, DOI 10.1590/S1677-54492007000400004; Ong KL, 2009, J ARTHROPLASTY, V24, P105, DOI 10.1016/j.arth.2009.04.027; PASCH AR, 1984, SURGERY, V95, P724; Pawar P, 2004, J IMMUNOL, V173, P1258, DOI 10.4049/jimmunol.173.2.1258; Pineda Carlos, 2009, Semin Plast Surg, V23, P80, DOI 10.1055/s-0029-1214160; REPINE JE, 1980, J INFECT DIS, V142, P869, DOI 10.1093/infdis/142.6.869; Rich J, 2005, DIABETES, V54, P2904, DOI 10.2337/diabetes.54.10.2904; RICHMAN CM, 1987, BLOOD, V70, P1792; Romano CL, 2010, J ORTHOP TRAUMATOL, V11, P167, DOI 10.1007/s10195-010-0106-y; Rubinstein R, 2008, CLIN EXP IMMUNOL, V154, P235, DOI 10.1111/j.1365-2249.2008.03742.x; SCHEFFLER P, 1994, CIRCULATION, V90, P818, DOI 10.1161/01.CIR.90.2.818; Shiga K, 2002, ANN OTO RHINOL LARYN, V111, P783, DOI 10.1177/000348940211100904; Silvestre JS, 2006, CIRC RES, V98, P4, DOI 10.1161/01.RES.0000200396.90220.41; Simons M, 2005, CIRCULATION, V111, P1556, DOI 10.1161/01.CIR.0000159345.00591.8F; Spatz M, 2003, CELL IMMUNOL, V221, P15, DOI 10.1016/S0008-8749(03)00043-1; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Suponitzky I, 1998, J ENDOCRINOL, V156, P51, DOI 10.1677/joe.0.1560051; TATER D, 1987, HORM METAB RES, V19, P642, DOI 10.1055/s-2007-1011899; Teupser D, 2011, J BIOL CHEM, V286, P6272, DOI 10.1074/jbc.M110.161414; Trampuz A, 2003, CLIN ORTHOP RELAT R, P69, DOI 10.1097/01.blo.0000087324.60612.93; ULICH TR, 1987, J IMMUNOL, V139, P3406; van Heeckeren AM, 2000, AM J RESP CRIT CARE, V161, P271, DOI 10.1164/ajrccm.161.1.9903019; VANDERPOLL T, 1992, BLOOD, V79, P693; Widmer AF, 2001, CLIN INFECT DIS, V33, pS94, DOI 10.1086/321863; Widomski D, 1997, IMMUNOPHARM IMMUNOT, V19, P165, DOI 10.3109/08923979709007656	62	7	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94758	10.1371/journal.pone.0094758	http://dx.doi.org/10.1371/journal.pone.0094758			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718359	Green Published, Green Submitted, gold			2022-12-25	WOS:000334339000144
J	McCallum, JW; Rowcliffe, JM; Cuthill, IC				McCallum, Jamie W.; Rowcliffe, J. Marcus; Cuthill, Innes C.			Conservation on International Boundaries: The Impact of Security Barriers on Selected Terrestrial Mammals in Four Protected Areas in Arizona, USA	PLOS ONE			English	Article							LARGE CARNIVORES; BIODIVERSITY; FRAGMENTATION; FORESTS; BORDER; IMMIGRATION; REDUCTION; PREDATORS; DEER	Several thousand terrestrial protected areas (PAs) lie on international boundaries. Because international boundaries can be focal points for trade, illegal activity and development, such PAs can be vulnerable to a range of anthropogenic threats. There is an increasing trend towards the erection of international boundary infrastructure (including fences, barriers and ditches) in many parts of the world, which may reduce the risk of these anthropogenic threats to some PAs. However this may restrict home range and access to resources for some native species. We sought to understand the impacts of these two different types of threat by using camera traps to measure the activity level of humans, native and invasive mammals in four US PAs on the Mexican international boundary. Comparisons were made between treatment areas with barriers and those without. Results showed that puma and coati were more likely to appear in treatment areas without barriers, whereas humans were not observed more frequently in one treatment area over another. The suggestion is that the intermittent fencing present in this part of the world does affect some native species, but does not necessarily restrict the movement of humans (including illegal migrants), who may negatively impact native species.	[McCallum, Jamie W.; Cuthill, Innes C.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Rowcliffe, J. Marcus] Zool Soc London, Inst Zool, London NW1 4RY, England; [McCallum, Jamie W.] Zool Soc London, Conservat Programmes, London, England	University of Bristol; Zoological Society of London; Zoological Society of London	McCallum, JW (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	jamie.mccallum@zsl.org	Rowcliffe, Marcus/G-3713-2018	Rowcliffe, Marcus/0000-0002-4286-6887				Abbas F, 2011, OECOLOGIA, V167, P401, DOI 10.1007/s00442-011-1994-0; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; Andreas P, 2003, INT SECURITY, V28, P78, DOI 10.1162/016228803322761973; Bailey R, 1989, ECOREGIONS, P1650; Bozarth CA, 2011, J MAMMAL, V92, P1070, DOI 10.1644/10-MAMM-A-223.1; Brockington Dan, 2002, FORTRESS CONSERVATIO; BRONSTEIN JL, 1994, Q REV BIOL, V69, P31, DOI 10.1086/418432; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Busch J, 2008, ECOL ECON, V67, P394, DOI 10.1016/j.ecolecon.2007.12.012; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; Cornelius WA, 2007, REGUL GOV, V1, P139, DOI 10.1111/j.1748-5991.2007.00007.x; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Creel S, 2014, ECOL LETT IN PRESS; Dalerum F, 2008, BIODIVERS CONSERV, V17, P2939, DOI 10.1007/s10531-008-9406-4; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Ewers RM, 2000, P R SOC LOND, V366, P3292; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Hamilton LS, 1996, BIODIVERS CONSERV; Hanks J., 2010, FENCING IMPACTS REV; Harris G., 2010, B ECOL SOC AM, V91, P352, DOI DOI 10.1890/0012-9623-91.3.352; Hilty JA, 2004, CONSERV BIOL, V18, P126, DOI 10.1111/j.1523-1739.2004.00225.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Kapos V, 2009, ORYX, V43, P336, DOI 10.1017/S0030605309990275; KARANTH KU, 1995, BIOL CONSERV, V71, P333, DOI 10.1016/0006-3207(94)00057-W; Karki SM, 2007, J WILDLIFE MANAGE, V71, P2707, DOI 10.2193/2006-275; Korpimaki E, 1998, ECOLOGY, V79, P2448, DOI 10.2307/176834; Lasky JR, 2011, DIVERS DISTRIB, V17, P673, DOI 10.1111/j.1472-4642.2011.00765.x; Lysenko I, 2007, GLOBAL LIST TRANSBOU; Maiorano L, 2008, P ROY SOC B-BIOL SCI, V275, P1297, DOI 10.1098/rspb.2007.1756; McDonald W, 2004, J APPL ECOL, V41, P82, DOI 10.1111/j.1365-2664.2004.00877.x; McDonald WR, 2004, OIKOS, V105, P397; McGarigal K, 2002, ECOL APPL, V12, P335, DOI 10.1890/1051-0761(2002)012[0335:CEOEAT]2.0.CO;2; McIntyre DL, 2002, PROF GEOGR, V54, P392, DOI 10.1111/0033-0124.00338; McShane TO, 2011, BIOL CONSERV, V144, P966, DOI 10.1016/j.biocon.2010.04.038; Moya H, 2007, POSSIBLE IMPACTS BOR; MURCIA C, 1995, TRENDS ECOL EVOL, V10, P58, DOI 10.1016/S0169-5347(00)88977-6; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Naughton-Treves L, 2005, ANNU REV ENV RESOUR, V30, P219, DOI 10.1146/annurev.energy.30.050504.164507; Newman D., 2006, EUR J SOC THEORY, V9, P171, DOI [10.1177/1368431006063331, DOI 10.1177/1368431006063331]; Novosseloff A., 2007, MURS ENTRE HOMMES; Oksanen L, 2001, OIKOS, V94, P27, DOI 10.1034/j.1600-0706.2001.11311.x; OMERNIK JM, 1987, ANN ASSOC AM GEOGR, V77, P118, DOI 10.1111/j.1467-8306.1987.tb00149.x; Packer C, 2013, ECOL LETT, V16, P635, DOI 10.1111/ele.12091; Peers MJL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051488; R Core Team, 2021, R LANG ENV STAT COMP; Ruxton GD, 2008, BEHAV ECOL, V19, P690, DOI 10.1093/beheco/arn020; Smallwood KS, 1999, ENVIRON CONSERV, V26, P102, DOI 10.1017/S0376892999000156; Soule ME, 2005, BIOSCIENCE, V55, P168, DOI 10.1641/0006-3568(2005)055[0168:SISCPM]2.0.CO;2; Soule ME, 2003, CONSERV BIOL, V17, P1238, DOI 10.1046/j.1523-1739.2003.01599.x; Struhsaker TT, 2005, BIOL CONSERV, V123, P45, DOI 10.1016/j.biocon.2004.10.007; Sundberg J, 2007, ENVIRON PLANN D, V25, P727, DOI 10.1068/d75j; Valenzuela D, 2002, J ZOOL, V258, P247, DOI 10.1017/S0952836902001358; Van Schoik DR, 2007, MONOGRAPH SW CONSORT, V15; Venables W.N., 2002, MODERN APPL STAT S P, Vfourth, DOI [10.1007/978-0-387-21706-2, DOI 10.1007/978-0-387-21706-2_10]; Waller DM, 1997, WILDLIFE SOC B, V25, P217; Wang H, 2003, MAMMALIA, V67, P513; Wolff JO, 1997, CONSERV BIOL, V11, P945, DOI 10.1046/j.1523-1739.1997.96136.x; Wonham MJ, 2006, ECOL LETT, V9, P706, DOI 10.1111/j.1461-0248.2006.00912.x	61	9	9	0	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93679	10.1371/journal.pone.0093679	http://dx.doi.org/10.1371/journal.pone.0093679			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717982	gold, Green Published, Green Submitted			2022-12-25	WOS:000334339000042
J	Bergouignan, A; Kealey, EH; Schmidt, SL; Jackman, MR; Bessesen, DH				Bergouignan, Audrey; Kealey, Elizabeth H.; Schmidt, Stacy L.; Jackman, Matthew R.; Bessesen, Daniel H.			Twenty-Four Hour Total and Dietary Fat Oxidation in Lean, Obese and Reduced-Obese Adults with and without a Bout of Exercise	PLOS ONE			English	Article							TYPE-2 DIABETIC SUBJECTS; SKELETAL-MUSCLE; ACID-METABOLISM; WEIGHT-LOSS; ENERGY-EXPENDITURE; PHYSICAL-ACTIVITY; LIPID OXIDATION; METAANALYSIS; REGAIN; MEAL	Background: It has been hypothesized that obese and reduced-obese individuals have decreased oxidative capacity, which contributes to weight gain and regain. Recent data have challenged this concept. Objective: To determine (1) whether total and dietary fat oxidation are decreased in obese and reduced-obese adults compared to lean but increase in response to an acute exercise bout and (2) whether regular physical activity attenuates these metabolic alterations. Design: We measured 24-hr total (whole-room calorimetry) and dietary fat (C-14-oleate) oxidation in Sedentary Lean (BMI = 21.5 = 1.6; n = 10), Sedentary Obese (BMI = 33.6 = 2.5; n = 9), Sedentary Reduced-Obese (RED-SED; BMI = 26.9 = 3.7; n = 7) and in Physically Active Reduced-Obese (RED-EX; BMI = 27.3 = 2.8; n = 12) men and women with or without an acute exercise bout where energy expended during exercise was not replaced. Results: Although Red-SED and Red-EX had a similar level of fatness, aerobic capacity and metabolic profiles were better in Red-EX only compared to Obese subjects. No significant between-group differences were seen in 24-hr respiratory quotient (RQ, Lean: 0.831 +/- 0.044, Obese: 0.852 +/- 0.023, Red-SED: 0.864 +/- 0.037, Red-EX: 0.842 +/- 0.039), total and dietary fat oxidation. A single bout of exercise increased total (+27.8%, p<0.0001) and dietary (+6.6%, p = 0.048) fat oxidation across groups. Although exercise did not impact RQ during the day, it decreased RQ during sleep (p = 0.01) in all groups. Red-EX oxidized more fat overnight than Red-SED subjects under both resting (p = 0.036) and negative energy balance (p = 0.003) conditions, even after adjustment for fat-free mass. Conclusion: Obese and reduced-obese individuals oxidize as much fat as lean both under eucaloric and negative energy balance conditions, which does not support the hypothesis of reduced oxidative capacity in these groups. Reduced-obese individuals who exercise regularly have markers of metabolic health similar to those seen in lean adults. Both the acute and chronic effects of exercise were primarily observed at night suggesting an important role of sleep in the regulation of lipid metabolism.	[Bergouignan, Audrey; Kealey, Elizabeth H.; Schmidt, Stacy L.; Bessesen, Daniel H.] Univ Colorado, Anschutz Hlth & Wellness Ctr, Aurora, CO 80045 USA; [Jackman, Matthew R.] Univ Colorado, Sch Med, Div Endocrinol Metab & Diabet, Aurora, CO USA; [Bessesen, Daniel H.] Denver Hlth Med Ctr, Denver, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Denver Health Medical Center	Bessesen, DH (corresponding author), Univ Colorado, Anschutz Hlth & Wellness Ctr, Anschutz Med Campus, Aurora, CO 80045 USA.	Daniel.Bessesen@ucdenver.edu	Bergouignan, Audrey/A-2750-2016	Bergouignan, Audrey/0000-0002-1266-5144	National Institutes of Health [K24DK002935]; NIH/NCRR Colorado CTSI [UL 1 RR025780]; Colorado Nutrition Obesity Research Center [P30DK048520]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520, K24DK002935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR Colorado CTSI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Colorado Nutrition Obesity Research Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	DHB received support from the National Institutes of Health through K24DK002935. The study was further supported by the NIH/NCRR Colorado CTSI Grant: UL 1 RR025780 and the Colorado Nutrition Obesity Research Center: P30DK048520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JW, 2001, AM J CLIN NUTR, V74, P579; ASTRUP A, 1994, AM J PHYSIOL, V266, pE592, DOI 10.1152/ajpendo.1994.266.4.E592; Bandyopadhyay GK, 2006, DIABETES, V55, P2277, DOI 10.2337/db06-0062; Bergouignan A, 2010, PLOS ONE, V7; Bergouignan A, 2009, PROG LIPID RES, V48, P128, DOI 10.1016/j.plipres.2009.02.004; Bergouignan A, 2009, DIABETES, V58, P367, DOI 10.2337/db08-0263; BESSESEN DH, 1995, OBES RES, V3, P179, DOI 10.1002/j.1550-8528.1995.tb00134.x; Binnert C, 1998, AM J CLIN NUTR, V67, P595, DOI 10.1093/ajcn/67.4.595; Blaak EE, 2004, P NUTR SOC, V63, P323, DOI 10.1079/PNS2004361; Blaak EE, 2000, DIABETES, V49, P2102, DOI 10.2337/diabetes.49.12.2102; Catenacci VA, 2007, NAT CLIN PRACT ENDOC, V3, P518, DOI 10.1038/ncpendmet0554; Hansen K, 2005, SPORTS MED, V35, P363, DOI 10.2165/00007256-200535050-00001; Hawkins KR, 2012, EUR J APPL PHYSIOL, V112, P3775, DOI 10.1007/s00421-012-2360-6; Hodson L, 2010, AM J PHYSIOL-ENDOC M, V299, pE584, DOI 10.1152/ajpendo.00272.2010; Hodson L, 2009, AM J PHYSIOL-ENDOC M, V296, pE64, DOI 10.1152/ajpendo.90730.2008; Holloway GP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1782, DOI 10.1152/ajpendo.00639.2006; Horton TJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE1192, DOI 10.1152/ajpendo.00164.2002; Jackman MR, 2008, AM J PHYSIOL-REG I, V294, pR1117, DOI 10.1152/ajpregu.00808.2007; Jackman MR, 2006, AM J PHYSIOL-ENDOC M, V291, pE1083, DOI 10.1152/ajpendo.00159.2006; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, pE1039, DOI 10.1152/ajpendo.2000.279.5.E1039; Larson-Meyer DE, 2010, MED SCI SPORT EXER, V42, P152, DOI 10.1249/MSS.0b013e3181ad7f17; Li ZP, 2005, ANN INTERN MED, V142, P532, DOI 10.7326/0003-4819-142-7-200504050-00012; MacLean PS, 2011, AM J PHYSIOL-REG I, V301, pR581, DOI 10.1152/ajpregu.00755.2010; MacLean PS, 2006, AM J PHYSIOL-REG I, V290, pR1577, DOI 10.1152/ajpregu.00810.2005; Maggard MA, 2005, ANN INTERN MED, V142, P547, DOI 10.7326/0003-4819-142-7-200504050-00013; Melanson EL, 2009, J APPL PHYSIOL, V107, P1847, DOI 10.1152/japplphysiol.00958.2009; Menshikova EV, 2005, AM J PHYSIOL-ENDOC M, V288, pE818, DOI 10.1152/ajpendo.00322.2004; Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981; Ogden LG, 2012, OBESITY, V20, P2039, DOI 10.1038/oby.2012.79; RABEN A, 1994, AM J PHYSIOL-ENDOC M, V267, pE549, DOI 10.1152/ajpendo.1994.267.4.E549; Redman LM, 2007, J CLIN ENDOCR METAB, V92, P865, DOI 10.1210/jc.2006-2184; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Santosa S, 2008, AM J CLIN NUTR, V88, P1134, DOI 10.1093/ajcn/88.4.1134; Sidossis LS, 1997, AM J PHYSIOL-ENDOC M, V272, pE1065, DOI 10.1152/ajpendo.1997.272.6.E1065; Sonko BJ, 2005, J NUTR, V135, P2159, DOI 10.1093/jn/135.9.2159; Votruba SB, 2005, INT J OBESITY, V29, P100, DOI 10.1038/sj.ijo.0802779; Votruba SB, 2002, MED SCI SPORT EXER, V34, P1757, DOI 10.1097/00005768-200211000-00011; Wadden TA, 2003, ENDOCRIN METAB CLIN, V32, P981, DOI 10.1016/S0889-8529(03)00072-0; Weiss EC, 2007, AM J PREV MED, V33, P34, DOI 10.1016/j.amepre.2007.02.040; Weiss EP, 2006, AM J CLIN NUTR, V84, P1033; Westerterp KR, 2008, AM J CLIN NUTR, V87, P132, DOI 10.1093/ajcn/87.1.132	43	16	16	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94181	10.1371/journal.pone.0094181	http://dx.doi.org/10.1371/journal.pone.0094181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714529	gold, Green Published, Green Submitted			2022-12-25	WOS:000334160900099
J	Dettmer, S; Peters, L; de Wall, C; Schaefer-Prokop, C; Schmidt, M; Warnecke, G; Gottlieb, J; Wacker, F; Shin, HO				Dettmer, Sabine; Peters, Lars; de Wall, Claudia; Schaefer-Prokop, Cornelia; Schmidt, Michael; Warnecke, Gregor; Gottlieb, Jens; Wacker, Frank; Shin, Hoen-oh			Bronchial Wall Measurements in Patients after Lung Transplantation: Evaluation of the Diagnostic Value for the Diagnosis of Bronchiolitis Obliterans Syndrome	PLOS ONE			English	Article							QUANTITATIVE COMPUTED-TOMOGRAPHY; AIRWAY DIMENSIONS; CT; STANDARDIZATION	Objectives: To prospectively evaluate quantitative airway wall measurements of thin-section CT for the diagnosis of Bronchiolitis Obliterans Syndrome (BOS) following lung transplantation. Materials and Methods: In 141 CT examinations, bronchial wall thickness (WT), the wall area percentage (WA%) calculated as the ratio of the bronchial wall area and the total area (sum of bronchial wall area and bronchial lumen area) and the difference of the WT on inspiration and expiration (WTdiff) were automatically measured in different bronchial generations. The measurements were correlated with the lung function parameters. WT and WA% in CT examinations of patients with (n = 25) and without (n = 116) BOS, were compared using the unpaired t-test and univariate analysis of variance, while also considering the differing lung volumes. Results: Measurements could be performed in 2,978 bronchial generations. WT, WA%, and WTdiff did not correlate with the lung function parameters (r<0.5). The WA% on inspiration was significantly greater in patients with BOS than in patients without BOS, even when considering the dependency of the lung volume on the measurements. WT on inspiration and expiration and WA% on expiration did not show significant differences between the groups. Conclusion: WA% on inspiration was significantly greater in patients with than in those without BOS. However, WA% measurements were significantly dependent on lung volume and showed a high variability, thus not allowing the sole use of bronchial wall measurements to differentiate patients with from those without BOS.	[Dettmer, Sabine; Peters, Lars; Wacker, Frank; Shin, Hoen-oh] Hannover Med Sch, Dept Radiol, Hannover, Germany; [de Wall, Claudia; Gottlieb, Jens] Hannover Med Sch, Dept Resp Med, Hannover, Germany; [Schaefer-Prokop, Cornelia] Meander Med Ctr, Amersfoort, Netherlands; [Schaefer-Prokop, Cornelia] Radboud Univ Nijmegen Med Ctr, DIAG, Nijmegen, Netherlands; [Schmidt, Michael] Fraunhofer MEVIS, Bremen, Germany; [Warnecke, Gregor] Hannover Med Sch, Dept Thorac & Cardiovasc Surg, Hannover, Germany	Hannover Medical School; Hannover Medical School; Meander Medisch Centrum; Radboud University Nijmegen; Hannover Medical School	Dettmer, S (corresponding author), Hannover Med Sch, Dept Radiol, Hannover, Germany.	dettmer.sabine@mh-hannover.de		Gottlieb, Prof. Jens/0000-0002-9540-9022	German Federal Ministry of Education and Research [01EO0802]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work (Dettmer and de Wall) was supported by a grant from the German Federal Ministry of Education and Research (reference number: 01EO0802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T, 2008, EUR RADIOL, V18, P2731, DOI 10.1007/s00330-008-1089-4; Al-Githmi I, 2006, EUR J CARDIO-THORAC, V30, P846, DOI 10.1016/j.ejcts.2006.09.027; Arcasoy SM, 1999, NEW ENGL J MED, V340, P1081, DOI 10.1056/NEJM199904083401406; Bakker ME, 2012, RESP MED, V106, P677, DOI 10.1016/j.rmed.2011.11.013; Bankier AA, 2001, RADIOLOGY, V218, P533, DOI 10.1148/radiology.218.2.r01fe09533; Berstad AE, 2006, EUR J RADIOL, V58, P124, DOI 10.1016/j.ejrad.2005.11.013; Boehler A, 1998, CHEST, V114, P1411, DOI 10.1378/chest.114.5.1411; Brillet PY, 2007, EUR RADIOL, V17, P1483, DOI 10.1007/s00330-006-0496-7; Chae EJ, 2011, ALLERGY ASTHMA IMMUN, V3, P111, DOI 10.4168/aair.2011.3.2.111; CHAMBERLAIN D, 1994, J HEART LUNG TRANSPL, V13, P963; COOPER JD, 1993, J HEART LUNG TRANSPL, V12, P713; Coxson Harvey O, 2008, Proc Am Thorac Soc, V5, P940, DOI 10.1513/pats.200806-057QC; de Jong PA, 2006, THORAX, V61, P799, DOI 10.1136/thx.2005.053249; Estenne M, 2002, J HEART LUNG TRANSPL, V21, P297, DOI 10.1016/S1053-2498(02)00398-4; Gottlieb J, 2008, TRANSPLANTATION, V85, P36, DOI 10.1097/01.tp.0000295981.84633.bc; Hasegawa M, 2006, AM J RESP CRIT CARE, V173, P1309, DOI 10.1164/rccm.200601-037OC; Kim N, 2008, KOREAN J RADIOL, V9, P226, DOI 10.3348/kjr.2008.9.3.226; Konen E, 2004, RADIOLOGY, V231, P467, DOI 10.1148/radiol.2312030563; Kuhnigk JM, 2005, RADIOGRAPHICS, V25, P525, DOI 10.1148/rg.252045070; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miller WT, 2001, J THORAC IMAG, V16, P76, DOI 10.1097/00005382-200104000-00002; Montaudon M, 2007, RADIOLOGY, V242, P573, DOI 10.1148/radiol.2422060030; Montaudon M, 2009, RADIOLOGY, V253, P844, DOI 10.1148/radiol.2533090303; MORRISH WF, 1991, RADIOLOGY, V179, P487, DOI 10.1148/radiology.179.2.2014297; Nakano Y, 2005, AM J RESP CRIT CARE, V171, P142, DOI 10.1164/rccm.200407-874OC; Nakano Y, 2002, CHEST, V122, p271S, DOI 10.1378/chest.122.6_suppl.271S-a; Nakano Y, 2002, PROC SPIE, V4683, P460, DOI 10.1117/12.463615; Ng YL, 2009, AM J ROENTGENOL, V192, pS1, DOI 10.2214/AJR.07.7061; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Reinhardt JM, 1997, IEEE T MED IMAGING, V16, P820, DOI 10.1109/42.650878; Schmidt M, 2010, PROC SPIE, V7624, DOI 10.1117/12.844453; Todd JL, 2011, CHEST, V140, P502, DOI 10.1378/chest.10-2838; Weinheimer O, 2008, IEEE T MED IMAGING, V27, P64, DOI 10.1109/TMI.2007.902798; Zach JA, 2012, INVEST RADIOL, V47, P596, DOI 10.1097/RLI.0b013e318262292e	34	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93783	10.1371/journal.pone.0093783	http://dx.doi.org/10.1371/journal.pone.0093783			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713820	Green Published, gold, Green Submitted			2022-12-25	WOS:000334160900048
J	Harris, R; de Jong, BM				Harris, Robert; de Jong, Bauke M.			Cerebral Activations Related to Audition-Driven Performance Imagery in Professional Musicians	PLOS ONE			English	Article							PARIETAL LOBE ACTIVATION; INTRAPARIETAL SULCUS; BROCAS AREA; BRAIN; PERCEPTION; CORTEX; PREMOTOR; SPACE; NETWORKS; PIANISTS	Functional Magnetic Resonance Imaging (fMRI) was used to study the activation of cerebral motor networks during auditory perception of music in professional keyboard musicians (n = 12). The activation paradigm implied that subjects listened to two-part polyphonic music, while either critically appraising the performance or imagining they were performing themselves. Two-part polyphonic audition and bimanual motor imagery circumvented a hemisphere bias associated with the convention of playing the melody with the right hand. Both tasks activated ventral premotor and auditory cortices, bilaterally, and the right anterior parietal cortex, when contrasted to 12 musically unskilled controls. Although left ventral premotor activation was increased during imagery (compared to judgment), bilateral dorsal premotor and right posterior-superior parietal activations were quite unique to motor imagery. The latter suggests that musicians not only recruited their manual motor repertoire but also performed a spatial transformation from the vertically perceived pitch axis (high and low sound) to the horizontal axis of the keyboard. Imagery-specific activations in controls were seen in left dorsal parietal-premotor and supplementary motor cortices. Although these activations were less strong compared to musicians, this overlapping distribution indicated the recruitment of a general 'mirror-neuron' circuitry. These two levels of sensori-motor transformations point towards common principles by which the brain organizes audition-driven music performance and visually guided task performance.	[Harris, Robert; de Jong, Bauke M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Harris, Robert; de Jong, Bauke M.] Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands; [Harris, Robert] Hanze Hsch Groningen, Groningen, Netherlands	University of Groningen; University of Groningen	de Jong, BM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	b.m.de.jong@umcg.nl		de Jong, Bauke M./0000-0002-6568-5739	Gratama Foundation, Harlingen; Hanze University; Prince Claus Conservatoire; Lectorate Lifelong Learning in Music, Groningen	Gratama Foundation, Harlingen; Hanze University; Prince Claus Conservatoire; Lectorate Lifelong Learning in Music, Groningen	Financial support was obtained from The Gratama Foundation, Harlingen (NL), the Hanze University, Prince Claus Conservatoire, and the Lectorate Lifelong Learning in Music, Groningen (NL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Angula-Perkins A, 2011, 17 ANN M ORG HUM BRA; Balter M, 2004, SCIENCE, V306, P1120, DOI 10.1126/science.306.5699.1120; Bangert M, 2006, NEUROIMAGE, V30, P917, DOI 10.1016/j.neuroimage.2005.10.044; Bangert M, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-26; Baumgart F, 1998, MED PHYS, V25, P2068, DOI 10.1118/1.598368; Bengtsson SL, 2009, CORTEX, V45, P62, DOI 10.1016/j.cortex.2008.07.002; Beudel M, 2011, HUM BRAIN MAPP, V32, P564, DOI 10.1002/hbm.21044; Beudel M, 2009, NEUROIMAGE, V44, P1032, DOI 10.1016/j.neuroimage.2008.09.028; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Brown S, 2006, EUR J NEUROSCI, V23, P2791, DOI 10.1111/j.1460-9568.2006.04785.x; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Camurri A, 2009, ACII 2009 3 INT C AF, V364, P2369; Chen JL, 2008, J COGNITIVE NEUROSCI, V20, P226, DOI 10.1162/jocn.2008.20018; Cupchik GC, 2001, BRAIN COGNITION, V46, P373, DOI 10.1006/brcg.2001.1295; D'Ausilio A, 2006, EUR J NEUROSCI, V24, P955, DOI 10.1111/j.1460-9568.2006.04960.x; de Jong BM, 2001, NEUROIMAGE, V14, P1128, DOI 10.1006/nimg.2001.0911; de Jong BM, 1999, COGNITIVE BRAIN RES, V8, P45, DOI 10.1016/S0926-6410(99)00005-1; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; Dick F, 2011, CEREB CORTEX, V21, P938, DOI 10.1093/cercor/bhq166; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Dissanayake E, 2000, ORIGINS OF MUSIC, P389; Foster NEV, 2010, CEREB CORTEX, V20, P1350, DOI 10.1093/cercor/bhp199; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fujioka T, 2005, J COGNITIVE NEUROSCI, V17, P1578, DOI 10.1162/089892905774597263; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; GEORGOPOULOS AP, 1991, ANNU REV NEUROSCI, V14, P361, DOI 10.1146/annurev.ne.14.030191.002045; Gibson J.J., 1977, PERCEIVING ACTING KN, P67; Gieteling EW, 2008, PAIN, V134, P302, DOI 10.1016/j.pain.2007.04.029; Goodale MA, 1998, CURR BIOL, V8, pR489, DOI 10.1016/S0960-9822(98)70314-8; Grahn JA, 2007, J COGNITIVE NEUROSCI, V19, P893, DOI 10.1162/jocn.2007.19.5.893; Grefkes C, 2005, J ANAT, V207, P3, DOI 10.1111/j.1469-7580.2005.00426.x; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Harris IM, 2000, BRAIN, V123, P65, DOI 10.1093/brain/123.1.65; Haslinger B, 2005, J COGNITIVE NEUROSCI, V17, P282, DOI 10.1162/0898929053124893; Haueisen J, 2001, J COGNITIVE NEUROSCI, V13, P786, DOI 10.1162/08989290152541449; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Itoh K, 2001, NEUROSCI LETT, V309, P41, DOI 10.1016/S0304-3940(01)02024-9; James CE, 2008, NEUROIMAGE, V42, P1597, DOI 10.1016/j.neuroimage.2008.06.025; Janata P, 2003, NAT NEUROSCI, V6, P682, DOI 10.1038/nn1081; Janata P, 2002, SCIENCE, V298, P2167, DOI 10.1126/science.1076262; Jancke L, 2001, CEREB CORTEX, V11, P114, DOI 10.1093/cercor/11.2.114; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; Keller PE, 2007, CONSCIOUS COGN, V16, P102, DOI 10.1016/j.concog.2005.12.004; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Koelsch S, 2005, CURR OPIN NEUROBIOL, V15, P207, DOI 10.1016/j.conb.2005.03.005; Koelsch S, 2006, CORTEX, V42, P518, DOI 10.1016/S0010-9452(08)70390-3; Koelsch S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00110; Kokotsaki D., 2007, MUSIC EDUC RES, V9, P93, DOI [DOI 10.1080/14613800601127577, 10.1080/14613800601127577]; Kornysheva K, 2010, HUM BRAIN MAPP, V31, P48, DOI 10.1002/hbm.20844; Lahav A, 2007, J NEUROSCI, V27, P308, DOI 10.1523/JNEUROSCI.4822-06.2007; Langheim FJP, 2002, NEUROIMAGE, V16, P901, DOI 10.1006/nimg.2002.1144; LEMAN M, 2008, EMBODIED MUSIC COGNI; Lewis JW, 2005, J NEUROSCI, V25, P5148, DOI 10.1523/JNEUROSCI.0419-05.2005; Lewis PA, 2004, NEUROPSYCHOLOGIA, V42, P1301, DOI 10.1016/j.neuropsychologia.2004.03.001; Lotze M, 2003, NEUROIMAGE, V20, P1817, DOI 10.1016/j.neuroimage.2003.07.018; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; McNeill W. H., 1995, KEEPING TOGETHER TIM; Meister IG, 2004, COGNITIVE BRAIN RES, V19, P219, DOI 10.1016/j.cogbrainres.2003.12.005; Nan Y, 2006, BRAIN RES, V1094, P179, DOI 10.1016/j.brainres.2006.03.115; Osnes B, 2011, BRAIN LANG, V116, P97, DOI 10.1016/j.bandl.2010.10.001; Parsons LM, 2001, ANN NY ACAD SCI, V930, P211, DOI 10.1111/j.1749-6632.2001.tb05735.x; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Patel AD, 2005, ANN NY ACAD SCI, V1060, P59, DOI 10.1196/annals.1360.005; Poulet JFA, 2007, TRENDS NEUROSCI, V30, P14, DOI 10.1016/j.tins.2006.11.005; Pressing J, 2005, GENERATIVE PROCESSES; RAUSCHER FH, 1995, NEUROSCI LETT, V185, P44, DOI 10.1016/0304-3940(94)11221-4; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rusconi E, 2005, ANN NY ACAD SCI, V1060, P195, DOI 10.1196/annals.1360.056; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; Sammler D, 2011, CORTEX, V47, P659, DOI 10.1016/j.cortex.2010.04.007; Satoh M, 2001, COGNITIVE BRAIN RES, V12, P101, DOI 10.1016/S0926-6410(01)00044-1; Schachner Adena, 2010, Communicative & Integrative Biology, V3, P290; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Schubotz RI, 2000, NEUROIMAGE, V11, P1, DOI 10.1006/nimg.1999.0514; Schubotz RI, 2007, TRENDS COGN SCI, V11, P211, DOI 10.1016/j.tics.2007.02.006; SERGENT J, 1992, SCIENCE, V257, P106, DOI 10.1126/science.1621084; Sluming V, 2007, J NEUROSCI, V27, P3799, DOI 10.1523/JNEUROSCI.0147-07.2007; Stewart L, 2003, NEUROIMAGE, V20, P71, DOI 10.1016/S1053-8119(03)00248-9; Tervaniemi M, 2003, COGNITIVE NEUROSCIEN; Tettamanti M, 2005, J COGNITIVE NEUROSCI, V17, P273, DOI 10.1162/0898929053124965; Trainor LJ, 2002, J COGNITIVE NEUROSCI, V14, P430, DOI 10.1162/089892902317361949; Vesia M, 2006, J NEUROPHYSIOL, V96, P3016, DOI 10.1152/jn.00411.2006; Warren JD, 2003, P NATL ACAD SCI USA, V100, P10038, DOI 10.1073/pnas.1730682100; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	89	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93681	10.1371/journal.pone.0093681	http://dx.doi.org/10.1371/journal.pone.0093681			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714661	Green Published, gold, Green Submitted			2022-12-25	WOS:000334160900043
J	Jiang, L; Wallerman, O; Younis, S; Rubin, CJ; Gilbert, ER; Sundstrom, E; Ghazal, A; Zhang, XL; Wang, L; Mikkelsen, TS; Andersson, G; Andersson, L				Jiang, Lin; Wallerman, Ola; Younis, Shady; Rubin, Carl-Johan; Gilbert, Elizabeth R.; Sundstrom, Elisabeth; Ghazal, Awaisa; Zhang, Xiaolan; Wang, Li; Mikkelsen, Tarjei S.; Andersson, Goran; Andersson, Leif			ZBED6 Modulates the Transcription of Myogenic Genes in Mouse Myoblast Cells	PLOS ONE			English	Article							HELIX-LOOP-HELIX; GROWTH; METHYLATIONS; DOMAIN; MYOD	ZBED6 is a recently discovered transcription factor, unique to placental mammals, that has evolved from a domesticated DNA transposon. It acts as a repressor at the IGF2 locus. Here we show that ZBED6 acts as a transcriptional modulator in mouse myoblast cells, where more than 700 genes were differentially expressed after Zbed6-silencing. The most significantly enriched GO term was muscle protein and contractile fiber, which was consistent with increased myotube formation. Twenty small nucleolar RNAs all showed increased expression after Zbed6-silencing. The co-localization of histone marks and ZBED6 binding sites and the effect of Zbed6-silencing on distribution of histone marks was evaluated by ChIP-seq analysis. There was a strong association between ZBED6 binding sites and the H3K4me3, H3K4me2 and H3K27ac modifications, which are usually found at active promoters, but no association with the repressive mark H3K27me3. Zbed6-silencing led to increased enrichment of active marks at myogenic genes, in agreement with the RNA-seq findings. We propose that ZBED6 preferentially binds to active promoters and modulates transcriptional activity without recruiting repressive histone modifications.	[Jiang, Lin; Wallerman, Ola; Younis, Shady; Rubin, Carl-Johan; Gilbert, Elizabeth R.; Sundstrom, Elisabeth; Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Younis, Shady] Ain Shams Univ, Dept Anim Prod, Cairo, Egypt; [Ghazal, Awaisa; Andersson, Goran; Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden; [Zhang, Xiaolan; Wang, Li; Mikkelsen, Tarjei S.] Broad Inst, Cambridge, MA USA; [Mikkelsen, Tarjei S.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Mikkelsen, Tarjei S.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Uppsala University; Egyptian Knowledge Bank (EKB); Ain Shams University; Swedish University of Agricultural Sciences; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University	Andersson, L (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden.	leif.andersson@imbim.uu.se	Andersson, Goran/AAK-6564-2020; Mikkelsen, Tarjei S/A-1306-2007	Andersson, Goran/0000-0001-5131-3144; Mikkelsen, Tarjei S/0000-0002-8133-3135; Rubin, Carl-Johan/0000-0001-8238-5052; Jiang, Lin/0000-0001-9123-5988; Wallerman, Ola/0000-0003-1037-7904; Younis, Shady/0000-0002-4319-1738	Swedish Research Council; Swedish Foundation for Strategic Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	The work was supported by grants from the Swedish Research Council and Swedish Foundation for Strategic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali SA, 2008, P NATL ACAD SCI USA, V105, P6632, DOI 10.1073/pnas.0800970105; Andersson L, 2010, TRANSCR-AUSTIN, V1, P144, DOI 10.4161/trns.1.3.13343; Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P421, DOI 10.1016/S0968-0004(00)01620-0; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beane J, 2011, CANCER PREV RES, V4, P803, DOI 10.1158/1940-6207.CAPR-11-0212; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blazejczyk M., 2007, FLEXARRAY STAT DATA; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Butter F, 2010, EMBO REP, V11, P305, DOI 10.1038/embor.2010.6; CALVI BR, 1991, CELL, V66, P465, DOI 10.1016/0092-8674(81)90010-6; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; FLORINI JR, 1991, J BIOL CHEM, V266, P15917; Gong XQ, 2002, J BIOL CHEM, V277, P12310, DOI 10.1074/jbc.M110228200; Kundaje A, 2012, GENOME RES, V22, P1735, DOI 10.1101/gr.136366.111; Markljung E, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000256; Michal B, 2007, FLEXARRAY STAT DATA, P69; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raghav SK, 2012, MOL CELL, V46, P335, DOI 10.1016/j.molcel.2012.03.017; Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sui SJH, 2007, NUCLEIC ACIDS RES, V35, pW245, DOI 10.1093/nar/gkm427; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; Van Laere AS, 2005, QTL QTN IDENTIFICATI; Wallerman O, 2009, NUCLEIC ACIDS RES, V37, P7498, DOI 10.1093/nar/gkp823; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	32	15	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94187	10.1371/journal.pone.0094187	http://dx.doi.org/10.1371/journal.pone.0094187			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714595	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900101
J	Jung, Y; Ng, JH; Keating, CP; Senthil-Kumar, P; Zhao, J; Randolph, MA; Winograd, JM; Evans, CL				Jung, Yookyung; Ng, Joanna H.; Keating, Cameron P.; Senthil-Kumar, Prabhu; Zhao, Jie; Randolph, Mark A.; Winograd, Jonathan M.; Evans, Conor L.			Comprehensive Evaluation of Peripheral Nerve Regeneration in the Acute Healing Phase Using Tissue Clearing and Optical Microscopy in a Rodent Model	PLOS ONE			English	Article							IN-VIVO; INJURIES; IMPROVES; REPAIR; ORGANS	Peripheral nerve injury (PNI), a common injury in both the civilian and military arenas, is usually associated with high healthcare costs and with patients enduring slow recovery times, diminished quality of life, and potential long-term disability. Patients with PNI typically undergo complex interventions but the factors that govern optimal response are not fully characterized. A fundamental understanding of the cellular and tissue-level events in the immediate postoperative period is essential for improving treatment and optimizing repair. Here, we demonstrate a comprehensive imaging approach to evaluate peripheral nerve axonal regeneration in a rodent PNI model using a tissue clearing method to improve depth penetration while preserving neural architecture. Sciatic nerve transaction and end-to-end repair were performed in both wild type and thy-1 GFP rats. The nerves were harvested at time points after repair before undergoing whole mount immunofluorescence staining and tissue clearing. By increasing the optic depth penetration, tissue clearing allowed the visualization and evaluation of Wallerian degeneration and nerve regrowth throughout entire sciatic nerves with subcellular resolution. The tissue clearing protocol did not affect immunofluorescence labeling and no observable decrease in the fluorescence signal was observed. Large-area, high-resolution tissue volumes could be quantified to provide structural and connectivity information not available from current gold-standard approaches for evaluating axonal regeneration following PNI. The results are suggestive of observed behavioral recovery in vivo after neurorrhaphy, providing a method of evaluating axonal regeneration following repair that can serve as an adjunct to current standard outcomes measurements. This study demonstrates that tissue clearing following whole mount immunofluorescence staining enables the complete visualization and quantitative evaluation of axons throughout nerves in a PNI model. The methods developed in this study could advance PNI research allowing both researchers and clinicians to further understand the individual events of axonal degeneration and regeneration on a multifaceted level.	[Jung, Yookyung; Zhao, Jie; Evans, Conor L.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02115 USA; [Ng, Joanna H.; Keating, Cameron P.; Senthil-Kumar, Prabhu; Randolph, Mark A.; Winograd, Jonathan M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Plast & Reconstruct Surg,Plast Surg Res Lab, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Evans, CL (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02115 USA.	Evans.Conor@mgh.harvard.edu	Senthil-kumar, Prabhu/AAE-2147-2019	Jung, Yookyung/0000-0003-2790-6016	American Society for Surgery of the Hand (Basic Science Grant); Department of Defense "Center for Integration of Medicine and Innovative Technology" (CIMIT) [W81XWH-09-2-0001]; National Institutes of Heath (NIH) Innovative Molecular Analysis Technologies (IMAT) program [R21 CA155535]; NIH Director's New Innovator Award [DP2 OD007096]; NATIONAL CANCER INSTITUTE [R21CA155535] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007096] Funding Source: NIH RePORTER	American Society for Surgery of the Hand (Basic Science Grant); Department of Defense "Center for Integration of Medicine and Innovative Technology" (CIMIT); National Institutes of Heath (NIH) Innovative Molecular Analysis Technologies (IMAT) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the American Society for Surgery of the Hand (Basic Science Grant, www.assh.org), the Department of Defense "Center for Integration of Medicine and Innovative Technology" (CIMIT, www.cimit.org) Grant Award #W81XWH-09-2-0001, the National Institutes of Heath (NIH) Innovative Molecular Analysis Technologies (IMAT, imat.cancer.gov) program, grant number R21 CA155535, and the NIH Director's New Innovator Award, grant number DP2 OD007096. Information on the New Innovator Award Program is at http://nihroadmap.nih.gov/newinnovator/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arous JB, 2011, J BIOMEDICAL OPTICS, V16; BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024; Belanger E, 2011, BIOMED OPT EXPRESS, V2, P2698, DOI 10.1364/BOE.2.002698; Belanger E, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.2.021107; Birch R, 2012, J BONE JOINT SURG BR, V94B, P523, DOI 10.1302/0301-620X.94B4.28483; Campbell WW, 2008, CLIN NEUROPHYSIOL, V119, P1951, DOI 10.1016/j.clinph.2008.03.018; Canty AJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3038; Chlebicki CA, 2010, LASER SURG MED, V42, P306, DOI 10.1002/lsm.20915; Dagum A B, 1998, J Hand Ther, V11, P111; Erturk A, 2013, EXP NEUROL, V242, P57, DOI 10.1016/j.expneurol.2012.10.018; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Evans CL, 2005, P NATL ACAD SCI USA, V102, P16807, DOI 10.1073/pnas.0508282102; FU SY, 1995, J NEUROSCI, V15, P3876; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Gordon T, 1997, Adv Neurol, V72, P185; Henry FP, 2009, PLAST RECONSTR SURG, V123, p123S, DOI 10.1097/PRS.0b013e318191c5b8; Henry FP, 2009, SURGERY, V145, P313, DOI 10.1016/j.surg.2008.11.005; Hirata K, 2002, MICROSC RES TECHNIQ, V57, P541, DOI 10.1002/jemt.10108; Huff TB, 2007, J MICROSC-OXFORD, V225, P175, DOI 10.1111/j.1365-2818.2007.01729.x; Hunter DA, 2007, J NEUROSCI METH, V166, P116, DOI 10.1016/j.jneumeth.2007.06.018; Isaacs J, 2010, J HAND SURG-AM, V35A, P491, DOI 10.1016/j.jhsa.2009.12.009; Kelly Patrick, ZPROJECT PLUGIN; Lakadamyali M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030826; Le TT, 2010, J LIPID RES, V51, P672, DOI 10.1194/jlr.D000638; Lee AC, 2003, EXP NEUROL, V184, P295, DOI 10.1016/S0014-4886(03)00258-9; Liu YA, 2011, NEUROGASTROENT MOTIL, V23, pE446, DOI 10.1111/j.1365-2982.2011.01773.x; Magill CK, 2010, ARCH FACIAL PLAST S, V12, P315, DOI 10.1001/archfacial.2010.71; Maricevic A, 1997, MIL MED, V162, P808, DOI 10.1093/milmed/162.12.808; Mathes SJ, 2005, PLASTIC SURG; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Misgeld T, 2006, NAT REV NEUROSCI, V7, P449, DOI 10.1038/nrn1905; Moore AM, 2012, J NEUROSCI METH, V204, P19, DOI 10.1016/j.jneumeth.2011.10.011; O'Neill AC, 2009, J SURG RES, V151, P33, DOI 10.1016/j.jss.2008.01.025; Pabari A, 2010, J PLAST RECONSTR AES, V63, P1941, DOI 10.1016/j.bjps.2009.12.010; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Sevrain D, 2013, EXP DERMATOL, V22, P290, DOI 10.1111/exd.12108; Shi YZ, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3641988; Siemionow M, 2009, INT REV NEUROBIOL, V87, P141, DOI 10.1016/S0074-7742(09)87008-6; Tapia JC, 2012, NEURON, V74, P816, DOI 10.1016/j.neuron.2012.04.017; Turney SG, 2012, COLD SPRING HARBOR P, V2012; Turney SG, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001352; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X; Wiberg Mikael, 2003, Surg Technol Int, V11, P303; Wood MD, 2011, ANN ANAT, V193, P321, DOI 10.1016/j.aanat.2011.04.008	45	32	34	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94054	10.1371/journal.pone.0094054	http://dx.doi.org/10.1371/journal.pone.0094054			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714405	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900076
J	Lutz, P; Parcina, M; Bekeredjian-Ding, I; Nischalke, HD; Nattermann, J; Sauerbruch, T; Hoerauf, A; Strassburg, CP; Spengler, U				Lutz, Philipp; Parcina, Marijo; Bekeredjian-Ding, Isabelle; Nischalke, Hans Dieter; Nattermann, Jacob; Sauerbruch, Tilman; Hoerauf, Achim; Strassburg, Christian P.; Spengler, Ulrich			Impact of Rifaximin on the Frequency and Characteristics of Spontaneous Bacterial Peritonitis in Patients with Liver Cirrhosis and Ascites	PLOS ONE			English	Article							PASTEURELLA-MULTOCIDA; RISK-FACTORS; INFECTIONS; PREVALENCE; RESISTANT	Background: Rifaximin is a non-absorbable antibiotic used to prevent relapses of hepatic encephalopathy which may also be a candidate for prophylaxis of spontaneous bacterial peritonitis (SBP). Aim: To detect the impact of rifaximin on the occurrence and characteristics of SBP. Methods: We prospectively studied all hospitalized patients that underwent a diagnostic paracentesis in our department from March 2012 to April 2013 for SBP and recorded all clinical data including type of SBP prophylaxis, prior use of rifaximin, concomitant complications of cirrhosis, as well as laboratory results and bacteriological findings. Patients were divided into the following three groups: no antibiotic prophylaxis, prophylaxis with rifaximin or with systemically absorbed antibiotic prophylaxis. Results: Our study cohort comprised 152 patients with advanced liver cirrhosis, 32 of whom developed SBP during the study period. As expected, our study groups differed regarding a history of hepatic encephalopathy and SBP before inclusion into the study. None of the 17 patients on systemic antibiotic prophylaxis developed SBP while 8/27 patients on rifaximin and 24/108 without prophylaxis had SBP (p = 0.02 and p = 0.04 versus systemic antibiotics, respectively). In general, episodes of SBP were similar for patients treated with rifaximin and those without any prophylaxis. However, Escherichia coli and enterococci were dominant in the ascites of patients without any prophylaxis, while mostly klebsiella species were recovered from the ascites samples in the rifaximin group. Conclusion: Rifaximin pretreatment did not lead to a reduction of SBP occurrence in hospitalized patients with advanced liver disease. However, the bacterial species causing SBP were changed by rifaximin.	[Lutz, Philipp; Nischalke, Hans Dieter; Nattermann, Jacob; Sauerbruch, Tilman; Strassburg, Christian P.; Spengler, Ulrich] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Parcina, Marijo; Bekeredjian-Ding, Isabelle; Hoerauf, Achim] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany	University of Bonn; University of Bonn	Lutz, P (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.	philipp.lutz@ukb.uni-bonn.de	Parcina, Marijo/ABG-4659-2020; Bekeredjian-Ding, Isabelle/I-6197-2013	Bekeredjian-Ding, Isabelle/0000-0001-6646-5888; Lutz, Philipp/0000-0002-4921-200X; Nischalke, Hans Dieter/0000-0002-3457-0023	German Center for Infection Research	German Center for Infection Research	This study was supported by a clinical leave stipend to PL by the German Center for Infection Research (DZIF, http://www.dzif.de/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appenrodt B, 2010, HEPATOLOGY, V51, P1327, DOI 10.1002/hep.23440; AVRIL JL, 1990, J CLIN MICROBIOL, V28, P1438, DOI 10.1128/JCM.28.6.1438-1440.1990; Bajaj JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060042; Bass NM, 2010, NEW ENGL J MED, V362, P1071, DOI 10.1056/NEJMoa0907893; Blei AT, 2001, AM J GASTROENTEROL, V96, P1968, DOI 10.1016/S0002-9270(01)02527-8; Bunchorntavakul C, 2012, WORLD J HEPATOL, V4, P158, DOI 10.4254/wjh.v4.i5.158; Coltart I, 2013, ARCH BIOCHEM BIOPHYS, V536, P189, DOI 10.1016/j.abb.2013.03.016; DELEO C, 1986, DRUG EXP CLIN RES, V12, P979; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; DuPont HL, 2004, CLIN MICROBIOL INFEC, V10, P1009, DOI 10.1111/j.1469-0691.2004.00997.x; Eltawil KM, 2012, WORLD J GASTROENTERO, V18, P767, DOI 10.3748/wjg.v18.i8.767; Fernandez J, 2012, HEPATOLOGY, V55, P1551, DOI 10.1002/hep.25532; Garcia-Tsao G, 2001, GASTROENTEROLOGY, V120, P726, DOI 10.1053/gast.2001.22580; GILLIS JC, 1995, DRUGS, V49, P467, DOI 10.2165/00003495-199549030-00009; GINES P, 1990, HEPATOLOGY, V12, P716, DOI 10.1002/hep.1840120416; Gines P, 2010, J HEPATOL, V53, P397, DOI 10.1016/j.jhep.2010.05.004; Gustot T, 2009, HEPATOLOGY, V50, P2022, DOI 10.1002/hep.23264; Haussinger D, 2008, GUT, V57, P1156, DOI 10.1136/gut.2007.122176; Hanouneh MA, 2012, J CLIN GASTROENTEROL, V46, P709, DOI 10.1097/MCG.0b013e3182506dbb; Harputluoglu MMM, 2012, INFLAMMATION, V35, P1512, DOI 10.1007/s10753-012-9465-2; HOOVER WW, 1993, DIAGN MICR INFEC DIS, V16, P111, DOI 10.1016/0732-8893(93)90004-Q; Jiang ZD, 2000, ANTIMICROB AGENTS CH, V44, P2205, DOI 10.1128/AAC.44.8.2205-2206.2000; Kothary V, 2013, ANTIMICROB AGENTS CH, V57, P811, DOI 10.1128/AAC.02163-12; Nischalke HD, 2011, J HEPATOL, V55, P1010, DOI 10.1016/j.jhep.2011.02.022; PELLETIER G, 1990, J HEPATOL, V10, P327, DOI 10.1016/0168-8278(90)90140-M; Rogers GB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074884; Scarpignato C, 2006, DIGESTION, V73, P13, DOI 10.1159/000089776; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Tamaskar I, 2004, SOUTH MED J, V97, P1113, DOI 10.1097/01.SMJ.0000144616.66917.8A; Tandon P, 2012, CLIN GASTROENTEROL H, V10, P1291, DOI 10.1016/j.cgh.2012.08.017; TANNER A, 2000, PERIODONTOL, V5, P26; Thuluvath PJ, 2001, AM J GASTROENTEROL, V96, P1232, DOI 10.1111/j.1572-0241.2001.03708.x; Tomas I, 2012, J CLIN PERIODONTOL, V39, P213, DOI 10.1111/j.1600-051X.2011.01784.x; Umgelter A, 2009, INFECTION, V37, P2, DOI 10.1007/s15010-008-8060-9; Valentin T, 2011, J INFECTION, V62, P34, DOI 10.1016/j.jinf.2010.11.004; Vlachogiannakos J, 2013, J GASTROEN HEPATOL, V28, P450, DOI 10.1111/jgh.12070; Wiest R, 2012, GUT, V61, P297, DOI 10.1136/gutjnl-2011-300779; Yakar T, 2010, DIGEST DIS SCI, V55, P1149, DOI 10.1007/s10620-009-0825-1; Zhu Q, 2012, J HEPATOL, V56, P893, DOI 10.1016/j.jhep.2011.11.013	39	40	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93909	10.1371/journal.pone.0093909	http://dx.doi.org/10.1371/journal.pone.0093909			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714550	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900059
J	Oskarsson, H; Wiklund, AKE; Thorsen, G; Danielsson, G; Kumblad, L				Oskarsson, Hanna; Wiklund, Ann-Kristin Eriksson; Thorsen, Gunnar; Danielsson, Gabriela; Kumblad, Linda			Community Interactions Modify the Effects of Pharmaceutical Exposure: A Microcosm Study on Responses to Propranolol in Baltic Sea Coastal Organisms	PLOS ONE			English	Article							MYTILUS-EDULIS; RISK-ASSESSMENT; BETA-BLOCKERS; ECOSYSTEM; BIODIVERSITY; CONTAMINANTS; ECOTOXICITY; POPULATIONS; PESTICIDES; FILTRATION	This study investigated the uptake and effects of a common human pharmaceutical, propranolol, on the structure and function of a coastal Baltic Sea model community consisting of macroalga (Ceramium tenuicorne), mussels (Mytilus edulis trossulus), amphipods (Gammarus spp.), water and sediment. The most sensitive species, the mussel, was affected to the same extent as in previous single species studies, while the effects on the amphipod and alga were smaller or even positive compared to experiments performed in less complex test systems. The observed cascade of beneficial effects was a result of inter-specific species interactions that buffered for more severe effects. The poor condition of the mussel led to a feeding shift from alga to mussel by the amphipods. The better food quality, due to the dietary shift, counteracted the effects of the exposure. Less amphipod grazing, together with increased levels of nutrients in the water was favourable for the alga, despite the negative effects of propranolol. This microcosm study showed effects on organisms on different organizational levels as well as interactions among the different components resulting in indirect exposure effects of both functional and structural nature. The combination of both direct and indirect effects would not have been detected using simpler single- or even two-species study designs. The observed structural changes would in the natural environment have a long-term influence on ecosystem function, especially in a low-biodiversity ecosystem like the Baltic Sea.	[Oskarsson, Hanna; Kumblad, Linda] Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden; [Wiklund, Ann-Kristin Eriksson] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden; [Thorsen, Gunnar] Stockholm Univ, Dept Analyt Chem, S-10691 Stockholm, Sweden; [Danielsson, Gabriela] Stockholm Univ, Dept Biochem & Biophys, S-10691 Stockholm, Sweden	Stockholm University; Stockholm University; Stockholm University; Stockholm University	Oskarsson, H (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, S-10691 Stockholm, Sweden.	hanna.oskarsson@su.se		Thorsen, Gunnar/0000-0002-0387-901X	Stockholm University Baltic Sea Center	Stockholm University Baltic Sea Center	The field sampling was financed by an Asko grant from Stockholm University Baltic Sea Center (http://www.su.se/ostersjocentrum/english/) to H. Oskarsson. Employees of the funder at the Asko Laboratory assisted with the collection of organisms. The funders had no role in the study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Adamo Shelley A., 2008, ISJ, V5, P12; ALEXANDER BS, 1987, J PHARM PHARMACOL, V39, P664, DOI 10.1111/j.2042-7158.1987.tb03452.x; Alsterberg C, 2013, P NATL ACAD SCI USA, V110, P8603, DOI 10.1073/pnas.1303797110; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andreozzi R, 2003, CHEMOSPHERE, V50, P1319, DOI 10.1016/S0045-6535(02)00769-5; Ankar S, 1978, CONTRIBUTIONS ASKO L, V11; Bendz D, 2005, J HAZARD MATER, V122, P195, DOI 10.1016/j.jhazmat.2005.03.012; Bengtsson B-E, 2005, LAKEMEDEL MILJO; Bonsdorff E, 1999, AUST J ECOL, V24, P312, DOI 10.1046/j.1442-9993.1999.00986.x; Calabrese EJ, 2008, ENVIRON TOXICOL CHEM, V27, P1451, DOI [10.1897/07-541.1, 10.1897/07-541]; Clausen I, 1996, MAR ECOL PROG SER, V141, P37, DOI 10.3354/meps141037; Clements WH, 2009, ENVIRON TOXICOL CHEM, V28, P1789, DOI 10.1897/09-140.1; Cleuvers M, 2003, TOXICOL LETT, V142, P185, DOI 10.1016/S0378-4274(03)00068-7; Elmgren R, 1997, MARINE BIODIVERSITY-BOOK, P319, DOI 10.1017/CBO9780511752360.015; Elmgren R, 2001, AMBIO, V30, P222, DOI 10.1639/0044-7447(2001)030[0222:UHIOTB]2.0.CO;2; Ericson H, 2010, AQUAT TOXICOL, V99, P223, DOI 10.1016/j.aquatox.2010.04.017; Escher BI, 2006, ENVIRON SCI TECHNOL, V40, P7402, DOI 10.1021/es052572v; Falas P, 2012, WATER SCI TECHNOL, V66, P783, DOI 10.2166/wst.2012.243; Fent K, 2006, AQUAT TOXICOL, V76, P122, DOI 10.1016/j.aquatox.2005.09.009; Ferrari B, 2004, ENVIRON TOXICOL CHEM, V23, P1344, DOI 10.1897/03-246; Fleeger JW, 2003, SCI TOTAL ENVIRON, V317, P207, DOI 10.1016/S0048-9697(03)00141-4; Forbes VE, 2012, ENVIRON TOXICOL CHEM, V31, P2663, DOI 10.1002/etc.2009; Forbes VE, 1999, ENVIRON TOXICOL CHEM, V18, P1544, DOI 10.1002/etc.5620180729; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huggett DB, 2002, ARCH ENVIRON CON TOX, V43, P229, DOI 10.1007/s00244-002-1182-7; Hughes A., 2012, NAT ED KNOWL, V3, P48; Jansson B-O, 1977, CONTRIBUTIONS ASKO L, V18; JANSSON BO, 1980, AMBIO, V9, P128; Jjemba PK, 2006, ECOTOX ENVIRON SAFE, V63, P113, DOI 10.1016/j.ecoenv.2004.11.011; Kautsky H, 1989, CONTRIBUTIONS ASKO L, V35; KAUTSKY N, 1987, MAR ECOL PROG SER, V38, P201, DOI 10.3354/meps038201; KAUTSKY U, 1995, THESIS STOCKHOLM U S; Koivisto M, 2011, MAR BIOL, V158, P945, DOI 10.1007/s00227-010-1621-3; KOLDING S, 1981, OIKOS, V37, P167, DOI 10.2307/3544461; KOLDING S, 1981, OIKOS, V37, P173, DOI 10.2307/3544462; Lacoste A, 2001, GEN COMP ENDOCR, V122, P252, DOI 10.1006/gcen.2001.7643; Lora-Vilchis MC, 2004, AQUAC RES, V35, P1086, DOI 10.1111/j.1365-2109.2004.01123.x; Macneil C, 1999, BIOL REV, V74, P375, DOI 10.1017/S0006323199005368; Maire O, 2007, MAR BIOL, V152, P1293, DOI 10.1007/s00227-007-0778-x; Massarsky A, 2011, J EXP ZOOL PART A, V315A, P251, DOI 10.1002/jez.672; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; Newell RIE, 2004, J SHELLFISH RES, V23, P51; Norling P, 2009, THESIS STOCKHOLM U S; Norling P, 2007, MAR ECOL PROG SER, V351, P163, DOI 10.3354/meps07033; Norling P, 2008, AQUAT BIOL, V4, P75, DOI 10.3354/ab00096; Oskarsson H, 2012, MAR ENVIRON RES, V74, P1, DOI 10.1016/j.marenvres.2011.11.001; Prevodnik A, 2007, AQUAT TOXICOL, V82, P63, DOI 10.1016/j.aquatox.2007.01.006; Relyea RA, 2005, ECOL APPL, V15, P1125, DOI 10.1890/04-0559; Relyea RA, 2008, ECOL APPL, V18, P1728, DOI 10.1890/08-0454.1; Rohr JR, 2006, TRENDS ECOL EVOL, V21, P606, DOI 10.1016/j.tree.2006.07.002; Ronnback P, 2007, AMBIO, V36, P534, DOI 10.1579/0044-7447(2007)36[534:EGASFS]2.0.CO;2; Ruist E, 2008, FOSFOR KVAVEFRAKTION; Sheehan P. J., 1984, EFFECTS POLLUTANTS E, P51; SHURE DJ, 1971, ECOLOGY, V52, P271, DOI 10.2307/1934585; SMITH R. L., 2003, ELEMENTS ECOLOGY; Stanley JK, 2006, ENVIRON TOXICOL CHEM, V25, P1780, DOI 10.1897/05-298R1.1; Wahlberg C., 2010, LAKEMEDELSRESTER STO; Widdows J., 1985, P3; Wiklund AKE, 2011, AQUAT BIOL, V14, P29, DOI 10.3354/ab00380; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Wulff F, 2001, AMBIO, V30, P254, DOI 10.1639/0044-7447(2001)030[0254:GAOCEM]2.0.CO;2; Zhu CJ, 1997, J APPL PHYCOL, V9, P189, DOI 10.1023/A:1007914806640	64	13	13	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93774	10.1371/journal.pone.0093774	http://dx.doi.org/10.1371/journal.pone.0093774			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713620	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900047
J	Erezyilmaz, DF; Hayward, A; Huang, Y; Paps, J; Acs, Z; Delgado, JA; Collantes, F; Kathirithamby, J				Erezyilmaz, Deniz F.; Hayward, Alex; Huang, Yan; Paps, Jordi; Acs, Zoltan; Delgado, Juan A.; Collantes, Francisco; Kathirithamby, Jeyaraney			Expression of the Pupal Determinant broad during Metamorphic and Neotenic Development of the Strepsipteran Xenos vesparum Rossi	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; STATUS-QUO ACTION; JUVENILE-HORMONE; TOBACCO HORNWORM; MANDUCA-SEXTA; DROSOPHILA METAMORPHOSIS; BTB DOMAIN; TRIBOLIUM-CASTANEUM; ISOFORM EXPRESSION; TEMPORAL PATTERNS	Derived members of the endoparasitic order Strepsiptera have acquired an extreme form of sexual dimorphism whereby males undergo metamorphosis and exist as free-living adults while females remain larviform, reaching sexual maturity within their hosts. Expression of the transcription factor, broad (br) has been shown to be required for pupal development in insects in which both sexes progress through metamorphosis. A surge of br expression appears in the last larval instar, as the epidermis begins pupal development. Here we ask if br is also up-regulated in the last larval instar of male Xenos vesparum Rossi (Stylopidae), and whether such expression is lost in neotenic larviform females. We clone three isoforms of br from X. vesparum (Xv'br), and show that they share greatest similarity to the Z1, Z3 and Z4 isoforms of other insect species. By monitoring Xv'br expression throughout development, we detect elevated levels of total br expression and the Xv'Z1, Xv'Z3, and Xv'Z4 isoforms in the last larval instar of males, but not females. By focusing on Xv'br expression in individual samples, we show that the levels of Xv'BTB and Xv'Z3 in the last larval instar of males are bimodal, with some males expressing 3X greater levels of Xv'br than fourth instar femlaes. Taken together, these data suggest that neoteny (and endoparasitism) in females of Strepsiptera Stylopidia could be linked to the suppression of pupal determination. Our work identifies a difference in metamorphic gene expression that is associated with neoteny, and thus provides insights into the relationship between metamorphic and neotenic development.	[Erezyilmaz, Deniz F.; Huang, Yan] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Paps, Jordi; Kathirithamby, Jeyaraney] Uppsala Univ, Uppsala Biomed Ctr, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden; [Acs, Zoltan] Kaposvar Univ, Fac Anim Sci, Kaposvar, Hungary; [Delgado, Juan A.; Collantes, Francisco] Univ Murcia, Fac Biol, Dept Zool, Murcia, Spain	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Uppsala University; Hungarian University of Agriculture & Life Sciences; Kaposvar University; University of Murcia	Erezyilmaz, DF (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	deniz.erezyilmaz@stonybrook.edu	Paps, Jordi/B-2098-2012; Collantes, Francisco/M-4798-2017; Collantes, Francisco/L-5937-2019	Paps, Jordi/0000-0003-2636-6636; Collantes, Francisco/0000-0002-8085-6399; Collantes, Francisco/0000-0002-8085-6399; Hayward, Alexander/0000-0001-7413-718X	Leverhulme Trust [F/08502/G]; Stony Brook University	Leverhulme Trust(Leverhulme Trust); Stony Brook University	Leverhulme Trust Research Grant to JK (no. No. F/08502/G) (http://www.leverhulme.ac.uk), Stony Brook University startup funds to DE (http://www.stonybrook.edu). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad KF, 1998, P NATL ACAD SCI USA, V95, P12123, DOI 10.1073/pnas.95.21.12123; Bayer CA, 1996, DEV BIOL, V177, P1, DOI 10.1006/dbio.1996.0140; BELYAEVA ES, 1980, CHROMOSOMA, V81, P281, DOI 10.1007/BF00285954; Cossgrove K, 1996, DEV BIOL, V180, P745; DIBELLO PR, 1991, GENETICS, V129, P385; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erezyilmaz DF, 2006, P NATL ACAD SCI USA, V103, P6925, DOI 10.1073/pnas.0509983103; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; HEMING BS, 1973, CAN J ZOOL, V51, P1211, DOI 10.1139/z73-175; Hodin J, 1998, DEV GENES EVOL, V208, P304, DOI 10.1007/s004270050186; Hodin J, 2000, DEV GENES EVOL, V210, P358, DOI 10.1007/s004270000079; Huang J. H., 2012, BIOCHIM BIOPHYS ACTA, V1830, P2178; KATHIRITHAMBY J, 1989, SYST ENTOMOL, V14, P41, DOI 10.1111/j.1365-3113.1989.tb00265.x; KATHIRITHAMBY J, 1984, ZOOL J LINN SOC-LOND, V82, P335, DOI 10.1111/j.1096-3642.1984.tb00647.x; Kathirithamby J, 2009, ANNU REV ENTOMOL, V54, P227, DOI 10.1146/annurev.ento.54.110807.090525; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kinzelbach RK, 1971, MORPHOLOGISCHE BEFUN, Vscheverlagsbuchhandlung, P256; KISS I, 1978, MOL GEN GENET, V164, P77, DOI 10.1007/BF00267601; Konopova B, 2008, DEVELOPMENT, V135, P559, DOI 10.1242/dev.016097; Konopova B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028728; Melnick A, 2000, MOL CELL BIOL, V20, P6550, DOI 10.1128/MCB.20.17.6550-6567.2000; Melnick A, 2002, MOL CELL BIOL, V22, P1804, DOI 10.1128/MCB.22.6.1804-1818.2002; Minakuchi C, 2011, INSECT BIOCHEM MOLEC, V41, P125, DOI 10.1016/j.ibmb.2010.11.004; Mugat B, 2000, DEV BIOL, V227, P104, DOI 10.1006/dbio.2000.9879; NIJHOUT HF, 1982, Q REV BIOL, V57, P109, DOI 10.1086/412671; Parthasarathy R, 2008, MECH DEVELOP, V125, P299, DOI 10.1016/j.mod.2007.11.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piulachs MD, 2010, INSECT BIOCHEM MOLEC, V40, P468, DOI 10.1016/j.ibmb.2010.04.006; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Reza AMS, 2004, COMP BIOCHEM PHYS B, V139, P753, DOI 10.1016/j.cbpc.2004.09.009; RIDDIFORD LM, 1978, GEN COMP ENDOCR, V34, P438, DOI 10.1016/0016-6480(78)90284-8; Riddiford LM, 1996, ARCH INSECT BIOCHEM, V32, P271, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;271::AID-ARCH2&gt;3.0.CO;2-W; RIDDIFORD LM, 1981, AM ZOOL, V21, P751; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Suzuki Y, 2008, DEVELOPMENT, V135, P569, DOI 10.1242/dev.015263; Trieblmayr K, 1981, MIKROSKOPIE, V38, P97; TRUMAN JW, 1974, DEV BIOL, V39, P247, DOI 10.1016/S0012-1606(74)80028-X; Uhlirova M, 2003, P NATL ACAD SCI USA, V100, P15607, DOI 10.1073/pnas.2136837100; VONKALM L, 1994, EMBO J, V13, P3505, DOI 10.1002/j.1460-2075.1994.tb06657.x; Wheeler WC, 1990, ANN ENTOMOL SOC AM, V83, P91; Zhou BH, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-39; Zhou BH, 1998, DEV BIOL, V203, P233, DOI 10.1006/dbio.1998.9059; Zhou BH, 2001, DEV BIOL, V231, P125, DOI 10.1006/dbio.2000.0143; Zhou XF, 2002, DEVELOPMENT, V129, P2259; ZOLLMAN S, 1994, P NATL ACAD SCI USA, V91, P10717, DOI 10.1073/pnas.91.22.10717	46	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93614	10.1371/journal.pone.0093614	http://dx.doi.org/10.1371/journal.pone.0093614			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709670	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000334159800039
J	Liu, D; Li, A; Mao, XG; Jing, RL				Liu, Dan; Li, Ang; Mao, Xinguo; Jing, Ruilian			Cloning and Characterization of TaPP2AbB"-alpha, a Member of the PP2A Regulatory Subunit in Wheat	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; LATERAL ROOT DEVELOPMENT; CATALYTIC SUBUNIT; GENE-EXPRESSION; AUXIN REDISTRIBUTION; STRESS-RESPONSE; SALT STRESS; SYSTEM; FAMILY; ORGANIZATION	Protein phosphatase 2A (PP2A), a major Serine/Threonine protein phosphatase, consists of three subunits; a highly conserved structural subunit A, a catalytic subunit C, and a highly variable regulatory subunit B which determines the substrate specificity. Although the functional mechanism of PP2A in signaling transduction in Arabidopsis is known, their physiological roles in wheat remain to be characterized. In this study, we identified a novel regulatory subunit B, TaPP2AbB"-alpha, in wheat (Triticum aestivum L.). Subcellular localization indicated that TaPP2AbB"-alpha is located in the cell membrane, cytoplasm and nucleus. It interacts with both TaPP2Aa and TaPP2Ac. Expression pattern analyses revealed that TaPP2AbB"-a is strongly expressed in roots, and responds to NaCl, polyethylene glycol (PEG), cold and abscisic acid (ABA) stresses at the transcription level. Transgenic Arabidopsis plants overexpressing TaPP2AbB"-alpha developed more lateral roots, especially when treated with mannitol or NaCl. These results suggest that TaPP2AbB"-alpha, in conjunction with the other two PP2A subunits, is involved in multi-stress response, and positively regulates lateral root development under osmotic stress.	[Liu, Dan; Li, Ang; Mao, Xinguo; Jing, Ruilian] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Jing, RL (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	jingrl@caas.net.cn	Xinguo, Mao/AAF-3195-2020	Xinguo, Mao/0000-0003-4712-437X	National Natural Science Foundation of China [31201206]; Science and Technology Project for Outstanding Ph.D. Supervisor of Beijing [YB20088210101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project for Outstanding Ph.D. Supervisor of Beijing	This study was supported by the National Natural Science Foundation of China (31201206, http://www.nsfc.gov.cn/), and Science and Technology Project for Outstanding Ph.D. Supervisor of Beijing (YB20088210101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antolin-Llovera M, 2011, PLANT SIGNAL BEHAV, V6, P1127, DOI 10.4161/psb.6.8.16363; Ballesteros I, 2013, PLANT J, V73, P862, DOI 10.1111/tpj.12078; Blakeslee JJ, 2008, PLANT PHYSIOL, V146, P539, DOI 10.1104/pp.107.112995; Brandt B, 2012, P NATL ACAD SCI USA, V109, P10593, DOI 10.1073/pnas.1116590109; Chen HM, 2008, PLANT PHYSIOL, V146, P368, DOI 10.1104/pp.107.111740; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Ditengou FA, 2008, P NATL ACAD SCI USA, V105, P18818, DOI 10.1073/pnas.0807814105; Farkas I, 2007, TRENDS PLANT SCI, V12, P169, DOI 10.1016/j.tplants.2007.03.003; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Garbers C, 1996, EMBO J, V15, P2115, DOI 10.1002/j.1460-2075.1996.tb00565.x; Gentry MS, 2002, MOL BIOL CELL, V13, P3477, DOI 10.1091/mbc.02-05-0065; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Harris DM, 1999, PLANT PHYSIOL, V121, P609, DOI 10.1104/pp.121.2.609; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Ito K, 2006, PHYSIOL PLANTARUM, V127, P260, DOI 10.1111/j.1399-3054.2006.00657.x; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Kirik A, 2012, PLANT CELL, V24, P1158, DOI 10.1105/tpc.111.094367; Kosova K, 2011, J PROTEOMICS, V74, P1301, DOI 10.1016/j.jprot.2011.02.006; Lavenus J, 2013, TRENDS PLANT SCI, V18, P455, DOI 10.1016/j.tplants.2013.04.006; Leung HT, 2013, AM J NEURO, V4, P46; Liu JL, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00075; Liu ShiHang, 2010, Scientia Agricultura Sinica, V43, P2197; Louis JV, 2011, P NATL ACAD SCI USA, V108, P6957, DOI 10.1073/pnas.1018777108; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Malamy JE, 2001, PLANT PHYSIOL, V127, P899, DOI 10.1104/pp.010406; Mao XG, 2010, J EXP BOT, V61, P683, DOI 10.1093/jxb/erp331; Michniewicz M, 2007, CELL, V130, P1044, DOI 10.1016/j.cell.2007.07.033; Munoz-Romero V, 2010, PLANT SOIL, V326, P97, DOI 10.1007/s11104-009-9983-3; Chavez-Aviles MN, 2013, PLANT SOIL, V368, P591, DOI 10.1007/s11104-012-1540-9; Pang XiaoBin, 2007, Acta Agronomica Sinica, V33, P333; Park S, 2013, CELL CALCIUM, V53, P217, DOI 10.1016/j.ceca.2012.12.001; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Peret B, 2009, TRENDS PLANT SCI, V14, P399, DOI 10.1016/j.tplants.2009.05.002; Reiter W, 2013, MOL CELL BIOL, V33, P1057, DOI 10.1128/MCB.00834-12; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schweighofer A, 2004, TRENDS PLANT SCI, V9, P236, DOI 10.1016/j.tplants.2004.03.007; Shi JF, 2010, AGR SCI CHINA, V9, P325, DOI 10.1016/S1671-2927(09)60100-0; Slupe A. M, 2011, ENZYME RES, V2011; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang WQ, 2011, NAT CELL BIOL, V13, P124, DOI 10.1038/ncb2151; Tian SJ, 2013, J EXP BOT, V64, P2063, DOI 10.1093/jxb/ert072; Wu G, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001258; Xu CY, 2007, ANN BOT-LONDON, V99, P439, DOI 10.1093/aob/mcl285; Yang L, 2004, MOL GENET GENOMICS, V272, P433, DOI 10.1007/s00438-004-1066-9; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yu RMK, 2005, PLANTA, V222, P757, DOI 10.1007/s00425-005-0018-x; Yu RMK, 2003, PLANT MOL BIOL, V51, P295, DOI 10.1023/A:1020771906524; Zhao JQ, 2010, GENE REGUL SYST BIO, V4, P135, DOI 10.4137/GRSB.S6065; Zhao YK, 2011, NEW PHYTOL, V189, P1122, DOI 10.1111/j.1469-8137.2010.03545.x	52	6	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94430	10.1371/journal.pone.0094430	http://dx.doi.org/10.1371/journal.pone.0094430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709994	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800145
J	Luo, QJ; Zhu, ZG; Zhu, ZJ; Yang, R; Qian, FJ; Chen, HM; Yan, XJ				Luo, Qijun; Zhu, Zhenggang; Zhu, Zhujun; Yang, Rui; Qian, Feijian; Chen, Haimin; Yan, Xiaojun			Different Responses to Heat Shock Stress Revealed Heteromorphic Adaptation Strategy of Pyropia haitanensis ( Bangiales, Rhodophyta)	PLOS ONE			English	Article							D-ISOFLORIDOSIDE; RED ALGAE; FLORIDOSIDE; PORPHYRA; METABOLISM; EXPRESSION; PROFILES; MANNITOL; DEFENSE; PLANTS	Pyropia has a unique heteromorphic life cycle with alternation stages between thallus and conchocelis, which lives at different water temperatures in different seasons. To better understand the different adaptation strategies for temperature stress, we tried to observe comparative biochemical changes of Pyropia haitanensis based on a short term heat shock model. The results showed that: (1) At normal temperature, free-living conchocelis contains significantly higher levels of H2O2, fatty acid-derived volatiles, the copy number of Phrboh and Phhsp70 genes, the activities of NADPH oxidase and floridoside than those in thallus. The released H2O2 and NADPH oxidase activity of conchocelis were more than 7 times higher than those of thallus. The copy number of Phrboh in conchocelis was 32 times that in thallus. (2) After experiencing heat shock at 35 degrees C for 30 min, the H2O2 contents, the mRNA levels of Phrboh and Phhsp70, NADPH oxidase activity and the floridoside content in thallus were all significantly increased. The mRNA levels of Phrboh increased 5.78 times in 5 min, NADPH oxidase activity increased 8.45 times in 20 min. (3) Whereas, in conchocelis, the changes in fatty acids and their down-stream volatiles predominated, significantly increasing levels of saturated fatty acids and decreasing levels of polyunsaturated fatty acids occurred, and the 8-carbon volatiles were accumulated. However, the changes in H2O2 content and expression of oxidant-related genes and enzymatic activity were not obvious. Overall, these results indicate that conchocelis maintains a high level of active protective apparatus to endure its survival at high temperature, while thallus exhibit typical stress responses to heat shock. It is concluded that Pyropia haitanensis has evolved a delicate strategy for temperature adaptation for its heteromorphic life cycle.	[Luo, Qijun; Zhu, Zhenggang; Zhu, Zhujun; Yang, Rui; Qian, Feijian; Chen, Haimin] Minist Educ, Key Lab Appl Marine Biotechnol, Ningbo, Zhejiang, Peoples R China; [Yan, Xiaojun] Ningbo Univ, Sch Marine Sci, Ningbo 315211, Zhejiang, Peoples R China	Ningbo University	Chen, HM (corresponding author), Minist Educ, Key Lab Appl Marine Biotechnol, Ningbo, Zhejiang, Peoples R China.	chenhaimin@nbu.edu.cn; xiaojunyan@hotmail.com	LUO, QI/GQH-7209-2022	Yan, Xiaojun/0000-0003-0257-0157; Zhu, Zhenggang/0000-0002-6085-525X	National Science Foundation (NSFC) [81370532]; National Spark Major Project [2013GA701001]; Ningbo Programs for Science and Technology Development [201201C1011016]; Zhejiang Major Technology Project for Breeding of New Variety [2012C12907-6]; K.C. Wong Magna Fund in Ningbo University; 151 talents Project	National Science Foundation (NSFC)(National Natural Science Foundation of China (NSFC)National Science Foundation (NSF)); National Spark Major Project; Ningbo Programs for Science and Technology Development; Zhejiang Major Technology Project for Breeding of New Variety; K.C. Wong Magna Fund in Ningbo University; 151 talents Project	This project was funded by National Science Foundation (NSFC) project (81370532), National Spark Major Project (No. 2013GA701001), Ningbo Programs for Science and Technology Development (201201C1011016), Zhejiang Major Technology Project for Breeding of New Variety (2012C12907-6), K.C. Wong Magna Fund in Ningbo University; and 151 talents Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanda-Nkpwatt D, 2006, BIOCONTROL, V51, P279, DOI 10.1007/s10526-005-4362-3; Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; Asamizu E, 2003, J PHYCOL, V39, P923, DOI 10.1046/j.1529-8817.2003.03003.x; Blouin NA, 2011, TRENDS PLANT SCI, V16, P29, DOI 10.1016/j.tplants.2010.10.004; Chitarra GS, 2004, APPL ENVIRON MICROB, V70, P2823, DOI 10.1128/AEM.70.5.2823-2829.2004; d'Ippolito G, 2005, ORG BIOMOL CHEM, V3, P4065, DOI 10.1039/b510640k; Eggert A, 2010, CELL ORIG LIFE EXTRE, V13, P443, DOI 10.1007/978-90-481-3795-4_24; Hahn A, 2011, PLANT CELL, V23, P741, DOI 10.1105/tpc.110.076018; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Herve C, 2006, CURR GENET, V49, P190, DOI 10.1007/s00294-005-0044-z; Hou HS, 2008, J LIAONING NORM U NA, V31, P487; Iwamoto K, 2005, MAR BIOTECHNOL, V7, P407, DOI 10.1007/s10126-005-0029-4; Jennings DB, 1998, P NATL ACAD SCI USA, V95, P15129, DOI 10.1073/pnas.95.25.15129; Ji M.H., 2004, SEAWEED CHEM, P518; KARSTEN U, 1993, PLANT PHYSIOL, V103, P485, DOI 10.1104/pp.103.2.485; Klahn S, 2010, J BACTERIOL, V192, P4403, DOI 10.1128/JB.00481-10; Knowles LO, 2012, J AGR FOOD CHEM, V60, P11173, DOI 10.1021/jf303299n; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Li SY, 2002, J PHYCOL, V38, P931, DOI 10.1046/j.1529-8817.2002.01143.x; Li SY., 1988, MAR SCI, V4, P58; Li YX, 2010, J AGR FOOD CHEM, V58, P578, DOI 10.1021/jf902811j; Liu W., 2012, J NINGBO U IN CHINES, V25, P17, DOI [10.3969/j.issn.1001-5132.2012.02.004, DOI 10.3969/J.ISSN.1001-5132.2012.02.004]; [鹿宁 Lu Ning], 2010, [武汉大学学报. 理学版, Journal of Wuhan University. Natural Science Edition], V56, P570; Rousch JM, 2003, J EXP MAR BIOL ECOL, V295, P145, DOI 10.1016/S0022-0981(03)00293-4; Sahoo D, 2002, CURR SCI INDIA, V83, P1313; SUKENIK A, 1993, AQUACULTURE, V117, P313, DOI 10.1016/0044-8486(93)90328-V; Sung DY, 2003, TRENDS PLANT SCI, V8, P179, DOI 10.1016/S1360-1385(03)00047-5; Wang SG, 2013, CHIN J OCEANOL LIMN, V44, P1378; Wang XJ, 2013, J APPL PHYCOL, V25, P1895, DOI 10.1007/s10811-013-0009-4; Waters ER, 1996, J EXP BOT, V47, P325, DOI 10.1093/jxb/47.3.325; Weinberger F, 2007, BIOL BULL-US, V213, P290, DOI 10.2307/25066646; William LM, 1988, ANAL CHEM, V60, P2711; Xie CT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-107; Yang R, 2013, BOT MAR, V56, P249, DOI 10.1515/bot-2012-0178; Zhang Yuan, 2011, Journal of Fisheries of China, V35, P379; [周文君 ZHOU Wenjun], 2006, [中国水产科学, Journal of Fishery Sciences of China], V13, P217	36	24	27	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94354	10.1371/journal.pone.0094354	http://dx.doi.org/10.1371/journal.pone.0094354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709783	Green Submitted, Green Published, gold			2022-12-25	WOS:000334159800139
J	Xue, G; Wang, XJ; Yang, Y; Liu, DG; Cheng, Y; Zhou, J; Cao, YK				Xue, Gang; Wang, Xiaojuan; Yang, Yong; Liu, Degui; Cheng, Ying; Zhou, Jun; Cao, Yongkuan			Colon Cancer-Specific Antigen-2 May Be Used as a Detecting and Prognostic Marker in Colorectal Cancer: A Preliminary Observation	PLOS ONE			English	Article							SERUM CARCINOEMBRYONIC ANTIGEN; UNITED-STATES; DIAGNOSIS; SURVEILLANCE; GUIDELINES; SOCIETY; CEA	Background: A specific and sensitive serum marker for colorectal cancer (CRC) detection and surveillance is central to effective treatment. It was preliminarily reported that some nuclear matrix proteins may be served as a specific blood based marker for colon cancer. The objective of this study is to evaluate the value of serum CCSA-2 detection in diagnosis, prognostic estimation and surveillance for CRC. Method: Serum CCSA-2 protein was measured in 181 various patient populations and 20 healthy donors before surgery. For 106 CRC patients, it was also measured on day 7 after surgery. Among them, 49 CRC patients' CCSA-2 protein were measured during the follow-up period according to NCCN Guideline. Results: The serum CCSA-2 concentration in CRC patients was significantly higher than which in other patients and healthy individuals. Serum CCSA-2, at the cut-off point of 64.10 ng/ mL, had a sensitivity of 98.10% and a specificity of 97.90% in separating CRC populations from all other individuals. The CCSA-2 assay was significantly more sensitive than CEA and CA19-9 assay in CRC detection. After surgery, the serum CCSA-2 level of CRC patients declined significantly, but it rebounded to a high level when recurrences occurred. The pre-operative serum CCSA-2 level in patients who had a relapse within the follow-up period was significantly higher than which in patients without relapse. Conclusions: Serum CCSA-2 not only may be a potential biomarker using in screening and surveillance of CRC, but also may be an independent prognostic marker for CRC patients. Further clinical trials need to be performed in a larger population of patients to ulteriorly confirm these results.	[Xue, Gang; Wang, Xiaojuan; Yang, Yong; Liu, Degui] Chengdu Mil Gen Hosp, Dept Breast & Thyroid Surg, Chengdu, Peoples R China; [Cheng, Ying] Chengdu Mil Gen Hosp, Dept Endocrinol, Chengdu, Peoples R China; [Zhou, Jun; Cao, Yongkuan] Chengdu Mil Gen Hosp, Dept Gen Surg, Chengdu, Peoples R China		Xue, G (corresponding author), Chengdu Mil Gen Hosp, Dept Breast & Thyroid Surg, Chengdu, Peoples R China.	kpardan@163.com			elite training foundation of Chengdu Military General Hospital; foundation of Sichuan Provincial Health Bureau [080009]	elite training foundation of Chengdu Military General Hospital; foundation of Sichuan Provincial Health Bureau	This work was supported by the elite training foundation of Chengdu Military General Hospital and the foundation of Sichuan Provincial Health Bureau (080009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin WS, 2010, LANCET, V375, P1624, DOI 10.1016/S0140-6736(10)60551-X; Brunagel G, 2002, CANCER RES, V62, P2437; Carpelan-Holmstrom M, 2004, TUMOR BIOL, V25, P228, DOI 10.1159/000081385; Di Cristofaro L, 2012, ACTA CHIR BELG, V112, P24, DOI 10.1080/00015458.2012.11680791; Espey DK, 2007, CANCER-AM CANCER SOC, V110, P2119, DOI 10.1002/cncr.23044; FEY EG, 1988, P NATL ACAD SCI USA, V85, P121, DOI 10.1073/pnas.85.1.121; Ghesani M, 2003, CLIN NUCL MED, V28, P608, DOI 10.1097/00003072-200307000-00021; Hara M, 2011, SURG TODAY, V41, P1357, DOI 10.1007/s00595-010-4519-2; Hawk ET, 2005, J CLIN ONCOL, V23, P378, DOI 10.1200/JCO.2005.08.097; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Knychalski Bartlomiej, 2012, Pol Przegl Chir, V84, P86, DOI 10.2478/v10035-012-0014-3; Labianca R, 2010, TUMORI, V96, P889, DOI 10.1177/548.6506; Leman ES, 2007, CANCER RES, V67, P5600, DOI 10.1158/0008-5472.CAN-07-0649; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Mandel JS, 2007, JNCI-J NATL CANCER I, V99, P1424, DOI 10.1093/jnci/djm166; Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203; Meissner HI, 2006, CANCER EPIDEM BIOMAR, V15, P389, DOI 10.1158/1055-9965.EPI-05-0678; Smith RA, 2007, CA-CANCER J CLIN, V57, P90, DOI 10.3322/canjclin.57.2.90; Smith RA, 2011, CA-CANCER J CLIN, V61, P8, DOI 10.3322/caac.20096; Walgenbach-Brunagel G, 2008, J CELL BIOCHEM, V104, P286, DOI 10.1002/jcb.21619; Yang XQ, 2011, ASIAN PAC J CANCER P, V12, P1251; Yeh CY, 2011, HEPATO-GASTROENTEROL, V58, P1171, DOI 10.5754/hge10564	23	2	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94252	10.1371/journal.pone.0094252	http://dx.doi.org/10.1371/journal.pone.0094252			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710115	Green Submitted, Green Published, gold			2022-12-25	WOS:000334159800128
J	Proellocks, NI; Herrmann, S; Buckingham, DW; Hanssen, E; Hodges, EK; Elsworth, B; Morahan, BJ; Coppel, RL; Cooke, BM				Proellocks, Nicholas I.; Herrmann, Susann; Buckingham, Donna W.; Hanssen, Eric; Hodges, Emma K.; Elsworth, Brendan; Morahan, Belinda J.; Coppel, Ross L.; Cooke, Brian M.			A lysine-rich membrane-associated PHISTb protein involved in alteration of the cytoadhesive properties of Plasmodium falciparum-infected red blood cells	FASEB JOURNAL			English	Article						malaria; pathogenesis; cytoskeleton; exported proteins	PARASITE PROTEINS; HUMAN ERYTHROCYTES; MALARIA PARASITES; HOST ERYTHROCYTE; MAURERS CLEFTS; CYTOADHERENCE; VIRULENCE; PFEMP1; EXPORT; KAHRP	The genomes of malaria parasites (Plasmodium spp.) contain a family of genes encoding proteins with a Plasmodium helical interspersed subtelomeric (PHIST) domain, most of which are predicted to be exported into the parasite-infected human red blood cell (iRBC). Here, using transgenic parasites and a combination of cellular, biochemical, and biophysical assays, we have characterized and determined the function of a novel member of the PHIST protein family in Plasmodium falciparum, termed lysine-rich membrane-associated PHISTb (LyMP). LyMP was shown to associate directly with the cytoskeleton of iRBCs where it plays a role in their abnormal ability to adhere to a protein expressed on vascular endothelial cells, resulting in sequestration. Deletion of LyMP dramatically reduced adhesion of iRBCs to CD36 by 55%, which was completely restored to wild-type levels on complementation. Intriguingly, in the absence of LyMP, formation of RBC membrane knobs and the level of surface exposure of the parasites' major cytoadhesive ligand, PfEMP1, were identical to those for the parental parasite line, demonstrating for the first time an additional mechanism that enhances cytoadherence of iRBCs beyond those already recognized. Our findings identify LyMP as a previously unknown RBC cytoskeletal-binding protein that is likely to be of major significance in the complex pathophysiology of falciparum malaria.	[Proellocks, Nicholas I.; Herrmann, Susann; Buckingham, Donna W.; Hodges, Emma K.; Elsworth, Brendan; Morahan, Belinda J.; Coppel, Ross L.; Cooke, Brian M.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Herrmann, Susann; Hanssen, Eric] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia	Monash University; University of Melbourne	Cooke, BM (corresponding author), Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia.	brian.cooke@monash.edu	Coppel, Ross L/A-6626-2008; Hanssen, Eric/A-7217-2013; Proellochs, Nick/ABB-5634-2020	Coppel, Ross L/0000-0002-4476-9124; Hanssen, Eric/0000-0002-4064-1844; Proellochs, Nick/0000-0003-3750-1135; HERRMANN, SUSANN/0000-0002-4953-5685	National Health and Medical Research Council of Australia (NHMRC); Faculty of Medicine, Nursing and Health Sciences of Monash University; Australian Postgraduate Award	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Faculty of Medicine, Nursing and Health Sciences of Monash University; Australian Postgraduate Award(Australian Government)	The authors thank Dr. Alexander Maier (Australian National University, Canberra) for providing the antiserum against PFB0090c (J-dots) and are grateful to the Australian Red Cross Blood Service for generously providing human RBCs for malaria culture. B. M. C. was supported by the National Health and Medical Research Council of Australia (NHMRC). The authors also acknowledge the Faculty of Medicine, Nursing and Health Sciences of Monash University for supporting N.I.P. with a Faculty Bridging Fellowship that enabled this work. E.H. was supported by an Australian Postgraduate Award.	Akinyi S, 2012, MOL MICROBIOL, V84, P816, DOI 10.1111/j.1365-2958.2012.08060.x; Boddey JA, 2009, TRAFFIC, V10, P285, DOI 10.1111/j.1600-0854.2008.00864.x; Cooke BM, 2006, J CELL BIOL, V172, P899, DOI 10.1083/jcb.200509122; Cooke BM, 2005, VET PARASITOL, V132, P273, DOI 10.1016/j.vetpar.2005.07.002; Cooke BM, 2004, TRENDS PARASITOL, V20, P581, DOI 10.1016/j.pt.2004.09.008; Cooke BM, 2004, SEMIN HEMATOL, V41, P173, DOI 10.1053/j.seminhematol.2004.01.004; Cooke BM, 2001, ADV PARASIT, V50, P1, DOI 10.1016/S0065-308X(01)50029-9; Cooke Brian M, 2002, Methods Mol Med, V72, P561, DOI 10.1385/1-59259-271-6:561; Cooke Brian M, 2002, Methods Mol Med, V72, P571, DOI 10.1385/1-59259-271-6:571; COPPEL RL, 1992, MOL BIOCHEM PARASIT, V50, P335, DOI 10.1016/0166-6851(92)90231-8; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; Cranmer SL, 1997, T ROY SOC TROP MED H, V91, P363, DOI 10.1016/S0035-9203(97)90110-3; Dluzewski A., 1984, T R SOC TROP MED HYG, V78, P622; Ganesan SM, 2011, MOL BIOCHEM PARASIT, V177, P29, DOI 10.1016/j.molbiopara.2011.01.004; Glenister FK, 2009, BLOOD, V113, P919, DOI 10.1182/blood-2008-05-157735; Glenister FK, 2002, BLOOD, V99, P1060, DOI 10.1182/blood.V99.3.1060; Gruring C, 2012, CELL HOST MICROBE, V12, P717, DOI 10.1016/j.chom.2012.09.010; Gruing C., 2011, NAT COMMUN, V2, P165; Haldar K, 2007, ANNU REV PATHOL-MECH, V2, P217, DOI 10.1146/annurev.pathol.2.010506.091913; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Kats LM, 2014, INT J PARASITOL, V44, P319, DOI 10.1016/j.ijpara.2014.01.003; Kilili GK, 2011, EUKARYOT CELL, V10, P1439, DOI 10.1128/EC.05180-11; Kulzer S, 2010, CELL MICROBIOL, V12, P1398, DOI 10.1111/j.1462-5822.2010.01477.x; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Mayer C, 2012, J BIOL CHEM, V287, P7182, DOI 10.1074/jbc.M111.330779; McMillan PJ, 2013, CELL MICROBIOL, V15, P1401, DOI 10.1111/cmi.12125; Mundwiler-Pachlatko E., 2013, P NATL ACAD SCI USA, V110, P1; Nilsson S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046980; Nunes MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011747; Oh SS, 2000, MOL BIOCHEM PARASIT, V108, P237, DOI 10.1016/S0166-6851(00)00227-9; Oyelade J, 2011, INFECT GENET EVOL, V11, P755, DOI 10.1016/j.meegid.2010.11.006; Pallavi R, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-236; Parish LA, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-160; Pei XH, 2005, J BIOL CHEM, V280, P31166, DOI 10.1074/jbc.M505298200; Przyborski JM, 2003, MOL BIOCHEM PARASIT, V132, P17, DOI 10.1016/S0166-6851(03)00212-3; Rug M, 2006, BLOOD, V108, P370, DOI 10.1182/blood-2005-11-4624; Sachs JD, 2002, SCIENCE, V298, P122, DOI 10.1126/science.1077900; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Saridaki T, 2009, TRAFFIC, V10, P137, DOI 10.1111/j.1600-0854.2008.00860.x; Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Waller KL, 2007, BBA-BIOMEMBRANES, V1768, P2145, DOI 10.1016/j.bbamem.2007.04.027; Waller KL, 1999, J BIOL CHEM, V274, P23808, DOI 10.1074/jbc.274.34.23808; Waller KL, 2002, MOL BIOCHEM PARASIT, V119, P125, DOI 10.1016/S0166-6851(01)00395-4; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Waterkeyn JG, 2000, EMBO J, V19, P2813, DOI 10.1093/emboj/19.12.2813; Wickham Mark E., 2001, EMBO (European Molecular Biology Organization) Journal, V20, P5636, DOI 10.1093/emboj/20.20.5636; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973	52	37	38	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2014	28	7					3103	3113		10.1096/fj.14-250399	http://dx.doi.org/10.1096/fj.14-250399			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AJ8JN	24706359				2022-12-25	WOS:000337949400031
J	Juneja, P; Horlacher, R; Bertrand, D; Krause, R; Marger, F; Welte, W				Juneja, Puneet; Horlacher, Reinhold; Bertrand, Daniel; Krause, Ryoko; Marger, Fabrice; Welte, Wolfram			An Internally Modulated, Thermostable, pH-sensitive Cys Loop Receptor from the Hydrothermal Vent Worm Alvinella pompejana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GATED ION-CHANNEL; CHLORIDE CHANNEL; PARASITIC NEMATODE; IVERMECTIN; DESENSITIZATION; ACTIVATION; MECHANISMS; MUSCLE	Cys loop receptors (CLRs) are commonly known as ligand-gated channels that transiently open upon binding of neurotransmitters to modify the membrane potential. However, a class of cation-selective bacterial homologues of CLRs have been found to open upon a sudden pH drop, suggesting further ligands and more functions of the homologues in prokaryotes. Here we report an anion-selective CLR from the hydrothermal vent annelid worm Alvinella pompejana that opens at low pH. A. pompejana expressed sequence tag databases were explored by us, and two full-length CLR sequences were identified, synthesized, cloned, expressed in Xenopus oocytes, and studied by two-electrode voltage clamp. One channel, named Alv-a1-pHCl, yielded functional receptors and opened upon a sudden pH drop but not by other known agonists. Sequence comparison showed that both CLR proteins share conserved characteristics with eukaryotic CLRs, such as an N-terminal helix, a cysteine loop motif, and an intracellular loop intermediate in length between the long loops of other eukaryotic CLRs and those of prokaryotic CLRs. Both full-length Alv-a1-pHCl and a truncated form, termed tAlv-a1-pHCl, lacking 37 amino-terminal residues that precede the N-terminal helix, formed functional channels in oocytes. After pH activation, tAlv-a1-pHCl showed desensitization and was not modulated by ivermectin. In contrast, pH-activated, full-length Alv-a1-pHCl showed a marked rebound current and was modulated significantly by ivermectin. A thermostability assay indicated that purified tAlv-a1-pHCl expressed in Sf9 cells denatured at a higher temperature than the nicotinic acetylcholine receptor from Torpedo californica.	[Juneja, Puneet; Welte, Wolfram] Univ Konstanz, Fachbereich Biol, D-78457 Constance, Germany; [Horlacher, Reinhold] Trenzyme, D-78467 Constance, Germany; [Bertrand, Daniel; Krause, Ryoko; Marger, Fabrice] HiQScreen Sarl, CH-1222 Geneva, Switzerland	University of Konstanz	Welte, W (corresponding author), Univ Konstanz, Fachbereich Biol, Univ Str 10, D-78457 Constance, Germany.	wolfram.welte@uni-konstanz.de	Juneja, Puneet/ABF-2997-2020; Juneja, Puneet/ABC-2748-2020; Juneja, Puneet/HHC-1232-2022	Juneja, Puneet/0000-0002-6774-2821; Miyazaki-Krause, Ryoko/0000-0003-1273-0417; Juneja, Puneet/0000-0002-8934-4509	EU [202088]; Konstanz Research School of Chemical Biology (KoRS-CB)	EU(European Commission); Konstanz Research School of Chemical Biology (KoRS-CB)	This work was supported by EU grant 202088 (Neurocypres) and by the Konstanz Research School of Chemical Biology (KoRS-CB).	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bar-Lev DD, 2011, J BIOL CHEM, V286, P43830, DOI 10.1074/jbc.M111.282715; Beg AA, 2008, CELL, V132, P149, DOI 10.1016/j.cell.2007.10.058; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Brownlee DJA, 1997, PARASITOLOGY, V115, P553, DOI 10.1017/S0031182097001601; Cary SC, 1998, NATURE, V391, P545, DOI 10.1038/35286; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Corringer PJ, 2012, STRUCTURE, V20, P941, DOI 10.1016/j.str.2012.05.003; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DESBRUYERES D, 1980, OCEANOL ACTA, V3, P267; Duret G, 2011, P NATL ACAD SCI USA, V108, P12143, DOI 10.1073/pnas.1104494108; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gagniere N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-634; GAILL F, 1995, J MOL BIOL, V246, P284, DOI 10.1006/jmbi.1994.0084; Gondhalekar AD, 2012, J MED ENTOMOL, V49, P122, DOI 10.1603/ME11106; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hoda JC, 2008, MOL PHARMACOL, V74, P379, DOI 10.1124/mol.107.044545; Hogg RC, 2008, J NEUROSCI METH, V169, P65, DOI 10.1016/j.jneumeth.2007.11.028; Holder T, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-2; Hu XQ, 2006, J BIOL CHEM, V281, P21781, DOI 10.1074/jbc.M600676200; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Jensen ML, 2005, J NEUROCHEM, V92, P217, DOI 10.1111/j.1471-4159.2004.02883.x; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kashiwagi S, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/701472; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; Le Bris N., 2007, Reviews in Environmental Science and Bio/Technology, V6, P197, DOI 10.1007/s11157-006-9112-1; McCavera S, 2009, MOL PHARMACOL, V75, P1347, DOI 10.1124/mol.108.053363; McKinnon NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035563; Millar NS, 2008, BRIT J PHARMACOL, V153, pS177, DOI 10.1038/sj.bjp.0707661; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Mounsey Kate E., 2007, Invertebrate Neuroscience, V7, P149, DOI 10.1007/s10158-007-0050-6; O'Toole KK, 2011, J BIOL CHEM, V286, P37990, DOI 10.1074/jbc.M111.258012; Papke RL, 2009, J PHARMACOL EXP THER, V329, P791, DOI 10.1124/jpet.108.150151; Schnizler K, 2005, J BIOL CHEM, V280, P16254, DOI 10.1074/jbc.M411759200; Shan Q, 2001, J BIOL CHEM, V276, P12556, DOI 10.1074/jbc.M011264200; Silberberg SD, 2007, NEURON, V54, P263, DOI 10.1016/j.neuron.2007.03.020; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Smart T. G., 2012, COLD SPRING HARB PER, V4, P1; Tasneem A, 2005, GENOME BIOL, V6; Thompson AJ, 2012, NEUROPHARMACOLOGY, V63, P761, DOI 10.1016/j.neuropharm.2012.05.027; Velisetty P, 2012, J BIOL CHEM, V287, P18467, DOI 10.1074/jbc.M112.348045; Wolstenholme AJ, 2005, PARASITOLOGY, V131, pS85, DOI 10.1017/S0031182005008218; Wooltorton JRA, 1997, EUR J NEUROSCI, V9, P2225, DOI 10.1111/j.1460-9568.1997.tb01641.x	47	4	4	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					15130	15140		10.1074/jbc.M113.525576	http://dx.doi.org/10.1074/jbc.M113.525576			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24719323	Green Published, hybrid			2022-12-25	WOS:000337248100063
J	Tan, EP; Villar, MT; E, L; Lu, JH; Selfridge, JE; Artigues, A; Swerdlow, RH; Slawson, C				Tan, Ee Phie; Villar, Maria T.; E, Lezi; Lu, Jianghua; Selfridge, J. Eva; Artigues, Antonio; Swerdlow, Russell H.; Slawson, Chad			Altering O-Linked beta-N-Acetylglucosamine Cycling Disrupts Mitochondrial Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; PROTEIN MODIFICATION; GLCNAC TRANSFERASE; CARDIAC MYOCYTES; GLCNACYLATION; GLUCOSE; HYPERGLYCEMIA; CANCER; MICE	Mitochondrial impairment is commonly found in many diseases such as diabetes, cancer, and Alzheimer disease. We demonstrate that the enzymes responsible for the addition or removal of the O-GlcNAc modification, O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA), respectively, are critical regulators of mitochondrial function. Using a SILAC (stable isotope labeling of amino acids in cell culture)-based proteomics screen, we quantified the changes in mitochondrial protein expression in OGT- and OGA-overexpressing cells. Strikingly, overexpression of OGT or OGA showed significant decreases in mitochondria-localized proteins involved in the respiratory chain and the tricarboxylic acid cycle. Furthermore, mitochondrial morphology was altered in these cells. Both cellular respiration and glycolysis were reduced in OGT/OGA-overexpressing cells. These data demonstrate that alterations in O-GlcNAc cycling profoundly affect energy and metabolite production.	[Tan, Ee Phie; Villar, Maria T.; Artigues, Antonio; Swerdlow, Russell H.; Slawson, Chad] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, MO 64108 USA; [Slawson, Chad] Univ Kansas, Med Ctr, Ctr Canc, Kansas City, MO 64108 USA; [E, Lezi; Lu, Jianghua; Selfridge, J. Eva; Swerdlow, Russell H.] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, MO 64108 USA; [Swerdlow, Russell H.; Slawson, Chad] Univ Kansas, Med Ctr, Alzheimers Dis Ctr, Kansas City, MO 64108 USA	University of Kansas; University of Kansas; University of Kansas; University of Kansas	Slawson, C (corresponding author), Univ Kansas, Med Ctr, 3901 Rainbow Blvd, Kansas City, MO 64108 USA.	cslawson@kumc.edu	E, Lezi/Q-4124-2017; Tan, Ee Phie/AAC-8378-2021	Selfridge, Jennifer/0000-0001-8979-1416	National Institutes of Health COBRE [9P20GM104936]; National Institutes of Health [S10RR027564]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG035982] Funding Source: NIH RePORTER	National Institutes of Health COBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the Electron Microscopy Research Laboratory (EMRL) for assistance with the electron microscopy. The EMRL is supported in part by National Institutes of Health COBRE Grant 9P20GM104936. The JEOL JEM-1400 TEM used in the study was purchased with funds from National Institutes of Health Grant S10RR027564.	Ball LE, 2006, MOL CELL PROTEOMICS, V5, P313, DOI 10.1074/mcp.M500314-MCP200; Bennett CE, 2013, LIFE SCI, V92, P657, DOI 10.1016/j.lfs.2012.09.007; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Burnham-Marusich AR, 2012, MITOCHONDRION, V12, P423, DOI 10.1016/j.mito.2012.04.004; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; Gottlieb RA, 2000, METHOD ENZYMOL, V322, P213; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Johnsen VL, 2013, PHYSIOL GENOMICS, V45, P17, DOI 10.1152/physiolgenomics.00111.2012; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Lazarou M, 2009, BBA-MOL CELL RES, V1793, P78, DOI 10.1016/j.bbamcr.2008.04.015; Lewis BA, 2013, BBA-GENE REGUL MECH, V1829, P1202, DOI 10.1016/j.bbagrm.2013.09.003; Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246; Medford HM, 2012, LIFE SCI, V90, P883, DOI 10.1016/j.lfs.2012.04.030; Ngoh GA, 2009, CIRC RES, V104, P41, DOI 10.1161/CIRCRESAHA.108.189431; Parker G, 2004, J BIOL CHEM, V279, P20636, DOI 10.1074/jbc.M312139200; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; Shin SH, 2011, AMINO ACIDS, V40, P885, DOI 10.1007/s00726-010-0719-8; Slawson C, 2005, J BIOL CHEM, V280, P32944, DOI 10.1074/jbc.M503396200; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Suarez J, 2008, AM J PHYSIOL-CELL PH, V295, pC1561, DOI 10.1152/ajpcell.00076.2008; Swerdlow RH, 2007, J NEUROSCI RES, V85, P3416, DOI 10.1002/jnr.21167; Tan EP, 2013, J BIOL CHEM, V288, P27085, DOI 10.1074/jbc.M113.470187; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Whelan SA, 2010, J BIOL CHEM, V285, P5204, DOI 10.1074/jbc.M109.077818; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Zeidan Q, 2010, MOL BIOL CELL, V21, P1922, DOI 10.1091/mbc.E09-11-0941	28	68	70	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14719	14730		10.1074/jbc.M113.525790	http://dx.doi.org/10.1074/jbc.M113.525790			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24713701	hybrid, Green Published			2022-12-25	WOS:000337248100028
J	Dominy, SS; Brown, JN; Ryder, MI; Gritsenko, M; Jacobs, JM; Smith, RD				Dominy, Stephen S.; Brown, Joseph N.; Ryder, Mark I.; Gritsenko, Marina; Jacobs, Jon M.; Smith, Richard D.			Proteomic Analysis of Saliva in HIV-Positive Heroin Addicts Reveals Proteins Correlated with Cognition	PLOS ONE			English	Article							IL-1 RECEPTOR ANTAGONIST; CENTRAL-NERVOUS-SYSTEM; CEREBROSPINAL-FLUID; NEURODEGENERATIVE DISEASES; TRANSMISSION EFFICIENCY; MAINTENANCE PATIENTS; ALZHEIMERS-DISEASE; QUALITY-CONTROL; ACCURATE MASS; BRAIN	The prevalence of HIV-associated neurocognitive disorders (HAND) remains high despite effective antiretroviral therapies. Multiple etiologies have been proposed over the last several years to account for this phenomenon, including the neurotoxic effects of antiretrovirals and co-morbid substance abuse; however, no underlying molecular mechanism has been identified. Emerging evidence in several fields has linked the gut to brain diseases, but the effect of the gut on the brain during HIV infection has not been explored. Saliva is the most accessible gut biofluid, and is therefore of great scientific interest for diagnostic and prognostic purposes. This study presents a longitudinal, liquid chromatography-mass spectrometry-based quantitative proteomics study investigating saliva samples taken from 8 HIV-positive (HIV+), 11 -negative (HIV-) heroin addicts. In addition, saliva samples were investigated from 11 HIV-, non-heroin addicted healthy controls. In the HIV+ group, 58 proteins were identified that show significant correlations with cognitive scores, implicating disruption of protein quality control pathways by HIV. Notably, only one protein from the HIV 2 heroin addict cohort showed a significant correlation with cognitive scores, and no proteins correlated with cognitive scores in the healthy control group. In addition, the majority of correlated proteins have been shown to be associated with exosomes, allowing us to propose that the salivary glands and/or oral epithelium may modulate brain function during HIV infection through the release of discrete packets of proteins in the form of exosomes.	[Dominy, Stephen S.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Brown, Joseph N.; Gritsenko, Marina; Jacobs, Jon M.; Smith, Richard D.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA USA; [Ryder, Mark I.] Univ Calif San Francisco, Dept Orofacial Sci, Div Periodontol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of California System; University of California San Francisco	Dominy, SS (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	stephen.dominy@ucsf.edu; rds@pnnl.gov	Smith, Richard D/J-3664-2012	Smith, Richard D/0000-0002-2381-2349	NIH [P01 DA026134, P41GM103493]; National Institutes of Health, University of California, San Francisco-Gladstone Institute of Virology and Immunology Center for AIDS Research [P30-AI027763]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA026134] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, University of California, San Francisco-Gladstone Institute of Virology and Immunology Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The majority of the research was funded through NIH grant P01 DA026134, including proteomics measurements from capabilities developed at PNNL under NIH grant P41GM103493. The IL1RA ELISA research was supported by a grant from the National Institutes of Health, University of California, San Francisco-Gladstone Institute of Virology and Immunology Center for AIDS Research, P30-AI027763. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Becker JT, 1999, J INT NEUROPSYCH SOC, V5, P41, DOI 10.1017/S1355617799511065; Bell JE, 2006, J NEUROIMMUNE PHARM, V1, P182, DOI 10.1007/s11481-006-9018-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bermejo-Pareja F, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-108; Brown JN, 2012, MOL CELL PROTEOMICS, V11, P605, DOI 10.1074/mcp.M111.016121; Byrd DA, 2013, J INT NEUROPSYCH SOC, V19, P463, DOI 10.1017/S1355617712001634; Cheng GLF, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.36; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Cockburn Andrew F, 2012, Investig Genet, V3, P19, DOI 10.1186/2041-2223-3-19; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Comte I, 2011, J CELL SCI, V124, P2438, DOI 10.1242/jcs.079954; Coren LV, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-64; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Darke S, 2012, DRUG ALCOHOL DEPEN, V126, P309, DOI 10.1016/j.drugalcdep.2012.05.032; Denier Niklaus, 2013, Front Psychiatry, V4, P135, DOI 10.3389/fpsyt.2013.00135; Devic I, 2011, BRAIN, V134, DOI 10.1093/brain/awr015; Diamond B, 2011, BIOESSAYS, V33, P588, DOI 10.1002/bies.201100042; Diez-Revuelta N, 2010, J CELL SCI, V123, P671, DOI 10.1242/jcs.058198; Dolan PJ, 2011, FEBS LETT, V585, P3424, DOI 10.1016/j.febslet.2011.09.032; Eldh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015353; Fernandes SP, 2010, J NEUROCHEM, V114, P1527, DOI 10.1111/j.1471-4159.2010.06869.x; Galea J, 2011, J CEREBR BLOOD F MET, V31, P439, DOI 10.1038/jcbfm.2010.103; Gelman BB, 2010, J NEUROIMMUNE PHARM, V5, P92, DOI 10.1007/s11481-009-9168-0; Gomes I, 2010, AAPS J, V12, P658, DOI 10.1208/s12248-010-9217-x; Gonzalez-Begne M, 2009, J PROTEOME RES, V8, P1304, DOI 10.1021/pr800658c; Goshen I, 2008, MOL PSYCHIATR, V13, P717, DOI 10.1038/sj.mp.4002055; Goshen I, 2007, PSYCHONEUROENDOCRINO, V32, P1106, DOI 10.1016/j.psyneuen.2007.09.004; Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100; Gruber VA, 2012, CLIN INFECT DIS, V54, P414, DOI 10.1093/cid/cir799; GUTIERREZ EG, 1994, J NEUROIMMUNOL, V55, P153, DOI 10.1016/0165-5728(94)90005-1; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Hu G, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.114; Jackrel ME, 2011, J CLIN INVEST, V121, P2972, DOI 10.1172/JCI59190; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Jaitly N, 2006, ANAL CHEM, V78, P7397, DOI 10.1021/ac052197p; Jarosz DF, 2010, SCIENCE, V330, P1820, DOI 10.1126/science.1195487; Jeffers L, 2011, Adv Dent Res, V23, P79, DOI 10.1177/0022034510396882; Johnson JL, 2011, BIOCH BIOPHYS ACTA; Kapsogeorgou EK, 2005, ARTHRITIS RHEUM-US, V52, P1517, DOI 10.1002/art.21005; Kelly RT, 2008, ANAL CHEM, V80, P143, DOI 10.1021/ac701647s; Kiebel GR, 2006, PROTEOMICS, V6, P1783, DOI 10.1002/pmic.200500500; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Kragh CL, 2012, BRAIN PATHOL, V22, P99, DOI 10.1111/j.1750-3639.2011.00545.x; Lai CPK, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00228; Laspiur JP, 2007, J NEUROIMMUNOL, V192, P157, DOI 10.1016/j.jneuroim.2007.08.004; Lazzeri G, 2006, ANN NY ACAD SCI, V1074, P174, DOI 10.1196/annals.1369.017; Marginean I, 2009, J AM SOC MASS SPECTR, V20, P682, DOI 10.1016/j.jasms.2008.12.004; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Matzke MM, 2013, PROTEOMICS, V13, P493, DOI 10.1002/pmic.201200269; MCLEOD DR, 1982, BEHAV RES METH INSTR, V14, P463, DOI 10.3758/BF03203313; Mintzer MZ, 2002, DRUG ALCOHOL DEPEN, V67, P41, DOI 10.1016/S0376-8716(02)00013-3; Monroe ME, 2008, COMPUT BIOL CHEM, V32, P215, DOI 10.1016/j.compbiolchem.2008.02.006; Monroe ME, 2007, BIOINFORMATICS, V23, P2021, DOI 10.1093/bioinformatics/btm281; Nam JW, 2007, ORAL DIS, V13, P187, DOI 10.1111/j.1601-0825.2006.01265.x; Narayanan A, 2013, J BIOL CHEM, V288, P20014, DOI 10.1074/jbc.M112.438895; Oh YS, 2006, AM J PHYSIOL-CELL PH, V291, pC76, DOI 10.1152/ajpcell.00508.2005; Ojha J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016550; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; Page JS, 2007, J AM SOC MASS SPECTR, V18, P1582, DOI 10.1016/j.jasms.2007.05.018; Palanisamy V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008577; Papandreou MJ, 2010, J BIOL CHEM, V285, P13788, DOI 10.1074/jbc.M109.066670; Park IW, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-234; Petritis K, 2006, ANAL CHEM, V78, P5026, DOI 10.1021/ac060143p; Proctor CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022038; Ramser J, 2008, AM J HUM GENET, V82, P188, DOI 10.1016/j.ajhg.2007.09.009; Rimaniol AC, 1997, J ACQ IMMUN DEF SYND, V16, P340, DOI 10.1097/00042560-199712150-00005; Rosano C, 2008, J AM GERIATR SOC, V56, P1618, DOI 10.1111/j.1532-5415.2008.01856.x; Rozek W, 2008, PROTEOM CLIN APPL, V2, P1498, DOI 10.1002/prca.200780114; Rozek W, 2007, J PROTEOME RES, V6, P4189, DOI 10.1021/pr070220c; SALTHOUSE TA, 1992, J GERONTOL, V47, pP121, DOI 10.1093/geronj/47.3.P121; Sheen VL, 2002, HUM MOL GENET, V11, P2845, DOI 10.1093/hmg/11.23.2845; Shi M, 2011, J ALZHEIMERS DIS, V27, P299, DOI 10.3233/JAD-2011-110731; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Spudich S, 2011, J INFECT DIS, V204, P753, DOI 10.1093/infdis/jir387; Spulber S, 2009, BRAIN BEHAV IMMUN, V23, P573, DOI 10.1016/j.bbi.2009.02.015; Spulber S, 2009, J NEUROIMMUNOL, V208, P46, DOI 10.1016/j.jneuroim.2009.01.010; Stanley JR, 2011, ANAL CHEM, V83, P6135, DOI 10.1021/ac2009806; Stockton SD, 2014, NEUROPSYCHOPHARMACOL, V39, P88, DOI 10.1038/npp.2013.227; Street JM, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-5; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Taverner T, 2012, BIOINFORMATICS; Taylor EB, 2011, BIOCHEM SOC T, V39, P1509, DOI 10.1042/BST0391509; Theodoraki MA, 2011, BIOCH BIOPHYS ACTA; Tischfield MA, 2011, CURR OPIN GENET DEV, V21, P286, DOI 10.1016/j.gde.2011.01.003; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Toro-Nieves DM, 2009, J NEUROVIROL, V15, P36, DOI 10.1080/13550280802385505; Verdejo A, 2005, DRUG ALCOHOL DEPEN, V78, P283, DOI 10.1016/j.drugalcdep.2004.11.006; Wang Chih-Hong, 2010, Open Hypertens J, V3, P1; Wang J, 2011, MOL NEUROBIOL, V44, P269, DOI 10.1007/s12035-011-8202-4; Wang WX, 2010, J CELL BIOCHEM, V111, P343, DOI 10.1002/jcb.22698; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Weihl CC, 2011, CURR ALZHEIMER RES, V8, P252; Wiederin J, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-8; Williams JL, 2013, CLIN IMMUNOL, V149, P236, DOI 10.1016/j.clim.2013.04.005; Yamanaka K, 2012, BBA-MOL CELL RES, V1823, P130, DOI 10.1016/j.bbamcr.2011.07.001; Yasuhara O, 1997, ACTA NEUROPATHOL, V93, P414, DOI 10.1007/s004010050633; Yuan K, 2010, NEUROSCI LETT, V482, P101, DOI 10.1016/j.neulet.2010.07.005; Yuan Y, 2009, BRAIN COGNITION, V71, P223, DOI 10.1016/j.bandc.2009.08.014; ZAVALA F, 1995, J IMMUNOL, V155, P2784; Zhou L, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-27; Zhuang XY, 2011, MOL THER, V19, P1769, DOI 10.1038/mt.2011.164; Zill P, 2011, EUR ARCH PSY CLIN N, V261, P121, DOI 10.1007/s00406-010-0129-7	105	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e89366	10.1371/journal.pone.0089366	http://dx.doi.org/10.1371/journal.pone.0089366			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717448	Green Submitted, Green Published, gold			2022-12-25	WOS:000334339000004
J	Herlemann, DPR; Manecki, M; Meeske, C; Pollehne, F; Labrenz, M; Schulz-Bull, D; Dittmar, T; Jurgens, K				Herlemann, Daniel P. R.; Manecki, Marcus; Meeske, Christian; Pollehne, Falk; Labrenz, Matthias; Schulz-Bull, Detlef; Dittmar, Thorsten; Juergens, Klaus			Uncoupling of Bacterial and Terrigenous Dissolved Organic Matter Dynamics in Decomposition Experiments	PLOS ONE			English	Article							MARINE BACTERIOPLANKTON; MASS-SPECTROMETRY; SURFACE WATERS; BOREAL RIVER; ARCTIC-OCEAN; SEA-ICE; CARBON; DIVERSITY; COMMUNITIES; EXTRACTION	The biodegradability of terrigenous dissolved organic matter (tDOM) exported to the sea has a major impact on the global carbon cycle, but our understanding of tDOM bioavailability is fragmentary. In this study, the effects of preparative tDOM isolation on microbial decomposition were investigated in incubation experiments consisting of mesocosms containing mesohaline water from the Baltic Sea. Dissolved organic carbon (DOC) consumption, molecular DOM composition, bacterial activities, and shifts in bacterial community structure were compared between mesocosms supplemented with riverine tDOM, either as filtered, particle-free river water or as a concentrate obtained by lyophilization/tangential ultrafiltration, and those containing only Baltic Sea water or river water. As shown using ultra-high-resolution mass spectrometry (15 Tesla Fourier-transform ion cyclotron resonance mass spectrometry, FT-ICR-MS) covering approximately 4600 different DOM compounds, the three DOM preparation protocols resulted in distinct patterns of molecular DOM composition. However, despite DOC losses of 4-16% and considerable bacterial production, there was no significant change in DOM composition during the 28-day experiment. Moreover, tDOM addition affected neither DOC degradation nor bacterial dynamics significantly, regardless of the tDOM preparation. This result suggested that the introduced tDOM was largely not bioavailable, at least on the temporal scale of our experiment, and that the observed bacterial activity and DOC decomposition mainly reflected the degradation of unknown, labile, colloidal and low-molecular weight DOM, both of which escape the analytical window of FT-ICR-MS. In contrast to the different tDOM preparations, the initial bacterial inoculum and batch culture conditions determined bacterial community succession and superseded the effects of tDOM addition. The uncoupling of tDOM and bacterial dynamics suggests that mesohaline bacterial communities cannot efficiently utilize tDOM and that in subarctic estuaries other factors are responsible for the removal of imported tDOM.	[Herlemann, Daniel P. R.; Manecki, Marcus; Meeske, Christian; Pollehne, Falk; Labrenz, Matthias; Schulz-Bull, Detlef; Juergens, Klaus] Warnemunde IOW, Leibniz Inst Balt Sea Res, Rostock, Germany; [Manecki, Marcus; Dittmar, Thorsten] Carl von Ossietzky Univ Oldenburg, Inst Chem & Biol Marine Environm, Res Grp Marine Geochem, ICBM MPI Bridging Grp, D-26111 Oldenburg, Germany	Leibniz Institut fur Ostseeforschung Warnemunde; Carl von Ossietzky Universitat Oldenburg	Jurgens, K (corresponding author), Warnemunde IOW, Leibniz Inst Balt Sea Res, Rostock, Germany.	klaus.juergens@io-warnemuende.de	Dittmar, Thorsten/L-7796-2013; Herlemann, Daniel/AAL-2569-2020	Dittmar, Thorsten/0000-0002-3462-0107; Herlemann, Daniel/0000-0002-8100-4649; Jurgens, Klaus/0000-0002-7999-9368; Pollehne, Falk/0000-0003-4419-6351	WGL PAKT ATKiM Project from the Leibnitz Society; Leibnitz Institute for Baltic Sea Research, Warnemunde	WGL PAKT ATKiM Project from the Leibnitz Society; Leibnitz Institute for Baltic Sea Research, Warnemunde	This work was supported by the WGL PAKT ATKiM Project from the Leibnitz Society and the Leibnitz Institute for Baltic Sea Research, Warnemunde. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAGAARD K, 1989, J GEOPHYS RES-OCEANS, V94, P14485, DOI 10.1029/JC094iC10p14485; Alling V, 2008, LIMNOL OCEANOGR, V53, P2594, DOI 10.4319/lo.2008.53.6.2594; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amon RMW, 2004, MAR CHEM, V92, P311, DOI 10.1016/j.marchem.2004.06.034; Amon RMW, 2001, LIMNOL OCEANOGR, V46, P287, DOI 10.4319/lo.2001.46.2.0287; Anderson LG, 1998, GLOBAL BIOGEOCHEM CY, V12, P455, DOI 10.1029/98GB01372; Baltar F, 2012, MICROBIOLOGYOPEN, V1, P214, DOI 10.1002/mbo3.25; BENNER R, 1992, SCIENCE, V255, P1561, DOI 10.1126/science.255.5051.1561; Bianchi TS, 2011, P NATL ACAD SCI USA, V108, P19473, DOI 10.1073/pnas.1017982108; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Brockmeyer B., 2013, INT J ORG CHEM, V3, P17; Brown JM, 2012, AQUAT MICROB ECOL, V66, P33, DOI 10.3354/ame01550; Cauwet G, 2002, MAR CHEM, V79, P193, DOI 10.1016/S0304-4203(02)00064-6; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cooper LW, 2005, J GEOPHYS RES-BIOGEO, V110, DOI 10.1029/2005JG000031; Deutsch B, 2012, BIOGEOSCIENCES, V9, P4465, DOI 10.5194/bg-9-4465-2012; Dinasquet J, 2013, ENV MICROBIOL; Dittmar T, 2001, GEOCHIM COSMOCHIM AC, V65, P4103, DOI 10.1016/S0016-7037(01)00688-3; Dittmar T, 2008, LIMNOL OCEANOGR-METH, V6, P230, DOI 10.4319/lom.2008.6.230; Eckert EM, 2012, ENVIRON MICROBIOL, V14, P794, DOI 10.1111/j.1462-2920.2011.02639.x; Elifantz H, 2007, AQUAT MICROB ECOL, V50, P39, DOI 10.3354/ame01145; Fellman JB, 2010, MAR CHEM, V121, P112, DOI 10.1016/j.marchem.2010.03.009; Freeman C, 2001, NATURE, V412, P785, DOI 10.1038/35090628; Fuchs BM, 2000, ENVIRON MICROBIOL, V2, P191, DOI 10.1046/j.1462-2920.2000.00092.x; FUHRMAN JA, 1982, MAR BIOL, V66, P109, DOI 10.1007/BF00397184; Fukuda R, 1998, APPL ENVIRON MICROB, V64, P3352; Gasol JM, 1999, APPL ENVIRON MICROB, V65, P4475; Gomez-Consarnau L, 2012, ENVIRON MICROBIOL, V14, P2361, DOI 10.1111/j.1462-2920.2012.02804.x; Grasshoff K., 1999, METHODS SEAWATER ANA; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Hedges JI, 1997, ORG GEOCHEM, V27, P319, DOI 10.1016/S0146-6380(97)00056-9; Herlemann DPR, 2013, MBIO, V4, DOI 10.1128/mBio.00569-12; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Humborg C, 2004, LIMNOL OCEANOGR, V49, P1871, DOI 10.4319/lo.2004.49.5.1871; Ingri J, 2000, CHEM GEOL, V166, P23, DOI 10.1016/S0009-2541(99)00178-3; Ingri J, 2005, AQUAT GEOCHEM, V11, P57, DOI 10.1007/s10498-004-2248-0; Ingri J, 1997, APPL GEOCHEM, V12, P483, DOI 10.1016/S0883-2927(97)00026-7; Jiao N, 2010, NAT REV MICROBIOL, V8, P593, DOI 10.1038/nrmicro2386; Judd KE, 2006, ECOLOGY, V87, P2068, DOI 10.1890/0012-9658(2006)87[2068:VIDOMC]2.0.CO;2; Jurgens K, 2000, J EXP MAR BIOL ECOL, V245, P127, DOI 10.1016/S0022-0981(99)00156-2; JURGENS K, 1994, MAR ECOL PROG SER, V112, P169, DOI 10.3354/meps112169; Koch J, 2007, ANAL BIOANAL CHEM, V387, P149, DOI 10.1007/s00216-006-0918-z; Kohler H., 2003, P MAR SCI, V6, P281, DOI DOI 10.1016/S1568-2692(03)80042-6; Kujawinski EB, 2002, MAR CHEM, V77, P133, DOI 10.1016/S0304-4203(01)00082-2; Kujawinski EB, 2011, ANNU REV MAR SCI, V3, P567, DOI 10.1146/annurev-marine-120308-081003; Landa M, 2013, AQUAT MICROB ECOL, V69, P157, DOI 10.3354/ame01632; Langenheder S, 2003, FEMS MICROBIOL ECOL, V45, P189, DOI 10.1016/S0168-6496(03)00149-1; Letscher RT, 2011, MAR CHEM, V123, P78, DOI 10.1016/j.marchem.2010.10.002; Lo Giudice A, 2010, POLAR BIOL, V33, P929, DOI 10.1007/s00300-010-0770-7; Lobbes JM, 2000, GEOCHIM COSMOCHIM AC, V64, P2973, DOI 10.1016/S0016-7037(00)00409-9; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Massana R, 2001, LIMNOL OCEANOGR, V46, P1181, DOI 10.4319/lo.2001.46.5.1181; Massana R, 2003, AQUAT MICROB ECOL, V32, P11, DOI 10.3354/ame032011; McGuire AD, 2009, ECOL MONOGR, V79, P523, DOI 10.1890/08-2025.1; MEYBECK M, 1982, AM J SCI, V282, P401, DOI 10.2475/ajs.282.4.401; MEYER JL, 1987, MICROB ECOL, V13, P13, DOI 10.1007/BF02014960; Mopper K, 2007, CHEM REV, V107, P419, DOI 10.1021/cr050359b; Moran MA, 1999, ESTUARIES, V22, P55, DOI 10.2307/1352927; Moran MA, 1997, LIMNOL OCEANOGR, V42, P1307, DOI 10.4319/lo.1997.42.6.1307; Moran MA, 2000, LIMNOL OCEANOGR, V45, P1254, DOI 10.4319/lo.2000.45.6.1254; Mou XZ, 2008, NATURE, V451, P708, DOI 10.1038/nature06513; Nelson CE, 2012, ENVIRON MICROBIOL, V14, P1500, DOI 10.1111/j.1462-2920.2012.02738.x; Oh KH, 2011, INT J SYST EVOL MICR, V61, P1382, DOI 10.1099/ijs.0.023994-0; Opsahl S, 1997, NATURE, V386, P480, DOI 10.1038/386480a0; Pinhassi J, 2003, APPL ENVIRON MICROB, V69, P199, DOI 10.1128/AEM.69.1.199-211.2003; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Raisanen J, 2004, CLIM DYNAM, V22, P13, DOI 10.1007/s00382-003-0365-x; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Ray JL, 2012, FEMS MICROBIOL ECOL, V82, P713, DOI 10.1111/j.1574-6941.2012.01443.x; Raymond PA, 2001, NATURE, V409, P497, DOI 10.1038/35054034; RIEMANN B, 1987, LIMNOL OCEANOGR, V32, P471, DOI 10.4319/lo.1987.32.2.0471; Robinson C, 1999, MAR ECOL PROG SER, V180, P23, DOI 10.3354/meps180023; Rohde K.-H., 1979, AUSGEWAHLTE METHODEN; Schafer H, 2000, ARCH MICROBIOL, V173, P138, DOI 10.1007/s002039900121; SHOLKOVITZ ER, 1976, GEOCHIM COSMOCHIM AC, V40, P831, DOI 10.1016/0016-7037(76)90035-1; Sjostedt J, 2012, APPL ENVIRON MICROB, V78, P1361, DOI 10.1128/AEM.05542-11; Smedberg E, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002567; Stein R, 2004, ORGANIC CARBON CYCLE IN THE ARCTIC OCEAN, P315; Strady E, 2008, CHEMOSPHERE, V70, P1309, DOI 10.1016/j.chemosphere.2007.07.051; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Topper B, 2013, FEMS MICROBIOL ECOL, V83, P202, DOI 10.1111/j.1574-6941.2012.01463.x; van Dongen BE, 2008, MAR CHEM, V112, P203, DOI 10.1016/j.marchem.2008.08.002; Wasmund N, 2011, J MARINE SYST, V87, P145, DOI 10.1016/j.jmarsys.2011.03.010; Weber F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041970; Weinbauer MG, 2002, APPL ENVIRON MICROB, V68, P1082, DOI 10.1128/AEM.68.3.1082-1087.2002; Wikner J, 1999, AQUAT MICROB ECOL, V17, P289, DOI 10.3354/ame017289; Wright ES, 2012, APPL ENVIRON MICROB, V78, P717, DOI 10.1128/AEM.06516-11; Yamamoto-Kawai M, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005000; Zhou JZ, 2011, ISME J, V5, P1303, DOI 10.1038/ismej.2011.11	92	43	43	5	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93945	10.1371/journal.pone.0093945	http://dx.doi.org/10.1371/journal.pone.0093945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718626	Green Published, Green Submitted, gold			2022-12-25	WOS:000334339000059
J	Mengel, F				Mengel, Friederike			Computer Games and Prosocial Behaviour	PLOS ONE			English	Article							PLAYING VIOLENT VIDEO; COOPERATION; DILEMMA; AGGRESSION	We relate different self-reported measures of computer use to individuals' propensity to cooperate in the Prisoner's dilemma. The average cooperation rate is positively related to the self-reported amount participants spend playing computer games. None of the other computer time use variables (including time spent on social media, browsing internet, working etc.) are significantly related to cooperation rates.	[Mengel, Friederike] Univ Essex, Dept Econ, Colchester CO4 3SQ, Essex, England; [Mengel, Friederike] Maastricht Univ, Dept Econ AE 1, Maastricht, Limburg, Netherlands	University of Essex; Maastricht University	Mengel, F (corresponding author), Univ Essex, Dept Econ, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.	fr.mengel@gmail.com			European Union [PERG08-GA-2010-277026]	European Union(European Commission)	Funding was obtained from a research grant from the European Union (grant PERG08-GA-2010-277026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2000, J PERS SOC PSYCHOL, V78, P772, DOI 10.1037//0022-3514.78.4.772; Anderson CA, 2010, PSYCHOL BULL, V136, P151, DOI 10.1037/a0018251; ANDREONI J, 1993, ECON J, V103, P570, DOI 10.2307/2234532; [Anonymous], 2008, PEW INTERNET AM LIFE; Bereby-Meyer Y, 2006, AM ECON REV, V96, P1029, DOI 10.1257/aer.96.4.1029; Bluemke M, 2010, AGGRESSIVE BEHAV, V36, P1, DOI 10.1002/ab.20329; Colwell J, 2000, BRIT J PSYCHOL, V91, P295, DOI 10.1348/000712600161844; Durkin K, 2002, J APPL DEV PSYCHOL, V23, P373, DOI 10.1016/S0193-3973(02)00124-7; Ewoldsen DR, 2012, CYBERPSYCH BEH SOC N, V15, P277, DOI 10.1089/cyber.2011.0308; Ferguson CJ, 2011, COMPUT HUM BEHAV, V27, P770, DOI 10.1016/j.chb.2010.10.026; Friedman D, 2012, AM ECON REV, V102, P337, DOI 10.1257/aer.102.1.337; Funk JB, 1996, J COMMUN, V46, P19, DOI 10.1111/j.1460-2466.1996.tb01472.x; Gentile DA, 2009, PERS SOC PSYCHOL B, V35, P752, DOI 10.1177/0146167209333045; Granic I, 2014, AM PSYCHOL, V69, P66, DOI 10.1037/a0034857; Greitemeyer T, 2011, CURR DIR PSYCHOL SCI, V20, P251, DOI 10.1177/0963721411415229; Grimm V, 2009, GAME ECON BEHAV, V66, P202, DOI 10.1016/j.geb.2008.05.005; Grusser SM, 2007, CYBERPSYCHOL BEHAV, V10, P290, DOI 10.1089/cpb.2006.9956; Konrath S, 2013, HDB RES TECHNOSELF I; Lemola S, 2011, PERS INDIV DIFFER, V51, P117, DOI 10.1016/j.paid.2011.03.024; Lo SK, 2005, CYBERPSYCHOL BEHAV, V8, P15, DOI 10.1089/cpb.2005.8.15; Schmidt D, 2001, J ECON BEHAV ORGAN, V46, P357, DOI 10.1016/S0167-2681(01)00158-5; Wiegman O, 1998, BRIT J SOC PSYCHOL, V37, P367, DOI 10.1111/j.2044-8309.1998.tb01177.x; Williamson P. A., 1987, J APPLIED DEV PSYCHO, V8, P453, DOI [10.1016/0193-3973(87)90033-5, DOI 10.1016/0193-3973(87)90033-5]	23	7	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94099	10.1371/journal.pone.0094099	http://dx.doi.org/10.1371/journal.pone.0094099			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24718635	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000334339000076
J	Riedl, M; Muller, A; Kraemer, JF; Penzel, T; Kurths, J; Wessel, N				Riedl, Maik; Mueller, Andreas; Kraemer, Jan F.; Penzel, Thomas; Kurths, Juergen; Wessel, Niels			Cardio-Respiratory Coordination Increases during Sleep Apnea	PLOS ONE			English	Article							RESPIRATORY SINUS ARRHYTHMIA; HEART-RATE; SYNCHRONIZATION; PHASE; OSCILLATIONS; VENTILATION; HUMANS; EVENT	Cardiovascular diseases are the main source of morbidity and mortality in the United States with costs of more than $ 170 billion. Repetitive respiratory disorders during sleep are assumed to be a major cause of these diseases. Therefore, the understanding of the cardio-respiratory regulation during these events is of high public interest. One of the governing mechanisms is the mutual influence of the cardiac and respiratory oscillations on their respective onsets, the cardio-respiratory coordination (CRC). We analyze this mechanism based on nocturnal measurements of 27 males suffering from obstructive sleep apnea syndrome. Here we find, by using an advanced analysis technique, the coordigram, not only that the occurrence of CRC is significantly more frequent during respiratory sleep disturbances than in normal respiration (p-value<10(-51)) but also more frequent after these events (p-value<10(-15)). Especially, the latter finding contradicts the common assumption that spontaneous CRC can only be observed in epochs of relaxed conditions, while our newly discovered epochs of CRC after disturbances are characterized by high autonomic stress. Our findings on the connection between CRC and the appearance of sleep-disordered events require a substantial extension of the current understanding of obstructive sleep apneas and hypopneas.	[Riedl, Maik; Mueller, Andreas; Kraemer, Jan F.; Kurths, Juergen; Wessel, Niels] Humboldt Univ, Dept Phys, Berlin, Germany; [Penzel, Thomas] Charite, Dept Cardiol, Sleep Med Ctr, D-13353 Berlin, Germany; [Kurths, Juergen] Potsdam Inst Climate Impact Res, Potsdam, Germany	Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Potsdam Institut fur Klimafolgenforschung	Wessel, N (corresponding author), Humboldt Univ, Dept Phys, Invalidenstr 110, Berlin, Germany.	niels.wessel@physik.hu-berlin.de	Penzel, Thomas/M-2344-2014	Penzel, Thomas/0000-0002-4304-0112; Wessel, Niels/0000-0003-0922-9971	Deutsche Forschungsgemeinschaft [RI2916/2-1, WE2834/5-1, PE628/4-1, KU837/23-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	MR, NW, AM, TP and JK acknowledge financial support from RI2916/2-1, WE2834/5-1, PE628/4-1, and KU837/23-1 (Deutsche Forschungsgemeinschaft). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartsch R, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.054102; Bartsch RP, 2012, P NATL ACAD SCI USA, V109, P10181, DOI 10.1073/pnas.1204568109; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; CHERNIACK NS, 1984, J CLIN INVEST, V73, P1501, DOI 10.1172/JCI111355; Cysarz D, 2004, AM J PHYSIOL-HEART C, V287, pH579, DOI 10.1152/ajpheart.01131.2003; Cysarz D, 2004, BIOMED ENG ONLINE, V3, DOI 10.1186/1475-925X-3-44; Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Galletly DC, 1997, BRIT J ANAESTH, V79, P35, DOI 10.1093/bja/79.1.35; Heidenreich PA, 2011, CIRCULATION, V123, P933, DOI 10.1161/CIR.0b013e31820a55f5; HIRSCH JA, 1981, AM J PHYSIOL, V241, pH620, DOI 10.1152/ajpheart.1981.241.4.H620; Iber C., 2007, AASM MANUAL SCORING; Kabir MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010602; Kotani K, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.051923; Larsen PD, 1999, BRIT J ANAESTH, V82, P685, DOI 10.1093/bja/82.5.685; MOSER M, 1995, BIOL RHYTHM RES, V26, P100, DOI 10.1080/09291019509360328; Niizeki K, 2012, AM J PHYSIOL-HEART C, V302, pH359, DOI 10.1152/ajpheart.00746.2011; PESSENHOFER H, 1975, PFLUG ARCH EUR J PHY, V355, P77, DOI 10.1007/BF00584801; Porta A, 2004, BIOL CYBERN, V91, P258, DOI 10.1007/s00422-004-0513-3; Porta A, 2000, MED BIOL ENG COMPUT, V38, P180, DOI 10.1007/BF02344774; Porta A, 2012, COMPUT BIOL MED, V42, P298, DOI 10.1016/j.compbiomed.2011.04.019; Raschke F, 1986, TEMPORAL DISORDER HU; Raschke F, 1991, RHYTHMUS PHYSL SYSTE; SALAMONE JA, 1983, J APPL PHYSIOL, V55, P61, DOI 10.1152/jappl.1983.55.1.61; Schafer C, 1998, NATURE, V392, P239, DOI 10.1038/32567; Silverman B.W., 1986, DENSITY ESTIMATION S; SOMERS D, 1993, BIOL CYBERN, V68, P393, DOI 10.1007/BF00198772; Task Force of The European Society of Cardiology and The North American Society of Pacing and Electrophysiology, 1996, EUR HEART J, V17; Toledo E, 2002, MED ENG PHYS, V24, P45, DOI 10.1016/S1350-4533(01)00114-X; Wallois F, 2008, AUTON NEUROSCI-BASIC, V143, P79, DOI 10.1016/j.autneu.2008.07.012; Wittmeier S, 2008, P NATL ACAD SCI USA, V105, P18000, DOI 10.1073/pnas.0809377105	31	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93866	10.1371/journal.pone.0093866	http://dx.doi.org/10.1371/journal.pone.0093866			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718564	gold, Green Published, Green Submitted			2022-12-25	WOS:000334339000052
J	Tsou, A; Thelwall, M; Mongeon, P; Sugimoto, CR				Tsou, Andrew; Thelwall, Mike; Mongeon, Philippe; Sugimoto, Cassidy R.			A Community of Curious Souls: An Analysis of Commenting Behavior on TED Talks Videos	PLOS ONE			English	Article							SCIENCE; YOUTUBE; COMMUNICATION; SCIENTISTS	The TED (Technology, Entertainment, Design) Talks website hosts video recordings of various experts, celebrities, academics, and others who discuss their topics of expertise. Funded by advertising and members but provided free online, TED Talks have been viewed over a billion times and are a science communication phenomenon. Although the organization has been derided for its populist slant and emphasis on entertainment value, no previous research has assessed audience reactions in order to determine the degree to which presenter characteristics and platform affect the reception of a video. This article addresses this issue via a content analysis of comments left on both the TED website and the YouTube platform (on which TED Talks videos are also posted). It was found that commenters were more likely to discuss the characteristics of a presenter on YouTube, whereas commenters tended to engage with the talk content on the TED website. In addition, people tended to be more emotional when the speaker was a woman (by leaving comments that were either positive or negative). The results can inform future efforts to popularize science amongst the public, as well as to provide insights for those looking to disseminate information via Internet videos.	[Tsou, Andrew; Sugimoto, Cassidy R.] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA; [Thelwall, Mike] Wolverhampton Univ, Sch Technol, Wolverhampton WV1 1DJ, W Midlands, England; [Mongeon, Philippe] Univ Montreal, Ecole Bibliothecon & Sci Informat, Quebec City, PQ, Canada	Indiana University System; Indiana University Bloomington; University of Wolverhampton; Universite de Montreal	Tsou, A (corresponding author), Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA.	atsou@umail.iu.edu	Thelwall, Mike/C-1449-2013; Sugimoto, Cassidy R/AAV-2705-2021; Mongeon, Philippe/H-1446-2012	Thelwall, Mike/0000-0001-6065-205X; Sugimoto, Cassidy R/0000-0001-8608-3203; Mongeon, Philippe/0000-0003-1021-059X	international funding initiative Digging into Data; National Science Foundation in the United States [1208804]; Joint Information Systems Committee (JISC) in the United Kingdom; Social Sciences and Humanities Research Council of Canada	international funding initiative Digging into Data; National Science Foundation in the United States(National Science Foundation (NSF)); Joint Information Systems Committee (JISC) in the United Kingdom; Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This manuscript is based upon work supported by the international funding initiative Digging into Data. Specifically, funding comes from the National Science Foundation in the United States (Grant No. 1208804) (URL: http://www.nsf.gov/funding/pgm_summ.jsp?pims_id = 501084), Joint Information Systems Committee (JISC) in the United Kingdom, and the Social Sciences and Humanities Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa, 2013, TOP SIT; Bentley P, 2011, PUBLIC UNDERST SCI, V20, P48, DOI 10.1177/0963662510384461; Berk R. A., 2009, INT J TECHNOL TEACH, V5, P1; Brossard D, 2013, P NATL ACAD SCI US; Brossard D, 2013, NY TIMES; Choi HY, 2012, ECON REC, V88, P2, DOI 10.1111/j.1475-4932.2012.00809.x; Chowdhury SA, 2012, 2012 SEVENTH INTERNATIONAL CONFERENCE ON BROADBAND, WIRELESS COMPUTING, COMMUNICATION AND APPLICATIONS (BWCCA 2012), P244, DOI 10.1109/BWCCA.2012.47; Clifton A, 2011, NURS EDUC TODAY, V31, P311, DOI 10.1016/j.nedt.2010.10.004; Conte R, 2012, EUR PHYS J-SPEC TOP, V214, P325, DOI 10.1140/epjst/e2012-01697-8; Davies SR, 2008, SCI COMMUN, V29, P413, DOI 10.1177/1075547008316222; Desmet Christy, 2009, ENGL J, V99, P65; DUNWOODY S, 1985, J COMMUN, V35, P26, DOI 10.1111/j.1460-2466.1985.tb01882.x; Frank A, 2013, NY TIMES; Gascoigne T, 1997, SCI COMMUN, V18, P265, DOI 10.1177/1075547097018003005; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; Jaffar AA, 2012, ANAT SCI EDUC, V5, P158, DOI 10.1002/ase.1268; Jones T, 2011, COMPUT SCH, V28, P75, DOI 10.1080/07380569.2011.553149; Juhasz A, 2009, CINEMA J, V48, P145; Jurgenson N, 2012, TED; King G, 2011, SCIENCE, V331, P719, DOI 10.1126/science.1197872; Kling R, 2007, INFORM SOC, V23, P205, DOI 10.1080/01972240701441556; Knosel M, 2011, J DENT EDUC, V75, P1558; LaBarre S., 2013, POPULAR SCI; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Martin-Sempere MJ, 2008, PUBLIC UNDERST SCI, V17, P349, DOI 10.1177/0963662506067660; Moat HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01801; National Science Board, 2012, SCI ENG IND; O'Brien C, 2012, LOS ANGELES TIMES; Preis T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01684; Preis T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00350; Robbins Martin, 2012, TROUBLE TED TALKS; Steyaert J, 2011, J SOCIAL INTERVENTIO, V20, P79; Sugimoto CR, 2013, J AM SOC INF SCI TEC, V64, P663, DOI 10.1002/asi.22764; Sugimoto CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062403; Taleb N. N, 2008, BLACK SWAN 2 EDITION; TED, 2012, TED; TED Blog, 2012, WHAT TALKS HAV RES M; Thelwall M, 2012, J AM SOC INF SCI TEC, V63, P616, DOI 10.1002/asi.21679; Tsfati Y, 2011, SCI COMMUN, V33, P143, DOI 10.1177/1075547010380385; Vogel L, 2011, CAN MED ASSOC J, V183, P647, DOI 10.1503/cmaj.109-3812; Weigold MF, 2001, SCI COMMUN, V23, P164, DOI 10.1177/1075547001023002005	43	44	44	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93609	10.1371/journal.pone.0093609	http://dx.doi.org/10.1371/journal.pone.0093609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24718634	Green Published, Green Submitted, gold			2022-12-25	WOS:000334339000038
J	Zels, S; Verlinden, H; Dillen, S; Vleugels, R; Nachman, RJ; Vanden Broeck, J				Zels, Sven; Verlinden, Heleen; Dillen, Senne; Vleugels, Rut; Nachman, Ronald J.; Vanden Broeck, Jozef			Signaling Properties and Pharmacological Analysis of Two Sulfakinin Receptors from the Red Flour Beetle, Tribolium castaneum	PLOS ONE			English	Article							SULFATED INSECT NEUROPEPTIDE; FOOD-INTAKE; DROSOPHILA-MELANOGASTER; FUNCTIONAL-CHARACTERIZATION; ALLATOTROPIN RECEPTOR; NEOBELLIERIA-BULLATA; AMERICAN COCKROACH; PROTEIN HORMONES; NERVOUS-SYSTEM; CHOLECYSTOKININ	Sulfakinin is an insect neuropeptide that constitutes an important component of the complex network of hormonal and neural factors that regulate feeding and digestion. The key modulating functions of sulfakinin are mediated by binding and signaling via G-protein coupled receptors. Although a substantial amount of functional data have already been reported on sulfakinins in different insect species, only little information is known regarding the properties of their respective receptors. In this study, we report on the molecular cloning, functional expression and characterization of two sulfakinin receptors in the red flour beetle, Tribolium castaneum. Both receptor open reading frames show extensive sequence similarity with annotated sulfakinin receptors from other insects. Comparison of the sulfakinin receptor sequences with homologous vertebrate cholecystokinin receptors reveals crucial conserved regions for ligand binding and receptor activation. Quantitative reverse transcriptase PCR shows that transcripts of both receptors are primarily expressed in the central nervous system of the beetle. Pharmacological characterization using 29 different peptide ligands clarified the essential requirements for efficient activation of these sulfakinin receptors. Analysis of the signaling pathway in multiple cell lines disclosed that the sulfakinin receptors of T. castaneum can stimulate both the Ca2+ and cyclic AMP second messenger pathways. This in depth characterization of two insect sulfakinin receptors may provide useful leads for the further development of receptor ligands with a potential applicability in pest control and crop protection.	[Zels, Sven; Verlinden, Heleen; Dillen, Senne; Vleugels, Rut; Vanden Broeck, Jozef] Katholieke Univ Leuven, Dept Biol, Louvain, Vlaams Brabant, Belgium; [Nachman, Ronald J.] USDA, Areawide Pest Management Res Unit, Southern Plains Agr Res Ctr, College Stn, TX USA	KU Leuven; United States Department of Agriculture (USDA)	Vanden Broeck, J (corresponding author), Katholieke Univ Leuven, Dept Biol, Louvain, Vlaams Brabant, Belgium.	Jozef.VandenBroeck@bio.kuleuven.be	Verlinden, Heleen/D-1033-2011	Verlinden, Heleen/0000-0001-6721-3973; Vanden Broeck, Jozef/0000-0001-7653-0516	Interuniversity Attraction Poles program [P7/40]; KU Leuven Research Foundation [GOA/11/02]; Agency for Innovation by Science and Technology (IWT); Research Foundation of Flanders (FWO)	Interuniversity Attraction Poles program(Belgian Federal Science Policy Office); KU Leuven Research Foundation; Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation of Flanders (FWO)(FWO)	The authors thank the Interuniversity Attraction Poles program (Belgian Science Policy Grant P7/40) and the KU Leuven Research Foundation (GOA/11/02) for financial support. SZ and RV were supported by the Agency for Innovation by Science and Technology (IWT). HV was supported by the Research Foundation of Flanders (FWO). The funders had no role in study desing, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Audsley N, 2011, PEPTIDES, V32, P434, DOI 10.1016/j.peptides.2010.08.028; Beeman RW, 2009, BEETLE BEETLE WRANGL; Chen X, 2012, FLY, V6, P290, DOI 10.4161/fly.21534; Chen X, 2012, J CELL BIOL, V196, P529, DOI 10.1083/jcb.201109044; Clynen E, 2009, INSECT BIOCHEM MOLEC, V39, P491, DOI 10.1016/j.ibmb.2009.06.001; Downer KE, 2007, J INSECT PHYSIOL, V53, P106, DOI 10.1016/j.jinsphys.2006.10.013; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; DUVE H, 1995, EUR J BIOCHEM, V232, P633, DOI 10.1111/j.1432-1033.1995.tb20854.x; East PD, 1997, TISSUE CELL, V29, P347, DOI 10.1016/S0040-8166(97)80010-9; FONAGY A, 1992, COMP BIOCHEM PHYS C, V103, P135, DOI 10.1016/0742-8413(92)90242-Y; Fourmy D, 2002, PHARMACOL TOXICOL, V91, P313, DOI 10.1034/j.1600-0773.2002.910608.x; Gigoux V, 1999, PROTEIN SCI, V8, P2347; Gigoux V, 1998, J BIOL CHEM, V273, P14380, DOI 10.1074/jbc.273.23.14380; Harshini S, 2002, PEPTIDES, V23, P1759, DOI 10.1016/S0196-9781(02)00152-3; Hauser F, 2010, J PROTEOME RES, V9, P5296, DOI 10.1021/pr100570j; Horodyski FM, 2011, INSECT BIOCHEM MOLEC, V41, P804, DOI 10.1016/j.ibmb.2011.06.002; Huybrechts J, 2010, INSECT MOL BIOL, V19, P87, DOI 10.1111/j.1365-2583.2009.00951.x; Janssen T, 2008, ENDOCRINOLOGY, V149, P2826, DOI 10.1210/en.2007-1772; Kiss B, 2013, GEN COMP ENDOCR, V191, P137, DOI 10.1016/j.ygcen.2013.05.023; Kubiak TM, 2002, BIOCHEM BIOPH RES CO, V291, P313, DOI 10.1006/bbrc.2002.6459; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; Maestro JL, 2001, EUR J BIOCHEM, V268, P5824, DOI 10.1046/j.0014-2956.2001.02527.x; Marciniak P, 2011, J COMP PHYSIOL B, V181, P721, DOI 10.1007/s00360-011-0563-5; Meyering-Vos M, 2007, J INSECT PHYSIOL, V53, P840, DOI 10.1016/j.jinsphys.2007.04.003; Miller LJ, 2008, PHARMACOL THERAPEUT, V119, P83, DOI 10.1016/j.pharmthera.2008.05.001; Nachman R J, 1988, Peptides, V9 Suppl 1, P137, DOI 10.1016/0196-9781(88)90237-9; Nachman RJ, 1997, ANN NY ACAD SCI, V814, P335, DOI 10.1111/j.1749-6632.1997.tb46178.x; Nachman RJ, 2005, PEPTIDES, V26, P115, DOI 10.1016/j.peptides.2004.07.018; NACHMAN RJ, 1986, BIOCHEM BIOPH RES CO, V140, P357, DOI 10.1016/0006-291X(86)91098-3; NACHMAN RJ, 1986, SCIENCE, V234, P71, DOI 10.1126/science.3749893; Nachman RJ, 1997, PEPTIDES, V18, P53, DOI 10.1016/S0196-9781(96)00233-1; Nichols R, 2007, PEPTIDES, V28, P767, DOI 10.1016/j.peptides.2007.01.009; NICHOLS R, 1988, J BIOL CHEM, V263, P12167; Nichols R, 1997, ANN NY ACAD SCI, V814, P315, DOI 10.1111/j.1749-6632.1997.tb46173.x; Nichols R, 2009, FRONT BIOSCI-LANDMRK, V14, P4035, DOI 10.2741/3510; Nichols R, 2008, PEPTIDES, V29, P2128, DOI 10.1016/j.peptides.2008.08.010; Ons S, 2009, PROTEOMICS, V9, P788, DOI 10.1002/pmic.200800499; Palmer GC, 2007, J INSECT PHYSIOL, V53, P1125, DOI 10.1016/j.jinsphys.2007.06.001; Predel R, 1999, EUR J BIOCHEM, V263, P552, DOI 10.1046/j.1432-1327.1999.00532.x; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; Schoofs L., 2013, HDB BIOL ACTIVE PEPT, P310; Shi Y, 2011, J BIOL CHEM, V286, P42390, DOI 10.1074/jbc.M111.275602; Soderberg Jeannette A E, 2012, Front Endocrinol (Lausanne), V3, P109, DOI 10.3389/fendo.2012.00109; Spit J, 2012, CAN J ZOOL, V90, P489, DOI 10.1139/Z2012-014; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VEENSTRA JA, 1989, NEUROPEPTIDES, V14, P145, DOI 10.1016/0143-4179(89)90038-3; VEENSTRA JA, 1995, HISTOCHEM CELL BIOL, V104, P337, DOI 10.1007/BF01458127; Verleyen P, 2004, BIOCHEM BIOPH RES CO, V316, P763, DOI 10.1016/j.bbrc.2004.02.115; Verlinden H, 2013, GEN COMP ENDOCR, V193, P193, DOI 10.1016/j.ygcen.2013.08.006; Vleugels R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065052; Vuerinckx K, 2011, INSECT BIOCHEM MOLEC, V41, P815, DOI 10.1016/j.ibmb.2011.06.003; Wei Z, 2000, J INSECT PHYSIOL, V46, P1259, DOI 10.1016/S0022-1910(00)00046-9; Wicher D, 2007, FRONT CELL NEUROSCI, V1, DOI [10.3389/neuro.03.003/2007, 10.3389/neuro.03.003.2007]; Yu N, 2013, PEPTIDES, pS0196; Yu N, 2013, GEN COMP ENDOCR, V188, P196, DOI 10.1016/j.ygcen.2013.03.006; Yu N, 2013, PEPTIDES, V41, P107, DOI 10.1016/j.peptides.2012.12.005; Zoephel J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041543	58	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94502	10.1371/journal.pone.0094502	http://dx.doi.org/10.1371/journal.pone.0094502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718573	Green Submitted, gold, Green Published			2022-12-25	WOS:000334339000129
J	Fan, SL; Meng, YY; Song, MZ; Pang, CY; Wei, HL; Liu, J; Zhan, XJ; Lan, JY; Feng, CH; Zhang, SX; Yu, SX				Fan, Shuli; Meng, Yanyan; Song, Meizhen; Pang, Chaoyou; Wei, Hengling; Liu, Ji; Zhan, Xianjin; Lan, Jiayang; Feng, Changhui; Zhang, Shengxi; Yu, Shuxun			Quantitative Phosphoproteomics Analysis of Nitric Oxide-Responsive Phosphoproteins in Cotton Leaf	PLOS ONE			English	Article							PROTEIN-PHOSPHORYLATION ANALYSIS; SERINE/ARGININE-RICH PROTEINS; ACID SIGNAL-TRANSDUCTION; ABSCISIC-ACID; ARABIDOPSIS-THALIANA; IN-VIVO; PLASMA-MEMBRANE; BINDING-PROTEIN; EXPRESSION; REVEALS	Knowledge of phosphorylation events and their regulation is crucial to understanding the functional biology of plant proteins, but very little is currently known about nitric oxide-responsive phosphorylation in plants. Here, we report the first large-scale, quantitative phosphoproteome analysis of cotton (Gossypium hirsutum) treated with sodium nitroprusside (nitric oxide donor) by utilizing the isobaric tag for relative and absolute quantitation (iTRAQ) method. A total of 1315 unique phosphopeptides, spanning 1528 non-redundant phosphorylation sites, were detected from 1020 cotton phosphoproteins. Among them, 183 phosphopeptides corresponding to 167 phosphoproteins were found to be differentially phosphorylated in response to sodium nitroprusside. Several of the phosphorylation sites that we identified, including RQxS, DSxE, TxxxxSP and SPxT, have not, to our knowledge, been reported to be protein kinase sites in other species. The phosphoproteins identified are involved in a wide range of cellular processes, including signal transduction, RNA metabolism, intracellular transport and so on. This study reveals unique features of the cotton phosphoproteome and provides new insight into the biochemical pathways that are regulated by nitric oxide.	[Fan, Shuli; Song, Meizhen; Pang, Chaoyou; Wei, Hengling; Liu, Ji; Yu, Shuxun] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Henan Province, Peoples R China; [Meng, Yanyan; Zhan, Xianjin; Lan, Jiayang; Feng, Changhui; Zhang, Shengxi] Hubei Acad Agr Sci, Crop Inst Econ, Key Lab Cotton Biol & Breeding Middle Reaches Cha, Wuhan, Hubei Province, Peoples R China; [Liu, Ji] Northwest A&F Univ, Coll Agron, Wuhan, Hubei Province, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Hubei Academy of Agricultural Sciences; Northwest A&F University - China	Zhang, SX (corresponding author), Hubei Acad Agr Sci, Crop Inst Econ, Key Lab Cotton Biol & Breeding Middle Reaches Cha, Wuhan, Hubei Province, Peoples R China.	zhangsx01@126.com; yu@cricaas.com.cn	Meng, Yan/HGC-0394-2022; meng, yan/GSE-2653-2022		National Basic Research Program of China (973 Program) [2010CB126006]; State Key Laboratory of Cotton Biology Open Fund [CB2013A01]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); State Key Laboratory of Cotton Biology Open Fund	This research was sponsored by the National Basic Research Program of China (973 Program; 2010CB126006) and supported by the State Key Laboratory of Cotton Biology Open Fund (CB2013A01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal GK, 2006, MOL CELL PROTEOMICS, V5, P2044, DOI 10.1074/mcp.M600084-MCP200; Ahlfors R, 2009, PLANT J, V58, P1, DOI 10.1111/j.1365-313X.2008.03756.x; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Asai S, 2009, MOL PLANT MICROBE IN, V22, P619, DOI 10.1094/MPMI-22-6-0619; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Beligni MV, 2000, PLANTA, V210, P215, DOI 10.1007/PL00008128; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Chou MF, 2011, CURR PROTOC BIOINFOR, V13.5, P24; Chou MF, 2011, CURR PROTOC BIOINFOR, V13.6, P8; COMPANY M, 1991, NATURE, V349, P487, DOI 10.1038/349487a0; van Bentem SDF, 2006, NUCLEIC ACIDS RES, V34, P3267, DOI 10.1093/nar/gkl429; del Giudice J, 2011, NEW PHYTOL, V191, P405, DOI 10.1111/j.1469-8137.2011.03693.x; Delbarre A, 1998, PLANT PHYSIOL, V116, P833, DOI 10.1104/pp.116.2.833; Delledonne M, 1998, NATURE, V394, P585, DOI 10.1038/29087; Durek P, 2010, NUCLEIC ACIDS RES, V38, pD828, DOI 10.1093/nar/gkp810; Elliott DJ, 2000, HUM MOL GENET, V9, P2117, DOI 10.1093/hmg/9.14.2117; Farley AR, 2011, J PROTEOME RES, V10, P1481, DOI 10.1021/pr100877m; Ferrarini A, 2008, MOL PLANT MICROBE IN, V21, P781, DOI 10.1094/MPMI-21-6-0781; Gao JJ, 2009, NUCLEIC ACIDS RES, V37, pD960, DOI 10.1093/nar/gkn733; Garcia-Mata C, 2007, NITRIC OXIDE-BIOL CH, V17, P143, DOI 10.1016/j.niox.2007.08.001; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Grimsrud PA, 2010, PLANT PHYSIOL, V152, P19, DOI 10.1104/pp.109.149625; Hass C, 2004, EMBO J, V23, P3290, DOI 10.1038/sj.emboj.7600337; He HQ, 2008, BIOCHEM BIOPH RES CO, V371, P883, DOI 10.1016/j.bbrc.2008.05.001; Hinnebusch AG, 2006, TRENDS BIOCHEM SCI, V31, P553, DOI 10.1016/j.tibs.2006.08.005; Hong JK, 2008, J EXP BOT, V59, P147, DOI 10.1093/jxb/erm244; Huang X, 2002, PLANTA, V215, P914, DOI 10.1007/s00425-002-0828-z; Kim HJ, 2006, P NATL ACAD SCI USA, V103, P814, DOI 10.1073/pnas.0505150103; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Kline KG, 2010, P NATL ACAD SCI USA, V107, P15986, DOI 10.1073/pnas.1007879107; Koizumi N, 1996, PLANT CELL PHYSIOL, V37, P862, DOI 10.1093/oxfordjournals.pcp.a029023; Kuhn JM, 2006, PLANT PHYSIOL, V140, P127, DOI 10.1104/pp.105.070318; Kunz JB, 2006, RNA, V12, P1015, DOI 10.1261/rna.12506; Lan P, 2011, PLANT PHYSIOL, V155, P821, DOI 10.1104/pp.110.169508; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Lopato S, 1996, P NATL ACAD SCI USA, V93, P3074, DOI 10.1073/pnas.93.7.3074; Lopato S, 1999, GENE DEV, V13, P987, DOI 10.1101/gad.13.8.987; Lorkovic ZJ, 2004, J BIOL CHEM, V279, P33890, DOI 10.1074/jbc.M400270200; Ma FF, 2012, J EXP BOT, V63, P4835, DOI 10.1093/jxb/ers161; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Mata CG, 2001, PLANT PHYSIOL, V126, P1196, DOI 10.1104/pp.126.3.1196; Meng YY, 2011, J PROTEOME RES, V10, P5416, DOI 10.1021/pr200671d; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Mishina TE, 2007, PLANT CELL ENVIRON, V30, P39, DOI 10.1111/j.1365-3040.2006.01604.x; Nakagami H, 2010, PLANT PHYSIOL, V153, P1161, DOI 10.1104/pp.110.157347; Niu YH, 2012, J INTEGR PLANT BIOL, V54, P516, DOI 10.1111/j.1744-7909.2012.01140.x; Ohnishi T, 2003, MOL CELL, V12, P1187, DOI 10.1016/S1097-2765(03)00443-X; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pagnussat GC, 2002, PLANT PHYSIOL, V129, P954, DOI 10.1104/pp.004036; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Palmieri MC, 2008, J EXP BOT, V59, P177, DOI 10.1093/jxb/erm345; Palusa SG, 2007, PLANT J, V49, P1091, DOI 10.1111/j.1365-313X.2006.03020.x; Parani M, 2004, PLANT BIOTECHNOL J, V2, P359, DOI 10.1111/j.1467-7652.2004.00085.x; Prado AM, 2004, DEVELOPMENT, V131, P2707, DOI 10.1242/dev.01153; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Reddy ASN, 2004, TRENDS PLANT SCI, V9, P541, DOI 10.1016/j.tplants.2004.09.007; Reiland S, 2009, PLANT PHYSIOL, V150, P889, DOI 10.1104/pp.109.138677; Romanov GA, 2008, FEBS LETT, V582, P874, DOI 10.1016/j.febslet.2008.02.016; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; Sandberg A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M112.016998; Sheen J, 1998, P NATL ACAD SCI USA, V95, P975, DOI 10.1073/pnas.95.3.975; Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32; Sun CM, 2011, P NATL ACAD SCI USA, V108, P20473, DOI 10.1073/pnas.1116821108; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tanou G, 2010, J PROTEOME RES, V9, P5994, DOI 10.1021/pr100782h; Tran HNN, 2012, MOL CELL PROTEOMICS, V11, P1140, DOI 10.1074/mcp.M112.018028; Umezawa T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003509; Unwin RD, 2010, NAT PROTOC, V5, P1574, DOI 10.1038/nprot.2010.123; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang PC, 2013, P NATL ACAD SCI USA, V110, P11205, DOI 10.1073/pnas.1308974110; Wang X, 2013, J PROTEOMICS, V78, P486, DOI 10.1016/j.jprot.2012.10.018; Whiteman SA, 2008, PLANT J, V56, P146, DOI 10.1111/j.1365-313X.2008.03578.x; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wunsche H, 2011, J EXP BOT, V62, P4605, DOI 10.1093/jxb/err171; Yang LM, 2013, J PROTEOME RES, V12, P1316, DOI 10.1021/pr300971n; Yao QM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00186; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zhang AY, 2011, PLANT CELL PHYSIOL, V52, P181, DOI 10.1093/pcp/pcq187; Zhang Y, 2013, NUCLEIC ACIDS RES, V41, P1343, DOI 10.1093/nar/gks1097; Zhao MG, 2007, PLANT PHYSIOL, V144, P206, DOI 10.1104/pp.107.096842; Zhao MG, 2009, PLANT PHYSIOL, V151, P755, DOI 10.1104/pp.109.140996; ZHENG CC, 1993, PLANT MOL BIOL, V23, P813, DOI 10.1007/BF00021536; Zhuang YL, 2003, MOL BIOL EVOL, V20, P1978, DOI 10.1093/molbev/msg203	83	28	29	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94261	10.1371/journal.pone.0094261	http://dx.doi.org/10.1371/journal.pone.0094261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714030	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900110
J	Gitsioudis, G; Hosch, W; Iwan, J; Voss, A; Atsiatorme, E; Hofmann, NP; Buss, SJ; Siebert, S; Kauczor, HU; Giannitsis, E; Katus, HA; Korosoglou, G				Gitsioudis, Gitsios; Hosch, Waldemar; Iwan, Johannes; Voss, Andreas; Atsiatorme, Edem; Hofmann, Nina P.; Buss, Sebastian J.; Siebert, Stefan; Kauczor, Hans-Ulrich; Giannitsis, Evangelos; Katus, Hugo A.; Korosoglou, Grigorios			When Do We Really Need Coronary Calcium Scoring Prior to Contrast-Enhanced Coronary Computed Tomography Angiography? Analysis by Age, Gender and Coronary Risk Factors	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; APPROPRIATE USE CRITERIA; CT ANGIOGRAPHY; DIAGNOSTIC-ACCURACY; ARTERY-DISEASE; RADIATION-EXPOSURE; IMAGE QUALITY; TUBE VOLTAGE; CALCIFICATION; PROTECTION	Aims: To investigate the value of coronary calcium scoring ( CCS) as a filter scan prior to coronary computed tomography angiography ( CCTA). Methods and Results: Between February 2008 and April 2011, 732 consecutive patients underwent clinically indicated CCTA. During this 'control phase', CCS was performed in all patients. In patients with CCS >= 800, CCTA was not performed. During a subsequent 'CCTA phase' ( May 2011-May 2012) another 200 consecutive patients underwent CCTA, and CCS was performed only in patients with increased probability for severe calcification according to age, gender and atherogenic risk factors. In patients where CCS was not performed, calcium scoring was performed in contrast-enhanced CCTA images. Significant associations were noted between CCS and age ( r = 0.30, p < 0.001) and coronary risk factors ( x(2) = 37.9; HR = 2.2; 95% CI = 1.7- 2.9, p < 0.001). Based on these associations, a <= 3% pre-test probability for CCS >= 800 was observed for males,61 yrs. and females < 79 yrs. According to these criteria, CCS was not performed in 106 of 200 ( 53%) patients during the 'CCTA phase', including 47 ( 42%) males and 59 ( 67%) females. This resulted in absolute radiation saving of similar to 1 mSv in 75% of patients younger than 60 yrs. Of 106 patients where CCS was not performed, estimated calcium scoring was indeed < 800 in 101 ( 95%) cases. Non-diagnostic image quality due to calcification was similar between the 'control phase' and the 'CCTA' group ( 0.25% versus 0.40%, p = NS). Conclusion: The value of CCS as a filter for identification of a high calcium score is limited in younger patients with intermediate risk profile. Omitting CCS in such patients can contribute to further dose reduction with cardiac CT studies.	[Gitsioudis, Gitsios; Iwan, Johannes; Atsiatorme, Edem; Hofmann, Nina P.; Buss, Sebastian J.; Giannitsis, Evangelos; Katus, Hugo A.; Korosoglou, Grigorios] Heidelberg Univ, Dept Cardiol, Heidelberg, Germany; [Hosch, Waldemar; Siebert, Stefan; Kauczor, Hans-Ulrich] Heidelberg Univ, Dept Diagnost & Intervent Radiol, Heidelberg, Germany; [Voss, Andreas] Heidelberg Univ, Inst Psychol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Gitsioudis, G (corresponding author), Heidelberg Univ, Dept Cardiol, Heidelberg, Germany.	gitsiosg@web.de	Gitsioudis, Gitsios/GSJ-4171-2022; Kauczor, Hans-Ulrich/AAU-5955-2021; Kauczor, HU/AAX-6033-2021; Voss, Andreas/F-5087-2011	Voss, Andreas/0000-0002-4499-3660				Arbab-Zadeh A, 2012, J AM COLL CARDIOL, V59, P379, DOI 10.1016/j.jacc.2011.06.079; Bauer RW, 2009, AM J ROENTGENOL, V193, P410, DOI 10.2214/AJR.08.1277; Bischoff B, EUR HEART J CARDIOVA, V13, P468; Bischoff B, 2009, JACC-CARDIOVASC IMAG, V2, P940, DOI 10.1016/j.jcmg.2009.02.015; Budoff MJ, 2010, JACC-CARDIOVASC IMAG, V3, P1229, DOI 10.1016/j.jcmg.2010.08.018; Callister TQ, 1998, NEW ENGL J MED, V339, P1972, DOI 10.1056/NEJM199812313392703; Chao SP, 2010, EUR HEART J, V31, P1916, DOI 10.1093/eurheartj/ehq072; de Graaf FR, 2010, EUR HEART J, V31, P1908, DOI 10.1093/eurheartj/ehp571; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; den Dekker MAM, 2012, EUR RADIOL, V22, P2688, DOI 10.1007/s00330-012-2551-x; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Earls JP, 2008, RADIOLOGY, V246, P742, DOI 10.1148/radiol.2463070989; Einstein AJ, 2007, JAMA-J AM MED ASSOC, V298, P317, DOI 10.1001/jama.298.3.317; Einstein AJ, 2009, JAMA-J AM MED ASSOC, V301, P545, DOI 10.1001/jama.2009.53; Gerber TC, 2009, CIRCULATION, V119, P1056, DOI 10.1161/CIRCULATIONAHA.108.191650; Gopal A, 2009, INT J CARDIOL, V132, P435, DOI 10.1016/j.ijcard.2007.08.072; Gottlieb I, 2010, J AM COLL CARDIOL, V55, P627, DOI 10.1016/j.jacc.2009.07.072; Guo SL, 2011, INT J CARDIOVAS IMAG, V27, P755, DOI 10.1007/s10554-010-9690-4; Hadamitzky M, 2011, CIRC-CARDIOVASC IMAG, V4, P16, DOI 10.1161/CIRCIMAGING.110.955351; Halliburton SS, 2011, J CARDIOVASC COMPUT, V5, P198, DOI 10.1016/j.jcct.2011.06.001; Hausleiter J, 2010, JACC-CARDIOVASC IMAG, V3, P1113, DOI 10.1016/j.jcmg.2010.08.016; Hosch W, 2013, EUR J RADIO IN PRESS; Hosch W, 2011, EUR J RADIOL; Hosch W, 2010, EUR J RADIOL; Hosch W, 2012, EUR J RADIOL, V81, P3568, DOI 10.1016/j.ejrad.2011.06.055; Hosch W, 2011, EUR J RADIOL, V80, P127, DOI 10.1016/j.ejrad.2010.07.011; Husmann L, 2008, EUR HEART J, V29, P191, DOI 10.1093/eurheartj/ehm613; Joshi PH, 2012, J NUCL CARDIOL, V19, P1226, DOI 10.1007/s12350-012-9626-6; Kim KP, 2009, ARCH INTERN MED, V169, P1188, DOI 10.1001/archinternmed.2009.162; Korosoglou G, 2010, EUR RADIOL, V20, P1841, DOI 10.1007/s00330-010-1753-3; Kuettner A, 2004, J AM COLL CARDIOL, V43, P831, DOI 10.1016/j.jacc.2003.05.015; Kwon SW, 2011, RADIOLOGY, V259, P92, DOI 10.1148/radiol.10100886; Litt HI, 2012, NEW ENGL J MED, V366, P1393, DOI 10.1056/NEJMoa1201163; Ong TK, 2006, AM HEART J, V151, DOI 10.1016/j.ahj.2005.12.027; Palumbo AA, 2009, EUR RADIOL, V19, P2127, DOI 10.1007/s00330-009-1398-2; PRYOR DB, 1993, ANN INTERN MED, V118, P81, DOI 10.7326/0003-4819-118-2-199301150-00001; Raggi P, 2005, CIRCULATION, V112, P563, DOI 10.1161/CIRCULATIONAHA.104.512681; Stevens NA, 1999, J AM COLL CARDIOL, V33, P403; Stolzmann P, 2008, AM J ROENTGENOL, V191, P1684, DOI 10.2214/AJR.07.4040; Stolzmann P, 2008, EUR RADIOL, V18, P592, DOI 10.1007/s00330-007-0786-8; Taylor AJ, 2010, J CARDIOVASC COMPUT, V4, P407, DOI 10.1016/j.jcct.2010.11.001; Taylor AJ, 2010, J AM COLL CARDIOL, V56, P1864, DOI 10.1016/j.jacc.2010.07.005; Truong Quynh, 2010, Rev Cardiovasc Med, V11, P271, DOI 10.3909/ricm0568; Ueda H, 2011, HEART VESSELS; Villines TC, 2011, J AM COLL CARDIOL, V58, P2533, DOI 10.1016/j.jacc.2011.10.851; Zimmermann E, 2011, ROFO-FORTSCHR RONTG, V183, P54, DOI 10.1055/s-0029-1245629	46	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e92396	10.1371/journal.pone.0092396	http://dx.doi.org/10.1371/journal.pone.0092396			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714677	gold, Green Published, Green Submitted			2022-12-25	WOS:000334160900006
J	Lin, Y; Liu, XR; Shan, B; Wu, J; Sharma, S; Sun, Y				Lin, Yi; Liu, Xiaorui; Shan, Bin; Wu, Ji; Sharma, Surendra; Sun, Yun			Prevention of CpG-Induced Pregnancy Disruption by Adoptive Transfer of In Vitro-Induced Regulatory T Cells	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; UTERINE NK CELLS; WILD-TYPE; TOLERANCE; EFFECTOR; MICE; ACTIVATION; CONVERSION; EXPRESSION; FAILURE	Objective: To elucidate the mechanism by which embryo-resorption and preterm birth were enhanced by pathogenic CpG motif and to develop a counter strategy for normal pregnancy outcome. Methods: This is an animal model-based study. In pregnant nonobese diabetic (NOD) mice and wild-type (WT) mice in the same strain background, an infection was mimicked by toll-like receptor 9 (TLR9) activation through CpG1826-injection. In vivo inactivation of IL-10 was performed to enhance pregnancy loss. Regulatory T cells induced by FTY720 in vitro from splenic CD4(+)CD25(-)Foxp3(-) cells (iTreg cells) were transferred to improve pregnancy outcomes in NOD mice. Results: Embryo-resorption and preterm birth were readily induced by CpG1826 in NOD mice, but not in WT mice. However, inactivation of IL-10 using neutralizing antibody injections enhanced pregnancy loss in WT mice exposed to CpG, while adoptive transfer of iTreg cells increased decidual Foxp3(+) Treg cells and IL-10(+) cell number and rescued pregnancy. Conclusions: NOD mice are prone to abortion and preterm birth. This can be attributed to lacking Treg cells and insufficient IL-10 expression. Adoptive transfer of iTreg cells can rescue CpG-mediated pregnancy failure.	[Lin, Yi; Liu, Xiaorui] Shanghai Jiao Tong Univ, Int Peace Matern & Child Hlth Hosp, Sch Med, Shanghai 200030, Peoples R China; [Shan, Bin] Washington State Univ, Spokane, WA USA; [Wu, Ji] Shanghai Jiao Tong Univ, BioX Inst, Key Lab Genet Dev & Neuropsychiat Disorders, Minist Educ, Shanghai 200030, Peoples R China; [Sharma, Surendra] Brown Univ, Women & Infants Hosp Rhode Isl, Warren Alpert Med Sch, Dept Pediat, Providence, RI 02912 USA; [Sun, Yun] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Reprod Med, Shanghai 200030, Peoples R China; [Sun, Yun] Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai, Peoples R China	Shanghai Jiao Tong University; Washington State University; Shanghai Jiao Tong University; Brown University; Women & Infants Hospital Rhode Island; Shanghai Jiao Tong University	Sun, Y (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Dept Reprod Med, Shanghai 200030, Peoples R China.	syun163@163.com		Shan, Bin/0000-0002-6869-2678	National Basic Research Program of China [2014CB943300, 2013CB967404]; National Natural Science Foundation of China [81370762, 81125004, 31171439]; Key Program for Basic Research of the Science and Technology Commission of Shanghai Municipality, China [12JC1405800]; Shanghai Jiao Tong University Medicine-Engineering Fund [YG2013ZD04, YG2013MS68]; Superfund Program Research National Institute of Environmental Health Sciences, USA (SPR NIEHS) [P42ES013660]; Fund for Outstanding Academic Leaders in Shanghai, China [12XD1406600, 2013-049]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Program for Basic Research of the Science and Technology Commission of Shanghai Municipality, China; Shanghai Jiao Tong University Medicine-Engineering Fund; Superfund Program Research National Institute of Environmental Health Sciences, USA (SPR NIEHS); Fund for Outstanding Academic Leaders in Shanghai, China	This work was supported by the National Basic Research Program of China (2014CB943300 and 2013CB967404), the National Natural Science Foundation of China (81370762, 81125004 and 31171439), the Key Program for Basic Research of the Science and Technology Commission of Shanghai Municipality, China (12JC1405800), Shanghai Jiao Tong University Medicine-Engineering Fund (YG2013ZD04 and YG2013MS68), the Superfund Program Research National Institute of Environmental Health Sciences, USA (SPR NIEHS grant P42ES013660), and the Fund for Outstanding Academic Leaders in Shanghai, China (12XD1406600 and 2013-049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Arck PC, 1999, CELL IMMUNOL, V196, P71, DOI 10.1006/cimm.1999.1535; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brinkmann V, 2007, PHARMACOL THERAPEUT, V115, P84, DOI 10.1016/j.pharmthera.2007.04.006; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Fischer K, 2002, J IMMUNOL METHODS, V259, P159, DOI 10.1016/S0022-1759(01)00507-5; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Havla J, 2013, J NEUROL, V260, P1382, DOI 10.1007/s00415-012-6808-8; Higuma-Myojo S, 2005, AM J REPROD IMMUNOL, V54, P21, DOI 10.1111/j.1600-0897.2005.00279.x; Kalkunte SS, 2009, J IMMUNOL, V182, P4085, DOI 10.4049/jimmunol.0803769; KATAOKA S, 1983, DIABETES, V32, P247, DOI 10.2337/diabetes.32.3.247; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Lee SH, 2009, J EXP MED, V206, P2235, DOI 10.1084/jem.20082387; Li C, 2009, J CELL BIOCHEM, V108, P447, DOI 10.1002/jcb.22271; Li LP, 2012, J IMMUNOL, V188, P4681, DOI 10.4049/jimmunol.1102628; Lin Y, 2005, J REPROD IMMUNOL, V68, P39, DOI 10.1016/j.jri.2005.05.002; Lin Y, 2008, CLIN IMMUNOL, V126, P104, DOI 10.1016/j.clim.2007.09.006; Lin Y, 2006, J IMMUNOL, V176, P4147, DOI 10.4049/jimmunol.176.7.4147; Lin Y, 2011, AM J PATHOL, V178, P506, DOI 10.1016/j.ajpath.2010.10.005; Lin Y, 2009, J REPROD IMMUNOL, V82, P12, DOI 10.1016/j.jri.2009.03.004; Lin Y, 2009, FERTIL STERIL, V91, P2687, DOI 10.1016/j.fertnstert.2008.01.109; Lin Y, 2009, FERTIL STERIL, V91, P2676, DOI 10.1016/j.fertnstert.2007.08.087; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Murphy SP, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.043; Murphy SP, 2005, J IMMUNOL, V175, P4084, DOI 10.4049/jimmunol.175.6.4084; O'Garra A, 2004, NAT MED, V10, P801, DOI 10.1038/nm0804-801; Parsons CH, 2006, J CLIN INVEST, V116, P1963, DOI 10.1172/JCI27249; Pedersen G, 2005, CLIN EXP IMMUNOL, V141, P298, DOI 10.1111/j.1365-2249.2005.02848.x; Robertson SA, 2006, J IMMUNOL, V177, P4888, DOI 10.4049/jimmunol.177.7.4888; Rocha-Campos AC, 2006, DIABETES, V55, P1163, DOI 10.2337/diabetes.55.04.06.db05-0908; Saito S, 2007, SEMIN IMMUNOPATHOL, V29, P115, DOI 10.1007/s00281-007-0067-2; Sehrawat S, 2008, J IMMUNOL, V180, P7636, DOI 10.4049/jimmunol.180.11.7636; Serpero LD, 2013, J NEUROIMMUNE PHARM, V8, P1106, DOI 10.1007/s11481-013-9465-5; Shigeru S, 2008, J REPROD IMMUNOL, V77, P14, DOI 10.1016/j.jri.2007.04.007; Sun Y, 2013, FERTIL STERIL, V99, P1759, DOI 10.1016/j.fertnstert.2013.01.121; Sun Y, 2011, AM J REPROD IMMUNOL, V66, P349, DOI 10.1111/j.1600-0897.2011.01010.x; Thaxton JE, 2009, J IMMUNOL, V183, P1144, DOI 10.4049/jimmunol.0900788; Trinchieri G, 2007, J EXP MED, V204, P239, DOI 10.1084/jem.20070104; Wang WJ, 2009, REPROD BIOMED ONLINE, V18, P95, DOI 10.1016/S1472-6483(10)60430-0; Yin GJ, 2011, J CELL BIOCHEM, V112, P773, DOI 10.1002/jcb.22893; Zhang Z, 2007, MINI-REV MED CHEM, V7, P845	44	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94702	10.1371/journal.pone.0094702	http://dx.doi.org/10.1371/journal.pone.0094702			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714634	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900142
J	Minamino, R; Tateno, M				Minamino, Ryoko; Tateno, Masaki			Tree Branching: Leonardo da Vinci's Rule versus Biomechanical Models	PLOS ONE			English	Article							CONSTANT-STRESS; HEIGHT GROWTH; SIZE; HYPOTHESIS; DIAMETER; SAFETY; SHOOT	This study examined Leonardo da Vinci's rule (i.e., the sum of the cross-sectional area of all tree branches above a branching point at any height is equal to the cross-sectional area of the trunk or the branch immediately below the branching point) using simulations based on two biomechanical models: the uniform stress and elastic similarity models. Model calculations of the daughter/mother ratio (i.e., the ratio of the total cross-sectional area of the daughter branches to the cross-sectional area of the mother branch at the branching point) showed that both biomechanical models agreed with da Vinci's rule when the branching angles of daughter branches and the weights of lateral daughter branches were small; however, the models deviated from da Vinci's rule as the weights and/or the branching angles of lateral daughter branches increased. The calculated values of the two models were largely similar but differed in some ways. Field measurements of Fagus crenata and Abies homolepis also fit this trend, wherein models deviated from da Vinci's rule with increasing relative weights of lateral daughter branches. However, this deviation was small for a branching pattern in nature, where empirical measurements were taken under realistic measurement conditions; thus, da Vinci's rule did not critically contradict the biomechanical models in the case of real branching patterns, though the model calculations described the contradiction between da Vinci's rule and the biomechanical models. The field data for Fagus crenata fit the uniform stress model best, indicating that stress uniformity is the key constraint of branch morphology in Fagus crenata rather than elastic similarity or da Vinci's rule. On the other hand, mechanical constraints are not necessarily significant in the morphology of Abies homolepis branches, depending on the number of daughter branches. Rather, these branches were often in agreement with da Vinci's rule.	[Minamino, Ryoko; Tateno, Masaki] Univ Tokyo, Grad Sch Sci, Nikko Bot Garden, Nikko, Tochigi, Japan	University of Tokyo	Minamino, R (corresponding author), Univ Tokyo, Grad Sch Sci, Nikko Bot Garden, Nikko, Tochigi, Japan.	ryokominamino@gmail.com			Japan Science Society [22-523]; Yamaguchi Educational and Scholarship Foundation	Japan Science Society; Yamaguchi Educational and Scholarship Foundation	Financial support for this study was provided by the Sasakawa Scientific Research Grant from The Japan Science Society [grant number 22-523] (http://www.jss.or.jp/ikusei/sasakawa/) and Yamaguchi Educational and Scholarship Foundation (http://yamaguchi-esf.or.jp/). No individuals employed or contracted by the funders (other than the named authors) played any role in this study.	Bertram JEA, 1989, TREES-STRUCT FUNCT, V3, P241, DOI 10.1007/BF00225358; da Vinci Leonardo, 1970, COURIER CORPORATION, P2; Dahle GA, 2010, TREES-STRUCT FUNCT, V24, P321, DOI 10.1007/s00468-009-0401-5; DEAN TJ, 1986, ANN BOT-LONDON, V58, P833, DOI 10.1093/oxfordjournals.aob.a087265; Dean TJ, 2002, TREES-STRUCT FUNCT, V16, P559, DOI 10.1007/s00468-002-0208-0; Evans LS, 2008, TREES-STRUCT FUNCT, V22, P283, DOI 10.1007/s00468-007-0182-7; Horn HS, 2000, SFI S SCI C, P199; KING D, 1981, OECOLOGIA, V51, P351, DOI 10.1007/BF00540905; KING D, 1978, RADIAT ENVIRON BIOPH, V15, P141, DOI 10.1007/BF01323263; KOZAK A, 1993, FOREST CHRON, V69, P438, DOI 10.5558/tfc69438-4; MATTHECK C, 1993, J THEOR BIOL, V165, P185, DOI 10.1006/jtbi.1993.1184; MCMAHON T, 1973, SCIENCE, V179, P1201, DOI 10.1126/science.179.4079.1201; MCMAHON TA, 1976, J THEOR BIOL, V59, P443, DOI 10.1016/0022-5193(76)90182-X; Meng SX, 2006, J EXP BOT, V57, P3175, DOI 10.1093/jxb/erl079; Nikinmaa Eero, 1992, Acta Forestalia Fennica, V235, P1; Niklas KJ, 2000, TREES-STRUCT FUNCT, V14, P230, DOI 10.1007/s004680050008; NIKLAS KJ, 1995, ANN BOT-LONDON, V75, P217, DOI 10.1006/anbo.1995.1015; Niklas KJ, 2000, J EXP BOT, V51, P797, DOI 10.1093/jexbot/51.345.797; Ryan MG, 1997, BIOSCIENCE, V47, P235, DOI 10.2307/1313077; Sone K, 2005, TREE PHYSIOL, V25, P39, DOI 10.1093/treephys/25.1.39; Sone K, 2009, J PLANT RES, V122, P41, DOI 10.1007/s10265-008-0177-5; Taneda H, 2004, AM J BOT, V91, P1949, DOI 10.3732/ajb.91.12.1949; Timoshenko S., 1955, STRENGTH MAT 1, V3; Watt MS, 2011, ECOL MODEL, V222, P3910, DOI 10.1016/j.ecolmodel.2011.10.011; West GB, 2005, J EXP BIOL, V208, P1575, DOI 10.1242/jeb.01589; WILSON BF, 1977, ANNU REV PLANT PHYS, V28, P23, DOI 10.1146/annurev.pp.28.060177.000323	26	24	25	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93535	10.1371/journal.pone.0093535	http://dx.doi.org/10.1371/journal.pone.0093535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714065	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900031
J	Tucholski, J; Pinner, AL; Simmons, MS; Meador-Woodruff, JH				Tucholski, Janusz; Pinner, Anita L.; Simmons, Micah S.; Meador-Woodruff, James H.			Evolutionarily Conserved Pattern of AMPA Receptor Subunit Glycosylation in Mammalian Frontal Cortex	PLOS ONE			English	Article							N-GLYCOSYLATION; PREFRONTAL CORTEX; ELDERLY-PATIENTS; LIGAND-BINDING; TOPOGRAPHY; REVEALS; GLYCANS; SITES	Protein glycosylation may contribute to the evolution of mammalian brain complexity by adapting excitatory neurotransmission in response to environmental and social cues. Balanced excitatory synaptic transmission is primarily mediated by glutamatergic neurotransmission. Previous studies have found that subunits of the AMPA subtype of glutamate receptor are N-glycosylated, which may play a critical role in AMPA receptor trafficking and function at the cell membrane. Studies have predominantly used rodent models to address altered glycosylation in human pathological conditions. Given the rate of mammalian brain evolution and the predicted rate of change in the brain-specific glycoproteome, we asked if there are species-specific changes in glycoprotein expression, focusing on the AMPA receptor. N-glycosylation of AMPA receptor subunits was investigated in rat (Rattus norvegicus), tree shrew (Tupaia glis belangeri), macaque (Macaca nemestrina), and human frontal cortex tissue using a combination of enzymatic deglycosylation and Western blot analysis, as well as lectin binding assays. We found that two AMPA receptor subunits, GluA2 and GluA4, are sensitive to deglycosylation with Endo H and PNGase F. When we enriched for glycosylated proteins using lectin binding assays, we found that all four AMPA receptor subunits are glycosylated, and were predominantly recognized by lectins that bind to glucose or mannose, N-acetylglucosamine (GlcNAc), or 1-6 alpha fucose. We found differences in glycosylation between different subunits, as well as modest differences in glycosylation of homologous subunits between different species.	[Tucholski, Janusz; Pinner, Anita L.; Simmons, Micah S.; Meador-Woodruff, James H.] Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Tucholski, J (corresponding author), Univ Alabama Birmingham, Dept Psychiat & Behav Neurobiol, Birmingham, AL 35294 USA.	jtuchol@uab.edu			NIH [MH53327]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH053327] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	NIH grant - MH53327 (JMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEIJON C, 1992, TRENDS BIOCHEM SCI, V17, P32, DOI 10.1016/0968-0004(92)90424-8; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Bauer D, 2008, SCHIZOPHR RES, V104, P108, DOI 10.1016/j.schres.2008.06.012; Bauer D, 2010, SCHIZOPHR RES, V117, P92, DOI 10.1016/j.schres.2009.07.025; Clark RAC, 1998, J NEUROCHEM, V70, P2594; Dingledine R, 1999, PHARMACOL REV, V51, P7; Drummond JB, 2013, SCHIZOPHR RES, V147, P32, DOI 10.1016/j.schres.2013.03.010; Everts I, 1997, MOL PHARMACOL, V52, P861, DOI 10.1124/mol.52.5.861; Freeze HH, 2001, CURR PROTOC MOL BIOL; Freeze HH, 2012, LANCET NEUROL, V11, P453, DOI 10.1016/S1474-4422(12)70040-6; Gabius HJ, 2004, CHEMBIOCHEM, V5, P740, DOI 10.1002/cbic.200300753; Gagneux P, 1999, GLYCOBIOLOGY, V9, P747, DOI 10.1093/glycob/9.8.747; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; HIRSCHBERG CB, 1987, ANNU REV BIOCHEM, V56, P63, DOI 10.1146/annurev.bi.56.070187.000431; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Iskratsch T, 2009, ANAL BIOCHEM, V386, P133, DOI 10.1016/j.ab.2008.12.005; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Morita I, 2009, NEUROSCIENCE, V164, P1685, DOI 10.1016/j.neuroscience.2009.09.065; Morita I, 2009, J BIOL CHEM, V284, P30209, DOI 10.1074/jbc.M109.024208; Mueller TM, 2014, NEUROPSYCHOPHARMACOL, V39, P528, DOI 10.1038/npp.2013.190; Pasternack A, 2003, J NEUROCHEM, V84, P1184, DOI 10.1046/j.1471-4159.2003.01611.x; Standley S, 1998, J NEUROCHEM, V70, P2434; Standley S, 2000, CELL MOL LIFE SCI, V57, P1508, DOI 10.1007/PL00000635; TRETTER V, 1991, EUR J BIOCHEM, V199, P647, DOI 10.1111/j.1432-1033.1991.tb16166.x; Tucholski J, 2013, SCHIZOPHR RES, V146, P177, DOI 10.1016/j.schres.2013.01.031; Zielinska DF, 2012, MOL CELL, V46, P542, DOI 10.1016/j.molcel.2012.04.031; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	30	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94255	10.1371/journal.pone.0094255	http://dx.doi.org/10.1371/journal.pone.0094255			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713873	Green Submitted, Green Published			2022-12-25	WOS:000334160900109
J	Wallner, S; Grandl, M; Konovalova, T; Sigruner, A; Kopf, T; Peer, M; Orso, E; Liebisch, G; Schmitz, G				Wallner, Stefan; Grandl, Margot; Konovalova, Tatiana; Sigruener, Alexander; Kopf, Thomas; Peer, Markus; Orso, Evelyn; Liebisch, Gerhard; Schmitz, Gerd			Monocyte to Macrophage Differentiation Goes along with Modulation of the Plasmalogen Pattern through Transcriptional Regulation	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; PARTIAL LEAST-SQUARES; OXIDATIVE STRESS; MICROARRAY DATA; FACTOR EGR-1; CHOLESTEROL; PROTEIN; HSP70; INFLAMMATION; LIPOPROTEIN	Background: Dysregulation of monocyte-macrophage differentiation is a hallmark of vascular and metabolic diseases and associated with persistent low grade inflammation. Plasmalogens represent ether lipids that play a role in diabesity and previous data show diminished plasmalogen levels in obese subjects. We therefore analyzed transcriptomic and lipidomic changes during monocyte-macrophage differentiation in vitro using a bioinformatic approach. Methods: Elutriated monocytes from 13 healthy donors were differentiated in vitro to macrophages using rhM-CSF under serum-free conditions. Samples were taken on days 0, 1, 4 and 5 and analyzed for their lipidomic and transcriptomic profiles. Results: Gene expression analysis showed strong regulation of lipidome-related transcripts. Enzymes involved in fatty acid desaturation and elongation were increasingly expressed, peroxisomal and ER stress related genes were induced. Total plasmalogen levels remained unchanged, while the PE plasmalogen species pattern became more similar to circulating granulocytes, showing decreases in PUFA and increases in MUFA. A partial least squares discriminant analysis (PLS/DA) revealed that PE plasmalogens discriminate the stage of monocyte-derived macrophage differentiation. Partial correlation analysis could predict novel potential key nodes including DOCK1, PDK4, GNPTAB and FAM126A that might be involved in regulating lipid and especially plasmalogen homeostasis during differentiation. An in silico transcription analysis of lipid related regulation revealed known motifs such as PPAR-gamma and KLF4 as well as novel candidates such as NFY, RNF96 and Zinc-finger proteins. Conclusion: Monocyte to macrophage differentiation goes along with profound changes in the lipid-related transcriptome. This leads to an induction of fatty-acid desaturation and elongation. In their PE-plasmalogen profile macrophages become more similar to granulocytes than monocytes, indicating terminal phagocytic differentiation. Therefore PE plasmalogens may represent potential biomarkers for cell activation. For the underlying transcriptional network we were able to predict a range of novel central key nodes and underlying transcription factors using a bioinformatic approach.	[Wallner, Stefan; Grandl, Margot; Konovalova, Tatiana; Sigruener, Alexander; Kopf, Thomas; Peer, Markus; Orso, Evelyn; Liebisch, Gerhard; Schmitz, Gerd] Univ Regensburg, Univ Hosp Regensburg, Inst Clin Chem & Lab Med, D-93053 Regensburg, Germany	University of Regensburg	Schmitz, G (corresponding author), Univ Regensburg, Univ Hosp Regensburg, Inst Clin Chem & Lab Med, D-93053 Regensburg, Germany.	gerd.schmitz@ukr.de	Liebisch, Gerhard/G-6130-2010	Liebisch, Gerhard/0000-0003-4886-0811	European Community [202272]; Deutsche Forschungsgemeinschaft [SFB-TR 13/A3]; Federal Ministry of Education and Research [FKZ01KU1216J]; European Lipidomics Initiative by EC [013032]	European Community(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); European Lipidomics Initiative by EC	The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 202272, IP-Project LipidomicNet. The project was also supported by the Deutsche Forschungsgemeinschaft (SFB-TR 13/A3), related to "The European Lipidomics Initiative; shaping the life sciences" a specific support action subsidized by the EC 2006-2007 (proposal number 013032). The results upon which this publication is based were partly funded by the Federal Ministry of Education and Research under the Project Number FKZ01KU1216J. The responsibility for the content of this publication lies with the author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaev VR, 1999, J CLIN INVEST, V103, P1697, DOI 10.1172/JCI6117; Bakhle YS, 1999, DRUGS TODAY, V35, P237, DOI 10.1358/dot.1999.35.4-5.552200; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Berbee JFP, 2006, FASEB J, V20, P2162, DOI 10.1096/fj.05-5639fje; Berry KAZ, 2004, J AM SOC MASS SPECTR, V15, P1499, DOI 10.1016/j.jasms.2004.07.009; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BUDDECKE E, 1959, H-S Z PHYSIOL CHEM, V314, P38, DOI 10.1515/bchm2.1959.314.1.38; Calder PC, 2012, J NUTR, V142, p592S, DOI 10.3945/jn.111.155259; Castelo R, 2006, J MACH LEARN RES, V7, P2621; Castelo R, 2012, METHODS MOL BIOL, V802, P215, DOI 10.1007/978-1-61779-400-1_14; Castelo R, 2009, J COMPUT BIOL, V16, P213, DOI 10.1089/cmb.2008.08TT; Colas R, 2011, DIABETOLOGIA, V54, P2931, DOI 10.1007/s00125-011-2272-8; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Doherty GJ, 2011, MOL BIOL CELL, V22, P4380, DOI 10.1091/mbc.E10-12-0936; Ecker J, 2010, P NATL ACAD SCI USA, V107, P7817, DOI 10.1073/pnas.0912059107; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Farooqui AA, 1999, METH MOL B, V109, P39; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Gautier EL, 2009, CIRCULATION, V119, P1795, DOI 10.1161/CIRCULATIONAHA.108.806158; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Gelissen IC, 1998, BIOCHEM J, V331, P231, DOI 10.1042/bj3310231; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOTTA Y, 1995, ADV BIOPHYS, V31, P101, DOI 10.1016/0065-227X(95)99386-4; Hulsmans M, 2010, J CELL MOL MED, V14, P70, DOI 10.1111/j.1582-4934.2009.00978.x; Ikeda M, 2008, FEBS LETT, V582, P2435, DOI 10.1016/j.febslet.2008.06.007; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; Klucken J, 2000, P NATL ACAD SCI USA, V97, P817, DOI 10.1073/pnas.97.2.817; Kondrakhin Yury V, 2008, In Silico Biol, V8, P383; KRISHNARAJU K, 1995, MOL CELL BIOL, V15, P5499; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Leidl K, 2008, BBA-MOL CELL BIOL L, V1781, P655, DOI 10.1016/j.bbalip.2008.07.008; Leonard AE, 2000, BIOCHEM J, V350, P765, DOI 10.1042/0264-6021:3500765; Lessig J, 2009, CURR MED CHEM, V16, P2021; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Liebisch G, 2013, J LIPID RES, V54, P1523, DOI 10.1194/jlr.M033506; Maeba R, 2007, J ATHEROSCLER THROMB, V14, P12, DOI 10.5551/jat.14.12; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Marquardt A, 2000, GENOMICS, V66, P175, DOI 10.1006/geno.2000.6196; Matsuzaka T, 2002, J LIPID RES, V43, P911; McAndrew RP, 2008, J BIOL CHEM, V283, P9435, DOI 10.1074/jbc.M709135200; Meimaridou E, 2009, J MOL ENDOCRINOL, V42, P1, DOI 10.1677/JME-08-0116; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Morano KA, 2007, ANN NY ACAD SCI, V1113, P1, DOI 10.1196/annals.1391.018; MULLER G, 1993, ARTERIOSCLER THROMB, V13, P1317, DOI 10.1161/01.ATV.13.9.1317; NGUYEN HQ, 1993, CELL, V72, P197, DOI 10.1016/0092-8674(93)90660-I; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; Parini P, 2004, CIRCULATION, V110, P2017, DOI 10.1161/01.CIR.0000143163.76212.0B; Piao L, 2011, GENE CHROMOSOME CANC, V50, P13, DOI 10.1002/gcc.20828; R Core Team, 2021, R LANG ENV STAT COMP; Reed BD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000133; Schroder O, 2003, CRIT CARE MED, V31, P73, DOI 10.1097/01.CCM.0000037972.16578.2B; Seo HS, 1997, ARTERIOSCL THROM VAS, V17, P3593, DOI 10.1161/01.ATV.17.12.3593; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stenvinkel P, 2004, NEPHROL DIAL TRANSPL, V19, P972, DOI 10.1093/ndt/gfh035; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; Tang CR, 2009, BBA-MOL CELL BIOL L, V1791, P563, DOI 10.1016/j.bbalip.2009.03.011; Tavaria M, 1996, CELL STRESS CHAPERON, V1, P23, DOI 10.1379/1466-1268(1996)001<0023:AHSGTT>2.3.CO;2; Tobert JA, 2003, NAT REV DRUG DISCOV, V2, P517, DOI 10.1038/nrd1112; Tsutsumi K., 2003, Current Vascular Pharmacology, V1, P11, DOI 10.2174/1570161033386673; VAN DS, 2012, BMC GENOMICS, V13, P535; Wallner S, 2011, CHEM PHYS LIPIDS, V164, P573, DOI 10.1016/j.chemphyslip.2011.06.008; Wang Y, 2008, J LIPID RES, V49, P1538, DOI 10.1194/jlr.M800123-JLR200; WATERBEEMD HVD, 1995, CHEMOMETRIC METHODS, P2; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Westerterp Marit, 2007, Atherosclerosis, V195, pe9, DOI 10.1016/j.atherosclerosis.2007.01.015; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972; Yvan-Charvet L, 2007, J CLIN INVEST, V117, P3900, DOI 10.1172/JCI33372; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	83	36	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94102	10.1371/journal.pone.0094102	http://dx.doi.org/10.1371/journal.pone.0094102			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714687	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900083
J	Hung, SK; Lee, MS; Chiou, WY; Lee, CC; Chen, YC; Lai, CL; Chien, NC; Hsu, WL; Liu, DW; Su, YC; Li, SC; Lai, HC; Tsai, SJ; Hsu, FC; Lin, HY				Hung, Shih-Kai; Lee, Moon-Sing; Chiou, Wen-Yen; Lee, Ching-Chih; Chen, Yi-Chun; Lai, Chun-Liang; Chien, Nai-Chuan; Hsu, Wen-Lin; Liu, Dai-Wei; Su, Yu-Chieh; Li, Szu-Chi; Lai, Hung-Chih; Tsai, Shiang-Jiun; Hsu, Feng-Chun; Lin, Hon-Yi			High Incidence of Ischemic Stroke Occurrence in Irradiated Lung Cancer Patients: A Population-Based Surgical Cohort Study	PLOS ONE			English	Article							INCREASED RISK; CARDIOVASCULAR-DISEASE; DIABETES-MELLITUS; VASCULAR DAMAGE; FOLLOW-UP; RADIOTHERAPY; PREVALENCE; CARCINOMA; SURVIVORS; MORTALITY	Background and Purpose: A high risk of stroke occurrence has been reported in several types of irradiated cancer patients. However, clinical data are lacking in irradiated lung cancer patients. The present study intended to explore a risk level of ischemic stroke occurrence in irradiated lung cancer patients. Methods: A nationwide population-based database obtained from the Taiwan National Health Insurance was analyzed. Between 2003 and 2006, we recruited 560 resected lung cancer patients into two study groups: surgery-plus-irradiation (n = 112) and surgery-alone (n = 448). Patients treated with chemotherapy were excluded. Propensity score match was used for pairing cases with a ratio of 1:4. Two-year ischemic-stroke-free survival was defined as the primary endpoint. Results: Three observations supported a high risk of ischemic stroke occurrence in patients with postoperative irradiation when compared with those patients with surgery alone: first, a high incidence per 1,000 person-year (22.3 versus 11.2, 1.99 folds); second, a low two-year ischemic-stroke-free survival rate (92.2% versus 98.1%, P = 0.019); and third, a high adjusted hazard ratio (HR, 4.19; 95% CI, 1.44-12.22; P = 0.009). More notably, the highest risk of ischemic stroke occurrence was found in irradiated patients who had diabetes mellitus (HR, 34.74; 95% CI,6.35-> 100; P < 0.0001). Conclusions: A high incidence of ischemic stroke was observed in irradiated lung cancer patients, especially in those with diabetes mellitus. For these patients, close clinical surveillance and strict diabetes control should be considered. Further studies to define detail biological mechanisms are encouraged.	[Hung, Shih-Kai; Lee, Moon-Sing; Chiou, Wen-Yen; Tsai, Shiang-Jiun; Hsu, Feng-Chun; Lin, Hon-Yi] Buddhist Dalin Tzu Chi Hosp, Radiat Dept, Dept Oncol, Dalin, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Hosp, Dept Otolaryngol, Dalin, Taiwan; [Chen, Yi-Chun] Buddhist Dalin Tzu Chi Hosp, Div Nephrol, Dalin, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Hosp, Div Chest Med, Dalin, Taiwan; [Chien, Nai-Chuan] Buddhist Dalin Tzu Chi Hosp, Div Thorac Surg, Dalin, Taiwan; [Su, Yu-Chieh; Li, Szu-Chi; Lai, Hung-Chih] Buddhist Dalin Tzu Chi Hosp, Div Hematol Oncol, Dalin, Taiwan; [Hsu, Wen-Lin; Liu, Dai-Wei] Buddhist Dalin Tzu Chi Hosp, Dept Radiat Oncol, Hualien, Taiwan; [Hung, Shih-Kai; Lee, Moon-Sing; Chiou, Wen-Yen; Lee, Ching-Chih; Chen, Yi-Chun; Lai, Chun-Liang; Chien, Nai-Chuan; Hsu, Wen-Lin; Liu, Dai-Wei; Su, Yu-Chieh; Li, Szu-Chi; Lai, Hung-Chih; Lin, Hon-Yi] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lin, Hon-Yi] Natl Chung Cheng Univ, Inst Mol Biol, Chiayi, Taiwan	Buddhist Tzu Chi General Hospital; Buddhist Tzu Chi General Hospital; Buddhist Tzu Chi General Hospital; Buddhist Tzu Chi General Hospital; Buddhist Tzu Chi General Hospital; Buddhist Tzu Chi General Hospital; Buddhist Tzu Chi General Hospital; Tzu Chi University; National Chung Cheng University	Lin, HY (corresponding author), Buddhist Dalin Tzu Chi Hosp, Radiat Dept, Dept Oncol, Dalin, Taiwan.	doc16021@gmail.com	Chen, Yi-Chun/GYJ-2065-2022	Hung, Shih-Kai/0000-0002-4945-528X; Su, Yu-Chieh/0000-0002-1771-9017; Chiou, Wen-Yen/0000-0002-5541-6834	Buddhist Dalin Tzu Chi Hospital [DTCRD-99-I-12, DTCRD-100(2)-I-14]	Buddhist Dalin Tzu Chi Hospital	This study is supported by research grants of Buddhist Dalin Tzu Chi Hospital: DTCRD-99-I-12 and DTCRD-100(2)-I-14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agur AMR, 2009, GRANTS ATLAS ANATOMY, Vxvi; Chen PC, 2011, STROKE, V42, P3034, DOI 10.1161/STROKEAHA.111.615534; Chien KL, 2010, STROKE, V41, P1858, DOI 10.1161/STROKEAHA.110.586222; Cui RZ, 2011, STROKE, V42, P2611, DOI 10.1161/STROKEAHA.111.614313; De Bruin ML, 2009, JNCI-J NATL CANCER I, V101, P928, DOI 10.1093/jnci/djp147; Dorresteijn LD, 2006, J CLIN ONCOL, V24, P1480, DOI 10.1200/JCO.2005.04.8538; Dorresteijn LDA, 2005, EUR J CANCER, V41, P1026, DOI 10.1016/j.ejca.2005.01.020; Engstrom G, 2001, STROKE, V32, P1098, DOI 10.1161/01.STR.32.5.1098; Fatehi-Hassanabad Z, 2010, EUR J PHARMACOL, V636, P8, DOI 10.1016/j.ejphar.2010.03.048; Granone P, 2000, EUR J CARDIO-THORAC, V18, P418, DOI 10.1016/S1010-7940(00)00539-X; Greene FL, 2006, AJCC CANC STAGING AT, Vix; Hall EJ., 2012, RADIOBIOLOGY RADIOLO; Halle M, 2011, J INTERN MED, V269, P469, DOI 10.1111/j.1365-2796.2011.02353.x; Huang YS, 2011, ORAL ONCOL, V47, P1092, DOI 10.1016/j.oraloncology.2011.07.024; Institutes TNHR, 2014, TAIW CANC CTR ACCR; Katz MH, 2010, EVALUATING CLIN PUBL; Lee CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050163; Lee CC, 2011, INT J RADIAT ONCOL, V81, pE833, DOI 10.1016/j.ijrobp.2010.11.036; Lee EJ, 2013, INT J STROKE; Levitt SH, 2003, INT J RADIAT ONCOL, V55, P645, DOI 10.1016/S0360-3016(02)04076-2; Lin HC, 2007, J URBAN HEALTH, V84, P604, DOI 10.1007/s11524-007-9195-1; Lin HW, 2011, LANCET ONCOL, V12, P900, DOI 10.1016/S1470-2045(11)70165-6; Maruyama K, 2005, NEW ENGL J MED, V352, P146, DOI 10.1056/NEJMoa040907; Moore KL, 2011, ESSENTIAL CLIN ANATO, Vxxviii; Moser EC, 2006, BLOOD, V107, P2912, DOI 10.1182/blood-2005-08-3392; Mueller S, 2013, INT J RADIAT ONCOL, V86, P649, DOI 10.1016/j.ijrobp.2013.03.034; Mueller S, 2013, INT J RADIAT ONCOL, V86, P643, DOI 10.1016/j.ijrobp.2013.03.004; Muhammad S, 2009, J ALZHEIMERS DIS, V16, P775, DOI 10.3233/JAD-2009-0982; National Comprehensive Cancer Network (NCCN), 2013, CLIN PRACT GUID ONC; Numico G, 2005, CANCER, V103, P994, DOI 10.1002/cncr.20893; Owonikoko TK, 2013, ONCOLOGIST; Phillips TL, 2010, LEIBEL PHILLIPS TXB; Rami-Porta R, 2009, ANN THORAC CARDIOVAS, V15, P4; Roger Veronique L, 2011, Circulation, V123, pe18, DOI 10.1161/CIR.0b013e3182009701; Romzova M, 2006, HUM IMMUNOL, V67, P706, DOI 10.1016/j.humimm.2006.05.006; Rosenbaum PR, 2010, SPRINGER SER STAT, P1, DOI 10.1007/978-1-4419-1213-8; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Schwartz F, 2009, J RURAL HEALTH, V25, P226, DOI 10.1111/j.1748-0361.2009.00222.x; Stang P, 2000, CHEST, V117, p354S, DOI 10.1378/chest.117.5_suppl_2.354S; Stewart FA, 2010, RADIAT RES, V174, P865, DOI 10.1667/RR1862.1; Steyerberg EW, 2019, CLIN PREDICTION MODE, V2nd, DOI 10.1007/978-0-387-77244-8; Stokes EL, 2011, INT J RADIAT ONCOL, V80, P403, DOI 10.1016/j.ijrobp.2010.02.041; Trodella L, 2002, RADIOTHER ONCOL, V62, P11, DOI 10.1016/S0167-8140(01)00478-9; Tsai SJ, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-41; Tsan YT, 2013, J CLIN ONCOL, V31, P1514, DOI 10.1200/JCO.2012.44.6831; VanderWeele TJ, 2013, EUR J EPIDEMIOL, V28, P113, DOI 10.1007/s10654-013-9770-6; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Walkey AJ, 2011, JAMA-J AM MED ASSOC, V306, P2248, DOI 10.1001/jama.2011.1615; Zoller B, 2012, EUR J CANCER, V48, P1875, DOI 10.1016/j.ejca.2012.01.005	49	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94377	10.1371/journal.pone.0094377	http://dx.doi.org/10.1371/journal.pone.0094377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709837	Green Published, gold, Green Submitted			2022-12-25	WOS:000334159800140
J	Kurtz, KH; Souza-Smith, FM; Moor, AN; Breslin, JW				Kurtz, Kristine H.; Souza-Smith, Flavia M.; Moor, Andrea N.; Breslin, Jerome W.			Rho Kinase Enhances Contractions of Rat Mesenteric Collecting Lymphatics	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; MYOSIN PHOSPHATASE; PUMP FUNCTION; INHIBITION; PHOSPHORYLATION; CA2+; PATHWAY; INFLAMMATION; FORCE	The mechanisms that control phasic and tonic contractions of lymphatic vessels are poorly understood. We hypothesized that rho kinase ROCK, previously shown to increase calcium ( Ca2+) sensitivity in vascular smooth muscle, enhances lymphatic contractile activity in a similar fashion. Contractions of isolated rat mesenteric lymphatic vessels were observed at a luminal pressure of 2 cm H2O in a 37 degrees C bath. The expression of ROCK in isolated rat mesenteric lymphatic vessels was assessed by Western blotting and confocal microscopy. The role of ROCK in contractile function was tested using two specific yet structurally distinct inhibitors: H1152 (0.1-10 mu M) and Y-27632 (0.5-50 mu M). In addition, lymphatics were transfected with constitutively active (ca)-ROCK protein (2 mu g/ml) to assess gain of contractile function. Vessel diameter and the concentration of intracellular free Ca2+ ([Ca2+](i)) were simultaneously measured in a subset of isolated lymphatics loaded with the Ca2+-sensing dye fura-2. The results show expression of both the ROCK1 and ROCK2 isoforms in lymphatic vessels. Inhibition of ROCK increased lymphatic end diastolic diameter and end systolic diameter in a concentration-dependent manner. Significant reductions in lymphatic tone and contraction amplitude were observed after treatment 1-10 mu M H1152 or 25-50 mu M Y-27632. H1152 (10 mu M) also significantly reduced contraction frequency. Transient increases in [ Ca2+] i preceded each phasic contraction, however this pattern was disrupted by either 10 mu M H1152 or 50 mM Y-27632 in the majority of lymphatics studied. The significant decrease in tone caused by H1152 or Y-27632 was not associated with a significant change in the basal [ Ca2+](i) between transients. Transfection with ca-ROCK protein enhanced lymphatic tone, but was not associated with a significant change in basal [ Ca2+](i). Our data suggest that ROCK mediates normal tonic constriction and influences phasic contractions in lymphatics. We propose that ROCK modulates Ca2+ sensitivity of contractile proteins in lymphatics.	[Kurtz, Kristine H.; Souza-Smith, Flavia M.] Louisiana State Univ, Hlth Sci Ctr, Dept Physiol, New Orleans, LA USA; [Moor, Andrea N.; Breslin, Jerome W.] Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; State University System of Florida; University of South Florida	Breslin, JW (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA.	jbreslin@health.usf.edu			National Institutes of Health [P20RR018766, R01HL098215, F32AA021049]; American Heart Association [0835388N]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [F32AA021049] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health grants P20RR018766, R01HL098215, and F32AA021049, and American Heart Association grant number 0835388N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli Veronique, 2006, Lymphatic Research and Biology, V4, P217, DOI 10.1089/lrb.2006.4406; BENOIT JN, 1991, AM J PHYSIOL, V261, pH1970, DOI 10.1152/ajpheart.1991.261.6.H1970; Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; Bridenbaugh EA, 2013, LYMPHAT RES BIOL, V11, P155, DOI 10.1089/lrb.2013.0023; Dougherty PJ, 2008, AM J PHYSIOL-REG I, V294, pR1524, DOI 10.1152/ajpregu.00888.2007; Dougherty PJ, 2014, AM J PHYSL HEART CIR; Fowler CJ, 1997, CLIN CHIM ACTA, V265, P247, DOI 10.1016/S0009-8981(97)00139-3; Gashev AA, 2004, MICROCIRCULATION, V11, P477, DOI 10.1080/10739680490476033; Gashev AA, 2013, LYMPHAT RES BIOL, V11, P2, DOI 10.1089/lrb.2013.0003; Hosaka K, 2003, AM J PHYSIOL-HEART C, V284, pH2015, DOI 10.1152/ajpheart.00763.2002; Ikenoya M, 2002, J NEUROCHEM, V81, P9, DOI 10.1046/j.1471-4159.2002.00801.x; Imtiaz MS, 2007, BIOPHYS J, V92, P3843, DOI 10.1529/biophysj.106.095687; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Lund AW, 2010, J MAMMARY GLAND BIOL, V15, P341, DOI 10.1007/s10911-010-9193-x; Nepiyushchikh ZV, 2011, J PHYSIOL-LONDON, V589, P5415, DOI 10.1113/jphysiol.2011.218446; Nobe K, 2001, CIRC RES, V88, P1283, DOI 10.1161/hh1201.092035; NOBLE D, 1991, P ROY SOC B-BIOL SCI, V246, P167, DOI 10.1098/rspb.1991.0140; Pang HA, 2005, AM J PHYSIOL-CELL PH, V289, pC352, DOI 10.1152/ajpcell.00111.2005; Si YH, 2013, SHOCK, V40, P49, DOI 10.1097/SHK.0b013e31829635cf; Somlyo AP, 2004, J MUSCLE RES CELL M, V25, P613; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Souza-Smith FM, 2011, JOVE-J VIS EXP, DOI 10.3791/3438; Souza-Smith FM, 2013, MICROCIRCULATION, V20, P377, DOI 10.1111/micc.12032; Souza-Smith FM, 2010, MICROCIRCULATION, V17, P514, DOI 10.1111/j.1549-8719.2010.00050.x; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Von Der Weid PY, 2001, ALIMENT PHARM THER, V15, P1115, DOI 10.1046/j.1365-2036.2001.01037.x; Wang W, 2009, AM J PHYSIOL-HEART C, V297, pH726, DOI 10.1152/ajpheart.00312.2009; Wang YD, 2010, GENE DEV, V24, P2115, DOI 10.1101/gad.1955910; Wang YP, 2009, CIRC RES, V104, P531, DOI 10.1161/CIRCRESAHA.108.188524; Wetzel P, 2002, AM J PHYSIOL-CELL PH, V283, pC1242, DOI 10.1152/ajpcell.00106.2002; Zhou H, 2012, CURR PHARM DESIGN, V18, P2964, DOI 10.2174/138161212800672688; Zhou Q, 2009, CURR PHARM DESIGN, V15, P3108, DOI 10.2174/138161209789057986; ZWEIFACH BW, 1975, AM J PHYSIOL, V228, P1326, DOI 10.1152/ajplegacy.1975.228.5.1326	33	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94082	10.1371/journal.pone.0094082	http://dx.doi.org/10.1371/journal.pone.0094082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710574	Green Published, gold, Green Submitted			2022-12-25	WOS:000334159800098
J	Pan, N; Lv, XW; Liang, R; Wang, LM; Liu, QL				Pan, Ning; Lv, Xiangwei; Liang, Rui; Wang, Liming; Liu, Qinlong			Suppression of Graft Regeneration, Not Ischemia/Reperfusion Injury, Is the Primary Cause of Small-for-Size Syndrome after Partial Liver Transplantation in Mice	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ADULT LIVING DONOR; N-TERMINAL-KINASE; HEPATIC ISCHEMIA; CYCLIN D1; MOUSE; EXPRESSION; PROLIFERATION; PROGRESSION; MECHANISMS	Background: Ischemia/reperfusion injury (IRI) is commonly considered to play a crucial role in the pathogenesis of small-for-size syndrome (SFSS) after liver transplantation. Rapid regeneration is also considered essential for the survival of SFS grafts. Methods: Mouse models of full-size orthotopic liver transplantation, 50% partial liver transplantation and 30% partial liver transplantation were established. Survival rate and serum alanine aminotransferase were observed. IRI was assessed by hepatic pathologic alterations, apoptosis and necrosis. Regeneration response was detected by mitotic index, BrdU incorporation and PCNA, Cyclin D1 and Cyclin E expression. The expression of mTOR, AKT, ERK, JNK2 and p70S6K, also involved in regeneration signaling pathways, were analyzed as well. Results: 30% partial liver graft resulted in a significantly low 7-day survival rate (P = 0.002) with no marked difference in tissue injury compared with the 50% partial graft group. Serum alanine aminotransferase levels were not significantly different between partial transplantation and full-size transplantation. Western blot analysis of caspase-3 and TUNEL staining also indicated no significant difference in apoptosis response between 30% partial transplantation and half-size or full-size transplantation (P = 0.436, P = 0.113, respectively). However, liver regeneration response indicators, mitotic index (P, 0.0001) and BrdU (P = 0.0022), were markedly lower in 30% LTx compared with 50% LTx. Suppressed expression of PCNA, cyclin D1, cyclin E, mTOR, JNK2, AKT, ERK and p70S6K was also detected by western blot. Conclusions: Liver regeneration is markedly suppressed in SFSS, and is more likely the primary cause of SFSS, rather than ischemia/reperfusion injury. Therapy for recovering graft regeneration could be a potentially important strategy to reduce the incidence of SFSS.	[Lv, Xiangwei; Liang, Rui; Wang, Liming; Liu, Qinlong] Dalian Med Univ, Affiliated Hosp 2, Dept Gen Surg, Dalian, Liaoning Provin, Peoples R China; [Pan, Ning] Dalian Med Univ, Affiliated Hosp 2, Dept Anesthesiol, Dalian, Liaoning Provin, Peoples R China	Dalian Medical University; Dalian Medical University	Liu, QL (corresponding author), Dalian Med Univ, Affiliated Hosp 2, Dept Gen Surg, Dalian, Liaoning Provin, Peoples R China.	qinlongliu@163.com			National Natural Science Foundation of China [81272368]; Supporting Plan for Talents in Colleges and Universities of Liaoning Province; Department of Education of Liaoning Province [LJQ2013099]; Industry and Technology Bureau of Dalian [2013J21DW022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Supporting Plan for Talents in Colleges and Universities of Liaoning Province; Department of Education of Liaoning Province; Industry and Technology Bureau of Dalian	National Natural Science Foundation of China(81272368). Supporting Plan for Talents in Colleges and Universities of Liaoning Province. Department of Education of Liaoning ProvinceNumber: LJQ2013099 Mechanisms of Mitochondrial Regeneration for Hepatic Regeneration after Small-for-size transplantation and Partial Hepatectomy. Industry and Technology Bureau of Dalian Number: 2013J21DW022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buitrago-Molina LE, 2009, HEPATOLOGY, V50, P500, DOI 10.1002/hep.23014; Cheng YF, 2009, AM J TRANSPLANT, V9, P1382, DOI 10.1111/j.1600-6143.2009.02626.x; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Cursio R, 1999, FASEB J, V13, P253, DOI 10.1096/fasebj.13.2.253; Dahm F, 2005, AM J TRANSPLANT, V5, P2605, DOI 10.1111/j.1600-6143.2005.01081.x; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2012, J HEPATOL, V57, P692, DOI 10.1016/j.jhep.2012.04.016; Fernandez L, 2003, TRANSPLANTATION, V76, P282, DOI 10.1097/01.TP.0000067529.82245.4E; Fu QX, 2013, APOPTOSIS, V18, P998, DOI 10.1007/s10495-013-0849-z; Fu WY, 2013, HEPATOL RES, V43, P300, DOI 10.1111/j.1872-034X.2012.01071.x; Furukawa H, 1999, TRANSPLANT P, V31, P1952, DOI 10.1016/S0041-1345(99)00225-0; Guo JY, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-79; Hong FF, 2012, J SURG RES, V178, P1015, DOI 10.1016/j.jss.2012.07.061; Humar A, 2004, LIVER TRANSPLANT, V10, P374, DOI 10.1002/lt.20096; KAWASAKI S, 1992, LANCET, V339, P580, DOI 10.1016/0140-6736(92)90867-3; Kiuchi T, 1999, TRANSPLANTATION, V67, P321, DOI 10.1097/00007890-199901270-00024; Kiuchi T, 2003, LIVER TRANSPLANT, V9, pS29, DOI 10.1053/jlts.2003.50198; Zuluaga GLL, 2013, TRANSPL P, V45, P25, DOI 10.1016/j.transproceed.2012.02.031; Liu HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065644; Liu Q, 2012, AM J TRANSPLANT, V12, P2052, DOI 10.1111/j.1600-6143.2012.04069.x; Liu Q, 2012, HPBSURGERY, V2012, P1; Lu CH, 2012, CLIN TRANSPLANT, V26, pE143, DOI 10.1111/j.1399-0012.2012.01621.x; Man K, 2001, ARCH SURG-CHICAGO, V136, P280, DOI 10.1001/archsurg.136.3.280; Mangnall D, 2003, LIVER INT, V23, P124, DOI 10.1034/j.1600-0676.2003.00812.x; Michalopoulos GK, 2007, J CELL PHYSIOL, V213, P286, DOI 10.1002/jcp.21172; Nelsen CJ, 2001, CANCER RES, V61, P8564; Nevzorova YA, 2009, GASTROENTEROLOGY, V137, P691, DOI 10.1053/j.gastro.2009.05.003; Oka K, 2013, BIOCHEM BIOPH RES CO, V435, P120, DOI 10.1016/j.bbrc.2013.04.052; Rehman H, 2011, TRANSPLANTATION, V91, P406, DOI 10.1097/TP.0b013e318204bdb2; Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135; Selzner M, 1999, HEPATOLOGY, V30, P469, DOI 10.1002/hep.510300215; STRASBERG SM, 1994, HEPATOLOGY, V20, P829, DOI 10.1002/hep.1840200410; Suzuki S, 2008, CURR OPIN ORGAN TRAN, V13, P142, DOI 10.1097/MOT.0b013e3282f6a164; Taki-Eldin A, 2012, EUR SURG RES, V48, P139, DOI 10.1159/000337865; Teoh NC, 2003, J GASTROEN HEPATOL, V18, P891, DOI 10.1046/j.1440-1746.2003.03056.x; Theruvath TP, 2008, AM J TRANSPLANT, V8, P1819, DOI 10.1111/j.1600-6143.2008.02336.x; Tian YH, 2006, P NATL ACAD SCI USA, V103, P4598, DOI 10.1073/pnas.0600499103; Tian YH, 2003, LIVER TRANSPLANT, V9, P789, DOI 10.1053/jlts.2003.50170; Tucker ON, 2005, CURR OPIN CRIT CARE, V11, P150, DOI 10.1097/01.ccx.0000157080.11117.45; Yao AH, 2010, J SURG RES, V161, P328, DOI 10.1016/j.jss.2009.02.013; Yao AH, 2007, TRANSPL IMMUNOL, V18, P37, DOI 10.1016/j.trim.2007.02.002; Zhang S, 2013, INT J CLIN EXP PATHO, V6, P870; Zhong Z, 2006, TRANSPLANTATION, V82, P241, DOI 10.1097/01.tp.0000228867.98158.d2	43	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93636	10.1371/journal.pone.0093636	http://dx.doi.org/10.1371/journal.pone.0093636			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709852	gold, Green Published			2022-12-25	WOS:000334159800041
J	Voigtsberger, S; Urner, M; Hasler, M; Z'Graggen, BR; Booy, C; Spahn, DR; Beck-Schimmer, B				Voigtsberger, Stefanie; Urner, Martin; Hasler, Melanie; Z'Graggen, Birgit Roth; Booy, Christa; Spahn, Donat R.; Beck-Schimmer, Beatrice			Modulation of Early Inflammatory Response by Different Balanced and Non-Balanced Colloids and Crystalloids in a Rodent Model of Endotoxemia	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; ACUTE KIDNEY INJURY; GELATINASE-ASSOCIATED LIPOCALIN; SEVERE SEPSIS; HYDROXYETHYLSTARCH; MICROCIRCULATION; PATHOPHYSIOLOGY; RESUSCITATION; EXPRESSION; BIOMARKERS	The use of hydroxyethyl starch (HES) in sepsis has been shown to increase mortality and acute kidney injury. However, the knowledge of the exact mechanism by which several fluids, especially starch preparations may impair end-organ function particularly in the kidney, is still missing. The aim of this study was to measure the influence of different crystalloid and colloid fluid compositions on the inflammatory response in the kidney, the liver and the lung using a rodent model of acute endotoxemia. Rats were anesthetized and mechanically ventilated. Lipopolysaccharide (5 mg/kg) was administered intravenously. After one hour crystalloids [lactate- buffered (RLac) or acetate-buffered (RAc)] were infused i.v. (30 ml/kg) in all groups. At 2 hours rats either received different crystalloids (75 ml/kg of RLac or RAc) or colloids (25 ml/kg of HES in saline or HES in RAc or gelatin in saline). Expression of messenger RNA for cytokine-induced neutrophil chemoattractant-1 (CINC-1), monocyte chemotactic protein-1 (MCP-1), necrosis factor a (TNFa) and intercellular adhesion molecule 1 (ICAM-1) was assessed in kidney, liver and lung tissue by real-time PCR after 4 hours. The use of acetate-buffered solutions was associated with a significantly higher expression of CINC-1 and TNFa mRNA in the liver, in the kidney and in the lung. Only marginal effects of gelatin and hydroxyethyl starch on mRNA expression of inflammatory mediators were observed. The study provides evidence that the type of buffering agent of different colloidal and crystalloid solutions might be a crucial factor determining the extent of early end-organ inflammatory response in sepsis.	[Voigtsberger, Stefanie; Urner, Martin; Hasler, Melanie; Spahn, Donat R.; Beck-Schimmer, Beatrice] Univ Zurich Hosp, Inst Anesthesiol, CH-8091 Zurich, Switzerland; [Urner, Martin; Z'Graggen, Birgit Roth; Booy, Christa; Beck-Schimmer, Beatrice] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Urner, Martin; Z'Graggen, Birgit Roth; Booy, Christa; Beck-Schimmer, Beatrice] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Beck-Schimmer, B (corresponding author), Univ Zurich Hosp, Inst Anesthesiol, CH-8091 Zurich, Switzerland.	beatrice.beckschimmer@uzh.ch	Urner, Martin/AAK-5701-2020	Urner, Martin/0000-0003-1133-4885	Swiss National Science Foundation Grant [3200B0-122305]; B. Braun, Melsungen, Germany; University of Zurich	Swiss National Science Foundation Grant(Swiss National Science Foundation (SNSF)); B. Braun, Melsungen, Germany; University of Zurich	This work was supported by the Swiss National Science Foundation Grant Nr. 3200B0-122305 and B. Braun, Melsungen, Germany. The project was supported by the University of Zurich with a grant for "protected research time'' for the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksu U, 2012, SHOCK, V37, P205, DOI 10.1097/SHK.0b013e31823ca89c; Bienholz A, 2012, AM J PHYSIOL-RENAL, V303, pF56, DOI 10.1152/ajprenal.00070.2012; BINGEL M, 1987, LANCET, V1, P14; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Campbell SJ, 2003, FASEB J, V17, P1168, DOI 10.1096/fj.02-0757fje; DASILVA AMT, 1993, NEW ENGL J MED, V328, P1457, DOI 10.1056/NEJM199305203282005; Davies PG, 2011, CRIT CARE, V15, DOI 10.1186/cc9966; Dejager L, 2011, TRENDS MICROBIOL, V19, P198, DOI 10.1016/j.tim.2011.01.001; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Doi K, 2009, J CLIN INVEST, V119, P2868, DOI 10.1172/JCI39421; Ernandez T, 2009, KIDNEY INT, V76, P262, DOI 10.1038/ki.2009.142; Ertmer C, 2011, CRIT CARE MED, V39, P783, DOI 10.1097/CCM.0b013e318206d403; Feldkamp T, 2004, AM J PHYSIOL-RENAL, V286, pF749, DOI 10.1152/ajprenal.00276.2003; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Godet G, 2001, LANCET, V358, P581, DOI 10.1016/S0140-6736(01)05719-1; Goldstein SL, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-135; Guidet B, 2012, CRIT CARE, V16, DOI 10.1186/cc11358; Guidet B, 2010, CRIT CARE, V14, DOI 10.1186/cc9230; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Han M, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-25; Handa O, 2006, J CLIN BIOCHEM NUTR, V38, P51, DOI 10.3164/jcbn.38.51; Hoffmann JN, 2002, ANESTHESIOLOGY, V97, P460, DOI 10.1097/00000542-200208000-00025; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Neveu H, 1996, NEPHROL DIAL TRANSPL, V11, P293, DOI 10.1093/oxfordjournals.ndt.a027256; Rabelink TJ, 2010, NAT REV NEPHROL, V6, P404, DOI 10.1038/nrneph.2010.65; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Schick MA, 2010, INTENS CARE MED, V36, P541, DOI 10.1007/s00134-009-1704-0; Selby NM, 2006, ASAIO J, V52, P62, DOI 10.1097/01.mat.0000189725.93808.58; Simon TP, 2012, CRIT CARE, V16, DOI 10.1186/cc11161; Soni N, 2012, CRIT CARE, V16, DOI 10.1186/cc11155; Thaha M, 2005, Acta Med Indones, V37, P145; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Urbschat A, 2011, BIOMARKERS, V16, pS22, DOI 10.3109/1354750X.2011.587129; VEECH RL, 1988, ADV ENZYME REGUL, V27, P313, DOI 10.1016/0065-2571(88)90024-6; Wan L, 2008, CRIT CARE MED, V36, pS198, DOI 10.1097/CCM.0b013e318168ccd5; WATANABE K, 1992, EXP MOL PATHOL, V56, P60, DOI 10.1016/0014-4800(92)90023-5; Wittlinger M, 2010, ANESTH ANALG, V110, P531, DOI 10.1213/ANE.0b013e3181c03c97; [No title captured]	42	12	13	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93863	10.1371/journal.pone.0093863	http://dx.doi.org/10.1371/journal.pone.0093863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709833	gold, Green Accepted, Green Submitted, Green Published			2022-12-25	WOS:000334159800060
J	Hermansen, TS; Thomsen, VO; Lillebaek, T; Ravn, P				Hermansen, Thomas Stig; Thomsen, Vibeke Ostergaard; Lillebaek, Troels; Ravn, Pernille			Non-Tuberculous Mycobacteria and the Performance of Interferon Gamma Release Assays in Denmark	PLOS ONE			English	Article							LATENT TUBERCULOSIS INFECTION; AVIUM COMPLEX; ACTIVE TUBERCULOSIS; LUNG-DISEASE; CHANGING EPIDEMIOLOGY; CLINICAL-FEATURES; PULMONARY-DISEASE; BOVIS BCG; DIAGNOSIS; PREVALENCE	Background: The QuantiFERON-TB-Gold Test (QFT) is more specific than the Mantoux skin-test to discriminate between Mycobacterium tuberculosis (MTB) and non-tuberculous mycobacterial (NTM) infections. Here we study the performance of the QFT in patients with NTM disease. Methods: From 2005 to 2011, nationwide patient data on positive NTM cultures (n = 925) were combined with nationwide data on QFT results (n = 16,133), both retrieved from the International Reference Laboratory of Mycobacteriology, Denmark. A total of 112 patients with NTM infections had a QFT performed, 53 patients had definite NTM disease, 10 had possible disease and 49 had NTM colonization. Results: QFT was positive in 8% (4/53) of patients with definite disease, 40% (4/10) with possible disease and 31% (15/49) with colonization. Positivity rate was lowest among patients with definite disease infected with NTM without the RD1 region 4% (2/50). None of the 15 children with MAC lymphadenitis had a positive QFT. Conclusion: This study is one of the largest assessing IGRAs in patients with NTM disease in a TB low-incidence setting. Our study showed that the QFT holds potential to discriminate between NTM and MTB infections. We found no positive IGRA test results among children with NTM not sharing the RD1-region of MTB resulting in a 100% specificity and we suggest that a QFT in a child presenting with cervical lymphadenitis may be helpful in distinguishing NTM from TB lymphadenitis.	[Hermansen, Thomas Stig; Ravn, Pernille] Nordsjaelland Hosp, Dept Thorac Med & Infect Dis, Hillerod, Denmark; [Hermansen, Thomas Stig; Thomsen, Vibeke Ostergaard; Lillebaek, Troels] Statens Serum Inst, Int Reference Lab Mycobacteriol, DK-2300 Copenhagen, Denmark	Statens Serum Institut	Hermansen, TS (corresponding author), Nordsjaelland Hosp, Dept Thorac Med & Infect Dis, Hillerod, Denmark.	thomasstighermansen@hotmail.com	Thomsen, Vibeke Østergaard/H-9370-2013	Thomsen, Vibeke Ostergaard/0000-0002-1653-6294; Lillebaek, Troels/0000-0002-2601-2718	research council of Hillerod Hospital, North Zealand Hospital, Hillerod; Olga Bryde Nielsens Fond, North Zealand Hospital, Hillerod	research council of Hillerod Hospital, North Zealand Hospital, Hillerod; Olga Bryde Nielsens Fond, North Zealand Hospital, Hillerod	This work was supported by a research grant from the research council of Hillerod Hospital, North Zealand Hospital, Hillerod. This work was supported by a research grant from Olga Bryde Nielsens Fond, North Zealand Hospital, Hillerod. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LV, 2008, SCAND J INFECT DIS, V40, P196, DOI 10.1080/00365540701642179; Adjemian J, 2012, AM J RESP CRIT CARE, V185, P881, DOI 10.1164/rccm.201111-2016OC; Andrejak C, 2010, AM J RESP CRIT CARE, V181, P514, DOI 10.1164/rccm.200905-0778OC; [Anonymous], EUR RESP J, V35, P619; Billinger ME, 2009, EMERG INFECT DIS, V15, P1562, DOI 10.3201/eid1510.090196; Cattamanchi A, 2011, JAIDS-J ACQ IMM DEF, V56, P230, DOI 10.1097/QAI.0b013e31820b07ab; Detjen AK, 2007, CLIN INFECT DIS, V45, P322, DOI 10.1086/519266; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Falkinham JO, 2002, CLIN CHEST MED, V23, P529, DOI 10.1016/S0272-5231(02)00014-X; Freeman Joshua, 2007, N Z Med J, V120, pU2580; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; Hernandez-Garduno E, 2009, INT J TUBERC LUNG D, V13, P1086; Hoffmann M, 2010, EUR INFECT DIS, V4, P23; Hoffmann M, 2010, SWISS MED WKLY, V140, P286, DOI smw-12960; HUEBNER RE, 1993, CLIN INFECT DIS, V17, P968, DOI 10.1093/clinids/17.6.968; Kobashi Y, 2009, INT J TUBERC LUNG D, V13, P1422; Kobashi Y, 2006, CLIN INFECT DIS, V43, P1540, DOI 10.1086/509327; Kuznetcova TI, 2012, INT OPHTHALMOL; Lee SK, 2012, SCAND J INFECT DIS, V44, P733, DOI 10.3109/00365548.2012.681695; Leidl L, 2010, EUR RESPIR J, V35, P619, DOI 10.1183/09031936.00045509; Lein AD, 1999, CLIN DIAGN LAB IMMUN, V6, P606, DOI 10.1128/CDLI.6.4.606-609.1999; Ling DI, 2011, PAEDIATR RESPIR REV, V12, P9, DOI 10.1016/j.prrv.2010.09.009; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Marras TK, 2007, THORAX, V62, P661, DOI 10.1136/thx.2006.070797; Park SY, 2009, SCAND J INFECT DIS, V41, P818, DOI 10.3109/00365540903214298; Prevots DR, 2010, AM J RESP CRIT CARE, V182, P970, DOI 10.1164/rccm.201002-0310OC; Ra SW, 2011, INT J TUBERC LUNG D, V15, P635, DOI 10.5588/ijtld.10.0485; Riazi S, 2012, ALLERGY ASTHMA PROC, V33, P217, DOI 10.2500/aap.2012.33.3574; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Siddiqi UR, 2012, TOHOKU J EXP MED, V226, P313, DOI 10.1620/tjem.226.313; Solovic I, 2010, EUR RESPIR J, V36, P1185, DOI 10.1183/09031936.00028510; Thomson RM, 2010, EMERG INFECT DIS, V16, P1576, DOI 10.3201/eid1610.091201; Tsai CF, 2011, T ROY SOC TROP MED H, V105, P148, DOI 10.1016/j.trstmh.2010.11.005; van Ingen J, 2012, EMERG INFECT DIS, V18, P653, DOI 10.3201/eid1804.110888; van Ingen J, 2009, J BACTERIOL, V191, P5865, DOI 10.1128/JB.00683-09; van Leeuwen RML, 2007, EUR RESPIR J, V29, P605, DOI 10.1183/09031936.00066506; Vincenti D, 2007, CLIN EXP IMMUNOL, V150, P91, DOI 10.1111/j.1365-2249.2007.03462.x; VONREYN CF, 1993, J CLIN MICROBIOL, V31, P3227, DOI 10.1128/JCM.31.12.3227-3230.1993; Wang JY, 2007, EMERG INFECT DIS, V13, P553, DOI 10.3201/eid1304.051195; Winthrop KL, 2010, AM J RESP CRIT CARE, V182, P977, DOI 10.1164/rccm.201003-0503OC	41	55	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93986	10.1371/journal.pone.0093986	http://dx.doi.org/10.1371/journal.pone.0093986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705675	gold, Green Published			2022-12-25	WOS:000334107500103
J	Fu, Q; Kim, S; Soto, D; De Arcangelis, V; DiPilato, L; Liu, SB; Xu, B; Shi, Q; Zhang, J; Xiang, YK				Fu, Qin; Kim, Sungjin; Soto, Dagoberto; De Arcangelis, Vania; DiPilato, Lisa; Liu, Shubai; Xu, Bing; Shi, Qian; Zhang, Jin; Xiang, Yang K.			A Long Lasting beta(1) Adrenergic Receptor Stimulation of cAMP/Protein Kinase A (PKA) Signal in Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; BETA(2)-ADRENERGIC RECEPTORS; PHOSPHODIESTERASE; PHOSPHORYLATION; CARDIOMYOCYTES; HOLOENZYME; ARRESTINS; BINDING; CELLS; HEART	Small-molecule, ligand-activated G protein-coupled receptors are generally thought to be rapidly desensitized within a period of minutes through receptor phosphorylation and internalization after repeated or prolonged stimulation. This transient G protein-coupled receptor activation remains at odds with many observed long-lasting cellular and physiological responses. Here, using live cell imaging of cAMP with a FRET-based biosensor and myocyte contraction assay, we show that the catecholamine-activated beta(1) adrenergic receptor (beta(1)AR) continuously stimulates second messenger cAMP synthesis in primary cardiac myocytes and neurons, which lasts for more than 8 h (a decay t(1/2) of 3.9 h) in cardiac myocytes. However, the beta(1)AR-induced cAMP signal is counterbalanced and masked by the receptor-bound phosphodiesterase (PDE) 4D8-dependent cAMP hydrolysis. Inhibition of PDE4 activity recovers the receptor-induced cAMP signal and promotes contractile response in mouse hearts during extended periods of agonist stimulation. beta(1)AR associates with PDE4D8 through the receptor C-terminal PDZ motif-dependent binding to synaptic-associated protein 97 (SAP97). Knockdown of SAP97 or mutation of the beta(1)AR PDZ motif disrupts the complex and promotes sustained agonist-induced cAMP activity, PKA phosphorylation, and cardiac myocyte contraction response. Together, these findings unveil a long lasting adrenergic signal in neurons and myocytes under prolonged stimulation and an underappreciated role of PDE that is essential in classic receptor signaling desensitization and in maintaining a long lasting cAMP equilibrium for ligand-induced physiological response.	[Fu, Qin; Kim, Sungjin; Xu, Bing; Shi, Qian; Xiang, Yang K.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Fu, Qin] Huazhong Univ Sci & Technol, Dept Pharmacol, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China; [Fu, Qin; Kim, Sungjin; Soto, Dagoberto; De Arcangelis, Vania; Liu, Shubai; Shi, Qian; Xiang, Yang K.] Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA; [DiPilato, Lisa; Zhang, Jin] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	University of California System; University of California Davis; Huazhong University of Science & Technology; University of Illinois System; University of Illinois Urbana-Champaign; Johns Hopkins University	Fu, Q (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.	fu_qin@aliyun.com; ykxiang@ucdavis.edu	Soto, Dagoberto I/N-6817-2014; Fu, Qin/O-6960-2014	Soto, Dagoberto I/0000-0002-7350-1530; Fu, Qin/0000-0002-7954-7708; liu, shubai/0000-0001-8929-4209; Shi, Qian/0000-0003-2634-9553	National Institutes of Health [DK073368, HL082646]; American Heart Association [0635331N]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK073368 (to J. Z.) and HL082646 (to Y. X.). This work was also supported by American Heart Association Grant 0635331N (to Y. X.).	Allen MD, 2006, ACS CHEM BIOL, V1, P371, DOI 10.1021/cb600202f; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; De Arcangelis V, 2010, MOL PHARMACOL, V78, P340, DOI 10.1124/mol.110.064444; De Arcangelis V, 2009, J BIOL CHEM, V284, P33824, DOI 10.1074/jbc.M109.020388; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Gardner LA, 2007, J BIOL CHEM, V282, P5085, DOI 10.1074/jbc.M608871200; Halls ML, 2010, EMBO J, V29, P2772, DOI 10.1038/emboj.2010.168; Hu LYA, 2000, J BIOL CHEM, V275, P38659, DOI 10.1074/jbc.M005938200; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Liu SB, 2012, P NATL ACAD SCI USA, V109, P6578, DOI 10.1073/pnas.1117862109; Lohse MJ, 2013, NATURE, V495, P457, DOI 10.1038/nature12086; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Nooh MM, 2014, J BIOL CHEM, V289, P2277, DOI 10.1074/jbc.M113.513481; Nooh MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063379; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Schweizer PA, 2010, CIRC-ARRHYTHMIA ELEC, V3, P542, DOI 10.1161/CIRCEP.110.949768; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; St Clair JR, 2013, CHANNELS, V7, P318, DOI 10.4161/chan.25293; Taylor SS, 2013, BBA-PROTEINS PROTEOM, V1834, P1271, DOI 10.1016/j.bbapap.2013.03.007; Wang DY, 2010, FASEB J, V24, P3511, DOI 10.1096/fj.10-156661; Wang Y, 2008, J BIOL CHEM, V283, P1799, DOI 10.1074/jbc.M705747200; Weiss S, 2013, CIRC RES, V113, P617, DOI 10.1161/CIRCRESAHA.113.301781; Werthmann RC, 2012, FASEB J, V26, P2043, DOI 10.1096/fj.11-195248; Xiang Y, 2005, P NATL ACAD SCI USA, V102, P909, DOI 10.1073/pnas.0405263102; Xiang Y, 2002, J BIOL CHEM, V277, P33783, DOI 10.1074/jbc.M204136200; Xiao RP, 2006, TRENDS PHARMACOL SCI, V27, P330, DOI 10.1016/j.tips.2006.04.009; Zhang P, 2012, SCIENCE, V335, P712, DOI 10.1126/science.1213979	33	21	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14771	14781		10.1074/jbc.M113.542589	http://dx.doi.org/10.1074/jbc.M113.542589			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24713698	Green Published, hybrid			2022-12-25	WOS:000337248100033
J	Hinton, L; Locock, L; Knight, M				Hinton, Lisa; Locock, Louise; Knight, Marian			Partner Experiences of "Near-Miss" Events in Pregnancy and Childbirth in the UK: A Qualitative Study	PLOS ONE			English	Article							BIRTH TRAUMA; FATHERS; RESUSCITATION; NARRATIVES; DEATH; WOMEN; LIFE; CARE	Objective: Severe life-threatening complications in pregnancy that require urgent medical intervention are commonly known as "near-miss" events. Although these complications are rare (1 in 100 births), there are potentially 8,000 women and their families in the UK each year who live through a life-threatening emergency and its aftermath. Near-miss obstetric emergencies can be traumatic and frightening for women, and their impact can last for years. There is little research that has explored how these events impact on partners. The objective of this interview study was to explore the impact of a near-miss obstetric emergency, focusing particularly on partners. Design: Qualitative study based on narrative interviews, video and audio recorded and transcribed for analysis. A qualitative interpretative approach was taken, combining thematic analysis with constant comparison. The analysis presented here focuses on the experiences of partners. Participants: Maximum variation sample included 35 women, 10 male partners, and one lesbian partner who had experienced a life-threatening obstetric emergency. Setting: Interviews were conducted in participants' own homes. Results: In the hospital, partner experiences were characterized by powerlessness and exclusion. Partners often found witnessing the emergency shocking and distressing. Support (from family or staff) was very important, and clear, honest communication from medical staff highly valued. The long-term emotional effects for some were profound; some experienced depression, flashbacks and post-traumatic stress disorder months and years after the emergency. These, in turn, affected the whole family. Little support was felt to be available, nor acknowledgement of their ongoing distress. Conclusion: Partners, as well as women giving birth, can be shocked to experience a life-threatening illness in childbirth. While medical staff may view a near-miss as a positive outcome for a woman and her baby, there can be long-term mental health consequences that can have profound impacts on the individual, but also their families.	[Hinton, Lisa; Locock, Louise] Univ Oxford, Nuffield Dept Primary Hlth Care Sci, Hlth Experiences Res Grp, Oxford, England; [Knight, Marian] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England	University of Oxford; University of Oxford	Hinton, L (corresponding author), Univ Oxford, Nuffield Dept Primary Hlth Care Sci, Hlth Experiences Res Grp, Oxford, England.	lisa.hinton@phc.ox.ac.uk	Knight, Marian/B-6225-2009; Hinton, Lisa/AAA-2266-2019	Knight, Marian/0000-0002-1984-4575; Hinton, Lisa/0000-0002-6082-3151	National Institute for Health Research (NIHR) [RP-PG-0608-10038]; National Institute for Health Research [NIHR-RP-011-032, RP-PG-0608-10038] Funding Source: researchfish	National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research funded by the National Institute for Health Research (NIHR) under the "Beyond maternal death: Improving the quality of maternity care through national studies of 'near-miss' maternal morbidity" programme (Programme Grant RP-PG-0608-10038). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ayers Susan, 2006, Psychol Health Med, V11, P389, DOI 10.1080/13548500600708409; Beck CT, 2008, NURS RES, V57, P228, DOI 10.1097/01.NNR.0000313494.87282.90; Beck CT, 2004, NURS RES, V53, P28, DOI 10.1097/00006199-200401000-00005; Cecatti JG, 2007, REPROD HEALTH MATTER, V15, P125, DOI 10.1016/S0968-8080(07)30333-9; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; Dellmann T., 2004, AUST J MIDWIFERY, V17, P20, DOI DOI 10.1016/S1448-8272(04)80014-2; Department of Health, 2007, MAT MATT CHOIC ACC C; Dolan A, 2011, SOCIOL HEALTH ILL, V33, P1019, DOI 10.1111/j.1467-9566.2011.01349.x; Draper Jan, 2003, Nurs Inq, V10, P66, DOI 10.1046/j.1440-1800.2003.00157.x; Elmir R, 2012, MIDWIFERY, V28, P228, DOI 10.1016/j.midw.2010.11.008; Erlandsson K, 2007, BIRTH-ISS PERINAT C, V34, P105, DOI 10.1111/j.1523-536X.2007.00162.x; Erlandsson K, 2011, J PERINAT EDUC, V20, P91, DOI 10.1891/1058-1243.20.2.91; Fagerskiold A, 2008, SCAND J CARING SCI, V22, P64, DOI 10.1111/j.1471-6712.2007.00585.x; Filippi V, 2000, STUD FAMILY PLANN, V31, P309, DOI 10.1111/j.1728-4465.2000.00309.x; Gamble J, 2004, AUSTR MIDWIFERY, V17, P12; Glaser B, 1978, DISCOV GROUNDED THEO; Green J., 2018, QUALITATIVE METHODS, VFourth; Hanson S, 2009, J PERINAT EDUC, V18, P12, DOI 10.1624/105812409X474672; Harvey ME, 2012, ARCH DIS CHILD-FETAL, V97, pF439, DOI 10.1136/archdischild-2011-301482; Hodge AN, 2009, COLLEGIAN, V16, P101, DOI 10.1016/j.colegn.2009.04.003; Jessop E, 2011, J REPROD INFANT PSYC, V29, pe25; Lewis GE, 2007, SAVING MOTHERS LIVES; Locock L, 2006, SOC SCI MED, V62, P1349, DOI 10.1016/j.socscimed.2005.08.011; Longworth HL, 2011, MIDWIFERY, V27, P588, DOI 10.1016/j.midw.2010.06.013; Mander R., 2004, MEN MATERNITY; McCreight BS, 2004, SOCIOL HEALTH ILL, V26, P326, DOI 10.1111/j.1467-9566.2004.00393.x; Miller T., 2011, MAKING SENSE FATHERH; National Institute for Health and Clinical Excellence, 2006, ROUT POSTN CAR WOM T; New South Wales Department of Health, 2007, SUPP FAM EARL PACK S; Nilsson C, 2009, MIDWIFERY, V25, pE1, DOI 10.1016/j.midw.2007.01.017; Pattinson RC, 2003, BRIT MED BULL, V67, P231, DOI 10.1093/bmb/ldg007; Patton M. Q., 1990, QUALITATIVE EVALUATI; Perinatal and Maternal Mortality Review Committee (PMMRC), 2006, PER MAT MORT NZ; Premberg A, 2011, MIDWIFERY, V27, P848, DOI 10.1016/j.midw.2010.09.002; Ramchandani P, 2005, LANCET, V365, P2201, DOI 10.1016/S0140-6736(05)66778-5; Redshaw M, 2013, BMC PREGNANCY CHILDB, V13; Snowdon C, 2012, MIDWIFERY, V28, P791, DOI 10.1016/j.midw.2011.12.012; Souza JP, 2009, BIRTH-ISS PERINAT C, V36, P149, DOI 10.1111/j.1523-536X.2009.00313.x; Steen M, 2012, MIDWIFERY, V28, P422, DOI 10.1016/j.midw.2011.06.009; Storeng KT, 2008, SOC SCI MED, V66, P545, DOI 10.1016/j.socscimed.2007.10.001; Storeng KT, 2010, SOC SCI MED, V71, P1749, DOI 10.1016/j.socscimed.2010.03.056; TNS System Three, 2005, NHS MAT SERV QUANT R; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089; White G, 2007, BRIT J MIDWIFERY, V15, P39, DOI DOI 10.12968/BJOM.2007.15.1.22679; Wolfberg AJ, 2004, AM J OBSTET GYNECOL, V191, P708, DOI 10.1016/j.ajog.2004.05.019	45	22	24	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e91735	10.1371/journal.pone.0091735	http://dx.doi.org/10.1371/journal.pone.0091735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24717799	Green Published, gold			2022-12-25	WOS:000334339000011
J	Fa, R; Roberts, DJ; Nandi, AK				Fa, Rui; Roberts, David J.; Nandi, Asoke K.			SMART: Unique Splitting-While-Merging Framework for Gene Clustering	PLOS ONE			English	Article							EXPRESSION DATA; COMMUNITY STRUCTURE; CLASS DISCOVERY; MICROARRAY; ALGORITHMS; CRITERIA; NUMBER	Successful clustering algorithms are highly dependent on parameter settings. The clustering performance degrades significantly unless parameters are properly set, and yet, it is difficult to set these parameters a priori. To address this issue, in this paper, we propose a unique splitting-while-merging clustering framework, named '' splitting merging awareness tactics '' (SMART), which does not require any a priori knowledge of either the number of clusters or even the possible range of this number. Unlike existing self-splitting algorithms, which over-cluster the dataset to a large number of clusters and then merge some similar clusters, our framework has the ability to split and merge clusters automatically during the process and produces the the most reliable clustering results, by intrinsically integrating many clustering techniques and tasks. The SMART framework is implemented with two distinct clustering paradigms in two algorithms: competitive learning and finite mixture model. Nevertheless, within the proposed SMART framework, many other algorithms can be derived for different clustering paradigms. The minimum message length algorithm is integrated into the framework as the clustering selection criterion. The usefulness of the SMART framework and its algorithms is tested in demonstration datasets and simulated gene expression datasets. Moreover, two real microarray gene expression datasets are studied using this approach. Based on the performance of many metrics, all numerical results show that SMART is superior to compared existing self-splitting algorithms and traditional algorithms. Three main properties of the proposed SMART framework are summarized as: (1) needing no parameters dependent on the respective dataset or a priori knowledge about the datasets, (2) extendible to many different applications, (3) offering superior performance compared with counterpart algorithms.	[Fa, Rui; Nandi, Asoke K.] Brunel Univ, Dept Elect & Comp Engn, Uxbridge UB8 3PH, Middx, England; [Roberts, David J.] Natl Hlth Serv Blood & Transplant, Oxford, England; [Roberts, David J.] Univ Oxford, John Radcliffe Hosp, Oxford OX3 9DU, England; [Nandi, Asoke K.] Univ Jyvaskyla, Dept Math Informat, Jyvaskyla, Finland	Brunel University; NHS Blood & Transplant (NHSBT); University of Oxford; University of Jyvaskyla	Fa, R (corresponding author), Brunel Univ, Dept Elect & Comp Engn, Uxbridge UB8 3PH, Middx, England.	Rui.Fa@brunel.ac.uk; asoke.nandi@brunel.ac.uk		Fa, Rui/0000-0003-4588-7971	National Institute for Health Research (NIHR), UK [NIHR-RP-PG-0310-1004-AN]; National Institute for Health Research [RP-PG-0310-1004] Funding Source: researchfish	National Institute for Health Research (NIHR), UK(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors are thankful for the financial support from National Institute for Health Research (NIHR), UK. The project reference is NIHR-RP-PG-0310-1004-AN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Jamous B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056432; Abu-Jamous B, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0990; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Baek J, 2011, BIOINFORMATICS, V27, P1269, DOI 10.1093/bioinformatics/btr112; Baek J, 2010, IEEE T PATTERN ANAL, V32, P1298, DOI 10.1109/TPAMI.2009.149; Bandyopadhyay S, 2007, BIOINFORMATICS, V23, P2859, DOI 10.1093/bioinformatics/btm418; Bishop CM, 2006, PATTERN RECOGN, P2006; Boly M, 2012, P NATL ACAD SCI USA, V109, P5856, DOI 10.1073/pnas.1111133109; Calinski T., 1974, COMMUNICATIONS STAT, V3, P1, DOI [DOI 10.1080/03610927408827101, 10.1080/03610927408827101]; Celeux G, 1996, J CLASSIF, V13, P195, DOI 10.1007/BF01246098; Celeux G, 1999, 4 INRIA RHON ALP FRA; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Dembele D, 2003, BIOINFORMATICS, V19, P973, DOI 10.1093/bioinformatics/btg119; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Fa R, 2011, 2 INT WORKSH GEN SIG; Fa R, 2014, IEEE T COMP IN PRESS; Fa R, 2012, 5 INT IEEE S COMM CO; Fa R, 2011, IEEE INT WORKS MACH; Figueiredo MAT, 2002, IEEE T PATTERN ANAL, V24, P381, DOI 10.1109/34.990138; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; FRALEY C, 1998, 329 U WASH DEP STAT; FRITZKE B, 1994, NEURAL NETWORKS, V7, P1441, DOI 10.1016/0893-6080(94)90091-4; Fritzke B., 1995, Advances in Neural Information Processing Systems 7, P625; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Halkidi M, 2002, SIGMOD REC, V31, P19, DOI 10.1145/601858.601862; Halkidi M, 2002, SIGMOD RECORD, V31, P40, DOI 10.1145/565117.565124; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jiang DX, 2004, IEEE T KNOWL DATA EN, V16, P1370, DOI 10.1109/TKDE.2004.68; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Lam BSY, 2007, SOFT COMPUT, V11, P341, DOI 10.1007/s00500-006-0087-1; Lanterman AD, 2001, INT STAT REV, V69, P185, DOI 10.2307/1403813; Lin CR, 2005, IEEE T KNOWL DATA EN, V17, P145, DOI 10.1109/TKDE.2005.21; Maulik U, 2002, IEEE T PATTERN ANAL, V24, P1650, DOI 10.1109/TPAMI.2002.1114856; Mavridis L, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-213; MCLACHLAN G, 2000, WILEY SER PROB STAT, P1; MCLACHLAN G. J, 2007, EM ALGORITHM EXTENSI; McLachlan GJ, 2002, BIOINFORMATICS, V18, P413, DOI 10.1093/bioinformatics/18.3.413; McNicholas PD, 2010, BIOINFORMATICS, V26, P2705, DOI 10.1093/bioinformatics/btq498; MILLIGAN GW, 1985, PSYCHOMETRIKA, V50, P159, DOI 10.1007/BF02294245; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Oliver J. J., 1996, Machine Learning. Proceedings of the Thirteenth International Conference (ICML '96), P364; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Qin J, 2003, BIOINFORMATICS, V19, P2097, DOI 10.1093/bioinformatics/btg288; RAND WM, 1971, J AM STAT ASSOC, V66, P846, DOI 10.2307/2284239; RISSANEN J, 1978, AUTOMATICA, V14, P465, DOI 10.1016/0005-1098(78)90005-5; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Rousseeuw PJ, 1990, FINDING GROUPS DATA; Salem SA, 2009, PATTERN ANAL APPL, V12, P79, DOI 10.1007/s10044-007-0099-1; Slonim N, 2005, P NATL ACAD SCI USA, V102, P18297, DOI 10.1073/pnas.0507432102; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Teschendorff AE, 2005, BIOINFORMATICS, V21, P3025, DOI 10.1093/bioinformatics/bti466; Thalamuthu A, 2006, BIOINFORMATICS, V22, P2405, DOI 10.1093/bioinformatics/btl406; Wallace CS, 1999, COMPUT J, V42, P270, DOI 10.1093/comjnl/42.4.270; Wu SH, 2004, IEEE T INF TECHNOL B, V8, P5, DOI 10.1109/TITB.2004.824724; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141; Xu Rui, 2010, IEEE Rev Biomed Eng, V3, P120, DOI 10.1109/RBME.2010.2083647; Yeung KY, 2001, BIOINFORMATICS, V17, P977, DOI 10.1093/bioinformatics/17.10.977; Zhang YJ, 2002, IEEE T NEURAL NETWOR, V13, P369, DOI 10.1109/72.991422; Zhao LP, 2001, P NATL ACAD SCI USA, V98, P5631, DOI 10.1073/pnas.101013198	67	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94141	10.1371/journal.pone.0094141	http://dx.doi.org/10.1371/journal.pone.0094141			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714159	Green Published, gold, Green Submitted			2022-12-25	WOS:000334160900093
J	Gray, SA; Reeve, RA				Gray, Sarah A.; Reeve, Robert A.			Preschoolers' Dot Enumeration Abilities Are Markers of Their Arithmetic Competence	PLOS ONE			English	Article							BASIC NUMERICAL CAPACITIES; WORKING-MEMORY; EXECUTIVE FUNCTIONS; DEVELOPMENTAL DYSCALCULIA; INDIVIDUAL-DIFFERENCES; OBJECT-FILES; NUMBER WORDS; CHILDREN; MATHEMATICS; SKILLS	The abilities to enumerate small sets of items (e. g., dots) and to compare magnitudes are claimed to be indexes of core numerical competences that scaffold early math development. Insofar as this is correct, these abilities may be diagnostic markers of math competence in preschoolers. However, unlike magnitude comparison abilities, little research has examined preschoolers' ability to enumerate small sets, or its significance for emerging math abilities; which is surprising since dot enumeration is a marker of school-aged children's math competence. It is nevertheless possible that general cognitive functions (working memory, response inhibition in particular) are associated with preschoolers' math abilities and underlie nascent dot enumeration abilities. We investigated whether preschoolers' dot enumeration abilities predict their non-verbal arithmetic ability, over and above the influence of working memory and response inhibition. Two measures of dot enumeration ability were examined-inverse efficiency and paradigm specific (response time profiles) measures-to determine which has the better diagnostic utility as a marker of math competence. Seventy-eight 42-to-57 month-olds completed dot enumeration, working memory, response inhibition, and non-verbal addition and subtraction tasks. Dot enumeration efficiency predicted arithmetic ability over and above the influence of general cognitive functions. While dot enumeration efficiency was a better predictor of arithmetic ability than paradigm specific response time profiles; the response time profile displaying the smallest subitizing range and steepest subitizing slope, also displayed poor addition abilities, suggesting a weak subitizing profile may have diagnostic significance in preschoolers. Overall, the findings support the claim that dot enumeration abilities and general cognitive functions are markers of preschoolers' math ability.	[Gray, Sarah A.; Reeve, Robert A.] Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia	University of Melbourne	Reeve, RA (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic, Australia.	r.reeve@unimelb.edu.au		Gray, Sarah/0000-0002-2491-2368	Australian Postgraduate Award	Australian Postgraduate Award(Australian Government)	SAG is supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baroody AJ, 2009, MATH THINK LEARN, V11, P41, DOI 10.1080/10986060802583956; Baroody AJ, 2009, EARLY EDUC DEV, V20, P80, DOI 10.1080/10409280802206619; Bartelet D, 2014, J EXP CHILD PSYCHOL, V117, P12, DOI 10.1016/j.jecp.2013.08.010; Benoit L, 2004, COGNITIVE DEV, V19, P291, DOI 10.1016/j.cogdev.2004.03.005; Bonny JW, 2013, J EXP CHILD PSYCHOL, V114, P375, DOI 10.1016/j.jecp.2012.09.015; Brocki KC, 2004, DEV NEUROPSYCHOL, V26, P571, DOI 10.1207/s15326942dn2602_3; Bruyer R, 2011, PSYCHOL BELG, V51, P5, DOI 10.5334/pb-51-1-5; Bull R, 2011, DEVELOPMENTAL SCI, V14, P679, DOI 10.1111/j.1467-7687.2010.01012.x; Butterworth B., 2003, DYSCALCULIA SCREENER; Butterworth B, 2010, TRENDS COGN SCI, V14, P534, DOI 10.1016/j.tics.2010.09.007; Canobi KH, 2005, J EXP CHILD PSYCHOL, V92, P220, DOI 10.1016/j.jecp.2005.06.001; Carey S, 2001, MIND LANG, V16, P37, DOI 10.1111/1468-0017.00155; CHI MTH, 1975, J EXP CHILD PSYCHOL, V19, P434, DOI 10.1016/0022-0965(75)90072-7; Clark CAC, 2013, CHILD DEV, V84, P662, DOI 10.1111/j.1467-8624.2012.01854.x; Clements D., 1999, TEACHING CHILDREN MA, V5, P400; Collins LindaM., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; De Smedt B, 2013, TRENDS NEUROSCI EDUC, V2, P48, DOI 10.1016/j.tine.2013.06.001; Desoete A, 2009, EDUC RES REV-NETH, V4, P55, DOI 10.1016/j.edurev.2008.11.003; Dowsett SM, 2000, DEV PSYCHOBIOL, V36, P161, DOI 10.1002/(SICI)1098-2302(200003)36:2<161::AID-DEV7>3.0.CO;2-0; Eigsti IM, 2006, PSYCHOL SCI, V17, P478, DOI 10.1111/j.1467-9280.2006.01732.x; Espy KA, 2004, DEV NEUROPSYCHOL, V26, P465, DOI 10.1207/s15326942dn2601_6; Espy KA, 1999, BRAIN COGNITION, V41, P178, DOI 10.1006/brcg.1999.1117; Feigenson L, 2002, PSYCHOL SCI, V13, P150, DOI 10.1111/1467-9280.00427; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Feigenson L, 2003, DEVELOPMENTAL SCI, V6, P568, DOI 10.1111/1467-7687.00313; Fuchs LS, 2010, DEV PSYCHOL, V46, P1731, DOI 10.1037/a0020662; Fuchs LS, 2010, CHILD DEV, V81, P1520, DOI 10.1111/j.1467-8624.2010.01489.x; Fuhs MW, 2013, DEVELOPMENTAL SCI, V16, P136, DOI 10.1111/desc.12013; Houde O, 2010, DEVELOPMENTAL SCI, V13, P876, DOI 10.1111/j.1467-7687.2009.00938.x; Hunting R., 2003, J MATH BEHAV, V22, P217, DOI DOI 10.1016/S0732-3123(03)00021-X; HUTTENLOCHER J, 1994, J EXP PSYCHOL GEN, V123, P284, DOI 10.1037/0096-3445.123.3.284; Hyde DC, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00150; Hyde DC, 2011, DEVELOPMENTAL SCI, V14, P360, DOI 10.1111/j.1467-7687.2010.00987.x; Iuculano T, 2008, DEVELOPMENTAL SCI, V11, P669, DOI 10.1111/j.1467-7687.2008.00716.x; Jordan NC, 2006, CHILD DEV, V77, P153, DOI 10.1111/j.1467-8624.2006.00862.x; Klein JS, 2000, CAN J EXP PSYCHOL, V54, P105, DOI 10.1037/h0087333; Koontz K. L., 1996, MATH COGNITION, V2, P1, DOI [10.1080/135467996387525, DOI 10.1080/135467996387525]; Kroesbergen EH, 2009, J PSYCHOEDUC ASSESS, V27, P226, DOI 10.1177/0734282908330586; Landerl K, 2004, COGNITION, V93, P99, DOI 10.1016/j.cognition.2003.11.004; Landerl K, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00459; Le Corre M, 2007, COGNITION, V105, P395, DOI 10.1016/j.cognition.2006.10.005; LEVINE SC, 1992, J EXP CHILD PSYCHOL, V53, P72, DOI 10.1016/S0022-0965(05)80005-0; Libertus ME, 2013, J EXP CHILD PSYCHOL, V116, P829, DOI 10.1016/j.jecp.2013.08.003; Libertus ME, 2013, LEARN INDIVID DIFFER, V25, P126, DOI 10.1016/j.lindif.2013.02.001; Libertus ME, 2011, DEVELOPMENTAL SCI, V14, P1292, DOI 10.1111/j.1467-7687.2011.01080.x; Lonnemann J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00783; Magidson J., 2003, DMA RES COUNCIL J; Mazzocco MMM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023749; McAuley T, 2011, J EXP CHILD PSYCHOL, V108, P453, DOI 10.1016/j.jecp.2010.08.009; Melcher D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029296; Ostergren R, 2013, J EXP CHILD PSYCHOL, V115, P405, DOI 10.1016/j.jecp.2013.03.007; Penner-Wilger M., 2007, P 29 ANN C COGNITIVE, P1385; Piazza M, 2011, COGNITION, V121, P147, DOI 10.1016/j.cognition.2011.05.007; Purpura DJ, 2013, AM EDUC RES J, V50, P178, DOI 10.3102/0002831212465332; Raghubar KP, 2010, LEARN INDIVID DIFFER, V20, P110, DOI 10.1016/j.lindif.2009.10.005; Rasmussen C, 2005, J EXP CHILD PSYCHOL, V91, P137, DOI 10.1016/j.jecp.2005.01.004; Reeve R, 2012, J EXP PSYCHOL GEN, V141, P649, DOI 10.1037/a0027520; Reigosa-Crespo V, 2012, DEV PSYCHOL, V48, P123, DOI 10.1037/a0025356; Sasanguie D, 2012, BRIT J DEV PSYCHOL, V30, P344, DOI 10.1111/j.2044-835X.2011.02048.x; Schleifer P, 2011, DEVELOPMENTAL SCI, V14, P280, DOI 10.1111/j.1467-7687.2010.00976.x; Shimomura T, 2011, ATTEN PERCEPT PSYCHO, V73, P1694, DOI 10.3758/s13414-011-0135-5; Shinskey JL, 2009, J EXP CHILD PSYCHOL, V103, P409, DOI 10.1016/j.jecp.2009.01.012; SILVERMAN IW, 1980, DEV PSYCHOL, V16, P539, DOI 10.1037/0012-1649.16.5.539; Simpson A, 2006, J EXP CHILD PSYCHOL, V94, P18, DOI 10.1016/j.jecp.2005.10.003; STARKEY P, 1995, BRIT J DEV PSYCHOL, V13, P399, DOI 10.1111/j.2044-835X.1995.tb00688.x; Thorell LB, 2009, DEVELOPMENTAL SCI, V12, P106, DOI 10.1111/j.1467-7687.2008.00745.x; Traff U, 2013, J EXP CHILD PSYCHOL, V116, P139, DOI 10.1016/j.jecp.2013.04.007; Trezise K, 2014, J EXP CHILD PSYCHOL, V121, P120, DOI 10.1016/j.jecp.2013.12.001; Trick LM, 2003, MEM COGNITION, V31, P1229, DOI 10.3758/BF03195806; Tuholski SW, 2001, MEM COGNITION, V29, P484, DOI 10.3758/BF03196399; Vanbinst K, 2012, MIND BRAIN EDUC, V6, P129, DOI 10.1111/j.1751-228X.2012.01148.x; Vermunt J.K., 2005, LATENT GOLD 40 USERS; Vermunt J.K., 2016, TECHNICAL GUIDE LATE; von Aster MG, 2007, DEV MED CHILD NEUROL, V49, P868, DOI 10.1111/j.1469-8749.2007.00868.x; Wiebe SA, 2012, CHILD DEV, V83, P1245, DOI 10.1111/j.1467-8624.2012.01765.x; Wiebe SA, 2011, J EXP CHILD PSYCHOL, V108, P436, DOI 10.1016/j.jecp.2010.08.008; Wutz A, 2013, ATTEN PERCEPT PSYCHO, V75, P921, DOI 10.3758/s13414-013-0454-9; WYNN K, 1992, COGNITIVE PSYCHOL, V24, P220, DOI 10.1016/0010-0285(92)90008-P	78	29	30	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94428	10.1371/journal.pone.0094428	http://dx.doi.org/10.1371/journal.pone.0094428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7FA	24714052	Green Published, gold			2022-12-25	WOS:000334160900131
J	Pappalardo, P; Rodriguez-Serrano, E; Fernandez, M				Pappalardo, Paula; Rodriguez-Serrano, Enrique; Fernandez, Miriam			Correlated Evolution between Mode of Larval Development and Habitat in Muricid Gastropods	PLOS ONE			English	Article							PROSOBRANCH EGG CAPSULES; REPRODUCTIVE STRATEGIES; SPECIES RICHNESS; LIFE-HISTORY; MARINE; PATTERNS; PHYLOGENY; DISPERSAL; ECOLOGY; SIZE	Larval modes of development affect evolutionary processes and influence the distribution of marine invertebrates in the ocean. The decrease in pelagic development toward higher latitudes is one of the patterns of distribution most frequently discussed in marine organisms (Thorson's rule), which has been related to increased larval mortality associated with long pelagic durations in colder waters. However, the type of substrate occupied by adults has been suggested to influence the generality of the latitudinal patterns in larval development. To help understand how the environment affects the evolution of larval types we evaluated the association between larval development and habitat using gastropods of the Muricidae family as a model group. To achieve this goal, we collected information on latitudinal distribution, sea water temperature, larval development and type of substrate occupied by adults. We constructed a molecular phylogeny for 45 species of muricids to estimate the ancestral character states and to assess the relationship between traits using comparative methods in a Bayesian framework. Our results showed high probability for a common ancestor of the muricids with nonpelagic (and nonfeeding) development, that lived in hard bottoms and cold temperatures. From this ancestor, a pelagic feeding larva evolved three times, and some species shifted to warmer temperatures or sand bottoms. The evolution of larval development was not independent of habitat; the most probable evolutionary route reconstructed in the analysis of correlated evolution showed that type of larval development may change in soft bottoms but in hard bottoms this change is highly unlikely. Lower sea water temperatures were associated with nonpelagic modes of development, supporting Thorson's rule. We show how environmental pressures can favor a particular mode of larval development or transitions between larval modes and discuss the reacquisition of feeding larva in muricids gastropods.	[Pappalardo, Paula] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Rodriguez-Serrano, Enrique] Univ Concepcion, Fac Ciencias Nat & Oceanog, Dept Zool, Concepcion, Chile; [Pappalardo, Paula; Fernandez, Miriam] Pontificia Univ Catolica Chile, Ctr Conservac Marina, Dept Ecol, Santiago, Chile	University System of Georgia; University of Georgia; Universidad de Concepcion; Pontificia Universidad Catolica de Chile	Pappalardo, P (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	paulapappalardo@gmail.com	Pappalardo, Paula/AFK-4906-2022	Pappalardo, Paula/0000-0003-0853-7681; Rodriguez-Serrano, Enrique/0000-0002-5049-8500	Fondecyt [1100592]; ICM [P10-033F]; CONICYT scholarship; LERNER GRAY fund for marine research; FIC of Ministerio de Economia, Fomento y Turismo of Chile;  [DIUC-213.113.085-1 AP]	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ICM; CONICYT scholarship(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); LERNER GRAY fund for marine research; FIC of Ministerio de Economia, Fomento y Turismo of Chile; 	This study was supported by Fondecyt 1100592 (http://www.conicyt.cl/fondecyt/) and the ICM P10-033F, developed with funds FIC of Ministerio de Economia, Fomento y Turismo of Chile granted to the Center for Marine Conservation (http://www.conservacionmarinauc.cl/). P. Pappalardo was supported through a CONICYT (http://www.conicyt.cl/) scholarship and also thanks a LERNER GRAY fund for marine research. E. Rodriguez-Serrano thanks grant DIUC-213.113.085-1 AP (http://www.udec.cl/vrid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barco A, 2010, MOL PHYLOGENET EVOL, V56, P1025, DOI 10.1016/j.ympev.2010.03.008; CASWELL H, 1981, AM NAT, V117, P529, DOI 10.1086/283733; CHAMBERS RJ, 1994, J MOLLUS STUD, V60, P415, DOI 10.1093/mollus/60.4.415; Chaparro OR, 2002, BIOL BULL, V203, P80, DOI 10.2307/1543460; CHRISTIANSEN FB, 1979, THEOR POPUL BIOL, V16, P267, DOI 10.1016/0040-5809(79)90017-0; Claremont M, 2008, J MOLLUS STUD, V74, P215, DOI 10.1093/mollus/eyn005; CLARK KB, 1978, J MOLLUS STUD, V44, P283; Collin R, 2004, EVOLUTION, V58, P1488; Collin R, 2003, MAR ECOL PROG SER, V247, P103, DOI 10.3354/meps247103; Collin R, 2007, BIOL BULL-US, V212, P83, DOI 10.2307/25066586; Cunha RL, 2005, SYST BIOL, V54, P634, DOI 10.1080/106351591007471; Cunningham CW, 1999, SYST BIOL, V48, P665, DOI 10.1080/106351599260238; DAsaro CN, 1997, OPHELIA, V46, P83, DOI 10.1080/00785326.1997.10432578; DASARO CN, 1991, OPHELIA, V35, P1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fernandez M, 2009, ECOL LETT, V12, P601, DOI 10.1111/j.1461-0248.2009.01315.x; Fortunato H, 2004, INVERTEBR REPROD DEV, V46, P139, DOI 10.1080/07924259.2004.9652617; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gallardo Carlos S., 1994, Gayana Zoologia, V58, P79; Gallardo CS, 2001, MAR BIOL, V138, P547, DOI 10.1007/s002270000477; Grantham BA, 2003, ECOL APPL, V13, pS108; HANSEN TA, 1983, SCIENCE, V220, P501, DOI 10.1126/science.220.4596.501; HANSEN TA, 1980, PALEOBIOLOGY, V6, P193, DOI 10.1017/S0094837300006758; Hart M, 2000, SEMIN CELL DEV BIOL, V11, P411, DOI 10.1006/scdb.2000.0194; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Ives AR, 2010, SYST BIOL, V59, P9, DOI 10.1093/sysbio/syp074; JABLONSKI D, 1983, BIOL REV, V58, P21, DOI 10.1111/j.1469-185X.1983.tb00380.x; Jeffery CH, 2003, MOL PHYLOGENET EVOL, V28, P99, DOI 10.1016/S1055-7903(03)00030-7; Leiva GE, 1998, REV CHIL HIST NAT, V71, P157; Levin L.A., 1995, ECOLOGY MARINE INVER, P464; LEVIN LA, 1984, ECOLOGY, V65, P1185, DOI 10.2307/1938326; Maddison WP, 2009, MESQUITE MODULAR SYS; Marshall DJ, 2012, ANNU REV ECOL EVOL S, V43, P97, DOI 10.1146/annurev-ecolsys-102710-145004; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Moran AL, 1999, BIOL BULL, V196, P229, DOI 10.2307/1542948; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pagel M., 2007, BAYESTRAITS VERSION; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Pagel Mark, 2002, VVolume 64, P269; Pappalardo P, 2014, GLOBAL ECOL BIOGEOGR, V23, P12, DOI 10.1111/geb.12115; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Pechenik JA, 1999, MAR ECOL PROG SER, V177, P269, DOI 10.3354/meps177269; Pringle JM, 2013, ECOLOGY IN PRESS; R Core Team, 2021, R LANG ENV STAT COMP; Rambaut A., 2007, TRACER V1 5; Roy K, 2000, P ROY SOC B-BIOL SCI, V267, P293, DOI 10.1098/rspb.2000.0999; SHUTO T, 1974, LETHAIA, V7, P239, DOI 10.1111/j.1502-3931.1974.tb00899.x; SPIGHT T M, 1977, Nautilus, V91, P67; SPIGHT TM, 1976, BIOL BULL, V150, P491, DOI 10.2307/1540687; STOCKMANNBOSBACH R, 1989, MAR BIOL, V102, P283, DOI 10.1007/BF00428479; STRATHMANN RR, 1982, AM NAT, V119, P91, DOI 10.1086/283892; STRATHMANN RR, 1985, ANNU REV ECOL SYST, V16, P339, DOI 10.1146/annurev.es.16.110185.002011; Tamura K, 2011, MOL BIOL EVOLUTION; THORSON G, 1950, BIOL REV, V25, P1, DOI 10.1111/j.1469-185X.1950.tb00585.x; VANCE RR, 1973, AM NAT, V107, P353, DOI 10.1086/282839; Vermeij GJ, 2000, PALEOBIOLOGY, V26, P19, DOI 10.1666/0094-8373(2000)026<0019:TMGSRP>2.0.CO;2; Zou SM, 2011, MOL PHYLOGENET EVOL, V61, P425, DOI 10.1016/j.ympev.2011.07.014	61	10	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94104	10.1371/journal.pone.0094104	http://dx.doi.org/10.1371/journal.pone.0094104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714732	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900084
J	Song, Y; Bian, Y; Petzold, M; Ung, COL				Song, Yan; Bian, Ying; Petzold, Max; Ung, Carolina Oi Lam			Prevalence and Trend of Major Transfusion-Transmissible Infections among Blood Donors in Western China, 2005 through 2010	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; B-VIRUS; RESIDUAL RISK; VACCINATION; IMPACT; HIV	Background: The prevalence of transfusion-transmissible infections (TTIs) in blood donations is important for evaluating blood safety and potential risks to the population. This study investigated the prevalence of TTIs among blood donors in Western China and suggested measures for policy-makers. Methods: The screening results of 66,311 donations between 2005 and 2010 from a central blood center in Western China were analyzed. The prevalence of hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and syphilis infections were expressed in percentages for the entire study group as well as groups by demographic characteristics and donation frequency, with differences analyzed using Fisher's exact or Chi-square test. Logistic regression was performed to identify the influencing factors of the detected results. Results: 1,769 (2.67%, 95% Cl 2.55-2.79%) of the donated blood had serological evidence of infection with at least one pathogen and 44 (0.07%, 95% Cl 0.05-0.09%) showed evidence of multiple infections. The seroprevalence of HBV, HCV, HIV, and syphilis infections was 0.87% (95% Cl 0.80-0.94%), 0.86% (95% Cl 0.79-0.93%), 0.31% (95% Cl 0.26-0.35%), and 0.70% (95% Cl 0.64-0.76%) respectively. Trend analysis for the prevalence of TTIs showed a significant increase from 2.44% to 3.71% (chi(2) = 100.72, p = 0.00) over this 6-year period. The positive rates for TTIs varied along demographic lines. The top three risk factors in test-positive donors were identified as age, education level and donation frequency. The older age group and lower educated group were linked to a higher prevalence of TTIs. A decreasing prevalence was associated with an increasing frequency of blood donations (chi(2) = 562.78, p = 0.00). Conclusions: Hepatitis B and C were found most, and often in conjunction with syphilis. These were the primary threats to blood safety. The high positivity rate and the increasing prevalence of TTIs among blood donors in Western China call for further actions.	[Song, Yan; Bian, Ying; Ung, Carolina Oi Lam] Univ Macau, Inst Chinese Med Sci, Taipa, Macau, Peoples R China; [Petzold, Max] Univ Gothenburg, Sahlgrenska Acad, Ctr Appl Biostat, Gothenburg, Sweden	University of Macau; University of Gothenburg	Bian, Y (corresponding author), Univ Macau, Inst Chinese Med Sci, Taipa, Macau, Peoples R China.	bianying@umac.mo	Ung, Carolina Oi Lam/AAR-2672-2020; bian, ying/ABI-8040-2020	bian, ying/0000-0002-1716-2925; Ung, Carolina Oi Lam/0000-0003-1915-5099				Adams V, 2009, SOC SCI MED, V68, P410, DOI 10.1016/j.socscimed.2008.11.006; Ameen R, 2005, TRANSFUSION, V45, P1973, DOI 10.1111/j.1537-2995.2005.00635.x; Chiavetta JA, 2003, CAN MED ASSOC J, V169, P767; China MoH WHO UNAIDS, 2006, 2005 UPD HIV AIDS EP; ChinaWindow, 2013, W REG DEV; Christensen PB, 1999, TRANSFUSION, V39, P188, DOI 10.1046/j.1537-2995.1999.39299154734.x; Dong RL, 2011, BIOMED ENVIRON SCI, V24, P207, DOI 10.3967/0895-3988.2011.03.001; Erwin K, 2006, MED ANTHROPOL Q, V20, P139, DOI 10.1525/maq.2006.20.2.139; Gao XF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-88; Guo XC, 1999, BIOMED ENVIRON SCI, V12, P227; Kafi-Abad SA, 2009, TRANSFUSION, V49, P2214, DOI 10.1111/j.1537-2995.2009.02245.x; Kim MJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-160; Li CQ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-176; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liang XF, 2009, J INFECT DIS, V200, P39, DOI 10.1086/599332; Luo ZB, 2012, INT J INFECT DIS, V16, pE82, DOI 10.1016/j.ijid.2011.10.009; Mathai Jaisy, 2002, Indian J Pathol Microbiol, V45, P319; National Bureau of Statistics of China, 2012, REP NAT POP CENS; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; Shan H, 2002, LANCET, V360, P1770, DOI 10.1016/S0140-6736(02)11669-2; Shang G, 2007, TRANSFUSION, V47, P529, DOI 10.1111/j.1537-2995.2006.01146.x; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Soldan K, 2005, Euro Surveill, V10, P9, DOI 10.2807/esm.10.02.00520-en; Soldan K, 2003, VOX SANG, V84, P274, DOI 10.1046/j.1423-0410.2003.00296.x; Wang DeWen, 2008, China Tropical Medicine, V8, P822; WHO, 2009, 100 VOL NONR DON BLO; World Health Organization, 2009, SCREEN DON BLOOD TRA; Xia GL, 1996, INT HEPATOL COMMUN, V5, P62, DOI 10.1016/S0928-4346(96)82012-3; Zou SM, 2004, TRANSFUSION, V44, P1640, DOI 10.1111/j.0041-1132.2004.04153.x; 文国新, 2010, [中国输血杂志, Chinese Journal of Blood Transfusion], V23, P937	30	30	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94528	10.1371/journal.pone.0094528	http://dx.doi.org/10.1371/journal.pone.0094528			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714490	Green Published, gold, Green Submitted			2022-12-25	WOS:000334160900138
J	Taloni, A; Alemi, AA; Ciusani, E; Sethna, JP; Zapperi, S; La Porta, CAM				Taloni, Alessandro; Alemi, Alexander A.; Ciusani, Emilio; Sethna, James P.; Zapperi, Stefano; La Porta, Caterina A. M.			Mechanical Properties of Growing Melanocytic Nevi and the Progression to Melanoma	PLOS ONE			English	Article							TUMOR-GROWTH; MALIGNANT PHENOTYPE; CELL POPULATIONS; CANCER-CELLS; HUMAN SKIN; IN-VITRO; STRESS; BEHAVIOR; PROLIFERATION; SPHEROIDS	Melanocytic nevi are benign proliferations that sometimes turn into malignant melanoma in a way that is still unclear from the biochemical and genetic point of view. Diagnostic and prognostic tools are then mostly based on dermoscopic examination and morphological analysis of histological tissues. To investigate the role of mechanics and geometry in the morpholgical dynamics of melanocytic nevi, we study a computation model for cell proliferation in a layered non-linear elastic tissue. Numerical simulations suggest that the morphology of the nevus is correlated to the initial location of the proliferating cell starting the growth process and to the mechanical properties of the tissue. Our results also support that melanocytes are subject to compressive stresses that fluctuate widely in the nevus and depend on the growth stage. Numerical simulations of cells in the epidermis releasing matrix metalloproteinases display an accelerated invasion of the dermis by destroying the basal membrane. Moreover, we suggest experimentally that osmotic stress and collagen inhibit growth in primary melanoma cells while the effect is much weaker in metastatic cells. Knowing that morphological features of nevi might also reflect geometry and mechanics rather than malignancy could be relevant for diagnostic purposes.	[Taloni, Alessandro; Zapperi, Stefano] CNR, Ist Energet & Interfasi, I-20133 Milan, Italy; [Alemi, Alexander A.; Sethna, James P.] Cornell Univ, Dept Phys, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Ciusani, Emilio] Ist Neurol Carlo Besta, Milan, Italy; [Zapperi, Stefano] Inst Sci Interchange Fdn, Turin, Italy; [La Porta, Caterina A. M.] Univ Milan, Dept Biosci, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Cornell University; IRCCS Istituto Neurologico Besta; University of Milan	La Porta, CAM (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	caterina.laporta@unimi.it	Taloni, Alessandro/AAF-1641-2020; Ciusani, Emilio/J-9822-2016; Taloni, Alessandro/N-3121-2016; Zapperi, Stefano/C-9473-2009; la porta, caterina/K-7345-2013	Taloni, Alessandro/0000-0002-8863-7166; Ciusani, Emilio/0000-0002-7285-123X; Taloni, Alessandro/0000-0002-8863-7166; Zapperi, Stefano/0000-0001-5692-5465; la porta, caterina/0000-0002-3010-8966	National Science Foundation [PHY-1066293]; NCI [U54CA143876]; European Research Council [AdG-2011 SIZEFFECTS]; MIUR [PRIN2010];  [NSF-PHY-0941095]; Division Of Materials Research [1312160] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [U54CA143876] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Research Council(European Research Council (ERC)European Commission); MIUR(Ministry of Education, Universities and Research (MIUR)); ; Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	CAMLP, JPS and SZ acknowledge the hospitality of the Aspen Center for Physics, which is supported by the National Science Foundation, Grant PHY-1066293. AA is supported by NSF-PHY-0941095; JSP by NCI U54CA143876; AT and SZ by the European Research Council AdG-2011 SIZEFFECTS; CAMLP by MIUR PRIN2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adra S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008511; Baraldi MM, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/02/P02032; Baxter LL, 2013, WIRES DEV BIOL, V2, P379, DOI 10.1002/wdev.72; Bitzek E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.170201; BONNETGONNET C, 1994, LANGMUIR, V10, P4012, DOI 10.1021/la00023a019; Chatelain Cyrille, 2011, Boissiera, V64, P13; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; CLARK WH, 1984, HUM PATHOL, V15, P1147, DOI 10.1016/S0046-8177(84)80310-X; CRAMER S F, 1988, Pediatric Pathology, V8, P253; Drasdo D, 2005, PHYS BIOL, V2, P133, DOI 10.1088/1478-3975/2/3/001; DRASDO D, 1995, PHYS REV E, V52, P6635, DOI 10.1103/PhysRevE.52.6635; Drasdo D, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/5/055025; Eikenberry S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000362; Galle J, 2005, BIOPHYS J, V88, P62, DOI 10.1529/biophysj.104.041459; Helmlinger G, 1997, NAT BIOTECHNOL, V15, P778, DOI 10.1038/nbt0897-778; Hendriks FM, 2003, SKIN RES TECHNOL, V9, P274, DOI 10.1034/j.1600-0846.2003.00019.x; Hendriks FM, 2006, MED ENG PHYS, V28, P259, DOI 10.1016/j.medengphy.2005.07.001; Hendriks FM, 2005, THESIS TU EINDHOVEN; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Holcombe M, 2012, INTEGR BIOL-UK, V4, P53, DOI 10.1039/c1ib00042j; Howell D, 1999, PHYS REV LETT, V82, P5241, DOI 10.1103/PhysRevLett.82.5241; JAMES AG, 1975, J APPL POLYM SCI, V19, P2033, DOI 10.1002/app.1975.070190723; Kim JK, 2012, GIORN ITAL DERMAT V, V147, P141; Kittler H, 2000, ARCH DERMATOL, V136, P316, DOI 10.1001/archderm.136.3.316; Koch TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033476; La Porta CAM, 2009, CURR CANCER DRUG TAR, V9, P391, DOI 10.2174/156800909788166574; Lekka M, 1999, EUR BIOPHYS J BIOPHY, V28, P312, DOI 10.1007/s002490050213; Long R, 2011, BIOPHYS J, V101, P643, DOI 10.1016/j.bpj.2011.06.049; Montel F, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/5/055008; Montel F, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.188102; MSC Software Corporation, 2001, THEOR US INF VERS 20; Nielsen MB, 2008, AM J PHYSIOL-CELL PH, V294, pC1046, DOI 10.1152/ajpcell.00134.2007; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Plank MJ, 2012, J R SOC INTERFACE, V9, P2983, DOI 10.1098/rsif.2012.0319; Racz B, 2007, BONE, V40, P1536, DOI 10.1016/j.bone.2007.02.011; Samuel MS, 2011, CANCER CELL, V19, P776, DOI 10.1016/j.ccr.2011.05.008; Simonsen TG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040006; Simpson MJ, 2013, B MATH BIOL, V75, P871, DOI 10.1007/s11538-013-9839-0; Taghizadeh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015183; Thingnes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040377; Treloar KK, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-137; Tse JM, 2012, P NATL ACAD SCI USA, V109, P911, DOI 10.1073/pnas.1118910109; Unna PG, 1893, BERL KLIN WOCHENSCHR, V30; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Walker DC, 2004, BIOSYSTEMS, V76, P89, DOI 10.1016/j.biosystems.2004.05.025; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Wu M, 2013, J THEOR BIOL, V320, P131, DOI 10.1016/j.jtbi.2012.11.031; Zalaudek I, 2009, SEMIN CUTAN MED SURG, V28, P149, DOI 10.1016/j.sder.2009.06.005; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	49	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94229	10.1371/journal.pone.0094229	http://dx.doi.org/10.1371/journal.pone.0094229			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709938	Green Submitted, gold, Green Published			2022-12-25	WOS:000334159800122
J	Zhang, TJ; Tully, DC; Zhou, SJ; He, N				Zhang, Tiejun; Tully, Damien C.; Zhou, Sujuan; He, Na			Characteristics of HCV Co-Infection among HIV Infected Individuals from an Area with High Risk of Blood-Borne Infections in Central China	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; NATURAL-HISTORY; LIVER FIBROSIS; DONORS; PROGRESSION; DISEASE; SEQUENCES; GENOTYPES	Objective: Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection has been proved to be a growing public health concern. The prevalence and genotypic pattern vary with geographic locations. Limited information is available to date with regard to HCV genotype and its clinical implications among those former commercial blood donor communities. The aims of this study were to genetically define the HCV genotype and associated clinical characteristics of HIV/ HCV co-infected patients from a region with commercial blood donation history in central China. Methods: A cross sectional study, including 164 HIV infected subjects, was conducted in Shanxi province central China. Serum samples were collected and HCV antibody testing, AST and ALT testing were performed. Seropositive samples were further subjected to RT-PCR followed by direct sequence coupled with phylogenetic analysis of Core-E1 and NS5B regions performed in comparison with known reference genotypes. Findings: A total of 139 subjects were HCV antibody positive. Genotype could be determined for 88 isolates. Phylogenetic analysis revealed that the predominant circulating subtype was HCV 1b (65.9%), followed by HCV 2a (34.1%). The HCV viral load in the subjects infected with HIV1b was significantly higher than those infected with HCV 2a (P = 0.006). No significant difference for HCV RNA level was detected between ART status, CD4+ cell count level and HIV RNA level. Serum AST and ALT level were likely to increase with HCV RNA level, although no significance was observed. Those who had conducted commercial donation later than 1991 (OR 3.43, 95% CI: 1.12-10.48) and had a short duration of donation (OR 0.35, 95% CI: 0.13-0.96) were more likely to be infected with HCV 1b. Conclusion: These results suggest that HCV subtype 1b predominates in this population, and the impact of HIV status and ART on HCV disease progression is not significantly correlated.	[Zhang, Tiejun; Zhou, Sujuan; He, Na] Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China; [Zhang, Tiejun; Zhou, Sujuan; He, Na] Fudan Univ, Key Lab Publ Hlth Safety, Minist Educ, Shanghai 200433, Peoples R China; [Tully, Damien C.] MIT, Ragon Inst MGH, Boston, MA USA; [Tully, Damien C.] Harvard Univ, Sch Med, Boston, MA USA	Fudan University; Fudan University; Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard Medical School	He, N (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Epidemiol, Shanghai 200433, Peoples R China.	nhe@shmu.edu.cn	Zhang, Tiejun/HDM-7091-2022; zhang, Tiejun/HGD-6858-2022	Tully, Damien/0000-0002-7620-9340	Program of excellent public health young talent of Shanghai [08GWQ058]; National Nature Science Foundation of China [81072345]; Shanghai Leading Disciplinary Project [GWZX0101]; National Science Foundation of China [81373062]; Doctoral Fund of Ministry of Education of China [20120071120050]	Program of excellent public health young talent of Shanghai; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Disciplinary Project; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This study was supported by Program of excellent public health young talent of Shanghai (08GWQ058), National Nature Science Foundation of China (81072345), Shanghai Leading Disciplinary Project (grant no. GWZX0101), National Science Foundation of China (grant no. 81373062) and Doctoral Fund of Ministry of Education of China (Grant No. 20120071120050 to TZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2002, HEPATOLOGY, V36, pS93, DOI 10.1053/jhep.2002.36389; Benhamou Y, 1999, HEPATOLOGY, V30, P1054, DOI 10.1002/hep.510300409; Bonacini M, 1999, J VIRAL HEPATITIS, V6, P203, DOI 10.1046/j.1365-2893.1999.00153.x; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Cohen J, 2004, SCIENCE, V304, P1438, DOI 10.1126/science.304.5676.1438; Danta M, 2008, J INFECT DIS, V197, P1558, DOI 10.1086/587843; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fu Y, 2011, J VIRAL HEPATITIS, V18, P42, DOI 10.1111/j.1365-2893.2010.01280.x; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Liu J, 2011, AIDS RES HUM RETROVI; Liu PP, 2008, AIDS RES HUM RETROV, V24, P1, DOI 10.1089/aid.2007.0144; Liu Zhen, 2006, Zhonghua Gan Zang Bing Za Zhi, V14, P464; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Piroth L, 1998, AIDS, V12, P381, DOI 10.1097/00002030-199804000-00006; Qian HZ, 2006, AIDS, V20, P1429, DOI 10.1097/01.aids.0000233577.33973.fa; Ragni MV, 2001, J INFECT DIS, V183, P1112, DOI 10.1086/319273; Romeo R, 1996, J VIRAL HEPATITIS, V3, P183, DOI 10.1111/j.1365-2893.1996.tb00093.x; Sabin CA, 1997, J INFECT DIS, V175, P164, DOI 10.1093/infdis/175.1.164; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Sherman KE, 2002, CLIN INFECT DIS, V34, P831, DOI 10.1086/339042; Shi Xiao-ming, 2006, Zhonghua Yufang Yixue Zazhi, V40, P427; Simmonds P, 1999, J HEPATOL, V31, P54, DOI 10.1016/S0168-8278(99)80375-4; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; SIMMONDS P, 1993, J GEN VIROL, V74, P2391, DOI 10.1099/0022-1317-74-11-2391; Soto B, 1997, J HEPATOL, V26, P1, DOI 10.1016/S0168-8278(97)80001-3; Sulkowski MS, 2000, CLIN INFECT DIS, V30, pS77, DOI 10.1086/313842; SUN YD, 1991, CHINESE MED J-PEKING, V104, P975; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Verma S, 2006, CLIN INFECT DIS, V42, P262, DOI 10.1086/499055; WU ZY, 1995, LANCET, V346, P61, DOI 10.1016/S0140-6736(95)92698-4; Zein NN, 2000, CLIN MICROBIOL REV, V13, P223, DOI 10.1128/CMR.13.2.223-235.2000; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004; Zhang MD, 2005, EMERG INFECT DIS, V11, P17, DOI 10.3201/eid1101.031005	34	6	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94219	10.1371/journal.pone.0094219	http://dx.doi.org/10.1371/journal.pone.0094219			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709894	gold, Green Published, Green Submitted			2022-12-25	WOS:000334159800121
J	Kirti, A; Rajaram, H; Apte, SK				Kirti, Anurag; Rajaram, Hema; Apte, Shree Kumar			The Hypothetical Protein 'All4779', and Not the Annotated 'Alr0088' and 'Alr7579' Proteins, Is the Major Typical Single-Stranded DNA Binding Protein of the Cyanobacterium, Anabaena sp PCC7120	PLOS ONE			English	Article							NITROGEN-FIXING CYANOBACTERIUM; SP STRAIN PCC7120; ESCHERICHIA-COLI; DEINOCOCCUS-RADIODURANS; GENETIC-RECOMBINATION; COMPLEXES; SSB; IDENTIFICATION; OVERPRODUCTION; TOLERANCE	Single-stranded DNA binding (SSB) proteins are essential for all DNA-dependent cellular processes. Typical SSB proteins have an N-terminal Oligonucleotide-Binding (OB) fold, a Proline/Glycine rich region, followed by a C-terminal acidic tail. In the genome of the heterocystous nitrogen-fixing cyanobacterium, Anabaena sp. strain PCC7120, alr0088 and alr7579 are annotated as coding for SSB, but are truncated and have only the OB-fold. In silico analysis of whole genome of Anabaena sp. strain PCC7120 revealed the presence of another ORF 'all4779', annotated as a hypothetical protein, but having an N-terminal OB-fold, a P/G-rich region and a C-terminal acidic tail. Biochemical characterisation of all three purified recombinant proteins revealed that they exist either as monomer or dimer and bind ssDNA, but differently. The All4779 bound ssDNA in two binding modes i.e. (All4779)(35) and (All4779)(66) depending on salt concentration and with a binding affinity similar to that of Escherichia coli SSB. On the other hand, Alr0088 bound in a single binding mode of 50-mer and Alr7579 only to large stretches of ssDNA, suggesting that All4779, in all likelihood, is the major typical bacterial SSB in Anabaena. Overexpression of All4779 in Anabaena sp. strain PCC7120 led to enhancement of tolerance to DNA-damaging stresses, such as gamma-rays, UV-irradiation, desiccation and mitomycinC exposure. The tolerance appears to be a consequence of reduced DNA damage or efficient DNA repair due to increased availability of All4779. The ORF all4779 is proposed to be re-annotated as Anabaena ssb gene.	[Kirti, Anurag; Rajaram, Hema; Apte, Shree Kumar] Bhabha Atom Res Ctr, Div Mol Biol, Bombay 400085, Maharashtra, India	Bhabha Atomic Research Center (BARC)	Rajaram, H (corresponding author), Bhabha Atom Res Ctr, Div Mol Biol, Bombay 400085, Maharashtra, India.	hemaraj@barc.gov.in						Apte Shree Kumar, 2001, PINSA-B, V67, P285; Bernstein DA, 2004, P NATL ACAD SCI USA, V101, P8575, DOI 10.1073/pnas.0401331101; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; BUJALOWSKI W, 1986, BIOCHEMISTRY-US, V25, P7799, DOI 10.1021/bi00372a003; Carlini L, 1998, FEBS LETT, V430, P197, DOI 10.1016/S0014-5793(98)00655-3; CASTENHOLZ RW, 1988, METHOD ENZYMOL, V167, P68; Chaurasia AK, 2008, J MICROBIOL METH, V73, P133, DOI 10.1016/j.mimet.2008.01.013; Curth U, 1996, NUCLEIC ACIDS RES, V24, P2706, DOI 10.1093/nar/24.14.2706; CURTH U, 1994, EUR J BIOCHEM, V221, P435, DOI 10.1111/j.1432-1033.1994.tb18756.x; Eggington JM, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-2; Kidane D, 2012, CRIT REV BIOCHEM MOL, V47, P531, DOI 10.3109/10409238.2012.729562; Kirti A, 2013, PHOTOSYNTH RES, V118, P147, DOI 10.1007/s11120-013-9904-4; Kozlov AG, 2010, J BIOL CHEM, V285, P17246, DOI 10.1074/jbc.M110.118273; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; MacKinney G, 1941, J BIOL CHEM, V140, P315; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; MOLINEUX IJ, 1975, NUCLEIC ACIDS RES, V2, P1821, DOI 10.1093/nar/2.10.1821; MOREAU PL, 1987, J MOL BIOL, V194, P621, DOI 10.1016/0022-2836(87)90239-7; MOREAU PL, 1988, J BACTERIOL, V170, P2493, DOI 10.1128/jb.170.6.2493-2500.1988; Nakasugi K, 2006, MICROBIOL-SGM, V152, P3623, DOI 10.1099/mic.0.29189-0; Olszewski M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-260; Ponomarev VA, 2003, J MOL MICROB BIOTECH, V5, P225, DOI 10.1159/000071074; Raghavan PS, 2011, PLANT MOL BIOL, V77, P407, DOI 10.1007/s11103-011-9821-x; Rajaram H, 2010, ARCH MICROBIOL, V192, P729, DOI 10.1007/s00203-010-0601-9; RECKMANN B, 1985, EUR J BIOCHEM, V152, P633, DOI 10.1111/j.1432-1033.1985.tb09242.x; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Singh H, 2013, PHOTOSYNTH RES, V118, P71, DOI 10.1007/s11120-013-9936-9; Singh H, 2010, J BIOSCIENCES, V35, P427, DOI 10.1007/s12038-010-0048-9; Wadsworth RIM, 2001, NUCLEIC ACIDS RES, V29, P914, DOI 10.1093/nar/29.4.914; Yadav T, 2012, NUCLEIC ACIDS RES, V40, P5546, DOI 10.1093/nar/gks173; Yoon HS, 1998, SCIENCE, V282, P935, DOI 10.1126/science.282.5390.935; Yura K, 1999, DNA Res, V6, P75, DOI 10.1093/dnares/6.2.75	33	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93592	10.1371/journal.pone.0093592	http://dx.doi.org/10.1371/journal.pone.0093592			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705540	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500046
J	Li, YJ; Wei, ZY; Zhang, JY; Yang, Z; Zhang, MJ				Li, Youjun; Wei, Zhiyi; Zhang, Junyi; Yang, Zhou; Zhang, Mingjie			Structural Basis of the Binding of Merlin FERM Domain to the E3 Ubiquitin Ligase Substrate Adaptor DCAF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF2 TUMOR-SUPPRESSOR; ERM PROTEINS; NEUROFIBROMATOSIS TYPE-2; CARGO RECOGNITION; CRYSTAL-STRUCTURE; GENE; MOESIN; TAIL; TUMORIGENESIS; ORGANIZATION	The tumor suppressor gene Nf2 product, Merlin, plays vital roles in controlling proper development of organ sizes by specifically binding to a large number of target proteins localized both in cytoplasm and nuclei. The FERM domain of Merlin is chiefly responsible for its binding to target proteins, although the molecular basis governing these interactions are poorly understood due to lack of structural information. Here, we report the crystal structure of the Merlin FERM domain in complex with its binding domain derived from the E3 ubiquitin ligase substrate adaptor DCAF1 (also known as VPRBP). Unlike target binding modes found in ERM proteins, the Merlin-FERM binding domain of DCAF1 folds as a beta-hairpin and binds to the alpha 1/beta 5-groove of the F3 lobe of Merlin-FERM via extensive hydrophobic interactions. In addition to providing the first structural glimpse of a Merlin-FERM.target complex, the structure of the Merlin.DCAF1 complex is likely to be valuable for understanding the interactions of Merlin with its binding partners other than DCAF1.	[Li, Youjun; Wei, Zhiyi; Zhang, Junyi; Yang, Zhou; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Wei, Zhiyi; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Ctr Syst Biol & Human Hlth, Sch Sci, Kowloon, Hong Kong, Peoples R China; [Wei, Zhiyi; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Inst Adv Study, Kowloon, Hong Kong, Peoples R China; [Wei, Zhiyi] South Univ Sci & Technol China, Dept Biol, Shenzhen, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Southern University of Science & Technology	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk	Wei, Zhiyi/N-9995-2019; Yang, Zhou/AAE-2295-2019; Wei, Zhiyi/C-4315-2014	Wei, Zhiyi/0000-0002-4446-6502; Yang, Zhou/0000-0003-4400-0902; Wei, Zhiyi/0000-0002-4446-6502; Zhang, Mingjie/0000-0001-9404-0190	Research Grant Council of Hong Kong [663610, 663811, 663812, HKUST6/CRF/10, SEG_HKUST06, AoE/M09/12, T13-607/12R]	Research Grant Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by Research Grant Council of Hong Kong Grants 663610, 663811, 663812, HKUST6/CRF/10, SEG_HKUST06, AoE/M09/12, and T13-607/12R (to M. Z.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Ghai R, 2013, P NATL ACAD SCI USA, V110, pE643, DOI 10.1073/pnas.1216229110; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hamada K, 2003, EMBO J, V22, P502, DOI 10.1093/emboj/cdg039; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hirano Y, 2011, EMBO J, V30, P2734, DOI 10.1038/emboj.2011.177; Kang BS, 2002, ACTA CRYSTALLOGR D, V58, P381, DOI 10.1107/S0907444901021175; Kissil JL, 2003, MOL CELL, V12, P841, DOI 10.1016/S1097-2765(03)00382-4; Li QZ, 2007, J MOL BIOL, V365, P1446, DOI 10.1016/j.jmb.2006.10.075; Li W, 2012, EMBO REP, V13, P204, DOI 10.1038/embor.2012.11; Li W, 2010, CELL, V140, P477, DOI 10.1016/j.cell.2010.01.029; McCartney BM, 1996, J CELL BIOL, V133, P843, DOI 10.1083/jcb.133.4.843; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; Mori T, 2008, J BIOL CHEM, V283, P29602, DOI 10.1074/jbc.M803606200; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Sher I, 2012, DEV CELL, V22, P703, DOI 10.1016/j.devcel.2012.03.008; Shimizu T, 2002, J BIOL CHEM, V277, P10332, DOI 10.1074/jbc.M109979200; Takai Y, 2008, J MOL BIOL, V381, P634, DOI 10.1016/j.jmb.2008.05.085; Takai Y, 2007, GENES CELLS, V12, P1329, DOI 10.1111/j.1365-2443.2007.01137.x; Tepass U, 2009, CURR OPIN GENET DEV, V19, P357, DOI 10.1016/j.gde.2009.05.006; Terawaki S, 2007, J BIOL CHEM, V282, P19854, DOI 10.1074/jbc.M609232200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TROFATTER JA, 1993, CELL, V72, P791, DOI 10.1016/0092-8674(93)90406-G; Wegener KL, 2008, J MOL BIOL, V382, P112, DOI 10.1016/j.jmb.2008.06.087; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wei ZY, 2011, P NATL ACAD SCI USA, V108, P3572, DOI 10.1073/pnas.1016567108; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025	37	11	11	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14674	14681		10.1074/jbc.M114.551184	http://dx.doi.org/10.1074/jbc.M114.551184			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24706749	Green Published, hybrid			2022-12-25	WOS:000337248100024
J	Song, D; Li, LS; Arsenault, PR; Tan, Q; Bigham, AW; Heaton-Johnson, KJ; Master, SR; Lee, FS				Song, Daisheng; Li, Lin-Sheng; Arsenault, Patrick R.; Tan, Qiulin; Bigham, Abigail W.; Heaton-Johnson, Katherine J.; Master, Stephen R.; Lee, Frank S.			Defective Tibetan PHD2 Binding to p23 Links High Altitude Adaption to Altered Oxygen Sensing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; NITRIC-OXIDE SYNTHASE; PULMONARY-HYPERTENSION; FUNCTION MUTATION; MOUSE MODEL; ADAPTATION; ERYTHROCYTOSIS; PATHWAY; ACTIVATION; PROTEIN	The Tibetan population has adapted to the chronic hypoxia of high altitude. Tibetans bear a genetic signature in the prolyl hydroxylase domain protein 2 (PHD2/EGLN1) gene, which encodes for the central oxygen sensor of the hypoxia-inducible factor (HIF) pathway. Recent studies have focused attention on two nonsynonymous coding region substitutions, D4E and C127S, both of which are markedly enriched in the Tibetan population. These amino acids reside in a region of PHD2 that harbors a zinc finger, which we have previously discovered binds to a Pro-Xaa-Leu-Glu (PXLE) motif in the HSP90 cochaperone p23, thereby recruiting PHD2 to the HSP90 pathway to facilitate HIF-alpha hydroxylation. We herein report that the Tibetan PHD2 haplotype (D4E/C127S) strikingly diminishes the interaction of PHD2 with p23, resulting in impaired PHD2 down-regulation of the HIF pathway. The defective binding to p23 depends on both the D4E and C127S substitutions. We also identify a PXLE motif in HSP90 itself that can mediate binding to PHD2 but find that this interaction is maintained with the D4E/C127S PHD2 haplotype. We propose that the Tibetan PHD2 variant is a loss of function (hypomorphic) allele, leading to augmented HIF activation to facilitate adaptation to high altitude.	[Song, Daisheng; Li, Lin-Sheng; Arsenault, Patrick R.; Tan, Qiulin; Heaton-Johnson, Katherine J.; Master, Stephen R.; Lee, Frank S.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bigham, Abigail W.] Univ Michigan, Dept Anthropol, Ann Arbor, MI 48109 USA	University of Pennsylvania; Pennsylvania Medicine; University of Michigan System; University of Michigan	Lee, FS (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Stellar Chance Labs 605, 422 Curie Blvd, Philadelphia, PA 19104 USA.	franklee@mail.med.upenn.edu	Arsenault, Patrick/F-3429-2011	Arsenault, Patrick/0000-0001-6670-0809; Lee, Frank/0000-0003-2511-1834; Master, Stephen/0000-0002-6808-631X	National Institutes of Health [R21-HL120751, R01-CA153347, R01-GM090301]; NATIONAL CANCER INSTITUTE [R01CA153347, P30CA016520] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL120751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21-HL120751 (to F. S. L.), R01-CA153347 (to F. S. L.), and R01-GM090301 (to F. S. L. and S. R. M.).	Arsenault PR, 2013, J BIOL CHEM, V288, P33571, DOI 10.1074/jbc.M113.482364; Beall CM, 2013, AM J HUM BIOL, V25, P141, DOI 10.1002/ajhb.22355; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Boutin AT, 2008, CELL, V133, P223, DOI 10.1016/j.cell.2008.02.038; Brusselmans K, 2003, J CLIN INVEST, V111, P1519, DOI 10.1172/JCI200315496; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Gale DP, 2008, BLOOD, V112, P919, DOI 10.1182/blood-2008-04-153718; Garcia-Cardena G, 1998, NATURE, V392, P821, DOI 10.1038/33934; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Hickey MM, 2010, J CLIN INVEST, V120, P827, DOI 10.1172/JCI36362; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; Katschinski DM, 2002, J BIOL CHEM, V277, P9262, DOI 10.1074/jbc.M110377200; Kline DD, 2002, P NATL ACAD SCI USA, V99, P821, DOI 10.1073/pnas.022634199; Lee CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019961; Lee FS, 2011, ANNU REV PATHOL-MECH, V6, P165, DOI 10.1146/annurev-pathol-011110-130321; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; Lorenzo F. R., 2010, AM SOC HEM ANN M DEC; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; MELILLO G, 1995, J EXP MED, V182, P1683, DOI 10.1084/jem.182.6.1683; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; Palmer LA, 1998, AM J PHYSIOL-LUNG C, V274, pL212, DOI 10.1152/ajplung.1998.274.2.L212; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Percy MJ, 2007, BLOOD, V110, P2193, DOI 10.1182/blood-2007-04-084434; Rytkonen KT, 2011, MOL BIOL EVOL, V28, P1913, DOI 10.1093/molbev/msr012; Scheinfeldt LB, 2013, NAT REV GENET, V14, P692, DOI 10.1038/nrg3604; Scortegagna M, 2005, BLOOD, V105, P3133, DOI 10.1182/blood-2004-05-1695; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Simonson TS, 2012, HUM GENET, V131, P527, DOI 10.1007/s00439-011-1109-3; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Song DS, 2013, J BIOL CHEM, V288, P9662, DOI 10.1074/jbc.M112.440552; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tan QL, 2013, J BIOL CHEM, V288, P17134, DOI 10.1074/jbc.M112.444059; Wang BB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017002; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wochnik GM, 2004, FEBS LETT, V560, P35, DOI 10.1016/S0014-5793(04)00066-3; Xiang K, 2013, MOL BIOL EVOL, V30, P1889, DOI 10.1093/molbev/mst090; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Yu F, 2001, CANCER RES, V61, P4136; Yu YJ, 2002, J VIROL, V76, P3731, DOI 10.1128/JVI.76.8.3731-3738.2002	48	56	59	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14656	14665		10.1074/jbc.M113.541227	http://dx.doi.org/10.1074/jbc.M113.541227			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24711448	hybrid, Green Published			2022-12-25	WOS:000337248100022
J	Fiz, JA; Jane, R; Lozano, M; Gomez, R; Ruiz, J				Antonio Fiz, Jose; Jane, Raimon; Lozano, Manuel; Gomez, Rosa; Ruiz, Juan			Detecting Unilateral Phrenic Paralysis by Acoustic Respiratory Analysis	PLOS ONE			English	Article							NORMAL LUNG SOUNDS; DIAPHRAGMATIC PARALYSIS; BIOACOUSTIC METHOD; PULMONARY-FUNCTION; SLEEP-APNEA; FLOW; VISUALIZATION; WAKEFULNESS; VENTILATION; DYSFUNCTION	The consequences of phrenic nerve paralysis vary from a considerable reduction in respiratory function to an apparently normal state. Acoustic analysis of lung sound intensity (LSI) could be an indirect non-invasive measurement of respiratory muscle function, comparing activity on the two sides of the thoracic cage. Lung sounds and airflow were recorded in ten males with unilateral phrenic paralysis and ten healthy subjects (5 men/5 women), during progressive increasing airflow maneuvers. Subjects were in sitting position and two acoustic sensors were placed on their back, on the left and right sides. LSI was determined from 1.2 to 2.4 L/s between 70 and 2000 Hz. LSI was significantly greater on the normal (19.3 +/- 4.0 dB) than the affected (5.7 +/- 3.5 dB) side in all patients (p = 0.0002), differences ranging from 9.9 to 21.3 dB (13.5 +/- 3.5 dB). In the healthy subjects, the LSI was similar on both left (15.1 +/- 6.3 dB) and right (17.4 +/- 5.7 dB) sides (p = 0.2730), differences ranging from 0.4 to 4.6 dB (2.3 +/- 1.6 dB). There was a positive linear relationship between the LSI and the airflow, with clear differences between the slope of patients (about 5 dB/L/s) and healthy subjects (about 10 dB/L/s). Furthermore, the LSI from the affected side of patients was close to the background noise level, at low airflows. As the airflow increases, the LSI from the affected side did also increase, but never reached the levels seen in healthy subjects. Moreover, the difference in LSI between healthy and paralyzed sides was higher in patients with lower FEV1 (%). The acoustic analysis of LSI is a relevant non-invasive technique to assess respiratory function. This method could reinforce the reliability of the diagnosis of unilateral phrenic paralysis, as well as the monitoring of these patients.	[Antonio Fiz, Jose; Gomez, Rosa; Ruiz, Juan] Hosp Badalona Germans Trias & Pujol, Serv Pneumol, Badalona, Spain; [Antonio Fiz, Jose; Jane, Raimon; Lozano, Manuel] Inst Bioengn Catalonia IBEC, Barcelona, Spain; [Antonio Fiz, Jose; Jane, Raimon] Biomed Res Networking Ctr Bioengn Biomat & Nanome, Barcelona, Spain; [Jane, Raimon] Univ Politecn Cataluna, Dept ESAII, Barcelona, Spain; [Lozano, Manuel] Germans Trias & Pujol Fdn IGTP, Hlth Sci Res Inst, Innovat Grp, Badalona, Spain	Hospital Germans Trias i Pujol; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Universitat Politecnica de Catalunya; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP)	Jane, R (corresponding author), Inst Bioengn Catalonia IBEC, Barcelona, Spain.	rjane@ibecbarcelona.eu	García, Manuel Lozano/S-2482-2018	García, Manuel Lozano/0000-0002-4146-9839; Jane, Raimon/0000-0002-6541-8729	Spanish Ministry of Economy and Competitiveness [TEC2010-21703-C03-01]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was made possible thanks to a collaboration agreement, between IBEC and IGTP, to create a joint research Unit, and it was supported in part by the Spanish Ministry of Economy and Competitiveness under grant TEC2010-21703-C03-01. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshaer H, 2011, J CLIN MONIT COMPUT, V25, P285, DOI 10.1007/s10877-011-9307-z; AMIS TC, 1980, CLIN SCI, V59, P485, DOI 10.1042/cs0590485; BALAJI S, 1990, BRIT HEART J, V64, P20; Boudarham J, 2013, CHEST, V144, P887, DOI 10.1378/chest.12-2317; BROCHARD L, 1989, AM REV RESPIR DIS, V139, P513, DOI 10.1164/ajrccm/139.2.513; Chetta A, 2005, RESP MED, V99, P39, DOI 10.1016/j.rmed.2004.04.016; Dellinger RP, 2008, RESPIRATION, V75, P60, DOI 10.1159/000103558; Dernaika TA, 2008, RESP CARE, V53, P351; DEVITA MA, 1993, CHEST, V103, P850, DOI 10.1378/chest.103.3.850; DiMarco AF, 2004, J APPL PHYSIOL, V96, P2120, DOI 10.1152/japplphysiol.00628.2003; EPSTEIN SW, 1979, CAN MED ASSOC J, V120, P1360; Fiz JA, 2008, CHEST, V133, P729, DOI 10.1378/chest.07-1102; Freilich S, 2011, THORAX, V66, P133, DOI 10.1136/thx.2010.145144; GAVRIELY N, 1994, EUR RESPIR J, V7, P35, DOI 10.1183/09031936.94.07010035; Gayan-Ramirez G, 2008, RESP MED, V102, P690, DOI 10.1016/j.rmed.2008.01.001; GHARAGOZLOO F, 1995, SURG ENDOSC-ULTRAS, V9, P1204; GIBSON GJ, 1989, THORAX, V44, P960, DOI 10.1136/thx.44.11.960; Golabbakhsh M, 2004, CAN C ELECT COMPUT E, V2, P751; Gross V, 2000, AM J RESP CRIT CARE, V162, P905, DOI 10.1164/ajrccm.162.3.9905104; Habib GS, 2012, J MED CASES, V3, P164; Hossain I, 2004, P ANN INT IEEE EMBS, V26, P3852; Hult P, 2000, MED ENG PHYS, V22, P425, DOI 10.1016/S1350-4533(00)00050-3; Kim SH, 2010, ANESTH ANALG, V110, P1349, DOI 10.1213/ANE.0b013e3181d5e4d8; Kompis M, 1997, P ANN INT IEEE EMBS, V19, P2047, DOI 10.1109/IEMBS.1997.758750; LISBOA C, 1986, AM REV RESPIR DIS, V134, P488; McCool FD, 2012, NEW ENGL J MED, V366, P932, DOI 10.1056/NEJMra1007236; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Montazeri A, 2012, ANN BIOMED ENG, V40, P916, DOI 10.1007/s10439-011-0456-5; Morice RC, 2010, J CARDIOTHORAC SURG, V5, DOI 10.1186/1749-8090-5-81; Oud M, 2000, IEEE T BIO-MED ENG, V47, P1450, DOI 10.1109/10.880096; Pasterkamp H, 1997, MED BIOL ENG COMPUT, V35, P103, DOI 10.1007/BF02534138; Pasterkamp H, 1997, AM J RESP CRIT CARE, V156, P974, DOI 10.1164/ajrccm.156.3.9701115; Roca J, 1998, EUR RESPIR J, V11, P1354, DOI 10.1183/09031936.98.11061354; ROUSSOS CS, 1977, AM REV RESPIR DIS, V116, P457, DOI 10.1164/arrd.1977.116.3.457; Scillia P, 2004, J APPL PHYSIOL, V96, P96, DOI 10.1152/japplphysiol.00761.2003; SHYKOFF BE, 1988, AM REV RESPIR DIS, V137, P872, DOI 10.1164/ajrccm/137.4.872; Sokolowska B, 2003, JPN J PHYSIOL, V53, P301, DOI 10.2170/jjphysiol.53.301; Tejman-Yarden S, 2006, ANESTH ANALG, V103, P1489, DOI 10.1213/01.ane.0000240909.48774.49; Torres-Jimenez A, 2008, IEEE ENG MED BIO, P4797, DOI 10.1109/IEMBS.2008.4650286; Watson AC, 2001, CRIT CARE MED, V29, P1325, DOI 10.1097/00003246-200107000-00005; Xu WD, 2005, J NEUROSURG, V103, P464, DOI 10.3171/jns.2005.103.3.0464; Yadollahi A, 2013, ANN BIOMED ENG, V41, P537, DOI 10.1007/s10439-012-0692-3; Yi LC, 2011, ARCH BRONCONEUMOL, V47, P310, DOI 10.1016/j.arbres.2010.12.011	43	18	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93595	10.1371/journal.pone.0093595	http://dx.doi.org/10.1371/journal.pone.0093595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718599	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000036
J	Chinier, E; N'Guyen, S; Lignon, G; Ter Minassian, A; Richard, I; Dinomais, M				Chinier, Eva; N'Guyen, Sylvie; Lignon, Gregoire; Ter Minassian, Aram; Richard, Isabelle; Dinomais, Mickael			Effect of Motor Imagery in Children with Unilateral Cerebral Palsy: fMRI Study	PLOS ONE			English	Article							CONGENITAL HEMIPARESIS; BRAIN; SELECTION; MOVEMENT; NETWORK; LATERALIZATION; REORGANIZATION; NORMALIZATION; ACTIVATION; EXECUTION	Background: Motor imagery is considered as a promising therapeutic tool for rehabilitation of motor planning problems in patients with cerebral palsy. However motor planning problems may lead to poor motor imagery ability. Aim: The aim of this functional magnetic resonance imaging study was to examine and compare brain activation following motor imagery tasks in patients with hemiplegic cerebral palsy with left or right early brain lesions. We tested also the influence of the side of imagined hand movement. Method: Twenty patients with clinical hemiplegic cerebral palsy (sixteen males, mean age 12 years and 10 months, aged 6 years 10 months to 20 years 10 months) participated in this study. Using block design, brain activations following motor imagery of a simple opening-closing hand movement performed by either the paretic or nonparetic hand was examined. Results: During motor imagery tasks, patients with early right brain damages activated bilateral fronto-parietal network that comprise most of the nodes of the network well described in healthy subjects. Inversely, in patients with left early brain lesion brain activation following motor imagery tasks was reduced, compared to patients with right brain lesions. We found also a weak influence of the side of imagined hand movement. Conclusion: Decreased activations following motor imagery in patients with right unilateral cerebral palsy highlight the dominance of the left hemisphere during motor imagery tasks. This study gives neuronal substrate to propose motor imagery tasks in unilateral cerebral palsy rehabilitation at least for patients with right brain lesions.	[Chinier, Eva; N'Guyen, Sylvie; Ter Minassian, Aram; Dinomais, Mickael] LUNAM, Nantes, France; [Chinier, Eva; N'Guyen, Sylvie; Ter Minassian, Aram; Dinomais, Mickael] Univ Angers, Lab Ingn Syst Automatise, Nantes, France; [Chinier, Eva; Richard, Isabelle; Dinomais, Mickael] Univ Angers, LUNAM, Dept Med Phys & Readaptat, Nantes, France; [N'Guyen, Sylvie] Univ Angers, LUNAM, CHU Angers, Dept Neuropediat, Nantes, France; [Lignon, Gregoire] Univ Angers, LUNAM, CHU Angers, Pole Imagerie, Nantes, France; [Ter Minassian, Aram] Univ Angers, LUNAM, CHU Angers, Pole Anesthesie Reanimat, Nantes, France	Universite d'Angers; Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Chinier, E (corresponding author), LUNAM, Nantes, France.	eva.chinier@hotmail.fr			university hospital of Angers; Societe Francaise de Medecine Physique et Readaptation (SOFMER); Societe Francophone d'Etudes et de Recherche sur les Handicaps de l'Enfance (SFERHE)	university hospital of Angers; Societe Francaise de Medecine Physique et Readaptation (SOFMER); Societe Francophone d'Etudes et de Recherche sur les Handicaps de l'Enfance (SFERHE)	The research was supported by the university hospital of Angers, the Societe Francaise de Medecine Physique et Readaptation (SOFMER) and the Societe Francophone d'Etudes et de Recherche sur les Handicaps de l'Enfance (SFERHE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Beckung E, 2002, DEV MED CHILD NEUROL, V44, P309; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Craje C, 2010, RES DEV DISABIL, V31, P1039, DOI 10.1016/j.ridd.2010.04.007; Craje C, 2009, BRAIN RES, V1261, P54, DOI 10.1016/j.brainres.2008.12.074; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Decety J, 1996, BEHAV BRAIN RES, V77, P45, DOI 10.1016/0166-4328(95)00225-1; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Dinomais M, 2013, RES DEV DISABIL, V34, P3487, DOI 10.1016/j.ridd.2013.07.008; Dinomais M, 2013, RES DEV DISABIL, V34, P1928, DOI 10.1016/j.ridd.2013.03.020; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Haaland KY, 2000, BRAIN, V123, P2306, DOI 10.1093/brain/123.11.2306; Harris IM, 2003, J COGNITIVE NEUROSCI, V15, P315, DOI 10.1162/089892903321593054; HEIL M, 1993, J EXP PSYCHOL HUMAN, V19, P1313, DOI 10.1037/0096-1523.19.6.1313; Hetu S, 2013, NEUROSCI BIOBEHAV R, V37, P930, DOI 10.1016/j.neubiorev.2013.03.017; Holmes P, 2008, J MOTOR BEHAV, V40, P433, DOI 10.3200/JMBR.40.5.433-445; Houwink A, 2011, RES DEV DISABIL, V32, P2157, DOI 10.1016/j.ridd.2011.07.012; Jackson PL, 2001, ARCH PHYS MED REHAB, V82, P1133, DOI 10.1053/apmr.2001.24286; Janssen L, 2011, RES DEV DISABIL, V32, P963, DOI 10.1016/j.ridd.2011.02.002; Jeannerod M, 1995, CURR OPIN NEUROBIOL, V5, P727, DOI 10.1016/0959-4388(95)80099-9; Johnson SH, 2002, J COGNITIVE NEUROSCI, V14, P841, DOI 10.1162/089892902760191072; Johnson SH, 2002, NEUROIMAGE, V17, P1693, DOI 10.1006/nimg.2002.1265; Johnson-Frey SH, 2005, CEREB CORTEX, V15, P681, DOI 10.1093/cercor/bhh169; Johnston MV, 2009, DEV DISABIL RES REV, V15, P94, DOI 10.1002/ddrr.64; Lebon F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037850; Maruff P, 1999, NEUROPSYCHOLOGIA, V37, P1317, DOI 10.1016/S0028-3932(99)00016-0; Mercier C, 2008, CEREB CORTEX, V18, P272, DOI 10.1093/cercor/bhm052; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Mutsaarts M, 2007, NEUROPSYCHOLOGIA, V45, P853, DOI 10.1016/j.neuropsychologia.2006.08.020; Mutsaarts M, 2006, EXP BRAIN RES, V172, P151, DOI 10.1007/s00221-005-0327-0; Sabate M, 2004, NEUROPSYCHOLOGIA, V42, P1041, DOI 10.1016/j.neuropsychologia.2003.12.015; Saito K, 2013, EXP BRAIN RES, V227, P333, DOI 10.1007/s00221-013-3513-5; Sakzewski L, 2009, PEDIATRICS, V123, pE1111, DOI 10.1542/peds.2008-3335; Schluter ND, 2001, NEUROPSYCHOLOGIA, V39, P105, DOI 10.1016/S0028-3932(00)00105-6; Seghier ML, 2008, NEUROIMAGE, V41, P1253, DOI 10.1016/j.neuroimage.2008.03.028; Sharma N, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00564; Sharma N, 2006, STROKE, V37, P1941, DOI 10.1161/01.STR.0000226902.43357.fc; SIRIGU A, 1995, NEUROREPORT, V6, P997, DOI 10.1097/00001756-199505090-00012; Sirigu A, 1996, SCIENCE, V273, P1564, DOI 10.1126/science.273.5281.1564; Solodkin A, 2004, CEREB CORTEX, V14, P1246, DOI 10.1093/cercor/bhh086; Staudt M, 2004, ANN NEUROL, V56, P854, DOI 10.1002/ana.20297; Staudt M, 2002, BRAIN, V125, P2222, DOI 10.1093/brain/awf227; Steenbergen B, 2004, COGNITIVE BRAIN RES, V19, P145, DOI 10.1016/j.cogbrainres.2003.11.008; Steenbergen B, 2007, NEUROPSYCHOLOGIA, V45, P3324, DOI 10.1016/j.neuropsychologia.2007.07.002; Steenbergen B, 2007, DISABIL REHABIL, V29, P13, DOI 10.1080/09638280600947591; Steenbergen B, 2009, DEV MED CHILD NEUROL, V51, P690, DOI 10.1111/j.1469-8749.2009.03371.x; Steenbergen B, 2006, DEV MED CHILD NEUROL, V48, P780, DOI 10.1017/S0012162206001666; Stinear CM, 2007, CLIN NEUROPHYSIOL, V118, P1794, DOI 10.1016/j.clinph.2007.05.008; van Elk M, 2010, BRAIN RES, V1349, P56, DOI 10.1016/j.brainres.2010.06.055; Williams J, 2011, RES DEV DISABIL, V32, P740, DOI 10.1016/j.ridd.2010.11.006; Zimmermann-Schlatter A, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-8	53	19	20	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93378	10.1371/journal.pone.0093378	http://dx.doi.org/10.1371/journal.pone.0093378			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718311	Green Published, Green Submitted, gold			2022-12-25	WOS:000334339000029
J	Shannon, G; Cordes, LS; Hardy, AR; Angeloni, LM; Crooks, KR				Shannon, Graeme; Cordes, Line S.; Hardy, Amanda R.; Angeloni, Lisa M.; Crooks, Kevin R.			Behavioral Responses Associated with a Human-Mediated Predator Shelter	PLOS ONE			English	Article							YELLOWSTONE-NATIONAL-PARK; GROUP-SIZE; TEMPORAL VARIATION; PREY INTERACTIONS; HUMAN DISTURBANCE; TROPHIC CASCADE; GRIZZLY BEARS; RISK; WOLVES; ELK	Human activities in protected areas can affect wildlife populations in a similar manner to predation risk, causing increases in movement and vigilance, shifts in habitat use and changes in group size. Nevertheless, recent evidence indicates that in certain situations ungulate species may actually utilize areas associated with higher levels of human presence as a potential refuge from disturbance-sensitive predators. We now use four-years of behavioral activity budget data collected from pronghorn 9Antilocapra americana) and elk (Cervus elephus) in Grand Teton National Park, USA to test whether predictable patterns of human presence can provide a shelter from predatory risk. Daily behavioral scans were conducted along two parallel sections of road that differed in traffic volume - with the main Teton Park Road experiencing vehicle use that was approximately thirty-fold greater than the River Road. At the busier Teton Park Road, both species of ungulate engaged in higher levels of feeding 927% increase in the proportion of pronghorn feeding and 21% increase for elk), lower levels of alert behavior 918% decrease for pronghorn and 9% decrease for elk) and formed smaller groups. These responses are commonly associated with reduced predatory threat. Pronghorn also exhibited a 30% increase in the proportion of individuals moving at the River Road as would be expected under greater exposure to predation risk. Our findings concur with the 'predator shelter hypothesis', suggesting that ungulates in GTNP use human presence as a potential refuge from predation risk, adjusting their behavior accordingly. Human activity has the potential to alter predator-prey interactions and drive trophic-mediated effects that could ultimately impact ecosystem function and biodiversity.	[Shannon, Graeme; Cordes, Line S.; Crooks, Kevin R.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Hardy, Amanda R.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA; [Angeloni, Lisa M.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University	Shannon, G (corresponding author), Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA.	graeme.shannon@colostate.edu	Shannon, Graeme/A-5790-2011	Shannon, Graeme/0000-0002-5039-4904	Federal Highway Administration	Federal Highway Administration	The National Park Service funded this study through a grant from the Federal Highway Administration, administered by the Cooperative Ecosystems Study Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeloni L, 2008, ANIM BEHAV, V75, P731, DOI 10.1016/j.anbehav.2007.08.007; [Anonymous], 1990, URSUS; Beale CM, 2004, J APPL ECOL, V41, P335, DOI 10.1111/j.0021-8901.2004.00900.x; Berger J, 2007, BIOL LETTERS, V3, P620, DOI 10.1098/rsbl.2007.0415; Berger KM, 2008, ECOLOGY, V89, P818, DOI 10.1890/07-0193.1; Brown CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040505; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Caro T, 2007, TRENDS ECOL EVOL, V22, P394, DOI 10.1016/j.tree.2007.06.003; Childress MJ, 2003, ANIM BEHAV, V66, P389, DOI 10.1006/anbe.2003.2217; Ciuti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050611; Creel S, 2007, SCIENCE, V315, P960, DOI 10.1126/science.1135918; DEHN MM, 1990, BEHAV ECOL SOCIOBIOL, V26, P337; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Ferrari MCO, 2009, ANIM BEHAV, V78, P579, DOI 10.1016/j.anbehav.2009.05.034; Frid A, 2002, CONSERV ECOL, V6; Gavin SD, 2006, CAN J ZOOL, V84, P1775, DOI 10.1139/Z06-175; Gibeau ML, 2002, BIOL CONSERV, V103, P227, DOI 10.1016/S0006-3207(01)00131-8; Halofsky JS, 2008, OECOLOGIA, V155, P869, DOI 10.1007/s00442-007-0956-z; Hebblewhite M, 2005, ECOLOGY, V86, P2135, DOI 10.1890/04-1269; Hebblewhite M, 2002, CAN J ZOOL, V80, P800, DOI 10.1139/Z02-059; Kaartinen S, 2005, ANN ZOOL FENN, V42, P523; Liley S, 2008, BEHAV ECOL, V19, P245, DOI 10.1093/beheco/arm116; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Lima SL, 1998, BIOSCIENCE, V48, P25, DOI 10.2307/1313225; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lung MA, 2007, BEHAV ECOL, V18, P12, DOI [10.1093/beheco/ar1066, 10.1093/beheco/arl066]; Mace RD, 1996, J APPL ECOL, V33, P1395, DOI 10.2307/2404779; Malo JE, 2011, BIODIVERS CONSERV, V20, P3477, DOI 10.1007/s10531-011-0136-7; Manor R, 2003, ECOL APPL, V13, P1830, DOI 10.1890/01-5354; Matassa CM, 2011, ECOLOGY, V92, P2258, DOI 10.1890/11-0424.1; MCLELLAN BN, 1988, J APPL ECOL, V25, P451, DOI 10.2307/2403836; Muhly TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017050; Musiani M, 2010, ECOL MODEL, V221, P2374, DOI 10.1016/j.ecolmodel.2010.06.019; Northrup JM, 2012, J APPL ECOL, V49, P1159, DOI 10.1111/j.1365-2664.2012.02180.x; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Ripple WJ, 2007, BIOL CONSERV, V138, P514, DOI 10.1016/j.biocon.2007.05.006; Ripple WJ, 2006, BIOL CONSERV, V133, P397, DOI 10.1016/j.biocon.2006.07.002; Ripple WJ, 2004, BIOSCIENCE, V54, P755, DOI 10.1641/0006-3568(2004)054[0755:WATEOF]2.0.CO;2; Rogala JK, 2011, ECOL SOC, V16, DOI 10.5751/ES-04251-160316; SIH A, 1980, SCIENCE, V210, P1041, DOI 10.1126/science.210.4473.1041; Stankowich T, 2008, BIOL CONSERV, V141, P2159, DOI 10.1016/j.biocon.2008.06.026; Taylor AR, 2003, ECOL APPL, V13, P951, DOI 10.1890/1051-0761(2003)13[951:WRTRAA]2.0.CO;2; Thompson MJ, 1998, WILDLIFE SOC B, V26, P477; TURNER GF, 1986, AM NAT, V128, P228, DOI 10.1086/284556; Verdolin JL, 2006, BEHAV ECOL SOCIOBIOL, V60, P457, DOI 10.1007/s00265-006-0172-6; Whittington J, 2005, ECOL APPL, V15, P543, DOI 10.1890/03-5317; Whittington J, 2004, ECOL SOC, V9; Winnie J, 2007, ANIM BEHAV, V73, P215, DOI 10.1016/j.anbehav.2006.07.007; [No title captured]	52	41	44	1	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94630	10.1371/journal.pone.0094630	http://dx.doi.org/10.1371/journal.pone.0094630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718624	gold, Green Published			2022-12-25	WOS:000334339000135
J	Bosnjak, M; Ristic, B; Arsikin, K; Mircic, A; Suzin-Zivkovic, V; Perovic, V; Bogdanovic, A; Paunovic, V; Markovic, I; Bumbasirevic, V; Trajkovic, V; Harhaji-Trajkovic, L				Bosnjak, Mihajlo; Ristic, Biljana; Arsikin, Katarina; Mircic, Aleksandar; Suzin-Zivkovic, Violeta; Perovic, Vladimir; Bogdanovic, Andrija; Paunovic, Verica; Markovic, Ivanka; Bumbasirevic, Vladimir; Trajkovic, Vladimir; Harhaji-Trajkovic, Ljubica			Inhibition of mTOR-Dependent Autophagy Sensitizes Leukemic Cells to Cytarabine-Induced Apoptotic Death	PLOS ONE			English	Article							OXIDATIVE STRESS; TARGETING AUTOPHAGY; RESISTANCE; PHOSPHORYLATION; ACTIVATION; MECHANISM; PATHWAY	The present study investigated the role of autophagy, a cellular self-digestion process, in the cytotoxicity of antileukemic drug cytarabine towards human leukemic cell lines (REH, HL-60, MOLT-4) and peripheral blood mononuclear cells from leukemic patients. The induction of autophagy was confirmed by acridine orange staining of intracellular acidic vesicles, electron microscopy visualization of autophagic vacuoles, as well as by the increase in autophagic proteolysis and autophagic flux, demonstrated by immunoblot analysis of p62 downregulation and LC3-I conversion to autophagosome-associated LC3-II in the presence of proteolysis inhibitors, respectively. Moreover, the expression of autophagy-related genes Atg4, Atg5 and Atg7 was stimulated by cytarabine in REH cells. Cytarabine reduced the phosphorylation of the major negative regulator of autophagy, mammalian target of rapamycin (mTOR), and its downstream target p70S6 kinase in REH cells, which was associated with downregulation of mTOR activator Akt and activation of extracellular signal-regulated kinase. Cytarabine had no effect on the activation of mTOR inhibitor AMP-activated protein kinase. Leucine, an mTOR activator, reduced both cytarabine-induced autophagy and cytotoxicity. Accordingly, pharmacological downregulation of autophagy with bafilomycin A1 and chloroquine, or RNA interference-mediated knockdown of LC3 beta or p62, markedly increased oxidative stress, mitochondrial depolarization, caspase activation and subsequent DNA fragmentation and apoptotic death in cytarabine-treated REH cells. Cytarabine also induced mTOR-dependent cytoprotective autophagy in HL-60 and MOLT-4 leukemic cell lines, as well as primary leukemic cells, but not normal leukocytes. These data suggest that the therapeutic efficiency of cytarabine in leukemic patients could be increased by the inhibition of the mTOR-dependent autophagic response.	[Bosnjak, Mihajlo; Mircic, Aleksandar; Suzin-Zivkovic, Violeta; Bumbasirevic, Vladimir] Univ Belgrade, Sch Med, Inst Histol & Embryol, Belgrade, Serbia; [Ristic, Biljana; Arsikin, Katarina; Perovic, Vladimir; Paunovic, Verica; Trajkovic, Vladimir] Univ Belgrade, Sch Med, Inst Microbiol & Immunol, Belgrade, Serbia; [Bogdanovic, Andrija] Univ Belgrade, Sch Med, Clin Ctr Serbia, Clin Hematol, Belgrade, Serbia; [Markovic, Ivanka] Univ Belgrade, Sch Med, Inst Med & Clin Biochem, Belgrade, Serbia; [Harhaji-Trajkovic, Ljubica] Univ Belgrade, Inst Biol Res, Belgrade, Serbia	University of Belgrade; University of Belgrade; Clinical Centre of Serbia; University of Belgrade; University of Belgrade; University of Belgrade	Trajkovic, V (corresponding author), Univ Belgrade, Sch Med, Inst Microbiol & Immunol, Dr Subotica 1, Belgrade, Serbia.	vtrajkovic@med.bg.ac.rs; buajk@yahoo.com	Markovic, Ivanka/AAJ-1243-2020; Bogdanovic, Andrija/AAF-2505-2020	Bogdanovic, Andrija/0000-0002-8288-7308; Harhaji-Trajkovic, Ljubica/0000-0001-8757-555X; Trajkovic, Vladimir/0000-0002-8061-2968; Perovic, Vladimir/0000-0002-1994-1738; bosnjak, mihajlo/0000-0002-5973-8275; Markovic, Ivanka/0000-0002-7961-3752; Paunovic, Verica/0000-0002-4912-7761; Ristic, Biljana/0000-0002-7255-6556	Ministry of Science and Technological Development of the Republic of Serbia [173053, 41025]	Ministry of Science and Technological Development of the Republic of Serbia(Ministry of Education, Science & Technological Development, Serbia)	The study was supported by the grants 173053 and 41025 from the Ministry of Science and Technological Development of the Republic of Serbia (http://www.mpn.gov.rs). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Banerji V., 2012, INT J CELL BIOL, V2012, DOI [10.1155/2012/59597622829831, DOI 10.1155/2012/59597622829831]; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Bezombes C, 2001, FASEB J, V15, P1583, DOI 10.1096/fj.00-0787fje; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Calabretta B, 2011, LEUKEMIA LYMPHOMA, V52, P54, DOI 10.3109/10428194.2010.546913; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Cheng J, 2012, TOXICOL MECH METHOD, V22, P512, DOI 10.3109/15376516.2012.686534; CONNOLLY DT, 1986, ANAL BIOCHEM, V152, P136, DOI 10.1016/0003-2697(86)90131-4; Cros E, 2004, LEUKEMIA LYMPHOMA, V45, P1123, DOI 10.1080/1042819032000159861; Evangelisti C, 2011, J CELL PHYSIOL, V226, P822, DOI 10.1002/jcp.22407; Fimia GM, 2010, CELL MOL LIFE SCI, V67, P1581, DOI 10.1007/s00018-010-0284-z; Grander D, 2009, AUTOPHAGY, V5, P1198, DOI 10.4161/auto.5.8.10122; Grimaldi C, 2012, LEUKEMIA, V26, P91, DOI 10.1038/leu.2011.269; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028491; Huang Y, 2011, AUTOPHAGY, V7, P1132, DOI 10.4161/auto.7.10.16636; Ichimura Y, 2008, J BIOL CHEM, V283, P22847, DOI 10.1074/jbc.M802182200; Ishdorj G, 2012, LEUKEMIA LYMPHOMA, V53, P26, DOI 10.3109/10428194.2011.604752; Jain MV, 2013, J CELL MOL MED, V17, P12, DOI 10.1111/jcmm.12001; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kaludjerovic GN, 2005, INT J CANCER, V116, P479, DOI 10.1002/ijc.21080; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kimball SR, 1999, J BIOL CHEM, V274, P11647, DOI 10.1074/jbc.274.17.11647; Kobayashi T, 1998, CELL DEATH DIFFER, V5, P584, DOI 10.1038/sj.cdd.4400382; Lamba JK, 2009, PHARMACOGENOMICS, V10, P1657, DOI [10.2217/pgs.09.118, 10.2217/PGS.09.118]; Li JY, 2010, AUTOPHAGY, V6, P711, DOI 10.4161/auto.6.6.12397; Li L, 2013, CELL SIGNAL, V25, P50, DOI 10.1016/j.cellsig.2012.09.020; Li L, 2012, FREE RADICAL BIO MED, V53, P1399, DOI 10.1016/j.freeradbiomed.2012.07.011; Liu L, 2011, LEUKEMIA, V25, P23, DOI 10.1038/leu.2010.225; Mahoney E, 2012, BLOOD, V120, P1262, DOI 10.1182/blood-2011-12-400184; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; Martelli AM, 2011, LEUKEMIA, V25, P1064, DOI 10.1038/leu.2011.46; Martelli AM, 2012, EXPERT OPIN THER TAR, V16, P729, DOI 10.1517/14728222.2012.694869; Maycotte P, 2012, AUTOPHAGY, V8, P200, DOI 10.4161/auto.8.2.18554; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Notte A, 2011, BIOCHEM PHARMACOL, V82, P427, DOI 10.1016/j.bcp.2011.06.015; Novotny L, 2009, NEOPLASMA, V56, P177; Ohtomo T, 2010, BIOCHEM BIOPH RES CO, V391, P310, DOI 10.1016/j.bbrc.2009.11.055; Pham NA, 2001, EXP CELL RES, V264, P345, DOI 10.1006/excr.2000.5148; Puissant A, 2010, CELL CYCLE, V9, P3470, DOI 10.4161/cc.9.17.13048; Puissant A, 2010, CANCER RES, V70, P1042, DOI 10.1158/0008-5472.CAN-09-3537; Robert G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007889; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sadowski-Debbing K, 2002, ARCH IMMUNOL THER EX, V50, P19; Schnekenburger M, 2011, BIOCHEM PHARMACOL, V81, P364, DOI 10.1016/j.bcp.2010.10.013; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; STENTOFT J, 1990, DRUG SAFETY, V5, P7, DOI 10.2165/00002018-199005010-00003; TETT SE, 1988, BRIT J CLIN PHARMACO, V26, P303, DOI 10.1111/j.1365-2125.1988.tb05281.x; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014	53	44	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94374	10.1371/journal.pone.0094374	http://dx.doi.org/10.1371/journal.pone.0094374			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714637	Green Published, gold, Green Submitted			2022-12-25	WOS:000334160900123
J	Jarajapu, YPR; Hazra, S; Segal, M; LiCalzi, S; Jhadao, C; Qian, K; Mitter, SK; Raizada, MK; Boulton, ME; Grant, MB				Jarajapu, Yagna P. R.; Hazra, Sugata; Segal, Mark; LiCalzi, Sergio; Jhadao, Chandra; Qian, Kevin; Mitter, Sayak K.; Raizada, Mohan K.; Boulton, Michael E.; Grant, Maria B.			Vasoreparative Dysfunction of CD34(+) Cells in Diabetic Individuals Involves Hypoxic Desensitization and Impaired Autocrine/Paracrine Mechanisms	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; GROWTH-FACTOR-BETA; MYOCARDIAL-INFARCTION; CEREBRAL-ARTERIES; CLONAL ANALYSIS; MYOGENIC TONE; NITRIC-OXIDE; STEM-CELLS; ANGIOGENESIS; ACTIVATION	We hypothesized that endothelial progenitor cells derived from individuals with diabetes would exhibit functional defects including inability to respond to hypoxia and altered paracrine/autocrine function that would impair the angiogenic potential of these cells. Circulating mononuclear cells isolated from diabetic (n = 69) and nondiabetic (n = 46) individuals were used to grow endothelial colony forming cells (ECFC), early endothelial progenitor cells (eEPCs) and isolate CD34(+) cells. ECFCs and eEPCs were established from only 15% of the diabetic individuals tested thus directing our main effort toward examination of CD34(+) cells. CD34(+) cells were plated in basal medium to obtain cell-free conditioned medium (CM). In CM derived from CD34(+) cells of diabetic individuals (diabetic-CM), the levels of stem cell factor, hepatocyte growth factor, and thrombopoietin were lower, and IL-1 beta and tumor necrosis factor (TNF alpha) levels were higher than CM derived from nondiabetic individuals (nondiabetic-CM). Hypoxia did not upregulate HIF1 alpha in CD34(+) cells of diabetic origin. Migration and proliferation of nondiabetic CD34(+) cells toward diabetic-CM were lower compared to nondiabetic-CM. Attenuation of pressure-induced constriction, potentiation of bradykinin relaxation, and generation of cGMP and cAMP in arterioles were observed with nondiabetic-CM, but not with diabetic-CM. Diabetic-CM failed to induce endothelial tube formation from vascular tissue. These results suggest that diabetic subjects with microvascular complications exhibit severely limited capacity to generate ex-vivo expanded endothelial progenitor populations and that the vasoreparative dysfunction observed in diabetic CD34(+) cells is due to impaired autocrine/paracrine function and reduced sensitivity to hypoxia.	[Jarajapu, Yagna P. R.] N Dakota State Univ, Coll Pharm Nursing & Allied Sci, Dept Pharmaceut Sci, Fargo, ND 58105 USA; [Jarajapu, Yagna P. R.; Hazra, Sugata; Jhadao, Chandra; Grant, Maria B.] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Segal, Mark] Univ Florida, Coll Med, Dept Nephrol, Gainesville, FL USA; [LiCalzi, Sergio; Qian, Kevin; Mitter, Sayak K.; Boulton, Michael E.; Grant, Maria B.] Indiana Univ, Sch Med, Dept Ophthalmol, Indianapolis, IN 46202 USA; [Raizada, Mohan K.] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL USA	North Dakota State University Fargo; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Indiana University System; Indiana University-Purdue University Indianapolis; State University System of Florida; University of Florida	Grant, MB (corresponding author), Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA.	mabgrant@iupui.edu			NIH [EY007739, EY012601, DK090730-02, U01HL087366, EY018358]; NATIONAL EYE INSTITUTE [R01EY012601, R01EY007739, R01EY018358, R29EY007739] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL087366, UM1HL087366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090730] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding Sources include NIH - EY007739, EY012601, DK090730-02, and U01HL087366 to MBG and EY018358 to MEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab N, 2002, BIOCHEM J, V362, P643, DOI 10.1042/0264-6021:3620643; Ali H, 1997, MED CLIN N AM, V81, P1, DOI 10.1016/S0025-7125(05)70503-4; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Awad O, 2006, ARTERIOSCL THROM VAS, V26, P758, DOI 10.1161/01.ATV.0000203513.29227.6f; Barcelos LS, 2009, CIRC RES, V104, P1095, DOI 10.1161/CIRCRESAHA.108.192138; Bhatwadekar AD, 2010, DIABETES, V59, P2010, DOI 10.2337/db10-0287; Brizzi MF, 1999, CIRC RES, V84, P785; Brock M, 2009, CIRC RES, V104, P1184, DOI 10.1161/CIRCRESAHA.109.197491; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Cai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021164; Dempsey RJ, 2003, J NEUROCHEM, V87, P586, DOI 10.1046/j.1471-4159.2003.02022.x; Eguchi M, 2008, J MOL CELL CARDIOL, V45, P661, DOI 10.1016/j.yjmcc.2008.08.002; Fadini GP, 2007, DIABETES CARE, V30, P1305, DOI 10.2337/dc06-2305; Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88; Fadini GP, 2006, EUR HEART J, V27, P2247, DOI 10.1093/eurheartj/ehl198; Fadini GP, 2009, ATHEROSCLEROSIS, V207, P213, DOI 10.1016/j.atherosclerosis.2009.03.040; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Goldschmidt-Clermont Pascal J, 2005, Rev Cardiovasc Med, V6 Suppl 3, pS22; Harraz M, 2001, STEM CELLS, V19, P304, DOI 10.1634/stemcells.19-4-304; He T, 2008, CIRC RES, V103, P80, DOI 10.1161/CIRCRESAHA.108.176057; He TR, 2005, AM J PHYSIOL-HEART C, V289, pH968, DOI 10.1152/ajpheart.01166.2004; Jarajapu YPR, 2008, EUR J PHARMACOL, V579, P298, DOI 10.1016/j.ejphar.2007.10.028; Jarajapu YPR, 2011, INVEST OPHTH VIS SCI, V52, P5093, DOI 10.1167/iovs.10-70911; Jarajapu YPR, 2010, CIRC RES, V106, P854, DOI 10.1161/CIRCRESAHA.109.213140; Jarajapu YPR, 2002, AM J PHYSIOL-HEART C, V283, pH2234, DOI 10.1152/ajpheart.00624.2002; Jarajapu YPR, 2001, J PHARMACOL EXP THER, V299, P729; JOHNSON PC, 1986, CIRC RES, V59, P483, DOI 10.1161/01.RES.59.5.483; Juul A, 2002, CIRCULATION, V106, P939, DOI 10.1161/01.CIR.0000027563.44593.CC; Katakam PVG, 2009, AM J PHYSIOL-REG I, V296, pR289, DOI 10.1152/ajpregu.90656.2008; Kielczewski JL, 2009, CIRC RES, V105, P897, DOI 10.1161/CIRCRESAHA.109.199059; Krenning G, 2009, J CELL MOL MED, V13, P2521, DOI 10.1111/j.1582-4934.2008.00479.x; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Loomans CJM, 2004, DIABETES, V53, P195, DOI 10.2337/diabetes.53.1.195; Losordo DW, 2007, CIRCULATION, V115, P3165, DOI 10.1161/CIRCULATIONAHA.106.687376; Mackie AR, 2011, TEX HEART I J, V38, P474; Majka M, 2001, BLOOD, V97, P3075, DOI 10.1182/blood.V97.10.3075; Martin-Ramirez J, 2012, NAT PROTOC, V7, P1709, DOI 10.1038/nprot.2012.093; Meng S, 2012, J MOL CELL CARDIOL, V53, P64, DOI 10.1016/j.yjmcc.2012.04.003; Milkiewicz M, 2004, J PHYSIOL-LONDON, V560, P21, DOI 10.1113/jphysiol.2004.069757; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Mohty M, 2011, EXP HEMATOL; Mukai N, 2008, EXP CELL RES, V314, P430, DOI 10.1016/j.yexcr.2007.11.016; Nakagawa T, 2006, J AM SOC NEPHROL, V17, P736, DOI 10.1681/ASN.2005070759; Narazaki M, 2006, BLOOD, V107, P3892, DOI 10.1182/blood-2005-10-4113; Orlandi A, 2010, BASIC RES CARDIOL, V105, P703, DOI 10.1007/s00395-010-0109-0; Ramos AL, 2010, CIRC RES, V107, P1460, DOI 10.1161/CIRCRESAHA.110.223669; Raval Z, 2013, CIRC RES, V112, P1288, DOI 10.1161/CIRCRESAHA.113.300565; Romero MJ, 2008, CIRC RES, V102, P95, DOI 10.1161/CIRCRESAHA.107.155028; Ronnstrand L, 2004, CELL MOL LIFE SCI, V61, P2535, DOI 10.1007/s00018-004-4189-6; Santos SCR, 2007, EXP CELL RES, V313, P1561, DOI 10.1016/j.yexcr.2007.02.020; Santhanam AVR, 2007, CIRC RES, V100, P1379, DOI 10.1161/01.RES.0000265848.55035.5d; Schatteman GC, 2000, J CLIN INVEST, V106, P571, DOI 10.1172/JCI9087; Schatteman GC, 2010, AM J PATHOL, V177, P2002, DOI 10.2353/ajpath.2010.091232; Schroder K, 2010, ANTIOXID REDOX SIGNA; Segal MS, 2006, DIABETES, V55, P102, DOI 10.2337/diabetes.55.1.102; Sekiguchi H, 2009, J CELL PHYSIOL, V219, P235, DOI 10.1002/jcp.21672; Semenza GL, 1999, ANN NY ACAD SCI, V874, P262, DOI 10.1111/j.1749-6632.1999.tb09241.x; Sieveking DP, 2008, J AM COLL CARDIOL, V51, P660, DOI 10.1016/j.jacc.2007.09.059; Smith G, 1999, BRIT J OPHTHALMOL, V83, P486, DOI 10.1136/bjo.83.4.486; Tan K, 2010, EXP EYE RES, V91, P229, DOI 10.1016/j.exer.2010.05.012; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Ulyatt C, 2011, BIOCHEM BIOPH RES CO, V404, P774, DOI 10.1016/j.bbrc.2010.12.057; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yoon CH, 2005, CIRCULATION, V112, P1618, DOI 10.1161/CIRCULATIONAHA.104.503433; Zhu GX, 2010, INT J CARDIOL, V138, P70, DOI 10.1016/j.ijcard.2008.10.042	67	43	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93965	10.1371/journal.pone.0093965	http://dx.doi.org/10.1371/journal.pone.0093965			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713821	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900068
J	Oppel, S; Marczakiewicz, P; Lachmann, L; Grzywaczewski, G				Oppel, Steffen; Marczakiewicz, Piotr; Lachmann, Lars; Grzywaczewski, Grzegorz			Improving Aquatic Warbler Population Assessments by Accounting for Imperfect Detection	PLOS ONE			English	Article							ACROCEPHALUS-PALUDICOLA; ESTIMATING ABUNDANCE; WESTERN MARGIN; COUNTS; MODELS; SONGBIRDS; TRENDS	Monitoring programs designed to assess changes in population size over time need to account for imperfect detection and provide estimates of precision around annual abundance estimates. Especially for species dependent on conservation management, robust monitoring is essential to evaluate the effectiveness of management. Many bird species of temperate grasslands depend on specific conservation management to maintain suitable breeding habitat. One such species is the Aquatic Warbler (Acrocephalus paludicola), which breeds in open fen mires in Central Europe. Aquatic Warbler populations have so far been assessed using a complete survey that aims to enumerate all singing males over a large area. Because this approach provides no estimate of precision and does not account for observation error, detecting moderate population changes is challenging. From 2011 to 2013 we trialled a new line transect sampling monitoring design in the Biebrza valley, Poland, to estimate abundance of singing male Aquatic Warblers. We surveyed Aquatic Warblers repeatedly along 50 randomly placed 1-km transects, and used binomial mixture models to estimate abundances per transect. The repeated line transect sampling required 150 observer days, and thus less effort than the traditional `full count' approach (175 observer days). Aquatic Warbler abundance was highest at intermediate water levels, and detection probability varied between years and was influenced by vegetation height. A power analysis indicated that our line transect sampling design had a power of 68% to detect a 20% population change over 10 years, whereas raw count data had a 9% power to detect the same trend. Thus, by accounting for imperfect detection we increased the power to detect population changes. We recommend to adopt the repeated line transect sampling approach for monitoring Aquatic Warblers in Poland and in other important breeding areas to monitor changes in population size and the effects of habitat management.	[Oppel, Steffen; Lachmann, Lars] Royal Soc Protect Birds, RSPB Ctr Conservat Sci, Sandy SG19 2DL, Beds, England; [Marczakiewicz, Piotr] Ogolnopolskie Towarzystwo Ochrony Ptakow, Marki, Poland; [Marczakiewicz, Piotr] Biebrzanski Pk Narodowy, Goniadz, Poland; [Grzywaczewski, Grzegorz] Univ Life Sci, Dept Zool Anim Ecol & Wildlife Management, Lublin, Poland	Royal Society for Protection of Birds	Oppel, S (corresponding author), Royal Soc Protect Birds, RSPB Ctr Conservat Sci, Sandy SG19 2DL, Beds, England.	steffen.oppel@rspb.org.uk	Oppel, Steffen/H-2771-2019	Oppel, Steffen/0000-0002-8220-3789; Grzywaczewski, Grzegorz/0000-0003-1136-0768	RSPB; Biebrza National Park;  [LIFE05 NAT/PL/000101]	RSPB; Biebrza National Park; 	Funding was provided by the project LIFE05 NAT/PL/000101 (http://ec.europa.eu/environment/life/), the RSPB (www.rspb.org.uk), and the Biebrza National Park. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldredge MW, 2007, J WILDLIFE MANAGE, V71, P2759, DOI 10.2193/2006-161; Alldredge MW, 2007, ECOL APPL, V17, P948, DOI 10.1890/06-0685; [Anonymous], 2010, R LANG ENV STAT COMP; Archaux F, 2012, METHODS ECOL EVOL, V3, P188, DOI 10.1111/j.2041-210X.2011.00142.x; Berthold P, 1998, NATURWISSENSCHAFTEN, V85, P350, DOI 10.1007/s001140050514; Buchanan GM, 2011, OSTRICH, V82, P81, DOI 10.2989/00306525.2011.603461; Buckland S.T., 2001, pi; Buckland ST, 2008, BIRD CONSERV INT, V18, pS91, DOI 10.1017/S0959270908000294; Buckland ST, 2006, AUK, V123, P345, DOI 10.1642/0004-8038(2006)123[345:PSFSRM]2.0.CO;2; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chandler RB, 2011, ECOLOGY, V92, P1429, DOI 10.1890/10-2433.1; Dail D, 2011, BIOMETRICS, V67, P577, DOI 10.1111/j.1541-0420.2010.01465.x; DYRCZ A, 1993, IBIS, V135, P181, DOI 10.1111/j.1474-919X.1993.tb02830.x; Etterson MA, 2009, ECOL APPL, V19, P2049, DOI 10.1890/08-1317.1; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Flade M, 2008, INT SPECIES ACTION P, P74; Flade M, 2011, J ORNITHOL, V152, P129, DOI 10.1007/s10336-011-0666-5; Gelman A., 2004, BAYESIAN DATA ANAL; Gottschalk TK, 2011, J ORNITHOL, V152, P421, DOI 10.1007/s10336-010-0601-1; Johnson DH, 2008, J WILDLIFE MANAGE, V72, P857, DOI 10.2193/2007-294; Katzner TE, 2011, ANIM CONSERV, V14, P328, DOI 10.1111/j.1469-1795.2011.00444.x; Kery M, 2005, ECOL APPL, V15, P1450, DOI 10.1890/04-1120; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M, 2008, AUK, V125, P336, DOI 10.1525/auk.2008.06185; Kery M, 2010, J ANIM ECOL, V79, P453, DOI 10.1111/j.1365-2656.2009.01632.x; Kery M, 2009, J APPL ECOL, V46, P1163, DOI 10.1111/j.1365-2664.2009.01724.x; Kloskowski Janusz, 1999, Vogelwelt, V120, P113; Kotowski W, 2013, BIOL CONSERV, V167, P292, DOI 10.1016/j.biocon.2013.08.021; Kozulin A, 2004, ACTA ORNITHOL, V39, P35, DOI 10.3161/068.039.0109; Kozulin Alexander, 1999, Vogelwelt, V120, P97; Krogulec J., 2003, Ornis Hungarica, V12-13, P191; Kubacka J, 2014, BIRD CONSERV INT, V24, P45, DOI 10.1017/S0959270913000154; Laake JL, 2011, J AGR BIOL ENVIR ST, V16, P389, DOI 10.1007/s13253-011-0059-5; Lachmann L., 2010, Grassland in a changing world. Proceedings of the 23rd General Meeting of the European Grassland Federation, Kiel, Germany, 29th August - 2nd September 2010, P711; Margalida A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026784; Newton I, 2004, IBIS, V146, P197, DOI 10.1111/j.1474-919X.2004.00293.x; Nichols JD, 2009, ENVIRON ECOL STAT SE, V3, P201, DOI 10.1007/978-0-387-78151-8_9; Norvell RE, 2003, AUK, V120, P1013, DOI 10.1642/0004-8038(2003)120[1013:ASCORA]2.0.CO;2; Oppel S, 2011, J AVIAN BIOL, V42, P342, DOI 10.1111/j.1600-048X.2011.05252.x; Plummer M., 2012, JAGS VERSION 3 3 0; Reynolds JH, 2011, BIOL CONSERV, V144, P1278, DOI 10.1016/j.biocon.2010.12.002; Royle JA, 2005, OIKOS, V110, P353, DOI 10.1111/j.0030-1299.2005.13534.x; Royle JA, 2004, ECOLOGY, V85, P1591, DOI 10.1890/03-3127; Royle JA, 2003, ECOLOGY, V84, P777, DOI 10.1890/0012-9658(2003)084[0777:EAFRPA]2.0.CO;2; Salewski V, 2013, J ORN IN PRESS; Schaefer HM, 2000, J ORNITHOL, V141, P418, DOI 10.1007/BF01651571; Schmeller DS, 2012, NAT CONSERV-BULGARIA, P41, DOI 10.3897/natureconservation.2.3644; Schmidt JH, 2013, BIOL CONSERV, V160, P130, DOI 10.1016/j.biocon.2013.01.007; Schulze-Hagen K., 1991, HDB VOGEL MITTELEURO; Schulze-Hagen Karl, 1999, Vogelwelt, V120, P87; Su Y.-S., 2012, R2JAGS PACKAGE RUNNI; Tanneberger F, 2009, BIODIVERS CONSERV, V18, P1475, DOI 10.1007/s10531-008-9495-0; Tanneberger F, 2008, J ORNITHOL, V149, P105, DOI 10.1007/s10336-007-0241-2; Tanneberger F, 2010, IBIS, V152, P347, DOI 10.1111/j.1474-919X.2010.01016.x; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Vickery JA, 2014, IBIS, V156, P1, DOI 10.1111/ibi.12118	56	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94406	10.1371/journal.pone.0094406	http://dx.doi.org/10.1371/journal.pone.0094406			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713994	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900130
J	Wang, T; Chen, BB; Kim, MS; Xie, Y; Xiao, GH				Wang, Tao; Chen, Beibei; Kim, MinSoo; Xie, Yang; Xiao, Guanghua			A Model-Based Approach to Identify Binding Sites in CLIP-Seq Data	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; RNA; PROTEIN; NETWORKS; TARGETS; REVEALS; GALAXY; DNA	Cross-linking immunoprecipitation coupled with high-throughput sequencing (CLIP-Seq) has made it possible to identify the targeting sites of RNA-binding proteins in various cell culture systems and tissue types on a genome-wide scale. Here we present a novel model-based approach (MiClip) to identify high-confidence protein-RNA binding sites from CLIP-seq datasets. This approach assigns a probability score for each potential binding site to help prioritize subsequent validation experiments. The MiClip algorithm has been tested in both HITS-CLIP and PAR-CLIP datasets. In the HITS-CLIP dataset, the signal/noise ratios of miRNA seed motif enrichment produced by the MiClip approach are between 17% and 301% higher than those by the ad hoc method for the top 10 most enriched miRNAs. In the PAR-CLIP dataset, the MiClip approach can identify similar to 50% more validated binding targets than the original ad hoc method and two recently published methods. To facilitate the application of the algorithm, we have released an R package, MiClip (http://cran.r-project.org/web/packages/MiClip/index.html), and a public web-based graphical user interface software (http://galaxy.qbrc.org/tool_runner?tool_id=mi_clip) for customized analysis.	[Wang, Tao; Chen, Beibei; Kim, MinSoo; Xie, Yang; Xiao, Guanghua] Univ Texas SW Med Ctr Dallas, Quantitat Biomed Res Ctr, Dept Clin Sci, Dallas, TX 75390 USA; [Chen, Beibei; Kim, MinSoo; Xie, Yang] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Xiao, GH (corresponding author), Univ Texas SW Med Ctr Dallas, Quantitat Biomed Res Ctr, Dept Clin Sci, Dallas, TX 75390 USA.	Guanghua.Xiao@UTSouthwestern.edu	Wang, Tao/K-3518-2016		National Institutes of Health [1R01CA172211, 5R01CA152301]; Cancer Prevention Research Institute of Texas [RP101251]; NATIONAL CANCER INSTITUTE [R01CA172211, R01CA152301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (http://www.nih.gov/) [1R01CA172211, 5R01CA152301]; and the Cancer Prevention Research Institute of Texas (http://www.cprit.state.tx.us/) [RP101251]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chou CH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-S1-S2; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hafner M, 2010, J VIS EXP; Hafner M, 2012, METHODS, V58, P94, DOI 10.1016/j.ymeth.2012.08.006; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hall DB, 2000, BIOMETRICS, V56, P1030, DOI 10.1111/j.0006-341X.2000.01030.x; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; HARTER SP, 1975, J AM SOC INFORM SCI, V26, P197, DOI 10.1002/asi.4630260402; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; Hu JJ, 2005, NUCLEIC ACIDS RES, V33, P4899, DOI 10.1093/nar/gki791; Iengar P, 2012, NUCLEIC ACIDS RES, V40, P6401, DOI 10.1093/nar/gks290; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Khorshid M, 2011, NUCLEIC ACIDS RES, V39, pD245, DOI 10.1093/nar/gkq940; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leung AKL, 2011, NAT STRUCT MOL BIOL, V18, P237, DOI 10.1038/nsmb.1991; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Licatalosi DD, 2012, GENE DEV, V26, P1626, DOI 10.1101/gad.191338.112; Macias S, 2012, NAT STRUCT MOL BIOL, V19, P760, DOI 10.1038/nsmb.2344; Neumann M, 2011, BRAIN, V134, P2595, DOI 10.1093/brain/awr201; Polymenidou M, 2011, NAT NEUROSCI, V14, P459, DOI 10.1038/nn.2779; R Development Core Team, 2012, R LANG ENV STAT COMP; Rudel S, 2011, NUCLEIC ACIDS RES, V39, P2330, DOI 10.1093/nar/gkq1032; Savage RS, 2010, BIOINFORMATICS, V26, pi158, DOI 10.1093/bioinformatics/btq210; Sievers C, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks697; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Uren PJ, 2012, BIOINFORMATICS, V28, P3013, DOI 10.1093/bioinformatics/bts569; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Xing HP, 2012, JOVE-J VIS EXP, DOI 10.3791/4273; Youn A, 2010, BIOINFORMATICS, V26, P1879, DOI 10.1093/bioinformatics/btq289; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873; Zhang CL, 2010, SCIENCE, V329, P439, DOI 10.1126/science.1191150; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	44	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93248	10.1371/journal.pone.0093248	http://dx.doi.org/10.1371/journal.pone.0093248			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714572	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900019
J	Yang, JT; Li, ZL; Wu, JY; Lu, FJ; Chen, CH				Yang, Jen-Tsung; Li, Zih-Ling; Wu, Jin-Yi; Lu, Fung-Jou; Chen, Ching-Hsein			An Oxidative Stress Mechanism of Shikonin in Human Glioma Cells	PLOS ONE			English	Article							ROS PRODUCTION; CYCLE ARREST; APOPTOSIS; GROWTH; PERMEABILIZATION; EXPRESSION; INDUCTION; CASPASES; DAMAGE; DEATH	Shikonin is a quinone-containing natural product that induces the apoptotic death of some cancer cell lines in culture through increasing intracellular reactive oxygen species (ROS). Quinone-based drugs have shown potential in the clinic, making shikonin an interesting compound to study. Our previous study found that shikonin induces apoptosis in neuroblastoma by induction of ROS, but its mechanism of action and scope of activity are unknown. In this study, we investigated the mode of oxidative stress of shikonin in human glioma cells. ROS induction by shikonin was of mitochondrial origin, as demonstrated by detection of superoxide with MitoSOX Red. Pre-incubation of shikonin with inhibitors of different complexes of the respiratory chain suggested that shikonin-induced ROS production occurred via complex II. In addition, NADPH oxidase and lipooxygenase are two other main ROS-generated sites in shikonin treatment. ROS production by shikonin resulted in the inhibition of nuclear translocation of Nrf2. Stable overexpression of Nrf2 in glioma cells inhibited ROS generation by shikonin. ROS generation from mitochondrial complex II, NADPH oxidase and lipooxygenase is likely the primary mechanism by which shikonin induces apoptosis in glioma cells. These findings also have relevance to the development of certain ROS producers as anti-cancer agents. These, along with shikonin have potential as novel chemotherapeutic agents on human glioma.	[Yang, Jen-Tsung; Li, Zih-Ling] Chang Gung Univ, Chang Gung Mem Hosp Chiayi, Coll Med, Dept Neurosurg, Tao Yuan, Taiwan; [Li, Zih-Ling; Wu, Jin-Yi; Chen, Ching-Hsein] Natl Chiayi Univ, Coll Life Sci, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan; [Lu, Fung-Jou] Chung Shan Med Univ, Inst Med, Taichung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Chiayi University; Chung Shan Medical University	Chen, CH (corresponding author), Natl Chiayi Univ, Coll Life Sci, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan.	chench@mail.ncyu.edu.tw			Chang Gung Memorial Hospital, R.O.C. [CMRPG6A0252]; National Science Council, Taiwan [NSC 102-2320-B-415-005-MY3]	Chang Gung Memorial Hospital, R.O.C.(Chang Gung Memorial Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by Chang Gung Memorial Hospital, R.O.C. (CMRPG6A0252, J.T.Y.) and in part by National Science Council, Taiwan (NSC 102-2320-B-415-005-MY3; National Science Council's, C.H.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldaba-Muruato LR, 2012, CAN J PHYSIOL PHARM, V90, P1469, DOI 10.1139/y2012-125; Bobba A, 2013, MITOCHONDRION, V13, P298, DOI 10.1016/j.mito.2013.03.008; Byun JY, 2009, MOL PHARMACOL, V76, P734, DOI 10.1124/mol.109.056259; Chen CH, 2003, PLANTA MED, V69, P1119, DOI 10.1055/s-2003-45193; Chen CH, 2012, ANN SURG ONCOL, V19, P3097, DOI 10.1245/s10434-012-2324-4; Conklin KA, 2004, J NUTR, V134, p3201S, DOI 10.1093/jn/134.11.3201S; Gao S, 2013, CANCER LETT, V333, P36, DOI 10.1016/j.canlet.2012.12.029; Garcia-Escudero V, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/162152; Garcia-Perez C, 2012, P NATL ACAD SCI USA, V109, P4497, DOI 10.1073/pnas.1118244109; Jaburek M, 2013, INT J BIOCHEM CELL B, V45, P816, DOI 10.1016/j.biocel.2013.01.010; James AM, 2007, J BIOL CHEM, V282, P14708, DOI 10.1074/jbc.M611463200; Kim HJ, 2003, ARCH PHARM RES, V26, P405, DOI 10.1007/BF02976698; Klaus V, 2010, ARCH BIOCHEM BIOPHYS, V496, P93, DOI 10.1016/j.abb.2010.02.002; Kuo HM, 2007, ANTICANCER RES, V27, P395; Lee HN, 2013, BIOCHEM PHARMACOL, V86, P759, DOI 10.1016/j.bcp.2013.07.002; MILLER MG, 1986, BIOCHEM PHARMACOL, V35, P1177, DOI 10.1016/0006-2952(86)90157-7; Nguyen MVC, 2013, BIOCHEM PHARMACOL, V85, P1644, DOI 10.1016/j.bcp.2013.03.023; Okayasu H, 2001, ANTICANCER RES, V21, P2387; Ozben T, 2007, J PHARM SCI-US, V96, P2181, DOI 10.1002/jps.20874; Pal HC, 2013, EXP DERMATOL, V22, P470, DOI 10.1111/exd.12181; Paletta-Silva R, 2013, INT J MOL SCI, V14, P3683, DOI 10.3390/ijms14023683; Ralph SJ, 2011, PHARM RES-DORDR, V28, P2695, DOI 10.1007/s11095-011-0566-7; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Rincheval V, 2012, CELL BIOL TOXICOL, V28, P239, DOI 10.1007/s10565-012-9219-9; Schramm A, 2012, VASC PHARMACOL, V56, P216, DOI 10.1016/j.vph.2012.02.012; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Waris G, 2006, J CARCINOG, V5, P14, DOI [10.1186/1477-3163-5-14, DOI 10.1186/1477-3163-5-14]; WU FYH, 1993, ONCOGENE, V8, P2237; Xu KH, 2010, LEUKEMIA RES, V34, P658, DOI 10.1016/j.leukres.2009.08.017	29	52	53	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94180	10.1371/journal.pone.0094180	http://dx.doi.org/10.1371/journal.pone.0094180			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714453	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900098
J	Yimer, G; Gry, M; Amogne, W; Makonnen, E; Habtewold, A; Petros, Z; Aderaye, G; Schuppe-Koistinen, I; Lindquist, L; Aklillu, E				Yimer, Getnet; Gry, Marcus; Amogne, Wondwossen; Makonnen, Eyasu; Habtewold, Abiy; Petros, Zelalem; Aderaye, Getachew; Schuppe-Koistinen, Ina; Lindquist, Lars; Aklillu, Eleni			Evaluation of Patterns of Liver Toxicity in Patients on Antiretroviral and Anti-Tuberculosis Drugs: A Prospective Four Arm Observational Study in Ethiopian Patients	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TERM EFAVIRENZ AUTOINDUCTION; HIV-POSITIVE PATIENTS; INDUCED HEPATOTOXICITY; PLASMA EXPOSURE; THERAPY; TUBERCULOSIS; INJURY; PHARMACOGENETICS; EXPERIENCE	Objectives: To evaluate the incidence, type, severity and predictors of antiretroviral and/or anti-tuberculosis drugs induced liver injury (DILI). Methods: A total of 1,060 treatment naive patients were prospectively enrolled into four treatment groups: HIV patients receiving efavirenz based HAART alone (Arm-1); TB-HIV co-infected patients with CD4 <= 200 cells/mu L, receiving concomitant rifampicin based anti-TB and efavirenz based HAART (Arm-2); TB-HIV co-infected patients with CD4>200 cells/mu L, receiving anti-TB alone (Arm-3); TB patients taking rifampicin based anti-TB alone (Arm-4). Liver enzyme levels were monitored at baseline, 1st, 2nd, 4th, 8th, 12th and 24th weeks during treatment. CD4 and HIV viral load was measured at baseline, 24th and 48th weeks. Data were analyzed using multivariate Cox Proportional Hazards Model. Results: A total of 159 patients (15%) developed DILI with severity grades 1, 2, 3 and 4 of 53.5%, 32.7%, 11.3% and 2.5% respectively. The incidence of cholestatic, hepatocellular or mixed pattern was 61%, 15% and 24%, respectively. Incidence of DILI was highest in Arm-2 (24.2%)>Arm-3 (10.8%)>Arm-1 (8.8%)>Arm-4 (2.9%). Concomitant anti-TB-HIV therapy increased the risk of DILI by 10-fold than anti-TB alone (p<0.0001). HIV co-infection increased the risk of anti-TB DILI by 4-fold (p = 0.004). HAART associated DILI was 3-fold higher than anti-TB alone, (p = 0.02). HAART was associated with cholestatic and grade 1 DILI whereas anti-TB therapy was associated with hepatocellular and grade >= 2. Treatment type, lower CD4, platelet, hemoglobin, higher serum AST and direct bilirubin levels at baseline were significant DILI predictors. There was no effect of DILI on immunologic recovery or virologic suppression rate of HAART. Conclusion: HAART associated DILI is mainly cholestatic and mild whereas hepatocellular or mixed pattern with high severity grade is more common in anti-tuberculosis DILI. TB-HIV co-infection, disease severity and concomitant treatment exacerbates the risk of DILI.	[Yimer, Getnet; Habtewold, Abiy; Aklillu, Eleni] Karolinska Univ, Huddinge Hosp, Karolinska Inst, Div Clin Pharmacol,Dept Lab Med, Stockholm, Sweden; [Yimer, Getnet; Makonnen, Eyasu; Habtewold, Abiy; Petros, Zelalem] Univ Addis Ababa, Coll Hlth Sci, Sch Med, Dept Pharmacol, Addis Ababa, Ethiopia; [Gry, Marcus] Former AstraZeneca R&D, Global Safety Assessment Mol Toxicol, Sodertalje, Sweden; [Amogne, Wondwossen; Aderaye, Getachew] Univ Addis Ababa, Coll Hlth Sci, Sch Med, Dept Internal Med, Addis Ababa, Ethiopia; [Schuppe-Koistinen, Ina] AstraZeneca, Innovat Med Personalised Healthcare & Biomarkers, Solna, Sweden; [Amogne, Wondwossen; Lindquist, Lars] Karolinska Univ, Hosp Huddinge I 73, Karolinska Inst, Dept Med,Div Infect Dis, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Addis Ababa University; AstraZeneca; Addis Ababa University; AstraZeneca; Karolinska Institutet; Karolinska University Hospital	Aklillu, E (corresponding author), Karolinska Univ, Huddinge Hosp, Karolinska Inst, Div Clin Pharmacol,Dept Lab Med, C1 68, Stockholm, Sweden.	Eleni.Aklillu@ki.se	Aklillu, Eleni/ABG-3461-2021; Degu, Wondwossen Amogne/GON-3590-2022; Amogne, Wondwossen/AGM-9855-2022; Yimer, Getnet/A-9436-2015	Aklillu, Eleni/0000-0002-9788-0790; Makonnen, Eyasu/0000-0002-9259-5288; Yimer, Getnet/0000-0002-1469-837X; Schuppe-Koistinen, Ina/0000-0002-1423-3089	European & Developing Countries Clinical Trials Partnership [CG_TA.05.40204_005, CT.2005.32030.001]; SIDA [HIV-2006-031, SWE 2007-270]; Swedish research council [VR 521-2011-3437]	European & Developing Countries Clinical Trials Partnership; SIDA; Swedish research council(Swedish Research CouncilEuropean Commission)	This study was supported by grants from European & Developing Countries Clinical Trials Partnership (grant numbers CG_TA.05.40204_005, CT.2005.32030.001) and SIDA (grant numbers HIV-2006-031, SWE 2007-270), Swedish research council (grant number VR 521-2011-3437). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AIDS CLIN TRIALS, 1996, TABL GRAD SEV AD ADV; Aithal GP, 2011, CLIN PHARMACOL THER, V89, P806, DOI 10.1038/clpt.2011.58; Bica I, 2001, CLIN INFECT DIS, V32, P492, DOI 10.1086/318501; Daly AK, 2010, PHARMACOGENOMICS, V11, P607, DOI [10.2217/pgs.10.24, 10.2217/PGS.10.24]; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Devarbhavi H, 2010, AM J GASTROENTEROL, V105, P2396, DOI 10.1038/ajg.2010.287; Dore GJ, 1999, J INFECT DIS, V180, P607, DOI 10.1086/314942; Elsharkawy AM, 2013, J CLIN VIROL, V58, P331, DOI 10.1016/j.jcv.2013.05.003; Habtewold A, 2011, J ANTIMICROB CHEMOTH, V66, P2350, DOI 10.1093/jac/dkr304; Hoffmann CJ, 2007, AIDS, V21, P1301, DOI 10.1097/QAD.0b013e32814e6b08; Inductivo-Yu I, 2008, CURR DRUG SAF, V3, P4, DOI 10.2174/157488608783333916; Jones M, 2012, SEMIN LIVER DIS, V32, P167, DOI 10.1055/s-0032-1316472; Kalyesubula R, 2011, AFR HEALTH SCI, V11, P16; Karvellas CJ, 2010, LIVER INT, V30, P826, DOI 10.1111/j.1478-3231.2010.02243.x; Lamar Zanetta S, 2011, J Int Assoc Physicians AIDS Care (Chic), V10, P183, DOI 10.1177/1545109711401411; Lee LSU, 2012, ANN ACAD MED SINGAP, V41, P559; M'Kada H, 2011, REGUL TOXICOL PHARM, V60, P290, DOI 10.1016/j.yrtph.2011.04.002; McRae MP, 2006, J PHARMACOL EXP THER, V318, P1068, DOI 10.1124/jpet.106.102657; Mugusi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040180; Mugusi SF, 2012, ANTIVIR THER, V17, P265, DOI 10.3851/IMP1956; Mukonzo JK, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-261; Nelson M, 2003, AIDS, V17, pF7, DOI 10.1097/00002030-200301030-00002; Neukam K, 2011, J ANTIMICROB CHEMOTH, V66, P2605, DOI 10.1093/jac/dkr357; Ngaimisi E, 2011, CLIN PHARMACOL THER, V90, P406, DOI 10.1038/clpt.2011.129; Ngaimisi E, 2010, CLIN PHARMACOL THER, V88, P676, DOI 10.1038/clpt.2010.172; Nunez M, 2010, HEPATOLOGY, V52, P1143, DOI 10.1002/hep.23716; Reisler RB, 2003, JAIDS-J ACQ IMM DEF, V34, P379, DOI 10.1097/00126334-200312010-00004; Russmann S, 2010, HEPATOLOGY, V52, P748, DOI 10.1002/hep.23720; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Sterling TR, 2010, CLIN INFECT DIS, V50, pS223, DOI 10.1086/651495; Stine JG, 2011, EXPERT OPIN DRUG MET, V7, P875, DOI 10.1517/17425255.2011.577415; Sulkowski MS, 2000, JAMA-J AM MED ASSOC, V283, P74, DOI 10.1001/jama.283.1.74; Tostmann A, 2007, TROP MED INT HEALTH, V12, P852, DOI 10.1111/j.1365-3156.2007.01871.x; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; Tostmann A, 2010, TROP MED INT HEALTH, V15, P268, DOI 10.1111/j.1365-3156.2009.02449.x; Walker UA, 2007, CURR OPIN HIV AIDS, V2, P293, DOI 10.1097/COH.0b013e328122dbaa; Wares DF, 2003, INT J TUBERC LUNG D, V7, P327; WHO, ANT THER HIV INF AD; Yimer G, 2012, PHARMACOGENOMICS J, V12, P499, DOI 10.1038/tpj.2011.34; Yimer G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027810; Yimer G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001809	41	36	37	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94271	10.1371/journal.pone.0094271	http://dx.doi.org/10.1371/journal.pone.0094271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714066	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900111
J	Lee, JB; Kim, TW; Min, YK; Yang, HM				Lee, Jeong-Beom; Kim, Tae-Wook; Min, Young-Ki; Yang, Hun-Mo			Long Distance Runners Present Upregulated Sweating Responses than Sedentary Counterparts	PLOS ONE			English	Article							SKIN BLOOD-FLOW; SUDOMOTOR FUNCTION; HEAT ACCLIMATION; EXERCISE; TEMPERATURE; SENSITIVITY; GLAND; RATS; ACETYLCHOLINE; VASODILATION	Relatively few studies have investigated peripheral sweating mechanisms of long-distance runners. The aim of this study was to compare peripheral sweating mechanisms in male long-distance runners, and sedentary counterparts. Thirty six subjects, including 20 sedentary controls and 16 long-distance runners (with 7-12 years of athletic training, average 9.2 +/- 2.1 years) were observed. Quantitative sudomotor axon reflex testing (QSART) with iontophoresis (2 mA for 5 min) and 10% acetylcholine (ACh) were performed to determine axon reflex-mediated and directly activated (DIR, muscarinic receptor) sweating. Sweat onset time, sweat rate, number of activated sweat glands, sweat output per gland and skin temperature were measured at rest while maximum oxygen uptake (VO(2)max) were measured during maximal cycling. Sweat rate, activated sweat glands, sweat output per gland, skin temperature and VO(2)max were significantly higher in the trained runners than in the sedentary controls. Sweat onset time was significantly shorter for the runners. In the group of long-distance runners, significant correlations were found between VO(2)max and sweat onset time (r(2) = 0.543, P < 0.01, n = 16), DIR sweat rate (r(2) = 0.584, P < 0.001, n = 16), sweat output per gland (r(2) = 0.539, P < 0.01, n = 16). There was no correlation between VO(2)max and activated sweat glands. These findings suggest that habitual long-distance running results in upregulation of the peripheral sweating mechanisms in humans. Additional research is needed to determine the molecular mechanism underlying these changes. These findings complement the existing sweating data in long-distance runners.	[Lee, Jeong-Beom; Min, Young-Ki; Yang, Hun-Mo] Soonchunhyang Univ, Coll Med, Dept Physiol, Cheonan, Chungcheongnamd, South Korea; [Kim, Tae-Wook] Soonchunhyang Univ, Grad Sch, Dept Hlth Care, Asan, Chungcheongnamd, South Korea	Soonchunhyang University; Soonchunhyang University	Kim, TW (corresponding author), Soonchunhyang Univ, Grad Sch, Dept Hlth Care, Asan, Chungcheongnamd, South Korea.	kimtw@sch.ac.kr						ARAKI T, 1981, J APPL PHYSIOL, V51, P1526, DOI 10.1152/jappl.1981.51.6.1526; Bae JS, 2006, PFLUG ARCH EUR J PHY, V453, P67, DOI 10.1007/s00424-006-0098-x; BAUM E, 1976, J APPL PHYSIOL, V40, P404, DOI 10.1152/jappl.1976.40.3.404; Bickel A, 2004, J NEUROL NEUROSUR PS, V75, P275; BITTEL JHM, 1980, EXPERIENTIA, V36, P560, DOI 10.1007/BF01965800; BUONO M J, 1992, Journal of Dermatological Science, V4, P33, DOI 10.1016/0923-1811(92)90053-E; BUONO MJ, 1988, J APPL PHYSIOL, V65, P811, DOI 10.1152/jappl.1988.65.2.811; BUONO MJ, 1991, AGE AGEING, V20, P439, DOI 10.1093/ageing/20.6.439; Chemali KR, 2001, ANN NEUROL, V49, P453; Chen H, 1998, CHINESE J PHYSIOL, V41, P161; Cheng LJ, 1999, J BIOMED SCI, V6, P22, DOI 10.1159/000025367; Cotter JD, 1997, EUR J APPL PHYSIOL O, V76, P181, DOI 10.1007/s004210050232; CRAWSHAW LI, 1975, PFLUG ARCH EUR J PHY, V354, P19, DOI 10.1007/BF00584500; Dawson B, 1989, J SPORT SCI, V7, P189, DOI 10.1080/02640418908729840; DELP MD, 1995, MED SCI SPORT EXER, V27, P1152; DiPasquale DM, 2003, JPN J PHYSIOL, V53, P427, DOI 10.2170/jjphysiol.53.427; Gonzalez-Alonso J, 1999, J APPL PHYSIOL, V86, P1032, DOI 10.1152/jappl.1999.86.3.1032; HENANE R, 1977, J APPL PHYSIOL, V43, P822, DOI 10.1152/jappl.1977.43.5.822; Heylen E, 2008, J SPORT MED PHYS FIT, V48, P246; IRION GL, 1987, AVIAT SPACE ENVIR MD, V58, P948; Kondo N, 2001, J APPL PHYSIOL, V90, P1877, DOI 10.1152/jappl.2001.90.5.1877; Lee JB, 2009, INT J BIOMETEOROL, V53, P149, DOI 10.1007/s00484-008-0197-9; Lee JB, 2008, KOREAN J PHYSIOL PHA, V12, P349, DOI 10.4196/kjpp.2008.12.6.349; Low PA, 2004, CLIN NEUROPHYSIOL, V115, P1506, DOI 10.1016/j.clinph.2004.01.023; LOW PA, 1983, ANN NEUROL, V14, P573, DOI 10.1002/ana.410140513; MCMURRAY RG, 1979, J APPL PHYSIOL, V46, P1086, DOI 10.1152/jappl.1979.46.6.1086; Merry TL, 2010, ACTA PHYSIOL, V198, P179, DOI 10.1111/j.1748-1716.2009.02051.x; Midgley AW, 2007, SPORTS MED, V37, P857, DOI 10.2165/00007256-200737100-00003; Mora-Rodriguez R, 2013, APPL PHYSIOL NUTR ME, V38, P73, DOI 10.1139/apnm-2012-0174; Morris SJ, 1996, J PHYSIOL-LONDON, V496, P531, DOI 10.1113/jphysiol.1996.sp021704; Noguchi M, 2002, NEUROPEPTIDES, V36, P327, DOI 10.1016/S0143-4179(02)00090-2; OGAWA T, 1986, JPN J PHYSIOL, V36, P417, DOI 10.2170/jjphysiol.36.417; PIWONKA RW, 1967, J APPL PHYSIOL, V22, P9, DOI 10.1152/jappl.1967.22.1.9; ROBERTS MF, 1977, J APPL PHYSIOL, V43, P133, DOI 10.1152/jappl.1977.43.1.133; SATO K, 1983, AM J PHYSIOL, V245, pR203, DOI 10.1152/ajpregu.1983.245.2.R203; Shibasaki Manabu, 2010, Front Biosci (Schol Ed), V2, P685; STROMME SB, 1977, J APPL PHYSIOL, V42, P833, DOI 10.1152/jappl.1977.42.6.833; SUGENOYA J, 1995, EUR J APPL PHYSIOL O, V71, P33, DOI 10.1007/BF00511230; TAYLOR NAS, 1986, SPORTS MED, V3, P387, DOI 10.2165/00007256-198603060-00001	39	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93976	10.1371/journal.pone.0093976	http://dx.doi.org/10.1371/journal.pone.0093976			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709823	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800080
J	Menon, M; Askinazi, OL; Schafer, DA				Menon, Manisha; Askinazi, Olga L.; Schafer, Dorothy A.			Dynamin2 Organizes Lamellipodial Actin Networks to Orchestrate Lamellar Actomyosin	PLOS ONE			English	Article							CLATHRIN-COATED PITS; FOCAL ADHESIONS; STRESS FIBERS; ALPHA-ACTININ; MIGRATING CELLS; RETROGRADE FLOW; CYTOSKELETON; BUNDLES; GTPASE; ENDOCYTOSIS	Actin networks in migrating cells exist as several interdependent structures: sheet-like networks of branched actin filaments in lamellipodia; arrays of bundled actin filaments co-assembled with myosin II in lamellae; and actin filaments that engage focal adhesions. How these dynamic networks are integrated and coordinated to maintain a coherent actin cytoskeleton in migrating cells is not known. We show that the large GTPase dynamin2 is enriched in the distal lamellipod where it regulates lamellipodial actin networks as they form and flow in U2-OS cells. Within lamellipodia, dynamin2 regulated the spatiotemporal distributions of a-actinin and cortactin, two actin-binding proteins that specify actin network architecture. Dynamin2's action on lamellipodial F-actin influenced the formation and retrograde flow of lamellar actomyosin via direct and indirect interactions with actin filaments and a finely tuned GTP hydrolysis activity. Expression in dynamin2-depleted cells of a mutant dynamin2 protein that restores endocytic activity, but not activities that remodel actin filaments, demonstrated that actin filament remodeling by dynamin2 did not depend of its functions in endocytosis. Thus, dynamin2 acts within lamellipodia to organize actin filaments and regulate assembly and flow of lamellar actomyosin. We hypothesize that through its actions on lamellipodial F-actin, dynamin2 generates F-actin structures that give rise to lamellar actomyosin and for efficient coupling of F-actin at focal adhesions. In this way, dynamin2 orchestrates the global actin cytoskeleton.	[Menon, Manisha; Askinazi, Olga L.; Schafer, Dorothy A.] Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA; [Schafer, Dorothy A.] Univ Virginia, Dept Cell Biol, Charlottesville, VA USA	University of Virginia; University of Virginia	Schafer, DA (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA.	das9w@virginia.edu			NIGMS [GM067222]; Department of Biology, University of Virginia; NATIONAL CANCER INSTITUTE [P30CA044579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067222] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Biology, University of Virginia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIGMS (www.nih.gov) GM067222 to D. A. S. and by interim funds from the Department of Biology, University of Virginia (www.bio.virginia.edu). The funders had no role in study design, data collection and analysis, decidio to publish, or preparation of the manuscript.	Alexandrova AY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003234; Anderson TW, 2008, MOL BIOL CELL, V19, P5006, DOI 10.1091/mbc.E08-01-0034; Aratyn-Schaus Y, 2011, MOL BIOL CELL, V22, P1330, DOI 10.1091/mbc.E10-11-0891; Brown CM, 2006, J CELL SCI, V119, P5204, DOI 10.1242/jcs.03321; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Burnette DT, 2011, NAT CELL BIOL, V13, P371, DOI 10.1038/ncb2205; Burridge K, 2013, J CELL BIOL, V200, P9, DOI 10.1083/jcb.201210090; CHOI CK, 2008, NAT CELL BIOL; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Chua J, 2009, P NATL ACAD SCI US; Courson DS, 2010, J BIOL CHEM, V285, P26350, DOI 10.1074/jbc.M110.123117; Destaing O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077956; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Gardel ML, 2008, J CELL BIOL, V183, P999, DOI 10.1083/jcb.200810060; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Giannone G, 2009, TRENDS CELL BIOL, V19, P475, DOI 10.1016/j.tcb.2009.07.001; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Hamao K, 2009, EXP CELL RES, V315, P1336, DOI 10.1016/j.yexcr.2009.01.025; HEATH JP, 1983, J CELL SCI, V60, P331; Henmi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028603; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kasai K, 1999, J BIOCHEM, V125, P780, DOI 10.1093/oxfordjournals.jbchem.a022349; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Liu YW, 2008, MOL BIOL CELL, V19, P5347, DOI 10.1091/mbc.E08-08-0890; MACIVER SK, 1991, J CELL BIOL, V115, P1621, DOI 10.1083/jcb.115.6.1621; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Menon M, 2013, INT REV CEL MOL BIO, V302, P187, DOI 10.1016/B978-0-12-407699-0.00003-0; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; MEYER RK, 1990, J CELL BIOL, V110, P2013, DOI 10.1083/jcb.110.6.2013; Mooren OL, 2009, J BIOL CHEM, V284, P23995, DOI 10.1074/jbc.M109.024398; Moravec R, 2012, J BIOL CHEM, V287, P31138, DOI 10.1074/jbc.M112.383117; Naumanen P, 2008, J MICROSC-OXFORD, V231, P446, DOI 10.1111/j.1365-2818.2008.02057.x; Nemethova M, 2008, J CELL BIOL, V180, P1233, DOI 10.1083/jcb.200709134; Oakes PW, 2012, J CELL BIOL, V196, P363, DOI 10.1083/jcb.201107042; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Razidlo GL, 2013, DEV CELL, V24, P573, DOI 10.1016/j.devcel.2013.02.010; Reymann AC, 2012, SCIENCE, V336, P1310, DOI 10.1126/science.1221708; Risca VI, 2012, P NATL ACAD SCI USA, V109, P2913, DOI 10.1073/pnas.1114292109; Rossier OM, 2010, EMBO J, V29, P1055, DOI 10.1038/emboj.2010.2; Schafer DA, 2002, CURR BIOL, V12, P1852, DOI 10.1016/S0960-9822(02)01228-9; Schwarz US, 2012, J CELL SCI, V125, P3051, DOI 10.1242/jcs.093716; Shemesh T, 2009, BIOPHYS J, V97, P1254, DOI 10.1016/j.bpj.2009.05.065; Song BD, 2004, J BIOL CHEM, V279, P40431, DOI 10.1074/jbc.M407007200; Stricker J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070652; Tanabe K, 2009, J CELL BIOL, V185, P939, DOI 10.1083/jcb.200803153; Taylor MJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001302; Thievessen I, 2013, J CELL BIOL, V202, P163, DOI 10.1083/jcb.201303129; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Tojkander S, 2011, CURR BIOL, V21, P539, DOI 10.1016/j.cub.2011.03.007; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Vicente-Manzanares M, 2007, J CELL BIOL, V176, P573, DOI 10.1083/jcb.200612043; WACHSSTOCK DH, 1993, BIOPHYS J, V65, P205, DOI 10.1016/S0006-3495(93)81059-2; Wang Y, 2011, MOL BIOL CELL, V22, P1529, DOI 10.1091/mbc.E10-09-0785; Watanabe N, 2002, SCIENCE, V295, P1083, DOI 10.1126/science.1067470	64	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94330	10.1371/journal.pone.0094330	http://dx.doi.org/10.1371/journal.pone.0094330			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710573	gold, Green Submitted, Green Published			2022-12-25	WOS:000334159800137
J	Niemi, NM; Sacoman, JL; Westrate, LM; Gaither, LA; Lanning, NJ; Martin, KR; MacKeigan, JP				Niemi, Natalie M.; Sacoman, Juliana L.; Westrate, Laura M.; Gaither, L. Alex; Lanning, Nathan J.; Martin, Katie R.; MacKeigan, Jeffrey P.			The Pseudophosphatase MK-STYX Physically and Genetically Interacts with the Mitochondrial Phosphatase PTPMT1	PLOS ONE			English	Article							PROTEIN; MYOTUBULARIN; CARDIOLIPIN; APOPTOSIS; COMPLEXES; MAP	We previously performed an RNA interference (RNAi) screen and found that the knockdown of the catalytically inactive phosphatase, MK-STYX [MAPK (mitogen-activated protein kinase) phospho-serine/threonine/tyrosine-binding protein], resulted in potent chemoresistance. Our follow-up studies demonstrated that knockdown of MK-STYX prevents cells from undergoing apoptosis through a block in cytochrome c release, but that MK-STYX does not localize proximal to the molecular machinery currently known to control this process. In an effort to define its molecular mechanism, we utilized an unbiased proteomics approach to identify proteins that interact with MK-STYX. We identified the mitochondrial phosphatase, PTPMT1 (PTP localized to mitochondrion 1), as the most significant and unique interaction partner of MK-STYX. We previously reported that knockdown of PTPMT1, an important component of the cardiolipin biosynthetic pathway, is sufficient to induce apoptosis and increase chemosensitivity. Accordingly, we hypothesized that MK-STYX and PTPMT1 interact and serve opposing functions in mitochondrial-dependent cell death. We confirmed that MK-STYX and PTPMT1 interact in cells and, importantly, found that MK-STYX suppresses PTPMT1 catalytic activity. Furthermore, we found that knockdown of PTPMT1 resensitizes MK-STYX knockdown cells to chemotherapeutics and restores the ability to release cytochrome c. Taken together, our data support a model in which MK-STYX controls apoptosis by negatively regulating PTPMT1. Given the important role of PTPMT1 in the production of cardiolipin and other phospholipids, this raises the possibility that dysregulated mitochondrial lipid metabolism may facilitate chemoresistance.	[Niemi, Natalie M.; Sacoman, Juliana L.; Westrate, Laura M.; Lanning, Nathan J.; Martin, Katie R.; MacKeigan, Jeffrey P.] Van Andel Res Inst, Lab Syst Biol, Grand Rapids, MI 49503 USA; [Gaither, L. Alex] Novartis Inst BioMed Res, Dev & Mol Pathways Dept, Cambridge, MA USA	Van Andel Institute; Novartis	MacKeigan, JP (corresponding author), Van Andel Res Inst, Lab Syst Biol, Grand Rapids, MI 49503 USA.	jeff.mackeigan@vai.org	Niemi, Natalie/AAH-6963-2021; Lanning, Nathan/AAI-2532-2019	Niemi, Natalie/0000-0002-5174-4005; Lanning, Nathan/0000-0002-0983-7451; MacKeigan, Jeffrey/0000-0002-0198-5679; Martin, Katie/0000-0002-3689-4814	National Institutes of Health National Cancer Institute grants [R01CA138651]; Novartis Institutes for BioMedical Research; NATIONAL CANCER INSTITUTE [R01CA138651] Funding Source: NIH RePORTER	National Institutes of Health National Cancer Institute grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Novartis Institutes for BioMedical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health National Cancer Institute grants R01CA138651 (J.P.M.). Novartis Institutes for BioMedical Research provided support in the form of a salary for author L.A.G., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions'' section.	Berg J. M., 2002, BIOCHEMISTRY-US; Berger P, 2006, HUM MOL GENET, V15, P569, DOI 10.1093/hmg/ddi473; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Choi SY, 2007, CELL DEATH DIFFER, V14, P597, DOI 10.1038/sj.cdd.4402020; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Copeland R. A., 2005, EVALUATION ENZYME IN; Doughty-Shenton D, 2010, J PHARMACOL EXP THER, V333, P584, DOI 10.1124/jpet.109.163329; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Grimsrud PA, 2012, CELL METAB, V16, P672, DOI 10.1016/j.cmet.2012.10.004; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HILL HD, 1968, ANAL BIOCHEM, V24, P9, DOI 10.1016/0003-2697(68)90054-7; Hinton SD, 2010, BIOCHEM J, V427, P349, DOI 10.1042/BJ20091383; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Kim SA, 2003, P NATL ACAD SCI USA, V100, P4492, DOI 10.1073/pnas.0431052100; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Mochizuki Y, 2003, P NATL ACAD SCI USA, V100, P9768, DOI 10.1073/pnas.1333958100; Moffat J, 2006, NAT REV MOL CELL BIO, V7, P177, DOI 10.1038/nrm1860; Nandurkar HH, 2003, P NATL ACAD SCI USA, V100, P8660, DOI 10.1073/pnas.1033097100; Niemi NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053803; Niemi NM, 2011, MOL CELL BIOL, V31, P1357, DOI 10.1128/MCB.00788-10; Pagliarini DJ, 2005, MOL CELL, V19, P197, DOI 10.1016/j.molcel.2005.06.008; Pagliarini DJ, 2004, J BIOL CHEM, V279, P38590, DOI 10.1074/jbc.M404959200; Potting C, 2013, CELL METAB, V18, P287, DOI 10.1016/j.cmet.2013.07.008; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Tierno MB, 2007, NAT PROTOC, V2, P1134, DOI 10.1038/nprot.2007.155; Wishart MJ, 1998, TRENDS BIOCHEM SCI, V23, P301, DOI 10.1016/S0968-0004(98)01241-9; Zhang J, 2011, CELL METAB, V13, P690, DOI 10.1016/j.cmet.2011.04.007; Zou J, 2009, J BIOL CHEM, V284, P2064, DOI 10.1074/jbc.M804292200	32	19	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93896	10.1371/journal.pone.0093896	http://dx.doi.org/10.1371/journal.pone.0093896			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709986	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800064
J	Oh, SW; Kim, S; Na, KY; Kim, KW; Chae, DW; Chin, HJ				Oh, Se Won; Kim, Sejoong; Na, Ki Young; Kim, Ki Woong; Chae, Dong-Wan; Chin, Ho Jun			Glomerular Filtration Rate and Proteinuria: Association with Mortality and Renal Progression in a Prospective Cohort of a Community- Based Elderly Population	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR MORTALITY; GENERAL-POPULATION; ALL-CAUSE; ALBUMINURIA; RISK; AGE; DECLINE; EPIDEMIOLOGY; PREDICTORS	Limited prospective data are available on the importance of estimated glomerular filtration rate (GFR) and proteinuria in the prediction of all-cause mortality (ACM) in community-based elderly populations. We examined the relationship between GFR or proteinuria and ACM in 949 randomly selected community-dwelling elderly subjects (aged >= 65 years) over a 5-year period. A spot urine sample was used to measure proteinuria by the dipstick test, and GFR was estimated using the chronic kidney disease-epidemiology collaboration (CKD-EPI) equation. Information about mortality and causes of death was collected by direct enquiry with the subjects and from the national mortality data. Compared to subjects without proteinuria, those with proteinuria of grade >= 1+ had a 1.725-fold (1.134-2.625) higher risk of ACM. Compared to subjects with GFR >= 90 ml/min/1.73 m(2), those with GFR, 45 ml/min/1.73 m(2) had a 2.357 -fold (1.170-4.750) higher risk for ACM. Among the 403 subjects included in the analysis of renal progression, the annual rate of GFR change during follow-up period was -0.52 +/- 2.35 ml/min/1.73 m(2) /year. The renal progression rate was 7.315-fold (1.841-29.071) higher in subjects with GFR<60 ml/min/1.73 m(2) than in those with GFR >= 60 ml/min/1.73 m(2). Among a community-dwelling elderly Korean population, decreased GFR of <45 ml/min/1.73 m(2) and proteinuria were independent risk factors for ACM.	[Oh, Se Won] Inje Univ, Coll Med, Dept Internal Med, Goyang City, Gyeonggi Do, South Korea; [Kim, Sejoong; Na, Ki Young; Chae, Dong-Wan; Chin, Ho Jun] Seoul Natl Univ, Bundang Hopsital, Songnam, South Korea; [Na, Ki Young; Chae, Dong-Wan; Chin, Ho Jun] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Kim, Ki Woong] Seoul Natl Univ, Coll Med, Dept Psychiat, Seoul 151, South Korea	Inje University; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Chin, HJ (corresponding author), Inje Univ, Coll Med, Dept Internal Med, Goyang City, Gyeonggi Do, South Korea.	mednep@snubh.org	Kim, Sejoong/J-5356-2015; Oh, Se Won/G-2632-2017	Kim, Sejoong/0000-0002-7238-9962; Oh, Se Won/0000-0003-3795-9322	Pfizer Global Pharmaceuticals [06-05-039]; Seongnam City Government in Korea [800-20050211]	Pfizer Global Pharmaceuticals(Pfizer); Seongnam City Government in Korea	This work was supported by an independent Research Grant (IRG) from Pfizer Global Pharmaceuticals (grant number 06-05-039) and a Grant for developing Seongnam Health Promotion Program for the Elderly from Seongnam City Government in Korea (grant number 800-20050211. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowling CB, 2012, J GERONTOL A-BIOL, V67, P1379, DOI 10.1093/gerona/gls173; Bowling CB, 2011, CLIN J AM SOC NEPHRO, V6, P2822, DOI 10.2215/CJN.06770711; Chin HJ, 2008, NEPHROL DIAL TRANSPL, V23, P2810, DOI 10.1093/ndt/gfn132; Christensson A, 2011, NEPHRON CLIN PRACT, V117, pC40, DOI 10.1159/000319646; Clase CM, 2011, ANN INTERN MED, V154, P310, DOI 10.7326/0003-4819-154-5-201103010-00005; Culleton BF, 1999, KIDNEY INT, V56, P2214, DOI 10.1046/j.1523-1755.1999.00773.x; Dalrymple LS, 2011, J GEN INTERN MED, V26, P379, DOI 10.1007/s11606-010-1511-x; DAVIES DF, 1950, J CLIN INVEST, V29, P496, DOI 10.1172/JCI102286; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Garg AX, 2002, KIDNEY INT, V61, P1486, DOI 10.1046/j.1523-1755.2002.00270.x; Glassock Richard J, 2009, Trans Am Clin Climatol Assoc, V120, P419; Hallan S, 2007, ARCH INTERN MED, V167, P2490, DOI 10.1001/archinte.167.22.2490; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Imai E, 2008, HYPERTENS RES, V31, P433, DOI 10.1291/hypres.31.433; Kim S, 2009, J KOREAN MED SCI, V24, pS11, DOI 10.3346/jkms.2009.24.S1.S11; Kimm H, 2009, STROKE, V40, P3422, DOI 10.1161/STROKEAHA.109.560649; Lee CS, 2010, J KOREAN MED SCI, V25, P1616, DOI 10.3346/jkms.2010.25.11.1616; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Muntner P, 2011, CLIN J AM SOC NEPHRO, V6, P2200, DOI 10.2215/CJN.02030311; Nerpin E, 2011, NEPHROL DIAL TRANSPL, V26, P2820, DOI 10.1093/ndt/gfq848; O'Hare AM, 2006, J AM SOC NEPHROL, V17, P846, DOI 10.1681/ASN.2005090986; Rifkin DE, 2010, NEPHROL DIAL TRANSPL, V25, P1560, DOI 10.1093/ndt/gfp646; Smink PA, 2012, AM J KIDNEY DIS, V60, P804, DOI 10.1053/j.ajkd.2012.06.017; Stengel B, 2011, NEPHROL DIAL TRANSPL, V26, P3286, DOI 10.1093/ndt/gfr323; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; van der Velde M, 2010, CLIN J AM SOC NEPHRO, V5, P2053, DOI 10.2215/CJN.08851209	29	20	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94120	10.1371/journal.pone.0094120	http://dx.doi.org/10.1371/journal.pone.0094120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709896	gold, Green Submitted, Green Published			2022-12-25	WOS:000334159800102
J	Rasala, BA; Chao, SS; Pier, M; Barrera, DJ; Mayfield, SP				Rasala, Beth A.; Chao, Syh-Shiuan; Pier, Matthew; Barrera, Daniel J.; Mayfield, Stephen P.			Enhanced Genetic Tools for Engineering Multigene Traits into Green Algae	PLOS ONE			English	Article							CHLAMYDOMONAS-REINHARDTII; SYNTHETIC BIOLOGY; ENDOPLASMIC-RETICULUM; BIOFUEL PRODUCTION; MICROALGAE; BIOTECHNOLOGY; MITOCHONDRIA; CHLOROPLAST; EXPRESSION; PROTEINS	Transgenic microalgae have the potential to impact many diverse biotechnological industries including energy, human and animal nutrition, pharmaceuticals, health and beauty, and specialty chemicals. However, major obstacles to sophisticated genetic and metabolic engineering in algae have been the lack of well-characterized transformation vectors to direct engineered gene products to specific subcellular locations, and the inability to robustly express multiple nuclear-encoded transgenes within a single cell. Here we validate a set of genetic tools that enable protein targeting to distinct subcellular locations, and present two complementary methods for multigene engineering in the eukaryotic green microalga Chlamydomonas reinhardtii. The tools described here will enable advanced metabolic and genetic engineering to promote microalgae biotechnology and product commercialization.	[Mayfield, Stephen P.] Univ Calif San Diego, Calif Ctr Algae Biotechnol, La Jolla, CA 92093 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Mayfield, SP (corresponding author), Univ Calif San Diego, Calif Ctr Algae Biotechnol, La Jolla, CA 92093 USA.	smayfield@ucsd.edu	Serrano-Ruiz, Juan Carlos/U-6297-2018	Serrano-Ruiz, Juan Carlos/0000-0002-9078-7390	Department of Energy [DE-EE0003373]; California Energy Commission (CILMSF) [500-10-039]; Life Technologies	Department of Energy(United States Department of Energy (DOE)); California Energy Commission (CILMSF); Life Technologies	This work was supported the by the Department of Energy (DE-EE0003373), the California Energy Commission (CILMSF # 500-10-039) and Life Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes D, 2005, MOL GENET GENOMICS, V274, P625, DOI 10.1007/s00438-005-0055-y; Beer LL, 2009, CURR OPIN BIOTECH, V20, P264, DOI 10.1016/j.copbio.2009.06.002; Cerutti H, 1997, PLANT CELL, V9, P925, DOI 10.1105/tpc.9.6.925; Chisti Y, 2008, TRENDS BIOTECHNOL, V26, P126, DOI 10.1016/j.tibtech.2007.12.002; Christaki E, 2011, INT J FOOD SCI NUTR, V62, P794, DOI 10.3109/09637486.2011.582460; de Felipe Pablo, 2004, Genet Vaccines Ther, V2, P13, DOI 10.1186/1479-0556-2-13; DEHOSTOS EL, 1988, J CELL BIOL, V106, P29, DOI 10.1083/jcb.106.1.29; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; DUMAS P, 1994, EMBO J, V13, P2483, DOI 10.1002/j.1460-2075.1994.tb06535.x; EHARA T, 1995, J CELL SCI, V108, P499; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Fischer N, 2001, MOL GENET GENOMICS, V265, P888, DOI 10.1007/s004380100485; Fuhrmann M, 1999, PLANT J, V19, P353, DOI 10.1046/j.1365-313X.1999.00526.x; Georgianna DR, 2012, NATURE, V488, P329, DOI 10.1038/nature11479; Gimpel JA, 2013, CURR OPIN CHEM BIOL, V17, P489, DOI 10.1016/j.cbpa.2013.03.038; Gomord V, 1997, PLANT J, V11, P313, DOI 10.1046/j.1365-313X.1997.11020313.x; Gong YM, 2011, J IND MICROBIOL BIOT, V38, P1879, DOI 10.1007/s10295-011-1032-6; Ha SH, 2010, PLANT BIOTECHNOL J, V8, P928, DOI 10.1111/j.1467-7652.2010.00543.x; Halpin C, 2005, PLANT BIOTECHNOL J, V3, P141, DOI 10.1111/j.1467-7652.2004.00113.x; Hannon M, 2010, BIOFUELS-UK, V1, P763, DOI 10.4155/BFS.10.44; Harris E.H, 2009, INTRO CHLAMYDOMONAS; Heinig U, 2013, CURR OPIN BIOTECH, V24, P239, DOI 10.1016/j.copbio.2012.11.006; Hiramatsu T, 2006, J PHYCOL, V42, P1048, DOI 10.1111/j.1529-8817.2006.00259.x; Jones CS, 2012, CURR OPIN BIOTECH, V23, P346, DOI 10.1016/j.copbio.2011.10.013; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Keasling JD, 2012, METAB ENG, V14, P189, DOI 10.1016/j.ymben.2012.01.004; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Mayfield SP, 2007, CURR OPIN BIOTECH, V18, P126, DOI 10.1016/j.copbio.2007.02.001; MORRIS GJ, 1985, J CELL SCI, V76, P145; Neupert J, 2009, PLANT J, V57, P1140, DOI 10.1111/j.1365-313X.2008.03746.x; Olaizola M, 2003, BIOMOL ENG, V20, P459, DOI 10.1016/S1389-0344(03)00076-5; Oyler GA, 2008, CURR OPIN BIOTECHNOL, V19, P430; Pulz O, 2004, APPL MICROBIOL BIOT, V65, P635, DOI 10.1007/s00253-004-1647-x; Purton S, 2005, PLANT CELL REP, V24, P629; Radakovits R, 2010, EUKARYOT CELL, V9, P486, DOI 10.1128/EC.00364-09; Raja R, 2008, CRIT REV MICROBIOL, V34, P77, DOI [10.1080/10408410802086783, 10.1080/10408410802086783 ]; Rasala BA, 2013, PLANT J, V74, P545, DOI 10.1111/tpj.12165; Rasala BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043349; Schroda M, 2004, PHOTOSYNTH RES, V82, P221, DOI 10.1007/s11120-004-2216-y; Specht E, 2010, BIOTECHNOL LETT, V32, P1373, DOI 10.1007/s10529-010-0326-5; Spolaore P, 2006, J BIOSCI BIOENG, V101, P87, DOI 10.1263/jbb.101.87; Sweetlove LJ, 2013, ANNU REV PLANT BIOL, V64, P723, DOI 10.1146/annurev-arplant-050312-120233; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; Wijffels RH, 2013, CURR OPIN BIOTECH, V24, P405, DOI 10.1016/j.copbio.2013.04.004; Zhang FZ, 2011, CURR OPIN BIOTECH, V22, P775, DOI 10.1016/j.copbio.2011.04.024	46	83	87	9	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94028	10.1371/journal.pone.0094028	http://dx.doi.org/10.1371/journal.pone.0094028			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710110	Green Submitted, Green Published, gold			2022-12-25	WOS:000334159800089
J	Yang, WJ; Yuan, GR; Cong, L; Xie, YF; Wang, JJ				Yang, Wen-Jia; Yuan, Guo-Rui; Cong, Lin; Xie, Yi-Fei; Wang, Jin-Jun			De novo Cloning and Annotation of Genes Associated with Immunity, Detoxification and Energy Metabolism from the Fat Body of the Oriental Fruit Fly, Bactrocera dorsalis	PLOS ONE			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEINS; TREHALOSE-PHOSPHATE-SYNTHASE; MOLECULAR CHARACTERIZATION; DROSOPHILA-MELANOGASTER; BROWN PLANTHOPPER; RNA INTERFERENCE; TRANSCRIPTOME; EXPRESSION; IDENTIFICATION; RESISTANCE	The oriental fruit fly, Bactrocera dorsalis, is a destructive pest in tropical and subtropical areas. In this study, we performed transcriptome-wide analysis of the fat body of B. dorsalis and obtained more than 59 million sequencing reads, which were assembled into 27,787 unigenes with an average length of 591 bp. Among them, 17,442 (62.8%) unigenes matched known proteins in the NCBI database. The assembled sequences were further annotated with gene ontology, cluster of orthologous group terms, and Kyoto encyclopedia of genes and genomes. In depth analysis was performed to identify genes putatively involved in immunity, detoxification, and energy metabolism. Many new genes were identified including serpins, peptidoglycan recognition proteins and defensins, which were potentially linked to immune defense. Many detoxification genes were identified, including cytochrome P450s, glutathione S-transferases and ATP-binding cassette (ABC) transporters. Many new transcripts possibly involved in energy metabolism, including fatty acid desaturases, lipases, alpha amylases, and trehalose-6-phosphate synthases, were identified. Moreover, we randomly selected some genes to examine their expression patterns in different tissues by quantitative real-time PCR, which indicated that some genes exhibited fat body-specific expression in B. dorsalis. The identification of a numerous transcripts in the fat body of B. dorsalis laid the foundation for future studies on the functions of these genes.	[Yang, Wen-Jia; Yuan, Guo-Rui; Cong, Lin; Xie, Yi-Fei; Wang, Jin-Jun] Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China	Southwest University - China	Wang, JJ (corresponding author), Southwest Univ, Coll Plant Protect, Key Lab Entomol & Pest Control Engn, Chongqing, Peoples R China.	jjwang7008@yahoo.com			Natural Science Foundation of Chongqing (CSTC) [2013jjB0176]; Program for Changjiang Scholars and Innovative Research Teams in Universities [IRT0976]; Modern Agro-industry (Citrus) Technology Research System; Fundamental Research Funds for the Central Universities of China [XDJK2013A017]	Natural Science Foundation of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); Program for Changjiang Scholars and Innovative Research Teams in Universities(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Modern Agro-industry (Citrus) Technology Research System; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities)	This research was funded in part by the Natural Science Foundation of Chongqing (CSTC, 2013jjB0176), the Program for Changjiang Scholars and Innovative Research Teams in Universities (IRT0976), the earmarked fund for Modern Agro-industry (Citrus) Technology Research System, and the Fundamental Research Funds for the Central Universities (XDJK2013A017) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Attardo GM, 2006, INSECT MOL BIOL, V15, P411, DOI 10.1111/j.1365-2583.2006.00649.x; Bao YY, 2012, GENOMICS, V99, P256, DOI 10.1016/j.ygeno.2012.02.002; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; CABIB E, 1958, J BIOL CHEM, V231, P259; Chamankhah A, 2003, INSECT BIOCHEM MOLEC, V33, P355, DOI 10.1016/S0965-1748(02)00263-1; Chen J, 2010, INSECT MOL BIOL, V19, P777, DOI 10.1111/j.1365-2583.2010.01038.x; Chen QF, 2002, J BIOL CHEM, V277, P3274, DOI 10.1074/jbc.M109479200; Cong L, 2012, FLA ENTOMOL, V95, P650, DOI 10.1653/024.095.0316; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; DUNN PE, 1986, ANNU REV ENTOMOL, V31, P321, DOI 10.1146/annurev.en.31.010186.001541; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Enayati AA, 2005, INSECT MOL BIOL, V14, P3, DOI 10.1111/j.1365-2583.2004.00529.x; Feitosa FM, 2006, J INSECT SCI, V6; Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X; FRIEDMAN S, 1978, ANNU REV ENTOMOL, V23, P389, DOI 10.1146/annurev.en.23.010178.002133; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; GILBY AR, 1965, ANNU REV ENTOMOL, V10, P141, DOI 10.1146/annurev.en.10.010165.001041; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Guz N, 2012, INSECT MOL BIOL, V21, P139, DOI 10.1111/j.1365-2583.2011.01129.x; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Huang Y, 2013, PESTIC BIOCHEM PHYS, V106, P1, DOI 10.1016/j.pestbp.2013.03.001; Huang YF, 2011, J INSECT PHYSIOL, V57, P1033, DOI 10.1016/j.jinsphys.2011.05.001; Janciauskiene S, 2001, BBA-MOL BASIS DIS, V1535, P221, DOI 10.1016/S0925-4439(01)00025-4; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jiang ZH, 2005, OBES RES, V13, P1898, DOI 10.1038/oby.2005.233; Jin T, 2011, PEST MANAG SCI, V67, P370, DOI 10.1002/ps.2076; Joussen N, 2008, PEST MANAG SCI, V64, P65, DOI 10.1002/ps.1472; Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078; Li H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065931; Li KB, 2003, BIOINFORMATICS, V19, P1585, DOI 10.1093/bioinformatics/btg192; Liu SM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-491; Liu Y, 2009, ARCH INSECT BIOCHEM, V71, P16, DOI 10.1002/arch.20290; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; MATSUI I, 1994, BIOCHEMISTRY-US, V33, P451, DOI 10.1021/bi00168a009; Pasupuleti M, 2012, CRIT REV BIOTECHNOL, V32, P143, DOI 10.3109/07388551.2011.594423; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Pavlidi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066533; Price DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022573; PROUDLOCK J W, 1971, Journal of Bioenergetics, V2, P327, DOI 10.1007/BF01963829; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Shen GM, 2013, INSECT MOL BIOL, V22, P354, DOI 10.1111/imb.12026; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Singh SP, 2001, EUR J BIOCHEM, V268, P2912, DOI 10.1046/j.1432-1327.2001.02179.x; SNYDER MJ, 1995, ARCH BIOCHEM BIOPHYS, V321, P13, DOI 10.1006/abbi.1995.1362; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044; Suwanchaichinda C, 2013, INSECT BIOCHEM MOLEC, V43, P555, DOI 10.1016/j.ibmb.2013.03.015; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang B, 2010, J INSECT PHYSIOL, V56, P813, DOI 10.1016/j.jinsphys.2010.02.009; Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772; Wicker-Thomas C, 1997, INSECT BIOCHEM MOLEC, V27, P963, DOI 10.1016/S0965-1748(97)00077-5; Xie W, 2012, INT J BIOL SCI, V8, P1142, DOI 10.7150/ijbs.4588; Yang J, 2007, PHYSIOL GENOMICS, V30, P223, DOI 10.1152/physiolgenomics.00018.2007; Yepiskoposyan H, 2006, NUCLEIC ACIDS RES, V34, P4866, DOI 10.1093/nar/gkl606; YU SM, 1991, J BIOL CHEM, V266, P21131; Zou Z, 2009, GENOMICS, V93, P367, DOI 10.1016/j.ygeno.2008.12.010	59	30	33	2	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94470	10.1371/journal.pone.0094470	http://dx.doi.org/10.1371/journal.pone.0094470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710118	gold, Green Submitted, Green Published			2022-12-25	WOS:000334159800149
J	Lu, RN; Wang, Q; Han, YL; Li, JY; Yang, XJ; Miao, DS				Lu, Ruinan; Wang, Qian; Han, Yongli; Li, Jianyong; Yang, Xiang-Jiao; Miao, Dengshun			Parathyroid Hormone Administration Improves Bone Marrow Microenvironment and Partially Rescues Haematopoietic Defects in Bmi1-Null Mice	PLOS ONE			English	Article							STEM-CELL NICHE; OSTEOBLAST DIFFERENTIATION; SELF-RENEWAL; NULL MICE; TRANSCRIPTION FACTOR; PROGENITOR CELLS; PTH; BMI-1; SKELETAL; ABNORMALITIES	The epigenetic regulator Bmi1 is key in haematopoietic stem cells, and its inactivation leads to defects in haematopoiesis. Parathyroid hormone (PTH), an important modulator of bone homeostasis, also regulates haematopoiesis, so we asked whether PTH administration improves bone marrow microenvironment and rescues the haematopoietic defects in Bmi1-null mice. The mice were treated with PTH1-34 (containing the first 34 residues of mature PTH), an anabolic drug currently used for treating osteoporosis, and compared with the vehicle-treated Bmi1(-/-) and wild-type littermates in terms of skeletal and haematopoietic phenotypes. We found that the administration significantly increased all parameters related to osteoblastic bone formation and significantly reduced the adipocyte number and PPAR gamma expression. The bone marrow cellularity, numbers of haematopoietic progenitors and stem cells in the femur, and numbers of lymphocytes and other white blood cells in the peripheral blood all increased significantly when compared to vehicle-treated Bmi1(-/-) mice. Moreover, the number of Jagged1-positive cells and percentage of Notch intracellular domain-positive bone marrow cells and protein expression levels of Jagged1 and NICD in bone tissue were also increased in Bmi1(-/-) mice upon PTH1-34 administration, whereas the up-regulation of PTH on both Notch1 and Jagged1 gene expression was blocked by the Notch inhibitor DAPT administration. These results thus indicate that PTH administration activates the notch pathway and partially rescues haematopoietic defects in Bmi1-null mice, further suggesting that haematopoietic defects in the animals are not only a result of reduced self-renewal of haematopoietic stem cells but also due to impaired bone marrow microenvironment.	[Lu, Ruinan; Wang, Qian; Han, Yongli; Miao, Dengshun] Nanjing Med Univ, Dept Human Anat, Res Ctr Bone & Stem Cells, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Lu, Ruinan; Li, Jianyong] Nanjing Med Univ, Affiliated Hosp 1, Dept Hematol, Nanjing, Jiangsu, Peoples R China; [Yang, Xiang-Jiao] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ, Canada; [Yang, Xiang-Jiao] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Yang, Xiang-Jiao] McGill Univ, Ctr Hlth, Dept Med, Montreal, PQ, Canada	Nanjing Medical University; Nanjing Medical University; McGill University; McGill University; McGill University	Miao, DS (corresponding author), Nanjing Med Univ, Dept Human Anat, Res Ctr Bone & Stem Cells, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	dsmiao@njmu.edu.cn		Miao, Dengshun/0000-0002-2682-3502	National Basic Research Program of China [2012CB966902]; MOST in China; CIHR in Canada [30911120486]	National Basic Research Program of China(National Basic Research Program of China); MOST in China; CIHR in Canada(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the National Basic Research Program of China (2012CB966902 to D. M.) and by a joint health research initiative grant supported by the MOST in China and the CIHR in Canada (30911120486 to D. M. and X.J.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Brunner S, 2008, EXP HEMATOL, V36, P1157, DOI 10.1016/j.exphem.2008.03.014; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; LEE K, 1993, BONE, V14, P341, DOI 10.1016/8756-3282(93)90162-4; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Lo Celso C, 2011, J CELL SCI, V124, P3529, DOI 10.1242/jcs.074112; Lyritis GP, 2010, ANN NY ACAD SCI, V1205, P277, DOI 10.1111/j.1749-6632.2010.05666.x; Miao DS, 2002, J CLIN INVEST, V109, P1173, DOI 10.1172/JCI200214817; Miao DS, 2004, ENDOCRINOLOGY, V145, P3554, DOI 10.1210/en.2003-1695; Miao DS, 2004, ENDOCRINOLOGY, V145, P2046, DOI 10.1210/en.2003-1097; Miao DS, 2002, J HISTOCHEM CYTOCHEM, V50, P333, DOI 10.1177/002215540205000305; Miao DS, 2005, J CLIN INVEST, V115, P2402, DOI 10.1172/JCI24918; Miao DS, 2001, ENDOCRINOLOGY, V142, P926, DOI 10.1210/en.142.2.926; Miyakoshi N, 2001, ENDOCRINOLOGY, V142, P4349, DOI 10.1210/en.142.10.4349; Trevisani VFM, 2008, SAO PAULO MED J, V126, P279, DOI 10.1590/S1516-31802008000500007; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pajcini KV, 2011, LEUKEMIA, V25, P1525, DOI 10.1038/leu.2011.127; Panda DK, 2004, J BIOL CHEM, V279, P16754, DOI 10.1074/jbc.M310271200; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Ren YX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023060; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; Tsomaia N, 2004, BIOCHEMISTRY-US, V43, P690, DOI 10.1021/bi035703i; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; WATSON P, 1995, BONE, V16, P357, DOI 10.1016/8756-3282(94)00051-4; Whitfield JF, 2005, J CELL BIOCHEM, V96, P278, DOI 10.1002/jcb.20526; Xue YB, 2005, J BONE MINER RES, V20, P1766, DOI 10.1359/JBMR.050608; Xue YB, 2005, HUM MOL GENET, V14, P1515, DOI 10.1093/hmg/ddi160; Yang D, 2007, BONE, V40, P1453, DOI 10.1016/j.bone.2007.02.001; Zhang HW, 2010, J BONE MINER RES, V25, P640, DOI 10.1359/jbmr.090812; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	41	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93864	10.1371/journal.pone.0093864	http://dx.doi.org/10.1371/journal.pone.0093864			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705625	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500081
J	Gray, EE; Guglietta, R; Khakh, BS; O'Dell, TJ				Gray, Erin E.; Guglietta, Ryan; Khakh, Baljit S.; O'Dell, Thomas J.			Inhibitory Interactions between Phosphorylation Sites in the C Terminus of alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid-type Glutamate Receptor GluA1 Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-II; AMPA RECEPTORS; SYNAPTIC PLASTICITY; GLUR1 SUBUNIT; REGULATORY PHOSPHORYLATION; PKA PHOSPHORYLATION; UNITARY CONDUCTANCE; DENDRITIC SPINES; NMDA RECEPTORS; PHOSPHATASE 2A	The C terminus of AMPA-type glutamate receptor (AMPAR) GluA1 subunits contains several phosphorylation sites that regulate AMPAR activity and trafficking at excitatory synapses. Although many of these sites have been extensively studied, little is known about the signaling mechanisms regulating GluA1 phosphorylation at Thr-840. Here, we report that neuronal depolarization in hippocampal slices induces a calcium and protein phosphatase 1/2A-dependent dephosphorylation of GluA1 at Thr-840 and a nearby site at Ser-845. Despite these similarities, inhibitors of NMDA-type glutamate receptors and protein phosphatase 2B prevented depolarization-induced Ser-845 dephosphorylation but had no effect on Thr-840 dephosphorylation. Instead, depolarization-induced Thr-840 dephosphorylation was prevented by blocking voltage-gated calcium channels, indicating that distinct Ca2+ sources converge to regulate GluA1 dephosphorylation at Thr-840 and Ser-845 in separable ways. Results from immunoprecipitation/depletion assays indicate that Thr-840 phosphorylation inhibits protein kinase A (PKA)-mediated increases in Ser-845 phosphorylation. Consistent with this, PKA-mediated increases in AMPAR currents, which are dependent on Ser-845 phosphorylation, were inhibited in HEK-293 cells expressing a Thr-840 phosphomimetic version of GluA1. Conversely, mimicking Ser-845 phosphorylation inhibited protein kinase C phosphorylation of Thr-840 in vitro, and PKA activation inhibited Thr-840 phosphorylation in hippocampal slices. Together, the regulation of Thr-840 and Ser-845 phosphorylation by distinct sources of Ca2+ influx and the presence of inhibitory interactions between these sites high-light a novel mechanism for conditional regulation of AMPAR phosphorylation and function.	[Gray, Erin E.; Guglietta, Ryan; Khakh, Baljit S.; O'Dell, Thomas J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Khakh, Baljit S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Gray, Erin E.; Guglietta, Ryan] Univ Calif Los Angeles, Interdept PhD Program Neurosci, Los Angeles, CA 90095 USA; [O'Dell, Thomas J.] UCLA Integrat Ctr Learning & Memory, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	O'Dell, TJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Ctr Hlth Sci 53 231, Box 951751, Los Angeles, CA 90095 USA.	todell@mednet.ucla.edu			National Institutes of Health [MH609197, T32MH85462, MH91384]; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH085462, R01MH060919, R34MH091384] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants MH609197 (to T. J. O.) and T32MH85462 and MH91384 (to E. E. G.).	Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Ahn JH, 2007, P NATL ACAD SCI USA, V104, P9876, DOI 10.1073/pnas.0703589104; Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Ahn JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026292; Balasuriya D, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.469205; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Bloodgood BL, 2007, CURR OPIN NEUROBIOL, V17, P345, DOI 10.1016/j.conb.2007.04.003; Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Carlisle HJ, 2008, J NEUROSCI, V28, P13673, DOI 10.1523/JNEUROSCI.4695-08.2008; Coba MP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000102; Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200; Delgado JY, 2007, J NEUROSCI, V27, P13210, DOI 10.1523/JNEUROSCI.3056-07.2007; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; HONKANEN RE, 1993, FEBS LETT, V330, P283, DOI 10.1016/0014-5793(93)80889-3; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; Jenkins MA, 2014, MOL PHARMACOL, V85, P618, DOI 10.1124/mol.113.091488; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Kristensen AS, 2011, NAT NEUROSCI, V14, P727, DOI 10.1038/nn.2804; Lee HK, 2007, MOL CELL NEUROSCI, V36, P86, DOI 10.1016/j.mcn.2007.06.003; Lee HK, 2006, PHARMACOL THERAPEUT, V112, P810, DOI 10.1016/j.pharmthera.2006.06.003; Lee HK, 2010, J NEUROPHYSIOL, V103, P479, DOI 10.1152/jn.00835.2009; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Luthi A, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-44; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Mansour M, 2001, NEURON, V32, P841, DOI 10.1016/S0896-6273(01)00520-7; Montgomery JM, 2004, TRENDS NEUROSCI, V27, P744, DOI 10.1016/j.tins.2004.10.006; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Palmer MJ, 2004, J NEUROSCI, V24, P4903, DOI 10.1523/JNEUROSCI.0170-04.2004; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; Poncer JC, 2002, J NEUROSCI, V22, P4406, DOI 10.1523/JNEUROSCI.22-11-04406.2002; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Santos SD, 2009, NEUROSCIENCE, V158, P105, DOI 10.1016/j.neuroscience.2008.02.037; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Tenorio G, 2010, LEARN MEMORY, V17, P627, DOI 10.1101/lm.1974510; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vanhoose AM, 2006, J NEUROSCI, V26, P1138, DOI 10.1523/JNEUROSCI.3572-05.2006; Vanhoose AM, 2003, J NEUROSCI, V23, P5827; Yuste R, 1999, J NEUROSCI, V19, P1976	53	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14600	14611		10.1074/jbc.M114.553537	http://dx.doi.org/10.1074/jbc.M114.553537			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24706758	hybrid, Green Published			2022-12-25	WOS:000337248100017
J	Lee, M; Lee, CH; Demin, AA; Munashingha, PR; Amangyeld, T; Kwon, B; Formosa, T; Seo, YS				Lee, Miju; Lee, Chul-Hwan; Demin, Annie Albert; Munashingha, Palinda Ruvan; Amangyeld, Tamir; Kwon, Buki; Formosa, Tim; Seo, Yeon-Soo			Rad52/Rad59-dependent Recombination as a Means to Rectify Faulty Okazaki Fragment Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION PROTEIN-A; DOUBLE-STRAND BREAKS; SISTER-CHROMATID COHESION; YEAST RAD52 PROTEIN; DNA-DAMAGE RESPONSE; ESSENTIAL IN-VIVO; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; END RESECTION; GENOME STABILITY	The correct removal of 5'-flap structures by Rad27 and Dna2 during Okazaki fragment maturation is crucial for the stable maintenance of genetic materials and cell viability. In this study, we identified RAD52, a key recombination protein, as a multicopy suppressor of dna2-K1080E, a lethal helicase-negative mutant allele of DNA2 in yeasts. In contrast, the overexpression of Rad51, which works conjointly with Rad52 in canonical homologous recombination, failed to suppress the growth defect of the dna2-K1080E mutation, indicating that Rad52 plays a unique and distinct role in Okazaki fragment metabolism. We found that the recombination-defective Rad52QDDD/AAAA mutant did not rescue dna2-K1080E, suggesting that Rad52-mediated recombination is important for suppression. The Rad52-mediated enzymatic stimulation of Dna2 or Rad27 is not a direct cause of suppression observed in vivo, as both Rad52 and Rad52-QDDD/AAAA proteins stimulated the endonuclease activities of both Dna2 and Rad27 to a similar extent. The recombination mediator activity of Rad52 was dispensable for the suppression, whereas both the DNA annealing activity and its ability to interact with Rad59 were essential. In addition, we found that several cohesion establishment factors, including Rsc2 and Elg1, were required for the Rad52-dependent suppression of dna2-K1080E. Our findings suggest a novel Rad52/Rad59-dependent, but Rad51-independent recombination pathway that could ultimately lead to the removal of faulty flaps in conjunction with cohesion establishment factors.	[Lee, Miju; Lee, Chul-Hwan; Demin, Annie Albert; Munashingha, Palinda Ruvan; Amangyeld, Tamir; Kwon, Buki; Seo, Yeon-Soo] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Formosa, Tim] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA	Korea Advanced Institute of Science & Technology (KAIST); Utah System of Higher Education; University of Utah	Seo, YS (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea.	yeonsooseo@kaist.ac.kr	Seo, Yeonsoo/C-1605-2011	Formosa, Tim/0000-0002-8477-2483; Kwon, Buki/0000-0002-7860-0458; Lee, Chul-Hwan/0000-0003-0643-0100	National Research Foundation of Korea Grant from the Ministry of Education, Science, and Technology [2012R1A2A2A01047260]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043424] Funding Source: NIH RePORTER	National Research Foundation of Korea Grant from the Ministry of Education, Science, and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Research Foundation of Korea Grant 2012R1A2A2A01047260 from the Ministry of Education, Science, and Technology.	Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2002, J BIOL CHEM, V277, P26632, DOI 10.1074/jbc.M111026200; Bae SH, 2001, NUCLEIC ACIDS RES, V29, P3069, DOI 10.1093/nar/29.14.3069; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Bi BY, 2004, P NATL ACAD SCI USA, V101, P9568, DOI 10.1073/pnas.0403205101; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Budd ME, 1997, MOL CELL BIOL, V17, P2136, DOI 10.1128/MCB.17.4.2136; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Cejka P, 2010, NATURE, V467, P112, DOI 10.1038/nature09355; Chai WH, 2013, CELL CYCLE, V12, P1985, DOI 10.4161/cc.25306; Chen XF, 2011, NAT STRUCT MOL BIOL, V18, P1015, DOI 10.1038/nsmb.2105; Choe W, 2002, MOL CELL BIOL, V22, P4202, DOI 10.1128/MCB.22.12.4202-4217.2002; Chung WH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000948; Cortes-Ledesma F, 2004, GENETICS, V168, P553, DOI 10.1534/genetics.104.030551; Davis AP, 2001, GENETICS, V159, P515; Debrauwere H, 2001, P NATL ACAD SCI USA, V98, P8263, DOI 10.1073/pnas.121075598; Feng Q, 2007, DNA REPAIR, V6, P27, DOI 10.1016/j.dnarep.2006.08.007; Fiorentino DF, 1997, MOL BIOL CELL, V8, P2519, DOI 10.1091/mbc.8.12.2519; Formosa T, 1999, GENETICS, V151, P1459; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Gary R, 1999, MOL CELL BIOL, V19, P5373; Haber JE, 1999, CELL, V97, P829, DOI 10.1016/S0092-8674(00)80795-3; Hanawalt PC, 2007, MOL CELL, V28, P702, DOI 10.1016/j.molcel.2007.11.014; Hollenhorst PC, 2000, GENETICS, V154, P1533; Hoopes LLM, 2002, MOL CELL BIOL, V22, P4136, DOI 10.1128/MCB.22.12.4136-4146.2002; Huang J, 2004, MOL CELL, V13, P739, DOI 10.1016/S1097-2765(04)00103-0; Huang JA, 2004, CELL CYCLE, V3, P973; Hubscher U, 2001, MOL CELLS, V12, P149; Ijpma AS, 2003, MOL BIOL CELL, V14, P987, DOI 10.1091/mbc.02-04-0057; Ira G, 2002, MOL CELL BIOL, V22, P6384, DOI 10.1128/MCB.22.18.6384-6392.2002; Irmisch A, 2009, EMBO J, V28, P144, DOI 10.1038/emboj.2008.273; Jin YH, 2003, J BIOL CHEM, V278, P1626, DOI 10.1074/jbc.M209803200; Kang HY, 2000, GENETICS, V155, P1055; Kang MJ, 2010, NUCLEIC ACIDS RES, V38, P7611, DOI 10.1093/nar/gkq651; Kang YH, 2010, CRIT REV BIOCHEM MOL, V45, P71, DOI 10.3109/10409230903578593; Kang YH, 2009, J BIOL CHEM, V284, P10376, DOI 10.1074/jbc.M808894200; Kim JH, 2005, NUCLEIC ACIDS RES, V33, P6137, DOI 10.1093/nar/gki900; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Krejci L, 2002, J BIOL CHEM, V277, P40132, DOI 10.1074/jbc.M206511200; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Kumar S, 2013, GENE DEV, V27, P313, DOI 10.1101/gad.204750.112; Lee CH, 2013, J BIOL CHEM, V288, P9468, DOI 10.1074/jbc.M112.418715; Lee CH, 2010, NUCLEIC ACIDS RES, V38, P1583, DOI 10.1093/nar/gkp1135; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; Li FY, 2008, MOL CELL, V30, P325, DOI 10.1016/j.molcel.2008.02.028; Li FY, 2013, EMBO J, V32, P461, DOI 10.1038/emboj.2012.345; Li X, 2008, CELL RES, V18, P99, DOI 10.1038/cr.2008.1; Liddell LC, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-229; Liefshitz B, 2011, MOL CELL BIOL, V31, P3921, DOI 10.1128/MCB.05974-11; Lin WQ, 2013, EMBO J, V32, P1425, DOI 10.1038/emboj.2013.88; Loeillet S, 2005, DNA REPAIR, V4, P459, DOI 10.1016/j.dnarep.2004.11.010; MacNeill SA, 2001, CURR BIOL, V11, pR842, DOI 10.1016/S0960-9822(01)00500-0; Maher RL, 2011, J CELL BIOCHEM, V112, P2672, DOI 10.1002/jcb.23211; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; Maradeo ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004707; Masuda-Sasa T, 2008, J BIOL CHEM, V283, P24359, DOI 10.1074/jbc.M802244200; MILNE GT, 1993, GENE DEV, V7, P1755, DOI 10.1101/gad.7.9.1755; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; Munashingha PR, 2012, J BIOL CHEM, V287, P8675, DOI 10.1074/jbc.M111.326470; Nguyen HD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066379; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Nimonkar AV, 2009, P NATL ACAD SCI USA, V106, P3077, DOI 10.1073/pnas.0813247106; Oum JH, 2011, MOL CELL BIOL, V31, P3924, DOI 10.1128/MCB.01269-10; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Parnas O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005497; Plate I, 2008, J BIOL CHEM, V283, P29077, DOI 10.1074/jbc.M804881200; Pohl TJ, 2008, MOL CELL BIOL, V28, P897, DOI 10.1128/MCB.00524-07; RIEZMAN H, 1983, EMBO J, V2, P2161, DOI 10.1002/j.1460-2075.1983.tb01717.x; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Shen BH, 1997, NUCLEIC ACIDS RES, V25, P3332, DOI 10.1093/nar/25.16.3332; Shi I, 2009, J BIOL CHEM, V284, P33275, DOI 10.1074/jbc.M109.057752; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; SIKORSKI RS, 1989, GENETICS, V122, P19; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Stewart JA, 2009, J BIOL CHEM, V284, P8283, DOI 10.1074/jbc.M809189200; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Symington LS, 1998, NUCLEIC ACIDS RES, V26, P5589, DOI 10.1093/nar/26.24.5589; Tomita K, 2004, MOL CELL BIOL, V24, P9557, DOI 10.1128/MCB.24.21.9557-9567.2004; Tsukamoto M, 2003, GENETICS, V165, P1703; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; Van Dyck E, 2001, EMBO REP, V2, P905, DOI 10.1093/embo-reports/kve201; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Weitao T, 2003, J BIOL CHEM, V278, P22513, DOI 10.1074/jbc.M301610200; Zheng L, 2011, J MOL CELL BIOL, V3, P23, DOI 10.1093/jmcb/mjq048; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5	103	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					15064	15079		10.1074/jbc.M114.548388	http://dx.doi.org/10.1074/jbc.M114.548388			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24711454	Green Published, hybrid			2022-12-25	WOS:000337248100058
J	Kwartler, CS; Chen, JY; Thakur, D; Li, SM; Baskin, K; Wang, S; Wang, ZV; Walker, L; Hill, JA; Epstein, HF; Taegtmeyer, H; Milewicz, DM				Kwartler, Callie S.; Chen, Jiyuan; Thakur, Dhananjay; Li, Shumin; Baskin, Kedryn; Wang, Shanzhi; Wang, Zhao V.; Walker, Lori; Hill, Joseph A.; Epstein, Henry F.; Taegtmeyer, Heinrich; Milewicz, Dianna M.			Overexpression of Smooth Muscle Myosin Heavy Chain Leads to Activation of the Unfolded Protein Response and Autophagic Turnover of Thick Filament-associated Proteins in Vascular Smooth Muscle Cells*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; ER Stress; Myosin; Protein Turnover; Unfolded Protein Response; Vascular Smooth Muscle Cells; Thoracic Aortic Aneurysms and Dissections	ENDOPLASMIC-RETICULUM STRESS; THORACIC AORTIC-ANEURYSMS; ANGIOTENSIN-II; LIGHT-CHAIN; DISSECTIONS; MUTATIONS; KINASE; MECHANISMS; ISOFORMS; DISEASE	Background: Genomic duplications involving the smooth muscle myosin heavy chain gene, MYH11, are associated with increased risk for acute aortic dissections. Results:MYH11 overexpression causes increased turnover of contractile proteins through increased autophagy. Conclusion:MYH11 duplications may predispose to aortic disease through increased turnover of contractile proteins and disruption of contractile signaling. Significance: Increased protein turnover may be an important mechanism by which genomic duplications cause human disease. Duplications spanning nine genes at the genomic locus 16p13.1 predispose individuals to acute aortic dissections. The most likely candidate gene in this region leading to the predisposition for dissection is MYH11, which encodes smooth muscle myosin heavy chain (SM-MHC). The effects of increased expression of MYH11 on smooth muscle cell (SMC) phenotypes were explored using mouse aortic SMCs with transgenic overexpression of one isoform of SM-MHC. We found that these cells show increased expression of Myh11 and myosin filament-associated contractile genes at the message level when compared with control SMCs, but not at the protein level due to increased protein degradation. Increased expression of Myh11 resulted in endoplasmic reticulum (ER) stress in SMCs, which led to a paradoxical decrease of protein levels through increased autophagic degradation. An additional consequence of ER stress in SMCs was increased intracellular calcium ion concentration, resulting in increased contractile signaling and contraction. The increased signals for contraction further promote transcription of contractile genes, leading to a feedback loop of metabolic abnormalities in these SMCs. We suggest that overexpression of MYH11 can lead to increased ER stress and autophagy, findings that may be globally implicated in disease processes associated with genomic duplications.	[Kwartler, Callie S.; Chen, Jiyuan; Baskin, Kedryn; Wang, Shanzhi; Taegtmeyer, Heinrich; Milewicz, Dianna M.] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA; [Kwartler, Callie S.; Chen, Jiyuan; Baskin, Kedryn; Wang, Shanzhi; Taegtmeyer, Heinrich; Milewicz, Dianna M.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Li, Shumin; Epstein, Henry F.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Wang, Zhao V.; Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med Cardiol, Dallas, TX 75390 USA; [Wang, Zhao V.; Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Walker, Lori] Univ Colorado, Dept Med, Denver, CO 80217 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Milewicz, DM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA.	Dianna.M.Milewicz@uth.tmc.edu	Kwartler, Callie/AGB-4204-2022	Kwartler, Callie/0000-0002-3722-9939; Wang, Zhao/0000-0002-9904-9538	National Institutes of Health [RO1HL62594, P50HL083794-01, P01HL110869-01]; Richard T. Pisani Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062594, P50HL083794, R01HL061483, P01HL110869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007257, P30DK079328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Richard T. Pisani Fund; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1HL62594, P50HL083794-01 and P01HL110869-01 (to D. M. M.) and a grant from the Richard T. Pisani Fund (to D. M. M.).	Ayala P, 2012, EXP MOL PATHOL, V92, P97, DOI 10.1016/j.yexmp.2011.10.012; Babu GJ, 2000, MICROSC RES TECHNIQ, V50, P532, DOI 10.1002/1097-0029(20000915)50:6<532::AID-JEMT10>3.0.CO;2-E; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Baskin KK, 2011, CIRC RES, V109, P1153, DOI 10.1161/CIRCRESAHA.111.252742; Bhatnagar S, 2012, J CELL PHYSIOL, V227, P1042, DOI 10.1002/jcp.22821; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Cao JM, 2010, HUM MOL GENET, V19, P1908, DOI 10.1093/hmg/ddq066; Ciechomska IA, 2013, ONCOGENE, V32, P1518, DOI 10.1038/onc.2012.174; Croons V, 2008, J PHARMACOL EXP THER, V325, P824, DOI 10.1124/jpet.107.132944; Croons V, 2007, J PHARMACOL EXP THER, V320, P986, DOI 10.1124/jpet.106.113944; Ding HL, 2009, J BIOL CHEM, V284, P15541, DOI 10.1074/jbc.M900888200; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Ejiri J, 2003, CARDIOVASC RES, V59, P988, DOI 10.1016/S0008-6363(03)00523-6; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; Guo DC, 2013, AM J HUM GENET, V93, P398, DOI 10.1016/j.ajhg.2013.06.019; Hart LS, 2012, J CLIN INVEST, V122, P4621, DOI 10.1172/JCI62973; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Katsanos CS, 2005, AM J PHYSIOL-ENDOC M, V289, pE1064, DOI 10.1152/ajpendo.00141.2005; Kuang SQ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002118; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; KUZNETSOV G, 1994, J BIOL CHEM, V269, P22990; Landsverk ML, 2007, J CELL BIOL, V177, P205, DOI 10.1083/jcb.200607084; Liang B, 2013, ARTERIOSCL THROM VAS, V33, P595, DOI 10.1161/ATVBAHA.112.300606; Lichter-Konecki U, 2011, MOL GENET METAB, V103, P323, DOI 10.1016/j.ymgme.2011.04.013; Mack CP, 2005, J THROMB HAEMOST, V3, P1976, DOI 10.1111/j.1538-7836.2005.01316.x; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; Madaro L, 2013, FASEB J, V27, P1990, DOI 10.1096/fj.12-215475; MARTIN AF, 1977, J BIOL CHEM, V252, P3422; Martin AF, 2007, AM J PHYSIOL-CELL PH, V293, pC238, DOI 10.1152/ajpcell.00567.2006; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; Mimori S, 2012, BIOL PHARM BULL, V35, P84, DOI 10.1248/bpb.35.84; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Morrow EM, 2010, J AM ACAD CHILD PSY, V49, P1091, DOI 10.1016/j.jaac.2010.08.009; Narita Masashi, 2012, Small GTPases, V3, P111, DOI 10.4161/sgtp.19422; Ochala J, 2011, J PHYSIOL-LONDON, V589, P2007, DOI 10.1113/jphysiol.2010.202044; Pannu H, 2007, HUM MOL GENET, V16, P2453, DOI 10.1093/hmg/ddm201; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Portbury AL, 2011, J BIOL CHEM, V286, P9929, DOI 10.1074/jbc.R110.170571; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Salazar M, 2011, METHOD ENZYMOL, V489, P297, DOI 10.1016/B978-0-12-385116-1.00017-0; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; She PX, 2011, AM J PHYSIOL-ENDOC M, V301, pE49, DOI 10.1152/ajpendo.00630.2010; Szymanski PT, 1999, BIOCHEMISTRY-US, V38, P3778, DOI 10.1021/bi981394y; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Vidal RL, 2012, AUTOPHAGY, V8, P970, DOI 10.4161/auto.20139; Vissers LELM, 2012, METHODS MOL BIOL, V838, P29, DOI 10.1007/978-1-61779-507-7_2; Wang L, 2010, AM J HUM GENET, V87, P701, DOI 10.1016/j.ajhg.2010.10.006; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Wengrod J, 2013, MOL CELL BIOL, V33, P2128, DOI 10.1128/MCB.00174-13; Xiong WF, 2009, ATHEROSCLEROSIS, V202, P128, DOI 10.1016/j.atherosclerosis.2008.03.029; Young ARJ, 2011, AUTOPHAGY, V7, P1387, DOI 10.4161/auto.7.11.17348; ZAK R, 1977, J BIOL CHEM, V252, P3430; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	61	27	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					14075	14088		10.1074/jbc.M113.499277	http://dx.doi.org/10.1074/jbc.M113.499277			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24711452	hybrid, Green Published			2022-12-25	WOS:000335984600037
J	Du, XJ; Tang, LL; Mao, YP; Sun, Y; Zeng, MS; Kang, TB; Jia, WH; Lin, AH; Ma, J				Du, Xiao-Jing; Tang, Ling-Long; Mao, Yan-Ping; Sun, Ying; Zeng, Mu-Sheng; Kang, Tie-Bang; Jia, Wei-Hua; Lin, Ai-Hua; Ma, Jun			The Pretreatment Albumin to Globulin Ratio Has Predictive Value for Long-Term Mortality in Nasopharyngeal Carcinoma	PLOS ONE			English	Article							SERUM-ALBUMIN; ANTIINFLAMMATORY DRUGS; CANCER; INFLAMMATION; SURVIVAL; NEUTROPHILS; MANAGEMENT; NUTRITION; PROGNOSIS; PROTEIN	Background: Low serum albumin is predictive of poor survival in nasopharyngeal carcinoma (NPC). We evaluated the ability of the pretreatment albumin/ globulin ratio (AGR) to predict long- term mortality in patients with NPC. Methods: This retrospective study examined an unselected cohort of 694 patients with NPC who had documented pretreatment total serum protein and serum albumin levels (ALB). AGR was calculated as [AGR = ALB/(total serum protein ALB)]. Survival analysis was used to evaluate the predictive value of AGR. Results: Multivariate analysis demonstrated that a low pretreatment serum AGR (< 1.4) was an independent predictor of poor OS (P = 0.029) and DMFS (P = 0.033). A low AGR was significantly associated with advanced stage disease ( P < 0.001), high white blood cell count (P = 0.033), high neutrophil count (P = 0.047), high total serum protein (P < 0.001) and low ALB (P < 0.001). Conclusion: The pretreatment AGR may represent a simple, potentially useful predictive biomarker for evaluating the longterm prognosis of patients with undifferentiated NPC.	[Du, Xiao-Jing; Tang, Ling-Long; Mao, Yan-Ping; Sun, Ying; Ma, Jun] Sun Yat Sen Univ, Dept Radiat Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Zeng, Mu-Sheng; Kang, Tie-Bang; Jia, Wei-Hua] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol Southern China, Guangzhou 510275, Guangdong, Peoples R China; [Lin, Ai-Hua] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Ma, J (corresponding author), Sun Yat Sen Univ, Dept Radiat Oncol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	drmajun@hotmail.com		zeng, musheng/0000-0003-3509-5591	Innovation Team Development Plan of the Ministry of Education of China [IRT1297]; Cultivating Foundation of Education-bureau of Guangdong Province [LYM11001]; Key Laboratory Construction Project of Guangzhou City, China [121800085]	Innovation Team Development Plan of the Ministry of Education of China; Cultivating Foundation of Education-bureau of Guangdong Province; Key Laboratory Construction Project of Guangzhou City, China	This work was supported by grants from the Innovation Team Development Plan of the Ministry of Education of China (IRT1297), the Cultivating Foundation of Education-bureau of Guangdong Province (LYM11001) and the Key Laboratory Construction Project of Guangzhou City, China (No. 121800085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An X, 2011, TUMOR BIOL, V32, P317, DOI 10.1007/s13277-010-0124-7; Azab B, 2013, INT J COLORECTAL DIS, V28, P1629, DOI 10.1007/s00384-013-1748-z; Azab BN, 2013, AM J SURG, V206, P764, DOI 10.1016/j.amjsurg.2013.03.007; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; Barber MD, 1999, NUTR CANCER, V35, P106, DOI 10.1207/S15327914NC352_2; Baujat B, 2006, INT J RADIAT ONCOL, V64, P47, DOI 10.1016/j.ijrobp.2005.06.037; BUSSON P, 1988, INT J CANCER, V42, P599, DOI 10.1002/ijc.2910420422; Chandra RK, 1999, P NUTR SOC, V58, P681, DOI 10.1017/S0029665199000890; Daugherty SE, 2011, AM J EPIDEMIOL, V173, P721, DOI 10.1093/aje/kwq437; Di Carlo E, 2001, BLOOD, V97, P339, DOI 10.1182/blood.V97.2.339; Edge SB, 2010, AJCC CANC STAGING MA; Gourzones C, 2012, SEMIN CANCER BIOL, V22, P127, DOI 10.1016/j.semcancer.2012.01.002; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; He JR, 2012, HEAD NECK-J SCI SPEC, V34, P1769, DOI 10.1002/hed.22008; Igarashi T, 2001, JPN J CLIN ONCOL, V31, P13, DOI 10.1093/jjco/hye004; Jin Y, 2013, HEAD NECK IN PRESS; KWONG D, 1994, INT J RADIAT ONCOL, V30, P1029, DOI 10.1016/0360-3016(94)90306-9; Langman MJS, 2000, BRIT MED J, V320, P1642, DOI 10.1136/bmj.320.7250.1642; LAURSEN I, 1990, ANTICANCER RES, V10, P343; Lee AWM, 2012, SEMIN RADIAT ONCOL, V22, P233, DOI 10.1016/j.semradonc.2012.03.008; Li G, 2013, HEAD NECK IN PRESS; Li JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054839; Lin JC, 2004, NEW ENGL J MED, V350, P2461, DOI 10.1056/NEJMoa032260; Maltoni M, 2002, HEMATOL ONCOL CLIN N, V16, P715, DOI 10.1016/S0889-8588(02)00024-2; McMillan DC, 2001, NUTR CANCER, V39, P210, DOI 10.1207/S15327914nc392_8; McMillan DC, 2008, P NUTR SOC, V67, P257, DOI 10.1017/S0029665108007131; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Muir C, 1987, IARC SCI PUBL, V5, P1; Muliawati Yanti, 2012, Acta Med Indones, V44, P154; Proctor MJ, 2011, EUR J CANCER, V47, P2633, DOI 10.1016/j.ejca.2011.03.028; Seaton K, 2001, J NATL MED ASSOC, V93, P490; Sonnenschein C, 1996, J STEROID BIOCHEM, V59, P147, DOI 10.1016/S0960-0760(96)00112-4; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wolden SL, 2006, INT J RADIAT ONCOL, V64, P57, DOI 10.1016/j.ijrobp.2005.03.057; Xia WX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076958; Xia WX, 2013, EUR J CANCER, V49, P2152, DOI 10.1016/j.ejca.2013.03.003	36	97	101	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94473	10.1371/journal.pone.0094473	http://dx.doi.org/10.1371/journal.pone.0094473			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718309	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000124
J	Moon, S; Cho, SB				Moon, Seongwuk; Cho, Seong Beom			Differential Impact of Science Policy on Subfields of Human Embryonic Stem Cell Research	PLOS ONE			English	Article							LINES	In this research, we examine how restrictive policy influenced performance in human embryonic stem cell research (hESC) between 1998 and 2008. In previous research, researchers argued whether restrictive policy decreased the performance of stem cell research in some nations, especially in the US. Here, we hypothesize that this policy influenced specific subfields of the hESC research. To investigate the selective policy effects, we categorize hESC research publications into three subfields-derivation, differentiation, and medical application research. Our analysis shows that restrictive policy had different effects on different subfields. In general, the US outperformed in overall hESC research throughout these periods. In the derivation of hESC, however, the US almost lost its competence under restrictive policy. Interestingly, the US scientific community showed prominent resilience in hESC research through international collaboration. We concluded that the US resilience and performance stemmed from the wide breadth of research portfolio of US scientists across the hESC subfields, combined with their strategic efforts to collaborate internationally on derivation research.	[Moon, Seongwuk] Sogang Univ, Grad Sch Management Technol, Seoul, South Korea; [Cho, Seong Beom] KCDC, Natl Inst Hlth, Ctr Genome Sci, Div Biomed Informat, Chungcheongbuk Do, South Korea	Sogang University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science	Moon, S (corresponding author), Sogang Univ, Grad Sch Management Technol, Seoul, South Korea.	seongwuk@gmail.com; sbcho@korea.kr			KDI School of Public Policy and Management, Seoul, Korea; Sogang University [201310008.01]	KDI School of Public Policy and Management, Seoul, Korea; Sogang University	Seongwuk Moon is grateful for the financial support from KDI School of Public Policy and Management, Seoul, Korea. This work was supported by the Sogang University Research Grant of 2013 (201310008.01). Seongwuk Moon is grateful for this financial support from Sogang University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Furman JL, 2012, J POLICY ANAL MANAG, V31, P661, DOI 10.1002/pam.21644; Guhr A, 2006, STEM CELLS, V24, P2187, DOI 10.1634/stemcells.2006-0053; Korobkin Russell, 2007, STEM CELL CENTURY LA; Levine AD, 2008, CELL STEM CELL, V2, P521, DOI 10.1016/j.stem.2008.05.008; Loser P, 2010, STEM CELLS, V28, P240, DOI 10.1002/stem.286; Scott CT, 2009, NAT BIOTECHNOL, V27, P696, DOI 10.1038/nbt0809-696; Scott CT, 2006, STEM CELL NOW FORM E; Smith JO, 2006, NAT BIOTECHNOL, V24, P391, DOI 10.1038/nbt0406-391; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145	10	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e86395	10.1371/journal.pone.0086395	http://dx.doi.org/10.1371/journal.pone.0086395			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717403	Green Submitted, Green Published, gold			2022-12-25	WOS:000334339000003
J	Rehman, SU; Yaseen, Z; Husain, MA; Sarwar, T; Ishqi, HM; Tabish, M				Rehman, Sayeed Ur; Yaseen, Zahid; Husain, Mohammed Amir; Sarwar, Tarique; Ishqi, Hassan Mubarak; Tabish, Mohammad			Interaction of 6 Mercaptopurine with Calf Thymus DNA - Deciphering the Binding Mode and Photoinduced DNA Damage	PLOS ONE			English	Article							MIXED-LIGAND COMPLEXES; CIRCULAR-DICHROISM; NUCLEIC-ACIDS; FLUORESCENCE-SPECTRA; METAL-COMPLEXES; GROOVE BINDING; TARGETS; RUTHENIUM(II); INTERCALATION; HOECHST-33258	DNA is one of the major intracellular targets for a wide range of anticancer and antibiotic drugs. Elucidating the binding between small molecules and DNA provides great help in understanding drug-DNA interactions and in designing of new and promising drugs for clinical use. The ability of small molecules to bind and interfere with DNA replication and transcription provides further insight into how the drugs control the expression of genes. Interaction of an antimetabolite anticancer drug 6mercaptopurine (6MP) with calf thymus DNA was studied using various approaches like UV-visible spectroscopy, fluorescence spectroscopy, CD, viscosity and molecular docking. UV-visible spectroscopy confirmed 6MP-DNA interaction. Steady state fluorescence experiments revealed a moderate binding constant of 7.48x10(3) M-1 which was consistent with an external binding mode. Competitive displacement assays further confirmed a non-intercalative binding mode of 6MP which was further confirmed by CD and viscosity experiments. Molecular docking further revealed the minimum energy conformation (-119.67 kJ/mole) of the complex formed between DNA and 6MP. Hence, the biophysical techniques and in-silico molecular docking approaches confirmed the groove binding/electrostatic mode of interaction between 6MP and DNA. Further, photo induced generation of ROS by 6MP was studied spectrophotometrically and DNA damage was assessed by plasmid nicking and comet assay. There was a significant increase in ROS generation and consequent DNA damage in the presence of light.	[Rehman, Sayeed Ur; Husain, Mohammed Amir; Sarwar, Tarique; Ishqi, Hassan Mubarak; Tabish, Mohammad] AM Univ, Fac Life Sci, Dept Biochem, Aligarh, Uttar Pradesh, India; [Yaseen, Zahid] AM Univ, Fac Sci, Dept Chem, Aligarh, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University	Tabish, M (corresponding author), AM Univ, Fac Life Sci, Dept Biochem, Aligarh, Uttar Pradesh, India.	tabish.bcmlab@gmail.com	Husain, Mohammed/E-3246-2017	Husain, Mohammed Amir/0000-0003-3488-2710; Ishqi, Hassan Mubarak/0000-0003-0939-0271	Council of Scientific and Industrial Research, New Delhi; University Grants Commission, New Delhi	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, New Delhi(University Grants Commission, India)	The authors are thankful to the Council of Scientific and Industrial Research, New Delhi, for the award of CSIR-SRF fellowship to SUR and A.M.U., Aligarh for providing the necessary facilities. They also thank University Grants Commission, New Delhi for providing financial assistance to their department under the DRS-III program and Advance Instrumentation Research Facility, Jawaharlal Nehru University, New Delhi, where CD experiments were performed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonincontro A, 2008, LANGMUIR, V24, P1973, DOI 10.1021/la701730h; CHEN AY, 1994, ANNU REV PHARMACOL, V34, P191, DOI 10.1146/annurev.pa.34.040194.001203; Chen QG, 1999, ANALYST, V124, P901, DOI 10.1039/a901174i; Ding YH, 2010, J PHYS CHEM B, V114, P2033, DOI 10.1021/jp9104757; Dong C, 2003, SPECTROCHIM ACTA A, V59, P3131, DOI 10.1016/S1386-1425(03)00121-5; Elder RM, 2011, BIOMACROMOLECULES, V12, P3870, DOI 10.1021/bm201113y; Guan Y, 2006, ANAL CHIM ACTA, V570, P21, DOI 10.1016/j.aca.2006.03.106; HILLEN W, 1980, NUCLEIC ACIDS RES, V8, P5427, DOI 10.1093/nar/8.22.5427; Hurley LH, 2002, NAT REV CANCER, V2, P188, DOI 10.1038/nrc749; IVANOV VI, 1973, BIOPOLYMERS, V12, P89, DOI 10.1002/bip.1973.360120109; Jain SS, 2003, NUCLEIC ACIDS RES, V31, P4608, DOI 10.1093/nar/gkg648; Kakkar R, 2002, J MOL STRUC-THEOCHEM, V579, P109, DOI 10.1016/S0166-1280(01)00721-7; Kashanian S, 2010, EUR FOOD RES TECHNOL, V230, P821, DOI 10.1007/s00217-010-1226-6; Kim Hyung-Lae, 2006, Genomics & Informatics, V4, P16; KUMAR CV, 1992, J CHEM SOC CHEM COMM, P470, DOI 10.1039/c39920000470; KUMAR CV, 1993, J PHOTOCH PHOTOBIO A, V74, P231, DOI 10.1016/1010-6030(93)80121-O; Kypr J, 2002, BIOPOLYMERS, V67, P275, DOI 10.1002/bip.10112; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; LEPECQ JB, 1967, J MOL BIOL, V27, P87, DOI 10.1016/0022-2836(67)90353-1; LERMAN LS, 1961, J MOL BIOL, V3, P18, DOI 10.1016/S0022-2836(61)80004-1; Li JF, 2009, TALANTA, V77, P1043, DOI 10.1016/j.talanta.2008.08.012; Liu HK, 2011, ACCOUNTS CHEM RES, V44, P349, DOI 10.1021/ar100140e; Liu YJ, 2008, SPECTROCHIM ACTA A, V70, P171, DOI 10.1016/j.saa.2007.07.029; Maheswari PU, 2004, J INORG BIOCHEM, V98, P219, DOI 10.1016/j.jinorgbio.2003.09.003; Maniatis T., 1982, MOL CLONING LAB MANU; MERGNY JL, 1992, SCIENCE, V256, P1681, DOI 10.1126/science.256.5064.1681; NAKAYAMA T, 1983, CARCINOGENESIS, V4, P765, DOI 10.1093/carcin/4.6.765; Nejedly K, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni008; Onoue S, 2009, CURR DRUG SAF, V4, P123, DOI 10.2174/157488609788173044; PILCH DS, 1995, BIOCHEMISTRY-US, V34, P9962, DOI 10.1021/bi00031a019; POOLZOBEL BL, 1993, FOOD CHEM TOXICOL, V31, P271, DOI 10.1016/0278-6915(93)90077-C; PYLE AM, 1989, J AM CHEM SOC, V111, P3051, DOI 10.1021/ja00190a046; Rafique B, 2013, BIOSENS BIOELECTRON, V44, P21, DOI 10.1016/j.bios.2012.12.028; Rahban M, 2010, J PHYS CHEM C, V114, P5798, DOI 10.1021/jp910656g; Rauf S, 2005, J PHARMACEUT BIOMED, V37, P205, DOI 10.1016/j.jpba.2004.10.037; SATYANARAYANA S, 1993, BIOCHEMISTRY-US, V32, P2573, DOI 10.1021/bi00061a015; SATYANARAYANA S, 1992, BIOCHEMISTRY-US, V31, P9319, DOI 10.1021/bi00154a001; Shi Y, 2011, BIOMACROMOLECULES, V12, P797, DOI 10.1021/bm101414w; Singh N.P., 1998, EXP CELL RES, V17, P184, DOI DOI 10.1016/0014-4827(88)90265-0; Song YM, 2000, SPECTROCHIM ACTA A, V56, P2491, DOI 10.1016/S1386-1425(00)00340-1; SPRECHER CA, 1979, BIOPOLYMERS, V18, P1009, DOI 10.1002/bip.1979.360180418; Swann PF, 1996, SCIENCE, V273, P1109, DOI 10.1126/science.273.5278.1109; Taki K, 2013, J TOXICOL SCI, V38, P159, DOI 10.2131/jts.38.159; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Tsiliki P, 2013, POLYHEDRON, V53, P215, DOI 10.1016/j.poly.2013.01.049; Vorlickova M, 1995, BIOPHYS J, V69, P2033, DOI 10.1016/S0006-3495(95)80073-1; Wang Y, 2009, INORG CHIM ACTA, V362, P377, DOI 10.1016/j.ica.2008.04.017	48	107	108	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93913	10.1371/journal.pone.0093913	http://dx.doi.org/10.1371/journal.pone.0093913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718609	Green Submitted, Green Published, gold			2022-12-25	WOS:000334339000057
J	Backfisch, B; Kozin, VV; Kirchmaier, S; Tessmar-Raible, K; Raible, F				Backfisch, Benjamin; Kozin, Vitaly V.; Kirchmaier, Stephan; Tessmar-Raible, Kristin; Raible, Florian			Tools for Gene-Regulatory Analyses in the Marine Annelid Platynereis dumerilii	PLOS ONE			English	Article							TRANSPOSON MEDIATED TRANSGENESIS; IN-SITU HYBRIDIZATION; ENHANCER DETECTION; GERM-LINE; CIONA-INTESTINALIS; CELL-TYPES; EVOLUTION; GENOME; TRANSFORMATION; REGISTRATION	The advent of high-throughput sequencing technology facilitates the exploration of a variety of reference species outside the few established molecular genetic model systems. Bioinformatic and gene expression analyses provide new ways for comparative analyses between species, for instance, in the field of evolution and development. Despite these advances, a critical bottleneck for the exploration of new model species remains the establishment of functional tools, such as the ability to experimentally express genes in specific cells of an organism. We recently established a first transgenic strain of the annelid Platynereis, using a Tc1/mariner-type Mos1 transposon vector. Here, we compare Mos1 with Tol2, a member of the hAT family of transposons. In Platynereis, Tol2-based constructs showed a higher frequency of nuclear genome insertion and sustained gene expression in the G0 generation. However, in contrast to Mos1-mediated transgenes, Tol2-mediated insertions failed to retain fluorescence in the G1 generation, suggesting a germ line-based silencing mechanism. Furthermore, we present three novel expression constructs that were generated by a simple fusion-PCR approach and allow either ubiquitous or cell-specific expression of a reporter gene. Our study indicates the versatility of Tol2 for transient transgenesis, and provides a template for transgenesis work in other emerging reference species.	[Backfisch, Benjamin; Kozin, Vitaly V.; Kirchmaier, Stephan; Tessmar-Raible, Kristin; Raible, Florian] Univ Vienna, MFPL, Vienna, Austria; [Backfisch, Benjamin; Tessmar-Raible, Kristin; Raible, Florian] Univ Vienna, Res Platform Marine Rhythms Life, Vienna, Austria; [Kozin, Vitaly V.] St Petersburg State Univ, Dept Embryol, St Petersburg 199034, Russia	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Vienna; Saint Petersburg State University	Raible, F (corresponding author), Univ Vienna, MFPL, Vienna, Austria.	florian.raible@mfpl.ac.at	Raible, Florian/G-6019-2011; Tessmar-Raible, Kristin/F-9642-2011; Kozin, Vitaly V./J-5047-2012	Tessmar-Raible, Kristin/0000-0002-8038-1741; Kozin, Vitaly V./0000-0003-1109-3508; Raible, Florian/0000-0002-4515-6485; Kirchmaier, Stephan/0000-0002-3870-8624	Research Platform "Marine Rhythms of Life"; University of Vienna; Research the Austrian Science Fund [(FWF): AY0041321]; European Research Council under the European Community's Seventh Framework Programme (FP7)/ERC [260304]; Austrian Science Fund (FWF) [Y 413] Funding Source: researchfish	Research Platform "Marine Rhythms of Life"; University of Vienna; Research the Austrian Science Fund; European Research Council under the European Community's Seventh Framework Programme (FP7)/ERC(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Our work was supported by the Research Platform "Marine Rhythms of Life" as well as start-up funds of the University of Vienna (to F. R. and K.T.-R.), and the Research the Austrian Science Fund (FWF): AY0041321 (to K.T.-R.). The research leading to these results has received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant Agreement 260304 (to F. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Allende ML, 2006, METHODS, V39, P212, DOI 10.1016/j.ymeth.2005.12.005; Arendt D, 2008, NAT REV GENET, V9, P868, DOI 10.1038/nrg2416; Asadulina A, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-27; Backfisch B, 2013, P NATL ACAD SCI USA, V110, P193, DOI 10.1073/pnas.1209657109; Bannister S, 2014, GENETICS, V197, P77, DOI 10.1534/genetics.113.161091; Bessa J, 2009, DEV DYNAM, V238, P2409, DOI 10.1002/dvdy.22051; Bolker J, 2012, NATURE, V491, P31, DOI 10.1038/491031a; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Christodoulou F, 2010, NATURE, V463, P1084, DOI 10.1038/nature08744; Cuypers MG, 2013, NUCLEIC ACIDS RES, V41, P2020, DOI 10.1093/nar/gks1295; Davidson EH, 2006, REG GEN GEN REG; Dawson A, 2003, MOL CELL, V11, P225, DOI 10.1016/S1097-2765(02)00798-0; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gonzalez-Estevez C, 2003, P NATL ACAD SCI USA, V100, P14046, DOI 10.1073/pnas.2335980100; Grabher C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S10; Halanych KM, 2004, ANNU REV ECOL EVOL S, V35, P229, DOI 10.1146/annurev.ecolsys.35.112202.130124; Hauenschild C., 1969, PLATYNEREIS DUMERILI; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Hozumi A, 2013, DEV DYNAM, V242, P30, DOI 10.1002/dvdy.23891; Ivics Z, 2010, MOBILE DNA-UK, V1, DOI 10.1186/1759-8753-1-25; Jaillet J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043365; Jekely G, 2008, NATURE, V456, P395, DOI 10.1038/nature07590; Jenner RA, 2007, NAT REV GENET, V8, P311, DOI 10.1038/nrg2062; Kerner P, 2009, EVOL DEV, V11, P513, DOI 10.1111/j.1525-142X.2009.00359.x; Kines KJ, 2008, FASEB J, V22, P2936, DOI 10.1096/fj.08-108308; Kocot KM, 2011, NATURE, V477, P452, DOI 10.1038/nature10382; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Mates L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S1; Matsuoka T, 2003, MOL CELL BIOL, V23, P6049, DOI 10.1128/MCB.23.17.6049-6062.2003; Mongin E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019747; Nam JM, 2010, P NATL ACAD SCI USA, V107, P3930, DOI 10.1073/pnas.1000147107; Pavlopoulos A, 2005, P NATL ACAD SCI USA, V102, P7888, DOI 10.1073/pnas.0501101102; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Raible F, 2005, SCIENCE, V310, P1325, DOI 10.1126/science.1119089; RASSOULZADEGAN M, 1986, CELL, V46, P513, DOI 10.1016/0092-8674(86)90876-7; Renfer E, 2010, P NATL ACAD SCI USA, V107, P104, DOI 10.1073/pnas.0909148107; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; Sasakura Y, 2003, P NATL ACAD SCI USA, V100, P7726, DOI 10.1073/pnas.1230736100; Sasakura Y, 2008, DEV DYNAM, V237, P39, DOI 10.1002/dvdy.21333; Sasakura Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S3; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Simakov O, 2013, BRIEF FUNCT GENOMICS, V12, P430, DOI 10.1093/bfgp/els049; Simakov O, 2013, NATURE, V493, P526, DOI 10.1038/nature11696; STINCHCOMB DT, 1985, MOL CELL BIOL, V5, P3484, DOI 10.1128/MCB.5.12.3484; Struck TH, 2011, NATURE, V471, P95, DOI 10.1038/nature09864; Takeuchi T, 2012, DNA RES, V19, P117, DOI 10.1093/dnares/dss005; Tessmar-Raible K, 2005, BIOTECHNIQUES, V39, P460, DOI 10.2144/000112023; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Tomer R, 2010, CELL, V142, P800, DOI 10.1016/j.cell.2010.07.043; Veedin-Rajan VB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075811; Zhou LQ, 2004, NATURE, V432, P995, DOI 10.1038/nature03157; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	56	13	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93076	10.1371/journal.pone.0093076	http://dx.doi.org/10.1371/journal.pone.0093076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714200	Green Published, gold, Green Submitted			2022-12-25	WOS:000334160900014
J	Davila, JL; Goff, LA; Ricupero, CL; Camarillo, C; Oni, EN; Swerdel, MR; Toro-Ramos, AJ; Li, JL; Hart, RP				Davila, Jonathan L.; Goff, Loyal A.; Ricupero, Christopher L.; Camarillo, Cynthia; Oni, Eileen N.; Swerdel, Mavis R.; Toro-Ramos, Alana J.; Li, Jiali; Hart, Ronald P.			A Positive Feedback Mechanism That Regulates Expression of miR-9 during Neurogenesis	PLOS ONE			English	Article							II HISTONE DEACETYLASES; LONG NONCODING RNAS; RADIAL GLIAL-CELLS; NEURAL STEM-CELLS; NEURONAL DIFFERENTIATION; TRANSCRIPTION FACTOR; MICRORNA EXPRESSION; GENE-EXPRESSION; MESSENGER-RNA; MEF2	MiR-9, a neuron-specific miRNA, is an important regulator of neurogenesis. In this study we identify how miR-9 is regulated during early differentiation from a neural stem-like cell. We utilized two immortalized rat precursor clones, one committed to neurogenesis (L2.2) and another capable of producing both neurons and non-neuronal cells (L2.3), to reproducibly study early neurogenesis. Exogenous miR-9 is capable of increasing neurogenesis from L2.3 cells. Only one of three genomic loci capable of encoding miR-9 was regulated during neurogenesis and the promoter region of this locus contains sufficient functional elements to drive expression of a luciferase reporter in a developmentally regulated pattern. Furthermore, among a large number of potential regulatory sites encoded in this sequence, Mef2 stood out because of its known pro-neuronal role. Of four Mef2 paralogs, we found only Mef2C mRNA was regulated during neurogenesis. Removal of predicted Mef2 binding sites or knockdown of Mef2C expression reduced miR-9-2 promoter activity. Finally, the mRNA encoding the Mef2C binding partner HDAC4 was shown to be targeted by miR-9. Since HDAC4 protein could be co-immunoprecipitated with Mef2C protein or with genomic Mef2 binding sequences, we conclude that miR-9 regulation is mediated, at least in part, by Mef2C binding but that expressed miR-9 has the capacity to reduce inhibitory HDAC4, stabilizing its own expression in a positive feedback mechanism.	[Hart, Ronald P.] Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08855 USA; Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Hart, RP (corresponding author), Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08855 USA.	rhart@rci.rutgers.edu	li, Jiali/HGF-2395-2022; Hart, Ronald P/D-5219-2009; Hart, Ronald P/G-6530-2019	li, Jiali/0000-0001-6202-7741; Hart, Ronald P/0000-0003-4836-8712; Hart, Ronald P/0000-0003-4836-8712; Goff, Loyal/0000-0003-2875-451X; Li, Jiali/0000-0002-0039-3671	National Institutes of Health (NIH) [R21 MH085088]; New Jersey Commission for Science and Technology; New Jersey Commission on Spinal Cord Research; National Science Foundation (NSF) IGERT training grant; NIH Pipeline Grant [5R25GM055145]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023522] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission for Science and Technology; New Jersey Commission on Spinal Cord Research; National Science Foundation (NSF) IGERT training grant(National Science Foundation (NSF)); NIH Pipeline Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from National Institutes of Health (NIH) (R21 MH085088) and the New Jersey Commission for Science and Technology. JD and CC were supported by fellowships from the New Jersey Commission on Spinal Cord Research; CLR was supported by a National Science Foundation (NSF) IGERT training grant; EO was supported by an NIH Pipeline Grant (5R25GM055145). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerblom M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00014; Annibali D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040269; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Bonev B, 2012, CELL REPORTS, V2, P10, DOI 10.1016/j.celrep.2012.05.017; Bonev B, 2011, DEV CELL, V20, P19, DOI 10.1016/j.devcel.2010.11.018; Campbell GRO, 2011, MOL CELL NEUROSCI, V46, P548, DOI 10.1016/j.mcn.2010.12.012; Chan JKL, 2003, J BIOL CHEM, V278, P23515, DOI 10.1074/jbc.M301922200; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cho EG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024027; Cohen TJ, 2009, FASEB J, V23, P99, DOI 10.1096/fj.08-115931; Coolen M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00220; Coolen M, 2012, DEV CELL, V22, P1052, DOI 10.1016/j.devcel.2012.03.003; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Goff Loyal A, 2007, J Biomol Tech, V18, P205; Goff LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007192; Han R, 2012, NEUROSCI LETT, V515, P147, DOI 10.1016/j.neulet.2012.03.032; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Houbaviy HB, 2005, RNA, V11, P1245, DOI 10.1261/rna.2890305; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Laneve P, 2010, NUCLEIC ACIDS RES, V38, P6895, DOI 10.1093/nar/gkq604; Lee YS, 2005, J BIOL CHEM, V280, P16635, DOI 10.1074/jbc.M412247200; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li H, 2008, P NATL ACAD SCI USA, V105, P9397, DOI 10.1073/pnas.0802876105; Li HD, 2004, DEV BIOL, V271, P225, DOI 10.1016/j.ydbio.2004.02.028; Li H, 2008, GLIA, V56, P646, DOI 10.1002/glia.20643; Li HD, 2008, DEV NEUROBIOL, V68, P1549, DOI 10.1002/dneu.20679; Li JL, 2012, NAT MED, V18, P783, DOI 10.1038/nm.2709; Lin X, 1996, MOL BRAIN RES, V42, P307, DOI 10.1016/S0169-328X(96)00135-0; Linseman DA, 2003, J BIOL CHEM, V278, P41472, DOI 10.1074/jbc.M307245200; Lu JR, 2000, MOL CELL, V6, P233, DOI 10.1016/S1097-2765(00)00025-3; Mansfield KD, 2012, NUCLEIC ACIDS RES, V40, P2734, DOI 10.1093/nar/gkr1114; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Mercer TR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-14; Miska EA, 1999, EMBO J, V18, P5099, DOI 10.1093/emboj/18.18.5099; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Ng SY, 2012, EMBO J, V31, P522, DOI 10.1038/emboj.2011.459; Ohtsuka T, 2011, STEM CELLS, V29, P1817, DOI 10.1002/stem.731; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Sando R, 2012, CELL, V151, P821, DOI 10.1016/j.cell.2012.09.037; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shibata M, 2008, J NEUROSCI, V28, P10415, DOI 10.1523/JNEUROSCI.3219-08.2008; Skreka K, 2012, NUCLEIC ACIDS RES, V40, P6001, DOI 10.1093/nar/gks311; Smith B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011109; Tan SL, 2012, GENES CELLS, V17, P952, DOI 10.1111/gtc.12009; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; Zhao CN, 2013, SCI REP-UK, V3, DOI 10.1038/srep01329; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576; Zhu BM, 2005, J BIOL CHEM, V280, P28749, DOI 10.1074/jbc.M502491200	62	20	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94348	10.1371/journal.pone.0094348	http://dx.doi.org/10.1371/journal.pone.0094348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714615	gold, Green Submitted, Green Published			2022-12-25	WOS:000334160900122
J	Pan, T; Wu, SX; He, X; Luo, HH; Zhang, YJ; Fan, MM; Geng, GN; Clarke Ruiz, V; Zhang, J; Mills, L; Bai, C; Zhang, H				Pan, Ting; Wu, Shuangxin; He, Xin; Luo, Haihua; Zhang, Yijun; Fan, Miaomiao; Geng, Guannan; Clarke Ruiz, Vivian; Zhang, Jim; Mills, Lisa; Bai, Chuan; Zhang, Hui			Necroptosis Takes Place in Human Immunodeficiency Virus Type-1 (HIV-1)-Infected CD4(+) T Lymphocytes	PLOS ONE			English	Article							HTLV-III/LAV ENVELOPE; MIXED LINEAGE KINASE; CELL-DEATH; HIV-1 TAT; PROGRAMMED NECROSIS; CHEMOKINE RECEPTORS; SIGNALING PATHWAYS; DOMAIN-LIKE; APOPTOSIS; MECHANISMS	Human immunodeficiency virus type 1 (HIV-1) infection is characterized by progressive depletion of CD4(+) T lymphocytes and dysfunction of the immune system. The numbers of CD4(+) T lymphocytes in the human body are maintained constantly by homeostatic mechanisms that failed during HIV-1 infection, resulting in progressive loss of CD4(+) T cells mainly via apoptosis. Recently, a non-apoptotic form of necrotic programmed cell death, named necroptosis, has been investigated in many biological and pathological processes. We then determine whether HIV-1-infected cells also undergo necroptosis. In this report, we demonstrate that HIV-1 not only induces apoptosis, but also mediates necroptosis in the infected primary CD4(+) T lymphocytes and CD4(+) T-cell lines. Necroptosis-dependent cytopathic effects are significantly increased in HIV-1-infected Jurkat cells that is lack of Fas-associated protein-containing death domain (FADD), indicating that necroptosis occurs as an alternative cell death mechanism in the absence of apoptosis. Unlike apoptosis, necroptosis mainly occurs in HIV-infected cells and spares bystander damage. Treatment with necrostatin-1(Nec-1), a RIP1 inhibitor that specifically blocks the necroptosis pathway, potently restrains HIV-1-induced cytopathic effect and interestingly, inhibits the formation of HIV-induced syncytia in CD4(+) T-cell lines. This suggests that syncytia formation is mediated, at least partially, by necroptosis-related processes. Furthermore, we also found that the HIV-1 infection-augmented tumor necrosis factor-alpha (TNF-alpha) plays a key role in inducing necroptosis and HIV-1 Envelope and Tat proteins function as its co-factors. Taken together, necroptosis can function as an alternative cell death pathway in lieu of apoptosis during HIV-1 infection, thereby also contributing to HIV-1-induced cytopathic effects. Our results reveal that in addition to apoptosis, necroptosis also plays an important role in HIV-1-induced pathogenesis.	[Pan, Ting; Wu, Shuangxin; He, Xin; Luo, Haihua; Zhang, Yijun; Fan, Miaomiao; Geng, Guannan; Bai, Chuan; Zhang, Hui] Sun Yat Sen Univ, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China; [Pan, Ting; Wu, Shuangxin; He, Xin; Luo, Haihua; Zhang, Yijun; Fan, Miaomiao; Geng, Guannan; Bai, Chuan; Zhang, Hui] Sun Yat Sen Univ, Zhongshan Sch Med, Minist Educ, Key Lab Trop Dis Control, Guangzhou 510275, Guangdong, Peoples R China; [Clarke Ruiz, Vivian; Zhang, Jim; Mills, Lisa] Thomas Jefferson Univ, Ctr Human Virol, Dept Med, Div Infect Dis, Philadelphia, PA 19107 USA	Sun Yat Sen University; Sun Yat Sen University; Jefferson University	Bai, C (corresponding author), Sun Yat Sen Univ, Inst Human Virol, Guangzhou 510275, Guangdong, Peoples R China.	baichuan@mail.sysu.edu.cn; hz08043@gmail.com	Zhang, Yijun/J-5485-2017; Pan, Ting/AAX-1933-2021	Zhang, Yijun/0000-0001-7971-2200; He, Xin/0000-0002-2131-2092; Pan, Ting/0000-0002-7106-7312	Guangdong Recruitment Program of Creative Research Groups [2009010058]; National Basic Research Program of China (973 Program) [2010CB912202]; Natural Science Foundation of China [30972620]; Natural Science Foundation of Guangdong [9251008901000022]	Guangdong Recruitment Program of Creative Research Groups; National Basic Research Program of China (973 Program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province)	This work was funded by the grants from Guangdong Recruitment Program of Creative Research Groups (NO. 2009010058), National Basic Research Program of China (973 Program) (No. 2010CB912202), Natural Science Foundation of China (No. 30972620), Natural Science Foundation of Guangdong (No. 9251008901000022) to HZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyavoo V, 1997, NAT MED, V3, P1117, DOI 10.1038/nm1097-1117; Badley AD, 2000, BLOOD, V96, P2951, DOI 10.1182/blood.V96.9.2951.h8002951_2951_2964; Bennasser Y, 2002, VIROLOGY, V303, P174, DOI 10.1006/viro.2002.1676; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; BRODER CC, 1995, P NATL ACAD SCI USA, V92, P9004, DOI 10.1073/pnas.92.19.9004; Chan FKM, 2012, CELL, V148, P17, DOI 10.1016/j.cell.2011.12.020; Chen EH, 2005, SCIENCE, V308, P369, DOI 10.1126/science.1104799; Chen PQ, 1997, J BIOL CHEM, V272, P22385, DOI 10.1074/jbc.272.36.22385; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Chu WM, 2012, CANC LETT; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Fauci AS, 1996, NATURE, V384, P529, DOI 10.1038/384529a0; Ferri KF, 2000, J EXP MED, V192, P1081, DOI 10.1084/jem.192.8.1081; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; Galluzzi L, 2008, CELL, V135, P1161, DOI 10.1016/j.cell.2008.12.004; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Huerta L, 2009, THESCIENTIFICWORLDJO, V9, P746, DOI 10.1100/tsw.2009.90; Lamkanfi M, 2007, CELL DEATH DIFFER, V14, P44, DOI 10.1038/sj.cdd.4402047; LI CJ, 1995, SCIENCE, V268, P429, DOI 10.1126/science.7716549; LIFSON JD, 1986, NATURE, V323, P725, DOI 10.1038/323725a0; LIFSON JD, 1986, SCIENCE, V232, P1123, DOI 10.1126/science.3010463; Liu C, 2012, J BIOL CHEM, V287, P29373, DOI 10.1074/jbc.M112.354001; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Mack C, 2008, P NATL ACAD SCI USA, V105, P3094, DOI 10.1073/pnas.0800168105; Marzo I, 1998, SCIENCE, V281, P2027, DOI 10.1126/science.281.5385.2027; MELLORS JW, 1991, J INFECT DIS, V163, P78, DOI 10.1093/infdis/163.1.78; MEYAARD L, 1992, SCIENCE, V257, P217, DOI 10.1126/science.1352911; Miao BC, 2009, METHODS MOL BIOL, V559, P79, DOI 10.1007/978-1-60327-017-5_6; Narayan N, 2012, NATURE, V492, P199, DOI 10.1038/nature11700; Osborn SL, 2010, P NATL ACAD SCI USA, V107, P13034, DOI 10.1073/pnas.1005997107; Perfettini JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002458; Perfettini JL, 2005, CELL DEATH DIFFER, V12, P916, DOI 10.1038/sj.cdd.4401584; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; PUMAROLASUNE T, 1987, ANN NEUROL, V21, P490, DOI 10.1002/ana.410210513; Rebsamen M, 2009, EMBO REP, V10, P916, DOI 10.1038/embor.2009.109; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Sawai H, 2011, BIOCHEM BIOPH RES CO, V411, P569, DOI 10.1016/j.bbrc.2011.06.186; Scheinberg MA, 2012, NAT REV RHEUMATOL, V8, P430, DOI 10.1038/nrrheum.2012.84; SHARER LR, 1986, HUM PATHOL, V17, P271, DOI 10.1016/S0046-8177(83)80220-2; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; SODROSKI J, 1986, NATURE, V322, P470, DOI 10.1038/322470a0; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Teng X, 2005, BIOORG MED CHEM LETT, V15, P5039, DOI 10.1016/j.bmcl.2005.07.077; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Van Herreweghe F, 2010, CELL MOL LIFE SCI, V67, P1567, DOI 10.1007/s00018-010-0283-0; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; WESSELINGH SL, 1993, ANN NEUROL, V33, P576, DOI 10.1002/ana.410330604; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109; Zhou ZR, 2012, PROTEIN CELL, V3, P811, DOI 10.1007/s13238-012-2083-9	62	45	46	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93944	10.1371/journal.pone.0093944	http://dx.doi.org/10.1371/journal.pone.0093944			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714696	Green Submitted, gold, Green Published			2022-12-25	WOS:000334160900065
J	Raykova, D; Klar, J; Azhar, A; Khan, TN; Malik, NA; Iqbal, M; Tariq, M; Baig, SM; Dahl, N				Raykova, Doroteya; Klar, Joakim; Azhar, Aysha; Khan, Tahir Naeem; Malik, Naveed Altaf; Iqbal, Muhammad; Tariq, Muhammad; Baig, Shahid Mahmood; Dahl, Niklas			Autosomal Recessive Transmission of a Rare KRT74 Variant Causes Hair and Nail Ectodermal Dysplasia: Allelism with Dominant Woolly Hair/Hypotrichosis	PLOS ONE			English	Article							PURE HAIR; GENE; KERATINS; EXPRESSION; HOXC13; MUTATIONS; MATRIX; UNIT	Pure hair and nail ectodermal dysplasia (PHNED) comprises a heterogeneous group of rare heritable disorders characterized by brittle hair, hypotrichosis, onychodystrophy and micronychia. Autosomal recessive (AR) PHNED has previously been associated with mutations in either KRT85 or HOXC13 on chromosome 12p11.1-q14.3. We investigated a consanguineous Pakistani family with AR PHNED linked to the keratin gene cluster on 12p11.1 but without detectable mutations in KRT85 and HOXC13. Whole exome sequencing of affected individuals revealed homozygosity for a rare c.821T> C variant (p.Phe274Ser) in the KRT74 gene that segregates AR PHNED in the family. The transition alters the highly conserved Phe274 residue in the coil 1B domain required for long-range dimerization of keratins, suggesting that the mutation compromises the stability of intermediate filaments. Immunohistochemical (IHC) analyses confirmed a strong keratin-74 expression in the nail matrix, the nail bed and the hyponychium of mouse distal digits, as well as in normal human hair follicles. Furthermore, hair follicles and epidermis of an affected family member stained negative for Keratin-74 suggesting a loss of function mechanism mediated by the Phe274Ser substitution. Our observations show for the first time that homozygosity for a KRT74 missense variant may be associated with AR PHNED. Heterozygous KRT74 mutations have previously been associated with autosomal dominant woolly hair/ hypotrichosis simplex (ADWH). Thus, our findings expand the phenotypic spectrum associated with KRT74 mutations and imply that a subtype of AR PHNED is allelic with ADWH.	[Raykova, Doroteya; Klar, Joakim; Dahl, Niklas] Uppsala Univ, Biomed Ctr, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden; [Azhar, Aysha; Khan, Tahir Naeem; Malik, Naveed Altaf; Tariq, Muhammad; Baig, Shahid Mahmood] Natl Inst Biotechnol & Genet Engn, Hlth Biotechnol Div, Human Mol Genet Lab, Faisalabad, Pakistan; [Iqbal, Muhammad] Nucl Med Hosp, Punjab Inst, Dept Nucl Med, Faisalabad, Pakistan	Uppsala University; Pakistan Institute of Engineering & Applied Science	Dahl, N (corresponding author), Uppsala Univ, Biomed Ctr, Dept Immunol Genet & Pathol, Sci Life Lab, Uppsala, Sweden.	Niklas.Dahl@igp.uu.se	Klar, Joakim/H-2900-2019; Tariq, Muhammad/I-4992-2013; BAig, Shahid Mahmood/AAS-8365-2020; Baig, Shahid Mahmood/I-7309-2015	Klar, Joakim/0000-0003-4185-7409; Tariq, Muhammad/0000-0002-5334-403X; Khan, Tahir/0000-0003-3096-8795; Iqbal, Muhammad/0000-0001-7202-6670	Swedish Research Council [K2013-66X-10829-20-3]; Uppsala University Hospital, funds at Uppsala University; Science for Life Laboratory; Swedish Society for Medical Reserach	Swedish Research Council(Swedish Research CouncilEuropean Commission); Uppsala University Hospital, funds at Uppsala University; Science for Life Laboratory; Swedish Society for Medical Reserach	This work was supported by grants from the Swedish Research Council (K2013-66X-10829-20-3), Uppsala University Hospital, funds at Uppsala University and the Science for Life Laboratory. JK is supported by the Swedish Society for Medical Reserach. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbareschi M, 1997, AM J MED GENET, V72, P91, DOI 10.1002/(SICI)1096-8628(19971003)72:1<91::AID-AJMG19>3.0.CO;2-P; Barthelemy NR, 2012, ANAL BIOCHEM, V421, P43, DOI 10.1016/j.ab.2011.10.011; CALZAVARAPINTON P, 1991, DERMATOLOGICA, V182, P184, DOI 10.1159/000247779; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Cui CY, 2013, J INVEST DERMATOL, V133, P1990, DOI 10.1038/jid.2013.84; Farooq M, 2013, HUM MUTAT, V34, P578, DOI 10.1002/humu.22271; Gauster M, 2013, HISTOL HISTOPATHOL, V28, P817, DOI 10.14670/HH-28.817; Harrison Shannon, 2004, Australas J Dermatol, V45, P103, DOI 10.1111/j.1440-0960.2004.00055.x; Irvine AD, 2009, AM J MED GENET A, V149A, P1970, DOI 10.1002/ajmg.a.32852; Jave-Suarez LF, 2002, J BIOL CHEM, V277, P3718, DOI 10.1074/jbc.M101616200; Kammerer RA, 1998, P NATL ACAD SCI USA, V95, P13419, DOI 10.1073/pnas.95.23.13419; Langbein L, 2003, J INVEST DERMATOL, V120, P512, DOI 10.1046/j.1523-1747.2003.12087.x; Langbein L, 2001, J BIOL CHEM, V276, P35123, DOI 10.1074/jbc.M103305200; Lee CH, 2012, NAT STRUCT MOL BIOL, V19, P707, DOI 10.1038/nsmb.2330; Lin ZM, 2012, AM J HUM GENET, V91, P906, DOI 10.1016/j.ajhg.2012.08.029; Maity B, 2012, METHOD CELL BIOL, V113, P81, DOI 10.1016/B978-0-12-407239-8.00005-7; McLean WHI, 2011, HUM MOL GENET, V20, pR189, DOI 10.1093/hmg/ddr379; Naeem M, 2006, J MED GENET, V43, P274, DOI 10.1136/jmg.2005.033381; Naeem M, 2006, BRIT J DERMATOL, V155, P1184, DOI 10.1111/j.1365-2133.2006.07509.x; Perrin C, 2004, BRIT J DERMATOL, V151, P362, DOI 10.1111/j.1365-2133.2004.06108.x; PINHEIRO M, 1992, CLIN GENET, V41, P296; Pruett ND, 2004, J BIOL CHEM, V279, P51524, DOI 10.1074/jbc.M404331200; Rasool M, 2010, EUR J DERMATOL, V20, P443, DOI 10.1684/ejd.2010.0962; Rice RH, 2011, J COSMET SCI, V62, P229; Shimomura Y, 2010, AM J HUM GENET, V86, P632, DOI 10.1016/j.ajhg.2010.02.025; Shimomura Y, 2010, J INVEST DERMATOL, V130, P892, DOI 10.1038/jid.2009.341; Steinmetz MO, 1998, EMBO J, V17, P1883, DOI 10.1093/emboj/17.7.1883; Talas U, 2000, J INVEST DERMATOL, V114, P165, DOI 10.1046/j.1523-1747.2000.00825.x; Wasif N, 2011, HUM GENET, V129, P419, DOI 10.1007/s00439-010-0938-9; Wu KC, 2000, MOL BIOL CELL, V11, P3539, DOI 10.1091/mbc.11.10.3539	31	13	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93607	10.1371/journal.pone.0093607	http://dx.doi.org/10.1371/journal.pone.0093607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714551	Green Published, gold, Green Submitted			2022-12-25	WOS:000334160900039
J	Shi, YJ; Frost, P; Hoang, B; Yang, YH; Bardeleben, C; Gera, J; Lichtenstein, A				Shi, Yijiang; Frost, Patrick; Hoang, Bao; Yang, Yonghui; Bardeleben, Carolyne; Gera, Joseph; Lichtenstein, Alan			MNK1-Induced eIF-4E Phosphorylation in Myeloma Cells: A Pathway Mediating IL-6-Induced Expansion and Expression of Genes Involved in Metabolic and Proteotoxic Responses	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; MULTIPLE-MYELOMA; BINDING-PROTEIN; IN-VIVO; MNK1; TRANSLATION; INITIATION; EIF4E; TRANSFORMATION; INHIBITORS	Because multiple myeloma (MM) cells are at risk for endoplasmic reticulum (ER) stress, they require a carefully regulated mechanism to promote protein translation of selected transcripts when proliferation is stimulated. MAPK-interacting kinases (MNKs) may provide this mechanism by enhancing cap-dependent translation of a small number of critical transcripts. We, thus, tested whether MNKs played a role in MM responses to the myeloma growth factor interleukin-6 (IL-6). IL-6 activated MNK1 phosphorylation and induced phosphorylation of its substrate, eIF-4E, in MM lines and primary specimens. MNK paralysis, achieved pharmacologically or by shRNA, prevented MM expansion stimulated by IL-6. A phosphodefective eIF-4E mutant also prevented the IL-6 response, supporting the notion that MNK's role was via phosphorylation of eIF-4E. Both pharmacological MNK inhibition and expression of the phosphodefective eIF-4E mutant inhibited MM growth in mice. Although critical for IL-6-induced expansion, eIF-4E phosphorylation had no significant effect on global translation or Ig expression. Deep sequencing of ribosome-protected mRNAs revealed a repertoire of genes involved in metabolic processes and ER stress modulation whose translation was regulated by eIF-4E phosphorylation. These data indicate MM cells exploit the MNK/eIF-4E pathway for selective mRNA translation without enhancing global translation and risking ER stress.	[Shi, Yijiang; Frost, Patrick; Hoang, Bao; Yang, Yonghui; Bardeleben, Carolyne; Gera, Joseph; Lichtenstein, Alan] Greater Los Angeles VA Healthcare Ctr, Dept Med Hematol Oncol, Los Angeles, CA 90073 USA; [Shi, Yijiang; Frost, Patrick; Hoang, Bao; Yang, Yonghui; Bardeleben, Carolyne; Gera, Joseph; Lichtenstein, Alan] Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA; [Shi, Yijiang; Frost, Patrick; Hoang, Bao; Yang, Yonghui; Bardeleben, Carolyne; Gera, Joseph; Lichtenstein, Alan] Jonsson Comprehens Canc Ctr, Los Angeles, CA 90034 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center	Lichtenstein, A (corresponding author), Greater Los Angeles VA Healthcare Ctr, Dept Med Hematol Oncol, Los Angeles, CA 90073 USA.	alan.lichtenstein@med.va.gov		Gera, Joseph/0000-0002-2908-6894	National Institutes of Health [2RO1CA111448, 1RO1CA132778, 1R21CA168491]; Veteran's Administration; Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE [R21CA168491, R01CA168700, R01CA132778, R01CA111448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran's Administration(US Department of Veterans Affairs); Multiple Myeloma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health grants 2RO1CA111448, 1RO1CA132778 and 1R21CA168491; research funds of the Veteran's Administration; The Multiple Myeloma Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Assouline S, 2009, BLOOD, V114, P257, DOI 10.1182/blood-2009-02-205153; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BILLADEAU D, 1995, CANCER RES, V55, P3640; Bredel M, 2005, CANCER RES, V65, P4088, DOI 10.1158/0008-5472.CAN-04-4229; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Clendening JW, 2010, BLOOD, V115, P4787, DOI 10.1182/blood-2009-07-230508; Fan SQ, 2009, CANCER BIOL THER, V8, P1463, DOI 10.4161/cbt.8.15.8960; Frost P, 2007, ONCOGENE, V26, P2255, DOI 10.1038/sj.onc.1210019; Frost P, 2004, BLOOD, V104, P4181, DOI 10.1182/blood-2004-03-1153; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Hoang B, 2010, BLOOD, V116, P4560, DOI 10.1182/blood-2010-05-285726; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; JERNBERGWIKLUND H, 1992, LEUKEMIA, V6, P310; Kentsis A, 2004, P NATL ACAD SCI USA, V101, P18105, DOI 10.1073/pnas.0406927102; Knauf U, 2001, MOL CELL BIOL, V21, P5500, DOI 10.1128/MCB.21.16.5500-5511.2001; Konicek BW, 2011, CANCER RES, V71, P1849, DOI 10.1158/0008-5472.CAN-10-3298; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Liu LD, 2012, NATURE, V483, P608, DOI 10.1038/nature10927; Lock R, 2011, MOL BIOL CELL, V22, P165, DOI 10.1091/mbc.E10-06-0500; Tirado-Velez JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046484; Munshi NC, 2004, BLOOD, V103, P1799, DOI 10.1182/blood-2003-02-0402; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Ogata A, 1997, J IMMUNOL, V159, P2212; Parra JL, 2005, J BIOL CHEM, V280, P37623, DOI 10.1074/jbc.M508356200; Paulin FEM, 1996, ONCOGENE, V13, P505; Pellagatti A, 2003, CANCER RES, V63, P3940; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Sharma S, 2008, CLIN CANCER RES, V14, P3262, DOI 10.1158/1078-0432.CCR-07-4153; Shi YJ, 2008, CANCER RES, V68, P10215, DOI 10.1158/0008-5472.CAN-08-1066; Suzuki A, 2005, ONCOGENE, V24, P6936, DOI 10.1038/sj.onc.1208844; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Topisirovic I, 2004, CANCER RES, V64, P8639, DOI 10.1158/0008-5472.CAN-04-2677; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Ueda T, 2010, P NATL ACAD SCI USA, V107, P13984, DOI 10.1073/pnas.1008136107; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wen XY, 1999, INT J ONCOL, V15, P173; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; Worch J, 2004, ONCOGENE, V23, P9162, DOI 10.1038/sj.onc.1208164; Yoshizawa A, 2010, CLIN CANCER RES, V16, P240, DOI 10.1158/1078-0432.CCR-09-0986	42	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94011	10.1371/journal.pone.0094011	http://dx.doi.org/10.1371/journal.pone.0094011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714040	gold, Green Published, Green Submitted			2022-12-25	WOS:000334160900070
J	Wang, X; Huang, Y; Niu, SB; Jiang, BG; Jia, N; van der Geest, L; Ni, XB; Sun, Y; Cao, WC				Wang, Xin; Huang, Yong; Niu, Si-bo; Jiang, Bao-Gui; Jia, Na; van der Geest, Leo; Ni, Xue-bing; Sun, Yi; Cao, Wu-Chun			Genetic Diversity of Salp15 in the Ixodes ricinus Complex (Acari: Ixodidae)	PLOS ONE			English	Article							TICK SALIVA IMMUNOSUPPRESSOR; LYME-DISEASE SPIROCHETE; RHIPICEPHALUS-APPENDICULATUS; ANTICOAGULANT PEPTIDE; BINDING-PROTEINS; GLAND PROTEIN; SENSU-LATO; IDENTIFICATION; VECTOR; IMMUNOGLOBULIN	Salp15, a 15-kDa tick salivary gland protein, is both essential for ticks to successfully obtain host blood and also facilitates transmission of Lyme borreliosis. To determine whether the Salp15 gene is expressed in Ixodes persulcatus and Ixodes sinensis, principle vectors of Lyme borreliosis in China, we studied transcriptions of this gene in semi-engorged larvae, nymph and adults of these two species. A total of eight Salp15 homologues, five in I. persulcatus and three in I. sinensis, were identified by reverse transcriptase-polymerase chain reaction (RT-PCR). Interestingly, the intra-species similarity of Salp15 is approximately equal to its interspecies similarity and more than one Salp15 protein is expressed in a certain tick developmental stage. Comparison of DNA and proteins with other available tick Salp15 homologues suggests that the Salp15 superfamily is genetically conserved and diverse in the Ixodes ricinus complex. These findings indicate that Salp15 proteins in the I. ricinus complex may play an essential role in interacting with the host immune system and transmission of Borrelia genospecies.	[Wang, Xin; Huang, Yong; Jiang, Bao-Gui; Jia, Na; Ni, Xue-bing; Sun, Yi; Cao, Wu-Chun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Wang, Xin; Sun, Yi] Wenzhou Ctr Dis Control & Prevent, Wenzhou, Peoples R China; [Niu, Si-bo] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China; [van der Geest, Leo] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Sect Populat Ecol, Amsterdam, Netherlands	Beijing Institute of Microbiology & Epidemiology; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; University of Amsterdam	Sun, Y (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	sunyi73@gmail.com	Jiang, Baogui/ABE-5439-2021	Yi, Sun/0000-0002-6871-6975	National Nature Foundation of P.R. China [30872196, 81271878]; Special Fund of the Ministry of Health of P. R. China [201202019]; National Critical Project for Science and Technology on Infectious Disease of P. R. China [2012ZX10004219]	National Nature Foundation of P.R. China(National Natural Science Foundation of China (NSFC)); Special Fund of the Ministry of Health of P. R. China; National Critical Project for Science and Technology on Infectious Disease of P. R. China	This work was supported by the National Nature Foundation of P.R. China (No. 30872196; 81271878); Special Fund of the Ministry of Health of P. R. China (Grant No. 201202019), National Critical Project for Science and Technology on Infectious Disease of P. R. China (Grant No. 2012ZX10004219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao OR, 2012, DM-DIS MON, V58, P335, DOI 10.1016/j.disamonth.2012.03.005; Anguita J, 2002, IMMUNITY, V16, P849, DOI 10.1016/S1074-7613(02)00325-4; BURGDORFER W, 1989, RHEUM DIS CLIN N AM, V15, P775; Cavassani KA, 2005, IMMUNOLOGY, V114, P235, DOI 10.1111/j.1365-2567.2004.02079.x; Dai JF, 2009, CELL HOST MICROBE, V6, P482, DOI 10.1016/j.chom.2009.10.006; Das S, 2001, J INFECT DIS, V184, P1056, DOI 10.1086/323351; Filippova N.A., 1991, P109; Garg R, 2006, J IMMUNOL, V177, P6579, DOI 10.4049/jimmunol.177.10.6579; Gillespie RD, 2001, J IMMUNOL, V166, P4319, DOI 10.4049/jimmunol.166.7.4319; Hannier S, 2004, IMMUNOLOGY, V113, P401, DOI 10.1111/j.1365-2567.2004.01975.x; Hao Q, 2011, J CLIN MICROBIOL, V49, P647, DOI 10.1128/JCM.00725-10; Hojgaard A, 2009, J MED ENTOMOL, V46, P1458, DOI 10.1603/033.046.0631; Hovius JW, 2008, J INFECT DIS, V198, P1189, DOI 10.1086/591917; Hovius JWR, 2007, VECTOR-BORNE ZOONOT, V7, P296, DOI 10.1089/vbz.2006.0624; Hovius JWR, 2008, PLOS MED, V5, P202, DOI 10.1371/journal.pmed.0050043; Hovius JWR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040031; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; JORDAN SP, 1990, BIOCHEMISTRY-US, V29, P11095, DOI 10.1021/bi00502a012; Juncadella IJ, 2007, FEMS IMMUNOL MED MIC, V49, P433, DOI 10.1111/j.1574-695X.2007.00223.x; Juncadella IJ, 2008, THESIS U MASS AMHERS; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu L, 2011, EMBO REP, V12, P1196, DOI 10.1038/embor.2011.177; Liu XQ, 2009, NUCLEIC ACIDS RES, V37, pW33, DOI 10.1093/nar/gkp428; Mori A, 2010, INSECT MOL BIOL, V19, P359, DOI 10.1111/j.1365-2583.2010.00994.x; Narasimhan S, 2004, P NATL ACAD SCI USA, V101, P1141, DOI 10.1073/pnas.0307669100; Nene V, 2004, INSECT BIOCHEM MOLEC, V34, P1117, DOI 10.1016/j.ibmb.2004.07.002; Oliver JH, 1996, J PARASITOL, V82, P926, DOI 10.2307/3284201; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ramamoorthi N, 2005, NATURE, V436, P573, DOI 10.1038/nature03812; Rechav Y, 2000, EXP APPL ACAROL, V24, P569, DOI 10.1023/A:1026531926109; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schuijt TJ, 2011, TRENDS PARASITOL, V27, P40, DOI 10.1016/j.pt.2010.06.006; Schuijt TJ, 2008, INFECT IMMUN, V76, P2888, DOI 10.1128/IAI.00232-08; Schwarz RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015788; Sun Y, 2003, VECTOR-BORNE ZOONOT, V3, P39, DOI 10.1089/153036603765627442; Titus RG, 2006, PARASITE IMMUNOL, V28, P131, DOI 10.1111/j.1365-3024.2006.00807.x; Tyson K, 2007, INSECT MOL BIOL, V16, P469, DOI 10.1111/j.1365-2583.2007.00742.x; Valenzuela JG, 2000, J BIOL CHEM, V275, P18717, DOI 10.1074/jbc.M001486200; Wang GQ, 1999, CLIN MICROBIOL REV, V12, P633, DOI 10.1128/CMR.12.4.633; WANG H, 1994, PARASITOLOGY, V109, P525, DOI 10.1017/S0031182000080781; WANG H, 1995, PARASITOLOGY, V111, P161, DOI 10.1017/S0031182000064908; WAXMAN L, 1990, SCIENCE, V248, P593, DOI 10.1126/science.2333510; Wu J, 2006, PROTEINS, V65, P808, DOI 10.1002/prot.21218; Xu G, 2003, J PARASITOL, V89, P452, DOI 10.1645/0022-3395(2003)089[0452:MPAITT]2.0.CO;2	44	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94131	10.1371/journal.pone.0094131	http://dx.doi.org/10.1371/journal.pone.0094131			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714063	gold, Green Published, Green Submitted			2022-12-25	WOS:000334160900091
J	Shentu, XP; Liu, WP; Zhan, XH; Xu, YP; Xu, JF; Yu, XP; Zhang, CX				Shentu, Xu-Ping; Liu, Wei-Ping; Zhan, Xiao-Huan; Xu, Yi-Peng; Xu, Jian-Feng; Yu, Xiao-Ping; Zhang, Chuan-Xi			Transcriptome Sequencing and Gene Expression Analysis of Trichoderma brevicompactum under Different Culture Conditions	PLOS ONE			English	Article							TRICHOTHECENE BIOSYNTHESIS; FUSARIUM; MYCOTOXINS; EVOLUTION; CLUSTER; GENOME	Background: Trichoderma brevicompactum is the Trichoderma species producing simple trichothecenes-trichodermin, a potential antifungal antibiotic and a protein synthesis inhibitor. However, the biosynthetic pathway of trichodermin in Trichoderma is not completely clarified. Therefore, transcriptome and gene expression profiling data for this species are needed as an important resource to better understand the mechanism of the trichodermin biosynthesis and provide a blueprint for further study of T. brevicompactum. Results: In this study, de novo assembly of the T. brevicompactum transcriptome using the short-read sequencing technology (Illumina) was performed. In addition, two digital gene expression (DGE) libraries of T. brevicompactum under the trichodermin-producing and trichodermin-nonproducing culture conditions, respectively, were constructed to identify the differences in gene expression. A total of 23,351 unique transcripts with a mean length of 856 bp were obtained by a new Trinity de novo assembler. The variations of the gene expression under different culture conditions were also identified. The expression profiling data revealed that 3,282 unique transcripts had a significantly differential expression under the trichodermin-producing condition, as compared to the trichodermin-nonproducing condition. This study provides a large amount of transcript sequence data that will contribute to the study of the trichodermin biosynthesis in T. brevicompactum. Furthermore, quantitative real-time PCR (qRT-PCR) was found to be useful to confirm the differential expression of the unique transcripts. Conclusion: Our study provides considerable gene expression information of T. brevicompactum at the transcriptional level, which will help accelerate the research on the trichodermin biosynthesis. Additionally, we have demonstrated the feasibility of using the Illumina sequencing based DGE system for gene expression profiling, and have shed new light on functional studies of the genes involved in T. brevicompactum biosynthesis.	[Shentu, Xu-Ping; Liu, Wei-Ping; Zhan, Xiao-Huan; Xu, Yi-Peng; Yu, Xiao-Ping] China Jiliang Univ, Coll Life Sci, Zhejiang Prov Key Lab Biometrol & Inspect & Quara, Hangzhou, Zhejiang, Peoples R China; [Shentu, Xu-Ping; Zhang, Chuan-Xi] Zhejiang Univ, Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Jian-Feng] Arkansas State Univ, Arkansas Biosci Inst, Jonesboro, AR USA; [Xu, Jian-Feng] Arkansas State Univ, Coll Agr, Jonesboro, AR USA	China Jiliang University; Zhejiang University; Arkansas State University; Arkansas State University	Yu, XP (corresponding author), China Jiliang Univ, Coll Life Sci, Zhejiang Prov Key Lab Biometrol & Inspect & Quara, Hangzhou, Zhejiang, Peoples R China.	yuxiaoping19630306@163.com; chxzhang@zju.edu.cn	Liu, Weiping/E-9208-2010; Zhang, Chuan-Xi/K-7978-2019	Liu, Weiping/0000-0002-1173-892X; Zhang, Chuan-Xi/0000-0002-7784-1188	National Basic Research Development Program of China [2011CB111602]; National Natural Science Foundation of China [31171860]; Zhejiang Province Natural Science Foundation [LY12C14012]; Zhejiang Province Programs for Science and Technology Development [2010C32063, 2013C32008]; Office Of The Director [1003970] Funding Source: National Science Foundation	National Basic Research Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang Province Programs for Science and Technology Development; Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by the National Basic Research Development Program of China (2011CB111602), the National Natural Science Foundation of China (31171860), the Zhejiang Province Natural Science Foundation (LY12C14012) and the Zhejiang Province Programs for Science and Technology Development (2010C32063, 2013C32008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Benjamini Y, 2001, ANN STAT, V29, P1165; Beremand M.N., 1992, HDB APPL MYCOLOGY, V5, P360; Brown DW, 2004, FUNGAL GENET BIOL, V41, P454, DOI 10.1016/j.fgb.2003.12.002; Cardoza RE, 2011, APPL ENVIRON MICROB, V77, P4867, DOI 10.1128/AEM.00595-11; Cardoza RE, 2007, FUNGAL GENET BIOL, V44, P269, DOI 10.1016/j.fgb.2006.11.013; CARRASCO L, 1973, BIOCHIM BIOPHYS ACTA, V312, P368, DOI 10.1016/0005-2787(73)90381-X; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Degenkolb T, 2008, MYCOL PROG, V7, P177, DOI 10.1007/s11557-008-0563-3; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grove J F, 2007, Fortschr Chem Org Naturst, V88, P63, DOI 10.1007/978-3-211-49389-2_2; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kimura M, 2007, BIOSCI BIOTECH BIOCH, V71, P2105, DOI 10.1271/bbb.70183; Kraus GF, 2004, MYCOLOGIA, V96, P1059, DOI 10.2307/3762089; Kubicek CP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r40; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Nielsen KF, 2005, J AGR FOOD CHEM, V53, P8190, DOI 10.1021/jf051279b; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Rubio MB, 2009, FUNGAL GENET BIOL, V46, P17, DOI 10.1016/j.fgb.2008.10.008; [申屠旭萍 SHENTU Xuping], 2008, [中国药学杂志, Chinese Pharmaceutical Journal], V43, P1755; TATE WP, 1973, J BIOL CHEM, V248, P7970; Tijerino A, 2011, FUNGAL GENET BIOL, V48, P285, DOI 10.1016/j.fgb.2010.11.012; UENO Y, 1984, FUND APPL TOXICOL, V4, pS124, DOI 10.1016/0272-0590(84)90144-1; UENO Y, 1985, CRC CR REV TOXICOL, V14, P99, DOI 10.3109/10408448509089851; Vogel JP, 2006, THEOR APPL GENET, V113, P186, DOI 10.1007/s00122-006-0285-3; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Ward TJ, 2002, P NATL ACAD SCI USA, V99, P9278, DOI 10.1073/pnas.142307199; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233	31	13	15	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94203	10.1371/journal.pone.0094203	http://dx.doi.org/10.1371/journal.pone.0094203			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710600	Green Published, gold, Green Submitted			2022-12-25	WOS:000334159800117
J	Cakebread, JA; Haitchi, HM; Xu, YH; Holgate, ST; Roberts, G; Davies, DE				Cakebread, Julie A.; Haitchi, Hans Michael; Xu, Yunhe; Holgate, Stephen T.; Roberts, Graham; Davies, Donna E.			Rhinovirus-16 Induced Release of IP-10 and IL-8 Is Augmented by Th2 Cytokines in a Pediatric Bronchial Epithelial Cell Model	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE; ASTHMA; EXPRESSION; INFECTION; EXACERBATIONS; RECEPTOR; INNATE; ICAM-1; SUPPRESSION; INHIBITION	Background: In response to viral infection, bronchial epithelial cells increase inflammatory cytokine release to activate the immune response and curtail viral replication. In atopic asthma, enhanced expression of Th2 cytokines is observed and we postulated that Th2 cytokines may augment the effects of rhinovirus-induced inflammation. Methods: Primary bronchial epithelial cell cultures from pediatric subjects were treated with Th2 cytokines for 24 h before infection with RV16. Release of IL-8, IP-10 and GM-CSF was measured by ELISA. Infection was quantified using RTqPCR and TCID50. Phosphatidyl inositol 3-kinase (PI3K) and P38 mitogen activated protein kinase (MAPK) inhibitors and dexamethasone were used to investigate differences in signaling pathways. Results: The presence of Th2 cytokines did not affect RV replication or viral titre, yet there was a synergistic increase in IP-10 release from virally infected cells in the presence of Th2 cytokines. Release of IL-8 and GM-CSF was also augmented. IP-10 release was blocked by a PI3K inhibitor and IL-8 by dexamethasone. Conclusion: Th2 cytokines increase release of inflammatory cytokines in the presence of rhinovirus infection. This increase is independent of effects of virus replication. Inhibition of the PI3K pathway inhibits IP-10 expression.	[Cakebread, Julie A.; Haitchi, Hans Michael; Xu, Yunhe; Holgate, Stephen T.; Roberts, Graham; Davies, Donna E.] Univ Southampton, Southampton Univ Hosp, Fac Med, Acad Unit Clin & Expt Sci, Southampton, Hants, England; [Holgate, Stephen T.; Roberts, Graham; Davies, Donna E.] Southampton Univ Hosp, NIHR Resp Biomed Res Unit, Southampton, Hants, England	University of Southampton; University of Southampton	Cakebread, JA (corresponding author), Ruakura Res Ctr, Hamilton, New Zealand.	Julie.Cakebread@agresearch.co.nz	Davies, Donna E/H-2993-2012	Davies, Donna/0000-0002-5117-2991; Roberts, Graham/0000-0003-2252-1248; Haitchi, Hans Michael/0000-0001-8603-302X; Cakebread, Julie/0000-0001-5937-6705	Asthma UK; Medical Research Council (UK) [G0501506]; Asthma, Allergy & Inflammation Research Charity; Medical Research Council [G0802804, G0501506, G0900453] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10021] Funding Source: researchfish; Asthma UK [06/053, 10/060] Funding Source: researchfish; MRC [G0900453, G0802804, G0501506] Funding Source: UKRI	Asthma UK; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Asthma, Allergy & Inflammation Research Charity; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Asthma UK, (http://www.asthma.org.uk/) a Medical Research Council (UK) grant (G0501506)(http://www.mrc.ac.uk/index.htm) and the Asthma, Allergy & Inflammation Research Charity (http://www.aaircharity.org/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andrews AL, 2006, J ALLERGY CLIN IMMUN, V118, P858, DOI 10.1016/j.jaci.2006.06.041; Bianco A, 1998, EUR RESPIR J, V12, P619, DOI 10.1183/09031936.98.12030619; Bossios A, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-114; Brightling CE, 2002, J ALLERGY CLIN IMMUN, V110, P899, DOI 10.1067/mai.2002.129698; Bucchieri F, 2002, AM J RESP CELL MOL, V27, P179, DOI 10.1165/ajrcmb.27.2.4699; Bulek K, 2010, IMMUNOL CELL BIOL, V88, P257, DOI 10.1038/icb.2009.113; Chang MMJ, 2001, AM J PHYSIOL-LUNG C, V280, pL107, DOI 10.1152/ajplung.2001.280.1.L107; Edwards MR, 2006, AM J RESP CELL MOL, V34, P616, DOI 10.1165/rcmb.2005-0385OC; Gern JE, 2000, AM J RESP CRIT CARE, V162, P2226, DOI 10.1164/ajrccm.162.6.2003019; Green RM, 2002, BMJ-BRIT MED J, V324, P763, DOI 10.1136/bmj.324.7340.763; Griego SD, 2000, J IMMUNOL, V165, P5211, DOI 10.4049/jimmunol.165.9.5211; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hollams EM, 2009, J ALLERGY CLIN IMMUN, V124, P463, DOI 10.1016/j.jaci.2009.06.019; Hu LM, 2000, CLIN CANCER RES, V6, P880; HURD SZ, 1991, J ALLERGY CLIN IMMUN, V88, P808; Jackson DJ, 2010, J ALLERGY CLIN IMMUN, V125, P1178, DOI 10.1016/j.jaci.2010.04.021; Jakiela B, 2008, AM J RESP CELL MOL, V38, P517, DOI 10.1165/rcmb.2007-0050OC; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Korpi-Steiner NL, 2010, CLIN EXP ALLERGY, V40, P1203, DOI 10.1111/j.1365-2222.2010.03546.x; Kumar S, 1999, BIOCHEM BIOPH RES CO, V263, P825, DOI 10.1006/bbrc.1999.1454; Lachowicz-Scroggins ME, 2010, AM J RESP CELL MOL, V43, P652, DOI 10.1165/rcmb.2009-0244OC; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Lordan JL, 2002, J IMMUNOL, V169, P407, DOI 10.4049/jimmunol.169.1.407; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Papi A, 1999, J BIOL CHEM, V274, P9707, DOI 10.1074/jbc.274.14.9707; Papi A, 1997, CLIN EXP ALLERGY, V27, P721, DOI 10.1046/j.1365-2222.1997.00090.x; Parry DE, 2000, J ALLERGY CLIN IMMUN, V105, P692, DOI 10.1067/mai.2000.104785; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Robinson DS, 2000, BRIT MED BULL, V56, P956, DOI 10.1258/0007142001903625; Skevaki CL, 2009, CLIN EXP ALLERGY, V39, P1700, DOI 10.1111/j.1365-2222.2009.03307.x; Sly PD, 2008, LANCET, V372, P1100, DOI 10.1016/S0140-6736(08)61451-8; Stern DA, 2008, LANCET, V372, P1058, DOI 10.1016/S0140-6736(08)61447-6; Striz I, 1999, AM J PHYSIOL-LUNG C, V277, pL58, DOI 10.1152/ajplung.1999.277.1.L58; SUBAUSTE MC, 1995, J CLIN INVEST, V96, P549, DOI 10.1172/JCI118067; Subrata LS, 2009, J IMMUNOL, V183, P2793, DOI 10.4049/jimmunol.0900695; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Wark PAB, 2007, J ALLERGY CLIN IMMUN, V120, P586, DOI 10.1016/j.jaci.2007.04.046; Wood LG, 2011, RESPIROLOGY, V16, P291, DOI 10.1111/j.1440-1843.2010.01897.x; Xatzipsalti M, 2008, CLIN EXP ALLERGY, V38, P466, DOI 10.1111/j.1365-2222.2007.02906.x	41	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94010	10.1371/journal.pone.0094010	http://dx.doi.org/10.1371/journal.pone.0094010			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705919	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000334107500110
J	Chouchani, ET; Methner, C; Buonincontri, G; Hu, CH; Logan, A; Sawiak, SJ; Murphy, MP; Krieg, T				Chouchani, Edward T.; Methner, Carmen; Buonincontri, Guido; Hu, Chou-Hui; Logan, Angela; Sawiak, Stephen J.; Murphy, Michael P.; Krieg, Thomas			Complex I Deficiency Due to Selective Loss of Ndufs4 in the Mouse Heart Results in Severe Hypertrophic Cardiomyopathy	PLOS ONE			English	Article							MITOCHONDRIA; CARDIOPROTECTION; MICE; MYOCARDIUM; METABOLISM; REDUCTION; RADICALS; SUBUNIT; SWITCH; PORE	Mitochondrial complex I, the primary entry point for electrons into the mitochondrial respiratory chain, is both critical for aerobic respiration and a major source of reactive oxygen species. In the heart, chronic dysfunction driving cardiomyopathy is frequently associated with decreased complex I activity, from both genetic and environmental causes. To examine the functional relationship between complex I disruption and cardiac dysfunction we used an established mouse model of mild and chronic complex I inhibition through heart-specific Ndufs4 gene ablation. Heart-specific Ndufs4-null mice had a decrease of similar to 50% in complex I activity within the heart, and developed severe hypertrophic cardiomyopathy as assessed by magnetic resonance imaging. The decrease in complex I activity, and associated cardiac dysfunction, occurred absent an increase in mitochondrial hydrogen peroxide levels in vivo, accumulation of markers of oxidative damage, induction of apoptosis, or tissue fibrosis. Taken together, these results indicate that diminished complex I activity in the heart alone is sufficient to drive hypertrophic cardiomyopathy independently of alterations in levels of mitochondrial hydrogen peroxide or oxidative damage.	[Chouchani, Edward T.; Methner, Carmen; Hu, Chou-Hui; Krieg, Thomas] Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England; [Chouchani, Edward T.; Logan, Angela; Murphy, Michael P.] MRC, Mitochondrial Biol Unit, Cambridge, England; [Buonincontri, Guido; Sawiak, Stephen J.] Univ Cambridge, Wolfson Brain Imaging Ctr, Cambridge CB2 1TN, England	University of Cambridge; University of Cambridge	Krieg, T (corresponding author), Univ Cambridge, Dept Med, Cambridge CB2 2QQ, England.	tk382@medschl.cam.ac.uk	Murphy, Michael P/C-2120-2009; Chouchani, Edward T./HCH-3775-2022; Sawiak, Stephen J/I-8944-2012; Buonincontri, Guido/L-5207-2017	Murphy, Michael P/0000-0003-1115-9618; Sawiak, Stephen J/0000-0003-4210-9816; Krieg, Thomas/0000-0002-5192-580X; Buonincontri, Guido/0000-0002-8386-639X; Chouchani, Edward/0000-0002-9203-8094	International Society for Heart Research (ISHRES/SERVIER research fellowship); Gates Cambridge Trust; Canadian Institutes of Health Research; UK Medical Research Council; British Heart Foundation [PG/12/42/29655]; Medical Research Council [MC_U105663142] Funding Source: researchfish; MRC [MC_U105663142] Funding Source: UKRI	International Society for Heart Research (ISHRES/SERVIER research fellowship); Gates Cambridge Trust; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the International Society for Heart Research (ISHRES/SERVIER research fellowship to C.M, the Gates Cambridge Trust and the Canadian Institutes of Health Research (doctoral scholarship and postdoctoral fellowship to E.T.C.), the UK Medical Research Council (E.T.C.,G.B., M.P.M. and A.L.), and the British Heart Foundation (PG/12/42/29655 to T.K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benit P, 2003, HUM MUTAT, V21, P582, DOI 10.1002/humu.10225; Blinova K, 2008, BIOCHEMISTRY-US, V47, P9636, DOI 10.1021/bi800307y; Bridges HR, 2011, BIOCHEM SOC T, V39, P799, DOI 10.1042/BST0390799; Bugiani M, 2004, BBA-BIOENERGETICS, V1659, P136, DOI 10.1016/j.bbabio.2004.09.006; Buonincontri G, 2013, J MAGN RESON IMAGING, V38, P468, DOI 10.1002/jmri.24001; Burwell LS, 2009, J MOL CELL CARDIOL, V46, P804, DOI 10.1016/j.yjmcc.2009.02.026; CHANCE B, 1961, J BIOL CHEM, V236, P1534; Chappell J. B., 1972, SUBCELLULAR COMPONEN, P77; Chen L, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003012; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Cocheme HM, 2011, CELL METAB, V13, P340, DOI 10.1016/j.cmet.2011.02.003; Di Lisa F, 1998, BBA-BIOENERGETICS, V1366, P69, DOI 10.1016/S0005-2728(98)00121-2; Fassone E, 2011, J MED GENET, V48, P691, DOI 10.1136/jmedgenet-2011-100340; Halestrap A, 2005, NATURE, V434, P578, DOI 10.1038/434578a; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100; Heiberg Einar, 2010, BMC Med Imaging, V10, P1, DOI 10.1186/1471-2342-10-1; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Ide T, 1999, CIRC RES, V85, P357, DOI 10.1161/01.RES.85.4.357; Ingraham CA, 2009, MITOCHONDRION, V9, P204, DOI 10.1016/j.mito.2009.02.001; Jung C, 2008, CARDIOVASC RES, V77, P766, DOI 10.1093/cvr/cvm089; Ke BX, 2012, P NATL ACAD SCI USA, V109, P6165, DOI 10.1073/pnas.1113987109; King MS, 2009, BIOCHEMISTRY-US, V48, P2053, DOI 10.1021/bi802282h; Kruse SE, 2008, CELL METAB, V7, P312, DOI 10.1016/j.cmet.2008.02.004; Marin-Garcia J, 2004, J CARD FAIL, V10, P55, DOI 10.1016/S1071-9164(03)00129-5; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Noureldin RA, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-17; Petruzzella V, 2001, HUM MOL GENET, V10, P529, DOI 10.1093/hmg/10.5.529; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; Quintana A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042904; Russell LK, 2005, J MOL CELL CARDIOL, V38, P81, DOI 10.1016/j.yjmcc.2004.10.010; Sterky FH, 2012, HUM MOL GENET, V21, P1078, DOI 10.1093/hmg/ddr537	32	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94157	10.1371/journal.pone.0094157	http://dx.doi.org/10.1371/journal.pone.0094157			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705922	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500129
J	Cote, IM; Darling, ES; Malpica-Cruz, L; Smith, NS; Green, SJ; Curtis-Quick, J; Layman, C				Cote, Isabelle M.; Darling, Emily S.; Malpica-Cruz, Luis; Smith, Nicola S.; Green, Stephanie J.; Curtis-Quick, Jocelyn; Layman, Craig			What Doesn't Kill You Makes You Wary? Effect of Repeated Culling on the Behaviour of an Invasive Predator	PLOS ONE			English	Article							FLIGHT INITIATION DISTANCE; INDO-PACIFIC LIONFISH; CORAL-REEFS; FISH; COMMUNITIES; COMPLEXITY; TRAITS; SIZE	As a result of being hunted, animals often alter their behaviour in ways that make future encounters with predators less likely. When hunting is carried out for conservation, for example to control invasive species, these behavioural changes can inadvertently impede the success of future efforts. We examined the effects of repeated culling by spearing on the behaviour of invasive predatory lionfish (Pterois volitans/miles) on Bahamian coral reef patches. We compared the extent of concealment and activity levels of lionfish at dawn and midday on 16 coral reef patches off Eleuthera, The Bahamas. Eight of the patches had been subjected to regular daytime removals of lionfish by spearing for two years. We also estimated the distance at which lionfish became alert to slowly approaching divers on culled and unculled reef patches. Lionfish on culled reefs were less active and hid deeper within the reef during the day than lionfish on patches where no culling had occurred. There were no differences at dawn when removals do not take place. Lionfish on culled reefs also adopted an alert posture at a greater distance from divers than lionfish on unculled reefs. More crepuscular activity likely leads to greater encounter rates by lionfish with more native fish species because the abundance of reef fish outside of shelters typically peaks at dawn and dusk. Hiding deeper within the reef could also make remaining lionfish less likely to be encountered and more difficult to catch by spearfishers during culling efforts. Shifts in the behaviour of hunted invasive animals might be common and they have implications both for the impact of invasive species and for the design and success of invasive control programs.	[Cote, Isabelle M.; Darling, Emily S.; Malpica-Cruz, Luis; Smith, Nicola S.; Green, Stephanie J.] Simon Fraser Univ, Dept Biol Sci, Earth Oceans Res Grp, Burnaby, BC V5A 1S6, Canada; [Smith, Nicola S.] Marine Resources & Local Govt, Dept Marine Resources, Minist Agr, Nassau, Bahamas; [Curtis-Quick, Jocelyn] Cape Eleuthera Inst, Rock Sound, Eleuthera, Bahamas; [Layman, Craig] N Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA	Simon Fraser University; University of North Carolina; North Carolina State University	Cote, IM (corresponding author), Simon Fraser Univ, Dept Biol Sci, Earth Oceans Res Grp, Burnaby, BC V5A 1S6, Canada.	imcote@sfu.ca	Cote, Isabelle/ABD-5898-2021; Malpica-Cruz, Luis/E-3298-2016; Green, Stephanie/AGE-1160-2022	Malpica-Cruz, Luis/0000-0003-0750-1652; Darling, Emily/0000-0002-1048-2838; Green, Stephanie/0000-0003-4705-7859; Smith, Nicola/0000-0002-1569-7790	Global Environment Facility/United Nations Environment Programme grant; Natural Sciences and Engineering Research Council of Canada Discovery grant; CONACyT scholarship from Mexico; NSERC Canada Graduate Fellowship; NOAA Coral Reef Conservation Grant; Carrow Foundation; Stone Family Foundation	Global Environment Facility/United Nations Environment Programme grant; Natural Sciences and Engineering Research Council of Canada Discovery grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); CONACyT scholarship from Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NSERC Canada Graduate Fellowship; NOAA Coral Reef Conservation Grant; Carrow Foundation; Stone Family Foundation	This research was supported by a Global Environment Facility/United Nations Environment Programme grant to the government of The Bahamas through the MTIASIC project (NSS), and a Natural Sciences and Engineering Research Council of Canada Discovery grant to IMC. LMC was supported by CONACyT scholarship from Mexico, SJG by an NSERC Canada Graduate Fellowship and NOAA Coral Reef Conservation Grant. Support to JCQ was provided by the Carrow Foundation and Stone Family Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins L, 2012, INVASIVE LIONFISH GU, P24; Alos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048030; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Biro PA, 2008, P NATL ACAD SCI USA, V105, P2919, DOI 10.1073/pnas.0708159105; Brook LA, 2012, J APPL ECOL, V49, P1278, DOI 10.1111/j.1365-2664.2012.02207.x; Brown GE, 2003, FISH FISH, V4, P227, DOI 10.1046/j.1467-2979.2003.00132.x; Brown Grant E., 2005, P34; Bshary R, 2002, ANIM COGN, V5, P1, DOI 10.1007/s10071-001-0116-5; Campbell K, 2005, CONSERV BIOL, V19, P1362, DOI 10.1111/j.1523-1739.2005.00228.x; Caro TM, 1999, BIOL CONSERV, V91, P91, DOI 10.1016/S0006-3207(99)00033-6; Casas F, 2009, ANIM CONSERV, V12, P346, DOI 10.1111/j.1469-1795.2009.00259.x; Ciuti S, 2012, P ROY SOC B-BIOL SCI, V279, P4407, DOI 10.1098/rspb.2012.1483; Cote IM, 2013, HDB METAANALYSIS ECO, P37; Cote IM, 2010, MAR ECOL PROG SER, V404, P219, DOI 10.3354/meps08458; Cruz F, 2005, BIOL CONSERV, V121, P473, DOI 10.1016/j.biocon.2004.05.018; Cure K, 2012, MAR ECOL PROG SER, V467, P181, DOI 10.3354/meps09942; Dill LM, 2003, ECOLOGY, V84, P1151, DOI 10.1890/0012-9658(2003)084[1151:BMIIIM]2.0.CO;2; Feary DA, 2011, CONSERV BIOL, V25, P341, DOI 10.1111/j.1523-1739.2010.01613.x; GALZIN R, 1987, MAR ECOL PROG SER, V41, P137, DOI 10.3354/meps041137; Gotanda KM, 2009, BEHAV ECOL SOCIOBIOL, V63, P1563, DOI 10.1007/s00265-009-0750-5; Green SJ, 2013, CORAL REEFS, V32, P413, DOI 10.1007/s00338-012-0987-8; Green SJ, 2014, ECOLOGICAL IN PRESS; GREEN SJ, 2011, MAR ECOL PROG SER, V433, P159, DOI DOI 10.3354/meps09208; Green SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032596; Guidetti P, 2008, J MAR BIOL ASSOC UK, V88, P625, DOI 10.1017/S0025315408000933; Helfman G.S., 1993, BEHAV TELEOST FISHES, V2, P479; HOBSON ES, 1972, FISH BULL NATL OC AT, V70, P715; Holway DA, 1999, TRENDS ECOL EVOL, V14, P328, DOI 10.1016/S0169-5347(99)01636-5; Januchowski-Hartley FA, 2012, MAR ECOL PROG SER, V469, P113, DOI 10.3354/meps09971; Januchowski-Hartley FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022761; Jud ZR, 2012, J EXP MAR BIOL ECOL, V414, P69, DOI 10.1016/j.jembe.2012.01.015; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Sutherland WJ, 2010, TRENDS ECOL EVOL, V25, P1, DOI 10.1016/j.tree.2009.10.003; Taylor AR, 2003, WILDLIFE SOC B, V31, P1263; Uusi-Heikkila S, 2008, TRENDS ECOL EVOL, V23, P419, DOI 10.1016/j.tree.2008.04.006; Warburton K, 2003, FISH FISH, V4, P203, DOI 10.1046/j.1467-2979.2003.00125.x	36	55	58	1	160	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94248	10.1371/journal.pone.0094248	http://dx.doi.org/10.1371/journal.pone.0094248			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705447	Green Submitted, Green Published, gold			2022-12-25	WOS:000334107500137
J	Huysentruyt, K; Alliet, P; Raes, M; Willekens, J; De Schutter, I; De Wachter, E; Malfroot, A; Devreker, T; Goyens, P; Vandenplas, Y; De Schepper, J				Huysentruyt, Koen; Alliet, Philippe; Raes, Marc; Willekens, Julie; De Schutter, Iris; De Wachter, Elke; Malfroot, Anne; Devreker, Thierry; Goyens, Philippe; Vandenplas, Yvan; De Schepper, Jean			Nutritional Status of Children Hospitalized for Parapneumonic Effusion	PLOS ONE			English	Article							RISK-FACTORS; EMPYEMA; PNEUMONIA; MALNUTRITION; ADMISSIONS; MANAGEMENT; BACTERIAL; OUTCOMES	Background & Aims: Among children hospitalized for pneumonia, those with parapneumonic effusion (PPE) are at particular risk for nutritional deterioration. This study aimed to 1) investigate the evolution of the nutritional status during hospitalization and at outpatient follow-up; 2) determine clinical risk factors for weight loss during hospitalization; 3) describe the nutritional interventions for these children. Methods: Retrospective chart review (January `07 - September `12) of 56 children with pneumonia, complicated by PPE in two Belgian hospitals for data on body weight and height at admission (t(0)) and discharge (t(1)), and two weeks (t(2)) and one month (t(3)) after discharge. Length of hospitalization (LoS), length of stay in paediatric intensive care (LoS(PICU)) and maximal in-hospital weight loss (t(max)) were calculated and nutritional interventions were recorded. Results: The median (range) age was 3.5 (1.0-14.8) years. Weight or height was lacking in five (8.9%) children at t(0) and in 28 (50%) at t(1); 21.4% was weighed only once during hospitalization. At t(max), respectively 17/44 and 5/44 children lost >= 5% and >= 10% of their weight. Median (range) LoS and LoS(PICU) were 18.0 (10-41) and 4.0 (0-23) days. One-fourth received a nutritional intervention. Weight for height at admission (WFH(t(0))) significantly predicted maximal weight loss (beta (95% CI) = -0.34 (-2.0--0.1); p = 0.03). At t(2) and t(3), 13/32 and 5/22 of the children with available follow-up data did not reach WFH(t(0)), whilst in 4/35 and 5/26 body weight remained >= 5% under the weight(t(0)). Conclusions: One-third of children with pneumonia complicated by PPE and monitored for weight and height, lost >= 5% of their body weight during hospitalization. One-fourth did not reach initial WFH one month after discharge. Those with a higher WFH at admission were at higher risk of weight loss. More attention for monitoring of weight loss and the nutritional policy during and after hospitalization is warranted.	[Huysentruyt, Koen] VUB, Univ Ziekenhuis Brussel, Dept Paediat, Brussels, Belgium; [Alliet, Philippe; Raes, Marc] Jessa Hosp, Dept Paediat, Hasselt, Belgium; [Willekens, Julie; De Schutter, Iris; De Wachter, Elke; Malfroot, Anne] VUB, Univ Ziekenhuis Brussel, Cyst Fibrosis Clin & Paediat Infect Dis, Dept Paediat Pulmonol, Brussels, Belgium; [Devreker, Thierry; Vandenplas, Yvan] VUB, Univ Ziekenhuis Brussel, Dept Paediat Gastroenterol, Brussels, Belgium; [Goyens, Philippe] Univ Childrens Hosp Queen Fabiola, Dept Paediat, Nutr & Metab Unit, Brussels, Belgium; [De Schepper, Jean] VUB, Univ Ziekenhuis Brussel, Dept Paediat Endocrinol, Brussels, Belgium	University Hospital Brussels; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel; University Hospital Brussels; Vrije Universiteit Brussel	De Schepper, J (corresponding author), VUB, Univ Ziekenhuis Brussel, Dept Paediat Endocrinol, Brussels, Belgium.	Jean.Deschepper@uzbrussel.be						Byington CL, 2002, CLIN INFECT DIS, V34, P434, DOI 10.1086/338460; Caksen H, 2003, J EMERG MED, V24, P474, DOI 10.1016/S0736-4679(03)00051-9; Chalmers JD, 2009, THORAX, V64, P592, DOI 10.1136/thx.2008.105080; Cirino Luís Marcelo Inaco, 2004, Sao Paulo Med. J., V122, P269, DOI 10.1590/S1516-31802004000600008; Clark JE, 2007, ARCH DIS CHILD, V92, P394, DOI 10.1136/adc.2006.097402; Cohen E, 2012, ARCH PEDIAT ADOL MED, V166, P999, DOI 10.1001/archpediatrics.2012.1055; Flood RG, 2008, PEDIATR INFECT DIS J, V27, P95, DOI 10.1097/INF.0b013e318157aced; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Grijalva CG, 2010, CLIN INFECT DIS, V50, P805, DOI 10.1086/650573; HARTMAN C, 2012, CLIN NUTR S, V7, P191; Huysentruyt K, 2013, ACTA PAEDIATR, V102, pE460, DOI 10.1111/apa.12344; Islam S, 2012, J PEDIATR SURG, V47, P2101, DOI 10.1016/j.jpedsurg.2012.07.047; Joosten KFM, 2008, CURR OPIN PEDIATR, V20, P590, DOI 10.1097/MOP.0b013e32830c6ede; Koshy E, 2010, THORAX, V65, P770, DOI 10.1136/thx.2010.137802; Nair H, 2013, LANCET, V381, P1380, DOI 10.1016/S0140-6736(12)61901-1; NWILOH J, 1989, J NATL MED ASSOC, V81, P525; O'Connor J, 2004, J PAEDIATR CHILD H, V40, P295, DOI 10.1111/j.1440-1754.2004.00367.x; Paraskakis E, 2012, CURR MED RES OPIN, V28, P1179, DOI 10.1185/03007995.2012.684674; Proesmans M, 2009, EUR J PEDIATR, V168, P639, DOI 10.1007/s00431-009-0929-9; Rocha Geila A., 2006, J. Pediatr. (Rio J.), V82, P70, DOI 10.2223/JPED.1440; Roelants M, 2009, ANN HUM BIOL, V36, P680, DOI 10.3109/03014460903049074; Sermet-Gaudelus I, 2000, AM J CLIN NUTR, V72, P64; Shouman B, 2012, EUR J PEDIATR, V171, P811, DOI 10.1007/s00431-011-1619-y; TAN TQ, 2002, PEDIATRICS, V110, pNIL81; van Wayenburg CAM, 2010, J PRIM HEALTH CARE, V2, P16, DOI 10.1071/HC10016; World Health Organization, 1999, MAN SEV MALN MAN PHY	26	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94242	10.1371/journal.pone.0094242	http://dx.doi.org/10.1371/journal.pone.0094242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705414	Green Published, Green Submitted, gold			2022-12-25	WOS:000334107500136
J	Kamali, M; Marek, PE; Peery, A; Antonio-Nkondjio, C; Ndo, C; Tu, ZJ; Simard, F; Sharakhov, IV				Kamali, Maryam; Marek, Paul E.; Peery, Ashley; Antonio-Nkondjio, Christophe; Ndo, Cyrille; Tu, Zhijian; Simard, Frederic; Sharakhov, Igor V.			Multigene Phylogenetics Reveals Temporal Diversification of Major African Malaria Vectors	PLOS ONE			English	Article							ANOPHELES-NILI GROUP; MOLECULAR-IDENTIFICATION; POPULATION-GENETICS; CYTOGENETIC MAP; GENOME SEQUENCE; GAMBIAE; CULICIDAE; DIPTERA; DIFFERENTIATION; DIVERGENCE	The major vectors of malaria in sub-Saharan Africa belong to subgenus Cellia. Yet, phylogenetic relationships and temporal diversification among African mosquito species have not been unambiguously determined. Knowledge about vector evolutionary history is crucial for correct interpretation of genetic changes identified through comparative genomics analyses. In this study, we estimated a molecular phylogeny using 49 gene sequences for the African malaria vectors An. gambiae, An. funestus, An. nili, the Asian malaria mosquito An. stephensi, and the outgroup species Culex quinquefasciatus and Aedes aegypti. To infer the phylogeny, we identified orthologous sequences uniformly distributed approximately every 5 Mb in the five chromosomal arms. The sequences were aligned and the phylogenetic trees were inferred using maximum likelihood and neighbor-joining methods. Bayesian molecular dating using a relaxed log normal model was used to infer divergence times. Trees from individual genes agreed with each other, placing An. nili as a basal clade that diversified from the studied malaria mosquito species 47.6 million years ago (mya). Other African malaria vectors originated more recently, and independently acquired traits related to vectorial capacity. The lineage leading to An. gambiae diverged 30.4 mya, while the African vector An. funestus and the Asian vector An. stephensi were the most closely related sister taxa that split 20.8 mya. These results were supported by consistently high bootstrap values in concatenated phylogenetic trees generated individually for each chromosomal arm. Genome-wide multigene phylogenetic analysis is a useful approach for discerning historic relationships among malaria vectors, providing a framework for the correct interpretation of genomic changes across species, and comprehending the evolutionary origins of this ubiquitous and deadly insect-borne disease.	[Kamali, Maryam; Marek, Paul E.; Peery, Ashley; Sharakhov, Igor V.] Virginia Polytech Inst & State Univ, Dept Entomol, Blacksburg, VA 24061 USA; [Antonio-Nkondjio, Christophe; Ndo, Cyrille] OCEAC, Malaria Res Lab, Yaounde, Cameroon; [Ndo, Cyrille; Simard, Frederic] IRD, MIVEGEC, UMR IRD224, CNRS5290,UM1,UM2, Montpellier, France; [Ndo, Cyrille] Univ Douala, Fac Med & Pharmaceut Sci, Douala, Cameroon; [Tu, Zhijian] Virginia Polytech Inst & State Univ, Dept Biochem, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Virginia Polytechnic Institute & State University	Sharakhov, IV (corresponding author), Virginia Polytech Inst & State Univ, Dept Entomol, Blacksburg, VA 24061 USA.	igor@vt.edu	Sharakhov, Igor/B-1972-2008; SIMARD, Frederic/J-9489-2016; Kamali, Maryam/AAH-4252-2020; Frederic, SIMARD/AFV-5001-2022	Sharakhov, Igor/0000-0003-0752-3747; SIMARD, Frederic/0000-0002-2871-5329; Frederic, SIMARD/0000-0002-2871-5329; Antonio Nkondjio, Christophe/0000-0003-0073-1578	National Institutes of Health [5R21AI079350, 5R21AI094289]; Wellcome Trust [WTO86423MA]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094289, R21AI079350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (http://www.nih.gov/) grants 5R21AI079350 and 5R21AI094289 (to I. V. S). C. A.-N. was supported by a Wellcome Trust (http://www.wellcome.ac.uk/) Intermediate Fellowship in Public Health and Tropical medicine (WTO86423MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, BIODIVERSITE PALUDIS; Antonio-Nkondjio C, 2006, J MED ENTOMOL, V43, P1215, DOI 10.1603/0022-2585(2006)43[1215:COTMVS]2.0.CO;2; Antonio-Nkondjio C, 2009, ACTA TROP, V112, P270, DOI 10.1016/j.actatropica.2009.08.009; Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Awono-Ambene HP, 2006, AM J TROP MED HYG, V75, P656, DOI 10.4269/ajtmh.2006.75.656; Awono-Ambene HP, 2004, J MED ENTOMOL, V41, P561, DOI 10.1603/0022-2585-41.4.561; AWONOAMBENE HP, 2009, AFRICA SCI MED AFR, V1, P13; Ayala D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-307; Ayala FJ, 2005, P NATL ACAD SCI USA, V102, P6535, DOI 10.1073/pnas.0501847102; Besansky NJ, 2003, P NATL ACAD SCI USA, V100, P10818, DOI 10.1073/pnas.1434337100; Bouckaert RR, 2010, BIOINFORMATICS, V26, P1372, DOI 10.1093/bioinformatics/btq110; Cockerell TDA, 1919, NATURE, V103, P44, DOI 10.1038/103044b0; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Fitch WM, 2000, TRENDS GENET, V16, P227, DOI 10.1016/S0168-9525(00)02005-9; Fontenille D, 2004, COMP IMMUNOL MICROB, V27, P357, DOI 10.1016/j.cimid.2004.03.005; Gao F, 2013, MOL PHYLOGENET EVOL, V68, P55, DOI 10.1016/j.ympev.2013.03.018; Garros C, 2005, J MED ENTOMOL, V42, P522, DOI 10.1603/0022-2585(2005)042[0522:MAAMPO]2.0.CO;2; George P, 2010, INSECT MOL BIOL, V19, P675, DOI 10.1111/j.1365-2583.2010.01025.x; Gingerich P.D., 2003, CAUSES CONSEQUENCES, V369, P463; Harbach RE, 2004, B ENTOMOL RES, V94, P537, DOI 10.1079/BER2004321; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hittinger CT, 2010, P NATL ACAD SCI USA, V107, P1476, DOI 10.1073/pnas.0910449107; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Kamali M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002960; Kamali M, 2011, J HERED, V102, P719, DOI 10.1093/jhered/esr072; Kengne P, 2003, MED VET ENTOMOL, V17, P67, DOI 10.1046/j.1365-2915.2003.00411.x; Koepfli KP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-10; Krzywinski J, 2003, ANNU REV ENTOMOL, V48, P111, DOI 10.1146/annurev.ento.48.091801.112647; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; Marshall JC, 2005, AM J TROP MED HYG, V73, P749, DOI 10.4269/ajtmh.2005.73.749; Megy K, 2012, NUCLEIC ACIDS RES, V40, pD729, DOI 10.1093/nar/gkr1089; Michel AP, 2005, INSECT MOL BIOL, V14, P375, DOI 10.1111/j.1365-2583.2005.00568.x; Moreno-Hagelsieb G, 2008, BIOINFORMATICS, V24, P319, DOI 10.1093/bioinformatics/btm585; Ndo C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058862; Neafsey DE, 2010, SCIENCE, V330, P514, DOI 10.1126/science.1193036; Neafsey DE, 2013, G3-GENES GENOM GENET, V3, P1191, DOI 10.1534/g3.113.006247; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Peery A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-202; Poinar G. O. Jr., 2000, Acta Geologica Hispanica, V35, P119; RAMBAUT A, 2012, FIGTREEAPPLICATION J; Reidenbach KR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-298; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sallum MAM, 2002, SYST ENTOMOL, V27, P361, DOI 10.1046/j.1365-3113.2002.00182.x; Sauquet H, 2012, SYST BIOL, V61, P289, DOI 10.1093/sysbio/syr116; Shalchian-Tabrizi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002098; Sharakhova MV, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r5; Sharakhova MV, 2013, INFECT GENET EVOL, V16, P341, DOI 10.1016/j.meegid.2013.03.010; Sharakhova MV, 2011, INFECT GENET EVOL, V11, P746, DOI 10.1016/j.meegid.2010.06.015; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Zavortink TJ, 2000, ANN ENTOMOL SOC AM, V93, P1230, DOI 10.1603/0013-8746(2000)093[1230:ANDSND]2.0.CO;2	60	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93580	10.1371/journal.pone.0093580	http://dx.doi.org/10.1371/journal.pone.0093580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705448	Green Published, gold			2022-12-25	WOS:000334107500043
J	Chawla, Y; Upadhyay, S; Khan, S; Nagarajan, SN; Forti, F; Nandicoori, VK				Chawla, Yogesh; Upadhyay, Sandeep; Khan, Shazia; Nagarajan, Sathya Narayanan; Forti, Francesca; Nandicoori, Vinay Kumar			Protein Kinase B ( PknB) of Mycobacterium tuberculosis Is Essential for Growth of the Pathogen in Vitro as well as for Survival within the Host	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Protein Kinases; Cell Growth; Cell Signaling; Mycobacteria; Protein Phosphorylation; PASTA Domain; PknB	MYCOLIC ACID BIOSYNTHESIS; SERINE/THREONINE KINASE; CELL-DIVISION; ACTIVATION MECHANISM; CATALYTIC DOMAIN; SER/THR KINASE; STREPTOCOCCUS-PNEUMONIAE; CRYSTAL-STRUCTURE; GENE REPLACEMENT; BINDING DOMAIN	Background:Mycobacterium tuberculosis PknB plays a critical role in modulating cell division and cell wall synthesis. Results: We present a comprehensive evaluation of the importance of various domains of PknB in modulating cell survival. Conclusion: The intracellular kinase domain and extracytoplasmic PASTA domains of PknB are essential for cell survival. Significance: PknB is essential for both in vitro growth and survival of the pathogen in vivo. The Mycobacterium tuberculosis protein kinase B (PknB) comprises an intracellular kinase domain, connected through a transmembrane domain to an extracellular region that contains four PASTA domains. The present study describes the comprehensive analysis of different domains of PknB in the context of viability in avirulent and virulent mycobacteria. We find stringent regulation of PknB expression necessary for cell survival, with depletion or overexpression of PknB leading to cell death. Although PknB-mediated kinase activity is essential for cell survival, active kinase lacking the transmembrane or extracellular domain fails to complement conditional mutants not expressing PknB. By creating chimeric kinases, we find that the intracellular kinase domain has unique functions in the virulent strain, which cannot be substituted by other kinases. Interestingly, we find that although the presence of the C-terminal PASTA domain is dispensable in the avirulent M. smegmatis, all four PASTA domains are essential in M. tuberculosis. The differential behavior of PknB vis-a-vis the number of essential PASTA domains and the specificity of kinase domain functions suggest that PknB-mediated growth and signaling events differ in virulent compared with avirulent mycobacteria. Mouse infection studies performed to determine the role of PknB in mediating pathogen survival in the host demonstrate that PknB is not only critical for growth of the pathogen in vitro but is also essential for the survival of the pathogen in the host.	[Chawla, Yogesh; Upadhyay, Sandeep; Khan, Shazia; Nagarajan, Sathya Narayanan; Nandicoori, Vinay Kumar] Natl Inst Immunol, New Delhi 110067, India; [Forti, Francesca] Univ Milan, Dipartimento Sci Biomol & Biotecnol, I-20133 Milan, Italy	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); University of Milan	Nandicoori, VK (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	Vinaykn@nii.ac.in	Chawla, Yogesh/AAB-8025-2019; Upadhyay, Sandeep/X-5218-2019; Upadhyay, Sandeep/ABF-5956-2020	Chawla, Yogesh/0000-0002-6679-518X; Upadhyay, Sandeep/0000-0001-5958-5419; Nandicoori, Vinay/0000-0002-5682-4178; NAGARAJAN, Sathya Narayanan/0000-0002-3902-3678	National Institute of Immunology (New Delhi, India); Department of Biotechnology, India	National Institute of Immunology (New Delhi, India); Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by grants from the National Institute of Immunology (New Delhi, India) and the Department of Biotechnology, India (to V.K.N.).	Av-Gay Y, 1999, INFECT IMMUN, V67, P5676, DOI 10.1128/IAI.67.11.5676-5682.1999; Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Barthe P, 2010, STRUCTURE, V18, P606, DOI 10.1016/j.str.2010.02.013; Boitel B, 2003, MOL MICROBIOL, V49, P1493, DOI 10.1046/j.1365-2958.2003.03657.x; CARRERA AC, 1993, P NATL ACAD SCI USA, V90, P442, DOI 10.1073/pnas.90.2.442; Chakraborti PK, 2011, TUBERCULOSIS, V91, P432, DOI 10.1016/j.tube.2011.04.005; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Dasgupta A, 2006, MICROBIOL-SGM, V152, P493, DOI 10.1099/mic.0.28630-0; Deol P, 2005, J BACTERIOL, V187, P3415, DOI 10.1128/JB.187.10.3415-3420.2005; Dessen A, 2001, J BIOL CHEM, V276, P45106, DOI 10.1074/jbc.M107608200; Duran R, 2005, BIOCHEM BIOPH RES CO, V333, P858, DOI 10.1016/j.bbrc.2005.05.173; Echenique J, 2004, INFECT IMMUN, V72, P2434, DOI 10.1128/IAI.72.4.2434-2437.2004; Fernandez P, 2006, J BACTERIOL, V188, P7778, DOI 10.1128/JB.00963-06; Forti F, 2009, J BIOTECHNOL, V140, P270, DOI 10.1016/j.jbiotec.2009.02.001; Gee CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002525; Grundner C, 2005, PROTEIN SCI, V14, P1918, DOI 10.1110/ps.051413405; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; Jayachandran R, 2014, CURR TOP MICROBIOL, V374, P189, DOI 10.1007/82_2012_273; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; Khan S, 2010, J BIOL CHEM, V285, P37860, DOI 10.1074/jbc.M110.143131; Leiba J, 2012, J BIOL CHEM, V287, P43607, DOI 10.1074/jbc.M112.418913; Lombana TN, 2010, STRUCTURE, V18, P1667, DOI 10.1016/j.str.2010.09.019; Mieczkowski C, 2008, EMBO J, V27, P3186, DOI 10.1038/emboj.2008.236; Mir M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002182; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Molle V, 2010, MOL MICROBIOL, V78, P1591, DOI 10.1111/j.1365-2958.2010.07446.x; MUNOZDORADO J, 1991, CELL, V67, P995, DOI 10.1016/0092-8674(91)90372-6; Munshi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060143; Narayan A, 2007, PHYSIOL GENOMICS, V29, P66, DOI 10.1152/physiolgenomics.00221.2006; O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x; Ortega C, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001746; Ortiz-Lombardia M, 2003, J BIOL CHEM, V278, P13094, DOI 10.1074/jbc.M300660200; Pandey AK, 2009, TUBERCULOSIS, V89, P12, DOI 10.1016/j.tube.2008.07.007; Parikh A, 2013, APPL ENVIRON MICROB, V79, P1718, DOI 10.1128/AEM.03695-12; Parikh A, 2009, J MOL BIOL, V386, P451, DOI 10.1016/j.jmb.2008.12.031; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915; Roumestand C, 2011, STRUCTURE, V19, P1525, DOI 10.1016/j.str.2011.07.011; Ruggiero A, 2012, CURR PROTEIN PEPT SC, V13, P756, DOI 10.2174/138920312804871201; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Sharma K, 2006, J BACTERIOL, V188, P2936, DOI 10.1128/JB.188.8.2936-2944.2006; Spitaler M, 2000, J BIOL CHEM, V275, P33289, DOI 10.1074/jbc.M002742200; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Tiwari D, 2009, J BIOL CHEM, V284, P27467, DOI 10.1074/jbc.M109.036095; Veyron-Churlet R, 2010, J BIOL CHEM, V285, P12714, DOI 10.1074/jbc.M110.105189; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Villarino A, 2005, J MOL BIOL, V350, P953, DOI 10.1016/j.jmb.2005.05.049; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Yeats C, 2002, TRENDS BIOCHEM SCI, V27, P438, DOI 10.1016/S0968-0004(02)02164-3; Young TA, 2003, NAT STRUCT BIOL, V10, P168, DOI 10.1038/nsb897	54	80	81	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 16	2014	289	20					13858	13875		10.1074/jbc.M114.563536	http://dx.doi.org/10.1074/jbc.M114.563536			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AH2XF	24706757	Green Published, hybrid			2022-12-25	WOS:000335984600019
J	De Roo, ML; Miccinesi, G; Onwuteaka-Philipsen, BD; Van Den Noortgate, N; Van den Block, L; Bonacchi, A; Donker, GA; Alonso, JEL; Moreels, S; Deliens, L; Francke, AL				De Roo, Maaike L.; Miccinesi, Guido; Onwuteaka-Philipsen, Bregje D.; Van Den Noortgate, Nele; Van den Block, Lieve; Bonacchi, Andrea; Donker, Ge A.; Alonso, Jose E. Lozano; Moreels, Sarah; Deliens, Luc; Francke, Anneke L.		EURO IMPACT	Actual and Preferred Place of Death of Home-Dwelling Patients in Four European Countries: Making Sense of Quality Indicators	PLOS ONE			English	Article							OF-LIFE CARE; PALLIATIVE-CARE; CANCER-PATIENTS; GENERAL-PRACTITIONERS; PATIENTS PREFERENCES; HEALTH-CARE; PEOPLE DIE; NETHERLANDS; CONGRUENCE; AWARENESS	Background: Dying at home and dying at the preferred place of death are advocated to be desirable outcomes of palliative care. More insight is needed in their usefulness as quality indicators. Our objective is to describe whether " the percentage of patients dying at home'' and "the percentage of patients who died in their place of preference'' are feasible and informative quality indicators. Methods and Findings: A mortality follow-back study was conducted, based on data recorded by representative GP networks regarding home-dwelling patients who died non-suddenly in Belgium (n = 1036), the Netherlands (n = 512), Italy (n = 1639) or Spain (n = 565). "The percentage of patients dying at home'' ranged between 35.3% (Belgium) and 50.6% (the Netherlands) in the four countries, while "the percentage of patients dying at their preferred place of death'' ranged between 67.8% (Italy) and 86.0% (Spain). Both indicators were strongly associated with palliative care provision by the GP (odds ratios of 1.55-13.23 and 2.30-6.63, respectively). The quality indicator concerning the preferred place of death offers a broader view than the indicator concerning home deaths, as it takes into account all preferences met in all locations. However, GPs did not know the preferences for place of death in 39.6% (the Netherlands) to 70.3% (Italy), whereas the actual place of death was known in almost all cases. Conclusion: GPs know their patients' actual place of death, making the percentage of home deaths a feasible indicator for collection by GPs. However, patients' preferred place of death was often unknown to the GP. We therefore recommend using information from relatives as long as information from GPs on the preferred place of death is lacking. Timely communication about the place where patients want to be cared for at the end of life remains a challenge for GPs.	[De Roo, Maaike L.; Onwuteaka-Philipsen, Bregje D.; Deliens, Luc; Francke, Anneke L.] Vrije Univ Amsterdam, Med Ctr, Expertise Ctr Palliat Care, EMGO Inst Hlth & Care Res,Dept Publ & Occupat Hlt, Amsterdam, Netherlands; [Miccinesi, Guido; Bonacchi, Andrea] Canc Prevent & Res Inst, ISPO, Clin & Descript Epidemiol Unit, Florence, Italy; [Van Den Noortgate, Nele] Ghent Univ Hosp, Dept Geriatr, Ghent, Belgium; [Van den Block, Lieve; Deliens, Luc] Vrije Univ Brussel, End Of Life Care Res Grp, Brussels, Belgium; [Van den Block, Lieve; Deliens, Luc] Univ Ghent, Vrije Univ Brussel, Brussels, Belgium; [Donker, Ge A.; Francke, Anneke L.] Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands; [Alonso, Jose E. Lozano] Govt Castilla & Leon, Reg Minist Hlth, Publ Hlth Directorate Gen, Valladolid, Spain; [Moreels, Sarah] WIV ISP, Sci Inst Publ Hlth Publ Hlth & Surveillance, Hlth Serv Res, Brussels, Belgium	Vrije Universiteit Amsterdam; Ghent University; Ghent University Hospital; Vrije Universiteit Brussel; Ghent University; Vrije Universiteit Brussel; Netherlands Institute for Health Services Research	De Roo, ML (corresponding author), Vrije Univ Amsterdam, Med Ctr, Expertise Ctr Palliat Care, EMGO Inst Hlth & Care Res,Dept Publ & Occupat Hlt, Amsterdam, Netherlands.	eol@vumc.nl	Donker, Gé/AAX-8564-2021; Van den Block, Lieve/D-1247-2011; Caraceni, Augusto/C-1012-2017; miccinesi, guido/AAB-5476-2022	Van den Block, Lieve/0000-0002-7770-348X; Caraceni, Augusto/0000-0002-0375-6204; miccinesi, guido/0000-0002-7452-9594; De Roo, Maaike/0000-0002-2972-0867; Deliens, Luc/0000-0002-8158-2422; Lozano Alonso, Jose Eugenio/0000-0003-2589-0671; Onwuteaka-Philipsen, Bregje/0000-0002-9440-1248; Moreels, Sarah/0000-0002-4020-9533; Bonacchi, Andrea/0000-0003-4703-4067; Harding, Richard/0000-0001-9653-8689; Donker, Ge/0000-0001-6314-9249	Institute for the Promotion of Innovation by Science and Technology in Flanders as a Strategic Basic Research project [SBO IWT 050158]; Vrije Universiteit Brussel; Ghent University; Antwerp University; Scientific Institute for Public Health, Belgium; VU University Medical Centre Amsterdam, the Netherlands; Italian Ministry of Health; Massimo Costantini (IRCCS AOU San Martino-IST, Genoa); Autonomous Community of Castilla y Leon; Comunitat Valenciana; EUROIMPACT: European Intersectorial; Multidisciplinary Palliative Care Research Training; European Union [264697]	Institute for the Promotion of Innovation by Science and Technology in Flanders as a Strategic Basic Research project; Vrije Universiteit Brussel; Ghent University(Ghent University); Antwerp University; Scientific Institute for Public Health, Belgium; VU University Medical Centre Amsterdam, the Netherlands(Netherlands Government); Italian Ministry of Health(Ministry of Health, Italy); Massimo Costantini (IRCCS AOU San Martino-IST, Genoa); Autonomous Community of Castilla y Leon; Comunitat Valenciana; EUROIMPACT: European Intersectorial; Multidisciplinary Palliative Care Research Training; European Union(European Commission)	Funding for the study came from the Institute for the Promotion of Innovation by Science and Technology in Flanders as a Strategic Basic Research project (SBO) (contract SBO IWT 050158) (2006-2010), as part of the "Monitoring Quality of End-of-Life Care (MELC) Study'', a collaboration between the Vrije Universiteit Brussel, Ghent University, Antwerp University, the Scientific Institute for Public Health, Belgium, and VU University Medical Centre Amsterdam, the Netherlands. Funding also came from the Italian Ministry of Health through the "Evaluation, testing and implementation of supportive care, care interventions, integrated programs and improving the quality of care for cancer patients'' program ("Integrated Oncology Project no6, years 2008-2011''), led by Massimo Costantini (IRCCS AOU San Martino-IST, Genoa), from the annual budgets of the Autonomous Community of Castilla y Leon and Comunitat Valenciana and from EUROIMPACT: European Intersectorial and Multidisciplinary Palliative Care Research Training, funded by the European Union Seventh Framework Programme (FP7/2007-2013, under grant agreement no [264697]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabom B, 2005, BRIT J GEN PRACT, V55, P684; Abarshi E, 2011, J PALLIAT MED, V14, P323, DOI 10.1089/jpm.2010.0312; Abarshi E, 2009, J PAIN SYMPTOM MANAG, V38, P568, DOI 10.1016/j.jpainsymman.2008.12.007; Abel J, 2013, BMJ SUPPORT PALLIAT, V3, P168, DOI 10.1136/bmjspcare-2012-000327; Agar M, 2008, PALLIATIVE MED, V22, P787, DOI 10.1177/0269216308092287; Barbera L, 2005, PALLIATIVE MED, V19, P435, DOI 10.1177/026921630501900515; Barclay S, 2009, BRIT J GEN PRACT, V59, P642, DOI 10.3399/bjgp09X454052; Beccaro M, 2006, J EPIDEMIOL COMMUN H, V60, P412, DOI 10.1136/jech.2005.043646; Bell CL, 2009, PALLIATIVE MED, V23, P482, DOI 10.1177/0269216309106318; Bell CL, 2010, J PAIN SYMPTOM MANAG, V39, P591, DOI 10.1016/j.jpainsymman.2009.07.007; Billingham MJ, 2013, BMJ SUPPORT PALLIAT, V3, P144, DOI 10.1136/bmjspcare-2012-000292; Brazil K, 2005, PALLIATIVE MED, V19, P492, DOI 10.1191/0269216305pm1050oa; Brogaard T, 2013, PALLIATIVE MED, V27, P155, DOI 10.1177/0269216312438468; Campbell SM, 2003, BRIT MED J, V326, P816, DOI 10.1136/bmj.326.7393.816; Claessen SJJ, 2011, J PAIN SYMPTOM MANAG, V42, P169, DOI 10.1016/j.jpainsymman.2010.10.267; Cohen J, 2008, PALLIATIVE MED, V22, P702, DOI 10.1177/0269216308092285; Cohen J, 2006, HEALTH POLICY, V78, P319, DOI 10.1016/j.healthpol.2005.11.003; Cohen J, 2010, J CLIN ONCOL, V28, P2267, DOI 10.1200/JCO.2009.23.2850; Costantini M, 1999, J PAIN SYMPTOM MANAG, V18, P243, DOI 10.1016/S0885-3924(99)00084-6; Currow DC, 2008, J PALLIAT CARE, V24, P144, DOI 10.1177/082585970802400303; Davies E, 2004, SOLID FACTS PALLIATI; De Roo ML, 2013, J PAIN SYMPTOM MANAG, V46, P556, DOI 10.1016/j.jpainsymman.2012.09.013; Deckers JGM, 2006, FAM PRACT, V23, P151, DOI 10.1093/fampra/cmi118; Department of Health, 2009, END LIF CAR STRAT QU; Desmedt M, 2002, SUPPORT CARE CANCER, V10, P343, DOI 10.1007/s00520-002-0345-4; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Earle CC, 2003, J CLIN ONCOL, V21, P1133, DOI 10.1200/JCO.2003.03.059; Fukui S, 2003, PALLIATIVE MED, V17, P445, DOI 10.1191/0269216303pm782oa; Gomes B, 2006, BMJ-BRIT MED J, V332, P515, DOI 10.1136/bmj.38740.614954.55; Gomes B, 2012, ANN ONCOL, V23, P2006, DOI 10.1093/annonc/mdr602; Gomes B, 2008, PALLIATIVE MED, V22, P33, DOI 10.1177/0269216307084606; Gomes B, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-7; Gott M, 2008, SOC SCI MED, V67, P1113, DOI 10.1016/j.socscimed.2008.05.024; Gruneir A, 2007, MED CARE RES REV, V64, P351, DOI 10.1177/1077558707301810; Hannon KL, 2012, PALLIATIVE MED, V26, P336, DOI 10.1177/0269216311406990; Higginson IJ, 2013, PALLIATIVE MED, V27, P918, DOI 10.1177/0269216313487940; Hoek JF, 2003, INT J GERIATR PSYCH, V18, P244, DOI 10.1002/gps.816; Holdsworth L, 2010, INT J PALLIAT NURS, V16, P424, DOI 10.12968/ijpn.2010.16.9.78634; Houttekier D, 2010, J PALLIAT MED, V13, P1461, DOI 10.1089/jpm.2010.0279; Howat A, 2007, PALLIATIVE MED, V21, P41, DOI 10.1177/0269216306072383; IIS, 2009, AT CUID PAL ORG COM; Jordhoy MS, 2000, LANCET, V356, P888, DOI 10.1016/S0140-6736(00)02678-7; Ko W, 2013, EUR J CANCER, V49, P1967, DOI 10.1016/j.ejca.2013.01.006; Macleod U, 2011, BRIT J HOSP MED, V72, P441, DOI 10.12968/hmed.2011.72.8.441; Meeussen K, 2011, J CLIN ONCOL, V29, P4327, DOI 10.1200/JCO.2011.34.9498; Meeussen K, 2009, BRIT J GEN PRACT, V59, P665, DOI 10.3399/bjgp09X454124; Ministerie van Volksgezondheid WeS, 2011, VER PALL ZORG PRAKT; Mitchell SL, 2005, J AM GERIATR SOC, V53, P299, DOI 10.1111/j.1532-5415.2005.53118.x; Paddy Miranda, 2011, Nurs Stand, V26, P33; Pasman HRW, 2009, J PAIN SYMPTOM MANAG, V38, P145, DOI 10.1016/j.jpainsymman.2008.07.008; Peruselli C, 1997, J PALLIAT CARE, V13, P34, DOI 10.1177/082585979701300306; Petkova H., 2012, UNDERSTANDING PLACE; Saugo M, 2008, TUMORI J, V94, P87; Sbanotto A, 1998, SUPPORT CARE CANCER, V6, P426, DOI 10.1007/s005200050189; Seale C, 1997, SOC SCI MED, V45, P477, DOI 10.1016/S0277-9536(96)00379-6; Tang ST, 2010, J PAIN SYMPTOM MANAG, V40, P566, DOI 10.1016/j.jpainsymman.2010.01.020; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Thomas C, 2004, SOC SCI MED, V58, P2431, DOI 10.1016/j.socscimed.2003.09.005; Van den Block Lieve, 2007, BMC Palliat Care, V6, P6; Van den Block L, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-73; van Gestel YRBM, 2012, MED CARE, V50, P662, DOI 10.1097/MLR.0b013e31824ebd9f; Vega Alonso Agustin Tomas, 2006, Gac Sanit, V20 Suppl 3, P52, DOI 10.1157/13101090	62	96	97	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93762	10.1371/journal.pone.0093762	http://dx.doi.org/10.1371/journal.pone.0093762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE7FA	24714736	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900046
J	Dhaliwal, SS; Welborn, TA; Goh, LGH; Howat, PA				Dhaliwal, Satvinder S.; Welborn, Timothy A.; Goh, Louise G. H.; Howat, Peter A.			Obesity as Assessed by Body Adiposity Index and Multivariable Cardiovascular Disease Risk	PLOS ONE			English	Article							CARDIOMETABOLIC RISK; MASS INDEX; FAT; ASSOCIATION; HEALTH; BMI; SEX; AGE	To assess the role of body adiposity index (BAI) in predicting cardiovascular disease (CVD) and coronary heart disease (CHD) mortality, in comparison with body mass index (BMI), waist circumference (WC), and the waist circumference to hip circumference ratio (WHR). This study was a prospective 15 year mortality follow-up of 4175 Australian males, free of heart disease, diabetes and stroke. The Framingham Risk Scores (FRS) for CHD and CVD death were calculated at baseline for all subjects. Multivariable logistic regression was used to assess the effects of the measures of obesity on CVD and CHD mortality, before adjustment and after adjustment for FRS. The predictive ability of BAI, though present in the unadjusted analyses, was generally not significant after adjustment for age and FRS for both CVD and CHD mortality. BMI behaved similarly to BAI in that its predictive ability was generally not significant after adjustments. Both WC and WHR were significant predictors of CVD and CHD mortality and remained significant after adjustment for covariates. BAI appeared to be of potential interest as a measure of % body fat and of obesity, but was ineffective in predicting CVD and CHD.	[Dhaliwal, Satvinder S.; Goh, Louise G. H.; Howat, Peter A.] Curtin Univ, Perth, WA 6845, Australia; [Welborn, Timothy A.] Sir Charles Gairdner Hosp, Perth, WA, Australia	Curtin University; University of Western Australia	Dhaliwal, SS (corresponding author), Curtin Univ, Perth, WA 6845, Australia.	S.Dhaliwal@curtin.edu.au			Healthway, the Western Australian Health Promotion Foundation	Healthway, the Western Australian Health Promotion Foundation	This study was originally supported by a competitive grant from Healthway, the Western Australian Health Promotion Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER H, 1990, MED J AUSTRALIA, V153, P367, DOI 10.5694/j.1326-5377.1990.tb136975.x; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Australian Risk Factor Prevalence Study Management Committee, 1990, SURV 3 1989; Barreira TV, 2012, MAYO CLIN PROC, V87, P452, DOI 10.1016/j.mayocp.2011.12.017; Barzi F, 2010, OBES REV, V11, P127, DOI 10.1111/j.1467-789X.2009.00605.x; Bennasar-Veny M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063999; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; de Lima JG, 2012, OBESITY, V20, P1140, DOI 10.1038/oby.2012.3; Dhaliwal SS, 2009, PREV MED, V49, P148, DOI 10.1016/j.ypmed.2009.06.023; Dhaliwal SS, 2009, AM J CARDIOL, V103, P1403, DOI 10.1016/j.amjcard.2008.12.048; Elisha B, 2013, EUR J NUTR, V52, P145, DOI 10.1007/s00394-011-0296-y; Freedman DZ, 2012, SUPERGRAVITY, P1, DOI 10.1017/CBO9781139026833; Freedman DS, 2013, OBESITY, V21, pE64, DOI 10.1002/oby.20054; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Godoy-Matos AF, 2012, OBESITY, V20, P440, DOI 10.1038/oby.2011.343; Goh LGH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004702; Hung CS, 2012, OBESITY, V20, P1141, DOI 10.1038/oby.2012.86; Huxley R, 2008, J HYPERTENS, V26, P169, DOI 10.1097/HJH.0b013e3282f16ad3; Jackson AS, 2002, INT J OBESITY, V26, P789, DOI 10.1038/sj.ijo.0802006; Johnson W, 2012, OBESITY, V20, P900, DOI 10.1038/oby.2011.346; Klein S, 2007, OBESITY, V15, P1061, DOI 10.1038/oby.2007.632; Lichtash CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065954; Lopez AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035281; Melmer A, 2013, OBESITY, V21, P775, DOI 10.1002/oby.20289; Moliner-Urdiales D, 2013, OBESITY; Schulze MB, 2012, DIABETOLOGIA, V55, P1660, DOI 10.1007/s00125-012-2499-z; Schulze MB, 2011, OBESITY, V19, P1729, DOI 10.1038/oby.2011.153; Snijder MB, 2012, OBESITY, V20, P1138, DOI 10.1038/oby.2011.338; Welborn TA, 2003, MED J AUSTRALIA, V179, P580, DOI 10.5694/j.1326-5377.2003.tb05704.x; World Health Organization, 1998, INT CLASS DIS MAN IN; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zhang Z-Q, 2013, CLIN ENDOCRINOLOGY	32	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94560	10.1371/journal.pone.0094560	http://dx.doi.org/10.1371/journal.pone.0094560			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714547	gold, Green Published			2022-12-25	WOS:000334160900139
J	El Emam, K; Arbuckle, L; Essex, A; Samet, S; Eze, B; Middleton, G; Buckeridge, D; Jonker, E; Moher, E; Earle, C				El Emam, Khaled; Arbuckle, Luk; Essex, Aleksander; Samet, Saeed; Eze, Benjamin; Middleton, Grant; Buckeridge, David; Jonker, Elizabeth; Moher, Ester; Earle, Craig			Secure Surveillance of Antimicrobial Resistant Organism Colonization or Infection in Ontario Long Term Care Homes	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; RESIDENTS; FACILITIES; PREVALENCE; STAFF; MRSA	long term care homes, yet there is a need to collect data about their prevalence for public health surveillance and intervention purposes. Objective: We conducted a point prevalence study to assess ARO rates in long term care homes in Ontario using a secure data collection system. Methods: All long term care homes in the province were asked to provide colonization or infection counts for methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and extended-spectrum beta-lactamase (ESBL) as recorded in their electronic medical records, and the number of current residents. Data was collected online during the October-November 2011 period using a Paillier cryptosystem that allows computation on encrypted data. Results: A provably secure data collection system was implemented. Overall, 82% of the homes in the province responded. MRSA was the most frequent ARO identified at 3 cases per 100 residents, followed by ESBL at 0.83 per 100 residents, and VRE at 0.56 per 100 residents. The microbiological findings and their distribution were consistent with available provincial laboratory data reporting test results for AROs in hospitals. Conclusions: We describe an ARO point prevalence study which demonstrated the feasibility of collecting data from long term care homes securely across the province and providing strong privacy and confidentiality assurances, while obtaining high response rates.	[El Emam, Khaled; Arbuckle, Luk; Jonker, Elizabeth; Moher, Ester] Childrens Hosp, Eastern Ontario Res Inst, Elect Hlth Informat Lab, Ottawa, ON, Canada; [El Emam, Khaled] Univ Ottawa, Ottawa, ON, Canada; [Essex, Aleksander] Western Univ, London, ON, Canada; [Samet, Saeed] Mem Univ Newfoundland, St John, NF, Canada; [Eze, Benjamin; Middleton, Grant] Privacy Analyt Inc, Ottawa, ON, Canada; [Buckeridge, David] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Earle, Craig] Inst Clin Evaluat Sci, Canc Res Program, Toronto, ON, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Western University (University of Western Ontario); Memorial University Newfoundland; McGill University; University of Toronto	El Emam, K (corresponding author), Childrens Hosp, Eastern Ontario Res Inst, Elect Hlth Informat Lab, Ottawa, ON, Canada.	kelemam@uottawa.ca		Samet, Saeed/0000-0002-5116-5484	Canada Research Chairs program; Ontario Institute for Cancer Research	Canada Research Chairs program(Canada Research Chairs); Ontario Institute for Cancer Research	The funders for this project were: (1) The Canada Research Chairs program through a research grant. (2) The Ontario Institute for Cancer Research through a research grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquisti A, 2012, J MARKETING RES, V49, P160, DOI 10.1509/jmr.09.0215; Bryce EA, 2000, INFECT CONT HOSP EP, V21, P270, DOI 10.1086/501757; Canadian Healthcare Technology, 2013, CBC CLAIMS PROV BLOC; Conchie SM, 2008, RISK ANAL, V28, P141, DOI 10.1111/j.1539-6924.2008.01006.x; Denis O, 2009, J ANTIMICROB CHEMOTH, V64, P1299, DOI 10.1093/jac/dkp345; El Emam K, 2013, J LAW MED ETHICS; El Emam K., 2013, GUIDE DE IDENTIFICAT; El Emam K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-454; El Emam K, 2011, J AM MED INFORM ASSN, V18, P212, DOI 10.1136/amiajnl-2011-000100; Gravely Steve D, 2009, J Healthc Inf Manag, V23, P33; Jackson Virginia, 2008, Biotechnol Healthc, V5, P57; Jarvis WR, 2007, AM J INFECT CONTROL, V35, P631, DOI 10.1016/j.ajic.2007.10.009; Kellerman SE, 2001, AM J PREV MED, V20, P61, DOI 10.1016/S0749-3797(00)00258-0; Koch AM, 2009, J HOSP INFECT, V71, P269, DOI 10.1016/j.jhin.2008.10.032; Kreman T, 2005, INFECT CONT HOSP EP, V26, P811, DOI 10.1086/502498; Kress A, 2004, MORB MORTAL WKLY R S, V53, P247; Lindner J.R., 2001, J AGR ED, V42, P43, DOI [DOI 10.5032/JAE.2001.04043, https://doi.org/10.5032/jae.2001.04043]; Lober William B, 2004, MMWR Suppl, V53, P203; Ludbrook J, 1998, AM STAT, V52, P127, DOI 10.2307/2685470; Manly BFJ, 1997, RANDOMIZATION BOOTST; Manzur A, 2008, CLIN MICROBIOL INFEC, V14, P867, DOI 10.1111/j.1469-0691.2008.02060.x; March A, 2010, CLIN MICROBIOL INFEC, V16, P934, DOI 10.1111/j.1469-0691.2009.03024.x; McGeer A, 2011, ANTIMICROBIAL RESIST; Muller M, 2002, Can Commun Dis Rep, V28, P113; MYLOTTE JM, 1992, INFECT CONT HOSP EP, V13, P711; O'Fallon E, 2009, INFECT CONT HOSP EP, V30, P1172, DOI 10.1086/648453; Paillier P, 1999, LECT NOTES COMPUT SC, V1592, P223; Public Health Ontario Provincial Infectious Diseases Advisory Committee, 2011, ANN A SCREEN TEST SU; Schwaber MJ, 2011, CLIN INFECT DIS, V53, P910, DOI 10.1093/cid/cir607; Standing Committee on Public Accounts, 2011, INF PREV CONTR LONG; Stone ND, 2008, INFECT CONT HOSP EP, V29, P143, DOI 10.1086/526437; THURN JR, 1991, J AM GERIATR SOC, V39, P1105, DOI 10.1111/j.1532-5415.1991.tb02877.x; Trick WE, 2001, J AM GERIATR SOC, V49, P270, DOI 10.1046/j.1532-5415.2001.4930270.x; Tsai J, 2009, THESIS CARNEGIE MELL; Wojcik R, 2007, OBTAINING DATA DIS S	35	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93285	10.1371/journal.pone.0093285	http://dx.doi.org/10.1371/journal.pone.0093285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714643	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900022
J	Cheng, JD; Huang, TL; Li, YF; Guo, YB; Zhu, YZ; Wang, QJ; Tan, XJ; Chen, WS; Zhang, YN; Cheng, WJ; Yamamoto, T; Jing, XB; Huang, JX				Cheng, Jidong; Huang, Tianliang; Li, Youfeng; Guo, Yubai; Zhu, Yuzhang; Wang, Qingjia; Tan, Xiaojun; Chen, Weisheng; Zhang, Yongneng; Cheng, Weijie; Yamamoto, Tetsuya; Jing, Xubin; Huang, Jiexiong			AMP-Activated Protein Kinase Suppresses the In Vitro and In Vivo Proliferation of Hepatocellular Carcinoma	PLOS ONE			English	Article							PEUTZ-JEGHERS-SYNDROME; METABOLIC SYNDROME; CELLULAR-ENERGY; CANCER CELLS; PHOSPHORYLATION; METFORMIN; RISK; SENSOR; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE-1-BETA-D-RIBOFURANOSIDE; CLASSIFICATION	AMP-activated protein kinase (AMPK) is a central metabolic sensor and plays an important role in regulating glucose, lipid and cholesterol metabolism. Therefore, AMPK is a key therapeutic target in diabetes. Recent pilot studies have suggested that diabetes drugs may reduce the risk of cancer by affecting the AMPK pathway. However, the association between AMPK and the proliferation of hepatocellular carcinoma (HCC) is unknown. In this study, we investigated the relationship between AMPK activity and the proliferation of HCC in cell lines, nude mice and human clinic samples. We first investigated the relationship between AMPK activity and cell proliferation in two HCC cell lines, PLC/PRF/5 and HepG2, by two AMPK activators, 5-aminoimidazole-4-carboxamide-1-h-D-ribofuranoside (AICAR) and metformain. AICAR and metformin treatment significantly inhibited the proliferation of HCC cells and induced cell cycle arrest at G1-S checkpoint. We then observed that metformin abrogated the growth of HCC xenografts in nude mice. The clinical pathology of AMPK activity in HCC, including cell proliferation, differential grade, tumor size and microvessel density, was studied by using 30 clinical tissue samples. In HCC tissue samples, phosphorylated AMPK was expressed mainly in cytoplasm. AMPK activity decreased significantly in HCC in comparison with paracancerous liver tissues (P < 0.05). AMPK activity was negatively correlated with the level of Ki-67 (a marker of cell proliferation), differential degradation and tumor size (P < 0.05), but not with microvessel density, hemorrhage or necrosis in HCC. Our findings suggest that AMPK activity inhibits the proliferation of HCC and AMPK might be an effective target for prevention and treatment of HCC.	[Cheng, Jidong; Huang, Tianliang; Li, Youfeng; Zhu, Yuzhang; Wang, Qingjia; Tan, Xiaojun; Chen, Weisheng; Zhang, Yongneng; Cheng, Weijie; Jing, Xubin] Shantou Univ, Affiliated Hosp 1, Dept Internal Med, Coll Med, Shantou, Guangdong, Peoples R China; [Guo, Yubai; Huang, Jiexiong] Shantou Univ, Affiliated Hosp 1, Dept Pathol, Coll Med, Shantou, Guangdong, Peoples R China; [Yamamoto, Tetsuya] Hyogo Coll Med, Dept Internal Med, Nishinomiya, Hyogo 6638501, Japan	Shantou University; Shantou University; Hyogo College of Medicine	Cheng, JD (corresponding author), Shantou Univ, Affiliated Hosp 1, Dept Internal Med, Coll Med, Shantou, Guangdong, Peoples R China.	chengjidong36@hotmail.com; xbjing@stu.edu.cn; hjxcyjhx@21cn.com	tan, xiao/GZL-0264-2022		National Natural Science Foundation of China [81070673, 81172263]; Special Foundation of Guangdong Province College Talent Introduction [10027425]; Natural Science Foundation of Guangdong province [10151503102000013, S2011010005102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Foundation of Guangdong Province College Talent Introduction; Natural Science Foundation of Guangdong province(National Natural Science Foundation of Guangdong Province)	This work was supported by grants from the National Natural Science Foundation of China (81070673 and 81172263), the Special Foundation of Guangdong Province College Talent Introduction (10027425), and the Natural Science Foundation of Guangdong province (10151503102000013 and S2011010005102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CARLING D, 1987, FEBS LETT, V223, P217, DOI 10.1016/0014-5793(87)80292-2; Chen HP, 2013, GUT, V62, P606, DOI 10.1136/gutjnl-2011-301708; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Garber K, 2006, SCIENCE, V312, P1158, DOI 10.1126/science.312.5777.1158; GIARDIELLO FM, 1987, NEW ENGL J MED, V316, P1511, DOI 10.1056/NEJM198706113162404; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hearle N, 2006, CLIN CANCER RES, V12, P3209, DOI 10.1158/1078-0432.CCR-06-0083; Horman S, 2002, CURR BIOL, V12, P1419, DOI 10.1016/S0960-9822(02)01077-1; Ichida F, 1996, INT HEPATOL COMMUN, V6, P112, DOI 10.1016/S0928-4346(96)00325-8; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Koomagi R, 1999, INT J CANCER, V84, P239, DOI 10.1002/(SICI)1097-0215(19990621)84:3<239::AID-IJC7>3.0.CO;2-S; Kyriakis John M, 2003, J Biol, V2, P26, DOI 10.1186/1475-4924-2-26; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Luo ZJ, 2005, TRENDS PHARMACOL SCI, V26, P69, DOI 10.1016/j.tips.2004.12.011; Nakau M, 2002, CANCER RES, V62, P4549; Nam M, 2008, ARCH BIOCHEM BIOPHYS, V479, P74, DOI 10.1016/j.abb.2008.07.029; Qu Z, 2012, HEPATOL RES, V42, P922, DOI 10.1111/j.1872-034X.2012.01007.x; Rahman MA, 2001, CLIN CANCER RES, V7, P1325; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Schutte K, 2009, DIGEST DIS, V27, P80, DOI 10.1159/000218339; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Short JD, 2010, MOL CARCINOGEN, V49, P429, DOI 10.1002/mc.20613; Siegel AB, 2009, CANCER-AM CANCER SOC, V115, P5651, DOI 10.1002/cncr.24687; Tamas P, 2006, J EXP MED, V203, P1665, DOI 10.1084/jem.20052469; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Wang W, 2009, ACTA PHYSIOL, V196, P55, DOI 10.1111/j.1748-1716.2009.01980.x; WOOD WJ, 1988, AM J SURG, V155, P663, DOI 10.1016/S0002-9610(88)80139-9; Xiang XQ, 2004, BIOCHEM BIOPH RES CO, V321, P161, DOI 10.1016/j.bbrc.2004.06.133	35	47	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93256	10.1371/journal.pone.0093256	http://dx.doi.org/10.1371/journal.pone.0093256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709998	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800027
J	Marin, C; Palomeque, MD; Marco-Jimenez, F; Vega, S				Marin, Clara; Palomeque, Maria-Dolores; Marco-Jimenez, Francisco; Vega, Santiago			Wild Griffon Vultures (Gyps fulvus) as a Source of Salmonella and Campylobacter in Eastern Spain	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; GULLS LARUS-RIDIBUNDUS; THERMOPHILIC CAMPYLOBACTER; ANTIMICROBIAL RESISTANCE; MOLECULAR EPIDEMIOLOGY; DISEASE BURDEN; AVIAN WILDLIFE; PIG PRODUCTION; FOOD-PRODUCTS; BIRDS	The existence of Campylobacter and Salmonella reservoirs in wildlife is a potential hazard to animal and human health; however, the prevalence of these species is largely unknown. Until now, only a few studies have evaluated the presence of Campylobacter and Salmonella in wild griffon vultures and based on a small number of birds. The aim of this study was to evaluate the presence of Campylobacter and Salmonella in wild griffon vultures (n = 97) during the normal ringing programme at the Cinctorres Observatory in Eastern Spain. In addition, the effect of ages of individuals (juveniles, subadult and adult) on the presence were compared. Campylobacter was isolated from 1 of 97 (1.0%) griffon vultures and identified as C. jejuni. Salmonella was isolated from 51 of 97 (52.6%) griffon vultures. No significant differences were found between the ages of individuals for the presence of Salmonella. Serotyping revealed 6 different serovars among two Salmonella enterica subspecies; S. enterica subsp. enterica (n = 49, 96.1%) and S. enterica subsp. salamae (n = 2, 3.9%). No more than one serovar was isolated per individual. The serovars isolated were S. Typhimurium (n = 42, 82.3%), S. Rissen (n = 4, 7.8%), S. Senftenberg (n = 3, 5.9%) and S. 4,12: b[-] (n = 2, 3.9%). Our results imply that wild griffon vultures are a risk factor for Salmonella transmission, but do not seem to be a reservoir for Campylobacter. We therefore rule out vultures as a risk factor for human campylobacteriosis. Nevertheless, further studies should be undertaken in other countries to confirm these results.	[Marin, Clara; Palomeque, Maria-Dolores; Vega, Santiago] Univ CEU Cardenal Herrera, Fac Vet, Dept Prod Anim, Inst Ciencias Biomed, Valencia, Spain; [Marco-Jimenez, Francisco] Univ Politecn Valencia, Inst Ciencia & Tecnol Anim, E-46071 Valencia, Spain	Universidad CEU Cardenal Herrera; Universitat Politecnica de Valencia	Marin, C (corresponding author), Univ CEU Cardenal Herrera, Fac Vet, Dept Prod Anim, Inst Ciencias Biomed, Valencia, Spain.	clara.marin@uch.ceu.es	Marin, Clara/S-1396-2016; Vega, Santiago/K-8172-2019; Vega, Santiago/AAI-3813-2021; Jiménez, Francisco Marco/I-7126-2012	Marin, Clara/0000-0001-6152-3778; Vega, Santiago/0000-0002-4220-6029; Jiménez, Francisco Marco/0000-0002-5226-4118	Conselleria de Infraestructuras, Territorio y Medio Ambiente (Regional Government/Generalitat Valenciana)	Conselleria de Infraestructuras, Territorio y Medio Ambiente (Regional Government/Generalitat Valenciana)	Funding for this project came from the Conselleria de Infraestructuras, Territorio y Medio Ambiente (Regional Government/Generalitat Valenciana). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], TECHN M SALM CAMP CH; Arguello H, 2013, RES VET SCI, V95, P334, DOI 10.1016/j.rvsc.2013.04.001; Arguello H, 2013, J FOOD PROTECT, V76, P899, DOI 10.4315/0362-028X.JFP-12-404; Astorga Marquez RJ, 2007, J FOOD PROTECT, V70, P1502; Benskin CMH, 2009, BIOL REV, V84, P349, DOI 10.1111/j.1469-185X.2008.00076.x; Bergmire-Sweat D., 2008, Morbidity and Mortality Weekly Report, V57, P69; Botti V, 2013, VET ITAL, V49, P195, DOI 10.12834/VetIt.2013.492.201.208; Broman T, 2002, J CLIN MICROBIOL, V40, P4594, DOI 10.1128/JCM.40.12.4594-4602.2002; Camina A, 2006, ACTA ORNITHOL, V41, P7, DOI 10.3161/068.041.0106; Camina Alvaro, 2004, P45; Chuma T, 2000, J VET MED SCI, V62, P1291, DOI 10.1292/jvms.62.1291; Clemente L, 2013, INT J FOOD MICROBIOL, V167, P221, DOI 10.1016/j.ijfoodmicro.2013.08.009; COOPER J E, 1975, Journal of Wildlife Diseases, V11, P389; COULSON JC, 1983, J HYG-CAMBRIDGE, V91, P437, DOI 10.1017/S0022172400060472; Davies RH, 2013, VET MICROBIOL, V166, P543, DOI 10.1016/j.vetmic.2013.07.003; Del Moral JC, 2001, BRUITRE LEONADS PENI; Denis M, 2013, VET REC, V173, P370, DOI 10.1136/vr.101901; Doorduyn Y, 2008, EPIDEMIOL INFECT, V136, P1225, DOI 10.1017/S095026880700996X; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; FERRER M, 1987, COMP BIOCHEM PHYS A, V87, P1123, DOI 10.1016/0300-9629(87)90049-1; French NP, 2009, APPL ENVIRON MICROB, V75, P779, DOI 10.1128/AEM.01979-08; GIRDWOOD RWA, 1985, J HYG-CAMBRIDGE, V95, P229, DOI 10.1017/S0022172400062665; Griekspoor P, 2013, MOL ECOL, V22, P1463, DOI 10.1111/mec.12144; Haagsma JA, 2010, EPIDEMIOL INFECT, V138, P1650, DOI 10.1017/S0950268810000531; Hamemeijer WJM, 1997, EBCC ATLAS EUROPEAN; Handeland K, 2002, EPIDEMIOL INFECT, V128, P523, DOI 10.1017/S0950268802007021; Hatch Jeremy J., 1996, International Journal of Environmental Health Research, V6, P5, DOI 10.1080/09603129609356867; Havelaar AH, 2012, INT J FOOD MICROBIOL, V156, P231, DOI 10.1016/j.ijfoodmicro.2012.03.029; HAWKEY C, 1985, AVIAN PATHOL, V14, P251, DOI 10.1080/03079458508436226; Hendriksen RS, 2008, FOODBORNE PATHOG DIS, V5, P605, DOI 10.1089/fpd.2007.0075; Hernandez J, 2003, EMERG INFECT DIS, V9, P753; Hughes LA, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-4; HUMPHREY TJ, 1988, VET REC, V123, P160, DOI 10.1136/vr.123.6.160; Jijon S, 2007, J ZOO WILDLIFE MED, V38, P409, DOI 10.1638/1042-7260(2007)38[409:SEIFWA]2.0.CO;2; Jong BC, 2005, EMERG INFECT DIS, V11, P398, DOI 10.3201/eid1103.040694; Kapperud G, 1998, AM J EPIDEMIOL, V147, P774, DOI 10.1093/oxfordjournals.aje.a009522; Kapperud G, 2003, AM J EPIDEMIOL, V158, P234, DOI 10.1093/aje/kwg139; Keller JI, 2011, J WILDLIFE DIS, V47, P750, DOI 10.7589/0090-3558-47.3.750; KEYMER IF, 1972, VET REC, V90, P579, DOI 10.1136/vr.90.21.579; KIRKPATRICK CE, 1986, J AM VET MED ASSOC, V189, P997; Kocabiyik AL, 2006, J WILDLIFE DIS, V42, P696, DOI 10.7589/0090-3558-42.3.696; Lafuente S, 2013, ENFERM INFEC MICR CL, V31, P32, DOI 10.1016/j.eimc.2012.05.013; Lopez B, 2012, 22 EUR C CLIN MICR I, P1578; Marin C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072350; Martinez-Abrain A, 2012, J APPL ECOL, V49, P109, DOI 10.1111/j.1365-2664.2011.02080.x; Mermin J, 2004, CLIN INFECT DIS, V38, pS253, DOI 10.1086/381594; Millan J, 2004, REV SCI TECH OIE, V23, P905, DOI 10.20506/rst.23.3.1529; Molina-Lopez RA, 2011, VET REC, V168, DOI 10.1136/vr.c7123; Nakadai A, 2005, J VET MED SCI, V67, P97, DOI 10.1292/jvms.67.97; Padungtod P, 2006, INT J FOOD MICROBIOL, V108, P346, DOI 10.1016/j.ijfoodmicro.2005.11.020; Palmgren H, 2006, EPIDEMIOL INFECT, V134, P635, DOI 10.1017/S0950268805005261; Palmgren H, 2004, J WILDLIFE DIS, V40, P583, DOI 10.7589/0090-3558-40.3.583; Petersen L, 2001, APPL ENVIRON MICROB, V67, P3115, DOI 10.1128/AEM.67.7.3115-3121.2001; Pezzoli L., 2007, EURO SURVEILL, V12, pii; Reche MP, 2003, J VET MED B, V50, P42, DOI 10.1046/j.1439-0450.2003.00623.x; Refsum T, 2002, APPL ENVIRON MICROB, V68, P5595, DOI 10.1128/AEM.68.11.5595-5599.2002; Reilly WJ, 1891, VET REC, V108, P553; Stepan RM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-153; Tauni MA, 2000, J SMALL ANIM PRACT, V41, P339, DOI 10.1111/j.1748-5827.2000.tb03214.x; Thompson SA, 2000, CAMPYLOBACTER, P321; van Pelt W, 2003, EPIDEMIOL INFECT, V130, P431, DOI 10.1017/S0950268803008392; Waldenstrom J, 2002, APPL ENVIRON MICROB, V68, P5911, DOI 10.1128/AEM.68.12.5911-5917.2002; Waldenstrom J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009082; Whiley H, 2013, INT J ENV RES PUB HE, V10, P5886, DOI 10.3390/ijerph10115886; WILSON JE, 1967, BRIT VET J, V123, P212, DOI 10.1016/S0007-1935(17)40005-4; YOGASUNDRAM K, 1989, AVIAN DIS, V33, P664, DOI 10.2307/1591142	66	31	32	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94191	10.1371/journal.pone.0094191	http://dx.doi.org/10.1371/journal.pone.0094191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710464	Green Submitted, Green Published, gold			2022-12-25	WOS:000334159800114
J	Markiewicz, A; Ksiazkiewicz, M; Welnicka-Jaskiewicz, M; Seroczynska, B; Skokowski, J; Szade, J; Zaczek, AJ				Markiewicz, Aleksandra; Ksiazkiewicz, Magdalena; Welnicka-Jaskiewicz, Marzena; Seroczynska, Barbara; Skokowski, Jaroslaw; Szade, Jolanta; Zaczek, Anna J.			Mesenchymal Phenotype of CTC-Enriched Blood Fraction and Lymph Node Metastasis Formation Potential	PLOS ONE			English	Article							CIRCULATING TUMOR-CELLS; BREAST-CANCER CELLS; RT-PCR DETECTION; PERIPHERAL-BLOOD; MESSENGER-RNA; MOLECULAR-DETECTION; BONE-MARROW; CARCINOEMBRYONIC ANTIGEN; PROGNOSTIC-SIGNIFICANCE; E-CADHERIN	Introduction: Circulating tumor cells (CTCs) that present mesenchymal phenotypes can escape standard methods of isolation, thus limiting possibilities for their characterization. Whereas mesenchymal CTCs are considered to be more malignant than epithelial CTCs, factors responsible for this aggressiveness have not been thoroughly defined. This study analyzed the molecular profile related to metastasis formation potential of CTC-enriched blood fractions obtained by marker unbiased isolation from breast cancer patients without (N-) and with lymph nodes metastases (N+). Materials and Methods: Blood samples drawn from 117 patients with early-stage breast cancer were enriched for CTCs using density gradient centrifugation and negative selection with anti-CD45 covered magnetic particles. In the resulting CTC-enriched blood fractions, expression of CK19, MGB1, VIM, TWIST1, SNAIL, SLUG, HER2, CXCR4 and uPAR was analyzed with qPCR. Results were correlated with patients' clinicopathological data. Results: CTCs (defined as expression of either CK19, MGB1 or HER2) were detected in 41%(20/49) of N- and 69% (34/49) of N+ patients (P = 0.004). CTC-enriched blood fractions of N+ patients were more frequently VIM (P = 0.02), SNAIL (P = 0.059) and uPAR-positive (P = 0.03). Positive VIM, CXCR4 and uPAR status correlated with > 3 lymph nodes involved (P = 0.003, P = 0.01 and P = 0.045, respectively). In the multivariate logistic regression MGB1 and VIM-positivity were independently related to lymph node involvement with corresponding overall risk of 3.2 and 4.2. Moreover, mesenchymal CTC-enriched blood fractions (CK192/VIM+ and MGB1+ or HER2+) had 4.88 and 7.85-times elevated expression of CXCR4 and uPAR, respectively, compared with epithelial CTC-enriched blood fractions (CK19+/VIM2 and MGB1+ or HER2+). Conclusions: Tumors of N+ patients have superior CTC-seeding and metastatic potential compared with N- patients. These differences can be attributed to VIM, uPAR and CXCR4 expression, which endow tumor cells with particularly malignant phenotypes.	[Markiewicz, Aleksandra; Ksiazkiewicz, Magdalena; Zaczek, Anna J.] Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Med Biotechnol, PL-80952 Gdansk, Poland; [Markiewicz, Aleksandra; Ksiazkiewicz, Magdalena; Zaczek, Anna J.] Med Univ Gdansk, Gdansk, Poland; [Markiewicz, Aleksandra] Med Univ Warsaw, Postgrad Sch Mol Med, Warsaw, Poland; [Welnicka-Jaskiewicz, Marzena] Med Univ Gdansk, Dept Radiotherapy & Oncol, Gdansk, Poland; [Seroczynska, Barbara; Skokowski, Jaroslaw] Med Univ Gdansk, Dept Med Lab Diagnost, Bank Frozen Tissues & Genet Specimens, Gdansk, Poland; [Skokowski, Jaroslaw] Med Univ Gdansk, Dept Surg Oncol, Gdansk, Poland; [Szade, Jolanta] Med Univ Gdansk, Dept Pathomorphol, Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Medical University of Warsaw; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Zaczek, AJ (corresponding author), Univ Gdansk, Intercollegiate Fac Biotechnol, Dept Med Biotechnol, PL-80952 Gdansk, Poland.	azaczek@gumed.edu.pl	; Markiewicz, Aleksandra/C-1493-2013	Szade, Jolanta/0000-0003-0429-0677; Markiewicz, Aleksandra/0000-0003-4590-4698; Welnicka-Jaskiewicz, Marzena/0000-0003-4578-6302; Zaczek, Anna J/0000-0003-1482-6068; Skokowski, Jaroslaw/0000-0002-3079-3502	National Centre for Research and Development [LIDER/13/117/L-1/09/NCBiR/2010]; system project "InnoDoktorant-Scholarships for PhD students, IIIrd edition''; European Union; European Commission from the FP7 project MOBI4Health	National Centre for Research and Development(National Centre for Research & Development, Poland); system project "InnoDoktorant-Scholarships for PhD students, IIIrd edition''; European Union(European Commission); European Commission from the FP7 project MOBI4Health	This work was supported by the National Centre for Research and Development LIDER/13/117/L-1/09/NCBiR/2010. In addition, this work was supported by the system project "InnoDoktorant-Scholarships for PhD students, IIIrd edition''. The project is co-financed by the European Union in the frame of the European Social Fund. Publication cost supported by the European Commission from the FP7 project MOBI4Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpaugh ML, 2002, ONCOGENE, V21, P3631, DOI 10.1038/sj.onc.1205389; Andergassen Ulrich, 2013, Cancers (Basel), V5, P1212, DOI 10.3390/cancers5041212; Andergassen U, 2013, INT J MOL SCI, V14, P1093, DOI 10.3390/ijms14011093; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Ashworth T R, 1869, MED J AUSTRALIA, V14, P146; Banys M, 2013, CLIN CHIM ACTA, V423, P39, DOI 10.1016/j.cca.2013.03.029; Benoy IH, 2006, BRIT J CANCER, V94, P672, DOI 10.1038/sj.bjc.6602985; Bidard FC, 2010, ANN ONCOL, V21, P729, DOI 10.1093/annonc/mdp391; Bonnomet A, 2012, ONCOGENE, V31, P3741, DOI 10.1038/onc.2011.540; Bonnomet A, 2010, J MAMMARY GLAND BIOL, V15, P261, DOI 10.1007/s10911-010-9174-0; Bossolasco P, 2002, CANCER DETECT PREV, V26, P60, DOI 10.1016/S0361-090X(02)00009-0; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chen Y, 2010, INT J BIOL MARKER, V25, P59, DOI 10.1177/172460081002500201; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Corradini P, 2001, ANN ONCOL, V12, P1693, DOI 10.1023/A:1013573108945; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Daskalaki A, 2009, BRIT J CANCER, V101, P589, DOI 10.1038/sj.bjc.6605183; Ghiso JAA, 1999, J CELL BIOL, V147, P89, DOI 10.1083/jcb.147.1.89; Giordano A, 2012, MOL CANCER THER, V11, P2526, DOI 10.1158/1535-7163.MCT-12-0460; Giuliano M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2907; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hemsen A, 2003, INT J CANCER, V107, P903, DOI 10.1002/ijc.11488; HEYNS W, 1983, J STEROID BIOCHEM, V19, P1689, DOI 10.1016/0022-4731(83)90345-X; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Ignatiadis M, 2008, CLIN CANCER RES, V14, P2593, DOI 10.1158/1078-0432.CCR-07-4758; Inokuchi M, 2003, BRIT J CANCER, V89, P1750, DOI 10.1038/sj.bjc.6601248; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kataoka A, 2000, INT J ONCOL, V16, P1147; Konigsberg R, 2011, ACTA ONCOL, V50, P700, DOI 10.3109/0284186X.2010.549151; Kundu GC, 1996, P NATL ACAD SCI USA, V93, P2915, DOI 10.1073/pnas.93.7.2915; Lakhani SR, 2012, WHO CLASSIFICATION T; Lasa A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074079; Leygue E, 1999, J PATHOL, V189, P28, DOI 10.1002/(SICI)1096-9896(199909)189:1<28::AID-PATH389>3.0.CO;2-H; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Lucci A, 2012, LANCET ONCOL, V13, P688, DOI 10.1016/S1470-2045(12)70209-7; Marchetti A, 2001, J PATHOL, V195, P186, DOI 10.1002/path.943; Markiewicz Aleksandra, 2013, Cancers (Basel), V5, P1485, DOI 10.3390/cancers5041485; Markou A, 2011, CLIN CHEM, V57, P421, DOI 10.1373/clinchem.2010.154328; McShane LM, 2006, BREAST CANCER RES TR, V100, P229, DOI 10.1007/s10549-006-9242-8; Mego M, 2012, INT J CANCER, V130, P808, DOI 10.1002/ijc.26037; Meng S, 2006, P NATL ACAD SCI USA, V103, P17361, DOI 10.1073/pnas.0608113103; Molloy TJ, 2011, BRIT J CANCER, V104, P1913, DOI 10.1038/bjc.2011.164; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Pecot CV, 2011, CANCER DISCOV, V1, P580, DOI 10.1158/2159-8290.CD-11-0215; Pierga JY, 2004, CLIN CANCER RES, V10, P1392, DOI 10.1158/1078-0432.CCR-0102-03; Rack BK, 2010, J CLIN ONCOLOGY; Raimondi C, 2011, BREAST CANCER RES TR, V130, P449, DOI 10.1007/s10549-011-1373-x; Raynor MP, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-24; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Reinholz MM, CLIN CANC RES, V17, P7183; Stathopoulou A, 2002, J CLIN ONCOL, V20, P3404, DOI 10.1200/JCO.2002.08.135; Stoecklein NH, 2010, INT J CANCER, V126, P589, DOI 10.1002/ijc.24916; Strati A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3395; Tamaki Y, 2009, CLIN CANCER RES, V15, P2879, DOI 10.1158/1078-0432.CCR-08-1881; Theys J, 2011, RADIOTHER ONCOL, V99, P392, DOI 10.1016/j.radonc.2011.05.044; Vazquez-Martin A, 2010, CELL CYCLE, V9, P3807, DOI 10.4161/cc.9.18.13131; Wulfing P, 2006, CLIN CANCER RES, V12, P1715, DOI 10.1158/1078-0432.CCR-05-2087; Xenidis N, 2009, J CLIN ONCOL, V27, P2177, DOI 10.1200/JCO.2008.18.0497; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522; Zaczek AJ, 2012, ONCOLOGIST, V17, P1246, DOI 10.1634/theoncologist.2012-0023; Zhao S, 2013, CELL BIOCHEM BIOPHYS, V65, P263, DOI 10.1007/s12013-012-9426-2; Zhao S, 2011, BREAST CANCER RES TR, V130, P809, DOI 10.1007/s10549-011-1379-4	62	35	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93901	10.1371/journal.pone.0093901	http://dx.doi.org/10.1371/journal.pone.0093901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709997	Green Submitted, gold, Green Published			2022-12-25	WOS:000334159800065
J	Okuno, M; Kano, H; Fujii, K; Bito, K; Naito, S; Leproux, P; Couderc, V; Hamaguchi, H				Okuno, Masanari; Kano, Hideaki; Fujii, Kenkichi; Bito, Kotatsu; Naito, Satoru; Leproux, Philippe; Couderc, Vincent; Hamaguchi, Hiro-o			Surfactant Uptake Dynamics in Mammalian Cells Elucidated with Quantitative Coherent Anti-Stokes Raman Scattering Microspectroscopy	PLOS ONE			English	Article							SODIUM LAURYL SULFATE; MAXIMUM-ENTROPY METHOD; CARS MICROSCOPY; CONTACT-DERMATITIS; IN-VIVO; ENDOCYTOSIS; IRRITATION; TRANSPORT; MEMBRANE; ENZYMES	The mechanism of surfactant-induced cell lysis has been studied with quantitative coherent anti-Stokes Raman scattering (CARS) microspectroscopy. The dynamics of surfactant molecules as well as intracellular biomolecules in living Chinese Hamster Lung (CHL) cells has been examined for a low surfactant concentration (0.01 w%). By using an isotope labeled surfactant having CD bonds, surfactant uptake dynamics in living cells has been traced in detail. The simultaneous CARS imaging of the cell itself and the internalized surfactant has shown that the surfactant molecules is first accumulated inside a CHL cell followed by a sudden leak of cytosolic components such as proteins to the outside of the cell. This finding indicates that surfactant uptake occurs prior to the cell lysis, contrary to what has been believed: surface adsorption of surfactant molecules has been thought to occur first with subsequent disruption of cell membranes. Quantitative CARS microspectroscopy enables us to determine the molecular concentration of the surfactant molecules accumulated in a cell. We have also investigated the effect of a drug, nocodazole, on the surfactant uptake dynamics. As a result of the inhibition of tubulin polymerization by nocodazole, the surfactant uptake rate is significantly lowered. This fact suggests that intracellular membrane trafficking contributes to the surfactant uptake mechanism.	[Okuno, Masanari; Kano, Hideaki; Hamaguchi, Hiro-o] Univ Tokyo, Dept Chem, Sch Sci, Bunkyo Ku, Tokyo 113, Japan; [Fujii, Kenkichi] Kao Corp, Safety Sci Res Labs, Haga, Tochigi, Japan; [Bito, Kotatsu; Naito, Satoru] Kao Corp, Analyt Sci Res Labs, Haga, Tochigi, Japan; [Leproux, Philippe; Couderc, Vincent] UMR CNRS, Inst Rech XLIM, Limoges, France; [Hamaguchi, Hiro-o] Natl Chiao Tung Univ, Inst Mol Sci, Hsinchu, Taiwan; [Hamaguchi, Hiro-o] Natl Chiao Tung Univ, Dept Appl Chem, Hsinchu, Taiwan	University of Tokyo; KAO Corporation; KAO Corporation; Centre National de la Recherche Scientifique (CNRS); National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Hamaguchi, H (corresponding author), Univ Tokyo, Dept Chem, Sch Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.	hhama@nctu.edu.tw	Leproux, Philippe/ABA-6725-2020; Masanari, Okuno/AGU-4731-2022; Okuno, Masanari/D-8465-2018; FUJII, Kenkichi/F-9108-2017	Leproux, Philippe/0000-0002-3854-413X; Okuno, Masanari/0000-0002-3682-9350; Kano, Hideaki/0000-0003-3682-7627; FUJII, Kenkichi/0000-0003-3442-025X	SENTAN project (Program-S) of the Japan Science and Technology Agency (JST); MEXT [477]; Global COE Program for "Chemistry Innovation"	SENTAN project (Program-S) of the Japan Science and Technology Agency (JST); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE Program for "Chemistry Innovation"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work is supported by the SENTAN project (Program-S) of the Japan Science and Technology Agency (JST). H. Kano gratefully acknowledges financial support by Grand-Aid for Scientific Research on Priority "Molecular Science for Supra Functional Systems" [477] from MEXT, and the Global COE Program for "Chemistry Innovation." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNER T, 1990, J INVEST DERMATOL, V95, P543, DOI 10.1111/1523-1747.ep12504896; Bonn M, 2009, J RAMAN SPECTROSC, V40, P763, DOI 10.1002/jrs.2253; Castillo C, 2009, GIARDIA AND CRYPTOSPORIDIUM: FROM MOLECULES TO DISEASE, P292, DOI 10.1079/9781845933913.0292; Cheng JX, 2002, J PHYS CHEM B, V106, P8493, DOI 10.1021/jp025771z; Day JPR, 2011, J PHYS CHEM B, V115, P7713, DOI 10.1021/jp200606e; Day JPR, 2010, J AM CHEM SOC, V132, P8433, DOI 10.1021/ja102069d; DECOURCELLES DD, 1985, J BIOL CHEM, V260, P7603; diNardo A, 1996, CONTACT DERMATITIS, V35, P86, DOI 10.1111/j.1600-0536.1996.tb02296.x; Ganikhanov F, 2006, OPT LETT, V31, P1872, DOI 10.1364/OL.31.001872; Kano H, 2007, ANAL CHEM, V79, P8967, DOI 10.1021/ac071416z; Kee TW, 2004, OPT LETT, V29, P2701, DOI 10.1364/OL.29.002701; Kokyama H, 1970, GANN, V61, P161; KOVAL M, 1989, J CELL BIOL, V108, P2169, DOI 10.1083/jcb.108.6.2169; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; MAYOR S, 1993, J CELL BIOL, V121, P1257, DOI 10.1083/jcb.121.6.1257; Moore PN, 2003, J COSMET SCI, V54, P29; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Okuno M, 2010, ANGEW CHEM INT EDIT, V49, P6773, DOI 10.1002/anie.201001560; PARKER FS, 1983, APPL INFRARED RAMAN; PARTEARROYO MA, 1990, BIOCHEM PHARMACOL, V40, P1323, DOI 10.1016/0006-2952(90)90399-6; Petrov GI, 2007, P NATL ACAD SCI USA, V104, P7776, DOI 10.1073/pnas.0702107104; Potma EO, 2005, CHEMPHYSCHEM, V6, P77, DOI 10.1002/cphc.200400390; Rinia HA, 2007, CHEMPHYSCHEM, V8, P279, DOI 10.1002/cphc.200600481; SALTON MRJ, 1951, J GEN MICROBIOL, V5, P391, DOI 10.1099/00221287-5-2-391; SAMSON F, 1979, J PHARMACOL EXP THER, V208, P411; Smith ARW, 2008, J APPL MICROBIOL, V105, P2161, DOI 10.1111/j.1365-2672.2008.03963.x; Tupker RA, 1997, CONTACT DERMATITIS, V37, P53, DOI 10.1111/j.1600-0536.1997.tb00041.x; van Manen HJ, 2008, ANAL CHEM, V80, P9576, DOI 10.1021/ac801841y; van Manen HJ, 2004, J PHYS CHEM B, V108, P18762, DOI 10.1021/jp046955b; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Vieira DB, 2006, J ANTIMICROB CHEMOTH, V58, P760, DOI 10.1093/jac/dkl312	32	12	12	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93401	10.1371/journal.pone.0093401	http://dx.doi.org/10.1371/journal.pone.0093401			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710120	Green Submitted, gold, Green Published			2022-12-25	WOS:000334159800031
J	Schogor, ALB; Huws, SA; Santos, GTD; Scollan, ND; Hauck, BD; Winters, AL; Kim, EJ; Petit, HV				Schogor, Ana L. B.; Huws, Sharon A.; Santos, Geraldo T. D.; Scollan, Nigel D.; Hauck, Barbara D.; Winters, Ana L.; Kim, Eun J.; Petit, Helene V.			Ruminal Prevotella spp. May Play an Important Role in the Conversion of Plant Lignans into Human Health Beneficial Antioxidants	PLOS ONE			English	Article							HUMAN INTESTINAL BACTERIA; COWS FED DIETS; POLYUNSATURATED FATTY-ACIDS; IN-VITRO METABOLISM; DAIRY-COWS; MAMMALIAN LIGNANS; SECOISOLARICIRESINOL DIGLUCOSIDE; FLAXSEED LIGNANS; PERENNIAL RYEGRASS; FECAL MICROBIOTA	Secoisolariciresinol diglucoside (SDG), the most abundant lignan in flaxseed, is metabolized by the ruminal microbiota into enterolignans, which are strong antioxidants. Enterolactone (EL), the main mammalian enterolignan produced in the rumen, is transferred into physiological fluids, with potentially human health benefits with respect to menopausal symptoms, hormone-dependent cancers, cardiovascular diseases, osteoporosis and diabetes. However, no information exists to our knowledge on bacterial taxa that play a role in converting plant lignans into EL in ruminants. In order to investigate this, eight rumen cannulated cows were used in a double 4x4 Latin square design and fed with four treatments: control with no flax meal (FM), or 5%, 10% and 15% FM (on a dry matter basis). Concentration of EL in the rumen increased linearly with increasing FM inclusion. Total rumen bacterial 16S rRNA concentration obtained using Q-PCR did not differ among treatments. PCR-T-RFLP based dendrograms revealed no global clustering based on diet indicating between animal variation. PCR-DGGE showed a clustering by diet effect within four cows that had similar basal ruminal microbiota. DNA extracted from bands present following feeding 15% FM and absent with no FM supplementation were sequenced and it showed that many genera, in particular Prevotella spp., contributed to the metabolism of lignans. A subsequent in vitro study using selected pure cultures of ruminal bacteria incubated with SDG indicated that 11 ruminal bacteria were able to convert SDG into secoisolariciresinol (SECO), with Prevotella spp. being the main converters. These data suggest that Prevotella spp. is one genus playing an important role in the conversion of plant lignans to human health beneficial antioxidants in the rumen.	[Schogor, Ana L. B.; Huws, Sharon A.; Scollan, Nigel D.; Hauck, Barbara D.; Winters, Ana L.] Aberystwyth Univ, IBERS, Aberystwyth, Dyfed, Wales; [Santos, Geraldo T. D.] Univ Estadual Maringa, Dept Zootecnia, Maringa, Parana, Brazil; [Kim, Eun J.] Kyungpook Natl Univ, Dept Anim Sci, Sangju, South Korea; [Petit, Helene V.] Agr & Agri Food Canada, Dairy & Swine Res & Dev Ctr, Sherbrooke, PQ, Canada	Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS); Universidade Estadual de Maringa; Kyungpook National University; Agriculture & Agri Food Canada	Petit, HV (corresponding author), Agr & Agri Food Canada, Dairy & Swine Res & Dev Ctr, Sherbrooke, PQ, Canada.	helene.petit@agr.gc.ca	Huws, Sharon/A-7768-2015; Kim, Eun Joong/HGF-1639-2022; SANTOS, GERALDO TADEU/AAP-3943-2020	Huws, Sharon/0000-0002-0966-5354; Kim, Eun Joong/0000-0002-5962-6994; SANTOS, GERALDO TADEU/0000-0003-3720-5790; Huws, Sharon/0000-0002-9284-2453	Agriculture and Agri-Food Canada; Institute of Biological, Environmental and Rural Sciences (IBERS), Aberystwyth University; BBSRC [BBS/E/W/10963A01D, BBS/E/W/10964A01A, BBS/E/W/10964A01B, BBS/E/W/10964A01C] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/W/10963A01D, BBS/E/W/10964A01C, BBS/E/W/10964A01A, BBS/E/W/10964A01B] Funding Source: researchfish	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Institute of Biological, Environmental and Rural Sciences (IBERS), Aberystwyth University; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The present study was funded by Agriculture and Agri-Food Canada and the molecular analysis was funded by the Institute of Biological, Environmental and Rural Sciences (IBERS), Aberystwyth University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlercreutz H, 1997, ANN MED, V29, P95, DOI 10.3109/07853899709113696; Antignac JP, 2004, FOOD CHEM, V87, P275, DOI 10.1016/j.foodchem.2003.12.013; Aura AM, 2006, EUR J NUTR, V45, P45, DOI 10.1007/s00394-005-0561-z; Beaud D, 2005, MICROBIOL-SGM, V151, P2323, DOI 10.1099/mic.0.27712-0; Blackwood CB, 2003, APPL ENVIRON MICROB, V69, P926, DOI 10.1128/AEM.69.2.926-932.2003; BORRIELLO SP, 1985, J APPL BACTERIOL, V58, P37, DOI 10.1111/j.1365-2672.1985.tb01427.x; Casamayor EO, 2002, ENVIRON MICROBIOL, V4, P338, DOI 10.1046/j.1462-2920.2002.00297.x; Clavel T, 2006, FEMS MICROBIOL ECOL, V55, P471, DOI 10.1111/j.1574-6941.2005.00057.x; Clavel T, 2005, APPL ENVIRON MICROB, V71, P6077, DOI 10.1128/AEM.71.10.6077-6085.2005; Clavel T, 2006, ANAEROBE, V12, P140, DOI 10.1016/j.anaerobe.2005.11.002; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Cortes C, 2008, J APPL MICROBIOL, V105, P1585, DOI 10.1111/j.1365-2672.2008.03922.x; Cortes C, 2013, BRIT J NUTR, V109, P433, DOI 10.1017/S0007114512001341; Enwall K, 2009, LETT APPL MICROBIOL, V48, P145, DOI 10.1111/j.1472-765X.2008.02498.x; Gagnon N, 2009, J DAIRY RES, V76, P455, DOI 10.1017/S0022029909990082; Gagnon N, 2009, BRIT J NUTR, V102, P1015, DOI 10.1017/S0007114509344104; Heinonen S, 2001, J AGR FOOD CHEM, V49, P3178, DOI 10.1021/jf010038a; Hobson PN, 1969, METHODS MICROBIOLOGY, V3, P133, DOI DOI 10.1016/S0580-9517(08)70504-X; Hojer A, 2012, J DAIRY SCI, V95, P4526, DOI 10.3168/jds.2011-5226; Holma R, 2013, BRIT J NUTR, V7, P1; Hu C, 2007, FOOD CHEM TOXICOL, V45, P2219, DOI 10.1016/j.fct.2007.05.017; Huws SA, 2007, J MICROBIOL METH, V70, P565, DOI 10.1016/j.mimet.2007.06.013; Huws SA, 2013, J APPL MICROBIOL, V115, P1081, DOI 10.1111/jam.12314; Huws SA, 2013, LETT APPL MICROBIOL, V56, P186, DOI 10.1111/lam.12033; Huws SA, 2011, ENVIRON MICROBIOL, V13, P1500, DOI 10.1111/j.1462-2920.2011.02452.x; Jin JS, 2011, FOOD CHEM, V124, P895, DOI 10.1016/j.foodchem.2010.07.015; Kim EJ, 2008, J NUTR, V138, P889, DOI 10.1093/jn/138.5.889; Krause DO, 2003, FEMS MICROBIOL REV, V27, P663, DOI 10.1016/S0168-6445(03)00072-X; Landete JM, 2012, FOOD RES INT, V46, P410, DOI 10.1016/j.foodres.2011.12.023; Lee MRF, 2002, ANIM SCI, V74, P587, DOI 10.1017/S1357729800052747; Liu Z, 2006, J NUTR, V136, P906, DOI 10.1093/jn/136.4.906; Matumoto-Pintro PT, 2011, J DAIRY RES, V78, P111, DOI 10.1017/S0022029910000853; Morris D.H., 2007, FLAX HLTH NUTR PRIME; *NAT RES COUNC, 2001, NUTR REQU DAIR CATTL; Nesbitt PD, 1999, AM J CLIN NUTR, V69, P549; OFFERT ED, 1993, GUIDE CARE USE EXPT; Penalvo JL, 2005, J AGR FOOD CHEM, V53, P9342, DOI 10.1021/jf051488w; Petit HV, 2011, ANIM FEED SCI TECH, V169, P46, DOI 10.1016/j.anifeedsci.2011.05.008; Petit HV, 2009, ANIMAL, V3, P1428, DOI 10.1017/S1751731109990346; Petit HV, 2009, ANIM FEED SCI TECH, V152, P103, DOI 10.1016/j.anifeedsci.2009.04.004; Petit HV, 2009, J DAIRY RES, V76, P257, DOI 10.1017/S0022029909003999; Prasad, 2000, Int J Angiol, V9, P220, DOI 10.1007/s005470000038; Prasad K, 1997, MOL CELL BIOCHEM, V168, P117, DOI 10.1023/A:1006847310741; Raffaelli B, 2002, J CHROMATOGR B, V777, P29, DOI 10.1016/S1570-0232(02)00092-2; SANGUINETTI CJ, 1994, BIOTECHNIQUES, V17, P914; Smalla K, 2007, J MICROBIOL METH, V69, P470, DOI 10.1016/j.mimet.2007.02.014; Steinshamn H, 2008, J DAIRY SCI, V91, P2715, DOI 10.3168/jds.2007-0857; THOMPSON LU, 1991, NUTR CANCER, V16, P43, DOI 10.1080/01635589109514139; Wang CZ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-115; Wang LQ, 2000, CHEM PHARM BULL, V48, P1606, DOI 10.1248/cpb.48.1606; Wang LQ, 2002, J CHROMATOGR B, V777, P289, DOI 10.1016/S1570-0232(02)00281-7; Zhou W, 2009, ANIM FEED SCI TECH, V150, P18, DOI 10.1016/j.anifeedsci.2008.07.006	52	35	41	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e87949	10.1371/journal.pone.0087949	http://dx.doi.org/10.1371/journal.pone.0087949			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709940	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800004
J	Gjidoda, A; Tagore, M; McAndrew, MJ; Woods, A; Floer, M				Gjidoda, Alison; Tagore, Mohita; McAndrew, Michael J.; Woods, Alexander; Floer, Monique			Nucleosomes Are Stably Evicted from Enhancers but Not Promoters upon Induction of Certain Pro-Inflammatory Genes in Mouse Macrophages	PLOS ONE			English	Article							CHROMATIN ARCHITECTURE; TRANSCRIPTION FACTORS; IMMUNE-RESPONSE; BETA ENHANCER; HUMAN GENOME; EXPRESSION; DNA; C/EBP; CELLS; RECOGNITION	Chromatin is thought to act as a barrier for binding of cis-regulatory transcription factors (TFs) to their sites on DNA and recruitment of the transcriptional machinery. Here we have analyzed changes in nucleosome occupancy at the enhancers as well as at the promoters of three pro-inflammatory genes when they are induced by bacterial lipopolysaccharides (LPS) in primary mouse macrophages. We find that nucleosomes are removed from the distal enhancers of IL12B and IL1A, as well as from the distal and proximal enhancers of IFNB1, and that clearance of enhancers correlates with binding of various cis-regulatory TFs. We further show that for IFNB1 the degree of nucleosome removal correlates well with the level of induction of the gene under different conditions. Surprisingly, we find that nucleosome occupancy at the promoters of IL12B and IL1A does not change significantly when the genes are induced, and that a considerably fraction of the cells is occupied by nucleosomes at any given time. We hypothesize that competing nucleosomes at the promoters of IL12B and IL1A may play a role in limiting the size of transcriptional bursts in individual cells, which may be important for controlling cytokine production in a population of immune cells.	[Gjidoda, Alison; Tagore, Mohita; McAndrew, Michael J.; Woods, Alexander; Floer, Monique] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University	Floer, M (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	floer@msu.edu		McAndrew, Michael/0000-0003-3479-0576; Tagore, Mohita/0000-0002-2586-1427	American Heart Association [13SDG17260004]	American Heart Association(American Heart Association)	This work was supported by a Scientist-Development-Grant from the American Heart Association (13SDG17260004) to MF. http://www.heart.org/HEARTORG/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Berrozpe G, 2013, CELL REP, V4, P445, DOI 10.1016/j.celrep.2013.07.001; Bert AG, 2007, MOL CELL BIOL, V27, P2870, DOI 10.1128/MCB.02323-06; BRETZ JD, 1994, P NATL ACAD SCI USA, V91, P7306, DOI 10.1073/pnas.91.15.7306; Bryant GO, 2008, PLOS BIOL, V6, P2928, DOI 10.1371/journal.pbio.0060317; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Deng WL, 2012, CELL, V149, P1233, DOI 10.1016/j.cell.2012.03.051; Floer M, 2008, P NATL ACAD SCI USA, V105, P2975, DOI 10.1073/pnas.0800053105; Floer M, 2010, CELL, V141, P407, DOI 10.1016/j.cell.2010.03.048; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Gervais AL, 2010, NUCLEIC ACIDS RES, V38, pW308, DOI 10.1093/nar/gkq485; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; GROVE M, 1993, MOL CELL BIOL, V13, P5276, DOI 10.1128/MCB.13.9.5276; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lefevre P, 2005, J BIOL CHEM, V280, P27552, DOI 10.1074/jbc.M502422200; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nociari M, 2007, J VIROL, V81, P4145, DOI 10.1128/JVI.02685-06; Panne D, 2004, EMBO J, V23, P4384, DOI 10.1038/sj.emboj.7600453; Rahman SM, 2012, J BIOL CHEM, V287, P34349, DOI 10.1074/jbc.M112.410613; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; SHARMA RC, 1993, BIOTECHNIQUES, V14, P176; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Teif VB, 2012, NAT STRUCT MOL BIOL, V19, P1185, DOI 10.1038/nsmb.2419; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang X, 2011, NAT STRUCT MOL BIOL, V18, P507, DOI 10.1038/nsmb.2017; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Weinmann AS, 1999, IMMUNITY, V11, P665, DOI 10.1016/S1074-7613(00)80141-7; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zeng L, 2010, J IMMUNOL, V185, P2324, DOI 10.4049/jimmunol.0903052; Zhao MW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001249; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024; Zhou L, 2007, MOL CELL BIOL, V27, P2698, DOI 10.1128/MCB.00788-06	50	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93971	10.1371/journal.pone.0093971	http://dx.doi.org/10.1371/journal.pone.0093971			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705533	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500099
J	Marinazzo, D; Pellicoro, M; Wu, GR; Angelini, L; Cortes, JM; Stramaglia, S				Marinazzo, Daniele; Pellicoro, Mario; Wu, Guorong; Angelini, Leonardo; Cortes, Jesus M.; Stramaglia, Sebastiano			Information Transfer and Criticality in the Ising Model on the Human Connectome	PLOS ONE			English	Article							BRAIN; CONNECTIVITY; ORGANIZATION; NETWORKS	We implement the Ising model on a structural connectivity matrix describing the brain at two different resolutions. Tuning the model temperature to its critical value, i.e. at the susceptibility peak, we find a maximal amount of total information transfer between the spin variables. At this point the amount of information that can be redistributed by some nodes reaches a limit and the net dynamics exhibits signature of the law of diminishing marginal returns, a fundamental principle connected to saturated levels of production. Our results extend the recent analysis of dynamical oscillators models on the connectome structure, taking into account lagged and directional influences, focusing only on the nodes that are more prone to became bottlenecks of information. The ratio between the outgoing and the incoming information at each node is related to the the sum of the weights to that node and to the average time between consecutive time flips of spins. The results for the connectome of 66 nodes and for that of 998 nodes are similar, thus suggesting that these properties are scale-independent. Finally, we also find that the brain dynamics at criticality is organized maximally to a rich-club w.r.t. the network of information flows.	[Marinazzo, Daniele; Wu, Guorong] Univ Ghent, Fac Psychol & Educ Sci, Dept Data Anal, B-9000 Ghent, Belgium; [Pellicoro, Mario; Angelini, Leonardo; Stramaglia, Sebastiano] Univ Bari, Dipartimento Fis, Bari, Italy; [Pellicoro, Mario; Angelini, Leonardo; Stramaglia, Sebastiano] Ist Nazl Fis Nucl, I-70126 Bari, Italy; [Wu, Guorong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China; [Cortes, Jesus M.] Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Cortes, Jesus M.; Stramaglia, Sebastiano] Hosp Univ Cruces, Biocruces Hlth Res Inst, Baracaldo, Spain	Ghent University; Universita degli Studi di Bari Aldo Moro; Istituto Nazionale di Fisica Nucleare (INFN); University of Electronic Science & Technology of China; Basque Foundation for Science; Hospital Universitario Cruces	Marinazzo, D (corresponding author), Univ Ghent, Fac Psychol & Educ Sci, Dept Data Anal, B-9000 Ghent, Belgium.	daniele.marinazzo@ugent.be	Cortes, Jesus/D-9949-2012; Marinazzo, Daniele/H-4793-2019; stramaglia, sebastiano/H-7582-2015	Cortes, Jesus/0000-0002-9059-8194; Marinazzo, Daniele/0000-0002-9803-0122; stramaglia, sebastiano/0000-0002-5873-8564	Belgian Science Policy - IUAP Cerebnet; China Scholarship Council; Ikerbasque: The Basque Foundation for Science; Junta de Andalucia [P09-FQM-4682]	Belgian Science Policy - IUAP Cerebnet; China Scholarship Council(China Scholarship Council); Ikerbasque: The Basque Foundation for Science; Junta de Andalucia(Junta de Andalucia)	DM acknowledges financial support from Belgian Science Policy - IUAP Cerebnet. www.belspo.be. GW acknowledges support from the China Scholarship Council http://en.csc.edu.cn/. JMC is supported by Ikerbasque: The Basque Foundation for Science. www.ikerbasque.net/. JMC acknowledges financial support from Junta de Andalucia, grant P09-FQM-4682 www.juntadeandalucia.es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barab?si AL., 2002, AM J PHYS, V71, P409, DOI [10.1119/1.1538577, DOI 10.1119/1.1538577]; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barabasi AL, 2001, PHYSICA A, V299, P559, DOI 10.1016/S0378-4371(01)00369-7; Barnett L, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.238701; Bossomaier T, 2012, TRANSFER ENTROPY LOG; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Cabral J, 2011, NEUROIMAGE, V57, P130, DOI 10.1016/j.neuroimage.2011.04.010; Chialvo DR, 2004, PHYSICA A, V340, P756, DOI 10.1016/j.physa.2004.05.064; Deco G, 2012, J NEUROSCI, V32, P3366, DOI 10.1523/JNEUROSCI.2523-11.2012; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Dorogovtsev SN, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016104; Expert P, 2011, J R SOC INTERFACE, V8, P472, DOI 10.1098/rsif.2010.0416; Fraiman D, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061922; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; GLAUBER RJ, 1963, J MATH PHYS, V4, P294, DOI 10.1063/1.1703954; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Gu SJ, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/2/025002; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Haimovici A, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.178101; Hasegawa T, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.026105; Herrero CP, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.067109; Herrero CP, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.066110; Hlavackova-Schindler K, 2007, PHYS REP, V441, P1, DOI 10.1016/j.physrep.2006.12.004; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Lau HW, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.022128; Liu YY, 2013, P NATL ACAD SCI USA, V110, P2460, DOI 10.1073/pnas.1215508110; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Marinazzo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045026; Marinazzo D, 2011, NEUROIMAGE, V58, P330, DOI 10.1016/j.neuroimage.2010.01.099; Marinazzo D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.144103; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Moretti P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3521; Nikoletopoulos T, 2004, J PHYS A-MATH GEN, V37, P6455, DOI 10.1088/0305-4470/37/25/003; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Pekalski A, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.057104; Pellicoro M, 2010, PHYSICA A, V389, P4747, DOI 10.1016/j.physa.2010.06.028; Roudi Y, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051915; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Samuelson P. A., 2001, MICROECONOMICS; Schreiber T, 2000, PHYS REV LETT, V85, P461, DOI 10.1103/PhysRevLett.85.461; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2011, RICH CLUB ORG HUMAN; Staniek M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.158101; WOLFF U, 1989, PHYS REV LETT, V62, P361, DOI 10.1103/PhysRevLett.62.361	44	46	46	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93616	10.1371/journal.pone.0093616	http://dx.doi.org/10.1371/journal.pone.0093616			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705627	Green Published, gold			2022-12-25	WOS:000334107500049
J	Elies, J; Dallas, ML; Boyle, JP; Scragg, JL; Duke, A; Steele, DS; Peers, C				Elies, Jacobo; Dallas, Mark L.; Boyle, John P.; Scragg, Jason L.; Duke, Adrian; Steele, Derek S.; Peers, Chris			Inhibition of the Cardiac Na+ Channel Nav1.5 by Carbon Monoxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME OXYGENASE-1; SODIUM-CHANNEL; NITRIC-OXIDE; CA2+ CHANNELS; SMOOTH-MUSCLE; QT DISPERSION; EXPRESSION; MICE; CARBOXYHEMOGLOBIN; MODULATION	Sublethal carbon monoxide (CO) exposure is frequently associated with myocardial arrhythmias, and our recent studies have demonstrated that these may be attributable to modulation of cardiac Na+ channels, causing an increase in the late current and an inhibition of the peak current. Using a recombinant expression system, we demonstrate that CO inhibits peak human Nav1.5 current amplitude without activation of the late Na+ current observed in native tissue. Inhibition was associated with a hyperpolarizing shift in the steady-state inactivation properties of the channels and was unaffected by modification of channel gating induced by anemone toxin (rATX-II). Systematic pharmacological assessment indicated that no recognized CO-sensitive intracellular signaling pathways appeared to mediate CO inhibition of Nav1.5. Inhibition was, however, markedly suppressed by inhibition of NO formation, but NO donors did not mimic or occlude channel inhibition by CO, indicating that NO alone did not account for the actions of CO. Exposure of cells to DTT immediately before CO exposure also dramatically reduced the magnitude of current inhibition. Similarly, L-cysteine and N-ethylmaleimide significantly attenuated the inhibition caused by CO. In the presence of DTT and the NO inhibitor N-omega-nitro-L-arginine methyl ester hydrochloride, the ability of CO to inhibit Nav1.5 was almost fully prevented. Our data indicate that inhibition of peak Na+ current (which can lead to Brugada syndrome-like arrhythmias) occurs via a mechanism distinct from induction of the late current, requires NO formation, and is dependent on channel redox state.	[Elies, Jacobo; Dallas, Mark L.; Boyle, John P.; Scragg, Jason L.; Peers, Chris] Univ Leeds, Dept Cardiovasc & Diabet Res, LIGHT, Fac Med & Hlth, Leeds LS2 9JT, W Yorkshire, England; [Duke, Adrian; Steele, Derek S.] Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds; University of Leeds	Peers, C (corresponding author), Univ Leeds, Dept Cardiovasc & Diabet Res, LIGHT, Fac Med & Hlth, Clarendon Way, Leeds LS2 9JT, W Yorkshire, England.	c.s.peers@leeds.ac.uk	Boyle, John/N-4868-2016; Dallas, Mark L/A-6654-2013; Elies, Jacobo/K-7684-2017; Dallas, Mark/Q-6117-2019	Elies, Jacobo/0000-0002-2518-8412; Dallas, Mark/0000-0002-5190-0522; Steele, Derek/0000-0002-1339-784X; Peers, Chris/0000-0002-8354-346X	British Heart Foundation; British Heart Foundation [PG/13/61/30410, RG/11/10/28924, PG/09/013/26885] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation.	ADAMS KF, 1988, J AM COLL CARDIOL, V12, P900, DOI 10.1016/0735-1097(88)90452-4; Ahmmed GU, 2001, CIRC RES, V89, P1005, DOI 10.1161/hh2301.100801; Berne P, 2012, CIRC J, V76, P1563, DOI 10.1253/circj.CJ-12-0717; Bhatia A, 2012, CURR PROB CARDIOLOGY, V37, P317, DOI 10.1016/j.cpcardiol.2012.03.004; Boczkowski J, 2006, TRENDS BIOCHEM SCI, V31, P614, DOI 10.1016/j.tibs.2006.09.001; Carnevali R, 1987, Minerva Med, V78, P175; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; COBB N, 1991, JAMA-J AM MED ASSOC, V266, P659, DOI 10.1001/jama.266.5.659; COSBY RS, 1963, AM J CARDIOL, V11, P93, DOI 10.1016/0002-9149(63)90039-0; D'Amico G, 2006, J CELL SCI, V119, P2291, DOI 10.1242/jcs.02914; Dallas ML, 2012, AM J RESP CRIT CARE, V186, P648, DOI 10.1164/rccm.201204-0688OC; Durante W, 2006, J CELL MOL MED, V10, P672, DOI 10.1111/j.1582-4934.2006.tb00427.x; Gandini C, 2001, J TOXICOL-CLIN TOXIC, V39, P35, DOI 10.1081/CLT-100102878; Harper A, 2004, AGE AGEING, V33, P105, DOI 10.1093/ageing/afh038; Henry CR, 2006, JAMA-J AM MED ASSOC, V295, P398, DOI 10.1001/jama.295.4.398; Henry TD, 2008, CIRCULATION, V118, P792, DOI 10.1161/CIRCULATIONAHA.107.750778; Hettiarachchi NT, 2012, ANTIOXID REDOX SIGN, V17, P744, DOI 10.1089/ars.2011.4398; KATZMAN GM, 1993, TOXICOL LETT, V69, P139, DOI 10.1016/0378-4274(93)90099-J; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Kurata Y, 1998, LIFE SCI, V63, P1023, DOI 10.1016/S0024-3205(98)00364-6; Lakkisto P, 2002, J MOL CELL CARDIOL, V34, P1357, DOI 10.1006/jmcc.2002.2094; Lim I, 2005, AM J PHYSIOL-GASTR L, V288, pG7, DOI 10.1152/ajpgi.00205.2004; Liu M, 2010, CIRC RES, V107, P967, DOI 10.1161/CIRCRESAHA.110.220673; Lowe JS, 2012, CARDIOVASC RES, V95, P300, DOI 10.1093/cvr/cvs160; Luo AT, 2007, CELL PHYSIOL BIOCHEM, V19, P9, DOI 10.1159/000099188; Macmillan CSA, 2001, ACTA ANAESTH SCAND, V45, P396, DOI 10.1034/j.1399-6576.2001.045003396.x; Makielski JC, 2003, CIRC RES, V93, P821, DOI 10.1161/01.RES.0000096652.14509.96; MEREDITH T, 1988, BMJ-BRIT MED J, V296, P77, DOI 10.1136/bmj.296.6615.77; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Omaye ST, 2002, TOXICOLOGY, V180, P139, DOI 10.1016/S0300-483X(02)00387-6; Prockop LD, 2007, J NEUROL SCI, V262, P122, DOI 10.1016/j.jns.2007.06.037; Rathel Thomas R., 2003, Biol Proced Online, V5, P136, DOI 10.1251/bpo55; ROMEY G, 1976, P NATL ACAD SCI USA, V73, P4055, DOI 10.1073/pnas.73.11.4055; Ryter Stefan W, 2004, Sci STKE, V2004, pRE6, DOI 10.1126/stke.2302004re6; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sari I, 2008, INHAL TOXICOL, V20, P879, DOI [10.1080/08958370801958622, 10.1080/08958370801958622 ]; Satran D, 2005, J AM COLL CARDIOL, V45, P1513, DOI 10.1016/j.jacc.2005.01.044; Scragg JL, 2008, J BIOL CHEM, V283, P24412, DOI 10.1074/jbc.M803037200; SHEPS DS, 1990, ANN INTERN MED, V113, P343, DOI 10.7326/0003-4819-113-5-343; Strege PR, 2011, AM J PHYSIOL-GASTR L, V300, pG1105, DOI 10.1152/ajpgi.00556.2010; Taille C, 2005, J BIOL CHEM, V280, P25350, DOI 10.1074/jbc.M503512200; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Ueda K, 2008, P NATL ACAD SCI USA, V105, P9355, DOI 10.1073/pnas.0801294105; Varon J, 1999, J EMERG MED, V17, P87, DOI 10.1016/S0736-4679(98)00128-0; Von Burg R, 1999, J APPL TOXICOL, V19, P379; Wu LY, 2005, PHARMACOL REV, V57, P585, DOI 10.1124/pr.57.4.3; Yatsuhashi T, 2002, CIRC J, V66, P846, DOI 10.1253/circj.66.846; Yet SF, 1999, J CLIN INVEST, V103, pR23, DOI 10.1172/JCI6163; Yet SF, 2001, CIRC RES, V89, P168, DOI 10.1161/hh1401.093314; Zeynalov E, 2009, NEUROTOX RES, V15, P133, DOI 10.1007/s12640-009-9014-4	51	15	15	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16421	16429		10.1074/jbc.M114.569996	http://dx.doi.org/10.1074/jbc.M114.569996			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24719320	Green Published, hybrid			2022-12-25	WOS:000337965700044
J	Rowley, SM; Kuriakose, T; Dockery, LM; Tran-Ngyuen, T; Gingerich, AD; Wei, L; Watford, WT				Rowley, Sean M.; Kuriakose, Teneema; Dockery, Lee M.; Thi Tran-Ngyuen; Gingerich, Aaron D.; Wei, Lai; Watford, Wendy T.			Tumor Progression Locus 2 (Tpl2) Kinase Promotes Chemokine Receptor Expression and Macrophage Migration during Acute Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autoimmunity; Chemokines; Inflammation; Lipopolysaccharide (LPS); Macrophages	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SIGNAL-REGULATED KINASE; NF-KAPPA-B; MICE LACKING; HOST-DEFENSE; MOUSE MODEL; T-CELLS; IN-VIVO; BACTERIAL LIPOPOLYSACCHARIDE; ACTIVATED MACROPHAGES	In autoimmune diseases, the accumulation of activated leukocytes correlates with inflammation and disease progression, and, therefore, the disruption of leukocyte trafficking is an active area of research. The serine/threonine protein kinase Tpl2 (MAP3K8) regulates leukocyte inflammatory responses and is also being investigated for therapeutic inhibition during autoimmunity. Here we addressed the contribution of Tpl2 to the regulation of macrophage chemokine receptor expression and migration in vivo using a mouse model of Tpl2 ablation. LPS stimulation of bone marrow-derived macrophages induced early CCR1 chemokine receptor expression but repressed CCR2 and CCR5 expression. Notably, early induction of CCR1 expression by LPS was dependent upon a signaling pathway involving Tpl2, PI3K, and ERK. On the contrary, Tpl2 was required to maintain the basal expression of CCR2 and CCR5 as well as to stabilize CCR5 mRNA expression. Consistent with impairments in chemokine receptor expression, tpl2(-/-) macrophages were defective in trafficking to the peritoneal cavity following thioglycollate-induced inflammation. Overall, this study demonstrates a Tpl2-dependent mechanism for macrophage expression of select chemokine receptors and provides further insight into how Tpl2 inhibition may be used therapeutically to disrupt inflammatory networks in vivo.	[Rowley, Sean M.; Kuriakose, Teneema; Dockery, Lee M.; Thi Tran-Ngyuen; Gingerich, Aaron D.; Watford, Wendy T.] Univ Georgia, Dept Infect Dis, Coll Vet Med, Athens, GA 30602 USA; [Wei, Lai] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510060, Guangdong, Peoples R China	University System of Georgia; University of Georgia; Sun Yat Sen University	Watford, WT (corresponding author), Univ Georgia, Dept Infect Dis, Coll Vet Med, 501 DW Brooks Dr, Athens, GA 30602 USA.	watfordw@uga.edu		Watford, Wendy/0000-0003-4261-5399; Kuriakose, Teneema/0000-0003-4032-1290	Office of the Vice President for Research, University of Georgia	Office of the Vice President for Research, University of Georgia	This work was supported by a startup fund from the Office of the Vice President for Research, University of Georgia (to W.T.W.).	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Amat M, 2006, BRIT J PHARMACOL, V149, P666, DOI 10.1038/sj.bjp.0706912; Archer KA, 2006, INFECT IMMUN, V74, P3325, DOI 10.1128/IAI.02049-05; Bandow K, 2012, FEBS LETT, V586, P1540, DOI 10.1016/j.febslet.2012.04.018; Banerjee A, 2006, P NATL ACAD SCI USA, V103, P3274, DOI 10.1073/pnas.0511113103; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Cao CZ, 2005, BLOOD, V106, P3234, DOI 10.1182/blood-2005-03-1288; Clark RA, 2006, J CLIN INVEST, V116, P2084, DOI 10.1172/JCI29441; Cusack K, 2009, BIOORG MED CHEM LETT, V19, P1722, DOI 10.1016/j.bmcl.2009.01.088; Dairaghi DJ, 2011, CLIN PHARMACOL THER, V89, P726, DOI 10.1038/clpt.2011.33; Dairaghi DJ, 2012, BLOOD, V120, P1449, DOI 10.1182/blood-2011-10-384784; Das S, 2005, J BIOL CHEM, V280, P23748, DOI 10.1074/jbc.M412837200; Davignon JL, 2013, RHEUMATOLOGY, V52, P590, DOI 10.1093/rheumatology/kes304; Domachowske JB, 2000, J IMMUNOL, V165, P2677, DOI 10.4049/jimmunol.165.5.2677; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Fleishaker DL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3685; Foti M, 1999, INT IMMUNOL, V11, P979, DOI 10.1093/intimm/11.6.979; Franchin G, 2000, J IMMUNOL, V164, P2592, DOI 10.4049/jimmunol.164.5.2592; Gao JL, 1997, J EXP MED, V185, P1959, DOI 10.1084/jem.185.11.1959; Garcia-Ramallo E, 2002, J IMMUNOL, V169, P6467, DOI 10.4049/jimmunol.169.11.6467; Gautier EL, 2009, ARTERIOSCL THROM VAS, V29, P1412, DOI 10.1161/ATVBAHA.108.180505; George D, 2009, CURR TOP MED CHEM, V9, P611, DOI 10.2174/156802609789007345; Green N, 2007, J MED CHEM, V50, P4728, DOI 10.1021/jm070436q; Hall JP, 2007, J BIOL CHEM, V282, P33295, DOI 10.1074/jbc.M703694200; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; HUITINGA I, 1990, J EXP MED, V172, P1025, DOI 10.1084/jem.172.4.1025; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Jones KL, 2011, BRIT J PHARMACOL, V162, P1453, DOI 10.1111/j.1476-5381.2010.01147.x; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; Kane LP, 2002, MOL CELL BIOL, V22, P5962, DOI 10.1128/MCB.22.16.5962-5974.2002; Khan IA, 2001, J IMMUNOL, V166, P1930, DOI 10.4049/jimmunol.166.3.1930; Kuipers HF, 2008, BLOOD, V112, P1610, DOI 10.1182/blood-2008-01-135111; Kurihara T, 1997, J EXP MED, V186, P1757, DOI 10.1084/jem.186.10.1757; Lee J, 2000, J LEUKOCYTE BIOL, V68, P909; Lopez-Pelaez M, 2012, MOL BIOL CELL, V23, P2982, DOI 10.1091/mbc.E12-02-0135; Lopez-Pelaez M, 2011, EUR J IMMUNOL, V41, P1733, DOI 10.1002/eji.201041101; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; Mielke LA, 2009, J IMMUNOL, V183, P7984, DOI 10.4049/jimmunol.0901336; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; Parker LC, 2004, J IMMUNOL, V172, P4977, DOI 10.4049/jimmunol.172.8.4977; Raborn ES, 2008, J NEUROIMMUNE PHARM, V3, P117, DOI 10.1007/s11481-007-9077-z; Robinson MJ, 2007, MOL CELL BIOL, V27, P7355, DOI 10.1128/MCB.00301-07; Rodriguez-Sosa M, 2003, IMMUNOL CELL BIOL, V81, P114, DOI 10.1046/j.0818-9641.2002.01132.x; Ruggiero T, 2009, FASEB J, V23, P2898, DOI 10.1096/fj.09-131342; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Seki E, 2009, J CLIN INVEST, V119, P1858, DOI 10.1172/JCI37444; Sica A, 1997, J EXP MED, V185, P969, DOI 10.1084/jem.185.5.969; Soria-Castro I, 2010, J BIOL CHEM, V285, P33805, DOI 10.1074/jbc.M110.169409; Stratis A, 2006, J CLIN INVEST, V116, P2094, DOI 10.1172/JCI27179; Sugimoto K, 2004, J CLIN INVEST, V114, P857, DOI 10.1172/JCI200420014; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Tak PP, 1997, ARTHRITIS RHEUM, V40, P217, DOI 10.1002/art.1780400206; Trebst C, 2001, AM J PATHOL, V159, P1701, DOI 10.1016/S0002-9440(10)63017-9; Tsatsanis C, 1998, P NATL ACAD SCI USA, V95, P3827, DOI 10.1073/pnas.95.7.3827; Verani A, 1997, J EXP MED, V185, P805, DOI 10.1084/jem.185.5.805; Wang HL, 2006, J CLIN INVEST, V116, P2105, DOI 10.1172/JCI27180; Weber C, 2001, BLOOD, V97, P1144, DOI 10.1182/blood.V97.4.1144; Xu L, 1997, J LEUKOCYTE BIOL, V62, P653, DOI 10.1002/jlb.62.5.653; Xu LL, 2000, EUR J IMMUNOL, V30, P227, DOI 10.1002/1521-4141(200001)30:1<227::AID-IMMU227>3.0.CO;2-X; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhou YH, 1998, J IMMUNOL, V160, P4018	63	23	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15788	15797		10.1074/jbc.M114.559344	http://dx.doi.org/10.1074/jbc.M114.559344			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24713702	Green Published, hybrid			2022-12-25	WOS:000337465400058
J	McClanahan, TR; Ateweberhan, M; Darling, ES; Graham, NAJ; Muthiga, NA				McClanahan, Timothy R.; Ateweberhan, Mebrahtu; Darling, Emily S.; Graham, Nicholas A. J.; Muthiga, Nyawira A.			Biogeography and Change among Regional Coral Communities across the Western Indian Ocean	PLOS ONE			English	Article							MARINE PROTECTED AREAS; CLIMATE-CHANGE; REEF; RESILIENCE; DIVERSITY; RECOVERY; SUSCEPTIBILITY; CONSERVATION; MANAGEMENT; MORTALITY	Coral reefs are biodiverse ecosystems structured by abiotic and biotic factors operating across many spatial scales. Regional-scale interactions between climate change, biogeography and fisheries management remain poorly understood. Here, we evaluated large-scale patterns of coral communities in the western Indian Ocean after a major coral bleaching event in 1998. We surveyed 291 coral reef sites in 11 countries and over 30 degrees of latitude between 2004 and 2011 to evaluate variations in coral communities post 1998 across gradients in latitude, mainland-island geography and fisheries management. We used linear mixed-effect hierarchical models to assess total coral cover, the abundance of four major coral families (acroporids, faviids, pocilloporids and poritiids), coral genus richness and diversity, and the bleaching susceptibility of the coral communities. We found strong latitudinal and geographic gradients in coral community structure and composition that supports the presence of a high coral cover and diversity area that harbours temperature-sensitive taxa in the northern Mozambique Channel between Tanzania, northern Mozambique and northern Madagascar. Coral communities in the more northern latitudes of Kenya, Seychelles and the Maldives were generally composed of fewer bleaching-tolerant coral taxa and with reduced richness and diversity. There was also evidence for continued declines in the abundance of temperature-sensitive taxa and community change after 2004. While there are limitations of our regional dataset in terms of spatial and temporal replication, these patterns suggest that large-scale interactions between biogeographic factors and strong temperature anomalies influence coral communities while smaller-scale factors, such as the effect of fisheries closures, were weak. The northern Mozambique Channel, while not immune to temperature disturbances, shows continued signs of resistance to climate disturbances and remains a priority for future regional conservation and management actions.	[McClanahan, Timothy R.; Ateweberhan, Mebrahtu; Muthiga, Nyawira A.] Wildlife Conservat Soc, Marine Programs, Bronx, NY USA; [Ateweberhan, Mebrahtu] Univ Warwick, Coventry CV4 7AL, W Midlands, England; [Darling, Emily S.] Simon Fraser Univ, Dept Biol Sci, Earth Ocean Res Grp, Burnaby, BC V5A 1S6, Canada; [Graham, Nicholas A. J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	Wildlife Conservation Society; University of Warwick; Simon Fraser University; James Cook University	McClanahan, TR (corresponding author), Wildlife Conservat Soc, Marine Programs, Bronx, NY USA.	tmcclanahan@wcs.org	McClanahan, Tim/K-4998-2019; Graham, Nicholas AJ/C-8360-2014	Graham, Nicholas AJ/0000-0002-0304-7467; McClanahan, Timothy/0000-0001-5821-3584; Darling, Emily/0000-0002-1048-2838	Western Indian Ocean Marine Science Association (WIOMSA) Marine Science for Management Program (MASMA) program; John D. and Catherine T. MacArthur Foundation; Coral Reef Targeted Research Group (World Bank); UK Department for International Development; Leverhulme Trust	Western Indian Ocean Marine Science Association (WIOMSA) Marine Science for Management Program (MASMA) program; John D. and Catherine T. MacArthur Foundation; Coral Reef Targeted Research Group (World Bank); UK Department for International Development; Leverhulme Trust(Leverhulme Trust)	This work was supported by the Western Indian Ocean Marine Science Association (WIOMSA) Marine Science for Management Program (MASMA) program, the John D. and Catherine T. MacArthur Foundation, the Coral Reef Targeted Research Group (World Bank), UK Department for International Development and Leverhulme Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ateweberhan M, 2011, CORAL REEFS, V30, P739, DOI 10.1007/s00338-011-0775-x; Ateweberhan M, 2010, MAR POLLUT BULL, V60, P964, DOI 10.1016/j.marpolbul.2010.03.033; Celliers L, 2002, MAR POLLUT BULL, V44, P1380, DOI 10.1016/S0025-326X(02)00302-8; Cote IM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000438; Darling ES, 2013, GLOBAL CHANGE BIOL, V19, P1930, DOI 10.1111/gcb.12191; Darling ES, 2012, ECOL LETT, V15, P1378, DOI 10.1111/j.1461-0248.2012.01861.x; Darling ES, 2010, CONSERV LETT, V3, P122, DOI 10.1111/j.1755-263X.2009.00089.x; de Ruijter WPM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013714; FAURE G, 1984, CR ACAD SCI III-VIE, V299, P637; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; Graham NAJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003039; Graham NAJ, 2011, OCEANOGR MAR BIOL, V49, P105; Hardman E., 2007, ATOLL RES BULL, V555, P1; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Jennings S, 1995, CORAL REEFS, V14, P225, DOI 10.1007/BF00334346; Jimenez H, 2012, J SEA RES, V72, P77, DOI 10.1016/j.seares.2012.04.011; Ledlie MH, 2007, CORAL REEFS, V26, P641, DOI 10.1007/s00338-007-0230-1; Maina J, 2008, ECOL MODEL, V212, P180, DOI 10.1016/j.ecolmodel.2007.10.033; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McClanahan TR, 2008, OECOLOGIA, V155, P169, DOI 10.1007/s00442-007-0890-0; McClanahan TR, 2007, CORAL REEFS, V26, P695, DOI 10.1007/s00338-006-0193-7; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McClanahan TR, 2008, CONSERV LETT, V1, P53, DOI 10.1111/j.1755-263X.2008.00008_1.x; McClanahan TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042884; McClanahan TR, 2011, GLOBAL CHANGE BIOL, V17, P2023, DOI 10.1111/j.1365-2486.2011.02395.x; McClanahan TR, 2009, MAR ECOL PROG SER, V380, P117, DOI 10.3354/meps07879; McClanahan TR, 2007, ECOL MONOGR, V77, P503, DOI 10.1890/06-1182.1; McClanahan TR, 2014, CURR OPIN ENV SUST, V7, P59, DOI 10.1016/j.cosust.2013.11.028; McClanahan TR, 2005, MAR ECOL PROG SER, V305, P301, DOI 10.3354/meps305301; MCCLANAHAN TR, 1990, OECOLOGIA, V83, P362, DOI 10.1007/BF00317561; Obura D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045013; Penven P, 2006, GEOPHYS RES LETT, V33; R Development Core Team, 2012, R LANG ENV STAT COMP; Sebastian CR, 2009, MAR BIOL, V156, P2049, DOI 10.1007/s00227-009-1236-8; Selig ER, 2012, GLOBAL CHANGE BIOL, V18, P1561, DOI 10.1111/j.1365-2486.2012.02658.x; Selig ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009278; Sheppard CRC, 2008, MAR ECOL PROG SER, V362, P109, DOI 10.3354/meps07436; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Tompkins EL, 2004, ECOL SOC, V9; Tscharntke T, 2012, BIOL REV, V87, P661, DOI 10.1111/j.1469-185X.2011.00216.x; West J, 2003, COMMENTARY, V115, P17; Wild C, 2011, MAR FRESHWATER RES, V62, P205, DOI 10.1071/MF10254; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3; Wilson SK, 2012, CONSERV BIOL, V26, P995, DOI 10.1111/j.1523-1739.2012.01926.x; Wooldridge S, 2005, MAR ECOL PROG SER, V295, P157, DOI 10.3354/meps295157; Zuur Alain F., 2009, P1	48	55	56	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93385	10.1371/journal.pone.0093385	http://dx.doi.org/10.1371/journal.pone.0093385			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718371	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000334339000030
J	Duong, NT; Morris, GE; Lam, LT; Zhang, QP; Sewry, CA; Shanahan, CM; Holt, I				Nguyen Thuy Duong; Morris, Glenn E.; Le Thanh Lam; Zhang, Qiuping; Sewry, Caroline A.; Shanahan, Catherine M.; Holt, Ian			Nesprins: Tissue-Specific Expression of Epsilon and Other Short Isoforms	PLOS ONE			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; NUCLEAR-MEMBRANE PROTEIN; REAL-TIME PCR; LAMIN A/C; ACTIN CYTOSKELETON; SKELETAL-MUSCLE; SUN PROTEINS; ENVELOPE; CELLS; ROLES	Nesprin-1-giant and nesprin-2-giant regulate nuclear positioning by the interaction of their C-terminal KASH domains with nuclear membrane SUN proteins and their N- terminal calponin-homology domains with cytoskeletal actin. A number of short isoforms lacking the actin-binding domains are produced by internal promotion. We have evaluated the significance of these shorter isoforms using quantitative RT-PCR and western blotting with site-specific monoclonal antibodies. Within a complete map of nesprin isoforms, we describe two novel nesprin-2 epsilon isoforms for the first time. Epsilon isoforms are similar in size and structure to nesprin-1-alpha. Expression of nesprin isoforms was highly tissue-dependent. Nesprin-2-epsilon- 1 was found in early embryonic cells, while nesprin-2-epsilon-2 was present in heart and other adult tissues, but not skeletal muscle. Some cell lines lack shorter isoforms and express only one of the two nesprin genes, suggesting that either of the giant nesprins is sufficient for basic cell functions. For the first time, localisation of endogenous nesprin away from the nuclear membrane was shown in cells where removal of the KASH domain by alternative splicing occurs. By distinguishing between degradation products and true isoforms on western blots, it was found that previously-described beta and gamma isoforms are expressed either at only low levels or with a limited tissue distribution. Two of the shortest alpha isoforms, nesprin-1-alpha-2 and nesprin-2-alpha-1, were found almost exclusively in cardiac and skeletal muscle and a highly conserved and alternatively- spliced exon, available in both nesprin genes, was always included in these tissues. These "muscle-specific'' isoforms are thought to form a complex with emerin and lamin A/C at the inner nuclear membrane and mutations in all three proteins cause Emery-Dreifuss muscular dystrophy and/or inherited dilated cardiomyopathy, disorders in which only skeletal muscle and/or heart are affected.	[Nguyen Thuy Duong; Morris, Glenn E.; Le Thanh Lam; Sewry, Caroline A.; Holt, Ian] RJAH Orthopaed Hosp, Wolfson Ctr Inherited Neuromuscular Dis, Oswestry, Shrops, England; [Nguyen Thuy Duong] Vietnam Acad Sci & Technol VAST, Inst Genome Res, Hanoi, Vietnam; [Morris, Glenn E.; Holt, Ian] Keele Univ, Inst Sci & Technol Med, Keele, Staffs, England; [Zhang, Qiuping; Shanahan, Catherine M.] Kings Coll London, James Black Ctr, Div Cardiovasc, London, England; [Sewry, Caroline A.] Inst Child Hlth, Dubowitz Neuromuscular Ctr, London, England; [Sewry, Caroline A.] Great Ormond St Hosp Sick Children, London, England	Keele University; Vietnam Academy of Science & Technology (VAST); Keele University; University of London; King's College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Holt, I (corresponding author), RJAH Orthopaed Hosp, Wolfson Ctr Inherited Neuromuscular Dis, Oswestry, Shrops, England.	ian.holt@rjah.nhs.uk	Zhang, Qiuping/L-3522-2019	Zhang, Qiuping/0000-0002-4000-3957; Shanahan, Catherine/0000-0002-8352-8171; Nguyen, Thuy Duong/0000-0001-8691-9138	British Heart Foundation [PG/11/71/29091]; Vietnam National Foundation for Science and Technology Development (NAFOSTED) [106.06-2010.62]; British Heart Foundation [PG/11/58/29004] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Vietnam National Foundation for Science and Technology Development (NAFOSTED)(National Foundation for Science & Technology Development (NAFOSTED)); British Heart Foundation(British Heart Foundation)	We thank the British Heart Foundation for grant support (PG/11/71/29091 to IH and GEM). NTD received funding from the Vietnam National Foundation for Science and Technology Development (NAFOSTED) (106.06-2010.62). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS PW, 1984, LAB INVEST, V50, P147; Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; Bastien P, 2008, J CLIN MICROBIOL, V46, P1897, DOI 10.1128/JCM.02258-07; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; GEY GO, 1952, CANCER RES, V12, P264; Gueneau L, 2009, AM J HUM GENET, V85, P338, DOI 10.1016/j.ajhg.2009.07.015; Haque F, 2010, J BIOL CHEM, V285, P3487, DOI 10.1074/jbc.M109.071910; Holt I, 2006, NEUROMUSCULAR DISORD, V16, P368, DOI 10.1016/j.nmd.2006.03.014; Lam LT, 2011, BIOCHEM BIOPH RES CO, V412, P291, DOI 10.1016/j.bbrc.2011.07.085; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Li C, 2011, CATAL TODAY, V175, P1, DOI 10.1016/j.cattod.2011.08.002; Liang WC, 2011, ANN NEUROL, V69, P1005, DOI 10.1002/ana.22338; Libotte T, 2005, MOL BIOL CELL, V16, P3411, DOI 10.1091/mbc.E04-11-1009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lombardi ML, 2011, BIOCHEM SOC T, V39, P1729, DOI 10.1042/BST20110686; Luke Y, 2008, J CELL SCI, V121, P1887, DOI 10.1242/jcs.019075; Manilal S, 1997, NEUROMUSCULAR DISORD, V7, P63, DOI 10.1016/S0960-8966(96)00405-1; Meinke P, 2011, BIOCHEM SOC T, V39, P1693, DOI 10.1042/BST20110658; Mislow JMK, 2002, FEBS LETT, V525, P135, DOI 10.1016/S0014-5793(02)03105-8; Mislow JMK, 2002, J CELL SCI, V115, P61; Morris GE, 2010, BIOCHEM SOC T, V38, P278, DOI 10.1042/BST0380278; Morris-Stiff GJ, 2010, EUR J GASTROEN HEPAT, V22, P886, DOI 10.1097/MEG.0b013e3283392a62; Nguyen TM, 2010, PROTEIN PROTOCOLS HD, P1961; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Pare GC, 2005, EXP CELL RES, V303, P388, DOI 10.1016/j.yexcr.2004.10.009; Pereboev A, 1996, Methods Mol Biol, V66, P195; Puckelwartz MJ, 2010, J MOL CELL CARDIOL, V48, P600, DOI 10.1016/j.yjmcc.2009.11.006; Puckelwartz MJ, 2009, HUM MOL GENET, V18, P607, DOI 10.1093/hmg/ddn386; Rajgor D, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.6; Rajgor D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040098; Randles KN, 2010, DEV DYNAM, V239, P998, DOI 10.1002/dvdy.22229; Rashmi RN, 2012, NUCLEUS-PHILA, V3, P172, DOI 10.4161/nucl.19090; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHANAHAN CM, 1993, CIRC RES, V73, P193, DOI 10.1161/01.RES.73.1.193; Simpson JG, 2008, BIOCHEM SOC T, V36, P1359, DOI 10.1042/BST0361359; Sosa BA, 2012, CELL, V149, P1035, DOI 10.1016/j.cell.2012.03.046; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Warren DT, 2010, J BIOL CHEM, V285, P1311, DOI 10.1074/jbc.M109.032557; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Zhang JL, 2010, HUM MOL GENET, V19, P329, DOI 10.1093/hmg/ddp499; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhang XC, 2007, DEVELOPMENT, V134, P901, DOI 10.1242/dev.02783; Zhen YY, 2002, J CELL SCI, V115, P3207; Zhou ZC, 2012, J BIOL CHEM, V287, P5317, DOI 10.1074/jbc.M111.304543	48	49	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94380	10.1371/journal.pone.0094380	http://dx.doi.org/10.1371/journal.pone.0094380			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718612	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000334339000112
J	Thompson, JJ; Blair, MR; Henrey, AJ				Thompson, Joseph J.; Blair, Mark R.; Henrey, Andrew J.			Over the Hill at 24: Persistent Age-Related CognitiveMotor Decline in Reaction Times in an Ecologically Valid Video Game Task Begins in Early Adulthood	PLOS ONE			English	Article							EXPERTISE; PERFORMANCE; ATTENTION; PERCEPTION; COGNITION; SKILL	Typically studies of the effects of aging on cognitive-motor performance emphasize changes in elderly populations. Although some research is directly concerned with when age-related decline actually begins, studies are often based on relatively simple reaction time tasks, making it impossible to gauge the impact of experience in compensating for this decline in a real world task. The present study investigates age-related changes in cognitive motor performance through adolescence and adulthood in a complex real world task, the real-time strategy video game StarCraft 2. In this paper we analyze the influence of age on performance using a dataset of 3,305 players, aged 16-44, collected by Thompson, Blair, Chen & Henrey [ 1]. Using a piecewise regression analysis, we find that age-related slowing of within-game, self-initiated response times begins at 24 years of age. We find no evidence for the common belief expertise should attenuate domainspecific cognitive decline. Domain-specific response time declines appear to persist regardless of skill level. A second analysis of dual-task performance finds no evidence of a corresponding age-related decline. Finally, an exploratory analyses of other age-related differences suggests that older participants may have been compensating for a loss in response speed through the use of game mechanics that reduce cognitive load.	[Thompson, Joseph J.; Blair, Mark R.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [Henrey, Andrew J.] Simon Fraser Univ, Dept Stat & Actuarial Sci, Burnaby, BC V5A 1S6, Canada	Simon Fraser University; Simon Fraser University	Thompson, JJ (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada.	jjthomps@sfu.ca			Social Sciences and Humanities Research Council of Canada	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This study was supported by funding from the Social Sciences and Humanities Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartzokis G, 2010, NEUROBIOL AGING, V31, P1554, DOI 10.1016/j.neurobiolaging.2008.08.015; BOSMAN EA, 1993, PSYCHOL AGING, V8, P87, DOI 10.1037/0882-7974.8.1.87; CHARNESS N, 1983, J VERB LEARN VERB BE, V22, P406, DOI 10.1016/S0022-5371(83)90264-5; CHASE WG, 1973, COGNITIVE PSYCHOL, V4, P55, DOI 10.1016/0010-0285(73)90004-2; Hastie T., 2009, UNSUPERVISED LEARNIN; Horner K L, 1986, Psychol Aging, V1, P319, DOI 10.1037/0882-7974.1.4.319; Jastrzembski TS, 2006, PSYCHOL AGING, V21, P401, DOI 10.1037/0882-7974.21.2.401; Kadota T, 2001, AM J NEURORADIOL, V22, P128; Kennedy Q, 2010, AVIAT SPACE ENVIR MD, V81, P489, DOI 10.3357/ASEM.2684.2010; Krampe RT, 1996, J EXP PSYCHOL GEN, V125, P331, DOI 10.1037/0096-3445.125.4.331; Land MF, 2001, VISION RES, V41, P3559, DOI 10.1016/S0042-6989(01)00102-X; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Lee H, 2012, ACTA PSYCHOL, V139, P146, DOI 10.1016/j.actpsy.2011.11.003; Lewis JM, 2011, P 33 ANN C COGN SCI, P687; MANE A, 1989, ACTA PSYCHOL, V71, P17, DOI 10.1016/0001-6918(89)90003-6; Meinz EJ, 2000, PSYCHOL AGING, V15, P297, DOI 10.1037/0882-7974.15.2.297; MORROW D, 1994, PSYCHOL AGING, V9, P134, DOI 10.1037/0882-7974.9.1.134; Palmeri TJ, 1997, J EXP PSYCHOL LEARN, V23, P324, DOI 10.1037/0278-7393.23.2.324; REITMAN JS, 1976, COGNITIVE PSYCHOL, V8, P336, DOI 10.1016/0010-0285(76)90011-6; SALTHOUSE TA, 1984, J EXP PSYCHOL GEN, V113, P345, DOI 10.1037/0096-3445.113.3.345; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Salvucci D.D., 2000, P 2000 S EYE TRACK R, P71, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; Schroeder DH, 2004, PERS INDIV DIFFER, V36, P393, DOI 10.1016/S0191-8869(03)00104-1; Shinoda H, 2001, VISION RES, V41, P3535, DOI 10.1016/S0042-6989(01)00199-7; Thompson JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072540; Tsang PS, 1998, PSYCHOL AGING, V13, P323, DOI 10.1037/0882-7974.13.2.323; Tun PA, 2008, DEV PSYCHOL, V44, P1421, DOI 10.1037/a0012845; Verhaeghen P, 2003, PSYCHOL AGING, V18, P443, DOI 10.1037/0882-7974.18.3.443	28	53	53	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94215	10.1371/journal.pone.0094215	http://dx.doi.org/10.1371/journal.pone.0094215			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24718593	Green Submitted, gold, Green Published			2022-12-25	WOS:000334339000091
J	He, Z; Tian, T; Guo, D; Wu, HJ; Chen, Y; Zhang, YC; Wan, Q; Zhao, HZ; Wang, CY; Shen, HJ; Zhao, L; Bu, XD; Wan, ML; Shen, CL				He, Ze; Tian, Tian; Guo, Dan; Wu, Huijuan; Chen, Yang; Zhang, Yongchen; Wan, Qing; Zhao, Huzi; Wang, Congyang; Shen, Hongjing; Zhao, Lei; Bu, Xiaodong; Wan, Meiling; Shen, Chuanlu			Cytoplasmic Retention of a Nucleocytoplasmic Protein TBC1D3 by Microtubule Network Is Required for Enhanced EGFR Signaling	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; C-CBL; NUCLEAR TRANSPORT; UBIQUITINATION; DEGRADATION; ENDOCYTOSIS; ONCOGENE; INTERNALIZATION; UBIQUITYLATION	The hominoid oncogene TBC1D3 enhances epidermal growth factor receptor (EGFR) signaling and induces cell transformation. However, little is known regarding its spatio-temporal regulation and mechanism of tumorigenesis. In the current study, we identified the microtubule subunit beta-tubulin as a potential interaction partner for TBC1D3 using affinity purification combined with mass spectrometry analysis. The interaction between TBC1D3 and beta-tubulin was confirmed by co-immunoprecipitation. Using the same method, we also revealed that TBC1D3 co-precipitated with endogenous alpha-tubulin, another subunit of the microtubule. In agreement with these results, microtubule cosedimentation assays showed that TBC1D3 associated with the microtubule network. The beta-tubulin-interacting site of TBC1D3 was mapped to amino acids 286,353 near the C-terminus of the TBC domain. Deletion mutation within these amino acids was shown to abolish the interaction of TBC1D3 with beta-tubulin. Interestingly, the deletion mutation caused a complete loss of TBC1D3 from the cytoplasmic filamentous and punctate structures, and TBC1D3 instead appeared in the nucleus. Consistent with this, wild-type TBC1D3 exhibited the same nucleocytoplasmic distribution in cells treated with the microtubule depolymerizing agent nocodazole, suggesting that the microtubule network associates with and retains TBC1D3 in the cytoplasm. We further found that deficiency in beta-tubulin-interacting resulted in TBC1D3's inability to inhibit c-Cbl recruitment and EGFR ubiquitination, ultimately leading to dysregulation of EGFR degradation and signaling. Taken together, these studies indicate a novel model by which the microtubule network regulates EGFR stability and signaling through tubulin dimer/oligomer interaction with the nucleocytoplasmic protein TBC1D3.	[He, Ze; Tian, Tian; Guo, Dan; Wu, Huijuan; Chen, Yang; Zhang, Yongchen; Wan, Qing; Zhao, Huzi; Wang, Congyang; Zhao, Lei; Bu, Xiaodong; Wan, Meiling; Shen, Chuanlu] Southeast Univ, Sch Med, Dept Pathol & Pathophysiol, Nanjing, Jiangsu, Peoples R China; [He, Ze] Southeast Univ, Inst Life Sci, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Jiangsu, Peoples R China; [Shen, Hongjing] SUNY Buffalo, Dept Biomed Sci, Buffalo, NY 14260 USA	Southeast University - China; Southeast University - China; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Shen, CL (corresponding author), Southeast Univ, Sch Med, Dept Pathol & Pathophysiol, Nanjing, Jiangsu, Peoples R China.	shencl37@163.com	Chen, Yang/L-7304-2018; Chen, Yang/AFL-4729-2022	Chen, Yang/0000-0001-7661-5923; 	National Natural Science Foundation of China [81272261, 81071803, 30971144]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants (No. 81272261, No. 81071803, and No. 30971144) from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bowers K, 2006, J BIOL CHEM, V281, P5094, DOI 10.1074/jbc.M508632200; Campbell EA, 2003, ADV DRUG DELIVER REV, V55, P761, DOI 10.1016/S0169-409X(03)00049-8; Carbonaro M, 2012, J BIOL CHEM, V287, P11859, DOI 10.1074/jbc.M112.345587; Chen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034919; Christofori G, 2003, NAT CELL BIOL, V5, P377, DOI 10.1038/ncb0503-377; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Dohner K, 2005, TRENDS MICROBIOL, V13, P320, DOI 10.1016/j.tim.2005.05.010; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Eden ER, 2012, TRAFFIC, V13, P329, DOI 10.1111/j.1600-0854.2011.01305.x; Frittoli E, 2008, MOL BIOL CELL, V19, P1304, DOI 10.1091/mbc.E07-06-0594; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haller K, 2004, J BIOL CHEM, V279, P49384, DOI 10.1074/jbc.M406046200; Hatanaka H, 2010, CANCER SCI, V101, P54, DOI 10.1111/j.1349-7006.2009.01348.x; Hodzic D, 2006, GENOMICS, V88, P731, DOI 10.1016/j.ygeno.2006.05.009; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Kong C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046485; Lam MHC, 2002, MOL ENDOCRINOL, V16, P390, DOI 10.1210/me.16.2.390; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Li X, 2012, ONCOGENE, V31, P4372, DOI 10.1038/onc.2011.608; Malki S, 2005, EXP CELL RES, V309, P468, DOI 10.1016/j.yexcr.2005.07.005; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Mikenberg I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000589; Moseley GW, 2007, MOL BIOL CELL, V18, P3204, DOI 10.1091/mbc.E07-01-0030; Moseley GW, 2009, J CELL SCI, V122, P3652, DOI 10.1242/jcs.045542; Okur MN, 2012, MOL CELL BIOL, V32, P817, DOI 10.1128/MCB.05647-11; Pareja F, 2012, ONCOGENE, V31, P4599, DOI 10.1038/onc.2011.587; Paulding CA, 2003, P NATL ACAD SCI USA, V100, P2507, DOI 10.1073/pnas.0437015100; Pei L, 2002, CANCER RES, V62, P5420; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Purev E, 2009, MOL BIOL CELL, V20, P4021, DOI 10.1091/mbc.E09-03-0248; Rathinasamy K, 2008, BIOCHEM PHARMACOL, V76, P1669, DOI 10.1016/j.bcp.2008.09.001; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Roth DM, 2007, TRAFFIC, V8, P673, DOI 10.1111/j.1600-0854.2007.00564.x; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Umebayashi K, 2008, MOL BIOL CELL, V19, P3454, DOI 10.1091/mbc.E07-10-0988; Wainszelbaum MJ, 2008, J BIOL CHEM, V283, P13233, DOI 10.1074/jbc.M800234200; Wainszelbaum MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031225; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Waterman H, 2002, EMBO J, V21, P303, DOI 10.1093/emboj/21.3.303; Wu WJ, 2003, CELL, V114, P715, DOI 10.1016/S0092-8674(03)00688-3; Yamasaki C, 2005, J BIOCHEM, V137, P287, DOI 10.1093/jb/mvi031; Ziegler Elizabeth C, 2005, Sci STKE, V2005, pre6, DOI 10.1126/stke.2842005re6	53	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94134	10.1371/journal.pone.0094134	http://dx.doi.org/10.1371/journal.pone.0094134			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714105	Green Published, gold, Green Submitted			2022-12-25	WOS:000334160900092
J	Krause, TA; Alex, AF; Engel, DR; Kurts, C; Eter, N				Krause, Torsten A.; Alex, Anne F.; Engel, Daniel R.; Kurts, Christian; Eter, Nicole			VEGF-Production by CCR2-Dependent Macrophages Contributes to Laser-Induced Choroidal Neovascularization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BONE-MARROW; MACULAR DEGENERATION; DENDRITIC CELLS; BLOOD-VESSELS; AGE; MICROGLIA; RECEPTOR; EXPRESSION; MONOCYTES	Age-related macular degeneration (AMD) is the most prevalent cause of blindness in the elderly, and its exsudative subtype critically depends on local production of vascular endothelial growth factor A (VEGF). Mononuclear phagocytes, such as macrophages and microglia cells, can produce VEGF. Their precursors, for example monocytes, can be recruited to sites of inflammation by the chemokine receptor CCR2, and this has been proposed to be important in AMD. To investigate the role of macrophages and CCR2 in AMD, we studied intracellular VEGF content in a laser-induced murine model of choroidal neovascularisation. To this end, we established a technique to quantify the VEGF content in cell subsets from the laser-treated retina and choroid separately. 3 days after laser, macrophage numbers and their VEGF content were substantially elevated in the choroid. Macrophage accumulation was CCR2-dependent, indicating recruitment from the circulation. In the retina, microglia cells were the main VEGF(+) phagocyte type. A greater proportion of microglia cells contained VEGF after laser, and this was CCR2-independent. On day 6, VEGF-expressing macrophage numbers had already declined, whereas numbers of VEGF(+) microglia cells remained increased. Other sources of VEGF detectable by flow cytometry included in dendritic cells and endothelial cells in both retina and choroid, and Muller cells/astrocytes in the retina. However, their VEGF content was not increased after laser. When we analyzed flatmounts of laser-treated eyes, CCR2-deficient mice showed reduced neovascular areas after 2 weeks, but this difference was not evident 3 weeks after laser. In summary, CCR2-dependent influx of macrophages causes a transient VEGF increase in the choroid. However, macrophages augmented choroidal neovascularization only initially, presumably because VEGF production by CCR2-independent eye cells prevailed at later time points. These findings identify macrophages as a relevant source of VEGF in laser-induced choroidal neovascularization but suggest that the therapeutic efficacy of CCR2-inhibition might be limited.	[Krause, Torsten A.; Engel, Daniel R.; Kurts, Christian] Rhein Freidrich Wilhelms Univ Bonn, Inst Expt Immunol, D-53113 Bonn, Germany; [Alex, Anne F.; Eter, Nicole] Univ Munster, Dept Ophthalmol, D-48149 Munster, Germany	University of Bonn; University of Munster	Kurts, C (corresponding author), Rhein Freidrich Wilhelms Univ Bonn, Inst Expt Immunol, D-53113 Bonn, Germany.	ckurts@web.de	Engel, Daniel Robert/C-5945-2013	Engel, Daniel Robert/0000-0001-7301-353X	Deutsche Forschungsgemeinschaft [SFBTR57, KU1063/8, ET 29/7-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (SFBTR57, KU1063/8 and ET 29/7-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Ambati J, 2012, NEURON, V75, P26, DOI 10.1016/j.neuron.2012.06.018; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Berardi S, 2013, J ONCOL, V2013, DOI 10.1155/2013/183602; Carmeliet P, 2009, NAT REV CLIN ONCOL, V6, P315, DOI 10.1038/nrclinonc.2009.64; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Dagkalis A, 2009, IMMUNOLOGY, V128, P25, DOI 10.1111/j.1365-2567.2009.03046.x; Engel DR, 2008, J IMMUNOL, V181, P5579, DOI 10.4049/jimmunol.181.8.5579; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; Eter N, 2008, INVEST OPHTH VIS SCI, V49, P3649, DOI 10.1167/iovs.07-1322; Funk M, 2009, OPHTHALMOLOGY, V116, P2393, DOI 10.1016/j.ophtha.2009.05.039; Ganesh BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018305; Gehrs KM, 2006, ANN MED, V38, P450, DOI 10.1080/07853890600946724; Granata F, 2010, J IMMUNOL, V184, P5232, DOI 10.4049/jimmunol.0902501; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Horster R, 2011, GRAEF ARCH CLIN EXP, V249, P645, DOI 10.1007/s00417-010-1588-2; Itaya M, 2007, INVEST OPHTH VIS SCI, V48, P5677, DOI 10.1167/iovs.07-0156; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jais A, 2011, VET IMMUNOL IMMUNOP, V140, P207, DOI 10.1016/j.vetimm.2010.12.005; Kezic J, 2008, J LEUKOCYTE BIOL, V84, P721, DOI 10.1189/jlb.0308166; Kezic JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068570; Kezic JM, 2013, INVEST OPHTH VIS SCI, V54, P854, DOI 10.1167/iovs.12-10876; Lewis GP, 2007, BRIT J OPHTHALMOL, V91, P1234, DOI 10.1136/bjo.2006.104612; Liu J, 2013, ACTA GEOL SIN-ENGL, V87, P1501, DOI 10.1111/1755-6724.12154; Luna G, 2010, MOL VIS, V16, P2511; Ma WX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007945; Mizutani M, 2012, J IMMUNOL, V188, P29, DOI 10.4049/jimmunol.1100421; Nagineni CN, 2012, J CELL PHYSIOL, V227, P116, DOI 10.1002/jcp.22708; Nakai K, 2008, INVEST OPHTH VIS SCI, V49, P3666, DOI 10.1167/iovs.07-1640; Nakayama M, 2013, NAT CELL BIOL, V15, P249, DOI 10.1038/ncb2679; Obeid E, 2013, INT J ONCOL, V43, P5, DOI 10.3892/ijo.2013.1938; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Portillo JAC, 2009, MOL VIS, V15, P1383; Riazy M, 2009, ATHEROSCLEROSIS, V204, P47, DOI 10.1016/j.atherosclerosis.2008.08.004; Saint-Geniez M, 2006, INVEST OPHTH VIS SCI, V47, P3135, DOI 10.1167/iovs.05-1229; Scheef E, 2005, MOL VIS, V11, P613; Schiwon M, 2014, CELL, V156, P456, DOI 10.1016/j.cell.2014.01.006; Scott A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011863; Sennlaub F, 2013, EMBO MOL MED, V5, P1775, DOI 10.1002/emmm.201302692; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Stone J, 1996, INVEST OPHTH VIS SCI, V37, P290; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; Tsutsumi-Miyahara C, 2004, BRIT J OPHTHALMOL, V88, P1217, DOI 10.1136/bjo.2003.036392; West H, 2005, DEVELOPMENT, V132, P1855, DOI 10.1242/dev.01732; Wong T, 2008, OPHTHALMOLOGY, V115, P116, DOI 10.1016/j.ophtha.2007.03.008; Wu WK, 2010, IMMUNOBIOLOGY, V215, P796, DOI 10.1016/j.imbio.2010.05.025; Xie P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028933; Yanni SE, 2010, EXP EYE RES, V91, P34, DOI 10.1016/j.exer.2010.03.019	49	58	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94313	10.1371/journal.pone.0094313	http://dx.doi.org/10.1371/journal.pone.0094313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714223	Green Published, gold, Green Submitted			2022-12-25	WOS:000334160900115
J	Gocha, ARS; Acharya, S; Groden, J				Gocha, April Renee Sandy; Acharya, Samir; Groden, Joanna			WRN Loss Induces Switching of Telomerase-Independent Mechanisms of Telomere Elongation	PLOS ONE			English	Article							PROMYELOCYTIC LEUKEMIA BODIES; WERNER-SYNDROME PROTEIN; HOMOLOGOUS RECOMBINATION; SYNDROME HELICASE; RECQ HELICASES; BLM HELICASE; CANCER-CELLS; DNA; ALT; MAINTENANCE	Telomere maintenance can occur in the presence of telomerase or in its absence, termed alternative lengthening of telomeres (ALT). ALT adds telomere repeats using recombination-based processes and DNA repair proteins that function in homologous recombination. Our previous work reported that the RecQ-like BLM helicase is required for ALT and that it unwinds telomeric substrates in vitro. WRN is also a RecQ-like helicase that shares many biochemical functions with BLM. WRN interacts with BLM, unwinds telomeric substrates, and co-localizes to ALT-associated PML bodies (APBs), suggesting that it may also be required for ALT processes. Using long-term siRNA knockdown of WRN in three ALT cell lines, we show that some, but not all, cell lines require WRN for telomere maintenance. VA-13 cells require WRN to prevent telomere loss and for the formation of APBs; Saos-2 cells do not. A third ALT cell line, U-2 OS, requires WRN for APB formation, however WRN loss results in p53-mediated apoptosis. In the absence of WRN and p53,U-2 OS cells undergo telomere loss for an intermediate number of population doublings (50-70), at which point they maintain telomere length even with the continued loss of WRN. WRN and the tumor suppressor BRCA1 co-localize to APBs in VA-13 and U-2 OS, but not in Saos-2 cells. WRN loss in U-2 OS is associated with a loss of BRCA1 from APBs. While the loss of WRN significantly increases telomere sister chromatid exchanges (T-SCE) in these three ALT cell lines, loss of both BRCA1 and WRN does not significantly alter TSCE. This work demonstrates that ALT cell lines use different telomerase-independent maintenance mechanisms that variably require the WRN helicase and that some cells can switch from one mechanism to another that permits telomere elongation in the absence of WRN. Our data suggest that BRCA1 localization may define these mechanisms.	[Gocha, April Renee Sandy; Acharya, Samir; Groden, Joanna] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Groden, J (corresponding author), Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	joanna.groden@osumc.edu			Ohio State University Pelotonia Fellowship Program; Blooma(sic)(TM)s Syndrome Foundation; National Institutes of Health [CA-117898]; National Center For Advancing Translational Sciences [8UL1TR000090-05, 8KL2TR000112-05, 8TL1TR000091-05]; NATIONAL CANCER INSTITUTE [R01CA117898, P30CA016058] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000091, KL2TR000112, UL1TR001070, UL1TR000090] Funding Source: NIH RePORTER	Ohio State University Pelotonia Fellowship Program; Blooma(sic)(TM)s Syndrome Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center For Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by The Ohio State University Pelotonia Fellowship Program [to AG]; The Blooma(sic)(TM) s Syndrome Foundation [to JG]; and the National Institutes of Health [CA-117898 to JG]. The project described was also supported by Award Number 8UL1TR000090-05, 8KL2TR000112-05, and 8TL1TR000091-05 from the National Center For Advancing Translational Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Advancing Translational Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Ballal RD, 2009, J BIOL CHEM, V284, P36083, DOI 10.1074/jbc.M109.025825; Baynton K, 2003, J BIOL CHEM, V278, P36476, DOI 10.1074/jbc.M303885200; Bechter OE, 2004, CANCER RES, V64, P3444, DOI 10.1158/0008-5472.CAN-04-0323; Bhattacharyya S, 2009, J BIOL CHEM, V284, P14966, DOI 10.1074/jbc.M900195200; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389; Cheng WH, 2006, NUCLEIC ACIDS RES, V34, P2751, DOI 10.1093/nar/gkl362; Crabbe L, 2004, SCIENCE, V306, P1951, DOI 10.1126/science.1103619; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Du XB, 2004, MOL CELL BIOL, V24, P8437, DOI 10.1128/MCB.24.19.8437-8446.2004; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Fasching CL, 2005, CANCER RES, V65, P2722, DOI 10.1158/0008-5472.CAN-04-2881; Gocha ARS, 2013, AM J PATHOL, V182, P41, DOI 10.1016/j.ajpath.2012.10.001; Gocha ARS, 2013, MUT RES IN PRESS; Hagelstrom RT, 2010, P NATL ACAD SCI USA, V107, P15768, DOI 10.1073/pnas.1006338107; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Henson JD, 2009, NAT BIOTECHNOL, V27, P1181, DOI 10.1038/nbt.1587; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Hu J, 2012, CELL, V148, P651, DOI 10.1016/j.cell.2011.12.028; Jiang KC, 2003, J BIOL CHEM, V278, P25207, DOI 10.1074/jbc.M300070200; Jiang WQ, 2005, MOL CELL BIOL, V25, P2708, DOI 10.1128/MCB.25.7.2708-2721.2005; Johnson FB, 2001, EMBO J, V20, P905, DOI 10.1093/emboj/20.4.905; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Laud PR, 2005, GENE DEV, V19, P2560, DOI 10.1101/gad.1321305; Li BM, 2008, MOL CELL BIOL, V28, P1892, DOI 10.1128/MCB.01364-07; Li BM, 2011, AGING-US, V3, P395, DOI 10.18632/aging.100308; Lillard-Wetherell K, 2004, HUM MOL GENET, V13, P1919, DOI 10.1093/hmg/ddh193; Lombard DB, 2000, MOL CELL BIOL, V20, P3286, DOI 10.1128/MCB.20.9.3286-3291.2000; Luciani JJ, 2006, J CELL SCI, V119, P2518, DOI 10.1242/jcs.02965; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Marciniak RA, 2005, CANCER RES, V65, P2730, DOI 10.1158/0008-5472.CAN-04-2888; McPherson JP, 2006, HUM MOL GENET, V15, P831, DOI 10.1093/hmg/ddl002; Mendez-Bermudez A, 2012, NUCLEIC ACIDS RES, V40, P10809, DOI 10.1093/nar/gks862; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Muntoni A, 2009, HUM MOL GENET, V18, P1017, DOI 10.1093/hmg/ddn436; Nabetani A, 2004, J BIOL CHEM, V279, P25849, DOI 10.1074/jbc.M312652200; Opresko PL, 2007, MECH AGEING DEV, V128, P423, DOI 10.1016/j.mad.2007.05.009; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Opresko PL, 2005, J BIOL CHEM, V280, P32069, DOI 10.1074/jbc.M505211200; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Ransburgh DJR, 2010, CANCER RES, V70, P988, DOI 10.1158/0008-5472.CAN-09-2850; Rusin M, 2009, MECH AGEING DEV, V130, P528, DOI 10.1016/j.mad.2009.06.005; Saintigny Y, 2002, MOL CELL BIOL, V22, P6971, DOI 10.1128/MCB.22.20.6971-6978.2002; Schulz VP, 1996, HUM GENET, V97, P750; Siddiqa A, 2012, J ONCOL, V2012, DOI 10.1155/2012/806382; Simons AM, 2006, CANCER RES, V66, P2012, DOI 10.1158/0008-5472.CAN-05-3296; Stavropoulos DJ, 2002, HUM MOL GENET, V11, P3135, DOI 10.1093/hmg/11.25.3135; Tahara H, 1997, ONCOGENE, V15, P1911, DOI 10.1038/sj.onc.1201377; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; VAZIRI H, 1993, AM J HUM GENET, V52, P661; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Wang Y, 2000, GENE DEV, V14, P927; Wu GK, 2000, J BIOL CHEM, V275, P30618, DOI 10.1074/jbc.C000390200; Wu GK, 2003, CANCER RES, V63, P2589; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Wyllie FS, 2000, NAT GENET, V24, P16, DOI 10.1038/71630; Yankiwski V, 2000, P NATL ACAD SCI USA, V97, P5214, DOI 10.1073/pnas.090525897; Yeager TR, 1999, CANCER RES, V59, P4175; Zhong ZH, 2007, J BIOL CHEM, V282, P29314, DOI 10.1074/jbc.M701413200	61	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93991	10.1371/journal.pone.0093991	http://dx.doi.org/10.1371/journal.pone.0093991			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709898	Green Published, gold, Green Submitted			2022-12-25	WOS:000334159800082
J	Kizis, D; Natskoulis, P; Nychas, GJE; Panagou, EZ				Kizis, Dimosthenis; Natskoulis, Pantelis; Nychas, George-John E.; Panagou, Efstathios Z.			Biodiversity and ITS-RFLP Characterisation of Aspergillus Section Nigri Isolates in Grapes from Four Traditional Grape-Producing Areas in Greece	PLOS ONE			English	Article							WINE-PRODUCING VINEYARDS; OCHRATOXIN-A PRODUCTION; DRIED VINE FRUITS; POPULATION COMPOSITION; BLACK ASPERGILLI; SOUTHERN EUROPE; CONTAMINATION; FUNGI; FOOD; CARBONARIUS	A study on the occurrence of Aspergillus section Nigri species on grapes from four traditional grape-producing areas in Greece during the 2011/ 2012 vintage, and their capability to produce OTA was conducted. One hundred and twenty-eight black aspergilli isolates were characterised at the species level initially by the use of morphological criteria in accordance with appropriate keys, followed by molecular characterisation performed with Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) of the 5.8 ribosomal RNA gene Internal Transcribed Spacer region (5.8 rRNA ITS). Restriction enzyme digestion of the ITS amplicons using the HhaI, HinfI and RsaI, endonucleases distinguished eleven different patterns of restriction fragment length polymorphism (RFLP), four for each of the HhaI and RsaI digests and three for HinfI. From a total number of 128 individual isolates, 124 were classified into four Aspergillus species corresponding to A. carbonarius, A. tubingensis, A. japonicus and A. ibericus, and the remaining 4 were classified as members of the A. niger aggregate. A. carbonarius and A. tubingensis being the main representative species were equally counted, with higher geographical representation of the former in southern and the latter in northern regions, respectively. All isolates were tested for their ochratoxigenic potential by use of High Performance Liquid Chromatography (HPLC) and Enzyme Linked Immuno Sorbent Assay (ELISA), resulting in significant interspecies differences in OTA production.	[Kizis, Dimosthenis; Natskoulis, Pantelis; Nychas, George-John E.; Panagou, Efstathios Z.] Agr Univ Athens, Dept Food Sci & Human Nutr, Lab Microbiol & Biotechnol Foods, GR-11855 Athens, Greece	Agricultural University of Athens	Kizis, D (corresponding author), Agr Univ Athens, Dept Food Sci & Human Nutr, Lab Microbiol & Biotechnol Foods, GR-11855 Athens, Greece.	dimosthenis_kizis@yahoo.gr	Panagou, Efstathios/I-6537-2019; Nychas, George/B-2734-2009; Natskoulis, Pantelis/AAX-4254-2021	Panagou, Efstathios/0000-0002-0317-1177; Nychas, George/0000-0002-2673-6425; Natskoulis, Pantelis/0000-0002-8121-5606	project 'Design and development of innovative tools for the detection of ochratoxigenic fungi in wine and table grapes FungalPrognosis 242'; European Union (European Social Fund ESF); Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: ARISTEIA-I	project 'Design and development of innovative tools for the detection of ochratoxigenic fungi in wine and table grapes FungalPrognosis 242'; European Union (European Social Fund ESF)(European Social Fund (ESF)European Commission); Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: ARISTEIA-I	This work has been supported by the project 'Design and development of innovative tools for the detection of ochratoxigenic fungi in wine and table grapes FungalPrognosis 242' that is co-financed by the European Union (European Social Fund ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning'' of the National Strategic Reference Framework (NSRF) - Research Funding Program: ARISTEIA-I, (www.fungalprognosis.gr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca ML, 2004, ANTON LEEUW INT J G, V86, P33, DOI 10.1023/B:ANTO.0000024907.85688.05; Abouzied MM, 2002, FOOD ADDIT CONTAM A, V19, P755, DOI 10.1080/02652030210145036; Accensi F, 2001, ANTON LEEUW INT J G, V79, P365, DOI 10.1023/A:1012003813985; Astoreca AL, 2010, TOXINS, V2, P2593, DOI 10.3390/toxins2112593; Battilani P, 2006, INT J FOOD MICROBIOL, V111, pS72, DOI 10.1016/j.ijfoodmicro.2006.03.014; Battilani P, 2003, J FOOD PROTECT, V66, P633, DOI 10.4315/0362-028X-66.4.633; Bau M, 2006, INT J FOOD MICROBIOL, V111, pS18, DOI 10.1016/j.ijfoodmicro.2006.03.008; Bau M, 2005, RES MICROBIOL, V156, P375, DOI 10.1016/j.resmic.2004.12.003; Bau M, 2005, INT J FOOD MICROBIOL, V98, P125, DOI 10.1016/j.ijfoodmicro.2004.05.015; Bau M, 2006, INT J FOOD MICROBIOL, V1, P111; Belli N, 2006, INT J FOOD MICROBIOL, V111, pS40, DOI 10.1016/j.ijfoodmicro.2006.03.011; Borman AM, 2007, J ANTIMICROB CHEMOTH, V61, pI7, DOI 10.1093/jac/dkm425; Bragulat MR, 2001, INT J FOOD MICROBIOL, V71, P139, DOI 10.1016/S0168-1605(01)00581-5; Cary JW, 2006, MYCOPATHOLOGIA, V162, P167, DOI 10.1007/s11046-006-0051-8; Chiotta ML, 2011, INT J FOOD MICROBIOL, V149, P171, DOI 10.1016/j.ijfoodmicro.2011.06.002; Chiotta ML, 2009, INT J FOOD MICROBIOL, V136, P137, DOI 10.1016/j.ijfoodmicro.2009.08.013; Communities T., 2005, OFFICIAL J EUROPEAN, V25, P3; de Cerain AL, 2002, FOOD ADDIT CONTAM A, V19, P1058, DOI 10.1080/02652030210145928; Diaz GA, 2009, INT J FOOD MICROBIOL, V133, P195, DOI 10.1016/j.ijfoodmicro.2009.04.018; Duarte SC, 2010, FOOD MICROBIOL, V27, P187, DOI 10.1016/j.fm.2009.11.016; El Khoury A, 2008, FOOD CHEM TOXICOL, V46, P2244, DOI 10.1016/j.fct.2008.02.026; el Khoury A, 2010, TOXINS, V2, P461, DOI 10.3390/toxins2040461; Esteban A, 2008, CURR MICROBIOL, V57, P348, DOI 10.1007/s00284-008-9201-1; European Commission, 2006, OFF J EUR UNION L, V1365, P6; European Commission (EC), 2012, RAP AL SYST FOOD FEE; Fuchs R, 2005, FOOD ADDIT CONTAM A, V22, P53, DOI 10.1080/02652030500309368; Kapetanakou AE, 2009, FOOD CONTROL, V20, P725, DOI 10.1016/j.foodcont.2008.09.008; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Labrinea EP, 2011, FOOD ADDIT CONTAM B, V4, P61, DOI 10.1080/19393210.2010.539707; Lasram S, 2007, INT J FOOD MICROBIOL, V114, P376, DOI 10.1016/j.ijfoodmicro.2006.09.027; Lasram S, 2012, FOOD CONTROL, V25, P75, DOI 10.1016/j.foodcont.2011.10.006; Leong SL, 2007, LETT APPL MICROBIOL, V45, P301, DOI 10.1111/j.1472-765X.2007.02189.x; Leong SLL, 2006, J AGR FOOD CHEM, V54, P6460, DOI 10.1021/jf061669d; Levin RE, 2012, INT J FOOD MICROBIOL, V156, P1, DOI 10.1016/j.ijfoodmicro.2012.03.001; Ponsone ML, 2012, TOXINS, V4, P364, DOI 10.3390/toxins4050364; Magan N, 2006, MYCOPATHOLOGIA, V162, P245, DOI 10.1007/s11046-006-0057-2; Magnoli C, 2003, LETT APPL MICROBIOL, V37, P179, DOI 10.1046/j.1472-765X.2003.01376.x; Martinez-Culebras PV, 2007, INT J FOOD MICROBIOL, V113, P147, DOI 10.1016/j.ijfoodmicro.2006.06.023; Martinez-Culebras PV, 2009, INT J FOOD MICROBIOL, V132, P33, DOI 10.1016/j.ijfoodmicro.2009.03.015; Mateo R, 2007, INT J FOOD MICROBIOL, V119, P79, DOI 10.1016/j.ijfoodmicro.2007.07.029; Matsuda Y, 2013, WORLD J GASTROENTERO, V19, P2587, DOI 10.3748/wjg.v19.i17.2587; Medina A, 2005, APPL ENVIRON MICROB, V71, P4696, DOI 10.1128/AEM.71.8.4696-4702.2005; Nugroho A.D., 2013, J FOOD SCI ENG, V3, P472; Oliveri C, 2008, INT J FOOD MICROBIOL, V127, P147, DOI 10.1016/j.ijfoodmicro.2008.06.021; Otteneder H, 2000, FOOD ADDIT CONTAM A, V17, P793, DOI 10.1080/026520300415345; Palencia ER, 2010, TOXINS, V2, P399, DOI 10.3390/toxins2040399; Palumbo JD, 2011, LETT APPL MICROBIOL, V52, P330, DOI 10.1111/j.1472-765X.2011.03004.x; Perrone G, 2007, STUD MYCOL, P53, DOI 10.3114/sim.2007.59.07; Perrone G, 2006, INT J FOOD MICROBIOL, V111, pS22, DOI 10.1016/j.ijfoodmicro.2006.03.009; Perrone G, 2013, FOOD ADDIT CONTAM A, V30, P1339, DOI 10.1080/19440049.2013.796594; Perrone G, 2011, FUNGAL BIOL-UK, V115, P1138, DOI 10.1016/j.funbio.2011.07.008; Pfohl-Leszkowicz A, 2007, MOL NUTR FOOD RES, V51, P61, DOI 10.1002/mnfr.200600137; Pietri A, 2001, FOOD ADDIT CONTAM A, V18, P647, DOI 10.1080/02652030110028353; Pitt JI, 2009, FUNGI AND FOOD SPOILAGE, THIRD EDITION, P1, DOI 10.1007/978-0-387-92207-2; Reddy L, 2010, TOXINS, V2, P771, DOI 10.3390/toxins2040771; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samson R. A., 2000, INTRO FOOD AIRBORNE, P389; Schmidt H, 2005, Mycotoxin Res, V21, P61, DOI 10.1007/BF02954820; Serra R, 2005, RES MICROBIOL, V156, P515, DOI 10.1016/j.resmic.2004.12.005; Serra R, 2003, INT J FOOD MICROBIOL, V88, P63, DOI 10.1016/S0168-1605(03)00085-0; Serra R, 2006, MYCOLOGIA, V98, P295, DOI 10.3852/mycologia.98.2.295; Spadaro D, 2012, TOXINS, V4, P42, DOI 10.3390/toxins4020042; Stefanovic V, 2009, NEPHRON CLIN PRACT, V112, pC51, DOI 10.1159/000213081; Susca A, 2013, INT J FOOD MICROBIOL, V165, P163, DOI 10.1016/j.ijfoodmicro.2013.04.027; Tittlemier SA, 2011, FOOD ADDIT CONTAM A, V28, P775, DOI 10.1080/19440049.2011.559278; Tjamos SE, 2006, INT J FOOD MICROBIOL, V111, pS61, DOI 10.1016/j.ijfoodmicro.2006.01.044; Tjamos SE, 2004, J PHYTOPATHOL, V152, P250, DOI 10.1111/j.1439-0434.2004.00838.x; Valero A, 2006, FOOD MICROBIOL, V23, P753, DOI 10.1016/j.fm.2006.01.005; Varga J, 2011, STUD MYCOL, P1, DOI 10.3114/sim.2011.69.01; Varga J, 2010, INT J FOOD MICROBIOL, V143, P143, DOI 10.1016/j.ijfoodmicro.2010.08.008; Velmourougane K, 2010, FOODBORNE PATHOG DIS, V7, P1279, DOI 10.1089/fpd.2010.0571; Visconti A, 2008, FOOD ADDIT CONTAM A, V25, P193, DOI 10.1080/02652030701744546; White T., 1990, PCR PROTOCOLS GUIDE, P315	73	31	33	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93923	10.1371/journal.pone.0093923	http://dx.doi.org/10.1371/journal.pone.0093923			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710283	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800072
J	Nobs, JB; Maerkl, SJ				Nobs, Jean-Bernard; Maerkl, Sebastian J.			Long-Term Single Cell Analysis of S. pombe on a Microfluidic Microchemostat Array	PLOS ONE			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; FISSION YEAST; BUDDING YEAST; GENE-EXPRESSION; CYCLE; GENOME; DEVICE; SIZE; VARIABILITY; INTEGRATION	Although Schyzosaccharomyces pombe is one of the principal model organisms for studying the cell cycle, surprisingly few methods have characterized S. pombe growth on the single cell level, and no methods exist capable of analyzing thousands of cells and tens of thousands of cell division events. We developed an automated microfluidic platform permitting S. pombe to be grown on-chip for several days under defined and changeable conditions. We developed an image processing pipeline to extract and quantitate several physiological parameters including cell length, time to division, and elongation rate without requiring synchronization of the culture. Over a period of 50 hours our platform analyzed over 100000 cell division events and reconstructed single cell lineages up to 10 generations in length. We characterized cell lengths and division times in a temperature shift experiment in which cells were initially grown at 30 degrees C and transitioned to 25 degrees C. Although cell length was identical at both temperatures at steady-state, we observed transient changes in cell length if the temperature shift took place during a critical phase of the cell cycle. We further show that cells born with normal length do divide over a wide range of cell lengths and that cell length appears to be controlled in the second generation, were large newly born cells have a tendency to divide more rapidly and thus at a normalized cell size. The platform is thus applicable to measure fine-details in cell cycle dynamics, should be a useful tool to decipher the molecular mechanism underlying size homeostasis, and will be generally applicable to study processes on the single cell level that require large numbers of precision measurements and single cell lineages.	[Nobs, Jean-Bernard; Maerkl, Sebastian J.] Ecole Polytech Fed Lausanne, Sch Engn, Inst Bioengn, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Maerkl, SJ (corresponding author), Ecole Polytech Fed Lausanne, Sch Engn, Inst Bioengn, Lausanne, Switzerland.	sebastian.maerkl@epfl.ch	Maerkl, Sebastian J. J/C-5438-2008	Maerkl, Sebastian J. J/0000-0003-1917-5268	SystemsX.ch Grant DynamiX-RTD [2008/005]; Ecole Polytechnique Federale de Lausanne	SystemsX.ch Grant DynamiX-RTD; Ecole Polytechnique Federale de Lausanne	This work was supported by a SystemsX.ch Grant DynamiX-RTD (2008/005) and the Ecole Polytechnique Federale de Lausanne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Balagadde FK, 2005, SCIENCE, V309, P137, DOI 10.1126/science.1109173; Bean JM, 2006, MOL CELL, V21, P3, DOI 10.1016/j.molcel.2005.10.035; Bennett MR, 2009, NAT REV GENET, V10, P628, DOI 10.1038/nrg2625; Blomberg A, 2011, CURR OPIN BIOTECH, V22, P94, DOI 10.1016/j.copbio.2010.10.013; Breslow DK, 2008, NAT METHODS, V5, P711, DOI 10.1038/nmeth.1234; Charvin G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001468; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; Denervaud N, 2013, P NATL ACAD SCI USA, V110, P15842, DOI 10.1073/pnas.1308265110; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Falconnet D, 2011, LAB CHIP, V11, P466, DOI [10.1039/c0lc00228c, 10.1039/c01c00228c]; Hachet O, 2012, CURR OPIN CELL BIOL, V24, P858, DOI 10.1016/j.ceb.2012.10.001; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Lee SS, 2012, P NATL ACAD SCI USA, V109, P4916, DOI 10.1073/pnas.1113505109; LEE SW, 1985, GENE, V39, P173, DOI 10.1016/0378-1119(85)90311-7; Leung K, 2012, P NATL ACAD SCI USA, V109, P7665, DOI 10.1073/pnas.1106752109; Long Z, 2013, LAB CHIP, V13, P947, DOI 10.1039/c2lc41196b; Maerkl SJ, 2009, INTEGR BIOL-UK, V1, P19, DOI 10.1039/b819762h; Marshall WF, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-101; Martin SG, 2009, NATURE, V459, P852, DOI 10.1038/nature08054; MITCHISON JM, 1985, J CELL SCI, V75, P357; Moseley JB, 2009, NATURE, V459, P857, DOI 10.1038/nature08074; Paige JS, 2012, SCIENCE, V335, P1194, DOI 10.1126/science.1218298; Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339; Pluskal T, 2011, FEBS J, V278, P1299, DOI 10.1111/j.1742-4658.2011.08050.x; Rajkumar AS, 2013, NAT GENET, V45, P1207, DOI 10.1038/ng.2729; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Ricicova M, 2013, P NATL ACAD SCI USA, V110, P11403, DOI 10.1073/pnas.1215850110; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Tian Y, 2013, LAB CHIP, V13, P4071, DOI 10.1039/c3lc50639h; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xie ZW, 2012, AGING CELL, V11, P599, DOI 10.1111/j.1474-9726.2012.00821.x; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048275	39	49	51	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93466	10.1371/journal.pone.0093466	http://dx.doi.org/10.1371/journal.pone.0093466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710337	Green Submitted, Green Published, gold			2022-12-25	WOS:000334159800035
J	Ye, H; Mandal, R; Catherman, A; Thomas, PM; Kelleher, NL; Ikonomidou, C; Li, LJ				Ye, Hui; Mandal, Rakesh; Catherman, Adam; Thomas, Paul M.; Kelleher, Neil L.; Ikonomidou, Chrysanthy; Li, Lingjun			Top-Down Proteomics with Mass Spectrometry Imaging: A Pilot Study towards Discovery of Biomarkers for Neurodevelopmental Disorders	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; CYTOCHROME-C; TISSUE-SECTIONS; PROTEINS; IDENTIFICATION; PEPTIDES; CANCER; ALZHEIMERS; APOPTOSIS; CALCIUM	In the developing mammalian brain, inhibition of NMDA receptor can induce widespread neuroapoptosis, inhibit neurogenesis and cause impairment of learning and memory. Although some mechanistic insights into adverse neurological actions of these NMDA receptor antagonists exist, our understanding of the full spectrum of developmental events affected by early exposure to these chemical agents in the brain is still limited. Here we attempt to gain insights into the impact of pharmacologically induced excitatory/inhibitory imbalance in infancy on the brain proteome using mass spectrometric imaging (MSI). Our goal was to study changes in protein expression in postnatal day 10 (P10) rat brains following neonatal exposure to the NMDA receptor antagonist dizocilpine (MK801). Analysis of rat brains exposed to vehicle or MK801 and comparison of their MALDI MS images revealed differential relative abundances of several proteins. We then identified these markers such as ubiquitin, purkinje cell protein 4 (PEP-19), cytochrome c oxidase subunits and calmodulin, by a combination of reversed-phase (RP) HPLC fractionation and top-down tandem MS platform. More in-depth large scale study along with validation experiments will be carried out in the future. Overall, our findings indicate that a brief neonatal exposure to a compound that alters excitatory/inhibitory balance in the brain has a long term effect on protein expression patterns during subsequent development, highlighting the utility of MALDI-MSI as a discovery tool for potential biomarkers.	[Ye, Hui] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Ye, Hui] China Pharmaceut Univ, Dept Pharmaceut Anal, Nanjing, Jiangsu, Peoples R China; [Ye, Hui; Li, Lingjun] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA; [Mandal, Rakesh; Ikonomidou, Chrysanthy] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA; [Catherman, Adam; Thomas, Paul M.; Kelleher, Neil L.] Northwestern Univ, Prote Ctr Excellence, Evanston, IL USA; [Li, Lingjun] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	China Pharmaceutical University; China Pharmaceutical University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Northwestern University; University of Wisconsin System; University of Wisconsin Madison	Ikonomidou, C (corresponding author), Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA.	ikonomidou@neurology.wisc.edu; lli@pharmacy.wisc.edu	Thomas, Paul M/A-6233-2011	Thomas, Paul M/0000-0003-2887-4765	University of Wisconsin [PRJ-26CH, PRJ-23FA, PRJ-25AH, PRJ 233-23CK]; National Institute of Child Health and Human Development [P30 HD03352]; National Institutes of Health (NIH) [R01DK071801]; NIH shared instrument program [S10 RR029531]; NIH [R01 GM067193, P30 DA018310]; Searle Funds at the Chicago Community Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018310] Funding Source: NIH RePORTER	University of Wisconsin; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH shared instrument program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Funds at the Chicago Community Trust; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by University of Wisconsin grants PRJ-26CH, PRJ-23FA, PRJ-25AH and Waisman grant PRJ 233-23CK to CI, a core grant to the Waisman Center from the National Institute of Child Health and Human Development (P30 HD03352), the National Institutes of Health (NIH) grant (R01DK071801 to LL). The authors would also like to acknowledge NIH shared instrument program for funding the instrument purchase (S10 RR029531 to LL). NLK thanks support from NIH grants R01 GM067193 and P30 DA018310 and the Searle Funds at the Chicago Community Trust (to Chicago Biomedical Consortium). LL acknowledges an H. I. Romnes Faculty Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badamchian M, 2003, INT IMMUNOPHARMACOL, V3, P1225, DOI 10.1016/S1567-5769(03)00024-9; Balluff B, 2011, AM J PATHOL, V179, P2720, DOI 10.1016/j.ajpath.2011.08.032; Beckingham K, 1998, BIOMETALS, V11, P359, DOI 10.1023/A:1009201824806; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Blaze MTM, 2012, ANALYST, V137, P5018, DOI 10.1039/c2an35922g; Bora A, 2008, J PROTEOME RES, V7, P4992, DOI 10.1021/pr800394e; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Cazares LH, 2009, CLIN CANCER RES, V15, P5541, DOI 10.1158/1078-0432.CCR-08-2892; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Chaurand P, 2002, CURR OPIN CHEM BIOL, V6, P676, DOI 10.1016/S1367-5931(02)00370-8; Chen RB, 2009, J AM SOC MASS SPECTR, V20, P1068, DOI 10.1016/j.jasms.2009.01.017; Chughtai K, 2013, J LIPID RES, V54, P333, DOI 10.1194/jlr.M027961; Craig-Schapiro R, 2010, BIOL PSYCHIAT, V68, P903, DOI 10.1016/j.biopsych.2010.08.025; Debois D, 2013, TOP CURR CHEM, V331, P117, DOI 10.1007/128_2012_363; Debois D, 2010, ANAL CHEM, V82, P4036, DOI 10.1021/ac902875q; Deininger SO, 2008, J PROTEOME RES, V7, P5230, DOI 10.1021/pr8005777; DeKeyser SS, 2007, J PROTEOME RES, V6, P1782, DOI 10.1021/pr060603v; Delbosc S, 2008, MOL MED, V14, P383, DOI 10.2119/2008-00030.Delbosc; Elsner M, 2012, J PROTEOMICS, V75, P4693, DOI 10.1016/j.jprot.2012.02.012; Feldkirchner S, 2012, PROTEOMICS, V12, P3598, DOI 10.1002/pmic.201100559; Ferguson JT, 2009, J AM SOC MASS SPECTR, V20, P1743, DOI 10.1016/j.jasms.2009.05.014; Fergusson J, 2000, NEUROSCI LETT, V279, P69, DOI 10.1016/S0304-3940(99)00917-9; Flint MS, 2010, J PROTEOME RES, V9, P509, DOI 10.1021/pr900861j; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gogolla N, 2009, J NEURODEV DISORD, V1, P172, DOI 10.1007/s11689-009-9023-x; Groseclose MR, 2007, J MASS SPECTROM, V42, P254, DOI 10.1002/jms.1177; Hanrieder J, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009308; Hardesty WM, 2011, J PROTEOMICS, V74, P1002, DOI 10.1016/j.jprot.2011.04.013; Hu S, 2008, CLIN CANCER RES, V14, P6246, DOI 10.1158/1078-0432.CCR-07-5037; Huttemann M, 2012, ADV EXP MED BIOL, V748, P237, DOI 10.1007/978-1-4614-3573-0_10; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Ishimura R, 2002, TOXICOL APPL PHARM, V185, P197, DOI 10.1006/taap.2002.9539; Johanson RA, 2000, J NEUROSCI, V20, P2860; Joshi B, 1999, CANCER RES, V59, P4343; Kaindl AM, 2006, CELL MOL LIFE SCI, V63, P399, DOI 10.1007/s00018-005-5348-0; Kaindl AM, 2007, NEUROTOX RES, V11, P203, DOI 10.1007/BF03033568; Kaindl AM, 2008, MOL CELL PROTEOMICS, V7, P2293, DOI 10.1074/mcp.M800030-MCP200; Kelleher NL, 2004, ANAL CHEM, V76, p196A, DOI 10.1021/ac0415657; Lagarrigue M, 2012, J PROTEOME RES, V11, P5453, DOI 10.1021/pr3006974; Lagarrigue M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005991; Lam YA, 2000, P NATL ACAD SCI USA, V97, P9902, DOI 10.1073/pnas.170173897; Li HH, 2011, ANAL CHEM, V83, P8794, DOI 10.1021/ac202356g; Li TA, 2011, MOL PLANT, V4, P361, DOI 10.1093/mp/ssq078; Lowenthal MS, 2005, CLIN CHEM, V51, P1933, DOI 10.1373/clinchem.2005.052944; MacAleese L, 2009, PROTEOMICS, V9, P819, DOI 10.1002/pmic.200800363; McNaught KSP, 2001, NAT REV NEUROSCI, V2, P589, DOI 10.1038/35086067; Meistermann H, 2006, MOL CELL PROTEOMICS, V5, P1876, DOI 10.1074/mcp.M500399-MCP200; Michalski A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.013698; Minerva L, 2008, PROTEOMICS, V8, P3763, DOI 10.1002/pmic.200800237; MONAGHAN DT, 1985, J NEUROSCI, V5, P2909; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Murphy RC, 2009, J LIPID RES, V50, pS317, DOI 10.1194/jlr.R800051-JLR200; Pereira CF, 2000, NEUROSCI RES, V37, P227, DOI 10.1016/S0168-0102(00)00124-3; Philp D, 2010, ANN NY ACAD SCI, V1194, P81, DOI 10.1111/j.1749-6632.2010.05479.x; Pierson J, 2004, J PROTEOME RES, V3, P289, DOI 10.1021/pr0499747; Pirman DA, 2013, ANAL CHEM, V85, P1081, DOI 10.1021/ac302960j; Popoli P, 2007, ANN NY ACAD SCI, V1112, P219, DOI 10.1196/annals.1415.033; Rauser S, 2010, J PROTEOME RES, V9, P1854, DOI 10.1021/pr901008d; Ruepp SU, 2002, TOXICOL SCI, V65, P135, DOI 10.1093/toxsci/65.1.135; Sampson JS, 2009, J AM SOC MASS SPECTR, V20, P667, DOI 10.1016/j.jasms.2008.12.003; Sanchez-Alcazar JA, 2001, CANCER RES, V61, P1038; Schey KL, 2013, ANAL CHEM, V85, P6767, DOI 10.1021/ac400832w; Seeley EH, 2008, P NATL ACAD SCI USA, V105, P18126, DOI 10.1073/pnas.0801374105; Skold K, 2006, J PROTEOME RES, V5, P262, DOI 10.1021/pr050281f; SLEMMON JR, 1994, J NEUROSCI, V14, P2225; Sosne G, 2004, INVEST OPHTH VIS SCI, V45, P1095, DOI 10.1167/iovs.03-1002; Stefovska VG, 2008, ANN NEUROL, V64, P434, DOI 10.1002/ana.21463; Stella DR, 2010, INVEST OPHTH VIS SCI, V51, P5153, DOI 10.1167/iovs.10-5302; Teng PN, 2011, J PROTEOME RES, V10, P1333, DOI 10.1021/pr101074p; Utal AK, 1999, NEUROSCIENCE, V88, P993; van Leeuwen FW, 1998, SCIENCE, V279, P242, DOI 10.1126/science.279.5348.242; Wang Z, 2008, J PROTEOME RES, V7, P2696, DOI 10.1021/pr700737h; Xu BGJ, 2002, J AM SOC MASS SPECTR, V13, P1292, DOI 10.1016/S1044-0305(02)00644-X; Zhang JA, 2010, J AM SOC MASS SPECTR, V21, P940, DOI 10.1016/j.jasms.2010.02.005	75	31	33	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e92831	10.1371/journal.pone.0092831	http://dx.doi.org/10.1371/journal.pone.0092831			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710523	Green Published, gold, Green Submitted			2022-12-25	WOS:000334159800018
J	Berube-Simard, FA; Prudhomme, C; Jeannotte, L				Berube-Simard, Felix-Antoine; Prudhomme, Christelle; Jeannotte, Lucie			YY1 Acts as a Transcriptional Activator of Hoxa5 Gene Expression in Mouse Organogenesis	PLOS ONE			English	Article							ACID RESPONSE ELEMENT; MURINE HOX-4.2 GENE; YIN YANG 1; REGULATORY ELEMENTS; TRANSGENIC MICE; AXIAL SKELETON; MUTANT MICE; IN-VIVO; GROWTH; DIFFERENTIATION	The Hox gene family encodes homeodomain-containing transcriptional regulators that confer positional information to axial and paraxial tissues in the developing embryo. The dynamic Hox gene expression pattern requires mechanisms that differentially control Hox transcription in a precise spatio-temporal fashion. This implies an integrated regulation of neighbouring Hox genes achieved through the sharing and the selective use of defined enhancer sequences. The Hoxa5 gene plays a crucial role in lung and gut organogenesis. To position Hoxa5 in the regulatory hierarchy that drives organ morphogenesis, we searched for cis-acting regulatory sequences and associated trans-acting factors required for Hoxa5 expression in the developing lung and gut. Using mouse transgenesis, we identified two DNA regions included in a 1.5-kb XbaI-XbaI fragment located in the Hoxa4-Hoxa5 intergenic domain and known to control Hoxa4 organ expression. The multifunctional YY1 transcription factor binds the two regulatory sequences in vitro and in vivo. Moreover, the mesenchymal deletion of the Yy1 gene function in mice results in a Hoxa5-like lung phenotype with decreased Hoxa5 and Hoxa4 gene expression. Thus, YY1 acts as a positive regulator of Hoxa5 expression in the developing lung and gut. Our data also support a role for YY1 in the coordinated expression of Hox genes for correct organogenesis.	[Berube-Simard, Felix-Antoine; Prudhomme, Christelle; Jeannotte, Lucie] Univ Laval, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ, Canada; [Berube-Simard, Felix-Antoine; Prudhomme, Christelle; Jeannotte, Lucie] Univ Laval, Ctr Rech Canc, Quebec City, PQ, Canada; [Berube-Simard, Felix-Antoine; Prudhomme, Christelle; Jeannotte, Lucie] Ctr Hosp Univ Quebec, Ctr Rech, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Jeannotte, L (corresponding author), Univ Laval, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ, Canada.	lucie.jeannotte@crhdq.ulaval.ca		Jeannotte, Lucie/0000-0001-5578-420X	Canadian Institutes of Health Research [MOP- 15139]; National Sciences and Engineering Research Council of Canada [194559]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Canadian Institutes of Health Research (MOP- 15139; to L.J.) and the National Sciences and Engineering Research Council of Canada (194559; to L.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; AKAM M, 1987, DEVELOPMENT, V101, P1; Aparicio O., 2005, CURRENT PROTOCOLS MO, V21, P31; Aubin J, 1997, DEV BIOL, V192, P432, DOI 10.1006/dbio.1997.8746; Aubin J, 2002, DEVELOPMENT, V129, P4075; Aubin J, 1999, AM J PHYSIOL-CELL PH, V277, pC965, DOI 10.1152/ajpcell.1999.277.5.C965; Bhalla SS, 2001, J BIOL CHEM, V276, P11439, DOI 10.1074/jbc.M100208200; Boucherat O, 2013, AM J PHYSIOL-LUNG C, V304, pL817, DOI 10.1152/ajplung.00006.2013; Boucherat O, 2012, BIOL OPEN, V1, P677, DOI 10.1242/bio.20121701; Cai Y, 2007, NAT STRUCT MOL BIOL, V14, P872, DOI 10.1038/nsmb1276; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Charite J, 1998, DEVELOPMENT, V125, P4349; Chen HX, 2007, CANCER RES, V67, P8007, DOI 10.1158/0008-5472.CAN-07-1405; Coulombe Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010600; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; DONY C, 1987, EMBO J, V6, P2965, DOI 10.1002/j.1460-2075.1987.tb02602.x; Dupe V, 1997, DEVELOPMENT, V124, P399; Garin E, 2006, DEV DYNAM, V235, P1858, DOI 10.1002/dvdy.20822; Gendronneau G, 2012, ENDOCRINOLOGY, V153, P1484, DOI 10.1210/en.2011-1766; Gilthorpe J, 2002, DEVELOPMENT, V129, P3887; Gregoire S, 2013, CIRC RES, V112, P900, DOI 10.1161/CIRCRESAHA.113.259259; Herriges JC, 2012, DEV DYNAM, V241, P1432, DOI 10.1002/dvdy.23823; Hogan B, 1994, MANIPULATING MOUSE E; Houle M, 2000, MOL CELL BIOL, V20, P6579, DOI 10.1128/MCB.20.17.6579-6586.2000; JAFFE L, 1990, J IMMUNOL, V145, P3474; JEANNOTTE L, 1993, GENE DEV, V7, P2085, DOI 10.1101/gad.7.11.2085; Khang K, 2009, NUCLEIC ACIDS RES, V37, P2003; Kim SY, 2006, DEVELOPMENT, V133, P4957, DOI 10.1242/dev.02677; Klug J, 1996, MOL CELL BIOL, V16, P6398; Kobrossy L, 2006, J BIOL CHEM, V281, P25926, DOI 10.1074/jbc.M602555200; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Larochelle C, 1999, DEV DYNAM, V214, P127, DOI 10.1002/(SICI)1097-0177(199902)214:2<127::AID-AJA3>3.0.CO;2-F; Li JY, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002688; Maconochie MK, 1997, GENE DEV, V11, P1885, DOI 10.1101/gad.11.14.1885; Mainguy G, 2003, TRENDS GENET, V19, P476, DOI 10.1016/S0168-9525(03)00202-6; Marshall H, 1996, FASEB J, V10, P969, DOI 10.1096/fasebj.10.9.8801179; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Meccia E, 2003, BBA-GENE STRUCT EXPR, V1626, P1, DOI 10.1016/S0167-4781(03)00018-6; Meunier D, 2003, DEV DYNAM, V227, P367, DOI 10.1002/dvdy.10325; Moreau J, 2002, DNA SEQUENCE, V13, P203, DOI 10.1080/10425170290034507; Nolte C, 2003, MECH DEVELOP, V120, P325, DOI 10.1016/S0925-4773(02)00442-2; Oosterveen T, 2003, EMBO J, V22, P262, DOI 10.1093/emboj/cdg029; Packer AI, 1998, DEVELOPMENT, V125, P1991; Parrish M, 2009, NEW ENCY NEUROSCIENC, P1221; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pilon N, 2007, DEVELOPMENT, V134, P2315, DOI 10.1242/dev.001206; POPPERL H, 1992, EMBO J, V11, P3673, DOI 10.1002/j.1460-2075.1992.tb05452.x; POPPERL H, 1993, MOL CELL BIOL, V13, P257; Ren GL, 2009, INT J BIOCHEM CELL B, V41, P1094, DOI 10.1016/j.biocel.2008.10.015; Rezai-Zadeh N, 2003, GENE DEV, V17, P1019, DOI 10.1101/gad.1068003; Rhee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058828; Santini S, 2003, GENOME RES, V13, P1111, DOI 10.1101/gr.700503; Sharpe J, 1998, EMBO J, V17, P1788, DOI 10.1093/emboj/17.6.1788; Spitz F, 2008, ADV GENET, V61, P175, DOI 10.1016/S0065-2660(07)00006-5; SUBRAMANIAN V, 1995, CELL, V83, P641, DOI 10.1016/0092-8674(95)90104-3; Tabaries S, 2005, MOL CELL BIOL, V25, P1389, DOI 10.1128/MCB.25.4.1389-1401.2005; Thomas MJ, 1999, GENE, V236, P197, DOI 10.1016/S0378-1119(99)00261-9; Trask MC, 2012, DEV BIOL, V368, P273, DOI 10.1016/j.ydbio.2012.05.031; Wang CC, 2007, CANCER RES, V67, P4816, DOI 10.1158/0008-5472.CAN-07-0504; Wang ZX, 2006, DEV BIOL, V297, P433, DOI 10.1016/j.ydbio.2006.05.019; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Yu H, 2010, MOL CELL BIOL, V30, P5071, DOI 10.1128/MCB.00396-10; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; ZAKANY J, 1988, NEURON, V1, P679, DOI 10.1016/0896-6273(88)90167-5	66	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93989	10.1371/journal.pone.0093989	http://dx.doi.org/10.1371/journal.pone.0093989			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705708	Green Submitted, Green Published, gold			2022-12-25	WOS:000334107500104
J	Chi, XX; Zhang, XM; Chen, TW; Huang, XH; Yang, L; Tang, W; Xiao, B				Chi, Xiao Xiao; Zhang, Xiao Ming; Chen, Tian Wu; Huang, Xiao Hua; Yang, Lin; Tang, Wei; Xiao, Bo			The Normal Transverse Mesocolon and Involvement of the Mesocolon in Acute Pancreatitis: An MRI Study	PLOS ONE			English	Article							SMALL-BOWEL MESENTERY; COMPUTED-TOMOGRAPHY; CT; DIAGNOSIS; SEVERITY	Objective: To study the MRI findings of the normal transverse mesocolon and the involvement of the mesocolon in acute pancreatitis (AP) as well as the relationship between the involvement of the mesocolon and the severity of AP. Materials and Methods: Forty patients without pancreatic disorders were retrospectively analyzed to observe the normal transverse mesocolon using MRI; 210 patients with AP confirmed by clinical and laboratory tests were retrospectively analyzed using MRI to observe transverse-mesocolon involvement (TMI). The severity of TMI was recorded as zero points (no abnormalities and transverse-mesocolon vessel involvement), one point (linear and patchy signal in the transverse mesocolon) or two points (transverse-mesocolon effusion). The AP severity was graded by the MRI severity index (MRSI) and the Acute Physiology And Chronic Healthy Evaluation II (APACHE II) scoring system. The correlations of TMI with MRSI and APACHE-II were analyzed. Results: In a normal transverse mesocolon, the display rates of the middle colic artery, the middle colic vein and the gastrocolic trunk on MRI were 95.0%, 82.5% and 100.0%, respectively. Of the 210 patients with AP, 130 patients (61.9%) had TMI. According to the TMI grading, 40%, 39% and 20% of the patients were graded at zero, one and two points, respectively. TMI was strongly correlated with the MRSI score (r = 0.759, P = 0.000) and the APACHE-II score (r = 0.384, P = 0.000). Conclusion: MRI could be used to visualize transverse-mesocolon involvement. The severity of TMI could reflect that of AP in the clinical setting and imaging. TMI might be a supplementary indicator of the severity of AP.	[Chi, Xiao Xiao; Zhang, Xiao Ming; Chen, Tian Wu; Huang, Xiao Hua; Yang, Lin; Tang, Wei; Xiao, Bo] Affiliated Hosp North Sichuan, Coll Med, Dept Radiol, Sichuan Key Lab Med Imaging, Nanchong, Sichuan, Peoples R China		Zhang, XM (corresponding author), Affiliated Hosp North Sichuan, Coll Med, Dept Radiol, Sichuan Key Lab Med Imaging, Nanchong, Sichuan, Peoples R China.	cjr.zhxm@vip.163.com	Zhang, Xiao Ming/H-7104-2019; XIAO, BO/ABD-8858-2021	Zhang, Xiao Ming/0000-0001-5327-8506; Xiao, Bo/0000-0001-5862-974X; Chi, Xiaoxiao/0000-0001-6463-4115				Amano Y, 2001, ABDOM IMAGING, V26, P59, DOI 10.1007/s002610000104; Arvanitakis M, 2004, GASTROENTEROLOGY, V126, P715, DOI 10.1053/j.gastro.2003.12.006; BALTHAZAR EJ, 1990, RADIOLOGY, V174, P331, DOI 10.1148/radiology.174.2.2296641; Blachar A, 2001, RADIOLOGY, V221, P422, DOI 10.1148/radiol.2212010126; Gosset Johan, 2004, JOP, V5, P48; Hirota M, 2002, PANCREAS, V25, P63, DOI 10.1097/00006676-200207000-00015; Ishikawa K, 2006, EUR J RADIOL, V60, P445, DOI 10.1016/j.ejrad.2006.06.014; Ji YF, 2012, ACAD RADIOL, V19, P571, DOI 10.1016/j.acra.2012.01.004; Kim J H, 2000, Korean J Radiol, V1, P43; Kim YK, 2006, J MAGN RESON IMAGING, V24, P1342, DOI 10.1002/jmri.20801; Le O, 2013, WORLD J RADIOL, V5, P106, DOI 10.4329/wjr.v5.i3.106; Lee SK, 2007, KOREAN J MED, V73, P237; Low RN, 2005, SEMIN ULTRASOUND CT, V26, P224, DOI 10.1053/j.sult.2005.04.003; Ly JN, 2002, RADIOL CLIN N AM, V40, P1289, DOI 10.1016/S0033-8389(02)00056-8; MENDEZ G, 1980, AM J ROENTGENOL, V135, P463, DOI 10.2214/ajr.135.3.463; Mindelzun RE, 1996, AM J ROENTGENOL, V167, P61, DOI 10.2214/ajr.167.1.8659422; Okino Y, 2001, RADIOGRAPHICS, V21, P1475, DOI 10.1148/radiographics.21.6.g01nv121475; OLIPHANT M, 1993, ABDOM IMAGING, V18, P109; Pamuklar Ertan, 2005, Magn Reson Imaging Clin N Am, V13, P313, DOI 10.1016/j.mric.2005.03.012; Papachristou GI, 2010, AM J GASTROENTEROL, V105, P435, DOI 10.1038/ajg.2009.622; Peng R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072792; Rahman SH, 2004, GASTROENTEROLOGY, V126, P1312, DOI 10.1053/j.gastro.2004.02.002; Russo MW, 2004, GASTROENTEROLOGY; Scaglione M, 2008, SEMIN ULTRASOUND CT, V29, P322, DOI 10.1053/j.sult.2008.06.009; Servin-Torres E, 2009, CIR CIR, V77, P407; SILVERMAN PM, 1984, AM J ROENTGENOL, V143, P953, DOI 10.2214/ajr.143.5.953; Stimac D, 2007, AM J GASTROENTEROL, V102, P997, DOI 10.1111/j.1572-0241.2007.01164.x; Tang W, 2011, EUR J RADIOL, V80, P637, DOI 10.1016/j.ejrad.2010.08.020; Triester SL, 2002, J CLIN GASTROENTEROL, V34, P167, DOI 10.1097/00004836-200202000-00014; Viremouneix L, 2007, J MAGN RESON IMAGING, V26, P331, DOI 10.1002/jmri.21037; Yang R, 2012, EUR J RADIOL, V81, P3041, DOI 10.1016/j.ejrad.2012.04.005	31	7	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93687	10.1371/journal.pone.0093687	http://dx.doi.org/10.1371/journal.pone.0093687			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705446	Green Submitted, gold, Green Published			2022-12-25	WOS:000334107500057
J	Schnecker, J; Wild, B; Hofhansl, F; Alves, RJE; Barta, J; Capek, P; Fuchslueger, L; Gentsch, N; Gittel, A; Guggenberger, G; Hofer, A; Kienzl, S; Knoltsch, A; Lashchinskiy, N; Mikutta, R; Santruckova, H; Shibistova, O; Takriti, M; Urich, T; Weltin, G; Richter, A				Schnecker, Joerg; Wild, Birgit; Hofhansl, Florian; Alves, Ricardo J. Eloy; Barta, Jiri; Capek, Petr; Fuchslueger, Lucia; Gentsch, Norman; Gittel, Antje; Guggenberger, Georg; Hofer, Angelika; Kienzl, Sandra; Knoltsch, Anna; Lashchinskiy, Nikolay; Mikutta, Robert; Santruckova, Hana; Shibistova, Olga; Takriti, Mounir; Urich, Tim; Weltin, Georg; Richter, Andreas			Effects of Soil Organic Matter Properties and Microbial Community Composition on Enzyme Activities in Cryoturbated Arctic Soils	PLOS ONE			English	Article							ECOENZYMATIC STOICHIOMETRY; CARBON POOLS; DECOMPOSITION; DEPTH; BACTERIAL; DYNAMICS; ARCHAEAL; SURFACE	Enzyme-mediated decomposition of soil organic matter (SOM) is controlled, amongst other factors, by organic matter properties and by the microbial decomposer community present. Since microbial community composition and SOM properties are often interrelated and both change with soil depth, the drivers of enzymatic decomposition are hard to dissect. We investigated soils from three regions in the Siberian Arctic, where carbon rich topsoil material has been incorporated into the subsoil (cryoturbation). We took advantage of this subduction to test if SOM properties shape microbial community composition, and to identify controls of both on enzyme activities. We found that microbial community composition (estimated by phospholipid fatty acid analysis), was similar in cryoturbated material and in surrounding subsoil, although carbon and nitrogen contents were similar in cryoturbated material and topsoils. This suggests that the microbial community in cryoturbated material was not well adapted to SOM properties. We also measured three potential enzyme activities (cellobiohydrolase, leucine-amino-peptidase and phenoloxidase) and used structural equation models (SEMs) to identify direct and indirect drivers of the three enzyme activities. The models included microbial community composition, carbon and nitrogen contents, clay content, water content, and pH. Models for regular horizons, excluding cryoturbated material, showed that all enzyme activities were mainly controlled by carbon or nitrogen. Microbial community composition had no effect. In contrast, models for cryoturbated material showed that enzyme activities were also related to microbial community composition. The additional control of microbial community composition could have restrained enzyme activities and furthermore decomposition in general. The functional decoupling of SOM properties and microbial community composition might thus be one of the reasons for low decomposition rates and the persistence of 400 Gt carbon stored in cryoturbated material.	[Schnecker, Joerg; Wild, Birgit; Hofhansl, Florian; Fuchslueger, Lucia; Hofer, Angelika; Kienzl, Sandra; Knoltsch, Anna; Takriti, Mounir; Richter, Andreas] Univ Vienna, Dept Microbiol & Ecosyst Sci, Div Terr Ecosyst Res, Vienna, Austria; [Schnecker, Joerg; Wild, Birgit; Alves, Ricardo J. Eloy; Gittel, Antje; Knoltsch, Anna; Takriti, Mounir; Urich, Tim; Richter, Andreas] Austrian Polar Res Inst, Vienna, Austria; [Alves, Ricardo J. Eloy; Urich, Tim] Univ Vienna, Div Archaea Biol & Ecogen, Dept Ecogen & Syst Biol, Vienna, Austria; [Barta, Jiri; Capek, Petr; Santruckova, Hana] Univ South Bohemia, Dept Ecosyst Biol, Ceske Budejovice, Czech Republic; [Gentsch, Norman; Guggenberger, Georg; Mikutta, Robert; Shibistova, Olga] Leibniz Univ Hannover, Inst Bodenkunde, D-30167 Hannover, Germany; [Gittel, Antje] Univ Bergen, Dept Biol, Ctr Geobiol, Bergen, Norway; [Lashchinskiy, Nikolay] Russian Acad Sci, Cent Siberian Bot Garden, Siberian Branch, Novosibirsk, Russia; [Shibistova, Olga] Russian Acad Sci, VN Sukachev Inst Forest, Siberian Branch, Krasnoyarsk, Russia; [Weltin, Georg] IAEA, Joint FAO IAEA Div Nucl Techn Food & Agr, Soil & Water Management & Crop Nutr Lab, A-1400 Vienna, Austria	University of Vienna; University of Vienna; University of South Bohemia Ceske Budejovice; Leibniz University Hannover; University of Bergen; Central Siberian Botanical Garden; Russian Academy of Sciences; Russian Academy of Sciences; Krasnoyarsk Science Center of the Siberian Branch of the Russian Academy of Sciences; Sukachev Institute of Forest, Siberian Branch, Russian Academy of Sciences; International Atomic Energy Agency	Schnecker, J (corresponding author), Univ Vienna, Dept Microbiol & Ecosyst Sci, Div Terr Ecosyst Res, Vienna, Austria.	joerg.schnecker@univie.ac.at	Santruckova, Hana/D-7365-2016; Guggenberger, Georg/C-8423-2013; Richter, Andreas/D-8483-2012; Lashchinskiy, Nikolay/I-5409-2018; Alves, Ricardo Jorge Eloy/C-2530-2013; Urich, Tim/J-8241-2016; Čapek, Petr/I-1518-2016; Wild, Birgit/E-6476-2012; Fuchslueger, Lucia/E-6687-2012; Schnecker, Jörg/E-6546-2012; Shibistova, Olga/AAP-1594-2020; Hofhansl, Florian/E-6656-2012	Santruckova, Hana/0000-0001-9947-5687; Guggenberger, Georg/0000-0002-6962-8264; Richter, Andreas/0000-0003-3282-4808; Alves, Ricardo Jorge Eloy/0000-0002-7567-3205; Urich, Tim/0000-0002-5718-1354; Čapek, Petr/0000-0001-9362-6384; Wild, Birgit/0000-0002-9611-0815; Fuchslueger, Lucia/0000-0002-9615-4439; Schnecker, Jörg/0000-0002-5160-2701; Hofhansl, Florian/0000-0003-0073-0946; Barta, Jiri/0000-0002-7319-303X; Mikutta, Robert/0000-0002-7186-6528; Lasinskii, Nikolai/0000-0003-1085-1987; Takriti, Mounir/0000-0003-1794-8802	Austrian Science Fund (FWF) as a part of the international program CryoCARB (Long-term Carbon Storage in Cryoturbated Arctic Soils) [FWF - I370-B17]; Osterreichische Gesellschaft fur Polarforschung; Austrian Science Fund (FWF) [I 370] Funding Source: researchfish	Austrian Science Fund (FWF) as a part of the international program CryoCARB (Long-term Carbon Storage in Cryoturbated Arctic Soils)(Austrian Science Fund (FWF)); Osterreichische Gesellschaft fur Polarforschung; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Funding for this research was provided by the Austrian Science Fund (FWF) as a part of the international program CryoCARB (Long-term Carbon Storage in Cryoturbated Arctic Soils; FWF - I370-B17). JS received a Julius-Payer-Stipendium by the Osterreichische Gesellschaft fur Polarforschung. The funders had no role in study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Allison SD, 2013, ECOLOGY, V94, P714, DOI 10.1890/12-1243.1; Alster CJ, 2013, SOIL BIOL BIOCHEM, V64, P68, DOI 10.1016/j.soilbio.2013.03.034; Blume E, 2002, APPL SOIL ECOL, V20, P171, DOI 10.1016/S0929-1393(02)00025-2; Bockheim JG, 2007, SOIL SCI SOC AM J, V71, P1335, DOI 10.2136/sssaj2006.0414N; Colman BP, 2013, SOIL BIOL BIOCHEM, V60, P65, DOI 10.1016/j.soilbio.2013.01.003; DeForest JL, 2012, BIOGEOCHEMISTRY, V109, P189, DOI 10.1007/s10533-011-9619-6; Djukic I, 2013, FEMS MICROBIOL ECOL, V83, P112, DOI 10.1111/j.1574-6941.2012.01449.x; Eilers KG, 2012, SOIL BIOL BIOCHEM, V50, P58, DOI 10.1016/j.soilbio.2012.03.011; Ekelund F, 2001, SOIL BIOL BIOCHEM, V33, P475, DOI 10.1016/S0038-0717(00)00188-7; Fierer N, 2003, GLOBAL CHANGE BIOL, V9, P1322, DOI 10.1046/j.1365-2486.2003.00663.x; FROSTEGARD A, 1991, J MICROBIOL METH, V14, P151, DOI 10.1016/0167-7012(91)90018-L; Gebauer RLE, 1996, PLANT SOIL, V178, P37, DOI 10.1007/BF00011161; Gittel A, 2014, ISME J, V8, P841, DOI 10.1038/ismej.2013.219; Grace JB., 2015, STRUCTURAL EQUATION; Harden JW, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051958; Harris D, 2001, SOIL SCI SOC AM J, V65, P1853, DOI 10.2136/sssaj2001.1853; Hartmann M, 2009, ENVIRON MICROBIOL, V11, P3045, DOI 10.1111/j.1462-2920.2009.02008.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hugelius G, 2010, PERMAFROST PERIGLAC, V21, P16, DOI 10.1002/ppp.677; IUSS Working Group WRB, 2006, WORLD REFERENCE BASE, V103; Kaiser C, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2006JG000258; Kaiser C, 2010, SOIL BIOL BIOCHEM, V42, P1650, DOI 10.1016/j.soilbio.2010.05.019; Kaiser C, 2010, NEW PHYTOL, V187, P843, DOI 10.1111/j.1469-8137.2010.03321.x; Kuhry P, 2010, PERMAFROST PERIGLAC, V21, P208, DOI 10.1002/ppp.684; Oelke C, 2004, PERMAFROST PERIGLAC, V15, P103, DOI 10.1002/ppp.485; Prosser JI, 2012, FEMS MICROBIOL ECOL, V81, P507, DOI 10.1111/j.1574-6941.2012.01435.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rumpel C, 2011, PLANT SOIL, V338, P143, DOI 10.1007/s11104-010-0391-5; Santruckova H, 2010, BOREAL ENVIRON RES, V15, P357; Schimel JP, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00348; Schnecker J, 2012, SOIL BIOL BIOCHEM, V51, P81, DOI 10.1016/j.soilbio.2012.03.029; Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x; Sinsabaugh RL, 2011, BIOGEOCHEMISTRY, V102, P31, DOI 10.1007/s10533-010-9482-x; Sinsabaugh RL, 2010, SOIL BIOL BIOCHEM, V42, P391, DOI 10.1016/j.soilbio.2009.10.014; Sinsabaugh RL, 2009, NATURE, V462, P795, DOI 10.1038/nature08632; Sistla SA, 2012, NEW PHYTOL, V196, P68, DOI 10.1111/j.1469-8137.2012.04234.x; Strickland MS, 2009, FUNCT ECOL, V23, P627, DOI 10.1111/j.1365-2435.2008.01515.x; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Talbot JM, 2013, SOIL BIOL BIOCHEM, V57, P282, DOI 10.1016/j.soilbio.2012.10.004; Waldrop MP, 2006, MICROB ECOL, V52, P470, DOI 10.1007/s00248-006-9100-6; Wild B, 2013, SOIL BIOL BIOCHEM, V67, P85, DOI 10.1016/j.soilbio.2013.08.004; Xu CH, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000846	42	49	52	4	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e94076	10.1371/journal.pone.0094076	http://dx.doi.org/10.1371/journal.pone.0094076			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705618	Green Published, Green Accepted, gold			2022-12-25	WOS:000334107500121
J	Senderskiy, IV; Timofeev, SA; Seliverstova, EV; Pavlova, OA; Dolgikh, VV				Senderskiy, Igor V.; Timofeev, Sergey A.; Seliverstova, Elena V.; Pavlova, Olga A.; Dolgikh, Viacheslav V.			Secretion of Antonospora (Paranosema) locustae Proteins into Infected Cells Suggests an Active Role of Microsporidia in the Control of Host Programs and Metabolic Processes	PLOS ONE			English	Article							PARASITE ENCEPHALITOZOON-CUNICULI; TYROSINE-PHOSPHATASE SHP-1; NF-KAPPA-B; THEILERIA-ANNULATA; PROTOZOAN PARASITES; GENE-EXPRESSION; NUCLEAR EXPORT; NOSEMA-GRYLLI; BINDING; GENOME	Molecular tools of the intracellular protozoan pathogens Apicomplexa and Kinetoplastida for manipulation of host cell machinery have been the focus of investigation for approximately two decades. Microsporidia, fungi-related microorganisms forming another large group of obligate intracellular parasites, are characterized by development in direct contact with host cytoplasm (the majority of species), strong minimization of cell machinery, and acquisition of unique transporters to exploit host metabolic system. All the aforementioned features are suggestive of the ability of microsporidia to modify host metabolic and regulatory pathways. Seven proteins of the microsporidium Antonospora (Paranosema) locustae with predicted signal peptides but without transmembrane domains were overexpressed in Escherichia coli. Western-blot analysis with antibodies against recombinant products showed secretion of parasite proteins from different functional categories into the infected host cell. Secretion of parasite hexokinase and alpha/beta-hydrolase was confirmed by immunofluorescence microscopy. In addition, this method showed specific accumulation of A. locustae hexokinase in host nuclei. Expression of hexokinase, trehalase, and two leucine-rich repeat proteins without any exogenous signal peptide led to their secretion in the yeast Pichia pastoris. In contrast, alpha/beta-hydrolase was not found in the culture medium, though a significant amount of this enzyme accumulated in the yeast membrane fraction. These results suggest that microsporidia possess a broad set of enzymes and regulatory proteins secreted into infected cells to control host metabolic processes and molecular programs.	[Senderskiy, Igor V.; Timofeev, Sergey A.; Pavlova, Olga A.; Dolgikh, Viacheslav V.] All Russian Inst Plant Protect, Lab Microbiol Control, St Petersburg, Pushkin, Russia; [Seliverstova, Elena V.] Sechenov Inst Evolutionary Physiol & Biochem, Lab Renal Physiol, St Petersburg, Russia	All-Russian Institute of Plant Protection; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Dolgikh, VV (corresponding author), All Russian Inst Plant Protect, Lab Microbiol Control, St Petersburg, Pushkin, Russia.	dol1slav@yahoo.com	Senderskiy, Igor/J-6839-2018; Seliverstova, Elena/AAN-4894-2020; Timofeev, Sergey/GWZ-8836-2022; Olga, Pavlova/AAO-4051-2020; Timofeev, Sergey/J-2236-2014	Senderskiy, Igor/0000-0001-8598-2282; Timofeev, Sergey/0000-0001-6664-3971; Olga, Pavlova/0000-0003-0528-5618; Seliverstova, Elena/0000-0003-2096-693X; Dolgikh, Viacheslav/0000-0002-2362-2633	Russian Foundation of Basic Research RFBR [N 12-04-01517]	Russian Foundation of Basic Research RFBR(Russian Foundation for Basic Research (RFBR))	This work was supported by the Russian Foundation of Basic Research RFBR, N 12-04-01517 [http://www.rfbr.ru/rffi/ru]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brosson D, 2006, PROTEOMICS, V6, P3625, DOI 10.1002/pmic.200500796; Campbell SE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003676; CANNING EU, 1962, J INSECT PATHOL, V4, P248; Carmen JC, 2007, MOL MICROBIOL, V64, P904, DOI 10.1111/j.1365-2958.2007.05714.x; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Cuomo CA, 2012, GENOME RES, V22, P2478, DOI 10.1101/gr.142802.112; DARWISH A, 1989, J PROTOZOOL, V36, P308, DOI 10.1111/j.1550-7408.1989.tb05369.x; del Aguila C, 2006, INT J PARASITOL, V36, P869, DOI 10.1016/j.ijpara.2006.04.002; Dolgikh Viacheslav V., 2000, Protistology, V1, P87; Dolgikh VV, 2011, EUKARYOT CELL, V10, P588, DOI 10.1128/EC.00283-10; Dolgikh VV, 2009, FEMS MICROBIOL LETT, V293, P285, DOI 10.1111/j.1574-6968.2009.01545.x; Dolgikh VV, 1997, J EUKARYOT MICROBIOL, V44, P246, DOI 10.1111/j.1550-7408.1997.tb05707.x; Gilbert LA, 2007, EUKARYOT CELL, V6, P73, DOI 10.1128/EC.00309-06; Halle M, 2009, J BIOL CHEM, V284, P6893, DOI 10.1074/jbc.M805861200; Heinz E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002979; Heussler VT, 2002, SCIENCE, V298, P1033, DOI 10.1126/science.1075462; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keeling PJ, 2010, GENOME BIOL EVOL, V2, P304, DOI 10.1093/gbe/evq022; Kikawada T, 2007, P NATL ACAD SCI USA, V104, P11585, DOI 10.1073/pnas.0702538104; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lindquist S, 2002, EUR J BIOCHEM, V269, P759, DOI 10.1046/j.0014-2956.2001.02666.x; Ling MF, 1995, NUCLEIC ACIDS RES, V23, P4924, DOI 10.1093/nar/23.23.4924; Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619; Metenier G, 2001, MICROBES INFECT, V3, P407, DOI 10.1016/S1286-4579(01)01398-3; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Molestina RE, 2005, J CELL SCI, V118, P5785, DOI 10.1242/jcs.02709; MONSTADT GM, 1991, BIOCHEM J, V273, P739, DOI 10.1042/bj2730739; Nandan D, 2005, CLIN IMMUNOL, V114, P266, DOI 10.1016/j.clim.2004.07.017; Nandan D, 2002, J BIOL CHEM, V277, P50190, DOI 10.1074/jbc.M209210200; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Neary CL, 2010, BIOCHEM BIOPH RES CO, V394, P1075, DOI 10.1016/j.bbrc.2010.03.129; Pelaez R, 2009, J BIOL CHEM, V284, P20548, DOI 10.1074/jbc.M109.013730; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Ravindran S, 2008, TRAFFIC, V9, P647, DOI 10.1111/j.1600-0854.2008.00723.x; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Sato T, 2006, GLYCOBIOLOGY, V16, P1194, DOI 10.1093/glycob/cwl035; Scanlon M, 1999, J EUKARYOT MICROBIOL, V46, p34S; Schmuckli-Maurer J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004839; SELEZNEV KV, 1995, J EUKARYOT MICROBIOL, V42, P288, DOI 10.1111/j.1550-7408.1995.tb01582.x; Shiels BR, 2004, EUKARYOT CELL, V3, P495, DOI 10.1128/EC.3.2.495-505.2004; Sibley LD, 2011, IMMUNOL REV, V240, P72, DOI 10.1111/j.1600-065X.2010.00990.x; Sokolova YY, 2002, ACTA PROTOZOOL, V41, P229; Swan DG, 2003, CELL MICROBIOL, V5, P947, DOI 10.1046/j.1462-5822.2003.00340.x; Swan DG, 2001, J CELL SCI, V114, P2747; Tsaousis AD, 2008, NATURE, V453, P553, DOI 10.1038/nature06903; Undeen AH, 1999, J INVERTEBR PATHOL, V73, P294, DOI 10.1006/jipa.1998.4834; WANG CS, 1993, BIOCHIM BIOPHYS ACTA, V1166, P1, DOI 10.1016/0005-2760(93)90277-G	50	24	34	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93585	10.1371/journal.pone.0093585	http://dx.doi.org/10.1371/journal.pone.0093585			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705470	Green Submitted, Green Published, gold			2022-12-25	WOS:000334107500044
J	Chowdhury, S; Mukhopadhyay, R; Saha, S; Mishra, A; Sengupta, S; Roy, S; Majumder, HK				Chowdhury, Sayan; Mukhopadhyay, Rupkatha; Saha, Sourav; Mishra, Amartya; Sengupta, Souvik; Roy, Syamal; Majumder, Hemanta K.			Flavone-resistant Leishmania donovani Overexpresses LdMRP2 Transporter in the Parasite and Activates Host MRP2 on Macrophages to Circumvent the Flavone-mediated Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR NRF2; BINDING CASSETTE TRANSPORTER; NF-KAPPA-B; MULTIDRUG-RESISTANCE; ANTIMONY-RESISTANT; NUCLEAR TRANSLOCATION; DNA TOPOISOMERASE; GENE-EXPRESSION; PROTEIN; LOCALIZATION	In parasites, ATP-binding cassette (ABC) transporters represent an important family of proteins related to drug resistance and other biological activities. Resistance of leishmanial parasites to therapeutic drugs continues to escalate in developing countries, and in many instances, it is due to overexpressed ABC efflux pumps. Progressively adapted baicalein (BLN)-resistant parasites (pB(25)R) show overexpression of a novel ABC transporter, which was classified as ABCC2 or Leishmania donovani multidrug resistance protein 2 (LdMRP2). The protein is primarily localized in the flagellar pocket region and in internal vesicles. Overexpressed LdABCC2 confers substantial BLN resistance to the parasites by rapid drug efflux. The BLN-resistant promastigotes when transformed into amastigotes in macrophage cells cannot be cured by treatment of macrophages with BLN. Amastigote resistance is concomitant with the overexpression of macrophage MRP2 transporter. Reporter analysis and site-directed mutagenesis assays demonstrated that antioxidant response element 1 is activated upon infection. The expression of this phase II detoxifying gene is regulated by NFE2-related factor 2 (Nrf2)-mediated antioxidant response element activation. In view of the fact that the signaling pathway of phosphoinositol 3-kinase controls microfilament rearrangement and translocation of actin-associated proteins, the current study correlates with the intricate pathway of phosphoinositol 3-kinase-mediated nuclear translocation of Nrf2, which activates MRP2 expression in macrophages upon infection by the parasites. In contrast, phalloidin, an agent that prevents depolymerization of actin filaments, inhibits Nrf2 translocation and Mrp(2) gene activation by pB(25)R infection. Taken together, these results provide insight into the mechanisms by which resistant clinical isolates of L. donovani induce intracellular events relevant to drug resistance.	[Chowdhury, Sayan; Saha, Sourav; Mishra, Amartya; Majumder, Hemanta K.] Indian Inst Chem Biol, Mol Parasitol Lab, Kolkata 700032, India; [Mukhopadhyay, Rupkatha; Roy, Syamal] Indian Inst Chem Biol, Infect Dis & Immunol Div, Kolkata 700032, India; [Sengupta, Souvik] Indian Assoc Cultivat Sci, Dept Phys Chem, Mol Biol Lab, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur	Majumder, HK (corresponding author), Indian Inst Chem Biol, Mol Parasitol Lab, 4 Raja SC Mullick Rd, Kolkata 700032, India.	hkmajumder@iicb.res.in	Mukhopadhyay, Rupkatha/AAY-4304-2020; Gupta, Souvik Sen/X-9547-2019; Mishra, Amartya/ABG-7216-2021	Gupta, Souvik Sen/0000-0001-7452-979X; Mukhopadhyay, Rupkatha/0000-0002-4120-2966	Department of Biotechnology, Government of India [BT/PR4456/MED/29/355/2012]; Council of Scientific and Industrial Research, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This research work was supported by Department of Biotechnology, Government of India Grant BT/PR4456/MED/29/355/2012.; Supported by a senior research fellowship from the Council of Scientific and Industrial Research, Government of India.	Akao T, 2009, BIOL PHARM BULL, V32, P2079, DOI 10.1248/bpb.32.2079; Araujo-Santos JM, 2005, BIOCHEM BIOPH RES CO, V330, P349, DOI 10.1016/j.bbrc.2005.02.176; Basu JM, 2008, ANTIMICROB AGENTS CH, V52, P1080, DOI 10.1128/AAC.01196-07; Basu R, 2005, J IMMUNOL, V174, P7160, DOI 10.4049/jimmunol.174.11.7160; Beverley SM, 1996, CELL, V87, P787, DOI 10.1016/S0092-8674(00)81984-4; BoseDasgupta S, 2008, CELL DEATH DIFFER, V15, P1629, DOI 10.1038/cdd.2008.85; BoseDasgupta S, 2008, MOL BIOCHEM PARASIT, V158, P176, DOI 10.1016/j.molbiopara.2007.12.007; Castanys-Munoz E, 2007, MOL MICROBIOL, V64, P1141, DOI 10.1111/j.1365-2958.2007.05653.x; Chowdhury S, 2012, EMBO MOL MED, V4, P1126, DOI 10.1002/emmm.201201316; Chowdhury S, 2011, MOL PHARMACOL, V80, P694, DOI 10.1124/mol.111.072785; Creek DJ, 2008, ANTIMICROB AGENTS CH, V52, P1291, DOI 10.1128/AAC.01033-07; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; Cuvillier A, 2000, J CELL SCI, V113, P2065; Das BB, 2006, NUCLEIC ACIDS RES, V34, P1121, DOI 10.1093/nar/gkj502; Das BB, 2004, FEBS LETT, V565, P81, DOI 10.1016/j.febslet.2004.03.078; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Decuypere S, 2005, ANTIMICROB AGENTS CH, V49, P4616, DOI 10.1128/AAC.49.11.4616-4621.2005; Dey S, 1996, P NATL ACAD SCI USA, V93, P2192, DOI 10.1073/pnas.93.5.2192; Dodge MA, 2004, MOL MICROBIOL, V51, P1563, DOI 10.1111/j.1365-2958.2003.03927.x; DOYLE PS, 1991, EXP PARASITOL, V73, P326, DOI 10.1016/0014-4894(91)90104-5; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; FUKAMI K, 1994, J BIOL CHEM, V269, P1518; Gong PF, 2002, ANTIOXID REDOX SIGN, V4, P249, DOI 10.1089/152308602753666307; Grassme HUC, 1996, INFECT IMMUN, V64, P1621; Gueiros FJ, 1995, EXP PARASITOL, V81, P480, DOI 10.1006/expr.1995.1141; Haldar AK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000907; Hayashi A, 2003, BIOCHEM BIOPH RES CO, V310, P824, DOI 10.1016/j.bbrc.2003.09.086; Holling TM, 2002, J IMMUNOL, V168, P763, DOI 10.4049/jimmunol.168.2.763; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jedlitschky G, 1996, CANCER RES, V56, P988; Kang KW, 2002, MOL PHARMACOL, V62, P1001, DOI 10.1124/mol.62.5.1001; Kaur J, 2000, BIOCHEM BIOPH RES CO, V271, P615, DOI 10.1006/bbrc.2000.2680; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; Kedzierski L, 2011, HUM VACCINES, V7, P1204, DOI 10.4161/hv.7.11.17752; Kobets T, 2012, CURR MED CHEM, V19, P1443, DOI 10.2174/092986712799828300; Lader AS, 1999, AM J PHYSIOL-CELL PH, V277, pC1277, DOI 10.1152/ajpcell.1999.277.6.C1277; Legare D, 2001, J BIOL CHEM, V276, P26301, DOI 10.1074/jbc.M102351200; Leprohon P, 2006, EUKARYOT CELL, V5, P1713, DOI 10.1128/EC.00152-06; Leprohon P, 2009, ANTIMICROB AGENTS CH, V53, P2646, DOI 10.1128/AAC.01474-08; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Mandal G, 2009, INDIAN J BIOCHEM BIO, V46, P86; Marquis JF, 2005, ANTIMICROB AGENTS CH, V49, P1441, DOI 10.1128/AAC.49.4.1441-1446.2005; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Min KJ, 2011, CELL SIGNAL, V23, P1505, DOI 10.1016/j.cellsig.2011.05.013; Mittra B, 2000, MOL MED, V6, P527, DOI 10.1007/BF03401792; Mukherjee A, 2007, J ANTIMICROB CHEMOTH, V59, P204, DOI 10.1093/jac/dkl494; Mukherjee B, 2013, P NATL ACAD SCI USA, V110, pE575, DOI [10.1073/pnas.1213839110, 10.]; Mukhopadhyay R, 2011, INT J PARASITOL, V41, P1311, DOI 10.1016/j.ijpara.2011.07.013; Mullin KA, 2001, MOL BIOL CELL, V12, P2364, DOI 10.1091/mbc.12.8.2364; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Perez-Victoria FJ, 2003, ANTIMICROB AGENTS CH, V47, P2397, DOI 10.1128/AAC.47.8.2397-2403.2003; Reguera RM, 2008, CURR DRUG TARGETS, V9, P966, DOI 10.2174/138945008786786118; Sauvage V, 2009, MOL BIOCHEM PARASIT, V167, P81, DOI 10.1016/j.molbiopara.2009.05.005; Seifert K, 2003, INT J ANTIMICROB AG, V22, P380, DOI 10.1016/S0924-8579(03)00125-0; Smith AJP, 2009, J MOL BIOL, V385, P714, DOI 10.1016/j.jmb.2008.11.035; Stockel B, 2000, EUR J BIOCHEM, V267, P1347, DOI 10.1046/j.1432-1327.2000.01106.x; Sullivan R, 1999, J BIOL CHEM, V274, P38140, DOI 10.1074/jbc.274.53.38140; Vince JE, 2008, EUKARYOT CELL, V7, P1256, DOI 10.1128/EC.00090-08; Vollrath V, 2006, BIOCHEM J, V395, P599, DOI 10.1042/BJ20051518; WAY M, 1995, J CELL BIOL, V128, P51, DOI 10.1083/jcb.128.1.51	64	6	6	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 6	2014	289	23					16129	16147		10.1074/jbc.M113.539742	http://dx.doi.org/10.1074/jbc.M113.539742			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ8ON	24706751	Green Published, hybrid			2022-12-25	WOS:000337965700020
J	Dyle, MC; Ebert, SM; Cook, DP; Kunkel, SD; Fox, DK; Bongers, KS; Bullard, SA; Dierdorff, JM; Adams, CM				Dyle, Michael C.; Ebert, Scott M.; Cook, Daniel P.; Kunkel, Steven D.; Fox, Daniel K.; Bongers, Kale S.; Bullard, Steven A.; Dierdorff, Jason M.; Adams, Christopher M.			Systems-based Discovery of Tomatidine as a Natural Small Molecule Inhibitor of Skeletal Muscle Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TOMATINE; EXPRESSION SIGNATURES; DEFICIENT MICE; FAT MASS; SARCOPENIA; HYPERTROPHY; ACTIVATION; MANAGEMENT; PROTECTS; TOMATOES	Skeletal muscle atrophy is a common and debilitating condition that lacks an effective therapy. To address this problem, we used a systems-based discovery strategy to search for a small molecule whose mRNA expression signature negatively correlates to mRNA expression signatures of human skeletal muscle atrophy. This strategy identified a natural small molecule from tomato plants, tomatidine. Using cultured skeletal myotubes from both humans and mice, we found that tomatidine stimulated mTORC1 signaling and anabolism, leading to accumulation of protein and mitochondria, and ultimately, cell growth. Furthermore, in mice, tomatidine increased skeletal muscle mTORC1 signaling, reduced skeletal muscle atrophy, enhanced recovery from skeletal muscle atrophy, stimulated skeletal muscle hypertrophy, and increased strength and exercise capacity. Collectively, these results identify tomatidine as a novel small molecule inhibitor of muscle atrophy. Tomatidine may have utility as a therapeutic agent or lead compound for skeletal muscle atrophy.	[Dyle, Michael C.; Ebert, Scott M.; Cook, Daniel P.; Kunkel, Steven D.; Fox, Daniel K.; Bongers, Kale S.; Bullard, Steven A.; Dierdorff, Jason M.; Adams, Christopher M.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Dyle, Michael C.; Ebert, Scott M.; Cook, Daniel P.; Kunkel, Steven D.; Fox, Daniel K.; Bongers, Kale S.; Bullard, Steven A.; Dierdorff, Jason M.; Adams, Christopher M.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Dyle, Michael C.; Ebert, Scott M.; Cook, Daniel P.; Kunkel, Steven D.; Fox, Daniel K.; Bongers, Kale S.; Bullard, Steven A.; Dierdorff, Jason M.; Adams, Christopher M.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA; [Bullard, Steven A.; Adams, Christopher M.] Iowa City Vet Affairs Med Ctr, Iowa City, IA 52246 USA	University of Iowa; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Adams, CM (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	christopher-adams@uiowa.edu		Adams, Christopher/0000-0002-5795-7212; Bongers, Kale/0000-0002-9297-9185; Cook, Daniel/0000-0002-1152-4454	University of Iowa Research Foundation; National Institutes of Health [AR059115-04, 1F31AG04603801, HL07638-27, F30AG04496401, F30AG04330401]; Dept. of Veterans Affairs Biomedical Laboratory Research & Development Service [IBX000976A]; Fraternal Order of Eagles Diabetes Research Center at the University of Iowa; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG046038, F30AG044964] Funding Source: NIH RePORTER; Veterans Affairs [I01RX001477, I01BX000976] Funding Source: NIH RePORTER	University of Iowa Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Veterans Affairs Biomedical Laboratory Research & Development Service; Fraternal Order of Eagles Diabetes Research Center at the University of Iowa; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the University of Iowa Research Foundation, the National Institutes of Health (Grants AR059115-04, 1F31AG04603801, HL07638-27, F30AG04496401, and F30AG04330401), the Dept. of Veterans Affairs Biomedical Laboratory Research & Development Service (Grant IBX000976A), and the Fraternal Order of Eagles Diabetes Research Center at the University of Iowa.	Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Belavy DL, 2009, EUR J APPL PHYSIOL, V107, P489, DOI 10.1007/s00421-009-1136-0; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Blattler SM, 2012, CELL METAB, V15, P505, DOI 10.1016/j.cmet.2012.03.008; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bongers KS, 2013, AM J PHYSIOL-ENDOC M, V305, pE907, DOI 10.1152/ajpendo.00380.2013; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Burks TN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002227; Burton LA, 2010, CLIN INTERV AGING, V5, P217; Caron AZ, 2009, J APPL PHYSIOL, V106, P2049, DOI 10.1152/japplphysiol.91505.2008; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Dubowitz V., 2007, MUSCLE BIOPSY PRACTI; Ebert SM, 2012, J BIOL CHEM, V287, P27290, DOI 10.1074/jbc.M112.374777; Friedman M, 2003, FOOD CHEM TOXICOL, V41, P61, DOI 10.1016/S0278-6915(02)00205-3; Friedman M, 2013, J AGR FOOD CHEM, V61, P9534, DOI 10.1021/jf402654e; Fujiwara Y, 2012, J AGR FOOD CHEM, V60, P2472, DOI 10.1021/jf204197r; Guo TQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004937; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Koh E, 2013, J SCI FOOD AGR, V93, P1537, DOI 10.1002/jsfa.5951; Kunkel SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039332; Kunkel SD, 2011, CELL METAB, V13, P627, DOI 10.1016/j.cmet.2011.03.020; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; MENDEZ J, 1960, METABOLISM, V9, P184; Michael K, 2000, Biol Res Nurs, V2, P117, DOI 10.1177/109980040000200205; RICK CM, 1994, P NATL ACAD SCI USA, V91, P12877, DOI 10.1073/pnas.91.26.12877; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Tan BHL, 2008, CURR OPIN CLIN NUTR, V11, P400, DOI 10.1097/MCO.0b013e328300ecc1	34	82	88	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14913	14924		10.1074/jbc.M114.556241	http://dx.doi.org/10.1074/jbc.M114.556241			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24719321	Green Published, hybrid			2022-12-25	WOS:000337248100042
J	Careaga, M; Rose, D; Tassone, F; Berman, RF; Hagerman, R; Ashwood, P				Careaga, Milo; Rose, Destanie; Tassone, Flora; Berman, Robert F.; Hagerman, Randi; Ashwood, Paul			Immune Dysregulation as a Cause of Autoinflammation in Fragile X Premutation Carriers: Link between FMRI CGG Repeat Number and Decreased Cytokine Responses	PLOS ONE			English	Article							PREMATURE OVARIAN FAILURE; PRIMARY IMMUNODEFICIENCY; TREMOR/ATAXIA SYNDROME; AUTOIMMUNITY LESSONS; EXPANDED ALLELES; TREMOR; GENE; IDENTIFICATION; ASSOCIATION; DYSFUNCTION	Background: Increased rates of autoinflammatory and autoimmune disorders have been observed in female premutation carriers of CGG repeat expansion alleles of between 55-200 repeats in the fragile X mental retardation 1 (FMR1) gene. To determine whether an abnormal immune profile was present at a cellular level that may predispose female carriers to autoinflammatory conditions, we investigated dynamic cytokine production following stimulation of blood cells. In addition, splenocyte responses were examined in an FMR1 CGG knock-in mouse model of the fragile X premutation. Methods: Human monocyte and peripheral blood leukocytes (PBLs) were isolated from the blood of 36 female FMR1 premutation carriers and 15 age-matched controls. Cells were cultured with media alone, LPS or PHA. In the animal model, splenocytes were isolated from 32 CGG knock-in mice and 32 wild type littermates. Splenocytes were cultured with media alone or LPS or PMA/ Ionomycin. Concentrations of cytokines (GM-CSF, IL-1 beta, IL-6, IL-10, IL-13, IL-17, IFN gamma, TNF alpha, and MCP- 1) were determined from the supernatants of cellular cultures via Luminex multiplex assay. Additionally, phenotypic cellular markers were assessed on cells isolated from human subjects via flow cytometry. Results: We found decreases in cytokine production in human premutation carriers as well as in the FMR1 knock-in mice when compared with controls. Levels of cytokines were found to be associated with CGG repeat length in both human and mouse. Furthermore, T cells from human premutation carriers showed decreases in cell surface markers of activation when compared with controls. Conclusions: In this study, FMR1 CGG repeat expansions are associated with decreased immune responses and immune dysregulation in both humans and mice. Deficits in immune responses in female premutation carriers may lead to increased susceptibility to autoimmunity and further research is warranted to determine the link between FMR1 CGG repeat lengths and onset of autoinflammatory conditions.	[Careaga, Milo; Rose, Destanie; Ashwood, Paul] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA; [Careaga, Milo; Rose, Destanie; Tassone, Flora; Berman, Robert F.; Hagerman, Randi; Ashwood, Paul] Univ Calif Davis, MIND Inst, Davis, CA 95616 USA; [Tassone, Flora] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Berman, Robert F.] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA; [Hagerman, Randi] Univ Calif Davis, Dept Pediat, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Ashwood, P (corresponding author), Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA.	pashwood@ucdavis.edu			National Institutes of Health (NIH) [HD036071, HD02274, RL1 AG032115, RL1 NS062411, R01 NS079775]; Jane Botsford Johnson Foundation; Peter Emch Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD079125, P30HD002274, R01HD036071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RL1NS062411, R01NS079775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RL1AG032115] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Botsford Johnson Foundation; Peter Emch Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (NIH) grants HD036071, HD02274, RL1 AG032115, RL1 NS062411, R01 NS079775, the Jane Botsford Johnson Foundation and Peter Emch Foundation. The above-mentioned funding agencies were not responsible for the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of this manuscript.	Alleva DG, 1998, J IMMUNOL, V161, P6878; Arason GJ, 2010, SCAND J IMMUNOL, V71, P317, DOI 10.1111/j.1365-3083.2010.02386.x; Ashwood P, 2004, J CLIN IMMUNOL, V24, P664, DOI 10.1007/s10875-004-6241-6; Berman RF, 2009, J INVEST MED, V57, P837, DOI 10.2310/JIM.0b013e3181af59d6; Bourgeois JA, 2011, J CLIN PSYCHIAT, V72, P175, DOI 10.4088/JCP.09m05407blu; Chen YC, 2010, HUM MOL GENET, V19, P196, DOI 10.1093/hmg/ddp479; Coffey SM, 2008, AM J MED GENET A, V146A, P1009, DOI 10.1002/ajmg.a.32060; CONWAY GS, 1995, LANCET, V346, P309, DOI 10.1016/S0140-6736(95)92194-X; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Enstrom AM, 2010, BRAIN BEHAV IMMUN, V24, P64, DOI 10.1016/j.bbi.2009.08.001; Enstrom AM, 2009, BRAIN BEHAV IMMUN, V23, P124, DOI 10.1016/j.bbi.2008.08.001; Filipovic-Sadic S, 2010, CLIN CHEM, V56, P399, DOI 10.1373/clinchem.2009.136101; Graber JJ, 2011, J NEUROL SCI, V305, P1, DOI 10.1016/j.jns.2011.03.026; Grammatikos AP, 2012, TRENDS MOL MED, V18, P101, DOI 10.1016/j.molmed.2011.10.005; Gupta S, 2013, CLIN REV ALLERG IMMU, V45, P162, DOI 10.1007/s12016-012-8345-8; Hagerman RJ, 2001, NEUROLOGY, V57, P127, DOI 10.1212/WNL.57.1.127; Hamlin AA, 2012, AM J MED GENET A, V158A, P1304, DOI 10.1002/ajmg.a.35323; Hessl D, 2011, BIOL PSYCHIAT, V70, P859, DOI 10.1016/j.biopsych.2011.05.033; Horwitz DA, 1998, ARTHRITIS RHEUM, V41, P838, DOI 10.1002/1529-0131(199805)41:5<838::AID-ART10>3.0.CO;2-S; Houssiau FA, 1997, CLIN EXP IMMUNOL, V108, P375, DOI 10.1046/j.1365-2249.1997.d01-1009.x; Jacquemont S, 2003, AM J HUM GENET, V72, P869, DOI 10.1086/374321; Mackay IR, 2010, J AUTOIMMUN, V35, P199, DOI 10.1016/j.jaut.2010.06.008; Marek D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-238; Roberts JE, 2009, AM J MED GENET B, V150B, P130, DOI 10.1002/ajmg.b.30786; Rodriguez-Revenga L, 2009, EUR J HUM GENET, V17, P1359, DOI 10.1038/ejhg.2009.51; Rodriguez-Revenga L, 2009, MENOPAUSE, V16, P944, DOI 10.1097/gme.0b013e3181a06a37; Sellier C, 2013, CELL REP, V3, P869, DOI 10.1016/j.celrep.2013.02.004; Seltzer MM, 2012, AM J MED GENET B, V159B, P589, DOI 10.1002/ajmg.b.32065; Sleasman J W, 1996, Adv Dent Res, V10, P57; Sullivan AK, 2005, HUM REPROD, V20, P402, DOI 10.1093/humrep/deh635; Tassone F, 2010, FRAGILE X-ASSOCIATED TREMOR ATAXIA SYNDROME (FXTAS), P1, DOI 10.1007/978-1-4419-5805-1; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Tassone F, 2008, J MOL DIAGN, V10, P43, DOI 10.2353/jmoldx.2008.070073; Tassone F, 2012, RESULTS PROBL CELL D, V54, P337, DOI 10.1007/978-3-642-21649-7_18; Todd PK, 2013, NEURON, V78, P440, DOI 10.1016/j.neuron.2013.03.026; Uzielli MLG, 1999, AM J MED GENET, V84, P300, DOI 10.1002/(SICI)1096-8628(19990528)84:3<300::AID-AJMG27>3.3.CO;2-X; Willemsen R, 2003, HUM MOL GENET, V12, P949, DOI 10.1093/hmg/ddg114; Winarni TI, 2012, AM J MED GENET A, V158A, P2473, DOI 10.1002/ajmg.a.35569	38	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94475	10.1371/journal.pone.0094475	http://dx.doi.org/10.1371/journal.pone.0094475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718368	gold, Green Published, Green Submitted			2022-12-25	WOS:000334339000125
J	Toth, AB; Lyons, SK; Behrensmeyer, AK				Toth, Aniko B.; Lyons, S. Kathleen; Behrensmeyer, Anna K.			A Century of Change in Kenya's Mammal Communities: Increased Richness and Decreased Uniqueness in Six Protected Areas	PLOS ONE			English	Article							SPATIALLY EXPLICIT; HABITAT LOSS; HYDE 3.1; CONSERVATION; DYNAMICS; DISTRIBUTIONS; ASSEMBLAGES; POPULATION; EXTINCTION; SERENGETI	The potential for large-scale biodiversity losses as a result of climate change and human impact presents major challenges for ecology and conservation science. Governments around the world have established national parks and wildlife reserves to help protect biodiversity, but there are few studies on the long-term consequences of this strategy. We use Kenya as a case study to investigate species richness and other attributes of mammal communities in 6 protected areas over the past century. Museum records from African expeditions that comprehensively sampled mammals from these same areas in the early 1900's provide a baseline for evaluating changes in species richness and community structure over time. We compare species lists assembled from archived specimens (1896-1950) to those of corresponding modern protected areas (19502013). Species richness in Kenya was stable or increased at 5 out of 6 sites from historical to modern times. Beta-diversity, in contrast, decreased across all sites. Potential biases such as variable historical vs. modern collection effort and detection of small-bodied, rare, and low-visibility species do not account for the observed results. We attribute the pattern of decreased beta diversity primarily to increased site occupancy by common species across all body size classes. Despite a decrease in land area available to wildlife, our data do not show the extinctions predicted by species-area relationships. Moreover, the results indicate that species-area curves based solely on protected areas could underestimate diversity because they do not account for mammal species whose ranges extend beyond protected area boundaries. We conclude that the 6 protected areas have been effective in preserving species richness in spite of continuing conversion of wild grasslands to cropland, but the overall decrease in beta diversity indicates a decline in the uniqueness of mammal communities that historically characterized Kenya's varied landscape.	[Toth, Aniko B.; Lyons, S. Kathleen; Behrensmeyer, Anna K.] Smithsonian Inst Washington, Natl Museum Nat Hist, Dept Paleobiol, Evolut Terr Ecosyst Program, Washington, DC 20560 USA	Smithsonian Institution; Smithsonian National Museum of Natural History	Toth, AB (corresponding author), Smithsonian Inst Washington, Natl Museum Nat Hist, Dept Paleobiol, Evolut Terr Ecosyst Program, Washington, DC 20560 USA.	totha@si.edu	Tóth, Anikó/AAT-6084-2021	Tóth, Anikó/0000-0002-3063-1917; Lyons, S. Kathleen/0000-0001-5112-2508	National Museum of Natural History internal grant; Direct For Biological Sciences [1257625] Funding Source: National Science Foundation	National Museum of Natural History internal grant; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was supported by a National Museum of Natural History internal grant to the Evolution of Terrestrial Ecosystems Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, AFR MAMM DAT; [Anonymous], 2014, ASS AFR PROT AR; [Anonymous], 2013, GLOBAL BIODIVERSITY; Bakker VJ, 2000, ECOLOGY, V81, P3530, DOI 10.1890/0012-9658(2000)081[3530:SDPIBS]2.0.CO;2; Becht R, 2002, HYDROBIOLOGIA, V488, P1, DOI 10.1023/A:1023318007715; Bleher A, 2006, KENYA BIODIV CONS, V15, P1159; Bouwman AF., 2006, INTEGRATED MODELLING, P1; C?lix M., 2018, EUROPEAN RED LIST SA; East R., 1999, AFRICAN ANTELOPE DAT; ESRI, 2011, ARCGIS DESKT REL 10; Fashing PJ, 2002, AFRICAN ZOOLOGY, V37, P2; Gallant AL, 2007, COPEIA, P967, DOI 10.1643/0045-8511(2007)7[967:GROHLA]2.0.CO;2; Goldewijk KK, 2011, GLOBAL ECOL BIOGEOGR, V20, P73, DOI 10.1111/j.1466-8238.2010.00587.x; Goldewijk KK, 2010, HOLOCENE, V20, P565, DOI 10.1177/0959683609356587; Goldson J, 1993, LAKE NAIVASHA RIPARI, P109; HANSKI I, 1982, OIKOS, V38, P210, DOI 10.2307/3544021; Harper DM, 2003, LAKE NAIVASHA; Heller E, 1909, SMITHSONIAN AFRICAN; Hill CM, 1997, INT J PEST MANAGE, V43, P77, DOI 10.1080/096708797229022; IUCN and UNEP-WCMC, 2013, WORLD DAT PROT AR WD; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Kenya Wildlife Service, 2012, OV PARKS RES; Kingdon J, 1997, KINGDON FIELD GUIDE; Kingdon J., 1971, E AFRICAN MAMMALS AT; Kingdon J, 1988, E AFRICAN MAMMALS AT, V3; Kingdon J, 1974, E AFRICAN MAMMALS AT, V2; Kingdon J., 1982, E AFRICAN MAMMALS AT, V3; KOKWARO JO, 1988, MONOGRAPH SYSTEMATIC, V25, P471; Loring JA, 1909, SMITHSONIAN AFRICAN; Lyons SK, 2013, MACROECOLOGICAL PATT, P114; Magurran AE, 2003, NATURE, V422, P714, DOI 10.1038/nature01547; Marquet PA, 1999, OIKOS, V85, P299, DOI 10.2307/3546496; Mearns EA, 1909, SMITHSONIAN AFRICAN; Mitchell N, 2009, BIOTA E AFRICA REPOR; Ngigi T.G., 2004, INT J ENVIRON STUD, V61, P281, DOI [10.1080/0020723032000170959, DOI 10.1080/0020723032000170959]; NMNH Collections, NMNH COLL; Ogutu JO, 2011, J ZOOL, V285, P99, DOI 10.1111/j.1469-7998.2011.00818.x; Ogutu JO, 2009, J ZOOL, V278, P1, DOI 10.1111/j.1469-7998.2008.00536.x; Roosevelt T, 1927, AFRICAN GAME TRAILS; ROOSEVELT T, 1914, LIFE HIST AFRICAN GA; Rybicki J, 2013, ECOL LETT, V16, P27, DOI 10.1111/ele.12065; Sinclair ARE, 2007, CONSERV BIOL, V21, P580, DOI 10.1111/j.1523-1739.2007.00699.x; Sinclair A.R.E., 1995, SERENGETI DYNAMICS E; Sinclair AR, 2008, DYNAMICS; Smith FA, 2003, ECOLOGY, V84, P3403, DOI 10.1890/02-9003; Songa JM, 2002, INT J PEST MANAGE, V48, P1, DOI 10.1080/09670870110052077; Waithaka J, 2012, KENYA WILDLIFE SERVI, V29, P21; Wearn OR, 2012, SCIENCE, V337, P228, DOI 10.1126/science.1219013; Western D, 2009, SCIENCE, V324, P1061, DOI 10.1126/science.1171155; Wilson AE, 2005, MAMMAL SPECIES WORLD; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; World Resources Institute, 2014, KEN GIS DAT	52	10	11	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93092	10.1371/journal.pone.0093092	http://dx.doi.org/10.1371/journal.pone.0093092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718262	Green Published, gold			2022-12-25	WOS:000334339000027
J	Zhang, XH; Qiao, GJ; Lu, PF				Zhang, Xiaohong; Qiao, Guijuan; Lu, Pengfei			Modulation of Fibroblast Growth Factor Signaling Is Essential for Mammary Epithelial Morphogenesis	PLOS ONE			English	Article							BRANCHING MORPHOGENESIS; RECEPTOR SPECIFICITY; DISTINCT ROLES; BREAST-CANCER; STEM-CELLS; GLAND; GENE; EXPRESSION; PATHWAY; MECHANISMS	Fibroblast growth factor (FGF) signaling is essential for vertebrate organogenesis, including mammary gland development. The mechanism whereby FGF signaling is regulated in the mammary gland, however, has remained unknown. Using a combination of mouse genetics and 3D ex vivo models, we tested the hypothesis that Spry2 gene, which encodes an inhibitor of signaling via receptor tyrosine kinases (RTKs) in certain contexts, regulates FGF signaling during mammary branching. We found that Spry2 is expressed at various stages of the developing mammary gland. Targeted removal of Spry2 function from mammary epithelium leads to accelerated epithelial invasion. Spry2 is up-regulated by FGF signaling activities and its loss sensitizes mammary epithelium to FGF stimulation, as indicated by increased expression of FGF target genes and epithelia invasion. By contrast, Spry2 gain-of-function in the mammary epithelium results in reduced FGF signaling, epithelial invasion, and stunted branching. Furthermore, reduction of Spry2 expression is correlated with tumor progression in the MMTV-PyMT mouse model. Together, the data show that FGF signaling modulation by Spry2 is essential for epithelial morphogenesis in the mammary gland and it functions to protect the epithelium against tumorigenesis.	[Zhang, Xiaohong; Qiao, Guijuan; Lu, Pengfei] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England	University of Manchester	Lu, PF (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England.	paul.pf.lu@gmail.com			National Institutes of Health [R03 HD060807]; Breakthrough Breast Cancer; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD060807] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breakthrough Breast Cancer; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was funded by grants from the National Institutes of Health (R03 HD060807) and Breakthrough Breast Cancer to PL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 2012, COLD SPRING HARBOR P, V4; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Calmont A, 2006, DEV CELL, V11, P339, DOI 10.1016/j.devcel.2006.06.015; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Faratian D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023772; Fata JE, 2007, DEV BIOL, V306, P193, DOI 10.1016/j.ydbio.2007.03.013; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Hynes NE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003186; Itoh N, 2008, DEV DYNAM, V237, P18, DOI 10.1002/dvdy.21388; Kim EJ, 2013, J MAMMARY GLAND BIOL, V18, P139, DOI 10.1007/s10911-013-9278-4; Klein OD, 2008, DEVELOPMENT, V135, P377, DOI 10.1242/dev.015081; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; Lu PF, 2008, SCIENCE, V322, P1506, DOI 10.1126/science.1162783; Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005; Lu PF, 2006, J MAMMARY GLAND BIOL, V11, P213, DOI 10.1007/s10911-006-9027-z; Lu PF, 2006, DEVELOPMENT, V133, P33, DOI 10.1242/dev.02172; Luetteke NC, 1999, DEVELOPMENT, V126, P2739; Mailleux AA, 2002, DEVELOPMENT, V129, P53; Mao JH, 2009, DEV CELL, V16, P600, DOI 10.1016/j.devcel.2009.02.005; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; Moraes RC, 2009, DEVELOPMENT, V136, P1423, DOI 10.1242/dev.023994; Moses H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003277; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Panagiotaki N, 2010, DEVELOPMENT, V137, P4005, DOI 10.1242/dev.053173; Parsa S, 2008, DEV BIOL, V317, P121, DOI 10.1016/j.ydbio.2008.02.014; PETERS G, 1983, CELL, V33, P369, DOI 10.1016/0092-8674(83)90418-X; Pond AC, 2013, STEM CELLS, V31, P178, DOI 10.1002/stem.1266; Rowzee A, 2008, J MAMMARY GLAND BIOL, V13, P361, DOI 10.1007/s10911-008-9102-8; Schedin P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003228; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Sigurdsson V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060798; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stern DF, 2000, BREAST CANCER RES, V2, P176, DOI 10.1186/bcr51; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966; Wagner KU, 2001, TRANSGENIC RES, V10, P545, DOI 10.1023/A:1013063514007; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Welm BE, 2002, J CELL BIOL, V157, P703, DOI 10.1083/jcb.200107119; Xian W, 2005, J CELL BIOL, V171, P663, DOI 10.1083/jcb.200505098; Xian W, 2007, MOL ENDOCRINOL, V21, P987, DOI 10.1210/me.2006-0518; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Zhu WT, 2013, DEV BIOL, V379, P235, DOI 10.1016/j.ydbio.2013.04.029	52	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e92735	10.1371/journal.pone.0092735	http://dx.doi.org/10.1371/journal.pone.0092735			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718286	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000018
J	Che, RB; Sun, YY; Sun, DQ; Xu, TJ				Che, Rongbo; Sun, Yueyan; Sun, Dianqiao; Xu, Tianjun			Characterization of the Miiuy Croaker (Miichthys miiuy) Transcriptome and Development of Immune-Relevant Genes and Molecular Markers	PLOS ONE			English	Article							CC-CHEMOKINE GENE; EXPRESSION ANALYSIS; RAINBOW-TROUT; SSR-MARKERS; SEQUENCE; CLONING; ANNOTATION; BACTERIA; TOOL	Background: The miiuy croaker (Miichthys miiuy) is an important species of marine fish that supports capture fisheries and aquaculture. At present commercial scale aquaculture of this species is limited due to diseases caused by pathogens and parasites which restrict production and limit commercial value. The lack of transcriptomic and genomic information for the miiuy croaker limits the ability of researchers to study the pathogenesis and immune system of this species. In this study we constructed a cDNA library from liver, spleen and kidney which was sequenced using Illumina paired-end sequencing to enable gene discovery and molecular marker development. Principal Findings: In our study, a total of 69,071 unigenes with an average length of 572 bp were obtained. Of these, 45,676 (66.13%) were successfully annotated in public databases. The unigenes were also annotated with Gene Ontology, Clusters of Orthologous Groups and KEGG pathways. Additionally, 498 immune-relevant genes were identified and classified. Furthermore, 14,885 putative simple sequence repeats (cSSRs) and 8,510 putative single nucleotide polymorphisms (SNPs) were identified from the 69,071 unigenes. Conclusion: The miiuy croaker (Miichthys miiuy) transcriptome data provides a large resource to identify new genes involved in many processes including those involved in the response to pathogens and diseases. Furthermore, the thousands of potential cSSR and SNP markers found in this study are important resources with respect to future development of molecular marker assisted breeding programs for the miiuy croaker.	[Che, Rongbo; Sun, Yueyan; Sun, Dianqiao; Xu, Tianjun] Zhejiang Ocean Univ, Coll Marine Sci, Lab Fish Biogenet & Immune Evolut, Zhoushan, Peoples R China	Zhejiang Ocean University	Xu, TJ (corresponding author), Zhejiang Ocean Univ, Coll Marine Sci, Lab Fish Biogenet & Immune Evolut, Zhoushan, Peoples R China.	tianjunxu@163.com			Nation Nature Science Foundation of China [31370049]; Important Science and Technology Specific Projects of Zhejiang Province [2011C14012]	Nation Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Important Science and Technology Specific Projects of Zhejiang Province	This study was supported by Nation Nature Science Foundation of China (31370049) and Important Science and Technology Specific Projects of Zhejiang Province (2011C14012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Bajgain P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-370; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Bondad-Reantaso MG, 2007, ASSESSMENT FRESHWATE; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Cheng YZ, 2011, FISH SHELLFISH IMMUN, V31, P439, DOI 10.1016/j.fsi.2011.06.016; Cheng YZ, 2011, FISH SHELLFISH IMMUN, V31, P148, DOI 10.1016/j.fsi.2011.02.024; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dumetz F, 2006, APPL ENVIRON MICROB, V72, P4845, DOI 10.1128/AEM.00279-06; Gong YF, 2009, J IMMUNOL, V182, P7749, DOI 10.4049/jimmunol.0804370; Grisez L., 2005, DIS ASIAN AQUACULTUR, P483; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jacob NM, 2010, BIOTECHNOL BIOENG, V105, P1002, DOI 10.1002/bit.22588; Li DJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-192; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lin AF, 2009, J IMMUNOL, V183, P7398, DOI 10.4049/jimmunol.0803955; Liu XZ, 2012, FISH SHELLFISH IMMUN, V32, P464, DOI 10.1016/j.fsi.2011.11.033; Lou B., 2004, CHIN J MOD FISH, V6, P11; Meng FX, 2012, FISH SHELLFISH IMMUN, V32, P1171, DOI 10.1016/j.fsi.2012.02.010; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Miller HC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-439; Morais S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-255; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peng YH, 2010, PEST MANAG SCI, V66, P1053, DOI 10.1002/ps.2004; Rozen S, 2000, Methods Mol Biol, V132, P365; Salem M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-564; Shan LZ, 2010, CHINA MAR SCI, V34, P75; Shan Xiu-Juan, 2009, Oceanologia et Limnologia Sinica, V40, P714; Sun YN, 2011, FISH PHYSIOL BIOCHEM, V37, P761, DOI 10.1007/s10695-011-9475-2; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Verschuere L, 2000, MICROBIOL MOL BIOL R, V64, P655, DOI 10.1128/MMBR.64.4.655-671.2000; Wang B, 2010, NUCLEIC ACIDS RES, V38, P5075, DOI 10.1093/nar/gkq256; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang RX, 2010, GENET MOL RES, V9, P931, DOI 10.4238/vol9-2gmr806; Wang XJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-716; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; Xia JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-356; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xu TJ, 2011, AQUACULTURE, V318, P25, DOI 10.1016/j.aquaculture.2011.04.034; Xu TJ, 2011, DEV COMP IMMUNOL, V35, P483, DOI 10.1016/j.dci.2010.12.003; Xu TJ, 2010, FISH SHELLFISH IMMUN, V29, P1099, DOI 10.1016/j.fsi.2010.08.013; Xu TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035449; Xu TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023823; Xu TJ, 2011, INT J MOL SCI, V12, P4021, DOI 10.3390/ijms12064021; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157	54	52	53	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94046	10.1371/journal.pone.0094046	http://dx.doi.org/10.1371/journal.pone.0094046			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714210	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900074
J	Huang, QL; Zhang, R; Hu, XH; Ding, SW; Qian, JG; Lei, T; Cao, X; Tao, L; Qian, ZY; Liu, HY				Huang, Qingling; Zhang, Rui; Hu, Xinhua; Ding, Shangwen; Qian, Jingguang; Lei, Ting; Cao, Xuan; Tao, Ling; Qian, Zhiyu; Liu, Hongyi			Disturbed Small-World Networks and Neurocognitive Function in Frontal Lobe Low-Grade Glioma Patients	PLOS ONE			English	Article							BRAIN-TUMOR PATIENTS; CORTICAL NETWORKS; CONNECTIVITY; INJECTION; IMAGES	Background: Brain tumor patients often associated with losses of the small-world configuration and neurocognitive functions before operations. However, few studies were performed on the impairments of frontal lobe low-grade gliomas (LGG) after tumor resection using small-world network features. Methodology/Principal Findings: To detect differences in the whole brain topology among LGG patients before and after operation, a combined study of neurocognitive assessment and graph theoretical network analysis of fMRI data was performed. We collected resting-state fMRI data of 12 carefully selected frontal lobe LGG patients before and after operation. We calculated the topological properties of brain functional networks in the 12 LGG, and compared with 12 healthy controls (HCs). We also applied Montreal Cognitive Assessment (MoCA) in a subset of patients (n = 12, including before and after operation groups) and HCs (n = 12). The resulting functional connectivity matrices were constructed for all 12 patients, and binary network analysis was performed. In the range of 0.05 <= K-cost <= 0.35, the functional networks in preoperative LGG and postoperative one both fitted the definition of small-worldness. We proposed K-net = 0.20 as small-world network interval, and the results showed that the topological properties were found to be disrupted in the two LGG groups, meanwhile the global efficiency increased and the local efficiency decreased. L-net in the two LGG groups both were longer than HCs. C-net in the LGG groups were smaller than HCs. Compared with the Hcs, MoCA in the two LGG groups were lower than HCs with significant difference, and the disturbed networks in the LGG were negatively related to worse MoCA scores. Conclusions: Disturbed small-worldness preperty in the two LGG groups was found and widely spread in the strength and spatial organization of brain networks, and the alterated small-world network may be responsible for cognitive dysfunction in frontal lobe LGG patients.	[Huang, Qingling] Nanjing Med Univ, Nanjing Brain Hosp, Dept Radiol, Nanjing, Jiangsu, Peoples R China; [Zhang, Rui; Hu, Xinhua; Lei, Ting; Liu, Hongyi] Nanjing Med Univ, Nanjing Brain Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China; [Ding, Shangwen; Tao, Ling; Qian, Zhiyu] Nanjing Univ Aeronaut & Astronaut, Dept Biomed Engn, Nanjing, Jiangsu, Peoples R China; [Qian, Jingguang] Nanjing Sport Inst, Dept Sci Res, Nanjing, Jiangsu, Peoples R China; [Cao, Xuan] Univ Florida, Dept Stat, Gainesville, FL 32611 USA	Nanjing Medical University; Nanjing Medical University; Nanjing University of Aeronautics & Astronautics; Nanjing Sport Institute; State University System of Florida; University of Florida	Qian, ZY (corresponding author), Nanjing Univ Aeronaut & Astronaut, Dept Biomed Engn, Nanjing, Jiangsu, Peoples R China.	zhiyu@nuaa.edu.cn; hyl18@126.com			Natural Scientific Foundation of China [31270998]; Science and Technology Development Program of Jiangsu Province [BL2012041]; Science and Technology Program of Nanjing [QRX11115]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Program of Jiangsu Province; Science and Technology Program of Nanjing	This work was supported by the grants from the Natural Scientific Foundation of China [Grant No. 31270998 for Jingguang Qian], the Science and Technology Development Program of Jiangsu Province [Grant No. BL2012041 for Hongyi Liu], and the Science and Technology Program of Nanjing [Grant No. QRX11115 for Qingling Huang]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Alstott J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000408; Bartolomei F, 2006, CLIN NEUROPHYSIOL, V117, P2039, DOI 10.1016/j.clinph.2006.05.018; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; BOSMA I, 2009, NONLINEAR BIOMED PHY, V1, P3; Bosma I, 2008, NEURO-ONCOLOGY, V10, P734, DOI 10.1215/15228517-2008-034; Brett M, 2001, NEUROIMAGE, V14, P486, DOI 10.1006/nimg.2001.0845; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Douw L, 2008, EXP NEUROL, V212, P285, DOI 10.1016/j.expneurol.2008.03.013; Douw L, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00174; Douw L, 2009, NEUROIMAGE, V46, P584, DOI 10.1016/j.neuroimage.2009.02.034; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Klein M, 2002, LANCET, V360, P1361, DOI 10.1016/S0140-6736(02)11398-5; Klein M, 2003, ANN NEUROL, V54, P514, DOI 10.1002/ana.10712; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Nudo RJ, 2007, STROKE, V38, P840, DOI 10.1161/01.STR.0000247943.12887.d2; Nudo RJ, 1996, J NEUROSCI, V16, P785; Ramasco JJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066106; Rosenow F, 2001, BRAIN, V124, P1683, DOI 10.1093/brain/124.9.1683; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Shaw E G, 1993, Oncology (Williston Park), V7, P97; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stephan KE, 2008, NEUROIMAGE, V42, P1, DOI 10.1016/j.neuroimage.2008.04.167; Taphoorn MJB, 2004, LANCET NEUROL, V3, P159, DOI 10.1016/S1474-4422(04)00680-5; WADA J, 1960, J NEUROSURG, V17, P266, DOI 10.3171/jns.1960.17.2.0266; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	33	33	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94095	10.1371/journal.pone.0094095	http://dx.doi.org/10.1371/journal.pone.0094095			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714669	Green Published, gold, Green Submitted			2022-12-25	WOS:000334160900082
J	Lunze, K; Yeboah-Antwi, K; Marsh, DR; Kafwanda, SN; Musso, A; Semrau, K; Waltensperger, KZ; Hamer, DH				Lunze, Karsten; Yeboah-Antwi, Kojo; Marsh, David R.; Kafwanda, Sarah Ngolofwana; Musso, Austen; Semrau, Katherine; Waltensperger, Karen Z.; Hamer, Davidson H.			Prevention and Management of Neonatal Hypothermia in Rural Zambia	PLOS ONE			English	Article							NEWBORN CARE PRACTICES; MORTALITY; PRETERM; INFANTS; BABIES; HEALTH	Background: Neonatal hypothermia is increasingly recognized as a risk factor for newborn survival. The World Health Organization recommends maintaining a warm chain and skin-to-skin care for thermoprotection of newborn children. Since little is known about practices related to newborn hypothermia in rural Africa, this study's goal was to characterize relevant practices, attitudes, and beliefs in rural Zambia. Methods and Findings: We conducted 14 focus group discussions with mothers and grandmothers and 31 in-depth interviews with community leaders and health officers in Lufwanyama District, a rural area in the Copperbelt Province, Zambia, enrolling a total of 171 participants. We analyzed data using domain analysis. In rural Lufwanyama, community members were aware of the danger of neonatal hypothermia. Caregivers' and health workers' knowledge of thermoprotective practices included birthplace warming, drying and wrapping of the newborn, delayed bathing, and immediate and exclusive breastfeeding. However, this warm chain was not consistently maintained in the first hours postpartum, when newborns are at greatest risk. Skin-to-skin care was not practiced in the study area. Having to assume household and agricultural labor responsibilities in the immediate postnatal period was a challenge for mothers to provide continuous thermal care to their newborns. Conclusions: Understanding and addressing community-based practices on hypothermia prevention and management might help improve newborn survival in resource-limited settings. Possible interventions include the implementation of skin-to-skin care in rural areas and the use of appropriate, low-cost newborn warmers to prevent hypothermia and support families in their provision of newborn thermal protection. Training family members to support mothers in the provision of thermoprotection for their newborns could facilitate these practices.	[Lunze, Karsten; Hamer, Davidson H.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Lunze, Karsten; Yeboah-Antwi, Kojo; Semrau, Katherine; Hamer, Davidson H.] Boston Univ, Ctr Global Hlth & Dev, Boston, MA USA; [Lunze, Karsten; Yeboah-Antwi, Kojo; Musso, Austen; Semrau, Katherine; Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA; [Marsh, David R.; Waltensperger, Karen Z.] Save Children US, Westport, CT USA; [Kafwanda, Sarah Ngolofwana] Trop Dis Res Ctr, Ndola, Zambia; [Hamer, Davidson H.] Zambia Ctr Appl Hlth Res & Dev, Lusaka, Zambia	Boston University; Boston University; Boston University; Save the Children; University of Zambia	Lunze, K (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	karsten.lunze@post.harvard.edu	Yeboah-Antwi, Kojo/AAI-8519-2020; Lunze, Karsten/AAL-7240-2021; Hamer, Davidson Howes/J-2020-2019	Lunze, Karsten/0000-0001-8495-0350; Hamer, Davidson Howes/0000-0002-4700-1495; Semrau, Katherine/0000-0002-8360-1391; Yeboah-Antwi, Kojo/0000-0002-3516-9266	United States Agency for International Development [GHS A-00-09-00013-00]	United States Agency for International Development(United States Agency for International Development (USAID))	The authors would like to acknowledge the United States Agency for International Development, the support of which - through Cooperative Agreement Number: GHS A-00-09-00013-00 - made this project and study possible. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayaz A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013783; Ayaz S, 2008, EUR J CONTRACEP REPR, V13, P282, DOI 10.1080/13625180802049427; Central Statistical Office, 2012, 2010 CENS POP HOUS; Choudhary S. P., 2000, Indian Journal of Pediatrics, V67, P491, DOI 10.1007/BF02760474; CHRISTENSSON K, 1995, J TROP PEDIATRICS, V41, P210, DOI 10.1093/tropej/41.4.210; CHRISTENSSON K, 1988, J TROP PEDIATRICS, V34, P208, DOI [10.1093/tropej/34.5.208-a, 10.1093/tropej/34.5.208]; Clark J, 2003, QUALITATIVE RES REV; Corbin Juliet M., 2007, BASICS QUALITATIVE R; Darmstadt GL, 2006, J PERINATOL, V26, P597, DOI 10.1038/sj.jp.7211569; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Dragovich D, 1997, ACTA PAEDIATR, V86, P645, DOI 10.1111/j.1651-2227.1997.tb08949.x; Embrace, 2013, EMBR GLOB INF THERM; Gill CJ, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d346; Hill Z, 2010, TROP MED INT HEALTH, V15, P1118, DOI 10.1111/j.1365-3156.2010.02593.x; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Kumar V, 2009, J PERINATOL, V29, P401, DOI 10.1038/jp.2008.233; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Leadford AE, 2013, PEDIATRICS, V132, pE128, DOI 10.1542/peds.2012-2030; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lunze K, 2012, J PERINATOL, V32, P317, DOI 10.1038/jp.2012.11; Lunze K, 2012, BMC MED IN PRESS; Moran AC, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-54; Mullany LC, 2010, SEMIN PERINATOL, V34, P426, DOI 10.1053/j.semperi.2010.09.007; Mullany LC, 2010, ARCH PEDIAT ADOL MED, V164, P650, DOI 10.1001/archpediatrics.2010.103; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Osrin D, 2002, BMJ-BRIT MED J, V325, P1063, DOI 10.1136/bmj.325.7372.1063; QSR International, 2013, NVIVO 10 RES SOFTW A; Sreeramareddy Chandrashekhar T, 2006, BMC Pregnancy Childbirth, V6, P27, DOI 10.1186/1471-2393-6-27; Thairu L, 2013, Trop Med Int Health, V18, P117, DOI 10.1111/tmi.12021; Thairu L, 2008, MATERN CHILD NUTR, V4, P194, DOI 10.1111/j.1740-8709.2008.00135.x; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UN Inter-agency Group for Child Mortality Estimation, 2012, LEV TRENDS CHILD MOR; Waiswa P, 2010, TROP MED INT HEALTH, V15, P1140, DOI 10.1111/j.1365-3156.2010.02603.x; Wirth M, 2012, GLOBAL HLTH DIPLOMAC, V2, P5; World Health Organization. Maternal and Newborn Health/Safe Motherhood, 1997, THERM PROT NEWB PRAC; Zupan J., 2005, PERINATAL MORTALITY	36	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e92006	10.1371/journal.pone.0092006	http://dx.doi.org/10.1371/journal.pone.0092006			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714630	gold, Green Published, Green Submitted			2022-12-25	WOS:000334160900003
J	Yokoyama, S; Kitamoto, S; Higashi, M; Goto, Y; Hara, T; Ikebe, D; Yamaguchi, T; Arisaka, Y; Niihara, T; Nishimata, H; Tanaka, S; Takaori, K; Batra, SK; Yonezawa, S				Yokoyama, Seiya; Kitamoto, Sho; Higashi, Michiyo; Goto, Yuko; Hara, Taro; Ikebe, Dai; Yamaguchi, Taketo; Arisaka, Yoshifumi; Niihara, Toru; Nishimata, Hiroto; Tanaka, Sadao; Takaori, Kyoichi; Batra, Surinder K.; Yonezawa, Suguru			Diagnosis of Pancreatic Neoplasms Using a Novel Method of DNA Methylation Analysis of Mucin Expression in Pancreatic Juice	PLOS ONE			English	Article							GENE-EXPRESSION; CANCER-CELLS; TUMORS; HYPERMETHYLATION; CLASSIFICATION; MUC5AC; IPMN	Mucins (MUC) play crucial roles in carcinogenesis and tumor invasion in pancreatic ductal adenocarcinoma (PDAC) and intraductal papillary mucinous neoplasms (IPMNs). Our immunohistochemistry (IHC) studies have shown a consensus position on mucin expression profiles in pancreatic neoplasms as follows: MUC1-positive but MUC2-negative expression in PDACs; MUC1-negative but MUC2-positive expression in intestinal-type IPMNs (dangerous type); MUC1-negative and MUC2-negative expression in gastric-type IPMNs (safe type); High MUC4 expression in PDAC patients with a poor outcome; and MUC4-positive expression in intestinal-type IPMNs. We also showed that three mucin genes (MUC1, MUC2 and MUC4) expression in cancer cell line was regulated by DNA methylation. We have developed a novel ' methylation-specific electrophoresis (MSE)' method to analyze the DNA methylation status of mucin genes by high sensitivity and resolution. By using the MSE method, we evaluated pancreatic juice samples from 45 patients with various pancreatic lesions. The results were compared with final diagnosis of the pancreatic lesions including IHC of mucin expression in the paired pancreatic tissues. The results indicated that the DNA methylation status of MUC1, MUC2 and MUC4 in pancreatic juice matched with the mucin expression in tissue. Analyses of the DNA methylation status of MUC1, MUC2 and MUC4 were useful for differential diagnosis of human pancreatic neoplasms, with specificity and sensitivity of 87% and 80% for PDAC; 100% and 88% for intestinal-type IPMN; and 88% and 77% for gastric-type IPMN, respectively. In conclusion, MSE analysis of human pancreatic juice may provide useful information for selection of treatment for pancreatic neoplasms.	[Yokoyama, Seiya; Kitamoto, Sho; Higashi, Michiyo; Goto, Yuko; Yonezawa, Suguru] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human Pathol, Kagoshima 890, Japan; [Hara, Taro] Chiba Canc Ctr, Div Endoscopy, Chiba 2608717, Japan; [Ikebe, Dai] Chiba Canc Ctr, Div Surg Pathol, Chiba 2608717, Japan; [Yamaguchi, Taketo] Chiba Canc Ctr, Div Gastroenterol, Chiba 2608717, Japan; [Arisaka, Yoshifumi] Kobe Univ, Grad Sch Med, Dept Gastroenterol, Kobe, Hyogo 657, Japan; [Niihara, Toru] Nanpuh Hosp, Div Gastroenterol, Kagoshima, Japan; [Tanaka, Sadao] Nanpuh Hosp, Div Surg Pathol, Kagoshima, Japan; [Takaori, Kyoichi] Kyoto Univ, Grad Sch Med, Dept Surg, Div Hepatobiliary Pancreat Surg & Transplantat, Kyoto, Japan; [Batra, Surinder K.] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Dept Biochem & Mol Biol, Omaha, NE USA	Kagoshima University; Chiba Cancer Center; Chiba Cancer Center; Chiba Cancer Center; Kobe University; Kyoto University; University of Nebraska System; University of Nebraska Medical Center	Yonezawa, S (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human Pathol, Kagoshima 890, Japan.	syoneza@m2.kufm.kagoshima-u.ac.jp	Kitamoto, Sho/AAE-4549-2021	Kitamoto, Sho/0000-0003-3597-6647	Princess Takamatsu Cancer Research Fund [11-24319]; Ministry of Education, Science, Sports, Culture and Technology, Japan [23390085, 24590447, 24701008]; Kodama Memorial Foundation, Japan; USPHS from the National Institutes of Health [CA78590]; NATIONAL CANCER INSTITUTE [R01CA078590] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24701008] Funding Source: KAKEN	Princess Takamatsu Cancer Research Fund; Ministry of Education, Science, Sports, Culture and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kodama Memorial Foundation, Japan; USPHS from the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a grant from the Princess Takamatsu Cancer Research Fund (11-24319) to S. Yonezawa; Grants-in-Aid for Scientific Research on Scientific Research (B) 23390085 to S. Yonezawa, Scientific Research (C) 24590447 to MH and Young Scientists (B) 24701008 to S. Yokoyama from the Ministry of Education, Science, Sports, Culture and Technology, Japan; by the Kodama Memorial Foundation, Japan (S. Yokoyama & MH); and by USPHS grant CA78590 from the National Institutes of Health to SKB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adsay NV, 2002, CANCER, V94, P62, DOI 10.1002/cncr.10203; Adsay NV., 2010, PATHOLOGY GENETICS T, P304; Begum S, 2011, CLIN CANCER RES, V17, P4494, DOI 10.1158/1078-0432.CCR-10-3436; Carvalho AL, 2008, CLIN CANCER RES, V14, P97, DOI 10.1158/1078-0432.CCR-07-0722; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Fawcett T, 2006, PATTERN RECOGN, V27, P4; Furukawa T, 2011, GUT, V60, P509, DOI 10.1136/gut.2010.210567; Hara T, 2013, ANN SURG, V257, P1103, DOI 10.1097/SLA.0b013e318281b824; Horinouchi M, 2003, ACTA HISTOCHEM CYTOC, V36, P443, DOI 10.1267/ahc.36.443; Hruban RH, 2010, WHO CLASSIFICATION T, P281; Ideno N, 2013, ANN SURG, V258, P141, DOI 10.1097/SLA.0b013e31828cd008; Ihaka R, 1996, J COMPUT GRAPH STAT, V5, P16; Kitazono I, 2013, PANCREAS, V42, P1120, DOI 10.1097/MPA.0b013e3182965915; Longnecker DS, 2000, WHO CLASSIFICATION T, P237; Matsubayashi H, 2006, CANCER RES, V66, P1208, DOI 10.1158/0008-5472.CAN-05-2664; Moniaux N, 2004, J HISTOCHEM CYTOCHEM, V52, P253, DOI 10.1177/002215540405200213; Nagata S, 2012, CANCER-AM CANCER SOC, V118, P4298, DOI 10.1002/cncr.27417; Nakamura A, 2002, J PATHOL, V197, P201, DOI 10.1002/path.1109; OSAKO M, 1993, CANCER, V71, P2191, DOI 10.1002/1097-0142(19930401)71:7<2191::AID-CNCR2820710705>3.0.CO;2-X; Saitou M, 2005, J CLIN PATHOL, V58, P845, DOI 10.1136/jcp.2004.023572; Shinozuka N, 2007, J HEPATO-BILIARY-PAN, V14, P569, DOI 10.1007/s00534-006-1203-4; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Yamada N, 2009, BRIT J CANCER, V100, P344, DOI 10.1038/sj.bjc.6604845; Yamada N, 2011, CLIN EPIGENET; Yamada N, 2008, CANCER RES, V68, P2708, DOI 10.1158/0008-5472.CAN-07-6844; Yamada N, 2006, INT J CANCER, V119, P1850, DOI 10.1002/ijc.22047; Yao F, 2013, AM J MED SCI, V346, P175, DOI 10.1097/MAJ.0b013e31827b94b6; Yokoyama S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-67; Yonezawa S, 1999, PATHOL INT, V49, P45, DOI 10.1046/j.1440-1827.1999.00823.x; Yonezawa S, 1997, HUM PATHOL, V28, P344, DOI 10.1016/S0046-8177(97)90134-9; Yonezawa S, 1998, PATHOL INT, V48, P319, DOI 10.1111/j.1440-1827.1998.tb03913.x; Yonezawa S, 2012, GASTRIC CANC; Yonezawa S, 2008, PROTEOMICS, V8, P3329, DOI 10.1002/pmic.200800040; Yonezawa S, 2011, PATHOL INT, V61, P697, DOI 10.1111/j.1440-1827.2011.02734.x; Yonezawa S, 2010, J HEPATO-BIL-PAN SCI, V17, P108, DOI 10.1007/s00534-009-0174-7; Yonezawa S, 2008, GUT LIVER, V2, P137, DOI 10.5009/gnl.2008.2.3.137	37	24	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93760	10.1371/journal.pone.0093760	http://dx.doi.org/10.1371/journal.pone.0093760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714692	gold, Green Submitted, Green Published			2022-12-25	WOS:000334160900045
J	Zhang, H; Wang, XY; Lin, XH; Liu, CX				Zhang, Hao; Wang, Xing-yuan; Lin, Xiao-hui; Liu, Chong-xin			Stability and Synchronization for Discrete-Time Complex-Valued Neural Networks with Time-Varying Delays	PLOS ONE			English	Article								In this paper, the synchronization problem for a class of discrete-time complex-valued neural networks with time-varying delays is investigated. Compared with the previous work, the time delay and parameters are assumed to be time-varying. By separating the real part and imaginary part, the discrete-time model of complex-valued neural networks is derived. Moreover, by using the complex-valued Lyapunov-Krasovskii functional method and linear matrix inequality as tools, sufficient conditions of the synchronization stability are obtained. In numerical simulation, examples are presented to show the effectiveness of our method.	[Zhang, Hao; Wang, Xing-yuan; Lin, Xiao-hui] Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dalian, Peoples R China; [Liu, Chong-xin] Xi An Jiao Tong Univ, Inst Elect Engn, Xian 710049, Peoples R China	Dalian University of Technology; Xi'an Jiaotong University	Zhang, H (corresponding author), Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dalian, Peoples R China.	wangxy@dlut.edu.cn; zhangh545@yahoo.com.cn	Wang, Xing-yuan/I-6353-2015		National Natural Science Foundation of China [61370145, 61173183, 60973152]; Doctoral Program Foundation of Institution of Higher Education of China [20070141014]; Program for Liaoning Excellent Talents in University [LR2012003]; National Natural Science Foundation of Liaoning province [20082165]; Fundamental Research Funds for the Central Universities [DUT12JB06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Program Foundation of Institution of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program for Liaoning Excellent Talents in University; National Natural Science Foundation of Liaoning province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research is supported by the National Natural Science Foundation of China (Nos: 61370145, 61173183, and 60973152), the Doctoral Program Foundation of Institution of Higher Education of China (No: 20070141014), Program for Liaoning Excellent Talents in University (No: LR2012003), the National Natural Science Foundation of Liaoning province (No: 20082165) and the Fundamental Research Funds for the Central Universities (No: DUT12JB06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arik S, 2000, IEEE T CIRCUITS-I, V47, P568, DOI 10.1109/81.841858; Boyd S., 1994, LINEAR MATRIX INEQUA; Chapelle O, 1999, IEEE T NEURAL NETWOR, V10, P1055, DOI 10.1109/72.788646; Chen DY, 2012, CHAOS, V22, DOI 10.1063/1.4721996; Duan CJ, 2010, DISCRETE DYN NAT SOC, V2010, DOI 10.1155/2010/368379; Georgieva A, 2009, IEEE T NEURAL NETWOR, V20, P675, DOI 10.1109/TNN.2008.2011903; Gong DW, 2012, NEUROCOMPUTING, V82, P14, DOI 10.1016/j.neucom.2011.09.026; Gonzalez-Miranda JM, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.047202; Hu J, 2012, IEEE T NEUR NET LEAR, V23, P853, DOI 10.1109/TNNLS.2012.2195028; Lin SH, 1997, IEEE T NEURAL NETWOR, V8, P114, DOI 10.1109/72.554196; Liu YR, 2008, IEEE T SYST MAN CY B, V38, P1314, DOI 10.1109/TSMCB.2008.925745; PECORA LM, 1990, PHYS REV LETT, V64, P821, DOI 10.1103/PhysRevLett.64.821; Rudin W., 1987, REAL COMPLEX ANAL, DOI DOI 10.1007/BFB0084190; SANGER TD, 1989, NEURAL NETWORKS, V2, P459, DOI 10.1016/0893-6080(89)90044-0; Wang XY, 2010, COMMUN NONLINEAR SCI, V15, P124, DOI 10.1016/j.cnsns.2009.03.035; Zhang H, 2007, IEEE T NEURAL NETWOR, V18, P1841, DOI 10.1109/TNN.2007.902958; Zhang ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039355; Zhou B, 2013, IEEE T NEUR NET LEAR, V24, P1227, DOI 10.1109/TNNLS.2013.2247626; Zhou W, 2009, IEEE T CIRCUITS-II, V56, P669, DOI 10.1109/TCSII.2009.2025625	19	22	22	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93838	10.1371/journal.pone.0093838	http://dx.doi.org/10.1371/journal.pone.0093838			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714386	Green Published, Green Submitted, gold			2022-12-25	WOS:000334160900056
J	Chen, Y; Dai, JH; Zhou, XQ; Liu, YJ; Zhang, W; Peng, GY				Chen, Yao; Dai, Jianhua; Zhou, Xueqian; Liu, Yunjie; Zhang, Wei; Peng, Guiyong			Raman Spectroscopy Analysis of the Biochemical Characteristics of Molecules Associated with the Malignant Transformation of Gastric Mucosa	PLOS ONE			English	Article							DNA; MICROSPECTROSCOPY; DISCRIMINATION; PROTEINS; CELLS	Objective: The purpose of this study was to comparatively analyze the signature Raman spectra of genomic DNA, nuclei, and tissue of normal gastric mucosa and gastric cancer and to investigate the biochemical transformation of molecules associated with gastric mucosa malignancy. Method: Genomic DNA, nuclei, and tissue from normal gastric mucosa and gastric cancer were analyzed by Raman spectroscopy. Results: 1) The Raman spectrum of gastric cancer genomic DNA showed that two peaks appeared, one at approximately 1090 cm(-1) with a higher intensity than the peak at 1050 cm(-1) in the spectrum. Characteristic peaks appeared at 950 cm-1, 1010 cm(- 1,) and 1100- 1600 cm(-1).2) Using a hematoxylin and eosin ( H& E)-stained section, the intensity of the characteristic peak of nucleic acids at 1085 cm(- 1) was increased and shifted to 1088 cm(- 1) in cancer cells. The relative intensity of the characteristic peaks of nucleoproteins at 755 cm (- 1) and 1607 cm (- 1) was significantly increased in cancer cells compared with normal cells. 3) Compared with normal tissues, the peak representing PO2- symmetric stretching vibration shifted from 1088 cm (- 1) to 1083 cm (- 1) in cancer tissue, and the characteristic peak for collagen at 938 cm (- 1) shifted to 944 cm (- 1). In addition, an extra characteristic peak indicating C = C stretching vibration appeared at 1379 cm (- 1) in the lipid spectrum in cancer tissue. Conclusions: The position, intensity, and shape of peaks in the Raman spectra of DNA, nuclei, and tissue from gastric cancer were significantly different compared with those of normal cells. These results indicate that the DNA phosphate backbone becomes unstable in cancer cells and might be broken; the relative content of histones is increased and stable; the relative collagen content is reduced, facilitating cancer cell metastasis; and the relative content of unsaturated fatty acids is increased, increasing the mobility of the plasma membrane of cancer cells.	[Chen, Yao; Dai, Jianhua; Zhou, Xueqian; Liu, Yunjie; Peng, Guiyong] Third Mil Med Univ, Southwest Hosp, Inst Gastroenterol, Chongqing, Peoples R China; [Zhang, Wei] Chinese Acad Sci, Chongqing Inst Green & Intelligent Technol, Key Lab Multiscale Mfg Technol, Chongqing, Peoples R China	Army Medical University; Chinese Academy of Sciences; Chongqing Institute of Green & Intelligent Technology, CAS	Peng, GY (corresponding author), Third Mil Med Univ, Southwest Hosp, Inst Gastroenterol, Chongqing, Peoples R China.	pgy63@163.com	Zhang, Wei/H-2082-2012; GUIYONG, PENG/AAM-7865-2020	Zhang, Wei/0000-0002-9756-9994; Zhou, Xueqian/0000-0003-1583-414X	National Natural Science Foundation of China [81272580]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was Supported by the National Natural Science Foundation of China (Grant No. 81272580). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergholt MS, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3556723; Chen YP, 2012, MED PHYS, V39, P5664, DOI 10.1118/1.4747269; Chowdary MVP, 2006, BIOPOLYMERS, V83, P556, DOI 10.1002/bip.20586; De Gelder J, 2007, J RAMAN SPECTROSC, V38, P1133, DOI 10.1002/jrs.1734; de Oliveira AF, 2010, ACTA CIR BRAS, V25, P434, DOI 10.1590/S0102-86502010000500009; Deng H, 2000, NUCLEIC ACIDS RES, V28, P3379, DOI 10.1093/nar/28.17.3379; Duraipandian S, 2012, ANAL CHEM, V84, P5913, DOI 10.1021/ac300394f; ERFURTH SC, 1975, BIOPOLYMERS, V14, P247, DOI 10.1002/bip.1975.360140202; Feng SY, 2011, BIOSENS BIOELECTRON, V26, P3167, DOI 10.1016/j.bios.2010.12.020; Huang ZW, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3420115; Huong PV, 1996, VIB SPECTROSC, V11, P17, DOI 10.1016/0924-2031(95)00057-7; Jangir DK, 2012, J PHOTOCH PHOTOBIO B, V114, P38, DOI 10.1016/j.jphotobiol.2012.05.005; Leslie DG, 2012, PEDIATR NEUROSURG, V48, P109, DOI 10.1159/000343285; Li SX, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.12.125003; Li XZ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.3.037003; Maiti NC, 2004, J AM CHEM SOC, V126, P2399, DOI 10.1021/ja0356176; Nemecek D, 2013, CURR PROTOC PROTEIN; PETICOLAS WL, 1995, METHOD ENZYMOL, V246, P389; PUPPELS GJ, 1990, NATURE, V347, P301, DOI 10.1038/347301a0; Schweitzer-Stenner Reinhard, 2012, Methods Mol Biol, V895, P315, DOI 10.1007/978-1-61779-927-3_19; Shen AG, 2005, VIB SPECTROSC, V37, P225, DOI 10.1016/j.vibspec.2004.10.001; Stone N, 2000, LARYNGOSCOPE, V110, P1756, DOI 10.1097/00005537-200010000-00037; Takahashi Y, 2014, J MECH BEHAV BIOMED, V31, P77, DOI 10.1016/j.jmbbm.2013.02.014; [Yang Jipeng 杨继朋], 2005, Chinese Optics Letters, V3, P705; Zhou Y, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.11.116021; Zhuang ZF, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.3.031103	26	34	37	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93906	10.1371/journal.pone.0093906	http://dx.doi.org/10.1371/journal.pone.0093906			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710050	Green Submitted, gold, Green Published			2022-12-25	WOS:000334159800067
J	Hipp, AL; Eaton, DAR; Cavender-Bares, J; Fitzek, E; Nipper, R; Manos, PS				Hipp, Andrew L.; Eaton, Deren A. R.; Cavender-Bares, Jeannine; Fitzek, Elisabeth; Nipper, Rick; Manos, Paul S.			A Framework Phylogeny of the American Oak Clade Based on Sequenced RAD Data	PLOS ONE			English	Article							AFLP MARKER EVOLUTION; GENE FLOW; FOREST TREES; ROGUE TAXA; HYBRIDIZATION; FAGACEAE; ACCURACY; INTROGRESSION; TAXONOMY; DIFFERENTIATION	Previous phylogenetic studies in oaks (Quercus, Fagaceae) have failed to resolve the backbone topology of the genus with strong support. Here, we utilize next-generation sequencing of restriction-site associated DNA (RAD-Seq) to resolve a framework phylogeny of a predominantly American clade of oaks whose crown age is estimated at 23-33 million years old. Using a recently developed analytical pipeline for RAD-Seq phylogenetics, we created a concatenated matrix of 1.40 E06 aligned nucleotides, constituting 27,727 sequence clusters. RAD-Seq data were readily combined across runs, with no difference in phylogenetic placement between technical replicates, which overlapped by only 43-64% in locus coverage. 17% (4,715) of the loci we analyzed could be mapped with high confidence to one or more expressed sequence tags in NCBI Genbank. A concatenated matrix of the loci that BLAST to at least one EST sequence provides approximately half as many variable or parsimony-informative characters as equal-sized datasets from the non-EST loci. The EST-associated matrix is more complete (fewer missing loci) and has slightly lower homoplasy than non-EST subsampled matrices of the same size, but there is no difference in phylogenetic support or relative attribution of base substitutions to internal versus terminal branches of the phylogeny. We introduce a partitioned RAD visualization method (implemented in the R package RADami; http://cran.r-project.org/web/packages/RADami) to investigate the possibility that suboptimal topologies supported by large numbers of loci-due, for example, to reticulate evolution or lineage sorting-are masked by the globally optimal tree. We find no evidence for strongly-supported alternative topologies in our study, suggesting that the phylogeny we recover is a robust estimate of large-scale phylogenetic patterns in the American oak clade. Our study is one of the first to demonstrate the utility of RAD-Seq data for inferring phylogeny in a 23-33 million year-old clade.	[Hipp, Andrew L.; Fitzek, Elisabeth] Morton Arboretum, Lisle, IL 60532 USA; [Hipp, Andrew L.; Eaton, Deren A. R.] Field Museum, Dept Bot, Chicago, IL USA; [Eaton, Deren A. R.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Cavender-Bares, Jeannine] Univ Minnesota, Coll Biol Sci, St Paul, MN 55108 USA; [Nipper, Rick] Floragenex Inc, Eugene, OR USA; [Manos, Paul S.] Duke Univ, Dept Biol, Durham, NC USA	Field Museum of Natural History (Chicago); University of Chicago; University of Minnesota System; University of Minnesota Twin Cities; Duke University	Hipp, AL (corresponding author), Morton Arboretum, Lisle, IL 60532 USA.	ahipp@mortonarb.org	Cavender-Bares, Jeannine/K-5716-2013	Eaton, Deren/0000-0002-5922-2770; Cavender-Bares, Jeannine/0000-0003-3375-9630; Fitzek, Elisabeth/0000-0001-9423-2993	U.S. National Science Foundation DEB [1146488, 1146380, 1146102]; Field Museum, Lester Armour Graduate fellowship; Direct For Biological Sciences [1146488, 0843665] Funding Source: National Science Foundation	U.S. National Science Foundation DEB(National Science Foundation (NSF)); Field Museum, Lester Armour Graduate fellowship; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by U.S. National Science Foundation DEB (http://nsf.gov/div/index.jsp?div = DEB) Awards #1146488 to AH, #1146380 to JCB, and #1146102 to PM, and a Field Museum (http://fieldmuseum.org) Lester Armour Graduate fellowship to DAE. Funding covered field work, lab work, data analysis, development of analytical tools, and manuscript preparation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberer A.J., 2011, ROGUENAROK EFFICIENT; Aberer AJ, 2013, SYST BIOL, V62, P162, DOI 10.1093/sysbio/sys078; Aldrich P. R., 2011, WILD CROP RELATIVES, P89, DOI DOI 10.1007/978-3-642-21250-5_6; Althoff DM, 2007, SYST BIOL, V56, P477, DOI 10.1080/10635150701427077; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ane C, 2007, MOL BIOL EVOL, V24, P412; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Borgardt SJ, 1999, AM J BOT, V86, P307, DOI 10.2307/2656753; Bruneaux M, 2013, MOL ECOL, V22, P565, DOI 10.1111/j.1365-294X.2012.05749.x; Bryant D, 2012, MOL BIOL EVOL, V29, P1917, DOI 10.1093/molbev/mss086; Burgarella C, 2009, HEREDITY, V102, P442, DOI 10.1038/hdy.2009.8; Burger W. C., 1975, Taxon, V24, P45, DOI 10.2307/1218998; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Cavender-Bares J, 2009, AM J BOT, V96, P1690, DOI 10.3732/ajb.0800315; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COOK RD, 1977, TECHNOMETRICS, V19, P15, DOI 10.2307/1268249; Coyne JA, 2004, SPECIATION, V37; DAGHLIAN CP, 1983, AM J BOT, V70, P639, DOI 10.2307/2443119; Denk T, 2010, TAXON, V59, P351, DOI 10.1002/tax.592002; DumolinLapegue S, 1997, GENETICS, V146, P1475; Dzialuk A, 2007, ANN BOT-LONDON, V99, P959, DOI 10.1093/aob/mcm043; Eaton DAR, 2013, SYST BIOL, V62, P689, DOI 10.1093/sysbio/syt032; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Emerson KJ, 2010, P NATL ACAD SCI USA, V107, P16196, DOI 10.1073/pnas.1006538107; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FELSENSTEIN J, 1992, EVOLUTION, V46, P159, DOI [10.2307/2409811, 10.1111/j.1558-5646.1992.tb01991.x]; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonzalez-Rodriguez A, 2004, AM J BOT, V91, P401, DOI 10.3732/ajb.91.3.401; Gugger PF, 2013, J BIOGEOGR, V40, P632, DOI 10.1111/j.1365-2699.2011.02610.x; Hamrick JL, 2004, FOREST ECOL MANAG, V197, P323, DOI 10.1016/j.foreco.2004.05.023; HARDIN JW, 1975, J ARNOLD ARBORETUM, V56, P336; Hipp A., 2014, RADAMI R PACKAGE PHY; Hipp Andrew L., 2007, Aliso, V23, P193; Hipp AL, 2008, SYST BOT, V33, P148, DOI 10.1600/036364408783887320; Hoban SM, 2009, BIOL LETTERS, V5, P324, DOI 10.1098/rsbl.2009.0031; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Huang HT, 2010, SYST BIOL, V59, P573, DOI 10.1093/sysbio/syq047; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223, DOI DOI 10.5169/SEALS-268384; Garcia-Pereira MJ, 2010, MOL BIOL EVOL, V27, P988, DOI 10.1093/molbev/msp315; Knowles L.L., 2010, ESTIMATING SPECIES T; Koopman WJM, 2005, SYST BIOL, V54, P197, DOI 10.1080/10635150590924181; Kremer A, 2012, TREE GENET GENOMES, V8, P583, DOI 10.1007/s11295-012-0498-3; Kubatko LS, 2009, SYST BIOL, V58, P478, DOI 10.1093/sysbio/syp055; Lagache L, 2013, MOL ECOL, V22, P423, DOI 10.1111/mec.12121; Lepais O, 2009, MOL ECOL, V18, P2228, DOI 10.1111/j.1365-294X.2009.04137.x; LEQUESNE WJ, 1969, SYST ZOOL, V18, P201; Lewis ZA, 2007, GENETICS, V177, P1163, DOI 10.1534/genetics.107.078147; Lexer C, 2006, MOL ECOL, V15, P2007, DOI 10.1111/j.1365-294X.2006.02896.x; LI WH, 1986, GENETICS, V113, P187; Luo RY, 2007, STAT APPL GENET MOL, V6; Luo RY, 2009, ANN APPL STAT, V3, P222, DOI 10.1214/08-AOAS212; Lynch M, 2008, MOL BIOL EVOL, V25, P2409, DOI 10.1093/molbev/msn185; Manos PS, 1999, MOL PHYLOGENET EVOL, V12, P333, DOI 10.1006/mpev.1999.0614; Manos PS, 1987, SYSTEMATIC BOT, V12, P265; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; Meng C, 2009, THEOR POPUL BIOL, V75, P35, DOI 10.1016/j.tpb.2008.10.004; Miller MR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r105; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Muir G, 2000, NATURE, V405, P1016, DOI 10.1038/35016640; Oh SH, 2008, TAXON, V57, P434, DOI 10.2307/25066014; Pages H., 2013, BIOSTRINGS STRING OB; Pearse IS, 2009, P NATL ACAD SCI USA, V106, P18097, DOI 10.1073/pnas.0904867106; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Petit RJ, 2004, NEW PHYTOL, V161, P151, DOI 10.1046/j.1469-8137.2003.00944.x; R Core Team, 2021, R LANG ENV STAT COMP; Rubin BER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033394; Savolainen O, 2007, ANNU REV ECOL EVOL S, V38, P595, DOI 10.1146/annurev.ecolsys.38.091206.095646; Sober E., 1991, RECONSTRUCTING PARSI; Stamatakis A, 2010, BIOINFORMATICS, V26, pi132, DOI 10.1093/bioinformatics/btq205; Stolting KN, 2013, MOL ECOL, V22, P842, DOI 10.1111/mec.12011; Thomson RC, 2010, SYST BIOL, V59, P42, DOI 10.1093/sysbio/syp075; Trueman JWH, 1998, SYST BIOL, V47, P733, DOI 10.1080/106351598260725; VANVALEN L, 1976, TAXON, V25, P233, DOI 10.2307/1219444; Wagner, 2019, VEGAN COMMUNITY ECOL, DOI DOI 10.1038/srep34212; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; Wang N, 2013, MOL ECOL, V22, P3098, DOI 10.1111/mec.12131; WHITTEMORE AT, 1991, P NATL ACAD SCI USA, V88, P2540, DOI 10.1073/pnas.88.6.2540; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Yilmaz A, 2011, CARYOLOGIA, V64, P297, DOI 10.1080/00087114.2011.10589795	81	163	169	2	184	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93975	10.1371/journal.pone.0093975	http://dx.doi.org/10.1371/journal.pone.0093975			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705617	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500101
J	Randall, LM; Manta, B; Hugo, M; Gil, M; Batthyany, C; Trujillo, M; Poole, LB; Denicola, A				Randall, Lia M.; Manta, Bruno; Hugo, Martin; Gil, Magdalena; Batthyany, Carlos; Trujillo, Madia; Poole, Leslie B.; Denicola, Ana			Nitration Transforms a Sensitive Peroxiredoxin 2 into a More Active and Robust Peroxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Hydrogen Peroxide; Oxidative Stress; Peroxiredoxin; Post-translational Modification; Redox Signaling; Overoxidation; Peroxynitrite; Tyrosine Nitration	2-CYS PEROXIREDOXIN; HYDROGEN-PEROXIDE; NITRIC-OXIDE; PHOSPHORYLATION; PEROXYNITRITE; INACTIVATION; H2O2; OLIGOMERIZATION; REDUCTION; EVOLUTION	Peroxiredoxins (Prx) are efficient thiol-dependent peroxidases and key players in the mechanism of H2O2-induced redox signaling. Any structural change that could affect their redox state, oligomeric structure, and/or interaction with other proteins could have a significant impact on the cascade of signaling events. Several post-translational modifications have been reported to modulate Prx activity. One of these, overoxidation of the peroxidatic cysteine to the sulfinic derivative, inactivates the enzyme and has been proposed as a mechanism of H2O2 accumulation in redox signaling (the floodgate hypothesis). Nitration of Prx has been reported in vitro as well as in vivo; in particular, nitrated Prx2 was identified in brains of Alzheimer disease patients. In this work we characterize Prx2 tyrosine nitration, a post-translational modification on a noncatalytic residue that increases its peroxidase activity and its resistance to overoxidation. Mass spectrometry analysis revealed that treatment of disulfide-oxidized Prx2 with excess peroxynitrite renders mainly mononitrated and dinitrated species. Tyrosine 193 of the YF motif at the C terminus, associated with the susceptibility toward overoxidation of eukaryotic Prx, was identified as nitrated and is most likely responsible for the protection of the peroxidatic cysteine against oxidative inactivation. Kinetic analyses suggest that tyrosine nitration facilitates the intermolecular disulfide formation, transforming a sensitive Prx into a robust one. Thus, tyrosine nitration appears as another mechanism to modulate these enzymes in the complex network of redox signaling.	[Randall, Lia M.; Manta, Bruno; Denicola, Ana] Univ Republica, Fac Ciencias, Inst Quim Biol, Lab Fisicoquim Biol, Montevideo 11400, Uruguay; [Randall, Lia M.; Hugo, Martin; Batthyany, Carlos; Trujillo, Madia; Denicola, Ana] Univ Republica, Fac Med, Ctr Free Rad & Biomed Res, Montevideo 11100, Uruguay; [Manta, Bruno] Inst Pasteur Montevideo, Lab Biol Redox Tripanosomas, Montevideo 11400, Uruguay; [Hugo, Martin; Batthyany, Carlos; Trujillo, Madia] Univ Republica, Fac Med, Dept Bioquim, Montevideo 11100, Uruguay; [Gil, Magdalena; Batthyany, Carlos] Inst Pasteur Montevideo, Unidad Bioquim & Proteom Analit, Montevideo 11400, Uruguay; [Gil, Magdalena] Minist Educ & Cultura, Inst Invest Biol Clemente Estable, Unidad Bioquim & Proteom Analit, Montevideo 11600, Uruguay; [Poole, Leslie B.] Wake Forest Sch Med, Dept Biochem, Winston Salem, NC 27157 USA	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Universidad de la Republica, Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Wake Forest University	Denicola, A (corresponding author), Univ Republica, Fac Ciencias, Inst Quim Biol, Lab Fisicoquim Biol, Igua 4225, Montevideo 11400, Uruguay.	denicola@fcien.edu.uy	Hugo, Martín/AAW-8351-2020	Hugo, Martín/0000-0003-3430-6457; Manta, Bruno/0000-0001-8366-8935; Gil, Magdalena/0000-0002-9039-014X; Trujillo, Madia/0000-0003-2087-017X; Denicola, Ana/0000-0002-5181-9708; Batthyany, Carlos/0000-0002-0627-1982; Poole, Leslie/0000-0003-0334-7328	National Institutes of Health [GM050389]; Comision Sectorial de Investigacion Cientifica UdelaR [CSIC C007-348]; Agencia Nacional de Investigacion e Innovacion [FCE_2011_1_S706, FCE_2007_217]; Comision Academica de Posgrados; UdelaR; PEDECIBA (Programa de Desarrollo de las Ciencias Basicas); Agencia Nacional de Investigacion e Innovacion; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comision Sectorial de Investigacion Cientifica UdelaR; Agencia Nacional de Investigacion e Innovacion; Comision Academica de Posgrados; UdelaR; PEDECIBA (Programa de Desarrollo de las Ciencias Basicas); Agencia Nacional de Investigacion e Innovacion; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM050389 (to L. B. P.). This work was also supported by Comision Sectorial de Investigacion Cientifica UdelaR Grant CSIC C007-348 (to A. D.) and Agencia Nacional de Investigacion e Innovacion Grants FCE_2011_1_S706 (to M. T.) and FCE_2007_217 (to B. M.).; Supported by Comision Academica de Posgrados, UdelaR, and PEDECIBA (Programa de Desarrollo de las Ciencias Basicas).; Supported in part by the Agencia Nacional de Investigacion e Innovacion.	BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bonilla M, 2011, J BIOL CHEM, V286, P4959, DOI 10.1074/jbc.M110.170761; Brito C, 1999, J IMMUNOL, V162, P3356; Budde H, 2003, BIOL CHEM, V384, P619, DOI 10.1515/BC.2003.069; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Cho CS, 2010, ANTIOXID REDOX SIGN, V13, P1, DOI 10.1089/ars.2009.2978; Copley SD, 2004, BIOCHEMISTRY-US, V43, P13981, DOI 10.1021/bi048947r; Day AM, 2012, MOL CELL, V45, P398, DOI 10.1016/j.molcel.2011.11.027; Denicola A., 2008, FREE RADICALS PATHOP, P39; Egwim IOC, 2001, ANAL BIOCHEM, V288, P188, DOI 10.1006/abio.2000.4891; Engelman R, 2013, J BIOL CHEM, V288, P11312, DOI 10.1074/jbc.M112.433755; Fang JG, 2007, P NATL ACAD SCI USA, V104, P18742, DOI 10.1073/pnas.0705904104; Ferrer-Sueta G, 2011, CHEM RES TOXICOL, V24, P434, DOI 10.1021/tx100413v; Flohe L, 2008, ANTIOXID REDOX SIGN, V10, P1485, DOI 10.1089/ars.2008.2059; Fomenko DE, 2011, P NATL ACAD SCI USA, V108, P2729, DOI 10.1073/pnas.1010721108; Ghesquiere B, 2009, MOL CELL PROTEOMICS, V8, P2642, DOI 10.1074/mcp.M900259-MCP200; Haynes AC, 2013, J BIOL CHEM, V288, P29714, DOI 10.1074/jbc.M113.473470; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Jang HH, 2006, FEBS LETT, V580, P351, DOI 10.1016/j.febslet.2005.12.030; Jonsson TJ, 2008, J BIOL CHEM, V283, P22890, DOI [10.1074/jbc.C800124200, 10.1074/jbc.M803244200]; Jornvall H, 2000, EXS, V88, pXI; Koo KH, 2002, ARCH BIOCHEM BIOPHYS, V397, P312, DOI 10.1006/abbi.2001.2700; Leite PF, 2004, WORLD J SURG, V28, P331, DOI 10.1007/s00268-003-7399-4; Lowther WT, 2011, ANTIOXID REDOX SIGN, V15, P99, DOI 10.1089/ars.2010.3564; Manta B, 2009, ARCH BIOCHEM BIOPHYS, V484, P146, DOI 10.1016/j.abb.2008.11.017; MOORE RB, 1991, J BIOL CHEM, V266, P18964; Nelson KJ, 2013, METHOD ENZYMOL, V527, P21, DOI 10.1016/B978-0-12-405882-8.00002-7; Olahova M, 2008, P NATL ACAD SCI USA, V105, P19839, DOI 10.1073/pnas.0805507105; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Park JW, 2011, BIOCHEMISTRY-US, V50, P3204, DOI 10.1021/bi101373h; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; Perkins A, 2013, BIOCHEMISTRY-US, V52, P8708, DOI 10.1021/bi4011573; Perry G, 2000, FREE RADICAL BIO MED, V28, P831, DOI 10.1016/S0891-5849(00)00158-1; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Peskin AV, 2013, J BIOL CHEM, V288, P14170, DOI 10.1074/jbc.M113.460881; Poole LB, 2000, BIOCHEMISTRY-US, V39, P6602, DOI 10.1021/bi000405w; Radi R, 2004, P NATL ACAD SCI USA, V101, P4003, DOI 10.1073/pnas.0307446101; Randall LM, 2013, METHOD ENZYMOL, V527, P41, DOI 10.1016/B978-0-12-405882-8.00003-9; Reed TT, 2009, J CELL MOL MED, V13, P2019, DOI 10.1111/j.1582-4934.2008.00478.x; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Romero N, 2003, J BIOL CHEM, V278, P44049, DOI 10.1074/jbc.M305895200; Salsbury FR, 2012, J PHYS CHEM B, V116, P6832, DOI 10.1021/jp212606k; Sayed AA, 2004, J BIOL CHEM, V279, P26159, DOI 10.1074/jbc.M401748200; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Sobotta MC, 2013, FREE RADICAL BIO MED, V60, P325, DOI 10.1016/j.freeradbiomed.2013.02.017; Trujillo M., 2010, NITRIC OXIDE BIOL PA, P61, DOI DOI 10.1016/B978-0-12-373866-0.00003-4; Trujillo M, 2008, ANTIOXID REDOX SIGN, V10, P1607, DOI 10.1089/ars.2008.2060; Turko IV, 2003, J BIOL CHEM, V278, P33972, DOI 10.1074/jbc.M303734200; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yuan Y, 2010, J BIOMOL STRUCT DYN, V28, P51, DOI 10.1080/07391102.2010.10507343; Zykova TA, 2010, J BIOL CHEM, V285, P29138, DOI 10.1074/jbc.M110.135905	58	37	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2014	289	22					15536	15543		10.1074/jbc.M113.539213	http://dx.doi.org/10.1074/jbc.M113.539213			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AJ2DL	24719319	Green Published, hybrid			2022-12-25	WOS:000337465400036
J	Double, MC; Andrews-Goff, V; Jenner, KCS; Jenner, MN; Laverick, SM; Branch, TA; Gales, NJ				Double, Michael C.; Andrews-Goff, Virginia; Jenner, K. Curt S.; Jenner, Micheline-Nicole; Laverick, Sarah M.; Branch, Trevor A.; Gales, Nicholas J.			Migratory Movements of Pygmy Blue Whales (Balaenoptera musculus brevicauda) between Australia and Indonesia as Revealed by Satellite Telemetry	PLOS ONE			English	Article							SOUTHERN-HEMISPHERE; NINGALOO REEF; WESTERN-AUSTRALIA; RHINCODON-TYPUS; SYMPATRIC AREA; CETACEANS; TRACKING; LINKS	In Australian waters during the austral summer, pygmy blue whales (Balaenoptera musculus brevicauda) occur predictably in two distinct feeding areas off western and southern Australia. As with other blue whale subspecies, outside the austral summer their distribution and movements are poorly understood. In order to describe the migratory movements of these whales, we present the satellite telemetry derived movements of eleven individuals tagged off western Australia over two years. Whales were tracked from between 8 and 308 days covering an average distance of 3,0096892 km (mean 6 se; range: 832 km-14,101 km) at a rate of 21.94 +/- 0.74 km per day (0.09 km-455.80 km/day). Whales were tagged during March and April and ultimately migrated northwards post tag deployment with the exception of a single animal which remained in the vicinity of the Perth Canyon/Naturaliste Plateau for its eight day tracking period. The tagged whales travelled relatively near to the Australian coastline (100.0 +/- 1.7 km) until reaching a prominent peninsula in the north-west of the state of Western Australia (North West Cape) after which they travelled offshore (238.0 +/- 13.9 km). Whales reached the northern terminus of their migration and potential breeding grounds in Indonesian waters by June. One satellite tag relayed intermittent information to describe aspects of the southern migration from Indonesia with the animal departing around September to arrive in the subtropical frontal zone, south of western Australia in December. Throughout their migratory range, these whales are exposed to impacts associated with industry, fishing and vessel traffic. These movements therefore provide a valuable tool to industry when assessing potential interactions with pygmy blue whales and should be considered by conservation managers and regulators when mitigating impacts of development. This is particularly relevant for this species as it continues to recover from past exploitation.	[Double, Michael C.; Andrews-Goff, Virginia; Laverick, Sarah M.; Gales, Nicholas J.] Australian Antarctic Div, Australian Marine Mammal Ctr, Kingston, Tas, Australia; [Jenner, K. Curt S.; Jenner, Micheline-Nicole] Ctr Whale Res Western Australia Inc, Fremantle, WA, Australia; [Branch, Trevor A.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA	Australian Antarctic Division; University of Washington; University of Washington Seattle	Double, MC (corresponding author), Australian Antarctic Div, Australian Marine Mammal Ctr, Kingston, Tas, Australia.	Mike.Double@aad.gov.au		Andrews-Goff, Virginia/0000-0002-4609-7317	Western Australian Marine Science Institute (WAMSI); Woodside Energy Ltd.	Western Australian Marine Science Institute (WAMSI); Woodside Energy Ltd.	This project was partly funded by the Western Australian Marine Science Institute (WAMSI). WAMSI received financial support for this project from Woodside Energy Ltd. as the operator of the Browse LNG Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Attard CRM, 2012, MOL ECOL, V21, P5715, DOI 10.1111/mec.12025; Attard CRM, 2010, CONSERV GENET, V11, P2437, DOI 10.1007/s10592-010-0121-9; Belkin I.M., 2007, ICES CM, V500, P21; Benson SR, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00053.1; Branch TA, 2007, MAR MAMMAL SCI, V23, P803, DOI 10.1111/j.1748-7692.2007.00137.x; Branch TA, 2007, MAMMAL REV, V37, P116, DOI 10.1111/j.1365-2907.2007.00106.x; Branch TA, 2009, MAR MAMMAL SCI, V25, P833, DOI 10.1111/j.1748-7692.2009.00292.x; Breed GA, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00021.1; Brown S. G., 1954, Discovery Reports, V26, P355; Bryant P.J., 1984, P375; Calambokidis J, 2009, MAR MAMMAL SCI, V25, P816, DOI 10.1111/j.1748-7692.2009.00298.x; Cetacean Specialist Group, 1996, IUCN 2013 IUCN RED L; De Deckker P, 2012, NAT GEOSCI, V5, P266, DOI [10.1038/ngeo1431, 10.1038/NGEO1431]; Di Iorio L, 2010, BIOL LETTERS, V6, P51, DOI 10.1098/rsbl.2009.0651; Freitas C, 2008, OECOLOGIA, V155, P193, DOI 10.1007/s00442-007-0894-9; Furnas M, 2007, CONT SHELF RES, V27, P958, DOI 10.1016/j.csr.2007.01.002; Gavrilov AN, 2013, J ACOUST SOC AM, V134, P2505, DOI 10.1121/1.4816576; Gavrilov AN, 2011, J ACOUST SOC AM, V130, P3651, DOI 10.1121/1.3651817; Geoscience Australia and BREE, 2012, AUSTR GAS RES ASS 20; Gill Peter C., 2002, Journal of Cetacean Research and Management, V4, P179; Gill PC, 2011, MAR ECOL PROG SER, V421, P243, DOI 10.3354/meps08914; Hays GC, 2006, ECOLOGY, V87, P2647, DOI 10.1890/0012-9658(2006)87[2647:FFMOLT]2.0.CO;2; Heide-Jorgensen MP, 2001, MAR MAMMAL SCI, V17, P949, DOI 10.1111/j.1748-7692.2001.tb01309.x; Hyrenbach KD, 2000, AQUAT CONSERV, V10, P437, DOI 10.1002/1099-0755(200011/12)10:6<437::AID-AQC425>3.3.CO;2-H; Ichihara T., 1966, WHALES DOLPHINS PORP, P79, DOI 10.1525/9780520321373-008; Jenner C, 2008, SCI COMM INT WHAL CO; Kato H, 2007, SCI COMM INT WHAL CO; Krutzen M, 2002, MAR MAMMAL SCI, V18, P863, DOI 10.1111/j.1748-7692.2002.tb01078.x; Longhurst A.R, 2007, EC GEOGR SEA 2 ED; Mackintosh NA., 1966, WHALES DOLPHINS PORP, P125; McCauley R, 2004, W AUSTR EXERCISE ARE; Melcon ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032681; Moore JK, 2000, J GEOPHYS RES-OCEANS, V105, P28709, DOI 10.1029/1999JC000043; Morin PA, 2005, MOL ECOL, V14, P3275, DOI 10.1111/j.1365-294X.2005.02651.x; Morton AB, 2002, ICES J MAR SCI, V59, P71, DOI 10.1006/jmsc.2001.1136; R Core Team, 2012, R LANG ENV STAT COMP; Rennie S, 2009, J MARINE SYST, V77, P21, DOI 10.1016/j.jmarsys.2008.11.008; Rice D.W., 1998, MARINE MAMMALS WORLD, V4; RICHARDSON WJ, 1986, J ACOUST SOC AM, V79, P1117, DOI 10.1121/1.393384; Rolland RM, 2012, P ROY SOC B-BIOL SCI, V279, P2363, DOI 10.1098/rspb.2011.2429; Salgado Kent CP, 2012, P AC 2012 NOV 21 23, P1; Samaran F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071561; Samaran Flore, 2010, Endangered Species Research, V12, P157, DOI 10.3354/esr00302; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Sleeman JC, 2007, MAR FRESHWATER RES, V58, P608, DOI 10.1071/MF06213; Stafford KM, 2011, MAR MAMMAL SCI, V27, P828, DOI 10.1111/j.1748-7692.2010.00437.x; Taylor JG, 1996, MAR FRESHWATER RES, V47, P637, DOI 10.1071/MF9960637; Tyack PL, 2008, J MAMMAL, V89, P549, DOI 10.1644/07-MAMM-S-307R.1; Tyack PL, 2002, MARINE MAMMAL BIOLOGY: AN EVOLUTIONARY APPROACH, P142; Wilson SG, 2006, MAR BIOL, V148, P1157, DOI 10.1007/s00227-005-0153-8	50	50	59	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93578	10.1371/journal.pone.0093578	http://dx.doi.org/10.1371/journal.pone.0093578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718589	gold, Green Published, Green Submitted			2022-12-25	WOS:000334339000035
J	Johnson, MA; Vidoni, S; Durigon, R; Pearce, SF; Rorbach, J; He, JY; Brea-Calvo, G; Minczuk, M; Reyes, A; Holt, IJ; Spinazzola, A				Johnson, Mark A.; Vidoni, Sara; Durigon, Romina; Pearce, Sarah F.; Rorbach, Joanna; He, Jiuya; Brea-Calvo, Gloria; Minczuk, Michal; Reyes, Aurelio; Holt, Ian J.; Spinazzola, Antonella			Amino Acid Starvation Has Opposite Effects on Mitochondrial and Cytosolic Protein Synthesis	PLOS ONE			English	Article							P70 S6 KINASE; LIFE-SPAN; CALORIE RESTRICTION; TRANSCRIPTION; BIOGENESIS; MTOR; RESPIRATION; DEGRADATION; CANCER; INTEGRATION	Amino acids are essential for cell growth and proliferation for they can serve as precursors of protein synthesis, be remodelled for nucleotide and fat biosynthesis, or be burnt as fuel. Mitochondria are energy producing organelles that additionally play a central role in amino acid homeostasis. One might expect mitochondrial metabolism to be geared towards the production and preservation of amino acids when cells are deprived of an exogenous supply. On the contrary, we find that human cells respond to amino acid starvation by upregulating the amino acid-consuming processes of respiration, protein synthesis, and amino acid catabolism in the mitochondria. The increased utilization of these nutrients in the organelle is not driven primarily by energy demand, as it occurs when glucose is plentiful. Instead it is proposed that the changes in the mitochondrial metabolism complement the repression of cytosolic protein synthesis to restrict cell growth and proliferation when amino acids are limiting. Therefore, stimulating mitochondrial function might offer a means of inhibiting nutrient-demanding anabolism that drives cellular proliferation.	[Johnson, Mark A.; Vidoni, Sara; Pearce, Sarah F.; Rorbach, Joanna; He, Jiuya; Brea-Calvo, Gloria; Minczuk, Michal; Reyes, Aurelio] Wellcome Trust Res Labs, Mitochondrial Biol Unit, MRC, Cambridge, England; [Durigon, Romina; Holt, Ian J.; Spinazzola, Antonella] Natl Inst Med Res, London NW7 1AA, England	Wellcome Trust Sanger Institute; MRC National Institute for Medical Research	Spinazzola, A (corresponding author), Natl Inst Med Res, Mill Hill, London NW7 1AA, England.	aspinaz@nimr.mrc.ac.uk	Pearce, Sarah/AAE-7196-2019; Brea-Calvo, Gloria/N-4728-2014; Spinazzola, Antonella/P-5298-2017; Spinazzola, Antonella/P-5791-2019; rorbach, Joanna/AAM-5683-2021; Minczuk, Michal/G-1638-2014	Brea-Calvo, Gloria/0000-0001-5536-6868; Spinazzola, Antonella/0000-0003-4242-8091; Spinazzola, Antonella/0000-0003-4242-8091; rorbach, Joanna/0000-0002-2891-2840; Minczuk, Michal/0000-0001-8242-1420; holt, ian/0000-0001-5468-0193	MRC [MC_U105697134];  [PIEF-GA-2009-255578]; Medical Research Council [MC_U105697135, MC_UP_1002/1, MC_U105697134, 1456890, 1365139, MC_U105663140, MC_PC_13029/1, MC_UP_1202/14] Funding Source: researchfish; MRC [MC_UP_1002/1, MC_UP_1202/14, MC_PC_13029/1, MC_U105697135, MC_U105663140] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by the MRC: number MC_U105697134. In addition, AS awarded a Marie Curie fellowship, grant agreement PIEF-GA-2009-255578. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandhakavi S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001598; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Carter HN, 2012, AM J PHYSIOL-CELL PH, V303, pC540, DOI 10.1152/ajpcell.00156.2012; Chomyn A, 1996, Methods Enzymol, V264, P197, DOI 10.1016/S0076-6879(96)64020-8; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Diaz F, 2008, CELL CALCIUM, V44, P24, DOI 10.1016/j.ceca.2007.12.004; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; Hamalainen RH, 2013, P NATL ACAD SCI USA, V110, pE3622, DOI 10.1073/pnas.1311660110; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hara-Kuge S, 2008, EXP CELL RES, V314, P3531, DOI 10.1016/j.yexcr.2008.09.015; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; He J, 2012, NUCLEIC ACIDS RES, V40, P6109, DOI 10.1093/nar/gks266; He J, 2012, NUCLEIC ACIDS RES, V40, P6097, DOI 10.1093/nar/gks257; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hunter SE, 2004, MITOCHONDRION, V4, P21, DOI 10.1016/j.mito.2004.04.003; Koc EC, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00183; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Litonin D, 2010, J BIOL CHEM, V285, P18129, DOI 10.1074/jbc.C110.128918; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Minczuk M, 2011, NUCLEIC ACIDS RES, V39, P4284, DOI 10.1093/nar/gkq1224; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Rossignol R, 2004, CANCER RES, V64, P985, DOI 10.1158/0008-5472.CAN-03-1101; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; Shutt TE, 2010, P NATL ACAD SCI USA, V107, P12133, DOI 10.1073/pnas.0910581107; Tyynismaa H, 2010, HUM MOL GENET, V19, P3948, DOI 10.1093/hmg/ddq310; Wang XM, 1998, BIOCHEM J, V334, P261, DOI 10.1042/bj3340261; WARBURG O, 1956, SCIENCE, V124, P269; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xi HL, 2007, GENOME RES, V17, P798, DOI 10.1101/gr.5754707; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	44	35	35	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93597	10.1371/journal.pone.0093597	http://dx.doi.org/10.1371/journal.pone.0093597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718614	gold, Green Submitted, Green Published			2022-12-25	WOS:000334339000037
J	Jones, BA; Madden, GJ; Wengreen, HJ; Aguilar, SS; Desjardins, EA				Jones, Brooke A.; Madden, Gregory J.; Wengreen, Heidi J.; Aguilar, Sheryl S.; Desjardins, E. Anne			Gamification of Dietary Decision-Making in an Elementary-School Cafeteria	PLOS ONE			English	Article							VEGETABLE CONSUMPTION; CHILDRENS FRUIT; PERCENTILE SCHEDULES; INTERVENTION; RISK	Despite the known health benefits of doing so, most US children do not consume enough fruits and vegetables (FV). School-based interventions can be effective in increasing FV consumption, but the most effective of these require that schools allocate their time, effort, and financial resources to implementing the program: expenditures that schools may be reluctant to provide in climates of academic accountability and economic austerity. The present demonstration project used a behaviorally based gamification approach to develop an intervention designed to increase FV consumption while minimizing material and labor costs to the school. During the intervention, the school (N = 180 students in grades K-8) played a cooperative game in which school-level goals were met by consuming higher-than-normal amounts of either fruit or vegetables (alternating-treatments experimental design). School-level consumption was quantified using a weight-based waste measure in the cafeteria. Over a period of 13 school days, fruit consumption increased by 66% and vegetable consumption by 44% above baseline levels. Use of an alternating-treatment time-series design with differential levels of FV consumption on days when fruit or vegetable was targeted for improvement supported the role of the intervention in these overall consumption increases. In post-intervention surveys, teachers rated the intervention as practical in the classroom and enjoyed by their students. Parent surveys revealed that children were more willing to try new FV at home and increased their consumption of FV following the intervention. These findings suggest that a behaviorally based gamification approach may prove practically useful in addressing concerns about poor dietary decision-making by children in schools.	[Jones, Brooke A.; Madden, Gregory J.] Utah State Univ, Dept Psychol, Logan, UT 84322 USA; [Wengreen, Heidi J.] Utah State Univ, Dept Nutr Dietet & Food Sci, Logan, UT 84322 USA; [Aguilar, Sheryl S.] Utah State Univ, Ctr Human Nutr Studies, Logan, UT 84322 USA; [Desjardins, E. Anne] Bear River Charter Sch, Logan, UT USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Jones, BA (corresponding author), Utah State Univ, Dept Psychol, Logan, UT 84322 USA.	jones.brookea@gmail.com	Madden, Gregory J/E-8524-2010; Lively, Curtis M/A-8057-2011; Clay, Keith/C-8730-2012	Madden, Gregory J/0000-0002-3663-1600; 	United States Department of Agriculture [ERS 59-5000-1-0033, ERS 59-5000-0-0065]	United States Department of Agriculture(United States Department of Agriculture (USDA))	This research was supported by grants from the United States Department of Agriculture (ERS 59-5000-1-0033 & ERS 59-5000-0-0065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AS, 2005, PUBLIC HEALTH NUTR, V8, P650, DOI 10.1079/PHN2004721; Athens ES, 2007, J APPL BEHAV ANAL, V40, P475, DOI 10.1901/jaba.2007.40-475; Bandura A., 1971, SOCIAL LEARNING THEO; Baranowski T, 2003, AM J PREV MED, V24, P52, DOI 10.1016/S0749-3797(02)00570-6; Barlow DH, 2009, SINGLE CASE EXPT DES, V3rd; Boeing H, 2012, EUR J NUTR, V51, P637, DOI 10.1007/s00394-012-0380-y; Borckardt J. J., 2013, METHODS PRINCIPLES, V1, P251, DOI DOI 10.1037/13937-011; Castronova E, 2001, EESIFO WORKING PAPER, V618; Crosbie J, 1994, ANAL CHANGE, P361; Curtin R, 2000, PUBLIC OPIN QUART, V64, P413, DOI 10.1086/318638; Echon RE, 2014, ADV IMAGE ANAL RES, P273; Epstein LH, 2001, OBES RES, V9, P171, DOI 10.1038/oby.2001.18; Evans CEL, 2012, AM J CLIN NUTR, V96, P889, DOI 10.3945/ajcn.111.030270; Fisher WW, 2003, J APPL BEHAV ANAL, V36, P387, DOI 10.1901/jaba.2003.36-387; Foerster SB, 1998, FAM COMMUNITY HEALTH, V21, P46, DOI 10.1097/00003727-199804000-00007; GALBICKA G, 1994, J APPL BEHAV ANAL, V27, P739, DOI 10.1901/jaba.1994.27-739; Galbicka G, 1997, PHYSIOL BEHAV, V62, P1165, DOI 10.1016/S0031-9384(97)00350-8; Guenther PM, 2006, J AM DIET ASSOC, V106, P1371, DOI 10.1016/j.jada.2006.06.002; Hall SS, 2009, J APPL BEHAV ANAL, V42, P171, DOI 10.1901/jaba.2009.42-171; He K, 2004, INT J OBESITY, V28, P1569, DOI 10.1038/sj.ijo.0802795; Hendy HM, 2005, APPETITE, V45, P250, DOI 10.1016/j.appet.2005.07.006; Hoffman JA, 2011, PREV MED, V52, P370, DOI 10.1016/j.ypmed.2011.02.013; Hoffman JA, 2010, J PEDIATR PSYCHOL, V35, P61, DOI 10.1093/jpepsy/jsp041; Horne PJ, 2009, EUR J CLIN NUTR, V63, P613, DOI 10.1038/ejcn.2008.34; Horne PJ, 2004, EUR J CLIN NUTR, V58, P1649, DOI 10.1038/sj.ejcn.1602024; Just D, 2013, PUBLIC HEALTH NUTR, V16, P2281, DOI 10.1017/S1368980013001468; KARAU SJ, 1995, CURR DIR PSYCHOL SCI, V4, P134, DOI 10.1111/1467-8721.ep10772570; Kazdin A.E., 2002, RES DESIGN CLIN PSYC, V3rd; Lamb RJ, 2004, DRUG ALCOHOL DEPEN, V76, P247, DOI 10.1016/j.drugalcdep.2004.05.008; Laraway S, 2003, J APPL BEHAV ANAL, V36, P407, DOI 10.1901/jaba.2003.36-407; Lowe CF, 2004, EUR J CLIN NUTR, V58, P510, DOI 10.1038/sj.ejcn.1601838; MACHADO A, 1989, J EXP ANAL BEHAV, V52, P155, DOI 10.1901/jeab.1989.52-155; Mangione-Smith R, 2002, HEALTH SERV RES, V37, P1603, DOI 10.1111/1475-6773.10482; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; Miltenberger RG, 2013, APA HDB BEHAV ANAL, V1, P121; Newland MC, 2013, BEHAV BRAIN RES, V253, P196, DOI 10.1016/j.bbr.2013.05.038; Pink D.H., 2010, DRIVE SURPRISING TRU; Reeves B, 2009, TOTAL ENGAGEMENT USI; Rolls BJ, 2004, NUTR REV, V62, P1, DOI [10.1301/nr.2004.jan.1-17, 10.1301/nr.2004.jan.1&ndash;17, 10.1111/j.1753-4887.2004.tb00001.x]; Skinner B.F., 2014, CONTINGENCIES REINFO; Striegel-Moore RH, 2006, PREV MED, V42, P223, DOI 10.1016/j.ypmed.2005.11.018; Wengreen HJ, 2013, J NUTR EDUC BEHAV, V45, P54, DOI 10.1016/j.jneb.2012.06.001	42	37	40	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93872	10.1371/journal.pone.0093872	http://dx.doi.org/10.1371/journal.pone.0093872			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AE9PC	24718587	gold, Green Submitted, Green Published			2022-12-25	WOS:000334339000054
J	Lee, DH; Cullum, JP; Anderson, JL; Daugherty, JL; Beckett, LM; Leskey, TC				Lee, Doo-Hyung; Cullum, John P.; Anderson, Jennifer L.; Daugherty, Jodi L.; Beckett, Lisa M.; Leskey, Tracy C.			Characterization of Overwintering Sites of the Invasive Brown Marmorated Stink Bug in Natural Landscapes Using Human Surveyors and Detector Canines	PLOS ONE			English	Article							HALYS HEMIPTERA-PENTATOMIDAE; HETEROPTERA; ABILITY; STAL; PEST	Halyomorpha halys is an invasive species from Asia causing major economic losses in agricultural production in the mid-Atlantic region of the United States. Unlike other crop pests, H. halys is also well-known for nuisance problems in urban, suburban, and rural areas, as massive numbers of adults often invade human-made structures to overwinter inside protected environments. Research efforts have focused on populations in human-made structures while overwintering ecology of H. halys in natural landscapes is virtually unknown. We explored forested landscapes in the mid-Atlantic region to locate and characterize natural overwintering structures used by H. halys. We also evaluated the use of detector canines to locate overwintering H. halys to enhance the accuracy and efficiency of surveys. From these studies, we indentified shared characteristics of overwintering sites used by H. halys in natural landscapes. Overwintering H. halys were recovered from dry crevices in dead, standing trees with thick bark, particularly oak (Quercus spp.)and locust (Robinia spp.); these characteristics were shared by 11.8% of all dead trees in surveyed landscapes. For trees with favorable characteristics, we sampled similar to 20% of the total above-ground tree area and recovered 5.9 adults per tree from the trees with H. halys present. Two detector canines were successfully trained to recognize and detect the odor of adult H. halys yielding >84% accuracy in laboratory and semi-field trials. Detector canines also found overwintering H. halys under field conditions. In particular, overwintering H. halys were recovered only from dead trees that yielded positive indications from the canines and shared key tree characteristics established by human surveyors. The identified characteristics of natural overwintering sites of H. halys will serve as baseline information to establish crop economic risk levels posed by overwintering populations, and accordingly develop sustainable management programs.	[Lee, Doo-Hyung; Leskey, Tracy C.] USDA ARS, Appalachian Fruit Res Stn, Kearneysville, WV 25430 USA; [Cullum, John P.] Virginia Tech, Dept Entomol, Winchester, VA USA; [Anderson, Jennifer L.; Daugherty, Jodi L.; Beckett, Lisa M.] Anim & Plant Hlth Inspect Serv, USDA, Natl Detector Dog Training Ctr, Newnan, GA USA	United States Department of Agriculture (USDA); Virginia Polytechnic Institute & State University; United States Department of Agriculture (USDA)	Lee, DH (corresponding author), Gachon Univ, Dept Life Sci, Songnam, Gyeonggi Do, South Korea.	dl343@cornell.edu			USDA-NIFA SCRI [2011-51181-30937]	USDA-NIFA SCRI	This work was supported in part by USDA-NIFA SCRI # 2011-51181-30937 award and a specific cooperative agreement with USDA-APHIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2009, MITTEILUNGEN THURING, V16, P10, DOI DOI 10.5281/ZENODO.45391; Brooks SE, 2003, J ECON ENTOMOL, V96, P1259, DOI 10.1603/0022-0493-96.4.1259; Brown Marmorated Stink Bug Working Group, 2012, BROWN MARM STINK BUG; Brown Marmorated Stink Bug Working Group, 2011, BROWN MARM STINK BUG; Callot Henry, 2013, Entomologiste (Paris), V69, P69; Coombs MT, 2000, ENVIRON ENTOMOL, V29, P1027, DOI 10.1603/0046-225X-29.5.1027; Fogain R., 2011, Journal of the Entomological Society of Ontario, V142, P45; Fujisawa T., 2001, JPN AGR TECHNOL, V45, P42; Hamilton George C., 2009, American Entomologist, V55, P19; Heckmann Ralf, 2012, Heteropteron, V36, P17; Hoebeke ER, 2003, P ENTOMOL SOC WASH, V105, P225; Inkley DB, 2012, J ENTOMOL SCI, V47, P125; Johnson GR, 1977, TRACKING DOG THEORY; JONES WA, 1981, ENVIRON ENTOMOL, V10, P409, DOI 10.1093/ee/10.3.409; Kobayashi T., 1969, B TOHOKU NATL AGR EX, V37, P123; Leather S. R., 1993, ECOLOGY INSECT OVERW; Lee DH, 2013, ENVIRON ENTOMOL, V42, P627, DOI 10.1603/EN13006; Leskey T. C., 2012, Outlooks on Pest Management, V23, P218, DOI 10.1564/23oct07; Leskey Tracy C., 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/535062; Pfiester M, 2008, J ECON ENTOMOL, V101, P1389, DOI 10.1603/0022-0493(2008)101[1389:AOBBCT]2.0.CO;2; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Qin W., 1990, PLANT PROT, V16, P22; Toyama M, 2006, APPL ENTOMOL ZOOL, V41, P309, DOI 10.1303/aez.2006.309; Ueno W., 1978, N JPN PEST RES B, V29, P16; WALLNER WE, 1976, ENVIRON ENTOMOL, V5, P183, DOI 10.1093/ee/5.1.183; Wang Y., 1988, ACTA AGR BOR SIN, V3, P96; Watanabe Mamoru, 1994, Japanese Journal of Sanitary Zoology, V45, P25; WELCH JB, 1990, J ECON ENTOMOL, V83, P1932, DOI 10.1093/jee/83.5.1932; Wermelinger B, 2008, ENTOMOL GESELLSCHAFT, V81, P1, DOI DOI 10.5169/SEALS-402954; Zhang Cuituan, 1993, Forest Research, V6, P271	30	60	61	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e91575	10.1371/journal.pone.0091575	http://dx.doi.org/10.1371/journal.pone.0091575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717734	gold, Green Submitted, Green Published			2022-12-25	WOS:000334339000010
J	Nokso-Koivisto, J; Chonmaitree, T; Jennings, K; Matalon, R; Block, S; Patel, JA				Nokso-Koivisto, Johanna; Chonmaitree, Tasnee; Jennings, Kristofer; Matalon, Reuben; Block, Stan; Patel, Janak A.			Polymorphisms of Immunity Genes and Susceptibility to Otitis Media in Children	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTION; RECEPTOR GENE; CYTOKINE; ASSOCIATION; RISK; SEVERITY; DISEASE; HERITABILITY; SYMPTOMS; INFANTS	Background: Acute otitis media (OM) is a common disease which often develops through complex interactions between the host, the pathogen and environmental factors. We studied single nucleotide polymorphisms (SNPs) of genes involved in innate and adaptive immunity, and other host and environmental factors for their role in OM. Methods: Using Sequenom Massarray platform, 21 SNPs were studied in 653 children from prospective (n = 202) and retrospective (n = 451) cohorts. Data were analyzed for the relationship between SNPs and upper respiratory infection (URI) frequency, risk of acute OM during URI episodes, and proneness to recurrent OM. Results: Increased risk for OM proneness was associated with CX3CR1 (Thr280Met) SNP and with a jointly interactive group of IL-10 (-1082) SNP, IL-1 beta (-511) wild type genotype and white race. Family history of OM proneness independently increased the risk for frequent URIs, OM occurrence during URI, and OM proneness. Additionally, IL-1 beta (-31) SNP was associated with increased risk for frequent URIs, but IL-10 (-592), IL-1 beta (-511), IL-5 (-746) and IL-8 (-251) SNPs were associated with decreased risk of URI. Conclusion: IL-1 beta (-31), CX3CR1 (Thr280Met), IL-10 (-1082) and IL-1 beta (-511) SNPs were associated with increased risk for frequent URIs or OM proneness.	[Nokso-Koivisto, Johanna; Chonmaitree, Tasnee; Matalon, Reuben; Patel, Janak A.] Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA; [Jennings, Kristofer] Univ Texas Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; [Block, Stan] Kentucky Pediat Res Inc, Bardstown, KY USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Patel, JA (corresponding author), Univ Texas Med Branch, Dept Pediat, Galveston, TX 77555 USA.	jpatel@utmb.edu		Jennings, Kristofer/0000-0002-5442-9326	National Institute of Deafness and Other Communication Disorders [R01 DC005841]; National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000071]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005841] Funding Source: NIH RePORTER	National Institute of Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute of Deafness and Other Communication Disorders [grant number R01 DC005841], and from the National Center for Advancing Translational Sciences [grant number UL1TR000071], National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alper CM, 2009, EUR ARCH OTO-RHINO-L, V266, P199, DOI 10.1007/s00405-008-0729-2; Amanatidou V, 2006, PEDIATR INFECT DIS J, V25, P410, DOI 10.1097/01.inf.0000214998.16248.b7; Casselbrant ML, 1999, JAMA-J AM MED ASSOC, V282, P2125, DOI 10.1001/jama.282.22.2125; Chantry CJ, 2006, PEDIATRICS, V117, P425, DOI 10.1542/peds.2004-2283; Chen Nijun, 2011, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V25, P197; Chonmaitree T, 2008, CLIN INFECT DIS, V46, P815, DOI 10.1086/528685; Duijts L, 2010, PEDIATRICS, V126, pE18, DOI 10.1542/peds.2008-3256; Emonts M, 2007, PEDIATRICS, V120, P814, DOI 10.1542/peds.2007-0524; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fritz RS, 1999, J INFECT DIS, V180, P586, DOI 10.1086/314938; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Hong SJ, 2005, J ALLERGY CLIN IMMUN, V115, P758, DOI 10.1016/j.jaci.2004.10.047; Hornsleth A, 2001, J CLIN VIROL, V21, P163, DOI 10.1016/S1386-6532(01)00159-7; Hull J, 2000, THORAX, V55, P1023, DOI 10.1136/thorax.55.12.1023; Lee YW, 2011, ANN OTO RHINOL LARYN, V120, P204, DOI 10.1177/000348941112000310; McCormick DP, 2011, INT J PEDIATR OTORHI, V75, P708, DOI 10.1016/j.ijporl.2011.02.021; Miyairi I, 2008, CLIN MICROBIOL REV, V21, P686, DOI 10.1128/CMR.00017-08; Nieters A, 2001, HUM GENET, V108, P241, DOI 10.1007/s004390100464; Patel JA, 2006, PEDIATRICS, V118, P2273, DOI 10.1542/peds.2006-0764; Patel JA, 2009, PEDIATR INFECT DIS J, V28, P1002, DOI 10.1097/INF.0b013e3181aa5b13; Revai K, 2009, CLIN INFECT DIS, V49, P257, DOI 10.1086/599833; Rovers M, 2002, AM J EPIDEMIOL, V155, P958, DOI 10.1093/aje/155.10.958; Rye MS, 2012, LARYNGOSCOPE, V122, P665, DOI 10.1002/lary.22506; Skoner DP, 1999, J INFECT DIS, V180, P10, DOI 10.1086/314823; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; Turner RB, 1998, CLIN INFECT DIS, V26, P840, DOI 10.1086/513922; Watanabe E, 2005, J TRAUMA, V59, P1181; Wiertsema SP, 2006, CLIN VACCINE IMMUNOL, V13, P892, DOI 10.1128/CVI.00100-06; Wiertsema SP, 2006, J ALLERGY CLIN IMMUN, V117, P1344, DOI 10.1016/j.jaci.2006.01.031	29	21	22	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93930	10.1371/journal.pone.0093930	http://dx.doi.org/10.1371/journal.pone.0093930			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718616	gold, Green Published, Green Submitted			2022-12-25	WOS:000334339000058
J	Otto, CRV; Roloff, GJ; Thames, RE				Otto, Clint R. V.; Roloff, Gary J.; Thames, Rachael E.			Comparing Population Patterns to Processes: Abundance and Survival of a Forest Salamander following Habitat Degradation	PLOS ONE			English	Article							DETECTION PROBABILITY PARAMETERS; NORTHERN HARDWOOD FORESTS; PLETHODONTID SALAMANDERS; TERRESTRIAL SALAMANDERS; CLOSURE ASSUMPTION; MOLE SALAMANDERS; TIMBER HARVEST; LAND-USE; AMPHIBIANS; OCCUPANCY	Habitat degradation resulting from anthropogenic activities poses immediate and prolonged threats to biodiversity, particularly among declining amphibians. Many studies infer amphibian response to habitat degradation by correlating patterns in species occupancy or abundance with environmental effects, often without regard to the demographic processes underlying these patterns. We evaluated how retention of vertical green trees (CANOPY) and coarse woody debris (CWD) influenced terrestrial salamander abundance and apparent survival in recently clearcut forests. Estimated abundance of unmarked salamanders was positively related to CANOPY ((beta) over cap (Canopy) = 0.21 (0.02-1.19; 95% CI), but not CWD ((beta) over cap (CWD) = 0.11 (-0.13-0.35) within 3,600 m(2) sites, whereas estimated abundance of unmarked salamanders was not related to CANOPY ((beta) over cap (Canopy) = -0.01 (-0.21-0.18) or CWD ((beta) over cap (CWD) = -0.02 (-0.23-0.19) for 9 m(2) enclosures. In contrast, apparent survival of marked salamanders within our enclosures over 1 month was positively influenced by both CANOPY and CWD retention ((beta) over cap (Canopy) = 0.73 (0.27-1.19; 95% CI) and (beta) over cap (CWD) = 1.01 (0.53-1.50). Our results indicate that environmental correlates to abundance are scale dependent reflecting habitat selection processes and organism movements after a habitat disturbance event. Our study also provides a cautionary example of how scientific inference is conditional on the response variable(s), and scale(s) of measure chosen by the investigator, which can have important implications for species conservation and management. Our research highlights the need for joint evaluation of population state variables, such as abundance, and population-level process, such as survival, when assessing anthropogenic impacts on forest biodiversity.	[Otto, Clint R. V.; Roloff, Gary J.; Thames, Rachael E.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA	Michigan State University	Otto, CRV (corresponding author), US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND 58401 USA.	cotto@usgs.gov			MDNR-Wildlife Division; federal Pittman-Robertson Wildlife Restoration Act grant; United States Fish and Wildlife Service (Michigan's Statewide Wildlife Research and Restoration Program) [W-147-R]; Rocky Mountain Goat Foundation; Michigan Society of Herpetologists	MDNR-Wildlife Division; federal Pittman-Robertson Wildlife Restoration Act grant; United States Fish and Wildlife Service (Michigan's Statewide Wildlife Research and Restoration Program); Rocky Mountain Goat Foundation; Michigan Society of Herpetologists	Support for this project was provided by the MDNR-Wildlife Division with funds from the federal Pittman-Robertson Wildlife Restoration Act grant administered by the United States Fish and Wildlife Service (W-147-R: Michigan's Statewide Wildlife Research and Restoration Program), the Rocky Mountain Goat Foundation, and the Michigan Society of Herpetologists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ash AN, 1997, CONSERV BIOL, V11, P983, DOI 10.1046/j.1523-1739.1997.96172.x; Bailey LL, 2004, J HERPETOL, V38, P370, DOI 10.1670/194-03A; Bailey LL, 2004, J WILDLIFE MANAGE, V68, P1, DOI 10.2193/0022-541X(2004)068[0001:EDPPFP]2.0.CO;2; Bennett LT, 2004, J APPL ECOL, V41, P585, DOI 10.1111/j.0021-8901.2004.00924.x; Bielecki J., 2006, STAND RETENTION GUID; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Chazal AC, 1998, ECOL APPL, V8, P1133, DOI 10.1890/1051-0761(1998)008[1133:ROMSTC]2.0.CO;2; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Davic RD, 2004, ANNU REV ECOL EVOL S, V35, P405, DOI 10.1146/annurev.ecolsys.35.112202.130116; Demaynadier Phillip G., 1995, Environmental Reviews, V3, P230, DOI 10.1139/a95-012; Ferraz G, 2007, SCIENCE, V315, P238, DOI 10.1126/science.1133097; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fiske IJ, 2011, J STAT SOFTW, V43, P1; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Franklin J.F., 1997, CREATING FORESTRY 21, P111; Grant EHC, 2008, J WILDLIFE MANAGE, V72, P1247, DOI 10.2193/2007-183; HEATWOLE H, 1962, ECOLOGY, V43, P460, DOI 10.2307/1933374; Hocking DJ, 2013, BIOL CONSERV, V167, P194, DOI 10.1016/j.biocon.2013.08.006; Hof C, 2011, NATURE, V480, P516, DOI 10.1038/nature10650; Homyack JA, 2009, BIOL CONSERV, V142, P110, DOI 10.1016/j.biocon.2008.10.003; Kendall WL, 2009, J APPL ECOL, V46, P1182, DOI 10.1111/j.1365-2664.2009.01732.x; Kendall WL, 1999, ECOLOGY, V80, P2517, DOI 10.1890/0012-9658(1999)080[2517:ROCCRM]2.0.CO;2; Knapp SM, 2003, CONSERV BIOL, V17, P752, DOI 10.1046/j.1523-1739.2003.02061.x; Kroll AJ, 2008, FOREST ECOL MANAG, V255, P3726, DOI 10.1016/j.foreco.2008.03.005; Kroll AJ, 2009, FOREST ECOL MANAG, V257, P1188, DOI 10.1016/j.foreco.2008.12.008; McDermott ME, 2009, BIOL CONSERV, V142, P212, DOI 10.1016/j.biocon.2008.10.016; McKenny HC, 2006, FOREST ECOL MANAG, V230, P186, DOI 10.1016/j.foreco.2006.04.034; Otto CRV, 2007, WETLANDS, V27, P261, DOI 10.1672/0277-5212(2007)27[261:IOWALC]2.0.CO;2; Otto CRV, 2013, ECOGRAPHY, V36, P1299, DOI 10.1111/j.1600-0587.2013.00137.x; Otto CRV, 2013, FOREST ECOL MANAG, V304, P275, DOI 10.1016/j.foreco.2013.04.023; Otto CRV, 2011, J HERPETOL, V45, P256, DOI 10.1670/10-039.1; Otto CRV, 2011, J WILDLIFE MANAGE, V75, P423, DOI 10.1002/jwmg.63; Patrick DA, 2006, FOREST ECOL MANAG, V234, P323, DOI 10.1016/j.foreco.2006.07.015; Peterman WE, 2011, FOREST ECOL MANAG, V262, P2344, DOI 10.1016/j.foreco.2011.08.030; Petranka, 1998, SALAMANDERS US CANAD; PETRANKA JW, 1993, CONSERV BIOL, V7, P363, DOI 10.1046/j.1523-1739.1993.07020363.x; Pollock K. H., 1982, J WILDLIFE MANAGE, V46, P757, DOI DOI 10.2307/3808568; Rittenhouse TAG, 2009, ECOLOGY, V90, P1620, DOI 10.1890/08-0326.1; Rittenhouse TAG, 2008, COPEIA, P807, DOI 10.1643/CH-07-176; Rosenvald R, 2008, FOREST ECOL MANAG, V255, P1, DOI 10.1016/j.foreco.2007.09.016; Rothermel BB, 2005, J HERPETOL, V39, P619, DOI 10.1670/251-04A.1; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Schmidt BR, 2005, CONSERV BIOL, V19, P1149, DOI 10.1111/j.1523-1739.2005.00164.x; Semlitsch RD, 2008, ECOL APPL, V18, P283, DOI 10.1890/07-0853.1; Semlitsch RD, 2009, BIOSCIENCE, V59, P853, DOI 10.1525/bio.2009.59.10.7; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Thompson ID, 2003, FOREST ECOL MANAG, V177, P441, DOI 10.1016/S0378-1127(02)00453-X; Todd BD, 2006, BIOL CONSERV, V133, P178, DOI 10.1016/j.biocon.2006.06.003; Van Horne P., 1983, J WILDLIFE MANAGE, V47, P893; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Welsh HH, 2008, BIOL CONSERV, V141, P1149, DOI 10.1016/j.biocon.2008.02.014; Welsh HH, 2001, CONSERV BIOL, V15, P558, DOI 10.1046/j.1523-1739.2001.015003558.x; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	54	16	16	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93859	10.1371/journal.pone.0093859	http://dx.doi.org/10.1371/journal.pone.0093859			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718498	gold, Green Published, Green Submitted			2022-12-25	WOS:000334339000051
J	Wilson, K; Lance, M; Jeffries, S; Acevedo-Gutierrez, A				Wilson, Kenady; Lance, Monique; Jeffries, Steven; Acevedo-Gutierrez, Alejandro			Fine-Scale Variability in Harbor Seal Foraging Behavior	PLOS ONE			English	Article							PHOCA-VITULINA-RICHARDSI; DIVING BEHAVIOR; PREY CONSUMPTION; ELEPHANT SEALS; CLASSIFICATION; SEX; MOVEMENT; PATTERNS; TACTICS; SYSTEM	Understanding the variability of foraging behavior within a population of predators is important for determining their role in the ecosystem and how they may respond to future ecosystem changes. However, such variability has seldom been studied in harbor seals on a fine spatial scale (<30 km). We used a combination of standard and Bayesian generalized linear mixed models to explore how environmental variables influenced the dive behavior of harbor seals. Time-depth recorders were deployed on harbor seals from two haul-out sites in the Salish Sea in 2007 (n = 18) and 2008 (n = 11). Three behavioral bout types were classified from six dive types within each bout; however, one of these bout types was related to haul-out activity and was excluded from analyses. Deep foraging bouts (Type I) were the predominant type used throughout the study; however, variation in the use of bout types was observed relative to haul-out site, season, sex, and light (day/night). The proportional use of Type I and Type II (shallow foraging/traveling) bouts differed dramatically between haul-out sites, seasons, sexes, and whether it was day or night; individual variability between seals also contributed to the observed differences. We hypothesize that this variation in dive behavior was related to habitat or prey specialization by seals from different haul-out sites, or individual variability between seals in the study area. The results highlight the potential influence of habitat and specialization on the foraging behavior of harbor seals, and may help explain the variability in diet that is observed between different haul-out site groups in this population.	[Wilson, Kenady; Acevedo-Gutierrez, Alejandro] Western Washington Univ, Dept Biol, Bellingham, WA 98225 USA; [Lance, Monique; Jeffries, Steven] Washington Dept Fish & Wildlife, Wildlife Sci Program, Lakewood, WA USA	Western Washington University; Washington Department of Fish & Wildlife (WDFW)	Wilson, K (corresponding author), Western Washington Univ, Dept Biol, Bellingham, WA 98225 USA.	kenady.wilson@duke.edu		Zucker-Scharff, Thomas/0000-0002-1790-7405; Acevedo-Gutierrez, Alejandro/0000-0002-9128-826X	National Science Foundation [0550443]; Western Washington University Department of Biology; Office of Research for Sponsored Programs; Washington Department of Fish and Wildlife	National Science Foundation(National Science Foundation (NSF)); Western Washington University Department of Biology; Office of Research for Sponsored Programs; Washington Department of Fish and Wildlife	This project was supported in part by Award #0550443 from the National Science Foundation (http://www.nsf.gov/) (A. A.) and by funds from the Western Washington University Department of Biology (http://www.biol.wwu.edu/biology/ (K. W.), the Office of Research for Sponsored Programs (http://www.wwu.edu/rsp/) (K. W.) and the Washington Department of Fish and Wildlife (http://wdfw.wa.gov) (S.J. and M. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin D, 2006, ECOLOGY, V87, P3095, DOI 10.1890/0012-9658(2006)87[3095:LMDAHT]2.0.CO;2; Baechler J, 2002, CAN J ZOOL, V80, P1569, DOI 10.1139/Z02-150; Beck CA, 2003, J ANIM ECOL, V72, P979, DOI 10.1046/j.1365-2656.2003.00761.x; Bjorge A, 1995, DEV MAR BIO, V4, P211; Boness DJ, 2006, BEHAV ECOL SOCIOBIOL, V61, P119, DOI 10.1007/s00265-006-0242-9; BONESS DJ, 1994, BEHAV ECOL SOCIOBIOL, V34, P95; Bowen WD, 1999, CAN J ZOOL, V77, P978, DOI 10.1139/cjz-77-6-978; Bowen WD, 2002, MAR ECOL PROG SER, V244, P235, DOI 10.3354/meps244235; BOYD IL, 1994, J ANIM ECOL, V63, P703, DOI 10.2307/5235; Bromaghin JF, 2013, FISH B-NOAA, V111, P13, DOI 10.7755/FB.111.1.2; Brooks C, 2008, J WILDLIFE MANAGE, V72, P527, DOI 10.2193/2007-061; Clark J. S, 2007, MODELS ECOLOGICAL DA; Coltman DW, 1997, ANIM BEHAV, V54, P663, DOI 10.1006/anbe.1997.0470; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; Davis RW, 2003, MAR ECOL PROG SER, V264, P109, DOI 10.3354/meps264109; Eguchi T, 2005, MAR MAMMAL SCI, V21, P283, DOI 10.1111/j.1748-7692.2005.tb01228.x; Gelman A., 2012, ARM DATA ANAL USING; Groot G, 1928, PACIFIC SALMON LIFE; Hardee S.E., 2008, THESIS W WASHINGTON; Harkonen T, 1999, J APPL ECOL, V36, P825, DOI 10.1046/j.1365-2664.1999.00434.x; HARKONEN TJ, 1987, NETH J SEA RES, V21, P331, DOI 10.1016/0077-7579(87)90007-X; Hastings KK, 2004, CAN J ZOOL, V82, P1755, DOI 10.1139/Z04-145; Higgs MD, 2012, BIOMETRICS, V68, P965, DOI 10.1111/j.1541-0420.2011.01710.x; HINDELL MA, 1991, AUST J ZOOL, V39, P595, DOI 10.1071/ZO9910595; Huber HR, 2001, MAR MAMMAL SCI, V17, P276, DOI 10.1111/j.1748-7692.2001.tb01271.x; Jeffries S, 2003, J WILDLIFE MANAGE, V67, P207, DOI 10.2307/3803076; Jeffries S. J., 2000, ATLAS SEAL SEA LION; Jeffries Steven J., 1993, Aquatic Mammals, V19, P21; Johnson A, 2007, CAN J ZOOL, V85, P290, DOI 10.1139/Z06-213; Kuhn CE, 2006, J EXP BIOL, V209, P4524, DOI 10.1242/jeb.02530; Lance MM, 2012, MAR ECOL PROG SER, V464, P257, DOI 10.3354/meps09880; LEBOEUF BJ, 1992, CAN J ZOOL, V70, P786, DOI 10.1139/z92-111; LEBOEUF BJ, 1988, CAN J ZOOL, V66, P446, DOI 10.1139/z88-064; Lesage V, 1999, CAN J ZOOL, V77, P74, DOI 10.1139/cjz-77-1-74; Lesage W, 2004, CAN J ZOOL, V82, P1070, DOI 10.1139/Z04-084; London JM, 2001, OBSERVATIONS HARBOR; Luxa K, 2013, AQUAT MAMM, V39, P10, DOI 10.1578/AM.39.1.2013.10; Macdonald D.W., 1978, P192; Middlemas SJ, 2006, P ROY SOC B-BIOL SCI, V273, P193, DOI 10.1098/rspb.2005.3215; OLESIUK PF, 1993, FISH B-NOAA, V91, P491; Olesiuk PF, 2010, DFO CAN SCI ADVIS SE, V2009; PAYNE PM, 1989, MAR MAMMAL SCI, V5, P173, DOI 10.1111/j.1748-7692.1989.tb00331.x; Peterson SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039046; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Schreer Jason F., 1998, Journal of Agricultural Biological and Environmental Statistics, V3, P383, DOI 10.2307/1400572; Schreer JF, 1996, MAR MAMMAL SCI, V12, P227, DOI 10.1111/j.1748-7692.1996.tb00573.x; SCHREER JF, 1995, MAR MAMMAL SCI, V11, P85, DOI 10.1111/j.1748-7692.1995.tb00277.x; Schreer JF, 2001, ECOL MONOGR, V71, P137, DOI 10.1890/0012-9615(2001)071[0137:CDPOPA]2.0.CO;2; Scordino J., 2010, W COAST PINNIPED PRO; Sumner MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007324; Suryan RM, 1998, MAR MAMMAL SCI, V14, P361, DOI 10.1111/j.1748-7692.1998.tb00728.x; Thomas AC, 2011, MAR ECOL PROG SER, V441, P225, DOI 10.3354/meps09370; Thompson PM, 1998, CAN J ZOOL, V76, P1044, DOI 10.1139/cjz-76-6-1044; Thomson R, 1994, PHYS OCEANOGRAPHY ST; Tollit DJ, 1998, J ZOOL, V244, P209, DOI 10.1111/j.1469-7998.1998.tb00026.x; WILLIAMS TM, 1985, PHYSIOL ZOOL, V58, P576, DOI 10.1086/physzool.58.5.30158584	56	15	16	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e92838	10.1371/journal.pone.0092838	http://dx.doi.org/10.1371/journal.pone.0092838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717815	gold, Green Published, Green Submitted			2022-12-25	WOS:000334339000022
J	Silva, R; Santos, RHS; Tavares, WD; Leite, GLD; Wilcken, CF; Serrao, JE; Zanuncio, JC				Silva-Filho, Reinildes; Silva Santos, Ricardo Henrique; Tavares, Wagner de Souza; Leite, Germano Leao Demolin; Wilcken, Carlos Frederico; Serrao, Jose Eduardo; Zanuncio, Jose Cola			Rice-Straw Mulch Reduces the Green Peach Aphid, Myzus persicae (Hemiptera: Aphididae) Populations on Kale, Brassica oleracea var. acephala (Brassicaceae) Plants	PLOS ONE			English	Article							BEMISIA-ARGENTIFOLII HOMOPTERA; LOW-LATITUDE APHID; BREVICORYNE-BRASSICAE; GOSSYPII GLOVER; BIOLOGICAL-CONTROL; ALATE APHIDS; GROWTH; YIELD; SOIL; PARAMETERS	Organic mulches, like peel and rice-straw, besides other materials affect the UV and temperature, which cause a reduction in the aphid arrival. The aim was to evaluate the effect of covering the soil with straw on the populations of the green peach aphid, Myzus persicae on the kale, Brassica oleracea var. acephala plants. The first experiment evaluated the direct effect of the rice-straw mulch and the second its indirect effect on aphid immigration, testing the plant characteristics that could lead to the landing preference of this insect. The third experiment evaluated the direct effect of the mulch on the aphid population. In the second and third experiments, four plants, each in a 14 L polyethylene pot with holes at the bottom, were used in areas with and without soil mulching. These pots were changed between areas, after seven days, to evaluate the effects of this change on the arrival of the winged aphids to the plants. Each plant was covered with anti-aphid gauze and inoculated with one winged M. persicae. Winged and apterous adults of this insect were counted per plant after 15 days. The temperature increased in the mulched plots to a maximum of 21-36(circle)C and to 18-32(circle)C in the plots with or without soil covering, respectively. Plant growth reduced the numbers of the winged aphids landing before and after they were moved to the bare soil plots. The nutrient content was similar in plants in both the mulched and no mulched plots. The population growth of M. persicae was higher in the control than in the mulched plots. This was partially due to temperatures close to 30(circle)C in these plots and changes in the plant physiology. The soil mulching with rice-straw decreased the M. persicae landing, increased the plot temperatures and improved the vegetative growth of the kale plants.	[Silva-Filho, Reinildes; Zanuncio, Jose Cola] Univ Fed Vicosa, Dept Biol Anim, Vicosa, MG, Brazil; [Silva Santos, Ricardo Henrique; Tavares, Wagner de Souza] Univ Fed Vicosa, Dept Fitotecnia, Vicosa, MG, Brazil; [Leite, Germano Leao Demolin] Univ Fed Minas Gerais, Inst Ciencias Agr, Montes Claros, Brazil; [Wilcken, Carlos Frederico] Univ Estadual Paulista, UNESP, Dept Protecao, Botucatu, SP, Brazil; [Serrao, Jose Eduardo] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Minas Gerais; Universidade Federal de Vicosa	Zanuncio, JC (corresponding author), Univ Fed Vicosa, Dept Biol Anim, Vicosa, MG, Brazil.	zanuncio@ufv.br	Wilcken, Carlos F/D-1596-2012	Wilcken, Carlos F/0000-0001-9875-4158	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Funding was received from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avalhaes CC, 2009, BIOSCI J, V25, P21; Ban D, 2009, J FOOD AGRIC ENVIRON, V7, P543; Birkhofer K, 2008, SOIL BIOL BIOCHEM, V40, P2297, DOI 10.1016/j.soilbio.2008.05.007; Broad ST, 2008, ENTOMOL EXP APPL, V129, P166, DOI 10.1111/j.1570-7458.2008.00762.x; Castoldi R, 2009, HORTIC BRAS, V27, P438, DOI 10.1590/S0102-05362009000400007; Chakraborty D, 2010, AGR WATER MANAGE, V97, P738, DOI 10.1016/j.agwat.2010.01.006; Chen CY, 2013, B ENTOMOL RES, V103, P406, DOI 10.1017/S0007485312000867; Chiu MC, 2012, ENTOMOL EXP APPL, V142, P216, DOI 10.1111/j.1570-7458.2011.01213.x; Cividanes FJ, 2010, PESQUI AGROPECU BRAS, V45, P7, DOI 10.1590/S0100-204X2010000100002; COSTELLO MJ, 1995, ENTOMOL EXP APPL, V75, P109, DOI 10.1007/BF02382169; Culjak TG, 2008, CEREAL RES COMMUN, V36, P27; da Costa JG, 2011, EUPHYTICA, V177, P299, DOI 10.1007/s10681-010-0250-8; Davis JA, 2006, ENVIRON ENTOMOL, V35, P1461, DOI 10.1603/0046-225X(2006)35[1461:EOHAFT]2.0.CO;2; Neto SED, 2009, CIENC RURAL, V39, P1362, DOI 10.1590/S0103-84782009005000071; Doring TF, 2004, ENTOMOL EXP APPL, V113, P53, DOI 10.1111/j.0013-8703.2004.00208.x; Durak R, 2013, CENT EUR J BIOL, V8, P570, DOI 10.2478/s11535-013-0161-x; Fernandez-Grandon GM, 2013, B ENTOMOL RES, V103, P466, DOI 10.1017/S0007485313000126; de Munoz FGG, 2007, ARCH INSECT BIOCHEM, V65, P20, DOI 10.1002/arch.20174; Gencsoylu I, 2004, J AGRON CROP SCI, V190, P381, DOI 10.1111/j.1439-037X.2004.00104.x; Gill HK, 2012, INT J PEST MANAGE, V58, P33, DOI 10.1080/09670874.2011.641606; Gill HK, 2011, FLA ENTOMOL, V94, P226, DOI 10.1653/024.094.0215; Gill HK, 2010, FLA ENTOMOL, V93, P183, DOI 10.1653/024.093.0206; Greer L, 2003, HORTTECHNOLOGY, V13, P276, DOI 10.21273/HORTTECH.13.2.0276; Hansen LM, 2012, ACTA AGR SCAND B-S P, V62, P132, DOI 10.1080/09064710.2011.583936; Haque I, 2006, BIOPHYS CHEM, V119, P224, DOI 10.1016/j.bpc.2005.09.016; Hayes RC, 2009, CROP PASTURE SCI, V60, P1184, DOI 10.1071/CP09095; Heimbach U., 2002, Gesunde Pflanzen, V54, P119, DOI 10.1046/j.1439-0345.2002.02021.x; Homma SK, 2012, SOIL TILL RES, V120, P147, DOI 10.1016/j.still.2012.01.001; Hu ZQ, 2013, ARCH BIOL SCI, V65, P247, DOI 10.2298/ABS1301247H; Ibarra L, 2001, SCI HORTIC-AMSTERDAM, V87, P139, DOI 10.1016/S0304-4238(00)00172-2; Kamara AY, 2000, J AGRON CROP SCI, V184, P73, DOI 10.1046/j.1439-037x.2000.00359.x; Karamanos AJ, 2004, J AGRON CROP SCI, V190, P262, DOI 10.1111/j.1439-037X.2004.00101.x; Kasirajan S, 2012, AGRON SUSTAIN DEV, V32, P501, DOI 10.1007/s13593-011-0068-3; Laakso K, 2000, PLANT CELL ENVIRON, V23, P461, DOI 10.1046/j.1365-3040.2000.00566.x; Latham LJ, 2001, AUST J AGR RES, V52, P683, DOI 10.1071/AR00144; Legarrea S, 2012, HORTIC SCI, V39, P74, DOI 10.17221/79/2011-HORTSCI; Leite GLD, 1999, ENTOMOL EXP APPL, V91, P267, DOI 10.1023/A:1003557718110; Magar SJ, 2008, INDIAN J AGR SCI, V78, P726; Mirmohammadi S, 2009, ANN ENTOMOL SOC AM, V102, P450, DOI 10.1603/008.102.0314; Moreno-Delafuente A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061543; Nyoike TW, 2010, INT J PEST MANAGE, V56, P31, DOI 10.1080/09670870902991815; Olinik JR, 2011, HORTIC BRAS, V29, P130, DOI 10.1590/S0102-05362011000100023; Palumbo JC, 2000, J ECON ENTOMOL, V93, P1688, DOI 10.1603/0022-0493-93.6.1688; Parajulee MN, 2007, ENVIRON ENTOMOL, V36, P666, DOI 10.1603/0046-225X(2007)36[666:IOCTOL]2.0.CO;2; Prasifka JR, 2006, ENVIRON ENTOMOL, V35, P1423, DOI 10.1603/0046-225X(2006)35[1423:EOLMOP]2.0.CO;2; Pullaro TC, 2006, AGR ECOSYST ENVIRON, V115, P97, DOI 10.1016/j.agee.2005.12.021; Rajabaskar D, 2013, ENTOMOL EXP APPL, V148, P172, DOI 10.1111/eea.12087; Ranger CM, 2009, ENVIRON ENTOMOL, V38, P129, DOI 10.1603/022.038.0116; Reddy N, 2006, J AGR FOOD CHEM, V54, P8077, DOI 10.1021/jf0617723; Reitz SR, 2003, J ECON ENTOMOL, V96, P1201, DOI 10.1603/0022-0493-96.4.1201; SAEG, 2007, SAEG SIST AN EST VER; Saeidi F, 2012, ENVIRON ENTOMOL, V41, P1638, DOI 10.1603/EN12127; Sarangi SK, 2010, INDIAN J AGR SCI, V80, P603; Satar S, 2008, J PLANT DIS PROTECT, V115, P69, DOI 10.1007/BF03356241; Saucke H, 2004, ANN APPL BIOL, V144, P347, DOI 10.1111/j.1744-7348.2004.tb00350.x; Schmidt NP, 2007, ENVIRON ENTOMOL, V36, P416, DOI 10.1603/0046-225X(2007)36[416:ALMABC]2.0.CO;2; Silva EE, 2011, HORTIC BRAS, V29, P57, DOI [10.1590/S0102-05362011000100010, 10.1590/S0102-05362011000100022]; Simmons AM, 2010, CROP PROT, V29, P898, DOI 10.1016/j.cropro.2010.04.003; Slosser JE, 1998, SOUTHWEST ENTOMOL, V23, P31; Summers CG, 2004, ENVIRON ENTOMOL, V33, P1447, DOI 10.1603/0046-225X-33.5.1447; Summers CG, 2002, CROP PROT, V21, P921, DOI 10.1016/S0261-2194(02)00067-4; Trdan S, 2008, INT J PEST MANAGE, V54, P309, DOI 10.1080/09670870802220596; van Toor RF, 2009, CROP PROT, V28, P599, DOI 10.1016/j.cropro.2009.03.019; Zamani AA, 2006, J APPL ENTOMOL, V130, P453, DOI 10.1111/j.1439-0418.2006.01088.x; Zanic K, 2013, SPAN J AGRIC RES, V11, P1120, DOI 10.5424/sjar/2013114-4349; Zanic K, 2009, J FOOD AGRIC ENVIRON, V7, P496; Znidarcic D., 2008, Acta Agriculturae Slovenica, V91, P361, DOI 10.2478/v10014-008-0016-3	67	11	11	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94174	10.1371/journal.pone.0094174	http://dx.doi.org/10.1371/journal.pone.0094174			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714367	gold, Green Submitted, Green Published			2022-12-25	WOS:000334160900096
J	Wagner, JM; Pajerowski, JD; Daniels, CL; McHugh, PM; Flynn, JA; Balliet, JW; Casimiro, DR; Subramanian, S				Wagner, James M.; Pajerowski, J. David; Daniels, Christopher L.; McHugh, Patrick M.; Flynn, Jessica A.; Balliet, John W.; Casimiro, Danilo R.; Subramanian, Shyamsundar			Enhanced Production of Chikungunya Virus-Like Particles Using a High-pH Adapted Spodoptera frugiperda Insect Cell Line	PLOS ONE			English	Article							SITE-DIRECTED MUTATIONS; E2 GLYCOPROTEINS; IN-VIVO; VACCINE; BACULOVIRUS; PALMITOYLATION; CHOLESTEROL; GENERATION; GROWTH; ENTRY	Chikungunya virus-like particles (VLPs) have potential to be used as a prophylactic vaccine based on testing in multiple animal models and are currently being evaluated for human use in a Phase I clinical trial. The current method for producing these enveloped alphavirus VLPs by transient gene expression in mammalian cells presents challenges for scalable and robust industrial manufacturing, so the insect cell baculovirus expression vector system was evaluated as an alternative expression technology. Subsequent to recombinant baculovirus infection of Sf21 cells in standard culture media (pH 6.2-6.4), properly processed Chikungunya structural proteins were detected and assembled capsids were observed. However, an increase in culture pH to 6.6-6.8 was necessary to produce detectable concentrations of assembled VLPs. Since this elevated production pH exceeds the optimum for growth medium stability and Sf21 culture, medium modifications were made and a novel insect cell variant (SfBasic) was derived by exposure of Sf21 to elevated culture pH for a prolonged period of time. The high-pH adapted SfBasic insect cell line described herein is capable of maintaining normal cell growth into the typical mammalian cell culture pH range of 7.0-7.2 and produces 11-fold higher Chikungunya VLP yields relative to the parental Sf21 cell line. After scale-up into stirred tank bioreactors, SfBasic derived VLPs were chromatographically purified and shown to be similar in size and structure to a VLP standard derived from transient gene expression in HEK293 cells. Total serum anti-Chikungunya IgG and neutralizing titers from guinea pigs vaccinated with SfBasic derived VLPs or HEK293 derived VLPs were not significantly different with respect to production method, suggesting that this adapted insect cell line and production process could be useful for manufacturing Chikungunya VLPs for use as a vaccine. The adaptation of Sf21 to produce high levels of recombinant protein and VLPs in an elevated pH range may also have applications for other pH-sensitive protein or VLP targets.	[Wagner, James M.; Pajerowski, J. David; Daniels, Christopher L.; McHugh, Patrick M.; Flynn, Jessica A.; Balliet, John W.; Casimiro, Danilo R.; Subramanian, Shyamsundar] Merck & Co Inc, Merck Res Labs, Vaccine Res & Dev, West Point, PA 19486 USA		Subramanian, S (corresponding author), Merck & Co Inc, Merck Res Labs, Vaccine Res & Dev, West Point, PA 19486 USA.	shyamsundar.subramanian@merck.com			Merck Co, Inc.	Merck Co, Inc.(Merck & Company)	All funding for this work was provided by Merck & Co, Inc. The funders provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahata W, 2012, J VIROL, V86, P8879, DOI 10.1128/JVI.00370-12; Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105; [Anonymous], 2011, GUIDE CARE USE LAB A, Veighth, DOI DOI 10.17226/12910; Armitage P., 2002, STAT METHODS MED RES; Blanchard P, 2003, VACCINE, V21, P4565, DOI 10.1016/S0264-410X(03)00503-6; Caglioti C, 2013, NEW MICROBIOL, V36, P211; Chen KC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-169; Cox MMJ, 2012, VACCINE, V30, P1759, DOI 10.1016/j.vaccine.2012.01.016; Dogan Ayse Dudu Altintas, 2013, Ugeskr Laeger, V175, P1716; Fauquet CM, 2005, VIRUS TAXONOMY 8 REP; Fernandes F, 2013, EXPERT REV VACCINES, V12, P225, DOI [10.1586/ERV.12.153, 10.1586/erv.12.153]; FUNKE C, 1995, VIROLOGY, V208, P289, DOI 10.1006/viro.1995.1151; Garcia-Arriaza J, 2014, J VIROL; Gerbal Muriel, 2000, In Vitro Cellular and Developmental Biology Animal, V36, P117, DOI 10.1290/1071-2690(2000)036<0117:AOAICL>2.3.CO;2; GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011; Grubbs F. E., 1974, PROCEDURES DETECTING; Hacker DL, 2009, BIOTECHNOL ADV, V27, P1023, DOI 10.1016/j.biotechadv.2009.05.008; HARRAP KA, 1977, VIROLOGY, V79, P14, DOI 10.1016/0042-6822(77)90330-0; HENSLER W, 1994, ANN NY ACAD SCI, V745, P149; IVANOVA L, 1993, J VIROL, V67, P2546, DOI 10.1128/JVI.67.5.2546-2551.1993; Kahrstrom CT, 2014, NAT REV MICROBIOL, V12, P151; Kruse Jr P. F., 1973, TISSUE CULTURE METHO; Kurstak E, 1980, INVERTEBRATE SYSTEMS; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Lee RCH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002050; LEVITT NH, 1986, VACCINE, V4, P157, DOI 10.1016/0264-410X(86)90003-4; LICARI PJ, 1993, BIOTECHNOL PROGR, V9, P146, DOI 10.1021/bp00020a005; Lipin DI, 2008, ARCH VIROL, V153, P2027, DOI 10.1007/s00705-008-0220-9; Liu FX, 2013, PROTEIN EXPRES PURIF, V90, P104, DOI 10.1016/j.pep.2013.05.009; Lu YPE, 1999, J VIROL, V73, P4272, DOI 10.1128/JVI.73.5.4272-4278.1999; Lu YPE, 2001, J VIROL, V75, P8329, DOI 10.1128/JVI.75.17.8329-8339.2001; MAIORELLA B, 1988, BIO-TECHNOL, V6, P1406, DOI 10.1038/nbt1288-1406; MARQUARDT MT, 1993, J CELL BIOL, V123, P57, DOI 10.1083/jcb.123.1.57; MEDINA M, 1995, CYTOTECHNOLOGY, V17, P21, DOI 10.1007/BF00749217; Metz SW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002124; Metz SW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-353; Metz SW, 2013, VACCINE; Moormann RJM, 2000, VET MICROBIOL, V73, P209, DOI 10.1016/S0378-1135(00)00146-2; Muthumani K, 2008, VACCINE, V26, P5128, DOI 10.1016/j.vaccine.2008.03.060; Olsen CH, 2003, INFECT IMMUN, V71, P6689, DOI 10.1128/IAI.71.12.6689-6692.2003; Pascual-Montano A, 2001, J STRUCT BIOL, V133, P233, DOI 10.1006/jsbi.2001.4369; PASUMARTHY MK, 1994, BIOTECHNOL PROGR, V10, P314, DOI 10.1021/bp00027a012; ROSS R. W., 1956, JOUR HYG, V54, P177; Ryan C, 1998, VIROLOGY, V249, P62, DOI 10.1006/viro.1998.9281; SCHARER CG, 1993, ARCH VIROL, V132, P237, DOI 10.1007/BF01309536; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; SUMMERS MD, 1976, J VIROL, V17, P962, DOI 10.1128/JVI.17.3.962-972.1976; Sun SY, 2013, ELIFE, V2, DOI 10.7554/eLife.00435; Thiboutot MM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000623; Tiwari M, 2009, VACCINE, V27, P2513, DOI 10.1016/j.vaccine.2009.02.062; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Valley-Omar Z, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-462; Van Aarle P., 2003, VVolume 114, P193; Vashishtha M, 1998, J CELL BIOL, V140, P91, DOI 10.1083/jcb.140.1.91; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; VOLLER A, 1978, J CLIN PATHOL, V31, P507, DOI 10.1136/jcp.31.6.507; Wang D, 2011, VACCINE, V29, P2803, DOI 10.1016/j.vaccine.2011.01.108; Wang E, 2008, VACCINE, V26, P5030, DOI 10.1016/j.vaccine.2008.07.054; Weaver SC, 2012, EXPERT REV VACCINES, V11, P1087, DOI [10.1586/ERV.12.84, 10.1586/erv.12.84]; Wu Yan-lei, 2011, Virologica Sinica, V26, P198, DOI 10.1007/s12250-011-3177-x; Youil R, 2003, HUM GENE THER, V14, P1017, DOI 10.1089/104303403766682278; Zhang SXX, 2003, J VIROL, V77, P6265, DOI 10.1128/JVI.77.11.6265-6273.2003; ZHIRNOV OP, 1986, VOP VIRUSOL+, P723	65	28	28	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94401	10.1371/journal.pone.0094401	http://dx.doi.org/10.1371/journal.pone.0094401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713807	gold, Green Published, Green Submitted			2022-12-25	WOS:000334160900128
J	Gan, XB; Sun, HJ; Chen, D; Zhang, LL; Zhou, H; Chen, LY; Zhou, YB				Gan, Xian-Bing; Sun, Hai-Jian; Chen, Dan; Zhang, Ling-Li; Zhou, Hong; Chen, Li-Yan; Zhou, Ye-Bo			Intermedin in the Paraventricular Nucleus Attenuates Cardiac Sympathetic Afferent Reflex in Chronic Heart Failure Rats	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; ADRENOMEDULLIN 2/INTERMEDIN-LIKE IMMUNOREACTIVITY; CENTRAL-NERVOUS-SYSTEM; OXIDATIVE STRESS; ANGIOTENSIN-II; BLOOD-PRESSURE; ENDOTHELIAL-CELLS; HYPERTENSIVE-RATS; NAD(P)H OXIDASE; AT(1) RECEPTOR	Background and Aim: Intermedin (IMD) is a member of calcitonin/ calcitonin gene-related peptide (CGRP) family together with adrenomedullin (AM) and amylin. It has a wide distribution in the central nervous system (CNS) especially in hypothalamic paraventricular nucleus (PVN). Cardiac sympathetic afferent reflex (CSAR) is enhanced in chronic heart failure (CHF) rats. The aim of this study is to determine the effect of IMD in the PVN on CSAR and its related mechanisms in CHF rats. Methodology/ Principal Findings: Rats were subjected to left descending coronary artery ligation to induce CHF or shamoperation (Sham). Renal sympathetic nerve activity (RSNA), mean arterial pressure (MAP) and heart rate (HR) were recorded. CSAR was evaluated by the RSNA and MAP responses to epicardial application of capsaicin. Acute experiments were carried out 8 weeks after coronary ligation or sham surgery under anesthesia. IMD and angiotensin II (Ang II) levels in the PVN were up-regulated in CHF rats. Bilateral PVN microinjection of IMD caused greater decreases in CSAR and the baseline RSNA and MAP in CHF rats than those in Sham rats. The decrease of CSAR caused by IMD was prevented by pretreatment with AM receptor antagonist AM22-52, but not CGRP receptor antagonist CGRP8-37. Ang II in the PVN significantly enhanced CSAR and superoxide anions level, which was inhibited by PVN pretreatment with IMD or tempol (a superoxide anions scavenger) in Sham and CHF rats. Conclusion: IMD in the PVN inhibits CSAR via AM receptor, and attenuates the effects of Ang II on CSAR and superoxide anions level in CHF rats. PVN superoxide anions involve in the effect of IMD on attenuating Ang II-induced CSAR response.	[Gan, Xian-Bing; Sun, Hai-Jian; Zhang, Ling-Li; Zhou, Ye-Bo] Nanjing Med Univ, Dept Physiol, Key Lab Cardiovasc Dis & Mol Intervent, Nanjing, Jiangsu, Peoples R China; [Gan, Xian-Bing; Chen, Dan] Anhui Univ Chinese Med, Dept Physiol, Hefei, Peoples R China; [Zhou, Hong] Nanjing Med Univ, Lab Ctr Basic Med Sci, Dept Med Physiol & Biochem, Nanjing, Jiangsu, Peoples R China; [Chen, Li-Yan] Harbin Med Univ, Affiliated Hosp 2, Dept Haematol, Harbin, Peoples R China	Nanjing Medical University; Anhui University of Chinese Medicine; Nanjing Medical University; Harbin Medical University	Zhou, YB (corresponding author), Nanjing Med Univ, Dept Physiol, Key Lab Cardiovasc Dis & Mol Intervent, Nanjing, Jiangsu, Peoples R China.	zhouyebo666@njmu.edu.cn		Zhou, Yebo/0000-0001-9465-1338	National Natural Science Foundation of China [81000106]; Jiangsu Higher Education Institutions of China [10KJB310004]; Nanjing Medical University of China [09JC013, JX 10131801056, 09NJMUZ04]; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Higher Education Institutions of China; Nanjing Medical University of China; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine	This work was supported by the funds from the National Natural Science Foundation of China (grant no. 81000106), the Jiangsu Higher Education Institutions of China (grant no. 10KJB310004), the Nanjing Medical University of China (grant no. 09JC013, JX 10131801056 and 09NJMUZ04), and the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2004, CURR HYPERTENS REP, V6, P55, DOI 10.1007/s11906-004-0012-x; Badoer E, 2010, AM J PHYSIOL-RENAL, V298, pF839, DOI 10.1152/ajprenal.00734.2009; Bell D, 2008, CELL PHYSIOL BIOCHEM, V21, P409, DOI 10.1159/000129633; Bell D, 2012, J PHYSIOL-LONDON, V590, P1181, DOI 10.1113/jphysiol.2011.221895; Chen AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040748; Chen HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064757; Chen L, 2006, BRAIN RES, V1086, P42, DOI 10.1016/j.brainres.2006.02.128; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Coote JH, 2005, EXP PHYSIOL, V90, P169, DOI 10.1113/expphysiol.2004.029041; Cui H, 2008, AUTON NEUROSCI-BASIC, V142, P45, DOI 10.1016/j.autneu.2008.07.009; Du YH, 2007, J APPL PHYSIOL, V102, P9, DOI 10.1152/japplphysiol.01032.2006; Floras JS, 2009, J AM COLL CARDIOL, V54, P375, DOI 10.1016/j.jacc.2009.03.061; Fujisawa Y, 2006, AM J PHYSIOL-HEART C, V290, pH1120, DOI 10.1152/ajpheart.00461.2005; Gan XB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025784; Gao J, 2012, PFLUG ARCH EUR J PHY, V463, P297, DOI 10.1007/s00424-011-1036-0; Gao L, 2004, CIRC RES, V95, P937, DOI 10.1161/01.RES.0000146676.04359.64; Grassi G, 2009, CURR VASC PHARMACOL, V7, P137, DOI 10.2174/157016109787455699; Hagiwara M, 2008, AM J PHYSIOL-RENAL, V295, pF1735, DOI 10.1152/ajprenal.90427.2008; Han Y, 2007, EUR J HEART FAIL, V9, P967, DOI 10.1016/j.ejheart.2007.07.004; Hashimoto H, 2008, AUTON NEUROSCI-BASIC, V139, P46, DOI 10.1016/j.autneu.2008.01.003; Kang YM, 2011, BASIC RES CARDIOL, V106, P1087, DOI 10.1007/s00395-011-0215-7; Li DP, 2007, HYPERTENSION, V49, P916, DOI 10.1161/01.HYP.0000259666.99449.74; Li H, 2013, CARDIOVASC DIABETOL, V12, DOI [10.1186/1475-2840-12-91, 10.1186/1475-2840-12-133]; Li P, 2013, PEPTIDES, V47, P1, DOI 10.1016/j.peptides.2013.05.002; Liu K, 2013, CLIN LAB, V59, P589, DOI 10.7754/Clin.Lab.2012.120708; Malliani A, 2002, HYPERTENSION, V39, P63, DOI 10.1161/hy0102.099200; Oliver KR, 2001, EUR J NEUROSCI, V14, P618, DOI 10.1046/j.0953-816x.2001.01688.x; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Pearson LJ, 2009, CELL PHYSIOL BIOCHEM, V23, P97, DOI 10.1159/000204098; Qiao X, 2013, AM J PHYSIOL-RENAL, V304, pF112, DOI 10.1152/ajprenal.00054.2012; Roh J, 2004, J BIOL CHEM, V279, P7264, DOI 10.1074/jbc.M305332200; Sharma NM, 2011, CARDIOVASC RES, V92, P348, DOI 10.1093/cvr/cvr217; SWEDBERG K, 1990, CIRCULATION, V82, P1730, DOI 10.1161/01.CIR.82.5.1730; Takahashi K, 2006, PEPTIDES, V27, P1383, DOI 10.1016/j.peptides.2005.11.004; Takahashi K, 2011, J MOL NEUROSCI, V43, P182, DOI 10.1007/s12031-010-9413-2; Taylor MM, 2005, AM J PHYSIOL-REG I, V288, pR919, DOI 10.1152/ajpregu.00744.2004; Wang HJ, 2005, AUTON NEUROSCI-BASIC, V121, P56, DOI 10.1016/j.autneu.2005.07.003; Wang W, 2000, Heart Fail Rev, V5, P57; Yang JH, 2009, REGUL PEPTIDES, V158, P19, DOI 10.1016/j.regpep.2009.05.012; Yuan Y, 2012, J GERIATR CARDIOL, V9, P17, DOI 10.3724/SP.J.1263.2012.00017; Zhang SJ, 2012, J BIOMED RES, V26, P425, DOI 10.7555/JBR.26.20120035; Zhang Y, 2006, BRAIN RES, V1082, P132, DOI 10.1016/j.brainres.2006.01.113; Zhao L, 2012, PEPTIDES, V33, P329, DOI 10.1016/j.peptides.2011.12.016; Zhong MK, 2008, EXP PHYSIOL, V93, P746, DOI 10.1113/expphysiol.2007.041632; Zhou YB, 2014, HYPERTENSION, V63, P330, DOI 10.1161/HYPERTENSIONAHA.113.01681; Zhu GQ, 2004, J APPL PHYSIOL, V97, P1746, DOI 10.1152/japplphysiol.00573.2004; Zhu GQ, 2004, AM J PHYSIOL-HEART C, V287, pH1828, DOI 10.1152/ajpheart.01245.2003	47	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94234	10.1371/journal.pone.0094234	http://dx.doi.org/10.1371/journal.pone.0094234			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709972	gold, Green Published, Green Submitted			2022-12-25	WOS:000334159800123
J	Moll, X; Garcia, F; Ferrer, RI; Santos, L; Aguilar, A; Andaluz, A				Moll, Xavier; Garcia, Felix; Isabel Ferrer, Rosa; Santos, Laura; Aguilar, Adria; Andaluz, Anna			Distribution of Methylene Blue after Injection into the Epidural Space of Anaesthetized Pregnant and Non-Pregnant Sheep	PLOS ONE			English	Article							VENOUS PLEXUS; ANESTHESIA; ANALGESIA; SPREAD; MIGRATION; BUPIVACAINE; COMPRESSION	The aim of the study was to determine the distribution of different volumes of methylene blue solution injected into the epidural space in anaesthetized pregnant and non-pregnant sheep, to evaluate its cranial distribution and to compare between them. Fifteen pregnant and fifteen non-pregnant sheep were included in the study. Sheep were anaesthetized and received 0.05, 0.1, or 0.2 mL/kg of a lumbosacral epidural solution containing 0.12% methylene blue in 0.9% saline. Thirty minutes after the epidural injection, the ewes were euthanized. The extension of the dye within the epidural space was measured, and the correlation between the volume of the dye injected and the number of stained vertebrae was evaluated. The cranial migration of the dye between pregnant and non-pregnant sheep was also compared. The results show that the volume of methylene blue injected epidurally into pregnant and non-pregnant sheep correlated directly with its cephalic distribution into the epidural space; and a volume of 0.1 mL/kg or 0.2 mL/kg stained up to the first lumbar segment in pregnant and non-pregnant sheep, respectively. Also, the results suggest that the volume of drugs administered into the epidural space of pregnant sheep should be half the volume that would be used in non-pregnant sheep.	[Moll, Xavier; Garcia, Felix; Isabel Ferrer, Rosa; Santos, Laura; Aguilar, Adria; Andaluz, Anna] Univ Autonoma Barcelona, Fac Vet, Dept Med & Cirurgia Anim, Bellaterra, Spain	Autonomous University of Barcelona	Moll, X (corresponding author), Univ Autonoma Barcelona, Fac Vet, Dept Med & Cirurgia Anim, Bellaterra, Spain.	xavier.moll@uab.cat	Moll, Xavier/H-3203-2018	Moll, Xavier/0000-0002-2992-9361; Andaluz, Anna/0000-0001-8097-8110				BARCLAY DL, 1968, AM J OBSTET GYNECOL, V101, P792, DOI 10.1016/0002-9378(68)90035-5; Batson OV, 1940, ANN SURG, V112, P138, DOI 10.1097/00000658-194007000-00016; Brenner L, 2011, BRIT J ANAESTH, V107, P229, DOI 10.1093/bja/aer128; Campagnol D, 2012, VET J, V192, P311, DOI 10.1016/j.tvjl.2011.08.019; DeRossi R, 2012, RES VET SCI, V92, P278, DOI 10.1016/j.rvsc.2010.11.006; Edmondson MA., 2012, SHEEP GOAT MED, P150, DOI [DOI 10.1016/B978-1-4377-2353-10008-3, 10.1016/B978-1-4377-2353-3.10008-3, DOI 10.1016/B978-1-4377-2353-3.10008-3]; Freire CD, 2010, VET ANAESTH ANALG, V37, P63, DOI 10.1111/j.1467-2995.2009.00493.x; Gorgi AA, 2006, AM J VET RES, V67, P219, DOI 10.2460/ajvr.67.2.219; Grau T, 2001, BRIT J ANAESTH, V86, P798, DOI 10.1093/bja/86.6.798; Hall L., 2001, VET ANAESTHESIA, P225; Hall L.W., 2001, VET ANAESTHESIA, V10, P341; Higuchi H, 2011, ANESTHESIOLOGY, V114, P1155, DOI 10.1097/ALN.0b013e31820a4c29; Hirabayashi Y, 1997, BRIT J ANAESTH, V78, P317, DOI 10.1093/bja/78.3.317; Igarashi T, 2000, ANESTHESIOLOGY, V92, P1631, DOI 10.1097/00000542-200006000-00021; Lansdowne JL, 2005, AM J VET RES, V66, P1324, DOI 10.2460/ajvr.2005.66.1324; Lee I, 2004, VET ANAESTH ANALG, V31, P190, DOI 10.1111/j.1467-2987.2004.00149.x; Lee I, 2004, VET ANAESTH ANALG, V31, P86, DOI 10.1111/j.1467-2987.2004.00150.x; Lee Inhyung, 2001, Vet Anaesth Analg, V28, P140, DOI 10.1046/j.1467-2987.2001.00042.x; Lopez MJ, 1997, AM J VET RES, V58, P786; MELLOR DJ, 1981, RES VET SCI, V30, P198, DOI 10.1016/S0034-5288(18)32581-5; Moll X, 2011, VET REC, V168, DOI 10.1136/vr.d164; Onuki E, 2010, ANESTH ANALG, V110, P148, DOI 10.1213/ANE.0b013e3181c04faf; Raffe MR, 2007, LUMB JONES VET ANEST; Scott PR, 1997, VET J, V154, P63, DOI 10.1016/S1090-0233(05)80009-7; SCOTT PR, 1994, THERIOGENOLOGY, V42, P891, DOI 10.1016/0093-691X(94)90457-T; Skarda RT, 1996, VET CLIN N AM-FOOD A, V12, P579, DOI 10.1016/S0749-0720(15)30390-X; Son WG, 2011, VET ANAESTH ANALG, V38, P510, DOI 10.1111/j.1467-2995.2011.00643.x; Takiguchi T, 2006, ANESTHESIOLOGY, V105, P848, DOI 10.1097/00000542-200610000-00033; Tranquilli WJ, 2007, LUMB JONESVETERINARY, V4th, P561; TRIM CM, 1989, J AM VET MED ASSOC, V194, P1292; Tusell JM, 2005, VET J, V169, P108, DOI 10.1016/j.tvjl.2004.01.030; VALVERDE A, 1989, CAN J ANAESTH, V36, P629, DOI 10.1007/BF03005412; Valverde A, 2008, VET CLIN N AM-SMALL, V38, P1205, DOI 10.1016/j.cvsm.2008.06.004; VERNON RG, 1981, BIOCHEM J, V200, P307, DOI 10.1042/bj2000307	34	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e92860	10.1371/journal.pone.0092860	http://dx.doi.org/10.1371/journal.pone.0092860			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709655	gold, Green Published, Green Submitted			2022-12-25	WOS:000334159800019
J	Nudds, RL				Nudds, Robert L.			Reassessment of the Wing Feathers of Archaeoptery lithographica Suggests No Robust Evidence for the Presence of Elongated Dorsal Wing Coverts	PLOS ONE			English	Article							EVOLUTION; FLIGHT; BIRDS; CONFUCIUSORNIS; SPECIMEN; RACHISES; THEROPOD; ORIGINS	Recently it was proposed that the primary feathers of Archaeopteryx lithographica (HMN1880) were overlaid by long covert feathers, and that a multilayered feathered wing was a feature of early fossils with feathered forelimbs. The proposed long covert feathers of Archaeopteryx were previously interpreted as dorsally displaced remiges or a second set of impressions made by the wing. The following study shows that the qualitative arguments forwarded in support of the elongated covert hypothesis are neither robust nor supported quantitatively. The idea that the extant bird wing with its single layer of overlapping primaries evolved from an earlier multilayered heavily coveted feathered forelimb as seen in Anchiornis huxleyi is reasonable. At this juncture, however, it is premature to conclude unequivocally that the wing of Archaeopteryx consisted of primary feathers overlaid with elongated coverts.	Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Nudds, RL (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	robert.nudds@manchester.ac.uk						Bock W.J., 1986, Memoirs of the California Academy of Sciences, P57; Burgers P, 1999, NATURE, V399, P60, DOI 10.1038/19967; de Beer G., 1954, CRAFTSMANS HDB; Dial KP, 2003, SCIENCE, V299, P402, DOI 10.1126/science.1078237; Dudley R, 2007, ANNU REV ECOL EVOL S, V38, P179, DOI 10.1146/annurev.ecolsys.37.091305.110014; Garner JP, 1999, P ROY SOC B-BIOL SCI, V266, P1259, DOI 10.1098/rspb.1999.0772; HEILMANN G, 1926, ORIGIN BIRDS; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Hummel D., 1980, Acta Congressus Internationalis Ornithologici, V1, P391; Longrich NR, 2012, CURR BIOL, V22, P2262, DOI 10.1016/j.cub.2012.09.052; Mayr G, 2005, SCIENCE, V310, P1483, DOI 10.1126/science.1120331; Mayr G, 2007, ZOOL J LINN SOC-LOND, V149, P97, DOI 10.1111/j.1096-3642.2006.00245.x; NORBERG UM, 1985, AM NAT, V126, P303, DOI 10.1086/284419; Nudds RL, 2010, SCIENCE, V330, DOI 10.1126/science.1193474; Nudds RL, 2010, SCIENCE, V328, P887, DOI 10.1126/science.1188895; Ostrom J.H., 1986, Memoirs of the California Academy of Sciences, P73; Paul GS, 2010, SCIENCE, V330, DOI 10.1126/science.1192963; Rietschel S., 1985, P251; Senter P, 2006, ACTA PALAEONTOL POL, V51, P305; Spedding GR, 1992, MECH ANIMAL LOCOMOTI; TUCKER VA, 1993, J EXP BIOL, V180, P285; VAZQUEZ RJ, 1992, J MORPHOL, V211, P259, DOI 10.1002/jmor.1052110303; Videler John J., 2000, Archaeopteryx, V18, P27; Wellnhofer P, 2008, ARCHAEOPTERYX URVOGE; Zheng Xiaoting, 2010, Science (Washington D C), V330	25	6	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93963	10.1371/journal.pone.0093963	http://dx.doi.org/10.1371/journal.pone.0093963			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710561	gold, Green Published, Green Submitted			2022-12-25	WOS:000334159800078
J	Chaillon, A; Samleerat, T; Zoveda, F; Ballesteros, S; Moreau, A; Ngo-Giang-Huong, N; Jourdain, G; Gianella, S; Lallemant, M; Depaulis, F; Barin, F				Chaillon, Antoine; Samleerat, Tanawan; Zoveda, Faustine; Ballesteros, Sebastien; Moreau, Alain; Ngo-Giang-Huong, Nicole; Jourdain, Gonzague; Gianella, Sara; Lallemant, Marc; Depaulis, Frantz; Barin, Francis			Estimating the Timing of Mother-to-Child Transmission of the Human Immunodeficiency Virus Type 1 Using a Viral Molecular Evolution Model	PLOS ONE			English	Article							PCR-MEDIATED RECOMBINATION; PHYLOGENETIC ANALYSIS; IN-UTERO; VERTICAL TRANSMISSION; SEXUAL TRANSMISSION; HIV-1 TRANSMISSION; GENETIC DIVERSITY; DNA-SEQUENCES; VARIANTS; HISTORY	Background: Mother-to-child transmission (MTCT) is responsible for most pediatric HIV-1 infections worldwide. It can occur during pregnancy, labor, or breastfeeding. Numerous studies have used coalescent and molecular clock methods to understand the epidemic history of HIV-1, but the timing of vertical transmission has not been studied using these methods. Taking advantage of the constant accumulation of HIV genetic variation over time and using longitudinally sampled viral sequences, we used a coalescent approach to investigate the timing of MTCT. Materials and Methods: Six-hundred and twenty-two clonal env sequences from the RNA and DNA viral population were longitudinally sampled from nine HIV-1 infected mother-and-child pairs [range: 277-1034 days]. For each transmission pair, timing of MTCT was determined using a coalescent-based model within a Bayesian statistical framework. Results were compared with available estimates of MTCT timing obtained with the classic biomedical approach based on serial HIV DNA detection by PCR assays. Results: Four children were infected during pregnancy, whereas the remaining five children were infected at time of delivery. For eight out of nine pairs, results were consistent with the transmission periods assessed by standard PCR-based assay. The discordance in the remaining case was likely confused by co-infection, with simultaneous introduction of multiple maternal viral variants at the time of delivery. Conclusions: The study provided the opportunity to validate the Bayesian coalescent approach that determines the timing of MTCT of HIV-1. It illustrates the power of population genetics approaches to reliably estimate the timing of transmission events and deepens our knowledge about the dynamics of viral evolution in HIV-infected children, accounting for the complexity of multiple transmission events.	[Chaillon, Antoine; Samleerat, Tanawan; Moreau, Alain; Barin, Francis] Univ Tours, INSERM, U966, Tours, France; [Chaillon, Antoine; Samleerat, Tanawan; Moreau, Alain; Barin, Francis] Univ Tours, Virol Lab, CHU Bretonneau, Tours, France; [Chaillon, Antoine; Gianella, Sara] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Samleerat, Tanawan] Chiang Mai Univ, Fac Associated Med Sci, Chiang Mai 50000, Thailand; [Zoveda, Faustine; Ballesteros, Sebastien; Depaulis, Frantz] Ecole Normale Super, CNRS, Unite Mixte Rech 7625, Lab Ecol & Evolut, Paris, France; [Ngo-Giang-Huong, Nicole; Jourdain, Gonzague; Lallemant, Marc] Inst Rech Dev, Chiang Mai, Thailand; [Ngo-Giang-Huong, Nicole; Jourdain, Gonzague; Lallemant, Marc] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; Universite de Tours; University of California System; University of California San Diego; Chiang Mai University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Harvard University; Harvard T.H. Chan School of Public Health	Chaillon, A (corresponding author), Univ Tours, INSERM, U966, Tours, France.	achaillon@ucsd.edu	Jourdain, Gonzague/F-9117-2017; Chaillon, Antoine/GNH-6121-2022; chaillon, antoine/GNH-1623-2022; Ngo-Giang-Huong, Nicole/G-2860-2017	Jourdain, Gonzague/0000-0002-3365-7020; Ngo-Giang-Huong, Nicole/0000-0001-8950-3234; Gianella, Sara/0000-0002-9927-0849; Depaulis, Frantz/0000-0001-5761-2751	Agence Nationale de Recherches sur le Sida et les Hepatites (ANRS, Paris, France); Institut de Recherche pour le Developpement (IRD, Paris, France); National Institutes of Health [5 R01 HD 33326]; Agence Nationale de Recherche (ANR biodiversite); French Ministry of Foreign Affairs; Thai Ministry of Higher Education; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033326] Funding Source: NIH RePORTER	Agence Nationale de Recherches sur le Sida et les Hepatites (ANRS, Paris, France)(French National Research Agency (ANR)); Institut de Recherche pour le Developpement (IRD, Paris, France); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agence Nationale de Recherche (ANR biodiversite)(French National Research Agency (ANR)); French Ministry of Foreign Affairs; Thai Ministry of Higher Education; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by funds from the Agence Nationale de Recherches sur le Sida et les Hepatites (ANRS, Paris, France), the Institut de Recherche pour le Developpement (IRD, Paris, France), the National Institutes of Health (5 R01 HD 33326), and the Agence Nationale de Recherche (ANR biodiversite). T Samleerat was supported by a doctoral fellowship from the French Ministry of Foreign Affairs and the Thai Ministry of Higher Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD N, 1995, J VIROL, V69, P1001, DOI 10.1128/JVI.69.2.1001-1012.1995; Bernard EJ, 2007, HIV MED, V8, P382, DOI 10.1111/j.1468-1293.2007.00486.x; BRIANT L, 1995, J VIROL, V69, P3778, DOI 10.1128/JVI.69.6.3778-3788.1995; BROSSARD Y, 1995, AIDS, V9, P359, DOI 10.1097/00002030-199509040-00007; BRYSON YJ, 1992, NEW ENGL J MED, V327, P1246, DOI 10.1056/NEJM199210223271718; Castro-Nallar E, 2012, MOL PHYLOGENET EVOL, V62, P777, DOI 10.1016/j.ympev.2011.11.019; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dickover RE, 2001, J VIROL, V75, P2194, DOI 10.1128/JVI.75.5.2194-2203.2001; Drummond A, 2003, ADV PARASIT, V54, P331, DOI 10.1016/S0065-308X(03)54008-8; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Eckert K A, 1991, PCR Methods Appl, V1, P17; Edwards CTT, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-28; English S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-54; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; HOLMES EC, 1995, PHILOS T R SOC B, V349, P33, DOI 10.1098/rstb.1995.0088; HORTON RM, 1995, MOL BIOTECHNOL, V3, P93, DOI 10.1007/BF02789105; HUDSON RR, 1983, THEOR POPUL BIOL, V23, P183, DOI 10.1016/0040-5809(83)90013-8; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Junqueira DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027489; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kaye M, 2009, AIDS RES HUM RETROV, V25, P741, DOI 10.1089/aid.2008.0306; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kishko M, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-67; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Kwiek JJ, 2008, AIDS, V22, P863, DOI 10.1097/QAD.0b013e3282f51ea0; Lahr DJG, 2009, BIOTECHNIQUES, V47, P857, DOI 10.2144/000113219; Lallemant M, 2000, NEW ENGL J MED, V343, P982, DOI 10.1056/NEJM200010053431401; Lee HY, 2009, J THEOR BIOL, V261, P341, DOI 10.1016/j.jtbi.2009.07.038; Lemey P, 2006, AIDS REV, V8, P125; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Nickle DC, 2003, J VIROL, V77, P5540, DOI 10.1128/JVI.77.9.5540-5546.2003; Pasquier C, 1998, J VIROL, V72, P8493, DOI 10.1128/JVI.72.11.8493-8501.1998; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Poon AFY, 2011, AIDS, V25, P2019, DOI 10.1097/QAD.0b013e32834b643c; Prendergast A, 2007, LANCET, V370, P68, DOI 10.1016/S0140-6736(07)61051-4; Pybus OG, 2000, GENETICS, V155, P1429; Rachinger A, 2011, AIDS, V25, P1035, DOI 10.1097/QAD.0b013e3283467020; Rachinger A, 2010, CLIN INFECT DIS, V50, P1309, DOI 10.1086/651687; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Renjifo B, 2003, VIROLOGY, V307, P278, DOI 10.1016/S0042-6822(02)00066-1; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; Rouzioux C, 1995, AM J EPIDEMIOL, V142, P1330, DOI 10.1093/oxfordjournals.aje.a117601; Russell ES, 2011, J VIROL, V85, P8253, DOI 10.1128/JVI.00197-11; Samleerat T, 2008, J INFECT DIS, V198, P868, DOI 10.1086/591251; SCARLATTI G, 1993, ANN NY ACAD SCI, V693, P277, DOI 10.1111/j.1749-6632.1993.tb26282.x; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Shen L, 2008, J ALLERGY CLIN IMMUN, V122, P22, DOI 10.1016/j.jaci.2008.05.033; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WOLINSKY SM, 1992, SCIENCE, V255, P1134, DOI 10.1126/science.1546316; Worobey M, 2008, NATURE, V455, P661, DOI 10.1038/nature07390; Zhang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009294; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhu TF, 1996, J VIROL, V70, P3098, DOI 10.1128/JVI.70.5.3098-3107.1996	62	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e90421	10.1371/journal.pone.0090421	http://dx.doi.org/10.1371/journal.pone.0090421			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24717647	gold, Green Submitted, Green Published			2022-12-25	WOS:000334339000008
J	Cheung, TT; Poon, RTP; Chok, KSH; Chan, ACY; Tsang, SHY; Dai, WC; Yau, TCC; Chan, SC; Fan, ST; Lo, CM				Cheung, Tan To; Poon, Ronnie T. P.; Chok, Kenneth S. H.; Chan, Albert C. Y.; Tsang, Simon H. Y.; Dai, Wing Chiu; Yau, Thomas C. C.; Chan, See Ching; Fan, Sheung Tat; Lo, Chung Mau			Management of Spontaneously Ruptured Hepatocellular Carcinomas in the Radiofrequency Ablation Era	PLOS ONE			English	Article							FOCUSED ULTRASOUND ABLATION; SINGLE-CENTER-EXPERIENCE; LIVER-TRANSPLANTATION; SURVIVAL ANALYSIS; CIRRHOSIS; EMBOLIZATION; CHEMOEMBOLIZATION; HEPATECTOMY; TOLERANCE; SELECTION	Background and aim: Spontaneous rupture of hepatocellular carcinoma (HCC) carries a high mortality. The use of radiofrequency ablation (RFA) in recent years has enriched the armamentarium for hemostasis of spontaneously ruptured HCCs but its results have not been documented. This study investigated the prognosis and outcome of spontaneous rupture of HCC as well as the results of using RFA for hemostasis. Patients and method: From January 1991 to December 2010, 5283 patients were diagnosed with HCC at our hospital, and 189 of them had spontaneous rupture of HCCs. They were grouped under two periods: period 1, 1991-2000, n = 70; period 2, 2001-2010, n = 119. RFA was available in period 2 only. Results: Hepatitis B virus infection was predominant in both periods. Surgical hemostasis was mainly achieved by hepatic artery ligation in period 1 and by RFA in period 2. The 30-day hospital mortality after surgical treatment was 55.6% (n = 18) in period 1 and 19.2% (n = 26) in period 2 (p = 0.012). Multivariate analysis identified 4 independent factors for better overall survival, namely, hemostasis by transarterial chemoembolization (hazard ratio 0.516, 95% confidence interval 0.354-0.751), hemostasis by RFA (hazard ratio 0.431, 95% confidence interval 0.236-0.790), having surgery as a subsequent treatment (hazard ratio 0.305, 95% confidence interval 0.186-0.498), and a serum total bilirubin level < 19 umol/L (hazard ratio 1.596, 95% confidence interval 1.137-2.241). Conclusion: The use of RFA for hemostasis during laparotomy greatly reduced the hospital mortality rate when compared with conventional hepatic artery ligation.	[Cheung, Tan To; Poon, Ronnie T. P.; Chok, Kenneth S. H.; Chan, Albert C. Y.; Tsang, Simon H. Y.; Dai, Wing Chiu; Yau, Thomas C. C.; Chan, See Ching; Fan, Sheung Tat; Lo, Chung Mau] Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Cheung, TT (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China.	tantocheung@hotmail.com	Chok, Kenneth Siu Ho/C-9606-2012; Chan, Albert/AAC-1642-2022; Yau, Thomas Chung Cheung/B-3429-2011	Chok, Kenneth Siu Ho/0000-0001-7921-3807; Chan, Albert/0000-0002-1383-2952; Yau, Thomas Chung Cheung/0000-0002-7114-0305				Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Buczkowski AK, 2006, J GASTROINTEST SURG, V10, P379, DOI 10.1016/j.gassur.2005.10.012; CHEARANAI O, 1983, CANCER, V51, P1532, DOI 10.1002/1097-0142(19830415)51:8<1532::AID-CNCR2820510829>3.0.CO;2-3; CHERQUI D, 1993, BRIT J SURG, V80, P747, DOI 10.1002/bjs.1800800631; Cherqui D, 2000, ANN SURG, V232, P753, DOI 10.1097/00000658-200012000-00004; Cheung TT, 2013, HPB, V15, P567, DOI 10.1111/hpb.12025; Cheung TT, 2013, ANN SURG, V257, P506, DOI 10.1097/SLA.0b013e31827b947a; Cheung TT, 2013, J NUCL MED, V54, P192, DOI 10.2967/jnumed.112.107516; Cheung TT, 2012, WORLD J SURG, V36, P2420, DOI 10.1007/s00268-012-1660-7; Cheung TT, 2011, LIVER TRANSPLANT, V17, P1218, DOI 10.1002/lt.22362; Cheung TT, 2009, J HEPATO-BILIARY-PAN, V16, P655, DOI 10.1007/s00534-009-0103-9; Chiappa Antonio, 2008, Surg Technol Int, V17, P33; Chun YH, 2011, EUR J CANCER, V47, P2568, DOI 10.1016/j.ejca.2011.07.002; Curley SA, 2000, ANN SURG, V232, P381, DOI 10.1097/00000658-200009000-00010; Fan S T, 1999, Swiss Surg, V5, P107, DOI 10.1024/1023-9332.5.3.107; Fan ST, 1998, HEPATO-GASTROENTEROL, V45, P1288; HERMANN RE, 1973, SURGERY, V74, P715; Kan RWM, 2012, ANZ J SURG, V82, P505, DOI 10.1111/j.1445-2197.2012.06121.x; Kaneko S, 2012, HEPATOL RES, V42, P523, DOI 10.1111/j.1872-034X.2012.00981.x; Kim JY, 2012, EUR J GASTROEN HEPAT, V24, P640, DOI 10.1097/MEG.0b013e3283524d32; LAI ECS, 1989, ANN SURG, V210, P24, DOI 10.1097/00000658-198907000-00004; Liu CL, 2001, J CLIN ONCOL, V19, P3725, DOI 10.1200/JCO.2001.19.17.3725; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Mazzaferro V, 2004, ANN SURG, V240, P900, DOI 10.1097/01.sla.0000143301.56154.95; Ng KKC, 2003, HEPATO-GASTROENTEROL, V50, P1641; ONG GB, 1972, BMJ-BRIT MED J, V4, P146, DOI 10.1136/bmj.4.5833.146; ONG GB, 1965, BRIT J SURG, V52, P123, DOI 10.1002/bjs.1800520210; Poon RTP, 2004, ANN SURG ONCOL, V11, P281, DOI 10.1245/ASO.2004.08.018; RADY MY, 1994, ANN EMERG MED, V24, P685, DOI 10.1016/S0196-0644(94)70279-9; SATO Y, 1985, GASTROENTEROLOGY, V89, P157, DOI 10.1016/0016-5085(85)90756-5; Silva MA, 2004, SEMIN HEMATOL, V41, P132, DOI 10.1053/j.seminhematol.2003.11.022; Toshikuni N, 2011, HEPATO-GASTROENTEROL, V58, P565; Yau T, 2009, CANCER-AM CANCER SOC, V115, P428, DOI 10.1002/cncr.24029; Yau T, 2008, CANCER, V113, P2742, DOI 10.1002/cncr.23878; Yau T, 2009, CANCER-AM CANCER SOC, V115, P5507, DOI 10.1002/cncr.24636	35	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94453	10.1371/journal.pone.0094453	http://dx.doi.org/10.1371/journal.pone.0094453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718254	Green Submitted, Green Published, gold			2022-12-25	WOS:000334339000122
J	Fratz, EJ; Hunter, GA; Ferreira, GC				Fratz, Erica J.; Hunter, Gregory A.; Ferreira, Gloria C.			Expression of Murine 5-Aminolevulinate Synthase Variants Causes Protoporphyrin IX Accumulation and Light-Induced Mammalian Cell Death	PLOS ONE			English	Article							DELTA-AMINOLEVULINATE SYNTHASE; PHOTODYNAMIC THERAPY; INTRAMITOCHONDRIAL LOCALIZATION; HEME-BIOSYNTHESIS; ACTIVE-SITE; BINDING; ACID; PRECURSOR; COFACTOR; SUBUNIT	5-Aminolevulinate synthase (ALAS; EC 2.3.1.37) catalyzes the first committed step of heme biosynthesis in animals. The erythroid-specific ALAS isozyme (ALAS2) is negatively regulated by heme at the level of mitochondrial import and, in its mature form, certain mutations of the murine ALAS2 active site loop result in increased production of protoporphyrin IX (PPIX), the precursor for heme. Importantly, generation of PPIX is a crucial component in the widely used photodynamic therapies (PDT) of cancer and other dysplasias. ALAS2 variants that cause high levels of PPIX accumulation provide a new means of targeted, and potentially enhanced, photosensitization. In order to assess the prospective utility of ALAS2 variants in PPIX production for PDT, K562 human erythroleukemia cells and HeLa human cervical carcinoma cells were transfected with expression plasmids for ALAS2 variants with greater enzymatic activity than the wild-type enzyme. The levels of accumulated PPIX in ALAS2-expressing cells were analyzed using flow cytometry with fluorescence detection. Further, cells expressing ALAS2 variants were subjected to white light treatments (21-22 kLux) for 10 minutes after which cell viability was determined. Transfection of HeLa cells with expression plasmids for murine ALAS2 variants, specifically for those with mutated mitochondrial presequences and a mutation in the active site loop, caused significant cellular accumulation of PPIX, particularly in the membrane. Light treatments revealed that ALAS2 expression results in an increase in cell death in comparison to aminolevulinic acid (ALA) treatment producing a similar amount of PPIX. The delivery of stable and highly active ALAS2 variants has the potential to expand and improve upon current PDT regimes.	[Fratz, Erica J.; Hunter, Gregory A.; Ferreira, Gloria C.] Morsani Coll Med, Dept Mol Med, Tampa, FL 33612 USA; [Ferreira, Gloria C.] Univ S Florida, Dept Chem, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Ferreira, GC (corresponding author), Morsani Coll Med, Dept Mol Med, Tampa, FL 33612 USA.	gferreir@health.usf.edu	Ferreira, Gloria C/A-4709-2012	Ferreira, Gloria C/0000-0001-9279-2217; Fratz-Berilla, Erica J./0000-0002-9259-0540	American Heart Association, Greater Southeast Affiliate [10GRNT4300073]; National Institutes of Health [GM080270]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080270] Funding Source: NIH RePORTER	American Heart Association, Greater Southeast Affiliate(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	American Heart Association, Greater Southeast Affiliate (#10GRNT4300073); National Institutes of Health (#GM080270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES IZ, 1981, J BIOL CHEM, V256, P9329; Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Issa MCA, 2010, AN BRAS DERMATOL, V85, P501, DOI 10.1590/S0365-05962010000400011; ANDERSSON LC, 1979, INT J CANCER, V24, P514, DOI 10.1002/ijc.2910240422; ANDERSSON LC, 1979, INT J CANCER, V23, P143, DOI 10.1002/ijc.2910230202; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Babilas P, 2006, EUR J DERMATOL, V16, P340; Bishop DF, 2012, J BIOL CHEM, V287, P28943, DOI 10.1074/jbc.M111.306423; BISHOP DF, 1990, GENOMICS, V7, P207, DOI 10.1016/0888-7543(90)90542-3; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; Buzzeo R, 2005, CLIN CANCER RES, V11, P6057, DOI 10.1158/1078-0432.CCR-04-2685; CANTI G, 1994, ANTI-CANCER DRUG, V5, P443, DOI 10.1097/00001813-199408000-00009; Cheung MC, 2005, ONCOLOGIST, V10, P412, DOI 10.1634/theoncologist.10-6-412; COX TC, 1990, AM J HUM GENET, V46, P107; Dailey TA, 2005, BIOCHEM J, V386, P381, DOI 10.1042/BJ20040570; Darlenski R, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.6.061208; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Felitsyn N, 2008, J NEUROCHEM, V106, P2068, DOI 10.1111/j.1471-4159.2008.05552.x; FERREIRA GC, 1993, PROTEIN SCI, V2, P1959, DOI 10.1002/pro.5560021117; FERREIRA GC, 1995, J BIOENERG BIOMEMBR, V27, P151, DOI 10.1007/BF02110030; FERREIRA GC, 1995, PROTEIN SCI, V4, P1001; Gagnebin J, 1999, GENE THER, V6, P1742, DOI 10.1038/sj.gt.3300992; Gong J, 1998, BIOCHEMISTRY-US, V37, P3509, DOI 10.1021/bi9719298; Gonzalez-Dominguez M, 2001, YEAST, V18, P41, DOI 10.1002/1097-0061(200101)18:1<41::AID-YEA654>3.0.CO;2-E; Goodfellow BJ, 2001, FEBS LETT, V505, P325, DOI 10.1016/S0014-5793(01)02818-6; Hoffbrand AV, 1997, J INTERN MED, V242, P37, DOI 10.1111/joim.1997.242.s740.37; HORWITZ SB, 1992, TRENDS PHARMACOL SCI, V13, P134; Hunter GA, 1999, BIOCHEMISTRY-US, V38, P12526, DOI 10.1021/bi995076q; Hunter GA, 2005, ARCH BIOCHEM BIOPHYS, V437, P128, DOI 10.1016/j.abb.2005.03.007; HUNTER GA, 1995, ANAL BIOCHEM, V226, P221, DOI 10.1006/abio.1995.1217; Hunter GA, 1999, BIOCHEMISTRY-US, V38, P3711, DOI 10.1021/bi982390w; Hunter GA, 1999, J BIOL CHEM, V274, P12222, DOI 10.1074/jbc.274.18.12222; Hunter GA, 2007, J BIOL CHEM, V282, P23025, DOI 10.1074/jbc.M609330200; Hunter GA, 2011, BBA-PROTEINS PROTEOM, V1814, P1467, DOI 10.1016/j.bbapap.2010.12.015; Ji ZY, 2006, J PHOTOCH PHOTOBIO B, V84, P213, DOI 10.1016/j.jphotobiol.2006.03.006; Jordan PM, 1990, BIOSYNTHESIS HEME CH, P55; Juknat AA, 2003, J PINEAL RES, V35, P1, DOI 10.1034/j.1600-079X.2003.00030.x; Katsumata N, 2009, LANCET, V374, P1331, DOI 10.1016/S0140-6736(09)61157-0; Korbelik M, 2010, METHODS MOL BIOL, V635, P147, DOI 10.1007/978-1-60761-697-9_11; Krammer B, 2008, PHOTOCH PHOTOBIO SCI, V7, P283, DOI 10.1039/b712847a; LATHROP JT, 1993, SCIENCE, V259, P522, DOI 10.1126/science.8424176; Lendrihas T, 2010, J BIOL CHEM, V285, P13704, DOI 10.1074/jbc.M109.074237; Lendrihas T, 2010, J BIOL CHEM, V285, P3351, DOI 10.1074/jbc.M109.066548; Lendrihas T, 2009, PROTEIN SCI, V18, P1847, DOI 10.1002/pro.195; MANFREDI JJ, 1982, J CELL BIOL, V94, P688, DOI 10.1083/jcb.94.3.688; MCKAY R, 1969, BIOCHEM J, V114, P455, DOI 10.1042/bj1140455; MOLEBAJER J, 1983, J CELL BIOL, V96, P527, DOI 10.1083/jcb.96.2.527; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Nikcevic G, 2003, CELL BIOL INT, V27, P735, DOI 10.1016/S1065-6995(03)00143-4; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Qi ZH, 2002, MOL CELL, V9, P155, DOI 10.1016/S1097-2765(01)00431-2; Ramalingam SS, 2009, ONCOLOGIST, V14, P412, DOI 10.1634/theoncologist.2008-0190; RIDDLE RD, 1989, P NATL ACAD SCI USA, V86, P792, DOI 10.1073/pnas.86.3.792; Roberts DJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004450.pub2; RYAN WL, 1966, NATURE, V212, P292, DOI 10.1038/212292a0; Sadlon TJ, 1999, INT J BIOCHEM CELL B, V31, P1153, DOI 10.1016/S1357-2725(99)00073-4; SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561; Sparano JA, 2008, NEW ENGL J MED, V358, P1663, DOI 10.1056/NEJMoa0707056; SRIVASTAVA G, 1983, BIOCHEM BIOPH RES CO, V110, P23, DOI 10.1016/0006-291X(83)91254-8; SUTHERLAND GR, 1988, AM J HUM GENET, V43, P331; Tan DW, 1996, BIOCHEMISTRY-US, V35, P8934, DOI 10.1021/bi952918m; Tan DW, 1998, PROTEIN SCI, V7, P1208, DOI 10.1002/pro.5560070516; Tan DW, 1998, BIOCHEMISTRY-US, V37, P1478, DOI 10.1021/bi971928f; VOLLAND C, 1988, J BIOL CHEM, V263, P8294; Warren CB, 2009, J AM ACAD DERMATOL, V61, P1033, DOI 10.1016/j.jaad.2009.03.048; WATANABE N, 1983, BIOCHEM BIOPH RES CO, V113, P377, DOI 10.1016/0006-291X(83)91737-0; Weiss TS, 2003, J HEPATOL, V38, P476, DOI 10.1016/S0168-8278(02)00454-3; Whatley SD, 2008, AM J HUM GENET, V83, P408, DOI 10.1016/j.ajhg.2008.08.003; YAMAUCHI K, 1980, J BIOL CHEM, V255, P1746; Yanamandra N, 2011, J PHARMACOL EXP THER, V337, P636, DOI 10.1124/jpet.110.172809; Zhang JS, 2002, J BIOL CHEM, V277, P44660, DOI 10.1074/jbc.M203584200; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x; ZUYDERHOUDT FM, 1969, BIOCHIM BIOPHYS ACTA, V178, P408, DOI 10.1016/0005-2744(69)90414-8	74	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93078	10.1371/journal.pone.0093078	http://dx.doi.org/10.1371/journal.pone.0093078			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718052	gold, Green Submitted, Green Published			2022-12-25	WOS:000334339000025
J	Xu, YP; Deng, Y; Ji, ZH; Liu, HB; Liu, YY; Peng, H; Wu, J; Fan, JP				Xu, Yaping; Deng, Yue; Ji, Zhenhua; Liu, Haibin; Liu, Yueyang; Peng, Hu; Wu, Jian; Fan, Jingping			Identification of Thyroid Carcinoma Related Genes with mRMR and Shortest Path Approaches	PLOS ONE			English	Article							BCL2 PROMOTER POLYMORPHISM; BREAST-CANCER; AA GENOTYPE; EXPRESSION; PROTEIN; GROWTH; -938C-GREATER-THAN-A; ASSOCIATION; MARKER; WOMEN	Thyroid cancer is a malignant neoplasm originated from thyroid cells. It can be classified into papillary carcinomas (PTCs) and anaplastic carcinomas (ATCs). Although ATCs are in an very aggressive status and cause more death than PTCs, their difference is poorly understood at molecular level. In this study, we focus on the transcriptome difference among PTCs, ATCs and normal tissue from a published dataset including 45 normal tissues, 49 PTCs and 11 ATCs, by applying a machine learning method, maximum relevance minimum redundancy, and identified 9 genes (BCL2, MRPS31, ID4, RASAL2, DLG2, MY01B, ZBTB5, PRKCQ and PPP6C) and 1 miscRNA (miscellaneous RNA, LOC646736) as important candidates involved in the progression of thyroid cancer. We further identified the protein-protein interaction (PPI) sub network from the shortest paths among the 9 genes in a PPI network constructed based on STRING database. Our results may provide insights to the molecular mechanism of the progression of thyroid cancer.	[Xu, Yaping; Deng, Yue; Ji, Zhenhua; Liu, Haibin; Liu, Yueyang; Peng, Hu; Wu, Jian; Fan, Jingping] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China	Naval Medical University	Wu, J (corresponding author), Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China.	jianwu2008@126.com; fanjingp@163.com			Foundation for Military Medicine, China [BWS11C035]	Foundation for Military Medicine, China	This work was funded by Foundation for Military Medicine, China (BWS11C035). The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ain KB, 1999, SEMIN SURG ONCOL, V16, P64, DOI 10.1002/(SICI)1098-2388(199901/02)16:1<64::AID-SSU10>3.3.CO;2-L; Aksoy M, 2005, ACTA CHIR BELG, V105, P644, DOI 10.1080/00015458.2005.11679794; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Bachmann HS, 2007, CLIN CANCER RES, V13, P5790, DOI 10.1158/1078-0432.CCR-06-2673; Bachmann HS, 2011, INT J CANCER, V129, P2390, DOI 10.1002/ijc.25904; Chen GG, 2008, CURR CANCER DRUG TAR, V8, P367, DOI 10.2174/156800908785133150; Chou KC, 2006, J PROTEOME RES, V5, P1888, DOI 10.1021/pr060167c; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Copland JA, 2006, ONCOGENE, V25, P2304, DOI 10.1038/sj.onc.1209267; Cronin SJF, 2007, IMMUNOL REV, V220, P151, DOI 10.1111/j.1600-065X.2007.00570.x; Csardi N., 2006, INT J COMP SYST, V1695, P1; Deleu S, 2002, EXP CELL RES, V279, P62, DOI 10.1006/excr.2002.5589; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Eberhardt NL, 2010, MOL CELL ENDOCRINOL, V321, P50, DOI 10.1016/j.mce.2009.10.013; Eun YG, 2011, CLIN EXP OTORHINOLAR, V4, P149, DOI 10.3342/ceo.2011.4.3.149; FRIEDMAN JH, 1975, IEEE T COMPUT, V24, P1000, DOI 10.1109/T-C.1975.224110; Fujimoto J, 1998, STEROIDS, V63, P146, DOI 10.1016/S0039-128X(97)00157-8; Hebrant A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037807; Heubner M, 2009, INT J BIOL MARKER, V24, P223, DOI 10.1177/172460080902400402; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kebebew E, 2004, J CLIN ENDOCR METAB, V89, P6105, DOI 10.1210/jc.2004-1234; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Leeman-Neill RJ, 2013, CANCER-AM CANCER SOC, V119, P1792, DOI 10.1002/cncr.27893; LEHRER SP, 1993, BREAST CANCER RES TR, V26, P175, DOI 10.1007/BF00689690; Li BQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039308; Li BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041629; Maha R, 2009, J RECEPT SIG TRANSD, V29, P113, DOI 10.1080/10799890902845682; Massart F, 2001, FERTIL STERIL, V75, P567, DOI 10.1016/S0015-0282(00)01760-X; McIver Bryan, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P221, DOI 10.2174/1568008043339802; Montero-Conde C, 2008, ONCOGENE, V27, P1554, DOI 10.1038/sj.onc.1210792; Nikiforova MN, 2003, J CLIN ENDOCR METAB, V88, P2318, DOI 10.1210/jc.2002-021907; Noetzel E, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-154; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Rigolet M, 1998, DNA Res, V5, P309, DOI 10.1093/dnares/5.5.309; Rossi D, 2008, BLOOD, V111, P466, DOI 10.1182/blood-2007-08-106823; Salvatore G, 2007, CANCER RES, V67, P10148, DOI 10.1158/0008-5472.CAN-07-1887; Smallridge RC, 2009, ENDOCR-RELAT CANCER, V16, P17, DOI 10.1677/ERC-08-0154; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973	38	22	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94022	10.1371/journal.pone.0094022	http://dx.doi.org/10.1371/journal.pone.0094022			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718460	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000068
J	Chen, WL; Chen, YM; Chu, HS; Lin, CT; Chow, LP; Chen, CT; Hu, FR				Chen, Wei-Li; Chen, Yan-Ming; Chu, Hsiao-Sang; Lin, Chung-Tien; Chow, Lu-Ping; Chen, Chih-Ta; Hu, Fung-Rong			Mechanisms Controlling the Effects of Bevacizumab (Avastin) on the Inhibition of Early but Not Late Formed Corneal Neovascularization	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BLOOD-VESSEL MATURATION; SUBCONJUNCTIVAL BEVACIZUMAB; ANTI-VEGF; OCULAR NEOVASCULARIZATION; MACULAR DEGENERATION; TYROSINE KINASE; PDGF-B; ANGIOGENESIS; INJECTION	Purpose: To evaluate the effects and underlying mechanisms of early and late subconjunctival injection of bevacizumab on the inhibition of corneal neovascularization (NV). Methods: Corneal NV was induced by closed eye contact lens wear followed by a silk suture tarsorrhaphy in rabbits. Weekly subconjunctival injections of bevacizumab (5.0 mg) for 1 month were started immediately (early treatment group) or 1 month after induction of corneal NV with continuous induction (late treatment group). The severity of corneal NV was evaluated. Immunostaining was used to evaluate the intracorneal diffusion of bevacizumab, and the existence of pericytes and smooth muscle cells around the NV. The expression of AM-3K, an anti-macrophage antibody, vascular endothelial growth factor (VEGF) with its receptors (VEGFR1 and VEGFR2), and vascular endothelial apoptosis were also evaluated. Western blot analysis was performed to quantify the expression level of VEGF, VEGFR1 and VEGFR2 on corneal epithelium and stroma in different groups. Results: Early treatment with bevacizumab inhibited corneal NV more significantly than late treatment. Intracorneal diffusion of bevacizumab was not different among different groups. Immunostaining showed pericytes and smooth muscle cells around newly formed vessels as early as 2 weeks after induction. Immunostaining and Western blot analysis showed that VEGF, VEGFR1, and VEGFR2 on corneal stroma increased significantly in no treatment groups and late treatment groups, but not in early treatment group. Bevacizumab significantly inhibited macrophage infiltration in the early but not late treatment group. Sporadic vascular endothelial apoptosis was found at 4 weeks in the late but not early treatment group. Conclusions: Early but not late injection of bevacizumab inhibited corneal NV. Late injection of bevacizumab did not alter macrophage infiltration, and can't inhibit the expression of VEGF, VEGFR1, and VEGFR2 on corneal vessels. The inhibition of corneal NV in early treatment group does not occur via vascular endothelial apoptosis.	[Chen, Wei-Li; Chen, Yan-Ming; Chu, Hsiao-Sang; Hu, Fung-Rong] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Chen, Wei-Li; Hu, Fung-Rong] Natl Taiwan Univ Hosp, Ctr Corneal Tissue Engn & Stem Cell Biol, Taipei, Taiwan; [Chen, Yan-Ming] I Shou Univ, E Da Hosp, Dept Ophthalmol, Kaohsiung, Taiwan; [Lin, Chung-Tien] Natl Taiwan Univ Hosp, Coll Bioresource & Agr, Dept Vet Med, Taipei, Taiwan; [Chow, Lu-Ping; Chen, Chih-Ta] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; E-Da Hospital; I Shou University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Hu, FR (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.	fungronghu@ntu.edu.tw		HU, FUNG-RONG/0000-0002-2102-5317; Chen, Yan-Ming/0000-0003-4602-3243; CHOW, LU-PING/0000-0002-4420-211X; CHEN, WEI-LI/0000-0002-1538-2414	National Taiwan University Hospital Plan Asia One; Department of Medical Research at the NTUH; National Taiwan University Hospital, Taipei, Taiwan [NTUH 97-S831, NTUH 98A103, NTUH-100S-1633]; National Science Council [NSC 97-2314-B-002-085-MY3]; Executive Yuan, Taiwan; E-Da Hospital/I-Shou University, Kaohsiung, Taiwan [EDAHP101004]	National Taiwan University Hospital Plan Asia One; Department of Medical Research at the NTUH; National Taiwan University Hospital, Taipei, Taiwan; National Science Council(Ministry of Science and Technology, Taiwan); Executive Yuan, Taiwan; E-Da Hospital/I-Shou University, Kaohsiung, Taiwan	Supported, in part, by the National Taiwan University Hospital Plan Asia One and the Department of Medical Research at the NTUH, the Research Grant NTUH 97-S831, NTUH 98A103, NTUH-100S-1633, National Taiwan University Hospital, Taipei, Taiwan and Grant NSC 97-2314-B-002-085-MY3 from the National Science Council, the Executive Yuan, Taiwan, and EDAHP101004, E-Da Hospital/I-Shou University, Kaohsiung, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LP, 1997, OPHTHALMIC RES, V29, P354, DOI 10.1159/000268033; ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Amano S, 1998, INVEST OPHTH VIS SCI, V39, P18; Anghelina M, 2006, AM J PATHOL, V168, P529, DOI 10.2353/ajpath.2006.050255; ASHTON N, 1966, BRIT J OPHTHALMOL, V50, P119, DOI 10.1136/bjo.50.3.119; Avery RL, 2006, OPHTHALMOLOGY, V113, P363, DOI 10.1016/j.ophtha.2005.11.019; Avery RL, 2006, OPHTHALMOLOGY, V113, P1695, DOI 10.1016/j.ophtha.2006.05.064; Azar Dimitri T, 2006, Trans Am Ophthalmol Soc, V104, P264; Bachmann B, 2010, OPHTHALMOLOGY, V117, P1300, DOI 10.1016/j.ophtha.2010.01.039; Bahar I, 2008, CURR EYE RES, V33, P23, DOI 10.1080/02713680701799101; Bandopadhyay R, 2001, J NEUROCYTOL, V30, P35, DOI 10.1023/A:1011965307612; Benelli U, 1997, INVEST OPHTH VIS SCI, V38, P274; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Bock F, 2007, INVEST OPHTH VIS SCI, V48, P2545, DOI 10.1167/iovs.06-0570; Chang JH, 2001, CURR OPIN OPHTHALMOL, V12, P242, DOI 10.1097/00055735-200108000-00002; Chen WL, 2009, CORNEA, V28, pS26, DOI 10.1097/ICO.0b013e3181ae8ff4; Chen WL, 2009, INVEST OPHTH VIS SCI, V50, P1659, DOI 10.1167/iovs.08-1997; Chu HS, 2011, CORNEA, V30, P60, DOI 10.1097/ICO.0b013e3181e458c5; COGAN DG, 1962, INVEST OPHTH VISUAL, V1, P253; Cursiefen C, 2005, AM J PATHOL, V166, P1367, DOI 10.1016/S0002-9440(10)62355-3; Cursiefen C, 2004, INVEST OPHTH VIS SCI, V45, P2666, DOI 10.1167/iovs.03-1380; Cursiefen C, 2003, BRIT J OPHTHALMOL, V87, P101, DOI 10.1136/bjo.87.1.101; Cursiefen C, 1998, CORNEA, V17, P611, DOI 10.1097/00003226-199811000-00008; DANA MR, 1995, CORNEA, V14, P604; Darland DC, 1999, J CLIN INVEST, V103, P157, DOI 10.1172/JCI6127; Dastjerdi MH, 2010, INVEST OPHTH VIS SCI, V51, P2411, DOI 10.1167/iovs.09-3745; Dell S, 2006, INVEST OPHTH VIS SCI, V47, P1928, DOI 10.1167/iovs.05-1071; DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256; Dhar K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-209; Dineen SP, 2008, CANCER RES, V68, P4340, DOI 10.1158/0008-5472.CAN-07-6705; Fujita N, 2010, INVEST OPHTH VIS SCI, V51, P790, DOI 10.1167/iovs.09-3420; Fujita S, 2007, INVEST OPHTH VIS SCI, V48, P3051, DOI 10.1167/iovs.06-1083; Gee MS, 2003, AM J PATHOL, V162, P183, DOI 10.1016/S0002-9440(10)63809-6; Goede V, 1998, LAB INVEST, V78, P1385; Hosseini H, 2007, CLIN EXP OPHTHALMOL, V35, P745, DOI 10.1111/j.1442-9071.2007.01572.x; Hurmeric V, 2008, CORNEA, V27, P357, DOI 10.1097/ICO.0b013e318160d019; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Kenyon BM, 1996, INVEST OPHTH VIS SCI, V37, P1625; Kim Sang Woo, 2008, Ophthalmology, V115, pe33, DOI 10.1016/j.ophtha.2008.02.013; Kim TI, 2008, CORNEA, V27, P349, DOI 10.1097/ICO.0b013e31815cf67d; Kohno RI, 2010, AM J OPHTHALMOL, V150, P223, DOI 10.1016/j.ajo.2010.03.016; Komohara Y, 2006, J HISTOCHEM CYTOCHEM, V54, P763, DOI 10.1369/jhc.5A6871.2006; Kubota T, 2010, RETINA-J RET VIT DIS, V30, P468, DOI 10.1097/IAE.0b013e3181bd2d7b; Lee P, 1998, SURV OPHTHALMOL, V43, P245, DOI 10.1016/S0039-6257(98)00035-6; Li ZR, 2012, CORNEA, V31, P1028, DOI 10.1097/ICO.0b013e31823f8b40; Lin CT, 2010, INVEST OPHTH VIS SCI, V51, P6277, DOI 10.1167/iovs.09-4571; Manzano RPA, 2007, BRIT J OPHTHALMOL, V91, P804, DOI 10.1136/bjo.2006.107912; Mastyugin V, 2001, CURR EYE RES, V23, P1, DOI 10.1076/ceyr.23.1.1.5422; MCCRACKEN JS, 1979, LAB INVEST, V41, P519; Michaelides M, 2010, OPHTHALMOLOGY, V117, P1078, DOI 10.1016/j.ophtha.2010.03.045; Michels S, 2005, OPHTHALMOLOGY, V112, P1035, DOI 10.1016/j.ophtha.2005.02.007; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Miller JW, 1997, DIABETES METAB REV, V13, P37, DOI 10.1002/(SICI)1099-0895(199703)13:1<37::AID-DMR174>3.0.CO;2-K; MOORE JW, 1985, AM J PATHOL, V120, P87; Moreno SF, 2008, BRIT J OPHTHALMOL, V92, P866; Motiejunaite R, 2008, EXP EYE RES, V86, P171, DOI 10.1016/j.exer.2007.10.013; Nguyen QD, 2005, BRIT J OPHTHALMOL, V89, P1368, DOI 10.1136/bjo.2005.066431; Nicholson BP, 2010, GRAEF ARCH CLIN EXP, V248, P915, DOI 10.1007/s00417-010-1315-z; Nisancioglu MH, 2010, CANCER RES, V70, P5109, DOI 10.1158/0008-5472.CAN-09-4245; Nucera S, 2011, INT J DEV BIOL, V55, P495, DOI 10.1387/ijdb.103227sn; Papathanassiou M, 2008, AM J OPHTHALMOL, V145, P424, DOI 10.1016/j.ajo.2007.11.003; Perez-Santonja JJ, 2010, AM J OPHTHALMOL, V150, P519, DOI 10.1016/j.ajo.2010.04.024; Philipp W, 2000, INVEST OPHTH VIS SCI, V41, P2514; Qian J, 2011, RETINA-J RET VIT DIS, V31, P161, DOI 10.1097/IAE.0b013e3181e46ad8; QUINN TP, 1993, P NATL ACAD SCI USA, V90, P7533, DOI 10.1073/pnas.90.16.7533; Roland CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007669; Safvati A, 2009, CURR EYE RES, V34, P501, DOI 10.1080/02713680902919557; Salnikov AV, 2006, INT J CANCER, V119, P2795, DOI 10.1002/ijc.22217; SCHLINGEMANN RO, 1990, AM J PATHOL, V136, P1393; SKALLI O, 1989, J HISTOCHEM CYTOCHEM, V37, P315, DOI 10.1177/37.3.2918221; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; Urao N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013440; Yu LL, 2008, INVEST OPHTH VIS SCI, V49, P522, DOI 10.1167/iovs.07-1175; Zakaria N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036451; Zeng L, 1996, J PATHOL, V178, P207; Zhang Z, 2010, CELL DEATH DIFFER, V17, P499, DOI 10.1038/cdd.2009.152	77	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94205	10.1371/journal.pone.0094205	http://dx.doi.org/10.1371/journal.pone.0094205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714670	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900105
J	Rothwell, JA; Fillatre, Y; Martin, JF; Lyan, B; Pujos-Guillot, E; Fezeu, L; Hercberg, S; Comte, B; Galan, P; Touvier, M; Manach, C				Rothwell, Joseph A.; Fillatre, Yoann; Martin, Jean-Francois; Lyan, Bernard; Pujos-Guillot, Estelle; Fezeu, Leopold; Hercberg, Serge; Comte, Blandine; Galan, Pilar; Touvier, Mathilde; Manach, Claudine			New Biomarkers of Coffee Consumption Identified by the Non-Targeted Metabolomic Profiling of Cohort Study Subjects	PLOS ONE			English	Article							MASS-SPECTROMETRY; CARDIOVASCULAR-DISEASE; CAFFEINE; RISK; DISCOVERY; HEALTH; METAANALYSIS; FLAVONOIDS; CAFESTOL; KAHWEOL	Coffee contains various bioactives implicated with human health and disease risk. To accurately assess the effects of overall consumption upon health and disease, individual intake must be measured in large epidemiological studies. Metabolomics has emerged as a powerful approach to discover biomarkers of intake for a large range of foods. Here we report the profiling of the urinary metabolome of cohort study subjects to search for new biomarkers of coffee intake. Using repeated 24-hour dietary records and a food frequency questionnaire, 20 high coffee consumers (183-540 mL/d) and 19 low consumers were selected from the French SU.VI.MAX2 cohort. Morning spot urine samples from each subject were profiled by high-resolution mass spectrometry. Partial least-square discriminant analysis of multidimensional liquid chromatography-mass spectrometry data clearly distinguished high consumers from low via 132 significant (p-value<0.05) discriminating features. Ion clusters whose intensities were most elevated in the high consumers were annotated using online and in-house databases and their identities checked using commercial standards and MS-MS fragmentation. The best discriminants, and thus potential markers of coffee consumption, were the glucuronide of the diterpenoid atractyligenin, the diketopiperazine cyclo(isoleucyl-prolyl), and the alkaloid trigonelline. Some caffeine metabolites, such as 1-methylxanthine, were also among the discriminants, however caffeine may be consumed from other sources and its metabolism is subject to inter-individual variation. Receiver operating characteristics curve analysis showed that the biomarkers identified could be used effectively in combination for increased sensitivity and specificity. Once validated in other cohorts or intervention studies, these specific single or combined biomarkers will become a valuable alternative to assessment of coffee intake by dietary survey and finally lead to a better understanding of the health implications of coffee consumption.	[Rothwell, Joseph A.; Fillatre, Yoann; Martin, Jean-Francois; Lyan, Bernard; Pujos-Guillot, Estelle; Comte, Blandine; Manach, Claudine] INRA, CRNH Auvergne, Human Nutr Unit, UMR 1019, Clermont Ferrand, France; [Rothwell, Joseph A.; Fillatre, Yoann; Comte, Blandine; Manach, Claudine] Clermont Univ, Human Nutr Unit, Clermont Ferrand, France; [Martin, Jean-Francois; Lyan, Bernard; Pujos-Guillot, Estelle] INRA, Clermont Ferrand, France; [Fezeu, Leopold; Hercberg, Serge; Galan, Pilar; Touvier, Mathilde] Univ Paris 07, Univ Paris 05,CNAM, Epidemiol & Biostat Res Ctr,INSERM U1153,INRA U11, Nutrit Epidemiol Res Team,Univ Paris 13,Sorbonne, Bobigny, France	INRAE; INRAE; heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Manach, C (corresponding author), INRA, CRNH Auvergne, Human Nutr Unit, UMR 1019, Clermont Ferrand, France.	claudine.manach@clermont.inra.fr	Rothwell, Joseph/AAN-1413-2021; Fezeu, Leopold/F-2804-2017; Touvier, Mathilde/E-8817-2017; Serge, Hercberg/F-3038-2017; HERCBERG, Serge/B-4429-2008; Pilar, Galan/F-2908-2017	Rothwell, Joseph/0000-0002-6927-3360; Fezeu, Leopold/0000-0002-7589-3179; Touvier, Mathilde/0000-0002-8322-8857; Serge, Hercberg/0000-0002-3168-1350; HERCBERG, Serge/0000-0002-3168-1350; Pilar, Galan/0000-0003-1706-3107; Comte, Blandine/0000-0002-4662-6581; Manach, Claudine/0000-0003-1094-3363; PUJOS-GUILLOT, Estelle/0000-0002-4693-5712; Fillatre, Yoann/0000-0002-2801-0337	French National Agency for Research [PhenoMeNEp-ANR-ALIA2010-007]; FEDER-Region Auvergne	French National Agency for Research(French National Research Agency (ANR)); FEDER-Region Auvergne	This work was supported by the French National Agency for Research (http://www.agence-nationale-recherche.fr/en/project-based-funding-to-advance-french-research/): project PhenoMeNEp-ANR-ALIA2010-007, Phenotyping using Metabolomics for Nutritional Epidemiology. YF was supported by a FEDER-Region Auvergne postdoctoral grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Habori M, 1998, PHYTOTHER RES, V12, P233, DOI 10.1002/(SICI)1099-1573(199806)12:4&lt;233::AID-PTR294&gt;3.0.CO;2-V; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLANCHARD J, 1983, EUR J CLIN PHARMACOL, V24, P93, DOI 10.1007/BF00613933; Bohn SK, 2012, FOOD FUNCT, V3, P575, DOI 10.1039/c2fo10288a; Briancon S, 2011, INT J EPIDEMIOL, V40, P1605, DOI 10.1093/ije/dyr161; Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412; Cornelis MC, 2007, CURR OPIN LIPIDOL, V18, P13, DOI 10.1097/MOL.0b013e3280127b04; Corti R, 2002, CIRCULATION, V106, P2935, DOI 10.1161/01.CIR.0000046228.97025.3A; De Roos B, 1998, J INTERN MED, V244, P451, DOI 10.1111/j.1365-2796.1998.00386.x; de Zwart FJ, 2003, FOOD CHEM, V83, P197, DOI 10.1016/S0308-8146(03)00063-3; Garrett R, 2013, LWT-FOOD SCI TECHNOL, V50, P496, DOI 10.1016/j.lwt.2012.08.016; Ginz M, 2000, J AGR FOOD CHEM, V48, P3528, DOI 10.1021/jf991256v; Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009; Ito H, 2005, BRIT J NUTR, V94, P500, DOI 10.1079/BJN20051522; Jenab M, 2009, HUM GENET, V125, P507, DOI 10.1007/s00439-009-0662-5; Kesse-Guyot E, 2011, ANN NUTR METAB, V57, P153, DOI 10.1159/000321680; Kuhnle GGC, 2012, J SCI FOOD AGR, V92, P1145, DOI 10.1002/jsfa.5631; Lang R, 2011, MOL NUTR FOOD RES, V55, P1613, DOI 10.1002/mnfr.201000656; Lees HJ, 2013, J PROTEOME RES, V12, P1527, DOI 10.1021/pr300900b; Liu JX, 2013, MAYO CLIN PROC, V88, P1493, DOI 10.1016/j.mayocp.2013.10.003; Llorach R, 2009, J PROTEOME RES, V8, P5060, DOI 10.1021/pr900470a; MENNEN LI, 2006, BRIT J NUTR, V96, P191, DOI DOI 10.1079/BJN20061808; Monteiro M, 2007, J NUTR, V137, P2196, DOI 10.1093/jn/137.10.2196; Nagy K, 2011, J CHROMATOGR A, V1218, P491, DOI 10.1016/j.chroma.2010.11.076; Noordzij M, 2005, J HYPERTENS, V23, P921, DOI 10.1097/01.hjh.0000166828.94699.1d; Obatomi DK, 1998, FOOD CHEM TOXICOL, V36, P335, DOI 10.1016/S0278-6915(98)00002-7; OBERMANN H, 1976, CHEM BER-RECL, V109, P3450, DOI 10.1002/cber.19761091024; Perez-Jimenez J, 2011, AM J CLIN NUTR, V93, P1220, DOI 10.3945/ajcn.110.007096; Pujos-Guillot E, 2013, J PROTEOME RES, V12, P1645, DOI 10.1021/pr300997c; Ranheim T, 2005, MOL NUTR FOOD RES, V49, P274, DOI 10.1002/mnfr.200400109; Scalbert A, 2009, METABOLOMICS, V5, P435, DOI 10.1007/s11306-009-0168-0; Silva JA, 2012, FOOD ANAL METHOD, V5, P1404, DOI 10.1007/s12161-012-9387-5; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019; van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512; van Dam RM, 2008, APPL PHYSIOL NUTR ME, V33, P1269, DOI 10.1139/H08-120; van der Kloet FM, 2009, J PROTEOME RES, V8, P5132, DOI 10.1021/pr900499r; Wold S, 1998, CHEMOMETR INTELL LAB, V44, P175, DOI 10.1016/S0169-7439(98)00109-9; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Yang A, 2010, PSYCHOPHARMACOLOGY, V211, P245, DOI 10.1007/s00213-010-1900-1; Zamora-Ros R, 2013, BRIT J NUTR, V109, P1498, DOI 10.1017/S0007114512003273; Zhang R, 2012, CENT EUR J MED, V7, P310, DOI 10.2478/s11536-011-0154-6	42	82	83	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93474	10.1371/journal.pone.0093474	http://dx.doi.org/10.1371/journal.pone.0093474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24713823	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900028
J	Zhou, T; Wang, T; Garcia, JGN				Zhou, Tong; Wang, Ting; Garcia, Joe G. N.			Genes Influenced by the Non-Muscle Isoform of Myosin Light Chain Kinase Impact Human Cancer Prognosis	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; EXPRESSION; MIGRATION; SURVIVAL; CLASSIFICATION; MDA-MB-231; GENECARDS; INVASION	The multifunctional non-muscle isoform of myosin light chain kinase (nmMLCK) is critical to the rapid dynamic coordination of the cytoskeleton involved in cancer cell proliferation and migration. We identified 45 nmMLCK-influenced genes by bioinformatic filtering of genome-wide expression in wild type and nmMLCK knockout (KO) mice exposed to preclinical models of murine acute inflammatory lung injury, pathologies that are well established to include nmMLCK as an essential participant. To determine whether these nmMLCK-influenced genes were relevant to human cancers, the 45 mouse genes were matched to 38 distinct human orthologs (M38 signature) (GeneCards definition) and underwent Kaplan-Meier survival analysis in training and validation cohorts. These studies revealed that in training cohorts, the M38 signature successfully identified cancer patients with poor overall survival in breast cancer (P<0.001), colon cancer (P<0.001), glioma (P<0.001), and lung cancer (P<0.001). In validation cohorts, the M38 signature demonstrated significantly reduced overall survival for high-score patients of breast cancer (P = 0.002), colon cancer (P = 0.035), glioma (P = 0.023), and lung cancer (P = 0.023). The association between M38 risk score and overall survival was confirmed by univariate Cox proportional hazard analysis of overall survival in the both training and validation cohorts. This study, providing a novel prognostic cancer gene signature derived from a murine model of nmMLCK-associated lung inflammation, strongly supports nmMLCK-involved pathways in tumor growth and progression in human cancers and nmMLCK as an attractive candidate molecular target in both inflammatory and neoplastic processes.	[Garcia, Joe G. N.] Univ Arizona, Arizona Resp Ctr, Tucson, AZ 85721 USA; Univ Arizona, Dept Med, Tucson, AZ USA	University of Arizona; University of Arizona	Garcia, JGN (corresponding author), Univ Arizona, Arizona Resp Ctr, Tucson, AZ 85721 USA.	skipgarcia@email.arizona.edu			National Institutes of Health [HL91899, HL58064]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants HL91899 and HL58064 (JGNG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkan D, 2008, CANCER RES, V68, P6241, DOI 10.1158/0008-5472.CAN-07-6849; Bravo-Cordero JJ, 2012, CURR OPIN CELL BIOL, V24, P277, DOI 10.1016/j.ceb.2011.12.004; Choi JK, 2003, BIOINFORMATICS, V19, pi84, DOI 10.1093/bioinformatics/btg1010; Cui WJ, 2010, ACTA PHARMACOL SIN, V31, P725, DOI 10.1038/aps.2010.56; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DRISKA SP, 1981, AM J PHYSIOL, V240, pC222, DOI 10.1152/ajpcell.1981.240.5.C222; Dudek SM, 2001, J APPL PHYSIOL, V91, P1487, DOI 10.1152/jappl.2001.91.4.1487; Freeman TJ, 2012, GASTROENTEROLOGY, V142, P562, DOI 10.1053/j.gastro.2011.11.026; GARCIA JGN, 1995, J CELL PHYSIOL, V163, P510, DOI 10.1002/jcp.1041630311; Garcia JGN, 1997, AM J RESP CELL MOL, V16, P489, DOI 10.1165/ajrcmb.16.5.9160829; Harrison SMW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-501; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Khuon S, 2010, J CELL SCI, V123, P431, DOI 10.1242/jcs.053793; Masur K, 2011, BRIT J CANCER, V104, P345, DOI 10.1038/sj.bjc.6606050; Mirzapoiazova T, 2011, AM J RESP CELL MOL, V44, P40, DOI 10.1165/rcmb.2009-0197OC; Nutt CL, 2003, CANCER RES, V63, P1602; Parmigiani G, 2002, J ROY STAT SOC B, V64, P717, DOI 10.1111/1467-9868.00358; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pitroda SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046104; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; R Development Core Team, 2005, R LANG ENV STAT COMP; Rebhan M, 1998, BIOINFORMATICS, V14, P656, DOI 10.1093/bioinformatics/14.8.656; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Siegler J, 2011, AM J RESP CRIT CARE, V183, pA5084; Spans L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090002; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uronis JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038422; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang B, 2013, BIOMED PHARMACOTHER, V67, P357, DOI 10.1016/j.biopha.2013.03.016; Wang T, 2014, AM J RESP C IN PRESS; Zhou XL, 2008, CANCER LETT, V270, P312, DOI 10.1016/j.canlet.2008.05.028	34	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94325	10.1371/journal.pone.0094325	http://dx.doi.org/10.1371/journal.pone.0094325			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714365	gold, Green Published, Green Submitted			2022-12-25	WOS:000334160900116
J	Miura, S; Kondo, J; Takimoto, A; Sano-Takai, H; Guo, L; Shukunami, C; Tanaka, H; Hiraki, Y				Miura, Shigenori; Kondo, Jun; Takimoto, Aki; Sano-Takai, Hiroko; Guo, Long; Shukunami, Chisa; Tanaka, Hideyuki; Hiraki, Yuji			The N- Terminal Cleavage of Chondromodulin-I in Growth- Plate Cartilage at the Hypertrophic and Calcified Zones during Bone Development	PLOS ONE			English	Article							MOLECULAR-CLONING; MESSENGER-RNA; ANGIOGENESIS; EXPRESSION; CHONDROCYTES; MATRIX; LOCALIZATION; TENOMODULIN; INHIBITOR; INVASION	Chondromodulin- I ( ChM- I) is a 20- 25 kDa anti- angiogenic glycoprotein in cartilage matrix. In the present study, we identified a novel 14- kDa species of ChM- I by immunoblotting, and purified it by immunoprecipitation with a newly raised monoclonal antibody against ChM- I. The N-terminal amino acid sequencing indicated that it was an N-terminal truncated form of ChM- I generated by the proteolytic cleavage at Asp (37) -Asp(38). This 14- kDa ChM- I was shown by the modified Boyden chamber assay to have very little inhibitory activity on the VEGF-A- induced migration of vascular endothelial cells in contrast to the intact 20- 25 kDa form of ChM- I ( ID50 = 8 nM). Immunohistochemistry suggested that 20-25 kDa ChM-I was exclusively localized in the avascular zones, i.e. the resting, proliferating, and prehypertrophic zones, of the cartilaginous molds of developing long bone, whereas the 14-kDa form of ChM-I was found in hypertrophic and calcified zones. Immunoblotting demonstrated that mature growth-plate chondrocytes isolated from rat costal cartilage actively secrete ChM-I almost exclusively as the intact 20-25 kDa form into the medium in primary culture. Taken together, our results suggest that intact 20-25 kDa ChM-I is stored as a component of extracellular matrix in the avascular cartilage zones, but it is inactivated by a single N-terminal proteolytic cleavage in the hypertrophic zone of growth-plate cartilage.	[Miura, Shigenori; Takimoto, Aki; Sano-Takai, Hiroko; Guo, Long; Tanaka, Hideyuki; Hiraki, Yuji] Kyoto Univ, Inst Frontier Med Sci, Dept Cellular Differentiat, Kyoto, Japan; [Kondo, Jun] Sci & Technol Res Ctr Inc, Div Res & Dev, Mitsubishi Chem Grp, Kanagawa, Japan; [Shukunami, Chisa] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Dent & Med Biochem, Hiroshima, Japan	Kyoto University; Mitsubishi Chemical Holdings Corporation; Mitsubishi Chemical; Hiroshima University	Hiraki, Y (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Cellular Differentiat, Kyoto, Japan.	hiraki@frontier.kyoto-u.ac.jp	GUO, Long/T-5237-2019; Shukunami, Chisa/G-2887-2019; 重徳, 三浦/GRJ-5008-2022	GUO, Long/0000-0002-9660-6941; Shukunami, Chisa/0000-0001-5616-6761; 重徳, 三浦/0000-0001-9206-2986	Ministry of Education, Culture, Sports, Science, and Technology, Japan [21510224]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (no. 21510224 to Yuji Hiraki). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dietz UH, 1999, DEV DYNAM, V216, P233, DOI 10.1002/(SICI)1097-0177(199911)216:3<233::AID-DVDY2>3.0.CO;2-G; EISENSTEIN R, 1973, AM J PATHOL, V73, P765; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; Fujii M, 2013, J ORTHOP RES, V31, P538, DOI 10.1002/jor.22257; Funaki H, 2001, INVEST OPHTH VIS SCI, V42, P1193; Hall Brian K., 2005, P316, DOI 10.1016/B978-012319060-4/50025-7; HIRAKI Y, 1991, BIOCHEM BIOPH RES CO, V175, P971, DOI 10.1016/0006-291X(91)91660-5; Hiraki Y, 1999, EUR J BIOCHEM, V260, P869, DOI 10.1046/j.1432-1327.1999.00227.x; Hiraki Y, 1997, J BIOL CHEM, V272, P32419, DOI 10.1074/jbc.272.51.32419; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; JAKOB W, 1978, EXP PATHOL-JENA, V15, P241, DOI 10.1016/S0014-4908(78)80064-7; Kondo J, 2011, J BONE MINER METAB, V29, P23, DOI 10.1007/s00774-010-0193-0; Kuettner K.E., 1983, SEFER RABIAH, V1, P281; Miura S, 2012, CANCER SCI, V103, P1311, DOI 10.1111/j.1349-7006.2012.02276.x; Miura S, 2010, EXP CELL RES, V316, P775, DOI 10.1016/j.yexcr.2009.12.009; Nakamichi Y, 2003, MOL CELL BIOL, V23, P636, DOI 10.1128/MCB.23.2.636-644.2003; NEAME PJ, 1990, J BIOL CHEM, V265, P9628; SHIMOMURA Y, 1975, CALC TISS RES, V19, P179, DOI 10.1007/BF02564002; Shukunami C, 1999, INT J DEV BIOL, V43, P39; Shukunami C, 1998, BIOCHEM BIOPH RES CO, V249, P885, DOI 10.1006/bbrc.1998.9233; Shukunami C, 2005, BIOCHEM BIOPH RES CO, V333, P299, DOI 10.1016/j.bbrc.2005.05.133; Shukunami C, 2007, CURR PHARM DESIGN, V13, P2101; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Takimoto A, 2009, DEV BIOL, V332, P196, DOI 10.1016/j.ydbio.2009.05.552; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wang QY, 2012, ARCH ORAL BIOL, V57, P620, DOI 10.1016/j.archoralbio.2011.12.006; Yoshioka M, 2006, NAT MED, V12, P1151, DOI 10.1038/nm1476; Yukata K, 2008, BONE, V43, P1047, DOI 10.1016/j.bone.2008.08.111	28	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94239	10.1371/journal.pone.0094239	http://dx.doi.org/10.1371/journal.pone.0094239			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710035	gold, Green Published, Green Submitted			2022-12-25	WOS:000334159800126
J	Takasuka, TE; Acheson, JF; Bianchetti, CM; Prom, BM; Bergeman, LF; Book, AJ; Currie, CR; Fox, BG				Takasuka, Taichi E.; Acheson, Justin F.; Bianchetti, Christopher M.; Prom, Ben M.; Bergeman, Lai F.; Book, Adam J.; Currie, Cameron R.; Fox, Brian G.			Biochemical Properties and Atomic Resolution Structure of a Proteolytically Processed beta-Mannanase from Cellulolytic Streptomyces sp SirexAA- E	PLOS ONE			English	Article							SUBSTRATE-SPECIFICITY; XYLANASE XYS1; HALSTEDII JM8; CELL-WALL; X-RAY; GENE; PURIFICATION; ENZYME; EXPRESSION; RETICULI	beta-mannanase SACTE_2347 from cellulolytic Streptomyces sp. SirexAA-E is abundantly secreted into the culture medium during growth on cellulosic materials. The enzyme is composed of domains from the glycoside hydrolase family 5 (GH5), fibronectin type-III (Fn3), and carbohydrate binding module family 2 (CBM2). After secretion, the enzyme is proteolyzed into three different, catalytically active variants with masses of 53, 42 and 34 kDa corresponding to the intact protein, loss of the CBM2 domain, or loss of both the Fn3 and CBM2 domains. The three variants had identical N-termini starting with Ala51, and the positions of specific proteolytic reactions in the linker sequences separating the three domains were identified. To conduct biochemical and structural characterizations, the natural proteolytic variants were reproduced by cloning and heterologously expressed in Escherichia coli. Each SACTE_2347 variant hydrolyzed only beta-1,4 mannosidic linkages, and also reacted with pure mannans containing partial galactosyl-and/ or glucosyl substitutions. Examination of the X-ray crystal structure of the GH5 domain of SACTE_2347 suggests that two loops adjacent to the active site channel, which have differences in position and length relative to other closely related mannanases, play a role in producing the observed substrate selectivity.	[Takasuka, Taichi E.; Bianchetti, Christopher M.; Prom, Ben M.; Bergeman, Lai F.; Book, Adam J.; Currie, Cameron R.; Fox, Brian G.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA; [Takasuka, Taichi E.; Acheson, Justin F.; Bianchetti, Christopher M.; Bergeman, Lai F.; Fox, Brian G.] Univ Wisconsin, Dept Biochem, Madison, WI 53705 USA; [Book, Adam J.; Currie, Cameron R.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Fox, BG (corresponding author), Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI 53706 USA.	bgfox@biochem.wisc.edu	Takasuka, Taichi/AAF-9441-2020	Takasuka, Taichi/0000-0002-4413-2924; Acheson, Justin/0000-0001-5051-9984	Department of Energy Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-ENG-38]	Department of Energy Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE))	This work was funded by the Department of Energy Great Lakes Bioenergy Research Center (DOE BER Office of Science DE-FC02-07ER64494). The use of Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract No. W-31-109-ENG-38. The use of Life Science Collaborative Access Team at the Advanced Photon Source was supported by the College of Agricultural and Life Sciences, Department of Biochemistry, and Graduate School of the University of Wisconsin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AS, 2011, ISME J, V5, P1323, DOI 10.1038/ismej.2011.14; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adham SAI, 2001, ARCH MICROBIOL, V177, P91, DOI 10.1007/s00203-001-0365-3; Akita M, 2004, ACTA CRYSTALLOGR D, V60, P1490, DOI 10.1107/S0907444904014313; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; ARCAND N, 1993, BIOCHEM J, V290, P857, DOI 10.1042/bj2900857; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Barr BK, 1996, BIOCHEMISTRY-US, V35, P586, DOI 10.1021/bi9520388; Bianchetti CM, 2013, J MOL BIOL, V425, P4267, DOI 10.1016/j.jmb.2013.05.030; Bianchetti CM, 2013, J BIOL CHEM, V288, P18574, DOI 10.1074/jbc.M113.475848; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Blommel PG, 2007, BIOTECHNOL PROGR, V23, P585, DOI 10.1021/bp070011x; Blommel Paul G., 2009, V498, P55, DOI 10.1007/978-1-59745-196-3_4; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dhawan S, 2007, CRIT REV BIOTECHNOL, V27, P197, DOI 10.1080/07388550701775919; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Gilbert HJ, 2010, PLANT PHYSIOL, V153, P444, DOI 10.1104/pp.110.156646; Hagglund P, 2003, J BIOTECHNOL, V101, P37, DOI 10.1016/S0168-1656(02)00290-0; Hilge M, 1998, STRUCTURE, V6, P1433, DOI 10.1016/S0969-2126(98)00142-7; Ishimizu T, 2004, J BIOL CHEM, V279, P38555, DOI 10.1074/jbc.M406886200; Kumagai Y, 2012, BIOCHIMIE, V94, P2783, DOI 10.1016/j.biochi.2012.09.012; Li CL, 2011, BIORESOURCE TECHNOL, V102, P6928, DOI 10.1016/j.biortech.2011.04.005; Liepman AH, 2007, PLANT PHYSIOL, V143, P1881, DOI 10.1104/pp.106.093989; Malek MA, 1995, MICROBIOS, V83, P229; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; MOORMANN M, 1993, APPL ENVIRON MICROB, V59, P1573, DOI 10.1128/AEM.59.5.1573-1578.1993; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petkowicz CLD, 2001, CARBOHYD POLYM, V44, P107, DOI 10.1016/S0144-8617(00)00212-5; RuizArribas A, 1997, APPL ENVIRON MICROB, V63, P2983, DOI 10.1128/AEM.63.8.2983-2988.1997; RUIZARRIBAS A, 1995, APPL ENVIRON MICROB, V61, P2414, DOI 10.1128/AEM.61.6.2414-2419.1995; Sabini E, 2000, ACTA CRYSTALLOGR D, V56, P3, DOI 10.1107/S0907444999013943; SCHLOCHTERMEIER A, 1992, MOL MICROBIOL, V6, P3611, DOI 10.1111/j.1365-2958.1992.tb01797.x; Shallom D, 2003, CURR OPIN MICROBIOL, V6, P219, DOI 10.1016/S1369-5274(03)00056-0; Tailford LE, 2009, BIOCHEMISTRY-US, V48, P7009, DOI 10.1021/bi900515d; Takasuka TE, 2014, METHODS MOL BIOL, V1118, P71, DOI 10.1007/978-1-62703-782-2_5; Takasuka TE, 2013, SCI REP-UK, V3, DOI 10.1038/srep01030; TAMARU Y, 1995, APPL ENVIRON MICROB, V61, P4454, DOI 10.1128/AEM.61.12.4454-4458.1995; Teleman A, 2003, CARBOHYD RES, V338, P525, DOI 10.1016/S0008-6215(02)00491-3; Tobimatsu Y, 2012, CHEMSUSCHEM, V5, P676, DOI 10.1002/cssc.201100573; Vasella A, 2002, CURR OPIN CHEM BIOL, V6, P619, DOI 10.1016/S1367-5931(02)00380-0; WANG QP, 1993, J BIOL CHEM, V268, P14096; White A, 1996, NAT STRUCT BIOL, V3, P149, DOI 10.1038/nsb0296-149; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; XU GY, 1995, BIOCHEMISTRY-US, V34, P6993, DOI 10.1021/bi00021a011; Zhang YL, 2008, J BIOL CHEM, V283, P31551, DOI 10.1074/jbc.M803409200	49	15	16	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94166	10.1371/journal.pone.0094166	http://dx.doi.org/10.1371/journal.pone.0094166			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710170	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800110
J	Williamson, TE; Brusatte, SL				Williamson, Thomas E.; Brusatte, Stephen L.			Small Theropod Teeth from the Late Cretaceous of the San Juan Basin, Northwestern New Mexico and Their Implications for Understanding Latest Cretaceous Dinosaur Evolution	PLOS ONE			English	Article							BEND NATIONAL-PARK; NORTH-AMERICA; BIG-BEND; TYRANNOSAURIDAE DINOSAURIA; SYSTEMATIC UTILITY; KIRTLAND FORMATION; WESTERN INTERIOR; AGUJA FORMATION; CREEK FORMATION; DIVERSITY	Studying the evolution and biogeographic distribution of dinosaurs during the latest Cretaceous is critical for better understanding the end-Cretaceous extinction event that killed off all non-avian dinosaurs. Western North America contains among the best records of Late Cretaceous terrestrial vertebrates in the world, but is biased against small-bodied dinosaurs. Isolated teeth are the primary evidence for understanding the diversity and evolution of small-bodied theropod dinosaurs during the Late Cretaceous, but few such specimens have been well documented from outside of the northern Rockies, making it difficult to assess Late Cretaceous dinosaur diversity and biogeographic patterns. We describe small theropod teeth from the San Juan Basin of northwestern New Mexico. These specimens were collected from strata spanning Santonian - Maastrichtian. We grouped isolated theropod teeth into several morphotypes, which we assigned to higher-level theropod clades based on possession of phylogenetic synapomorphies. We then used principal components analysis and discriminant function analyses to gauge whether the San Juan Basin teeth overlap with, or are quantitatively distinct from, similar tooth morphotypes from other geographic areas. The San Juan Basin contains a diverse record of small theropods. Late Campanian assemblages differ from approximately co-eval assemblages of the northern Rockies in being less diverse with only rare representatives of troodontids and a Dromaeosaurus-like taxon. We also provide evidence that erect and recurved morphs of a Richardoestesia- like taxon represent a single heterodont species. A late Maastrichtian assemblage is dominated by a distinct troodontid. The differences between northern and southern faunas based on isolated theropod teeth provide evidence for provinciality in the late Campanian and the late Maastrichtian of North America. However, there is no indication that major components of small-bodied theropod diversity were lost during the Maastrichtian in New Mexico. The same pattern seen in northern faunas, which may provide evidence for an abrupt dinosaur extinction.	[Williamson, Thomas E.] New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; [Brusatte, Stephen L.] Univ Edinburgh, Sch GeoSci, Edinburgh, Midlothian, Scotland	University of Edinburgh	Williamson, TE (corresponding author), New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA.	thomas.williamson@state.nm.us	Williamson, Thomas/AAW-9320-2020; Brusatte, Stephen/O-9663-2014	Brusatte, Stephen/0000-0001-7525-7319; Williamson, Thomas/0000-0002-2856-9632	National Science Foundation [EAR 0207750, EAR 1325544]; Bureau of Land Management (BLM) Challenge Cost Share grants; BLM National Landscapes Conservation System grant; Directorate For Geosciences [1325544, 1325612] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Bureau of Land Management (BLM) Challenge Cost Share grants; BLM National Landscapes Conservation System grant; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	National Science Foundation, grants EAR 0207750 to TEW and EAR 1325544 to TEW and SLB provided support. Bureau of Land Management (BLM) Challenge Cost Share grants to TEW and a BLM National Landscapes Conservation System grant provided support to TEW and SLB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarante JFA, 2002, NEW MEXICO GEOLOGY, V24, P68; Anderson RY., 1960, STATE BUREAU MINES M, V6, P1; [Anonymous], 1983, MESOZOIC PALEOGEOGRA; ARMSTRONG-ZIEGLER J G, 1980, Fieldiana Geology, P1; ARMSTRONGZIEGLER JG, 1978, J PALEONTOL, V52, P480; Bakker R.T., 1988, HUNTERIA, V1, P1, DOI DOI 10.5281/ZEN0D0.1037529; Baltz EHJ, 1966, 524D524D US GEOL SUR, pD1; Barrett PM, 2009, P ROY SOC B-BIOL SCI, V276, P2667, DOI 10.1098/rspb.2009.0352; Baszio Sven, 1997, Courier Forschungsinstitut Senckenberg, V196, P33; Benson RBJ, 2008, J VERTEBR PALEONTOL, V28, P732, DOI 10.1671/0272-4634(2008)28[732:NIOSAT]2.0.CO;2; Bourdon J., 2011, NEW MEXICO MUSEUM NA, V52, P1; BOWN TM, 1981, PALAEOGEOGR PALAEOCL, V34, P31, DOI 10.1016/0031-0182(81)90057-2; Brusatte SL, 2012, B AM MUS NAT HIST, V366, P197; Brusatte SL, 2013, THESIS COLUMBIA U NE; Brusatte SL, 2007, J VERTEBR PALEONTOL, V27, P1052, DOI 10.1671/0272-4634(2007)27[1052:TSUOTE]2.0.CO;2; Brusatte SL, 2013, ACTA PALAEONTOL POL, V58, P47, DOI 10.4202/app.2011.0141; Brusatte SL, 2013, B AM MUS NAT HIST, P3; Brusatte SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1815; Brusatte SL, 2010, SCIENCE, V329, P1481, DOI 10.1126/science.1193304; Buckley LG, 2010, CAN J EARTH SCI, V47, P1227, DOI 10.1139/E10-029; Carr T.D., 2000, NEW MEXICO MUSEUM NA, V17, P113; Carr TD, 2005, J VERTEBR PALEONTOL, V25, P119, DOI 10.1671/0272-4634(2005)025[0119:ANGASO]2.0.CO;2; Carr TD, 2004, ZOOL J LINN SOC-LOND, V142, P479, DOI 10.1111/j.1096-3642.2004.00130.x; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Carr TD, 2011, NATURWISSENSCHAFTEN, V98, P241, DOI 10.1007/s00114-011-0762-7; Carr TD, 2010, J VERTEBR PALEONTOL, V30, P1, DOI 10.1080/02724630903413032; Cifelli Richard L., 2004, P21; Cifelli RL, 1997, P NATL ACAD SCI USA, V94, P11163, DOI 10.1073/pnas.94.21.11163; Clemens W.A., 1986, CONTRIBUTIONS GEOLOG, V3, P55, DOI DOI 10.2113/GSR0CKY.24.SPECIAL_; Clemens WA, 1973, CRETACEOUS TERTIARY, P154; Cope E. D., 1876, P ACAD NAT SCI PHILA, V28, P248; Currie P.J., 1990, P107, DOI 10.1017/CBO9780511608377.011; Currie P.J., 1987, Journal of Vertebrate Paleontology, V7, P72; Currie PJ, 1995, J VERTEBR PALEONTOL, V15, P576, DOI 10.1080/02724634.1995.10011250; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P191; D'Emic MD, 2011, J VERTEBR PALEONTOL, V31, P1072, DOI 10.1080/02724634.2011.595856; Denton R, 2004, J VERTEBR PALEONTOL, V24, p52A; Eaton J.G., 1999, UTAH GEOLOGICAL SURV, V99-1, P345; Eberth DA, 2013, CAN J EARTH SCI, V50, P701, DOI 10.1139/cjes-2012-0185; Erickson GM, 2010, CAN J EARTH SCI, V47, P1269, DOI 10.1139/E10-051; Evans DC, 2013, NATURWISSENSCHAFTEN, V100, P1041, DOI 10.1007/s00114-013-1107-5; Evans DC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2749; Fassett J.E., 2009, PALAEONTOL ELECTRON, V12, p3A; Fassett J.E., 2000, NEW MEXICO MUSEUM NA, V17, P221; Fassett JE, 2011, GEOLOGY, V39, P159, DOI 10.1130/G31466.1; Fassett James E., 1997, New Mexico Geological Society Field Conference Guidebook, V48, P239; Fassett JE, 2002, GEOL SOC AM SPEC PAP, V356, P307; Fassett JE, 1987, CRETACEOUS TERTIARY, P17; Fastovsky D. E., 2005, GSA TODAY, V15; Fiorillo AR, 2008, PALAIOS, V23, P322, DOI 10.2110/palo.2007.p07-036r; Fiorillo AR, 2000, J VERTEBR PALEONTOL, V20, P675, DOI 10.1671/0272-4634(2000)020[0675:TTFTPC]2.0.CO;2; Flynn LJ, 1986, LATE CRETACEOUS MAMM, P1; Fv Huene, 1914, FOSSILIUM CATALOGUS, V4, P1; Gates TA, 2010, PALAEOGEOGR PALAEOCL, V291, P371, DOI 10.1016/j.palaeo.2010.03.008; Gates TA, ACTA PALAEO IN PRESS; Gates TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042135; Gilmore C.W., 1924, CANADIAN B DEP GEOLO, V1, P1; Gradstein FM, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P1; Hall JP, 1991, LOWER VERTEBRA UNPUB; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Heizler MT, 2013, GEOLOGICAL SOC AM AB; Hunter JP, 2010, J VERTEBR PALEONTOL, V30, P885, DOI 10.1080/02724631003763490; HUTCHINSON PJ, 1985, NEW MEXICO BUREAU MI, V195, P25; Jasinski SE., 2011, NEW MEXICO MUSEUM NA, V53, P216; Jasinski S, 2009, J VERTEBR PALEONTOL, V29, p122A; Johnson Sally C., 2003, New Mexico Geological Society Field Conference Guidebook, V54, P353; Kielan-Jaworowska Z., 2005, MAMMALS AGE DINOSAUR; Kirkland JI, 1997, ABSTRACTS PROGRAMS G, V29; Larson DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054329; Larson DW, 2008, CAN J EARTH SCI, V45, P1455, DOI 10.1139/E08-070; Lehman T.M., 1981, P189; Lehman Thomas M., 2001, P310; Lehman Thomas M., 1997, P223; LEHMAN TM, 1987, PALAEOGEOGR PALAEOCL, V60, P189, DOI 10.1016/0031-0182(87)90032-0; Lehman TM, 1985, NEW MEXICO BUREAU MI, V195, P55; LEHMAN TM, 1984, J VERTEBR PALEONTOL, V4, P602; Lillegraven JA, 1986, AM MUS NOVIT, V2840, p1 ; Loewen MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079420; Lofgren Donald L., 2004, P43; Longrich Nick, 2008, P135; Lucas S.G., 2000, NEW MEXICO MUSEUM NA, V17, P95; Lucas S. G., 1988, NEW MEXICO BUREAU MI, V122, P49; Lucas S. G., 2009, PALAEONTOL ELECTRON, V12, P1; Lucas SG, 2003, NEW MEXICO MUSEUM NA, V17, P83; Luo ZX, 2001, NATURE, V409, P53, DOI 10.1038/35051023; MADSEN JH, 1974, J PALEONTOL, V48, P27; Magana J, 2013, J VERTEBR PALEONTOL, P169; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Matthew WD, 1922, B AM MUS NAT HIST, V56, P367; Mcdonald AT, 2010, J VERTEBR PALEONTOL, V30, P799, DOI 10.1080/02724631003763516; Mitchell JS, 2012, P NATL ACAD SCI USA, V109, P18857, DOI 10.1073/pnas.1202196109; Osborn HF, 1905, B AM MUS NAT HIST, V21, P259; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Parrish J. Michael, 1999, P319; Pearson DA, 2002, GEOL S AM S, P145; Pence R, 1986, NEW MEXICO GEOLOGY, V8, P69; Peppe DJ, 2013, GEOLOGICAL SOC AM AB, P114; Rigby Jr J.K., 1987, GEOLOGICAL SOC AM SP, V209, P51, DOI [10.1130/SPE209-p51, DOI 10.1130/SPE209-P51]; Roberts EM, 2005, CRETACEOUS RES, V26, P307, DOI 10.1016/j.cretres.2005.01.002; Rowe T., 1992, Journal of Vertebrate Paleontology, V12, P472; Russell DA, 2002, GEOL S AM S, P169; Russell L. S., 1964, Contributions of the Royal Ontario Museum of Zoology, VNo. 61, P1; RUSSELL L S, 1975, P137; Samman T, 2005, ACTA PALAEONTOL POL, V50, P757; Sampson SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012292; Sampson SD, 2005, J VERTEBR PALEONTOL, V25, P469, DOI 10.1671/0272-4634(2005)025[0469:TRFTUC]2.0.CO;2; Sankey JT, 2002, J PALEONTOL, V76, P751, DOI 10.1666/0022-3360(2002)076<0751:STABTF>2.0.CO;2; Sankey JT, 2005, LIFE O PAST, P127; Sankey JT, 2001, J PALEONTOL, V75, P208, DOI 10.1666/0022-3360(2001)075<0208:LCSDAF>2.0.CO;2; Sankey Julia T., 2001, Occasional Papers of the Museum of Natural Science Louisiana State University, V77, P1; Sankey Julia T., 2008, P61; Sankey Julia T., 2008, P117; Sereno PC, 2009, J SYST PALAEONTOL, V7, P455, DOI 10.1017/S1477201909990034; SLOAN RE, 1969, P N AM PAL CONV E, P00427; Smith JB, 2005, J VERTEBR PALEONTOL, V25, P865, DOI 10.1671/0272-4634(2005)025[0865:HITRIF]2.0.CO;2; Smith JB, 2005, ANAT REC PART A, V285A, P699, DOI 10.1002/ar.a.20206; Sullivan R.M., 2005, 56 FIELD C GUID GEOL, V56, P395; Sullivan RM, 2005, J PALEONTOL, V79, P564, DOI 10.1666/0022-3360(2005)079<0564:ROTCDT>2.0.CO;2; Sullivan Robert M., 2003, New Mexico Geological Society Field Conference Guidebook, V54, P369; Sullivan Robert M., 2006, Bulletin of the New Mexico Museum of Natural History and Science, P7; Sullivan Robert M., 2006, Bulletin of the New Mexico Museum of Natural History and Science, P253; Templeman T, 2013, J VERTEBR PALEONTOL, V2013, P224; Turner AH, 2012, B AM MUS NAT HIST, P5; Upchurch P, 2011, GEOL SOC SPEC PUBL, V358, P209, DOI 10.1144/SP358.14; Vavrek MJ, 2010, P NATL ACAD SCI USA, V107, P8265, DOI 10.1073/pnas.0913645107; Weishampel DB., 2004, DINOSAURIA; Williamson T.E., 1997, NEW MEXICO MUSEUM NA, V11, P51; Williamson TE, 1996, J VERTEBR PALEONTOL, V16, P421, DOI 10.1080/02724634.1996.10011331; Williamson TE, 1998, NEW MEXICO GEOLOGY, V20, P54; Williamson TE, 1989, NEW MEXICO GEOLOGICA, V40, P239; Williamson TE, 2005, LATEST CRETACEOUS TY; Williamson TE, 2013, NEW VERTEBRATE LOCAL; Williamson TE, 2001, NEW MEXICO GEOLOGY, V23, P64; WILLIAMSON TE, 2001, GEOLOGICAL SOC AM AB, V33, pA21; Williamson TE, 1996, B NEW MEXICO MUSEUM, V8, P1; Williamson T, 2003, J VERTEBR PALEONTOL, V23, p110A; Williamson Thomas E., 1998, Journal of Vertebrate Paleontology, V18, p86A; Williamson TE, 2008, J VERTEBR PALEONTOL, V28, P803, DOI 10.1671/0272-4634(2008)28[803:MMFTNM]2.0.CO;2; Williamson TE, 2008, J VERTEBR PALEONTOL, V28, P1218, DOI 10.1671/0272-4634-28.4.1218; Wilson Gregory P., 2005, Journal of Mammalian Evolution, V12, P53, DOI 10.1007/s10914-005-6943-4; Wilson GP, 2010, J VERTEBR PALEONTOL, V30, P499, DOI 10.1080/02724631003620955; Woodburne M.O., 2006, STRATIGRAPHY, V3, P229; Woodburne M. O., 2004, LATE CRETACEOUS CENO; Zanno LE, 2005, J VERTEBR PALEONTOL, V25, P897, DOI 10.1671/0272-4634(2005)025[0897:ANOTMF]2.0.CO;2; Zanno Lindsay E., 2013, P504; Zanno LE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3827; Zanno LE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024487; Zanno LE, 2011, HIST BIOL, V23, P317, DOI 10.1080/08912963.2010.543952	149	27	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93190	10.1371/journal.pone.0093190	http://dx.doi.org/10.1371/journal.pone.0093190			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709990	Green Published, gold, Green Submitted			2022-12-25	WOS:000334159800026
J	Barrett, LT; Evans, JP; Gasparini, C				Barrett, Luke T.; Evans, Jonathan P.; Gasparini, Clelia			The Effects of Perceived Mating Opportunities on Patterns of Reproductive Investment by Male Guppies	PLOS ONE			English	Article							MALE MATE CHOICE; SPERM COMPETITION RISK; CRYPTIC MALE CHOICE; POECILIA-RETICULATA; TRINIDADIAN GUPPY; INSEMINATION EFFICIENCY; FEMALE PRESENCE; BEHAVIOR; PREFERENCES; EVOLUTION	Males pay considerable reproductive costs in acquiring mates (precopulatory sexual selection) and in producing ejaculates that are effective at fertilising eggs in the presence of competing ejaculates (postcopulatory sexual selection). Given these costs, males must balance their reproductive investment in a given mating to optimise their future reproductive potential. Males are therefore expected to invest in reproduction prudently according to the likelihood of obtaining future matings. In this study we tested this prediction by determining whether male reproductive investment varies with expected future mating opportunities, which were experimentally manipulated by visually exposing male guppies (Poecilia reticulata) to high or low numbers of females in the absence of competing males. Our experiment did not reveal consistent effects of perceived future mating opportunity on either precopulatory (male mate choice and mating behaviour) or postcopulatory (sperm quality and quantity) investment. However, we did find that male size and female availability interacted to influence mating behaviour; large males visually deprived of females during the treatment phase became more choosy and showed greater interest in their preferred female than those given continuous visual access to females. Overall, our results suggest males tailor pre- rather than postcopulatory traits according to local female availability, but critically, these effects depend on male size.	[Barrett, Luke T.; Evans, Jonathan P.; Gasparini, Clelia] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, WA, Australia	University of Western Australia	Gasparini, C (corresponding author), Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, WA, Australia.	clelia.gasparini@uwa.edu.au	Gasparini, Clelia/F-2159-2011; Evans, Jonathan/A-1992-2011; Barrett, Luke T/T-9622-2019	Barrett, Luke T/0000-0002-2820-0421	School of Animal Biology at the University of Western Australia; Marie Curie International Outgoing Fellowship within the European Community [272613]; Australian Research Council [DP120100773]	School of Animal Biology at the University of Western Australia; Marie Curie International Outgoing Fellowship within the European Community; Australian Research Council(Australian Research Council)	This research was funded by a student grant to L. T. B. from the School of Animal Biology at the University of Western Australia, a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme (grant no. 272613) to C. G., and a Discovery Grant from the Australian Research Council to J.P.E. (grant no. DP120100773). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS MV, 1993, ANIM BEHAV, V45, P673, DOI 10.1006/anbe.1993.1082; Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; [Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; Arriaga LR, 2013, PEERJ, V1, DOI 10.7717/peerj.140; Barton K., 2013, MUMIN MULTI MODEL IN; BILLARD R, 1969, ANN BIOL ANIM BIOCH, V9, P251, DOI 10.1051/rnd:19690208; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; Boschetto C, 2011, BEHAV ECOL SOCIOBIOL, V65, P813, DOI 10.1007/s00265-010-1085-y; Bozynski CC, 2003, ANIM BEHAV, V65, P53, DOI 10.1006/anbe.2002.2024; Brooks R, 2002, GENETICA, V116, P343, DOI 10.1023/A:1021228308636; Brooks R, 2001, EVOLUTION, V55, P1644, DOI 10.1111/j.0014-3820.2001.tb00684.x; Byrne PG, 2006, P ROY SOC B-BIOL SCI, V273, P917, DOI 10.1098/rspb.2005.3372; Cornwallis CK, 2006, EVOLUTION, V60, P1486, DOI 10.1111/j.0014-3820.2006.tb01227.x; Development Core Team, 2013, R LANG ENV STAT COMP; Devigili A, 2013, BEHAV ECOL, V24, P740, DOI 10.1093/beheco/ars204; Dosen LD, 2004, ETHOLOGY, V110, P245, DOI 10.1111/j.1439-0310.2004.00965.x; Dosen LD, 2004, BEHAV ECOL SOCIOBIOL, V55, P266, DOI 10.1007/s00265-003-0710-4; Edward DA, 2011, TRENDS ECOL EVOL, V26, P647, DOI 10.1016/j.tree.2011.07.012; Engqvist L, 2005, J EVOLUTION BIOL, V18, P116, DOI 10.1111/j.1420-9101.2004.00792.x; Engqvist L, 2002, BEHAV ECOL, V13, P632, DOI 10.1093/beheco/13.5.632; Engqvist L, 2001, P ROY SOC B-BIOL SCI, V268, P729, DOI 10.1098/rspb.2000.1423; EVANS J.P., 2011, ECOLOGY EVOLUTION PO; Evans JP, 2009, NATURWISSENSCHAFTEN, V96, P771, DOI 10.1007/s00114-009-0529-6; Evans JP, 2001, P ROY SOC B-BIOL SCI, V268, P719, DOI 10.1098/rspb.2000.1577; Evans JP, 1999, ANIM BEHAV, V58, P1001, DOI 10.1006/anbe.1999.1212; Fox J., 2019, R COMPANION APPL REG, V3rd ed; GARDINER DM, 1978, COMP BIOCHEM PHYS A, V59, P165, DOI 10.1016/0300-9629(78)90200-1; Gasparini C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.3072; Gasparini C, 2012, NATURWISSENSCHAFTEN, V99, P417, DOI 10.1007/s00114-012-0908-2; Gasparini C, 2009, BIOL LETTERS, V5, P792, DOI 10.1098/rsbl.2009.0413; Guevara-Fiore P, 2010, BEHAV ECOL SOCIOBIOL, V64, P1665, DOI 10.1007/s00265-010-0980-6; Herdman EJE, 2004, ETHOLOGY, V110, P97, DOI 10.1111/j.1439-0310.2003.00960.x; HIRSHFIELD MF, 1975, P NATL ACAD SCI USA, V72, P2227, DOI 10.1073/pnas.72.6.2227; Houde A.E., 1997, SEX COLOR MATE CHOIC; Jeswiet SB, 2012, BEHAV ECOL, V23, P195, DOI 10.1093/beheco/arr175; Jeswiet SB, 2011, ETHOLOGY, V117, P422, DOI 10.1111/j.1439-0310.2011.01891.x; Johnstone RA, 1996, EVOLUTION, V50, P1382, DOI [10.2307/2410876, 10.1111/j.1558-5646.1996.tb03912.x]; Jordan LA, 2012, EVOLUTION, V66, P280, DOI 10.1111/j.1558-5646.2011.01421.x; Kelley JL, 1999, NATURE, V401, P661, DOI 10.1038/44314; Kelly CD, 2011, BIOL REV, V86, P863, DOI 10.1111/j.1469-185X.2011.00175.x; Kolluru GR, 2009, BEHAV ECOL, V20, P131, DOI 10.1093/beheco/arn124; Kuckuck Constanze, 1997, Zeitschrift fuer Fischkunde, V4, P73; Liley N. R., 1966, Behaviour Suppl, V13, P1; Makowicz AM, 2010, BEHAVIOUR, V147, P1657, DOI 10.1163/000579510X528206; Matthews IM, 1997, P ROY SOC B-BIOL SCI, V264, P695, DOI 10.1098/rspb.1997.0099; Middleton K, 2012, JNT JOHNSON NEYMAN T; Miller LK, 2005, EVOLUTION, V59, P2414; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; NAKATSURU K, 1982, SCIENCE, V216, P753, DOI 10.1126/science.216.4547.753; Parker G.A., 1983, P141; Pettersson LB, 2004, BEHAV ECOL SOCIOBIOL, V55, P461, DOI 10.1007/s00265-003-0727-8; Pilastro A, 2007, ANIM BEHAV, V74, P321, DOI 10.1016/j.anbehav.2006.09.016; Pilastro A, 1999, P ROY SOC B-BIOL SCI, V266, P1887, DOI 10.1098/rspb.1999.0862; Preston BT, 2001, NATURE, V409, P681, DOI 10.1038/35055617; Rahman MM, 2013, ECOL EVOL, V3, P2197, DOI 10.1002/ece3.632; Reinhold K, 2002, J EVOLUTION BIOL, V15, P201, DOI 10.1046/j.1420-9101.2002.00390.x; REYNOLDS JD, 1992, P ROY SOC B-BIOL SCI, V250, P57, DOI 10.1098/rspb.1992.0130; Rios-Cardenas O, 2011, ECOLOGY EVOLUTION PO; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8	59	14	14	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93780	10.1371/journal.pone.0093780	http://dx.doi.org/10.1371/journal.pone.0093780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705713	gold, Green Published			2022-12-25	WOS:000334107500066
J	Wu, XM; Gao, H; Bleday, R; Zhu, ZL				Wu, Xiaoming; Gao, Hong; Bleday, Ronald; Zhu, Zhenglun			Homeobox Transcription Factor VentX Regulates Differentiation and Maturation of Human Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERLEUKIN-6 GENE; ACTIVATION; MACROPHAGES; EXPRESSION; MONOCYTES; PROMOTES; SUSCEPTIBILITY; INHIBITION; PRECURSORS; SWITCHES	Dendritic cells (DCs) are specialized antigen presentation cells that play critical roles in the initiation and regulation of immune responses. The molecular determinants of DC differentiation and maturation are target of extensive investigation. VentX is a human homeobox transcriptional factor that regulates proliferation and differentiation of hematopoietic cells. In the current study, we report that ablation of VentX expression in monocytes significantly impaired their differentiation into DCs. Conversely, overexpression of VentX in monocytic THP1 cells accelerated their differentiation toward DCs. We showed that VentX regulates DC differentiation, in part, through modulating IL6 expression. Clinically, we found that VentX expression was elevated in intestinal lamina propria DCs (LPDCs) of inflamed mucosa from inflammatory bowel disease patients. Knockdown experiments suggested that VentX is essential for the maturation of LPDCs. In addition, corticosteroid treatment markedly decreased VentX expression in LPDCs and enforced expression of VentX counteracted the effects of corticosteroid on DCs maturation. Our data suggest that VentX is a critical transcriptional regulator of DC differentiation and maturation, and a potential target of immune regulation and therapy.	[Wu, Xiaoming; Zhu, Zhenglun] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Gastroenterol Div, Boston, MA 02115 USA; [Bleday, Ronald] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Surg, Boston, MA 02115 USA; [Gao, Hong] Tufts Med Ctr, Dept Med, Boston, MA 02111 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Tufts Medical Center	Zhu, ZL (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.	zzhu@partners.org			National Institutes of Health, American Cancer Society; Brigham and Women's Hospital	National Institutes of Health, American Cancer Society; Brigham and Women's Hospital	This work was supported, in whole or in part, by grants from the National Institutes of Health, American Cancer Society, and a research fund from Brigham and Women's Hospital (to Z. Z.).	Appel S, 2006, BLOOD, V107, P3265, DOI 10.1182/blood-2005-06-2480; Bell SJ, 2001, J IMMUNOL, V166, P4958, DOI 10.4049/jimmunol.166.8.4958; Berges C, 2005, BIOCHEM BIOPH RES CO, V333, P896, DOI 10.1016/j.bbrc.2005.05.171; Chim CS, 2008, J CLIN PATHOL, V61, P1214, DOI 10.1136/jcp.2008.060152; Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763; de Jong EC, 1999, J LEUKOCYTE BIOL, V66, P201, DOI 10.1002/jlb.66.2.201; Delneste Y, 2003, BLOOD, V101, P143, DOI 10.1182/blood-2002-04-1164; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Faggioli L, 2004, BBA-MOL CELL RES, V1692, P17, DOI 10.1016/j.bbamcr.2004.03.001; Gabriele L, 2004, BLOOD, V103, P980, DOI 10.1182/blood-2003-03-0981; Gao H, 2007, CELL RES, V17, P345, DOI 10.1038/cr.2007.20; Gao H, 2012, J BIOL CHEM, V287, P29979, DOI 10.1074/jbc.M112.383018; Gao H, 2010, CANCER RES, V70, P202, DOI 10.1158/0008-5472.CAN-09-2668; Grassl C, 1999, J AM SOC NEPHROL, V10, P1466; Hart AL, 2005, GASTROENTEROLOGY, V129, P50, DOI 10.1053/j.gastro.2005.05.013; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Kramer JL, 2002, BRIT J HAEMATOL, V117, P727, DOI 10.1046/j.1365-2141.2002.03498.x; Le Naour F, 2001, J BIOL CHEM, V276, P17920, DOI 10.1074/jbc.M100156200; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Mellman I, 2005, ADV EXP MED BIOL, V560, P63; Menetrier-Caux C, 1998, BLOOD, V92, P4778, DOI 10.1182/blood.V92.12.4778; Mitani H, 2000, BRIT J HAEMATOL, V109, P288, DOI 10.1046/j.1365-2141.2000.02020.x; Piemonti L, 1999, J IMMUNOL, V162, P6473; PIGNATA C, 1990, GUT, V31, P879, DOI 10.1136/gut.31.8.879; Rawat VPS, 2010, P NATL ACAD SCI USA, V107, P16946, DOI 10.1073/pnas.1001878107; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; SANTHANAM U, 1991, P NATL ACAD SCI USA, V88, P7605, DOI 10.1073/pnas.88.17.7605; Segura E, 2013, IMMUNITY, V38, P336, DOI 10.1016/j.immuni.2012.10.018; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Valencia J, 2011, J IMMUNOL, V187, P4129, DOI 10.4049/jimmunol.1101243; Wu XM, 2011, J CLIN INVEST, V121, P2599, DOI 10.1172/JCI45556; Wu XM, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206078; Yang JM, 2012, CANCER RES, V72, P4682, DOI 10.1158/0008-5472.CAN-12-0440; Zhong YF, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-169	41	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 23	2014	289	21					14633	14643		10.1074/jbc.M113.509158	http://dx.doi.org/10.1074/jbc.M113.509158			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AI9JE	24706756	hybrid, Green Published			2022-12-25	WOS:000337248100020
J	Bao, H; Kommadath, A; Plastow, GS; Tuggle, CK; Guan, LL; Stothard, P				Bao, Hua; Kommadath, Arun; Plastow, Graham S.; Tuggle, Christopher K.; Guan, Le Luo; Stothard, Paul			MicroRNA Buffering and Altered Variance of Gene Expression in Response to Salmonella Infection	PLOS ONE			English	Article							RNA-BINDING PROTEINS; SINGLE-CELL; NETWORK; TARGET; STOCHASTICITY; CANALIZATION; ROBUSTNESS; IMPACT	One potential role of miRNAs is to buffer variation in gene expression, although conflicting results have been reported. To investigate the buffering role of miRNAs in response to Salmonella infection in pigs, we sequenced miRNA and mRNA in whole blood from 15 pig samples before and after Salmonella challenge. By analyzing inter-individual variation in gene expression patterns, we found that for moderately and lowly expressed genes, putative miRNA targets showed significantly lower expression variance compared with non-miRNA-targets. Expression variance between highly expressed miRNA targets and non-miRNA-targets was not significantly different. Further, miRNA targets demonstrated significantly reduced variance after challenge whereas non-miRNA-targets did not. RNA binding proteins (RBPs) are significantly enriched among the miRNA targets with dramatically reduced variance of expression after Salmonella challenge. Moreover, we found evidence that targets of young (less-conserved) miRNAs showed lower expression variance compared with targets of old (evolutionarily conserved) miRNAs. These findings point to the importance of a buffering effect of miRNAs for relatively lowly expressed genes, and suggest that the reduced expression variation of RBPs may play an important role in response to Salmonella infection.	[Bao, Hua; Kommadath, Arun; Plastow, Graham S.; Guan, Le Luo; Stothard, Paul] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Tuggle, Christopher K.] Iowa State Univ, Dept Anim Sci, Ames, IA USA	University of Alberta; Iowa State University	Guan, LL (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	lguan@ualberta.ca; stothard@ualberta.ca	Kommadath, Arun/I-4644-2019	Kommadath, Arun/0000-0003-3587-6670; Plastow, Graham/0000-0002-3774-3110	Applied Livestock Genomics Program [ALGP13]; Genome Alberta; Alberta Livestock and Meat Agency	Applied Livestock Genomics Program; Genome Alberta; Alberta Livestock and Meat Agency	This work is supported by the Applied Livestock Genomics Program (ALGP13) funded by Genome Alberta and Alberta Livestock and Meat Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-609; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Ciafre SA, 2013, RNA BIOL, V10, P935, DOI 10.4161/rna.24641; Cook KB, 2011, NUCLEIC ACIDS RES, V39, pD301, DOI 10.1093/nar/gkq1069; Cui QH, 2007, TRENDS GENET, V23, P372, DOI 10.1016/j.tig.2007.04.003; Cui QH, 2007, BIOCHEM BIOPH RES CO, V352, P733, DOI 10.1016/j.bbrc.2006.11.080; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; Enright AJ, 2004, GENOME BIOL, V5; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Herranz H, 2010, GENE DEV, V24, P1339, DOI 10.1101/gad.1937010; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Komurov K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-154; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Li L, 2012, J INSECT PHYSIOL, V58, P1438, DOI 10.1016/j.jinsphys.2012.08.008; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Lu J, 2012, GENOME RES, V22, P1243, DOI 10.1101/gr.132514.111; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Mar JC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002207; Marinov GK, 2014, GENOME RES, V24, P496, DOI 10.1101/gr.161034.113; Mehta P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.58; Mittal N, 2011, J MOL BIOL, V409, P466, DOI 10.1016/j.jmb.2011.03.064; Mittal N, 2009, P NATL ACAD SCI USA, V106, P20300, DOI 10.1073/pnas.0906940106; Osella M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001101; Pelaez N, 2012, CURR TOP DEV BIOL, V99, P237, DOI 10.1016/B978-0-12-387038-4.00009-4; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; True JR, 2001, EVOL DEV, V3, P109, DOI 10.1046/j.1525-142x.2001.003002109.x; Woloshen V, 2011, J PATHOG, V2011, DOI 10.4061/2011/278697; Wu CI, 2009, GENOME RES, V19, P734, DOI 10.1101/gr.084640.108; Wu K., 2007, GLOBIN REDUCTION PRO; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yang Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S14; Yiakouvaki A, 2012, J CLIN INVEST, V122, P48, DOI 10.1172/JCI45021; Zhang Y, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-127	43	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94352	10.1371/journal.pone.0094352	http://dx.doi.org/10.1371/journal.pone.0094352			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718561	Green Submitted, Green Published, gold			2022-12-25	WOS:000334339000108
J	Costa, SCP; Lesser, CF				Costa, Sonia C. P.; Lesser, Cammie F.			A Multifunctional Region of the Shigella Type 3 Effector IpgB1 Is Important for Secretion from Bacteria and Membrane Targeting in Eukaryotic Cells	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; VIRULENCE FACTORS; PSEUDOMONAS-EXOS; PROTEIN; INVASION; SYSTEM; MOTIF; IDENTIFICATION; LOCALIZATION; EXPRESSION	Type 3 secretion systems are complex nanomachines used by many Gram-negative bacteria to deliver tens of proteins (effectors) directly into host cells. Once delivered into host cells, effectors often target to specific cellular loci where they usurp host cell processes to their advantage. Here, using the yeast model system, we identify the membrane localization domain (MLD) of IpgB1, a stretch of 20 amino acids enriched for hydrophobic residues essential for the targeting of this effector to the plasma membrane. Embedded within these residues are ten that define the IpgB1 chaperone-binding domain for Spa15. As observed with dedicated class IA chaperones that mask hydrophobic MLDs, Spa15, a class IB chaperone, promotes IpgB1 stability by binding this hydrophobic region. However, despite being stable, an IpgB1 allele that lacks the MLD is not recognized as a secreted substrate. Similarly, deletion of the chaperone binding domains of IpgB1 and three additional Spa15-dependent effectors result in alleles that are no longer recognized as secreted substrates despite the presence of intact N-terminal secretion signal sequences. This is in contrast with MLD-containing effectors that bind class IA dedicated chaperones, as deletion of the MLD of these effectors alleviates the chaperone requirement for secretion. These observations indicate that at least for substrates of class IB chaperones, the chaperone-effector complex plays a major role in defining type 3 secreted proteins and highlight how a single region of an effector can play important roles both within prokaryotic and eukaryotic cells.	[Lesser, Cammie F.] Massachusetts Gen Hosp, Div Infect Dis, Dept Med Microbiol & Immunol, Cambridge, MA USA; Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University	Lesser, CF (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Dept Med Microbiol & Immunol, Cambridge, MA USA.	clesser@mgh.harvard.edu			National Institutes of Health [R01 AI064285, R21 AI096134]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064285, R21AI096134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Work was conducted through support from the National Institutes of Health (R01 AI064285 and R21 AI096134). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031; Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Costa SCP, 2012, MBIO, V3, DOI 10.1128/mBio.00243-11; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; French CT, 2009, CELL MICROBIOL, V11, P1735, DOI 10.1111/j.1462-5822.2009.01361.x; Geissler B, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00075; Hachani A, 2008, MICROBES INFECT, V10, P260, DOI 10.1016/j.micinf.2007.11.011; Handa Y, 2007, NAT CELL BIOL, V9, P121, DOI 10.1038/ncb1526; Hicks SW, 2011, CELL HOST MICROBE, V10, P9, DOI 10.1016/j.chom.2011.06.003; Huang J, 2008, NATURE, V456, P112, DOI 10.1038/nature07355; Huang ZW, 2009, NAT STRUCT MOL BIOL, V16, P853, DOI 10.1038/nsmb.1647; Isaksson EL, 2009, INFECT IMMUN, V77, P4740, DOI 10.1128/IAI.00333-09; Klink BU, 2010, J BIOL CHEM, V285, P17197, DOI 10.1074/jbc.M110.107953; Knodler LA, 2011, CELL MICROBIOL, V13, P1497, DOI 10.1111/j.1462-5822.2011.01635.x; Krall R, 2004, J BIOL CHEM, V279, P2747, DOI 10.1074/jbc.M301963200; Lesser CF, 2001, EMBO J, V20, P1840, DOI 10.1093/emboj/20.8.1840; Letzelter M, 2006, EMBO J, V25, P3223, DOI 10.1038/sj.emboj.7601202; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Niebuhr K, 2000, MOL MICROBIOL, V38, P8, DOI 10.1046/j.1365-2958.2000.02041.x; Ogawa M, 2003, MOL MICROBIOL, V48, P913, DOI 10.1046/j.1365-2958.2003.03489.x; Ohya K, 2005, J BIOL CHEM, V280, P24022, DOI 10.1074/jbc.M502509200; Page AL, 2002, MOL MICROBIOL, V43, P1533, DOI 10.1046/j.1365-2958.2002.02835.x; Reinicke AT, 2005, J BIOL CHEM, V280, P14620, DOI 10.1074/jbc.M500076200; Rodgers L, 2010, J BACTERIOL, V12; Schmitz AM, 2009, NAT METHODS, V6, P500, DOI 10.1038/nmeth.1337; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Siggers KA, 2008, CELL HOST MICROBE, V4, P8, DOI 10.1016/j.chom.2008.06.004; Sisko JL, 2006, MOL MICROBIOL, V60, P51, DOI 10.1111/j.1365-2958.2006.05074.x; Slagowski NL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040009; Valdivia R, 2004, EUKARYOT CELL, V3; Zhang Y, 2005, INFECT IMMUN, V73, P7938, DOI 10.1128/IAI.73.12.7938-7945.2005; Zhang Y, 2007, J BIOL CHEM, V282, P13022, DOI 10.1074/jbc.M606305200	32	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e93461	10.1371/journal.pone.0093461	http://dx.doi.org/10.1371/journal.pone.0093461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718571	Green Published, Green Submitted, gold			2022-12-25	WOS:000334339000034
J	Ding, WX; Zhang, XF; Huang, HP; Ding, N; Zhang, SJ; Hutchinson, SZ; Zhang, XL				Ding, Wenxiao; Zhang, Xiaofeng; Huang, Hanpeng; Ding, Ning; Zhang, Shijiang; Hutchinson, Sean Z.; Zhang, Xilong			Adiponectin Protects Rat Myocardium against Chronic Intermittent Hypoxia-Induced Injury via Inhibition of Endoplasmic Reticulum Stress	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; LEFT-VENTRICULAR DYSFUNCTION; ISCHEMIA-REPERFUSION INJURY; ADIPOSE-SPECIFIC PROTEIN; DILATED CARDIOMYOPATHY; PRESSURE-OVERLOAD; INDUCED APOPTOSIS; CYTOCHROME-C; CELL-DEATH; HYPOADIPONECTINEMIA	Obstructive sleep apnea syndrome (OSAS) is associated with many cardiovascular disorders such as heart failure, hypertension, atherosclerosis, and arrhythmia and so on. Of the many associated factors, chronic intermittent hypoxia (CIH) in particular is the primary player in OSAS. To assess the effects of CIH on cardiac function secondary to OSAS, we established a model to study the effects of CIH on Wistar rats. Specifically, we examined the possible underlying cellular mechanisms of hypoxic tissue damage and the possible protective role of adiponectin against hypoxic insults. In the first treatment group, rats were exposed to CIH conditions (nadir O2, 5-6%) for 8 hours/day, for 5 weeks. Subsequent CIH-induced cardiac dysfunction was measured by echocardiograph. Compared with the normal control (NC) group, rats in the CIH-exposed group experienced elevated levels of left ventricular end-systolic dimension and left ventricular end-systolic volume and depressed levels of left ventricular ejection fraction and left ventricular fractional shortening (p<0.05). However, when adiponectin (Ad) was added in CIH + Ad group, we saw a rescue in the elevations of the aforementioned left ventricular function (p < 0.05). To assess critical cardiac injury, we detected myocardial apoptosis by Terminal deoxynucleotidyl transfer-mediated dUTP nick end-labeling (TUNEL) analysis. It was showed that the apoptosis percentage in CIH group (2.948%) was significantly higher than that in NC group (0.4167%) and CIH + Ad group (1.219%) (p<0.05). Protein expressions of cleaved caspase-3, cleaved caspase-9, and cleaved-caspase-12 validated our TUNEL results (p<0.05). Mechanistically, our results demonstrated that the proteins expressed with endoplasmic reticulum stress and the expression of reactive oxygen species (ROS) were significantly elevated under CIH conditions, whereas Ad supplementation partially decreased them. Overall, our results suggested that Ad augmentation could improve CIH-induced left ventricular dysfunction and associated myocardial apoptosis by inhibition of ROS-dependent ER stress.	[Ding, Wenxiao; Zhang, Xiaofeng; Huang, Hanpeng; Ding, Ning; Zhang, Xilong] Nanjing Med Univ, Affiliated Hosp 1, Dept Respirol, Nanjing, Jiangsu, Peoples R China; [Zhang, Shijiang] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiothorac Surg, Nanjing, Jiangsu, Peoples R China; [Hutchinson, Sean Z.] Morsani Coll Med, Tampa, FL USA	Nanjing Medical University	Zhang, XL (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Respirol, Nanjing, Jiangsu, Peoples R China.	zhangxilong1952@163.com			National Natural Science Foundation of China [81370184, 81270312]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 81370184 and 81270312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANVERSA P, 1993, CARDIOVASC RES, V27, P145, DOI 10.1093/cvr/27.2.145; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; BELTRAMI CA, 1995, J MOL CELL CARDIOL, V27, P291, DOI 10.1016/S0022-2828(08)80028-4; Bian YF, 2011, J INVEST MED, V59, P921, DOI 10.2310/JIM.0b013e318216ad04; Bitter T, 2012, Herzschrittmacherther Elektrophysiol, V23, P22, DOI 10.1007/s00399-011-0164-8; Brisco Meredith A, 2010, Curr Heart Fail Rep, V7, P175, DOI 10.1007/s11897-010-0033-5; Chen L, 2005, AM J RESP CRIT CARE, V172, P915, DOI 10.1164/rccm.200504-560OC; Chen L, 2008, J APPL PHYSIOL, V104, P218, DOI 10.1152/japplphysiol.00301.2007; Chen L, 2010, J APPL PHYSIOL, V109, P1675, DOI 10.1152/japplphysiol.01372.2009; Ding W, 2012, BIOCHEM BIOPH RES CO, V418, P451, DOI 10.1016/j.bbrc.2012.01.037; Duda MK, 2007, CARDIOVASC RES, V76, P303, DOI 10.1016/j.cardiores.2007.07.002; Eymin B, 1997, CANCER RES, V57, P686; Frantz S, 2003, J MOL CELL CARDIOL, V35, P685, DOI 10.1016/S0022-2828(03)00113-5; Friedman AD, 1996, CANCER RES, V56, P3250; Goldstein BJ, 2009, NAT CLIN PRACT CARD, V6, P27, DOI 10.1038/ncpcardio1398; Hashimoto N, 2006, METABOLISM, V55, P1653, DOI 10.1016/j.metabol.2006.08.005; Hochhauser E, 2003, AM J PHYSIOL-HEART C, V284, pH2351, DOI 10.1152/ajpheart.00783.2002; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Huang HP, 2012, SLEEP BREATH, V16, P505, DOI 10.1007/s11325-011-0532-y; Iwashima Y, 2004, HYPERTENSION, V43, P1318, DOI 10.1161/01.HYP.0000129281.03801.4b; Kim I, 2009, J BIOL CHEM, V284, P1593, DOI 10.1074/jbc.M807308200; Kim SM, 2012, J CARDIOL, V60, P475, DOI 10.1016/j.jjcc.2012.07.007; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Lam JCM, 2008, SLEEP, V31, P1721, DOI 10.1093/sleep/31.12.1721; Liu ZW, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-158; Lu DY, 2013, J BIOL CHEM, V288, P8491, DOI 10.1074/jbc.M112.442061; Lui MMS, 2012, J THORAC DIS, V4, P164, DOI 10.3978/j.issn.2072-1439.2012.01.06; Magalang UJ, 2006, ANTIOXID REDOX SIGN, V8, P2179, DOI 10.1089/ars.2006.8.2179; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Minamino T, 2010, CIRC RES, V107, P1071, DOI 10.1161/CIRCRESAHA.110.227819; Mocanu MM, 2000, BRIT J PHARMACOL, V130, P197, DOI 10.1038/sj.bjp.0703336; Momoi T, 2004, J CHEM NEUROANAT, V28, P101, DOI 10.1016/j.jchemneu.2004.05.008; Morishima N, 2002, J BIOL CHEM, V277, P34287, DOI 10.1074/jbc.M204973200; Nguyen M, 2000, MOL CELL BIOL, V20, P6731, DOI 10.1128/MCB.20.18.6731-6740.2000; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Ouchi N, 2006, TRENDS CARDIOVAS MED, V16, P141, DOI 10.1016/j.tcm.2006.03.001; Ouchi N, 2007, CLIN CHIM ACTA, V380, P24, DOI 10.1016/j.cca.2007.01.026; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Park M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019143; Pedrosa RP, 2011, ARQ BRAS CARDIOL, V97, pE40; Peralta C, 2011, CURR MED CHEM, V18, P2016, DOI 10.2174/092986711795590039; Pineiro R, 2005, FEBS LETT, V579, P5163, DOI 10.1016/j.febslet.2005.07.098; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; Rasheva VI, 2009, APOPTOSIS, V14, P996, DOI 10.1007/s10495-009-0341-y; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sawada T, 2010, J MOL CELL CARDIOL, V48, P1280, DOI 10.1016/j.yjmcc.2010.02.004; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2007, J MOL CELL CARDIOL, V42, P1065, DOI 10.1016/j.yjmcc.2007.03.808; Shibata R, 2007, CARDIOVASC RES, V74, P471, DOI 10.1016/j.cardiores.2007.02.010; Shim CY, 2010, YONSEI MED J, V51, P375, DOI 10.3349/ymj.2010.51.3.375; Shimano M, 2010, J MOL CELL CARDIOL, V49, P210, DOI 10.1016/j.yjmcc.2010.02.021; Shore GC, 2011, CURR OPIN CELL BIOL, V23, P143, DOI 10.1016/j.ceb.2010.11.003; Skurk C, 2008, EUR HEART J, V29, P1168, DOI 10.1093/eurheartj/ehn136; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Tabas I, 2010, CIRC RES, V107, P839, DOI 10.1161/CIRCRESAHA.110.224766; Tao L, 2007, CIRCULATION, V115, P1408, DOI 10.1161/CIRCULATIONAHA.106.666941; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yaoita H, 2000, CARDIOVASC RES, V45, P630, DOI 10.1016/S0008-6363(99)00349-1; Zhang XF, 2013, CHINESE MED J-PEKING, V126, P3270, DOI 10.3760/cma.j.issn.0366-6999.20131660; Zhang XL, 2004, CHINESE MED J-PEKING, V117, P1603	64	63	71	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94545	10.1371/journal.pone.0094545	http://dx.doi.org/10.1371/journal.pone.0094545			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718591	Green Published, gold, Green Submitted			2022-12-25	WOS:000334339000131
J	Guo, WS; Yang, GW; Wu, W; He, L; Sun, MY				Guo, Wensheng; Yang, Guowu; Wu, Wei; He, Lei; Sun, Mingyu			A Parallel Attractor Finding Algorithm Based on Boolean Satisfiability for Genetic Regulatory Networks	PLOS ONE			English	Article							FUNCTIONAL-ANALYSIS; SIMULATION; MODEL; PREDICTS	In biological systems, the dynamic analysis method has gained increasing attention in the past decade. The Boolean network is the most common model of a genetic regulatory network. The interactions of activation and inhibition in the genetic regulatory network are modeled as a set of functions of the Boolean network, while the state transitions in the Boolean network reflect the dynamic property of a genetic regulatory network. A difficult problem for state transition analysis is the finding of attractors. In this paper, we modeled the genetic regulatory network as a Boolean network and proposed a solving algorithm to tackle the attractor finding problem. In the proposed algorithm, we partitioned the Boolean network into several blocks consisting of the strongly connected components according to their gradients, and defined the connection between blocks as decision node. Based on the solutions calculated on the decision nodes and using a satisfiability solving algorithm, we identified the attractors in the state transition graph of each block. The proposed algorithm is benchmarked on a variety of genetic regulatory networks. Compared with existing algorithms, it achieved similar performance on small test cases, and outperformed it on larger and more complex ones, which happens to be the trend of the modern genetic regulatory network. Furthermore, while the existing satisfiability-based algorithms cannot be parallelized due to their inherent algorithm design, the proposed algorithm exhibits a good scalability on parallel computing architectures.	[Guo, Wensheng; Yang, Guowu] Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu 610054, Sichuan, Peoples R China; [Guo, Wensheng; Wu, Wei; He, Lei] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90024 USA; [Sun, Mingyu] Shanghai Univ Tradit Chinese Med, ShuGuang Hosp, Inst Liver Dis, Shanghai, Peoples R China; [Sun, Mingyu] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA	University of Electronic Science & Technology of China; University of California System; University of California Los Angeles; Shanghai University of Traditional Chinese Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Guo, WS (corresponding author), Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu 610054, Sichuan, Peoples R China.	wensh7608@gmail.com; mysun248@hotmail.com			National Natural Science Foundation of China [81273729, 61272175]; National Basic Research 973 Program of China [2010CB328004]; Major Project of Shanghai Municipal ST Commission [11DZ1971702]; Wang Bao-En Hepatic Fibrosis Research fund [20100048]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research 973 Program of China(National Basic Research Program of China); Major Project of Shanghai Municipal ST Commission; Wang Bao-En Hepatic Fibrosis Research fund	This work was partially supported by the National Natural Science Foundation of China (No. 81273729, 61272175), the National Basic Research 973 Program of China (No. 2010CB328004), the Major Project of Shanghai Municipal S&T Commission (No. 11DZ1971702), and Wang Bao-En Hepatic Fibrosis Research fund (20100048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akutsu T, 2012, IEEE ACM T COMPUT BI, V9, P1410, DOI 10.1109/TCBB.2012.87; Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Aldana M, 2003, PHYSICA D, V185, P45, DOI 10.1016/S0167-2789(03)00174-X; BRYANT RE, 1986, IEEE T COMPUT, V35, P677, DOI 10.1109/TC.1986.1676819; Chaos A, 2006, J PLANT GROWTH REGUL, V25, P278, DOI 10.1007/s00344-006-0068-8; Chautard E, 2009, PATHOL BIOL, V57, P324, DOI 10.1016/j.patbio.2008.10.004; Cheng DH, 2011, COMMUN CONTROL ENG, P1, DOI 10.1007/978-0-85729-097-7; Cho DY, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002820; Christoph Mussel MH, 2013, BOOLNET; Clarke E, 2001, FORM METHOD SYST DES, V19, P7, DOI 10.1023/A:1011276507260; Davidich MI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001672; De Jong H, 2002, J COMPUT BIOL, V9, P67, DOI 10.1089/10665270252833208; de Jong H, 2003, BIOINFORMATICS, V19, P336, DOI 10.1093/bioinformatics/btf851; Di Cara A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-462; Dubrova E, 2005, IEEE IC CAD, P479, DOI 10.1109/ICCAD.2005.1560115; Dubrova E, 2011, IEEE ACM T COMPUT BI, V8, P1393, DOI 10.1109/TCBB.2010.20; Een N, 2004, LECT NOTES COMPUT SC, V2919, P502, DOI 10.1007/978-3-540-24605-3_37; Faure A, 2006, BIOINFORMATICS, V22, pE124, DOI 10.1093/bioinformatics/btl210; Filippone M, 2008, PATTERN RECOGN, V41, P176, DOI 10.1016/j.patcog.2007.05.018; Gabow HN, 2000, INFORM PROCESS LETT, V74, P107, DOI 10.1016/S0020-0190(00)00051-X; Garg A, 2007, LECT NOTES COMPUT SC, V4453, P62; Johnson D. B., 1975, SIAM Journal on Computing, V4, P77, DOI 10.1137/0204007; Karl S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-306; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Klamt S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-56; Klamt S, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-2; Krumsiek J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-233; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Mateti P., 1976, SIAM Journal on Computing, V5, P90, DOI 10.1137/0205007; Mendoza L, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-13; Zhao QC, 2005, IEEE T NEURAL NETWOR, V16, P1715, DOI 10.1109/TNN.2005.857944; Zhao Y, 2013, IEEE T AUTOMAT CONTR, V58, P1976, DOI 10.1109/TAC.2013.2251819; Zheng DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060593	34	20	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94258	10.1371/journal.pone.0094258	http://dx.doi.org/10.1371/journal.pone.0094258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718686	Green Submitted, gold, Green Published			2022-12-25	WOS:000334339000098
J	Yoon, JH; Won, JU; Ahn, YS; Roh, J				Yoon, Jin-Ha; Won, Jong-Uk; Ahn, Yeon-Soon; Roh, Jaehoon			Poor Lung Function Has Inverse Relationship with Microalbuminuria, an Early Surrogate Marker of Kidney Damage and Atherosclerosis: The 5(th) Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; SYSTEMIC INFLAMMATION; RISK-FACTOR; PREVALENCE; MORTALITY; COPD; MANIFESTATIONS; ASSOCIATION	Background: Despite epidemiological evidences of relationship between poor lung function and atherosclerosis, the relationship between poor lung function and microalbuminuria (MAU), an early surrogate marker of both kidney damage and atherosclerosis, is not well understood. Hence, we plan to investigate the relationship between poor lung function and MAU using multivariate models to adjust for other atherogenic risk factors. Methods: We used data from the 5(th) Korean National Health and Nutrition Examination Survey. Poor lung function is determined by spirometric measurement, primarily through estimation of the forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1). Declines in the percent predicted FVC (> 80%) and in the FEV1/ FVC ratio (> 0.7) are defined as restrictive and obstructive patterns, respectively. Urine albumin to urine creatinine levels ratio (UACR) were measured in spot urine samples. MAU was defined as UACR > 30 mg/g. Results: Inverse relationship was observed between lung function and UACR. In an age-adjusted regression model, the regression coefficient (B) of 10% lower FVC was 11.09 in men (P = 0.002), which remained significant after adjustment for SBP, FBG, triglyceride level, BMI, smoking history, and heavy alcohol consumption (B = 7.52, P = 0.043). When the restrictive pattern was compared to the normal pattern, the odds ratios (OR) (95% confidence interval, 95% CI) for MAU were 1.90 (1.32-2.72) in men, after adjustment for age, hypertension, diabetes mellitus, triglyceride level, obesity, smoking history, physical activity, and heavy alcohol consumption. Conclusions: Our study, the first investigation in Asia, demonstrated that the restrictive pattern is related to MAU in men. Furthermore, there was linear relationship between lower FVC and UACR. Thus, our current study suggests that poor lung function, particularly the restrictive pattern, is related to kidney damage as well as atherosclerosis.	[Yoon, Jin-Ha; Won, Jong-Uk; Roh, Jaehoon] Yonsei Univ, Coll Med, Inst Occupat Hlth, Seoul, South Korea; [Yoon, Jin-Ha; Won, Jong-Uk; Roh, Jaehoon] Yonsei Univ, Coll Med, Dept Prevent Med & Publ Hlth, Seoul, South Korea; [Yoon, Jin-Ha; Won, Jong-Uk; Roh, Jaehoon] Yonsei Univ, Coll Med, Grad Sch Publ Hlth, Seoul, South Korea; [Ahn, Yeon-Soon] Dongguk Univ, Ilsan Hosp, Dept Occupat & Environm Med, Goyang, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Dongguk University; NHIS Ilsan Hospital	Roh, J (corresponding author), Yonsei Univ, Coll Med, Inst Occupat Hlth, Seoul, South Korea.	jhroh@yuhs.ac		Yoon, Jin-Ha/0000-0003-4198-2955; Won, Jong-Uk/0000-0002-9200-3297				Akpinar EE, 2012, TUBERK TORAK, V60, P230, DOI 10.5578/tt.4018; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Cerasola G, 2010, J HYPERTENS, V28, P2357, DOI 10.1097/HJH.0b013e32833ec377; Choi JK, 2005, TUBERC RESPIR DIS, V58, P230, DOI 10.4046/trd.2005.58.3.230; Curkendall SM, 2006, EUR J EPIDEMIOL, V21, P803, DOI 10.1007/s10654-006-9066-1; de Zeeuw D, 2006, J AM SOC NEPHROL, V17, P2100, DOI 10.1681/ASN.2006050517; Ferretti A, 2001, CHEST, V119, P1401, DOI 10.1378/chest.119.5.1401; Fimognari FL, 2010, CURR VASC PHARMACOL, V8, P573; Garg JP, 2002, VASC MED, V7, P35, DOI 10.1191/1358863x02vm412ra; Gruffydd-Jones K, 2011, PRIM CARE RESP J, V20, P199, DOI 10.4104/pcrj.2011.00011; Hancox RJ, 2007, THORAX, V62, P1064, DOI 10.1136/thx.2006.076877; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; JENSEN JS, 1995, CLIN SCI, V88, P629, DOI 10.1042/cs0880629; Johnston AK, 2008, THORAX, V63, P599, DOI 10.1136/thx.2007.088112; Lee YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076244; Lu Y, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-53; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Mannino DM, 2006, RESP MED, V100, P115, DOI 10.1016/j.rmed.2005.03.035; Mannino DM, 2005, INT J TUBERC LUNG D, V9, P613; Mercken EM, 2005, AM J RESP CRIT CARE, V172, P994, DOI 10.1164/rccm.200411-1580OC; Nussbaumer-Ochsner Y, 2011, CHEST, V139, P165, DOI 10.1378/chest.10-1252; Orth SR, 1998, KIDNEY INT, V54, P926, DOI 10.1046/j.1523-1755.1998.00067.x; Schroeder EB, 2003, AM J EPIDEMIOL, V158, P1171, DOI 10.1093/aje/kwg276; Shibata Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083725; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; van Gestel YRBM, 2010, RESP MED, V104, P712, DOI 10.1016/j.rmed.2009.10.027; Won JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083273; Yoo KH, 2011, RESPIROLOGY, V16, P659, DOI 10.1111/j.1440-1843.2011.01951.x; Yoon Jin-Ha, 2012, Toxicology and Environmental Health Sciences, V4, P139, DOI 10.1007/s13530-012-0128-3; Zhang YH, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/819584	31	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2014	9	4							e94125	10.1371/journal.pone.0094125	http://dx.doi.org/10.1371/journal.pone.0094125			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE9PC	24718679	gold, Green Submitted, Green Published			2022-12-25	WOS:000334339000078
J	Cai, LY; He, HS; Wu, ZW; Lewis, BL; Liang, Y				Cai, Longyan; He, Hong S.; Wu, Zhiwei; Lewis, Benard L.; Liang, Yu			Development of Standard Fuel Models in Boreal Forests of Northeast China through Calibration and Validation	PLOS ONE			English	Article							GREAT XINGAN MOUNTAINS; MAPPING WILDLAND FUELS; FIRE SPREAD; SENSITIVITY-ANALYSIS; MEASUREMENT UNCERTAINTY; LANDSCAPE; BEHAVIOR; CLASSIFICATION; ACCUMULATION; PREDICTION	Understanding the fire prediction capabilities of fuel models is vital to forest fire management. Various fuel models have been developed in the Great Xing'an Mountains in Northeast China. However, the performances of these fuel models have not been tested for historical occurrences of wildfires. Consequently, the applicability of these models requires further investigation. Thus, this paper aims to develop standard fuel models. Seven vegetation types were combined into three fuel models according to potential fire behaviors which were clustered using Euclidean distance algorithms. Fuel model parameter sensitivity was analyzed by the Morris screening method. Results showed that the fuel model parameters 1-hour time-lag loading, dead heat content, live heat content, 1-hour time-lag SAV(Surface Area-to-Volume), live shrub SAV, and fuel bed depth have high sensitivity. Two main sensitive fuel parameters: 1-hour time-lag loading and fuel bed depth, were determined as adjustment parameters because of their high spatio-temporal variability. The FARSITE model was then used to test the fire prediction capabilities of the combined fuel models (uncalibrated fuel models). FARSITE was shown to yield an unrealistic prediction of the historical fire. However, the calibrated fuel models significantly improved the capabilities of the fuel models to predict the actual fire with an accuracy of 89%. Validation results also showed that the model can estimate the actual fires with an accuracy exceeding 56% by using the calibrated fuel models. Therefore, these fuel models can be efficiently used to calculate fire behaviors, which can be helpful in forest fire management.	[Cai, Longyan; He, Hong S.; Wu, Zhiwei; Liang, Yu] Univ Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China; [He, Hong S.; Lewis, Benard L.] Univ Missouri, Sch Nat Resources, Columbia, MO USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University of Chinese Academy of Sciences, CAS; University of Missouri System; University of Missouri Columbia	Wu, ZW (corresponding author), Univ Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China.	sanbei82@163.com	Yu, Liang/AFO-1361-2022; Wu, Zhiwei/AHC-9115-2022	He, Hong S./0000-0002-3983-2512	National Natural Science Foundation of China [41071120, 31200362]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by The National Natural Science Foundation of China (Grant Nos. 41071120 and 31200362). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini F.A, 1979, ESTIMATING WINDSPEED; ALBINI FA, 1986, COMBUST SCI TECHNOL, V48, P65, DOI 10.1080/00102208608923884; Anderson H. E., 1982, BARK BEETLES FUELS F, P143; Anderson HE, 1983, PREDICTING WIND DRIV; ANDREWS P.L, 2003, BEHAVEPLUS FIRE MODE; Andrews P.L., 1986, GEN TECHNICAL REPORT, P1; Arca B, 2005, VALIDATION FARSITE M; Arca B, 2007, INT J WILDLAND FIRE, V16, P563, DOI 10.1071/WF06070; Arroyo LA, 2008, FOREST ECOL MANAG, V256, P1239, DOI 10.1016/j.foreco.2008.06.048; BAKER WL, 1989, CAN J FOREST RES, V19, P700, DOI 10.1139/x89-109; Barton HA, 2007, TOXICOL SCI, V99, P395, DOI 10.1093/toxsci/kfm100; Burgan R, 1984, BEHAVE FIRE BEHAV PR; Burgan RE, 1987, CONCEPTS INTERPRETED; Carlson JD, 2003, INT J REMOTE SENS, V24, P1601, DOI 10.1080/01431160210144651; Chang Y, 2008, FOREST ECOL MANAG, V254, P445, DOI 10.1016/j.foreco.2007.04.050; Chang Y, 2007, INT J WILDLAND FIRE, V16, P34, DOI 10.1071/WF05093; Chen Hong-wei, 2008, Shengtaixue Zazhi, V27, P50; Clark JS, 1988, EFFECT CLIMATE CHANG; de Zorzi P, 2002, ACCREDIT QUAL ASSUR, V7, P182, DOI 10.1007/s00769-002-0447-1; DODGE M, 1972, SCIENCE, V177, P139, DOI 10.1126/science.177.4044.139; Du JH, 2004, STUDY BASAL INFORM D; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Fernandes PAM, 2001, FOREST ECOL MANAG, V144, P67, DOI 10.1016/S0378-1127(00)00363-7; Finney M.A., 1998, FARSITE FIRE AREA SI; Finney MA, 2003, INT J WILDLAND FIRE, V12, P167, DOI 10.1071/WF03010; Finney MA, 2009, FARSITE FIRE AREA SI; Finney MA, 1997, USE FARSITE SIMULATI, P17; Francos A, 2003, RELIAB ENG SYST SAFE, V79, P205, DOI 10.1016/S0951-8320(02)00231-4; Fujioka FM, 2002, INT J WILDLAND FIRE, V11, P193, DOI 10.1071/WF02004; Hu HaiQing, 2005, Scientia Silvae Sinicae, V41, P96; [胡天宇 Hu Tianyu], 2012, [生态学报, Acta Ecologica Sinica], V32, P6984; Iliopoulos N, 2013, ADV METEOROLOGY CLIM, P131; Keane RE, 2001, INT J WILDLAND FIRE, V10, P301, DOI 10.1071/WF01028; Lenhart T, 2002, PHYS CHEM EARTH, V27, P645, DOI 10.1016/S1474-7065(02)00049-9; [李月辉 LI YueHui], 2006, [生态学报, Acta Ecologica Sinica], V26, P3347; Liu Z, 2012, GLOBAL CHANGE BIOL; McCaw WL, 2002, FOREST ECOL MANAG, V158, P263, DOI 10.1016/S0378-1127(00)00719-2; MORRIS MD, 1991, TECHNOMETRICS, V33, P161, DOI 10.2307/1269043; Palmer MD, 2011, INT J CLIMATOL, V31, P980, DOI 10.1002/joc.2224; Parsons RA, 2011, ECOL MODEL, V222, P679, DOI 10.1016/j.ecolmodel.2010.10.023; Phillips SD, 1998, PRECIS ENG, V22, P87, DOI 10.1016/S0141-6359(98)00006-3; Pierce KB, 2009, CAN J FOREST RES, V39, P1901, DOI 10.1139/X09-102; Pinel F, 2012, LECT NOTES COMPUT SC, V7053, P204, DOI 10.1007/978-3-642-25261-7_16; Ramsey MH, 1997, SCI TOTAL ENVIRON, V198, P243, DOI 10.1016/S0048-9697(97)05456-9; Reich RM, 2004, INT J WILDLAND FIRE, V13, P119, DOI 10.1071/WF02049; REVELLE W, 1979, MULTIVAR BEHAV RES, V14, P57, DOI 10.1207/s15327906mbr1401_4; Riccardi CL, 2007, CAN J FOREST RES, V37, P2394, DOI 10.1139/X07-143; Rothermel R., 1972, MATH MODEL PREDICTIN; Ryu SR, 2007, LANDSCAPE URBAN PLAN, V83, P275, DOI 10.1016/j.landurbplan.2007.05.002; SAINTARNAUD S, 2003, CURRENT SOCIOLOGY, V0051; Salis M, 2008, SENSITIVITY FIRE BEH; Saltelli A, 2005, CHEM REV, V105, P2811, DOI 10.1021/cr040659d; Schladow SG, 1997, ECOL MODEL, V96, P111, DOI 10.1016/S0304-3800(96)00063-4; Scott JH, 2005, BARK BEETLES FUELS F, P66; Shan Y L, 2003, STUDY FOREST FUEL DA; Sparks JC, 2002, RESTOR ECOL, V10, P714, DOI 10.1046/j.1526-100X.2002.01052.x; Stephens SL, 1998, FOREST ECOL MANAG, V105, P21, DOI 10.1016/S0378-1127(97)00293-4; Stratton R.D, 2006, GUIDANCE SPATIAL WIL; Stratton RD, 2004, J FOREST, V102, P32; Van Wagtendonk JW., 1996, SIERRA NEVADA ECOSYS, VII, P1155; Wang XG, 2007, LANDSCAPE URBAN PLAN, V79, P84, DOI 10.1016/j.landurbplan.2006.03.010; Wu ZW, 2011, ENVIRON MANAGE, V48, P1148, DOI 10.1007/s00267-011-9707-3; Wu ZW, 2013, ENVIRON MANAGE, V52, P821, DOI 10.1007/s00267-013-0128-3; Wu ZW, 2013, SCI TOTAL ENVIRON, V454, P30, DOI 10.1016/j.scitotenv.2013.02.058; Xu H., 1997, ACTA ECOL SIN, V17, P337; Zhou Y., 1991, VEGETATION GREAT XIN	67	9	11	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e94043	10.1371/journal.pone.0094043	http://dx.doi.org/10.1371/journal.pone.0094043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714164	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900073
J	Moore, D; Paquette, C; Shropshire, JD; Seier, E; Joplin, KH				Moore, Darrell; Paquette, Caleb; Shropshire, J. Dylan; Seier, Edith; Joplin, Karl H.			Extensive Reorganization of Behavior Accompanies Ontogeny of Aggression in Male Flesh Flies	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; FEEDING TERRITORIALITY; GENE-EXPRESSION; COSTS; SEX; AGE; EXPERIENCE; BENEFITS; INSECTS	Aggression, costly in both time and energy, is often expressed by male animals in defense of valuable resources such as food or potential mates. Here we present a new insect model system for the study of aggression, the male flesh fly Sarcophaga crassipalpis, and ask whether there is an ontogeny of aggression that coincides with reproductive maturity. After establishing that reproductive maturity occurs by day 3 of age (post-eclosion), we examined the behavior of socially isolated males from different age cohorts (days 1, 2, 3, 4, and 6) upon introduction, in a test arena, with another male of the same age. The results show a pronounced development of aggression with age. The change from relative indifference to heightened aggression involves a profound increase in the frequency of high-intensity aggressive behaviors between days 1 and 3. Also noteworthy is an abrupt increase in the number of statistically significant transitions involving these full-contact agonistic behaviors on day 2. This elevated activity is trimmed back somewhat by day 3 and appears to maintain a stable plateau thereafter. No convincing evidence was found for escalation of aggression nor the establishment of a dominance relationship over the duration of the encounters. Despite the fact that aggressive interactions are brief, lasting only a few seconds, a major reorganization in the relative proportions of four major non-aggressive behaviors (accounting for at least 96% of the total observation time for each age cohort) accompanies the switch from low to high aggression. A series of control experiments, with single flies in the test arenas, indicates that these changes occur in the absence of the performance of aggressive behaviors. This parallel ontogeny of aggressive and non-aggressive behaviors has implications for understanding how the entire behavioral repertoire may be organized and reorganized to accommodate the needs of the organism.	[Moore, Darrell; Paquette, Caleb; Shropshire, J. Dylan; Joplin, Karl H.] E Tennessee State Univ, Dept Biol Sci, Johnson City, TN 37614 USA; [Seier, Edith] E Tennessee State Univ, Dept Math & Stat, Johnson City, TN 37614 USA	East Tennessee State University; East Tennessee State University	Moore, D (corresponding author), E Tennessee State Univ, Dept Biol Sci, Johnson City, TN 37614 USA.	moored@etsu.edu		Shropshire, Dylan/0000-0003-4221-2178; Seier, Edith/0000-0002-8519-9869	United States Department of Agriculture [2006-35302-7278]; Howard Hughes Medical Institute [52005872]	United States Department of Agriculture(United States Department of Agriculture (USDA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The authors thank the United States Department of Agriculture (2006-35302-7278) and the Howard Hughes Medical Institute (52005872) for funding this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baier A, 2002, J EXP BIOL, V205, P1233; Bishop YM., 2007, DISCRETE MULTIVARIAT; Boroczky K, 2013, P NATL ACAD SCI USA, V110, P3615, DOI 10.1073/pnas.1212466110; Briffa M, 2008, P R SOC B, V275, P1305, DOI 10.1098/rspb.2008.0025; Brown J. L., 1964, Wilson Bulletin, V76, P160; Brown J.L., 1970, ANNU REV ECOL SYST, V1, P239; Carney GE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-288; CARPENTER FL, 1983, P NATL ACAD SCI-BIOL, V80, P7259, DOI 10.1073/pnas.80.23.7259; Castro N, 2006, AGGRESSIVE BEHAV, V32, P474, DOI 10.1002/ab.20147; Certel SJ, 2007, P NATL ACAD SCI USA, V104, P4706, DOI 10.1073/pnas.0700328104; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; DAVIES NB, 1978, ANIM BEHAV, V26, P138, DOI 10.1016/0003-3472(78)90013-1; DEJONG P, 1984, BIOMETRICS, V40, P101, DOI 10.2307/2530748; DELAMOTTE I, 1983, NATURWISSENSCHAFTEN, V70, P451, DOI 10.1007/BF01079611; Dierick HA, 2007, NAT PROTOC, V2, P2712, DOI 10.1038/nprot.2007.404; DOW MA, 1975, NATURE, V254, P511, DOI 10.1038/254511a0; Edwards DH, 1997, CURR OPIN NEUROBIOL, V7, P812, DOI 10.1016/S0959-4388(97)80140-7; Egge AR, 2011, BEHAV ECOL SOCIOBIOL, V65, P369, DOI 10.1007/s00265-010-1054-5; Ellis LL, 2011, GENETICS, V187, P157, DOI 10.1534/genetics.110.122754; Farris SM, 2001, J NEUROSCI, V21, P6395, DOI 10.1523/JNEUROSCI.21-16-06395.2001; Gilbert C, 2007, J INSECT BEHAV, V20, P427, DOI 10.1007/s10905-007-9088-x; GILL FB, 1975, ECOLOGY, V56, P333, DOI 10.2307/1934964; HART DD, 1987, AM ZOOL, V27, P371; HOFFMANN AA, 1987, ANIM BEHAV, V35, P807, DOI 10.1016/S0003-3472(87)80117-3; HOFFMANN AA, 1990, ANIM BEHAV, V40, P526, DOI 10.1016/S0003-3472(05)80533-0; HOFFMANN AA, 1990, J INSECT BEHAV, V3, P1, DOI 10.1007/BF01049191; Holdsworth AR, 2000, AM MIDL NAT, V143, P201, DOI 10.1674/0003-0031(2000)143[0201:MGAABT]2.0.CO;2; Issa FA, 2006, CURR BIOL, V16, P2217, DOI 10.1016/j.cub.2006.08.065; IVES AR, 1991, ECOL MONOGR, V61, P75, DOI 10.2307/1943000; JACOBS ME, 1960, ECOLOGY, V41, P182, DOI 10.2307/1931952; JACOBS ME, 1978, BEHAV GENET, V8, P487, DOI 10.1007/BF01067478; JAEGER RG, 1981, AM NAT, V117, P962, DOI 10.1086/283780; Kain J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2908; Kemp DJ, 2004, P ROY SOC B-BIOL SCI, V271, P1707, DOI 10.1098/rspb.2004.2775; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kravitz EA, 2003, CURR OPIN NEUROBIOL, V13, P736, DOI 10.1016/j.conb.2003.10.003; Lorenz K., 1966, AGGRESSION; MARLER CA, 1988, BEHAV ECOL SOCIOBIOL, V23, P21, DOI 10.1007/BF00303053; Nichols JG, 2012, NEURON BRAIN; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Panhuis TM, 1999, BEHAV ECOL SOCIOBIOL, V46, P221, DOI 10.1007/s002650050613; Paquette C, 2008, PHYSIOL ENTOMOL, V33, P382, DOI 10.1111/j.1365-3032.2008.00646.x; PERES CA, 1989, BEHAV ECOL SOCIOBIOL, V25, P227, DOI 10.1007/BF00302922; PHILLIS RW, 1993, GENETICS, V133, P581; Ruedi EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006150; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; WHITHAM TG, 1986, ECOLOGY, V67, P139, DOI 10.2307/1938512; Yurkovic A, 2006, P NATL ACAD SCI USA, V103, P17519, DOI 10.1073/pnas.0608211103; Zar J. H., 1996, BIOSTATISTICAL ANAL; Zwarts L, 2011, P NATL ACAD SCI USA, V108, P17070, DOI 10.1073/pnas.1113877108	51	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93196	10.1371/journal.pone.0093196	http://dx.doi.org/10.1371/journal.pone.0093196			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714439	Green Submitted, Green Published, gold			2022-12-25	WOS:000334160900017
J	Bell, MP; Renner, DN; Johnson, AJ; Pavelko, KD				Bell, Michael P.; Renner, Danielle N.; Johnson, Aaron J.; Pavelko, Kevin D.			An Elite Controller of Picornavirus Infection Targets an Epitope That Is Resistant to Immune Escape	PLOS ONE			English	Article							MURINE ENCEPHALOMYELITIS VIRUS; T-CELL RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; THEILERS VIRUS; DEMYELINATING DISEASE; PERSISTENT INFECTION; VIRAL PERSISTENCE; DANIELS STRAIN; DA STRAIN; IMMUNODOMINANCE	The emergence of novel viral pathogens can lead to devastating consequences in the infected population. However, on occasion, rare hyper-responsive elite controllers are able to mount a protective primary response to infection and clear the new pathogen. Factors distinguishing elite controllers from other members of the population are not completely understood. We have been using Theiler's murine encephalomyelitis as a model of primary infection in mice and clearance of the virus is limited to one MHC genotype capable of generating a protective response to a single viral peptide VP2(121-130). The genetics of host susceptibility to TMEV, a natural mouse pathogen, has been studied extensively and non-protective CD8 responses to other peptides have been documented, however, little is known why the protective response to infection focuses on the VP2(121- 130) peptide. To study this question, we have generated TMEV mutants that encode for mutations within the VP2(121- 130) peptide. We find that very few of mutants are able to assemble and infect in vitro. These mutations are not related to virus RNA structure since non-coding mutations do not interfere with assembly. In the rare event when functional VP2(121- 130) mutant viruses did emerge, they were attenuated to some level or retained the ability to develop an immune response to the wild-type VP2(121- 130) sequence, demonstrating that the virus is incapable of escaping the protective response. These findings advance our understanding of how characteristics of the host immune response and an infectious agent can interact to lead to the appearance of rare super controllers in a population. Furthermore, the immutable nature of the viral antigen highlights the importance of choosing appropriate vaccine antigens and has implications for the development of agents that are able to generate protective CD8 T-cell responses.	[Bell, Michael P.; Johnson, Aaron J.; Pavelko, Kevin D.] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Johnson, Aaron J.] Mayo Clin, Mayo Grad Sch, Dept Neurol, Rochester, MN USA; [Renner, Danielle N.] Mayo Clin, Neurobiol Dis Program, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Pavelko, KD (corresponding author), Mayo Clin, Dept Immunol, Rochester, MN 55905 USA.	pavelko.kevin@mayo.edu	Pavelko, Kevin D/K-7072-2019	Pavelko, Kevin D/0000-0001-7555-1315	National Institutes of Health [5R01CA104996-09]; NATIONAL CANCER INSTITUTE [R01CA104996, P50CA108961, P30CA015083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Institutes of Health (5R01CA104996-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; AZOULAY A, 1994, J VIROL, V68, P4049, DOI 10.1128/JVI.68.6.4049-4052.1994; Bava KA, 2004, NUCLEIC ACIDS RES, V32, pD120, DOI 10.1093/nar/gkh082; Blinkova O, 2009, J VIROL, V83, P4631, DOI 10.1128/JVI.02085-08; Borson ND, 1997, J VIROL, V71, P5244, DOI 10.1128/JVI.71.7.5244-5250.1997; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Brahic M, 2005, ANNU REV MICROBIOL, V59, P279, DOI 10.1146/annurev.micro.59.030804.121242; Deb C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012478; FALK K, 1991, J EXP MED, V174, P425, DOI 10.1084/jem.174.2.425; Farrington LA, 2013, J IMMUNOL, V190, P3410, DOI 10.4049/jimmunol.1203151; FELTKAMP MCW, 1993, EUR J IMMUNOL, V23, P2242, DOI 10.1002/eji.1830230929; GRANT RA, 1992, P NATL ACAD SCI USA, V89, P2061, DOI 10.1073/pnas.89.6.2061; HILL AVS, 1991, NATURE, V352, P595, DOI 10.1038/352595a0; Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553; Jnaoui K, 1998, VIROLOGY, V244, P397, DOI 10.1006/viro.1998.9134; Johnson AJ, 1999, J VIROL, V73, P3702, DOI 10.1128/JVI.73.5.3702-3708.1999; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; LEE WM, 1993, J VIROL, V67, P2110, DOI 10.1128/JVI.67.4.2110-2122.1993; Lewis MJ, 2012, J VIROL, V86, P7459, DOI 10.1128/JVI.06724-11; Liang Z, 2008, J VIROL, V82, P11545, DOI 10.1128/JVI.01160-08; Lienert K, 1996, IMMUNOL CELL BIOL, V74, P349, DOI 10.1038/icb.1996.62; Lin XQ, 1998, J VIROL, V72, P1262, DOI 10.1128/JVI.72.2.1262-1269.1998; Lipton HL, 2008, REV MED VIROL, V18, P347, DOI 10.1002/rmv.585; Lobert PE, 1999, P NATL ACAD SCI USA, V96, P11560, DOI 10.1073/pnas.96.20.11560; Lyman MA, 2002, J VIROL, V76, P3125, DOI 10.1128/JVI.76.7.3125-3134.2002; McCright IJ, 2002, J NEUROVIROL, V8, P100, DOI 10.1080/13550280290049561; Mendez-Fernandez YV, 2003, EUR J IMMUNOL, V33, P2501, DOI 10.1002/eji.200324007; Myoung J, 2007, VIROLOGY, V360, P159, DOI 10.1016/j.virol.2006.09.045; NICHOLSON SM, 1994, J NEUROIMMUNOL, V52, P19, DOI 10.1016/0165-5728(94)90157-0; Nikolich-Zugich J, 2004, MICROBES INFECT, V6, P501, DOI 10.1016/j.micinf.2004.01.006; Njenga MK, 1996, J VIROL, V70, P1729, DOI 10.1128/JVI.70.3.1729-1737.1996; Obar JJ, 2006, J VIROL, V80, P8303, DOI 10.1128/JVI.00237-06; Pavelko KD, 2003, J NEUROSCI, V23, P481, DOI 10.1523/JNEUROSCI.23-02-00481.2003; Pavelko KD, 2000, MOL CELL NEUROSCI, V15, P495, DOI 10.1006/mcne.2000.0843; Pavelko KD, 2007, BRAIN PATHOL, V17, P184, DOI 10.1111/j.1750-3639.2007.00062.x; Pavelko KD, 2013, MOL THER, V21, P1087, DOI 10.1038/mt.2013.52; Pavelko KD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002541; Pavelko KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020217; PRITCHARD AE, 1992, VIROLOGY, V191, P469, DOI 10.1016/0042-6822(92)90212-8; RODRIGUEZ M, 1983, LAB INVEST, V49, P672; RODRIGUEZ M, 1986, J EXP MED, V163, P620, DOI 10.1084/jem.163.3.620; RODRIGUEZ M, 1985, J IMMUNOL, V135, P2145; ROOS RP, 1989, J VIROL, V63, P5492, DOI 10.1128/JVI.63.12.5492-5496.1989; Ruhl M, 2012, J VIROL, V86, P991, DOI 10.1128/JVI.05603-11; Sato S, 1996, VIROLOGY, V226, P327, DOI 10.1006/viro.1996.0660; Schirmbeck R, 2008, MOL THER, V16, P1609, DOI 10.1038/mt.2008.141; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Smith CL, 2005, J IMMUNOL, V175, P8431, DOI 10.4049/jimmunol.175.12.8431; Valkenburg SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001039; Yewdell JW, 2006, IMMUNITY, V25, P533, DOI 10.1016/j.immuni.2006.09.005; ZURBRIGGEN A, 1989, J EXP MED, V170, P2037, DOI 10.1084/jem.170.6.2037	51	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94332	10.1371/journal.pone.0094332	http://dx.doi.org/10.1371/journal.pone.0094332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710606	Green Published, gold, Green Submitted			2022-12-25	WOS:000334159800138
J	Berger, A; Dohnt, K; Tielen, P; Jahn, D; Becker, J; Wittmann, C				Berger, Antje; Dohnt, Katrin; Tielen, Petra; Jahn, Dieter; Becker, Judith; Wittmann, Christoph			Robustness and Plasticity of Metabolic Pathway Flux among Uropathogenic Isolates of Pseudomonas aeruginosa	PLOS ONE			English	Article							ISOCITRATE LYASE; URINARY-TRACT; CORYNEBACTERIUM-GLUTAMICUM; IN-VIVO; VIRULENCE FACTORS; BACTERIAL; ADAPTATION; INFECTION; SYSTEMS; PUTIDA	Pseudomonas aeruginosa is a human pathogen that frequently causes urinary tract and catheter-associated urinary tract infections. Here, using C-13-metabolic flux analysis, we conducted quantitative analysis of metabolic fluxes in the model strain P. aeruginosa PAO1 and 17 clinical isolates. All P. aeruginosa strains catabolized glucose through the Entner-Doudoroff pathway with fully respiratory metabolism and no overflow. Together with other NADPH supplying reactions, this high-flux pathway provided by far more NADPH than needed for anabolism: a benefit for the pathogen to counteract oxidative stress imposed by the host. P. aeruginosa recruited the pentose phosphate pathway exclusively for biosynthesis. In contrast to glycolytic metabolism, which was conserved among all isolates, the flux through pyruvate metabolism, the tricarboxylic acid cycle, and the glyoxylate shunt was highly variable, likely caused by adaptive processes in individual strains during infection. This aspect of metabolism was niche-specific with respect to the corresponding flux because strains isolated from the urinary tract clustered separately from those originating from catheter-associated infections. Interestingly, most glucose-grown strains exhibited significant flux through the glyoxylate shunt. Projection into the theoretical flux space, which was computed using elementary flux-mode analysis, indicated that P. aeruginosa metabolism is optimized for efficient growth and exhibits significant potential for increasing NADPH supply to drive oxidative stress response.	[Berger, Antje; Dohnt, Katrin; Becker, Judith; Wittmann, Christoph] Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Engn, D-38106 Braunschweig, Germany; [Tielen, Petra; Jahn, Dieter] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Becker, Judith; Wittmann, Christoph] Univ Saarland, Inst Syst Biotechnol, D-66123 Saarbrucken, Germany	Braunschweig University of Technology; Braunschweig University of Technology; Saarland University	Wittmann, C (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Biochem Engn, D-38106 Braunschweig, Germany.	christoph.wittmann@uni-saarland.de		Wittmann, Christoph/0000-0002-7952-985X; Jahn, Dieter/0000-0002-4064-9205	German Federal Ministry of Eduction and Research in the initiative Medical Infection Genomics [315833D]	German Federal Ministry of Eduction and Research in the initiative Medical Infection Genomics	This work was financially supported by the German Federal Ministry of Eduction and Research (www.bmbf.de) through grant 315833D in the initiative Medical Infection Genomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian D, 2013, NUCLEIC ACIDS RES, V41, P1, DOI 10.1093/nar/gks1039; Bereket W, 2012, EUR REV MED PHARMACO, V16, P1039; Blank LM, 2008, FEBS J, V275, P5173, DOI 10.1111/j.1742-4658.2008.06648.x; Breidenstein EBM, 2011, TRENDS MICROBIOL, V19, P419, DOI 10.1016/j.tim.2011.04.005; Chang SL, 2006, PEDIATR CLIN N AM, V53, P379, DOI 10.1016/j.pcl.2006.02.011; Chavarria M, 2013, ENVIRON MICROBIOL, V15, P1772, DOI 10.1111/1462-2920.12069; Chen PR, 2011, ANTIOXID REDOX SIGN, V14, P1107, DOI 10.1089/ars.2010.3374; Damron FH, 2012, MOL MICROBIOL, V84, P595, DOI 10.1111/j.1365-2958.2012.08049.x; Dash M, 2003, DATA KNOWL ENG, V44, P109, DOI 10.1016/S0169-023X(02)00138-6; Dohnt K, 2011, J MICROBIOL METH, V87, P302, DOI 10.1016/j.mimet.2011.09.002; Dunn MF, 2009, MICROBIOL-SGM, V155, P3166, DOI 10.1099/mic.0.030858-0; Eschbach E, 2006, J BACTERIOL, V186, P4596; Fang FC, 2005, INFECT IMMUN, V73, P2547, DOI 10.1128/IAI.73.4.2547-2549.2005; FILISETTICOZZI TMCC, 1991, ANAL BIOCHEM, V197, P157, DOI 10.1016/0003-2697(91)90372-Z; Flamholz A, 2013, P NATL ACAD SCI USA, V110, P10039, DOI 10.1073/pnas.1215283110; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Furch T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-209; Fuhrer T, 2005, J BACTERIOL, V187, P1581, DOI 10.1128/JB.187.5.1581-1590.2005; Hamood AN, 1996, J SURG RES, V61, P425, DOI 10.1006/jsre.1996.0140; Hellerstein MK, 2008, METAB ENG, V10, P1, DOI 10.1016/j.ymben.2007.09.003; Hindre T, 2012, NAT REV MICROBIOL, V10, P352, DOI 10.1038/nrmicro2750; Hoboth C, 2009, J INFECT DIS, V200, P118, DOI 10.1086/599360; Hogardt M, 2013, CURR TOP MICROBIOL, V358, P91, DOI 10.1007/82_2011_199; Hogardt M, 2010, INT J MED MICROBIOL, V300, P557, DOI 10.1016/j.ijmm.2010.08.008; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kelleher JK, 2001, METAB ENG, V3, P100, DOI 10.1006/mben.2001.0185; Kind S, 2013, METAB ENG, V15, P184, DOI 10.1016/j.ymben.2012.07.005; Kohlstedt M, 2010, APPL MICROBIOL BIOT, V88, P1065, DOI 10.1007/s00253-010-2854-2; Kondrashov FA, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-31; Kretzschmar U, 2008, ARCH MICROBIOL, V190, P151, DOI 10.1007/s00203-008-0381-7; Kromer JO, 2008, MICROBIOL-SGM, V154, P3917, DOI 10.1099/mic.0.2008/021204-0; Kucheria R, 2005, POSTGRAD MED J, V81, P83, DOI 10.1136/pgmj.2004.023036; Le Gac M, 2012, P NATL ACAD SCI USA, V109, P9487, DOI 10.1073/pnas.1207091109; Lindsey TL, 2008, MICROBIOL-SGM, V154, P1616, DOI 10.1099/mic.0.2007/014506-0; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; Marx A, 1996, BIOTECHNOL BIOENG, V49, P111, DOI 10.1002/(SICI)1097-0290(19960120)49:2<111::AID-BIT1>3.0.CO;2-T; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Melzer G, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-120; Mittal Rahul, 2009, J Infect Public Health, V2, P101, DOI 10.1016/j.jiph.2009.08.003; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; Oberhardt MA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001116; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Poblete-Castro I, 2013, METAB ENG, V15, P113, DOI 10.1016/j.ymben.2012.10.004; Quek LE, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-25; REINSCHEID DJ, 1994, J BACTERIOL, V176, P3474, DOI 10.1128/JB.176.12.3474-3483.1994; Romano AH, 1996, RES MICROBIOL, V147, P448, DOI 10.1016/0923-2508(96)83998-2; ROSENBLOOM J, 1995, ADV EXP MED BIOL, V385, P161; Rumbaugh KP, 1999, J HOSP INFECT, V43, P211, DOI 10.1053/jhin.1999.0252; Schneider K, 2010, BIOPROC BIOSYST ENG, V33, P541, DOI 10.1007/s00449-009-0367-0; Singh R, 2007, J BACTERIOL, V189, P6665, DOI 10.1128/JB.00555-07; SMITH RA, 1957, J BIOL CHEM, V229, P305; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; STORZ G, 1990, TRENDS GENET, V6, P363, DOI 10.1016/0168-9525(90)90278-E; Storz G, 1999, CURR OPIN MICROBIOL, V2, P188, DOI 10.1016/S1369-5274(99)80033-2; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tamma PD, 2012, CLIN MICROBIOL REV, V25, P450, DOI 10.1128/CMR.05041-11; Tielen P, 2011, INT J MED MICROBIOL, V301, P282, DOI 10.1016/j.ijmm.2010.10.005; van Winden WA, 2002, BIOTECHNOL BIOENG, V80, P477, DOI 10.1002/bit.10393; Wall DM, 2005, INFECT IMMUN, V73, P6736, DOI 10.1128/IAI.73.10.6736-6741.2005; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Wittmann C, 2002, APPL ENVIRON MICROB, V68, P5843, DOI 10.1128/AEM.68.12.5843-5859.2002; Wittmann C, 2002, ANAL BIOCHEM, V307, P379, DOI 10.1016/S0003-2697(02)00030-1; Wittmann C, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-6; Wittmann C, 2007, J BIOTECHNOL, V132, P375, DOI 10.1016/j.jbiotec.2007.07.495; Zamboni N, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r99	66	44	46	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e88368	10.1371/journal.pone.0088368	http://dx.doi.org/10.1371/journal.pone.0088368			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709961	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800005
J	Liu, YQ; Chew, MH; Goh, XW; Tan, SY; Loi, CTT; Tan, YM; Law, HY; Koh, PK; Tang, CL				Liu, Yanqun; Chew, Min Hoe; Goh, Xue Wei; Tan, Soo Yong; Loi, Carol Tien Tau; Tan, Yuen Ming; Law, Hai Yang; Koh, Poh Koon; Tang, Choong Leong			Systematic Study on Genetic and Epimutational Profile of a Cohort of Amsterdam Criteria-Defined Lynch Syndrome in Singapore	PLOS ONE			English	Article							NONPOLYPOSIS COLORECTAL-CANCER; MUTATION DETECTION RATE; GENOMIC REARRANGEMENTS; PROMOTER METHYLATION; MSH2; MLH1; HNPCC; FAMILIES; PREDISPOSITION; GUIDELINES	Background: Germline defects of mismatch repair (MMR) genes underlie Lynch Syndrome (LS). We aimed to gain comprehensive genetic and epigenetic profiles of LS families in Singapore, which will facilitate efficient molecular diagnosis of LS in Singapore and the region. Methods: Fifty nine unrelated families were studied. Mutations in exons, splice-site junctions and promoters of five MMR genes were scanned by high resolution melting assay followed by DNA sequencing, large fragment deletions/duplications and promoter methylation in MLH1, MSH2, MSH6 and PMS2 were evaluated by multiplex ligation-dependent probe amplification. Tumor microsatellite instability (MSI) was assessed with five mononucleotide markers and immunohistochemical staining (IHC) was also performed. Results: Pathogenic defects, all confined to MLH1 and MSH2, were identified in 17 out of 59 (28.8%) families. The mutational spectrum was highly heterogeneous and 28 novel variants were identified. One recurrent mutation in MLH1 (c.793C>T) was also observed. 92.9% sensitivity for indication of germline mutations conferred by IHC surpassed 64.3% sensitivity by MSI. Furthermore, 15.6% patients with MSS tumors harbored pathogenic mutations. Conclusions: Among major ethnic groups in Singapore, all pathogenic germline defects were confined to MLH1 and MSH2. Caution should be applied when the Amsterdam criteria and consensus microsatellite marker panel recommended in the revised Bethesda guidelines are applied to the local context. We recommend a screening strategy for the local LS by starting with tumor IHC and the hotspot mutation testing at MLH1 c.793C>T followed by comprehensive mutation scanning in MLH1 and MSH2 prior to proceeding to other MMR genes.	[Liu, Yanqun; Chew, Min Hoe; Goh, Xue Wei; Loi, Carol Tien Tau; Koh, Poh Koon; Tang, Choong Leong] Singapore Gen Hosp, Dept Colorectal Surg, Singapore, Singapore; [Tan, Soo Yong] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Tan, Yuen Ming; Law, Hai Yang] KK Womens & Childrens Hosp, Dept Paediat Med, Singapore, Singapore	Singapore General Hospital; Singapore General Hospital; KK Women's & Children's Hospital	Liu, YQ (corresponding author), Singapore Gen Hosp, Dept Colorectal Surg, Singapore, Singapore.	liu.yan.qun@sgh.com.sg		Tan, Soo-Yong/0000-0002-6348-2823	Biomedical Research Council, Singapore [08/1/27/19/572]	Biomedical Research Council, Singapore(Agency for Science Technology & Research (A*STAR))	The present study was financially supported by a grant from Biomedical Research Council, Singapore (No. 08/1/27/19/572, website www.a-star.edu.sg/bmrc). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, CLIN GASTROENTEROL H, V6, P206, DOI 10.1016/j.cgh.2007.10.011; Baudhuin LM, 2005, GASTROENTEROLOGY, V129, P846, DOI 10.1053/j.gastro.2005.06.026; Bonis Peter A, 2007, Evid Rep Technol Assess (Full Rep), P1; Chan TL, 2004, AM J HUM GENET, V74, P1035, DOI 10.1086/383591; Chew MH, 2008, ANZ J SURG, V78, P556, DOI 10.1111/j.1445-2197.2008.04570.x; Di Fiore F, 2004, J MED GENET, V41, P18, DOI 10.1136/jmg.2003.012062; Domingo E, 2005, ONCOGENE, V24, P3995, DOI 10.1038/sj.onc.1208569; Domingo E, 2004, J MED GENET, V41, P664, DOI 10.1136/jmg.2004.020651; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Evans DG, 2007, SEMIN ONCOL, V34, P411, DOI 10.1053/j.seminoncol.2007.07.001; Evans GD, 2006, J CLIN ONCOL, V24, P1960, DOI 10.1200/JCO.2005.05.3207; Funkhouser WK, 2012, J MOL DIAGN, V14, P91, DOI 10.1016/j.jmoldx.2011.11.001; Jensen LH, 2008, COLORECTAL DIS, V10, P490, DOI 10.1111/j.1463-1318.2007.01378.x; Joensuu EI, 2008, CANCER RES, V68, P4597, DOI 10.1158/0008-5472.CAN-07-6645; Lee SC, 2005, CLIN GENET, V68, P137, DOI 10.1111/j.1399-0004.2005.00469.x; Ligtenberg MJL, 2009, NAT GENET, V41, P112, DOI 10.1038/ng.283; Liu YQ, 2008, CANCER BIOMARK, V4, P111, DOI 10.3233/CBM-2008-4207; Nakagawa H, 2009, ONCOL REP, V21, P1577, DOI 10.3892/or_00000390; Nakahara M, 1997, CANCER EPIDEM BIOMAR, V6, P1057; Park JG, 2002, INT J COLORECTAL DIS, V17, P109, DOI 10.1007/s003840100348; Peltomaki P, 2004, DIS MARKERS, V20, P269, DOI 10.1155/2004/305058; Plaschke J, 2003, J MED GENET, V40, P597, DOI 10.1136/jmg.40.8.597; Rumilla K, 2011, J MOL DIAGN, V13, P93, DOI 10.1016/j.jmoldx.2010.11.011; Shia J, 2008, J MOL DIAGN, V10, P293, DOI 10.2353/jmoldx.2008.080031; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Tang R, 2009, CLIN GENET, V75, P334, DOI 10.1111/j.1399-0004.2009.01162.x; Thodi G, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-544; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Vasen HFA, 2007, J MED GENET, V44, P353, DOI 10.1136/jmg.2007.048991; Vasen HFA, 1999, GASTROENTEROLOGY, V116, P1453, DOI 10.1016/S0016-5085(99)70510-X; VASEN HFA, 1991, DIS COLON RECTUM, V34, P424, DOI 10.1007/BF02053699; Wagner A, 2003, AM J HUM GENET, V72, P1088, DOI 10.1086/373963; Wang XL, 2006, WORLD J GASTROENTERO, V12, P4074, DOI 10.3748/wjg.v12.i25.4074; Wei WQ, 2010, J BIOINFORM COMPUT B, V8, P111, DOI 10.1142/S0219720010005154; Xicola R.M., 2009, COLORECTAL CANC EARL, P149	35	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e94170	10.1371/journal.pone.0094170	http://dx.doi.org/10.1371/journal.pone.0094170			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710284	Green Published, gold, Green Submitted			2022-12-25	WOS:000334159800111
J	Morato, RG; Ferraz, KMPMD; de Paula, RC; de Campos, CB				Morato, Ronaldo Goncalves; Micchi de Barros Ferraz, Katia Maria Paschoaletto; de Paula, Rogerio Cunha; de Campos, Claudia Bueno			Identification of Priority Conservation Areas and Potential Corridors for Jaguars in the Caatinga Biome, Brazil	PLOS ONE			English	Article							PANTHERA-ONCA; PUMA-CONCOLOR; HABITAT; LANDSCAPE; POPULATIONS; PREDICTION; DENSITIES; MOVEMENT	The jaguar, Panthera onca, is a top predator with the extant population found within the Brazilian Caatinga biome now known to be on the brink of extinction. Designing new conservation units and potential corridors are therefore crucial for the long-term survival of the species within the Caatinga biome. Thus, our aims were: 1) to recognize suitable areas for jaguar occurrence, 2) to delineate areas for jaguar conservation (PJCUs), 3) to design corridors among priority areas, and 4) to prioritize PJCUs. A total of 62 points records of jaguar occurrence and 10 potential predictors were analyzed in a GIS environment. A predictive distributional map was obtained using Species Distribution Modeling (SDM) as performed by the Maximum Entropy (Maxent) algorithm. Areas equal to or higher than the median suitability value of 0.595 were selected as of high suitability for jaguar occurrence and named as Priority Jaguar Conservation Units (PJCU). Ten PJCUs with sizes varying from 23.6 km(2) to 4,311.0 km(2) were identified. Afterwards, we combined the response curve, as generated by SDM, and expert opinions to create a permeability matrix and to identify least cost corridors and buffer zones between each PJCU pair. Connectivity corridors and buffer zone for jaguar movement included an area of 8.884,26 km(2) and the total corridor length is about 160.94 km. Prioritizing criteria indicated the PJCU representing c. a. 68.61% of the total PJCU area (PJCU # 1) as of high priority for conservation and connectivity with others PJCUs (PJCUs # 4, 5 and 7) desirable for the long term survival of the species. In conclusion, by using the jaguar as a focal species and combining SDM and expert opinion we were able to create a valid framework for practical conservation actions at the Caatinga biome. The same approach could be used for the conservation of other carnivores.	[Morato, Ronaldo Goncalves; de Paula, Rogerio Cunha; de Campos, Claudia Bueno] Ctr Nacl Pesquisa & Conservacao Mamiferos Carnivo, Inst Chico Mendes Conservacao Biodiversidade, Minist Meio Ambiente, Atibaia, SP, Brazil; [Morato, Ronaldo Goncalves; Micchi de Barros Ferraz, Katia Maria Paschoaletto; de Paula, Rogerio Cunha; de Campos, Claudia Bueno] Inst Conservacao Carnivoros Neotropicais, Atibaia, SP, Brazil; [Micchi de Barros Ferraz, Katia Maria Paschoaletto] Univ Sao Paulo, Escola Super Agr Luiz De Queiroz, Dept Ciencias Florestais, Piracicaba, SP, Brazil	Universidade de Sao Paulo	Ferraz, KMPMD (corresponding author), Inst Conservacao Carnivoros Neotropicais, Atibaia, SP, Brazil.	katia.ferraz@usp.br	Ferraz, Katia Maria P. M. B./D-7244-2012; DE PAULA, ROGERIO/S-2182-2017	Ferraz, Katia Maria P. M. B./0000-0002-7870-8696; Morato, Ronaldo/0000-0002-8304-9779; DE PAULA, ROGERIO/0000-0003-1943-8320	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Programa de Revitalizacao do Rio Sao Francisco/Diretoria de Recursos Hidricos e Ambiente Urbano/Ministerio de Meio Ambiente; Instituto Chico Mendes de Conservacao da Biodiversidade; Instituto Fazenda Tamandua; BOVESPA-Social	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Programa de Revitalizacao do Rio Sao Francisco/Diretoria de Recursos Hidricos e Ambiente Urbano/Ministerio de Meio Ambiente; Instituto Chico Mendes de Conservacao da Biodiversidade; Instituto Fazenda Tamandua; BOVESPA-Social	The authors thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) for financial support. The authors are grateful with Programa de Revitalizacao do Rio Sao Francisco/Diretoria de Recursos Hidricos e Ambiente Urbano/Ministerio de Meio Ambiente, Instituto Chico Mendes de Conservacao da Biodiversidade, Instituto Fazenda Tamandua and BOVESPA-Social for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVES J. J. A., 2007, CLIMEP CLIMATOLOGIA, V2, P58; Andrade-Lima D., 1981, REV BRAS BOTA NICA, V4, P149; [Anonymous], [No title captured]; [Anonymous], 2011, MON DESM BIOM BRAS S; Astete S, 2008, THESIS U BRASILIA; Astete S, 2012, THESIS U BRASILIA; Beier P, 1998, CONSERV BIOL, V7, P94; Beyer HL, 2004, HAWTHS ANAL TOOLS AR; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; CARROLL C, 2006, CONNECTIVITY CONSERV, P369; CRAWSHAW PG, 1991, J ZOOL, V223, P357, DOI 10.1111/j.1469-7998.1991.tb04770.x; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Cruz MAOM, 2005, BIODIVERSIDADE BIOMA, P182; Cullen Jr L, 2006, THESIS U KENT; Cullen Junior L., 2005, Natureza & Conservacao, V3, P43; De Angelo C, 2011, DIVERS DISTRIB, V17, P422, DOI 10.1111/j.1472-4642.2011.00746.x; de Paula Rogerio C., 2012, Cat News, P19; Dickson BG, 2005, J WILDLIFE MANAGE, V69, P264, DOI 10.2193/0022-541X(2005)069&lt;0264:IOVTAR&gt;2.0.CO;2; Dickson BG, 2002, J WILDLIFE MANAGE, V66, P1235, DOI 10.2307/3802956; Doko T., 2008, ISPRS 2008, P267; Doko T, 2011, ECOL MODEL, V222, P748, DOI 10.1016/j.ecolmodel.2010.11.005; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Emperaire L., 1984, Brasil Florestal, V14, P5; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Frankel OH, 1981, CONSERVATION EVOLUTI; Galetti M, 2013, SCIENCE, V342, P930, DOI 10.1126/science.342.6161.930-a; Haag T, 2010, MOL ECOL, V19, P4906, DOI 10.1111/j.1365-294X.2010.04856.x; Hess GR, 2001, LANDSCAPE URBAN PLAN, V55, P195, DOI 10.1016/S0169-2046(01)00155-4; Hilty J. A., 2006, CORRIDOR ECOLOGY SCI; IBGE (Inst.Brasileiro de Geografia e Estatuistica), 2004, MAP BIOM BRAS 1 APR; INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATISTICA - IBGE, 2010, ATL CENS DEM; Jackson P., 1996, BIOL CONSERVATION; Jorge MLSP, 2013, BIOL CONSERV, V163, P49, DOI 10.1016/j.biocon.2013.04.018; Kautz R, 2006, BIOL CONSERV, V130, P118, DOI 10.1016/j.biocon.2005.12.007; Miller Brian, 2002, P303; MMA, 2011, DIAGN MACR EC EC BAC; Morato RG., 2013, BIODIVERSIDADE BRASI, V3, P122; Morato Ronaldo G., 2007, Cat News, V47, P23; Nascimento JL, 2011, ATLAS FAUNA BRASILEI; Noss R.F., 2006, CONNECTIVITY CONSERV, P587, DOI [10.1017/CBO9780511754821.026, DOI 10.1017/CBO9780511754821.026]; Noss RF, 1996, CONSERV BIOL, V10, P949, DOI 10.1046/j.1523-1739.1996.10040949.x; OLIVEIRA J. A., 2003, ECOLOGIA CONSERVACAO, P275; Paula RC, PLANO ACAO IN PRESS; Paula RC, 2011, DIAGNOSTICO MACROZON, P266; PDE, 2011, REL PLAN DES EN 2020; PEARSON RG, 2007, SPECIES DISTRIBUTION; Peterson AT, 2008, ECOL MODEL, V213, P63, DOI 10.1016/j.ecolmodel.2007.11.008; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Prado D., 2003, ECOLOGIA CONSERVACAO, P3, DOI DOI 10.1641/0006-3568(2004)054[0413:TNDHHC]2.0.CO;2; Rabinowitz A, 2010, BIOL CONSERV, V143, P939, DOI 10.1016/j.biocon.2010.01.002; Rodriguez-Soto C, 2011, DIVERS DISTRIB, V17, P350, DOI 10.1111/j.1472-4642.2010.00740.x; Rosques S, ORYX IN PRESS; Roura-Pascual N, 2009, BIOL INVASIONS, V11, P1017, DOI 10.1007/s10530-008-9313-3; Sampaio Everardo V. S. B., 1995, P35, DOI 10.1017/CBO9780511753398.003; Sanderson EW, 2002, CONSERV BIOL, V16, P58, DOI 10.1046/j.1523-1739.2002.00352.x; Saterberg T, 2013, NATURE, V499, P468, DOI 10.1038/nature12277; SCHALLER GB, 1980, BIOTROPICA, V12, P161, DOI 10.2307/2387967; Scognamillo D, 2003, J ZOOL, V259, P269, DOI 10.1017/S0952836902003230; Silveira L, 2004, THESIS U BRASILIA; Silveira L, 2010, ORYX, V44, P104, DOI 10.1017/S0030605309990433; SNUC, 2000, DIARIO OFICIAL UNIAO; Sollmann R, 2013, BIOL CONSERV, V167, P242, DOI 10.1016/j.biocon.2013.08.003; Sondgerath D, 2002, LANDSCAPE ECOL, V17, P57, DOI 10.1023/A:1015237002145; Sunquist ME, 2002, WILD CATS WORLD; THIEL RP, 1985, AM MIDL NAT, V113, P404, DOI 10.2307/2425590; Tobler MW, 2013, BIOL CONSERV, V159, P109, DOI 10.1016/j.biocon.2012.12.009; Torres N.M., 2012, DIVERS DISTRIB, V2012, P1; Wilson CD, 2011, BIOL CONSERV, V144, P821, DOI 10.1016/j.biocon.2010.11.014; ZELLER K., 2007, JAGUARS NEW MILLENNI; Zeller KA, 2011, BIOL CONSERV, V144, P892, DOI 10.1016/j.biocon.2010.12.003	72	30	30	1	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e92950	10.1371/journal.pone.0092950	http://dx.doi.org/10.1371/journal.pone.0092950			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709817	Green Published, Green Submitted, gold			2022-12-25	WOS:000334159800021
J	Ruocco, LA; Treno, C; Carnevale, UAG; Arra, C; Boatto, G; Nieddu, M; Pagano, C; Illiano, P; Barbato, F; Tino, A; Carboni, E; Laviola, G; Lacivita, E; Leopoldo, M; Adriani, W; Sadile, AG				Ruocco, Lucia A.; Treno, Concetta; Carnevale, Ugo A. Gironi; Arra, Claudio; Boatto, Gianpiero; Nieddu, Maria; Pagano, Cristina; Illiano, Placido; Barbato, Fabiana; Tino, Angela; Carboni, Ezio; Laviola, Giovanni; Lacivita, Enza; Leopoldo, Marcello; Adriani, Walter; Sadile, Adolfo G.			Prepuberal Stimulation of 5-HT7-R by LP-211 in a Rat Model of Hyper-Activity and Attention-Deficit: Permanent Effects on Attention, Brain Amino Acids and Synaptic Markers in the Fronto-Striatal Interface	PLOS ONE			English	Article							NAPLES HIGH-EXCITABILITY; PREFRONTAL CORTEX; ANIMAL-MODEL; D-ASPARTATE; GLUTAMATERGIC NEUROTRANSMISSION; DOPAMINE NEUROTRANSMISSION; FUNCTIONAL CONNECTIVITY; RECEPTOR; FOREBRAIN; SEROTONIN	The cross-talk at the prefronto-striatal interface involves excitatory amino acids, different receptors, transducers and modulators. We investigated long-term effects of a prepuberal, subchronic 5-HT7-R agonist (LP-211) on adult behaviour, amino acids and synaptic markers in a model for Attention-Deficit/Hyperactivity Disorder (ADHD). Naples High Excitability rats (NHE) and their Random Bred controls (NRB) were daily treated with LP-211 in the 5th and 6th postnatal week. One month after treatment, these rats were tested for indices of activity, non selective (NSA), selective spatial attention (SSA) and emotionality. The quantity of L-Glutamate (L-Glu), L-Aspartate (L-Asp) and L-Leucine (L-Leu), dopamine transporter (DAT), NMDAR1 subunit and CAMKII alpha, were assessed in prefrontal cortex (PFC), dorsal (DS) and ventral striatum (VS), for their role in synaptic transmission, neural plasticity and information processing. Prepuberal LP-211 (at lower dose) reduced horizontal activity and (at higher dose) increased SSA, only for NHE but not in NRB rats. Prepuberal LP-211 increased, in NHE rats, L-Glu in the PFC and L-Asp in the VS (at 0.250 mg/kg dose), whereas (at 0.125 mg/kg dose) it decreased L-Glu and L-Asp in the DS. The L-Glu was decreased, at 0.125 mg/kg, only in the VS of NRB rats. The DAT levels were decreased with the 0.125 mg/kg dose (in the PFC), and increased with the 0.250 mg/kg dose (in the VS), significantly for NHE rats. The basal NMDAR1 level was higher in the PFC of NHE than NRB rats; LP-211 treatment (at 0.125 mg/kg dose) decreased NMDAR1 in the VS of NRB rats. This study represents a starting point about the impact of developmental 5-HT7-R activation on neuro-physiology of attentive processes, executive functions and their neural substrates.	[Ruocco, Lucia A.; Treno, Concetta; Carnevale, Ugo A. Gironi; Sadile, Adolfo G.] Univ Naples 2, Sch Med, Dept Expt Med, Naples, Italy; [Arra, Claudio] Natl Canc Inst, Anim Facil, Naples, Italy; [Boatto, Gianpiero; Nieddu, Maria] Univ Sassari, Dept Chem & Pharm, I-07100 Sassari, Italy; [Pagano, Cristina; Illiano, Placido; Barbato, Fabiana; Tino, Angela] CNR, Ist Cibernet Eduardo Caianiello, I-80125 Naples, Italy; [Carboni, Ezio] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Laviola, Giovanni; Adriani, Walter] Ist Super Sanita, Dept Cell Biol & Neurosci, Sect Behav Neurosci, I-00161 Rome, Italy; [Leopoldo, Marcello] Univ Bari, Dept Med Chem, Bari, Italy	Universita della Campania Vanvitelli; IRCCS Fondazione Pascale; University of Sassari; Consiglio Nazionale delle Ricerche (CNR); Istituto di Cibernetica "Eduardo Caianiello" (ICIB-CNR); University of Cagliari; Istituto Superiore di Sanita (ISS); Universita degli Studi di Bari Aldo Moro	Sadile, AG (corresponding author), Univ Naples 2, Sch Med, Dept Expt Med, Naples, Italy.	agsadile@alice.it	Laviola, Giovanni/K-4392-2016; Carboni, Ezio/AAU-4585-2021; Nieddu, Maria/HDM-6360-2022; Adriani, Walter/N-9329-2017; Tino, Angela/E-8425-2014; Laviola, Giovanni/AAA-2391-2022	Laviola, Giovanni/0000-0003-0388-0835; Nieddu, Maria/0000-0001-7589-0464; Adriani, Walter/0000-0002-0067-4430; Tino, Angela/0000-0002-9673-1064; Laviola, Giovanni/0000-0003-0388-0835; Leopoldo, Marcello/0000-0001-8401-2815; Arra, Claudio/0000-0003-3162-2091; Boatto, Gianpiero/0000-0001-6271-2378; Lacivita, Enza/0000-0003-2443-1174; sadile, adolfo/0000-0003-2470-3328; Pagano, Cristina/0000-0002-9181-6595	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	Young Investigator "ADHD-sythe" Project 2009-2012 and ERA-net PrioMedChild "NeuroGenMRI" Project 2011-2015 from the Italian Ministry of Health (local unit to LAR, Principal Investigator WA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriani W, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-54; Adriani Walter, 2012, Curr Top Behav Neurosci, V9, P113, DOI 10.1007/7854_2011_156; Andersen SL, 1997, N-S ARCH PHARMACOL, V356, P173, DOI 10.1007/PL00005038; Arnsten AFT, 2012, NEURON, V76, P223, DOI 10.1016/j.neuron.2012.08.038; Arnsten AFT, 2009, CNS DRUGS, V23, P33, DOI 10.2165/00023210-200923000-00005; Bauer M, 2012, CURR PHARM DESIGN, V18, P1568, DOI 10.2174/138161212799958611; Berke JD, 2009, J NEUROPHYSIOL, V101, P1575, DOI 10.1152/jn.91106.2008; Bonaventure P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020210; Broadhurst P.L., 1960, EXPERIMENTS PERSONAL, V1, P1; Canese R, 2013, PSYCHOPHARM IN PRESS; Carnevale UAG, 2007, BEHAV BRAIN RES, V183, P130, DOI 10.1016/j.bbr.2007.05.032; D'Aniello A, 2007, BRAIN RES REV, V53, P215, DOI 10.1016/j.brainresrev.2006.08.005; Davids E, 2003, BRAIN RES REV, V42, P1, DOI 10.1016/S0165-0173(02)00274-6; DiChiara G, 1996, BEHAV PHARMACOL, V7, P640; Dobbing J., 1968, APPLIED NEUROCHEMIST, P287; Eriksson TM, 2008, EUR J PHARMACOL, V596, P107, DOI 10.1016/j.ejphar.2008.08.026; Errico F, 2008, J NEUROSCI, V28, P10404, DOI 10.1523/JNEUROSCI.1618-08.2008; Esposito F, 2009, ARCH ITAL BIOL, V147, P11; Esposito F, 2008, MAGN RESON IMAGING, V26, P905, DOI 10.1016/j.mri.2008.01.045; Filipek PA, 1997, NEUROLOGY, V48, P589, DOI 10.1212/WNL.48.3.589; Fumagalli F, 2008, MOL PHARMACOL, V73, P1484, DOI 10.1124/mol.107.043786; Fumagalli F, 2010, PHARMACOL RES, V62, P523, DOI 10.1016/j.phrs.2010.07.009; Genro JP, 2010, EXPERT REV NEUROTHER, V10, P587, DOI [10.1586/ern.10.17, 10.1586/ERN.10.17]; Girault JA, 2012, ADV EXP MED BIOL, V970, P407, DOI 10.1007/978-3-7091-0932-8_18; Grace AA, 1997, TRENDS NEUROSCI, V20, P31, DOI 10.1016/S0166-2236(96)10064-3; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hedlund PB, 2010, NEUROSCI LETT, V481, P12, DOI 10.1016/j.neulet.2010.06.036; Hirano Shigeki, 2013, Brain Nerve, V65, P659; HOLM S, 1979, SCAND J STAT, V6, P65; Huang CS, 2005, CELL, V123, P105, DOI 10.1016/j.cell.2005.07.033; Illiano P., 2011, Society for Neuroscience Abstract Viewer and Itinerary Planner, V41; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kelly A M Clare, 2007, Curr Psychiatry Rep, V9, P401, DOI 10.1007/s11920-007-0052-4; Leopoldo M, 2011, PHARMACOL THERAPEUT, V129, P120, DOI 10.1016/j.pharmthera.2010.08.013; Manuel-Apolinar L, 2004, BEHAV BRAIN RES, V148, P179, DOI 10.1016/S0166-4328(03)00186-4; Marco EM, 2011, NEUROSCI BIOBEHAV R, V35, P1722, DOI 10.1016/j.neubiorev.2011.02.011; Marmiroli P, 2012, CURR MED CHEM, V19, P1269, DOI 10.2174/092986712799462711; Masana M, 2012, CURR TOP MED CHEM, V12, P2357, DOI 10.2174/156802612805289872; Mayer ML, 2011, STRUCTURE, V19, P1370, DOI 10.1016/j.str.2011.08.009; Niciu MJ, 2012, PHARMACOL BIOCHEM BE, V100, P656, DOI 10.1016/j.pbb.2011.08.008; Ochiishi T, 1998, BRAIN RES, V790, P129, DOI 10.1016/S0006-8993(98)00058-4; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Papa M, 1996, NEUROREPORT, V7, P3017, DOI 10.1097/00001756-199611250-00044; Papa M, 2000, NEUROSCI BIOBEHAV R, V24, P149, DOI 10.1016/S0149-7634(99)00052-4; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Perez-Garcia G, 2006, BEHAV BRAIN RES, V169, P83, DOI 10.1016/j.bbr.2005.12.013; Perez-Garcia G, 2009, BEHAV BRAIN RES, V202, P102, DOI 10.1016/j.bbr.2009.03.027; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ruocco LA, 2010, BEHAV BRAIN RES, V210, P99, DOI 10.1016/j.bbr.2010.02.020; Ruocco LA, 2009, BEHAV BRAIN RES, V198, P37, DOI 10.1016/j.bbr.2008.11.006; Ruocco LA, 2009, BEHAV BRAIN RES, V198, P24, DOI 10.1016/j.bbr.2008.11.029; Ruocco LA, 2011, MOL MECH NEUROSCIENC; Ruocco LA, 2014, SYNAPSE, V68, P159, DOI 10.1002/syn.21724; Ruocco LA, 2009, PSYCHIAT THEOR APPL, P85; Ruocco LA, 2009, EUR NEUROPSYCHOPHARM, V19, P693, DOI 10.1016/j.euroneuro.2009.02.005; SADILE AG, 1993, REV NEUROSCIENCE, V4, P287; SADILE AG, 1988, ADV BIOSCI, V70, P177; Sarkisyan G, 2009, BEHAV BRAIN RES, V202, P26, DOI 10.1016/j.bbr.2009.03.011; Sesack SR, 2010, NEUROPSYCHOPHARMACOL, V35, P27, DOI 10.1038/npp.2009.93; Speranza L, 2013, NEUROPHARMACOLOGY, V67, P155, DOI 10.1016/j.neuropharm.2012.10.026; Teicher MH, 2003, NEUROSCI LETT, V339, P169, DOI 10.1016/S0304-3940(02)01475-1; TEICHER MH, 1995, DEV BRAIN RES, V89, P167, DOI 10.1016/0165-3806(95)00109-Q; Viggiano D, 2003, NEUROSCI BIOBEHAV R, V27, P623, DOI 10.1016/j.neubiorev.2003.08.006; Viggiano D, 2003, NEUROSCI BIOBEHAV R, V27, P683, DOI 10.1016/j.neubiorev.2003.08.011; Viggiano D, 2002, BEHAV GENET, V32, P315, DOI 10.1023/A:1020210221156; Waagepetersen HS, 2007, HDB NEUROCHEMISTRY M, P1, DOI 10.1007/978-0-387-30373; YOVELL Y, 1987, P NATL ACAD SCI USA, V84, P9285, DOI 10.1073/pnas.84.24.9285; YOVELL Y, 1992, P NATL ACAD SCI USA, V89, P6526, DOI 10.1073/pnas.89.14.6526	69	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e83003	10.1371/journal.pone.0083003	http://dx.doi.org/10.1371/journal.pone.0083003			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24709857	Green Published, gold			2022-12-25	WOS:000334159800002
J	Song, XQ; Li, X; Gao, JS; Zhao, JP; Li, YH; Fan, XD; Lv, LX				Song, Xueqin; Li, Xue; Gao, Jinsong; Zhao, Jingping; Li, Youhui; Fan, Xiaoduo; Lv, Luxian			APOA-I: A Possible Novel Biomarker for Metabolic Side Effects in First Episode Schizophrenia	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; CEREBROSPINAL-FLUID; EXPRESSION; BRAIN; PROTEINS; RECEPTOR; WEIGHT; PLASMA	The purpose of this study was to investigate the change in plasma protein expression in first episode schizophrenia after an 8-week treatment with risperidone, and to explore potential biomarkers for metabolic side effects associated with risperidone treatment. Eighty first-episode schizophrenia patientswere enrolled in the study. Fifteen of the 80 patients were randomly selected to undergo proteomic analysis. Plasma proteins were obtained before and after the 8-week risperidone treatment, and measured using two-dimensional gel electrophoresis (2-DE), Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry(MALDI-TOF/TOF) and peptide mass fingerprinting. Proteins with the highest fold changes after risperidone treatment were then measured for all 80 patients using enzyme linked immunosorbent assay (ELISA). The relationship between changes in plasma protein levels and changes in metabolic parameters after risperidone treatment was examined. In 15 randomly selected patients, approximately 1,500 protein spots were detected in each gel by 2-DE. Of those proteins, 22 spots showed significant difference in abundance after risperidone treatment (p's < 0.05). After MALDITOF peptide mass fingerprinting, apolipoprotein A-I (APOA-I) and Guanine Nucleotide Binding Protein, Alpha Stimulating (GNAS), were found to have the highest fold changes. The content of APOA-I was significantly increased, and the content of GNAS was significantly decreased after risperidone treatment (p's < 0.05). The analysis in the entire study sample showed similar findings in changes of APOA-I and GNAS after risperidone treatment. Further analysis showed significant relationships between changesin APOA-1 and changes in triglyceride, total cholesterol, and body mass index after controlling for age, gender and family history of diabetes. Similar analysis showed a trend positive relationship between changes in GNAS and changes in BMI. Using proteomic analysis, the study suggested that APOA-I might be a novel biomarkers related to metabolic side effects in first episode schizophrenia treated with risperidone.	[Song, Xueqin; Li, Xue; Gao, Jinsong; Li, Youhui] Zhengzhou Univ, Affiliated Hosp 1, Dept Psychiat, Zhengzhou 450052, Peoples R China; [Song, Xueqin; Lv, Luxian] Xinxiang Med Univ, Henan Key Lab Biol Psychiat, Xinxiang, Peoples R China; [Song, Xueqin; Fan, Xiaoduo] Univ Massachusetts, Sch Med, UMass Mem Med Ctr, Worcester, MA USA; [Zhao, Jingping] Cent S Univ, Xiangya Hosp 2, Mental Hlth Inst, Changsha, Hunan, Peoples R China; [Lv, Luxian] Xinxiang Med Univ, Affiliated Hosp 2, Dept Psychiat, Xinxiang, Peoples R China	Zhengzhou University; Xinxiang Medical University; University of Massachusetts System; University of Massachusetts Worcester; Central South University; Xinxiang Medical University	Song, XQ (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Psychiat, Zhengzhou 450052, Peoples R China.	sxqzhll@126.com; lvluxian@126.com	zhao, jing/B-3868-2019; Fan, Xiaoduo/AAV-1268-2020	Fan, Xiaoduo/0000-0003-4299-8924	National Natural Science Foundation of China [30971058, 81071090]; Natural Science Foundation of Henan [102300413208, 112300413226]; Youth Fund of the First Affiliated Hospital of Zhengzhou University; First Affiliated Hospital of Zhengzhou University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Henan; Youth Fund of the First Affiliated Hospital of Zhengzhou University; First Affiliated Hospital of Zhengzhou University	Funding for this study was provided by the National Natural Science Foundation of China (No. 30971058 to XQS, No. 81071090 to LL), the Natural Science Foundation of Henan (No. 102300413208, 112300413226 to LL), the Youth Fund of the First Affiliated Hospital of Zhengzhou University (to XL), the Youth Fund of the First Affiliated Hospital of Zhengzhou University (to XQS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai JH, 2006, PROTEOMICS, V6, P538, DOI 10.1002/pmic.200500257; EUBANKS JH, 1992, GENOMICS, V14, P1010, DOI 10.1016/S0888-7543(05)80124-7; Hahn S, 2006, EUR J ENDOCRINOL, V155, P763, DOI 10.1530/eje.1.02275; Huang JTJ, 2008, MOL PSYCHIATR, V13, P1118, DOI 10.1038/sj.mp.4002108; La YJ, 2007, J NEURAL TRANSM, V114, P657, DOI 10.1007/s00702-006-0607-2; Leucht S, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008016.pub2; Martins Daniel, 2007, Briefings in Functional Genomics & Proteomics, V6, P70, DOI 10.1093/bfgp/elm009; Martins-De-Souza D, 2010, WORLD J BIOL PSYCHIA, V11, P719, DOI 10.3109/15622971003758748; Mei JF, 2006, SCHIZOPHR RES, V84, P204, DOI 10.1016/j.schres.2006.02.016; MENG QH, 1995, J BIOL CHEM, V270, P8588, DOI 10.1074/jbc.270.15.8588; Meyer JM, 2002, J CLIN PSYCHIAT, V63, P425, DOI 10.4088/JCP.v63n0509; Meyer JM, 2008, SCHIZOPHR RES, V101, P273, DOI 10.1016/j.schres.2007.12.487; Murphy AJ, 2013, J PHARMACOL EXP THER, V344, P41, DOI 10.1124/jpet.112.199257; Padrao AI, 2012, PROTEOM CLIN APPL, V6, P447, DOI 10.1002/prca.201200044; Ramachandran S, 2012, PROTEOMICS, V12, P2808, DOI 10.1002/pmic.201100586; Roerig JL, 2011, CNS DRUGS, V25, P1035, DOI 10.2165/11596300-000000000-00000; Sadler NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047996; Vasconcelos SMM, 2004, BIOCHEM CELL BIOL, V82, P315, DOI 10.1139/o03-081; Wang ES, 2010, ACTA NEUROL SCAND, V122, P350, DOI 10.1111/j.1600-0404.2009.01318.x; Wang X, 2009, EUR J CANCER CARE, V18, P625, DOI 10.1111/j.1365-2354.2008.00965.x; Wright WT, 2006, ATHEROSCLEROSIS, V185, P353, DOI 10.1016/j.atherosclerosis.2005.06.043; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Yang L, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002016; Yang XJ, 1997, MOL ENDOCRINOL, V11, P1053, DOI 10.1210/me.11.8.1053; Yu J, 2012, ONCOL REP, V27, P748, DOI 10.3892/or.2011.1565	25	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2014	9	4							e93902	10.1371/journal.pone.0093902	http://dx.doi.org/10.1371/journal.pone.0093902			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7EP	24710015	gold, Green Published			2022-12-25	WOS:000334159800066
J	Kosovec, JE; Zaidi, AH; Komatsu, Y; Kasi, PM; Cothron, K; Thompson, DV; Lynch, E; Jobe, BA				Kosovec, Juliann E.; Zaidi, Ali H.; Komatsu, Yoshihiro; Kasi, Pashtoon M.; Cothron, Kyle; Thompson, Diane V.; Lynch, Edward; Jobe, Blair A.			Establishing Magnetic Resonance Imaging as an Accurate and Reliable Tool to Diagnose and Monitor Esophageal Cancer in a Rat Model	PLOS ONE			English	Article							BARRETTS-ESOPHAGUS; GENE-EXPRESSION; GASTROESOPHAGEAL-REFLUX; ANIMAL-MODELS; LIVER-CANCER; ADENOCARCINOMA; MRI; ANASTOMOSIS; CARCINOMA	Objective: To assess the reliability of magnetic resonance imaging (MRI) for detection of esophageal cancer in the Levrat model of end-to-side esophagojejunostomy. Background: The Levrat model has proven utility in terms of its ability to replicate Barrett's carcinogenesis by inducing gastroduodenoesophageal reflux (GDER). Due to lack of data on the utility of non-invasive methods for detection of esophageal cancer, treatment efficacy studies have been limited, as adenocarcinoma histology has only been validated post-mortem. It would therefore be of great value if the validity and reliability of MRI could be established in this setting. Methods: Chronic GDER reflux was induced in 19 male Sprague-Dawley rats using the modified Levrat model. At 40 weeks post-surgery, all animals underwent endoscopy, MRI scanning, and post-mortem histological analysis of the esophagus and anastomosis. With post-mortem histology serving as the gold standard, assessment of presence of esophageal cancer was made by five esophageal specialists and five radiologists on endoscopy and MRI, respectively. Results: The accuracy of MRI and endoscopic analysis to correctly identify cancer vs. no cancer was 85.3% and 50.5%, respectively. ROC curves demonstrated that MRI rating had an AUC of 0.966 (p<0.001) and endoscopy rating had an AUC of 0.534 (p = 0.804). The sensitivity and specificity of MRI for identifying cancer vs. no-cancer was 89.1% and 80% respectively, as compared to 45.5% and 57.5% for endoscopy. False positive rates of MRI and endoscopy were 20% and 42.5%, respectively. Conclusions: MRI is a more reliable diagnostic method than endoscopy in the Levrat model. The non-invasiveness of the tool and its potential to volumetrically quantify the size and number of tumors likely makes it even more useful in evaluating novel agents and their efficacy in treatment studies of esophageal cancer.	[Kosovec, Juliann E.; Zaidi, Ali H.; Komatsu, Yoshihiro; Jobe, Blair A.] Allegheny Hlth Network, Inst Treatment Esophageal & Thorac Dis, Pittsburgh, PA 15212 USA; [Kasi, Pashtoon M.] Univ Pittsburgh, Med Ctr, Int Scholars Program, Pittsburgh, PA USA; [Cothron, Kyle] Allegheny Hlth Network, Dept Radiol, Pittsburgh, PA USA; [Thompson, Diane V.] Allegheny Hlth Network, Dept Med, Pittsburgh, PA USA; [Lynch, Edward] Allegheny Hlth Network, Dept Pathol, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Jobe, BA (corresponding author), Allegheny Hlth Network, Inst Treatment Esophageal & Thorac Dis, Pittsburgh, PA 15212 USA.	bjobe1@wpahs.org	Kasi, Pashtoon Murtaza/M-2569-2019	Kasi, Pashtoon Murtaza/0000-0002-5169-7085				Budde MD, 2012, CLIN EXP METASTAS, V29, P51, DOI 10.1007/s10585-011-9428-2; Buskens CJ, 2006, J SURG RES, V135, P337, DOI 10.1016/j.jss.2006.04.023; Buttar NS, 2002, GASTROENTEROLOGY, V122, P1101, DOI 10.1053/gast.2002.32371; Chen XX, 1999, CARCINOGENESIS, V20, P1801, DOI 10.1093/carcin/20.9.1801; Cheng P, 2005, WORLD J GASTROENTERO, V11, P5117; Gibson MK, 2013, ANN SURG, V258, P82, DOI 10.1097/SLA.0b013e318270500d; Greenawalt DM, 2007, INT J CANCER, V120, P1914, DOI 10.1002/ijc.22501; Hao Y, 2006, GASTROENTEROLOGY, V131, P925, DOI 10.1053/j.gastro.2006.04.026; Jankowski JA, 2000, LANCET, V356, P2079, DOI 10.1016/S0140-6736(00)03411-5; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Li Y, 2007, DIS ESOPHAGUS, V20, P372, DOI 10.1111/j.1442-2050.2007.00713.x; Lu S, 2009, DIS ESOPHAGUS, V22, P323, DOI 10.1111/j.1442-2050.2008.00909.x; Macke RA, 2011, ANN NY ACAD SCI, V1232, P392, DOI 10.1111/j.1749-6632.2011.06061.x; Miwa K, 1996, INT J CANCER, V67, P269, DOI 10.1002/(SICI)1097-0215(19960717)67:2<269::AID-IJC19>3.0.CO;2-6; Oh DS, 2009, SURG ENDOSC, V23, P1346, DOI 10.1007/s00464-008-0169-5; Paulson TG, 2004, CANCER CELL, V6, P11, DOI 10.1016/j.ccr.2004.06.021; Petre C, 1996, MAGNET RESON MED, V35, P532, DOI 10.1002/mrm.1910350412; Reid BJ, 2010, NAT REV CANCER, V10, P87, DOI 10.1038/nrc2773; Schiffman SC, 2010, SURG ENDOSC, V24, P2835, DOI 10.1007/s00464-010-1059-1; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Viera AJ, 2005, FAM MED, V37, P360; Xu XJ, 2000, J SURG RES, V88, P120, DOI 10.1006/jsre.1999.5774; Yamaguchi M, 2013, J MAGN RESON IMAGING, V38, P225, DOI 10.1002/jmri.23969; Yamashita Y, 1998, J Gastrointest Surg, V2, P350, DOI 10.1016/S1091-255X(98)80074-7; Yoon Harry H, 2007, Curr Oncol Rep, V9, P184, DOI 10.1007/s11912-007-0020-5	25	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93694	10.1371/journal.pone.0093694	http://dx.doi.org/10.1371/journal.pone.0093694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705451	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500058
J	Perez-Traves, L; Lopes, CA; Querol, A; Barrio, E				Perez-Traves, Laura; Lopes, Christian A.; Querol, Amparo; Barrio, Eladio			On the Complexity of the Saccharomyces bayanus Taxon: Hybridization and Potential Hybrid Speciation	PLOS ONE			English	Article							VAR. UVARUM; MOLECULAR CHARACTERIZATION; NATURAL HYBRIDS; YEAST STRAINS; CEREVISIAE; KUDRIAVZEVII; GENOME; WINE; EVOLUTION; SEQUENCE	Although the genus Saccharomyces has been thoroughly studied, some species in the genus has not yet been accurately resolved; an example is S. bayanus, a taxon that includes genetically diverse lineages of pure and hybrid strains. This diversity makes the assignation and classification of strains belonging to this species unclear and controversial. They have been subdivided by some authors into two varieties (bayanus and uvarum), which have been raised to the species level by others. In this work, we evaluate the complexity of 46 different strains included in the S. bayanus taxon by means of PCR-RFLP analysis and by sequencing of 34 gene regions and one mitochondrial gene. Using the sequence data, and based on the S. bayanus var. bayanus reference strain NBRC 1948, a hypothetical pure S. bayanus was reconstructed for these genes that showed alleles with similarity values lower than 97% with the S. bayanus var. uvarum strain CBS 7001, and of 99-100% with the non S. cerevisiae portion in S. pastorianus Weihenstephan 34/70 and with the new species S. eubayanus. Among the S. bayanus strains under study, different levels of homozygosity, hybridization and introgression were found; however, no pure S. bayanus var. bayanus strain was identified. These S. bayanus hybrids can be classified into two types: homozygous (type I) and heterozygous hybrids (type II), indicating that they have been originated by different hybridization processes. Therefore, a putative evolutionary scenario involving two different hybridization events between a S. bayanus var. uvarum and unknown European S. eubayanus-like strains can be postulated to explain the genomic diversity observed in our S. bayanus var. bayanus strains.	[Perez-Traves, Laura; Lopes, Christian A.; Querol, Amparo; Barrio, Eladio] CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol, E-46010 Valencia, Spain; [Lopes, Christian A.] Univ Nacl Comahue, Fac Ingn, CONICET UNCo,Dept Quim,Grp Biodiversidad & Biotec, Inst Multidisciplinario Invest & Desarrollo IDEPA, Buenos Aires, Neuquen, Argentina; [Barrio, Eladio] Univ Valencia, Dept Genet, Valencia, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Instituto de Agroquimica y Tecnologia de los Alimentos (IATA); Universidad Nacional del Comahue; University of Valencia	Barrio, E (corresponding author), CSIC, Inst Agroquim & Tecnol Alimentos, Dept Biotecnol, Jaime Roig 11, E-46010 Valencia, Spain.	eladio.barrio@uv.es	Barrio, Eladio/G-8969-2015; Querol, Amparo/H-3782-2012; Querol, Amparo/AAW-7469-2020	Barrio, Eladio/0000-0003-1024-954X; Querol, Amparo/0000-0002-6478-6845; Querol, Amparo/0000-0002-6478-6845	Spanish Government [AGL2009-12673-CO2, AGL2012-39937-CO2]; CSIC; Fundacion Carolina for the I3P and Formacion Permanente	Spanish Government(Spanish GovernmentEuropean Commission); CSIC; Fundacion Carolina for the I3P and Formacion Permanente	This work was supported by grants AGL2009-12673-CO2 (01 and 02) and AGL2012-39937-CO2 (01 and 02) from the Spanish Government to AQ and EB, respectively. LP-T and CAL acknowledge to CSIC and Fundacion Carolina for the I3P and Formacion Permanente fellowships respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belloch C, 2000, INT J SYST EVOL MICR, V50, P405, DOI 10.1099/00207713-50-1-405; Berger KH, 2000, TRENDS MICROBIOL, V8, P508, DOI 10.1016/S0966-842X(00)01862-X; Casaregola S, 2001, INT J SYST EVOL MICR, V51, P1607, DOI 10.1099/00207713-51-4-1607; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Dunn B, 2008, GENOME RES, V18, P1610, DOI 10.1101/gr.076075.108; FELSENSTEIN J, 1985, SYST ZOOL, V34, P152, DOI 10.2307/2413323; Gibson BR, 2013, YEAST, V30, P255, DOI 10.1002/yea.2960; Gonzalez SS, 2008, APPL ENVIRON MICROB, V74, P2314, DOI 10.1128/AEM.01867-07; Gonzalez SS, 2006, FEMS YEAST RES, V6, P1221, DOI 10.1111/j.1567-1364.2006.00126.x; Greig D, 2002, SCIENCE, V298, P1773, DOI 10.1126/science.1076374; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; Nguyen HV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025821; Joubert R, 2000, YEAST, V16, P511, DOI 10.1002/(SICI)1097-0061(200004)16:6<511::AID-YEA544>3.0.CO;2-I; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kodama Y, 2006, TOP CURR GENET, V15, P145, DOI 10.1007/b106370; Kurtzman C.P., 2003, FEMS YEAST RES, V1554, P1; Libkind D, 2011, P NATL ACAD SCI USA, V108, P14539, DOI 10.1073/pnas.1105430108; Liti G, 2006, GENETICS, V174, P839, DOI 10.1534/genetics.106.062166; Masneuf-Pomarede I, 2007, SYST APPL MICROBIOL, V30, P75, DOI 10.1016/j.syapm.2006.02.006; Nakao Y, 2009, DNA RES, V16, P115, DOI 10.1093/dnares/dsp003; Naumov G. I., 2000, Mikrobiologiya, V69, P410; Naumov GI, 2001, INT J FOOD MICROBIOL, V65, P163, DOI 10.1016/S0168-1605(00)00515-8; Naumova ES, 2011, RES MICROBIOL, V162, P204, DOI 10.1016/j.resmic.2010.09.023; Naumova ES, 2005, YEAST, V22, P1099, DOI 10.1002/yea.1298; Nguyen HV, 1997, SYST APPL MICROBIOL, V20, P286, DOI 10.1016/S0723-2020(97)80075-6; Nguyen HV, 2000, SYST APPL MICROBIOL, V23, P71, DOI 10.1016/S0723-2020(00)80048-X; Nguyen HV, 2005, FEMS YEAST RES, V5, P471, DOI 10.1016/j.femsyr.2004.12.004; Peris D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-407; Peris D, 2012, YEAST, V29, P81, DOI 10.1002/yea.2891; Piskur J, 1998, INT J SYST BACTERIOL, V48, P1015, DOI 10.1099/00207713-48-3-1015; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pulvirenti A, 2000, FEMS MICROBIOL LETT, V192, P191, DOI 10.1016/S0378-1097(00)00431-6; QUEROL A, 1992, APPL ENVIRON MICROB, V58, P2948, DOI 10.1128/AEM.58.9.2948-2953.1992; Rainieri S, 1999, FEMS MICROBIOL LETT, V177, P177, DOI 10.1111/j.1574-6968.1999.tb13729.x; Rainieri S, 2006, APPL ENVIRON MICROB, V72, P3968, DOI 10.1128/AEM.02769-05; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Rieseberg LH, 2009, CURR BIOL, V19, pR119, DOI 10.1016/j.cub.2008.12.016; Ryu SL, 1996, YEAST, V12, P757, DOI 10.1002/(SICI)1097-0061(19960630)12:8<757::AID-YEA970>3.0.CO;2-H; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Valles BS, 2007, FOOD MICROBIOL, V24, P25, DOI 10.1016/j.fm.2006.04.001; Vaughan-Martini A, 2011, YEASTS: A TAXONOMIC STUDY, VOLS 1-3, 5TH EDITION, P733, DOI 10.1016/B978-0-444-52149-1.00061-6; Yamagishi H, 1999, SYST APPL MICROBIOL, V22, P341, DOI 10.1016/S0723-2020(99)80041-1	45	51	51	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93729	10.1371/journal.pone.0093729	http://dx.doi.org/10.1371/journal.pone.0093729			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705561	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500061
J	Yamanaka, T; Wong, HK; Tosaki, A; Bauer, PO; Wada, K; Kurosawa, M; Shimogori, T; Hattori, N; Nukina, N				Yamanaka, Tomoyuki; Wong, Hon Kit; Tosaki, Asako; Bauer, Peter O.; Wada, Koji; Kurosawa, Masaru; Shimogori, Tomomi; Hattori, Nobutaka; Nukina, Nobuyuki			Large-Scale RNA Interference Screening in Mammalian Cells Identifies Novel Regulators of Mutant Huntingtin Aggregation	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; EXPANDED POLYGLUTAMINE; TRANSCRIPTION FACTOR; MOUSE MODELS; DISEASE; PROTEIN; DROSOPHILA; DEGRADATION; TOXICITY; DEATH	In polyglutamine (polyQ) diseases including Huntington's disease (HD), mutant proteins containing expanded polyQ stretch form aggregates in neurons. Genetic or RNAi screenings in yeast, C. elegans or Drosophila have identified multiple genes modifying polyQ aggregation, a few of which are confirmed effective in mammals. However, the overall molecular mechanism underlying polyQ protein aggregation in mammalian cells still remains obscure. We here perform RNAi screening in mouse neuro2a cells to identify mammalian modifiers for aggregation of mutant huntingtin, a causative protein of HD. By systematic cell transfection and automated cell image analysis, we screen similar to 12000 shRNA clones and identify 111 shRNAs that either suppress or enhance mutant huntingtin aggregation, without altering its gene expression. Classification of the shRNA-targets suggests that genes with various cellular functions such as gene transcription and protein phosphorylation are involved in modifying the aggregation. Subsequent analysis suggests that, in addition to the aggregation-modifiers sensitive to proteasome inhibition, some of them, such as a transcription factor Tcf20, and kinases Csnk1d and Pik3c2a, are insensitive to it. As for Tcf20, which contains polyQ stretches at N-terminus, its binding to mutant huntingtin aggregates is observed in neuro2a cells and in HD model mouse neurons. Notably, except Pik3c2a, the rest of the modifiers identified here are novel. Thus, our first large-scale RNAi screening in mammalian system identifies previously undescribed genetic players that regulate mutant huntingtin aggregation by several, possibly mammalian-specific mechanisms.	[Yamanaka, Tomoyuki; Kurosawa, Masaru; Nukina, Nobuyuki] Juntendo Univ, Grad Sch Med, Dept Neurosci Neurodegenerat Disorders, Tokyo, Japan; [Yamanaka, Tomoyuki; Wong, Hon Kit; Tosaki, Asako; Bauer, Peter O.; Wada, Koji; Kurosawa, Masaru; Nukina, Nobuyuki] RIKEN Brain Sci Inst, Lab Struct Neuropathol, Saitama, Japan; [Yamanaka, Tomoyuki; Kurosawa, Masaru; Shimogori, Tomomi; Nukina, Nobuyuki] RIKEN Brain Sci Inst, Lab Mol Mech Thalamus Dev, Saitama, Japan; [Wong, Hon Kit] Brigham & Womens Hosp, Dept Neurol, Ctr Neurol Dis, Boston, MA 02115 USA; [Wong, Hon Kit] Harvard Univ, Sch Med, Harvard Inst Med, Boston, MA USA; [Hattori, Nobutaka] Juntendo Univ, Grad Sch Med, Dept Neurol, Tokyo, Japan; [Yamanaka, Tomoyuki; Kurosawa, Masaru; Nukina, Nobuyuki] JST, CREST, Tokyo, Japan	Juntendo University; RIKEN; RIKEN; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Juntendo University; Japan Science & Technology Agency (JST)	Nukina, N (corresponding author), Juntendo Univ, Grad Sch Med, Dept Neurosci Neurodegenerat Disorders, Tokyo, Japan.	nnukina@juntendo.ac.jp	Shimogori, Tomomi/L-2893-2013; Bauer, Peter O./AAD-6502-2022; Nukina, Nobuyuki/GPP-6265-2022; Hattori, Nobutaka/ACR-0069-2022; Wong, Hon-Kit/G-3944-2014	Shimogori, Tomomi/0000-0002-6931-5401; Bauer, Peter O./0000-0003-2811-1354; Yamanaka, Tomoyuki/0000-0002-5378-4326; Wong, Hon-Kit/0000-0003-0049-8454	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [24111553, 23700430, 22110004, 22240037, 24659436]; Life Science Foundation of Japan; Mochida Memorial Foundation for Medical and Pharmaceutical Research; CREST from JST; Ministry of Health, Welfare and Labor	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Life Science Foundation of Japan(Life Science Foundation of Japan); Mochida Memorial Foundation for Medical and Pharmaceutical Research; CREST from JST(Core Research for Evolutional Science and Technology (CREST)); Ministry of Health, Welfare and Labor(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid from Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan for TY (24111553, 23700430) and NN (22110004, 22240037, 24659436); by Life Science Foundation of Japan for TY; by Mochida Memorial Foundation for Medical and Pharmaceutical Research for TY; by CREST from JST for NN; and by Grant-in-Aid for the Research on Measures for Ataxic Diseases from the Ministry of Health, Welfare and Labor for NN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; Bauer PO, 2009, J BIOL CHEM, V284, P13153, DOI 10.1074/jbc.M809229200; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; Chan HYE, 2000, HUM MOL GENET, V9, P2811, DOI 10.1093/hmg/9.19.2811; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Damrath E, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002920; Diaz-Hernandez M, 2009, FASEB J, V23, P1893, DOI 10.1096/fj.08-122275; Doi H, 2004, FEBS LETT, V571, P171, DOI 10.1016/j.febslet.2004.06.077; Doi H, 2008, J BIOL CHEM, V283, P6489, DOI 10.1074/jbc.M705306200; Domin J, 2000, J BIOL CHEM, V275, P11943, DOI 10.1074/jbc.275.16.11943; Doumanis J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007275; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Fujimoto M, 2005, J BIOL CHEM, V280, P34908, DOI 10.1074/jbc.M506288200; Furukawa Y, 2009, J NEUROSCI, V29, P5153, DOI 10.1523/JNEUROSCI.0783-09.2009; Garcia SM, 2007, GENE DEV, V21, P3006, DOI 10.1101/gad.1575307; Goehler H, 2004, MOL CELL, V15, P853, DOI 10.1016/j.molcel.2004.09.016; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Harris DP, 2011, MOL CELL BIOL, V31, P63, DOI 10.1128/MCB.00468-10; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Iwata A, 2009, J BIOL CHEM, V284, P9796, DOI 10.1074/jbc.M809739200; Jabado O, 2004, CELL DEATH DIFFER, V11, P618, DOI 10.1038/sj.cdd.4401397; Jana NR, 2005, J BIOL CHEM, V280, P11635, DOI 10.1074/jbc.M412042200; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; Lejeune FX, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-91; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; Liang YD, 2009, BRAIN RES, V1286, P221, DOI 10.1016/j.brainres.2009.06.049; Liu CR, 2012, CELL, V148, P690, DOI 10.1016/j.cell.2011.12.032; Lu BX, 2013, NAT NEUROSCI, V16, P562, DOI 10.1038/nn.3367; Matsumoto G, 2011, MOL CELL, V44, P279, DOI 10.1016/j.molcel.2011.07.039; Meriin AB, 2001, J CELL BIOL, V153, P851, DOI 10.1083/jcb.153.4.851; Meunier FA, 2005, MOL BIOL CELL, V16, P4841, DOI 10.1091/mbc.E05-02-0171; Miller JP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003042; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Murakami T, 2004, ANN NEUROL, V55, P439, DOI 10.1002/ana.20064; Nagai Y, 2003, HUM MOL GENET, V12, P1253, DOI 10.1093/hmg/ddg144; Nagai Y, 2000, J BIOL CHEM, V275, P10437, DOI 10.1074/jbc.275.14.10437; Nollen EAA, 2004, P NATL ACAD SCI USA, V101, P6403, DOI 10.1073/pnas.0307697101; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Silva MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002438; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; van Ham TJ, 2010, CELL, V142, P601, DOI 10.1016/j.cell.2010.07.020; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vo SH, 2012, PLOS ONE, V7; Wacker JL, 2009, J NEUROSCI, V29, P9104, DOI 10.1523/JNEUROSCI.2250-09.2009; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Wang GH, 1999, NEUROREPORT, V10, P2435, DOI 10.1097/00001756-199908200-00001; Weiss KR, 2012, GENETICS, V190, P581, DOI 10.1534/genetics.111.133710; Wong HK, 2008, HUM MOL GENET, V17, P3223, DOI 10.1093/hmg/ddn218; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yamanaka T, 2008, EMBO J, V27, P827, DOI 10.1038/emboj.2008.23; Yamanaka T, 2006, J CELL SCI, V119, P2107, DOI 10.1242/jcs.02938; Yamanaka T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4354; Yamanaka T, 2010, METHODS MOL BIOL, V648, P215, DOI 10.1007/978-1-60761-756-3_14; Yamanaka T, 2010, HUM MOL GENET, V19, P2099, DOI 10.1093/hmg/ddq087; Yoshioka K, 2012, NAT MED, V18, P1560, DOI 10.1038/nm.2928; Zhang S, 2010, GENETICS, V184, P1165, DOI 10.1534/genetics.109.112516	68	8	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2014	9	4							e93891	10.1371/journal.pone.0093891	http://dx.doi.org/10.1371/journal.pone.0093891			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE6MJ	24705917	Green Published, gold, Green Submitted			2022-12-25	WOS:000334107500087
J	Jia, H; Pustovyy, OM; Waggoner, P; Beyers, RJ; Schumacher, J; Wildey, C; Barrett, J; Morrison, E; Salibi, N; Denney, TS; Vodyanoy, VJ; Deshpande, G				Jia, Hao; Pustovyy, Oleg M.; Waggoner, Paul; Beyers, Ronald J.; Schumacher, John; Wildey, Chester; Barrett, Jay; Morrison, Edward; Salibi, Nouha; Denney, Thomas S.; Vodyanoy, Vitaly J.; Deshpande, Gopikrishna			Functional MRI of the Olfactory System in Conscious Dogs	PLOS ONE			English	Article							ADENYLATE-CYCLASE ACTIVITY; HUMAN BRAIN; SIGNAL CHANGES; FMRI; ACTIVATION; RESPONSES; CORTEX; BULB; RAT; STIMULATION	We depend upon the olfactory abilities of dogs for critical tasks such as detecting bombs, landmines, other hazardous chemicals and illicit substances. Hence, a mechanistic understanding of the olfactory system in dogs is of great scientific interest. Previous studies explored this aspect at the cellular and behavior levels; however, the cognitive-level neural substrates linking them have never been explored. This is critical given the fact that behavior is driven by filtered sensory representations in higher order cognitive areas rather than the raw odor maps of the olfactory bulb. Since sedated dogs cannot sniff, we investigated this using functional magnetic resonance imaging of conscious dogs. We addressed the technical challenges of head motion using a two pronged strategy of behavioral training to keep dogs' head as still as possible and a single camera optical head motion tracking system to account for residual jerky movements. We built a custom computer-controlled odorant delivery system which was synchronized with image acquisition, allowing the investigation of brain regions activated by odors. The olfactory bulb and piriform lobes were commonly activated in both awake and anesthetized dogs, while the frontal cortex was activated mainly in conscious dogs. Comparison of responses to low and high odor intensity showed differences in either the strength or spatial extent of activation in the olfactory bulb, piriform lobes, cerebellum, and frontal cortex. Our results demonstrate the viability of the proposed method for functional imaging of the olfactory system in conscious dogs. This could potentially open up a new field of research in detector dog technology.	[Jia, Hao; Beyers, Ronald J.; Denney, Thomas S.; Deshpande, Gopikrishna] Auburn Univ, Dept Elect & Comp Engn, MRI Res Ctr, Auburn, AL 36849 USA; [Pustovyy, Oleg M.; Morrison, Edward; Vodyanoy, Vitaly J.] Auburn Univ, Dept Anat Physiol & Pharmacol, Auburn, AL 36849 USA; [Waggoner, Paul] Auburn Univ, Canine Detect Res Inst, Auburn, AL 36849 USA; [Schumacher, John] Auburn Univ, Dept Clin Sci, Auburn, AL 36849 USA; [Wildey, Chester] MRRA Inc, Euless, TX USA; [Barrett, Jay] Auburn Univ, Coll Vet Med, Auburn, AL 36849 USA; [Salibi, Nouha] Siemens Healthcare, MR R&D, Malvern, PA USA; [Denney, Thomas S.; Deshpande, Gopikrishna] Auburn Univ, Dept Psychol, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University; Auburn University System; Auburn University; Siemens AG; Auburn University System; Auburn University	Deshpande, G (corresponding author), Auburn Univ, Dept Elect & Comp Engn, MRI Res Ctr, Auburn, AL 36849 USA.	gopi@auburn.edu	; Wang, Nian/HDM-2087-2022	Deshpande, Gopikrishna/0000-0001-7471-5357; Denney, Thomas/0000-0002-6695-4777; Wang, Nian/0000-0001-7743-0728	Auburn University Intramural Level-3 from the Office of the Vice President for Research, Auburn University; Defense Advanced Research Projects Agency [W911QX-13-C-0123]	Auburn University Intramural Level-3 from the Office of the Vice President for Research, Auburn University; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	The authors acknowledge financial support for this work from Auburn University Intramural Level-3 research grant from the Office of the Vice President for Research, Auburn University. This work was also supported by The Defense Advanced Research Projects Agency (government contract/grant number W911QX-13-C-0123). The views, opinions, and/or findings contained in this article are those of the authors and should not be interpreted as representing the official views or policies, either expressed or implied, of the Defense Advanced Research Projects Agency, Department of Defense or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; BANDETTINI PA, 1992, MAGNET RESON MED, V25, P390, DOI 10.1002/mrm.1910250220; Bear MF, 2007, NEUROSCIENCE EXPLORI, P265; Bednarski R, 2011, J AM ANIM HOSP ASSOC, V47, P377, DOI 10.5326/JAAHA-MS-5846; Bensafi M, 2008, NEUROSCIENCE, V154, P832, DOI 10.1016/j.neuroscience.2008.03.079; Berns GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038027; Boyett-Anderson JM, 2003, NEUROIMAGE, V20, P257, DOI 10.1016/S1053-8119(03)00288-X; BRANTZAWADZKI M, 1992, RADIOLOGY, V182, P769, DOI 10.1148/radiology.182.3.1535892; BUTTS K, 1994, MAGNET RESON MED, V31, P67, DOI 10.1002/mrm.1910310111; Datta R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052140; De Groof G, 2013, BEHAV BRAIN RES, V239, P43, DOI 10.1016/j.bbr.2012.10.044; DOTY RL, 1990, BRAIN RES, V527, P130, DOI 10.1016/0006-8993(90)91070-W; Ferris CF, 2011, REV NEUROSCIENCE, V22, P665, DOI 10.1515/RNS.2011.050; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Frederick BR, 1962, J COMP PHYSIOL PSYCH, V55, P773; Frey S, 2011, NEUROIMAGE, V55, P1435, DOI 10.1016/j.neuroimage.2011.01.040; Friston KJ, 2000, NEUROIMAGE, V12, P466, DOI 10.1006/nimg.2000.0630; Gottfried JA, 2005, BRAIN RES REV, V50, P287, DOI 10.1016/j.brainresrev.2005.08.004; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Harel D, 2003, COMPUT BIOL CHEM, V27, P121, DOI 10.1016/S1476-9271(02)00092-0; Hirai T, 1996, NEUROPATH APPL NEURO, V22, P531, DOI 10.1111/j.1365-2990.1996.tb01132.x; Howell TJ, 2012, BEHAV PROCESS, V89, P8, DOI 10.1016/j.beproc.2011.09.009; Jensen P, 2007, BEHAVIOURAL BIOLOGY OF DOGS, P1, DOI 10.1079/9781845931872.0000; Kandel, 2000, PRICIPLES NEURAL SCI; Kondoh T, 2005, CHEM SENSES, V30, pI172, DOI 10.1093/chemse/bjh169; KRESTEL D, 1984, NEUROSCI BIOBEHAV R, V8, P169, DOI 10.1016/0149-7634(84)90037-X; Kruse A, 2007, DEFENSE SCI RES TECH; Kujala MV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061818; Lorig TS, 1999, BEHAV RES METH INS C, V31, P370, DOI 10.3758/BF03207734; LOWE G, 1988, CHEM SENSES, V13, P710; Lowen SB, 2006, BEHAV RES METHODS, V38, P307, DOI 10.3758/BF03192782; MacFarlane DL, 2010, IEEE ENG MED BIO, P5673, DOI 10.1109/IEMBS.2010.5627894; Martin C, 2007, NEUROIMAGE, V36, P1288, DOI 10.1016/j.neuroimage.2007.04.029; Mori K, 2005, CHEM SENSES, V30, pI103, DOI 10.1093/chemse/bjh135; NADI NS, 1980, J NEUROCHEM, V34, P138, DOI 10.1111/j.1471-4159.1980.tb04632.x; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Orban GA, 2001, CURR OPIN NEUROL, V14, P47, DOI 10.1097/00019052-200102000-00008; OTTOSON D, 1955, Acta Physiol Scand Suppl, V35, P1; Oxley JC, 2009, ASPECTS OF EXPLOSIVES DETECTION, P27, DOI 10.1016/B978-0-12-374533-0.00003-9; PATHIRANA S, 1992, J AM CHEM SOC, V114, P1404, DOI 10.1021/ja00030a041; Peeters RR, 2001, MAGN RESON IMAGING, V19, P821, DOI 10.1016/S0730-725X(01)00391-5; Poellinger A, 2001, NEUROIMAGE, V13, P547, DOI 10.1006/nimg.2000.0713; Popp R, 2004, ACTA NEUROBIOL EXP, V64, P171; PRICE S, 1978, CHEM SENS FLAV, V3, P51, DOI 10.1093/chemse/3.1.51; Qin L, 2009, MAGN RESON MED, V62, P924, DOI 10.1002/mrm.22076; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Ross H. E., 1996, EH WEBER TACTILE SEN, V2; Savic I, 2005, CHEM SENSES, V30, pI222, DOI 10.1093/chemse/bjh194; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; Sicard K, 2003, J CEREBR BLOOD F MET, V23, P472, DOI 10.1097/01.WCB.0000054755.93668.20; Slotnick B, 2005, OLFACTOMETRY MICE; Sobel N, 1998, NATURE, V392, P282, DOI 10.1038/32654; Sommer JU, 2012, J NEUROSCI METH, V209, P189, DOI 10.1016/j.jneumeth.2012.05.026; Studzinski CM, 2005, PROG NEURO-PSYCHOPH, V29, P489, DOI 10.1016/j.pnpbp.2004.12.014; Szetei V, 2003, APPL ANIM BEHAV SCI, V83, P141, DOI 10.1016/S0168-1591(03)00114-X; Tornqvist H, 2013, ANIM COGN, V16, P973, DOI 10.1007/s10071-013-0630-2; Tremblay M, 2005, MAGN RESON MED, V53, P141, DOI 10.1002/mrm.20319; Viswaprakash N, 2009, CHEM SENSES, V34, P547, DOI 10.1093/chemse/bjp031; Vodyanoy V, 2005, US Patent, Patent No. [6,979,298, 69792982712]; Walker DB, 2006, APPL ANIM BEHAV SCI, V97, P241, DOI 10.1016/j.applanim.2005.07.009; Wildey C, 2011, APPL OPTICS, V50, P2088, DOI 10.1364/AO.50.002088; Williams M, 2002, APPL ANIM BEHAV SCI, V78, P55, DOI 10.1016/S0168-1591(02)00081-3; Williams M, 1998, P SOC PHOTO-OPT INS, V3575, P291, DOI 10.1117/12.334998; Wilson DA, 1998, J NEUROPHYSIOL, V79, P1425, DOI 10.1152/jn.1998.79.3.1425; Xiong JH, 1995, HUM BRAIN MAPP, V3, P287, DOI 10.1002/hbm.460030404; Yang XJ, 1998, P NATL ACAD SCI USA, V95, P7715, DOI 10.1073/pnas.95.13.7715; Youngentob SL, 2006, BEHAV NEUROSCI, V120, P1337, DOI 10.1037/0735-7044.120.6.1337; Zald DH, 1997, P NATL ACAD SCI USA, V94, P4119, DOI 10.1073/pnas.94.8.4119; Zald DH, 2000, INT J PSYCHOPHYSIOL, V36, P165, DOI 10.1016/S0167-8760(99)00110-5; Zobel S, 2010, J NEUROL, V257, P2037, DOI 10.1007/s00415-010-5656-7	70	182	187	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86362	10.1371/journal.pone.0086362	http://dx.doi.org/10.1371/journal.pone.0086362			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24710347	gold, Green Published			2022-12-25	WOS:000330288000090
J	Lin, YF; Nagasawa, H; Little, JB; Kato, TA; Shih, HY; Xie, XJ; Wilson, PF; Brogan, JR; Kurimasa, A; Chen, DJ; Bedford, JS; Chen, BPC				Lin, Yu-Fen; Nagasawa, Hatsumi; Little, John B.; Kato, Takamitsu A.; Shih, Hung-Ying; Xie, Xian-Jin; Wilson, Paul F., Jr.; Brogan, John R.; Kurimasa, Akihiro; Chen, David J.; Bedford, Joel S.; Chen, Benjamin P. C.			Differential Radiosensitivity Phenotypes of DNA-PKcs Mutations Affecting NHEJ and HRR Systems following Irradiation with Gamma-Rays or Very Low Fluences of Alpha Particles	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; SISTER-CHROMATID EXCHANGES; RADIATION-SENSITIVE MUTANT; POTENTIALLY LETHAL DAMAGE; CELL-CYCLE PROGRESSION; DOUBLE-STRAND BREAKS; ATAXIA-TELANGIECTASIA; IONIZING-RADIATION; CHROMOSOME-ABERRATIONS; CATALYTIC SUBUNIT	We have examined cell-cycle dependence of chromosomal aberration induction and cell killing after high or low dose-rate gamma irradiation in cells bearing DNA-PKcs mutations in the S2056 cluster, the T2609 cluster, or the kinase domain. We also compared sister chromatid exchanges (SCE) production by very low fluences of alpha-particles in DNA-PKcs mutant cells, and in homologous recombination repair (HRR) mutant cells including Rad51C, Rad51D, and Fancg/xrcc9. Generally, chromosomal aberrations and cell killing by gamma-rays were similarly affected by mutations in DNA-PKcs, and these mutant cells were more sensitive in G(1) than in S/G(2) phase. In G(1)-irradiated DNA-PKcs mutant cells, both chromosome- and chromatid-type breaks and exchanges were in excess than wild-type cells. For cells irradiated in late S/G(2) phase, mutant cells showed very high yields of chromatid breaks compared to wild-type cells. Few exchanges were seen in DNA-PKcs-null, Ku80-null, or DNA-PKcs kinase dead mutants, but exchanges in excess were detected in the S2506 or T2609 cluster mutants. SCE induction by very low doses of alpha-particles is resulted from bystander effects in cells not traversed by alpha-particles. SCE seen in wild-type cells was completely abolished in Rad51C- or Rad51D-deficient cells, but near normal in Fancg/xrcc9 cells. In marked contrast, very high levels of SCEs were observed in DNA-PKcs-null, DNA-PKcs kinase-dead and Ku80-null mutants. SCE induction was also abolished in T2609 cluster mutant cells, but was only slightly reduced in the S2056 cluster mutant cells. Since both non-homologous end-joining (NHEJ) and HRR systems utilize initial DNA lesions as a substrate, these results suggest the possibility of a competitive interference phenomenon operating between NHEJ and at least the Rad51C/D components of HRR; the level of interaction between damaged DNA and a particular DNA-PK component may determine the level of interaction of such DNA with a relevant HRR component.	[Lin, Yu-Fen; Shih, Hung-Ying; Chen, David J.; Chen, Benjamin P. C.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Nagasawa, Hatsumi; Kato, Takamitsu A.; Brogan, John R.; Bedford, Joel S.] Colorado State Univ, Dept & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Little, John B.] Harvard Univ, Sch Med, Dept Genet & Complex Dis, Boston, MA USA; [Xie, Xian-Jin] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Wilson, Paul F., Jr.] Brookhaven Natl Lab, Dept Biosci, Upton, NY 11973 USA; [Kurimasa, Akihiro] Tottori Univ, Grad Sch Med Sci, Inst Regenerat Med & Biofunct, Tottori 680, Japan	University of Texas System; University of Texas Southwestern Medical Center Dallas; Colorado State University; Harvard University; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; United States Department of Energy (DOE); Brookhaven National Laboratory	Chen, BPC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA.	benjamin.chen@utsouthwestern.edu	Kato, Takamitsu A/D-7969-2015; Lin, Yu-Fen/A-2570-2016	Kato, Takamitsu/0000-0002-6263-600X	National Cancer Institute/National Institutes of Health [CA166677]; U.S. Department of Energy Low Dose Radiation Research Program [DE-FG02-07ER64350, DE-FG02-05ER64089]; Cancer Prevention Research Institute of Texas [RP110465-P1]; NATIONAL CANCER INSTITUTE [R01CA162804, R01CA166677] Funding Source: NIH RePORTER	National Cancer Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Energy Low Dose Radiation Research Program(United States Department of Energy (DOE)); Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants CA166677 from the National Cancer Institute/National Institutes of Health, DE-FG02-07ER64350 and DE-FG02-05ER64089 from the U.S. Department of Energy Low Dose Radiation Research Program, and RP110465-P1 from the Cancer Prevention Research Institute of Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARLETT CF, 1980, CANCER RES, V40, P926; Bedford JS, 2002, RADIAT RES, V158, P251, DOI 10.1667/0033-7587(2002)158[0251:HACHIR]2.0.CO;2; BEDFORD JS, 1978, RADIAT RES, V76, P573, DOI 10.2307/3574806; CARRANO AV, 1973, MUTAT RES, V17, P341, DOI 10.1016/0027-5107(73)90006-7; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Chen BPC, 2005, J BIOL CHEM, V280, P14709, DOI 10.1074/jbc.M408827200; CORNFORTH MN, 1987, RADIAT RES, V111, P385, DOI 10.2307/3576926; COX R, 1978, ARCH DIS CHILD, V53, P386, DOI 10.1136/adc.53.5.386; Cui XP, 2005, MOL CELL BIOL, V25, P10842, DOI 10.1128/MCB.25.24.10842-10852.2005; DEWEY WC, 1971, P NATL ACAD SCI USA, V68, P667, DOI 10.1073/pnas.68.3.667; DEWEY WC, 1962, RADIAT RES, V16, P503, DOI 10.2307/3571085; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; DRITSCHILO A, 1984, RADIAT RES, V100, P387, DOI 10.2307/3576359; FORNACE AJ, 1980, MUTAT RES, V70, P323, DOI 10.1016/0027-5107(80)90022-6; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; HALL EJ, 1964, RADIAT RES, V22, P305, DOI 10.2307/3571661; Hashimoto M, 2001, J BIOL CHEM, V276, P12827, DOI 10.1074/jbc.M010906200; HIGURASHI M, 1973, CANCER-AM CANCER SOC, V32, P380, DOI 10.1002/1097-0142(197308)32:2<380::AID-CNCR2820320214>3.0.CO;2-2; Hinz JM, 2006, NUCLEIC ACIDS RES, V34, P1358, DOI 10.1093/nar/gkl020; Hsu FM, 2012, TRANSL CANCER RES, V1, P22, DOI 10.3978/j.issn.2218-676X.2012.04.01; HSU TC, 1958, J NATL CANCER I, V21, P437; ILIAKIS GE, 1991, INT J RADIAT BIOL, V59, P321, DOI 10.1080/09553009114550311; JEGGO PA, 1982, BIOCHIMIE, V64, P713, DOI 10.1016/S0300-9084(82)80116-8; Jeggo PA, 2006, DNA REPAIR, V5, P1192, DOI 10.1016/j.dnarep.2006.05.011; JONES NJ, 1987, MUTAT RES, V183, P279, DOI 10.1016/0167-8817(87)90011-3; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; Kurimasa A, 1999, MOL CELL BIOL, V19, P3877; Leenhouts HP, 1978, ADV RADIAT BIOL, P55; Lin JYD, 1997, RADIAT RES, V147, P166, DOI 10.2307/3579417; LITTLE JB, 1985, RADIAT RES, V101, P81, DOI 10.2307/3576305; METTING NF, 1995, HEALTH PHYS, V68, P710, DOI 10.1097/00004032-199505000-00012; NAGASAWA H, 1985, MUTAT RES, V148, P71, DOI 10.1016/0027-5107(85)90209-X; Nagasawa H, 2005, RADIAT RES, V164, P141, DOI 10.1667/RR3420; NAGASAWA H, 1981, RADIAT RES, V87, P538, DOI 10.2307/3575519; NAGASAWA H, 1989, RADIAT RES, V118, P559, DOI 10.2307/3577413; NAGASAWA H, 1983, MUTAT RES, V107, P315, DOI 10.1016/0027-5107(83)90173-2; NAGASAWA H, 1994, INT J RADIAT BIOL, V66, P373, DOI 10.1080/09553009414551311; NAGASAWA H, 1992, CANCER RES, V52, P6394; NAGASAWA H, 1992, RADIAT RES, V132, P375, DOI 10.2307/3578247; NAGASAWA H, 1983, MUTAT RES, V109, P297, DOI 10.1016/0027-5107(83)90054-4; Nagasawa H, 2008, DNA REPAIR, V7, P515, DOI 10.1016/j.dnarep.2007.11.014; Nagasawa H, 2011, RADIAT RES, V175, P83, DOI 10.1667/RR2092.1; Nagasawa H, 2010, MUTAT RES-GEN TOX EN, V701, P12, DOI 10.1016/j.mrgentox.2010.03.003; NATARAJAN AT, 1979, HUM GENET, V52, P127; PAINTER RB, 1980, P NATL ACAD SCI-BIOL, V77, P7315, DOI 10.1073/pnas.77.12.7315; PARSHAD R, 1983, P NATL ACAD SCI-BIOL, V80, P5612, DOI 10.1073/pnas.80.18.5612; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; Perryman LE, 2004, VET PATHOL, V41, P95, DOI 10.1354/vp.41-2-95; Priestley A, 1998, NUCLEIC ACIDS RES, V26, P1965, DOI 10.1093/nar/26.8.1965; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Revell SH., 1983, RAD INDUCED CHROMOSO, P215; Roberts SA, 2010, NATURE, V464, P1214, DOI 10.1038/nature08926; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Scott D, 1993, ATAXIA TELANGIECTASI, P101; Shao ZP, 2012, DNA REPAIR, V11, P310, DOI 10.1016/j.dnarep.2011.12.007; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; STACKHOUSE MA, 1993, RADIAT RES, V136, P241, DOI 10.2307/3578617; STACKHOUSE MA, 1994, INT J RADIAT BIOL, V65, P571, DOI 10.1080/09553009414550661; STACKHOUSE MA, 1993, RADIAT RES, V136, P250, DOI 10.2307/3578618; Sun J, 2012, J BIOL CHEM, V287, P4936, DOI 10.1074/jbc.M111.306167; TAYLOR AMR, 1976, NATURE, V260, P441, DOI 10.1038/260441a0; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; Tebbs RS, 2005, DNA REPAIR, V4, P11, DOI 10.1016/j.dnarep.2004.06.013; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; THOMPSON LH, 1980, MUTAT RES, V74, P21, DOI 10.1016/0165-1161(80)90188-0; TOBEY RA, 1971, CANCER RES, V31, P46; Wang XS, 2008, CANCER RES, V68, P971, DOI 10.1158/0008-5472.CAN-07-6272; WEICHSELBAUM RR, 1978, NATURE, V271, P261, DOI 10.1038/271261a0; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; WHITMORE GF, 1989, INT J RADIAT BIOL, V56, P657, DOI 10.1080/09553008914551881; ZAMPETTIBOSSELER F, 1981, INT J RADIAT BIOL, V39, P547, DOI 10.1080/09553008114550651; ZDZIENICKA MZ, 1987, MUTAT RES, V178, P235, DOI 10.1016/0027-5107(87)90274-0; Zhang SC, 2011, J CELL BIOL, V193, P295, DOI 10.1083/jcb.201009074	74	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2014	9	4							e93579	10.1371/journal.pone.0093579	http://dx.doi.org/10.1371/journal.pone.0093579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE7FA	24714417	Green Published, gold, Green Submitted			2022-12-25	WOS:000334160900037
J	Chen, ZF; Zhang, HM; Wang, H; Matsumura, K; Wong, YH; Ravasi, T; Qian, PY				Chen, Zhang-Fan; Zhang, Huoming; Wang, Hao; Matsumura, Kiyotaka; Wong, Yue Him; Ravasi, Timothy; Qian, Pei-Yuan			Quantitative Proteomics Study of Larval Settlement in the Barnacle Balanus amphitrite	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; STATISTICAL-MODEL; ARGININE KINASE; GENE-EXPRESSION; CYPRIS LARVAE; CYCLIC-AMP; METAMORPHOSIS; PROTEIN; MUSCLE; INVOLVEMENT	Barnacles are major sessile components of the intertidal areas worldwide, and also one of the most dominant fouling organisms in fouling communities. Larval settlement has a crucial ecological effect not only on the distribution of the barnacle population but also intertidal community structures. However, the molecular mechanisms involved in the transition process from the larval to the juvenile stage remain largely unclear. In this study, we carried out comparative proteomic profiles of stage II nauplii, stage VI nauplii, cyprids, and juveniles of the barnacle Balanus amphitrite using labelfree quantitative proteomics, followed by the measurement of the gene expression levels of candidate proteins. More than 700 proteins were identified at each stage; 80 were significantly up-regulated in cyprids and 95 in juveniles vs other stages. Specifically, proteins involved in energy and metabolism, the nervous system and signal transduction were significantly up-regulated in cyprids, whereas proteins involved in cytoskeletal remodeling, transcription and translation, cell proliferation and differentiation, and biomineralization were up-regulated in juveniles, consistent with changes associated with larval metamorphosis and tissue remodeling in juveniles. These findings provided molecular evidence for the morphological, physiological and biological changes that occur during the transition process from the larval to the juvenile stages in B. amphitrite.	[Chen, Zhang-Fan; Wang, Hao; Matsumura, Kiyotaka; Wong, Yue Him; Qian, Pei-Yuan] Hong Kong Univ Sci & Technol, Div Life Sci, KAUST Global Collaborat Res Program, Hong Kong, Hong Kong, Peoples R China; [Zhang, Huoming] King Abdullah Univ Sci & Technol, Biosci Core Lab, Thuwal, Saudi Arabia; [Ravasi, Timothy] King Abdullah Univ Sci & Technol, Integrat Syst Biol Lab, Thuwal, Saudi Arabia	Hong Kong University of Science & Technology; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology	Qian, PY (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, KAUST Global Collaborat Res Program, Hong Kong, Hong Kong, Peoples R China.	boqianpy@ust.hk	Ravasi, Timothy/B-8777-2008	Zhang, Huoming/0000-0001-5416-0358; Qian, Pei-Yuan/0000-0003-4074-9078; Ravasi, Timothy/0000-0002-9950-465X	Research Grants Council of the Hong Kong Special Administrative Region [GRF662413, AoE/P-04/04-II]; King Abdullah University of Science and Technology [SA-C0040/UK-C0016]	Research Grants Council of the Hong Kong Special Administrative Region(Hong Kong Research Grants Council); King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	This study was supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region (GRF662413 and AoE/P-04/04-II) and an award from the King Abdullah University of Science and Technology (SA-C0040/UK-C0016) to P.-Y. Qian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anil AC, 2010, J EXP MAR BIOL ECOL, V392, P89, DOI 10.1016/j.jembe.2010.04.012; Arbeitman MN, 2000, CELL, V101, P67, DOI 10.1016/S0092-8674(00)80624-8; BAXTER GT, 1992, BIOL BULL, V183, P147, DOI 10.2307/1542416; Berg J.M., 2002, BIOCHEMISTRY-US, V5th ed.; BERNARD FJ, 1962, J MORPHOL, V110, P19, DOI 10.1002/jmor.1051100103; BIANCHI A, 1990, J BIOL CHEM, V265, P1502; Bishop CD, 2001, BIOL BULL, V201, P394, DOI 10.2307/1543617; Bishop CD, 2001, J EXP ZOOL, V289, P374, DOI 10.1002/jez.1019; Braisted JC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-529; Chamberlin ME, 1997, J EXP BIOL, V200, P2789; Chandramouli KH, 2013, J PROTEOME RES, V12, P1344, DOI 10.1021/pr3010088; Chandramouli KH, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-51; Chen WT, 2008, DEV NEUROBIOL, V68, P1029, DOI 10.1002/dneu.20644; Chen ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022913; CHOU TC, 1952, J BIOL CHEM, V196, P89; Clare AS, 1996, BIOFOULING, V10, P141, DOI 10.1080/08927019609386276; CLARE AS, 1995, J EXP BIOL, V198, P655; COSTLOW JOHN D., 1959, PHYSIOL ZOOL, V32, P177; De Gregoris TB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-62; DREYFUSS G, 1988, TRENDS BIOCHEM SCI, V13, P86, DOI 10.1016/0968-0004(88)90046-1; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faimali M, 2003, BIOFOULING, V19, P213, DOI 10.1080/0892701021000044228; Footitt S, 2007, J EXP BOT, V58, P2959, DOI 10.1093/jxb/erm146; Gallus L, 2010, BIOFOULING, V26, P155, DOI 10.1080/08927010903391193; GIRAUD MM, 1981, COMP BIOCHEM PHYS A, V69, P381, DOI 10.1016/0300-9629(81)92993-5; Godenschwege TA, 2006, CURR BIOL, V16, P12, DOI 10.1016/j.cub.2005.11.062; Goss DJ, 2013, WIRES RNA, V4, P167, DOI 10.1002/wrna.1151; Gunter HM, 2007, DEV GENES EVOL, V217, P603, DOI 10.1007/s00427-007-0171-2; Han Z, 2013, J PROTEOME RES, V12, P2090, DOI 10.1021/pr301083e; Harrison PJH, 1999, BIOL BULL, V197, P144, DOI 10.2307/1542611; He LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064130; Heikkila JJ, 1997, CELL MOL LIFE SCI, V53, P114, DOI 10.1007/PL00000573; Heyland A, 2006, INTEGR COMP BIOL, V46, P743, DOI 10.1093/icb/icl023; Kamino K, 2000, J BIOL CHEM, V275, P27360; Kaneko Y, 2006, ZOOL SCI, V23, P533, DOI 10.2108/zsj.23.533; Katti C, 2010, J EXP BIOL, V213, P2589, DOI 10.1242/jeb.043869; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Knight J, 2000, J MAR BIOL ASSOC UK, V80, P113; KOULISH S, 1973, J MORPHOL, V140, P1, DOI 10.1002/jmor.1051400102; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Lagersson NC, 2002, MAR BIOL, V141, P513, DOI 10.1007/s00227-002-0854-1; Lagersson NC, 2002, J MAR BIOL ASSOC UK, V82, P573, DOI 10.1017/S0025315402005891; LANE ME, 1993, GENE DEV, V7, P1229, DOI 10.1101/gad.7.7a.1229; LEE JK, 1993, J CELL BIOL, V123, P1797, DOI 10.1083/jcb.123.6.1797; Levine MZ, 2001, J NEUROBIOL, V49, P277, DOI 10.1002/neu.10010; Li HL, 2010, J EXP MAR BIOL ECOL, V389, P45, DOI 10.1016/j.jembe.2010.03.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; LUCAS MI, 1979, MAR BIOL, V55, P221, DOI 10.1007/BF00396822; Mahroof R, 2005, COMP BIOCHEM PHYS A, V141, P247, DOI 10.1016/j.cbpb.2005.05.044; Maruzzo D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037408; Melotte V, 2010, FASEB J, V24, P4153, DOI 10.1096/fj.09-151464; Meng W, 2008, ANAL CHEM, V80, P9797, DOI 10.1021/ac801344z; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Neale JH, 2000, J NEUROCHEM, V75, P443, DOI 10.1046/j.1471-4159.2000.0750443.x; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Okazaki Y, 2000, GENE, V250, P127, DOI 10.1016/S0378-1119(00)00184-0; Pechenik JA, 2007, BIOL BULL-US, V213, P160, DOI 10.2307/25066632; Qian PY, 1999, HYDROBIOLOGIA, V402, P239, DOI 10.1023/A:1003704928668; Ritossa F, 1996, CELL STRESS CHAPERON, V1, P97, DOI 10.1379/1466-1268(1996)001<0097:DOTHSR>2.3.CO;2; Rozen S, 2000, Methods Mol Biol, V132, P365; SCHLAEPFER DD, 1990, J CELL BIOL, V111, P229, DOI 10.1083/jcb.111.1.229; SCHNEIDER A, 1989, INSECT BIOCHEM, V19, P471, DOI 10.1016/0020-1790(89)90029-2; Shimizu K, 1996, J EXP ZOOL, V276, P87, DOI 10.1002/(SICI)1097-010X(19961001)276:2<87::AID-JEZ1>3.0.CO;2-9; SRERE PA, 1953, J AM CHEM SOC, V75, P4874, DOI 10.1021/ja01115a547; Strumpf D, 1998, J CELL BIOL, V143, P1259, DOI 10.1083/jcb.143.5.1259; Thiyagarajan V, 2008, PROTEOMICS, V8, P3164, DOI 10.1002/pmic.200700904; UNDERWOOD AJ, 1989, TRENDS ECOL EVOL, V4, P16, DOI 10.1016/0169-5347(89)90008-6; Wang H, 2010, PROTEOMICS, V10, P2972, DOI 10.1002/pmic.201000056; Wang H, 2013, RES VET SCI, V95, P1125, DOI 10.1016/j.rvsc.2013.07.022; WOOLLACOTT RM, 1971, J MORPHOL, V134, P351, DOI 10.1002/jmor.1051340307; WROBLEWSKA B, 1993, J NEUROCHEM, V61, P943, DOI 10.1111/j.1471-4159.1993.tb03606.x; YAMAMOTO H, 1995, ZOOL SCI, V12, P391, DOI 10.2108/zsj.12.391; Yamamoto H, 1996, J EXP ZOOL, V275, P339, DOI 10.1002/(SICI)1097-010X(19960801)275:5<339::AID-JEZ2>3.0.CO;2-Q; Yamamoto H, 1997, ZOOL SCI, V14, P887, DOI 10.2108/zsj.14.887; Zhang HM, 2007, PROTEOMICS, V7, P1654, DOI 10.1002/pmic.200600579; Zhang HM, 2011, J PROTEOME RES, V10, P349, DOI 10.1021/pr100817v; Zhang HM, 2010, PROTEOMICS, V10, P2780, DOI 10.1002/pmic.201000066; Zhang YF, 2012, ACS CHEM BIOL, V7, P1049, DOI 10.1021/cb200545s; Zhang YF, 2011, BIOFOULING, V27, P467, DOI 10.1080/08927014.2011.583985; Zhang Y, 2010, J PROTEOME RES, V9, P4851, DOI 10.1021/pr100645z; Zhang Y, 2010, J PROTEOME RES, V9, P3146, DOI 10.1021/pr1000384; Zhao J, 2001, EUR J NEUROSCI, V13, P340, DOI 10.1046/j.1460-9568.2001.01396.x	83	55	55	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2014	9	2							e88744	10.1371/journal.pone.0088744	http://dx.doi.org/10.1371/journal.pone.0088744			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7GP	24714416	gold, Green Published, Green Submitted			2022-12-25	WOS:000331266000059
J	Jiang, YH; Liu, HT; Kuo, HC				Jiang, Yuan-Hong; Liu, Hsin-Tzu; Kuo, Hann-Chorng			Decrease of Urinary Nerve Growth Factor but Not Brain-Derived Neurotrophic Factor in Patients with Interstitial Cystitis/Bladder Pain Syndrome Treated with Hyaluronic Acid	PLOS ONE			English	Article							DYSFUNCTION; THERAPY	Aims: To investigate urinary nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF) levels in interstitial cystitis/bladder pain syndrome (IC/BPS) patients after hyaluronic acid (HA) therapy. Methods: Thirty-three patients with IC/BPS were prospectively studied; a group of 45 age-matched healthy subjects served as controls. All IC/BPS patients received nine intravesical HA instillations during the 6-month treatment regimen. Urine samples were collected for measuring urinary NGF and BDNF levels at baseline and 2 weeks after the last HA treatment. The clinical parameters including visual analog scale (VAS) of pain, daily frequency nocturia episodes, functional bladder capacity (FBC) and global response assessment (GRA) were recorded. Urinary NGF and BDNF levels were compared between IC/BPS patients and controls at baseline and after HA treatment. Results: Urinary NGF, NGF/Cr, BDNF, and BDNF/Cr levels were significantly higher in IC/BPS patients compared to controls. Both NGF and NGF/Cr levels significantly decreased after HA treatment. Urinary NGF and NGF/Cr levels significantly decreased in the responders with a VAS pain reduction by 2 (both p < 0.05) and the GRA improved by 2 (both p < 0.05), but not in non-responders. Urinary BDNF and BDNF/Cr did not decrease in responders or non-responders after HA therapy. Conclusions: Urinary NGF, but not BDNF, levels decreased significantly after HA therapy; both of these factors remained higher than in controls even after HA treatment. HA had a beneficial effect on IC/BPS, but it was limited. The reduction of urinary NGF levels was significant in responders, with a reduction of pain and improved GRA.	[Jiang, Yuan-Hong; Liu, Hsin-Tzu; Kuo, Hann-Chorng] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan; [Jiang, Yuan-Hong; Liu, Hsin-Tzu; Kuo, Hann-Chorng] Tzu Chi Univ, Hualien, Taiwan; [Liu, Hsin-Tzu] Tzu Chi Univ, Inst Pharmacol & Toxicol, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Tzu Chi University	Kuo, HC (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan.	hck@tzuchi.com.tw		Chen, Peisong/0000-0003-0640-3663; Liao, Chun-Hou/0000-0002-7340-110X				Antunes-Lopes T, 2013, J UROLOGY, V189, P359, DOI 10.1016/j.juro.2012.08.187; Chung SD, 2012, PAIN PHYSICIAN, V15, P197; Daha LK, 2005, EUR UROL, V47, P393, DOI 10.1016/j.eururo.2004.10.022; Daha LK, 2008, SCAND J UROL NEPHROL, V42, P369, DOI 10.1080/00365590701871518; Engelhardt PF, 2011, INT UROGYNECOL J, V22, P401, DOI 10.1007/s00192-010-1294-y; Frias B, 2011, CURR NEUROPHARMACOL, V9, P553, DOI 10.2174/157015911798376253; Ho DR, 2011, INT J UROL, V18, P525, DOI 10.1111/j.1442-2042.2011.02779.x; Homma Y, 2009, INT J UROL, V16, P597, DOI 10.1111/j.1442-2042.2009.02326.x; Hurst RE, 1996, UROLOGY, V48, P817, DOI 10.1016/S0090-4295(96)00322-6; HURST RE, 1987, J UROLOGY, V138, P433, DOI 10.1016/S0022-5347(17)43180-6; Iavazzo C, 2007, EUR UROL, V51, P1534, DOI 10.1016/j.eururo.2007.03.020; Kallestrup EB, 2005, SCAND J UROL NEPHROL, V39, P143, DOI 10.1080/00365590410015876-1; Kuo HannChorng, 2012, Clinical Investigation, V2, P1085; Lai MC, 2013, INT J UROL, V20, P203, DOI 10.1111/j.1442-2042.2012.03135.x; Liu HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044687; Liu HT, 2009, BJU INT, V104, P1476, DOI 10.1111/j.1464-410X.2009.08675.x; Lokeshwar VB, 2006, J UROLOGY, V176, P1001, DOI 10.1016/j.juro.2006.04.012; Morales A, 1996, J UROLOGY, V156, P45, DOI 10.1016/S0022-5347(01)65933-0; Nickel JC, 2005, UROLOGY, V65, P654, DOI 10.1016/j.urology.2004.10.071; Nickel JC, 2004, MED CLIN N AM, V88, P467, DOI 10.1016/S0025-7125(03)00151-2; Ochodnicky P, 2012, NAT REV UROL, V9, P628, DOI 10.1038/nrurol.2012.178; Ochodnicky P, 2011, NEUROUROL URODYNAM, V30, P1227, DOI 10.1002/nau.21022; Parsons CL, 2007, UROLOGY, V69, P9, DOI 10.1016/j.urology.2006.03.084; PARSONS CL, 1991, J UROLOGY, V145, P732, DOI 10.1016/S0022-5347(17)38437-9; Pezet S, 2002, BRAIN RES REV, V40, P240, DOI 10.1016/S0165-0173(02)00206-0; Pinto R, 2010, NEUROSCIENCE, V166, P907, DOI 10.1016/j.neuroscience.2010.01.015; Pinto R, 2010, EUR UROL, V58, P360, DOI 10.1016/j.eururo.2010.02.031; Porru D, 1997, UROL INT, V59, P26, DOI 10.1159/000283012; Riedl CR, 2008, INT UROGYNECOL J, V19, P717, DOI 10.1007/s00192-007-0515-5; Shie JH, 2011, BJU INT, V108, pE136, DOI 10.1111/j.1464-410X.2010.09911.x; Steers WD, 2006, NAT CLIN PRACT UROL, V3, P101, DOI 10.1038/ncpuro0408; Tyagi P, 2012, J UROLOGY, V187, P2243, DOI 10.1016/j.juro.2012.01.034; Vizzard MA, 2000, EXP NEUROL, V161, P273, DOI 10.1006/exnr.1999.7254	33	32	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 10	2014	9	3							e91609	10.1371/journal.pone.0091609	http://dx.doi.org/10.1371/journal.pone.0091609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC9FH	24614892	Green Submitted, Green Published, gold			2022-12-25	WOS:000332839300143
J	Xiao, JB; Ding, Y; Huang, J; Li, QS; Liu, Y; Ni, W; Zhang, YQ; Zhu, YF; Chen, LH; Chen, B				Xiao, Jianbiao; Ding, Yi; Huang, Jing; Li, Qisheng; Liu, Ying; Ni, Wen; Zhang, Yuqin; Zhu, Yanfei; Chen, Longhua; Chen, Bin			The Association of HMGB1 Gene with the Prognosis of HCC	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; RECURRENT HEPATOCELLULAR-CARCINOMA; HIGH-MOBILITY-GROUP-BOX-1 HMGB1; INCREASED EXPRESSION; CHROMATIN PROTEIN; POOR-PROGNOSIS; GASTRIC-CANCER; UNITED-STATES; CYTOKINE; CELLS	High-mobility group box 1 protein (HMGB1) is an evolutionarily ancient and critical regulator of cell death and survival. HMGB1 is a chromatin-associated nuclear protein molecule that triggers extracellular damage. The expression of HMGB1 has been reported in many types of cancers, but the role of HMGB1 in hepato cellular carcinoma (HCC) is unknown. The aim of this study was to analyze the roles of HMGB1 in HCC progression using HCC clinical samples. We also investigated the clinical outcomes of HCC samples with a special focus on HMBG1 expression. In an immunohistochemical study conducted on 208 cases of HCC, HMGB1 had high expression in 134 cases(64.4%). The HMGB1 expression level did not correlate with any clinicopathological parameters, except alpha fetoprotein (AFP) (p = 0.041) and CLIP stage (p = 0.007). However, survival analysis showed that the group with HMBG1 overexpression had a significantly shorter overall survival time than the group with a down-regulatedexpression of HMBG1 (HR = 0.568, CI (0.398, 0.811), p = 0.002). Multivariate analysis showed that HMGB1 expression was a significant and independent prognostic parameter (HR = 0.562, CI (0.388, 0.815), p = 0.002) for HCC patients. The ability of proliferation, migration and invasion of HCC cells was suppressed with the disruption of endogenous HMGB1 using small interfering RNAs. On the other hand, the ability of proliferation, migration and invasion of HCC cells was strengthened when the expression endogenous HMGB1 was enhanced using HMGB1 DNA. HMGB1 expression may be a novel and independent predictor for the prognosis of HCC patients. The overexpression of HMGB1 in HCC could be a novel, effective, and supplementary biomarker for HCC, since it plays a vital role in the progression of HCC.	[Xiao, Jianbiao; Ding, Yi; Huang, Jing; Li, Qisheng; Liu, Ying; Ni, Wen; Zhang, Yuqin; Zhu, Yanfei; Chen, Longhua] Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China; [Chen, Bin] Peoples Liberat Army, Guangzhou Mil Command, Gen Hosp, Dept Sci & Training, Guangzhou, Guangdong, Peoples R China; [Huang, Jing] Guangdong Med Coll, Affiliated Hosp, Dept Canc Ctr, Zhanjiang, Guangdong, Peoples R China	Southern Medical University - China; Southern Theater Command General Hospital; Guangdong Medical University	Chen, LH (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China.	chenlhsmu@126.com; cbgzzyy@163.com	Ding, Yi/CAG-6304-2022; Ma, Jinxing/D-9981-2013; Lang, Eric J/A-1136-2017; Wang, Zhiwei/F-5666-2012; Wise, Andrew/B-5943-2014	Cerminara, Nadia/0000-0001-8207-5871; Ding, Yi/0000-0001-5035-9255; Kotsurovskyy, Yuriy/0000-0002-1288-518X; Ma, Jinxing/0000-0002-5087-3972; Yan, Xiaolong/0000-0003-2419-9707; Lang, Eric J/0000-0002-8524-9854; Wang, Zhiwei/0000-0001-6729-2237; Wise, Andrew/0000-0001-9715-8784; Apps, Richard/0000-0002-2064-3359	National Natural Science Foundation of China [81101822]; Guangzhou science and technology [11C26090521]; Guangdong Provincal Science Foundation [10451001002005047, S2013010014185]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou science and technology; Guangdong Provincal Science Foundation	Grant support: National Natural Science Foundation of China (No. 81101822), Guangzhou science and technology key projects (No. 11C26090521), Guangdong Provincal Science Foundation (No. 10451001002005047, No. S2013010014185). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 2007, ANTICANCER RES, V27, P449; Bianchi ME, 2004, TRENDS CELL BIOL, V14, P287, DOI 10.1016/j.tcb.2004.04.004; Block TM, 2003, ONCOGENE, V22, P5093, DOI 10.1038/sj.onc.1206557; Brezniceanu ML, 2003, FASEB J, V17, P1295, DOI 10.1096/fj.02-0621fje; Capocaccia R, 2007, AM J GASTROENTEROL, V102, P1661, DOI 10.1111/j.1572-0241.2007.01337.x; Choi YR, 2003, CANCER RES, V63, P2188; Dong XD, 2007, J IMMUNOTHER, V30, P596, DOI 10.1097/CJI.0b013e31804efc76; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; Ellerman JE, 2007, CLIN CANCER RES, V13, P2836, DOI 10.1158/1078-0432.CCR-06-1953; Kim DY, 2007, ONCOLOGY-BASEL, V72, P52, DOI 10.1159/000111707; Kostova N, 2010, MOL CELL BIOCHEM, V337, P251, DOI 10.1007/s11010-009-0305-0; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Kuniyasu H, 2002, J PATHOL, V196, P163, DOI 10.1002/path.1031; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Maeda S, 2007, BIOCHEM BIOPH RES CO, V360, P394, DOI 10.1016/j.bbrc.2007.06.065; Muller S, 2004, J INTERN MED, V255, P332, DOI 10.1111/j.1365-2796.2003.01296.x; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Naghavi MH, 2003, VIROLOGY, V314, P179, DOI 10.1016/S0042-6822(03)00453-7; Ng KK, 2008, ARCH SURG-CHICAGO, V143, P68, DOI 10.1001/archsurg.2007.15; Poon RTP, 2000, ANN SURG, V232, P10, DOI 10.1097/00000658-200007000-00003; Poser I, 2003, MOL CELL BIOL, V23, P2991, DOI 10.1128/MCB.23.8.2991-2998.2003; Rudmik LR, 2005, J SURG ONCOL, V92, P347, DOI 10.1002/jso.20393; Tang DL, 2010, BBA-GENE REGUL MECH, V1799, P131, DOI 10.1016/j.bbagrm.2009.11.014; Thomas MB, 2005, J CLIN ONCOL, V23, P2892, DOI 10.1200/JCO.2005.03.196; Ulloa L, 2005, NAT REV DRUG DISCOV, V4, P673, DOI 10.1038/nrd1797; Ulloa L, 2003, ARTHRITIS RHEUM, V48, P876, DOI 10.1002/art.10854; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; Ulloa L, 2006, CYTOKINE GROWTH F R, V17, P189, DOI 10.1016/j.cytogfr.2006.01.003; Volp K, 2006, GUT, V55, P234, DOI 10.1136/gut.2004.062729; Wu D, 2008, J PATHOL, V216, P167, DOI 10.1002/path.2391; Xu YF, 2010, J HEPATOL, V53, P872, DOI 10.1016/j.jhep.2010.05.019; Zhang HK, 2008, CANCER LETT, V261, P183, DOI 10.1016/j.canlet.2007.11.019	34	83	85	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2014	9	2							e89097	10.1371/journal.pone.0089097	http://dx.doi.org/10.1371/journal.pone.0089097			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB3TA	25121125	gold, Green Published			2022-12-25	WOS:000331711900089
J	Wang, ZT; Akamatsu, T; Wang, KX; Wang, D				Wang, Zhitao; Akamatsu, Tomonari; Wang, Kexiong; Wang, Ding			The Diel Rhythms of Biosonar Behavior in the Yangtze Finless Porpoise (Neophocaena asiaeorientalis asiaeorientalis) in the Port of the Yangtze River: The Correlation between Prey Availability and Boat Traffic	PLOS ONE			English	Article							PANTROPICAL SPOTTED DOLPHINS; PHOCAENOIDES-ASIAEORIENTALIS; ECHOLOCATION BEHAVIOR; TEMPORAL PATTERNS; BEAKED-WHALES; FOOD-HABITS; CONSERVATION; SIGNALS; SONAR; MOVEMENTS	Information on the habitat use of the critically endangered Yangtze finless porpoise (Neophocaena asiaeorientalis asiaeorientalis) is critical for its conservation. The diel biosonar behavior of the porpoise in the port areas of the Yangtze River was examined along with simultaneous observations of fish density and boat traffic. Biosonar pulses from the porpoises were detected for 1233 min (5.77%) over a 21,380 min duration of effective observations. In total, 190 (5.63%) buzzes (an indication of prey capture attempts) were recorded among the 3372 identified click trains. Of the 168 echolocation encounters (bouts of click trains less than eight min apart), 150 (89.3%) involved single animals, indicating that solitary porpoises were frequently present and feeding in the port areas. Significant diel patterns were evident involving the biosonar behavior of the porpoises (including click trains and buzzes), fish density and boat traffic. The frequencies of the click trains and buzzes were significantly lower during the day than in the evening and at night, which suggests that porpoises in this region are primarily engaged in crepuscular and nocturnal foraging. The lack of a significant diel pattern in the echolocation encounters indicates the importance of the port in porpoise conservation. A forced feeding schedule may be associated with the lack of a significant correlation between porpoise acoustics and boat traffic. Overall, prey availability appears to be the primary factor that attracts porpoises. Additionally, porpoises tend to migrate or remain downstream in the morning and migrate or remain upstream in the evening, most likely to follow their prey. The findings of this study can be used to improve the conservation of the Yangtze finless porpoise.	[Wang, Zhitao; Wang, Kexiong; Wang, Ding] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China; [Wang, Zhitao] Univ Chinese Acad Sci, Beijing, Peoples R China; [Akamatsu, Tomonari] Natl Res Inst Fisheries Engn, Fisheries Res Agcy, Ibaraki, Japan	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Japan Fisheries Research & Education Agency (FRA)	Wang, KX (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China.	wangk@ihb.ac.cn; wangd@ihb.ac.cn	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-Z-4]; National Natural Science Foundation of China [31170501, 31070347]; Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China [201203086]; Ministry of Science and Technology of China [2011BAG07B05-3]; State Oceanic Administration of China [201105011-3]; CREST, Japan Science and Technology Agency; Ocean Park Conservation Foundation, Hong Kong; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China); State Oceanic Administration of China; CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ocean Park Conservation Foundation, Hong Kong; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-4), the National Natural Science Foundation of China (31170501 and 31070347), the Special Fund for Agro-scientific Research in the Public Interest of the Ministry of Agriculture of China (201203086), Ministry of Science and Technology of China (2011BAG07B05-3), State Oceanic Administration of China (201105011-3), CREST, Japan Science and Technology Agency and the Ocean Park Conservation Foundation, Hong Kong (There is no grant code). The funders had no roles in designing the study, collecting and analyzing data or preparing and deciding where to publish the manuscript.	Akamatsu T, 2008, J ACOUST SOC AM, V123, P4403, DOI 10.1121/1.2912449; Akamatsu T, 2000, J ACOUST SOC AM, V108, P1353, DOI 10.1121/1.1287841; Akamatsu T, 2005, MAR TECHNOL SOC J, V39, P3, DOI 10.4031/002533205787443980; Akamatsu T, 2005, J ACOUST SOC AM, V117, P3325, DOI 10.1121/1.1893325; Akamatsu T, 2010, J EXP BIOL, V213, P146, DOI 10.1242/jeb.037655; Akamatsu T, 2007, DEEP-SEA RES PT II, V54, P290, DOI 10.1016/j.dsr2.2006.11.006; Au W.W, 2008, PRINCIPLES MARINE BI; Au WWL, 2013, J ACOUST SOC AM, V133, P3119, DOI 10.1121/1.4798360; Baird RW, 2001, CAN J ZOOL, V79, P988, DOI 10.1139/cjz-79-6-988; Barros NB, 2002, RAFFLES B ZOOL, P115; Benoit-Bird KJ, 2004, MAR MAMMAL SCI, V20, P215, DOI 10.1111/j.1748-7692.2004.tb01152.x; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; Carlstrom J, 2005, MAR MAMMAL SCI, V21, P1, DOI 10.1111/j.1748-7692.2005.tb01204.x; Dawson S, 2013, ENDANGER SPECIES RES, V21, P45, DOI 10.3354/esr00508; Dong Shou-Yue, 2012, Acta Hydrobiologica Sinica, V36, P246; Evans W.E., 1974, P385; Fabi G, 2002, ICES J MAR SCI, V59, pS309, DOI 10.1006/jmsc.2002.1194; FOOTE KG, 1987, J ACOUST SOC AM, V82, P981, DOI 10.1121/1.395298; Gannier Alexandre, 1999, Aquatic Mammals, V25, P123; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Henderson EE, 2012, MAR MAMMAL SCI, V28, P439, DOI 10.1111/j.1748-7692.2011.00498.x; Hines, 2017, OCCUPANCY ESTIMATION; Johnston DW, 2008, BIOL LETTERS, V4, P208, DOI 10.1098/rsbl.2007.0614; Kajimura H., 1981, FISH B-NOAA, V78, P951; Keenan SE, 2003, AM FISH S S, V36, P167; Kimura S, 2013, J ACOUST SOC AM, V133, P3128, DOI 10.1121/1.4796129; Kimura S, 2012, MAR MAMMAL SCI, V28, P308, DOI 10.1111/j.1748-7692.2011.00490.x; Kimura S, 2009, J ACOUST SOC AM, V125, P547, DOI 10.1121/1.3021302; Leeney RH, 2011, AQUAT MAMM, V37, P151, DOI 10.1578/AM.37.2.2011.151; Li S., 2008, BIOACOUSTICS, V17, P174, DOI [10.1080/09524622.2008.9753806, DOI 10.1080/09524622.2008.9753806]; Li SH, 2006, J ACOUST SOC AM, V120, P1803, DOI 10.1121/1.2335674; Li SH, 2010, WILDL PROT DESTR EXT, P343; Lin PC, 2013, J APPL ICHTHYOL, V29, P1402, DOI 10.1111/jai.12342; Linnenschmidt M, 2013, MAR MAMMAL SCI, V29, pE77, DOI 10.1111/j.1748-7692.2012.00592.x; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; Miller PJO, 2004, P ROY SOC B-BIOL SCI, V271, P2239, DOI 10.1098/rspb.2004.2863; Payne NL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2363; Pilleri G., 1970, P27; Rasmussen MH, 2013, DEEP-SEA RES PT II, V88-89, P97, DOI 10.1016/j.dsr2.2012.07.011; Reubens JT, 2014, J SEA RES, V85, P214, DOI 10.1016/j.seares.2013.05.005; Richard S, 2010, SCIENCE, V329, P378; Robertson KM, 1997, FISH B-NOAA, V95, P334; Sasaki-Yamamoto Y, 2013, MAR MAMMAL SCI, V29, P589, DOI 10.1111/j.1748-7692.2012.00590.x; Scott MD, 2009, MAR MAMMAL SCI, V25, P137, DOI 10.1111/j.1748-7692.2008.00241.x; Shirakihara M, 2008, J MAMMAL, V89, P1248, DOI 10.1644/07-MAMM-A-264.1; Soldevilla MS, 2010, J ACOUST SOC AM, V127, P124, DOI 10.1121/1.3257586; Todd VLG, 2009, ICES J MAR SCI, V66, P734, DOI 10.1093/icesjms/fsp035; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Wang D., 2013, NEOPHOCAENA ASIAEORI, V2013, DOI DOI 10.2305/IUCN.UK.2013-1.RLTS.T43205774A45893487.EN; Wang D, 2009, CHINESE SCI BULL, V54, P3473, DOI 10.1007/s11434-009-0522-7; Wang KX, 2005, J ACOUST SOC AM, V118, P1180, DOI 10.1121/1.1945487; Wang ZT, 2014, INTEGRATIVE ZOOLOGY, V9; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Wei Zhou, 2003, Acta Zoologica Sinica, V49, P163; Xiao JQ, 2005, ZOO BIOL, V24, P531, DOI 10.1002/zoo.20070; Yerushalmi S, 2009, ECOL LETT, V12, P970, DOI 10.1111/j.1461-0248.2009.01343.x; Zar J. H., 2009, BIOSTATISTICAL ANAL; Zhao XJ, 2008, BIOL CONSERV, V141, P3006, DOI 10.1016/j.biocon.2008.09.005; Zimmer WM., 2011, PASSIVE ACOUSTIC MON, DOI 10.1017/CBO9780511977107	59	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 13	2014	9	5							e97907	10.1371/journal.pone.0097907	http://dx.doi.org/10.1371/journal.pone.0097907			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH8EY	25116432	Green Published, Green Submitted, gold			2022-12-25	WOS:000336369200137
J	Wang, ZL; Luo, XF; Li, MT; Xu, D; Zhou, S; Chen, HZ; Gao, N; Chen, Z; Zhang, LL; Zeng, XF				Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Chen, Hou-Zao; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng			Resveratrol Possesses Protective Effects in a Pristane-Induced Lupus Mouse Model	PLOS ONE			English	Article							INDUCED APOPTOSIS; BALB/C MICE; AUTOANTIBODIES; MECHANISMS; DIFFERENTIATION; DISEASE; CELLS; SIRT1	Background: Systemic lupus erythematosus (SLE) is a multisystemic autoimmune disease characterized by the production of autoantibodies. To date, no therapy has been found to satisfactorily treat SLE. SIRT1 deficiency results in the development of an autoimmune syndrome in mice, including a high titer of anti-nuclear antibody in serum, immunoglobulin deposition in the kidney, and immune complex glomerulonephritis. Resveratrol is an activator of SIRT1 and possesses anti-inflammation and immune-regulatory properties. Objective: To evaluate the preventative effects of resveratrol on a pristane-induced lupus animal model and assess its putative immune modulation effects. Methods: BALB/c mice received a single intraperitoneal injection of 0.5 ml of pristane on day 1 and then various doses of resveratrol were given to the mice daily starting on day 2 and continuing for seven months. The autoantibodies in serum and supernatants were measured. Single cells isolated from spleen, isolated CD4+ T cells, and CD19+ B cells were cultured with or without resveratrol in vitro and assessed by flow cytometry. Results: Resveratrol attenuated proteinuria, immunoglobuin depositon in kidney, and glomerulonephritis as well as IgG1 and IgG2a in serum in pristane-induced lupus mice. Resveratrol also suppressed CD69 and CD71 expression on CD4+ T cells as well as CD4+ T cell proliferation, induced CD4+ T cell apoptosis, and decreased CD4 IFN gamma(+) Th1 cells and the ratio of Th1/Th2 cells in vitro. In vitro antibody production and proliferation of B cells were also inhibited. Conclusion: Resveratrol possesses protective effects in pristane-induced lupus mice and may represent a novel approach for the management of SLE.	[Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100021, Peoples R China; [Wang, Zhuo-Long; Luo, Xiao-Fang; Li, Meng-Tao; Xu, Dong; Zhou, Shuang; Gao, Na; Chen, Zhen; Zhang, Ling-Ling; Zeng, Xiao-Feng] Chinese Acad Med Sci, Key Lab Rheumatol & Clin Immunol, Minist Educ, Beijing 100730, Peoples R China; [Chen, Hou-Zao] Peking Union Med Coll, Natl Lab Med Mol Biol, Inst Basic Med Sci, Beijing 100021, Peoples R China; [Chen, Hou-Zao] Chinese Acad Med Sci, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College	Zeng, XF (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100021, Peoples R China.	zengxfpumc@gmail.com	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	Chinese National Key Technology R&D Program, Ministry of Science and Technology [2008BAI59B02]; Chinese National High Technology Research and Development Program, Ministry of Science and Technology [2012AA02A513]; Young Investigator Project, Peking Union Medical College Hospital [I457200]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	Chinese National Key Technology R&D Program, Ministry of Science and Technology; Chinese National High Technology Research and Development Program, Ministry of Science and Technology(National High Technology Research and Development Program of China); Young Investigator Project, Peking Union Medical College Hospital; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the Chinese National Key Technology R&D Program, Ministry of Science and Technology (2008BAI59B02); the Chinese National High Technology Research and Development Program, Ministry of Science and Technology (2012AA02A513) and the Young Investigator Project, Peking Union Medical College Hospital (I457200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bereswill S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015099; Csiszar A, 2009, HYPERTENSION, V54, P668, DOI 10.1161/HYPERTENSIONAHA.109.133397; Cui XL, 2010, CANCER PREV RES, V3, P549, DOI 10.1158/1940-6207.CAPR-09-0117; Danila MI, 2009, RHEUMATOLOGY, V48, P542, DOI 10.1093/rheumatology/kep012; Dorrie J, 2001, CANCER RES, V61, P4731; Gao XZ, 2012, ANN RHEUM DIS, V71, P129, DOI 10.1136/ard.2011.149831; He MX, 2013, CELL DEATH DIFFER, V20, P188, DOI 10.1038/cdd.2012.148; Hoffman RW, 2004, CLIN IMMUNOL, V113, P4, DOI 10.1016/j.clim.2004.05.001; Imler TJ, 2009, INT IMMUNOPHARMACOL, V9, P134, DOI 10.1016/j.intimp.2008.10.015; Izawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048798; Ko YC, 2011, CANCER LETT, V309, P46, DOI 10.1016/j.canlet.2011.05.014; Kuo PL, 2002, LIFE SCI, V72, P23, DOI 10.1016/S0024-3205(02)02177-X; Kwon HS, 2008, CELL HOST MICROBE, V3, P158, DOI 10.1016/j.chom.2008.02.002; Lee PY, 2008, J EXP MED, V205, P2995, DOI 10.1084/jem.20080462; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Miyake K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/980286; Monneaux F, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2711; Nakata R, 2012, BIOL PHARM BULL, V35, P273, DOI 10.1248/bpb.35.273; Padayatty SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011414, 10.1371/journal.pone.0015288]; Pervaiz S, 2003, FASEB J, V17, P1975, DOI 10.1096/fj.03-0168rev; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Richards HB, 1999, CLIN EXP IMMUNOL, V115, P547; Roman V, 2002, BRIT J HAEMATOL, V117, P842, DOI 10.1046/j.1365-2141.2002.03520.x; SATOH M, 1995, P NATL ACAD SCI USA, V92, P10934, DOI 10.1073/pnas.92.24.10934; SATOH M, 1994, J EXP MED, V180, P2341, DOI 10.1084/jem.180.6.2341; Savarese E, 2008, ARTHRITIS RHEUM, V58, P1107, DOI 10.1002/art.23407; Sequeira J, 2008, EXP CELL RES, V314, P3069, DOI 10.1016/j.yexcr.2008.07.011; Sestak AL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2176; Sharma S, 2007, CLIN EXP IMMUNOL, V147, P155, DOI 10.1111/j.1365-2249.2006.03257.x; Singh UP, 2010, J PHARMACOL EXP THER, V332, P829, DOI 10.1124/jpet.109.160838; Surh YJ, 2001, MUTAT RES-FUND MOL M, V480, P243, DOI 10.1016/S0027-5107(01)00183-X; Svajger U, 2010, IMMUNOLOGY, V129, P525, DOI 10.1111/j.1365-2567.2009.03205.x; Takahashi S, 1996, J CLIN INVEST, V97, P1597, DOI 10.1172/JCI118584; Wallace DJ, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-77; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017783, 10.1371/journal.pone.0027081]; Zou T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075139; Zunino SJ, 2009, J NUTR, V139, P1603, DOI 10.3945/jn.109.105064	39	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2014	9	12							e114792	10.1371/journal.pone.0114792	http://dx.doi.org/10.1371/journal.pone.0114792			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX8FY	25116432	Green Submitted, gold, Green Published			2022-12-25	WOS:000347146700054
J	Wang, Z; Li, Y; Childress, AR; Detre, JA				Wang, Ze; Li, Yin; Childress, Anna Rose; Detre, John A.			Brain Entropy Mapping Using fMRI	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; APPROXIMATE ENTROPY; COMPLEXITY ANALYSIS; SAMPLE ENTROPY; FUNCTIONAL MRI; DEFAULT MODE; NETWORKS; DISEASE; NOVELTY	Entropy is an important trait for life as well as the human brain. Characterizing brain entropy (BEN) may provide an informative tool to assess brain states and brain functions. Yet little is known about the distribution and regional organization of BEN in normal brain. The purpose of this study was to examine the whole brain entropy patterns using a large cohort of normal subjects. A series of experiments were first performed to validate an approximate entropy measure regarding its sensitivity, specificity, and reliability using synthetic data and fMRI data. Resting state fMRI data from a large cohort of normal subjects (n = 1049) from multi-sites were then used to derive a 3-dimensional BEN map, showing a sharp low-high entropy contrast between the neocortex and the rest of brain. The spatial heterogeneity of resting BEN was further studied using a data-driven clustering method, and the entire brain was found to be organized into 7 hierarchical regional BEN networks that are consistent with known structural and functional brain parcellations. These findings suggest BEN mapping as a physiologically and functionally meaningful measure for studying brain functions.	[Wang, Ze; Li, Yin; Childress, Anna Rose] Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [Wang, Ze; Detre, John A.] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Detre, John A.] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Wang, Z (corresponding author), Univ Penn, Perelman Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA.	zewang@mail.med.upenn.edu	Wang, Zhi-Tao/F-1176-2015; zhang, lingling/HDM-2189-2022; meng, li/GVT-2063-2022	Wang, Zhi-Tao/0000-0002-5734-7385; Chen, Hou-Zao/0000-0001-6805-3182; Zhang, Tong/0000-0003-1148-4322	National Institutes of Health [R21DC011074, 8P41-EB015893, 5R33DA026114-04]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC011074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R33DA026114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants: R21DC011074, and 8P41-EB015893, and 5R33DA026114-04. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2008, HUM BRAIN MAP POSTER, P496; Bassett DS, 2012, NEUROIMAGE, V59, P2196, DOI 10.1016/j.neuroimage.2011.10.002; Baumgartner R, 2000, MAGN RESON IMAGING, V18, P845, DOI 10.1016/S0730-725X(00)00171-5; BERGSTROM R M, 1969, Developmental Psychobiology, V2, P139, DOI 10.1002/dev.420020304; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bruna R, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/3/036007; Buxton R., 2002, INTRO FUNCTIONAL MAG; Chen CH, 2012, SCIENCE, V335, P1634, DOI 10.1126/science.1215330; Chen X, 2005, P ANN INT IEEE EMBS, P4212; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; de Araujo DB, 2003, NEUROIMAGE, V20, P311, DOI 10.1016/S1053-8119(03)00306-9; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fernandez A, 2010, ALZ DIS ASSOC DIS, V24, P182, DOI 10.1097/WAD.0b013e3181c727f7; Frith CD, 1995, HUM BRAIN MAPP, V3, P153, DOI 10.1002/hbm.460030209; HITCHCOCK DR, 1967, ICARUS, V7, P149, DOI 10.1016/0019-1035(67)90059-0; Hu ZH, 2006, IEEE IMAGE PROC, P2861, DOI 10.1109/ICIP.2006.313026; Hyvarinen A, 1998, ADV NEUR IN, V10, P273; Kiebel SJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000209; Kolmogorov AN, 1998, THEOR COMPUT SCI, V207, P387, DOI 10.1016/S0304-3975(98)00075-9; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; Li Z, 2012, JMRI; Li ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044556; Liu CY, 2013, J MAGN RESON IMAGING, V38, P36, DOI 10.1002/jmri.23961; Lovelock James, 1979, GAIA NEW LOOK LIFE E; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Palazzolo JA, 1998, AM J PHYSIOL-HEART C, V274, pH1099, DOI 10.1152/ajpheart.1998.274.4.H1099; PINCUS SM, 1994, AM J PHYSIOL, V266, pH1643, DOI 10.1152/ajpheart.1994.266.4.H1643; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Pinker S., 1997, MIND WORKS; Poza J, 2008, ANN BIOMED ENG, V36, P141, DOI 10.1007/s10439-007-9402-y; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rezek IA, 1998, IEEE T BIO-MED ENG, V45, P1186, DOI 10.1109/10.709563; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Rosso OA, 2001, J NEUROSCI METH, V105, P65, DOI 10.1016/S0165-0270(00)00356-3; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sandler S.I, 2006, CHEM ENG THERMODYNAM; Schrodinger E., 1944, WHAT IS LIFE PHYS AS; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Singer W, 2009, EUR REV, V17, P321, DOI 10.1017/S1062798709000751; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; Sokunbi MO, 2011, IEEE T BIO-MED ENG, V58, P3206, DOI 10.1109/TBME.2011.2164793; Strange BA, 2005, NEURAL NETWORKS, V18, P225, DOI 10.1016/j.neunet.2004.12.004; TONONI G, 1994, P NATL ACAD SCI USA, V91, P5033, DOI 10.1073/pnas.91.11.5033; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang Z., 2012, 3 BIENN C REST STAT, P208; Wang Z, 2012, 2012 ANN M ORG HUM B; Wang Z, 2007, NEUROIMAGE, V36, P1139, DOI 10.1016/j.neuroimage.2007.03.072; Wang Z, 2009, NEUROIMAGE, V46, P608, DOI 10.1016/j.neuroimage.2009.03.016; Yang AC, 2013, NEUROBIOL AGING, V34, P428, DOI 10.1016/j.neurobiolaging.2012.05.004; Ze Wang A.M., 2013, 2013 ANN M INT SOC M, P4861; Ze Wang JS, 2013, 2013 ANN M SOC NEUR, P7491; Zhu HT, 2006, 9 INT C CONTR AUT RO, P1	57	444	463	25	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2014	9	3							e89948	10.1371/journal.pone.0089948	http://dx.doi.org/10.1371/journal.pone.0089948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6GL	25116432	Green Published, gold, Green Submitted			2022-12-25	WOS:000333355300008
